data_1ees_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1ees _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.431 0.634 . . . . 10.0 110.088 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.582 ' HA ' HD22 ' A' ' 177' ' ' LEU . 30.1 mm100 -129.57 -24.32 2.77 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.552 -0.717 . . . . 10.0 109.997 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.596 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 95.1 m -57.84 115.93 3.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 10.0 111.289 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -122.85 132.77 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.592 -0.843 . . . . 10.0 109.898 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 75' ' ' THR . 46.4 mmtt -123.2 101.65 7.5 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.431 ' HA ' HG22 ' A' ' 77' ' ' VAL . 47.4 t -113.24 145.17 41.47 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.885 0.85 . . . . 10.0 112.801 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG2' HG22 ' A' ' 75' ' ' THR . 0.2 OUTLIER -151.59 -176.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 16' ' ' LYS . 22.7 m -91.59 108.55 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 10.0 109.877 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HB ' HG11 ' A' ' 80' ' ' VAL . 2.1 t -113.47 -170.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.977 -1.077 . . . . 10.0 110.19 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 80' ' ' VAL . . . 137.62 -144.77 16.26 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.73 20.22 16.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 10.0 109.637 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.19 75.87 0.99 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.034 -1.626 . . . . 10.0 109.034 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.63 -174.59 3.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.427 -1.043 . . . . 10.0 109.766 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.521 ' HB ' ' CD2' ' B' ' 29' ' ' PHE . 40.6 t -67.13 161.77 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 10.0 110.647 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -53.02 111.97 1.98 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.427 -1.869 . . . . 10.0 108.427 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 8' ' ' VAL . 11.1 tppt? -48.61 -28.0 3.18 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.179 -1.189 . . . . 10.0 110.428 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -66.01 -30.62 71.2 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.15 -0.969 . . . . 10.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' B' ' 26' ' ' THR . 16.3 p -63.2 -9.89 13.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.175 . . . . 10.0 109.733 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.685 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 5.3 mt -94.81 -34.08 12.62 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.424 -0.797 . . . . 10.0 110.184 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 19' ' ' LEU . 79.4 mt -46.49 -30.46 2.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.617 ' CG2' ' HB2' ' A' ' 26' ' ' ASN 0.251 1.7 mm -85.76 -47.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.749 0.785 . . . . 10.0 109.552 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 21' ' ' ILE . 57.1 m -48.26 -38.34 18.4 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.887 -1.125 . . . . 10.0 108.115 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.692 ' CZ ' ' HG ' ' A' ' 165' ' ' LEU . 20.2 m-85 -68.06 -31.0 70.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 21' ' ' ILE . 95.9 m -76.83 -51.87 10.52 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.847 -0.533 . . . . 10.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 t -178.99 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 115.875 1.805 . . . . 10.0 115.875 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.617 ' HB2' ' CG2' ' A' ' 21' ' ' ILE . 15.4 m120 -67.47 -8.32 32.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.088 -1.632 . . . . 10.0 113.085 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' O ' ' O ' ' B' ' 27' ' ' GLY . 26.4 pttt 33.59 -131.6 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 121.195 -0.941 . . . . 10.0 111.262 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 2.7 p90 . . . . . 0 N--CA 1.507 2.381 0 O-C-N 120.5 -1.375 . . . . 10.0 112.815 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' B' ' 19' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 123.266 1.507 . . . . 10.0 114.945 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG2' ' HA3' ' B' ' 21' ' ' GLY 0.279 2.5 t -45.99 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 116.226 1.936 . . . . 10.0 116.226 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.613 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 4.6 t80 -32.29 154.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.944 0.878 . . . . 10.0 111.603 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -168.03 83.0 0.18 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 50.8 t30 -113.66 109.11 18.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.159 -0.963 . . . . 10.0 110.017 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.677 ' CD2' ' HA ' ' B' ' 16' ' ' HIS . 3.6 t80 -128.43 128.35 44.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.694 -0.629 . . . . 10.0 110.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.58 94.68 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.626 ' HB ' ' CE1' ' A' ' 40' ' ' TYR 0.296 51.6 t -163.94 178.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.394 0.616 . . . . 10.0 110.227 -176.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 18.9 m -125.24 126.47 45.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.522 -0.736 . . . . 10.0 109.502 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -73.76 165.71 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 10.0 110.024 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.539 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 51.5 mtt -137.69 104.79 5.41 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.199 -1.0 . . . . 10.0 109.531 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.563 ' CG2' ' HB2' ' B' ' 7' ' ' GLU . 38.7 mt -123.75 128.79 74.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.751 -0.593 . . . . 10.0 109.734 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 52.18 21.39 8.13 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 8.61 67.87 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.155 -1.203 . . . . 10.0 110.302 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.47 112.56 65.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.836 -1.39 . . . . 10.0 110.976 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 44.1 Cg_endo -74.4 139.35 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.951 1.501 . . . . 10.0 110.251 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 43' ' ' THR . 3.6 t80 -117.49 121.37 40.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -0.95 . . . . 10.0 109.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 1.1 m -74.82 119.82 19.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.625 -1.297 . . . . 10.0 110.151 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 13.3 mt -123.11 149.31 44.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.915 . . . . 10.0 110.592 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 5' ' ' LYS . . . -170.89 110.47 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.752 -1.213 . . . . 10.0 110.332 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -150.41 168.43 24.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -1.211 . . . . 10.0 110.076 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 32.9 p90 -166.36 140.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.882 -1.136 . . . . 10.0 111.218 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 3.8 t70 -119.72 159.99 23.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.394 -0.816 . . . . 10.0 110.444 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.524 ' HA ' ' CB ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -56.31 -168.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.841 0.829 . . . . 10.0 112.131 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.539 ' CB ' HG11 ' A' ' 36' ' ' VAL . . . 53.5 70.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.637 -0.664 . . . . 10.0 110.865 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 66' ' ' ARG . . . -75.33 -9.04 84.3 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.326 -1.91 . . . . 10.0 108.326 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.602 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.8 tt0 -156.45 24.51 0.35 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.422 -1.046 . . . . 10.0 110.22 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 4.4 tt0 79.3 -7.63 1.71 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.494 -0.754 . . . . 10.0 109.963 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 1.1 m-20 -94.28 -11.47 30.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 10.0 108.759 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 46.7 m-85 62.65 26.67 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.142 -1.059 . . . . 10.0 108.142 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 30.5 t0 -114.88 -36.49 4.45 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.111 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 6.3 mmt85 -56.4 -26.18 52.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.905 -1.122 . . . . 10.0 108.934 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -103.81 10.88 36.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.827 -0.546 . . . . 10.0 109.751 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.666 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -82.79 -20.37 0.28 Allowed Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 113.356 0.873 . . . . 10.0 113.356 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 45.9 Cg_endo -75.33 2.07 7.2 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 N-CA-C 110.37 -0.665 . . . . 10.0 110.37 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -52.78 -64.47 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.199 -0.938 . . . . 10.0 112.184 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.487 ' H ' ' CG ' ' A' ' 70' ' ' LEU . 24.8 t 41.98 27.08 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.367 -1.458 . . . . 10.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 71' ' ' SER . 2.1 t80 -179.84 120.6 0.22 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 10.0 110.744 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.28 118.33 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.838 1.441 . . . . 10.0 110.225 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.71 66.74 1.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.964 -1.085 . . . . 10.0 110.584 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.572 HG22 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -145.33 99.99 3.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.16 -0.963 . . . . 10.0 109.703 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.55 ' CA ' HG23 ' A' ' 108' ' ' THR . 21.6 m-20 -24.63 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.953 0.724 . . . . 10.0 112.953 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.509 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -94.03 118.0 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.964 -1.085 . . . . 10.0 110.781 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.491 ' CB ' HG21 ' A' ' 9' ' ' VAL . 97.3 m-85 -111.33 127.6 55.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 10.0 111.203 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.546 HD21 ' CD2' ' A' ' 111' ' ' LEU . 1.9 mm? -95.44 97.69 9.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 10.0 108.342 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.518 ' O ' HG21 ' A' ' 113' ' ' VAL . 1.6 m -106.41 148.18 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.397 -0.814 . . . . 10.0 109.822 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 7.2 t -138.17 122.37 18.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.855 -1.153 . . . . 10.0 110.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.536 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 43.0 p90 -124.46 172.95 8.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.239 -0.913 . . . . 10.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.467 ' OG ' ' CG2' ' A' ' 85' ' ' VAL . 47.3 t -105.24 148.81 26.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.7 -1.25 . . . . 10.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 19.4 m -86.79 19.02 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.478 -0.764 . . . . 10.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.562 ' CA ' HD11 ' A' ' 129' ' ' LEU . 35.3 m -128.0 48.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.39 -0.819 . . . . 10.0 110.513 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.6 m -123.2 166.18 19.27 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.287 -0.883 . . . . 10.0 110.358 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.527 ' CB ' ' ND2' ' A' ' 132' ' ' ASN . 48.2 Cg_endo -72.44 105.9 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.965 1.508 . . . . 10.0 111.056 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 39.46 42.9 0.93 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.304 -0.873 . . . . 10.0 110.836 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.515 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 65.6 m -79.15 -49.51 12.47 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.022 . . . . 10.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.617 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 34.9 t80 -57.53 -30.38 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.336 -0.853 . . . . 10.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 57.4 mm-40 -70.47 -15.09 62.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.051 -1.031 . . . . 10.0 110.504 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -84.63 -21.46 30.28 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.18 -1.008 . . . . 10.0 111.38 -178.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.628 ' CG2' ' HD3' ' A' ' 94' ' ' LYS . 4.2 m -87.68 -16.38 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 117.765 -1.574 . . . . 10.0 108.544 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' A' ' 93' ' ' VAL . 1.2 mmtp -68.68 -37.45 79.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 4.4 pt-20 -95.51 8.29 43.73 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.306 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -111.18 -52.09 2.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.58 -1.248 . . . . 10.0 112.595 -178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.562 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 19.7 m95 -95.59 -18.79 20.29 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.502 -0.749 . . . . 10.0 111.527 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' A' ' 149' ' ' LEU . 2.1 t -85.45 -46.85 0.61 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 120.97 -1.081 . . . . 10.0 111.5 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.4 Cg_endo -74.85 -24.15 13.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 108.759 -1.285 . . . . 10.0 108.759 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.52 ' C ' HG12 ' A' ' 101' ' ' ILE . 8.6 tt0 -87.59 -22.53 24.72 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.52 HG12 ' C ' ' A' ' 100' ' ' GLU . 4.2 mm 60.55 125.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.524 HG23 ' HB ' ' A' ' 108' ' ' THR . 1.2 m -40.84 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.04 -1.037 . . . . 10.0 109.761 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 0.1 OUTLIER -108.32 10.74 27.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.222 -0.924 . . . . 10.0 109.778 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.565 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 17.5 m80 82.52 14.08 0.47 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.902 0.382 . . . . 10.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.551 ' HB3' ' CD ' ' A' ' 106' ' ' PRO . 1.6 t -170.65 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 118.814 -1.154 . . . . 10.0 112.029 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 105' ' ' CYS . 37.7 Cg_endo -63.77 -21.74 69.51 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.338 1.178 . . . . 10.0 111.532 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 106' ' ' PRO . 2.0 mttt 47.49 51.13 14.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.733 -1.229 . . . . 10.0 108.843 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.591 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 1.4 m -45.65 150.48 0.93 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.591 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 39.6 Cg_endo -63.66 149.92 89.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.746 1.393 . . . . 10.0 112.748 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.586 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -131.73 109.5 10.21 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.546 ' CD2' HD21 ' A' ' 79' ' ' LEU . 1.9 mm? -77.2 95.4 4.29 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.028 -1.069 . . . . 10.0 109.388 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 155' ' ' VAL . 19.1 mt -75.62 142.02 42.73 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.154 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 155' ' ' VAL . 2.0 t -148.32 -177.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.596 -1.315 . . . . 10.0 112.332 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -125.4 120.61 3.95 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.752 -1.739 . . . . 10.0 108.752 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 23.4 p -78.32 139.2 38.85 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.829 -1.395 . . . . 10.0 110.952 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 115' ' ' THR . 56.7 mt-30 34.41 57.38 0.67 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.204 0.526 . . . . 10.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.706 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -79.75 -27.72 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 10.0 110.592 -178.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 25.1 t0 -51.88 61.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.835 0.826 . . . . 10.0 111.966 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.706 ' N ' ' O ' ' A' ' 117' ' ' ILE . 20.1 tp 152.79 -39.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 1.2 mpt_? -46.04 -25.66 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.855 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 4.1 p30 -84.69 -0.13 52.4 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.306 -0.872 . . . . 10.0 111.145 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.466 ' O ' HD13 ' A' ' 126' ' ' ILE . 5.8 p-10 -83.32 160.14 60.35 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.88 -1.138 . . . . 10.0 109.944 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.83 22.73 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.55 1.289 . . . . 10.0 111.769 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.464 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 4.2 m -109.68 -47.6 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.976 -1.078 . . . . 10.0 109.79 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.459 HG23 ' OD1' ' A' ' 122' ' ' ASP . 6.6 t -78.44 -27.14 46.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.828 -1.915 . . . . 10.0 105.828 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 120' ' ' ARG 0.283 1.0 OUTLIER -53.19 -28.82 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.391 -1.337 . . . . 10.0 107.391 177.02 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -52.99 -40.41 63.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.578 0.704 . . . . 10.0 111.308 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -60.4 -34.13 73.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.472 -0.767 . . . . 10.0 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.89 -39.16 90.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.831 -1.168 . . . . 10.0 109.659 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -52.83 -44.56 66.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.568 -0.708 . . . . 10.0 111.232 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -54.66 -18.12 4.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.149 -0.97 . . . . 10.0 110.376 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.527 ' ND2' ' CB ' ' A' ' 87' ' ' PRO . 8.1 t30 -126.9 -53.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.735 -1.228 . . . . 10.0 110.279 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -137.03 116.01 12.36 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.596 -0.69 . . . . 10.0 110.518 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.577 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -74.97 -3.02 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.697 -0.627 . . . . 10.0 110.5 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 93.97 6.55 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.579 -0.701 . . . . 10.0 109.277 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 49.3 Cg_endo -73.75 161.71 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.898 1.473 . . . . 10.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.525 HG12 ' CG ' ' A' ' 90' ' ' PHE . 1.5 tp -100.83 134.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.266 -0.896 . . . . 10.0 109.505 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.1 p -120.04 165.56 17.59 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.352 -0.843 . . . . 10.0 109.807 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.71 -35.13 29.41 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.829 1.436 . . . . 10.0 111.063 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.09 -15.81 63.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.113 -0.992 . . . . 10.0 110.999 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.3 m -98.36 -36.54 9.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -64.57 -29.12 70.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.802 . . . . 10.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.81 -41.47 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.019 -1.05 . . . . 10.0 109.314 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -56.16 -36.96 68.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 10.0 109.465 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.544 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 4.2 tp -62.06 -49.55 75.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.116 -0.99 . . . . 10.0 108.902 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 151' ' ' ALA . . . -60.11 -44.44 94.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.036 . . . . 10.0 109.406 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -78.04 -7.96 57.58 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.525 -0.734 . . . . 10.0 110.297 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.9 t70 -98.6 -37.88 9.36 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.388 1.09 . . . . 10.0 109.235 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.617 ' CD2' ' O ' ' A' ' 149' ' ' LEU 0.26 0.0 OUTLIER -103.07 -1.15 29.64 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.513 -178.658 . . . . . . . . 4 4 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 24.4 mttm 67.78 54.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 10.0 111.359 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 146' ' ' ALA . . . -86.24 -150.36 0.15 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 110' ' ' PHE . 9.9 p -116.54 -51.56 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.567 -1.333 . . . . 10.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.51 ' CD ' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -172.42 142.31 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.603 -1.31 . . . . 10.0 111.238 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 142' ' ' ALA . 46.6 t80 -94.26 110.15 21.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 10.0 109.069 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -116.19 -168.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.973 -1.08 . . . . 10.0 112.087 -178.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.435 ' HA ' HG11 ' A' ' 113' ' ' VAL . 19.1 mt-10 -153.27 147.04 25.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 10.0 110.781 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.564 ' CB ' ' CB ' ' A' ' 165' ' ' LEU . 25.6 p -148.07 152.51 37.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 10.0 111.275 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.537 ' HB3' ' OG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -135.14 86.23 2.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.192 -1.41 . . . . 10.0 107.192 178.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.571 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . . . -24.37 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 162' ' ' GLN . 1.7 tp -94.12 -55.05 3.34 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.403 -1.436 . . . . 10.0 112.196 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 24.5 p -64.68 -26.68 68.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.96 -1.087 . . . . 10.0 111.008 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.536 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.8 mt-30 79.26 77.05 0.05 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.528 -0.732 . . . . 10.0 112.024 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.471 ' HG3' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -78.35 47.99 0.73 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 10.0 110.006 178.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 163' ' ' LYS . . . 43.49 41.68 5.46 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.706 -1.358 . . . . 10.0 109.706 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.692 ' HG ' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.11 2.51 3.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 10.0 112.704 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.593 ' N ' HD12 ' A' ' 165' ' ' LEU . 26.9 tttp -58.47 -23.64 58.28 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.782 -1.199 . . . . 10.0 108.694 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -76.86 -17.61 58.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.692 -0.63 . . . . 10.0 111.038 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 155' ' ' VAL . 42.8 t -67.9 -41.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.822 -1.174 . . . . 10.0 108.775 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -86.55 -47.57 9.12 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.599 0.714 . . . . 10.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -51.88 -35.14 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.336 -0.852 . . . . 10.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.543 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.3 mm-40 -90.02 -11.28 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.058 . . . . 10.0 110.771 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.541 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -91.74 -15.27 28.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.038 -1.097 . . . . 10.0 108.038 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.567 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 53.9 mt -73.63 -49.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.097 -0.641 . . . . 10.0 109.322 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 171' ' ' GLU . 2.1 pt? -76.35 -19.12 58.5 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 118.813 -1.155 . . . . 10.0 111.113 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.41 -14.78 34.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 10.0 110.085 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.495 ' CB ' HG13 ' A' ' 77' ' ' VAL . . . -70.25 -44.87 67.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 10.0 109.653 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 2' ' ' GLN . 0.7 OUTLIER -74.64 -29.09 61.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.744 0.783 . . . . 10.0 109.055 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -129.81 151.77 50.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 10.0 110.601 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.44 92.49 4.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 10.0 110.065 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.02 165.94 12.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.499 -0.75 . . . . 10.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.62 -149.76 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -73.23 96.18 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 N-CA-C 109.772 -0.896 . . . . 10.0 109.772 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 19.6 mm-40 -49.56 -169.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.605 0.717 . . . . 10.0 110.249 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.647 HG12 ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -77.64 -42.47 29.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.756 -1.215 . . . . 10.0 111.949 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.647 ' N ' HG12 ' B' ' 8' ' ' ILE . 20.7 t -134.78 172.67 12.65 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.06 -1.025 . . . . 10.0 111.348 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.577 ' CG ' ' O ' ' B' ' 10' ' ' LEU . 1.5 pp -167.25 98.02 0.64 Allowed Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.293 -0.963 . . . . 10.0 111.805 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.539 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 38.4 Cg_endo -69.19 134.69 29.85 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 N-CA-C 108.001 -1.577 . . . . 10.0 108.001 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' B' ' 11' ' ' PRO . 0.9 OUTLIER -53.13 -169.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.689 -1.257 . . . . 10.0 111.388 -178.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.502 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 6.0 p30 -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.992 0.901 . . . . 10.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.593 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 49.9 m-85 -54.92 -165.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.8 0.81 . . . . 10.0 111.547 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' B' ' 14' ' ' PHE . 1.5 tt0 -43.59 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.677 ' HA ' ' CD2' ' A' ' 40' ' ' TYR . 14.2 p80 -146.58 -169.41 3.27 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.569 0.699 . . . . 10.0 111.871 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.563 HG23 ' CE1' ' B' ' 19' ' ' HIS . 1.0 OUTLIER -79.85 163.17 24.59 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.972 0.891 . . . . 10.0 112.423 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.581 ' O ' ' O ' ' A' ' 37' ' ' PHE . 3.3 mp -126.19 175.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.798 -0.816 . . . . 10.0 108.798 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.563 ' CE1' HG23 ' B' ' 17' ' ' THR . 79.3 m-70 -141.59 115.55 9.24 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.491 -1.38 . . . . 10.0 112.094 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.545 ' C ' ' HB ' ' A' ' 36' ' ' VAL . 18.4 t -144.96 103.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 114.055 1.132 . . . . 10.0 114.055 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.655 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . -150.69 -72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.614 -0.995 . . . . 10.0 110.614 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.556 ' O ' ' CG2' ' B' ' 25' ' ' VAL . 69.1 t80 175.86 134.02 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.66 -1.607 . . . . 10.0 106.66 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' B' ' 22' ' ' PHE . 89.0 m-20 -39.0 131.37 1.41 Allowed 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 122.043 0.925 . . . . 10.0 111.252 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 69.47 46.41 0.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.865 -0.522 . . . . 10.0 111.383 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 25.4 t -111.0 -57.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.919 -1.113 . . . . 10.0 109.181 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 38.6 m -51.85 -24.84 6.72 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.176 0.988 . . . . 10.0 109.228 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 26' ' ' ASN . . . -115.63 46.25 1.19 Allowed Glycine 0 N--CA 1.482 1.757 0 N-CA-C 107.727 -2.149 . . . . 10.0 107.727 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 2.2 mt-10 -162.58 123.54 2.51 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.643 0.735 . . . . 10.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 1.0 OUTLIER -122.24 129.26 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 178.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' GLY . 16.6 p -143.85 174.16 11.07 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.587 -0.696 . . . . 10.0 111.032 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' THR . . . 35.78 -152.65 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.448 -1.061 . . . . 10.0 110.448 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.405 ' O ' HG22 ' B' ' 32' ' ' ILE . 0.5 OUTLIER -150.81 70.45 8.69 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.99 . . . . 10.0 109.473 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.512 ' HB2' ' CH2' ' B' ' 36' ' ' TRP . 51.0 Cg_endo -73.61 177.85 7.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.573 1.828 . . . . 10.0 111.92 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB3' ' CZ3' ' B' ' 36' ' ' TRP . 24.3 tt0 -57.83 159.45 5.4 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 10.0 111.006 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 21.2 pt20 -83.51 11.82 6.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.719 -0.613 . . . . 10.0 111.376 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.597 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 0.8 OUTLIER 70.18 36.53 1.85 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.768 0.794 . . . . 10.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.484 ' HA ' HD13 ' A' ' 70' ' ' LEU . . . -168.57 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.66 -0.65 . . . . 10.0 110.904 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CG ' ' OE1' ' B' ' 35' ' ' GLN . 2.2 mmt180 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 120.676 -1.265 . . . . 10.0 110.131 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.066 0.46 . . . . 10.0 110.122 . . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 1.8 mt-30 -95.75 -17.94 20.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.8 m -43.2 99.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.631 -0.668 . . . . 10.0 110.54 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.61 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -116.45 121.03 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 10.0 110.595 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.555 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -93.47 131.27 38.84 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.554 ' CB ' ' HB2' ' A' ' 55' ' ' LEU . 94.4 m -110.36 103.79 12.48 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.743 -1.223 . . . . 10.0 110.39 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.455 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 46.1 t -142.82 162.8 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.229 -0.988 . . . . 10.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.553 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -80.46 152.14 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.157 -1.017 . . . . 10.0 109.432 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 79' ' ' LEU . 3.3 t -83.13 -170.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.255 -0.903 . . . . 10.0 110.193 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.489 ' CA ' ' HG2' ' B' ' 35' ' ' GLN . . . -95.58 42.16 2.36 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.776 -1.202 . . . . 10.0 111.218 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' OD2' HG23 ' A' ' 80' ' ' VAL . 2.5 t0 -82.16 -31.35 30.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.707 -1.467 . . . . 10.0 109.006 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA2' ' C ' ' B' ' 34' ' ' GLU . . . 61.48 51.53 57.18 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.236 -1.546 . . . . 10.0 109.236 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' B' ' 33' ' ' PRO . . . -160.32 -77.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 10.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 81' ' ' CYS . 89.5 t -112.17 117.94 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 10.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CZ2' ' B' ' 36' ' ' TRP . . . -98.95 143.79 16.82 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.784 -1.326 . . . . 10.0 109.784 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -65.4 -21.42 66.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 10.0 112.283 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -99.52 -36.14 9.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.389 -1.444 . . . . 10.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.565 ' HB2' ' O ' ' B' ' 28' ' ' GLU . 26.2 p -73.71 -29.91 62.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.024 -1.047 . . . . 10.0 109.798 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' B' ' 29' ' ' PHE . 3.7 mm? -86.78 -18.02 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.868 -1.145 . . . . 10.0 110.49 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.52 -41.4 76.69 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.038 0.923 . . . . 10.0 108.878 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' B' ' 28' ' ' GLU . 7.3 mm -69.04 -39.78 80.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.71 0.767 . . . . 10.0 110.205 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -47.16 -45.93 23.15 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.585 -0.846 . . . . 10.0 109.814 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.674 ' CD1' HD13 ' A' ' 165' ' ' LEU . 4.9 m-85 -93.58 3.76 55.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.651 -1.281 . . . . 10.0 110.184 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 24' ' ' THR . 2.9 m -110.94 -21.25 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.816 -1.177 . . . . 10.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -88.07 -76.25 0.39 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.456 -1.403 . . . . 10.0 108.647 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.555 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.1 m120 -156.17 -33.66 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.563 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.555 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 175.03 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.188 0.518 . . . . 10.0 109.95 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.683 0 O-C-N 121.183 -0.948 . . . . 10.0 112.26 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 5.8 t . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.352 0.596 . . . . 10.0 110.865 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.533 HG13 ' CG ' ' A' ' 62' ' ' GLU . 65.3 t 61.57 5.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.747 -0.595 . . . . 10.0 111.101 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' O ' ' O ' ' A' ' 38' ' ' ASP . 1.7 t80 -42.29 100.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.476 -0.765 . . . . 10.0 109.829 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.7 ' HB2' ' N ' ' B' ' 19' ' ' HIS . 0.5 OUTLIER -47.19 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.884 0.85 . . . . 10.0 111.648 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -156.55 -167.61 2.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.932 -1.73 . . . . 10.0 111.417 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.62 ' CE1' HD13 ' B' ' 18' ' ' ILE . 7.8 m-30 -112.96 153.48 27.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.411 -0.805 . . . . 10.0 112.852 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.576 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . . . -135.64 119.69 17.57 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.594 ' CG2' ' N ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -171.81 176.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.368 -1.458 . . . . 10.0 111.709 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.594 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 66.1 m -129.49 130.92 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.773 -0.58 . . . . 10.0 110.21 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' B' ' 12' ' ' SER . 13.2 t -105.17 150.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 10.0 109.42 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.699 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 94.7 mtp -117.65 95.62 5.02 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.798 -1.556 . . . . 10.0 106.798 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 3.2 mp -102.8 130.46 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.136 0.493 . . . . 10.0 111.513 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.601 ' CA ' ' CG2' ' B' ' 8' ' ' ILE . . . 40.1 27.69 0.14 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.837 -1.173 . . . . 10.0 110.745 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.76 18.18 45.41 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.011 -1.288 . . . . 10.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.0 mm-40 -114.87 98.98 51.35 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.294 . . . . 10.0 109.87 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.89 118.34 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.972 1.511 . . . . 10.0 110.94 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' ' CG2' ' A' ' 43' ' ' THR . 2.7 m-85 -89.05 117.6 28.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.992 -1.068 . . . . 10.0 109.385 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 3.1 m -100.56 104.19 15.53 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.065 -1.022 . . . . 10.0 111.029 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.0 pp -158.08 178.44 10.2 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.444 -1.302 . . . . 10.0 111.381 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 41' ' ' ALA . . . -170.32 111.46 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.965 -1.654 . . . . 10.0 108.965 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.599 ' CD1' ' CB ' ' A' ' 39' ' ' ASN . 1.8 tm? -130.47 132.8 45.85 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.846 -1.385 . . . . 10.0 110.781 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 p90 -152.57 155.31 37.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 10.0 109.789 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 15.8 t0 -99.15 179.8 4.49 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.631 -1.293 . . . . 10.0 110.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.7 m -104.81 117.3 33.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 10.0 111.137 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . . . -65.7 91.2 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 10.0 110.256 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 61' ' ' GLN . . . -68.92 63.07 0.5 Allowed Glycine 0 N--CA 1.485 1.908 0 N-CA-C 107.816 -2.114 . . . . 10.0 107.816 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ALA . 22.0 tt0 75.03 21.03 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.985 -0.715 . . . . 10.0 110.569 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 59' ' ' ALA . 9.0 mm-40 -50.07 -46.08 53.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.338 -1.345 . . . . 10.0 109.68 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER 162.37 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.163 -0.961 . . . . 10.0 110.923 178.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -178.06 44.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.916 -1.115 . . . . 10.0 109.3 -179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 13.9 p-10 -81.4 38.5 0.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.306 -0.871 . . . . 10.0 110.169 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -49.91 -28.06 6.13 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.272 -0.892 . . . . 10.0 109.111 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.523 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 mp -81.67 11.12 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 10.0 109.361 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 4.5 ptt85 -60.19 -24.76 1.63 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.852 . . . . 10.0 112.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 47.9 Cg_endo -89.92 86.57 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 109.523 -0.991 . . . . 10.0 109.523 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -117.64 -78.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.965 . . . . 10.0 111.831 -178.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.5 m 62.03 39.62 13.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 10.0 109.365 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 76.79 41.94 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 10.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.43 113.44 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.135 1.598 . . . . 10.0 110.385 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -163.62 89.59 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 10.0 110.184 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.577 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 23.0 m -145.89 98.64 3.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.104 -0.997 . . . . 10.0 109.173 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 19.9 t70 -25.77 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.046 0.45 . . . . 10.0 112.15 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -107.68 126.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.947 -1.096 . . . . 10.0 109.897 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.577 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-85 -130.33 139.41 50.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 10.0 110.921 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.606 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 1.9 mm? -113.6 98.54 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 80' ' ' VAL . 9.3 p -97.37 137.47 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 10.0 110.846 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 65.3 m -121.47 112.15 18.16 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.263 -0.898 . . . . 10.0 110.609 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CZ ' ' HD1' ' A' ' 90' ' ' PHE . 35.1 p90 -129.24 160.37 33.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.214 -0.928 . . . . 10.0 110.538 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 116' ' ' GLN . 51.0 m -79.16 162.54 25.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.34 -0.85 . . . . 10.0 111.277 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.15 23.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.672 -0.643 . . . . 10.0 110.349 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -142.02 28.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.201 -0.937 . . . . 10.0 109.875 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -85.93 -173.84 0.46 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.03 . . . . 10.0 110.294 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 50.4 Cg_endo -75.2 72.09 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.889 1.468 . . . . 10.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 m 46.87 40.64 9.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.351 -0.843 . . . . 10.0 110.189 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 11.8 p -76.46 -25.68 54.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 10.0 110.689 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 74.1 t80 -75.1 -18.7 60.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.475 -0.765 . . . . 10.0 112.617 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.79 -17.34 36.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.458 -1.401 . . . . 10.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' A' ' 89' ' ' SER . 0.6 OUTLIER -88.84 -14.9 35.85 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.051 -1.03 . . . . 10.0 109.673 179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.569 ' CG2' ' HD3' ' A' ' 94' ' ' LYS . 12.8 m -84.76 -20.8 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 118.863 -1.135 . . . . 10.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.67 ' CE ' ' CZ ' ' A' ' 90' ' ' PHE . 20.8 mmtt -80.08 -30.54 39.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.919 0.866 . . . . 10.0 109.544 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -96.88 9.44 41.87 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.65 -0.82 . . . . 10.0 109.415 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.8 -51.43 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.094 -1.042 . . . . 10.0 111.044 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 35.5 m95 -90.53 -40.52 11.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.187 -0.946 . . . . 10.0 112.376 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.556 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 92.0 t -53.0 -47.75 94.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.581 -1.324 . . . . 10.0 111.135 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.3 Cg_endo -75.14 -17.26 19.39 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.215 1.113 . . . . 10.0 110.644 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -69.52 -23.95 63.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.097 -1.002 . . . . 10.0 111.551 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.526 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 18.0 mt 54.75 99.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.564 -1.335 . . . . 10.0 109.776 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.578 ' CG2' ' CG ' ' A' ' 106' ' ' PRO . 21.0 m -46.89 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 10.0 109.6 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 37.6 t60 -110.46 -6.73 14.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.269 -0.894 . . . . 10.0 108.752 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 154.79 -49.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.547 ' H ' ' HD3' ' A' ' 106' ' ' PRO . 0.6 OUTLIER -176.14 46.19 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.716 -0.675 . . . . 10.0 110.746 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.578 ' CG ' ' CG2' ' A' ' 102' ' ' THR . 57.0 Cg_endo -78.94 -29.47 3.33 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.288 1.152 . . . . 10.0 109.539 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 71.1 57.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.53 0.681 . . . . 10.0 110.511 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.568 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 2.9 m -46.55 149.6 1.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 10.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 38.4 Cg_endo -63.56 114.22 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.683 1.359 . . . . 10.0 110.762 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.487 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 2.2 t80 -115.11 107.6 15.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.458 -0.776 . . . . 10.0 109.173 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.599 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.0 mm? -96.32 103.69 15.61 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.59 0.71 . . . . 10.0 109.61 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 83.7 mt -85.88 143.29 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.663 -0.648 . . . . 10.0 111.029 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.49 HG23 HG21 ' A' ' 168' ' ' VAL . 2.6 t -141.86 170.53 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.992 -1.068 . . . . 10.0 111.482 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.93 98.13 0.3 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 106.934 -2.467 . . . . 10.0 106.934 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 27.1 p -114.55 -171.12 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 10.0 111.501 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 115' ' ' THR . 78.3 mt-30 56.55 18.44 3.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.53 -0.731 . . . . 10.0 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.744 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -82.94 -22.01 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.934 -0.706 . . . . 10.0 109.297 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 7.7 p-10 -51.52 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 122.051 0.929 . . . . 10.0 111.057 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.744 ' N ' ' O ' ' A' ' 117' ' ' ILE . 17.3 tp 157.85 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.558 ' HA ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.03 -43.01 14.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.0 p-10 -50.29 -23.49 2.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.507 0.67 . . . . 10.0 109.682 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 76.9 m-20 -87.59 138.08 31.87 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.993 -0.683 . . . . 10.0 110.201 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.09 23.37 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.174 1.618 . . . . 10.0 110.865 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 t -102.52 -50.65 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.882 -1.136 . . . . 10.0 110.285 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.524 ' CB ' HD22 ' A' ' 119' ' ' LEU . 6.1 t -78.57 -26.45 45.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 120' ' ' ARG 0.295 1.1 mp -61.24 -23.22 29.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.555 -1.202 . . . . 10.0 107.801 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -49.09 -41.06 34.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.586 0.708 . . . . 10.0 110.501 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -89.26 -30.59 18.38 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.608 0.718 . . . . 10.0 110.397 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 4.8 mp -74.73 -49.85 19.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 10.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.498 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -61.74 -42.68 99.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.599 -0.688 . . . . 10.0 110.394 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -53.69 -20.07 4.92 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.007 -1.077 . . . . 10.0 108.997 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -85.16 -44.09 13.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 10.0 109.648 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 133.95 19.79 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.538 0.685 . . . . 10.0 109.926 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -83.23 -4.16 58.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 10.0 110.269 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.18 103.04 48.02 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 10.0 111.54 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.92 162.4 42.3 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.033 1.544 . . . . 10.0 109.952 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.588 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -99.55 138.28 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 10.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.8 p -126.07 170.21 10.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 10.0 109.737 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 43.3 Cg_endo -68.63 -15.02 40.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.531 1.279 . . . . 10.0 110.46 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.38 -42.04 54.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 10.0 109.762 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -75.52 -40.95 56.31 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.732 -0.605 . . . . 10.0 110.553 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.89 -44.94 65.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 10.0 111.269 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.8 -43.93 48.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 10.0 109.619 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 67.4 tttt -66.42 -40.32 89.48 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.508 -0.745 . . . . 10.0 109.294 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.538 HD12 ' HG3' ' A' ' 94' ' ' LYS . 2.1 tt -63.66 -48.26 77.94 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.559 -0.856 . . . . 10.0 109.42 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' A' ' 151' ' ' ALA . . . -58.42 -42.12 86.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 10.0 108.93 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -80.66 1.86 28.26 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.679 -0.808 . . . . 10.0 108.991 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.559 ' HB3' ' CD1' ' A' ' 149' ' ' LEU . 14.4 t70 -79.21 -31.82 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.48 -0.763 . . . . 10.0 112.214 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.676 ' O ' ' CB ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -135.65 -8.17 2.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.032 -1.668 . . . . 10.0 113.088 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.676 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 6.2 pttt 125.93 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.899 0.88 . . . . 10.0 111.703 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -116.83 -177.44 3.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.882 -1.136 . . . . 10.0 109.65 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.598 ' CG1' ' N ' ' A' ' 153' ' ' LYS . 1.1 t -90.16 -78.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.766 -1.208 . . . . 10.0 109.531 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.598 ' N ' ' CG1' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -171.93 164.53 6.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.023 -1.048 . . . . 10.0 111.093 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 57.8 t80 -104.76 101.1 10.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.411 -0.806 . . . . 10.0 109.562 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.2 t -87.76 169.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 10.0 109.137 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.434 ' N ' HG12 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -134.64 121.67 21.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.929 -1.107 . . . . 10.0 109.737 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.6 p -141.23 169.99 16.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.051 -1.031 . . . . 10.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.562 ' N ' ' HB2' ' A' ' 162' ' ' GLN . 1.1 t -143.76 118.6 9.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.691 -0.631 . . . . 10.0 109.576 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 23' ' ' TYR . . . -12.25 -54.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.569 0.951 . . . . 10.0 113.569 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.5 pp -131.9 -3.82 3.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.471 -1.393 . . . . 10.0 111.788 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 158' ' ' SER . 59.5 m -98.05 -90.17 0.28 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.664 -1.273 . . . . 10.0 111.995 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.562 ' HB2' ' N ' ' A' ' 158' ' ' SER . 1.7 mm-40 -38.3 -39.44 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.945 . . . . 10.0 111.98 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 18.4 ttpt 49.5 26.29 1.65 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.056 -1.058 . . . . 10.0 108.938 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -94.62 -8.3 59.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.008 -1.637 . . . . 10.0 109.008 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.81 -9.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.414 -1.051 . . . . 10.0 112.306 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -70.17 -46.19 65.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.352 -1.468 . . . . 10.0 111.061 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.405 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 1.4 m-80 -59.39 -27.97 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 10.0 108.298 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.542 HG13 ' CD1' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -51.48 -50.68 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.576 0.703 . . . . 10.0 110.897 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.523 ' N ' ' CG1' ' A' ' 168' ' ' VAL . 18.4 t80 -87.14 -25.74 23.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.499 -0.751 . . . . 10.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.507 ' O ' HD23 ' A' ' 174' ' ' LEU . 21.0 t70 -50.39 -49.55 54.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 10.0 109.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.0 mp0 -67.12 -45.02 78.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 10.0 110.257 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.491 ' HB1' HD22 ' A' ' 111' ' ' LEU . . . -50.95 -21.21 1.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 10.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.586 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 24.4 mm -70.07 -43.86 78.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 10.0 110.338 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.639 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.42 -23.82 34.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.577 -1.327 . . . . 10.0 111.068 -178.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 109' ' ' PRO . . . -87.46 -11.55 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 10.0 111.322 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.61 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -80.42 -45.92 16.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.229 . . . . 10.0 109.991 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.586 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 1.1 mp -89.99 -19.62 24.24 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.96 0.886 . . . . 10.0 108.917 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 10.0 110.337 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.576 -1.41 . . . . 10.0 109.576 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -75.89 145.08 40.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 10.0 109.99 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.48 ' CD ' HD11 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -98.85 93.36 6.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.056 -1.028 . . . . 10.0 110.614 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.422 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 30.2 mm-40 -129.75 159.64 35.88 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.439 0.638 . . . . 10.0 110.49 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.643 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.26 -158.18 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 106.834 -1.543 . . . . 10.0 106.834 177.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -67.41 112.47 2.59 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 N-CA-C 109.236 -1.101 . . . . 10.0 109.236 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' B' ' 6' ' ' PRO . 12.1 tp10 -55.29 -128.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.605 0.717 . . . . 10.0 110.717 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.601 ' CG2' ' CA ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -78.97 -101.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.892 -1.13 . . . . 10.0 109.682 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.593 ' N ' HG12 ' B' ' 8' ' ' ILE . 25.3 t -142.91 112.2 6.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.341 -1.475 . . . . 10.0 111.895 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.699 ' HB3' ' O ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -171.04 97.54 0.42 Allowed Pre-proline 0 N--CA 1.489 1.517 0 CA-C-O 121.632 0.73 . . . . 10.0 109.605 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.69 99.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.074 1.849 . . . . 10.0 111.214 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.4 m -136.62 98.41 3.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.691 -1.255 . . . . 10.0 109.748 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.588 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -167.4 138.79 3.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.63 -1.228 . . . . 10.0 112.364 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.559 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 58.3 m-85 -115.71 107.31 14.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.695 . . . . 10.0 110.305 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.589 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -88.81 174.19 8.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.782 1.277 . . . . 10.0 113.242 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -90.0 -165.75 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.552 -1.204 . . . . 10.0 112.317 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -119.41 146.12 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.669 -0.645 . . . . 10.0 109.816 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.62 HD13 ' CE1' ' A' ' 40' ' ' TYR . 1.3 mp -76.77 173.06 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 10.0 112.463 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.7 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 27.4 m170 -141.95 117.28 10.16 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.436 0.902 . . . . 10.0 113.436 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.495 ' HB ' ' HD1' ' A' ' 37' ' ' PHE . 2.8 p -144.93 143.58 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.237 -0.914 . . . . 10.0 110.562 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 62' ' ' GLU . . . -148.12 30.69 1.33 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.668 -1.253 . . . . 10.0 110.178 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.563 ' O ' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -171.69 91.26 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.021 -1.282 . . . . 10.0 110.392 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' B' ' 24' ' ' ALA . 4.1 m-20 -67.39 151.78 46.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.852 -1.155 . . . . 10.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.71 54.92 0.69 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.671 -0.643 . . . . 10.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.483 HG12 ' HB ' ' B' ' 26' ' ' THR . 0.9 OUTLIER -113.61 -36.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.239 -0.984 . . . . 10.0 108.687 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.53 HG22 ' N ' ' B' ' 29' ' ' PHE 0.262 0.5 OUTLIER -149.62 11.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.125 -1.03 . . . . 10.0 112.946 -178.148 . . . . . . . . 4 4 . 1 . 002 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 59.09 30.56 67.17 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.719 -2.952 . . . . 10.0 105.719 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 1.0 OUTLIER 59.34 16.68 5.23 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.692 0.758 . . . . 10.0 109.328 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -143.26 147.82 35.41 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.211 0.529 . . . . 10.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.54 ' O ' ' CE1' ' B' ' 29' ' ' PHE . 19.0 p -134.81 -178.55 5.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.163 . . . . 10.0 110.213 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.19 -28.73 9.56 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.013 -1.089 . . . . 10.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.497 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 31.4 mm -132.97 50.76 5.99 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.605 -1.527 . . . . 10.0 111.56 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 55.8 Cg_endo -75.5 150.58 36.28 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.615 1.324 . . . . 10.0 110.651 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.529 ' C ' ' HA2' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -75.12 -169.75 1.0 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.998 -1.064 . . . . 10.0 109.226 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 1.2 mp0 -76.43 20.4 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.19 -0.944 . . . . 10.0 110.779 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.555 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 8.5 m-90 65.7 20.71 11.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.802 -1.555 . . . . 10.0 106.802 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.431 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -155.02 83.06 1.08 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.475 ' HD2' ' OE2' ' B' ' 34' ' ' GLU . 22.2 tpt180 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 122.751 1.262 . . . . 10.0 107.988 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.57 ' CG ' HD23 ' A' ' 177' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.705 0.288 . . . . 10.0 110.41 . . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -179.19 152.78 0.56 Allowed 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.166 -0.959 . . . . 10.0 110.002 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 2' ' ' GLN . 85.1 m 61.42 48.43 5.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 113.707 1.003 . . . . 10.0 113.707 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -112.66 128.86 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.159 -1.588 . . . . 10.0 110.942 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.573 ' O ' ' CG2' ' A' ' 75' ' ' THR . 4.1 mmtm -118.11 147.53 43.2 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.3 t -119.26 106.05 11.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.837 -1.165 . . . . 10.0 109.993 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 8' ' ' VAL . 4.0 t -128.41 170.88 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.769 -1.207 . . . . 10.0 110.966 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 16' ' ' LYS . 8.5 t -85.25 129.92 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.469 -0.769 . . . . 10.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' OE1' ' B' ' 35' ' ' GLN . 40.6 t -132.46 176.55 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.972 -1.08 . . . . 10.0 111.567 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' B' ' 35' ' ' GLN . . . 131.95 -173.27 20.7 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.067 -1.613 . . . . 10.0 109.067 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 11' ' ' ASP . 2.3 p30 -84.67 15.43 3.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.432 . . . . 10.0 109.559 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 89.27 52.8 2.63 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.588 -1.805 . . . . 10.0 108.588 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -133.13 105.2 6.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.721 -0.87 . . . . 10.0 109.19 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 4.5 t 66.71 119.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -0.806 . . . . 10.0 109.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.498 ' O ' HD21 ' A' ' 19' ' ' LEU . . . -90.13 115.07 4.5 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.912 -1.675 . . . . 10.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.54 -19.98 2.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.65 -1.5 . . . . 10.0 111.482 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 8' ' ' VAL . 88.9 m -82.1 -41.8 20.03 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.721 -1.237 . . . . 10.0 111.809 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 23.7 p -79.73 1.79 25.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.809 -1.182 . . . . 10.0 109.909 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.613 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 3.2 mm? -109.11 -41.31 4.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.843 -1.161 . . . . 10.0 109.52 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 165' ' ' LEU . 1.5 tp -48.14 -34.07 9.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.594 HG13 ' CG2' ' B' ' 26' ' ' THR . 2.5 mm -73.83 -41.7 53.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.409 -0.959 . . . . 10.0 108.409 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 23.0 t -48.55 -41.76 31.36 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.445 -0.902 . . . . 10.0 110.117 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -97.26 -0.63 46.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.556 -1.34 . . . . 10.0 109.405 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 17.5 m -109.99 -19.01 13.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.012 . . . . 10.0 112.58 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -116.76 -72.34 0.69 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.231 -1.543 . . . . 10.0 111.544 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.621 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 34.1 m-20 -147.73 -33.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.311 -1.356 . . . . 10.0 112.773 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 165.83 -138.8 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 O-C-N 121.331 -0.856 . . . . 10.0 111.606 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.131 -0.981 . . . . 10.0 113.457 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.528 ' CB ' ' HB ' ' B' ' 26' ' ' THR . 22.3 p . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 58' ' ' THR . 58.1 t 62.99 -43.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.72 -0.613 . . . . 10.0 111.358 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.724 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 7.8 p90 -36.38 100.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.161 0.981 . . . . 10.0 110.374 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.574 ' HA ' HD12 ' B' ' 18' ' ' ILE . 1.5 m-20 -167.71 102.92 0.49 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 117.297 -1.761 . . . . 10.0 112.489 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.623 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 61.4 t30 -147.8 98.78 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.069 -1.019 . . . . 10.0 108.361 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CD2' ' O ' ' B' ' 16' ' ' HIS . 75.6 m-85 -139.73 147.05 40.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.86 -1.136 . . . . 10.0 112.65 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 98.55 3.42 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' B' ' 15' ' ' GLU . 7.5 p -135.23 -173.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -0.854 . . . . 10.0 110.269 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 94.1 m -136.72 167.29 21.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.48 152.24 37.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.215 -1.031 . . . . 10.0 108.215 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.53 ' CB ' ' HD2' ' B' ' 11' ' ' PRO . 7.1 mtm -144.67 131.15 19.82 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.001 -0.68 . . . . 10.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.569 ' CD1' HG12 ' A' ' 44' ' ' VAL . 1.4 mp -147.94 114.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.204 -0.935 . . . . 10.0 110.693 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 67.51 6.5 42.14 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.934 -1.267 . . . . 10.0 109.934 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.54 24.06 6.31 Favored Glycine 0 N--CA 1.489 2.179 0 O-C-N 121.064 -1.257 . . . . 10.0 110.008 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 13.7 pt-20 -118.67 111.33 37.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.33 . . . . 10.0 109.723 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.49 146.94 57.03 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.87 1.458 . . . . 10.0 111.542 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.8 m-85 -136.71 107.12 6.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.348 -0.845 . . . . 10.0 111.122 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.584 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 47.3 m -83.64 153.04 24.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.164 -0.96 . . . . 10.0 109.169 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 1.4 pp -167.26 166.34 14.81 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.716 -1.24 . . . . 10.0 110.765 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.61 131.92 2.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.405 -1.478 . . . . 10.0 109.405 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.63 124.03 49.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -1.034 . . . . 10.0 109.403 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.623 ' CE1' ' OD1' ' A' ' 39' ' ' ASN . 5.1 m-85 -135.96 104.51 5.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.11 -0.994 . . . . 10.0 110.259 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD2' ' HA ' ' A' ' 36' ' ' VAL . 23.5 t0 -105.34 146.36 29.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.141 -0.975 . . . . 10.0 110.231 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.533 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 66.5 m -45.72 131.15 9.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.345 -0.847 . . . . 10.0 109.283 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -101.26 89.75 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.607 -0.683 . . . . 10.0 111.305 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . -53.41 -23.78 20.49 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.558 -2.217 . . . . 10.0 107.558 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' B' ' 21' ' ' GLY . 29.1 tt0 178.02 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 122.004 -0.704 . . . . 10.0 109.516 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 64' ' ' TYR . 9.6 tm-20 -53.62 -51.95 61.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.129 -0.982 . . . . 10.0 110.687 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER 177.05 -17.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.275 -0.891 . . . . 10.0 110.988 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 19.9 p90 -119.74 16.53 12.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.004 -1.06 . . . . 10.0 109.395 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 38.0 t0 -37.42 -30.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.729 -0.607 . . . . 10.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.483 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 12.6 ptp180 -51.03 -22.22 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 10.0 110.004 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.528 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.9 mm? -106.95 11.41 29.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 10.0 109.048 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.613 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 10.6 ttp-105 -54.48 -37.98 60.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.775 -0.578 . . . . 10.0 111.641 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 39.8 Cg_endo -68.06 59.19 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 109.953 -0.826 . . . . 10.0 109.953 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HG ' ' H ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -92.72 -57.34 2.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.61 -0.681 . . . . 10.0 109.986 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.589 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 1.5 t 58.44 53.24 6.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.245 -0.909 . . . . 10.0 109.628 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 72' ' ' TYR . 1.2 p90 -149.11 113.72 3.6 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 118.564 -1.254 . . . . 10.0 112.542 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.23 94.65 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.509 1.473 . . . . 10.0 109.971 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.98 76.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.791 -1.193 . . . . 10.0 110.791 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.573 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 54.1 m -144.83 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.179 -0.951 . . . . 10.0 109.626 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 75' ' ' THR . 2.3 m-20 -18.95 -53.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.449 0.642 . . . . 10.0 111.843 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -88.84 123.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.442 -0.903 . . . . 10.0 109.352 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.496 ' O ' HD22 ' A' ' 111' ' ' LEU . 93.8 m-85 -116.01 139.96 49.74 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.403 -0.81 . . . . 10.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.547 ' CD1' HG12 ' A' ' 168' ' ' VAL . 1.6 mm? -108.15 98.17 7.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 80' ' ' VAL . 9.2 p -92.84 122.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.619 -0.832 . . . . 10.0 110.708 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.82 104.3 11.19 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.564 -0.71 . . . . 10.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.467 ' CA ' HG21 ' A' ' 115' ' ' THR . 13.0 p90 -136.57 179.82 6.14 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.221 -0.925 . . . . 10.0 109.239 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.433 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 90.2 p -75.28 161.5 29.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.861 -1.149 . . . . 10.0 111.333 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' HG21 ' A' ' 137' ' ' ILE . 6.6 m -78.78 -9.87 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.616 . . . . 10.0 111.134 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -115.17 -82.29 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.99 -1.069 . . . . 10.0 108.116 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.5 t 66.38 147.66 0.11 Allowed Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 120.407 -1.433 . . . . 10.0 111.79 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.632 ' HA ' ' HG3' ' A' ' 134' ' ' GLN . 49.9 Cg_endo -76.76 167.78 24.73 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 124.384 1.728 . . . . 10.0 112.247 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 1.0 OUTLIER 71.77 15.35 5.87 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.985 178.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.498 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.5 t 61.64 102.01 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.023 -1.048 . . . . 10.0 110.474 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -46.76 -31.77 3.2 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.395 -0.922 . . . . 10.0 109.046 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 73.9 tt0 -53.55 -29.39 36.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 10.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.61 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.17 -11.82 58.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 10.0 109.535 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.63 -36.04 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.181 -0.949 . . . . 10.0 109.391 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -71.14 -17.75 62.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.458 -0.897 . . . . 10.0 109.285 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.84 -4.82 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.111 -0.993 . . . . 10.0 110.804 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -78.37 -41.63 32.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 10.0 110.469 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.476 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 24.2 m95 -80.52 -27.84 37.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.428 -0.795 . . . . 10.0 110.195 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.589 ' CG1' ' CD2' ' A' ' 149' ' ' LEU . 93.9 t -52.83 -50.77 79.47 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.159 -0.963 . . . . 10.0 110.861 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.5 Cg_endo -68.35 -17.95 44.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.277 1.146 . . . . 10.0 109.731 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -58.02 -29.57 65.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 10.0 110.142 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 7.0 mt 63.01 106.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.301 -0.874 . . . . 10.0 111.417 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.614 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -49.17 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.363 -0.977 . . . . 10.0 108.363 178.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.606 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 40.4 m170 -105.19 -7.62 18.9 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.162 -0.961 . . . . 10.0 110.181 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 1.7 m-70 174.68 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 10.0 109.764 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.614 ' O ' ' CG2' ' A' ' 102' ' ' THR . 81.3 m -119.2 144.91 37.16 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.058 . . . . 10.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.05 91.67 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 123.679 1.358 . . . . 10.0 110.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -153.36 18.31 0.55 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.201 -0.937 . . . . 10.0 109.591 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -56.25 131.58 75.4 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.254 -0.904 . . . . 10.0 109.634 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 135.69 25.7 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.557 1.293 . . . . 10.0 109.637 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.505 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -132.48 106.01 7.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.288 -0.882 . . . . 10.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.581 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -74.91 95.61 2.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.972 -1.862 . . . . 10.0 105.972 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 46.2 mt -70.08 139.07 52.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 111' ' ' LEU . 2.9 t -149.6 167.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.141 . . . . 10.0 111.454 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.463 ' O ' ' CG2' ' A' ' 117' ' ' ILE . . . -124.52 107.27 1.0 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.956 -2.057 . . . . 10.0 107.956 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.467 HG21 ' CA ' ' A' ' 82' ' ' PHE . 3.5 t -93.88 155.62 17.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -1.189 . . . . 10.0 110.543 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 48.73 48.65 19.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.832 . . . . 10.0 109.894 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.738 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER -82.62 -13.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 10.0 110.662 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 51.3 p30 -52.01 51.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 112.3 0.481 . . . . 10.0 112.3 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.738 ' N ' ' O ' ' A' ' 117' ' ' ILE . 12.3 tp 152.47 -34.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' CG ' HG22 ' A' ' 85' ' ' VAL . 10.9 tpp180 -55.54 -33.87 64.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.504 0.669 . . . . 10.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.15 -14.43 60.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 10.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 119' ' ' LEU . 70.9 m-20 -82.7 142.12 45.33 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.233 -0.917 . . . . 10.0 110.837 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.44 22.99 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.12 1.59 . . . . 10.0 111.558 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -103.07 -50.57 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.757 -1.214 . . . . 10.0 109.967 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 t -74.26 -28.16 61.09 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.411 -2.07 . . . . 10.0 105.411 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 120' ' ' ARG 0.29 0.6 OUTLIER -51.1 -30.88 10.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 176.888 . . . . . . . . 4 4 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.3 -47.82 46.72 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.885 0.85 . . . . 10.0 110.235 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -37.29 62.58 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.466 0.651 . . . . 10.0 110.005 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.616 ' O ' ' NE2' ' A' ' 134' ' ' GLN . 3.4 mp -55.64 -27.1 47.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.114 0.959 . . . . 10.0 109.942 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.25 -28.39 57.1 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.405 -1.434 . . . . 10.0 109.022 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -69.94 -17.31 63.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.015 -0.674 . . . . 10.0 109.982 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.597 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -129.25 34.28 4.42 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.204 -1.398 . . . . 10.0 112.589 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 55.91 63.94 1.88 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.135 -0.978 . . . . 10.0 110.225 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.632 ' HG3' ' HA ' ' A' ' 87' ' ' PRO . 2.5 mt-30 -128.86 80.99 2.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.447 ' C ' HG11 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -84.2 140.13 39.44 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.78 . . . . 10.0 109.901 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.53 161.65 40.31 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.203 1.633 . . . . 10.0 111.741 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.571 HG12 ' CE2' ' A' ' 90' ' ' PHE . 3.5 tp -126.64 139.92 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 10.0 109.479 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -118.78 165.42 16.84 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.323 -0.86 . . . . 10.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.9 Cg_endo -65.67 -21.57 58.72 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.8 1.421 . . . . 10.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -70.54 -47.66 59.29 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.283 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -77.9 -42.15 34.24 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.916 -0.714 . . . . 10.0 110.292 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.88 90.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.912 -1.118 . . . . 10.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 20.4 mm-40 -52.95 -48.19 67.55 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.483 -0.887 . . . . 10.0 110.132 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -62.18 -34.63 76.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.175 -0.953 . . . . 10.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 8.8 tp -66.46 -50.08 64.52 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.905 -1.122 . . . . 10.0 108.222 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -59.09 -41.62 88.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.284 -0.885 . . . . 10.0 109.95 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 147' ' ' ARG . 40.3 mmm-85 -78.61 -7.29 57.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.344 -0.847 . . . . 10.0 110.18 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.502 ' CB ' HD13 ' A' ' 149' ' ' LEU . 2.5 m-20 -76.88 -48.66 17.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.028 -1.045 . . . . 10.0 110.806 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.589 ' CD2' ' CG1' ' A' ' 98' ' ' VAL . 2.2 mp -102.09 9.84 39.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 10.0 109.819 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 5.6 mtpt 81.51 23.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.028 0.918 . . . . 10.0 110.512 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -64.26 -176.34 0.21 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.581 ' CG1' HD13 ' A' ' 111' ' ' LEU . 2.5 p -84.99 -77.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.773 -1.204 . . . . 10.0 111.83 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.505 ' H ' ' CG1' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -173.66 -179.04 1.72 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.437 -1.414 . . . . 10.0 110.889 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 68.1 t80 -108.7 120.86 43.7 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 10.0 109.778 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.57 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -124.51 -169.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.226 -0.922 . . . . 10.0 109.349 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -157.2 144.42 18.62 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.291 -1.364 . . . . 10.0 112.679 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 27.4 p -157.49 162.43 38.89 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.448 0.642 . . . . 10.0 110.133 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.639 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 18.9 p -133.14 172.84 12.12 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 108.49 -0.93 . . . . 10.0 108.49 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.737 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -54.96 -64.85 0.7 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.894 0.702 . . . . 10.0 112.894 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.443 HD12 ' OG1' ' A' ' 161' ' ' THR . 4.0 pp -132.91 -3.83 3.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.66 -1.275 . . . . 10.0 112.13 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.4 m -96.33 -53.56 3.57 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.65 -1.282 . . . . 10.0 113.167 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -63.25 -53.03 59.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.757 -1.215 . . . . 10.0 111.327 -178.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 161' ' ' THR . 0.4 OUTLIER 66.19 27.78 10.25 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 -177.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.51 -17.23 42.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.653 HD12 ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.98 -18.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.186 . . . . 10.0 110.796 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.483 ' N ' HD22 ' A' ' 165' ' ' LEU . 1.5 tttt -71.97 -31.44 66.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.681 -1.262 . . . . 10.0 109.658 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -69.38 -45.1 70.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 10.0 109.582 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 31.1 t -53.31 -18.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.661 0.743 . . . . 10.0 110.2 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.495 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 m-85 -84.3 -40.52 17.87 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 10.0 111.902 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.474 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 22.8 t70 -65.69 -52.19 53.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.89 -1.131 . . . . 10.0 112.268 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -63.92 -25.53 68.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.773 -1.204 . . . . 10.0 109.972 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 171' ' ' GLU . . . -66.87 -32.07 73.09 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.264 -0.897 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 49.0 mm -62.74 -50.27 80.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.413 -0.804 . . . . 10.0 109.696 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.521 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -72.63 -34.07 67.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.56 -0.712 . . . . 10.0 111.073 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.492 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -85.24 -2.35 57.95 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.154 -0.966 . . . . 10.0 110.202 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -87.12 -22.31 25.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.052 -1.03 . . . . 10.0 110.129 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.57 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -100.22 -20.38 15.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 10.0 108.793 179.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 118.09 -0.957 . . . . 10.0 110.426 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' ' 49' ' ' GLU . 46.4 m -128.4 156.65 42.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.297 -1.119 . . . . 10.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -81.66 97.66 8.01 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.151 -0.968 . . . . 10.0 108.582 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.055 . . . . 10.0 111.024 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.682 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -72.24 -154.47 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.682 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 38.2 Cg_endo -65.74 73.87 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-N 119.062 0.701 . . . . 10.0 110.523 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' B' ' 5' ' ' ARG . 3.3 tp10 -53.32 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.591 -0.693 . . . . 10.0 110.073 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.641 HG12 ' N ' ' B' ' 9' ' ' SER . 0.2 OUTLIER -79.56 -50.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.7 -1.25 . . . . 10.0 112.25 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.641 ' N ' HG12 ' B' ' 8' ' ' ILE . 61.0 m -88.82 146.72 24.81 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.808 -1.182 . . . . 10.0 110.994 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.8 98.05 0.43 Allowed Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.359 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 45' ' ' MET . 51.4 Cg_endo -86.16 97.56 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.229 1.647 . . . . 10.0 109.073 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.1 p -68.37 160.61 29.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.07 -1.019 . . . . 10.0 111.894 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.2 m-20 -124.14 155.86 37.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.525 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 69.0 m-85 -85.33 156.09 21.05 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.028 0.918 . . . . 10.0 112.672 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 15.9 pt-20 -120.09 154.71 34.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.609 0.719 . . . . 10.0 110.316 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -49.87 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 10.0 111.142 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' B' ' 18' ' ' ILE . 4.3 t -159.5 144.37 15.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.672 -1.268 . . . . 10.0 110.685 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.575 HG12 ' N ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER -160.67 177.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.721 -0.612 . . . . 10.0 109.613 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.2 t-80 -143.07 160.23 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.675 -1.266 . . . . 10.0 111.548 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.625 ' N ' ' CB ' ' A' ' 37' ' ' PHE . 5.8 p -69.74 148.46 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.192 0.996 . . . . 10.0 112.711 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -127.31 42.68 1.43 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.132 -2.387 . . . . 10.0 107.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.627 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.2 OUTLIER -178.94 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.528 -0.983 . . . . 10.0 109.705 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 23' ' ' ASP . 17.3 p-10 -57.95 155.12 11.18 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.85 0.833 . . . . 10.0 112.688 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.21 57.98 0.63 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.781 -0.575 . . . . 10.0 112.37 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 42.5 t -113.01 -26.83 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.987 -1.071 . . . . 10.0 109.72 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.594 ' CG2' HG13 ' A' ' 21' ' ' ILE . 3.3 m -107.91 -22.23 12.52 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.533 ' HA2' ' CG2' ' A' ' 21' ' ' ILE . . . -90.49 35.2 3.9 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 106.923 -2.471 . . . . 10.0 106.923 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 28' ' ' PHE . 19.6 mt-10 -149.92 120.41 7.43 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.475 -1.014 . . . . 10.0 110.304 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 3.8 t80 -124.21 142.71 51.01 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.25 -0.906 . . . . 10.0 108.701 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.5 p -141.06 -46.59 0.39 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.153 -0.967 . . . . 10.0 109.566 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.11 51.02 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.449 -1.86 . . . . 10.0 108.449 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.434 ' HA ' HD11 ' B' ' 32' ' ' ILE . 21.1 mm -73.55 132.64 80.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.835 -0.803 . . . . 10.0 110.02 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 56.3 Cg_endo -80.54 79.88 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.718 1.378 . . . . 10.0 112.243 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' B' ' 33' ' ' PRO . 33.7 tt0 173.61 122.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.005 -1.059 . . . . 10.0 111.126 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.619 ' O ' ' CG ' ' B' ' 36' ' ' TRP . 10.4 pt20 -78.3 -37.73 44.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.706 -0.622 . . . . 10.0 109.658 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.619 ' CG ' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 152.52 33.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.752 0.787 . . . . 10.0 109.066 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -139.97 -21.74 0.87 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.716 -0.615 . . . . 10.0 110.096 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 10.0 mmm180 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.128 . . . . 10.0 109.397 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 6.4 tmm? . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.14 0.495 . . . . 10.0 109.943 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 75.17 51.09 0.08 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 -178.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 3' ' ' THR . 2.2 m -173.13 75.0 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.467 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -105.3 136.36 39.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.167 -1.583 . . . . 10.0 110.026 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.624 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -118.33 114.25 22.67 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.82 105.3 17.3 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.518 -1.363 . . . . 10.0 110.734 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.458 HG23 ' OG1' ' A' ' 75' ' ' THR . 45.7 t -136.3 145.45 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.315 -0.954 . . . . 10.0 110.675 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -77.96 141.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.657 -0.652 . . . . 10.0 109.278 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.552 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 1.5 p -161.38 172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.138 -0.976 . . . . 10.0 110.205 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.552 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 149.54 176.22 22.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -49.34 -21.94 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.252 . . . . 10.0 110.373 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 45.84 0.07 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.556 -1.418 . . . . 10.0 109.556 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.2 -91.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -1.193 . . . . 10.0 110.039 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.8 t 50.26 -125.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 10.0 111.148 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 96.53 7.47 57.96 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 108.378 -1.889 . . . . 10.0 108.378 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -57.96 -18.6 24.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.038 -1.272 . . . . 10.0 109.477 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.413 ' HB ' ' HE3' ' A' ' 16' ' ' LYS . 4.9 t -86.48 -24.9 25.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.483 ' SG ' ' O ' ' A' ' 15' ' ' GLY . 26.9 p -97.7 -8.22 29.18 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.029 -1.044 . . . . 10.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 ' CG ' ' B' ' 29' ' ' PHE . 1.4 mt -74.6 -38.36 62.62 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.585 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 0.9 OUTLIER -59.29 -37.81 78.62 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 177.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.598 ' CG2' ' O ' ' B' ' 26' ' ' THR . 7.2 mm -70.59 -51.38 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 115.032 -0.985 . . . . 10.0 108.651 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 17.3 p -51.3 -40.41 58.94 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.178 -0.952 . . . . 10.0 109.546 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.618 ' CE1' ' O ' ' A' ' 160' ' ' LEU . 10.7 t80 -79.89 -32.71 40.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.9 -1.125 . . . . 10.0 110.862 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 20' ' ' LEU . 33.9 p -97.04 -9.63 27.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 10.0 112.789 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.575 ' OG1' ' CA ' ' B' ' 27' ' ' GLY . 81.1 p -102.18 -88.07 0.39 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.133 -1.604 . . . . 10.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.717 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.2 p30 -123.55 -33.21 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 116.997 -1.881 . . . . 10.0 113.029 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 152.94 -141.84 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 CA-C-N 119.052 0.842 . . . . 10.0 111.638 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.191 0.996 . . . . 10.0 110.505 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 105.577 -2.009 . . . . 10.0 105.577 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.592 HG11 ' CA ' ' A' ' 60' ' ' GLY . 3.2 t -79.36 -96.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.485 -0.759 . . . . 10.0 111.2 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 64' ' ' TYR . 3.5 t80 -62.78 112.26 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 119.635 -1.915 . . . . 10.0 108.148 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.457 ' CG ' ' CD1' ' A' ' 55' ' ' LEU . 3.0 t0 -150.79 111.27 4.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 10.0 111.488 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.531 ' HA ' ' CE1' ' A' ' 56' ' ' PHE . 7.8 m-20 -120.65 97.93 5.79 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 12.2 t80 -132.37 125.48 30.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.399 -0.813 . . . . 10.0 110.972 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' C ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.38 96.38 2.98 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.466 -2.05 . . . . 10.0 105.466 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.61 HG11 ' N ' ' B' ' 14' ' ' PHE . 2.2 t -149.76 -177.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.895 -1.122 . . . . 10.0 111.864 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.571 HG22 ' N ' ' A' ' 44' ' ' VAL . 18.6 m -163.16 176.78 9.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.457 -0.571 . . . . 10.0 109.457 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.598 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 98.5 t -145.49 134.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.921 -1.112 . . . . 10.0 108.871 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.613 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 58.0 mtp -85.31 128.23 34.62 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 117.362 -1.735 . . . . 10.0 107.698 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.598 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -124.84 94.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.751 -1.218 . . . . 10.0 108.97 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.653 ' CA ' ' CG2' ' B' ' 8' ' ' ILE . . . 62.73 19.88 61.19 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.51 34.32 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.392 -1.483 . . . . 10.0 109.392 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.488 ' O ' HG12 ' A' ' 46' ' ' ILE . 4.6 tt0 -112.64 95.91 34.6 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.391 -1.064 . . . . 10.0 110.84 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.7 138.64 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.867 1.456 . . . . 10.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' HG21 ' A' ' 43' ' ' THR . 4.7 t80 -110.75 110.87 21.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 10.0 109.56 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.547 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 89.4 m -68.49 128.33 36.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.217 -0.927 . . . . 10.0 111.749 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.428 ' HG ' ' C ' ' A' ' 52' ' ' THR . 13.3 mt -134.59 138.67 44.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.249 -0.907 . . . . 10.0 109.864 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -170.43 126.52 1.35 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.541 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 3.0 pp -144.45 160.28 41.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 10.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 55' ' ' LEU . 17.7 m-85 -158.5 146.72 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 10.0 109.053 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 10.7 t0 -153.89 175.75 12.97 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.945 -1.097 . . . . 10.0 110.938 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 36' ' ' VAL . 1.8 t -45.89 166.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.646 -0.659 . . . . 10.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -100.5 89.76 4.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.458 -0.776 . . . . 10.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.592 ' CA ' HG11 ' A' ' 36' ' ' VAL . . . -62.33 -57.33 17.24 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 106.704 -2.558 . . . . 10.0 106.704 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.549 ' HG2' ' CA ' ' B' ' 21' ' ' GLY . 17.8 mt-30 -62.52 -21.48 65.56 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 51.02 66.97 1.02 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.669 0.747 . . . . 10.0 111.33 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 37' ' ' PHE . 13.1 p-10 -119.18 23.59 11.24 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.654 -0.654 . . . . 10.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 1.2 p90 -177.4 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 10.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 51.39 21.02 1.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.064 . . . . 10.0 111.271 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 9.6 mmt180 -56.61 -30.27 63.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.697 -1.252 . . . . 10.0 108.971 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.567 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 4.6 mm? -79.03 7.69 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.68 -0.638 . . . . 10.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.686 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 9.8 ttp180 -60.35 -22.86 1.03 Allowed Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.118 -0.989 . . . . 10.0 112.195 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 44.2 Cg_endo -90.01 22.95 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 N-CA-C 109.263 -1.091 . . . . 10.0 109.263 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.686 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 1.4 pt? -33.68 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.741 -0.6 . . . . 10.0 111.335 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 58.3 m -37.46 -34.22 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.554 0.693 . . . . 10.0 110.213 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' LEU . 28.4 t80 -84.71 115.93 62.98 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.387 -0.821 . . . . 10.0 109.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.89 150.09 33.99 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.722 1.38 . . . . 10.0 111.395 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.561 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.4 56.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 10.0 110.257 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.624 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 99.3 m -143.5 92.73 2.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.251 -0.906 . . . . 10.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 75' ' ' THR . 11.8 m-20 -31.9 -39.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.98 0.419 . . . . 10.0 111.913 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 3.4 m -114.26 135.05 55.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.332 1.063 . . . . 10.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.566 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 71.3 m-85 -121.66 149.7 42.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.688 -0.632 . . . . 10.0 110.488 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.537 ' CD1' HG11 ' A' ' 168' ' ' VAL . 1.4 mm? -119.75 97.98 5.89 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.175 -0.953 . . . . 10.0 108.466 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 113' ' ' VAL . 2.6 p -108.07 144.65 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.012 -1.055 . . . . 10.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.521 ' CB ' ' HB ' ' A' ' 113' ' ' VAL . 42.0 t -144.7 134.94 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.235 -0.916 . . . . 10.0 110.627 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 19.1 p90 -142.08 171.66 13.75 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.8 t -79.08 150.29 31.87 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.816 -1.178 . . . . 10.0 111.611 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.541 ' O ' HG22 ' A' ' 137' ' ' ILE . 27.3 m -102.54 -14.72 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.498 -0.751 . . . . 10.0 110.681 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.553 ' CA ' HD22 ' A' ' 129' ' ' LEU . 3.5 m -81.81 -41.83 18.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.701 -1.249 . . . . 10.0 108.676 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.7 m -54.31 120.3 25.11 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.382 -0.824 . . . . 10.0 110.28 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 55.7 Cg_endo -82.39 25.09 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.815 1.429 . . . . 10.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.496 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 9.0 t -62.64 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.99 -1.069 . . . . 10.0 109.898 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 29.7 t -122.53 65.61 0.95 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 10.0 111.683 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 1.8 t80 -64.54 -19.29 65.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.85 -1.156 . . . . 10.0 109.521 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.491 ' HG3' ' HE2' ' A' ' 94' ' ' LYS . 8.5 tt0 -69.65 -29.26 66.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.447 -0.783 . . . . 10.0 111.042 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -83.56 -15.07 50.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.177 . . . . 10.0 111.025 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.474 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 29.2 m -94.55 -26.69 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.827 -1.171 . . . . 10.0 108.998 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -80.66 -29.22 36.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.431 -0.907 . . . . 10.0 109.167 178.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -89.14 -4.77 58.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 10.0 110.603 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -83.97 -50.01 8.42 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.019 -1.051 . . . . 10.0 112.547 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 39.6 m95 -76.9 -24.08 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.055 -1.028 . . . . 10.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.575 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 62.7 t -67.41 -51.89 30.96 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.646 -1.283 . . . . 10.0 111.606 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -72.85 -8.27 22.07 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.289 1.152 . . . . 10.0 110.416 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -81.38 -31.58 33.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 10.0 112.607 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 pt -129.25 -10.17 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.352 -1.468 . . . . 10.0 113.022 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 81.7 p -72.57 -5.23 35.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.492 -1.38 . . . . 10.0 110.656 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -64.61 -43.13 94.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.045 -1.034 . . . . 10.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -100.67 -27.84 13.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.485 -0.759 . . . . 10.0 109.355 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 102' ' ' THR . 74.3 m -120.49 82.18 32.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 40.1 Cg_endo -65.79 152.4 81.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.842 1.443 . . . . 10.0 110.347 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 6.8 mtmt 60.72 47.3 8.21 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.82 -0.55 . . . . 10.0 111.027 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' HD2' ' A' ' 109' ' ' PRO . 89.0 m -72.97 133.87 81.54 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 108' ' ' THR . 37.0 Cg_endo -62.37 129.13 25.73 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.529 1.278 . . . . 10.0 109.747 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 6.6 t80 -136.96 111.34 8.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.358 -0.839 . . . . 10.0 109.722 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 1.4 mm? -90.99 99.86 12.82 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.722 0.772 . . . . 10.0 111.333 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.564 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.2 mt -74.29 148.92 41.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HB ' ' CB ' ' A' ' 81' ' ' CYS . 2.7 t -147.15 179.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.822 -1.173 . . . . 10.0 111.391 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.35 133.41 9.24 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.894 -2.082 . . . . 10.0 107.894 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 82' ' ' PHE . 28.9 m -100.12 132.82 45.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.92 -1.341 . . . . 10.0 111.393 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 52.12 61.36 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 10.0 111.03 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.766 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -79.38 -19.96 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.045 -1.034 . . . . 10.0 109.249 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 119' ' ' LEU . 12.6 p-10 -48.82 61.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.16 0.981 . . . . 10.0 111.22 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 pp 158.56 -24.56 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.722 -1.126 . . . . 10.0 108.462 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 14.5 tpt180 -43.41 -44.31 5.66 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.592 0.71 . . . . 10.0 109.666 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.99 -11.19 7.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 10.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.547 ' O ' HD12 ' A' ' 126' ' ' ILE . 43.7 t0 -104.83 120.31 50.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 10.0 110.534 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.49 24.43 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 10.0 111.035 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -105.85 -50.46 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.065 -1.022 . . . . 10.0 110.93 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 119' ' ' LEU . 6.0 t -72.09 -30.62 65.28 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.076 -2.194 . . . . 10.0 105.076 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 122' ' ' ASP 0.304 0.8 OUTLIER -48.64 -26.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.211 -1.359 . . . . 10.0 107.862 176.309 . . . . . . . . 4 4 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -54.32 -36.71 64.04 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.181 0.991 . . . . 10.0 109.676 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -21.95 61.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.518 -0.739 . . . . 10.0 110.878 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 4.0 mp -57.74 -37.79 74.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.292 -0.88 . . . . 10.0 109.627 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.82 82.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.525 -0.734 . . . . 10.0 109.867 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -51.17 -28.55 11.43 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.901 -1.12 . . . . 10.0 108.677 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.565 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 1.3 m120 -90.27 -66.77 0.89 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.228 -0.989 . . . . 10.0 110.553 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.599 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.5 mptp? -140.33 160.5 39.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.8 -0.563 . . . . 10.0 109.548 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.599 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -97.28 1.48 49.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 10.0 111.313 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.513 ' O ' ' CA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -120.52 98.53 48.27 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 10.0 111.188 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 87' ' ' PRO . 42.2 Cg_endo -73.95 160.59 42.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.888 1.725 . . . . 10.0 111.255 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.68 136.95 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.954 -1.091 . . . . 10.0 109.997 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 73.0 p -128.23 167.78 17.72 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.434 -0.791 . . . . 10.0 110.822 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -65.37 -12.45 34.94 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.941 1.495 . . . . 10.0 110.907 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 1.5 mt-10 -78.6 -15.61 58.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.094 . . . . 10.0 109.839 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.6 m -94.93 -45.1 7.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.185 -0.947 . . . . 10.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.57 69.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 10.0 110.571 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 2.8 tt0 -50.24 -34.64 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.853 . . . . 10.0 109.74 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -74.84 -47.4 30.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.338 -0.851 . . . . 10.0 110.284 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 94' ' ' LYS . 1.1 tp -55.91 -44.7 78.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.02 -1.05 . . . . 10.0 109.409 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 151' ' ' ALA . . . -61.74 -50.22 73.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 10.0 109.951 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -18.01 62.47 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.523 -0.871 . . . . 10.0 109.515 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 144' ' ' LYS . 9.7 m-20 -85.96 -57.65 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 10.0 110.856 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -84.67 4.24 33.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.157 -0.964 . . . . 10.0 110.754 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.0 mttp 69.49 60.1 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.375 1.084 . . . . 10.0 112.352 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.546 ' N ' HD12 ' A' ' 149' ' ' LEU . . . -96.96 -154.09 0.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.333 -0.849 . . . . 10.0 108.71 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 15.8 t -100.04 -81.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.207 -0.997 . . . . 10.0 108.657 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.427 ' N ' ' CG1' ' A' ' 152' ' ' VAL . 2.7 tttm -173.73 159.28 3.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.43 -0.908 . . . . 10.0 111.858 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.598 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -82.77 105.04 13.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.541 -0.725 . . . . 10.0 109.466 178.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.478 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -102.12 -172.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -148.45 137.11 21.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.821 -1.174 . . . . 10.0 109.973 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.499 ' SG ' ' CB ' ' A' ' 16' ' ' LYS . 30.1 p -138.15 116.24 11.73 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.422 -0.911 . . . . 10.0 111.484 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.531 ' N ' HD23 ' A' ' 165' ' ' LEU . 6.2 m -102.6 156.73 17.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.572 ' HB1' HD23 ' A' ' 19' ' ' LEU . . . -93.62 -94.0 0.16 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 120.435 -1.416 . . . . 10.0 111.072 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.651 HD22 ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -47.29 -20.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.463 -1.295 . . . . 10.0 109.001 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -93.42 -44.35 8.3 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.077 -1.015 . . . . 10.0 109.533 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.591 ' HB2' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm0? 61.59 68.91 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 10.0 110.745 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.46 ' HE2' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -97.89 36.86 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.445 -0.902 . . . . 10.0 111.328 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.78 30.03 0.72 Allowed Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.623 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -54.7 -47.41 73.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.229 -1.159 . . . . 10.0 110.714 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -71.41 -21.28 62.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.315 -0.865 . . . . 10.0 110.526 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -70.78 -39.4 73.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.021 -1.049 . . . . 10.0 111.275 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 79' ' ' LEU . 39.6 t -58.48 -50.79 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.811 -1.181 . . . . 10.0 110.212 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 80.4 t80 -68.27 -36.26 79.12 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.48 -0.762 . . . . 10.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.8 t0 -53.75 -47.56 70.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.867 -1.146 . . . . 10.0 110.478 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . 11.4 mm-40 -54.82 -40.46 69.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 10.0 109.857 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 111' ' ' LEU . . . -59.59 -21.35 60.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.139 -0.976 . . . . 10.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 37.2 mm -63.25 -40.52 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.254 -0.904 . . . . 10.0 110.038 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.53 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -87.17 -15.71 37.52 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.638 -1.289 . . . . 10.0 110.946 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.04 -11.08 23.36 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.977 -1.077 . . . . 10.0 110.596 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.526 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -82.35 -42.82 18.2 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.941 -1.099 . . . . 10.0 109.74 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.599 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -96.61 -14.53 22.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.366 -0.834 . . . . 10.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.791 -1.099 . . . . 10.0 110.318 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.443 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . 68.6 m -99.74 37.04 1.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.318 -1.107 . . . . 10.0 110.036 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -64.19 103.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 10.0 110.934 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -128.51 178.02 6.59 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.756 0.789 . . . . 10.0 110.724 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.559 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -67.44 -179.99 0.51 Allowed Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.899 -1.889 . . . . 10.0 105.899 177.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' B' ' 7' ' ' GLU . 42.8 Cg_endo -69.41 55.28 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 N-CA-C 110.35 -0.673 . . . . 10.0 110.35 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.577 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.8 tp10 15.14 -142.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.693 0.759 . . . . 10.0 112.814 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.653 ' CG2' ' CA ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -88.25 -110.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.245 -0.909 . . . . 10.0 109.203 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.536 ' N ' HG12 ' B' ' 8' ' ' ILE . 6.1 t -158.12 105.64 1.95 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.081 -1.637 . . . . 10.0 112.031 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.6 OUTLIER -122.91 103.21 37.1 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.97 . . . . 10.0 109.916 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.91 99.12 0.45 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.373 1.196 . . . . 10.0 109.856 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.5 m -157.15 99.39 1.79 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.39 -0.819 . . . . 10.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 11.6 p-10 -148.63 154.86 40.28 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.818 -1.153 . . . . 10.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.61 ' N ' HG11 ' A' ' 42' ' ' VAL . 48.1 m-85 -84.64 -165.29 1.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.274 1.035 . . . . 10.0 113.165 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.541 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.3 tp10 -53.38 -167.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.88 0.848 . . . . 10.0 111.891 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -138.03 -166.94 2.06 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 40' ' ' TYR . 9.8 t -119.24 -171.8 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.933 -1.104 . . . . 10.0 112.05 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.59 HG12 ' CZ ' ' A' ' 37' ' ' PHE . 1.3 pp -112.4 -177.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -101.08 155.91 17.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.062 . . . . 10.0 111.831 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.7 ' CG2' ' CE2' ' B' ' 22' ' ' PHE . 11.2 m -80.0 152.73 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.483 0.658 . . . . 10.0 111.281 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 61' ' ' GLN . . . -87.69 133.39 11.77 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.162 -1.575 . . . . 10.0 109.162 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.7 ' CE2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER 179.0 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.88 -1.365 . . . . 10.0 112.914 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.442 ' C ' ' N ' ' B' ' 25' ' ' VAL . 15.2 t70 -76.99 116.39 17.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.786 -1.196 . . . . 10.0 107.907 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 46.41 26.11 0.45 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.789 -1.194 . . . . 10.0 107.837 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.479 ' HA ' ' OE2' ' B' ' 28' ' ' GLU 0.262 2.4 t -109.84 -14.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.564 0.697 . . . . 10.0 109.383 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.648 ' HB ' ' CD2' ' B' ' 22' ' ' PHE . 1.3 t -83.47 32.88 0.46 Allowed 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.798 -0.564 . . . . 10.0 111.181 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.575 ' CA ' ' OG1' ' A' ' 25' ' ' THR . . . -161.31 69.94 0.23 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.642 -1.783 . . . . 10.0 108.642 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.9 mt-10 -151.47 131.61 13.52 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.964 0.888 . . . . 10.0 111.43 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.621 ' CG ' HD23 ' A' ' 19' ' ' LEU . 1.9 t80 -142.7 142.41 31.99 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' B' ' 29' ' ' PHE . 2.2 p -162.14 -66.13 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 10.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.79 111.5 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.073 -1.611 . . . . 10.0 109.073 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 pt -131.93 158.9 74.22 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.217 . . . . 10.0 110.308 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' B' ' 34' ' ' GLU . 42.2 Cg_endo -70.43 139.99 39.15 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.985 1.519 . . . . 10.0 109.942 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.531 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 3.0 tm-20 56.87 124.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 10.0 110.433 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' B' ' 36' ' ' TRP . 2.3 pm0 -96.31 -30.11 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 10.0 111.244 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.61 ' CG ' ' O ' ' B' ' 36' ' ' TRP . 7.8 t-105 -165.5 27.78 0.05 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.186 0.993 . . . . 10.0 110.099 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.495 ' C ' ' HG3' ' B' ' 34' ' ' GLU . . . -158.48 85.27 0.85 Allowed 'General case' 0 C--N 1.287 -2.113 0 O-C-N 121.798 -0.564 . . . . 10.0 109.64 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.531 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 2.4 ttt180 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 10.0 110.038 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mm100 -74.94 -26.86 59.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.595 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.4 m -46.23 106.16 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.907 -0.495 . . . . 10.0 110.941 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.614 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -128.03 119.94 52.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.735 -1.586 . . . . 10.0 111.054 178.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.544 ' O ' ' CG2' ' A' ' 75' ' ' THR . 4.5 mttm -103.8 124.55 49.12 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.895 -1.52 . . . . 10.0 106.895 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.513 ' CB ' HD21 ' A' ' 55' ' ' LEU . 2.4 t -89.01 108.0 19.35 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.884 -1.127 . . . . 10.0 110.886 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.539 ' HB ' ' CG2' ' A' ' 75' ' ' THR . 60.0 t -139.17 163.97 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 10.0 109.476 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' VAL . 36.5 t -73.36 157.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.006 -1.059 . . . . 10.0 109.713 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -43.58 170.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 10.0 109.984 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -104.94 -29.27 5.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.082 -1.607 . . . . 10.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD2' HG22 ' A' ' 80' ' ' VAL . 42.0 m-20 -42.59 -61.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 10.0 110.039 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' B' ' 35' ' ' GLN . . . 92.2 5.8 65.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' HD11 ' B' ' 32' ' ' ILE . . . -43.76 -30.93 0.71 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -1.109 . . . . 10.0 110.865 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.451 ' HA ' HG13 ' B' ' 32' ' ' ILE . 53.1 t -148.92 -69.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.07 -1.019 . . . . 10.0 110.405 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.06 74.32 0.06 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 4.4 tttm -65.15 -13.0 57.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -1.056 . . . . 10.0 109.707 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -50.27 -29.52 9.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 10.0 110.073 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.586 ' CB ' ' O ' ' B' ' 26' ' ' THR . 27.3 p -78.4 -2.46 38.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.076 -1.015 . . . . 10.0 111.127 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.598 HD13 ' CE2' ' A' ' 23' ' ' TYR . 1.7 mm? -84.39 -40.22 18.09 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.892 -1.13 . . . . 10.0 109.02 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 24' ' ' THR . 0.8 OUTLIER -52.57 -38.73 60.54 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.619 -0.832 . . . . 10.0 109.206 178.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.629 ' CG2' ' HA2' ' B' ' 27' ' ' GLY . 3.4 mm -80.42 -45.56 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.418 -0.801 . . . . 10.0 110.399 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 19.7 t -45.84 -50.8 13.85 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.026 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.667 ' CD2' HD13 ' A' ' 165' ' ' LEU . 36.6 m-85 -81.49 0.24 38.75 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.847 -1.158 . . . . 10.0 110.43 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.594 ' O ' ' HB ' ' A' ' 25' ' ' THR . 20.1 m -97.93 -54.17 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.404 -1.318 . . . . 10.0 110.779 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' A' ' 24' ' ' THR . 14.6 t 175.75 -39.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.115 -0.991 . . . . 10.0 112.424 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 65.2 m-20 -85.4 32.39 0.57 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.737 -1.227 . . . . 10.0 111.53 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 22' ' ' SER 0.261 8.7 ttpp -45.26 -167.28 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.846 0.831 . . . . 10.0 112.863 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.621 ' CB ' ' CB ' ' B' ' 28' ' ' GLU . 51.1 t80 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.242 -0.911 . . . . 10.0 111.523 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.619 ' O ' ' CG2' ' B' ' 20' ' ' VAL . 4.2 t . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 110.017 -0.364 . . . . 10.0 110.017 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 35' ' ' THR . 16.9 t 77.56 5.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.019 -0.426 . . . . 10.0 110.664 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.58 ' HA ' ' CG1' ' B' ' 20' ' ' VAL . 73.9 t80 -39.55 161.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.784 0.802 . . . . 10.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.617 ' CB ' ' CD1' ' B' ' 18' ' ' ILE . 3.7 p30 -79.13 -161.08 0.28 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.346 1.07 . . . . 10.0 113.391 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.583 ' O ' ' CG2' ' B' ' 17' ' ' THR . 1.4 m120 -152.9 -171.52 3.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD2' ' CG2' ' B' ' 17' ' ' THR . 69.6 m-85 -121.72 152.87 38.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 10.0 111.647 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.689 ' CB ' ' CZ ' ' A' ' 56' ' ' PHE . . . -131.18 99.51 4.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.302 -0.874 . . . . 10.0 109.715 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.6 ' CB ' ' HB3' ' B' ' 15' ' ' GLU . 1.4 p -131.44 -168.9 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 122.104 0.954 . . . . 10.0 111.182 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 23.2 m -142.43 151.5 41.85 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.585 0.707 . . . . 10.0 110.005 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -136.08 126.2 41.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.456 -0.778 . . . . 10.0 109.527 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.574 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 30.9 mtt -90.87 96.56 10.7 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.69 -1.204 . . . . 10.0 109.625 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.583 ' CG2' ' HG3' ' B' ' 7' ' ' GLU . 1.4 mp -72.03 104.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.548 -0.72 . . . . 10.0 110.049 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 43.65 35.06 2.89 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.776 -1.202 . . . . 10.0 110.428 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.52 2.17 30.92 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.879 -1.365 . . . . 10.0 110.802 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' ILE . 79.6 mt-10 -117.45 110.73 40.53 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.741 -1.446 . . . . 10.0 110.297 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.2 Cg_endo -75.13 135.75 19.25 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.566 1.298 . . . . 10.0 110.706 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -99.76 122.85 43.36 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 10.0 110.749 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.595 ' CB ' ' HA ' ' A' ' 3' ' ' THR . 30.2 p -84.6 98.32 10.1 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.05 -1.031 . . . . 10.0 109.439 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 51' ' ' TYR . 6.8 mt -121.48 126.67 49.83 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.662 -1.215 . . . . 10.0 109.672 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.48 ' HA2' ' CB ' ' A' ' 41' ' ' ALA . . . -141.35 100.8 0.27 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.531 -1.828 . . . . 10.0 108.531 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.559 HD13 ' CB ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -115.36 117.24 29.88 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.224 -1.162 . . . . 10.0 110.581 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.689 ' CZ ' ' CB ' ' A' ' 41' ' ' ALA . 20.9 m-85 -134.59 144.4 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 22.1 m-20 -105.78 160.76 14.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.475 -1.391 . . . . 10.0 110.008 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CD1' ' B' ' 36' ' ' TRP . 4.3 t -70.42 -177.94 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.06 . . . . 10.0 110.97 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . . . -111.04 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.708 -0.62 . . . . 10.0 109.409 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.02 -34.51 38.88 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 107.781 -2.128 . . . . 10.0 107.781 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CB ' ' HA3' ' B' ' 21' ' ' GLY . 20.4 tt0 -99.94 -19.19 16.72 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 10.0 109.863 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 65.4 mt-10 58.64 84.98 0.1 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.269 -0.895 . . . . 10.0 110.564 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 61' ' ' GLN . 55.6 m-20 -96.4 -10.39 27.74 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 3.9 p90 -140.3 -35.1 0.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 10.0 109.571 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 2.7 p30 38.11 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 10.0 111.074 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' TYR . 1.7 mmm-85 -58.16 -32.59 68.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.066 -1.021 . . . . 10.0 109.287 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.593 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -79.93 7.67 8.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -0.759 . . . . 10.0 110.097 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.664 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -52.16 -36.44 32.03 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.335 -0.853 . . . . 10.0 112.74 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.583 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 48.9 Cg_endo -77.6 10.49 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 122.62 0.8 . . . . 10.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.664 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -45.94 -64.47 0.73 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.935 -1.103 . . . . 10.0 111.954 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 70' ' ' LEU . 67.4 m 41.06 32.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.899 -1.126 . . . . 10.0 109.969 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 6.7 t80 -171.33 127.8 0.66 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 10.0 110.677 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.96 130.59 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.997 1.525 . . . . 10.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 4.1 mt-30 -138.32 67.35 1.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.232 -0.917 . . . . 10.0 108.943 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 95.1 m -144.67 92.1 2.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 10.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.1 m-20 -39.13 -30.46 0.05 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.661 -0.65 . . . . 10.0 111.178 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 5' ' ' LYS . 1.5 p -112.82 118.22 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.819 -1.176 . . . . 10.0 110.021 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 23.3 m-85 -119.29 133.92 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.429 -0.794 . . . . 10.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HD22 ' A' ' 111' ' ' LEU . 1.2 mm? -104.36 97.43 7.37 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -96.1 147.02 6.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.783 -0.767 . . . . 10.0 110.357 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -113.9 101.89 9.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.078 0.942 . . . . 10.0 110.882 -178.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CE2' ' CG1' ' A' ' 80' ' ' VAL . 35.9 m-85 -92.44 178.32 5.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -0.977 . . . . 10.0 110.003 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.4 m -108.96 158.2 17.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 10.0 109.262 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 137' ' ' ILE . 4.1 t -99.18 -19.03 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.16 -0.962 . . . . 10.0 111.188 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 129' ' ' LEU . 4.1 t -96.59 -60.16 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.01 -1.056 . . . . 10.0 110.209 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -73.39 114.84 35.36 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.393 -0.817 . . . . 10.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 52.5 Cg_endo -88.59 -3.45 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.076 1.566 . . . . 10.0 110.495 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 133' ' ' LYS . 4.1 p -75.1 21.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.289 -0.882 . . . . 10.0 112.115 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 19.5 t -131.4 -31.39 1.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 10.0 109.934 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -72.8 -53.0 12.69 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.095 -1.003 . . . . 10.0 110.678 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 9.3 tp10 -49.79 -17.9 0.41 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.029 -1.044 . . . . 10.0 112.037 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.557 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -91.37 -18.96 23.44 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.497 -1.377 . . . . 10.0 110.822 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.616 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 3.6 m -91.06 -18.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 118.39 -1.324 . . . . 10.0 109.306 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 21.2 mmtt -88.65 -20.38 24.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.924 . . . . 10.0 109.138 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -95.99 -0.68 50.31 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.442 178.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -91.54 -51.69 5.14 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.773 -1.171 . . . . 10.0 112.578 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.616 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 34.3 p-90 -95.37 -26.01 16.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.81 -1.181 . . . . 10.0 111.771 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.1 t -53.77 -43.39 96.19 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.705 -1.247 . . . . 10.0 109.777 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 42.1 Cg_endo -75.93 -24.28 11.54 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.292 1.154 . . . . 10.0 110.147 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 6.3 mm-40 -61.27 -13.17 16.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.907 -1.121 . . . . 10.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 24.9 mm 71.68 82.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 10.0 111.311 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -16.66 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -56.46 -47.26 79.55 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.65 -1.241 . . . . 10.0 107.65 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -64.85 -40.35 95.01 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.466 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -81.99 -176.6 0.8 Allowed Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.724 -0.61 . . . . 10.0 109.42 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 50.5 Cg_endo -77.84 19.72 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.832 1.438 . . . . 10.0 112.856 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 58.35 67.1 0.98 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.377 -1.452 . . . . 10.0 108.929 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.492 HG23 ' HD2' ' A' ' 109' ' ' PRO . 21.0 m -45.46 134.89 5.86 Favored Pre-proline 0 N--CA 1.49 1.571 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.915 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 108' ' ' THR . 42.6 Cg_endo -69.79 140.75 43.33 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.984 1.518 . . . . 10.0 110.997 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.556 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -136.95 113.28 9.96 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.704 0.764 . . . . 10.0 110.939 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.3 mm? -87.98 97.0 10.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 1.6 tt -79.14 124.07 27.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.038 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.527 HG21 ' CG1' ' A' ' 168' ' ' VAL . 2.4 t -139.92 164.82 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 10.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -111.61 156.15 15.74 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.119 -1.993 . . . . 10.0 108.119 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.531 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 9.6 t -138.01 160.91 38.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.365 . . . . 10.0 111.169 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 115' ' ' THR . 7.2 mt-30 58.98 36.67 24.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.526 -0.734 . . . . 10.0 109.903 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.729 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -72.63 -19.52 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.351 -0.843 . . . . 10.0 109.751 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 7.6 t70 -51.75 58.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 122.156 0.979 . . . . 10.0 112.125 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 3.6 tp 162.27 -23.63 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.526 -1.215 . . . . 10.0 108.131 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -50.88 -33.24 23.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.16 -26.56 60.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 10.0 109.901 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.0 OUTLIER -93.53 132.02 31.11 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.452 -0.78 . . . . 10.0 110.549 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -87.0 23.26 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.471 1.447 . . . . 10.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 47.5 t -110.68 -50.62 2.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -0.98 . . . . 10.0 111.016 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 126' ' ' ILE . 10.0 t -70.11 -27.22 64.41 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.565 ' CD1' ' O ' ' A' ' 122' ' ' ASP 0.306 1.2 mp -51.91 -25.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 10.0 107.361 176.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 25.6 tt0 -58.46 -42.04 86.55 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.282 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -55.92 -41.64 74.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.529 -0.732 . . . . 10.0 110.665 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.546 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -75.72 -33.85 60.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 10.0 109.549 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' LYS . . . -52.52 -50.2 63.3 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.326 0.584 . . . . 10.0 110.277 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -28.91 61.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.258 -0.901 . . . . 10.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.483 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.4 t30 -71.56 -52.19 19.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.951 . . . . 10.0 109.985 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.573 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 3.2 mmtt -134.38 155.75 49.74 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.549 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -105.43 24.09 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.005 . . . . 10.0 111.157 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -148.74 92.95 4.33 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 10.0 109.391 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.72 160.61 48.84 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.183 1.622 . . . . 10.0 110.519 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 84' ' ' VAL . 4.6 tp -102.07 133.68 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.464 -0.939 . . . . 10.0 108.464 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.9 p -119.67 165.04 18.72 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 121.182 -0.949 . . . . 10.0 110.159 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.6 Cg_endo -64.13 -32.3 63.72 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.935 1.492 . . . . 10.0 110.369 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.529 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 17.3 pt-20 -74.14 -29.82 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 10.0 109.456 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.1 m -80.13 -41.02 26.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.79 . . . . 10.0 110.247 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.21 68.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.471 -0.768 . . . . 10.0 110.54 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 18.9 tt0 -57.11 -42.57 81.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 10.0 109.637 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 14.5 mtmt -68.6 -40.33 80.49 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.161 -0.962 . . . . 10.0 109.494 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.508 HD23 ' CE ' ' A' ' 94' ' ' LYS . 6.6 tt -56.0 -43.45 77.67 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.029 -1.044 . . . . 10.0 109.671 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -51.17 54.73 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 10.0 108.648 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -60.6 -30.37 69.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 10.0 109.624 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 144' ' ' LYS . 32.9 t70 -67.99 -45.06 75.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.307 -0.871 . . . . 10.0 110.301 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.67 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -92.76 14.78 16.23 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.089 0.947 . . . . 10.0 108.964 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 151' ' ' ALA . 8.9 mttp 56.23 38.28 29.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.786 0.803 . . . . 10.0 110.299 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -60.97 -141.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.198 -0.601 . . . . 10.0 109.563 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.556 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -117.43 -57.7 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.959 -1.088 . . . . 10.0 110.477 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.46 ' HD2' ' CD ' ' A' ' 171' ' ' GLU . 0.9 OUTLIER -170.89 145.09 2.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.116 -1.434 . . . . 10.0 111.813 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.49 ' HB2' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -90.79 119.49 31.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -124.53 -168.88 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.863 -1.148 . . . . 10.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.497 ' CA ' HG12 ' A' ' 113' ' ' VAL . 6.0 tt0 -146.82 152.7 39.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.975 . . . . 10.0 110.335 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.559 ' CB ' ' CB ' ' A' ' 165' ' ' LEU . 31.1 p -160.36 145.18 14.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 10.0 111.394 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 162' ' ' GLN . 18.4 m -149.91 103.79 3.25 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -37.02 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.562 0.696 . . . . 10.0 112.316 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.429 ' HA ' ' OE2' ' B' ' 28' ' ' GLU . 0.3 OUTLIER -57.61 -7.9 0.76 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.532 HG23 ' CB ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -134.78 -92.52 0.31 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.069 -1.644 . . . . 10.0 114.669 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 7.5 mm-40 -11.55 -69.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.817 0.817 . . . . 10.0 112.657 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.628 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 11.7 mttt 62.57 30.35 17.06 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.815 0.817 . . . . 10.0 109.44 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.0 -0.94 5.49 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.97 -1.652 . . . . 10.0 108.97 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.701 ' N ' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -65.89 -7.75 18.32 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.279 -1.13 . . . . 10.0 111.847 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.483 ' N ' HD11 ' A' ' 165' ' ' LEU . 11.5 mtmt -56.77 -33.05 66.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.581 -1.324 . . . . 10.0 109.827 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -70.35 -33.71 71.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 10.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 165' ' ' LEU . 7.3 t -49.22 -35.84 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.752 -1.218 . . . . 10.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -78.91 -40.93 30.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 10.0 110.734 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.472 ' O ' HD21 ' A' ' 174' ' ' LEU . 14.4 m-20 -54.1 -46.7 72.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.185 -0.947 . . . . 10.0 111.429 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.486 ' OE2' ' CG2' ' A' ' 155' ' ' VAL . 6.9 pt-20 -66.15 -35.01 79.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 10.0 112.158 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.569 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -66.86 -17.95 65.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.597 -1.314 . . . . 10.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.533 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 22.1 mt -66.88 -44.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.366 -0.934 . . . . 10.0 109.119 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -85.09 -17.84 36.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 10.0 111.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.498 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -95.54 -0.49 51.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.906 -1.122 . . . . 10.0 110.141 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.614 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -87.95 -49.09 7.29 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.434 -0.791 . . . . 10.0 109.973 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.542 ' HB3' ' NE2' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -88.55 -16.58 32.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.552 -0.718 . . . . 10.0 109.598 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 177' ' ' LEU . 2.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.035 -0.984 . . . . 10.0 110.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 109.532 -1.427 . . . . 10.0 109.532 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.429 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . 68.7 m -59.66 152.29 22.82 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -1.112 . . . . 10.0 110.328 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 102.05 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.567 -0.708 . . . . 10.0 111.366 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -118.68 159.86 22.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -0.835 . . . . 10.0 110.133 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.657 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.55 -150.02 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.657 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 42.6 Cg_endo -70.88 85.72 0.77 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 N-CA-C 109.844 -0.868 . . . . 10.0 109.844 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.583 ' HG3' ' CG2' ' A' ' 46' ' ' ILE . 17.9 mm-40 -53.53 -164.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.648 -0.657 . . . . 10.0 110.826 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.404 HG13 ' H ' ' B' ' 9' ' ' SER . 1.5 pp -81.3 -51.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 10.0 112.472 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.404 ' H ' HG13 ' B' ' 8' ' ' ILE . 43.7 t -159.09 164.99 34.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.422 -1.424 . . . . 10.0 111.624 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -158.89 106.83 1.59 Allowed Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.577 -0.849 . . . . 10.0 111.951 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 42.6 Cg_endo -69.34 115.07 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.155 1.608 . . . . 10.0 109.607 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.81 178.39 0.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.399 -0.813 . . . . 10.0 111.609 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 43' ' ' THR . 1.7 t0 -135.09 -169.32 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.957 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' B' ' 14' ' ' PHE . 5.1 m-85 -99.88 152.71 19.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 10.0 110.435 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -160.7 163.44 32.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.38 -0.825 . . . . 10.0 110.641 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -149.9 167.23 27.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.721 -1.192 . . . . 10.0 112.039 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.583 ' CG2' ' O ' ' A' ' 39' ' ' ASN 0.257 2.4 p -124.34 162.47 23.72 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.676 -0.64 . . . . 10.0 111.115 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.617 ' CD1' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -93.31 -167.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.932 -1.105 . . . . 10.0 109.153 177.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -112.68 157.48 21.21 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.728 -1.233 . . . . 10.0 111.377 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.1 p -122.73 152.7 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.022 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.54 ' HA3' ' CB ' ' A' ' 61' ' ' GLN . . . -147.33 179.16 24.45 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.211 -1.556 . . . . 10.0 109.211 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 4.4 m-85 62.3 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.298 -1.119 . . . . 10.0 111.417 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.469 ' O ' ' C ' ' B' ' 24' ' ' ALA . 7.0 p-10 -66.71 157.57 32.37 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.578 0.704 . . . . 10.0 111.915 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 24.98 46.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.318 0.58 . . . . 10.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 23' ' ' ASP . 1.2 t -104.58 -33.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.596 ' CG2' ' O ' ' B' ' 26' ' ' THR . 0.7 OUTLIER -128.61 17.82 6.34 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.811 0.815 . . . . 10.0 109.411 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.629 ' HA2' ' CG2' ' A' ' 21' ' ' ILE . . . -61.43 -22.3 61.11 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.621 ' CB ' ' CB ' ' A' ' 28' ' ' PHE . 3.0 tt0 -153.09 -151.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.633 -0.922 . . . . 10.0 109.041 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -103.78 115.35 30.32 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 120.922 -1.111 . . . . 10.0 110.32 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.589 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 p -130.3 -89.01 0.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 10.0 110.076 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -80.24 -115.28 0.3 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.481 ' O ' HG23 ' B' ' 32' ' ' ILE . 2.6 tt -173.27 56.14 0.2 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 10.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 44.4 Cg_endo -71.77 155.06 58.85 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.781 1.411 . . . . 10.0 110.883 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.593 ' HG3' ' CG ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -61.19 153.37 26.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.342 -0.849 . . . . 10.0 110.475 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 0.5 OUTLIER -73.92 -57.37 4.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.349 -0.844 . . . . 10.0 111.234 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.569 ' CD1' ' OG1' ' A' ' 58' ' ' THR . 3.3 t90 174.26 27.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.584 -0.697 . . . . 10.0 109.838 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . 178.22 15.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.266 -0.896 . . . . 10.0 112.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.593 ' CG ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 119.974 -1.704 . . . . 10.0 108.109 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.403 ' C ' ' HG2' ' A' ' 2' ' ' GLN . 6.9 mtm . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.963 0.411 . . . . 10.0 110.05 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.504 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 28.9 mm100 -146.21 -33.83 0.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.019 -1.05 . . . . 10.0 109.743 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.537 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 51.8 m -56.54 110.93 0.86 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.324 -0.86 . . . . 10.0 111.01 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -108.33 128.01 64.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.86 -1.136 . . . . 10.0 110.088 178.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.623 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.7 ttmt -112.23 109.54 19.28 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 51.7 t -93.94 102.6 14.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.59 -1.319 . . . . 10.0 110.369 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.78 163.14 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.71 -1.196 . . . . 10.0 110.765 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.551 HG21 ' CG2' ' A' ' 17' ' ' THR . 1.9 t -78.26 154.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.295 -0.878 . . . . 10.0 109.388 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -160.39 174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.854 -1.154 . . . . 10.0 110.353 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.578 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 115.2 173.5 17.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.651 -1.78 . . . . 10.0 108.651 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.13 -29.43 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.712 -1.463 . . . . 10.0 108.894 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 163.7 -81.29 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.721 -1.752 . . . . 10.0 108.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . 39.96 -131.88 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.992 . . . . 10.0 110.937 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 115' ' ' THR . 6.1 m -110.72 153.89 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 10.0 111.748 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -111.96 110.13 2.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.229 -1.548 . . . . 10.0 109.229 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.13 -20.63 7.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.761 -1.435 . . . . 10.0 110.896 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.551 ' CG2' HG21 ' A' ' 8' ' ' VAL . 11.4 t -73.82 -32.17 63.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.762 -1.212 . . . . 10.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' B' ' 29' ' ' PHE . 18.3 p -73.68 -15.68 61.23 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.618 -1.301 . . . . 10.0 107.673 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.678 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 53.7 mt -95.69 -23.42 17.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -46.85 -43.38 18.58 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.842 0.829 . . . . 10.0 109.046 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.642 ' CG2' ' HB2' ' A' ' 26' ' ' ASN . 4.6 mm -74.72 -39.88 46.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 19' ' ' LEU . 4.6 p -52.02 -49.25 63.75 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 119.435 -0.906 . . . . 10.0 110.254 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.757 ' CE2' ' CD1' ' A' ' 165' ' ' LEU . 4.7 m-85 -62.05 -34.09 75.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.377 -1.452 . . . . 10.0 109.706 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -72.79 -51.99 16.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.562 -0.855 . . . . 10.0 111.048 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.532 HG22 ' ND2' ' A' ' 26' ' ' ASN . 11.8 t -169.49 -20.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.959 -1.896 . . . . 10.0 114.563 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.642 ' HB2' ' CG2' ' A' ' 21' ' ' ILE . 4.8 m-80 -79.29 -8.67 59.22 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.454 -1.404 . . . . 10.0 111.223 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.57 ' NZ ' ' O ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 14.86 -146.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 114.359 1.244 . . . . 10.0 114.359 178.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' B' ' 30' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.507 2.408 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.605 ' O ' ' CG2' ' B' ' 20' ' ' VAL . 68.9 p . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' B' ' 26' ' ' THR . 16.5 t 63.1 -6.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.57 -1.331 . . . . 10.0 111.811 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -67.58 95.29 0.47 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 120.474 -1.391 . . . . 10.0 109.368 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HA ' HG22 ' B' ' 18' ' ' ILE . 2.3 m-20 -165.78 103.69 0.69 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.308 -1.757 . . . . 10.0 114.278 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.561 ' H ' ' CG2' ' B' ' 18' ' ' ILE . 53.5 t30 -134.59 97.17 3.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.858 -1.151 . . . . 10.0 108.471 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' B' ' 15' ' ' GLU . 2.9 m-30 -118.76 146.58 44.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.669 -0.644 . . . . 10.0 111.063 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.529 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -171.72 98.07 0.18 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.08 -1.013 . . . . 10.0 109.262 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.581 HG12 ' O ' ' B' ' 14' ' ' PHE . 30.9 m -156.15 -165.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.988 0.899 . . . . 10.0 112.276 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.512 ' O ' ' HB3' ' B' ' 12' ' ' SER . 20.3 m -130.24 155.23 46.63 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.294 0.569 . . . . 10.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' B' ' 12' ' ' SER . 11.6 t -131.2 150.99 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.589 -0.694 . . . . 10.0 109.215 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.617 ' O ' ' O ' ' B' ' 10' ' ' LEU . 10.6 mtp -110.52 93.14 4.34 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.978 -1.489 . . . . 10.0 107.661 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.542 ' N ' HD11 ' A' ' 46' ' ' ILE . 1.8 mp -72.57 103.01 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 O-C-N 120.594 -1.316 . . . . 10.0 109.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.621 ' CA ' ' HB3' ' B' ' 9' ' ' SER . . . 51.0 30.56 23.26 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.404 -1.379 . . . . 10.0 110.119 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.92 6.12 37.65 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 120.845 -1.385 . . . . 10.0 110.592 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.6 tp10 -110.87 115.1 53.65 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.234 -1.157 . . . . 10.0 109.758 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.7 Cg_endo -71.59 139.0 33.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.947 1.498 . . . . 10.0 110.88 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.1 163.04 15.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 10.0 111.9 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.58 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.1 m -122.99 104.75 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.65 147.93 31.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.789 -1.195 . . . . 10.0 110.893 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.44 99.98 0.17 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.044 -1.623 . . . . 10.0 109.044 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -138.34 139.81 39.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -1.177 . . . . 10.0 110.269 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.564 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 18.4 p90 -162.06 139.96 8.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.136 -0.978 . . . . 10.0 110.139 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 m-20 -104.25 170.1 8.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.097 -1.002 . . . . 10.0 110.476 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.501 HG21 ' CD2' ' B' ' 36' ' ' TRP . 5.5 t -43.55 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 10.0 111.927 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -133.29 90.53 2.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.526 -0.733 . . . . 10.0 110.652 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -66.87 71.14 0.18 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 106.885 -2.486 . . . . 10.0 106.885 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER 64.02 28.69 14.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.541 -0.976 . . . . 10.0 109.216 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -58.95 -58.59 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.834 -1.166 . . . . 10.0 109.768 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.8 OUTLIER 175.09 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.256 -0.903 . . . . 10.0 110.147 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.607 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -151.7 -34.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 10.0 109.917 -179.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.8 t0 79.05 20.99 0.7 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.365 0.602 . . . . 10.0 109.616 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.474 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -58.73 -19.11 37.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 178.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.48 ' C ' HD22 ' A' ' 70' ' ' LEU . 1.1 pp -55.23 -16.32 3.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.531 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 1.1 ttm180 -99.68 -52.98 0.19 Allowed Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 45.7 Cg_endo -70.54 -16.51 34.28 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 120.466 0.778 . . . . 10.0 112.625 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.623 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -54.84 -10.91 0.52 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.678 -1.264 . . . . 10.0 111.949 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.554 ' HA ' ' O ' ' B' ' 37' ' ' ALA . 1.0 OUTLIER -45.83 -31.78 2.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.953 -1.092 . . . . 10.0 110.449 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 134.44 34.42 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 10.0 111.27 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.616 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 43.3 Cg_endo -80.27 159.2 23.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.899 1.473 . . . . 10.0 110.588 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 163.91 78.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.29 0.567 . . . . 10.0 109.586 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.623 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 89.1 m -146.83 99.59 3.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.312 -0.867 . . . . 10.0 109.962 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 75' ' ' THR . 81.5 m-20 -38.86 -30.59 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.487 -0.758 . . . . 10.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.539 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.5 OUTLIER -119.02 120.37 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 10.0 109.337 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.574 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 67.0 m-85 -108.19 129.48 55.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.909 -1.12 . . . . 10.0 111.906 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 111' ' ' LEU . 2.0 mm? -104.05 97.05 7.09 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -107.24 145.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.101 -0.999 . . . . 10.0 110.495 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.509 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 39.4 t -141.43 126.17 18.01 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.157 -0.964 . . . . 10.0 111.192 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CA ' ' OG1' ' A' ' 115' ' ' THR . 1.8 p90 -135.01 168.26 19.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.441 -0.787 . . . . 10.0 110.654 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.6 t -77.3 161.06 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 10.0 109.74 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.479 HG13 HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -110.74 14.98 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 10.0 111.118 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 129' ' ' LEU . 3.0 m -125.48 -17.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.69 -1.257 . . . . 10.0 111.716 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.63 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -60.66 -159.7 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.992 -1.067 . . . . 10.0 110.096 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.3 Cg_endo -71.9 178.31 6.01 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 122.804 0.897 . . . . 10.0 110.099 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.84 66.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.246 -0.909 . . . . 10.0 110.087 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' PRO . 66.1 m -89.96 -15.28 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.691 . . . . 10.0 110.537 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 137' ' ' ILE . 6.1 t80 -86.24 -50.23 7.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 10.0 110.188 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -65.65 -30.59 71.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.545 -0.722 . . . . 10.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -79.29 -14.22 59.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.821 -1.174 . . . . 10.0 109.58 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.653 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 2.7 t -83.84 -21.81 8.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.612 -1.305 . . . . 10.0 107.914 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -72.12 -37.87 69.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 178.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 1.4 pt-20 -69.49 -10.53 58.45 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.943 -0.703 . . . . 10.0 109.263 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -87.34 -52.37 5.42 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.316 -0.954 . . . . 10.0 112.582 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.653 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 54.9 p-90 -93.91 -15.93 24.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.752 -1.217 . . . . 10.0 112.444 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.595 HG23 ' CZ3' ' A' ' 97' ' ' TRP . 58.8 t -66.9 -50.78 41.47 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.745 -1.222 . . . . 10.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.543 ' O ' HG13 ' A' ' 101' ' ' ILE . 44.0 Cg_endo -71.58 -20.64 26.7 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.21 1.111 . . . . 10.0 109.761 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 5.7 mm-40 -57.14 -35.97 70.14 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.344 -0.943 . . . . 10.0 109.264 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 99' ' ' PRO . 10.2 mt 55.15 118.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.379 -0.825 . . . . 10.0 110.881 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 105' ' ' CYS . 4.2 p -48.66 -24.91 1.52 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.001 -1.062 . . . . 10.0 109.07 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -76.2 -33.13 59.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.528 -0.732 . . . . 10.0 109.843 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 1.4 t-80 -105.91 -16.71 14.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 10.0 110.847 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 102' ' ' THR . 1.1 m -166.4 175.51 2.21 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.041 . . . . 10.0 110.085 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 105' ' ' CYS . 43.0 Cg_endo -70.72 86.72 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.641 1.337 . . . . 10.0 111.747 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.611 ' HB3' ' N ' ' A' ' 102' ' ' THR . 8.5 tttp -102.58 4.88 38.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 10.0 109.589 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.58 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 90.8 m -43.02 147.48 0.67 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 10.0 110.309 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 34.3 Cg_endo -58.22 160.67 15.57 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.019 1.813 . . . . 10.0 112.81 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' HG11 ' A' ' 152' ' ' VAL . 1.7 p90 -151.01 144.53 24.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.2 1.0 . . . . 10.0 109.417 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 152' ' ' VAL . 1.2 mm? -77.88 99.68 6.07 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.841 0.829 . . . . 10.0 109.745 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 75.5 mt -62.9 146.87 51.88 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 3.0 t -148.39 173.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.46 -1.4 . . . . 10.0 111.929 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -109.66 138.43 14.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.842 -1.703 . . . . 10.0 108.842 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.55 ' OG1' ' CA ' ' A' ' 82' ' ' PHE . 97.1 m -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.003 -1.292 . . . . 10.0 110.626 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.8 tp60 41.9 59.8 2.43 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.432 -0.793 . . . . 10.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.77 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -61.54 -42.05 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.998 -1.482 . . . . 10.0 106.998 179.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 4.8 p30 -51.91 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.284 1.04 . . . . 10.0 110.385 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 162.34 -28.07 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -47.47 -41.43 20.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.592 0.711 . . . . 10.0 109.62 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.529 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 77.5 m-20 -67.57 -10.14 49.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.401 -0.812 . . . . 10.0 109.99 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 119' ' ' LEU . 14.8 t0 -82.3 117.15 67.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.824 . . . . 10.0 109.301 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.62 23.77 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.154 1.607 . . . . 10.0 110.97 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 37.2 t -107.84 -49.35 3.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.167 -0.958 . . . . 10.0 109.932 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.433 HG21 HD12 ' A' ' 126' ' ' ILE . 14.4 t -75.06 -31.25 61.23 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 130' ' ' ALA 0.295 1.2 mp -56.02 -23.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 176.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 124' ' ' SER . 12.4 tt0 -47.99 -42.25 27.36 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.382 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -71.13 -49.55 42.95 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.48 -0.763 . . . . 10.0 110.547 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 86' ' ' SER . 4.9 mp -67.3 -43.68 81.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.67 0.748 . . . . 10.0 110.691 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.478 ' HB3' HG21 ' A' ' 126' ' ' ILE . . . -56.22 -42.46 77.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 10.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -52.23 -21.3 3.27 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.214 -0.929 . . . . 10.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.583 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 3.1 t30 -85.9 -68.12 0.76 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.381 -0.825 . . . . 10.0 111.242 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.512 ' HD3' ' ND2' ' A' ' 132' ' ' ASN . 0.4 OUTLIER -124.59 129.4 50.51 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.532 -0.73 . . . . 10.0 110.6 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.648 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER -84.25 9.05 13.9 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.357 -0.839 . . . . 10.0 109.172 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -118.6 94.03 46.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.415 -0.803 . . . . 10.0 110.368 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 162.35 28.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.586 1.524 . . . . 10.0 110.182 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 90' ' ' PHE . 2.4 tp -103.98 146.61 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.004 -1.06 . . . . 10.0 110.34 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.4 p -132.69 171.12 9.7 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 10.0 110.102 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.625 ' CB ' ' CD1' ' A' ' 154' ' ' TYR . 40.0 Cg_endo -71.69 -22.55 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.551 1.29 . . . . 10.0 111.445 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -55.15 21.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.085 . . . . 10.0 109.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -65.4 -39.85 92.7 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.372 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.47 -30.01 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.009 -1.057 . . . . 10.0 111.144 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.38 -49.3 67.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.183 -0.948 . . . . 10.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 148' ' ' ASP . 7.2 ttmt -62.91 -44.01 97.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.347 -0.941 . . . . 10.0 109.078 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.48 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.0 tt -59.32 -33.51 71.21 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.486 -0.758 . . . . 10.0 109.157 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -67.34 -50.02 61.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.69 0.757 . . . . 10.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -84.34 -10.12 57.87 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.35 -0.94 . . . . 10.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 144' ' ' LYS . 37.6 t0 -93.77 -37.55 11.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.599 -1.313 . . . . 10.0 110.795 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.4 mp -101.07 24.75 8.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 10.0 109.735 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.9 mtpt 61.95 39.21 13.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.561 -0.745 . . . . 10.0 112.017 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -95.26 -156.05 0.5 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.71 -66.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.473 -1.392 . . . . 10.0 110.259 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -172.68 174.8 3.59 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.679 -1.608 . . . . 10.0 112.003 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.625 ' CD1' ' CB ' ' A' ' 139' ' ' PRO . 41.5 p90 -104.34 133.6 48.97 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -137.71 -169.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.307 -0.871 . . . . 10.0 109.781 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.494 ' CA ' HG11 ' A' ' 113' ' ' VAL . 78.4 mm-40 -144.13 162.86 35.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.016 -1.053 . . . . 10.0 110.138 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 163' ' ' LYS . 15.5 p -164.89 133.82 3.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.282 -0.886 . . . . 10.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.525 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 32.6 t -120.78 173.38 7.25 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . . . -86.67 -78.76 0.28 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 120.899 -1.126 . . . . 10.0 111.789 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 160' ' ' LEU . 3.8 pp -91.49 -4.25 55.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.434 -1.416 . . . . 10.0 111.108 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.1 m -96.1 -32.41 12.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.087 -1.008 . . . . 10.0 111.466 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.9 mt-30 75.92 67.84 0.07 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.236 -0.915 . . . . 10.0 109.772 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -102.9 102.73 12.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.831 -1.147 . . . . 10.0 109.719 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 168' ' ' VAL . . . 78.14 10.51 86.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.36 -1.896 . . . . 10.0 108.36 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.757 ' CD1' ' CE2' ' A' ' 23' ' ' TYR 0.254 0.2 OUTLIER -54.34 -51.84 63.46 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.995 0.902 . . . . 10.0 110.78 -179.658 . . . . . . . . 4 4 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -80.91 -10.56 59.7 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.809 -0.557 . . . . 10.0 111.101 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.465 ' HB3' HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -85.31 -31.57 22.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.193 -0.942 . . . . 10.0 110.342 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.543 HG11 ' CD1' ' A' ' 79' ' ' LEU . 2.8 t -71.92 -25.82 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.02 -1.05 . . . . 10.0 108.219 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -76.2 -49.68 16.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.314 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 26.2 m-20 -63.03 -49.88 72.88 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.282 -0.886 . . . . 10.0 112.269 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.463 ' O ' HD23 ' A' ' 174' ' ' LEU . 24.2 mm-40 -60.89 -40.79 94.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.896 -1.128 . . . . 10.0 111.25 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -60.54 -22.5 63.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.98 -1.075 . . . . 10.0 109.925 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 169' ' ' PHE . 18.2 mm -61.13 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.219 -0.926 . . . . 10.0 109.864 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.34 -45.85 65.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.255 -0.903 . . . . 10.0 110.557 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.2 4.42 23.53 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.351 -0.843 . . . . 10.0 110.532 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 172' ' ' ALA . . . -84.47 -39.37 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 10.0 110.666 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -101.83 -14.76 17.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 10.0 110.409 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.877 -1.059 . . . . 10.0 110.68 -179.626 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.411 . . . . 10.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.533 ' O ' ' N ' ' B' ' 4' ' ' GLU . 54.3 m -98.81 33.5 2.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.244 -1.151 . . . . 10.0 110.646 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 174' ' ' LEU . 1.3 ttmt -50.15 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 10.0 110.597 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 2' ' ' SER . 31.9 mm-40 -134.74 167.61 20.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.186 -0.946 . . . . 10.0 110.664 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.635 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.03 -153.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.158 -1.052 . . . . 10.0 108.158 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.635 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.3 Cg_endo -69.87 84.22 0.68 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 N-CA-C 109.463 -1.014 . . . . 10.0 109.463 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.512 ' CG ' HG21 ' A' ' 46' ' ' ILE . 1.3 tp10 -44.43 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.79 0.805 . . . . 10.0 111.115 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.615 ' CD1' ' N ' ' B' ' 9' ' ' SER . 1.6 pp -91.56 -23.39 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 122.566 1.174 . . . . 10.0 107.939 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.621 ' HB3' ' CA ' ' A' ' 47' ' ' GLY . 43.3 m -57.24 -166.64 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.68 -1.145 . . . . 10.0 112.205 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.617 ' O ' ' O ' ' A' ' 45' ' ' MET . 0.2 OUTLIER -37.48 117.23 0.82 Allowed Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.478 1.288 . . . . 10.0 114.478 -176.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.475 ' HD2' HD11 ' B' ' 10' ' ' LEU . 49.7 Cg_endo -93.95 111.31 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.488 1.459 . . . . 10.0 109.266 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -86.51 -168.01 2.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.799 -1.188 . . . . 10.0 110.054 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 147.03 0.97 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.499 -0.75 . . . . 10.0 110.009 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.581 ' O ' HG12 ' A' ' 42' ' ' VAL . 80.2 m-85 -90.88 163.16 14.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 10.0 110.14 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.65 ' CB ' ' CD2' ' A' ' 40' ' ' TYR . 2.3 mp0 -50.59 179.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.991 0.901 . . . . 10.0 112.322 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -81.3 -167.42 1.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.764 0.792 . . . . 10.0 112.719 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.3 m -85.46 152.81 22.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.688 -0.633 . . . . 10.0 109.843 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.704 HG22 ' HA ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -123.83 129.09 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 10.0 109.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 17.2 t60 -141.93 151.04 42.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.639 -1.288 . . . . 10.0 112.728 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.7 p -120.9 154.96 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.331 0.586 . . . . 10.0 111.181 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' B' ' 22' ' ' PHE . . . -124.31 56.64 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 106.93 -2.468 . . . . 10.0 106.93 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.632 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.0 OUTLIER 172.06 101.43 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.534 -0.98 . . . . 10.0 109.529 -177.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.445 ' O ' ' C ' ' B' ' 24' ' ' ALA . 9.8 t0 -61.77 139.94 58.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.114 -0.991 . . . . 10.0 111.165 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.454 ' O ' ' OE1' ' B' ' 28' ' ' GLU . . . 33.79 61.83 0.46 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.558 -0.714 . . . . 10.0 111.336 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 19.4 t -113.13 -27.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.163 -0.961 . . . . 10.0 110.818 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -121.19 -12.25 8.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 10.0 111.181 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.567 ' HA3' ' CB ' ' A' ' 26' ' ' ASN . . . -72.7 -29.91 64.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.239 -1.944 . . . . 10.0 108.239 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 13.2 mt-10 -83.44 97.63 9.08 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.925 0.869 . . . . 10.0 109.781 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.652 ' CE1' ' CG ' ' B' ' 33' ' ' PRO . 0.8 OUTLIER -110.64 144.52 39.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 120.07 -0.652 . . . . 10.0 109.404 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.639 ' CG2' ' CE1' ' A' ' 28' ' ' PHE . 7.2 p -148.14 -39.25 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.203 -0.936 . . . . 10.0 110.39 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.51 -154.56 11.43 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 120.046 -1.073 . . . . 10.0 110.773 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.07 76.21 6.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.782 -0.834 . . . . 10.0 111.621 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.652 ' CG ' ' CE1' ' B' ' 29' ' ' PHE . 43.9 Cg_endo -74.24 171.32 18.25 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.838 1.441 . . . . 10.0 109.199 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.38 171.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 10.0 111.642 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.508 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -94.25 16.55 14.62 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.758 -0.589 . . . . 10.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.508 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 53.4 m0 58.85 52.99 6.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 10.0 111.616 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -177.83 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.358 -0.839 . . . . 10.0 111.593 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? . . . . . 0 N--CA 1.499 1.998 0 O-C-N 120.964 -1.085 . . . . 10.0 110.792 -179.271 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.206 0.527 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -143.91 -14.51 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.224 -0.922 . . . . 10.0 110.542 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.62 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 57.0 m -71.91 112.43 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.302 -0.874 . . . . 10.0 111.758 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -106.26 121.63 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 118.854 -1.138 . . . . 10.0 108.974 177.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.585 ' O ' ' CG2' ' A' ' 75' ' ' THR . 2.3 mmtm -94.0 113.78 25.83 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.791 -1.189 . . . . 10.0 107.791 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.3 m -99.69 105.08 16.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.223 -0.923 . . . . 10.0 109.231 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.546 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 39.7 t -143.02 146.8 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.94 -1.104 . . . . 10.0 111.084 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.448 HG21 ' OG1' ' A' ' 17' ' ' THR . 21.8 t -59.77 141.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 10.0 109.961 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 80' ' ' VAL . 25.7 m -72.73 -169.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 10.0 110.925 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.67 11.06 6.03 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -49.96 -46.71 52.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.303 -1.116 . . . . 10.0 109.15 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 134.32 -12.41 4.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 81' ' ' CYS . . . -69.99 172.37 7.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.478 -1.013 . . . . 10.0 109.347 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' B' ' 29' ' ' PHE . 2.5 p -58.63 161.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.995 -1.066 . . . . 10.0 109.237 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' B' ' 35' ' ' GLN . . . -71.7 112.25 4.02 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.336 . . . . 10.0 109.761 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -49.75 -29.3 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.035 -1.274 . . . . 10.0 108.593 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.448 ' OG1' HG21 ' A' ' 8' ' ' VAL . 94.6 m -59.84 -33.02 71.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.503 -0.748 . . . . 10.0 109.371 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' B' ' 26' ' ' THR . 1.9 t -81.77 -13.86 57.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.601 -0.84 . . . . 10.0 109.899 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' B' ' 29' ' ' PHE . 4.4 mt -92.58 -31.19 15.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 10.0 109.486 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.13 -31.41 72.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 10.0 107.683 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.548 HG21 ' CG2' ' B' ' 26' ' ' THR 0.26 9.3 mm -72.19 -45.86 60.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.33 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 21' ' ' ILE . 20.1 p -48.85 -26.1 2.24 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.905 -1.118 . . . . 10.0 108.611 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 165' ' ' LEU . 2.8 m-85 -86.3 -26.02 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 10.0 108.596 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 21' ' ' ILE . 56.2 m -89.91 -31.15 17.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.667 . . . . 10.0 111.651 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.494 HG23 HG22 ' A' ' 21' ' ' ILE . 1.5 p -92.29 -81.32 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.613 -1.304 . . . . 10.0 109.687 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.643 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 8.9 m-80 -148.62 -30.19 0.28 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.931 -0.708 . . . . 10.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 6.4 pttt 145.96 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 CA-C-O 121.146 0.498 . . . . 10.0 109.815 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.595 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 113.076 0.769 . . . . 10.0 113.076 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.59 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.995 0.426 . . . . 10.0 111.427 . . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 37' ' ' PHE . 1.6 t 158.28 -78.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.594 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 29.9 t80 -61.3 140.22 58.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 10.0 110.96 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' HA ' HG13 ' B' ' 18' ' ' ILE . 35.6 t0 -164.56 85.73 0.44 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 39' ' ' ASN . 4.0 p-10 -104.96 103.46 13.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 10.0 111.421 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.583 ' CG ' ' HA ' ' B' ' 16' ' ' HIS . 0.2 OUTLIER -170.24 -168.4 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 10.0 110.076 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.04 165.22 28.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.045 -1.035 . . . . 10.0 110.358 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.564 ' CG1' ' HA ' ' B' ' 14' ' ' PHE . 60.2 t -155.57 171.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 10.0 110.972 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.461 HG21 ' N ' ' A' ' 44' ' ' VAL . 85.4 m -140.17 146.24 38.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.816 -0.552 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.551 HG12 ' CD1' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -105.34 170.64 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.007 -1.058 . . . . 10.0 109.443 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.489 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 8.4 mtt -144.0 121.71 11.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.447 -0.783 . . . . 10.0 109.93 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.599 ' CG2' ' HB2' ' B' ' 7' ' ' GLU . 1.4 mp -138.0 130.62 40.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.357 -0.84 . . . . 10.0 109.535 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 46.72 23.27 1.37 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.34 -1.504 . . . . 10.0 109.34 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.61 2.34 67.57 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.061 -1.258 . . . . 10.0 110.214 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.3 111.58 54.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.049 -1.265 . . . . 10.0 111.163 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.11 152.35 67.47 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.87 1.458 . . . . 10.0 109.906 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' CB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -116.06 163.55 15.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.072 -1.017 . . . . 10.0 110.876 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.62 ' CG2' ' HA ' ' A' ' 3' ' ' THR 0.256 39.0 m -124.21 112.51 17.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.78 -0.575 . . . . 10.0 109.795 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 4' ' ' ILE . 3.4 pp -146.59 179.94 7.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.9 -1.125 . . . . 10.0 111.445 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 53' ' ' LEU . . . -169.26 133.38 2.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.481 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.8 tm? -124.59 123.97 41.21 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.062 -1.257 . . . . 10.0 110.338 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -133.51 112.95 11.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 10.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.1 t0 -92.24 134.78 34.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 10.0 109.658 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' B' ' 36' ' ' TRP . 12.4 t -84.22 98.24 9.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 10.0 111.982 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.585 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . 164.7 62.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.358 -0.839 . . . . 10.0 109.89 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 37' ' ' PHE . . . -40.41 -30.07 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.347 -1.501 . . . . 10.0 109.347 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.499 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 1.9 pt20 -170.82 23.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -1.124 . . . . 10.0 111.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 8.2 mt-10 -150.63 -93.71 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.881 -1.137 . . . . 10.0 110.606 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 4.5 p30 169.74 47.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.689 -1.257 . . . . 10.0 111.073 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.582 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 55.5 p90 -162.12 -44.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.861 -1.15 . . . . 10.0 111.237 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 1.8 t0 77.06 113.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.32 -0.863 . . . . 10.0 111.901 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -21.88 12.82 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.598 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 18.1 mt -84.26 5.9 24.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.469 -0.769 . . . . 10.0 109.01 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.609 ' CG ' ' HD3' ' A' ' 69' ' ' PRO . 1.8 ptt180 -52.32 -32.48 9.13 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 113.709 1.003 . . . . 10.0 113.709 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.609 ' HD3' ' CG ' ' A' ' 68' ' ' ARG . 53.4 Cg_endo -74.66 76.58 3.21 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 CA-C-N 120.038 1.049 . . . . 10.0 110.325 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -101.0 -29.98 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.87 -1.144 . . . . 10.0 111.184 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.473 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 43.9 24.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 10.0 110.667 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -164.3 98.59 0.91 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.915 -1.115 . . . . 10.0 111.678 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 48.4 Cg_endo -69.76 167.66 23.81 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.925 1.487 . . . . 10.0 111.134 178.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 67.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.537 -0.727 . . . . 10.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.615 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 52.6 m -145.42 97.85 3.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.398 -0.814 . . . . 10.0 109.493 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 64.5 m-20 -33.7 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.169 0.509 . . . . 10.0 111.36 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -122.26 120.25 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.085 -1.01 . . . . 10.0 110.423 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 39.3 m-85 -116.48 140.61 49.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.616 -0.677 . . . . 10.0 109.735 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' HG11 ' A' ' 9' ' ' VAL . 1.1 mm? -113.96 98.96 7.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.932 -1.105 . . . . 10.0 108.819 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.537 ' N ' HG13 ' A' ' 9' ' ' VAL . 12.9 p -106.31 148.05 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.553 -0.717 . . . . 10.0 110.893 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.581 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 41.2 t -134.59 125.15 26.63 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.863 . . . . 10.0 110.805 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 13.6 p90 -136.66 157.72 46.11 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.242 -0.983 . . . . 10.0 110.345 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.428 ' OG ' HG23 ' A' ' 85' ' ' VAL . 44.0 t -83.4 137.69 33.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 10.0 112.133 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.527 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 18.7 m -90.53 2.32 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.666 -0.646 . . . . 10.0 109.859 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.509 ' O ' HD13 ' A' ' 129' ' ' LEU . 35.0 m -119.21 48.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 10.0 109.187 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . 21.1 p -133.36 176.69 2.71 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 42.3 Cg_endo -70.52 158.8 54.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.306 1.161 . . . . 10.0 110.733 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 87' ' ' PRO . 3.6 m -31.3 87.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.477 0.656 . . . . 10.0 111.899 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' PRO . 31.0 t -117.14 -54.2 2.42 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 10.0 109.832 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE1' ' HE2' ' A' ' 94' ' ' LYS . 8.8 t80 -49.41 -38.49 29.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.105 . . . . 10.0 109.303 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -60.84 -35.4 76.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 10.0 109.719 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.516 ' ND2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -69.96 -15.43 63.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.362 -0.836 . . . . 10.0 109.527 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.534 ' O ' ' NE1' ' A' ' 97' ' ' TRP . 62.1 t -87.76 -16.0 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.209 -0.932 . . . . 10.0 109.405 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.609 ' HE2' ' CE1' ' A' ' 90' ' ' PHE . 2.6 mmtt -85.8 -29.54 23.71 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 5.7 pt-20 -94.4 5.97 50.16 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.481 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -95.92 -51.83 4.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 10.0 112.317 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 93' ' ' VAL . 49.6 p-90 -104.06 -25.5 12.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.748 -1.22 . . . . 10.0 111.694 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.0 t -64.87 -41.91 59.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.838 -1.164 . . . . 10.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.7 Cg_endo -82.65 -23.32 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.431 1.227 . . . . 10.0 110.635 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.5 mm-40 -93.87 7.48 44.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.031 . . . . 10.0 110.363 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 101' ' ' ILE . 37.0 mm 59.32 103.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 10.0 111.023 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 103' ' ' HIS . 1.6 m -44.7 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.428 -0.952 . . . . 10.0 108.428 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.551 ' O ' ' CB ' ' A' ' 104' ' ' HIS . 21.3 m-70 -113.23 -6.38 13.61 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.497 -0.752 . . . . 10.0 109.295 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.578 ' O ' ' CB ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER 157.07 16.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 -178.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.669 ' N ' ' CD ' ' A' ' 106' ' ' PRO . 5.5 t 83.04 34.65 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.853 -0.53 . . . . 10.0 110.026 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 105' ' ' CYS . 56.8 Cg_endo -80.85 -18.27 9.15 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 O-C-N 123.177 1.093 . . . . 10.0 109.603 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 64.0 54.22 1.74 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.596 0.713 . . . . 10.0 110.558 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 13.5 t -52.29 157.8 2.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.505 -0.747 . . . . 10.0 109.552 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 42.4 Cg_endo -70.5 140.0 38.91 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.294 1.154 . . . . 10.0 110.404 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' O ' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -135.61 112.41 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.297 -0.877 . . . . 10.0 109.662 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.564 HD12 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -77.08 97.63 4.77 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.106 -0.996 . . . . 10.0 109.242 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.629 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 11.2 mt -69.91 141.01 53.19 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 47.0 t -140.94 168.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.805 -1.184 . . . . 10.0 112.509 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.517 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -107.52 159.23 14.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.285 -1.926 . . . . 10.0 108.285 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' C ' ' A' ' 82' ' ' PHE . 85.5 m -115.55 120.41 39.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.399 . . . . 10.0 111.341 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.32 55.57 5.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.582 -0.699 . . . . 10.0 111.375 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.723 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -55.74 -22.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.084 . . . . 10.0 108.714 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 21.3 t70 -52.0 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.453 1.12 . . . . 10.0 110.708 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.723 ' N ' ' O ' ' A' ' 117' ' ' ILE . 16.0 tp 159.71 -24.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.447 -1.252 . . . . 10.0 108.381 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -49.12 -42.77 40.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.748 -0.595 . . . . 10.0 109.6 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.404 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m-20 -53.92 -20.2 5.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.021 -1.049 . . . . 10.0 109.234 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.479 ' CB ' HD11 ' A' ' 119' ' ' LEU . 51.8 t0 -82.53 118.0 70.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.688 . . . . 10.0 110.537 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 48.4 Cg_endo -90.58 23.0 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.661 1.574 . . . . 10.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 p -101.36 -49.41 4.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 10.0 110.149 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.435 HG21 HD23 ' A' ' 119' ' ' LEU . 6.1 t -78.89 -26.83 43.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.201 -2.148 . . . . 10.0 105.201 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.54 ' HA ' HD23 ' A' ' 129' ' ' LEU 0.281 1.1 mp -56.66 -26.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 176.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 53.2 tt0 -49.38 -35.07 17.74 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.636 -0.711 . . . . 10.0 111.128 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -61.81 -38.31 87.64 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.188 -0.945 . . . . 10.0 110.744 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -59.03 -32.9 70.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 10.0 110.086 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -56.23 -45.01 80.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 10.0 109.833 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -55.94 -16.89 5.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.337 -0.852 . . . . 10.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.99 -18.3 5.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.922 -1.111 . . . . 10.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -165.57 110.54 0.87 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.014 -1.054 . . . . 10.0 109.998 -179.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.52 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -71.91 -24.62 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 10.0 110.511 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -98.12 104.83 24.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 10.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 44.1 Cg_endo -71.54 154.47 60.11 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.793 1.417 . . . . 10.0 110.379 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.527 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.5 tp -94.08 135.38 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 10.0 109.013 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 16.2 p -124.01 168.81 11.8 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.325 -0.859 . . . . 10.0 109.589 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 42.0 Cg_endo -66.3 -15.27 47.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.527 1.278 . . . . 10.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.66 -37.81 22.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 10.0 110.426 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.6 m -79.33 -32.66 43.4 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.538 -0.726 . . . . 10.0 110.821 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.27 -44.86 74.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 10.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -64.52 -27.76 69.19 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.27 -0.972 . . . . 10.0 109.453 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.477 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 2.0 mmtp -67.53 -43.89 79.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.11 -0.994 . . . . 10.0 108.639 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.574 ' CD1' ' HE3' ' A' ' 94' ' ' LYS . 4.3 tt -63.05 -46.22 88.53 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.416 ' HA ' ' HB1' ' A' ' 151' ' ' ALA . . . -52.22 -43.12 64.1 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.816 0.817 . . . . 10.0 109.179 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 3.8 ttp85 -55.6 -28.74 56.89 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.524 0.678 . . . . 10.0 109.463 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 149' ' ' LEU . 22.9 t70 -78.17 -43.95 27.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.623 -0.673 . . . . 10.0 110.776 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.691 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 5.7 mp -88.06 9.83 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 10.0 108.88 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 10.2 mttt 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.895 0.855 . . . . 10.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.9 -151.34 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.197 -0.668 . . . . 10.0 109.197 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.564 ' CG1' HD12 ' A' ' 111' ' ' LEU . 1.4 p -116.86 -64.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.594 -1.316 . . . . 10.0 110.747 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -173.9 140.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.453 -1.404 . . . . 10.0 111.863 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 29.0 t80 -84.78 108.06 17.27 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.388 -0.925 . . . . 10.0 109.889 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.6 OUTLIER -103.61 -169.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.752 . . . . 10.0 110.174 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -127.74 160.29 32.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.958 . . . . 10.0 110.14 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 165' ' ' LEU 0.251 1.6 t -166.02 135.87 3.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 10.0 110.238 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.556 ' OG ' ' CG ' ' A' ' 163' ' ' LYS . 34.2 m -131.17 83.88 2.14 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.078 -1.453 . . . . 10.0 107.078 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -29.26 -53.2 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.691 -1.141 . . . . 10.0 113.132 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.407 ' CD1' ' C ' ' A' ' 160' ' ' LEU . 1.8 tp -71.06 -53.75 13.6 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.693 -1.254 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.4 p -84.74 -89.54 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.911 -1.118 . . . . 10.0 111.169 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.6 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 2.4 pt20 159.28 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 10.0 109.364 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.556 ' CG ' ' OG ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -105.33 69.19 0.83 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.026 -1.069 . . . . 10.0 110.591 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.528 ' HA3' ' HG2' ' A' ' 156' ' ' GLU . . . 76.98 0.93 71.24 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.993 -1.643 . . . . 10.0 108.993 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -50.12 -44.41 52.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.42 -1.047 . . . . 10.0 109.608 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.474 ' N ' HD12 ' A' ' 165' ' ' LEU . 14.8 tttm -70.69 -25.64 63.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.156 -0.965 . . . . 10.0 109.367 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 19.3 m120 -75.45 -33.89 60.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 10.0 111.641 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 10.7 t -57.96 -49.75 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.786 -1.197 . . . . 10.0 110.056 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.26 -40.0 88.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.659 -0.651 . . . . 10.0 110.43 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 20.6 t0 -60.12 -46.41 89.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 10.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.5 -42.63 99.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 10.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.541 ' CB ' ' HG ' ' A' ' 111' ' ' LEU . . . -56.28 -24.52 43.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 10.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 77.4 mt -63.92 -47.03 92.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.115 -0.99 . . . . 10.0 109.595 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.526 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.07 -41.45 70.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 10.0 111.087 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.51 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -80.71 -2.72 48.0 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.198 -0.938 . . . . 10.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.588 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -87.67 -22.5 24.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.045 -1.035 . . . . 10.0 110.821 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -90.06 -22.19 21.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.077 -1.015 . . . . 10.0 110.138 -179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.025 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.254 -1.538 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -124.23 140.44 52.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.174 -1.192 . . . . 10.0 110.475 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HE2' HD12 ' A' ' 174' ' ' LEU . 10.1 tptt -84.26 103.15 13.21 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.204 -0.935 . . . . 10.0 108.511 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -82.66 152.61 25.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.238 -0.914 . . . . 10.0 110.692 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.76 -48.14 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.77 -0.581 . . . . 10.0 110.555 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.2 Cg_endo -91.32 24.06 0.58 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.977 -1.201 . . . . 10.0 108.977 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.599 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 2.0 pm0 -39.55 166.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.544 0.688 . . . . 10.0 111.659 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.85 -88.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 10.0 111.192 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 86.5 p -82.37 171.19 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 10.0 111.96 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.673 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.96 96.8 0.48 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 10.0 111.818 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.489 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 46.9 Cg_endo -76.1 133.61 15.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.418 1.22 . . . . 10.0 109.117 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 56.4 p -93.16 117.95 30.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 10.0 111.105 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.09 136.45 54.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.523 -0.736 . . . . 10.0 109.303 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HA ' ' CG1' ' A' ' 42' ' ' VAL . 11.4 p90 -139.98 166.53 24.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.939 -1.101 . . . . 10.0 110.635 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -164.19 110.88 1.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.087 -1.008 . . . . 10.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HA ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 p80 -165.76 137.54 3.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 10.0 110.17 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.508 ' C ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -150.59 98.48 2.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 10.0 110.636 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.573 HG13 ' HA ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -155.55 -170.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.4 p-80 -141.81 153.75 44.73 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 117.6 -1.64 . . . . 10.0 112.605 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 35' ' ' THR . 3.5 m -103.39 152.34 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.461 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -124.09 73.77 0.4 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.742 -1.218 . . . . 10.0 110.313 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.553 ' CD2' HG22 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 167.4 97.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.385 -1.067 . . . . 10.0 109.189 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' B' ' 24' ' ' ALA . 21.1 m-20 -61.33 154.48 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.438 -0.789 . . . . 10.0 111.815 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.475 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 39.76 38.11 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.638 . . . . 10.0 111.065 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.553 HG22 ' CD2' ' B' ' 22' ' ' PHE . 37.1 t -111.39 -23.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 10.0 108.821 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 10.0 t -88.97 -10.61 47.04 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.36 0.6 . . . . 10.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.63 -0.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.517 -1.433 . . . . 10.0 109.517 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' B' ' 28' ' ' GLU . 6.8 pt-20 -104.51 122.11 44.86 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.969 -1.312 . . . . 10.0 110.733 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.3 OUTLIER -121.59 118.61 29.66 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.736 -0.839 . . . . 10.0 108.736 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.566 HG23 ' CE1' ' A' ' 28' ' ' PHE . 23.0 p -122.19 -4.99 8.93 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.986 -0.685 . . . . 10.0 109.589 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.89 39.09 0.78 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.167 -1.573 . . . . 10.0 109.167 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.494 HG23 HD13 ' B' ' 32' ' ' ILE . 28.4 mm -69.0 142.15 92.94 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.329 -1.1 . . . . 10.0 110.435 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.498 ' O ' ' C ' ' B' ' 34' ' ' GLU . 45.0 Cg_endo -68.9 177.61 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.293 1.681 . . . . 10.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' B' ' 37' ' ' ALA . 5.4 tm-20 -23.09 138.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.437 0.637 . . . . 10.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 7.6 mm100 -100.81 -71.72 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.67 0.989 . . . . 10.0 113.67 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.546 ' CZ3' HG11 ' A' ' 7' ' ' VAL . 16.5 t90 -108.69 30.36 6.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.357 -0.839 . . . . 10.0 112.611 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -178.18 89.3 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 118.986 -1.086 . . . . 10.0 111.383 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.546 ' HA ' ' HG3' ' B' ' 34' ' ' GLU . 5.3 ttp180 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.513 ' HE1' ' OE1' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.283 0.563 . . . . 10.0 109.703 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -177.9 -160.74 0.05 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 10.0 110.749 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.514 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 85.0 m 41.25 58.29 2.64 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.36 -0.837 . . . . 10.0 111.019 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.615 HG13 ' N ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -143.16 150.52 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 117.28 -1.768 . . . . 10.0 113.804 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.615 ' N ' HG13 ' A' ' 4' ' ' ILE . 27.9 mtmt -131.32 126.1 34.45 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.279 -0.888 . . . . 10.0 109.601 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.463 ' C ' ' CG2' ' A' ' 7' ' ' VAL . 10.0 t -85.36 129.98 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.133 -0.979 . . . . 10.0 109.336 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 76' ' ' ASP . 4.1 t -146.97 175.97 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.919 -1.113 . . . . 10.0 110.421 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 17' ' ' THR . 0.0 OUTLIER -108.93 146.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.537 -1.352 . . . . 10.0 111.178 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.625 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.27 -168.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.211 -0.93 . . . . 10.0 110.389 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.625 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 114.02 134.9 5.96 Favored Glycine 0 C--N 1.29 -1.994 0 N-CA-C 109.251 -1.54 . . . . 10.0 109.251 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.24 -14.8 19.72 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.507 -0.996 . . . . 10.0 110.054 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 163.49 -108.17 0.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.941 -1.664 . . . . 10.0 108.941 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 69.54 -130.3 0.08 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.03 -1.277 . . . . 10.0 110.933 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.518 ' C ' ' HG3' ' B' ' 35' ' ' GLN . 17.8 m -110.4 148.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.186 . . . . 10.0 110.618 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -51.58 137.95 29.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.6 -28.27 11.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.671 -1.488 . . . . 10.0 110.72 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.516 ' CG2' HG21 ' A' ' 8' ' ' VAL . 77.1 p -88.88 -37.44 15.31 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.492 -0.755 . . . . 10.0 110.336 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.547 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 21.8 p -85.35 -13.46 49.47 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.925 -1.109 . . . . 10.0 109.745 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.644 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 4.4 mm? -81.9 -42.89 18.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.36 -1.463 . . . . 10.0 109.048 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.6 tt -46.85 -37.74 9.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.632 -1.248 . . . . 10.0 107.632 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.556 ' CG2' ' CG2' ' A' ' 25' ' ' THR 0.256 5.6 mm -67.86 -46.99 81.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.779 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 19' ' ' LEU . 47.5 p -48.3 -31.52 6.11 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.596 -0.842 . . . . 10.0 109.843 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.644 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 3.4 m-85 -93.77 -18.86 21.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.785 -1.197 . . . . 10.0 109.399 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 93.5 m -94.4 -22.5 18.26 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 10.0 112.604 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.556 ' CG2' ' CG2' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -109.16 -77.84 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.033 -1.667 . . . . 10.0 110.891 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.633 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 80.4 m-20 -152.19 -23.68 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.144 -1.423 . . . . 10.0 113.025 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 49.5 pttt 167.68 -158.7 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 O-C-N 120.855 -1.153 . . . . 10.0 112.481 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.585 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 2.7 p90 . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 115.055 1.502 . . . . 10.0 115.055 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' HG12 ' B' ' 20' ' ' VAL . 34.6 p . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.629 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 44.3 t -57.07 -74.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.777 -0.577 . . . . 10.0 109.752 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 19.8 t80 -45.05 123.43 3.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HA ' ' CD1' ' B' ' 18' ' ' ILE . 12.1 t0 -149.73 86.59 1.46 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.381 -1.328 . . . . 10.0 111.479 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.486 ' N ' HD13 ' B' ' 18' ' ' ILE . 19.1 t-20 -97.82 99.98 11.33 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.721 -1.215 . . . . 10.0 107.721 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' B' ' 16' ' ' HIS . 2.3 m-85 -122.69 121.44 36.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.661 . . . . 10.0 109.63 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' B' ' 14' ' ' PHE . . . -112.48 116.12 29.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 10.0 110.253 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' B' ' 15' ' ' GLU . 40.1 t -132.86 173.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.897 -1.127 . . . . 10.0 110.244 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 67.6 m -155.03 151.27 28.23 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.767 -0.773 . . . . 10.0 110.216 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' B' ' 12' ' ' SER . 0.1 OUTLIER -144.83 128.67 12.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.491 -0.883 . . . . 10.0 111.357 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.571 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -86.8 97.57 10.7 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.336 -0.946 . . . . 10.0 109.417 178.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.496 ' N ' HD11 ' A' ' 46' ' ' ILE . 2.9 mp -78.96 114.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.073 -1.017 . . . . 10.0 108.27 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.633 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 55.69 19.76 21.84 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 118.654 -1.736 . . . . 10.0 109.189 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.93 -8.13 31.5 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.349 -1.089 . . . . 10.0 110.645 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.513 ' OE1' ' HE1' ' A' ' 1' ' ' MET . 30.1 mm-40 -96.43 105.33 21.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.28 . . . . 10.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 44.3 Cg_endo -71.19 130.71 18.0 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.495 1.463 . . . . 10.0 110.387 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CE1' HD13 ' A' ' 46' ' ' ILE . 3.8 m-30 -98.18 118.31 34.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.838 -1.163 . . . . 10.0 111.616 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.591 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 1.7 p -92.28 99.23 12.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.077 -1.014 . . . . 10.0 108.568 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.03 147.33 44.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.039 -1.038 . . . . 10.0 110.94 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.62 109.52 0.96 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.04 -1.624 . . . . 10.0 109.04 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.529 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -98.28 127.45 44.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -1.204 . . . . 10.0 110.543 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.413 ' N ' HD21 ' A' ' 55' ' ' LEU . 11.5 t80 -137.92 122.12 18.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.947 . . . . 10.0 111.283 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -107.8 164.73 12.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.902 -1.124 . . . . 10.0 109.719 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' B' ' 36' ' ' TRP . 99.6 m -47.44 164.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.798 -1.189 . . . . 10.0 111.001 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' A' ' 62' ' ' GLU . . . -104.74 91.68 3.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.73 -0.606 . . . . 10.0 109.961 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.553 ' HA3' HG21 ' B' ' 20' ' ' VAL . . . -48.01 -41.47 21.76 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.843 -2.503 . . . . 10.0 106.843 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 20.3 pt20 -71.87 -31.93 66.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 5.6 mt-10 56.42 81.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.813 0.816 . . . . 10.0 111.681 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.537 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 97.9 m-20 -126.38 3.92 6.98 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.32 0.581 . . . . 10.0 109.513 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 171.46 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 10.0 110.911 -178.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 5.4 p-10 -113.83 15.61 18.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.828 -1.17 . . . . 10.0 110.808 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.467 ' O ' ' CG ' ' A' ' 70' ' ' LEU . 11.7 ptt-85 -77.83 -33.99 52.09 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.091 -1.006 . . . . 10.0 110.136 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.581 ' HA ' HD23 ' A' ' 70' ' ' LEU . 4.9 mt -111.41 5.27 19.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.909 -1.12 . . . . 10.0 111.726 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.444 ' NH2' ' HG3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -97.07 -54.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.474 -1.391 . . . . 10.0 113.296 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.486 ' CD ' ' O ' ' A' ' 65' ' ' ASP . 42.8 Cg_endo -71.46 -62.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.233 1.123 . . . . 10.0 111.335 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.713 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -50.62 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.383 -0.823 . . . . 10.0 111.855 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.627 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 17.4 p -31.37 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.416 0.626 . . . . 10.0 110.371 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 p90 48.13 138.62 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.3 0 N-CA-C 113.383 0.883 . . . . 10.0 113.383 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.97 167.28 27.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.65 1.567 . . . . 10.0 111.205 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -83.39 32.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.19 -0.944 . . . . 10.0 110.588 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 27.7 m -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 4.6 p-10 160.78 118.69 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.525 HG13 HD13 ' A' ' 4' ' ' ILE . 16.0 m -64.47 157.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.944 -1.872 . . . . 10.0 105.944 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 72' ' ' TYR . 43.9 m-85 -121.86 155.63 35.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.085 -1.634 . . . . 10.0 114.451 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.554 ' CD1' HG13 ' A' ' 168' ' ' VAL . 2.3 mm? -118.71 97.68 5.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 9' ' ' VAL . 14.3 p -110.03 154.97 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.119 -0.988 . . . . 10.0 109.708 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.519 ' CB ' ' OG1' ' A' ' 115' ' ' THR . 4.7 m -123.3 109.33 13.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.946 -1.096 . . . . 10.0 111.663 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 93' ' ' VAL . 93.8 m-85 -87.89 168.7 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 10.0 109.918 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.2 m -75.91 157.59 33.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.988 -1.07 . . . . 10.0 108.417 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.477 HG23 ' HG3' ' A' ' 120' ' ' ARG . 3.5 p -81.91 -23.1 9.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.745 -1.222 . . . . 10.0 111.09 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.591 ' CG1' ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -129.86 -88.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.847 -1.158 . . . . 10.0 108.808 178.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.575 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 44.52 -171.72 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.497 -0.752 . . . . 10.0 109.675 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 53.3 Cg_endo -73.34 162.84 39.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.421 1.222 . . . . 10.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -63.03 78.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.117 . . . . 10.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 87' ' ' PRO . 29.1 t -106.36 -45.83 4.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.848 . . . . 10.0 110.791 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.447 ' O ' HG21 ' A' ' 93' ' ' VAL . 62.5 t80 -49.14 -19.4 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.156 -0.965 . . . . 10.0 110.193 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.79 -19.75 51.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.333 -0.855 . . . . 10.0 111.634 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.68 -14.6 26.19 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.388 -1.445 . . . . 10.0 109.38 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 94' ' ' LYS . 31.5 m -85.58 -30.87 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.215 -0.994 . . . . 10.0 108.435 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.517 ' HE2' ' CD1' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.16 -25.68 59.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.118 -0.989 . . . . 10.0 109.801 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -96.23 3.21 53.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 10.0 111.109 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.26 -50.33 3.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.571 -1.331 . . . . 10.0 111.06 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.64 -40.22 13.48 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.92 -1.112 . . . . 10.0 113.251 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.558 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 55.9 t -70.78 -51.62 11.35 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.33 -1.481 . . . . 10.0 112.806 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 40.1 Cg_endo -64.71 -21.1 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.311 1.164 . . . . 10.0 109.365 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.584 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 64.6 tt0 -51.39 -57.0 10.12 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.127 -0.983 . . . . 10.0 109.999 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 149.67 119.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 109.743 -0.465 . . . . 10.0 109.743 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 108' ' ' THR . 25.3 m -92.36 -83.97 0.29 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 36.7 m-70 -107.73 -11.47 15.41 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 103' ' ' HIS . 4.5 p80 173.11 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.565 -1.272 . . . . 10.0 107.565 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.444 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 96.9 m -130.98 164.98 38.38 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.456 ' HB2' ' CG1' ' A' ' 98' ' ' VAL . 38.8 Cg_endo -67.88 92.04 0.37 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 123.608 1.32 . . . . 10.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 107' ' ' LYS . 1.6 tttt -139.31 9.45 2.49 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.441 -0.787 . . . . 10.0 109.982 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 102' ' ' THR . 23.6 m -46.21 139.95 5.47 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.679 -1.263 . . . . 10.0 109.843 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HG3' HG11 ' A' ' 77' ' ' VAL . 51.2 Cg_endo -70.76 117.65 5.26 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.003 1.528 . . . . 10.0 108.352 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.429 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -126.59 110.23 12.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.289 -0.882 . . . . 10.0 111.711 -177.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.588 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 1.2 mm? -85.6 98.08 10.45 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.526 -1.287 . . . . 10.0 107.526 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 70.1 mt -84.13 127.87 34.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.042 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 19.2 t -133.5 165.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.857 . . . . 10.0 110.131 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -116.28 112.25 2.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -92.89 160.86 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.375 -1.073 . . . . 10.0 111.358 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 59.93 43.72 14.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.497 -0.752 . . . . 10.0 110.481 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.732 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -74.32 -18.97 17.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 179.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.537 ' N ' HD12 ' A' ' 117' ' ' ILE . 13.2 m-20 -53.46 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 122.7 1.238 . . . . 10.0 110.499 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.732 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.8 pp 166.44 -27.68 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 114.138 -1.392 . . . . 10.0 107.596 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.0 OUTLIER -46.12 -41.75 12.81 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.726 0.774 . . . . 10.0 109.07 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.88 -23.31 63.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.549 0.69 . . . . 10.0 110.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 124' ' ' SER . 27.0 t70 -93.04 119.63 67.56 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 10.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.92 21.83 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 124.277 1.672 . . . . 10.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.469 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 32.2 t -107.19 -45.0 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 10.0 110.169 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.401 HG21 HD13 ' A' ' 126' ' ' ILE . 7.1 t -71.63 -30.26 65.57 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 129' ' ' LEU 0.315 0.9 OUTLIER -50.87 -26.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.188 -1.369 . . . . 10.0 108.315 177.18 . . . . . . . . 4 4 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -54.8 -40.45 69.5 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.509 0.671 . . . . 10.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -81.86 -36.03 28.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.462 -0.773 . . . . 10.0 109.904 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.534 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 8.5 mt -59.41 -45.29 91.92 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.778 -1.201 . . . . 10.0 108.586 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -49.01 -39.27 26.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 10.0 110.357 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -53.95 -19.09 4.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.571 -0.706 . . . . 10.0 111.13 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -118.36 -2.15 11.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.311 -1.356 . . . . 10.0 111.964 -178.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.548 ' HG2' ' ND2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -158.15 -25.51 0.08 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.148 -0.97 . . . . 10.0 111.043 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 40.79 19.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.753 -0.592 . . . . 10.0 111.595 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' LYS . 1.2 ptmt -153.77 95.1 2.87 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.776 -1.203 . . . . 10.0 110.036 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.591 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 44.4 Cg_endo -71.07 156.84 59.13 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 O-C-N 124.055 1.555 . . . . 10.0 110.357 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.0 mm -93.7 122.35 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 10.0 109.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.1 p -118.95 173.36 3.48 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.515 -0.74 . . . . 10.0 109.219 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.8 Cg_endo -63.37 -10.17 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.803 0.896 . . . . 10.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -94.12 -44.96 7.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 10.0 109.836 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -48.78 45.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 10.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.431 ' CB ' ' CG ' ' A' ' 154' ' ' TYR . . . -62.47 -40.38 96.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 10.0 111.297 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 27.0 tt0 -61.18 -39.85 91.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.126 . . . . 10.0 109.526 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -60.61 -49.55 77.07 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.665 -1.214 . . . . 10.0 108.416 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.517 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 4.3 tt -57.82 -37.79 74.41 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.028 -1.045 . . . . 10.0 109.238 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.519 ' O ' HD13 ' A' ' 149' ' ' LEU . . . -66.57 -35.61 80.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 120.017 -0.673 . . . . 10.0 109.633 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -15.44 60.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.141 -0.975 . . . . 10.0 109.277 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 11.8 t0 -70.3 -10.41 58.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.436 -0.79 . . . . 10.0 110.928 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.666 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.75 31.06 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 10.0 111.028 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.4 ' HG3' ' C ' ' A' ' 149' ' ' LEU . 3.4 mtpt 60.03 36.65 21.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.82 0.819 . . . . 10.0 110.314 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.49 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -71.19 -176.23 1.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.588 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 12.7 t -87.48 -81.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.459 ' HD2' ' OE2' ' A' ' 171' ' ' GLU . 1.6 tttp -173.74 159.38 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.549 -0.72 . . . . 10.0 110.072 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CG ' ' CB ' ' A' ' 142' ' ' ALA . 43.1 t80 -93.98 100.37 12.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.714 -1.241 . . . . 10.0 109.886 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.588 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -95.15 -167.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.51 -0.744 . . . . 10.0 109.328 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -136.05 149.65 48.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.66 -1.275 . . . . 10.0 112.262 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -162.9 138.41 6.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.335 -0.853 . . . . 10.0 109.424 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' LEU . 5.0 t -148.13 114.18 5.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 10.0 110.065 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.67 ' CB ' ' CE2' ' B' ' 29' ' ' PHE . . . 3.21 -65.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.739 1.385 . . . . 10.0 114.739 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -131.9 -38.51 1.12 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.758 -1.214 . . . . 10.0 112.079 -177.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.1 p -60.91 -71.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 10.0 111.788 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.52 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 4.4 mm100 -36.6 -69.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.631 -0.668 . . . . 10.0 111.43 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.629 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER 66.05 25.27 10.92 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.637 -0.825 . . . . 10.0 110.532 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.82 2.89 9.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.192 -1.963 . . . . 10.0 108.192 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.632 HD13 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -58.27 -14.76 7.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.666 -0.902 . . . . 10.0 111.944 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.424 ' H ' HD11 ' A' ' 165' ' ' LEU . 9.4 mtmt -63.15 -36.07 82.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.445 -1.409 . . . . 10.0 110.952 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -38.56 91.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 10.0 111.103 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 5.8 t -52.8 -34.38 20.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.815 -1.178 . . . . 10.0 110.412 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.89 -24.28 55.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 10.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -74.21 -43.89 55.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.042 -1.063 . . . . 10.0 110.088 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.459 ' OE2' ' HD2' ' A' ' 153' ' ' LYS . 36.4 mt-10 -60.58 -32.94 72.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 10.0 109.995 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -61.23 -24.78 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.772 -1.205 . . . . 10.0 109.76 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 18.8 mm -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.08 -1.013 . . . . 10.0 109.736 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.534 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -76.41 -41.88 46.22 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.004 -1.06 . . . . 10.0 109.986 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.531 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -79.81 -4.2 51.08 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.447 -0.783 . . . . 10.0 109.824 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.494 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . . . -76.41 -43.17 41.59 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.191 -0.943 . . . . 10.0 108.95 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -108.09 -20.6 13.11 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.56 0.695 . . . . 10.0 109.814 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.184 -0.912 . . . . 10.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 108.517 -1.833 . . . . 10.0 108.517 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' B' ' 4' ' ' GLU . 2.0 m -107.75 55.25 0.65 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.218 -1.166 . . . . 10.0 110.476 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -51.64 105.48 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 10.0 110.457 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' B' ' 2' ' ' SER . 1.5 mt-10 -96.01 156.0 16.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.608 -0.682 . . . . 10.0 110.388 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.613 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -108.6 -50.3 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.159 -0.963 . . . . 10.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 55.6 Cg_endo -95.67 32.3 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 108.298 -1.462 . . . . 10.0 108.298 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.5 pp20? -38.57 158.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.912 -0.493 . . . . 10.0 109.676 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.633 HG13 ' HA2' ' A' ' 47' ' ' GLY . 2.1 pp -81.52 -53.33 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.233 . . . . 10.0 112.184 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.474 ' N ' HD11 ' B' ' 8' ' ' ILE . 30.6 t -160.94 173.81 14.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.325 -1.484 . . . . 10.0 111.462 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 45' ' ' MET . 1.2 pp -164.39 99.2 0.89 Allowed Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.119 -1.032 . . . . 10.0 111.929 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 44.2 Cg_endo -72.65 104.95 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.862 1.453 . . . . 10.0 109.343 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.505 ' HA ' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -53.02 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.956 . . . . 10.0 111.037 -179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -138.31 -168.88 2.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' ALA . 21.6 m-85 -97.13 165.21 12.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.7 -1.25 . . . . 10.0 111.796 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 6.1 pm0 -119.85 171.05 8.69 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.8 -0.562 . . . . 10.0 110.39 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.527 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -92.16 -174.97 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.006 -1.059 . . . . 10.0 110.356 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -147.1 133.47 19.59 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.122 -0.986 . . . . 10.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.66 ' HB ' ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -150.07 -177.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.916 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -142.37 154.91 45.04 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.989 -1.069 . . . . 10.0 110.645 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 2.8 p -91.11 148.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 10.0 110.503 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -99.42 47.94 1.3 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.55 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -177.74 104.62 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.234 -1.156 . . . . 10.0 109.032 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.39 142.0 49.67 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.808 0.813 . . . . 10.0 112.343 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.466 ' O ' ' HG2' ' B' ' 28' ' ' GLU . . . 51.57 51.71 16.17 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.746 -0.596 . . . . 10.0 112.38 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.55 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 52.1 t -113.32 -39.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.649 -1.282 . . . . 10.0 110.547 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.521 HG22 ' N ' ' B' ' 27' ' ' GLY . 3.1 t -61.58 -22.78 65.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.137 -0.977 . . . . 10.0 110.18 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.532 ' CA ' ' CG2' ' A' ' 21' ' ' ILE . . . -106.3 31.12 8.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 106.841 -2.504 . . . . 10.0 106.841 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 2.8 mp0 -128.55 114.07 16.26 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.261 1.029 . . . . 10.0 110.663 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.67 ' CE2' ' CB ' ' A' ' 159' ' ' ALA . 15.6 t80 -128.67 140.32 51.81 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.707 0.765 . . . . 10.0 109.955 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -146.29 -69.52 0.26 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.97 1.2 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.631 -1.271 . . . . 10.0 111.289 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.5 ' HB ' ' HD3' ' B' ' 33' ' ' PRO . 2.0 mt -63.29 -55.65 34.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.629 -1.512 . . . . 10.0 111.217 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.5 ' HD3' ' HB ' ' B' ' 32' ' ' ILE . 44.1 Cg_endo -70.56 169.38 20.07 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.326 1.172 . . . . 10.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.4 tp10 -78.63 167.67 20.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.991 -1.068 . . . . 10.0 109.371 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 11.5 mp0 -81.08 19.62 0.88 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.484 -0.76 . . . . 10.0 111.469 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.581 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 4.8 m95 89.9 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 123.074 1.416 . . . . 10.0 107.504 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.617 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . . . -156.81 81.09 0.94 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.217 -1.356 . . . . 10.0 108.613 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.512 ' CA ' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.061 -1.025 . . . . 10.0 108.719 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 1.5 mpp? . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.905 0.384 . . . . 10.0 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 2.3 mt-30 -139.01 -39.99 0.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 10.0 110.249 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.607 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -44.09 101.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.972 . . . . 10.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 52' ' ' THR . 2.1 tt -106.47 140.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.658 -1.217 . . . . 10.0 110.302 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.7 mmtt -112.85 137.05 51.77 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 18.2 t -118.85 108.42 14.8 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.807 -1.183 . . . . 10.0 110.317 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.484 HG23 ' OG1' ' A' ' 75' ' ' THR . 9.1 t -137.81 163.62 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 10.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.1 t -87.02 141.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 10.0 110.548 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 8' ' ' VAL . 46.1 t -136.42 174.69 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.374 -0.829 . . . . 10.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 125.04 130.6 3.52 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.864 -1.295 . . . . 10.0 109.864 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.82 -27.57 43.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -1.075 . . . . 10.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 140.92 127.61 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.02 -1.232 . . . . 10.0 110.02 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 169.59 -67.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 10.0 109.703 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.513 ' HB ' ' CG2' ' A' ' 115' ' ' THR . 13.4 t -147.93 107.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 10.0 109.525 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -74.08 99.1 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.882 -1.287 . . . . 10.0 109.882 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HG3' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -52.64 -36.97 57.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.296 . . . . 10.0 109.709 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.2 m -52.71 -39.57 62.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.436 -0.79 . . . . 10.0 110.792 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' SER . 14.5 p -81.89 -15.77 52.86 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.673 -1.267 . . . . 10.0 108.988 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 159' ' ' ALA . 10.2 mt -84.34 -30.52 25.43 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.906 0.86 . . . . 10.0 109.12 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -54.69 -39.3 67.99 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.488 ' O ' HG21 ' A' ' 25' ' ' THR . 3.5 mm -91.27 -42.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 121.666 0.746 . . . . 10.0 109.911 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 32.9 t -47.6 -40.5 19.52 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.303 -0.959 . . . . 10.0 109.974 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 160' ' ' LEU . 9.4 t80 -100.83 1.46 40.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.238 -1.385 . . . . 10.0 110.625 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 6.3 m -107.21 -19.09 13.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.984 -1.072 . . . . 10.0 111.325 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.488 HG21 ' O ' ' A' ' 21' ' ' ILE . 11.3 t -112.23 -43.04 3.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.731 -1.23 . . . . 10.0 111.16 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.3 m-20 -155.87 -48.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.492 -1.283 . . . . 10.0 112.512 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.661 ' HD3' ' C ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 168.88 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.217 -0.927 . . . . 10.0 111.892 -178.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.483 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 22.4 p90 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 37' ' ' PHE . 20.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.0 0.429 . . . . 10.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.584 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 89.8 t -28.22 -33.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 121.325 0.583 . . . . 10.0 111.321 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -38.94 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 10.0 109.759 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -170.38 91.07 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 119.879 -1.763 . . . . 10.0 113.776 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 8.2 t30 -135.88 149.75 49.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 10.0 108.604 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 2.6 m-85 -167.2 113.84 0.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.402 -1.436 . . . . 10.0 111.702 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 15' ' ' GLU . . . -93.69 108.85 20.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.92 -1.141 . . . . 10.0 107.92 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' B' ' 14' ' ' PHE . 44.1 t -135.87 171.93 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.184 -1.407 . . . . 10.0 112.31 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 51' ' ' TYR . 54.7 m -147.28 170.6 16.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' B' ' 12' ' ' SER . 1.3 p -161.35 129.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.89 -1.131 . . . . 10.0 111.561 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.6 ' CB ' ' HB3' ' B' ' 10' ' ' LEU . 1.3 mmt -104.95 129.06 53.44 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.826 -1.15 . . . . 10.0 108.131 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.557 ' CG2' ' O ' ' B' ' 6' ' ' PRO . 33.6 mt -132.05 99.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.913 -1.117 . . . . 10.0 110.194 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.603 ' CA ' ' CG2' ' B' ' 8' ' ' ILE . . . 59.76 24.05 59.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.038 -1.625 . . . . 10.0 109.038 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.72 6.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -127.29 95.47 36.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.17 -1.194 . . . . 10.0 110.538 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 51.5 Cg_endo -83.19 132.68 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.236 1.65 . . . . 10.0 112.008 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HB2' HG11 ' A' ' 44' ' ' VAL . 2.7 m-85 -93.65 150.69 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 10.0 109.29 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.607 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 23.3 m -136.25 100.32 4.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.786 -1.196 . . . . 10.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.552 ' CB ' HG22 ' A' ' 4' ' ' ILE . 3.0 pp -149.3 176.35 10.62 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.393 -1.323 . . . . 10.0 112.813 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.408 ' N ' ' CD1' ' A' ' 53' ' ' LEU . . . -170.82 118.52 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 107.67 -2.172 . . . . 10.0 107.67 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.537 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . 2.0 pp -129.78 159.58 36.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.647 -1.502 . . . . 10.0 111.138 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 15.9 p90 -165.69 131.77 2.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 10.0 110.568 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -81.38 176.84 9.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 10.0 110.095 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.576 ' OG1' ' CE2' ' B' ' 36' ' ' TRP . 99.1 m -40.2 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 10.0 111.43 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . . . -146.65 63.01 1.2 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 10.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.19 69.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.275 -1.13 . . . . 10.0 110.275 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' HB2' ' HA3' ' B' ' 21' ' ' GLY . 64.7 tp60 -115.77 -28.79 6.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.065 -1.256 . . . . 10.0 111.23 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 7.3 tp10 -63.53 -50.02 71.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.871 -1.143 . . . . 10.0 110.572 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -142.74 0.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 10.0 111.323 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.2 m-85 65.35 40.26 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.821 -1.178 . . . . 10.0 107.821 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -78.7 47.72 0.75 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.85 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.534 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 17.4 mtp180 -82.82 -26.28 31.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.437 -0.789 . . . . 10.0 109.53 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.77 -6.66 14.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 10.0 111.888 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -92.75 -54.9 0.25 Allowed Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 120.376 -1.453 . . . . 10.0 113.19 -177.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.597 ' CD ' HD23 ' A' ' 70' ' ' LEU . 43.0 Cg_endo -77.61 -5.02 15.17 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.528 1.278 . . . . 10.0 111.987 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.597 HD23 ' CD ' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -101.81 -98.8 0.27 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.773 -1.205 . . . . 10.0 110.966 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.504 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 40.1 m -36.38 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.744 -0.598 . . . . 10.0 110.467 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 70' ' ' LEU . 15.6 m-85 -103.47 91.92 3.66 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 10.0 109.056 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 71' ' ' SER . 45.4 Cg_endo -70.62 147.43 57.32 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.787 1.414 . . . . 10.0 110.555 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' CD ' ' O ' ' A' ' 74' ' ' GLN . 3.2 pp0? -169.37 57.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.221 -0.924 . . . . 10.0 110.583 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.571 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 18.0 m -145.01 98.05 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.162 -0.961 . . . . 10.0 110.099 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -34.37 -33.21 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 10.0 110.487 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -111.25 120.24 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.313 -0.867 . . . . 10.0 109.644 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 47.7 m-85 -115.41 140.92 48.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.906 -1.121 . . . . 10.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 3.4 mm? -109.39 99.35 8.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 10.0 109.562 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.586 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 7.1 p -103.82 151.02 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 10.0 110.131 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 115' ' ' THR . 3.2 t -126.71 103.8 7.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 10.0 111.496 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.586 ' CZ ' HG21 ' A' ' 80' ' ' VAL . 67.7 m-85 -89.89 140.05 29.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 10.0 111.056 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -92.52 138.59 31.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.214 -0.929 . . . . 10.0 110.169 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 14.4 m -81.42 -17.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 10.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.496 ' N ' HG21 ' A' ' 84' ' ' VAL . 17.8 m -102.6 38.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.774 0.797 . . . . 10.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 87' ' ' PRO . 47.7 t -110.04 154.34 42.76 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.677 -0.639 . . . . 10.0 109.37 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.564 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 47.9 Cg_endo -68.93 73.62 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.735 1.387 . . . . 10.0 111.099 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG3' ' A' ' 133' ' ' LYS . 43.4 m 39.91 55.04 2.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 10.0 110.429 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.442 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 62.7 p -91.9 -36.74 13.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 10.0 110.547 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.408 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 2.9 p90 -50.3 -29.96 10.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.09 . . . . 10.0 110.338 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -67.47 -35.7 79.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.901 . . . . 10.0 110.036 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.32 -12.81 61.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 10.0 109.39 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.446 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t -88.87 -12.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.39 -0.819 . . . . 10.0 109.346 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 6.8 mmtt -89.03 -35.75 16.19 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.0 pt-20 -80.0 -5.05 55.04 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.26 -0.576 . . . . 10.0 110.082 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -102.02 -44.89 5.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.935 -1.103 . . . . 10.0 111.763 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.559 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 35.9 m95 -89.59 -29.05 19.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.294 -0.878 . . . . 10.0 112.028 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' A' ' 149' ' ' LEU . 62.8 t -62.28 -47.9 88.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.545 -1.347 . . . . 10.0 110.596 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 48.9 Cg_endo -74.68 -15.56 21.53 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 109.115 -1.148 . . . . 10.0 109.115 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 40.9 tt0 -58.97 -29.25 67.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.754 -0.591 . . . . 10.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.528 ' CG2' ' HA ' ' A' ' 104' ' ' HIS . 3.6 mt 57.57 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 10.0 109.603 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.56 ' CG2' ' HG2' ' A' ' 106' ' ' PRO . 3.9 m -43.29 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.345 -0.847 . . . . 10.0 109.08 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 104' ' ' HIS . 4.8 m-70 -110.45 -15.9 13.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.528 ' HA ' ' CG2' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 162.45 -55.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 6.9 t -168.06 44.58 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.207 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.579 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 56.4 Cg_endo -81.26 -26.1 3.56 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 N-CA-C 109.083 -1.16 . . . . 10.0 109.083 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.579 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 1.6 pttp 55.66 52.85 10.33 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.342 1.067 . . . . 10.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 10.0 t -45.38 155.17 0.46 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 10.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 38.9 Cg_endo -66.35 148.77 84.81 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.76 1.4 . . . . 10.0 110.486 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -139.07 111.9 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 10.0 110.023 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.612 HD11 ' CG1' ' A' ' 152' ' ' VAL . 1.6 mm? -80.84 98.08 7.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.316 -0.865 . . . . 10.0 109.358 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 56.1 mt -70.22 140.11 52.38 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 111' ' ' LEU . 4.5 t -148.1 168.22 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.809 -1.182 . . . . 10.0 111.679 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.37 150.04 16.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.748 -1.741 . . . . 10.0 108.748 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' PHE . 24.1 m -103.49 129.94 50.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.353 . . . . 10.0 110.756 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 14' ' ' VAL . 69.4 mt-30 53.27 50.03 18.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 10.0 110.377 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.796 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -65.29 -25.27 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.028 -1.045 . . . . 10.0 110.017 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.8 p-10 -52.06 59.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.267 1.032 . . . . 10.0 110.051 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.796 ' N ' ' O ' ' A' ' 117' ' ' ILE . 9.8 tp 158.64 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -50.35 -40.11 48.25 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.81 -0.556 . . . . 10.0 109.928 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -28.77 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 10.0 109.993 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.6 130.35 56.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 10.0 110.834 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.3 Cg_endo -86.18 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.664 1.576 . . . . 10.0 110.079 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -98.47 -50.98 4.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 10.0 110.198 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 119' ' ' LEU . 6.4 t -75.53 -32.37 60.45 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.014 -2.217 . . . . 10.0 105.014 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.525 ' N ' HD13 ' A' ' 126' ' ' ILE 0.293 1.1 mp -50.69 -28.25 5.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 176.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -52.18 -29.89 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.65 0.738 . . . . 10.0 110.471 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 6.4 mmtp -55.75 -36.93 67.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.492 -0.755 . . . . 10.0 111.606 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -57.85 -49.81 75.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.685 -1.26 . . . . 10.0 109.566 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -49.56 -41.23 40.97 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.735 -0.603 . . . . 10.0 111.466 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -21.76 56.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.26 -0.9 . . . . 10.0 110.203 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 12.7 p-10 -128.49 -46.82 1.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 10.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 129' ' ' LEU . 5.2 mmtp -121.74 144.95 48.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.631 -0.668 . . . . 10.0 109.287 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -99.54 6.33 45.85 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.257 -0.902 . . . . 10.0 110.557 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -131.76 94.02 26.34 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 10.0 109.91 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.61 160.65 48.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.128 1.593 . . . . 10.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.548 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -75.68 133.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.023 . . . . 10.0 108.649 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.2 p -131.19 168.84 15.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.152 -0.968 . . . . 10.0 109.744 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.3 Cg_endo -68.71 -33.11 22.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.758 1.399 . . . . 10.0 109.351 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.48 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 15.6 pt-20 -71.18 -23.87 62.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.822 . . . . 10.0 109.181 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.477 ' OG1' ' OG1' ' A' ' 138' ' ' THR . 57.4 m -80.03 -40.87 26.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 10.0 109.017 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.472 -0.768 . . . . 10.0 109.31 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 139' ' ' PRO . 37.4 mt-10 -59.63 -42.84 93.61 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.079 -0.648 . . . . 10.0 109.692 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -61.56 -39.79 92.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.373 -0.829 . . . . 10.0 109.434 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.493 ' O ' HD11 ' A' ' 149' ' ' LEU . 3.8 tp -65.03 -46.45 81.25 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.061 -1.024 . . . . 10.0 108.431 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -57.66 -45.1 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 10.0 110.383 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -26.37 64.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.406 -0.809 . . . . 10.0 109.882 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.63 -49.95 16.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.324 -0.86 . . . . 10.0 110.574 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.668 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 6.5 mp -90.37 1.68 56.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 10.0 108.975 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 151' ' ' ALA . 6.2 mtmt 65.49 30.31 10.8 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.639 0.733 . . . . 10.0 109.847 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.34 -146.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.955 -0.698 . . . . 10.0 109.463 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.612 ' CG1' HD11 ' A' ' 111' ' ' LEU . 2.7 p -117.51 -57.15 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.368 -1.458 . . . . 10.0 112.047 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.69 151.59 2.93 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 118.148 -1.421 . . . . 10.0 112.291 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.9 p90 -87.54 124.51 33.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 10.0 110.329 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -126.36 -168.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.355 -0.84 . . . . 10.0 109.879 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.414 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 1.9 mt-10 -143.16 144.44 32.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.016 -1.052 . . . . 10.0 110.502 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 168' ' ' VAL . 79.8 m -144.28 129.8 19.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.898 0.856 . . . . 10.0 111.4 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.541 ' OG ' ' OG1' ' A' ' 161' ' ' THR . 3.9 t -120.74 173.32 7.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.54 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . . . -93.66 -93.44 0.17 Allowed 'General case' 0 C--N 1.29 -1.99 0 O-C-N 120.984 -1.073 . . . . 10.0 110.438 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.639 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -54.67 -39.19 67.82 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.067 -1.021 . . . . 10.0 109.49 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.541 ' OG1' ' OG ' ' A' ' 158' ' ' SER . 75.0 p -79.39 -35.34 40.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.152 -1.592 . . . . 10.0 110.953 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.554 ' CG ' ' HG ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 58.02 67.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.785 -1.197 . . . . 10.0 109.858 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 0.0 OUTLIER -87.3 56.8 4.13 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.64 -0.824 . . . . 10.0 111.047 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 168' ' ' VAL . . . 125.6 11.41 4.09 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.416 -1.374 . . . . 10.0 111.001 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.554 ' HG ' ' CG ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -54.52 -34.18 61.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.718 -1.46 . . . . 10.0 109.556 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -88.15 -25.01 23.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 10.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -70.91 -38.78 72.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 10.0 111.206 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 3.5 t -68.94 -36.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.833 -1.167 . . . . 10.0 109.325 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 173' ' ' ILE . 60.7 t80 -60.11 -37.76 80.97 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.687 -0.633 . . . . 10.0 110.01 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 10.7 m-20 -67.66 -46.63 71.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -0.943 . . . . 10.0 111.358 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.07 -30.61 69.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 10.0 110.359 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.543 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -70.56 -24.47 62.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.062 . . . . 10.0 109.324 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 27.8 mm -64.55 -44.74 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.434 -0.791 . . . . 10.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.541 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.85 -31.91 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.803 -1.185 . . . . 10.0 110.629 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 109' ' ' PRO . . . -89.01 0.79 56.37 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.472 -0.768 . . . . 10.0 110.838 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 172' ' ' ALA . . . -88.89 -37.23 15.47 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.933 -1.105 . . . . 10.0 110.195 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.587 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.95 -13.54 16.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.385 -0.822 . . . . 10.0 109.716 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.42 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -89.96 47.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 10.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.2 100.49 4.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.067 -1.021 . . . . 10.0 110.664 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.463 ' CB ' ' OE1' ' B' ' 7' ' ' GLU . 14.3 mm-40 -101.52 175.67 5.49 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.542 0.687 . . . . 10.0 110.168 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.36 -146.49 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -76.11 13.72 1.23 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 CA-C-N 119.277 0.777 . . . . 10.0 111.815 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.513 ' CB ' HG21 ' A' ' 46' ' ' ILE . 0.7 OUTLIER 36.72 -150.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.229 -0.919 . . . . 10.0 110.166 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.603 ' CG2' ' CA ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -82.57 -115.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.943 -1.132 . . . . 10.0 107.943 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.504 ' N ' HG12 ' B' ' 8' ' ' ILE . 7.8 t -159.08 110.11 2.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.084 -1.635 . . . . 10.0 111.348 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -116.94 119.96 34.52 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.146 -0.971 . . . . 10.0 108.869 178.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.95 100.09 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.67 1.353 . . . . 10.0 112.928 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 m -149.17 126.01 11.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.597 -0.69 . . . . 10.0 109.575 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' THR . 5.9 p-10 -170.89 148.82 2.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.395 -1.441 . . . . 10.0 113.15 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.577 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 5.4 m-85 -129.63 -176.33 3.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.538 ' HA ' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -173.81 149.77 1.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.592 -1.318 . . . . 10.0 112.436 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.9 t60 -171.29 117.34 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.537 -0.727 . . . . 10.0 110.068 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 39' ' ' ASN . 9.3 t -128.82 158.46 38.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.868 -1.145 . . . . 10.0 112.261 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.547 HG13 ' HB3' ' A' ' 39' ' ' ASN . 1.3 pp -121.5 -168.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.642 . . . . 10.0 109.265 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 63.1 m80 -136.25 157.28 47.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 10.0 111.877 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.584 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 10.2 p -97.63 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.538 -0.726 . . . . 10.0 112.062 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 61' ' ' GLN . . . -108.41 65.48 0.25 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.669 -2.172 . . . . 10.0 107.669 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.587 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 0.3 OUTLIER 175.32 114.24 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.433 -1.039 . . . . 10.0 108.673 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.489 ' HA ' HG23 ' A' ' 35' ' ' THR . 32.4 t70 -62.1 152.4 32.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.28 -0.888 . . . . 10.0 112.349 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.51 ' N ' ' CG2' ' A' ' 35' ' ' THR . . . 37.82 71.78 0.14 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.733 -0.604 . . . . 10.0 112.524 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.587 ' CG2' ' HB3' ' B' ' 22' ' ' PHE . 15.4 t -113.15 -46.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.966 -1.084 . . . . 10.0 109.767 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.495 ' HB ' ' N ' ' A' ' 36' ' ' VAL . 1.1 t -82.57 -28.15 31.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.31 0.576 . . . . 10.0 110.51 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 36.35 3.82 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.26 -1.936 . . . . 10.0 108.26 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 36.4 tt0 -142.18 128.95 20.48 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.554 -0.968 . . . . 10.0 110.953 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -140.9 114.54 8.87 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 122.233 1.016 . . . . 10.0 109.284 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.446 HG23 ' O ' ' B' ' 29' ' ' PHE . 5.1 p -146.82 -49.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.576 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . 177.83 89.71 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.063 -1.615 . . . . 10.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.516 ' CG2' ' HD2' ' B' ' 33' ' ' PRO . 83.1 mt -120.0 147.11 43.71 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.195 -1.179 . . . . 10.0 110.445 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 42.7 Cg_endo -69.45 129.26 17.6 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 10.0 109.767 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.498 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.1 tp10 55.92 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 10.0 109.617 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.604 ' O ' ' CE3' ' B' ' 36' ' ' TRP . 72.5 mt-30 -93.08 -27.25 17.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.952 -1.092 . . . . 10.0 112.521 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.604 ' CE3' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 162.61 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.104 -1.073 . . . . 10.0 108.104 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . -175.19 75.64 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.498 ' CA ' ' HG2' ' B' ' 34' ' ' GLU . 3.9 mtm180 . . . . . 0 C--N 1.293 -1.876 0 N-CA-C 107.295 -1.372 . . . . 10.0 107.295 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 1' ' ' MET . 3.3 ptp . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.807 0.813 . . . . 10.0 109.843 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' HD21 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -153.86 -35.63 0.1 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.617 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 89.8 m -53.17 94.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.374 -0.829 . . . . 10.0 110.246 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -109.12 132.27 57.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.524 -1.271 . . . . 10.0 110.062 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.4 mtpp -122.85 104.75 9.47 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' HD22 ' A' ' 55' ' ' LEU . 29.9 p -108.98 152.85 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.143 -0.973 . . . . 10.0 111.75 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.56 162.53 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.759 -0.588 . . . . 10.0 110.102 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.484 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 16.0 m -81.76 137.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 10.0 111.472 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -152.29 169.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.307 -0.871 . . . . 10.0 109.741 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.535 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 150.39 88.88 0.07 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.974 -1.251 . . . . 10.0 109.974 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' GLY . 3.8 t0 40.88 25.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -1.072 . . . . 10.0 111.048 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 71.63 36.85 62.04 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.499 -1.44 . . . . 10.0 109.499 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . -108.97 -140.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.532 -0.981 . . . . 10.0 109.657 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.545 HG11 ' CE2' ' B' ' 29' ' ' PHE . 4.7 m -88.27 161.7 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 10.0 109.648 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -92.2 -174.16 42.09 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.274 -1.13 . . . . 10.0 110.274 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.514 ' CE ' ' HA ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -110.59 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -1.064 . . . . 10.0 111.001 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 19' ' ' LEU . 73.7 m -50.8 -36.45 37.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.036 -1.04 . . . . 10.0 109.041 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.716 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 25.3 p -67.22 4.32 0.97 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.128 0.966 . . . . 10.0 109.718 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.795 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 3.8 mt -110.46 -38.82 5.11 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.285 -1.509 . . . . 10.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' CD2' ' A' ' 165' ' ' LEU . 21.1 tp -44.63 -46.2 10.01 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.853 -1.154 . . . . 10.0 111.227 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.621 HG21 ' CA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -90.33 -31.14 5.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 117.093 -1.843 . . . . 10.0 109.858 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 21.9 t -47.44 -44.14 24.6 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.346 -0.942 . . . . 10.0 110.311 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.493 ' HB2' ' C ' ' A' ' 159' ' ' ALA . 67.0 t80 -86.42 -0.89 56.94 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.55 -1.344 . . . . 10.0 109.951 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 4.3 m -108.93 -42.87 4.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.851 -1.155 . . . . 10.0 113.984 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.506 ' CG2' ' OD1' ' A' ' 26' ' ' ASN . 60.0 m -117.38 -93.06 0.51 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 119.95 -1.719 . . . . 10.0 111.515 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.577 ' O ' ' CA ' ' B' ' 27' ' ' GLY . 0.1 OUTLIER -135.81 -21.64 1.47 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.277 -0.889 . . . . 10.0 110.34 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 22' ' ' SER . 14.4 mttt -148.87 -139.32 0.09 Allowed 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.729 -1.952 . . . . 10.0 105.729 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.716 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.285 -2.203 0 C-N-CA 116.357 -2.137 . . . . 10.0 115.384 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 28' ' ' PHE . 2.9 m . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 120.93 0.395 . . . . 10.0 111.369 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 38.6 t 77.46 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.763 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -33.75 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.141 0.972 . . . . 10.0 110.648 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -170.15 112.22 0.44 Allowed 'General case' 0 C--N 1.289 -2.033 0 O-C-N 119.374 -2.079 . . . . 10.0 112.221 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.565 ' HB3' ' CG1' ' B' ' 18' ' ' ILE . 0.9 OUTLIER -166.4 96.93 0.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.217 -0.927 . . . . 10.0 108.558 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' B' ' 16' ' ' HIS . 17.4 p90 -171.77 176.95 3.5 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.354 -0.938 . . . . 10.0 111.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.522 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -171.23 98.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.615 ' CG2' ' O ' ' B' ' 15' ' ' GLU . 16.6 m -157.5 -166.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 10.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' B' ' 13' ' ' ASP . 24.1 m -105.35 166.83 10.15 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.967 -0.693 . . . . 10.0 111.319 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 2.9 t -127.7 139.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.398 -0.964 . . . . 10.0 108.398 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.561 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 3.1 mtt -102.57 102.16 12.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.349 -1.34 . . . . 10.0 110.426 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' B' ' 7' ' ' GLU . 2.3 mp -110.24 118.59 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.06 . . . . 10.0 110.167 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 54.41 16.96 7.48 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.178 -1.169 . . . . 10.0 110.178 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.03 18.35 34.45 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -110.59 115.89 53.21 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.39 -1.065 . . . . 10.0 110.315 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 45.8 Cg_endo -69.24 119.4 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.824 1.434 . . . . 10.0 110.272 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' ' 43' ' ' THR . 3.9 m-30 -97.52 179.93 4.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 10.0 110.72 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.617 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 5.0 m -146.27 132.66 19.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 10.0 110.039 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 53' ' ' LEU . 1.3 pp -172.27 174.04 4.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.739 -1.225 . . . . 10.0 111.593 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.87 105.4 0.21 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.163 -1.975 . . . . 10.0 108.163 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -105.52 135.48 46.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.64 -1.506 . . . . 10.0 110.409 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.515 ' N ' HD23 ' A' ' 55' ' ' LEU . 16.1 m-85 -129.03 103.25 6.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 10.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' THR . 51.1 t0 -105.96 121.04 43.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 10.0 109.421 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASP . 13.7 t -39.4 129.39 1.82 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.074 -1.016 . . . . 10.0 111.466 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -72.17 -73.52 0.19 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.811 -0.556 . . . . 10.0 111.515 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 69.98 7.4 59.29 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.985 -1.646 . . . . 10.0 108.985 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 177.91 -26.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -1.093 . . . . 10.0 110.903 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -41.87 -71.14 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.858 -1.152 . . . . 10.0 110.383 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 7.2 t70 164.34 -13.77 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.698 -0.626 . . . . 10.0 110.697 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 39' ' ' ASN . 38.2 p90 -110.86 17.33 20.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.865 -1.147 . . . . 10.0 109.312 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.1 t70 -49.52 -23.7 1.73 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.434 -0.791 . . . . 10.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -49.92 -36.62 28.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.04 -1.038 . . . . 10.0 109.223 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.568 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 1.6 mt -92.66 11.49 26.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.505 -0.747 . . . . 10.0 110.041 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.658 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -73.37 -22.13 0.48 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.275 -0.891 . . . . 10.0 112.959 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 42.8 Cg_endo -78.21 85.12 1.87 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 CA-C-O 121.944 0.727 . . . . 10.0 110.546 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.568 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.27 -47.15 1.2 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.795 0.807 . . . . 10.0 109.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' B' ' 37' ' ' ALA . 5.6 m 59.91 12.78 3.26 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.948 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -101.98 110.4 62.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 10.0 112.038 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.433 ' C ' ' HG3' ' A' ' 74' ' ' GLN . 48.6 Cg_endo -76.93 148.59 28.2 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.107 1.583 . . . . 10.0 110.7 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.559 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.04 67.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 10.0 109.283 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -143.18 87.35 1.96 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.101 -1.0 . . . . 10.0 109.982 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 9.6 m-20 -20.29 -44.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.456 0.91 . . . . 10.0 113.456 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' THR . 1.1 m -110.5 144.32 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.818 -1.176 . . . . 10.0 111.26 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.606 ' CD2' ' O ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -156.25 157.41 35.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 10.0 110.977 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.585 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -107.32 98.65 8.25 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 178.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.597 HG13 ' CE2' ' A' ' 82' ' ' PHE . 3.9 p -85.07 148.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 10.0 109.95 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.52 ' C ' ' CG2' ' A' ' 115' ' ' THR . 41.1 m -117.26 103.16 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.767 -1.173 . . . . 10.0 113.516 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.597 ' CE2' HG13 ' A' ' 80' ' ' VAL . 43.8 m-85 -99.84 147.69 25.23 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.293 -0.879 . . . . 10.0 109.232 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.504 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 46.6 t -90.42 141.1 29.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.513 -1.367 . . . . 10.0 108.95 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.529 ' CG2' ' HG3' ' A' ' 120' ' ' ARG . 2.0 t -80.32 5.58 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.905 . . . . 10.0 110.375 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.558 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 33.9 m -143.31 59.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.931 0.872 . . . . 10.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.577 ' CB ' ' CD ' ' A' ' 87' ' ' PRO . 2.7 p -125.13 -165.53 0.08 OUTLIER Pre-proline 0 C--N 1.287 -2.125 0 O-C-N 121.376 -0.828 . . . . 10.0 108.773 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 43.4 Cg_endo -76.18 60.76 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.277 1.146 . . . . 10.0 109.621 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 87' ' ' PRO . 43.6 p 32.86 51.5 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.104 0.478 . . . . 10.0 111.54 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.1 p -77.02 -25.42 52.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 10.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 73.0 t80 -59.22 -40.21 85.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 10.0 111.51 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -70.77 -22.87 62.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.914 -1.116 . . . . 10.0 110.828 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -20.8 28.12 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.807 -1.183 . . . . 10.0 109.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 90' ' ' PHE . 23.1 m -84.23 -29.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.151 -1.02 . . . . 10.0 109.931 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -70.87 -34.03 71.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.072 -1.018 . . . . 10.0 109.6 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.555 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 7.2 pt-20 -80.26 -8.22 59.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 10.0 110.971 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 2.1 mmtm -81.73 -52.75 6.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 10.0 111.655 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -73.24 -9.88 59.17 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.982 -1.073 . . . . 10.0 112.202 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.564 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 77.6 t -76.48 -50.2 2.75 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.621 -1.3 . . . . 10.0 110.828 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.1 Cg_endo -73.42 -25.8 14.96 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.209 1.11 . . . . 10.0 110.647 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -77.07 -23.74 51.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.287 -0.883 . . . . 10.0 110.998 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 49.0 mm 60.15 103.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.026 -1.046 . . . . 10.0 110.329 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.489 HG23 ' OG1' ' A' ' 108' ' ' THR . 2.3 m -47.04 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 10.0 108.623 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 104' ' ' HIS . 5.5 m170 -112.1 -4.85 14.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.323 -0.861 . . . . 10.0 109.51 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 160.87 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 50.8 t -142.26 137.37 15.61 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 149' ' ' LEU . 44.1 Cg_endo -69.82 80.29 0.91 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.681 1.358 . . . . 10.0 110.68 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' THR . 34.4 mtpt -118.16 -14.44 9.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.469 -0.77 . . . . 10.0 111.181 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.489 ' OG1' HG23 ' A' ' 102' ' ' THR . 52.1 m -46.3 136.08 7.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.718 -1.239 . . . . 10.0 109.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 175' ' ' ALA . 37.5 Cg_endo -64.9 111.9 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 10.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.522 ' O ' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -117.94 103.88 10.37 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.757 0.789 . . . . 10.0 110.209 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.616 HD13 ' CG1' ' A' ' 152' ' ' VAL . 1.7 mm? -77.41 98.57 5.3 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 90.0 mt -74.03 135.82 43.08 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 112' ' ' LEU . 10.8 t -143.28 169.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 10.0 112.552 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.87 153.88 19.54 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.479 -2.248 . . . . 10.0 107.479 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.52 ' CG2' ' C ' ' A' ' 81' ' ' CYS . 76.3 p -101.04 127.57 47.49 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.497 -1.59 . . . . 10.0 111.057 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 118' ' ' ASP . 0.8 OUTLIER 40.31 55.06 2.82 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.849 -0.74 . . . . 10.0 110.16 178.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.764 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -40.78 -28.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 C-N-CA 119.467 -0.893 . . . . 10.0 110.16 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.526 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.3 p-10 -52.69 60.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.17 0.986 . . . . 10.0 110.524 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.764 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.4 OUTLIER 161.77 -27.95 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -47.09 -38.33 11.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.77 17.75 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 10.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.46 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 6.9 t70 -104.28 110.84 64.81 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 10.0 110.857 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.32 15.46 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.072 1.564 . . . . 10.0 110.779 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 122' ' ' ASP . 47.1 t -109.89 -49.93 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 10.0 109.857 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.496 ' CG2' ' HG ' ' A' ' 119' ' ' LEU . 4.7 t -73.67 -24.39 59.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.515 -2.031 . . . . 10.0 105.515 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.487 ' N ' HD11 ' A' ' 126' ' ' ILE 0.301 0.6 OUTLIER -59.98 -20.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 176.859 . . . . . . . . 4 4 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -48.26 -45.34 34.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.672 -0.642 . . . . 10.0 110.396 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 36.5 mmtt -84.96 -13.77 49.65 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.425 -0.797 . . . . 10.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 6.1 mp -95.91 -40.45 9.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.233 -0.917 . . . . 10.0 109.554 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . . . -57.96 -39.67 78.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.137 -0.977 . . . . 10.0 109.72 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 11.2 pttt -55.66 -20.31 13.59 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.398 -0.814 . . . . 10.0 109.746 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -118.69 9.64 12.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.351 -0.843 . . . . 10.0 109.299 178.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.533 ' CE ' ' HB3' ' A' ' 136' ' ' PRO . 2.3 tmtt? -141.0 82.99 1.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.102 -0.703 . . . . 10.0 109.102 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.486 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 1.3 mp0 -65.39 -24.44 67.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -132.79 115.88 14.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 10.0 109.422 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.533 ' HB3' ' CE ' ' A' ' 133' ' ' LYS . 40.1 Cg_endo -67.01 159.4 52.18 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.799 1.421 . . . . 10.0 110.494 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -103.95 134.29 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.289 -0.882 . . . . 10.0 109.564 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.1 p -125.87 164.46 33.01 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 10.0 109.541 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.6 Cg_endo -65.64 -13.65 40.86 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.883 1.465 . . . . 10.0 109.823 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.98 -20.86 29.9 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.764 -0.774 . . . . 10.0 110.1 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -96.74 -42.32 8.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 10.0 110.744 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.62 ' HB2' ' CD2' ' A' ' 154' ' ' TYR . . . -73.79 -26.42 60.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 10.0 110.488 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.9 tt0 -61.22 -39.07 88.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 10.0 109.847 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -65.69 -40.1 91.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.895 . . . . 10.0 109.1 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 145' ' ' LEU . 4.1 tt -63.04 -40.7 98.51 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.367 -0.833 . . . . 10.0 109.238 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.421 ' HA ' ' HB1' ' A' ' 151' ' ' ALA . . . -63.58 -44.84 92.91 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.821 0.819 . . . . 10.0 109.088 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -59.91 -25.8 65.42 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.361 -0.536 . . . . 10.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.419 ' C ' HD13 ' A' ' 149' ' ' LEU . 34.8 t0 -70.26 -48.8 55.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.09 -1.006 . . . . 10.0 110.827 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.653 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.5 mp -93.11 24.55 3.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 10.0 108.931 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 151' ' ' ALA . 1.0 OUTLIER 51.91 27.3 4.21 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.741 0.781 . . . . 10.0 109.389 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -57.04 -160.19 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.616 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.3 p -108.49 -65.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.677 -1.264 . . . . 10.0 111.761 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.474 ' HE3' ' HG3' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -174.02 157.74 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.016 -1.678 . . . . 10.0 112.106 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 142' ' ' ALA . 4.1 t80 -107.61 112.61 25.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 10.0 110.107 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.572 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -103.36 -168.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.429 -0.794 . . . . 10.0 110.604 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 22.4 tt0 -170.28 98.55 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.221 -0.924 . . . . 10.0 109.749 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.616 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 73.8 m -153.0 156.35 38.65 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.107 -0.996 . . . . 10.0 111.608 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 162' ' ' GLN . 3.7 m -140.86 114.75 9.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.795 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . . . -74.09 -87.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.428 -1.42 . . . . 10.0 111.025 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' B' ' 29' ' ' PHE . 0.0 OUTLIER -31.32 -33.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 122.32 1.057 . . . . 10.0 109.383 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -93.94 -70.79 0.69 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.341 -0.845 . . . . 10.0 112.218 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -109.13 -107.71 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.377 -1.452 . . . . 10.0 112.021 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 162' ' ' GLN . 12.2 pttt 174.48 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.425 -0.797 . . . . 10.0 109.521 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.58 49.1 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.145 -1.026 . . . . 10.0 110.75 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.616 ' HA ' ' CB ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -59.39 -2.07 0.28 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.409 -1.054 . . . . 10.0 113.097 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 8.9 tttt -59.69 -48.84 80.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.39 -1.444 . . . . 10.0 110.432 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -56.45 -39.75 73.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.437 -0.789 . . . . 10.0 111.755 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.572 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 46.3 t -53.74 -48.34 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.819 -1.175 . . . . 10.0 111.034 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -78.6 -37.97 41.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.242 -0.911 . . . . 10.0 111.368 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.505 ' O ' HD22 ' A' ' 174' ' ' LEU . 16.5 m-20 -60.91 -40.26 92.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.876 -1.14 . . . . 10.0 110.946 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 41.0 mm-40 -62.03 -46.05 90.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 10.0 111.28 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.479 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . . . -54.36 -24.45 19.54 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.986 . . . . 10.0 110.379 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 28.6 mm -63.85 -42.86 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.415 -0.914 . . . . 10.0 109.841 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -86.17 -17.07 35.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 10.0 111.01 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.75 -1.18 41.13 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.938 -1.101 . . . . 10.0 109.812 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.472 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -87.96 -40.89 13.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 10.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.23 -11.83 18.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 10.0 109.505 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.04 -0.981 . . . . 10.0 110.025 -179.815 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.439 ' CA ' ' CG ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -112.37 131.9 55.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 10.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -88.38 99.96 12.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.137 -0.977 . . . . 10.0 110.115 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.2 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.74 -0.6 . . . . 10.0 110.001 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.38 -91.15 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.117 -0.989 . . . . 10.0 109.231 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 53.8 Cg_endo -76.57 -10.45 18.71 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 N-CA-C 108.423 -1.414 . . . . 10.0 108.423 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 3.3 pt-20 41.25 -162.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.776 -0.578 . . . . 10.0 110.121 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.419 HD11 ' CA ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -134.77 -67.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.034 -1.041 . . . . 10.0 110.579 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 47.5 t -103.32 132.11 49.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 10.0 111.604 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.577 ' O ' ' CD1' ' B' ' 10' ' ' LEU . 1.2 tm? -149.36 101.77 3.32 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 120.598 -1.314 . . . . 10.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -91.2 -168.5 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.406 2.071 . . . . 10.0 108.15 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 67.0 m -108.97 173.58 6.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.736 -1.228 . . . . 10.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 43' ' ' THR . 5.3 m-20 -134.33 -165.22 1.62 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.799 0.809 . . . . 10.0 111.657 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.567 ' CB ' HG11 ' A' ' 42' ' ' VAL . 18.5 m-85 -45.39 -166.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.25 1.024 . . . . 10.0 112.426 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.615 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 57.1 mt-10 -41.24 154.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.088 -1.008 . . . . 10.0 111.806 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -139.32 -171.1 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 10.0 110.722 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 40' ' ' TYR . 47.2 p -58.65 156.07 11.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.769 0.795 . . . . 10.0 112.064 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.565 ' CG1' ' HB3' ' A' ' 39' ' ' ASN . 1.3 pp -128.31 -168.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 74.0 m-70 -109.19 143.89 38.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.503 -1.373 . . . . 10.0 112.277 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 33.3 t -130.82 152.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.695 -0.628 . . . . 10.0 110.838 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -112.02 -175.17 19.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.817 -1.313 . . . . 10.0 109.817 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' B' ' 31' ' ' GLY . 46.0 t80 166.37 116.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.711 -0.876 . . . . 10.0 108.752 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' B' ' 22' ' ' PHE . 12.6 t70 -39.41 152.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.105 -0.638 . . . . 10.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.452 ' O ' ' CD ' ' B' ' 28' ' ' GLU . . . 63.11 79.85 0.25 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.735 -1.58 . . . . 10.0 106.735 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.589 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.5 -21.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.882 0.849 . . . . 10.0 110.572 -176.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.475 ' C ' ' O ' ' A' ' 26' ' ' ASN . 10.0 t -48.79 -15.96 0.11 Allowed 'General case' 0 C--N 1.286 -2.16 0 O-C-N 120.962 -1.086 . . . . 10.0 112.948 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 26' ' ' ASN . . . 148.22 85.64 0.06 OUTLIER Glycine 0 N--CA 1.504 3.178 0 N-CA-C 109.358 -1.497 . . . . 10.0 109.358 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' B' ' 28' ' ' GLU . 19.7 pm0 -129.82 -146.4 0.31 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.746 -0.855 . . . . 10.0 109.422 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.634 ' HB3' HD22 ' A' ' 160' ' ' LEU . 13.9 p90 -135.35 145.23 47.18 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.521 ' CG2' ' C ' ' B' ' 29' ' ' PHE . 1.7 t 30.99 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.082 0.468 . . . . 10.0 110.559 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.58 ' O ' ' CE1' ' B' ' 22' ' ' PHE . . . -153.77 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.694 -1.762 . . . . 10.0 108.694 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.417 HG22 ' C ' ' B' ' 31' ' ' GLY . 10.7 pt -127.83 145.29 54.48 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.519 -0.989 . . . . 10.0 109.187 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.09 83.22 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.562 1.296 . . . . 10.0 109.925 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' B' ' 38' ' ' ARG . 2.8 tm-20 -160.13 155.6 25.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.568 -0.708 . . . . 10.0 110.315 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' B' ' 36' ' ' TRP . 2.2 tt0 -91.59 -71.3 0.64 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.027 -1.046 . . . . 10.0 109.7 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.593 ' CD1' ' HG2' ' B' ' 35' ' ' GLN . 0.4 OUTLIER -172.13 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.103 -0.998 . . . . 10.0 112.571 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' SER . . . -130.32 -19.1 3.16 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.478 -0.763 . . . . 10.0 110.468 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.542 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 6.6 mtt180 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.404 -1.435 . . . . 10.0 108.108 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' CA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.523 ' HA ' ' CD2' ' A' ' 177' ' ' LEU . 7.9 mm100 -133.1 0.87 3.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.002 . . . . 10.0 110.532 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.539 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.9 m -64.74 100.62 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 10.0 110.51 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -114.65 133.73 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.994 -1.082 . . . . 10.0 111.096 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.595 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 26.2 mmtt -121.23 100.65 7.17 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.517 -0.92 . . . . 10.0 108.517 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.21 106.58 15.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.04 -1.038 . . . . 10.0 109.75 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' HG21 ' A' ' 75' ' ' THR . 71.7 t -133.67 147.56 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 10.0 110.11 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.536 ' CG2' ' HA2' ' A' ' 15' ' ' GLY . 14.2 m -91.2 115.72 30.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.424 -0.798 . . . . 10.0 110.295 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.498 HG13 ' CG ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -139.7 -166.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.277 -0.889 . . . . 10.0 110.045 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' ' CG2' ' A' ' 80' ' ' VAL . . . 126.43 -144.83 15.36 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 10.0 109.81 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.88 -37.84 20.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -1.223 . . . . 10.0 109.897 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 133.8 31.88 0.38 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.526 ' O ' HG22 ' B' ' 32' ' ' ILE . . . -61.27 -133.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.991 -1.3 . . . . 10.0 109.066 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.514 HG21 ' CG2' ' B' ' 32' ' ' ILE . 5.0 t -128.93 -24.79 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.546 -1.347 . . . . 10.0 111.144 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 8' ' ' VAL . . . 157.0 128.94 1.09 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.351 -1.404 . . . . 10.0 110.062 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -57.77 -24.53 57.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.205 -1.173 . . . . 10.0 110.154 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -59.37 -32.73 70.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 10.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HB2' ' CB ' ' B' ' 28' ' ' GLU . 16.6 p -61.0 -29.03 69.46 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.138 -0.976 . . . . 10.0 110.388 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.565 ' CD1' ' CB ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -80.51 -30.31 37.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.941 -1.1 . . . . 10.0 110.718 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 24' ' ' THR . 12.8 tp -49.2 -30.65 7.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.101 -0.999 . . . . 10.0 110.122 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 26' ' ' ASN . 3.8 mm -106.74 -44.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 10.0 109.7 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.526 ' HB2' ' CA ' ' B' ' 27' ' ' GLY . 39.6 t -49.7 -40.07 39.12 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.364 -0.934 . . . . 10.0 109.303 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -82.09 -28.93 32.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.07 . . . . 10.0 109.311 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 25.2 m -65.58 -50.22 65.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 10.0 110.7 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.555 HG21 ' N ' ' A' ' 26' ' ' ASN . 14.7 t -175.24 -37.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.2 -1.4 . . . . 10.0 112.693 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.567 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.3 m120 -70.75 -9.79 58.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.156 -0.965 . . . . 10.0 111.985 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.618 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 0.8 OUTLIER 33.75 -150.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 10.0 110.661 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.47 ' HA ' HG23 ' B' ' 26' ' ' THR . 12.6 p90 . . . . . 0 C--N 1.298 -1.658 0 O-C-N 121.167 -0.958 . . . . 10.0 111.437 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.572 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 16.8 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 35' ' ' THR . 54.9 t -163.62 -96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.334 -0.854 . . . . 10.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 6.8 t80 -57.22 141.11 47.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 10.0 111.122 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' B' ' 18' ' ' ILE . 4.8 t70 -164.31 101.37 0.84 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.252 -0.905 . . . . 10.0 110.376 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.58 ' CB ' HG22 ' B' ' 18' ' ' ILE . 0.4 OUTLIER -104.86 118.26 36.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.237 -1.54 . . . . 10.0 109.279 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CE2' ' HG3' ' B' ' 15' ' ' GLU . 6.5 m-85 -146.72 113.53 6.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.068 -1.02 . . . . 10.0 111.107 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' B' ' 15' ' ' GLU . . . -118.41 115.29 24.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.72 -1.238 . . . . 10.0 109.976 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.417 HG21 ' O ' ' B' ' 14' ' ' PHE . 0.9 OUTLIER -135.94 -168.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 10.0 111.462 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' B' ' 13' ' ' ASP . 20.2 m -163.71 145.16 9.15 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.493 0.663 . . . . 10.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HB ' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.73 123.75 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.381 -0.824 . . . . 10.0 109.771 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 7.3 mtm -92.06 98.19 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.869 -1.133 . . . . 10.0 109.406 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 1.9 mp -86.36 120.93 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.593 -0.692 . . . . 10.0 109.874 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 44.6 26.38 1.05 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 110.02 -24.88 17.79 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.012 -1.287 . . . . 10.0 111.307 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.46 110.98 30.82 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 120.714 -1.462 . . . . 10.0 110.545 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.3 Cg_endo -73.64 141.06 30.42 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.044 1.549 . . . . 10.0 111.042 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.6 t80 -91.9 122.33 34.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.358 -0.839 . . . . 10.0 109.524 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 3' ' ' THR 0.258 56.3 m -107.54 99.69 9.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.8 . . . . 10.0 109.772 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 4' ' ' ILE . 1.8 pp -144.23 168.63 19.59 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.341 -1.344 . . . . 10.0 112.33 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.479 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.4 126.9 1.32 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.87 -2.092 . . . . 10.0 107.87 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 38' ' ' ASP . 2.0 pp -124.55 142.32 51.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.82 -1.4 . . . . 10.0 110.354 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -139.82 104.91 5.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 10.0 110.837 -178.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 79.4 m-20 -80.97 -179.66 7.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.172 -0.955 . . . . 10.0 110.497 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -85.33 -175.97 5.93 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.549 1.166 . . . . 10.0 113.361 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -142.0 -70.83 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 61' ' ' GLN . . . 40.54 24.09 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.117 -1.193 . . . . 10.0 110.117 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.543 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 1.4 mm-40 -171.47 -35.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.214 -1.168 . . . . 10.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 2.0 mt-10 -54.6 -80.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 117.813 -1.555 . . . . 10.0 108.861 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER 172.1 27.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 10.0 111.595 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.16 -52.43 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.672 -1.267 . . . . 10.0 110.807 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 24.0 t0 42.0 32.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.472 -0.767 . . . . 10.0 109.361 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.19 1.91 29.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.469 -0.769 . . . . 10.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.58 ' O ' HD23 ' A' ' 70' ' ' LEU . 2.4 mp -103.72 -14.46 16.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.413 -0.804 . . . . 10.0 110.03 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 3.9 ttt180 -82.26 -27.38 0.43 Allowed Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.7 Cg_endo -81.78 5.6 6.2 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.859 0.926 . . . . 10.0 111.072 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.614 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 2.0 pt? -49.34 -40.46 35.45 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.399 -0.813 . . . . 10.0 112.97 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.568 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 34.3 m 49.38 21.03 0.51 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.67 -1.269 . . . . 10.0 110.841 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 71' ' ' SER . 13.2 m-85 -143.92 130.61 10.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.925 -1.109 . . . . 10.0 110.366 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 50.8 Cg_endo -72.88 150.07 48.7 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.832 1.438 . . . . 10.0 111.276 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -177.48 47.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.047 0.927 . . . . 10.0 109.708 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.595 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 57.5 m -140.25 89.74 2.31 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.149 -0.97 . . . . 10.0 110.228 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -42.58 -30.72 0.38 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.53 -0.731 . . . . 10.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 13.6 m -123.19 124.84 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.78 -1.2 . . . . 10.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 1.7 m-85 -116.5 154.57 30.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.421 -0.799 . . . . 10.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.504 HD22 ' CD2' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -111.0 97.95 7.19 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.843 -1.169 . . . . 10.0 107.843 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -103.39 125.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.159 -0.963 . . . . 10.0 111.033 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 4.2 m -127.38 125.96 41.63 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.299 -0.875 . . . . 10.0 109.084 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -135.91 178.85 6.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 10.0 110.245 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 t -81.03 149.5 29.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 10.0 112.059 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.48 -2.01 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.704 -0.623 . . . . 10.0 110.125 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' HG ' ' A' ' 129' ' ' LEU . 22.9 m -132.97 53.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.75 0.786 . . . . 10.0 109.842 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 19.4 p -121.29 158.39 53.38 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 121.513 -0.742 . . . . 10.0 110.5 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 120.64 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.557 . . . . 10.0 111.647 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m 44.41 64.77 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 10.0 111.612 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -124.22 -43.34 2.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.677 -1.264 . . . . 10.0 110.918 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.631 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 6.4 t80 -56.12 -50.21 71.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.828 -1.17 . . . . 10.0 110.694 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.96 -15.33 12.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.955 -1.091 . . . . 10.0 111.823 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -86.9 -20.21 27.74 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.698 -1.251 . . . . 10.0 111.079 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.568 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 19.3 m -90.18 -14.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.552 -1.343 . . . . 10.0 108.896 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 90' ' ' PHE . 25.9 mmtt -88.14 -33.41 18.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.15 0.976 . . . . 10.0 108.842 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 10.6 pt-20 -78.76 -5.82 54.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.105 -0.702 . . . . 10.0 109.105 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -84.24 -50.23 8.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 10.0 112.27 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 20.7 m95 -80.99 -23.8 38.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.014 -1.054 . . . . 10.0 113.376 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.544 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 4.4 t -69.23 -50.54 20.16 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.048 -1.658 . . . . 10.0 110.676 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.7 Cg_endo -72.84 -6.23 18.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.139 1.073 . . . . 10.0 109.564 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 101' ' ' ILE . 0.5 OUTLIER -68.98 -32.96 72.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 10.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 100' ' ' GLU . 2.7 pt 36.0 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.481 0.658 . . . . 10.0 111.318 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -47.11 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 109.416 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.475 ' H ' ' CG2' ' A' ' 102' ' ' THR . 30.4 m80 -106.74 -4.63 19.19 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.432 -0.793 . . . . 10.0 109.395 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -175.8 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 10.0 109.948 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.503 ' O ' HG23 ' A' ' 102' ' ' THR . 20.0 p -134.77 167.46 22.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 10.0 110.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 54.4 Cg_endo -81.01 72.38 6.55 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.773 1.407 . . . . 10.0 111.411 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -112.84 -10.11 13.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 10.0 112.029 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -52.92 125.39 39.65 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 120.687 -1.258 . . . . 10.0 110.432 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.72 153.12 48.43 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.052 1.553 . . . . 10.0 111.952 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 151' ' ' ALA . 21.8 p90 -165.02 156.57 15.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.231 -1.025 . . . . 10.0 108.231 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 1.9 mm? -102.9 103.32 13.46 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 122.104 0.954 . . . . 10.0 111.007 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 88.2 mt -66.33 138.57 57.7 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.179 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.566 ' CG2' HG11 ' A' ' 168' ' ' VAL . 1.4 t -150.42 171.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.792 -1.192 . . . . 10.0 111.776 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.25 122.11 3.04 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.486 -1.846 . . . . 10.0 108.486 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 31.0 p -100.55 170.96 8.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.165 -1.197 . . . . 10.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.22 33.95 8.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.473 -0.767 . . . . 10.0 109.392 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.769 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -69.05 -21.88 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 10.0 109.688 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 17.3 t70 -51.45 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.958 0.885 . . . . 10.0 110.282 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.769 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.2 tp 160.33 -30.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.017 -1.105 . . . . 10.0 108.017 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -47.46 -37.5 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.57 0.7 . . . . 10.0 109.876 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.487 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 64.2 t0 -55.74 -24.83 37.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 10.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -90.22 109.4 33.09 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.24 -0.913 . . . . 10.0 111.249 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 51.5 Cg_endo -76.92 24.12 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.592 1.528 . . . . 10.0 112.142 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 m -100.97 -47.05 4.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.748 -1.22 . . . . 10.0 109.728 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.488 HG22 HD12 ' A' ' 126' ' ' ILE . 3.4 t -71.94 -26.34 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.035 -2.209 . . . . 10.0 105.035 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 125' ' ' THR 0.301 1.1 mp -50.69 -26.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.15 -38.84 54.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.521 0.677 . . . . 10.0 110.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 128' ' ' LYS . 13.0 mptt -75.22 -44.6 45.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.469 -0.769 . . . . 10.0 110.679 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.511 ' N ' HD13 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -60.16 -49.1 78.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.854 0.835 . . . . 10.0 108.971 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . -52.97 -40.92 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.469 0.652 . . . . 10.0 109.582 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -25.21 11.77 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.946 -1.097 . . . . 10.0 110.009 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -88.59 -48.65 7.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 10.0 112.177 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -126.98 0.84 6.58 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.484 -0.76 . . . . 10.0 110.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER 45.52 23.32 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 10.0 111.494 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -154.19 101.06 2.45 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.033 -1.042 . . . . 10.0 111.781 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.03 160.12 43.43 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.124 1.592 . . . . 10.0 109.919 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.631 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -81.77 128.19 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.529 -1.357 . . . . 10.0 109.077 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.5 p -125.37 170.89 8.41 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.475 -0.765 . . . . 10.0 110.404 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.5 Cg_endo -68.21 -7.27 19.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.786 1.414 . . . . 10.0 110.519 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -92.58 -38.54 11.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 10.0 110.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.565 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 84.3 m -74.68 -44.68 48.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.635 -0.665 . . . . 10.0 111.593 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.67 -38.54 47.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 111.581 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 143' ' ' GLU . 5.4 tm-20 -62.97 -27.04 69.13 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.792 -1.193 . . . . 10.0 108.94 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -49.59 10.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 10.0 109.93 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.482 ' CD1' ' HB3' ' A' ' 94' ' ' LYS . 5.1 tt -56.2 -41.82 76.19 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.237 -0.914 . . . . 10.0 110.022 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.34 73.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 10.0 108.89 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -60.23 -29.07 68.51 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.823 -0.751 . . . . 10.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.03 -47.49 51.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 10.0 110.499 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.731 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -90.05 16.33 8.56 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.075 0.94 . . . . 10.0 108.966 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 27.12 1.99 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.798 0.809 . . . . 10.0 109.525 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 110' ' ' PHE . . . -63.68 -148.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.137 -0.625 . . . . 10.0 109.877 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.556 HG23 ' CB ' ' A' ' 175' ' ' ALA . 19.1 t -98.51 -75.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.231 -0.987 . . . . 10.0 109.963 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -173.56 -177.18 1.4 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.739 -1.184 . . . . 10.0 111.637 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -110.69 116.54 31.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.709 -0.619 . . . . 10.0 110.358 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.537 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -122.77 -168.98 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.954 -1.091 . . . . 10.0 110.169 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.97 143.49 11.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 10.0 111.403 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 28.4 p -159.19 177.28 11.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.472 -0.767 . . . . 10.0 111.301 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.559 ' CB ' ' CB ' ' A' ' 162' ' ' GLN . 47.1 t -144.91 170.58 15.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 10.0 109.725 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' B' ' 29' ' ' PHE . . . -89.59 -48.77 7.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 10.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.407 HD11 HG21 ' A' ' 161' ' ' THR . 2.0 pp -118.61 -0.7 11.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 10.0 112.176 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.502 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -120.13 -80.07 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.429 -1.42 . . . . 10.0 111.968 -178.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.559 ' CB ' ' CB ' ' A' ' 158' ' ' SER . 5.7 tp60 -40.73 -63.75 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.991 -1.068 . . . . 10.0 112.071 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 25.2 mttt 70.14 51.01 0.41 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.932 0.872 . . . . 10.0 109.295 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.84 24.37 2.59 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.316 -1.514 . . . . 10.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -78.78 1.43 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -1.224 . . . . 10.0 110.767 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -39.47 32.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.851 -1.156 . . . . 10.0 109.596 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.35 -40.77 97.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.173 -0.954 . . . . 10.0 110.682 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.566 HG11 ' CG2' ' A' ' 113' ' ' VAL . 4.3 t -59.23 -28.21 38.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.185 -0.947 . . . . 10.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 169' ' ' PHE . 4.4 t80 -84.04 -21.34 31.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.488 -0.757 . . . . 10.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.405 ' O ' HD22 ' A' ' 174' ' ' LEU . 53.7 t0 -74.31 -49.45 22.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.091 -1.005 . . . . 10.0 111.135 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.471 ' HA ' HD21 ' A' ' 174' ' ' LEU . 1.1 mm-40 -58.22 -37.22 74.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 10.0 110.578 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.535 ' CB ' HD21 ' A' ' 111' ' ' LEU . . . -55.61 -32.71 63.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.158 -0.964 . . . . 10.0 110.045 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 66.9 mt -60.8 -44.3 97.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.153 -0.967 . . . . 10.0 110.132 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.566 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -70.57 -30.59 67.34 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.732 -1.23 . . . . 10.0 111.567 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -86.37 -17.78 33.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 10.0 111.234 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -65.72 -30.97 71.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 10.0 109.318 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.603 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -110.35 -11.68 14.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 10.0 110.188 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.959 -1.019 . . . . 10.0 110.439 -179.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 108.809 -1.716 . . . . 10.0 108.809 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -130.14 136.92 49.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.488 -1.007 . . . . 10.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' B' ' 3' ' ' LYS . 5.7 tptt -99.38 103.31 15.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.01 -1.057 . . . . 10.0 108.388 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.495 ' HB3' ' OE2' ' B' ' 7' ' ' GLU . 6.1 mm-40 -104.28 161.03 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.306 -0.871 . . . . 10.0 110.769 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.622 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.07 -153.26 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.564 -1.272 . . . . 10.0 107.564 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.622 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 40.3 Cg_endo -69.85 90.88 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 109.91 -0.842 . . . . 10.0 109.91 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.552 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 39.1 mm-40 -56.6 -152.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.893 -0.505 . . . . 10.0 110.691 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' B' ' 9' ' ' SER . 2.7 pp -79.64 -51.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.756 -1.215 . . . . 10.0 111.406 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.588 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 32.2 t -155.3 171.5 19.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.594 -1.316 . . . . 10.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.601 ' O ' HD11 ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.25 133.33 3.28 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 118.857 -1.137 . . . . 10.0 113.023 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 46.3 Cg_endo -86.4 177.16 4.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 N-CA-C 108.459 -1.4 . . . . 10.0 108.459 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -133.48 148.75 51.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.633 -1.292 . . . . 10.0 111.655 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -104.55 -179.65 4.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.64 -0.662 . . . . 10.0 109.471 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.417 ' O ' HG21 ' A' ' 42' ' ' VAL . 21.6 m-85 -91.81 164.4 13.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.987 -1.07 . . . . 10.0 111.113 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.618 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 1.5 pm0 -127.85 177.25 6.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.2 0.524 . . . . 10.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.473 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 7.5 m-70 -95.6 166.23 11.94 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.487 -0.758 . . . . 10.0 111.901 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.527 ' O ' HG21 ' B' ' 18' ' ' ILE . 42.5 m -128.91 146.23 51.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.422 -0.799 . . . . 10.0 110.669 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.63 ' N ' HD12 ' B' ' 18' ' ' ILE . 0.2 OUTLIER -159.42 -171.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 10.0 110.481 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 64.6 m80 -140.02 156.73 46.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.552 -0.718 . . . . 10.0 109.73 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 14.0 m -105.98 143.72 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 10.0 112.658 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -147.85 132.62 4.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.543 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 0.4 OUTLIER 173.46 114.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.175 -1.191 . . . . 10.0 109.416 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' B' ' 22' ' ' PHE . 83.3 m-20 -39.46 132.74 1.49 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.78 . . . . 10.0 109.121 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.63 70.04 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.289 -1.004 . . . . 10.0 108.289 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 2.0 t -88.16 -17.98 8.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 122.543 1.163 . . . . 10.0 108.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.542 ' OG1' ' O ' ' A' ' 26' ' ' ASN 0.287 7.2 t -48.72 -19.05 0.32 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.713 -1.131 . . . . 10.0 111.175 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -154.51 -33.9 0.03 OUTLIER Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.513 -1.835 . . . . 10.0 108.513 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . 0.1 OUTLIER 52.45 23.96 2.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.769 -0.842 . . . . 10.0 111.394 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.608 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 51.6 t80 -112.35 115.6 28.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 122.093 0.949 . . . . 10.0 109.937 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' B' ' 29' ' ' PHE . 33.5 p -156.51 -70.14 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.509 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.46 118.1 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.033 -1.227 . . . . 10.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -150.95 160.9 31.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -1.158 . . . . 10.0 109.51 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 34' ' ' GLU . 55.8 Cg_endo -76.85 136.91 17.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.906 1.477 . . . . 10.0 111.126 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.574 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 2.6 tt0 55.04 146.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.671 0.748 . . . . 10.0 110.736 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HG2' ' N ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -85.85 -63.46 1.32 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.923 -1.111 . . . . 10.0 111.399 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 65.7 t90 -143.48 21.1 1.87 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.341 -0.85 . . . . 10.0 108.892 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.609 ' HB2' ' O ' ' B' ' 36' ' ' TRP . . . 167.1 132.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.026 -1.101 . . . . 10.0 108.026 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.574 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 CA-C-O 122.563 1.173 . . . . 10.0 109.63 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.15 0.5 . . . . 10.0 110.056 . . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 1.7 mt-30 -136.71 2.62 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.29 -0.881 . . . . 10.0 110.03 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.518 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 3.0 m -60.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.364 -0.835 . . . . 10.0 109.555 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.612 HG21 ' HA ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.97 132.32 57.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.705 -1.198 . . . . 10.0 110.425 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -121.07 97.56 5.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.313 -0.867 . . . . 10.0 110.522 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -79.67 111.49 16.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 10.0 111.003 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.505 HG21 ' CG2' ' A' ' 75' ' ' THR . 56.1 t -131.06 172.47 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 10.0 108.962 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' B' ' 35' ' ' GLN . 46.5 t -92.04 130.83 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.753 -1.217 . . . . 10.0 111.729 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.54 HG11 ' CG1' ' A' ' 80' ' ' VAL . 74.4 t -145.34 179.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 80' ' ' VAL . . . 122.35 170.53 13.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.79 -1.324 . . . . 10.0 109.79 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -50.75 -39.51 52.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.151 . . . . 10.0 109.859 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.631 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 151.14 159.05 8.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.547 -1.421 . . . . 10.0 109.547 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.604 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . 179.82 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -1.097 . . . . 10.0 108.852 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.604 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.7 t 149.22 89.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . 42.68 92.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.365 -1.494 . . . . 10.0 109.365 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -49.47 -34.62 17.33 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.918 -1.342 . . . . 10.0 109.296 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.2 m -49.84 -25.22 2.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.738 -1.226 . . . . 10.0 108.724 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' B' ' 26' ' ' THR . 13.7 p -63.73 -18.26 63.85 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.233 -0.987 . . . . 10.0 108.706 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.582 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 1.2 mm? -69.36 -33.31 72.88 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.15 -0.969 . . . . 10.0 108.863 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -48.61 -37.75 19.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 10.0 108.829 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.567 ' CD1' HG23 ' B' ' 26' ' ' THR . 1.5 mm -64.3 -43.6 97.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.68 0.752 . . . . 10.0 110.012 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.515 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 40.3 t -47.89 -44.26 29.43 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.335 -0.946 . . . . 10.0 109.738 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CZ ' ' CD1' ' A' ' 165' ' ' LEU . 6.9 m-85 -90.98 -3.81 56.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.573 -0.705 . . . . 10.0 109.676 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 14.4 m -112.41 -33.46 6.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.855 . . . . 10.0 112.403 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 m -136.58 -82.51 0.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.187 -1.57 . . . . 10.0 113.064 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.506 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 2.3 m120 -153.89 51.42 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.626 -1.296 . . . . 10.0 113.724 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.569 ' HG2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 30.81 -131.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.619 -0.675 . . . . 10.0 112.676 177.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.635 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 11.0 p90 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.216 0.531 . . . . 10.0 110.765 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.673 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 1.3 p . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.806 0.812 . . . . 10.0 111.567 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.645 ' HB ' ' CG1' ' B' ' 20' ' ' VAL 0.273 74.1 t -55.77 -8.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 112.46 0.541 . . . . 10.0 112.46 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.73 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -32.69 87.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.43 1.11 . . . . 10.0 113.46 -177.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' VAL . 11.4 m-20 -157.53 104.74 2.01 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 120.718 -1.239 . . . . 10.0 111.368 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.621 ' CB ' ' CG1' ' B' ' 18' ' ' ILE . 0.6 OUTLIER -170.42 102.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 10.0 108.651 178.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -153.66 175.22 13.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.669 -1.212 . . . . 10.0 112.177 -178.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.578 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -165.71 148.37 7.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.829 -0.748 . . . . 10.0 110.791 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.603 HG23 ' N ' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -171.52 -165.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.41 -0.806 . . . . 10.0 111.105 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 51' ' ' TYR . 74.9 m -137.38 146.05 44.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 10.0 110.217 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -103.6 176.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.244 -0.91 . . . . 10.0 109.467 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.581 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 39.5 mtp -154.37 126.18 7.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 10.0 110.472 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.558 ' CD1' HG11 ' A' ' 44' ' ' VAL . 2.7 mp -139.06 123.43 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 10.0 109.196 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.93 22.41 6.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.49 6.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.0 mt-10 -120.81 99.56 47.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.293 -1.122 . . . . 10.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 43.6 Cg_endo -71.6 136.31 27.99 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.632 1.333 . . . . 10.0 110.319 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -99.88 157.02 16.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.102 -0.999 . . . . 10.0 110.347 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.518 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 40.1 m -126.95 106.62 9.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 10.0 111.973 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HA ' HG21 ' A' ' 4' ' ' ILE . 1.9 pt? -148.37 166.71 27.24 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.438 -1.414 . . . . 10.0 111.293 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.16 134.99 3.2 Favored Glycine 0 C--N 1.288 -2.092 0 N-CA-C 108.629 -1.789 . . . . 10.0 108.629 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.6 pp -153.19 167.45 29.24 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.112 -1.228 . . . . 10.0 110.308 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.475 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 22.4 p90 -170.29 131.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 10.0 110.908 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 5.1 p-10 -99.09 176.83 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 10.0 110.252 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -40.75 162.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.167 0.984 . . . . 10.0 112.638 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.639 ' HA ' ' CG1' ' B' ' 20' ' ' VAL . . . -134.39 68.93 1.47 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.512 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' B' ' 22' ' ' PHE . . . -43.61 -82.23 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 107.904 -2.078 . . . . 10.0 107.904 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.273 -1.134 . . . . 10.0 107.951 177.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 61' ' ' GLN . 8.5 pt-20 41.99 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.406 1.098 . . . . 10.0 111.034 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.5 -12.73 57.6 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 1.2 p90 -133.83 -27.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.851 -0.531 . . . . 10.0 109.693 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 68' ' ' ARG . 5.3 t70 43.12 35.98 0.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 10.0 110.496 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.8 -7.83 59.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.986 -1.071 . . . . 10.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -111.63 4.14 18.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 10.0 110.358 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.7 mmt180 -53.61 -40.53 81.25 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.214 -0.929 . . . . 10.0 111.868 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 52.5 Cg_endo -83.72 78.71 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.414 1.218 . . . . 10.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.584 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -105.61 -105.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 10.0 110.488 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 47.07 35.7 3.66 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -148.26 114.92 3.91 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 120.154 -0.618 . . . . 10.0 110.948 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' GLN . 53.9 Cg_endo -75.52 -151.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.925 1.487 . . . . 10.0 110.004 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 76.64 79.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.79 . . . . 10.0 111.275 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.5 m -139.09 96.67 3.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 75' ' ' THR . 71.0 m-20 -23.14 -41.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.856 -0.611 . . . . 10.0 112.37 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -142.13 130.09 21.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.894 -1.129 . . . . 10.0 110.838 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 9' ' ' VAL . 3.7 p90 -148.25 170.19 18.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.055 -1.028 . . . . 10.0 110.596 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.5 HD12 HG12 ' A' ' 168' ' ' VAL . 4.1 mt -112.34 102.53 10.67 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.86 . . . . 10.0 110.067 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.565 HG23 ' CE2' ' A' ' 82' ' ' PHE . 1.7 m -98.79 127.52 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.676 -0.861 . . . . 10.0 108.676 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 0.5 OUTLIER -105.66 100.44 10.0 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.638 -1.288 . . . . 10.0 112.048 -178.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 80' ' ' VAL . 57.6 m-85 -86.86 176.1 7.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.247 -0.908 . . . . 10.0 109.908 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 47.9 t -100.72 142.67 31.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -0.845 . . . . 10.0 108.878 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.533 ' CG2' ' CG ' ' A' ' 120' ' ' ARG . 34.0 m -56.16 -16.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.041 -1.037 . . . . 10.0 110.675 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.489 HG23 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -112.66 -88.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.868 -1.145 . . . . 10.0 109.293 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 34.25 75.27 0.47 Allowed Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.942 -0.474 . . . . 10.0 110.612 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.467 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 43.6 Cg_endo -69.79 162.12 43.3 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.978 1.515 . . . . 10.0 110.62 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.505 ' OG ' ' HD3' ' A' ' 133' ' ' LYS . 15.8 m 47.42 39.37 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.783 . . . . 10.0 111.402 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.544 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -135.06 -68.6 0.52 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.91 -1.119 . . . . 10.0 110.38 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.548 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 p90 -57.18 -16.67 8.53 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.322 -0.861 . . . . 10.0 110.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.46 ' HG2' ' CZ ' ' A' ' 90' ' ' PHE . 18.1 mt-10 -78.59 -24.54 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 10.0 110.208 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -80.95 -14.76 57.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 10.0 110.311 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.552 HG22 ' HD3' ' A' ' 94' ' ' LYS . 16.6 m -87.93 -22.74 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 118.288 -1.365 . . . . 10.0 108.486 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HE2' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.43 -27.73 63.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -89.39 -1.27 57.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 13.3 mmtm -102.46 -53.16 2.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.948 -1.101 . . . . 10.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.431 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 41.7 m95 -90.32 -38.37 13.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.704 -1.247 . . . . 10.0 112.547 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.534 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.7 t -64.22 -51.06 64.51 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.541 -1.349 . . . . 10.0 111.29 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -67.58 -16.05 46.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.055 1.029 . . . . 10.0 109.556 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ILE . 5.0 tm-20 -55.54 -51.39 67.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.347 -0.846 . . . . 10.0 109.957 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CB ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 163.32 1.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.522 -0.736 . . . . 10.0 112.114 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.672 ' CG2' ' CB ' ' A' ' 107' ' ' LYS . 46.9 p -60.1 -26.84 66.53 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.279 -1.513 . . . . 10.0 111.314 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -10.06 18.54 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.376 -0.828 . . . . 10.0 111.418 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -120.0 -3.42 10.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.718 -1.238 . . . . 10.0 110.926 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.506 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 24.9 p -161.17 166.57 14.93 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.902 -1.124 . . . . 10.0 110.65 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 38.1 Cg_endo -65.36 110.39 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.741 1.39 . . . . 10.0 109.304 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.672 ' CB ' ' CG2' ' A' ' 102' ' ' THR 0.261 0.0 OUTLIER -92.35 -95.46 0.14 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.89 0.852 . . . . 10.0 111.06 -178.052 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.593 ' H ' ' CG ' ' A' ' 107' ' ' LYS . 1.1 m -167.26 120.36 0.78 Allowed Pre-proline 0 C--N 1.29 -1.992 0 C-N-CA 120.064 -0.655 . . . . 10.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 42.1 Cg_endo -68.62 149.91 74.24 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.938 1.494 . . . . 10.0 111.052 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.6 ' CE1' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -129.7 119.78 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 10.0 108.89 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.574 HD11 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -75.05 97.24 3.37 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 51.1 mt -63.81 144.47 57.02 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.81 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 65.4 t -154.66 157.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 10.0 111.619 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.1 154.39 19.87 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.78 -1.728 . . . . 10.0 108.78 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 45.9 p -120.79 136.74 54.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.877 -1.366 . . . . 10.0 110.518 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.0 OUTLIER 39.75 50.86 2.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.944 0.878 . . . . 10.0 108.718 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.763 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -83.29 -32.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.173 -177.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -52.35 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.999 0.904 . . . . 10.0 111.064 -177.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.763 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.9 tp 153.03 -33.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.849 -1.167 . . . . 10.0 107.849 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.533 ' CG ' ' CG2' ' A' ' 84' ' ' VAL . 24.6 tpp180 -53.86 -27.83 32.4 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 19.3 t0 -72.23 -5.76 38.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 10.0 110.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.459 ' OD2' HD12 ' A' ' 119' ' ' LEU . 17.0 m-20 -79.82 157.91 73.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 10.0 110.668 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.0 23.04 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.935 1.756 . . . . 10.0 111.507 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.8 p -105.8 -46.97 4.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.043 -1.035 . . . . 10.0 109.324 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 120' ' ' ARG . 8.2 t -69.98 -27.65 64.89 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.497 ' N ' HD11 ' A' ' 126' ' ' ILE 0.307 0.7 OUTLIER -49.26 -27.53 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.144 -1.389 . . . . 10.0 107.427 177.1 . . . . . . . . 4 4 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.03 -37.44 61.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.049 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -82.52 -50.75 8.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 10.0 111.426 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.491 ' CD2' ' HA ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -67.92 -20.72 65.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.631 -1.293 . . . . 10.0 109.261 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -62.07 -40.87 97.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.491 -0.756 . . . . 10.0 109.968 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -62.46 -18.19 61.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 10.0 109.678 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 12.3 t-20 -97.99 -72.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 10.0 110.281 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.505 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 1.2 mptp? -149.55 144.35 26.19 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.347 -0.846 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -86.02 21.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 10.0 110.404 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 93.92 24.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.124 -0.985 . . . . 10.0 110.633 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 46.1 Cg_endo -83.17 156.67 14.91 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.158 1.609 . . . . 10.0 110.841 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -89.25 114.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -0.944 . . . . 10.0 109.057 179.109 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.6 p -114.72 169.25 6.86 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.386 -0.821 . . . . 10.0 109.631 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 36.7 Cg_endo -61.84 -19.39 65.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.43 1.226 . . . . 10.0 110.523 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.59 -41.93 44.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 10.0 108.749 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.5 m -83.35 -41.18 18.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 154' ' ' TYR . . . -52.24 -41.8 63.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.6 -0.687 . . . . 10.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.27 -49.6 76.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.429 -0.795 . . . . 10.0 109.259 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' ASP . 22.9 mttm -60.53 -39.93 89.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.487 -0.931 . . . . 10.0 108.487 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.565 ' CD2' ' HE2' ' A' ' 94' ' ' LYS . 10.4 tt -58.67 -39.51 80.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.592 -0.693 . . . . 10.0 109.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -69.76 -48.08 60.6 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.627 -0.829 . . . . 10.0 108.85 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.42 -23.71 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.729 0.776 . . . . 10.0 108.98 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 144' ' ' LYS . 38.2 t70 -54.6 -27.49 39.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.594 -0.691 . . . . 10.0 111.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.629 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.26 38.1 0.79 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.914 -1.116 . . . . 10.0 112.402 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 18.0 mtpt 64.49 38.08 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.317 -0.864 . . . . 10.0 112.197 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -72.97 -158.39 0.05 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.574 ' CG1' HD11 ' A' ' 111' ' ' LEU . 2.1 p -114.9 -62.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.323 -1.486 . . . . 10.0 111.358 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -173.04 156.48 3.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.385 -1.447 . . . . 10.0 112.714 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.532 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 78.9 t80 -101.32 105.73 16.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 10.0 109.521 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 1.3 t -96.81 -167.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 10.0 110.854 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.37 139.53 48.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.477 -0.764 . . . . 10.0 110.463 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 165' ' ' LEU . 2.7 t -166.96 133.0 2.23 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.337 1.065 . . . . 10.0 110.969 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.69 ' C ' ' HB3' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -150.98 80.03 1.32 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.596 ' HB2' ' CD1' ' B' ' 29' ' ' PHE . . . -21.11 -43.48 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.49 0.922 . . . . 10.0 113.49 -177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.0 tp -76.56 -59.26 2.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.366 -1.458 . . . . 10.0 110.069 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -115.3 39.08 3.03 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 123.179 1.466 . . . . 10.0 108.611 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.69 ' HB3' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -59.38 -106.96 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 113.604 -1.634 . . . . 10.0 111.798 -177.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 6.6 mttt 71.69 63.02 0.14 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.665 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.31 -21.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.554 -1.308 . . . . 10.0 111.05 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.751 ' CD1' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -62.59 -8.24 6.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.401 -1.647 . . . . 10.0 110.912 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.54 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.0 ptmt -65.2 -31.57 72.8 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.962 -1.086 . . . . 10.0 109.537 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.58 -27.7 60.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.454 -0.779 . . . . 10.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 11.9 t -53.32 -48.17 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 10.0 109.676 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.533 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 t80 -73.55 -30.51 63.1 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.866 -0.521 . . . . 10.0 111.259 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.519 ' O ' HD21 ' A' ' 174' ' ' LEU . 6.1 m-20 -69.37 -46.17 67.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 10.0 111.781 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 -25.32 59.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.209 . . . . 10.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 111' ' ' LEU . . . -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.196 -0.94 . . . . 10.0 109.491 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.562 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 26.3 mm -63.24 -48.03 89.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.299 -0.96 . . . . 10.0 109.305 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -73.44 -42.97 61.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 10.0 110.784 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.498 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -76.23 -2.08 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 10.0 111.065 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.549 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . . . -87.82 -30.63 20.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.985 -1.072 . . . . 10.0 110.659 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -85.77 -17.19 36.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -0.855 . . . . 10.0 109.163 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 118.07 -0.967 . . . . 10.0 110.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.464 -1.454 . . . . 10.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -89.43 56.34 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -1.142 . . . . 10.0 110.602 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -77.38 98.21 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 10.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -91.3 155.22 18.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.824 . . . . 10.0 110.192 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.664 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.35 -152.09 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.664 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.7 Cg_endo -69.95 87.35 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 N-CA-C 110.279 -0.701 . . . . 10.0 110.279 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 22.6 mm-40 -50.92 -175.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 10.0 110.155 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.422 HD11 ' CB ' ' B' ' 9' ' ' SER . 1.7 pp -79.77 -44.43 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.016 -1.053 . . . . 10.0 111.271 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.5 t -126.25 163.66 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.659 -1.276 . . . . 10.0 110.828 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.658 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.37 96.79 0.51 Allowed Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.764 -1.174 . . . . 10.0 113.367 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 40.2 Cg_endo -81.91 157.71 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 N-CA-C 108.007 -1.574 . . . . 10.0 108.007 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -149.02 125.24 10.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.14 -1.6 . . . . 10.0 112.2 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 43' ' ' THR . 10.0 m-20 -80.35 156.97 26.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.152 -1.055 . . . . 10.0 108.152 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.546 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 29.0 m-85 -110.34 142.63 41.74 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.411 -1.431 . . . . 10.0 111.301 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.625 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -58.93 143.28 48.45 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.361 0.601 . . . . 10.0 112.335 -177.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.616 ' C ' ' HB3' ' A' ' 40' ' ' TYR . 8.1 t60 -88.58 97.6 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.521 -0.737 . . . . 10.0 109.798 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 40' ' ' TYR . 4.2 m -83.85 155.35 22.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.874 0.845 . . . . 10.0 112.934 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.621 ' CG1' ' CB ' ' A' ' 39' ' ' ASN . 1.9 pp -125.98 -167.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 37' ' ' PHE . 22.2 m-70 -123.14 143.87 49.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 10.0 110.605 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.645 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 41.2 t -135.41 155.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.446 -0.784 . . . . 10.0 110.413 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -122.67 151.76 16.87 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.0 -1.095 . . . . 10.0 112.737 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.602 ' HB3' ' CB ' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 159.33 112.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' B' ' 24' ' ' ALA . 8.3 m-20 -44.66 143.32 1.41 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.465 -0.772 . . . . 10.0 111.653 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 19.82 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 120.968 0.413 . . . . 10.0 111.762 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.602 ' CB ' ' HB3' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -112.59 -41.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.438 -0.789 . . . . 10.0 109.322 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.567 HG23 ' CD1' ' A' ' 21' ' ' ILE . 13.2 t -53.58 -18.3 2.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.62 -0.675 . . . . 10.0 109.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.512 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -128.09 25.51 4.89 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 107.78 -2.128 . . . . 10.0 107.78 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 23.9 tt0 -92.93 110.25 21.71 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.854 -1.38 . . . . 10.0 111.995 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.596 ' CD1' ' HB2' ' A' ' 159' ' ' ALA . 45.7 t80 -140.75 111.06 6.69 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.515 -1.22 . . . . 10.0 109.297 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.466 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 47.6 p -116.67 -79.61 0.59 Allowed 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.465 -0.939 . . . . 10.0 108.465 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.469 ' O ' HG13 ' B' ' 32' ' ' ILE . . . 139.16 97.18 0.37 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.721 -1.228 . . . . 10.0 110.971 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.57 HG23 ' CD ' ' B' ' 33' ' ' PRO . 0.1 OUTLIER 178.51 -51.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.111 -1.229 . . . . 10.0 110.284 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.57 ' CD ' HG23 ' B' ' 32' ' ' ILE . 49.3 Cg_endo -92.44 154.31 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.712 1.375 . . . . 10.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.58 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -49.19 174.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 10.0 108.762 178.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.631 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 23.7 mt-30 -88.42 -73.78 0.48 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.457 -1.402 . . . . 10.0 111.946 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.585 ' O ' ' CD2' ' B' ' 36' ' ' TRP . 0.4 OUTLIER -122.61 19.26 10.37 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.311 1.053 . . . . 10.0 108.792 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.532 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -112.75 52.34 0.79 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 122.199 1.0 . . . . 10.0 108.794 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.401 ' C ' ' HG2' ' A' ' 2' ' ' GLN . 3.8 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.157 0.503 . . . . 10.0 110.503 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.566 ' NE2' HD22 ' A' ' 177' ' ' LEU . 24.9 mm100 -146.61 -38.53 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.332 -0.855 . . . . 10.0 109.607 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.585 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.8 m -47.28 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 10.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -111.07 130.46 64.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.286 -0.966 . . . . 10.0 108.892 177.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER -113.19 98.57 7.21 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.412 -0.915 . . . . 10.0 109.598 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.1 t -84.88 101.31 12.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.283 -0.885 . . . . 10.0 109.072 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.51 ' CG2' HG21 ' A' ' 75' ' ' THR . 48.4 t -121.84 142.46 38.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.135 -1.026 . . . . 10.0 110.739 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.543 ' CG2' ' HA3' ' A' ' 15' ' ' GLY . 2.4 p -63.29 125.86 20.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.671 -0.643 . . . . 10.0 109.994 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.628 ' HB ' ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -141.64 168.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.148 -0.97 . . . . 10.0 109.672 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 169.97 158.19 13.47 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.7 -1.36 . . . . 10.0 109.7 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -50.03 -22.62 1.67 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.404 -1.056 . . . . 10.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.0 35.4 0.08 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.599 -1.4 . . . . 10.0 109.599 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 32' ' ' ILE . . . -125.55 -155.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -1.103 . . . . 10.0 109.661 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' B' ' 29' ' ' PHE . 20.1 t -69.71 108.79 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 10.0 109.471 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' HA3' ' CG2' ' A' ' 8' ' ' VAL . . . -52.55 164.51 1.64 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.888 -1.285 . . . . 10.0 109.888 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -87.68 5.89 37.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -1.086 . . . . 10.0 110.267 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 14.1 t -75.08 -43.06 55.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.167 -0.958 . . . . 10.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' B' ' 26' ' ' THR . 30.8 p -74.72 -9.23 58.37 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.375 -1.33 . . . . 10.0 108.429 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.576 ' CD1' ' CB ' ' A' ' 159' ' ' ALA . 3.9 mm? -76.8 -36.2 57.11 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.385 -0.822 . . . . 10.0 109.631 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -37.79 49.82 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.197 -1.038 . . . . 10.0 108.197 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.543 HG22 ' CA ' ' B' ' 27' ' ' GLY . 1.4 mm -91.61 -51.76 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.685 0.755 . . . . 10.0 109.912 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.626 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 68.4 m -49.52 -45.59 47.45 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.51 -0.876 . . . . 10.0 109.808 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -67.58 -32.47 73.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 10.0 109.726 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 m -75.77 -51.85 11.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 10.0 112.073 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.513 HG22 ' N ' ' A' ' 26' ' ' ASN . 15.3 t -153.67 -46.15 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.54 -1.664 . . . . 10.0 113.82 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.53 ' O ' ' O ' ' A' ' 27' ' ' LYS . 30.5 m120 -67.98 -23.67 65.06 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.907 -1.12 . . . . 10.0 111.596 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.626 ' N ' ' HA ' ' A' ' 22' ' ' SER . 2.6 pttt 24.37 -148.59 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.287 1.042 . . . . 10.0 113.249 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.523 ' CE2' HG23 ' B' ' 30' ' ' THR . 15.0 t80 . . . . . 0 C--N 1.299 -1.612 0 O-C-N 121.085 -1.01 . . . . 10.0 109.504 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 82.5 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 122.177 0.989 . . . . 10.0 112.68 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.748 ' N ' HG13 ' B' ' 20' ' ' VAL . 73.2 t -50.64 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CD2' HG13 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.757 -1.214 . . . . 10.0 110.213 -175.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' VAL . 57.0 t0 -133.66 85.64 2.22 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.663 -0.698 . . . . 10.0 110.564 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' B' ' 17' ' ' THR . 2.0 t-20 -84.4 99.65 10.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.916 -1.115 . . . . 10.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.97 120.71 41.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 10.0 109.652 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' B' ' 15' ' ' GLU . . . -124.0 137.13 54.64 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.693 -1.203 . . . . 10.0 111.023 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 41' ' ' ALA . 55.8 t -157.94 170.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.012 . . . . 10.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 51' ' ' TYR . 85.1 m -149.82 146.55 27.21 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.95 133.17 10.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 120.912 -1.118 . . . . 10.0 112.133 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.56 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 27.0 mtp -92.4 99.82 12.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 10.0 109.794 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.701 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 5.7 mt -88.16 130.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 10.0 110.636 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' B' ' 8' ' ' ILE . . . 43.78 25.77 0.65 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.267 -1.533 . . . . 10.0 109.267 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 96.87 21.66 20.36 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.225 -1.15 . . . . 10.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.499 ' C ' ' HA ' ' A' ' 45' ' ' MET . 27.9 mt-10 -126.34 105.43 24.64 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.972 -1.31 . . . . 10.0 110.526 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 41.4 Cg_endo -67.26 131.45 25.05 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 124.028 1.541 . . . . 10.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CE1' HD21 ' A' ' 53' ' ' LEU . 1.5 t80 -88.53 152.26 21.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 10.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 23.7 m -130.38 98.72 4.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.706 . . . . 10.0 109.267 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' CE1' ' A' ' 51' ' ' TYR . 2.3 pp -152.33 173.6 14.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.12 -1.432 . . . . 10.0 112.259 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' CD1' ' A' ' 53' ' ' LEU . . . -172.5 134.38 2.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.151 -1.98 . . . . 10.0 108.151 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.495 ' O ' HD13 ' A' ' 55' ' ' LEU . 4.0 pp -130.32 152.43 49.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.683 -1.481 . . . . 10.0 110.712 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 16.8 p90 -169.81 150.45 3.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 10.0 110.432 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 63.6 m-20 -93.04 172.96 7.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.222 -0.923 . . . . 10.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -64.28 -169.03 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.117 0.961 . . . . 10.0 112.078 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.553 ' CB ' ' HB2' ' A' ' 62' ' ' GLU . . . -111.34 72.11 0.77 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -39.91 -43.69 2.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.675 -1.37 . . . . 10.0 109.675 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -143.81 13.62 1.7 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.259 -1.142 . . . . 10.0 110.864 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 64' ' ' TYR . 13.4 mm-40 -53.05 -39.14 63.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.765 -1.209 . . . . 10.0 109.147 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 35.0 m-20 67.21 10.37 7.66 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 62' ' ' GLU . 4.5 m-85 -101.45 -32.57 10.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 64' ' ' TYR . 9.7 t70 20.45 49.16 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.226 0.536 . . . . 10.0 111.28 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' TYR . 42.8 mtp180 -83.22 -37.06 24.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.328 -0.858 . . . . 10.0 110.419 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.477 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.1 mt -108.13 4.58 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 10.0 110.626 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.719 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -100.27 3.04 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 118.934 -1.107 . . . . 10.0 113.54 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_endo -79.37 52.98 4.51 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 N-CA-C 108.196 -1.502 . . . . 10.0 108.196 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 71' ' ' SER . 1.7 pt? -53.28 -52.9 57.57 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 121.572 -0.705 . . . . 10.0 112.225 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 26.2 t 39.99 27.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.011 . . . . 10.0 109.601 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.47 158.75 0.74 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 10.0 110.017 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 47.1 Cg_endo -72.99 107.75 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.696 1.366 . . . . 10.0 109.44 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -137.69 36.95 2.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.805 -1.184 . . . . 10.0 110.962 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.615 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 97.7 m -144.66 91.99 2.24 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.177 -0.952 . . . . 10.0 108.885 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 75' ' ' THR . 10.0 m-20 -24.25 -48.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 5' ' ' LYS . 2.3 m -114.5 133.61 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.983 -1.073 . . . . 10.0 110.986 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -119.77 131.45 55.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 10.0 112.074 -178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.433 ' H ' ' CG1' ' A' ' 9' ' ' VAL . 2.6 mm? -103.67 98.33 8.22 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' CE2' ' A' ' 82' ' ' PHE . 2.6 p -114.96 161.45 13.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.356 -0.84 . . . . 10.0 110.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 23.0 p -124.74 101.6 7.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 10.0 111.2 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' HG13 ' A' ' 80' ' ' VAL . 51.9 m-85 -87.26 174.29 8.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 10.0 110.401 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -118.94 130.83 55.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 10.0 109.852 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG2' ' CG ' ' A' ' 120' ' ' ARG . 27.8 m -67.14 -10.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.132 -0.98 . . . . 10.0 109.913 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 35.3 m -115.8 43.17 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 10.0 109.89 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 36.7 t -105.55 140.06 20.79 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.775 . . . . 10.0 109.784 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 46.9 Cg_endo -71.38 114.46 3.94 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.04 1.547 . . . . 10.0 111.515 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 87' ' ' PRO . 75.3 m 38.9 60.08 1.49 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.426 -0.796 . . . . 10.0 111.458 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.482 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 3.4 t -100.21 -66.16 0.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.086 . . . . 10.0 110.035 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.539 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -48.52 -26.01 1.97 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.344 -0.847 . . . . 10.0 110.301 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.89 -19.43 65.87 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.029 -1.044 . . . . 10.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -84.77 -16.24 42.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 10.0 110.067 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.582 ' HB ' ' CE2' ' A' ' 97' ' ' TRP . 18.1 m -88.95 -19.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.821 -1.174 . . . . 10.0 109.005 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.58 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.83 -32.84 57.85 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 178.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -85.16 0.38 51.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -111.38 -51.75 2.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.102 -1.039 . . . . 10.0 111.379 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 15.2 m0 -72.97 -30.61 63.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.347 -0.846 . . . . 10.0 111.81 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.549 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 16.8 t -70.89 -47.89 15.05 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 10.0 111.362 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -70.7 -14.3 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.077 1.041 . . . . 10.0 111.397 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 3.5 mm-40 -67.04 -39.64 86.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.916 -1.115 . . . . 10.0 110.223 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 100' ' ' GLU . 11.3 mt 44.22 85.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.322 -0.951 . . . . 10.0 109.59 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -44.23 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 10.0 110.133 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.426 ' H ' HG22 ' A' ' 102' ' ' THR . 7.1 t60 -103.57 -13.96 16.35 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.192 -0.943 . . . . 10.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -173.25 -48.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.551 ' O ' ' CG2' ' A' ' 102' ' ' THR . 73.2 m -119.08 164.75 19.56 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.07 112.98 3.52 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.538 1.283 . . . . 10.0 110.282 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -144.18 0.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.885 -1.134 . . . . 10.0 111.728 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.478 HG22 ' HD2' ' A' ' 109' ' ' PRO . 14.4 m -47.69 134.89 10.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.681 -1.262 . . . . 10.0 108.819 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 41.8 Cg_endo -68.38 130.54 21.31 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.561 1.295 . . . . 10.0 109.775 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CE1' ' CZ2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -137.58 113.85 10.09 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.032 0.92 . . . . 10.0 110.931 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 152' ' ' VAL . 1.8 mm? -82.19 100.29 9.76 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -91.3 117.47 29.68 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.889 0.852 . . . . 10.0 110.352 -178.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.538 ' CG2' HG12 ' A' ' 168' ' ' VAL . 1.6 t -126.3 177.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 10.0 111.618 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.48 159.29 14.6 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 82' ' ' PHE . 87.1 m -113.59 140.77 47.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.302 . . . . 10.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 48.61 36.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 10.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.76 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -47.39 -24.82 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.261 -0.976 . . . . 10.0 110.864 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.737 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 3.6 p-10 -52.67 52.33 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 121.397 0.618 . . . . 10.0 112.222 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.76 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 157.34 -53.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.569 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -40.07 -30.16 0.09 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.277 -0.874 . . . . 10.0 110.23 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 37.3 t0 -68.02 -19.04 64.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 10.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 3.4 m-20 -82.13 148.4 59.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 10.0 110.27 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 22.74 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.067 1.562 . . . . 10.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 21.0 p -102.95 -50.25 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 10.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.537 HG23 ' N ' ' A' ' 126' ' ' ILE . 4.0 t -70.55 -30.44 67.16 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.163 -2.162 . . . . 10.0 105.163 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 125' ' ' THR 0.298 0.8 OUTLIER -49.54 -30.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.707 -1.59 . . . . 10.0 106.707 176.515 . . . . . . . . 4 4 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 124' ' ' SER . 1.5 tp10 -52.84 -38.62 61.63 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.876 0.846 . . . . 10.0 109.971 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -56.5 -39.61 73.57 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.922 -0.487 . . . . 10.0 111.041 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 85' ' ' VAL . 3.2 mt -51.41 -47.75 62.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.938 -1.101 . . . . 10.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.53 59.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.569 -0.707 . . . . 10.0 110.397 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.93 -23.83 0.88 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.232 -0.918 . . . . 10.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 2.1 p-10 -127.95 -25.54 3.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.037 . . . . 10.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.538 ' CE ' ' O ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -147.79 118.31 7.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.597 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -65.16 -22.36 66.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.61 -0.682 . . . . 10.0 111.855 -178.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -108.33 95.24 15.24 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.048 -1.032 . . . . 10.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.502 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 43.5 Cg_endo -72.49 157.54 52.67 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.977 1.514 . . . . 10.0 109.763 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.472 HG22 ' HA ' ' A' ' 84' ' ' VAL . 5.8 tp -100.49 127.4 53.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 10.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.6 p -125.1 169.83 10.36 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.507 -0.746 . . . . 10.0 109.223 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -63.1 -11.78 26.65 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.637 1.335 . . . . 10.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -83.95 -51.06 7.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 10.0 110.218 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.7 m -68.55 -39.94 80.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 10.0 110.514 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . . . -51.16 -27.39 8.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 10.0 110.039 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HB2' ' CD1' ' A' ' 154' ' ' TYR . 32.0 tt0 -67.38 -49.95 61.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 10.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.5 72.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.196 -0.94 . . . . 10.0 108.976 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.517 ' CG ' ' HE2' ' A' ' 94' ' ' LYS . 2.5 tt -64.08 -49.72 71.17 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.398 -0.813 . . . . 10.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.0 97.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -57.85 -24.45 57.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.014 -0.674 . . . . 10.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 145' ' ' LEU . 51.0 t0 -58.33 -55.19 38.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.34 -0.85 . . . . 10.0 109.428 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 6.7 mp -96.55 9.23 42.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.007 -1.109 . . . . 10.0 108.007 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.9 mttp 61.86 35.99 16.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.044 0.926 . . . . 10.0 109.62 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -58.12 -154.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.476 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 111' ' ' LEU . 4.3 t -89.08 -76.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.945 -1.097 . . . . 10.0 110.627 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 2.1 tppt? -174.88 159.83 2.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.281 -1.368 . . . . 10.0 112.125 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 18.0 p90 -84.26 112.57 20.41 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.658 0.742 . . . . 10.0 109.98 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -115.71 -169.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 10.0 110.637 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.08 144.49 21.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 10.0 109.928 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.625 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 24.0 p -149.42 148.93 30.04 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.023 0.916 . . . . 10.0 111.738 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 161' ' ' THR . 0.2 OUTLIER -149.13 96.06 2.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.599 ' CB ' ' HB3' ' B' ' 29' ' ' PHE . . . -35.73 -56.41 0.68 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.618 -0.676 . . . . 10.0 112.071 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 pp -99.98 -11.02 20.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.667 -1.271 . . . . 10.0 113.796 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 30.0 m -98.79 -90.19 0.3 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 119.93 -1.731 . . . . 10.0 111.613 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 9.9 mt-30 -52.61 -68.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.731 -1.231 . . . . 10.0 110.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 24.8 mtmm 74.07 57.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.597 0.713 . . . . 10.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 26.77 0.24 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.643 -1.783 . . . . 10.0 108.643 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.625 ' HB3' ' CB ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -72.42 4.85 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -1.037 . . . . 10.0 111.758 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.426 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -52.81 -22.59 5.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 10.0 109.543 178.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 20.2 m120 -69.13 -38.49 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 10.0 110.049 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.538 HG12 ' CG2' ' A' ' 113' ' ' VAL . 17.2 t -49.71 -40.11 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 10.0 109.179 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -79.98 -26.07 40.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 10.0 110.329 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 21.8 m-20 -58.65 -45.72 88.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.008 . . . . 10.0 110.148 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 171' ' ' GLU . 5.6 mm-40 -74.68 -26.0 59.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.032 . . . . 10.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -67.11 -31.72 72.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 10.0 109.586 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.57 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 46.3 mt -59.15 -46.99 91.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.462 -0.774 . . . . 10.0 109.977 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 0.4 OUTLIER -70.13 -35.5 74.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.203 -0.936 . . . . 10.0 110.686 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -88.56 -3.39 58.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.39 -0.819 . . . . 10.0 109.866 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.516 ' CB ' HG13 ' A' ' 4' ' ' ILE . . . -77.94 -33.76 51.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 10.0 110.049 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -98.08 -24.05 15.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 10.0 109.182 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.022 -0.989 . . . . 10.0 110.208 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 10.0 109.723 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 15.5 m 54.24 49.82 17.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -1.147 . . . . 10.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 105.01 2.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 10.0 109.749 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 2' ' ' SER . 15.8 mm-40 -100.81 162.85 12.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.522 -0.736 . . . . 10.0 110.404 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.659 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -69.42 -147.84 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.4 Cg_endo -69.66 87.5 0.54 Allowed 'Trans proline' 0 N--CA 1.481 0.766 0 CA-C-N 119.549 0.874 . . . . 10.0 110.327 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' B' ' 6' ' ' PRO . 2.8 mp0 -54.11 -164.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.514 ' CD1' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -80.41 -71.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.421 -1.424 . . . . 10.0 109.923 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -149.32 -175.2 4.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.375 -1.33 . . . . 10.0 112.2 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -163.35 138.3 4.97 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 119.223 -0.991 . . . . 10.0 112.846 -178.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 50.3 Cg_endo -81.01 153.83 19.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 108.243 -1.484 . . . . 10.0 108.243 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -129.64 151.23 50.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.399 -1.438 . . . . 10.0 111.689 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -108.06 170.26 8.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.667 -0.864 . . . . 10.0 108.667 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.11 148.46 48.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.674 -1.266 . . . . 10.0 111.37 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 3.8 tm-20 -148.0 -179.93 7.27 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -136.98 -175.3 3.99 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 117.267 -1.773 . . . . 10.0 113.511 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 39' ' ' ASN . 15.1 t -121.62 -169.7 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.863 0.84 . . . . 10.0 112.41 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.621 HG13 ' CD2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -122.28 -168.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.739 -0.6 . . . . 10.0 109.691 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 17.2 p80 -100.24 155.66 17.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.656 -1.277 . . . . 10.0 113.41 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.748 HG13 ' N ' ' A' ' 36' ' ' VAL 0.255 40.7 t -109.91 155.45 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.22 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.21 54.34 0.59 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.99 -1.644 . . . . 10.0 108.99 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.508 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 177.19 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.263 . . . . 10.0 109.874 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -71.42 152.77 42.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.532 -0.73 . . . . 10.0 111.309 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.496 ' O ' ' CG ' ' B' ' 28' ' ' GLU . . . 50.06 38.01 15.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.597 -0.689 . . . . 10.0 111.431 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.624 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 54.8 t -111.0 -22.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.829 -1.175 . . . . 10.0 107.829 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.6 t -88.18 -26.56 22.34 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.466 0.651 . . . . 10.0 109.902 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -116.42 39.84 2.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.231 -1.948 . . . . 10.0 108.231 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 9.9 mp0 -140.03 122.26 15.89 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.883 0.849 . . . . 10.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.599 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 8.0 t80 -116.87 128.11 54.93 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.523 HG23 ' CE2' ' A' ' 28' ' ' PHE . 47.1 p -141.13 -44.9 0.38 Allowed 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.649 -0.657 . . . . 10.0 110.45 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 130.44 76.7 0.16 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.995 -1.242 . . . . 10.0 109.995 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 26.5 pt -110.05 160.89 26.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.282 -1.128 . . . . 10.0 109.318 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.572 ' O ' ' C ' ' B' ' 34' ' ' GLU . 47.9 Cg_endo -73.85 175.16 11.16 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.706 1.371 . . . . 10.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.572 ' C ' ' O ' ' B' ' 33' ' ' PRO . 2.3 tm-20 -1.0 114.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 121.203 0.525 . . . . 10.0 112.373 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -97.45 -71.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.041 -1.037 . . . . 10.0 111.89 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.628 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.05 -12.5 19.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.122 0.963 . . . . 10.0 111.247 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -90.81 60.64 4.51 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.429 ' HA ' ' CD ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 10.0 108.9 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.091 0.472 . . . . 10.0 110.225 . . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 2.4 mt-30 -130.92 -3.48 4.04 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.104 -0.997 . . . . 10.0 109.9 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.603 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 23.7 m -68.39 106.18 2.42 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 10.0 110.878 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -109.22 123.75 65.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.057 -1.057 . . . . 10.0 109.397 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.571 ' O ' ' CG2' ' A' ' 75' ' ' THR . 7.4 mmmt -107.71 130.75 54.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.563 ' HB2' ' CB ' ' A' ' 55' ' ' LEU . 60.8 m -109.87 116.62 31.98 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.124 -1.03 . . . . 10.0 110.056 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' OG1' ' A' ' 75' ' ' THR . 25.5 t -126.79 166.19 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.688 . . . . 10.0 109.986 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' B' ' 35' ' ' GLN . 0.5 OUTLIER -101.52 125.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 10.0 110.257 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 78' ' ' PHE . 12.0 t -132.73 -171.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 10.0 109.534 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 80' ' ' VAL . . . 109.26 171.48 20.71 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.411 -1.476 . . . . 10.0 109.411 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 82' ' ' PHE . 1.4 m-20 -45.32 -37.17 4.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 10.0 109.684 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA2' ' OE1' ' B' ' 35' ' ' GLN . . . 150.25 143.28 3.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 33' ' ' PRO . . . -157.32 -130.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -1.125 . . . . 10.0 110.205 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.575 ' O ' ' CZ2' ' B' ' 36' ' ' TRP . 60.5 t -119.78 -44.51 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.957 -1.089 . . . . 10.0 110.974 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -176.65 -177.69 45.82 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.899 -1.28 . . . . 10.0 109.899 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HE3' ' CB ' ' A' ' 6' ' ' CYS . 6.0 ttpm? -97.79 -50.49 4.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.18 . . . . 10.0 110.386 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.8 p -72.15 -18.31 61.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 10.0 110.026 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.531 ' O ' ' OG ' ' A' ' 22' ' ' SER . 28.3 p -63.92 -17.2 63.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 10.0 110.79 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.502 ' N ' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.09 -38.59 11.53 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.001 -1.062 . . . . 10.0 110.759 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 50.4 tp -55.19 -38.34 68.24 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.673 -1.211 . . . . 10.0 108.541 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' THR 0.273 6.3 tp -80.98 -30.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.697 0.76 . . . . 10.0 110.039 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.583 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . 38.4 m -46.93 -54.54 9.83 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.793 -1.163 . . . . 10.0 108.724 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.694 ' CG ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.62 3.75 51.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.481 -1.688 . . . . 10.0 111.035 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.583 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 19.2 m -77.1 -52.54 9.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.481 -1.288 . . . . 10.0 107.821 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -179.59 -71.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.695 -1.202 . . . . 10.0 113.745 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' ' OG1' ' B' ' 26' ' ' THR . 26.1 m-20 -85.78 48.59 1.62 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.806 -1.184 . . . . 10.0 112.076 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.626 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 3.2 pttt -44.92 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.222 1.01 . . . . 10.0 111.872 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 39.3 t80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 114.819 1.414 . . . . 10.0 114.819 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.597 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 22.5 p . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.35 0.595 . . . . 10.0 111.921 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.672 ' N ' HG12 ' B' ' 20' ' ' VAL . 71.6 t -58.66 -90.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 10.0 110.213 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.529 ' CD2' ' HB ' ' B' ' 18' ' ' ILE . 1.7 t80 -47.26 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 10.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' ' CE2' ' A' ' 40' ' ' TYR . 9.4 t0 -141.02 84.2 1.92 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.408 -0.807 . . . . 10.0 109.666 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.523 ' CB ' HD13 ' B' ' 18' ' ' ILE . 9.6 t-20 -79.32 99.26 7.03 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.786 -1.196 . . . . 10.0 109.928 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' B' ' 16' ' ' HIS . 21.1 m-85 -91.93 121.16 33.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.416 -0.802 . . . . 10.0 109.832 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -145.83 96.72 2.85 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.52 -0.872 . . . . 10.0 111.293 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' B' ' 14' ' ' PHE . 82.4 t -162.64 -165.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.597 ' O ' ' CB ' ' B' ' 13' ' ' ASP . 40.1 m -126.43 165.67 18.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.588 -1.945 . . . . 10.0 112.139 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -123.59 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.56 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 0.5 OUTLIER -101.18 107.31 18.68 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.981 -1.074 . . . . 10.0 109.998 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.567 ' HA ' ' CB ' ' B' ' 10' ' ' LEU . 3.7 mp -121.7 130.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 10.0 110.376 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.87 25.01 8.88 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.0 13.76 71.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 10.0 109.561 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -116.18 123.52 30.76 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.344 -1.092 . . . . 10.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.08 141.45 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.52 . . . . 10.0 110.709 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.487 ' HB2' ' CB ' ' A' ' 44' ' ' VAL . 2.0 m-30 -109.97 116.32 31.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.317 -0.864 . . . . 10.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.603 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 58.1 m -85.35 106.91 17.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 10.0 109.923 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 4.3 mt -121.58 153.38 38.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 10.0 111.063 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.51 99.4 0.16 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 6' ' ' CYS . 3.3 pp -138.07 167.75 21.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -1.221 . . . . 10.0 110.644 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 27.1 p90 -169.11 130.03 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.834 . . . . 10.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 11.0 t0 -82.05 160.95 23.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.92 -1.112 . . . . 10.0 109.045 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.591 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 8.9 m -128.52 159.79 34.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.744 -1.222 . . . . 10.0 111.481 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . . . 75.04 28.79 1.02 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.973 0.892 . . . . 10.0 109.143 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.59 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . -80.88 -75.08 1.1 Allowed Glycine 0 C--N 1.297 -1.588 0 N-CA-C 106.972 -2.451 . . . . 10.0 106.972 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.504 ' HA ' ' N ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER -89.14 20.5 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -1.082 . . . . 10.0 110.098 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.613 ' O ' ' CZ ' ' A' ' 64' ' ' TYR . 60.3 mm-40 -104.22 -48.91 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 10.0 110.421 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 31.8 t0 66.12 47.9 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 10.0 109.448 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.613 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER 157.16 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.423 0.63 . . . . 10.0 109.553 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.3 p30 36.92 53.54 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 10.0 111.763 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -52.93 -29.13 26.83 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.582 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.5 mp -82.32 10.9 6.12 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.251 0.548 . . . . 10.0 109.755 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.577 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -63.07 -18.06 0.44 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.582 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -84.04 80.42 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 CA-C-N 120.043 1.051 . . . . 10.0 110.206 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -90.73 -28.36 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.75 . . . . 10.0 110.366 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.47 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 30.7 t 42.75 25.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 10.0 110.615 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 16.2 m-85 -120.22 93.06 47.83 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.018 -1.051 . . . . 10.0 110.488 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.89 73.35 6.06 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 10.0 111.168 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.74 65.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 10.0 109.924 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.611 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 48.1 m -143.84 96.18 2.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.4 t70 -33.32 -31.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 120.83 0.348 . . . . 10.0 111.417 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' THR . 3.1 m -122.69 123.5 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.205 -0.934 . . . . 10.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.611 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 21.3 m-85 -109.56 143.15 39.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.3 -0.875 . . . . 10.0 109.89 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.555 ' CD1' ' CG1' ' A' ' 168' ' ' VAL . 1.1 mm? -108.35 97.99 7.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.108 . . . . 10.0 110.414 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HA2' ' A' ' 10' ' ' GLY . 2.1 m -105.45 131.55 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 10.0 108.658 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.457 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 41.3 t -136.98 124.45 22.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.795 -1.19 . . . . 10.0 110.963 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 8.1 p90 -149.55 179.63 7.83 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.458 -0.897 . . . . 10.0 111.35 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 m -75.21 163.14 27.83 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.244 -0.91 . . . . 10.0 111.148 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.52 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -127.83 9.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 10.0 112.5 -178.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -80.49 -72.56 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.127 -1.608 . . . . 10.0 107.751 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 129' ' ' LEU . 60.8 m -76.8 135.26 67.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.665 -1.272 . . . . 10.0 108.496 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 42.1 Cg_endo -72.37 -23.92 20.03 Favored 'Trans proline' 0 C--N 1.297 -2.139 0 O-C-N 123.662 1.348 . . . . 10.0 110.144 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 89' ' ' SER . 66.7 m 41.26 38.96 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 88' ' ' SER . 15.3 m 64.13 40.36 6.99 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.377 0.608 . . . . 10.0 110.243 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.576 ' CE1' ' CZ ' ' A' ' 82' ' ' PHE . 7.1 t80 -48.59 -26.34 2.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 10.0 108.761 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.5 tt0 -56.85 -27.43 60.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 10.0 109.072 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.506 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.12 -22.07 61.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.88 0.848 . . . . 10.0 109.396 179.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.53 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 6.8 t -82.85 -8.43 11.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.261 -0.899 . . . . 10.0 109.356 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 mmtp -86.63 -32.44 20.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 8.0 pt-20 -84.08 3.13 36.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.846 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -103.37 -50.29 3.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.964 -1.094 . . . . 10.0 111.843 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 5.6 m0 -86.52 -49.06 7.84 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.98 -1.075 . . . . 10.0 112.022 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.539 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 18.2 t -54.21 -50.39 84.89 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.861 -1.149 . . . . 10.0 111.575 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 43.2 Cg_endo -70.54 -15.92 34.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.089 1.047 . . . . 10.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -54.2 -30.25 49.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 10.0 109.119 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 4.6 mt 60.24 114.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.493 -0.883 . . . . 10.0 110.223 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -49.83 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 109.632 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 7.3 p80 -109.49 6.97 24.58 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.367 -0.833 . . . . 10.0 109.546 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 169.59 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 10.0 109.575 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 102' ' ' THR . 75.8 m -119.66 155.71 54.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.51 -0.744 . . . . 10.0 110.205 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 55.2 Cg_endo -76.6 73.41 5.22 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.149 1.605 . . . . 10.0 111.64 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 18.5 ttpt -126.9 -2.02 6.56 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.698 -1.251 . . . . 10.0 109.826 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.476 ' OG1' ' HB ' ' A' ' 102' ' ' THR . 96.3 m -46.22 129.24 7.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.118 -0.989 . . . . 10.0 109.721 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 47.0 Cg_endo -71.75 149.22 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.81 1.426 . . . . 10.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 97' ' ' TRP . 43.6 m-85 -132.99 119.58 20.27 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.081 -1.048 . . . . 10.0 111.772 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.5 mm? -88.79 93.38 9.56 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.235 -1.395 . . . . 10.0 107.235 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 2.2 mt -70.99 147.2 48.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.469 -0.769 . . . . 10.0 109.617 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 80' ' ' VAL . 1.8 t -146.51 178.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.952 . . . . 10.0 111.32 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -126.3 116.35 2.53 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.814 -1.715 . . . . 10.0 108.814 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.457 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 64.4 m -81.79 123.72 29.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.067 -1.254 . . . . 10.0 109.723 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.552 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 3.6 mt-30 47.1 69.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.741 ' C ' ' CD1' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -93.83 -45.41 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.969 -0.692 . . . . 10.0 111.41 -177.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 35.8 t70 -51.43 56.16 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 121.921 0.867 . . . . 10.0 112.86 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 2.5 tp 152.95 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.552 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 17.6 tpp180 -58.66 -17.72 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' CG2' ' A' ' 84' ' ' VAL . 14.6 m-20 -111.54 19.51 18.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.84 -0.537 . . . . 10.0 110.548 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.589 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 21.2 p-10 -80.63 145.41 58.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.025 -1.047 . . . . 10.0 108.994 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.57 24.19 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.382 1.727 . . . . 10.0 112.469 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -110.23 -48.13 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.56 -1.337 . . . . 10.0 110.288 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.515 ' CG2' ' OD1' ' A' ' 122' ' ' ASP . 9.3 t -86.49 -24.68 25.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.09 -1.818 . . . . 10.0 106.09 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 122' ' ' ASP 0.278 1.1 mp -62.68 -21.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 176.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -47.84 -46.68 31.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.625 0.726 . . . . 10.0 109.636 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 -41.33 12.5 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.509 -0.744 . . . . 10.0 111.192 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 85' ' ' VAL . 4.6 mt -57.09 -41.58 79.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 10.0 110.999 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.994 -1.067 . . . . 10.0 109.214 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -71.2 -8.51 54.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 10.0 110.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 57.9 t-20 -65.82 -33.62 76.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 10.0 110.496 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.616 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mptt -117.67 -68.03 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 143.53 -17.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 123.377 0.671 . . . . 10.0 110.023 177.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -136.48 94.9 13.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.978 -1.077 . . . . 10.0 110.844 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.05 161.5 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.028 1.541 . . . . 10.0 110.657 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 7.1 tp -102.76 134.97 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 10.0 109.232 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.7 p -120.2 172.23 4.84 Favored Pre-proline 0 C--N 1.295 -1.777 0 O-C-N 121.238 -0.914 . . . . 10.0 109.062 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.65 -17.41 52.69 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.276 1.146 . . . . 10.0 109.703 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 mt-10 -79.7 -42.78 23.95 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.81 . . . . 10.0 109.945 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 m -73.9 -43.5 58.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.359 -0.838 . . . . 10.0 109.889 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 154' ' ' TYR . . . -57.75 -50.38 73.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 10.0 110.752 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 3.0 pp20? -65.92 -30.41 70.99 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.209 -0.997 . . . . 10.0 108.966 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -71.22 -35.82 71.64 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.444 HD12 ' HE2' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -60.73 -45.8 92.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.036 -1.098 . . . . 10.0 108.036 178.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -59.66 -50.17 74.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.887 0.851 . . . . 10.0 109.114 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 147' ' ' ARG . 4.7 ttm180 -65.55 -17.75 64.81 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.48 0.657 . . . . 10.0 109.729 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -67.92 -18.74 64.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.824 . . . . 10.0 110.97 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.628 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -152.03 38.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.9 -1.125 . . . . 10.0 111.326 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 8.9 mttp 62.08 53.43 2.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.005 0.907 . . . . 10.0 112.105 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -105.36 173.15 6.43 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.895 -0.779 . . . . 10.0 108.895 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 153' ' ' LYS . 2.9 t -71.23 -87.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.005 -1.06 . . . . 10.0 110.821 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.558 ' N ' ' CG1' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.12 168.75 4.05 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.088 -1.007 . . . . 10.0 111.006 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 77.6 t80 -81.04 119.0 22.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 10.0 110.581 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.576 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -118.83 -169.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.141 -0.974 . . . . 10.0 110.463 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -146.36 138.54 25.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.661 -1.274 . . . . 10.0 111.874 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.606 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 30.1 t -141.2 130.56 23.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.131 0.967 . . . . 10.0 111.373 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 162' ' ' GLN . 18.9 m -148.35 81.15 1.47 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.997 0.903 . . . . 10.0 109.387 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.663 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . . . -52.98 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.995 . . . . 10.0 111.062 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.554 ' HB2' ' CE2' ' B' ' 29' ' ' PHE 0.262 0.4 OUTLIER -48.05 -50.7 27.1 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.961 -1.087 . . . . 10.0 110.288 -179.825 . . . . . . . . 4 4 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.533 ' N ' HD11 ' A' ' 160' ' ' LEU . 1.1 m -76.8 -70.52 0.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.227 0.825 . . . . 10.0 113.227 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.656 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -123.85 -91.16 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.0 -1.688 . . . . 10.0 112.238 -178.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.731 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 1.3 mmtt 124.36 -154.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.788 1.235 . . . . 10.0 108.531 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.11 14.06 46.89 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.535 -2.626 . . . . 10.0 106.535 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.731 ' CD1' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -84.34 5.23 27.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.964 -0.618 . . . . 10.0 111.478 -178.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -50.47 -27.57 6.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 10.0 108.613 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.515 ' HB3' ' CG1' ' A' ' 155' ' ' VAL . 25.9 t-20 -65.12 -43.95 90.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.526 -0.734 . . . . 10.0 109.813 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 93.9 t -50.54 -29.39 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 10.0 109.165 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 14.8 m-85 -96.78 -22.14 17.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.74 -0.6 . . . . 10.0 109.958 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 20.1 t0 -67.54 -51.29 52.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 10.0 111.067 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.504 ' CB ' HG11 ' A' ' 152' ' ' VAL . 4.8 mt-10 -72.34 -40.5 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 10.0 111.097 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.458 ' HB1' ' HG ' ' A' ' 111' ' ' LEU . . . -54.8 -31.77 59.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.988 -1.07 . . . . 10.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 30.1 mt -58.48 -44.16 88.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.995 -1.065 . . . . 10.0 109.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 0.5 OUTLIER -76.69 -48.59 18.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 10.0 112.182 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.3 -10.27 22.93 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.354 -0.841 . . . . 10.0 110.865 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -79.0 -41.41 29.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 10.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.58 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -77.3 -19.91 55.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.402 -0.811 . . . . 10.0 109.164 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 117.982 -1.009 . . . . 10.0 110.341 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.495 -1.442 . . . . 10.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -106.19 138.01 43.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -1.145 . . . . 10.0 110.567 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.44 102.56 9.32 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.42 -0.8 . . . . 10.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -101.56 140.39 35.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.687 -0.633 . . . . 10.0 110.926 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.632 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -98.77 -49.02 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 10.0 110.213 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 51.9 Cg_endo -83.62 -18.15 5.83 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.086 -1.159 . . . . 10.0 109.086 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' B' ' 6' ' ' PRO . 0.5 OUTLIER 32.93 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.521 0.677 . . . . 10.0 111.71 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.519 HG13 ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -141.96 -61.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.071 -1.018 . . . . 10.0 110.117 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 t -134.44 132.09 38.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 10.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.567 ' CB ' ' HA ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -132.33 99.62 15.9 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.546 -0.721 . . . . 10.0 111.176 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 41.6 Cg_endo -72.54 117.06 4.95 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.604 1.318 . . . . 10.0 108.761 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -47.82 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 10.0 111.202 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -151.96 -166.66 2.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.857 -0.527 . . . . 10.0 109.717 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.626 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 24.0 m-85 -109.49 -170.05 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.99 1.108 . . . . 10.0 113.99 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.625 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -160.85 -169.69 2.48 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.8 t60 -136.07 146.93 47.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.022 -1.049 . . . . 10.0 110.837 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 40' ' ' TYR . 2.8 t -150.27 143.33 24.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.173 -1.579 . . . . 10.0 112.203 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -110.99 -167.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.479 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 68.3 t60 -107.38 153.4 22.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.775 -1.203 . . . . 10.0 112.275 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.672 HG12 ' N ' ' A' ' 36' ' ' VAL . 1.6 m -124.98 153.1 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.729 0.776 . . . . 10.0 111.405 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.504 ' N ' ' HA ' ' A' ' 61' ' ' GLN . . . -134.62 98.43 0.31 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.32 -1.912 . . . . 10.0 108.32 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.51 ' O ' ' CG2' ' B' ' 25' ' ' VAL . 1.1 t80 -179.34 117.46 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.014 -1.286 . . . . 10.0 109.314 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 22' ' ' PHE . 16.0 t0 -38.95 156.3 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.643 0.735 . . . . 10.0 111.133 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.01 46.73 10.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.667 -0.646 . . . . 10.0 110.512 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 64.9 t -78.54 -17.59 13.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.515 ' OG1' ' HB3' ' A' ' 26' ' ' ASN 0.256 5.7 t -50.06 -29.87 9.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.874 -1.057 . . . . 10.0 111.747 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -134.99 4.44 4.23 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.16 -1.976 . . . . 10.0 108.16 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER 54.08 19.99 2.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.416 -1.05 . . . . 10.0 110.664 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.554 ' CE2' ' HB2' ' A' ' 160' ' ' LEU . 4.2 t80 -113.15 133.08 55.21 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.762 -0.586 . . . . 10.0 109.973 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.532 ' CB ' ' O ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER 161.97 135.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.238 0.542 . . . . 10.0 110.95 179.524 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 -179.61 50.98 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.051 -1.219 . . . . 10.0 110.051 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 1.1 pp -143.17 36.1 0.21 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.26 -1.141 . . . . 10.0 112.055 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 46.2 Cg_endo -73.2 171.64 17.19 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.172 1.091 . . . . 10.0 109.437 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' PRO . 41.8 tp10 -48.96 167.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.699 -1.25 . . . . 10.0 108.788 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.606 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 2.1 mp0 -82.13 20.08 1.08 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.39 -0.819 . . . . 10.0 110.853 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.606 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 3.5 m95 87.84 49.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.62 ' HA ' HD21 ' A' ' 70' ' ' LEU . . . 168.56 99.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.455 -0.942 . . . . 10.0 108.455 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.438 ' HD2' ' HD3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.291 -1.971 0 N-CA-C 106.294 -1.743 . . . . 10.0 106.294 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 2.5 ttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.478 0.656 . . . . 10.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 4' ' ' ILE . 7.6 mm-40 -149.51 -83.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.545 ' HA ' HG22 ' A' ' 52' ' ' THR . 4.3 m -38.87 91.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.584 -0.697 . . . . 10.0 110.171 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 52' ' ' THR . 1.6 tt -135.59 138.76 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.088 -1.008 . . . . 10.0 110.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.587 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.35 122.84 28.64 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.132 0.968 . . . . 10.0 111.313 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.549 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 40.4 t -71.34 126.1 28.73 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.746 0.784 . . . . 10.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.43 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.667 . . . . 10.0 109.212 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.608 HG22 ' CE3' ' B' ' 36' ' ' TRP . 71.5 t -93.87 143.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.05 -1.031 . . . . 10.0 109.82 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' B' ' 35' ' ' GLN . 0.3 OUTLIER -132.74 -166.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.505 -0.747 . . . . 10.0 110.397 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 89.49 -158.92 27.95 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.567 -1.413 . . . . 10.0 109.567 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.59 -10.19 57.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.986 -1.302 . . . . 10.0 109.4 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.498 ' CA ' ' HG3' ' B' ' 35' ' ' GLN . . . 112.07 89.68 1.87 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . -166.15 50.03 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.211 -1.17 . . . . 10.0 110.265 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.484 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.5 OUTLIER 68.32 157.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.058 -1.026 . . . . 10.0 109.411 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.614 ' O ' ' CD2' ' A' ' 19' ' ' LEU . . . -122.87 -153.32 8.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.756 -1.738 . . . . 10.0 108.756 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.55 ' NZ ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.01 0.36 21.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.523 -0.986 . . . . 10.0 110.873 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 -50.63 18.23 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.315 -0.866 . . . . 10.0 111.493 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' B' ' 26' ' ' THR . 31.9 p -61.88 -17.89 58.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.778 -1.201 . . . . 10.0 109.443 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.614 ' CD2' ' O ' ' A' ' 15' ' ' GLY . 0.4 OUTLIER -79.21 -28.15 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.371 -0.831 . . . . 10.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -49.57 -41.39 41.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.604 -1.31 . . . . 10.0 109.331 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.675 ' HB ' ' HA2' ' B' ' 27' ' ' GLY . 1.2 mm -84.59 -39.97 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.369 1.08 . . . . 10.0 109.09 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 19' ' ' LEU . 16.1 t -46.73 -49.21 19.95 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.359 -0.837 . . . . 10.0 110.546 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 162' ' ' GLN . 29.8 m-85 -79.94 -14.28 58.72 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.002 -1.061 . . . . 10.0 110.316 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 m -100.04 -31.63 11.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 10.0 112.849 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.502 HG21 HD13 ' A' ' 21' ' ' ILE . 82.8 p -110.74 -90.2 0.48 Allowed 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.051 -1.656 . . . . 10.0 112.118 -177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.573 ' C ' ' HG3' ' A' ' 27' ' ' LYS . 47.7 t-20 -159.85 20.96 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.51 -0.744 . . . . 10.0 111.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER 26.86 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.431 0.901 . . . . 10.0 113.431 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER . . . . . 0 N--CA 1.502 2.141 0 O-C-N 121.951 -0.468 . . . . 10.0 110.244 -178.066 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 37' ' ' PHE . 5.1 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.644 0.735 . . . . 10.0 112.18 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 38' ' ' ASP . 1.6 t -54.42 -14.18 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.559 -0.713 . . . . 10.0 111.058 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.722 ' N ' ' HA ' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -35.69 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.511 -0.743 . . . . 10.0 109.989 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 36' ' ' VAL . 68.5 m-20 -137.79 131.96 31.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.913 2.19 . . . . 10.0 116.913 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.706 ' HB3' ' N ' ' B' ' 18' ' ' ILE 0.26 35.1 p-10 -104.9 107.37 18.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.007 -0.997 . . . . 10.0 111.101 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 39' ' ' ASN . 23.8 m-85 -155.21 108.84 2.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 119.368 -2.082 . . . . 10.0 113.101 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -171.65 99.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.423 -1.325 . . . . 10.0 107.423 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' N ' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -156.11 -168.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.899 -1.125 . . . . 10.0 111.436 -177.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 27.0 m -151.68 115.55 4.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.648 -0.821 . . . . 10.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -79.76 152.05 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.556 . . . . 10.0 110.047 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.6 ' O ' ' O ' ' B' ' 10' ' ' LEU . 33.6 mtm -127.43 92.89 3.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.339 -1.344 . . . . 10.0 108.125 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 38.3 mt -95.6 141.13 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 120.909 0.385 . . . . 10.0 110.249 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' B' ' 7' ' ' GLU . . . 40.97 26.96 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 86.24 33.33 14.64 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.161 -1.199 . . . . 10.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HG3' ' CG ' ' B' ' 4' ' ' GLU . 52.7 mm-40 -127.46 102.52 23.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.085 -1.244 . . . . 10.0 110.723 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 48.0 Cg_endo -74.92 124.2 8.48 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.874 1.46 . . . . 10.0 110.303 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' THR . 6.3 m-30 -99.83 110.99 23.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.683 -1.261 . . . . 10.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.559 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 1.4 m -71.69 117.04 12.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.636 -0.665 . . . . 10.0 110.546 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.467 ' HG ' ' C ' ' A' ' 52' ' ' THR . 5.2 mt -137.71 160.72 38.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.884 -1.135 . . . . 10.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 5' ' ' LYS . . . -170.92 110.87 0.38 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.959 -1.256 . . . . 10.0 109.959 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 40' ' ' TYR . 2.2 pp -138.57 152.53 48.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.97 -1.312 . . . . 10.0 111.924 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 20.6 p90 -160.27 140.65 11.67 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.307 -0.86 . . . . 10.0 108.766 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.519 ' HA ' ' CZ3' ' B' ' 36' ' ' TRP . 1.7 m-20 -92.8 154.37 18.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.804 -1.185 . . . . 10.0 111.468 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.633 ' HB ' ' CD2' ' B' ' 36' ' ' TRP . 1.6 t -60.55 133.77 56.42 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 10.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 20' ' ' VAL . . . -87.12 79.1 8.74 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.677 -0.64 . . . . 10.0 111.439 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.541 ' N ' ' HA2' ' B' ' 21' ' ' GLY . . . -42.94 -50.07 6.14 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.559 -2.617 . . . . 10.0 106.559 177.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 3.5 mm-40 -62.99 -44.18 96.73 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 4.5 mt-10 65.41 84.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.121 0.962 . . . . 10.0 111.366 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.452 ' OD2' HG11 ' B' ' 20' ' ' VAL . 21.5 m-20 -95.52 -8.86 34.01 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.811 0.815 . . . . 10.0 108.858 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.4 p90 -139.65 10.32 2.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.664 -0.865 . . . . 10.0 108.664 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.1 p-10 -30.62 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.26 0.552 . . . . 10.0 112.101 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -48.46 -26.88 2.33 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.829 -1.169 . . . . 10.0 109.451 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.558 ' N ' HD11 ' A' ' 67' ' ' LEU . 8.4 mp -97.02 6.68 48.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.432 -0.792 . . . . 10.0 110.273 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.618 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -72.69 -24.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.103 -0.998 . . . . 10.0 112.891 -179.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 38.0 Cg_endo -70.91 71.42 2.1 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 109.275 -1.086 . . . . 10.0 109.275 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.567 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -69.93 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.793 -0.567 . . . . 10.0 111.519 -178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.494 ' H ' ' CG ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER 54.67 35.21 23.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.805 -1.185 . . . . 10.0 108.482 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.54 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 4.9 m-85 -118.1 -53.48 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.629 -0.669 . . . . 10.0 111.222 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.587 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 55.7 Cg_endo -85.92 76.8 2.7 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 122.978 0.988 . . . . 10.0 111.296 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.16 0.32 52.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.904 -1.122 . . . . 10.0 110.443 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 75' ' ' THR . 2.7 m -140.1 84.21 1.96 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.287 -0.883 . . . . 10.0 110.048 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.52 -97.62 0.15 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.704 -0.622 . . . . 10.0 109.424 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.549 ' CG1' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -140.78 118.53 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 10.0 108.743 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.448 ' O ' HD23 ' A' ' 111' ' ' LEU . 21.4 m-85 -114.85 125.51 53.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.018 . . . . 10.0 111.443 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.52 HD22 HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -111.47 99.76 8.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 178.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 112' ' ' LEU . 1.7 p -82.64 133.79 28.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.618 -0.676 . . . . 10.0 110.457 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.452 ' C ' ' OG1' ' A' ' 115' ' ' THR . 11.3 t -124.27 101.21 7.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.176 -0.953 . . . . 10.0 109.161 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.8 p90 -133.53 162.24 32.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.662 -1.215 . . . . 10.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' HG22 ' A' ' 85' ' ' VAL . 63.6 m -75.76 158.64 31.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.648 -0.658 . . . . 10.0 110.328 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.462 ' HB ' HG23 ' A' ' 137' ' ' ILE . 29.7 m -107.9 -11.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.472 -0.767 . . . . 10.0 109.403 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.491 ' O ' HD23 ' A' ' 129' ' ' LEU . 33.9 m -68.62 -1.93 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.776 . . . . 10.0 109.701 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.2 m -128.08 82.86 67.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.201 -0.937 . . . . 10.0 109.871 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 44.2 Cg_endo -63.81 -19.26 66.71 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.35 1.711 . . . . 10.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.474 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 67.9 m -89.04 22.36 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 10.0 109.122 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.547 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 46.9 t -124.75 -56.23 1.59 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.779 -0.576 . . . . 10.0 109.881 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.531 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.4 p90 -53.38 -39.95 64.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.631 -1.293 . . . . 10.0 109.469 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 17.8 pt-20 -67.55 -26.5 66.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.555 -0.715 . . . . 10.0 109.55 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -77.13 -14.3 59.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.224 -0.922 . . . . 10.0 108.667 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 90' ' ' PHE . 32.9 t -88.5 -16.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.787 0.803 . . . . 10.0 109.601 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 1.1 mmtt -86.22 -33.48 20.73 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 5.4 pt-20 -77.02 -9.04 58.44 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.163 -0.615 . . . . 10.0 109.421 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -90.3 -52.4 4.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.844 -1.16 . . . . 10.0 111.976 -178.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -93.09 -31.83 14.68 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.563 -1.336 . . . . 10.0 112.487 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.0 t -54.32 -46.75 98.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.572 -1.33 . . . . 10.0 110.863 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 44.4 Cg_endo -73.9 -23.41 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.323 1.17 . . . . 10.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 29.1 mm-40 -63.46 -16.36 60.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 10.0 110.772 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.499 ' CG2' ' CA ' ' A' ' 104' ' ' HIS . 9.6 mm 56.62 104.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.141 -0.975 . . . . 10.0 110.058 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.554 ' HB ' ' CG ' ' A' ' 106' ' ' PRO . 5.9 m -44.08 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 4.8 t-160 -112.89 -15.43 12.9 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.524 -0.735 . . . . 10.0 110.23 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 0.5 OUTLIER 165.91 -49.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.875 -1.528 . . . . 10.0 106.875 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.583 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 19.5 t 179.26 58.92 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 CA-C-N 115.206 -0.906 . . . . 10.0 108.924 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.632 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 52.2 Cg_endo -89.62 -62.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.002 1.527 . . . . 10.0 110.191 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 108.2 51.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 124.972 1.309 . . . . 10.0 110.905 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.487 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 31.2 m -45.88 144.29 2.88 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.892 -1.13 . . . . 10.0 109.319 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 43.7 Cg_endo -69.6 144.49 55.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.763 1.402 . . . . 10.0 110.776 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.448 ' C ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -133.66 113.02 11.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.399 -0.813 . . . . 10.0 111.641 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.6 mm? -83.09 97.41 8.77 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.548 HD22 ' CB ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -77.02 145.68 37.84 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.413 -0.804 . . . . 10.0 110.447 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.0 t -152.97 176.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.147 -0.97 . . . . 10.0 111.83 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -112.32 159.82 13.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.42 -1.872 . . . . 10.0 108.42 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 82' ' ' PHE . 81.8 m -127.03 150.75 49.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.675 -1.485 . . . . 10.0 111.457 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.504 ' N ' HG22 ' A' ' 115' ' ' THR . 4.2 pt20 33.6 57.35 0.54 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.376 0.607 . . . . 10.0 110.97 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -80.13 -25.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 10.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 15.7 t0 -52.48 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.566 1.174 . . . . 10.0 110.708 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.741 ' N ' ' O ' ' A' ' 117' ' ' ILE . 4.6 tp 167.42 -30.24 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.035 -1.439 . . . . 10.0 107.634 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 ttp180 -46.5 -38.56 9.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -55.07 -25.53 31.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 10.0 109.503 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 119' ' ' LEU . 6.8 m-20 -92.63 150.6 40.03 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 10.0 111.526 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 56.2 Cg_endo -80.79 17.15 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.578 1.831 . . . . 10.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.9 p -96.68 -50.75 4.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.984 -1.072 . . . . 10.0 110.188 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.469 ' O ' ' CD ' ' A' ' 128' ' ' LYS . 15.3 t -71.74 -28.11 63.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.832 -2.284 . . . . 10.0 104.832 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.493 HD12 HD13 ' A' ' 129' ' ' LEU 0.304 0.4 OUTLIER -49.67 -27.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 176.794 . . . . . . . . 4 4 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -50.12 -32.07 14.99 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.495 0.664 . . . . 10.0 109.998 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 125' ' ' THR . 0.3 OUTLIER -65.64 -32.19 73.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.334 -0.854 . . . . 10.0 110.391 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 126' ' ' ILE . 7.9 mt -54.71 -38.69 67.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.109 -0.994 . . . . 10.0 109.373 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.559 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -54.15 -51.28 64.78 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.551 -0.86 . . . . 10.0 109.512 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -71.74 -13.28 61.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.014 . . . . 10.0 108.398 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 17.1 m120 -126.93 46.39 2.51 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.771 -0.581 . . . . 10.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 68.08 135.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 10.0 110.322 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.74 3.71 21.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 10.0 110.686 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 27.2 mmtp -101.53 99.49 11.59 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 10.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.66 161.74 44.74 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.862 1.454 . . . . 10.0 112.155 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.462 HG23 ' HB ' ' A' ' 84' ' ' VAL . 2.2 tp -84.71 143.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 10.0 109.011 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 43.6 p -134.4 171.26 9.34 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 10.0 110.312 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.1 Cg_endo -65.98 -30.55 47.99 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.556 1.293 . . . . 10.0 110.473 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -67.54 -38.13 83.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 10.0 109.01 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 m -88.79 -38.96 14.24 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.518 0.675 . . . . 10.0 109.484 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -69.05 -36.17 77.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.692 -0.63 . . . . 10.0 110.343 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 5.2 tt0 -65.31 -37.56 87.49 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.351 -0.843 . . . . 10.0 109.403 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 42.3 tttp -66.79 -36.04 81.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 10.0 108.806 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.484 HD23 ' HE3' ' A' ' 94' ' ' LYS . 2.9 tp -62.56 -48.97 77.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.537 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -63.47 -49.35 73.95 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.564 -0.854 . . . . 10.0 109.435 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -27.1 68.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.281 0.562 . . . . 10.0 109.567 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 1.9 m-20 -74.68 -47.45 31.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 10.0 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 3.2 mp -88.73 12.07 15.92 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.892 0.853 . . . . 10.0 109.445 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 19.2 mtmt 59.69 33.11 21.81 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.816 0.817 . . . . 10.0 110.216 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -61.58 -152.85 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.145 -0.622 . . . . 10.0 110.117 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.593 ' CG2' ' CB ' ' A' ' 175' ' ' ALA . 0.6 OUTLIER -117.97 -51.52 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.035 -1.041 . . . . 10.0 111.471 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -172.52 143.62 1.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.613 -1.235 . . . . 10.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 53.8 p90 -90.32 121.64 32.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 10.0 109.623 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.552 ' CG1' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -127.14 -169.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 10.0 110.771 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -145.69 148.21 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 10.0 110.033 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.54 ' CB ' ' CB ' ' A' ' 165' ' ' LEU . 27.6 p -156.52 154.11 29.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.326 -0.859 . . . . 10.0 109.171 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.572 ' OG ' ' CG2' ' A' ' 161' ' ' THR . 1.3 t -149.61 88.47 1.56 Allowed 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.066 -1.054 . . . . 10.0 109.933 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -42.84 -79.86 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.519 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -31.3 -39.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.216 1.008 . . . . 10.0 109.351 -178.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.572 ' CG2' ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -111.2 -97.91 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.021 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.644 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 158.75 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.833 . . . . 10.0 109.754 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.497 ' HB3' ' CA ' ' A' ' 157' ' ' CYS . 21.8 tptt -105.47 43.59 1.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.851 -1.155 . . . . 10.0 110.221 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.44 40.84 87.17 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.741 -1.344 . . . . 10.0 109.741 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.625 HD13 ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -61.71 -12.27 15.77 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.237 -1.155 . . . . 10.0 110.785 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.458 ' N ' HD12 ' A' ' 165' ' ' LEU . 2.5 mttp -53.24 -29.67 33.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.889 -1.132 . . . . 10.0 109.834 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -70.86 -29.79 66.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 10.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.552 HG23 ' CG1' ' A' ' 155' ' ' VAL . 2.3 t -66.86 -19.37 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 10.0 110.035 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 173' ' ' ILE . 25.4 t80 -96.55 -45.3 6.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.212 -0.93 . . . . 10.0 112.094 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.472 ' O ' HD23 ' A' ' 174' ' ' LEU . 1.3 m-20 -51.22 -49.14 61.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.985 -1.072 . . . . 10.0 110.82 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.78 -39.73 76.46 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.087 -1.008 . . . . 10.0 110.137 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -54.85 -27.24 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.514 ' O ' HD11 ' A' ' 177' ' ' LEU . 34.8 mm -67.14 -45.93 85.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.959 -1.088 . . . . 10.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -80.49 -27.63 37.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.945 -1.097 . . . . 10.0 109.954 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -85.43 -1.66 57.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.763 . . . . 10.0 109.418 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -83.11 -42.43 17.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.329 -0.857 . . . . 10.0 110.497 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -87.73 -19.12 28.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.494 -0.754 . . . . 10.0 109.826 -178.555 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 175' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 120.858 -1.151 . . . . 10.0 109.998 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.661 -1.376 . . . . 10.0 109.661 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.3 m -119.55 157.59 28.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -1.159 . . . . 10.0 110.748 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.08 100.66 13.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.376 -0.828 . . . . 10.0 110.022 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.543 ' CG ' ' HG3' ' A' ' 49' ' ' GLU . 53.4 mm-40 -81.28 157.99 24.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.876 . . . . 10.0 110.669 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.699 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -118.09 -52.32 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.481 -0.762 . . . . 10.0 110.129 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.699 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.7 Cg_endo -89.59 21.37 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.26 1.137 . . . . 10.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.482 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.0 pt-20 -55.39 168.44 0.37 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.956 . . . . 10.0 110.353 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.591 ' CG2' ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -80.27 -148.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 10.0 108.649 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.591 ' N ' ' CG2' ' B' ' 8' ' ' ILE . 66.6 m -121.55 98.6 6.04 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.262 -0.899 . . . . 10.0 108.864 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.72 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -132.8 98.06 16.51 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.334 -0.854 . . . . 10.0 111.093 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -90.31 111.39 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.704 1.371 . . . . 10.0 110.25 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 43' ' ' THR . 14.0 m -142.27 102.81 4.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 10.0 111.151 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.542 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 7.5 p-10 -170.84 132.09 0.87 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.486 -0.759 . . . . 10.0 110.488 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.49 100.02 2.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 10.0 112.389 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.635 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 27.2 tt0 -173.01 123.65 0.42 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.592 -0.693 . . . . 10.0 109.217 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -163.72 151.13 12.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.538 -1.352 . . . . 10.0 111.639 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.551 ' N ' ' HB2' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -136.48 104.3 5.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.083 -1.011 . . . . 10.0 110.584 179.163 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.706 ' N ' ' HB3' ' A' ' 39' ' ' ASN . 31.7 mm -50.84 106.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.998 -1.064 . . . . 10.0 112.769 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.663 ' C ' ' HA ' ' A' ' 37' ' ' PHE . 55.4 m170 -102.75 116.45 32.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.019 . . . . 10.0 111.096 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.722 ' HA ' ' N ' ' A' ' 37' ' ' PHE . 3.1 p -87.55 149.09 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.219 -0.926 . . . . 10.0 113.461 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 59' ' ' ALA . . . -143.47 -65.65 0.02 OUTLIER Glycine 0 CA--C 1.538 1.491 0 C-N-CA 119.791 -1.195 . . . . 10.0 112.137 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.495 ' O ' ' HB ' ' B' ' 25' ' ' VAL . 5.6 t80 -177.32 126.94 0.15 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 120.674 -1.486 . . . . 10.0 109.227 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' B' ' 22' ' ' PHE . 9.4 m-20 -38.47 148.27 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.853 0.835 . . . . 10.0 111.471 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.497 ' CB ' ' OE2' ' B' ' 28' ' ' GLU . . . 52.87 31.35 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.37 0.507 . . . . 10.0 112.37 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' B' ' 22' ' ' PHE . 9.8 t -109.63 -31.56 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 5.4 t -94.21 -0.61 55.04 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.593 0.711 . . . . 10.0 109.145 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.675 ' HA2' ' HB ' ' A' ' 21' ' ' ILE . . . -114.28 2.9 23.78 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.738 -1.22 . . . . 10.0 110.159 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 1.7 pm0 -178.12 -158.69 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.982 -1.305 . . . . 10.0 110.602 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 14' ' ' VAL . 1.2 t80 -131.39 135.29 47.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.72 0.772 . . . . 10.0 109.508 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.562 HG21 ' CD2' ' A' ' 28' ' ' PHE . 15.0 p -151.01 -64.32 0.19 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.461 -0.774 . . . . 10.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -70.86 171.13 45.62 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.116 -1.193 . . . . 10.0 110.116 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 15.8 mm -125.72 47.79 2.45 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.904 . . . . 10.0 110.198 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 45.7 Cg_endo -71.01 171.97 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.977 1.514 . . . . 10.0 110.385 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' B' ' 35' ' ' GLN . 1.8 tp10 -50.57 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 10.0 109.73 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.632 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -81.62 19.11 1.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.195 -0.94 . . . . 10.0 109.45 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.633 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 37.1 m0 71.1 39.38 0.98 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -172.34 74.06 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 113.386 -1.734 . . . . 10.0 106.887 -178.389 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.472 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 6.7 mtm180 . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 107.238 -1.393 . . . . 10.0 107.238 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.178 0.513 . . . . 10.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -164.72 25.36 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.163 -0.961 . . . . 10.0 109.453 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.554 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 30.2 m -89.47 127.01 35.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.581 -0.699 . . . . 10.0 110.303 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.39 136.2 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.281 -0.968 . . . . 10.0 110.266 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.545 ' O ' HG21 ' A' ' 75' ' ' THR . 6.6 mtpt -124.53 98.95 5.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 10.0 109.595 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.445 ' C ' HG22 ' A' ' 7' ' ' VAL . 8.6 t -82.37 99.83 9.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.895 -1.128 . . . . 10.0 110.764 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 75' ' ' THR . 61.7 t -134.29 144.48 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 10.0 109.442 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' B' ' 37' ' ' ALA . 94.4 t -59.67 166.04 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 10.0 110.925 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG2' ' N ' ' A' ' 79' ' ' LEU . 3.4 t -112.39 -174.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.426 -0.797 . . . . 10.0 109.348 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.508 ' HA2' ' N ' ' B' ' 38' ' ' ARG . . . -63.39 -144.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.014 -1.089 . . . . 10.0 110.417 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . 0.449 ' OD2' HG21 ' A' ' 80' ' ' VAL . 5.9 m-20 62.24 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.416 -1.049 . . . . 10.0 109.951 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.515 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 112.14 54.16 0.49 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.029 -1.228 . . . . 10.0 110.029 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -175.94 68.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -1.22 . . . . 10.0 110.559 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 10.9 p -179.1 58.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 10.0 109.715 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.571 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -103.95 88.28 0.61 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.832 -1.307 . . . . 10.0 109.832 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.13 -31.56 63.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.795 -1.415 . . . . 10.0 110.7 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.423 ' HB ' ' OD2' ' A' ' 57' ' ' ASP . 11.3 m -62.47 -41.32 98.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 10.0 111.481 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.535 ' CA ' ' O ' ' B' ' 26' ' ' THR . 17.8 m -95.07 -15.47 23.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.748 -1.22 . . . . 10.0 110.449 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.6 mm? -93.02 -34.79 13.57 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.145 -0.972 . . . . 10.0 109.808 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.58 -37.18 77.82 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.647 -1.983 . . . . 10.0 105.647 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.521 HG21 ' CA ' ' B' ' 27' ' ' GLY 0.266 0.4 OUTLIER -63.41 -50.19 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.328 -1.36 . . . . 10.0 107.328 176.34 . . . . . . . . 4 4 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.648 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 23.8 m -49.05 -49.72 39.99 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.633 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 33.9 m-85 -72.96 -29.34 63.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.959 -1.088 . . . . 10.0 110.442 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -65.32 -50.37 65.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 10.0 109.396 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -169.6 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.253 -0.979 . . . . 10.0 111.095 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.511 ' HB3' ' CG2' ' A' ' 21' ' ' ILE . 35.8 t-20 -61.15 -20.46 62.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 10.0 111.473 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.648 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 26.13 -134.02 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.873 -0.517 . . . . 10.0 111.994 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CE1' ' CG2' ' B' ' 30' ' ' THR . 6.1 t80 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.02 -1.05 . . . . 10.0 112.924 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.42 ' C ' ' HB ' ' B' ' 26' ' ' THR . 46.7 p . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 122.38 1.086 . . . . 10.0 113.47 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.704 ' HB ' ' CG2' ' B' ' 20' ' ' VAL 0.256 6.9 t -70.6 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-N 115.296 -0.865 . . . . 10.0 110.311 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.69 ' H ' ' CG2' ' B' ' 20' ' ' VAL . 0.8 OUTLIER -33.45 129.42 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.572 0.701 . . . . 10.0 110.957 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 10.0 t70 -138.96 83.45 1.95 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HB3' HG13 ' B' ' 18' ' ' ILE . 7.4 t-20 -88.42 98.45 11.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -0.932 . . . . 10.0 110.511 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.557 ' CD2' ' HB3' ' B' ' 15' ' ' GLU . 19.6 m-85 -127.69 116.03 19.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.222 -0.923 . . . . 10.0 109.453 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.597 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -133.69 100.34 4.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.05 -1.031 . . . . 10.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.716 ' HB ' ' O ' ' B' ' 14' ' ' PHE . 3.1 t -167.33 -166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.601 ' H ' ' CG1' ' A' ' 42' ' ' VAL . 52.0 m -137.15 161.65 35.56 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 119.452 -2.03 . . . . 10.0 113.636 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.738 ' CA ' ' HB3' ' B' ' 13' ' ' ASP . 0.7 OUTLIER -105.25 -176.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.765 -0.585 . . . . 10.0 110.59 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.607 ' O ' ' O ' ' B' ' 10' ' ' LEU . 27.5 mtp -139.74 96.56 3.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.937 -1.105 . . . . 10.0 108.836 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 49' ' ' GLU . 11.6 mt -102.43 131.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.783 -0.573 . . . . 10.0 111.146 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' B' ' 8' ' ' ILE . . . 38.2 27.81 0.04 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.346 -1.102 . . . . 10.0 110.346 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 98.97 -16.85 58.96 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.958 -1.319 . . . . 10.0 110.652 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -101.74 108.59 56.61 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.283 . . . . 10.0 110.153 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 42.8 Cg_endo -73.63 156.58 49.17 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.063 1.559 . . . . 10.0 111.668 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.55 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 1.9 m-85 -105.95 113.96 27.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.034 . . . . 10.0 112.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.554 ' HB ' ' HA ' ' A' ' 3' ' ' THR 0.271 98.2 m -75.82 110.07 9.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 10.0 109.459 178.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.542 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 3.7 pp -149.32 173.25 13.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 10.0 112.857 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.54 118.02 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.688 -2.165 . . . . 10.0 107.688 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.514 ' C ' ' CD2' ' A' ' 56' ' ' PHE . 4.6 pp -129.25 149.55 51.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.728 -1.454 . . . . 10.0 111.332 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.514 ' CD2' ' C ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -172.16 129.38 0.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 10.0 110.088 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD2' ' HB ' ' A' ' 17' ' ' THR . 1.3 m-20 -102.62 158.3 16.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.059 -1.026 . . . . 10.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.601 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 13.9 t -43.55 147.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.011 . . . . 10.0 109.68 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.609 ' CB ' HG11 ' A' ' 36' ' ' VAL . . . 177.57 -72.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.783 . . . . 10.0 112.144 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 45.38 52.62 8.59 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.154 -1.979 . . . . 10.0 108.154 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.52 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 16.4 mm-40 60.77 40.56 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.679 -0.895 . . . . 10.0 109.869 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.3 OUTLIER 174.24 -70.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 10.0 111.092 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.572 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER 169.14 44.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.897 -1.127 . . . . 10.0 110.314 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -148.94 -49.93 0.15 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.84 . . . . 10.0 109.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 69.45 80.86 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.681 0.753 . . . . 10.0 109.825 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 26.6 ttp180 -52.32 -26.81 13.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.642 -0.661 . . . . 10.0 110.371 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.511 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -86.03 -0.62 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 10.0 110.276 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.616 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -110.85 13.24 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 -178.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -60.99 126.64 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 N-CA-C 108.613 -1.341 . . . . 10.0 108.613 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.591 ' CD1' ' HA ' ' B' ' 37' ' ' ALA . 0.2 OUTLIER -113.62 -77.38 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 10.0 111.874 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.512 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 19.5 m 61.31 34.39 18.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.148 -0.97 . . . . 10.0 108.482 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.09 131.44 6.44 Favored Pre-proline 0 N--CA 1.487 1.399 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.673 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.31 79.85 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.719 1.378 . . . . 10.0 110.03 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -131.06 60.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 10.0 110.242 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 9.9 m -144.47 96.91 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.143 -0.973 . . . . 10.0 109.435 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.471 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 84.8 m-20 -38.52 -27.86 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.947 -0.47 . . . . 10.0 111.198 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 5' ' ' LYS . 17.7 m -130.38 116.73 37.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.717 -1.239 . . . . 10.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-85 -109.2 130.87 55.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.477 -0.764 . . . . 10.0 108.997 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.614 HD12 ' CE1' ' A' ' 169' ' ' PHE . 2.5 mm? -103.21 96.94 7.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.091 . . . . 10.0 109.08 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 80' ' ' VAL . 14.8 p -108.8 143.7 18.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.662 -0.649 . . . . 10.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.461 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 53.7 t -133.75 129.71 37.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.259 -0.976 . . . . 10.0 110.569 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 24.2 p90 -137.15 178.0 7.43 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.387 -0.82 . . . . 10.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.7 p -76.68 162.54 27.64 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.126 -0.984 . . . . 10.0 111.556 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG1' ' OH ' ' A' ' 154' ' ' TYR . 28.4 m -112.96 -1.5 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 121.325 -0.86 . . . . 10.0 111.69 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.518 ' CG2' ' HG3' ' A' ' 120' ' ' ARG . 14.5 m -128.88 38.05 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.849 -1.157 . . . . 10.0 111.468 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 59.8 m -95.97 149.23 35.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.057 -1.027 . . . . 10.0 108.964 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.49 ' CB ' ' CG ' ' A' ' 132' ' ' ASN . 41.0 Cg_endo -67.49 113.04 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.632 1.333 . . . . 10.0 110.382 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 41.5 m 54.5 64.13 1.92 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 10.0 109.987 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 86' ' ' SER . 22.1 p -116.55 -60.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 10.0 110.949 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 9.4 t80 -59.96 -38.87 83.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.011 -1.055 . . . . 10.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.48 -17.63 64.9 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.844 -1.16 . . . . 10.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -77.62 -21.62 52.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 10.0 110.353 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.56 HG22 ' HD3' ' A' ' 94' ' ' LYS . 2.2 m -89.72 -5.09 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.591 -1.243 . . . . 10.0 109.414 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 90' ' ' PHE . 12.9 mmtt -94.49 -32.72 13.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.137 -0.977 . . . . 10.0 108.391 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 3.6 pt-20 -77.64 -10.85 59.74 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.021 -0.672 . . . . 10.0 109.221 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 99' ' ' PRO . 2.7 tttt -112.35 -50.53 2.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 10.0 111.852 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 60.6 m95 -69.39 -47.11 65.21 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.564 -0.71 . . . . 10.0 112.256 -178.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.571 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 98.9 t -55.93 -49.28 93.92 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.49 -1.381 . . . . 10.0 110.331 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.4 Cg_endo -72.86 -12.92 26.55 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.257 1.135 . . . . 10.0 110.643 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -68.69 -36.68 78.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 10.0 110.601 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.562 ' CG2' ' HA ' ' A' ' 104' ' ' HIS . 78.6 mt 55.11 85.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.206 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 103' ' ' HIS . 1.9 m -39.37 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.681 0.753 . . . . 10.0 110.114 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.557 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 6.0 m170 -109.87 -2.98 16.91 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.5 -0.75 . . . . 10.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 101' ' ' ILE . 66.2 t60 80.37 16.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.622 0.725 . . . . 10.0 109.494 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.603 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.8 OUTLIER -150.76 -65.81 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.808 -0.757 . . . . 10.0 111.44 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 41.6 Cg_endo -68.81 -31.3 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.51 1.268 . . . . 10.0 111.892 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 42.31 63.12 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.367 1.079 . . . . 10.0 108.485 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 76' ' ' ASP . 8.7 t -44.91 141.46 3.03 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.674 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 43.1 Cg_endo -69.99 163.39 38.65 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.286 1.677 . . . . 10.0 112.068 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 152' ' ' VAL . 86.5 m-85 -127.13 114.69 18.04 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.698 -0.626 . . . . 10.0 109.701 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.588 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -73.95 92.59 2.12 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 15.8 mt -69.33 139.33 54.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.732 -0.605 . . . . 10.0 109.372 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.0 t -144.98 -179.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.965 -1.085 . . . . 10.0 111.41 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -118.49 125.14 6.3 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 52.9 m -92.42 140.83 29.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.971 -1.311 . . . . 10.0 111.36 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 115' ' ' THR . 6.9 mm100 40.14 57.44 2.4 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.196 -0.602 . . . . 10.0 109.754 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -76.87 -29.21 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.29 -0.964 . . . . 10.0 110.103 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.64 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 44.2 t0 -51.73 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.459 0.647 . . . . 10.0 111.85 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.7 OUTLIER 147.33 -30.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 CA-C-N 114.858 -1.064 . . . . 10.0 108.572 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 15.2 tpp180 -55.51 -31.35 61.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.778 -0.577 . . . . 10.0 110.315 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -86.88 4.93 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 10.0 111.044 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -82.29 165.74 40.86 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 10.0 110.403 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 54.9 Cg_endo -79.2 23.38 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.074 1.565 . . . . 10.0 111.086 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 t -108.45 -50.14 3.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.92 -1.112 . . . . 10.0 110.278 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 126' ' ' ILE . 14.5 t -79.06 -28.09 43.14 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.779 -1.934 . . . . 10.0 105.779 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 120' ' ' ARG 0.289 1.4 mp -59.82 -22.59 24.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -48.89 -33.66 11.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.49 0.662 . . . . 10.0 109.864 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.36 -49.05 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.661 -0.649 . . . . 10.0 110.775 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 86' ' ' SER . 1.3 tm? -49.87 -50.48 45.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 10.0 110.963 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -55.82 -49.94 71.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.201 -0.937 . . . . 10.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -60.01 -22.49 62.67 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.612 -0.68 . . . . 10.0 110.027 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.49 ' CG ' ' CB ' ' A' ' 87' ' ' PRO . 23.0 t-20 -99.68 -62.46 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.934 -1.104 . . . . 10.0 111.337 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -109.69 -0.36 18.59 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.365 -0.835 . . . . 10.0 111.494 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 0.6 OUTLIER 64.13 -44.52 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.707 . . . . 10.0 112.334 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.509 ' HD2' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -113.99 128.71 25.49 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 120.94 -1.1 . . . . 10.0 111.087 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.1 161.65 44.07 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.877 1.462 . . . . 10.0 110.527 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 4.1 tp -95.36 133.19 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.921 -1.112 . . . . 10.0 109.506 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.6 p -123.8 179.17 1.12 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 10.0 109.399 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.575 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 44.2 Cg_endo -73.52 -26.64 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.228 1.12 . . . . 10.0 110.421 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -66.87 -47.9 70.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 10.0 110.413 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.1 m -74.65 -39.75 61.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.504 -0.747 . . . . 10.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.51 -35.67 77.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 10.0 110.663 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -51.41 -39.74 57.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.351 -0.843 . . . . 10.0 109.955 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -49.21 78.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.333 -0.854 . . . . 10.0 110.422 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 149' ' ' LEU . 7.7 tt -58.61 -33.17 69.71 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.013 -1.055 . . . . 10.0 109.644 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HA ' ' HB1' ' A' ' 151' ' ' ALA . . . -71.32 -48.18 52.03 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.889 0.852 . . . . 10.0 109.471 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -63.46 -26.92 68.95 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.303 -0.559 . . . . 10.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB3' HD11 ' A' ' 149' ' ' LEU . 20.4 t0 -79.61 -40.25 29.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 10.0 110.659 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.3 mp -91.47 20.83 4.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 10.0 109.125 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.412 ' HD3' ' HD2' ' A' ' 107' ' ' LYS . 4.8 mtpt 57.03 20.6 5.57 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.935 0.874 . . . . 10.0 109.41 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 146' ' ' ALA . . . -69.36 -174.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.588 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.2 p -91.59 -72.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.826 -1.172 . . . . 10.0 111.578 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.558 ' H ' ' CG1' ' A' ' 152' ' ' VAL . 5.4 tttt -173.86 173.46 3.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.217 -1.552 . . . . 10.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.593 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 18.6 t80 -112.26 104.44 12.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 10.0 109.448 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -109.17 -168.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 10.0 110.405 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 155' ' ' VAL . 67.3 mt-10 -152.51 135.57 15.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.784 -1.198 . . . . 10.0 111.164 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 162' ' ' GLN . 28.1 p -152.4 172.74 16.03 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.722 0.773 . . . . 10.0 109.563 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 162' ' ' GLN . 34.0 t -140.9 175.17 9.83 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.633 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -73.22 -54.62 7.98 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.409 -0.807 . . . . 10.0 111.97 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -129.23 -22.54 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.736 -1.227 . . . . 10.0 113.39 -178.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' CD1' ' A' ' 160' ' ' LEU . 10.0 t -90.47 -51.87 5.19 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.312 -1.492 . . . . 10.0 113.637 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 6.7 tp60 -59.76 -63.21 1.38 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.308 -1.495 . . . . 10.0 111.696 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 28.4 ttpt 79.47 34.67 0.18 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.513 0.673 . . . . 10.0 109.383 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.19 20.64 10.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.886 -1.686 . . . . 10.0 108.886 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -78.04 4.96 10.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -1.091 . . . . 10.0 110.652 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -93.78 -44.15 8.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.037 -1.039 . . . . 10.0 110.085 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.44 -31.44 72.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 10.0 110.142 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.496 HG21 HG12 ' A' ' 155' ' ' VAL . 14.5 t -65.09 -49.23 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.27 -0.894 . . . . 10.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 9.0 m-85 -76.82 -23.65 52.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.389 -0.82 . . . . 10.0 111.302 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.37 -50.3 60.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.896 -1.127 . . . . 10.0 111.766 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.423 ' HG3' HG21 ' A' ' 152' ' ' VAL . 20.0 pt-20 -61.23 -24.59 66.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 10.0 109.825 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -67.53 -26.54 66.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.244 -0.982 . . . . 10.0 109.045 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.508 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 34.2 mm -60.18 -45.54 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 10.0 110.179 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -74.36 -38.14 63.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 10.0 109.642 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -78.56 -6.59 55.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.489 -0.757 . . . . 10.0 109.712 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' A' ' 4' ' ' ILE . . . -77.76 -38.15 47.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 10.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.592 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -76.51 -34.79 58.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 10.0 110.286 -178.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.893 -1.051 . . . . 10.0 110.159 179.884 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 108.977 -1.649 . . . . 10.0 108.977 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.506 ' O ' ' N ' ' B' ' 4' ' ' GLU . 13.8 m -111.3 44.9 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -1.112 . . . . 10.0 111.211 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 10.0 109.305 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.561 ' HB3' ' HD2' ' B' ' 6' ' ' PRO . 2.2 mm-40 -92.16 144.48 25.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.856 -1.152 . . . . 10.0 110.116 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.32 -41.74 14.36 Favored Pre-proline 0 C--N 1.292 -1.909 0 O-C-N 121.724 -0.61 . . . . 10.0 110.645 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 43.3 Cg_endo -89.39 57.78 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.746 1.393 . . . . 10.0 112.418 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -97.78 160.72 14.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.69 -1.256 . . . . 10.0 108.327 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.511 ' CG1' ' HA2' ' A' ' 47' ' ' GLY . 5.8 pt -80.39 -117.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.879 -1.138 . . . . 10.0 109.376 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -147.58 104.05 3.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.69 -1.256 . . . . 10.0 109.628 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 45' ' ' MET . 14.2 tp -143.65 97.13 5.52 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 118.957 -1.097 . . . . 10.0 112.092 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -101.37 98.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.166 1.911 . . . . 10.0 108.685 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.4 m -148.5 99.59 3.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.248 -1.532 . . . . 10.0 112.895 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.738 ' HB3' ' CA ' ' A' ' 44' ' ' VAL . 5.0 p-10 -143.17 153.44 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.984 0.897 . . . . 10.0 112.153 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.716 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 53.6 m-85 -110.37 -172.25 2.0 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.636 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -174.88 -170.5 0.47 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 10.0 110.562 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.544 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 22.8 m170 -104.52 168.98 8.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.454 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 6.7 t -151.5 146.22 25.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.583 -1.323 . . . . 10.0 111.805 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.523 HD11 ' CG ' ' A' ' 37' ' ' PHE . 1.6 pp -149.18 179.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.358 -0.979 . . . . 10.0 108.358 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -134.5 159.27 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 10.0 112.496 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.704 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 54.2 t -104.74 153.34 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.564 0.697 . . . . 10.0 112.394 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.541 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -106.5 63.95 0.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.661 -1.776 . . . . 10.0 108.661 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.64 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.3 OUTLIER -170.57 100.74 0.25 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.452 -1.028 . . . . 10.0 109.371 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -53.09 150.07 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.822 0.82 . . . . 10.0 111.968 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 39.21 51.31 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.865 -0.522 . . . . 10.0 112.254 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 38.9 t -111.77 -25.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.784 -1.198 . . . . 10.0 108.487 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.535 ' O ' ' CA ' ' A' ' 18' ' ' CYS . 11.3 t -70.64 -20.66 62.71 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.29 53.45 0.74 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 106.902 -2.479 . . . . 10.0 106.902 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.25 58.02 1.69 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.681 -0.893 . . . . 10.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.616 ' CD1' ' HB3' ' A' ' 159' ' ' ALA . 20.4 t80 -85.78 133.17 34.0 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-O 122.059 0.933 . . . . 10.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.619 ' CG2' ' CE1' ' A' ' 28' ' ' PHE . 19.2 p -146.9 -178.83 6.4 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.08 81.13 0.04 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.59 -1.804 . . . . 10.0 108.59 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' B' ' 30' ' ' THR . 90.2 mt -111.67 145.5 32.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.366 -1.079 . . . . 10.0 111.474 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.0 Cg_endo -69.91 178.59 4.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.933 1.755 . . . . 10.0 110.462 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' B' ' 33' ' ' PRO . 34.3 tt0 -8.0 131.07 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.518 0.932 . . . . 10.0 113.518 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.515 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -83.4 -70.52 0.56 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.641 0.734 . . . . 10.0 109.862 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.601 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -172.99 24.64 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.912 -0.715 . . . . 10.0 111.58 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.591 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . -127.36 -28.62 2.79 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.495 -0.753 . . . . 10.0 109.552 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CB ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.495 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.11 0.481 . . . . 10.0 109.91 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 68.7 79.17 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.891 0.853 . . . . 10.0 109.278 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 3' ' ' THR . 1.2 m -175.95 78.56 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.585 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -115.24 121.51 67.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.764 -1.21 . . . . 10.0 110.615 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.563 ' O ' ' CG2' ' A' ' 75' ' ' THR . 62.0 mttt -128.93 112.66 14.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 55' ' ' LEU . 26.4 p -94.67 141.29 28.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.058 -1.057 . . . . 10.0 110.444 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.402 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 57.9 t -144.72 152.26 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.565 -0.709 . . . . 10.0 109.224 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.558 HG21 ' CE3' ' B' ' 36' ' ' TRP . 35.0 m -65.84 102.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.204 -0.935 . . . . 10.0 111.309 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 79' ' ' LEU . 21.3 t -109.53 177.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.213 -0.93 . . . . 10.0 109.143 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CG2' ' A' ' 80' ' ' VAL . . . 151.74 166.99 14.51 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.502 -1.332 . . . . 10.0 110.062 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -47.79 -27.63 2.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.304 -1.116 . . . . 10.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 140.83 43.72 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.699 -1.36 . . . . 10.0 109.699 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.8 -114.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.343 -1.092 . . . . 10.0 109.687 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.584 ' O ' ' CH2' ' B' ' 36' ' ' TRP . 80.0 t -113.89 -92.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.736 -1.227 . . . . 10.0 110.657 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.482 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 170.14 144.65 4.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.927 -1.269 . . . . 10.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.552 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.14 -23.17 61.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.977 . . . . 10.0 111.77 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.512 ' OG1' ' CG1' ' A' ' 8' ' ' VAL . 16.6 m -62.66 -50.27 71.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.938 -1.101 . . . . 10.0 112.03 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 35' ' ' THR . 31.3 p -78.59 8.77 4.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.46 -1.4 . . . . 10.0 110.3 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.613 ' CD2' ' HB2' ' B' ' 29' ' ' PHE . 0.7 OUTLIER -88.0 -28.01 21.69 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.553 -1.342 . . . . 10.0 107.622 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.47 ' O ' ' OG1' ' A' ' 24' ' ' THR . 0.4 OUTLIER -69.65 -34.19 73.65 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.532 HG21 ' HA3' ' B' ' 27' ' ' GLY . 6.7 mm -75.25 -48.18 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 27' ' ' LYS . 26.9 t -54.29 -43.08 70.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.595 ' CG ' ' CB ' ' A' ' 162' ' ' GLN . 74.8 t80 -77.78 -0.94 29.0 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.743 -1.223 . . . . 10.0 109.442 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 22.2 m -112.09 -49.1 2.99 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.411 ' CG2' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.85 -84.66 0.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.011 -1.681 . . . . 10.0 114.032 -176.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.522 ' O ' ' HB2' ' A' ' 27' ' ' LYS . 2.8 m-20 -67.32 -33.49 75.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 10.0 112.033 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER 59.96 -144.71 0.52 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.048 -1.061 . . . . 10.0 110.082 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.525 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 2.4 t80 . . . . . 0 N--CA 1.491 1.579 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.058 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.614 HG22 ' CZ3' ' B' ' 36' ' ' TRP . 3.7 t . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 120.853 0.359 . . . . 10.0 110.29 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 t -148.45 -114.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.836 -1.165 . . . . 10.0 110.554 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.619 ' CD2' ' HG3' ' A' ' 62' ' ' GLU . 4.4 t80 -102.26 105.87 16.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.831 -1.168 . . . . 10.0 111.928 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -128.0 93.08 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.311 -0.868 . . . . 10.0 109.433 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 36.0 t-20 -91.27 98.75 11.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.405 -1.318 . . . . 10.0 110.399 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CB ' HD13 ' A' ' 55' ' ' LEU . 16.5 t80 -107.36 126.92 53.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -153.88 112.88 3.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.807 -1.183 . . . . 10.0 110.454 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -131.12 172.39 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.779 -0.768 . . . . 10.0 109.724 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 44' ' ' VAL . 63.8 m -135.66 148.97 49.15 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.31 -0.956 . . . . 10.0 110.388 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 1.1 t -118.88 174.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 3.8 mtt -149.96 120.67 7.54 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.546 -0.862 . . . . 10.0 109.956 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.582 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 1.4 mp -134.64 126.75 48.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.305 -0.998 . . . . 10.0 108.305 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 48.08 31.09 8.0 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.271 -1.532 . . . . 10.0 109.271 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.19 31.52 31.18 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.099 -1.236 . . . . 10.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -119.68 115.77 33.54 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.846 -1.384 . . . . 10.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.91 141.54 21.44 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.859 1.452 . . . . 10.0 111.193 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 177' ' ' LEU . 0.5 OUTLIER -103.45 112.56 25.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 10.0 110.305 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 4' ' ' ILE . 27.5 p -78.05 100.28 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 10.0 110.186 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 22.3 mt -117.58 140.32 49.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.666 -1.271 . . . . 10.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.54 130.23 2.28 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.219 -1.552 . . . . 10.0 109.219 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.527 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -137.99 132.29 32.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 10.0 108.863 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 50.8 p90 -157.26 148.98 22.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 10.0 112.4 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 58' ' ' THR . 23.7 m-20 -124.05 -169.37 1.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.835 -0.54 . . . . 10.0 110.455 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -45.85 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.25 1.024 . . . . 10.0 112.532 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB1' ' CB ' ' A' ' 65' ' ' ASP . . . -157.24 42.17 0.33 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.723 -1.236 . . . . 10.0 109.851 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -47.63 -27.45 4.48 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.422 -2.271 . . . . 10.0 107.422 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.588 ' CG ' ' HA3' ' B' ' 21' ' ' GLY . 2.4 tp60 -73.34 -55.85 5.85 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.855 -0.791 . . . . 10.0 109.259 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 5.3 mm-40 -59.88 -40.71 89.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.086 -1.046 . . . . 10.0 110.131 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 7.5 t70 75.61 38.85 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.008 0.908 . . . . 10.0 108.588 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -151.96 5.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.943 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.545 ' CB ' ' HB1' ' A' ' 59' ' ' ALA . 19.1 t70 -115.17 25.56 10.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.692 -1.255 . . . . 10.0 111.131 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.471 ' O ' ' CD1' ' A' ' 70' ' ' LEU . 60.3 mtm180 -83.94 -25.44 30.11 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.096 -1.002 . . . . 10.0 109.364 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.528 ' O ' HD21 ' A' ' 70' ' ' LEU . 20.8 mt -111.41 10.34 21.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.558 -0.714 . . . . 10.0 110.35 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -102.17 -41.91 0.21 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 114.038 1.125 . . . . 10.0 114.038 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 41.4 Cg_endo -69.4 -42.71 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.842 0.917 . . . . 10.0 111.727 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -48.85 -19.84 0.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.21 -0.931 . . . . 10.0 109.695 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.568 ' N ' HD22 ' A' ' 70' ' ' LEU . 14.2 m -126.83 51.33 1.87 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.538 -0.726 . . . . 10.0 110.059 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -109.68 75.66 0.83 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.215 -0.928 . . . . 10.0 111.987 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 71' ' ' SER . 52.2 Cg_endo -77.31 -0.88 11.04 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.957 1.503 . . . . 10.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -81.56 49.69 1.36 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.954 -1.091 . . . . 10.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.578 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 82.3 m -142.0 84.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.443 -0.785 . . . . 10.0 110.296 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 5.2 m-20 -55.09 -22.63 17.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 10.0 109.979 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.551 ' CG1' HD11 ' A' ' 4' ' ' ILE . 2.5 m -118.65 116.75 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.578 ' CZ ' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -107.03 144.47 33.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 10.0 110.137 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.478 ' CD1' ' CG1' ' A' ' 168' ' ' VAL . 1.9 mm? -103.46 97.81 7.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.994 . . . . 10.0 108.866 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.524 HG22 ' CZ ' ' A' ' 82' ' ' PHE . 4.7 p -98.78 130.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.581 -0.699 . . . . 10.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.499 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 28.2 p -133.61 115.09 14.25 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.126 -0.984 . . . . 10.0 110.731 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CZ ' HG22 ' A' ' 80' ' ' VAL . 94.6 m-85 -97.21 157.77 15.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.584 -0.697 . . . . 10.0 110.967 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' THR . 57.1 m -85.13 157.06 20.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.427 -0.796 . . . . 10.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.71 -10.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.403 -0.81 . . . . 10.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.474 HG11 ' CE ' ' A' ' 133' ' ' LYS . 8.6 m -134.54 -53.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 10.0 110.116 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER 44.9 -172.82 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.029 -1.044 . . . . 10.0 111.987 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 53.7 Cg_endo -82.6 41.17 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.194 1.628 . . . . 10.0 111.468 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 133' ' ' LYS . 3.5 m 39.78 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 10.0 110.795 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.538 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 3.4 t -175.63 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.839 -1.163 . . . . 10.0 111.649 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' CE ' ' A' ' 94' ' ' LYS . 27.2 t80 -90.66 -23.94 20.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.794 -1.191 . . . . 10.0 109.466 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -22.75 28.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.179 -0.951 . . . . 10.0 108.855 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -83.37 -13.98 53.78 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.258 -0.977 . . . . 10.0 110.151 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.549 HG21 ' HD3' ' A' ' 94' ' ' LYS . 1.6 m -87.72 -16.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 118.162 -1.415 . . . . 10.0 109.28 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.657 ' CE ' ' CE1' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -81.66 -41.54 21.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 10.0 109.271 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -76.85 -4.62 44.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.993 -0.683 . . . . 10.0 109.172 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -111.72 -47.51 3.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.05 -1.031 . . . . 10.0 111.688 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 8.0 m0 -77.24 -49.09 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 10.0 112.318 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.544 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 4.6 t -65.67 -46.59 67.46 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.687 -1.258 . . . . 10.0 112.814 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 39.1 Cg_endo -69.09 -12.79 35.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 N-CA-C 109.338 -1.062 . . . . 10.0 109.338 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.9 mt-10 -89.36 -58.95 2.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 10.0 109.569 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER 161.18 80.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 10.0 108.798 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 108' ' ' THR . 2.5 m -48.1 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 10.0 109.744 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 46.0 t-80 -105.38 -22.45 13.03 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.524 ' NE2' ' SG ' ' A' ' 105' ' ' CYS . 5.5 p80 178.31 -33.49 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 104' ' ' HIS . 4.8 p -144.66 160.04 48.9 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HB3' HG13 ' A' ' 98' ' ' VAL . 43.8 Cg_endo -72.4 84.56 1.16 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.645 1.339 . . . . 10.0 109.743 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 176.02 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.405 -0.809 . . . . 10.0 111.363 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.575 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 99.8 m -51.66 150.98 6.35 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 10.0 110.31 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 37.6 Cg_endo -63.59 110.21 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.865 1.455 . . . . 10.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.13 100.24 8.94 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.27 0.557 . . . . 10.0 109.631 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 152' ' ' VAL . 1.6 mm? -78.37 97.92 5.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.508 ' C ' ' CG2' ' A' ' 113' ' ' VAL . 64.5 mt -78.23 154.48 31.0 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.793 -0.567 . . . . 10.0 109.836 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.508 ' CG2' ' C ' ' A' ' 112' ' ' LEU . 6.3 t -156.53 175.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.96 -1.087 . . . . 10.0 111.31 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -124.3 96.79 0.53 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 116' ' ' GLN . 1.3 m -95.16 170.97 9.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -1.086 . . . . 10.0 110.947 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.535 ' N ' ' CG2' ' A' ' 115' ' ' THR . 36.6 tp60 57.94 38.12 26.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.48 -0.762 . . . . 10.0 110.831 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.752 ' C ' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -95.35 -36.67 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 178.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.7 p-10 -52.13 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.554 1.169 . . . . 10.0 110.352 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.752 ' N ' ' O ' ' A' ' 117' ' ' ILE . 13.0 tp 159.25 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.187 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -45.72 -42.48 11.84 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 178.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' ARG . 3.8 m-20 -45.94 -25.73 0.59 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.433 -0.907 . . . . 10.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.472 ' HB3' ' CD1' ' A' ' 119' ' ' LEU . 62.7 t0 -94.84 123.17 58.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.668 -0.645 . . . . 10.0 110.759 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.9 Cg_endo -80.76 24.73 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.607 1.538 . . . . 10.0 110.536 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 73.1 m -96.52 -50.46 4.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 10.0 110.366 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.443 ' HB ' HD22 ' A' ' 119' ' ' LEU . 1.6 t -72.8 -33.58 66.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.906 -2.257 . . . . 10.0 104.906 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.466 ' N ' HD11 ' A' ' 126' ' ' ILE 0.301 0.9 OUTLIER -49.43 -30.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.267 -1.382 . . . . 10.0 107.267 176.573 . . . . . . . . 4 4 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -51.65 -43.88 62.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.594 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -75.09 -32.25 61.4 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.538 -0.726 . . . . 10.0 110.054 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' LYS . 4.3 mt -77.11 -36.95 55.15 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.272 -0.893 . . . . 10.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.25 -49.42 53.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 10.0 110.267 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -26.51 4.97 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.212 -0.93 . . . . 10.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.79 7.69 9.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.378 -0.929 . . . . 10.0 111.56 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.93 82.69 2.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.802 -1.186 . . . . 10.0 109.838 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.49 -17.95 61.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.847 -1.158 . . . . 10.0 109.424 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 113.44 4.41 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HB3' ' HE3' ' A' ' 133' ' ' LYS . 40.5 Cg_endo -68.89 157.12 63.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.907 1.477 . . . . 10.0 110.529 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 137' ' ' ILE . 0.4 OUTLIER -103.27 132.03 50.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.358 -0.839 . . . . 10.0 109.738 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.9 p -122.89 167.72 13.8 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.299 -0.876 . . . . 10.0 110.046 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -66.79 -24.82 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 10.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.43 -35.46 77.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 10.0 109.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.6 m -84.81 -31.28 23.95 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.255 0.55 . . . . 10.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.44 -34.14 65.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 10.0 111.53 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -56.16 -43.5 78.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.927 -1.108 . . . . 10.0 109.369 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -63.9 -41.02 97.8 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.495 -0.882 . . . . 10.0 108.681 179.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.632 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 3.1 tt -59.87 -50.72 72.68 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.56 -0.712 . . . . 10.0 109.34 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.533 ' CA ' ' HB1' ' A' ' 151' ' ' ALA . . . -57.43 -41.38 80.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.156 -0.965 . . . . 10.0 108.632 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -79.49 -0.15 32.01 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.531 -0.731 . . . . 10.0 109.388 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 15.8 t0 -86.51 -10.53 53.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.582 -0.699 . . . . 10.0 110.476 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.28 32.11 0.47 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 10.0 111.673 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.3 mttt 62.24 41.2 10.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 10.0 111.649 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.533 ' HB1' ' CA ' ' A' ' 146' ' ' ALA . . . -80.31 -163.38 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.739 -0.601 . . . . 10.0 109.538 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG2' ' CB ' ' A' ' 175' ' ' ALA . 40.3 t -98.04 -79.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.991 . . . . 10.0 109.969 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.438 ' N ' HG11 ' A' ' 152' ' ' VAL . 6.3 tptp -172.57 165.22 5.57 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.759 -0.776 . . . . 10.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 40.5 p90 -96.33 124.44 40.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.777 . . . . 10.0 109.751 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -111.86 -169.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.174 -0.954 . . . . 10.0 110.237 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 31.4 mt-10 -130.15 135.18 47.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.147 -0.971 . . . . 10.0 109.789 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.478 ' SG ' HD23 ' A' ' 165' ' ' LEU . 6.5 t -150.9 124.76 9.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.962 -1.086 . . . . 10.0 111.205 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 30.0 m -128.39 154.61 45.82 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 177.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.536 ' CB ' HD22 ' A' ' 19' ' ' LEU . . . -99.65 -45.85 5.63 Favored 'General case' 0 C--N 1.283 -2.301 0 O-C-N 120.469 -1.395 . . . . 10.0 108.305 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.549 ' C ' ' CD1' ' A' ' 160' ' ' LEU 0.294 2.7 tm? -61.58 -51.29 69.16 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.751 0.786 . . . . 10.0 109.215 177.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 28.6 m -102.94 -18.79 14.87 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 113.204 0.816 . . . . 10.0 113.204 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.595 ' CB ' ' CG ' ' A' ' 23' ' ' TYR . 1.7 tt0 61.01 75.31 0.42 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.367 -1.458 . . . . 10.0 109.203 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 4.6 tptt -95.08 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.921 -0.711 . . . . 10.0 111.767 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.58 31.56 1.34 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.4 -1.381 . . . . 10.0 110.796 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -54.99 -43.2 73.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.965 -1.314 . . . . 10.0 110.512 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.22 -35.78 58.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 10.0 110.825 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -60.83 -32.54 71.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.267 -0.896 . . . . 10.0 111.585 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.516 ' HA ' HG22 ' A' ' 155' ' ' VAL . 34.6 t -64.41 -46.75 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.83 -1.169 . . . . 10.0 110.492 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.35 -28.03 64.81 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.493 -0.754 . . . . 10.0 111.753 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.47 ' O ' HD23 ' A' ' 174' ' ' LEU . 19.3 t70 -57.51 -50.02 74.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.771 -1.206 . . . . 10.0 111.992 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.471 ' OE2' HD11 ' A' ' 111' ' ' LEU . 12.7 pt-20 -68.58 -23.9 64.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.903 -1.123 . . . . 10.0 110.814 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -70.77 -21.16 62.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.016 -1.052 . . . . 10.0 109.05 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.577 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 9.8 mm -67.32 -43.34 88.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 10.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -73.13 -42.35 62.97 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.029 -1.044 . . . . 10.0 111.645 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.548 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -82.56 -2.58 54.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.323 -0.861 . . . . 10.0 109.944 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -78.47 -43.13 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.302 -0.874 . . . . 10.0 109.704 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.577 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -107.05 -23.34 12.35 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.746 0.784 . . . . 10.0 110.307 -178.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.988 -1.006 . . . . 10.0 110.354 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.396 -1.481 . . . . 10.0 109.396 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 1.0 OUTLIER 73.23 137.54 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -1.007 . . . . 10.0 111.173 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -98.33 87.1 3.79 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.174 -0.954 . . . . 10.0 109.374 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 49' ' ' GLU . 41.3 mt-10 -119.38 171.3 8.42 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.747 0.784 . . . . 10.0 110.569 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.614 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.57 -161.55 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 178.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.614 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 40.5 Cg_endo -66.89 80.57 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.305 -1.075 . . . . 10.0 109.305 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.494 ' CB ' ' CG2' ' A' ' 46' ' ' ILE . 10.9 pm0 -45.98 175.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.447 0.641 . . . . 10.0 110.666 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.604 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 0.2 OUTLIER -135.19 -39.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 10.0 110.621 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.1 t -123.0 151.41 41.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 10.0 110.985 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.66 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -167.44 97.83 0.63 Allowed Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 120.716 -1.24 . . . . 10.0 112.801 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.516 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 45.2 Cg_endo -73.91 145.51 36.1 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.668 1.351 . . . . 10.0 109.085 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -97.16 154.91 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.936 -1.103 . . . . 10.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -151.91 136.56 17.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 10.0 109.623 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.405 ' HA ' HG13 ' A' ' 42' ' ' VAL . 43.0 m-85 -123.56 143.22 50.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 10.0 110.515 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 42.9 tp10 -146.7 147.21 30.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 10.0 109.896 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 19' ' ' HIS . 2.3 t60 -143.17 129.17 19.59 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 10.0 109.93 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -96.06 -167.94 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 10.0 110.468 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.599 HG13 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.59 179.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 10.0 111.736 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 16' ' ' HIS . 13.2 m80 -122.62 162.65 21.48 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.622 0.725 . . . . 10.0 111.528 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 37' ' ' PHE . 6.4 m -64.49 152.64 8.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.588 ' HA3' ' CG ' ' A' ' 61' ' ' GLN . . . -73.96 151.7 44.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.689 -1.364 . . . . 10.0 109.689 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.585 ' CG ' HG22 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 67.61 97.86 0.06 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.415 -1.05 . . . . 10.0 109.326 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -53.76 143.23 21.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 10.0 110.658 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.468 ' HB1' ' OD1' ' A' ' 26' ' ' ASN . . . 59.32 31.03 20.84 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.433 -0.792 . . . . 10.0 111.954 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.585 HG22 ' CG ' ' B' ' 22' ' ' PHE . 21.4 t -113.7 -17.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.917 -1.114 . . . . 10.0 109.997 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 10.3 t -83.48 31.73 0.46 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.674 -0.641 . . . . 10.0 110.958 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.532 ' HA3' HG21 ' A' ' 21' ' ' ILE . . . -113.07 -91.64 1.95 Allowed Glycine 0 N--CA 1.488 2.111 0 O-C-N 120.85 -1.156 . . . . 10.0 110.225 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.52 ' OE2' ' CD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -1.14 124.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.859 1.314 . . . . 10.0 113.986 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.613 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -120.79 142.79 49.25 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.484 -1.235 . . . . 10.0 109.239 178.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.476 ' OG1' HG12 ' B' ' 32' ' ' ILE . 68.7 p -152.33 -137.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 10.0 110.314 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.92 45.77 1.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.494 ' CG2' ' HD2' ' B' ' 33' ' ' PRO . 50.4 mm -68.29 144.21 96.44 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.256 -1.144 . . . . 10.0 109.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 41.0 Cg_endo -70.79 141.51 41.21 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.954 1.502 . . . . 10.0 111.699 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 9.6 tp10 53.58 163.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.012 0.911 . . . . 10.0 112.058 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 4.5 mm100 -89.91 19.4 4.86 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.58 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.623 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 3.8 m-90 87.33 26.86 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-O 122.549 1.166 . . . . 10.0 108.071 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.578 ' CA ' ' HA ' ' A' ' 70' ' ' LEU . . . -160.99 85.87 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.138 -1.431 . . . . 10.0 107.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.456 ' HA ' ' CD ' ' B' ' 34' ' ' GLU . 3.2 ttm180 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 122.721 1.248 . . . . 10.0 108.537 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 15.2 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.306 0.574 . . . . 10.0 110.6 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -144.23 -86.11 0.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.202 -0.936 . . . . 10.0 109.275 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' THR . 3.5 m -41.26 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.943 -0.473 . . . . 10.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.71 ' N ' ' O ' ' A' ' 2' ' ' GLN . 1.9 tt -136.01 154.02 33.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 118.231 -1.388 . . . . 10.0 113.321 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.69 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -135.23 109.66 8.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.816 0.817 . . . . 10.0 110.716 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 76' ' ' ASP . 30.1 m -67.98 142.64 55.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.931 -1.106 . . . . 10.0 109.882 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.488 ' CG2' ' C ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -167.49 -169.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.846 -1.159 . . . . 10.0 111.004 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.0 t -105.47 164.49 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.548 -0.72 . . . . 10.0 110.279 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 80' ' ' VAL . 27.7 m -79.99 -168.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.913 -1.117 . . . . 10.0 111.718 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.539 ' CA ' ' HB2' ' B' ' 37' ' ' ALA . . . -148.27 17.17 1.33 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.54 -34.92 78.07 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.073 -1.251 . . . . 10.0 108.995 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 141.25 -151.73 22.79 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.985 -1.246 . . . . 10.0 109.985 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.73 160.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -1.094 . . . . 10.0 111.4 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.474 ' O ' ' NE2' ' B' ' 35' ' ' GLN . 12.4 p -52.57 152.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.445 -0.784 . . . . 10.0 109.981 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -65.24 161.32 41.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -88.68 -32.34 18.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 10.0 109.316 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.5 p -67.66 -26.15 66.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.506 -0.746 . . . . 10.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' B' ' 26' ' ' THR . 24.8 p -75.12 -0.1 18.02 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.821 -1.175 . . . . 10.0 110.073 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.647 HD22 ' HB2' ' B' ' 29' ' ' PHE . 6.3 mt -104.19 -21.46 13.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 10.0 109.866 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.51 -35.81 81.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.745 0.784 . . . . 10.0 110.136 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 26' ' ' ASN . 1.6 mm -97.87 -45.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.858 0.837 . . . . 10.0 109.404 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.574 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 15.9 t -49.33 -46.92 47.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.386 -0.926 . . . . 10.0 109.757 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -67.68 -45.68 74.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.354 -1.466 . . . . 10.0 110.628 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 5.5 p -58.73 -51.19 71.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.647 -1.283 . . . . 10.0 110.442 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.65 -59.93 0.13 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 118.001 -1.48 . . . . 10.0 114.218 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.563 ' HB2' HG21 ' A' ' 21' ' ' ILE . 20.3 m-20 -49.45 -26.07 3.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.846 -1.159 . . . . 10.0 111.562 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.574 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.4 OUTLIER 29.54 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 112.753 0.649 . . . . 10.0 112.753 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.164 . . . . 10.0 111.216 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.63 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 32.7 p . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.252 0.549 . . . . 10.0 111.482 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 35' ' ' THR . 27.8 t 80.01 3.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.356 0.598 . . . . 10.0 109.572 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.618 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 45.4 t80 -41.27 124.6 2.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.776 ' CB ' ' HB ' ' B' ' 18' ' ' ILE . 5.5 m-20 -64.46 -153.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.769 -1.172 . . . . 10.0 111.504 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.567 ' CB ' ' CD1' ' A' ' 55' ' ' LEU . 2.5 t-20 -154.09 -163.11 1.55 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.137 -0.977 . . . . 10.0 111.79 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' B' ' 16' ' ' HIS . 41.3 p90 -131.97 -174.49 3.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.775 0.798 . . . . 10.0 110.974 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.556 ' CB ' ' CA ' ' A' ' 54' ' ' GLY . . . -156.67 139.02 14.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -164.75 -176.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.145 . . . . 10.0 110.701 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 44' ' ' VAL . 58.6 m -121.5 144.34 48.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.981 -0.688 . . . . 10.0 109.983 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 45' ' ' MET . 0.9 OUTLIER -111.37 164.32 7.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.314 -0.866 . . . . 10.0 108.844 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.525 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -150.55 103.91 3.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.364 -0.976 . . . . 10.0 108.364 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.498 HG22 ' HB2' ' B' ' 7' ' ' GLU . 4.2 mt -125.02 130.1 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.062 -1.024 . . . . 10.0 110.904 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.513 ' HA2' HG21 ' B' ' 8' ' ' ILE . . . 40.24 27.17 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 95.85 30.4 7.99 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.701 -1.238 . . . . 10.0 110.097 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.492 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -120.98 94.97 49.04 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 120.898 -1.354 . . . . 10.0 110.447 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.57 144.52 28.54 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.094 1.576 . . . . 10.0 111.134 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CE1' ' OE1' ' A' ' 49' ' ' GLU . 1.7 m-85 -126.66 122.62 35.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.466 -0.771 . . . . 10.0 109.092 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.584 ' HB ' ' C ' ' A' ' 2' ' ' GLN 0.265 93.5 m -108.43 97.41 7.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 10.0 109.836 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -153.37 174.93 13.7 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.634 -1.626 . . . . 10.0 111.895 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.556 ' CA ' ' CB ' ' A' ' 41' ' ' ALA . . . -172.55 136.54 3.81 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 108.589 -1.804 . . . . 10.0 108.589 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.567 ' CD1' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -131.71 135.27 46.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.895 -1.356 . . . . 10.0 109.659 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -133.76 158.95 42.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' THR . 28.7 t0 -124.17 171.17 10.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.887 -1.133 . . . . 10.0 109.787 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -45.87 -176.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.122 -1.031 . . . . 10.0 110.647 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 62' ' ' GLU . . . -144.56 75.12 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.864 -1.147 . . . . 10.0 110.517 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -15.41 59.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.305 -1.518 . . . . 10.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.461 ' HB2' ' CA ' ' B' ' 21' ' ' GLY . 26.1 mt-30 -144.53 -16.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.119 -1.224 . . . . 10.0 111.643 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' B' ' 18' ' ' ILE . 1.8 tt0 -62.52 -48.71 78.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.479 -1.388 . . . . 10.0 109.285 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 4.3 t0 -134.21 1.28 3.2 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.706 -0.621 . . . . 10.0 109.559 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 17.4 m-85 66.64 37.65 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.552 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 t0 -137.43 72.83 1.42 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.026 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 9.6 ptt180 -85.03 -30.61 24.0 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.623 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.478 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 20.6 mt -86.86 -25.58 24.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 10.0 111.29 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.696 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 mtm-85 -109.85 12.68 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.729 -1.232 . . . . 10.0 114.242 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.3 Cg_endo -73.59 0.96 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 110.189 -0.735 . . . . 10.0 110.189 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -102.46 -113.94 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.426 -0.796 . . . . 10.0 110.819 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER 42.43 44.11 3.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 10.0 110.662 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.699 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -160.16 174.37 4.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 10.0 110.753 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.699 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 36.6 Cg_endo -62.11 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.112 1.059 . . . . 10.0 110.862 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 1.3 mp0 54.21 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.35 -1.469 . . . . 10.0 108.311 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -139.58 86.63 2.12 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.358 -0.839 . . . . 10.0 112.404 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.69 ' HB3' ' O ' ' A' ' 5' ' ' LYS . 1.6 t70 -110.48 -72.72 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 24.8 m -141.92 112.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.792 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.645 ' CZ ' ' HA ' ' A' ' 75' ' ' THR . 84.0 m-85 -88.65 127.3 35.57 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.711 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 9' ' ' VAL . 4.0 mm? -100.76 97.93 8.51 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.215 -0.928 . . . . 10.0 109.662 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.651 ' N ' HG13 ' A' ' 9' ' ' VAL . 7.5 p -106.65 150.55 9.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.961 -0.695 . . . . 10.0 109.947 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.6 m -133.13 118.86 19.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.924 -1.11 . . . . 10.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.526 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 31.4 p90 -127.03 166.66 17.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.457 -0.777 . . . . 10.0 110.431 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -78.93 158.51 28.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.63 -1.293 . . . . 10.0 111.852 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 28.4 m -114.39 2.9 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.607 -0.683 . . . . 10.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.539 ' CA ' HD12 ' A' ' 129' ' ' LEU . 19.2 m -105.58 39.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 10.0 109.761 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.558 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 73.0 m -114.94 172.13 3.88 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 40.2 Cg_endo -68.71 81.1 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.048 1.026 . . . . 10.0 110.771 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 37.76 39.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.206 0.527 . . . . 10.0 110.844 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.8 m -62.0 -38.26 87.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.047 -1.033 . . . . 10.0 110.81 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.572 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 16.3 p90 -48.46 -38.15 19.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 10.0 111.071 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 9.6 tt0 -59.22 -37.93 78.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.345 -0.847 . . . . 10.0 110.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.525 ' ND2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -68.62 -18.32 64.28 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.223 -0.923 . . . . 10.0 109.771 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' ND2' ' A' ' 92' ' ' ASN . 64.6 t -89.62 -7.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 10.0 109.449 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -93.29 -25.58 17.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 8.3 pt-20 -94.78 2.67 55.52 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.403 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -110.08 -49.03 3.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.989 -1.069 . . . . 10.0 111.79 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.57 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 24.5 m95 -89.9 -33.21 16.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.751 -1.218 . . . . 10.0 111.643 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.558 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 96.3 t -71.7 -49.96 10.52 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.658 -1.276 . . . . 10.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -70.57 -10.49 28.02 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.178 1.094 . . . . 10.0 109.764 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 22.4 tt0 -64.06 -48.58 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 10.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.485 ' O ' ' HD2' ' A' ' 106' ' ' PRO . 20.9 tt -176.43 -29.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.053 -1.029 . . . . 10.0 110.395 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 106' ' ' PRO . 58.3 p -61.76 -11.95 14.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.272 -0.892 . . . . 10.0 109.977 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -55.62 -35.21 65.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.337 -0.852 . . . . 10.0 110.59 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -152.1 10.18 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.965 -1.094 . . . . 10.0 111.937 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . 0.67 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 1.7 m -113.12 -81.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.452 -1.405 . . . . 10.0 111.103 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.67 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 55.2 Cg_endo -74.84 -22.99 14.61 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 122.557 0.767 . . . . 10.0 112.029 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 106' ' ' PRO . 6.0 tttt 45.8 42.93 9.38 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.729 -1.232 . . . . 10.0 109.85 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 75' ' ' THR . 18.5 m -67.1 139.37 95.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.433 -0.792 . . . . 10.0 110.573 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 48.8 Cg_endo -71.94 125.14 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.091 1.574 . . . . 10.0 110.067 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.492 ' N ' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -100.06 99.79 10.57 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.548 -0.72 . . . . 10.0 110.224 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.67 HD11 ' CG1' ' A' ' 152' ' ' VAL . 2.7 mm? -75.67 96.89 3.67 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.665 -1.235 . . . . 10.0 107.665 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.0 mt -80.02 113.44 18.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.643 -0.708 . . . . 10.0 110.114 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 80' ' ' VAL . 1.6 t -120.01 -175.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.087 -1.008 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -147.09 101.56 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.8 t -99.73 178.09 4.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.246 . . . . 10.0 110.955 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 115' ' ' THR . 31.2 mt-30 58.88 30.09 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 10.0 109.17 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -80.17 -13.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.951 -0.7 . . . . 10.0 110.581 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 5.5 p-10 -51.59 58.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 122.493 1.139 . . . . 10.0 111.544 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER 165.72 -28.54 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -50.82 -29.54 11.97 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.729 -0.607 . . . . 10.0 109.367 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.28 -26.76 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 10.0 109.709 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -93.3 123.57 60.22 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.568 -0.708 . . . . 10.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.0 Cg_endo -78.15 24.35 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.89 1.468 . . . . 10.0 111.41 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 15.6 m -98.09 -50.55 4.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.967 -1.083 . . . . 10.0 110.39 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.435 ' CG2' HD12 ' A' ' 126' ' ' ILE . 14.3 t -72.22 -29.73 64.24 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 126' ' ' ILE 0.306 1.1 mp -51.82 -26.51 7.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.109 -1.405 . . . . 10.0 107.365 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' SER . 28.9 tt0 -50.6 -29.35 10.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.926 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -61.39 -29.08 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.709 . . . . 10.0 111.345 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.559 ' N ' HD11 ' A' ' 129' ' ' LEU . 9.2 mp -65.12 -42.92 93.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.804 -1.185 . . . . 10.0 109.835 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.66 -30.4 65.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.762 -0.586 . . . . 10.0 110.662 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 8.5 mmtp -64.85 -15.06 61.36 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -127.64 -41.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 10.0 110.739 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.466 ' HD2' ' HB2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -149.66 136.46 19.45 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.401 -0.812 . . . . 10.0 110.213 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.595 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -82.15 -10.11 59.29 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.362 0.601 . . . . 10.0 110.315 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 98.47 37.74 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 10.0 111.764 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.521 ' HB3' HD23 ' A' ' 129' ' ' LEU . 45.1 Cg_endo -71.56 161.79 44.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.372 1.722 . . . . 10.0 109.904 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.504 ' CG2' ' HB ' ' A' ' 84' ' ' VAL . 1.5 tp -77.84 116.67 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.626 -1.296 . . . . 10.0 109.682 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 42.9 p -121.8 172.19 5.34 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -67.66 -16.56 46.87 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.25 1.132 . . . . 10.0 111.331 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.516 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -79.62 -24.78 41.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 10.0 109.263 178.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.3 m -97.21 -35.0 10.9 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.662 0.744 . . . . 10.0 109.341 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.491 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -72.3 -39.9 67.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.778 -0.576 . . . . 10.0 110.904 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 25.7 mt-10 -62.23 -50.22 72.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.569 -0.852 . . . . 10.0 109.597 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -61.24 -42.18 98.17 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.562 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 4.8 tt -58.8 -45.68 89.35 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.33 -0.856 . . . . 10.0 109.399 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.493 ' O ' ' HB1' ' A' ' 151' ' ' ALA . . . -60.33 -48.7 80.6 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.522 0.677 . . . . 10.0 109.629 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 10.3 mtm-85 -71.13 -14.36 62.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.231 -0.918 . . . . 10.0 109.314 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 9.4 t0 -69.3 -13.33 62.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 10.0 111.115 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.51 26.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.025 -1.047 . . . . 10.0 110.155 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER 64.45 36.27 8.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.684 0.754 . . . . 10.0 110.637 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 146' ' ' ALA . . . -69.4 -155.59 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.67 ' CG1' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -118.77 -62.29 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.781 -1.199 . . . . 10.0 111.112 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -171.99 154.73 3.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.521 -1.362 . . . . 10.0 112.041 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 54.3 t80 -106.8 101.4 10.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 10.0 108.981 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.536 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -107.42 -170.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.469 -0.769 . . . . 10.0 110.139 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -152.56 133.39 14.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.08 -1.013 . . . . 10.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 115' ' ' THR . 26.9 p -153.63 157.75 40.11 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.557 -0.905 . . . . 10.0 108.557 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' A' ' 162' ' ' GLN . 54.0 m -138.68 164.32 29.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.185 -1.042 . . . . 10.0 108.185 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' B' ' 29' ' ' PHE . . . -62.06 -59.26 5.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.631 -1.293 . . . . 10.0 112.33 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.58 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 2.6 pp -121.16 4.7 10.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.454 -1.404 . . . . 10.0 112.898 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.493 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -104.07 -47.34 4.2 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.333 -1.479 . . . . 10.0 113.544 -178.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.567 ' O ' ' HB3' ' A' ' 163' ' ' LYS . 10.7 mm100 -91.51 -44.38 9.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.444 -1.41 . . . . 10.0 112.026 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 15.4 ttpt 63.95 28.73 14.5 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.205 1.002 . . . . 10.0 109.325 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -109.45 15.86 32.18 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.088 -1.605 . . . . 10.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.622 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -69.51 -3.17 13.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.541 -0.976 . . . . 10.0 110.471 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -89.65 -25.32 21.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 10.0 109.946 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -34.92 23.39 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.092 -1.005 . . . . 10.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 16.2 t -59.62 -38.77 77.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 10.0 110.692 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 t80 -80.17 -44.05 20.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 10.0 111.796 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.543 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 29.7 t70 -52.51 -44.08 65.47 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.528 -1.358 . . . . 10.0 110.688 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -60.62 -41.82 95.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.237 -0.914 . . . . 10.0 111.466 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.581 ' HB3' HD21 ' A' ' 111' ' ' LEU . . . -56.14 -33.21 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 10.0 111.092 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 20.8 mm -61.01 -44.68 98.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 118.316 -1.354 . . . . 10.0 108.423 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -70.84 -21.04 62.48 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.375 -0.828 . . . . 10.0 109.839 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.548 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -95.95 -7.5 36.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.397 -0.814 . . . . 10.0 111.005 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -85.97 -33.65 21.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.017 . . . . 10.0 111.343 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -100.31 -10.65 21.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.767 -1.208 . . . . 10.0 109.418 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.191 . . . . 10.0 109.138 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 10.0 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 2' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 56.9 m -80.39 36.82 0.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.09 -1.241 . . . . 10.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 174' ' ' LEU . 9.4 mtpp -61.0 100.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 10.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 2' ' ' SER . 9.2 mm-40 -108.43 161.97 14.54 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.588 0.709 . . . . 10.0 111.262 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.681 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.48 -143.17 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.202 -1.036 . . . . 10.0 108.202 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.681 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 43.9 Cg_endo -74.27 7.31 2.62 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 CA-C-N 119.448 0.839 . . . . 10.0 110.626 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.525 ' OE1' ' CA ' ' B' ' 7' ' ' GLU . 0.0 OUTLIER 41.81 -149.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 10.0 110.517 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.523 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 0.0 OUTLIER -100.48 -99.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.46 -0.775 . . . . 10.0 109.951 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.488 ' N ' HG12 ' B' ' 8' ' ' ILE . 31.1 m -78.12 151.96 33.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.592 -1.317 . . . . 10.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' B' ' 10' ' ' LEU . 0.8 OUTLIER -164.89 98.81 0.84 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.459 -1.401 . . . . 10.0 112.348 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 45' ' ' MET . 45.0 Cg_endo -75.72 124.18 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.771 1.406 . . . . 10.0 108.893 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.8 m -93.14 166.37 12.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.44 174.99 10.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -149.23 150.04 31.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.724 -1.235 . . . . 10.0 111.62 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -170.85 117.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.67 -0.644 . . . . 10.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . 0.527 ' HB2' ' CB ' ' A' ' 40' ' ' TYR . 2.3 p-80 -162.83 156.42 20.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.624 -1.297 . . . . 10.0 111.737 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.531 ' O ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -166.95 96.25 0.51 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.297 -0.877 . . . . 10.0 110.226 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.776 ' HB ' ' CB ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -172.9 167.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.605 . . . . 10.0 109.466 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.42 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 50.0 t60 -145.75 159.6 42.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.211 -1.556 . . . . 10.0 114.551 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 37' ' ' PHE . 4.8 p -69.08 146.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.648 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.515 ' N ' HG23 ' B' ' 20' ' ' VAL . . . -146.48 155.84 26.71 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.364 -1.894 . . . . 10.0 108.364 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.598 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 8.1 m-30 58.81 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.213 -1.169 . . . . 10.0 110.359 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.65 157.55 14.33 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.634 0.73 . . . . 10.0 111.764 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.89 43.89 5.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.69 -0.631 . . . . 10.0 111.331 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' B' ' 22' ' ' PHE . 6.7 t -111.7 -35.1 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 119.356 -0.938 . . . . 10.0 108.663 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.568 ' HB ' ' N ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -101.93 7.44 41.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 177.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.56 ' CA ' HG21 ' A' ' 21' ' ' ILE . . . -125.14 24.87 5.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.881 -2.088 . . . . 10.0 107.881 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 11.3 tt0 -158.66 132.59 7.71 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.647 ' HB2' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -110.04 118.92 37.69 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.238 1.018 . . . . 10.0 110.7 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.432 HG23 ' C ' ' B' ' 29' ' ' PHE . 71.7 p -143.07 162.31 35.87 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.575 -0.739 . . . . 10.0 109.664 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.467 ' O ' HG22 ' B' ' 32' ' ' ILE . . . 45.43 -165.9 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.205 -1.158 . . . . 10.0 110.205 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.467 HG22 ' O ' ' B' ' 31' ' ' GLY . 24.2 pt -143.01 52.87 2.35 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.372 -1.075 . . . . 10.0 110.458 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 55.5 Cg_endo -74.72 163.14 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.83 1.437 . . . . 10.0 111.05 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.489 ' OE2' ' O ' ' A' ' 10' ' ' GLY . 3.6 tp10 -43.7 155.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.963 . . . . 10.0 109.97 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 14' ' ' VAL . 4.1 mm-40 -67.83 -66.76 0.52 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.238 -0.985 . . . . 10.0 111.141 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.625 ' O ' ' CD2' ' B' ' 36' ' ' TRP . 9.4 t90 -161.96 21.05 0.11 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 122.51 1.148 . . . . 10.0 108.114 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.547 ' HA ' ' CG ' ' A' ' 70' ' ' LEU . . . -155.95 93.92 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.081 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.411 ' HA ' ' CD ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.466 -1.309 . . . . 10.0 107.466 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.085 0.469 . . . . 10.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 4' ' ' ILE . 2.8 mm100 -78.72 -48.54 14.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.236 -0.915 . . . . 10.0 108.776 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.56 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -40.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.976 -0.75 . . . . 10.0 108.976 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.598 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 1.2 tt -134.55 149.06 29.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.001 -1.079 . . . . 10.0 111.935 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.466 ' HG3' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -126.95 119.38 26.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 7.5 m -89.32 135.31 33.65 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.732 0.777 . . . . 10.0 109.479 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 9' ' ' VAL . 11.0 t -144.31 158.5 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.46 -0.775 . . . . 10.0 109.972 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.577 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 30.5 m -63.83 136.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.44 -0.787 . . . . 10.0 111.235 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.532 HG12 ' CG1' ' A' ' 80' ' ' VAL . 7.6 t -145.27 -173.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.558 -0.714 . . . . 10.0 109.242 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 80' ' ' VAL . . . 126.93 -129.05 6.42 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.942 -1.263 . . . . 10.0 109.942 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.98 22.95 14.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.435 -1.038 . . . . 10.0 109.224 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' B' ' 33' ' ' PRO . . . 100.82 90.07 2.07 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.644 -1.782 . . . . 10.0 108.644 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . 0.49 ' C ' ' HA ' ' B' ' 35' ' ' GLN . . . -141.18 96.16 2.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 10.0 110.659 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.468 HG22 ' OE1' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -82.91 133.59 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.918 -1.114 . . . . 10.0 109.684 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.545 ' O ' HD22 ' A' ' 19' ' ' LEU . . . 98.75 2.42 57.35 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.914 -1.136 . . . . 10.0 110.356 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.2 tttt -51.0 -47.73 61.52 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.024 -1.28 . . . . 10.0 111.013 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 22.7 m -62.06 -30.94 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.283 -1.511 . . . . 10.0 109.645 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.56 ' O ' ' HB ' ' A' ' 21' ' ' ILE . 14.9 m -70.18 -11.8 61.15 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.742 -1.224 . . . . 10.0 108.916 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.651 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 4.3 mm? -70.26 -30.67 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -49.29 -40.36 34.45 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.841 -1.541 . . . . 10.0 106.841 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.7 mm -67.54 -36.5 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 122.349 1.071 . . . . 10.0 108.948 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.573 ' HA ' ' CA ' ' A' ' 27' ' ' LYS . 3.5 p -60.05 -42.29 94.16 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.883 -0.727 . . . . 10.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.651 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 31.7 m-85 -71.52 -7.45 47.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.824 -1.172 . . . . 10.0 108.768 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 20' ' ' LEU . 66.5 p -107.65 -44.31 4.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.531 -0.867 . . . . 10.0 110.143 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 26' ' ' ASN . 1.9 t -166.2 -65.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 116.798 -1.961 . . . . 10.0 115.361 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 15.9 t-20 -79.0 45.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.018 -1.676 . . . . 10.0 113.181 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.573 ' CA ' ' HA ' ' A' ' 22' ' ' SER . 0.0 OUTLIER -56.04 -126.71 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.577 -0.702 . . . . 10.0 111.392 179.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 3.8 t80 . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.558 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.558 ' CG2' ' O ' ' A' ' 35' ' ' THR . 91.2 t -156.88 -97.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.636 -1.29 . . . . 10.0 111.995 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' B' ' 19' ' ' HIS . 1.7 t80 -70.86 126.94 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 10.0 110.522 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.603 ' HB3' ' CG ' ' A' ' 56' ' ' PHE . 3.2 t70 -160.89 -177.82 6.4 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.055 -1.028 . . . . 10.0 110.103 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.507 ' HB3' ' CG2' ' B' ' 18' ' ' ILE . 1.2 t-20 -167.63 102.65 0.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 10.0 109.125 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.675 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 7.3 t80 -92.76 141.73 28.12 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.989 -1.07 . . . . 10.0 110.577 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -159.58 98.16 1.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 10.0 109.38 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . 0.675 ' CG2' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -144.79 -174.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 10.0 110.622 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.57 ' O ' ' CB ' ' B' ' 13' ' ' ASP . 6.8 m -142.07 146.66 35.69 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 12' ' ' SER . 18.1 t -120.91 136.86 56.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.629 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 10.3 mtt -89.36 109.45 20.36 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 117.736 -1.586 . . . . 10.0 109.181 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.25 109.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.185 -1.572 . . . . 10.0 109.544 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.419 ' HA2' ' CG2' ' B' ' 8' ' ' ILE . . . 50.02 28.09 11.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.07 -28.0 17.09 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 111.15 16.15 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.246 . . . . 10.0 110.475 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 56.0 Cg_endo -73.04 134.64 21.73 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.159 1.61 . . . . 10.0 109.561 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.481 ' OH ' HG21 ' A' ' 173' ' ' ILE . 1.4 t80 -89.34 139.97 29.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.752 -1.218 . . . . 10.0 109.549 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -122.06 97.88 5.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 10.0 110.343 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.534 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 3.8 pp -148.85 171.36 16.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.733 -1.229 . . . . 10.0 111.621 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -173.28 120.85 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.377 -1.889 . . . . 10.0 108.377 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.613 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.5 pp -157.58 144.69 18.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.408 -1.643 . . . . 10.0 112.845 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.603 ' CG ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -174.66 172.34 3.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.251 -0.905 . . . . 10.0 110.384 175.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -90.82 157.33 17.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 10.0 110.187 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.5 m -129.29 135.74 49.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.028 . . . . 10.0 111.662 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 36' ' ' VAL . . . 55.85 -152.44 0.37 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.39 -0.819 . . . . 10.0 110.934 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' HG12 ' B' ' 25' ' ' VAL . . . 96.09 -7.84 67.22 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.236 -1.946 . . . . 10.0 108.236 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.557 ' CG ' ' HB2' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -152.84 -41.76 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.509 -0.994 . . . . 10.0 110.444 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 8.7 mm-40 -73.1 -43.25 62.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.502 -1.279 . . . . 10.0 109.386 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 2.1 t70 73.46 52.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.627 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -165.24 0.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.195 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 64' ' ' TYR . 6.1 p30 -22.53 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.493 0.663 . . . . 10.0 112.487 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -54.29 -34.16 60.26 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 178.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.59 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 83.7 mt -76.43 6.24 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.442 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.574 ' CG ' ' HD3' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -57.82 -31.29 9.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.826 -1.171 . . . . 10.0 113.651 -179.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.59 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 52.0 Cg_endo -72.47 81.11 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 CA-C-N 119.36 0.807 . . . . 10.0 110.037 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.7 OUTLIER -108.72 -34.14 6.78 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.751 -1.218 . . . . 10.0 110.913 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.657 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 77.16 -17.3 0.57 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 10.0 110.808 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.657 ' CB ' ' O ' ' A' ' 71' ' ' SER . 79.2 t80 104.29 115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.838 0 C-N-CA 123.682 0.793 . . . . 10.0 111.181 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 43.9 Cg_endo -71.58 164.7 34.86 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.89 1.469 . . . . 10.0 109.307 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 1.1 mt-30 -139.35 7.01 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.821 -1.174 . . . . 10.0 111.11 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -141.78 84.89 1.91 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.852 -1.155 . . . . 10.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.466 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -174.15 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.516 -0.74 . . . . 10.0 109.015 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.582 HG11 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -163.91 143.19 2.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.19 -0.944 . . . . 10.0 108.801 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 14.0 m-85 -131.72 119.56 21.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.899 -1.126 . . . . 10.0 111.942 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' CB ' ' A' ' 111' ' ' LEU . 1.1 mm? -90.58 97.85 11.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 10.0 109.043 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.57 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 11.0 m -99.38 150.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 10.0 110.35 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.6 p -123.66 108.41 12.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 10.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 80' ' ' VAL . 97.9 m-85 -91.96 139.54 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.207 -0.933 . . . . 10.0 111.058 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.5 p -77.98 163.64 25.78 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 1.9 m -119.43 -14.64 8.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 10.0 110.321 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 32.7 m -115.11 44.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.798 0.809 . . . . 10.0 109.868 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.603 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -133.83 -159.13 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 41.6 Cg_endo -73.26 142.85 34.44 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 122.715 0.85 . . . . 10.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 m -65.29 77.15 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.007 -1.077 . . . . 10.0 109.695 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' PRO . 80.1 p -105.05 -15.71 15.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 10.0 111.642 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.5 p90 -49.79 -39.73 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.258 . . . . 10.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 1.5 tt0 -62.21 -34.17 75.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 10.0 110.269 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.503 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -72.11 -14.01 61.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.063 -1.023 . . . . 10.0 109.682 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 97' ' ' TRP . 21.2 t -87.95 -18.03 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 10.0 109.444 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.629 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 3.7 mmtt -85.42 -35.53 21.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -82.74 -1.03 50.32 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.162 0.506 . . . . 10.0 109.847 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -111.24 -50.01 2.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.832 -1.167 . . . . 10.0 112.052 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.598 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 50.1 m95 -84.77 -49.36 8.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 10.0 112.339 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 23.2 t -52.79 -46.48 96.58 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.657 -1.277 . . . . 10.0 109.951 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.0 Cg_endo -71.75 -16.3 29.88 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.392 1.206 . . . . 10.0 109.779 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 43.5 tt0 -63.36 -16.55 60.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 10.0 109.72 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt 69.02 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.472 0.653 . . . . 10.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 103' ' ' HIS . 2.1 m -52.39 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.868 . . . . 10.0 108.916 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . 0.503 ' N ' ' CG2' ' A' ' 102' ' ' THR . 10.9 p-80 -110.54 -4.2 15.61 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 10.0 108.174 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.5 OUTLIER 162.58 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 35.6 t -138.15 131.49 16.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 42.7 Cg_endo -69.84 67.67 1.77 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.757 1.399 . . . . 10.0 111.256 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 -11.04 15.08 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.057 -1.027 . . . . 10.0 110.659 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.471 ' HB ' HG23 ' A' ' 102' ' ' THR . 12.9 t -49.21 147.3 5.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.653 -1.279 . . . . 10.0 109.715 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.62 130.42 26.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.852 1.448 . . . . 10.0 110.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.457 ' O ' HG13 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -112.8 102.21 10.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.44 -0.787 . . . . 10.0 109.667 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.599 HD12 ' CG1' ' A' ' 152' ' ' VAL . 2.6 mm? -78.62 95.41 5.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.817 -1.153 . . . . 10.0 108.026 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 12.5 mt -72.31 137.91 47.0 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 22.8 t -148.43 158.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.787 -1.196 . . . . 10.0 111.594 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -96.56 148.21 18.92 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.765 -1.734 . . . . 10.0 108.765 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 81' ' ' CYS . 30.5 m -111.35 126.71 55.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.167 -1.196 . . . . 10.0 110.638 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 44.17 62.18 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.438 -0.789 . . . . 10.0 110.412 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.766 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -83.89 -29.24 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.206 -0.997 . . . . 10.0 109.542 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -52.47 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.427 1.108 . . . . 10.0 110.175 -177.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER 166.73 -26.66 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.219 -1.355 . . . . 10.0 107.827 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -51.14 -33.21 25.73 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.307 0.575 . . . . 10.0 109.731 178.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 75.7 m-20 -73.77 -11.46 60.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.027 . . . . 10.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.447 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 38.0 t0 -86.4 115.86 63.73 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 10.0 110.162 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.47 21.65 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.734 1.386 . . . . 10.0 111.447 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 38.7 t -105.59 -51.24 3.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 10.0 109.993 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.452 ' CG2' HD11 ' A' ' 126' ' ' ILE . 14.3 t -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.967 -2.235 . . . . 10.0 104.967 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 130' ' ' ALA 0.296 1.3 mp -54.47 -23.56 11.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.227 -1.351 . . . . 10.0 107.79 176.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -49.21 -41.73 37.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.583 0.706 . . . . 10.0 110.172 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 1.8 mmmm -92.44 -41.32 10.37 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.603 -0.686 . . . . 10.0 109.994 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 6.0 mp -65.83 -32.75 74.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.761 . . . . 10.0 109.403 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -59.88 -51.51 69.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 10.0 109.869 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -64.62 -25.33 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.196 -1.002 . . . . 10.0 108.903 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.57 ' ND2' ' N ' ' A' ' 87' ' ' PRO . 2.2 t30 -69.38 -8.64 48.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 10.0 110.583 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -167.67 115.3 0.75 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 10.0 108.557 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.511 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -64.51 -19.9 65.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 10.0 111.904 -178.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -137.67 106.34 8.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.747 -1.221 . . . . 10.0 110.284 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 160.45 46.45 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.487 . . . . 10.0 109.654 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.4 tp -86.86 138.35 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.782 -1.199 . . . . 10.0 109.704 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 55.8 p -131.43 166.33 28.79 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.463 -0.773 . . . . 10.0 109.813 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 42.4 Cg_endo -67.8 -11.5 32.31 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.737 1.388 . . . . 10.0 110.965 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 75.2 mt-10 -75.16 -44.3 47.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.946 -1.096 . . . . 10.0 109.405 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -77.72 -36.55 50.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.662 0.744 . . . . 10.0 109.388 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -64.93 -49.94 68.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 10.0 111.476 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.3 -46.94 62.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.009 -1.057 . . . . 10.0 109.578 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 3.2 mtpm? -70.68 -30.05 66.53 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.542 -0.863 . . . . 10.0 109.439 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -69.53 -38.95 77.73 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.332 -0.855 . . . . 10.0 109.693 178.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 151' ' ' ALA . . . -65.71 -49.67 67.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 10.0 108.263 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -24.07 67.53 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.852 -0.739 . . . . 10.0 109.166 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 21.1 t70 -59.97 -30.93 69.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 10.0 111.177 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.591 ' CD2' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -132.87 29.9 4.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.888 -1.132 . . . . 10.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 31.9 mttt 67.45 36.08 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 10.0 112.176 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 146' ' ' ALA . . . -69.68 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.221 -0.991 . . . . 10.0 108.929 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG1' HD12 ' A' ' 111' ' ' LEU . 2.4 p -114.57 -58.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.596 -1.315 . . . . 10.0 112.014 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HB3' ' OE2' ' A' ' 171' ' ' GLU . 2.8 ttmm -172.3 148.72 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.367 -1.458 . . . . 10.0 111.675 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.561 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 83.9 t80 -86.0 121.7 29.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 10.0 110.466 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.51 ' HB ' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -130.03 -174.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.868 -1.145 . . . . 10.0 110.169 179.4 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -148.09 149.23 31.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.862 -1.149 . . . . 10.0 112.195 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.0 p -148.22 156.09 42.14 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.905 0.859 . . . . 10.0 110.894 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.571 ' HB2' ' CG ' ' A' ' 163' ' ' LYS . 1.7 t -139.38 89.8 2.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.627 0.727 . . . . 10.0 109.495 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 158' ' ' SER . . . -12.05 -58.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.554 0.946 . . . . 10.0 113.554 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -106.99 -43.12 4.72 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.056 -1.028 . . . . 10.0 112.84 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 158' ' ' SER . 6.3 p -65.25 -23.58 67.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.264 -1.523 . . . . 10.0 109.577 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' OE1' ' A' ' 162' ' ' GLN . 0.3 OUTLIER 71.19 77.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.457 -0.777 . . . . 10.0 110.946 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 158' ' ' SER . 12.6 mmmt -80.86 23.43 0.55 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.529 -0.868 . . . . 10.0 111.865 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.27 45.41 11.43 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.101 -1.2 . . . . 10.0 110.101 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.644 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -74.96 -3.37 31.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.339 -1.095 . . . . 10.0 112.774 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . 0.501 ' N ' HD12 ' A' ' 165' ' ' LEU . 5.7 ttmt -53.62 -38.99 64.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.57 -1.331 . . . . 10.0 110.223 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -75.6 -26.1 57.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 10.0 111.684 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 165' ' ' LEU . 87.7 t -52.88 -51.49 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 10.0 111.353 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CZ ' ' OD1' ' A' ' 170' ' ' ASP . 2.3 p90 -85.16 -32.23 22.83 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.699 -0.801 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.58 ' OD1' ' CZ ' ' A' ' 169' ' ' PHE . 1.0 OUTLIER -56.45 -41.54 76.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.993 -1.067 . . . . 10.0 110.972 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.44 ' OE1' HG13 ' A' ' 155' ' ' VAL . 9.0 pt-20 -69.8 -30.64 68.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.991 -1.068 . . . . 10.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . 0.547 ' CB ' HD11 ' A' ' 111' ' ' LEU . . . -71.49 -4.61 27.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.012 -1.055 . . . . 10.0 109.457 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.547 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 44.9 mm -82.52 -46.0 19.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.549 -0.861 . . . . 10.0 108.967 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 170' ' ' ASP . 0.3 OUTLIER -83.63 -30.97 26.48 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.738 -1.185 . . . . 10.0 108.679 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -77.03 -0.28 23.95 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.393 -0.817 . . . . 10.0 108.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -90.04 -39.25 13.04 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.378 -0.826 . . . . 10.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -89.74 -19.94 24.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 10.0 109.393 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.283 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . 0.405 ' HA2' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 55.43 33.28 20.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -1.012 . . . . 10.0 110.767 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.76 89.39 5.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.099 -1.001 . . . . 10.0 110.274 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.486 ' C ' ' HD2' ' B' ' 6' ' ' PRO . 3.1 mt-10 -92.81 118.83 31.52 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.209 -0.932 . . . . 10.0 110.245 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.716 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -71.72 -21.38 0.5 Allowed Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 121.38 -0.825 . . . . 10.0 111.903 178.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 44.3 Cg_endo -88.06 -9.77 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 O-C-N 122.597 0.788 . . . . 10.0 111.044 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.466 ' OE1' ' CB ' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -53.57 171.27 0.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 118.47 -1.292 . . . . 10.0 109.713 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' B' ' 9' ' ' SER . 0.4 OUTLIER -78.16 -169.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.011 -1.477 . . . . 10.0 107.011 177.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.619 ' N ' ' CG2' ' B' ' 8' ' ' ILE . 33.3 t -129.02 98.9 5.08 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 118.994 -1.082 . . . . 10.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.629 ' HB3' ' O ' ' A' ' 45' ' ' MET . 41.1 tp -92.5 99.89 3.27 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 118.558 -1.257 . . . . 10.0 108.994 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' B' ' 9' ' ' SER . 37.8 Cg_endo -61.29 99.43 0.16 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.194 1.102 . . . . 10.0 110.795 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 12' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 4.9 m -152.36 99.83 2.53 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.327 -0.858 . . . . 10.0 111.422 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -169.17 121.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.62 -0.675 . . . . 10.0 110.353 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -159.42 102.93 1.58 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.005 -1.059 . . . . 10.0 110.558 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.571 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.64 106.5 0.22 Allowed 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.273 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -166.82 123.24 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 10.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 17' ' ' THR . . . . . 0.488 ' O ' HG22 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -161.97 111.28 1.51 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.92 . . . . 10.0 110.183 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.507 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -153.43 -173.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.044 -1.035 . . . . 10.0 110.296 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 64.2 m80 -115.35 142.8 46.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.082 -1.011 . . . . 10.0 110.569 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 1.1 p -142.88 149.11 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.485 -0.76 . . . . 10.0 111.346 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -87.95 -124.67 2.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.254 -1.938 . . . . 10.0 108.254 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER 173.54 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -1.152 . . . . 10.0 111.363 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.557 ' HB2' ' CG ' ' A' ' 61' ' ' GLN . 9.4 t70 -144.05 159.41 42.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.683 -0.635 . . . . 10.0 109.537 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.557 ' CB ' ' HG3' ' B' ' 28' ' ' GLU . . . -61.03 -5.54 1.46 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.905 -1.122 . . . . 10.0 109.913 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' B' ' 28' ' ' GLU 0.276 0.5 OUTLIER -49.67 -34.98 9.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.883 1.325 . . . . 10.0 107.566 178.878 . . . . . . . . 4 4 . 1 . 019 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -52.63 -32.59 42.59 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.111 -1.404 . . . . 10.0 111.064 -179.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 26' ' ' ASN . . . -123.79 -7.92 6.48 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.655 -1.778 . . . . 10.0 108.655 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.557 ' HG3' ' CB ' ' B' ' 24' ' ' ALA . 18.3 mt-10 -83.74 39.94 0.71 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.68 -0.894 . . . . 10.0 110.453 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.558 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 46.3 t80 -76.07 94.97 3.53 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.756 -1.202 . . . . 10.0 107.756 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.584 HG23 ' CD2' ' A' ' 28' ' ' PHE . 34.3 p -112.89 -19.22 12.04 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.19 -0.914 . . . . 10.0 110.491 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.62 -167.53 14.68 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.129 -1.588 . . . . 10.0 109.129 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.442 ' CD1' ' N ' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -133.59 69.47 76.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.239 -1.153 . . . . 10.0 110.811 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.4 Cg_endo -74.22 156.57 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.088 1.572 . . . . 10.0 108.464 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -35.21 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.268 -0.895 . . . . 10.0 111.003 -178.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -73.26 -71.22 0.32 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.496 0.665 . . . . 10.0 112.039 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.542 ' O ' HD13 ' A' ' 70' ' ' LEU . 41.1 t90 -157.26 34.65 0.28 Allowed 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.53 ' CB ' HD12 ' A' ' 70' ' ' LEU . . . -157.8 83.69 0.88 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.53 ' HD3' ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' CG ' ' A' ' 1' ' ' MET . 2.2 ptm . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.401 0.62 . . . . 10.0 110.149 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -74.92 -33.66 62.02 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.676 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.2 m -40.79 118.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' ILE . . . . . 0.538 HG13 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -104.16 127.27 58.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.16 -1.816 . . . . 10.0 110.77 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LYS . . . . . 0.584 ' O ' ' CG2' ' A' ' 75' ' ' THR . 1.8 mttp -121.42 97.78 5.67 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.493 ' SG ' HD11 ' A' ' 4' ' ' ILE . 19.6 m -118.19 120.43 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.848 -1.141 . . . . 10.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' VAL . . . . . 0.553 ' CG2' HG22 ' A' ' 75' ' ' THR . 47.1 t -127.55 144.6 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.488 -0.93 . . . . 10.0 108.488 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' B' ' 36' ' ' TRP . 33.6 m -62.73 116.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.287 -0.883 . . . . 10.0 110.709 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' LEU . 77.2 t -115.72 177.69 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.182 -0.949 . . . . 10.0 109.136 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 167.78 172.64 35.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.23 18.49 13.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.118 -1.225 . . . . 10.0 109.731 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLY . . . . . 0.54 ' CA ' ' OE1' ' B' ' 34' ' ' GLU . . . 74.61 51.74 7.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 -54.41 2.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.529 -0.983 . . . . 10.0 110.785 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . 0.464 HG13 ' OE1' ' A' ' 116' ' ' GLN . 6.3 m -136.26 -7.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 10.0 111.586 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' B' ' 35' ' ' GLN . . . 81.64 81.63 0.86 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 3.8 tptt -63.04 -27.24 69.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.54 -0.977 . . . . 10.0 112.008 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.531 ' OG1' ' CG2' ' A' ' 8' ' ' VAL . 93.9 m -55.15 -51.85 65.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.399 -1.438 . . . . 10.0 110.188 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . 0.562 ' CB ' ' HA ' ' B' ' 26' ' ' THR . 31.0 p -74.81 0.23 16.14 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.44 -0.904 . . . . 10.0 109.985 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' LEU . . . . . 0.624 HD21 ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -88.16 -36.07 17.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.003 -1.061 . . . . 10.0 109.097 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 16' ' ' LYS . 4.3 mm? -51.68 -38.55 55.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -76.67 -51.34 19.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.641 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 21' ' ' ILE . 49.3 m -46.27 -40.85 12.22 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 119.077 -1.049 . . . . 10.0 108.846 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -64.22 -23.28 67.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.187 -0.946 . . . . 10.0 109.461 177.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' ILE . 63.2 m -105.04 -29.97 10.07 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.686 0.755 . . . . 10.0 109.889 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -137.73 64.5 1.51 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.73 -1.581 . . . . 10.0 106.73 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -33.96 49.75 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.583 1.553 . . . . 10.0 114.406 -177.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.802 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -67.22 109.12 2.96 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.381 -0.824 . . . . 10.0 110.749 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' PHE . . . . . 0.547 ' CD1' HG23 ' B' ' 30' ' ' THR . 43.4 t80 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.237 -0.914 . . . . 10.0 110.406 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 21' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 120.823 0.345 . . . . 10.0 111.9 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' VAL . . . . . 0.543 HG12 ' CG2' ' A' ' 58' ' ' THR . 78.6 t -95.29 10.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.654 -1.279 . . . . 10.0 109.017 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' B' ' 18' ' ' ILE . 1.3 m-30 -33.91 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.087 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASP . . . . . 0.788 ' HB2' ' HA ' ' B' ' 18' ' ' ILE . 1.5 m-20 -85.81 -149.02 0.13 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.903 -1.519 . . . . 10.0 108.594 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 1.3 t-20 -133.7 -163.62 1.38 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -128.05 163.27 24.94 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.605 -1.31 . . . . 10.0 112.194 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' ALA . . . . . 0.568 ' HB1' ' CE2' ' A' ' 56' ' ' PHE . . . -153.65 153.72 32.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -172.34 -168.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 120.528 -1.357 . . . . 10.0 111.625 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 51' ' ' TYR . 92.3 m -132.39 153.31 50.92 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.503 -0.771 . . . . 10.0 109.887 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . 0.522 HG13 ' CG ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -142.07 -171.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.039 . . . . 10.0 110.395 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' MET . . . . . 0.54 ' HB2' ' HG2' ' B' ' 11' ' ' PRO . 85.6 mtp -142.65 138.45 30.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.647 . . . . 10.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . 0.564 HG13 ' HB2' ' B' ' 10' ' ' LEU . 1.1 mp -146.91 115.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.222 -0.924 . . . . 10.0 109.714 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.01 27.58 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.656 -1.259 . . . . 10.0 109.98 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' GLY . . . . . 0.521 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.37 -16.18 49.22 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.189 -1.183 . . . . 10.0 111.412 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' B' ' 4' ' ' GLU . 1.7 mp0 -98.69 105.04 28.0 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.553 -1.557 . . . . 10.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 52.2 Cg_endo -82.91 151.74 14.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.894 1.471 . . . . 10.0 112.269 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CG ' HG13 ' A' ' 44' ' ' VAL . 2.8 m-30 -81.52 174.07 11.79 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . 0.676 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 16.2 m -152.73 124.1 7.67 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.611 -1.306 . . . . 10.0 112.249 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . 0.518 ' C ' ' CG2' ' A' ' 4' ' ' ILE . 0.3 OUTLIER 64.65 -169.21 0.2 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.93 0.871 . . . . 10.0 113.282 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 41' ' ' ALA . . . -169.72 -167.17 29.86 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.054 -1.618 . . . . 10.0 109.054 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -111.22 156.57 21.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -1.116 . . . . 10.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PHE . . . . . 0.568 ' CE2' ' HB1' ' A' ' 41' ' ' ALA . 56.9 m-85 -132.88 166.03 23.26 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.346 -0.613 . . . . 10.0 109.346 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 58' ' ' THR . 8.1 t70 -104.57 179.69 4.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.772 -1.205 . . . . 10.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' THR . . . . . 0.543 ' CG2' HG12 ' A' ' 36' ' ' VAL . 12.0 t -45.26 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.469 1.128 . . . . 10.0 112.425 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -132.94 63.35 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 10.0 109.114 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -49.42 -39.94 30.04 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.646 -2.582 . . . . 10.0 106.646 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 2.7 tp60 -63.92 -35.62 81.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.7 mt-10 55.63 32.76 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.939 0.876 . . . . 10.0 109.819 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 5.6 t70 -90.08 -5.68 56.29 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.527 -0.916 . . . . 10.0 108.527 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -139.23 -38.33 0.49 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.13 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.2 p30 38.9 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.187 -0.605 . . . . 10.0 109.998 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -58.17 -36.87 73.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.745 -1.222 . . . . 10.0 109.173 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.631 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 5.1 mt -91.77 13.86 17.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.331 0.586 . . . . 10.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -81.47 -13.12 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 114.341 1.238 . . . . 10.0 114.341 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.631 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -69.71 67.76 1.7 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 109.031 -1.18 . . . . 10.0 109.031 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.612 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 4.9 mt -50.46 -71.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.559 0.695 . . . . 10.0 111.665 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . 0.476 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 21.7 p -35.31 -29.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.958 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -98.29 105.83 31.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.415 -0.803 . . . . 10.0 108.859 178.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 71' ' ' SER . 43.4 Cg_endo -77.83 113.93 3.55 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.859 1.452 . . . . 10.0 110.721 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -133.77 60.61 1.7 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.477 -0.764 . . . . 10.0 110.288 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 3.8 m -144.25 97.33 3.03 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.934 -1.104 . . . . 10.0 109.545 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' THR . 14.5 t70 -28.83 -38.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.662 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -121.09 136.96 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.269 -0.894 . . . . 10.0 109.706 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 41.8 m-85 -115.7 144.67 43.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LEU . . . . . 0.486 HD11 ' CG1' ' A' ' 168' ' ' VAL . 0.5 OUTLIER -114.01 102.34 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 10.0 109.129 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 4.4 p -96.8 151.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.982 . . . . 10.0 108.812 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' CYS . . . . . 0.505 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 19.8 t -134.8 100.37 4.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.847 -1.158 . . . . 10.0 112.496 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 47.8 m-85 -88.45 156.18 19.26 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.316 -0.865 . . . . 10.0 109.884 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' SER . . . . . 0.581 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 18.8 m -85.01 147.12 26.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.843 -1.161 . . . . 10.0 109.282 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 117' ' ' ILE . 43.7 t -47.62 -60.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.077 -1.014 . . . . 10.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . 0.52 ' HB ' ' CD2' ' A' ' 129' ' ' LEU . 3.8 t -78.75 -62.52 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.581 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.7 OUTLIER 44.8 179.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.847 0 CA-C-O 121.58 0.705 . . . . 10.0 112.375 178.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 52.2 Cg_endo -78.72 145.99 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.462 1.77 . . . . 10.0 109.985 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 135' ' ' LYS . 95.2 p -68.38 67.81 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 10.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.3 OUTLIER -136.69 13.37 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 10.0 111.666 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 82' ' ' PHE . 16.9 t80 -71.33 -34.15 70.29 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.619 -1.301 . . . . 10.0 110.64 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -74.69 -29.89 61.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.026 -1.046 . . . . 10.0 110.982 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -86.89 -9.69 55.12 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.741 -1.183 . . . . 10.0 109.496 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 97' ' ' TRP . 14.4 t -90.35 -36.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.996 -1.065 . . . . 10.0 109.102 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HE2' ' CD1' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.26 -25.39 62.45 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 10.0 110.095 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 12.9 pt-20 -78.52 -25.06 45.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 10.0 111.616 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 25.2 mttp -110.93 -50.65 2.93 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.892 -1.13 . . . . 10.0 111.998 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' TRP . . . . . 0.595 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 23.1 m0 -64.42 -17.19 63.55 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.297 -0.877 . . . . 10.0 112.405 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' VAL . . . . . 0.528 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 53.8 t -82.91 -50.7 0.72 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.772 -1.205 . . . . 10.0 112.033 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.8 Cg_endo -68.58 -6.47 17.83 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.119 1.063 . . . . 10.0 111.209 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 mm-40 -90.48 -32.0 16.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.876 -1.14 . . . . 10.0 110.464 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -91.96 -29.14 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.038 -1.039 . . . . 10.0 110.239 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 98' ' ' VAL . 69.9 p -62.26 -12.18 19.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 10.0 109.915 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -57.56 -40.68 79.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.558 -0.714 . . . . 10.0 110.639 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.96 -33.76 39.29 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 10.0 110.803 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.3 t -136.29 128.49 17.37 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 10.0 110.092 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.29 126.5 13.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.117 1.588 . . . . 10.0 111.851 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.84 52.07 11.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.37 -0.831 . . . . 10.0 111.119 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' THR . . . . . 0.474 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 22.4 m -63.31 145.17 97.24 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 10.0 109.61 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 41.1 Cg_endo -68.37 157.63 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.642 1.338 . . . . 10.0 109.365 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' PHE . . . . . 0.583 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -159.95 121.97 3.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.94 -1.1 . . . . 10.0 111.237 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.534 HD13 ' CG1' ' A' ' 152' ' ' VAL . 1.0 OUTLIER -92.29 102.51 15.01 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.149 0.975 . . . . 10.0 110.682 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 71.2 mt -75.56 135.24 40.58 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.817 -0.809 . . . . 10.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 19.4 t -133.75 169.96 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.654 -1.279 . . . . 10.0 112.694 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -140.35 107.11 0.52 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.583 -2.207 . . . . 10.0 107.583 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 2.8 t -106.75 -179.51 3.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.267 . . . . 10.0 111.708 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 83' ' ' SER . 16.9 mt-30 61.56 48.16 5.98 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.798 -0.564 . . . . 10.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ILE . . . . . 0.792 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -107.37 -50.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.167 -0.958 . . . . 10.0 110.118 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 11.6 t0 -52.7 61.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.191 0.996 . . . . 10.0 109.947 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER 152.57 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.339 -1.3 . . . . 10.0 108.41 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -46.73 -37.4 8.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 10.0 109.135 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.0 -21.99 9.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.42 -0.8 . . . . 10.0 109.542 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ASP . . . . . 0.521 ' OD1' ' HD2' ' A' ' 123' ' ' PRO . 22.9 t0 -84.28 131.77 49.63 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 10.0 110.889 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.521 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 51.7 Cg_endo -78.22 24.66 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.925 1.487 . . . . 10.0 111.265 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' SER . . . . . 0.488 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 37.1 m -102.76 -46.96 4.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.002 -1.061 . . . . 10.0 109.843 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' THR . . . . . 0.543 HG21 ' N ' ' A' ' 126' ' ' ILE . 6.8 t -78.41 -27.42 46.65 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.493 -2.039 . . . . 10.0 105.493 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ILE . . . . . 0.543 ' N ' HG21 ' A' ' 125' ' ' THR 0.29 1.1 mp -57.06 -25.26 22.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 177.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.24 -50.18 50.65 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.747 0.784 . . . . 10.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -65.06 -44.77 87.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.691 -0.63 . . . . 10.0 111.062 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' LEU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 134' ' ' GLN . 5.6 mt -59.92 -35.51 75.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.235 -0.916 . . . . 10.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' ALA . . . . . 0.631 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -49.62 -42.24 44.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.606 -0.684 . . . . 10.0 110.294 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -19.9 42.17 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.46 -0.775 . . . . 10.0 110.498 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -123.07 43.89 2.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.953 -1.092 . . . . 10.0 112.348 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.1 mptm? 67.72 150.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 10.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' GLN . . . . . 0.631 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -116.77 66.24 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 10.0 111.387 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' A' ' 88' ' ' SER . 5.0 mmmt -104.83 94.68 7.8 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.112 -0.992 . . . . 10.0 108.958 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 43.7 Cg_endo -71.22 161.43 45.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.075 1.566 . . . . 10.0 110.681 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 137' ' ' ILE . 3.9 tp -120.13 121.41 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.215 -0.928 . . . . 10.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 19.4 p -108.46 164.29 15.06 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.22 -0.925 . . . . 10.0 109.206 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 38.3 Cg_endo -67.51 -29.16 37.61 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.589 1.31 . . . . 10.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.78 -34.12 72.6 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.5 m -93.38 -33.51 13.84 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.746 0.784 . . . . 10.0 109.054 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . 0.492 ' CB ' ' CD1' ' A' ' 154' ' ' TYR . . . -75.38 -38.56 59.93 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.601 -0.687 . . . . 10.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.0 mt-10 -59.54 -49.23 78.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.258 -0.901 . . . . 10.0 109.836 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -45.26 93.42 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 10.0 109.156 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 149' ' ' LEU . 2.8 tt -60.05 -49.37 77.93 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.228 -1.026 . . . . 10.0 108.228 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.71 68.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 10.0 109.128 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 1.6 mtp-105 -72.23 -4.85 31.89 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.603 -0.686 . . . . 10.0 109.873 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.15 -52.04 7.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 10.0 110.278 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -89.94 4.86 48.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 10.0 109.309 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 1.8 mttp 73.16 31.17 1.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -55.89 -159.82 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.952 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 0.8 OUTLIER -119.08 -54.74 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 118.941 -1.103 . . . . 10.0 111.516 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.53 147.14 2.32 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.934 -1.506 . . . . 10.0 112.621 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 154' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 43.2 t80 -97.64 100.05 11.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.735 -0.603 . . . . 10.0 109.45 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 155' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 1.9 t -101.39 -170.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 10.0 110.367 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.22 168.2 23.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 10.0 110.184 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' THR . 7.3 p -176.99 164.8 2.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.157 -0.965 . . . . 10.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 165' ' ' LEU . 60.2 m -146.27 128.23 15.49 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.605 -0.685 . . . . 10.0 109.939 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 160' ' ' LEU . . . -63.86 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.621 -0.674 . . . . 10.0 111.597 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.561 ' CD2' ' CD2' ' B' ' 29' ' ' PHE . 0.4 OUTLIER -28.06 -52.95 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.57 1.176 . . . . 10.0 109.481 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -95.74 -102.28 0.16 Allowed 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.731 -1.122 . . . . 10.0 110.43 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' GLN . . . . . 0.597 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 159.27 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 -178.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' LYS . . . . . 0.502 ' HD2' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -97.35 27.37 4.25 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.566 -1.254 . . . . 10.0 112.545 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' GLY . . . . . 0.44 ' C ' ' HB3' ' A' ' 157' ' ' CYS . . . 135.95 14.96 0.95 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 118.708 -1.711 . . . . 10.0 111.99 177.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -49.36 -53.44 22.34 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.177 -1.778 . . . . 10.0 109.833 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -67.14 -29.49 69.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.463 0.649 . . . . 10.0 109.588 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ASN . . . . . 0.482 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 1.3 m120 -62.3 -32.11 72.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 10.0 111.4 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 46.5 t -70.88 -49.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.448 -1.408 . . . . 10.0 109.171 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' PHE . . . . . 0.425 ' O ' HG13 ' A' ' 173' ' ' ILE . 92.4 t80 -59.31 -22.92 61.97 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.762 -0.586 . . . . 10.0 110.452 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.506 ' O ' HD23 ' A' ' 174' ' ' LEU . 80.8 m-20 -59.17 -50.93 72.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 10.0 110.416 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' GLU . . . . . 0.495 ' HA ' HD22 ' A' ' 174' ' ' LEU . 51.2 mp0 -65.88 -31.52 72.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.036 -1.04 . . . . 10.0 108.883 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.19 67.69 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.814 -0.554 . . . . 10.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 72.1 mt -63.61 -43.71 98.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.091 -1.044 . . . . 10.0 108.542 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' LEU . . . . . 0.532 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.75 -42.33 67.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.188 -0.945 . . . . 10.0 110.179 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.1 -0.12 30.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.526 -0.733 . . . . 10.0 109.985 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 4' ' ' ILE . . . -83.33 -44.57 14.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.898 . . . . 10.0 109.851 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.6 OUTLIER -98.85 -17.56 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.822 . . . . 10.0 109.302 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 118.003 -0.998 . . . . 10.0 110.028 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -126.54 150.2 48.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -1.131 . . . . 10.0 110.196 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 3' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -117.96 88.41 2.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.365 -0.835 . . . . 10.0 109.272 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 4' ' ' GLU . . . . . 0.447 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 2.8 mm-40 -87.36 178.18 6.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.84 0.828 . . . . 10.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 5' ' ' ARG . . . . . 0.632 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.12 -149.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 6' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -72.14 0.37 7.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 CA-C-N 119.325 0.795 . . . . 10.0 110.589 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 7' ' ' GLU . . . . . 0.464 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.8 mm-40 46.21 -165.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 10.0 110.427 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.35 -45.01 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 10.0 111.661 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 9' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 47' ' ' GLY . 67.4 m -122.08 151.32 41.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.221 . . . . 10.0 112.137 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 10' ' ' LEU . . . . . 0.71 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -170.84 97.53 0.43 Allowed Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.363 -0.836 . . . . 10.0 113.153 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 11' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -77.35 156.08 32.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 N-CA-C 107.877 -1.624 . . . . 10.0 107.877 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -117.68 163.49 16.39 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.587 -1.321 . . . . 10.0 111.966 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.32 176.46 10.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.073 -1.084 . . . . 10.0 108.073 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -170.63 144.61 2.38 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.784 -1.198 . . . . 10.0 110.792 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 15' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 59.8 tt0 -141.02 137.48 32.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -121.77 129.44 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.036 -1.04 . . . . 10.0 112.103 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.54 98.22 3.31 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 18' ' ' ILE . . . . . 0.788 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.4 mp -106.45 140.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 19' ' ' HIS . . . . . 0.572 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 33.8 m170 -132.89 123.59 26.29 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.353 -0.842 . . . . 10.0 110.94 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 20' ' ' VAL . . . . . 0.511 HG23 ' HB ' ' A' ' 36' ' ' VAL . 1.4 p -140.37 130.18 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 10.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 21' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -145.56 10.87 1.71 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.846 -1.302 . . . . 10.0 109.846 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 22' ' ' PHE . . . . . 0.43 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -143.93 85.26 1.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.334 -1.098 . . . . 10.0 109.794 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 23' ' ' ASP . . . . . 0.48 ' O ' ' CB ' ' B' ' 24' ' ' ALA . 10.7 t70 -56.97 151.88 14.01 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.565 0.698 . . . . 10.0 111.416 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 24' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' B' ' 23' ' ' ASP . . . 69.98 19.84 6.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.557 -0.714 . . . . 10.0 111.099 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 25' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' B' ' 22' ' ' PHE . 25.3 t -110.47 -39.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.057 -1.027 . . . . 10.0 110.281 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 26' ' ' THR . . . . . 0.562 ' HA ' ' CB ' ' A' ' 18' ' ' CYS . 6.5 m -94.95 -10.04 32.23 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.314 -0.866 . . . . 10.0 112.605 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 27' ' ' LYS . . . -111.59 -15.89 9.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.629 -1.788 . . . . 10.0 108.629 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 28' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -86.3 108.44 18.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.638 1.209 . . . . 10.0 110.683 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 29' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -117.8 113.65 22.11 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.31 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 30' ' ' THR . . . . . 0.547 HG23 ' CD1' ' A' ' 28' ' ' PHE . 42.3 p -154.78 -61.94 0.12 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.483 -0.78 . . . . 10.0 109.78 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 31' ' ' GLY . . . . . 0.468 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -165.52 66.62 0.21 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.611 -1.796 . . . . 10.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 32' ' ' ILE . . . . . 0.554 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 11.2 pt -102.77 168.26 9.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.349 -1.089 . . . . 10.0 110.947 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 33' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' B' ' 32' ' ' ILE . 38.6 Cg_endo -65.42 178.12 2.27 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.004 1.528 . . . . 10.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 34' ' ' GLU . . . . . 0.54 ' OE1' ' CA ' ' A' ' 12' ' ' GLY . 6.6 tp10 -36.56 160.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.744 0.783 . . . . 10.0 111.89 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 35' ' ' GLN . . . . . 0.428 ' HB2' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -72.63 -70.68 0.33 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.583 -0.698 . . . . 10.0 112.768 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 36' ' ' TRP . . . . . 0.586 ' CB ' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -141.27 22.44 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 10.0 110.101 -179.003 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' B' B ' 37' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . . . 178.96 99.7 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.817 0.818 . . . . 10.0 110.026 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' B' B ' 38' ' ' ARG . . . . . 0.526 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.8 ttt180 . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 106.902 -1.518 . . . . 10.0 106.902 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.44 ' O ' ' O ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.431 0.634 . . . . 10.0 110.088 . . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.582 ' HA ' HD22 ' A' ' 177' ' ' LEU . 30.1 mm100 -129.57 -24.32 2.77 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.552 -0.717 . . . . 10.0 109.997 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.596 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 95.1 m -57.84 115.93 3.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 10.0 111.289 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.491 HG23 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -122.85 132.77 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.592 -0.843 . . . . 10.0 109.898 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 75' ' ' THR . 46.4 mmtt -123.2 101.65 7.5 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.431 ' HA ' HG22 ' A' ' 77' ' ' VAL . 47.4 t -113.24 145.17 41.47 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.885 0.85 . . . . 10.0 112.801 -177.825 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.572 ' CG2' HG22 ' A' ' 75' ' ' THR . 0.2 OUTLIER -151.59 -176.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.483 HG12 ' N ' ' A' ' 16' ' ' LYS . 22.7 m -91.59 108.55 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 10.0 109.877 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HB ' HG11 ' A' ' 80' ' ' VAL . 2.1 t -113.47 -170.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.977 -1.077 . . . . 10.0 110.19 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.411 ' HA2' ' HB ' ' A' ' 80' ' ' VAL . . . 137.62 -144.77 16.26 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.73 20.22 16.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 10.0 109.637 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.19 75.87 0.99 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.034 -1.626 . . . . 10.0 109.034 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.63 -174.59 3.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.427 -1.043 . . . . 10.0 109.766 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.521 ' HB ' ' CD2' ' B' ' 29' ' ' PHE . 40.6 t -67.13 161.77 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 10.0 110.647 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.486 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -53.02 111.97 1.98 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.427 -1.869 . . . . 10.0 108.427 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.483 ' N ' HG12 ' A' ' 8' ' ' VAL . 11.1 tppt? -48.61 -28.0 3.18 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.179 -1.189 . . . . 10.0 110.428 -178.974 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.1 m -66.01 -30.62 71.2 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.15 -0.969 . . . . 10.0 111.072 -179.809 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.572 ' HA ' ' O ' ' B' ' 26' ' ' THR . 16.3 p -63.2 -9.89 13.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.175 . . . . 10.0 109.733 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.685 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 5.3 mt -94.81 -34.08 12.62 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.424 -0.797 . . . . 10.0 110.184 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.422 ' C ' ' O ' ' A' ' 19' ' ' LEU . 79.4 mt -46.49 -30.46 2.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.617 ' CG2' ' HB2' ' A' ' 26' ' ' ASN 0.251 1.7 mm -85.76 -47.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.749 0.785 . . . . 10.0 109.552 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 21' ' ' ILE . 57.1 m -48.26 -38.34 18.4 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.887 -1.125 . . . . 10.0 108.115 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.692 ' CZ ' ' HG ' ' A' ' 165' ' ' LEU . 20.2 m-85 -68.06 -31.0 70.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.58 ' N ' ' O ' ' A' ' 21' ' ' ILE . 95.9 m -76.83 -51.87 10.52 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.847 -0.533 . . . . 10.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.509 ' HB ' ' O ' ' A' ' 24' ' ' THR . 2.9 t -178.99 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 115.875 1.805 . . . . 10.0 115.875 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.617 ' HB2' ' CG2' ' A' ' 21' ' ' ILE . 15.4 m120 -67.47 -8.32 32.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.088 -1.632 . . . . 10.0 113.085 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' HG3' ' HD3' ' A' ' 29' ' ' PRO . 26.4 pttt 33.59 -131.6 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 121.195 -0.941 . . . . 10.0 111.262 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 2.7 p90 -145.33 50.65 1.14 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 120.5 -1.375 . . . . 10.0 112.815 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.633 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 46.4 Cg_endo -103.53 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.775 1.65 . . . . 10.0 110.396 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.2 p -166.98 36.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 10.0 110.149 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' CD ' ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -78.61 -169.65 1.8 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.571 1.176 . . . . 10.0 111.853 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 5.8 t80 -109.33 120.07 41.38 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.825 -1.079 . . . . 10.0 109.006 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.691 ' CG2' ' HD2' ' A' ' 34' ' ' PRO 0.286 2.4 p -145.42 161.59 40.68 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.191 -0.943 . . . . 10.0 109.688 -177.926 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.691 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 33.5 Cg_endo -55.65 168.76 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 122.935 0.966 . . . . 10.0 110.63 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' B' ' 19' ' ' HIS . 0.3 OUTLIER -92.96 165.23 12.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 123.266 1.507 . . . . 10.0 114.945 -176.373 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.655 ' CG2' ' HA3' ' B' ' 21' ' ' GLY 0.279 2.5 t -45.99 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 116.226 1.936 . . . . 10.0 116.226 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.613 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 4.6 t80 -32.29 154.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.944 0.878 . . . . 10.0 111.603 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.528 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -168.03 83.0 0.18 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.423 ' HB2' ' CZ ' ' A' ' 37' ' ' PHE . 50.8 t30 -113.66 109.11 18.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.159 -0.963 . . . . 10.0 110.017 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.677 ' CD2' ' HA ' ' B' ' 16' ' ' HIS . 3.6 t80 -128.43 128.35 44.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.694 -0.629 . . . . 10.0 110.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.58 94.68 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.626 ' HB ' ' CE1' ' A' ' 40' ' ' TYR 0.296 51.6 t -163.94 178.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.394 0.616 . . . . 10.0 110.227 -176.845 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.566 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 18.9 m -125.24 126.47 45.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.522 -0.736 . . . . 10.0 109.502 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.512 HG13 ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -73.76 165.71 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 10.0 110.024 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.539 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 51.5 mtt -137.69 104.79 5.41 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.199 -1.0 . . . . 10.0 109.531 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.563 ' CG2' ' HB2' ' B' ' 7' ' ' GLU . 38.7 mt -123.75 128.79 74.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.751 -0.593 . . . . 10.0 109.734 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 52.18 21.39 8.13 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 8.61 67.87 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.155 -1.203 . . . . 10.0 110.302 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.47 112.56 65.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.836 -1.39 . . . . 10.0 110.976 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.473 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 44.1 Cg_endo -74.4 139.35 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.951 1.501 . . . . 10.0 110.251 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.566 ' O ' ' HA ' ' A' ' 43' ' ' THR . 3.6 t80 -117.49 121.37 40.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -0.95 . . . . 10.0 109.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.596 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 1.1 m -74.82 119.82 19.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.625 -1.297 . . . . 10.0 110.151 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.48 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 13.3 mt -123.11 149.31 44.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.915 . . . . 10.0 110.592 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' O ' ' HA ' ' A' ' 5' ' ' LYS . . . -170.89 110.47 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.752 -1.213 . . . . 10.0 110.332 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -150.41 168.43 24.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -1.211 . . . . 10.0 110.076 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.528 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 32.9 p90 -166.36 140.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.882 -1.136 . . . . 10.0 111.218 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.41 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 3.8 t70 -119.72 159.99 23.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.394 -0.816 . . . . 10.0 110.444 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.524 ' HA ' ' CB ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -56.31 -168.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.841 0.829 . . . . 10.0 112.131 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.539 ' CB ' HG11 ' A' ' 36' ' ' VAL . . . 53.5 70.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.637 -0.664 . . . . 10.0 110.865 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.469 ' HA3' ' HB2' ' A' ' 66' ' ' ARG . . . -75.33 -9.04 84.3 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.326 -1.91 . . . . 10.0 108.326 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.602 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.8 tt0 -156.45 24.51 0.35 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.422 -1.046 . . . . 10.0 110.22 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 4.4 tt0 79.3 -7.63 1.71 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.494 -0.754 . . . . 10.0 109.963 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.492 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 1.1 m-20 -94.28 -11.47 30.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 10.0 108.759 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.492 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 46.7 m-85 62.65 26.67 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.142 -1.059 . . . . 10.0 108.142 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.405 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 30.5 t0 -114.88 -36.49 4.45 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.111 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.469 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 6.3 mmt85 -56.4 -26.18 52.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.905 -1.122 . . . . 10.0 108.934 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.535 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -103.81 10.88 36.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.827 -0.546 . . . . 10.0 109.751 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.666 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -82.79 -20.37 0.28 Allowed Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 113.356 0.873 . . . . 10.0 113.356 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 45.9 Cg_endo -75.33 2.07 7.2 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 N-CA-C 110.37 -0.665 . . . . 10.0 110.37 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.585 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER -52.78 -64.47 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.199 -0.938 . . . . 10.0 112.184 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.522 ' HA ' ' N ' ' B' ' 40' ' ' LEU . 24.8 t 41.98 27.08 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.367 -1.458 . . . . 10.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.455 ' HB2' ' O ' ' A' ' 71' ' ' SER . 2.1 t80 -179.84 120.6 0.22 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 10.0 110.744 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.28 118.33 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.838 1.441 . . . . 10.0 110.225 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.71 66.74 1.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.964 -1.085 . . . . 10.0 110.584 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.572 HG22 ' CG2' ' A' ' 7' ' ' VAL . 0.0 OUTLIER -145.33 99.99 3.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.16 -0.963 . . . . 10.0 109.703 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.55 ' CA ' HG23 ' A' ' 108' ' ' THR . 21.6 m-20 -24.63 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.953 0.724 . . . . 10.0 112.953 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.509 ' O ' ' CG2' ' A' ' 77' ' ' VAL . 1.0 OUTLIER -94.03 118.0 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.964 -1.085 . . . . 10.0 110.781 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.491 ' CB ' HG21 ' A' ' 9' ' ' VAL . 97.3 m-85 -111.33 127.6 55.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 10.0 111.203 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.546 HD21 ' CD2' ' A' ' 111' ' ' LEU . 1.9 mm? -95.44 97.69 9.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 10.0 108.342 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.518 ' O ' HG21 ' A' ' 113' ' ' VAL . 1.6 m -106.41 148.18 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.397 -0.814 . . . . 10.0 109.822 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 7.2 t -138.17 122.37 18.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.855 -1.153 . . . . 10.0 110.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.536 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 43.0 p90 -124.46 172.95 8.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.239 -0.913 . . . . 10.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.467 ' OG ' ' CG2' ' A' ' 85' ' ' VAL . 47.3 t -105.24 148.81 26.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.7 -1.25 . . . . 10.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.481 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 19.4 m -86.79 19.02 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.478 -0.764 . . . . 10.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.562 ' CA ' HD11 ' A' ' 129' ' ' LEU . 35.3 m -128.0 48.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.39 -0.819 . . . . 10.0 110.513 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.51 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 49.6 m -123.2 166.18 19.27 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.287 -0.883 . . . . 10.0 110.358 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.527 ' CB ' ' ND2' ' A' ' 132' ' ' ASN . 48.2 Cg_endo -72.44 105.9 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.965 1.508 . . . . 10.0 111.056 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 39.46 42.9 0.93 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.304 -0.873 . . . . 10.0 110.836 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.515 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 65.6 m -79.15 -49.51 12.47 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.022 . . . . 10.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.617 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 34.9 t80 -57.53 -30.38 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.336 -0.853 . . . . 10.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.413 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 57.4 mm-40 -70.47 -15.09 62.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.051 -1.031 . . . . 10.0 110.504 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -84.63 -21.46 30.28 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.18 -1.008 . . . . 10.0 111.38 -178.796 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.628 ' CG2' ' HD3' ' A' ' 94' ' ' LYS . 4.2 m -87.68 -16.38 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 117.765 -1.574 . . . . 10.0 108.544 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.628 ' HD3' ' CG2' ' A' ' 93' ' ' VAL . 1.2 mmtp -68.68 -37.45 79.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.427 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 4.4 pt-20 -95.51 8.29 43.73 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.306 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.562 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -111.18 -52.09 2.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.58 -1.248 . . . . 10.0 112.595 -178.951 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.562 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 19.7 m95 -95.59 -18.79 20.29 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.502 -0.749 . . . . 10.0 111.527 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.614 ' CG1' ' HB2' ' A' ' 149' ' ' LEU . 2.1 t -85.45 -46.85 0.61 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 120.97 -1.081 . . . . 10.0 111.5 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.536 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 51.4 Cg_endo -74.85 -24.15 13.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 108.759 -1.285 . . . . 10.0 108.759 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.52 ' C ' HG12 ' A' ' 101' ' ' ILE . 8.6 tt0 -87.59 -22.53 24.72 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.52 HG12 ' C ' ' A' ' 100' ' ' GLU . 4.2 mm 60.55 125.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.524 HG23 ' HB ' ' A' ' 108' ' ' THR . 1.2 m -40.84 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.04 -1.037 . . . . 10.0 109.761 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.565 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 0.1 OUTLIER -108.32 10.74 27.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.222 -0.924 . . . . 10.0 109.778 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.565 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 17.5 m80 82.52 14.08 0.47 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.902 0.382 . . . . 10.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.551 ' HB3' ' CD ' ' A' ' 106' ' ' PRO . 1.6 t -170.65 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 118.814 -1.154 . . . . 10.0 112.029 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.551 ' CD ' ' HB3' ' A' ' 105' ' ' CYS . 37.7 Cg_endo -63.77 -21.74 69.51 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.338 1.178 . . . . 10.0 111.532 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 106' ' ' PRO . 2.0 mttt 47.49 51.13 14.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.733 -1.229 . . . . 10.0 108.843 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.591 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 1.4 m -45.65 150.48 0.93 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.591 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 39.6 Cg_endo -63.66 149.92 89.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.746 1.393 . . . . 10.0 112.748 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.586 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -131.73 109.5 10.21 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.546 ' CD2' HD21 ' A' ' 79' ' ' LEU . 1.9 mm? -77.2 95.4 4.29 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.028 -1.069 . . . . 10.0 109.388 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.464 ' O ' HG22 ' A' ' 155' ' ' VAL . 19.1 mt -75.62 142.02 42.73 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.154 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 155' ' ' VAL . 2.0 t -148.32 -177.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.596 -1.315 . . . . 10.0 112.332 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.536 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -125.4 120.61 3.95 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.752 -1.739 . . . . 10.0 108.752 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 23.4 p -78.32 139.2 38.85 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.829 -1.395 . . . . 10.0 110.952 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 115' ' ' THR . 56.7 mt-30 34.41 57.38 0.67 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.204 0.526 . . . . 10.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.706 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -79.75 -27.72 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 10.0 110.592 -178.822 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.563 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 25.1 t0 -51.88 61.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.835 0.826 . . . . 10.0 111.966 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.706 ' N ' ' O ' ' A' ' 117' ' ' ILE . 20.1 tp 152.79 -39.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.628 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 1.2 mpt_? -46.04 -25.66 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.855 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 4.1 p30 -84.69 -0.13 52.4 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.306 -0.872 . . . . 10.0 111.145 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.466 ' O ' HD13 ' A' ' 126' ' ' ILE . 5.8 p-10 -83.32 160.14 60.35 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.88 -1.138 . . . . 10.0 109.944 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.83 22.73 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.55 1.289 . . . . 10.0 111.769 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.464 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 4.2 m -109.68 -47.6 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.976 -1.078 . . . . 10.0 109.79 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.459 HG23 ' OD1' ' A' ' 122' ' ' ASP . 6.6 t -78.44 -27.14 46.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.828 -1.915 . . . . 10.0 105.828 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.555 ' CD1' ' O ' ' A' ' 120' ' ' ARG 0.283 1.0 OUTLIER -53.19 -28.82 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.391 -1.337 . . . . 10.0 107.391 177.02 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -52.99 -40.41 63.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.578 0.704 . . . . 10.0 111.308 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -60.4 -34.13 73.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.472 -0.767 . . . . 10.0 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.586 HD12 ' N ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -61.89 -39.16 90.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.831 -1.168 . . . . 10.0 109.659 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -52.83 -44.56 66.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.568 -0.708 . . . . 10.0 111.232 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -54.66 -18.12 4.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.149 -0.97 . . . . 10.0 110.376 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.527 ' ND2' ' CB ' ' A' ' 87' ' ' PRO . 8.1 t30 -126.9 -53.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.735 -1.228 . . . . 10.0 110.279 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -137.03 116.01 12.36 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.596 -0.69 . . . . 10.0 110.518 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.577 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -74.97 -3.02 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.697 -0.627 . . . . 10.0 110.5 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 93.97 6.55 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.579 -0.701 . . . . 10.0 109.277 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 49.3 Cg_endo -73.75 161.71 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.898 1.473 . . . . 10.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.525 HG12 ' CG ' ' A' ' 90' ' ' PHE . 1.5 tp -100.83 134.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.266 -0.896 . . . . 10.0 109.505 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.48 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 20.1 p -120.04 165.56 17.59 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.352 -0.843 . . . . 10.0 109.807 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.48 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.71 -35.13 29.41 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.829 1.436 . . . . 10.0 111.063 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.09 -15.81 63.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.113 -0.992 . . . . 10.0 110.999 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.3 m -98.36 -36.54 9.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -64.57 -29.12 70.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.802 . . . . 10.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.81 -41.47 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.019 -1.05 . . . . 10.0 109.314 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -56.16 -36.96 68.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 10.0 109.465 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.544 HD23 ' CZ ' ' A' ' 90' ' ' PHE . 4.2 tp -62.06 -49.55 75.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.116 -0.99 . . . . 10.0 108.902 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.514 ' HA ' ' HB2' ' A' ' 151' ' ' ALA . . . -60.11 -44.44 94.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.036 . . . . 10.0 109.406 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -78.04 -7.96 57.58 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.525 -0.734 . . . . 10.0 110.297 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.9 t70 -98.6 -37.88 9.36 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.388 1.09 . . . . 10.0 109.235 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.617 ' CD2' ' O ' ' A' ' 149' ' ' LEU 0.26 0.0 OUTLIER -103.07 -1.15 29.64 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.513 -178.658 . . . . . . . . 4 4 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.558 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 24.4 mttm 67.78 54.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 10.0 111.359 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.514 ' HB2' ' HA ' ' A' ' 146' ' ' ALA . . . -86.24 -150.36 0.15 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.586 HG12 ' O ' ' A' ' 110' ' ' PHE . 9.9 p -116.54 -51.56 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.567 -1.333 . . . . 10.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.51 ' CD ' HG11 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -172.42 142.31 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.603 -1.31 . . . . 10.0 111.238 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 142' ' ' ALA . 46.6 t80 -94.26 110.15 21.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 10.0 109.069 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.538 HG22 HG22 ' A' ' 113' ' ' VAL . 0.8 OUTLIER -116.19 -168.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.973 -1.08 . . . . 10.0 112.087 -178.595 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.435 ' HA ' HG11 ' A' ' 113' ' ' VAL . 19.1 mt-10 -153.27 147.04 25.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 10.0 110.781 -179.719 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.564 ' CB ' ' CB ' ' A' ' 165' ' ' LEU . 25.6 p -148.07 152.51 37.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 10.0 111.275 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.537 ' HB3' ' OG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -135.14 86.23 2.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.192 -1.41 . . . . 10.0 107.192 178.66 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.571 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . . . -24.37 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.505 ' O ' ' HG3' ' A' ' 162' ' ' GLN . 1.7 tp -94.12 -55.05 3.34 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.403 -1.436 . . . . 10.0 112.196 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.537 ' OG1' ' HB3' ' A' ' 158' ' ' SER . 24.5 p -64.68 -26.68 68.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.96 -1.087 . . . . 10.0 111.008 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.536 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.8 mt-30 79.26 77.05 0.05 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.528 -0.732 . . . . 10.0 112.024 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.471 ' HG3' HG13 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -78.35 47.99 0.73 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 10.0 110.006 178.319 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 163' ' ' LYS . . . 43.49 41.68 5.46 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.706 -1.358 . . . . 10.0 109.706 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.692 ' HG ' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.11 2.51 3.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 10.0 112.704 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.593 ' N ' HD12 ' A' ' 165' ' ' LEU . 26.9 tttp -58.47 -23.64 58.28 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.782 -1.199 . . . . 10.0 108.694 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -76.86 -17.61 58.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.692 -0.63 . . . . 10.0 111.038 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.478 HG22 ' HB ' ' A' ' 155' ' ' VAL . 42.8 t -67.9 -41.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.822 -1.174 . . . . 10.0 108.775 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -86.55 -47.57 9.12 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.599 0.714 . . . . 10.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -51.88 -35.14 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.336 -0.852 . . . . 10.0 111.789 -179.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.543 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.3 mm-40 -90.02 -11.28 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.058 . . . . 10.0 110.771 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.541 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -91.74 -15.27 28.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.038 -1.097 . . . . 10.0 108.038 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.567 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 53.9 mt -73.63 -49.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.097 -0.641 . . . . 10.0 109.322 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.543 ' CD2' ' HA ' ' A' ' 171' ' ' GLU . 2.1 pt? -76.35 -19.12 58.5 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 118.813 -1.155 . . . . 10.0 111.113 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.41 -14.78 34.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 10.0 110.085 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.495 ' CB ' HG13 ' A' ' 77' ' ' VAL . . . -70.25 -44.87 67.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 10.0 109.653 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.582 HD22 ' HA ' ' A' ' 2' ' ' GLN . 0.7 OUTLIER -74.64 -29.09 61.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.744 0.783 . . . . 10.0 109.055 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -129.81 151.77 50.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 10.0 110.601 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.44 92.49 4.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 10.0 110.065 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.02 165.94 12.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.499 -0.75 . . . . 10.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.65 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.62 -149.76 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.65 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -73.23 96.18 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 N-CA-C 109.772 -0.896 . . . . 10.0 109.772 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.563 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 19.6 mm-40 -49.56 -169.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.605 0.717 . . . . 10.0 110.249 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.647 HG12 ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -77.64 -42.47 29.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.756 -1.215 . . . . 10.0 111.949 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.647 ' N ' HG12 ' B' ' 8' ' ' ILE . 20.7 t -134.78 172.67 12.65 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.06 -1.025 . . . . 10.0 111.348 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.577 ' CG ' ' O ' ' B' ' 10' ' ' LEU . 1.5 pp -167.25 98.02 0.64 Allowed Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.293 -0.963 . . . . 10.0 111.805 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.539 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 38.4 Cg_endo -69.19 134.69 29.85 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 N-CA-C 108.001 -1.577 . . . . 10.0 108.001 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' B' ' 11' ' ' PRO . 0.9 OUTLIER -53.13 -169.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.689 -1.257 . . . . 10.0 111.388 -178.465 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.502 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 6.0 p30 -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.992 0.901 . . . . 10.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.593 ' HB2' ' CG1' ' A' ' 42' ' ' VAL . 49.9 m-85 -54.92 -165.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.8 0.81 . . . . 10.0 111.547 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.495 ' O ' ' O ' ' B' ' 14' ' ' PHE . 1.5 tt0 -43.59 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.677 ' HA ' ' CD2' ' A' ' 40' ' ' TYR . 14.2 p80 -146.58 -169.41 3.27 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.569 0.699 . . . . 10.0 111.871 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.563 HG23 ' CE1' ' B' ' 19' ' ' HIS . 1.0 OUTLIER -79.85 163.17 24.59 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.972 0.891 . . . . 10.0 112.423 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.581 ' O ' ' O ' ' A' ' 37' ' ' PHE . 3.3 mp -126.19 175.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.798 -0.816 . . . . 10.0 108.798 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.563 ' CE1' HG23 ' B' ' 17' ' ' THR . 79.3 m-70 -141.59 115.55 9.24 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.491 -1.38 . . . . 10.0 112.094 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.545 ' C ' ' HB ' ' A' ' 36' ' ' VAL . 18.4 t -144.96 103.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 114.055 1.132 . . . . 10.0 114.055 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.655 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . -150.69 -72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.614 -0.995 . . . . 10.0 110.614 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.556 ' O ' ' CG2' ' B' ' 25' ' ' VAL . 69.1 t80 175.86 134.02 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.66 -1.607 . . . . 10.0 106.66 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.443 ' C ' ' O ' ' B' ' 22' ' ' PHE . 89.0 m-20 -39.0 131.37 1.41 Allowed 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 122.043 0.925 . . . . 10.0 111.252 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.505 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 69.47 46.41 0.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.865 -0.522 . . . . 10.0 111.383 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.586 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 25.4 t -111.0 -57.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.919 -1.113 . . . . 10.0 109.181 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.572 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 38.6 m -51.85 -24.84 6.72 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.176 0.988 . . . . 10.0 109.228 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.61 ' HA3' ' HB2' ' A' ' 26' ' ' ASN . . . -115.63 46.25 1.19 Allowed Glycine 0 N--CA 1.482 1.757 0 N-CA-C 107.727 -2.149 . . . . 10.0 107.727 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.586 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 2.2 mt-10 -162.58 123.54 2.51 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.643 0.735 . . . . 10.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.557 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 1.0 OUTLIER -122.24 129.26 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 178.643 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' GLY . 16.6 p -143.85 174.16 11.07 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.587 -0.696 . . . . 10.0 111.032 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' THR . . . 35.78 -152.65 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.448 -1.061 . . . . 10.0 110.448 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.405 ' O ' HG22 ' B' ' 32' ' ' ILE . 0.5 OUTLIER -150.81 70.45 8.69 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.99 . . . . 10.0 109.473 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.512 ' HB2' ' CH2' ' B' ' 36' ' ' TRP . 51.0 Cg_endo -73.61 177.85 7.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.573 1.828 . . . . 10.0 111.92 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.452 ' HB3' ' CZ3' ' B' ' 36' ' ' TRP . 24.3 tt0 -57.83 159.45 5.4 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 10.0 111.006 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.597 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 21.2 pt20 -83.51 11.82 6.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.719 -0.613 . . . . 10.0 111.376 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.597 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 0.8 OUTLIER 70.18 36.53 1.85 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.768 0.794 . . . . 10.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.484 ' HA ' HD13 ' A' ' 70' ' ' LEU . . . -168.57 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.66 -0.65 . . . . 10.0 110.904 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CG ' ' OE1' ' B' ' 35' ' ' GLN . 2.2 mmt180 -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.676 -1.265 . . . . 10.0 110.131 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.54 ' CD2' HD21 ' A' ' 70' ' ' LEU . 2.5 mp -50.3 -13.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -0.994 . . . . 10.0 111.696 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.522 ' N ' ' HA ' ' A' ' 71' ' ' SER . 0.9 OUTLIER -65.58 -8.76 21.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.648 -1.283 . . . . 10.0 110.771 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.68 47.53 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.598 0.713 . . . . 10.0 109.495 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 3.7 t -104.91 -168.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.618 -0.676 . . . . 10.0 110.177 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.7 m -85.49 54.37 3.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 10.0 110.099 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -62.02 174.04 0.96 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 10.0 110.291 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' B' ' 46' ' ' THR . 48.1 mt -88.26 -65.92 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.412 -0.805 . . . . 10.0 110.904 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.448 ' O ' ' O ' ' B' ' 45' ' ' ILE . 50.1 m . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 118.016 -0.992 . . . . 10.0 110.126 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.552 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.066 0.46 . . . . 10.0 110.122 . . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.566 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 1.8 mt-30 -95.75 -17.94 20.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.559 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.8 m -43.2 99.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.631 -0.668 . . . . 10.0 110.54 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.61 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -116.45 121.03 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 10.0 110.595 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.555 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -93.47 131.27 38.84 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.016 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.554 ' CB ' ' HB2' ' A' ' 55' ' ' LEU . 94.4 m -110.36 103.79 12.48 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.743 -1.223 . . . . 10.0 110.39 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.455 ' HB ' ' OG1' ' A' ' 75' ' ' THR . 46.1 t -142.82 162.8 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.229 -0.988 . . . . 10.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.553 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -80.46 152.14 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.157 -1.017 . . . . 10.0 109.432 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.606 ' CG2' ' N ' ' A' ' 79' ' ' LEU . 3.3 t -83.13 -170.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.255 -0.903 . . . . 10.0 110.193 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.489 ' CA ' ' HG2' ' B' ' 35' ' ' GLN . . . -95.58 42.16 2.36 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.776 -1.202 . . . . 10.0 111.218 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' OD2' HG23 ' A' ' 80' ' ' VAL . 2.5 t0 -82.16 -31.35 30.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.707 -1.467 . . . . 10.0 109.006 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.529 ' HA2' ' C ' ' B' ' 34' ' ' GLU . . . 61.48 51.53 57.18 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.236 -1.546 . . . . 10.0 109.236 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.515 ' O ' ' HG2' ' B' ' 33' ' ' PRO . . . -160.32 -77.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 10.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.529 ' HB ' ' CB ' ' A' ' 81' ' ' CYS . 89.5 t -112.17 117.94 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 10.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CZ2' ' B' ' 36' ' ' TRP . . . -98.95 143.79 16.82 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.784 -1.326 . . . . 10.0 109.784 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -65.4 -21.42 66.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 10.0 112.283 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -99.52 -36.14 9.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.389 -1.444 . . . . 10.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.565 ' HB2' ' O ' ' B' ' 28' ' ' GLU . 26.2 p -73.71 -29.91 62.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.024 -1.047 . . . . 10.0 109.798 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.59 HD11 ' HB2' ' B' ' 29' ' ' PHE . 3.7 mm? -86.78 -18.02 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.868 -1.145 . . . . 10.0 110.49 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.52 -41.4 76.69 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.038 0.923 . . . . 10.0 108.878 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.563 ' HB ' ' HB3' ' B' ' 28' ' ' GLU . 7.3 mm -69.04 -39.78 80.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.71 0.767 . . . . 10.0 110.205 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -47.16 -45.93 23.15 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.585 -0.846 . . . . 10.0 109.814 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.674 ' CD1' HD13 ' A' ' 165' ' ' LEU . 4.9 m-85 -93.58 3.76 55.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.651 -1.281 . . . . 10.0 110.184 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 24' ' ' THR . 2.9 m -110.94 -21.25 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.816 -1.177 . . . . 10.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.513 HG21 ' CG2' ' A' ' 33' ' ' VAL . 0.6 OUTLIER -88.07 -76.25 0.39 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.456 -1.403 . . . . 10.0 108.647 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.555 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 19.1 m120 -156.17 -33.66 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.563 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.562 ' HD3' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER 175.03 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.188 0.518 . . . . 10.0 109.95 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -139.68 -62.63 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.183 -0.948 . . . . 10.0 112.26 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.518 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -74.58 0.4 8.72 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.101 1.053 . . . . 10.0 113.02 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.562 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 25.4 m -161.17 51.41 0.25 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.321 -1.487 . . . . 10.0 111.507 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -115.45 103.51 10.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.072 -1.018 . . . . 10.0 110.84 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.569 ' HA ' ' CB ' ' B' ' 24' ' ' ALA . 2.1 t80 -63.59 59.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.718 . . . . 10.0 110.322 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.579 ' N ' ' O ' ' A' ' 31' ' ' GLU . 3.7 m -127.23 167.43 17.89 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.375 -0.828 . . . . 10.0 109.912 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.459 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 40.9 Cg_endo -70.16 146.1 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.709 1.373 . . . . 10.0 109.57 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 5.8 t -118.81 156.26 29.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.841 -1.162 . . . . 10.0 110.865 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.533 HG13 ' CG ' ' A' ' 62' ' ' GLU . 65.3 t 61.57 5.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.747 -0.595 . . . . 10.0 111.101 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' O ' ' O ' ' A' ' 38' ' ' ASP . 1.7 t80 -42.29 100.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.476 -0.765 . . . . 10.0 109.829 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.7 ' HB2' ' N ' ' B' ' 19' ' ' HIS . 0.5 OUTLIER -47.19 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.884 0.85 . . . . 10.0 111.648 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.599 ' CB ' ' CD1' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -156.55 -167.61 2.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.932 -1.73 . . . . 10.0 111.417 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.62 ' CE1' HD13 ' B' ' 18' ' ' ILE . 7.8 m-30 -112.96 153.48 27.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.411 -0.805 . . . . 10.0 112.852 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.576 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . . . -135.64 119.69 17.57 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.594 ' CG2' ' N ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -171.81 176.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.368 -1.458 . . . . 10.0 111.709 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.594 ' N ' ' CG2' ' A' ' 42' ' ' VAL . 66.1 m -129.49 130.92 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.773 -0.58 . . . . 10.0 110.21 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.602 ' HA ' ' O ' ' B' ' 12' ' ' SER . 13.2 t -105.17 150.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 10.0 109.42 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.699 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 94.7 mtp -117.65 95.62 5.02 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.798 -1.556 . . . . 10.0 106.798 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.659 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 3.2 mp -102.8 130.46 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.136 0.493 . . . . 10.0 111.513 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.601 ' CA ' ' CG2' ' B' ' 8' ' ' ILE . . . 40.1 27.69 0.14 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.837 -1.173 . . . . 10.0 110.745 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.76 18.18 45.41 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.011 -1.288 . . . . 10.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.0 mm-40 -114.87 98.98 51.35 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.294 . . . . 10.0 109.87 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -77.89 118.34 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.972 1.511 . . . . 10.0 110.94 -179.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.526 ' O ' ' CG2' ' A' ' 43' ' ' THR . 2.7 m-85 -89.05 117.6 28.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.992 -1.068 . . . . 10.0 109.385 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.559 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 3.1 m -100.56 104.19 15.53 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.065 -1.022 . . . . 10.0 111.029 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.525 ' HA ' ' O ' ' A' ' 4' ' ' ILE . 3.0 pp -158.08 178.44 10.2 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.444 -1.302 . . . . 10.0 111.381 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.576 ' HA2' ' HA ' ' A' ' 41' ' ' ALA . . . -170.32 111.46 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.965 -1.654 . . . . 10.0 108.965 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.599 ' CD1' ' CB ' ' A' ' 39' ' ' ASN . 1.8 tm? -130.47 132.8 45.85 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.846 -1.385 . . . . 10.0 110.781 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.515 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 p90 -152.57 155.31 37.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 10.0 109.789 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.547 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 15.8 t0 -99.15 179.8 4.49 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.631 -1.293 . . . . 10.0 110.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.7 m -104.81 117.3 33.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 10.0 111.137 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.569 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . . . -65.7 91.2 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 10.0 110.256 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.519 ' O ' ' CB ' ' A' ' 61' ' ' GLN . . . -68.92 63.07 0.5 Allowed Glycine 0 N--CA 1.485 1.908 0 N-CA-C 107.816 -2.114 . . . . 10.0 107.816 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ALA . 22.0 tt0 75.03 21.03 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.985 -0.715 . . . . 10.0 110.569 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.569 ' HG2' ' HA ' ' A' ' 59' ' ' ALA . 9.0 mm-40 -50.07 -46.08 53.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.338 -1.345 . . . . 10.0 109.68 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER 162.37 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.163 -0.961 . . . . 10.0 110.923 178.839 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -178.06 44.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.916 -1.115 . . . . 10.0 109.3 -179.351 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 13.9 p-10 -81.4 38.5 0.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.306 -0.871 . . . . 10.0 110.169 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -49.91 -28.06 6.13 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.272 -0.892 . . . . 10.0 109.111 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.523 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 3.1 mp -81.67 11.12 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 10.0 109.361 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.635 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 4.5 ptt85 -60.19 -24.76 1.63 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.852 . . . . 10.0 112.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 47.9 Cg_endo -89.92 86.57 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 109.523 -0.991 . . . . 10.0 109.523 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.49 ' O ' ' HB2' ' A' ' 71' ' ' SER . 0.1 OUTLIER -117.64 -78.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.965 . . . . 10.0 111.831 -178.617 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.49 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.5 m 62.03 39.62 13.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 10.0 109.365 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 76.79 41.94 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 10.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.43 113.44 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.135 1.598 . . . . 10.0 110.385 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -163.62 89.59 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 10.0 110.184 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.577 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 23.0 m -145.89 98.64 3.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.104 -0.997 . . . . 10.0 109.173 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 19.9 t70 -25.77 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.046 0.45 . . . . 10.0 112.15 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.555 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -107.68 126.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.947 -1.096 . . . . 10.0 109.897 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.577 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 1.4 m-85 -130.33 139.41 50.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 10.0 110.921 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.606 ' N ' ' CG2' ' A' ' 9' ' ' VAL . 1.9 mm? -113.6 98.54 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.496 HG12 ' O ' ' A' ' 80' ' ' VAL . 9.3 p -97.37 137.47 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 10.0 110.846 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.539 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 65.3 m -121.47 112.15 18.16 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.263 -0.898 . . . . 10.0 110.609 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.433 ' CZ ' ' HD1' ' A' ' 90' ' ' PHE . 35.1 p90 -129.24 160.37 33.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.214 -0.928 . . . . 10.0 110.538 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.407 ' OG ' ' HB2' ' A' ' 116' ' ' GLN . 51.0 m -79.16 162.54 25.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.34 -0.85 . . . . 10.0 111.277 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.7 m -102.15 23.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.672 -0.643 . . . . 10.0 110.349 -179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.558 ' O ' ' HB3' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -142.02 28.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.201 -0.937 . . . . 10.0 109.875 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.566 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -85.93 -173.84 0.46 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.03 . . . . 10.0 110.294 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.566 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 50.4 Cg_endo -75.2 72.09 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.889 1.468 . . . . 10.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 m 46.87 40.64 9.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.351 -0.843 . . . . 10.0 110.189 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.534 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 11.8 p -76.46 -25.68 54.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 10.0 110.689 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 74.1 t80 -75.1 -18.7 60.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.475 -0.765 . . . . 10.0 112.617 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.79 -17.34 36.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.458 -1.401 . . . . 10.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.534 ' OD1' ' HA ' ' A' ' 89' ' ' SER . 0.6 OUTLIER -88.84 -14.9 35.85 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.051 -1.03 . . . . 10.0 109.673 179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.569 ' CG2' ' HD3' ' A' ' 94' ' ' LYS . 12.8 m -84.76 -20.8 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 118.863 -1.135 . . . . 10.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' CE ' ' CZ ' ' A' ' 90' ' ' PHE . 20.8 mmtt -80.08 -30.54 39.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.919 0.866 . . . . 10.0 109.544 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.476 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -96.88 9.44 41.87 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.65 -0.82 . . . . 10.0 109.415 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.8 -51.43 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.094 -1.042 . . . . 10.0 111.044 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 35.5 m95 -90.53 -40.52 11.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.187 -0.946 . . . . 10.0 112.376 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.556 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 92.0 t -53.0 -47.75 94.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.581 -1.324 . . . . 10.0 111.135 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.556 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.3 Cg_endo -75.14 -17.26 19.39 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.215 1.113 . . . . 10.0 110.644 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -69.52 -23.95 63.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.097 -1.002 . . . . 10.0 111.551 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.526 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 18.0 mt 54.75 99.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.564 -1.335 . . . . 10.0 109.776 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.578 ' CG2' ' CG ' ' A' ' 106' ' ' PRO . 21.0 m -46.89 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 10.0 109.6 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 37.6 t60 -110.46 -6.73 14.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.269 -0.894 . . . . 10.0 108.752 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 154.79 -49.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.547 ' H ' ' HD3' ' A' ' 106' ' ' PRO . 0.6 OUTLIER -176.14 46.19 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.716 -0.675 . . . . 10.0 110.746 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.578 ' CG ' ' CG2' ' A' ' 102' ' ' THR . 57.0 Cg_endo -78.94 -29.47 3.33 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.288 1.152 . . . . 10.0 109.539 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.571 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 71.1 57.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.53 0.681 . . . . 10.0 110.511 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.568 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 2.9 m -46.55 149.6 1.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 10.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.568 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 38.4 Cg_endo -63.56 114.22 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.683 1.359 . . . . 10.0 110.762 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.487 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 2.2 t80 -115.11 107.6 15.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.458 -0.776 . . . . 10.0 109.173 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.599 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.0 mm? -96.32 103.69 15.61 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.59 0.71 . . . . 10.0 109.61 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 83.7 mt -85.88 143.29 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.663 -0.648 . . . . 10.0 111.029 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.49 HG23 HG21 ' A' ' 168' ' ' VAL . 2.6 t -141.86 170.53 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.992 -1.068 . . . . 10.0 111.482 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -134.93 98.13 0.3 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 106.934 -2.467 . . . . 10.0 106.934 177.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.539 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 27.1 p -114.55 -171.12 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 10.0 111.501 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.448 ' HB2' ' O ' ' A' ' 115' ' ' THR . 78.3 mt-30 56.55 18.44 3.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.53 -0.731 . . . . 10.0 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.744 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -82.94 -22.01 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.934 -0.706 . . . . 10.0 109.297 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 7.7 p-10 -51.52 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 122.051 0.929 . . . . 10.0 111.057 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.744 ' N ' ' O ' ' A' ' 117' ' ' ILE . 17.3 tp 157.85 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.558 ' HA ' ' CD1' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.03 -43.01 14.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.0 p-10 -50.29 -23.49 2.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.507 0.67 . . . . 10.0 109.682 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.441 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 76.9 m-20 -87.59 138.08 31.87 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.993 -0.683 . . . . 10.0 110.201 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -80.09 23.37 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.174 1.618 . . . . 10.0 110.865 179.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 t -102.52 -50.65 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.882 -1.136 . . . . 10.0 110.285 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.524 ' CB ' HD22 ' A' ' 119' ' ' LEU . 6.1 t -78.57 -26.45 45.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.558 ' CD1' ' HA ' ' A' ' 120' ' ' ARG 0.295 1.1 mp -61.24 -23.22 29.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.555 -1.202 . . . . 10.0 107.801 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -49.09 -41.06 34.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.586 0.708 . . . . 10.0 110.501 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -89.26 -30.59 18.38 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.608 0.718 . . . . 10.0 110.397 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.6 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 4.8 mp -74.73 -49.85 19.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 10.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.498 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -61.74 -42.68 99.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.599 -0.688 . . . . 10.0 110.394 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -53.69 -20.07 4.92 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.007 -1.077 . . . . 10.0 108.997 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.522 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -85.16 -44.09 13.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 10.0 109.648 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 133.95 19.79 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.538 0.685 . . . . 10.0 109.926 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -83.23 -4.16 58.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 10.0 110.269 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.18 103.04 48.02 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 10.0 111.54 -179.139 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.1 Cg_endo -69.92 162.4 42.3 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.033 1.544 . . . . 10.0 109.952 178.88 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.588 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -99.55 138.28 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 10.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.518 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.8 p -126.07 170.21 10.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 10.0 109.737 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.518 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 43.3 Cg_endo -68.63 -15.02 40.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.531 1.279 . . . . 10.0 110.46 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.38 -42.04 54.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 10.0 109.762 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -75.52 -40.95 56.31 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.732 -0.605 . . . . 10.0 110.553 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.89 -44.94 65.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 10.0 111.269 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.8 -43.93 48.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 10.0 109.619 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.461 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 67.4 tttt -66.42 -40.32 89.48 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.508 -0.745 . . . . 10.0 109.294 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.538 HD12 ' HG3' ' A' ' 94' ' ' LYS . 2.1 tt -63.66 -48.26 77.94 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.559 -0.856 . . . . 10.0 109.42 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.541 ' CB ' ' HB2' ' A' ' 151' ' ' ALA . . . -58.42 -42.12 86.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 10.0 108.93 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -80.66 1.86 28.26 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.679 -0.808 . . . . 10.0 108.991 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.559 ' HB3' ' CD1' ' A' ' 149' ' ' LEU . 14.4 t70 -79.21 -31.82 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.48 -0.763 . . . . 10.0 112.214 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.676 ' O ' ' CB ' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -135.65 -8.17 2.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.032 -1.668 . . . . 10.0 113.088 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.676 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 6.2 pttt 125.93 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.899 0.88 . . . . 10.0 111.703 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.541 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -116.83 -177.44 3.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.882 -1.136 . . . . 10.0 109.65 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.598 ' CG1' ' N ' ' A' ' 153' ' ' LYS . 1.1 t -90.16 -78.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.766 -1.208 . . . . 10.0 109.531 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.598 ' N ' ' CG1' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -171.93 164.53 6.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.023 -1.048 . . . . 10.0 111.093 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 57.8 t80 -104.76 101.1 10.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.411 -0.806 . . . . 10.0 109.562 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.488 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 38.2 t -87.76 169.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 10.0 109.137 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.434 ' N ' HG12 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -134.64 121.67 21.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.929 -1.107 . . . . 10.0 109.737 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.529 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.6 p -141.23 169.99 16.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.051 -1.031 . . . . 10.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.562 ' N ' ' HB2' ' A' ' 162' ' ' GLN . 1.1 t -143.76 118.6 9.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.691 -0.631 . . . . 10.0 109.576 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.648 ' O ' ' CZ ' ' A' ' 23' ' ' TYR . . . -12.25 -54.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.569 0.951 . . . . 10.0 113.569 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.532 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.5 pp -131.9 -3.82 3.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.471 -1.393 . . . . 10.0 111.788 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.541 ' HB ' ' HB3' ' A' ' 158' ' ' SER . 59.5 m -98.05 -90.17 0.28 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.664 -1.273 . . . . 10.0 111.995 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.562 ' HB2' ' N ' ' A' ' 158' ' ' SER . 1.7 mm-40 -38.3 -39.44 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.945 . . . . 10.0 111.98 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.634 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 18.4 ttpt 49.5 26.29 1.65 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.056 -1.058 . . . . 10.0 108.938 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -94.62 -8.3 59.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.008 -1.637 . . . . 10.0 109.008 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.81 -9.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.414 -1.051 . . . . 10.0 112.306 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.404 ' N ' ' O ' ' A' ' 164' ' ' GLY . 0.0 OUTLIER -70.17 -46.19 65.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.352 -1.468 . . . . 10.0 111.061 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.405 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 1.4 m-80 -59.39 -27.97 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 10.0 108.298 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.542 HG13 ' CD1' ' A' ' 79' ' ' LEU . 0.5 OUTLIER -51.48 -50.68 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.576 0.703 . . . . 10.0 110.897 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.523 ' N ' ' CG1' ' A' ' 168' ' ' VAL . 18.4 t80 -87.14 -25.74 23.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.499 -0.751 . . . . 10.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.507 ' O ' HD23 ' A' ' 174' ' ' LEU . 21.0 t70 -50.39 -49.55 54.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 10.0 109.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.409 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.0 mp0 -67.12 -45.02 78.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 10.0 110.257 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.491 ' HB1' HD22 ' A' ' 111' ' ' LEU . . . -50.95 -21.21 1.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 10.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.586 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 24.4 mm -70.07 -43.86 78.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 10.0 110.338 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.639 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.42 -23.82 34.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.577 -1.327 . . . . 10.0 111.068 -178.99 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.478 ' HB3' ' HB3' ' A' ' 109' ' ' PRO . . . -87.46 -11.55 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 10.0 111.322 -179.166 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.61 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -80.42 -45.92 16.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.229 . . . . 10.0 109.991 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.586 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 1.1 mp -89.99 -19.62 24.24 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.96 0.886 . . . . 10.0 108.917 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 10.0 110.337 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.433 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.576 -1.41 . . . . 10.0 109.576 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -75.89 145.08 40.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 10.0 109.99 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.48 ' CD ' HD11 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -98.85 93.36 6.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.056 -1.028 . . . . 10.0 110.614 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.422 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 30.2 mm-40 -129.75 159.64 35.88 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.439 0.638 . . . . 10.0 110.49 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.643 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.26 -158.18 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 106.834 -1.543 . . . . 10.0 106.834 177.697 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.643 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -67.41 112.47 2.59 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 N-CA-C 109.236 -1.101 . . . . 10.0 109.236 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.519 ' O ' ' O ' ' B' ' 6' ' ' PRO . 12.1 tp10 -55.29 -128.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.605 0.717 . . . . 10.0 110.717 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.601 ' CG2' ' CA ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -78.97 -101.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.892 -1.13 . . . . 10.0 109.682 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.593 ' N ' HG12 ' B' ' 8' ' ' ILE . 25.3 t -142.91 112.2 6.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.341 -1.475 . . . . 10.0 111.895 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.699 ' HB3' ' O ' ' A' ' 45' ' ' MET . 0.0 OUTLIER -171.04 97.54 0.42 Allowed Pre-proline 0 N--CA 1.489 1.517 0 CA-C-O 121.632 0.73 . . . . 10.0 109.605 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.69 99.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.074 1.849 . . . . 10.0 111.214 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.602 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.4 m -136.62 98.41 3.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.691 -1.255 . . . . 10.0 109.748 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.588 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -167.4 138.79 3.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.63 -1.228 . . . . 10.0 112.364 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.559 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 58.3 m-85 -115.71 107.31 14.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.695 . . . . 10.0 110.305 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.589 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -88.81 174.19 8.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.782 1.277 . . . . 10.0 113.242 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -90.0 -165.75 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.552 -1.204 . . . . 10.0 112.317 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -119.41 146.12 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.669 -0.645 . . . . 10.0 109.816 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.62 HD13 ' CE1' ' A' ' 40' ' ' TYR . 1.3 mp -76.77 173.06 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 10.0 112.463 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.7 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 27.4 m170 -141.95 117.28 10.16 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.436 0.902 . . . . 10.0 113.436 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.495 ' HB ' ' HD1' ' A' ' 37' ' ' PHE . 2.8 p -144.93 143.58 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.237 -0.914 . . . . 10.0 110.562 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 62' ' ' GLU . . . -148.12 30.69 1.33 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.668 -1.253 . . . . 10.0 110.178 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.563 ' O ' ' CG2' ' A' ' 35' ' ' THR . 0.3 OUTLIER -171.69 91.26 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.021 -1.282 . . . . 10.0 110.392 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' B' ' 24' ' ' ALA . 4.1 m-20 -67.39 151.78 46.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.852 -1.155 . . . . 10.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.571 ' HA ' ' O ' ' A' ' 31' ' ' GLU . . . 34.71 54.92 0.69 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.671 -0.643 . . . . 10.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.483 HG12 ' HB ' ' B' ' 26' ' ' THR . 0.9 OUTLIER -113.61 -36.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.239 -0.984 . . . . 10.0 108.687 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.53 HG22 ' N ' ' B' ' 29' ' ' PHE 0.262 0.5 OUTLIER -149.62 11.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.125 -1.03 . . . . 10.0 112.946 -178.148 . . . . . . . . 4 4 . 1 . 002 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.499 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 59.09 30.56 67.17 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.719 -2.952 . . . . 10.0 105.719 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.565 ' O ' ' HB2' ' A' ' 18' ' ' CYS . 1.0 OUTLIER 59.34 16.68 5.23 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.692 0.758 . . . . 10.0 109.328 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.597 ' CE1' ' HB2' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -143.26 147.82 35.41 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.211 0.529 . . . . 10.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.54 ' O ' ' CE1' ' B' ' 29' ' ' PHE . 19.0 p -134.81 -178.55 5.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.163 . . . . 10.0 110.213 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.19 -28.73 9.56 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.013 -1.089 . . . . 10.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.497 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 31.4 mm -132.97 50.76 5.99 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.605 -1.527 . . . . 10.0 111.56 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.515 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 55.8 Cg_endo -75.5 150.58 36.28 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.615 1.324 . . . . 10.0 110.651 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.529 ' C ' ' HA2' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -75.12 -169.75 1.0 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.998 -1.064 . . . . 10.0 109.226 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.555 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 1.2 mp0 -76.43 20.4 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.19 -0.944 . . . . 10.0 110.779 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.555 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 8.5 m-90 65.7 20.71 11.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.802 -1.555 . . . . 10.0 106.802 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.482 ' HB2' HD23 ' B' ' 39' ' ' LEU . . . -155.02 83.06 1.08 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' B' ' 42' ' ' THR . 22.2 tpt180 -70.27 55.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.751 1.262 . . . . 10.0 107.988 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.482 HD23 ' HB2' ' B' ' 37' ' ' ALA . 2.8 pp -91.55 -21.46 20.85 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.553 -1.203 . . . . 10.0 111.219 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.524 HD12 ' HB2' ' B' ' 41' ' ' GLN . 3.8 pp -77.84 5.18 10.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.998 -1.064 . . . . 10.0 111.771 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.524 ' HB2' HD12 ' B' ' 40' ' ' LEU . 0.3 OUTLIER -154.35 -85.79 0.06 Allowed 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.124 -0.985 . . . . 10.0 111.3 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.507 ' O ' ' CG ' ' B' ' 38' ' ' ARG . 72.6 p -129.87 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 10.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.45 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 53.0 m -79.07 7.51 7.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.494 -0.754 . . . . 10.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.444 ' O ' ' ND2' ' B' ' 44' ' ' ASN . 0.9 OUTLIER -117.36 134.44 54.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.01 . . . . 10.0 110.945 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.485 HD11 ' HA2' ' A' ' 60' ' ' GLY . 7.0 mt -97.5 176.28 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.606 -0.684 . . . . 10.0 109.31 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.291 179.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.57 ' CG ' HD23 ' A' ' 177' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.705 0.288 . . . . 10.0 110.41 . . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -179.19 152.78 0.56 Allowed 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.166 -0.959 . . . . 10.0 110.002 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.565 ' HB ' ' O ' ' A' ' 2' ' ' GLN . 85.1 m 61.42 48.43 5.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 113.707 1.003 . . . . 10.0 113.707 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.1 OUTLIER -112.66 128.86 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.159 -1.588 . . . . 10.0 110.942 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.573 ' O ' ' CG2' ' A' ' 75' ' ' THR . 4.1 mmtm -118.11 147.53 43.2 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.3 t -119.26 106.05 11.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.837 -1.165 . . . . 10.0 109.993 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.555 HG13 ' N ' ' A' ' 8' ' ' VAL . 4.0 t -128.41 170.88 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.769 -1.207 . . . . 10.0 110.966 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.563 HG22 ' HG3' ' A' ' 16' ' ' LYS . 8.5 t -85.25 129.92 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.469 -0.769 . . . . 10.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.5 HG12 ' OE1' ' B' ' 35' ' ' GLN . 40.6 t -132.46 176.55 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.972 -1.08 . . . . 10.0 111.567 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.515 ' O ' ' NE2' ' B' ' 35' ' ' GLN . . . 131.95 -173.27 20.7 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.067 -1.613 . . . . 10.0 109.067 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 11' ' ' ASP . 2.3 p30 -84.67 15.43 3.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.432 . . . . 10.0 109.559 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.607 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 89.27 52.8 2.63 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.588 -1.805 . . . . 10.0 108.588 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.495 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -133.13 105.2 6.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.721 -0.87 . . . . 10.0 109.19 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 4.5 t 66.71 119.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -0.806 . . . . 10.0 109.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.498 ' O ' HD21 ' A' ' 19' ' ' LEU . . . -90.13 115.07 4.5 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.912 -1.675 . . . . 10.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.563 ' HG3' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.54 -19.98 2.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.65 -1.5 . . . . 10.0 111.482 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.437 ' OG1' ' CG2' ' A' ' 8' ' ' VAL . 88.9 m -82.1 -41.8 20.03 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.721 -1.237 . . . . 10.0 111.809 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.534 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 23.7 p -79.73 1.79 25.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.809 -1.182 . . . . 10.0 109.909 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.613 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 3.2 mm? -109.11 -41.31 4.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.843 -1.161 . . . . 10.0 109.52 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.456 ' HA ' HD23 ' A' ' 165' ' ' LEU . 1.5 tp -48.14 -34.07 9.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.594 HG13 ' CG2' ' B' ' 26' ' ' THR . 2.5 mm -73.83 -41.7 53.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.409 -0.959 . . . . 10.0 108.409 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.489 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 23.0 t -48.55 -41.76 31.36 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.445 -0.902 . . . . 10.0 110.117 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -97.26 -0.63 46.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.556 -1.34 . . . . 10.0 109.405 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 17.5 m -109.99 -19.01 13.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.012 . . . . 10.0 112.58 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.466 HG22 ' CG2' ' A' ' 33' ' ' VAL . 37.8 m -116.76 -72.34 0.69 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.231 -1.543 . . . . 10.0 111.544 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.621 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 34.1 m-20 -147.73 -33.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.311 -1.356 . . . . 10.0 112.773 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.621 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 165.83 -138.8 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 O-C-N 121.331 -0.856 . . . . 10.0 111.606 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.0 OUTLIER -137.62 -45.14 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.131 -0.981 . . . . 10.0 113.457 -177.731 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.562 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 42.7 Cg_endo -91.17 4.21 4.24 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 N-CA-C 114.739 1.015 . . . . 10.0 114.739 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.408 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 9.1 t -172.38 71.95 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.605 -1.935 . . . . 10.0 112.312 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.581 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 13.2 pt-20 -148.93 126.2 11.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.835 -1.166 . . . . 10.0 111.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 33.9 t80 -89.08 116.27 27.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 10.0 108.82 178.717 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.581 ' CG1' ' HG3' ' A' ' 31' ' ' GLU . 0.1 OUTLIER -162.01 160.33 21.82 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.342 -0.849 . . . . 10.0 110.133 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.545 ' HD2' HG22 ' A' ' 33' ' ' VAL . 36.9 Cg_endo -61.28 131.89 38.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.758 1.399 . . . . 10.0 109.09 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.528 ' CB ' ' HB ' ' B' ' 26' ' ' THR . 22.3 p -137.99 154.63 49.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.604 -1.31 . . . . 10.0 113.24 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.533 ' CG1' ' O ' ' A' ' 58' ' ' THR . 58.1 t 62.99 -43.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.72 -0.613 . . . . 10.0 111.358 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.724 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 7.8 p90 -36.38 100.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.161 0.981 . . . . 10.0 110.374 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.574 ' HA ' HD12 ' B' ' 18' ' ' ILE . 1.5 m-20 -167.71 102.92 0.49 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 117.297 -1.761 . . . . 10.0 112.489 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.623 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 61.4 t30 -147.8 98.78 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.069 -1.019 . . . . 10.0 108.361 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CD2' ' O ' ' B' ' 16' ' ' HIS . 75.6 m-85 -139.73 147.05 40.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.86 -1.136 . . . . 10.0 112.65 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . . . . . . . . . . . -140.85 98.55 3.42 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 177.363 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.588 ' HB ' ' HB3' ' B' ' 15' ' ' GLU . 7.5 p -135.23 -173.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -0.854 . . . . 10.0 110.269 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.547 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 94.1 m -136.72 167.29 21.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.569 HG12 ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.48 152.24 37.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.215 -1.031 . . . . 10.0 108.215 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.53 ' CB ' ' HD2' ' B' ' 11' ' ' PRO . 7.1 mtm -144.67 131.15 19.82 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.001 -0.68 . . . . 10.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.569 ' CD1' HG12 ' A' ' 44' ' ' VAL . 1.4 mp -147.94 114.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.204 -0.935 . . . . 10.0 110.693 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 67.51 6.5 42.14 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.934 -1.267 . . . . 10.0 109.934 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.54 24.06 6.31 Favored Glycine 0 N--CA 1.489 2.179 0 O-C-N 121.064 -1.257 . . . . 10.0 110.008 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' CG ' ' O ' ' A' ' 49' ' ' GLU . 13.7 pt-20 -118.67 111.33 37.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.33 . . . . 10.0 109.723 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.49 146.94 57.03 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.87 1.458 . . . . 10.0 111.542 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.547 ' O ' ' HA ' ' A' ' 43' ' ' THR . 2.8 m-85 -136.71 107.12 6.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.348 -0.845 . . . . 10.0 111.122 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.584 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 47.3 m -83.64 153.04 24.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.164 -0.96 . . . . 10.0 109.169 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.535 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 1.4 pp -167.26 166.34 14.81 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.716 -1.24 . . . . 10.0 110.765 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -170.61 131.92 2.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.405 -1.478 . . . . 10.0 109.405 -179.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.63 124.03 49.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -1.034 . . . . 10.0 109.403 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.623 ' CE1' ' OD1' ' A' ' 39' ' ' ASN . 5.1 m-85 -135.96 104.51 5.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.11 -0.994 . . . . 10.0 110.259 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.436 ' OD2' ' HA ' ' A' ' 36' ' ' VAL . 23.5 t0 -105.34 146.36 29.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.141 -0.975 . . . . 10.0 110.231 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.533 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 66.5 m -45.72 131.15 9.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.345 -0.847 . . . . 10.0 109.283 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.504 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -101.26 89.75 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.607 -0.683 . . . . 10.0 111.305 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . -53.41 -23.78 20.49 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.558 -2.217 . . . . 10.0 107.558 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.486 ' HB3' ' O ' ' B' ' 21' ' ' GLY . 29.1 tt0 178.02 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 122.004 -0.704 . . . . 10.0 109.516 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 64' ' ' TYR . 9.6 tm-20 -53.62 -51.95 61.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.129 -0.982 . . . . 10.0 110.687 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER 177.05 -17.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.275 -0.891 . . . . 10.0 110.988 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.504 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 19.9 p90 -119.74 16.53 12.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.004 -1.06 . . . . 10.0 109.395 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.483 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 38.0 t0 -37.42 -30.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.729 -0.607 . . . . 10.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.483 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 12.6 ptp180 -51.03 -22.22 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 10.0 110.004 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.528 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.9 mm? -106.95 11.41 29.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 10.0 109.048 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.613 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 10.6 ttp-105 -54.48 -37.98 60.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.775 -0.578 . . . . 10.0 111.641 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.613 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 39.8 Cg_endo -68.06 59.19 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 109.953 -0.826 . . . . 10.0 109.953 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.589 ' HG ' ' H ' ' A' ' 71' ' ' SER . 0.3 OUTLIER -92.72 -57.34 2.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.61 -0.681 . . . . 10.0 109.986 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.601 ' CA ' ' HB2' ' B' ' 39' ' ' LEU . 1.5 t 58.44 53.24 6.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.245 -0.909 . . . . 10.0 109.628 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.638 ' CG ' ' O ' ' A' ' 72' ' ' TYR . 1.2 p90 -149.11 113.72 3.6 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 118.564 -1.254 . . . . 10.0 112.542 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.23 94.65 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.509 1.473 . . . . 10.0 109.971 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.98 76.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.791 -1.193 . . . . 10.0 110.791 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.573 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 54.1 m -144.83 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.179 -0.951 . . . . 10.0 109.626 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 75' ' ' THR . 2.3 m-20 -18.95 -53.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.449 0.642 . . . . 10.0 111.843 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -88.84 123.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.442 -0.903 . . . . 10.0 109.352 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.496 ' O ' HD22 ' A' ' 111' ' ' LEU . 93.8 m-85 -116.01 139.96 49.74 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.403 -0.81 . . . . 10.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.547 ' CD1' HG12 ' A' ' 168' ' ' VAL . 1.6 mm? -108.15 98.17 7.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.456 HG11 ' O ' ' A' ' 80' ' ' VAL . 9.2 p -92.84 122.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.619 -0.832 . . . . 10.0 110.708 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.82 104.3 11.19 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.564 -0.71 . . . . 10.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.467 ' CA ' HG21 ' A' ' 115' ' ' THR . 13.0 p90 -136.57 179.82 6.14 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.221 -0.925 . . . . 10.0 109.239 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.433 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 90.2 p -75.28 161.5 29.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.861 -1.149 . . . . 10.0 111.333 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.442 ' HB ' HG21 ' A' ' 137' ' ' ILE . 6.6 m -78.78 -9.87 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.616 . . . . 10.0 111.134 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.584 ' CG1' ' O ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -115.17 -82.29 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.99 -1.069 . . . . 10.0 108.116 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.5 t 66.38 147.66 0.11 Allowed Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 120.407 -1.433 . . . . 10.0 111.79 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.632 ' HA ' ' HG3' ' A' ' 134' ' ' GLN . 49.9 Cg_endo -76.76 167.78 24.73 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 124.384 1.728 . . . . 10.0 112.247 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 1.0 OUTLIER 71.77 15.35 5.87 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.985 178.855 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.498 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.5 t 61.64 102.01 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.023 -1.048 . . . . 10.0 110.474 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.593 ' CE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -46.76 -31.77 3.2 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.395 -0.922 . . . . 10.0 109.046 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.502 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 73.9 tt0 -53.55 -29.39 36.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 10.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.61 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -82.17 -11.82 58.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 10.0 109.535 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 89.1 t -89.63 -36.04 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.181 -0.949 . . . . 10.0 109.391 179.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.593 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -71.14 -17.75 62.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.458 -0.897 . . . . 10.0 109.285 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.61 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.84 -4.82 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.111 -0.993 . . . . 10.0 110.804 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -78.37 -41.63 32.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 10.0 110.469 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.476 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 24.2 m95 -80.52 -27.84 37.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.428 -0.795 . . . . 10.0 110.195 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.589 ' CG1' ' CD2' ' A' ' 149' ' ' LEU . 93.9 t -52.83 -50.77 79.47 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.159 -0.963 . . . . 10.0 110.861 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.587 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.5 Cg_endo -68.35 -17.95 44.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.277 1.146 . . . . 10.0 109.731 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.544 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -58.02 -29.57 65.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 10.0 110.142 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.544 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 7.0 mt 63.01 106.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.301 -0.874 . . . . 10.0 111.417 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.614 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -49.17 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.363 -0.977 . . . . 10.0 108.363 178.653 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.606 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 40.4 m170 -105.19 -7.62 18.9 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.162 -0.961 . . . . 10.0 110.181 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 1.7 m-70 174.68 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 10.0 109.764 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.614 ' O ' ' CG2' ' A' ' 102' ' ' THR . 81.3 m -119.2 144.91 37.16 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.058 . . . . 10.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.05 91.67 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 123.679 1.358 . . . . 10.0 110.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' CG ' ' O ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -153.36 18.31 0.55 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.201 -0.937 . . . . 10.0 109.591 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -56.25 131.58 75.4 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.254 -0.904 . . . . 10.0 109.634 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 135.69 25.7 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.557 1.293 . . . . 10.0 109.637 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.505 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -132.48 106.01 7.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.288 -0.882 . . . . 10.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.581 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -74.91 95.61 2.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.972 -1.862 . . . . 10.0 105.972 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.572 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 46.2 mt -70.08 139.07 52.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.522 HG21 ' O ' ' A' ' 111' ' ' LEU . 2.9 t -149.6 167.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.141 . . . . 10.0 111.454 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.463 ' O ' ' CG2' ' A' ' 117' ' ' ILE . . . -124.52 107.27 1.0 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.956 -2.057 . . . . 10.0 107.956 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.467 HG21 ' CA ' ' A' ' 82' ' ' PHE . 3.5 t -93.88 155.62 17.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -1.189 . . . . 10.0 110.543 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 48.73 48.65 19.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.832 . . . . 10.0 109.894 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.738 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.5 OUTLIER -82.62 -13.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 10.0 110.662 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 51.3 p30 -52.01 51.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 112.3 0.481 . . . . 10.0 112.3 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.738 ' N ' ' O ' ' A' ' 117' ' ' ILE . 12.3 tp 152.47 -34.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' CG ' HG22 ' A' ' 85' ' ' VAL . 10.9 tpp180 -55.54 -33.87 64.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.504 0.669 . . . . 10.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.15 -14.43 60.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 10.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 119' ' ' LEU . 70.9 m-20 -82.7 142.12 45.33 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.233 -0.917 . . . . 10.0 110.837 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_endo -75.44 22.99 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.12 1.59 . . . . 10.0 111.558 179.269 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -103.07 -50.57 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.757 -1.214 . . . . 10.0 109.967 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 t -74.26 -28.16 61.09 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.411 -2.07 . . . . 10.0 105.411 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.404 ' CD1' ' O ' ' A' ' 120' ' ' ARG 0.29 0.6 OUTLIER -51.1 -30.88 10.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 176.888 . . . . . . . . 4 4 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.3 -47.82 46.72 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.885 0.85 . . . . 10.0 110.235 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -37.29 62.58 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.466 0.651 . . . . 10.0 110.005 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.616 ' O ' ' NE2' ' A' ' 134' ' ' GLN . 3.4 mp -55.64 -27.1 47.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.114 0.959 . . . . 10.0 109.942 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.25 -28.39 57.1 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.405 -1.434 . . . . 10.0 109.022 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -69.94 -17.31 63.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.015 -0.674 . . . . 10.0 109.982 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.597 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -129.25 34.28 4.42 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.204 -1.398 . . . . 10.0 112.589 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.441 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 55.91 63.94 1.88 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.135 -0.978 . . . . 10.0 110.225 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.632 ' HG3' ' HA ' ' A' ' 87' ' ' PRO . 2.5 mt-30 -128.86 80.99 2.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.447 ' C ' HG11 ' A' ' 85' ' ' VAL . 0.1 OUTLIER -84.2 140.13 39.44 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.78 . . . . 10.0 109.901 -179.782 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.6 Cg_endo -66.53 161.65 40.31 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.203 1.633 . . . . 10.0 111.741 -179.228 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.571 HG12 ' CE2' ' A' ' 90' ' ' PHE . 3.5 tp -126.64 139.92 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 10.0 109.479 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.481 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -118.78 165.42 16.84 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.323 -0.86 . . . . 10.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.481 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.9 Cg_endo -65.67 -21.57 58.72 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.8 1.421 . . . . 10.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -70.54 -47.66 59.29 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.283 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -77.9 -42.15 34.24 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.916 -0.714 . . . . 10.0 110.292 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.88 90.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.912 -1.118 . . . . 10.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.439 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 20.4 mm-40 -52.95 -48.19 67.55 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.483 -0.887 . . . . 10.0 110.132 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -62.18 -34.63 76.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.175 -0.953 . . . . 10.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.494 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 8.8 tp -66.46 -50.08 64.52 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.905 -1.122 . . . . 10.0 108.222 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.532 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -59.09 -41.62 88.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.284 -0.885 . . . . 10.0 109.95 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HD2' ' HA ' ' A' ' 147' ' ' ARG . 40.3 mmm-85 -78.61 -7.29 57.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.344 -0.847 . . . . 10.0 110.18 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.502 ' CB ' HD13 ' A' ' 149' ' ' LEU . 2.5 m-20 -76.88 -48.66 17.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.028 -1.045 . . . . 10.0 110.806 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.589 ' CD2' ' CG1' ' A' ' 98' ' ' VAL . 2.2 mp -102.09 9.84 39.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 10.0 109.819 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 5.6 mtpt 81.51 23.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.028 0.918 . . . . 10.0 110.512 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.532 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -64.26 -176.34 0.21 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.581 ' CG1' HD13 ' A' ' 111' ' ' LEU . 2.5 p -84.99 -77.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.773 -1.204 . . . . 10.0 111.83 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.505 ' H ' ' CG1' ' A' ' 152' ' ' VAL . 0.2 OUTLIER -173.66 -179.04 1.72 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.437 -1.414 . . . . 10.0 110.889 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 68.1 t80 -108.7 120.86 43.7 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 10.0 109.778 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.57 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -124.51 -169.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.226 -0.922 . . . . 10.0 109.349 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -157.2 144.42 18.62 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.291 -1.364 . . . . 10.0 112.679 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.56 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 27.4 p -157.49 162.43 38.89 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.448 0.642 . . . . 10.0 110.133 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.639 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 18.9 p -133.14 172.84 12.12 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 108.49 -0.93 . . . . 10.0 108.49 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.737 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -54.96 -64.85 0.7 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.894 0.702 . . . . 10.0 112.894 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.443 HD12 ' OG1' ' A' ' 161' ' ' THR . 4.0 pp -132.91 -3.83 3.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.66 -1.275 . . . . 10.0 112.13 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.513 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.4 m -96.33 -53.56 3.57 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.65 -1.282 . . . . 10.0 113.167 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.557 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -63.25 -53.03 59.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.757 -1.215 . . . . 10.0 111.327 -178.406 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.513 ' HG3' ' O ' ' A' ' 161' ' ' THR . 0.4 OUTLIER 66.19 27.78 10.25 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 -177.728 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.51 -17.23 42.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.653 HD12 ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -49.98 -18.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.186 . . . . 10.0 110.796 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.483 ' N ' HD22 ' A' ' 165' ' ' LEU . 1.5 tttt -71.97 -31.44 66.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.681 -1.262 . . . . 10.0 109.658 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -69.38 -45.1 70.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 10.0 109.582 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.57 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 31.1 t -53.31 -18.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.661 0.743 . . . . 10.0 110.2 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.495 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 m-85 -84.3 -40.52 17.87 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 10.0 111.902 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.474 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 22.8 t70 -65.69 -52.19 53.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.89 -1.131 . . . . 10.0 112.268 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.537 ' HG3' ' N ' ' A' ' 172' ' ' ALA . 0.7 OUTLIER -63.92 -25.53 68.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.773 -1.204 . . . . 10.0 109.972 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.537 ' N ' ' HG3' ' A' ' 171' ' ' GLU . . . -66.87 -32.07 73.09 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.264 -0.897 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 49.0 mm -62.74 -50.27 80.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.413 -0.804 . . . . 10.0 109.696 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.521 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -72.63 -34.07 67.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.56 -0.712 . . . . 10.0 111.073 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.492 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -85.24 -2.35 57.95 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.154 -0.966 . . . . 10.0 110.202 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.548 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -87.12 -22.31 25.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.052 -1.03 . . . . 10.0 110.129 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.57 HD23 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -100.22 -20.38 15.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 10.0 108.793 179.272 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 118.09 -0.957 . . . . 10.0 110.426 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' ' 49' ' ' GLU . 46.4 m -128.4 156.65 42.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.297 -1.119 . . . . 10.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -81.66 97.66 8.01 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.151 -0.968 . . . . 10.0 108.582 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.055 . . . . 10.0 111.024 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.682 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -72.24 -154.47 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.682 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 38.2 Cg_endo -65.74 73.87 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-N 119.062 0.701 . . . . 10.0 110.523 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.483 ' N ' ' O ' ' B' ' 5' ' ' ARG . 3.3 tp10 -53.32 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.591 -0.693 . . . . 10.0 110.073 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.641 HG12 ' N ' ' B' ' 9' ' ' SER . 0.2 OUTLIER -79.56 -50.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.7 -1.25 . . . . 10.0 112.25 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.641 ' N ' HG12 ' B' ' 8' ' ' ILE . 61.0 m -88.82 146.72 24.81 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.808 -1.182 . . . . 10.0 110.994 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -170.8 98.05 0.43 Allowed Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.359 179.812 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.53 ' HD2' ' CB ' ' A' ' 45' ' ' MET . 51.4 Cg_endo -86.16 97.56 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.229 1.647 . . . . 10.0 109.073 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.1 p -68.37 160.61 29.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.07 -1.019 . . . . 10.0 111.894 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.48 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.2 m-20 -124.14 155.86 37.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.525 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 69.0 m-85 -85.33 156.09 21.05 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.028 0.918 . . . . 10.0 112.672 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.607 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 15.9 pt-20 -120.09 154.71 34.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.609 0.719 . . . . 10.0 110.316 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -49.87 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 10.0 111.142 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.405 ' O ' ' CG2' ' B' ' 18' ' ' ILE . 4.3 t -159.5 144.37 15.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.672 -1.268 . . . . 10.0 110.685 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.575 HG12 ' N ' ' A' ' 39' ' ' ASN . 0.8 OUTLIER -160.67 177.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.721 -0.612 . . . . 10.0 109.613 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.523 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.2 t-80 -143.07 160.23 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.675 -1.266 . . . . 10.0 111.548 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.625 ' N ' ' CB ' ' A' ' 37' ' ' PHE . 5.8 p -69.74 148.46 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.192 0.996 . . . . 10.0 112.711 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.486 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -127.31 42.68 1.43 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.132 -2.387 . . . . 10.0 107.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.627 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.2 OUTLIER -178.94 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.528 -0.983 . . . . 10.0 109.705 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.437 ' OD1' ' N ' ' B' ' 23' ' ' ASP . 17.3 p-10 -57.95 155.12 11.18 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.85 0.833 . . . . 10.0 112.688 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.21 57.98 0.63 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.781 -0.575 . . . . 10.0 112.37 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.627 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 42.5 t -113.01 -26.83 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.987 -1.071 . . . . 10.0 109.72 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.594 ' CG2' HG13 ' A' ' 21' ' ' ILE . 3.3 m -107.91 -22.23 12.52 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.533 ' HA2' ' CG2' ' A' ' 21' ' ' ILE . . . -90.49 35.2 3.9 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 106.923 -2.471 . . . . 10.0 106.923 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.522 ' HG2' ' O ' ' A' ' 28' ' ' PHE . 19.6 mt-10 -149.92 120.41 7.43 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.475 -1.014 . . . . 10.0 110.304 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.601 ' O ' ' CD1' ' A' ' 28' ' ' PHE . 3.8 t80 -124.21 142.71 51.01 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.25 -0.906 . . . . 10.0 108.701 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.5 p -141.06 -46.59 0.39 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.153 -0.967 . . . . 10.0 109.566 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.11 51.02 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.449 -1.86 . . . . 10.0 108.449 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.434 ' HA ' HD11 ' B' ' 32' ' ' ILE . 21.1 mm -73.55 132.64 80.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.835 -0.803 . . . . 10.0 110.02 -179.95 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.545 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 56.3 Cg_endo -80.54 79.88 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.718 1.378 . . . . 10.0 112.243 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.545 ' HB2' ' O ' ' B' ' 33' ' ' PRO . 33.7 tt0 173.61 122.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.005 -1.059 . . . . 10.0 111.126 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.619 ' O ' ' CG ' ' B' ' 36' ' ' TRP . 10.4 pt20 -78.3 -37.73 44.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.706 -0.622 . . . . 10.0 109.658 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.619 ' CG ' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 152.52 33.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.752 0.787 . . . . 10.0 109.066 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.424 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -139.97 -21.74 0.87 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.716 -0.615 . . . . 10.0 110.096 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 10.0 mmm180 -75.26 7.22 3.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.128 . . . . 10.0 109.397 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.601 ' HB2' ' CA ' ' A' ' 71' ' ' SER . 0.4 OUTLIER -41.28 -25.93 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.33 -0.856 . . . . 10.0 110.207 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.529 ' HB3' ' CB ' ' A' ' 71' ' ' SER . 2.8 pp -80.44 8.69 7.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.093 -1.004 . . . . 10.0 111.48 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.48 ' O ' ' CG ' ' B' ' 41' ' ' GLN . 3.5 tt0 -171.75 75.03 0.05 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.276 -0.89 . . . . 10.0 109.933 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.431 ' O ' ' N ' ' B' ' 44' ' ' ASN . 11.7 t -122.1 160.79 24.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 10.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 61.8 m -66.39 62.88 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.518 -0.739 . . . . 10.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.431 ' N ' ' O ' ' B' ' 42' ' ' THR . 77.8 m-20 -69.08 -36.04 77.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.029 . . . . 10.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' B' ' 46' ' ' THR . 1.1 pt -100.52 -163.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.268 -0.895 . . . . 10.0 110.591 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.538 ' CB ' ' O ' ' B' ' 45' ' ' ILE . 1.6 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.976 -1.012 . . . . 10.0 109.949 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.53 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 6.4 tmm? . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.14 0.495 . . . . 10.0 109.943 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.53 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 75.17 51.09 0.08 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 -178.935 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.561 ' CG2' ' O ' ' A' ' 3' ' ' THR . 2.2 m -173.13 75.0 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.467 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.547 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -105.3 136.36 39.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.167 -1.583 . . . . 10.0 110.026 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.624 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -118.33 114.25 22.67 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.82 105.3 17.3 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.518 -1.363 . . . . 10.0 110.734 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.458 HG23 ' OG1' ' A' ' 75' ' ' THR . 45.7 t -136.3 145.45 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.315 -0.954 . . . . 10.0 110.675 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 29.6 m -77.96 141.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.657 -0.652 . . . . 10.0 109.278 179.519 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.552 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 1.5 p -161.38 172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.138 -0.976 . . . . 10.0 110.205 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.552 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 149.54 176.22 22.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -49.34 -21.94 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.252 . . . . 10.0 110.373 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 139.28 45.84 0.07 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.556 -1.418 . . . . 10.0 109.556 179.793 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.2 -91.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -1.193 . . . . 10.0 110.039 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG22 ' O ' ' A' ' 9' ' ' VAL . 2.8 t 50.26 -125.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 10.0 111.148 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.508 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 96.53 7.47 57.96 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 108.378 -1.889 . . . . 10.0 108.378 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' NZ ' ' HB2' ' A' ' 169' ' ' PHE . 0.2 OUTLIER -57.96 -18.6 24.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.038 -1.272 . . . . 10.0 109.477 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.507 ' CG2' ' HB3' ' A' ' 34' ' ' PRO . 4.9 t -86.48 -24.9 25.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.513 ' HB2' ' C ' ' A' ' 33' ' ' VAL . 26.9 p -97.7 -8.22 29.18 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.029 -1.044 . . . . 10.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.621 HD23 ' CG ' ' B' ' 29' ' ' PHE . 1.4 mt -74.6 -38.36 62.62 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.585 ' N ' ' CD1' ' A' ' 165' ' ' LEU . 0.9 OUTLIER -59.29 -37.81 78.62 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 177.204 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.598 ' CG2' ' O ' ' B' ' 26' ' ' THR . 7.2 mm -70.59 -51.38 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 115.032 -0.985 . . . . 10.0 108.651 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.418 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 17.3 p -51.3 -40.41 58.94 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.178 -0.952 . . . . 10.0 109.546 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.618 ' CE1' ' O ' ' A' ' 160' ' ' LEU . 10.7 t80 -79.89 -32.71 40.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.9 -1.125 . . . . 10.0 110.862 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 ' CG2' ' O ' ' A' ' 20' ' ' LEU . 33.9 p -97.04 -9.63 27.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 10.0 112.789 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.575 ' OG1' ' CA ' ' B' ' 27' ' ' GLY . 81.1 p -102.18 -88.07 0.39 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.133 -1.604 . . . . 10.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.717 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.2 p30 -123.55 -33.21 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 116.997 -1.881 . . . . 10.0 113.029 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.717 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 152.94 -141.84 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 CA-C-N 119.052 0.842 . . . . 10.0 111.638 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.709 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 0.2 OUTLIER -146.94 88.93 5.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-O 122.191 0.996 . . . . 10.0 110.505 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.625 ' HD2' ' CB ' ' B' ' 28' ' ' GLU . 44.4 Cg_endo -89.93 -61.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.113 1.875 . . . . 10.0 111.259 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.1 m -168.2 46.69 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.348 -1.47 . . . . 10.0 114.179 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.59 ' HG2' ' CB ' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -170.05 -175.96 2.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.188 -1.57 . . . . 10.0 110.365 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.561 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 1.4 m-85 -108.11 136.77 47.23 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.512 0.673 . . . . 10.0 110.05 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.638 ' CG1' ' O ' ' B' ' 25' ' ' VAL 0.339 25.6 m -128.24 64.04 65.26 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.304 -0.872 . . . . 10.0 110.916 -177.995 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.507 ' HB3' ' CG2' ' A' ' 17' ' ' THR . 64.9 Cg_endo -91.78 174.2 2.36 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.787 1.414 . . . . 10.0 109.974 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p -63.03 96.28 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.577 -2.009 . . . . 10.0 105.577 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.592 HG11 ' CA ' ' A' ' 60' ' ' GLY . 3.2 t -79.36 -96.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.485 -0.759 . . . . 10.0 111.2 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.688 ' CE1' ' CE1' ' A' ' 64' ' ' TYR . 3.5 t80 -62.78 112.26 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 119.635 -1.915 . . . . 10.0 108.148 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.457 ' CG ' ' CD1' ' A' ' 55' ' ' LEU . 3.0 t0 -150.79 111.27 4.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 10.0 111.488 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.531 ' HA ' ' CE1' ' A' ' 56' ' ' PHE . 7.8 m-20 -120.65 97.93 5.79 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.508 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 12.2 t80 -132.37 125.48 30.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.399 -0.813 . . . . 10.0 110.972 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' C ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.38 96.38 2.98 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.466 -2.05 . . . . 10.0 105.466 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.61 HG11 ' N ' ' B' ' 14' ' ' PHE . 2.2 t -149.76 -177.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.895 -1.122 . . . . 10.0 111.864 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.571 HG22 ' N ' ' A' ' 44' ' ' VAL . 18.6 m -163.16 176.78 9.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.457 -0.571 . . . . 10.0 109.457 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.598 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 98.5 t -145.49 134.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.921 -1.112 . . . . 10.0 108.871 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.613 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 58.0 mtp -85.31 128.23 34.62 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 117.362 -1.735 . . . . 10.0 107.698 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.598 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 0.9 OUTLIER -124.84 94.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.751 -1.218 . . . . 10.0 108.97 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.653 ' CA ' ' CG2' ' B' ' 8' ' ' ILE . . . 62.73 19.88 61.19 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.51 34.32 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.392 -1.483 . . . . 10.0 109.392 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' O ' HG12 ' A' ' 46' ' ' ILE . 4.6 tt0 -112.64 95.91 34.6 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.391 -1.064 . . . . 10.0 110.84 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.7 138.64 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.867 1.456 . . . . 10.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.491 ' O ' HG21 ' A' ' 43' ' ' THR . 4.7 t80 -110.75 110.87 21.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 10.0 109.56 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.547 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 89.4 m -68.49 128.33 36.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.217 -0.927 . . . . 10.0 111.749 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.428 ' HG ' ' C ' ' A' ' 52' ' ' THR . 13.3 mt -134.59 138.67 44.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.249 -0.907 . . . . 10.0 109.864 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.46 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -170.43 126.52 1.35 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.541 ' O ' ' CD2' ' A' ' 56' ' ' PHE . 3.0 pp -144.45 160.28 41.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 10.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.541 ' CD2' ' O ' ' A' ' 55' ' ' LEU . 17.7 m-85 -158.5 146.72 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 10.0 109.053 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.545 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 10.7 t0 -153.89 175.75 12.97 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.945 -1.097 . . . . 10.0 110.938 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.508 HG23 HG12 ' A' ' 36' ' ' VAL . 1.8 t -45.89 166.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.646 -0.659 . . . . 10.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.496 ' HB2' ' HA ' ' A' ' 62' ' ' GLU . . . -100.5 89.76 4.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.458 -0.776 . . . . 10.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.592 ' CA ' HG11 ' A' ' 36' ' ' VAL . . . -62.33 -57.33 17.24 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 106.704 -2.558 . . . . 10.0 106.704 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.549 ' HG2' ' CA ' ' B' ' 21' ' ' GLY . 17.8 mt-30 -62.52 -21.48 65.56 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.496 ' HA ' ' HB2' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 51.02 66.97 1.02 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.669 0.747 . . . . 10.0 111.33 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 37' ' ' PHE . 13.1 p-10 -119.18 23.59 11.24 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.654 -0.654 . . . . 10.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 1.2 p90 -177.4 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 10.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 51.39 21.02 1.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.064 . . . . 10.0 111.271 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 9.6 mmt180 -56.61 -30.27 63.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.697 -1.252 . . . . 10.0 108.971 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.567 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 4.6 mm? -79.03 7.69 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.68 -0.638 . . . . 10.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.686 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 9.8 ttp180 -60.35 -22.86 1.03 Allowed Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.118 -0.989 . . . . 10.0 112.195 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 44.2 Cg_endo -90.01 22.95 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 N-CA-C 109.263 -1.091 . . . . 10.0 109.263 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.686 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 1.4 pt? -33.68 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.741 -0.6 . . . . 10.0 111.335 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.523 ' HA ' ' CG ' ' B' ' 39' ' ' LEU . 58.3 m -37.46 -34.22 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.554 0.693 . . . . 10.0 110.213 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' LEU . 28.4 t80 -84.71 115.93 62.98 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.387 -0.821 . . . . 10.0 109.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.89 150.09 33.99 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.722 1.38 . . . . 10.0 111.395 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.561 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.4 56.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 10.0 110.257 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.624 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 99.3 m -143.5 92.73 2.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.251 -0.906 . . . . 10.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 75' ' ' THR . 11.8 m-20 -31.9 -39.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.98 0.419 . . . . 10.0 111.913 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.565 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 3.4 m -114.26 135.05 55.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.332 1.063 . . . . 10.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.566 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 71.3 m-85 -121.66 149.7 42.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.688 -0.632 . . . . 10.0 110.488 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.537 ' CD1' HG11 ' A' ' 168' ' ' VAL . 1.4 mm? -119.75 97.98 5.89 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.175 -0.953 . . . . 10.0 108.466 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.474 ' O ' HG21 ' A' ' 113' ' ' VAL . 2.6 p -108.07 144.65 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.012 -1.055 . . . . 10.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.521 ' CB ' ' HB ' ' A' ' 113' ' ' VAL . 42.0 t -144.7 134.94 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.235 -0.916 . . . . 10.0 110.627 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 19.1 p90 -142.08 171.66 13.75 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 43.8 t -79.08 150.29 31.87 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.816 -1.178 . . . . 10.0 111.611 -178.762 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.541 ' O ' HG22 ' A' ' 137' ' ' ILE . 27.3 m -102.54 -14.72 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.498 -0.751 . . . . 10.0 110.681 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.553 ' CA ' HD22 ' A' ' 129' ' ' LEU . 3.5 m -81.81 -41.83 18.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.701 -1.249 . . . . 10.0 108.676 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.7 m -54.31 120.3 25.11 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.382 -0.824 . . . . 10.0 110.28 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 55.7 Cg_endo -82.39 25.09 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.815 1.429 . . . . 10.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.496 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 9.0 t -62.64 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.99 -1.069 . . . . 10.0 109.898 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 29.7 t -122.53 65.61 0.95 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 10.0 111.683 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 1.8 t80 -64.54 -19.29 65.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.85 -1.156 . . . . 10.0 109.521 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.491 ' HG3' ' HE2' ' A' ' 94' ' ' LYS . 8.5 tt0 -69.65 -29.26 66.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.447 -0.783 . . . . 10.0 111.042 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -83.56 -15.07 50.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.177 . . . . 10.0 111.025 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.474 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 29.2 m -94.55 -26.69 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.827 -1.171 . . . . 10.0 108.998 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.548 ' HB3' ' CE1' ' A' ' 90' ' ' PHE . 0.0 OUTLIER -80.66 -29.22 36.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.431 -0.907 . . . . 10.0 109.167 178.917 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -89.14 -4.77 58.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 10.0 110.603 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -83.97 -50.01 8.42 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.019 -1.051 . . . . 10.0 112.547 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 39.6 m95 -76.9 -24.08 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.055 -1.028 . . . . 10.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.575 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 62.7 t -67.41 -51.89 30.96 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.646 -1.283 . . . . 10.0 111.606 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.575 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -72.85 -8.27 22.07 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.289 1.152 . . . . 10.0 110.416 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -81.38 -31.58 33.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 10.0 112.607 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . . . . . . . . . 8.0 pt -129.25 -10.17 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.352 -1.468 . . . . 10.0 113.022 -178.17 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.475 ' CG2' ' O ' ' A' ' 98' ' ' VAL . 81.7 p -72.57 -5.23 35.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.492 -1.38 . . . . 10.0 110.656 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -64.61 -43.13 94.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.045 -1.034 . . . . 10.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -100.67 -27.84 13.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.485 -0.759 . . . . 10.0 109.355 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.441 ' O ' ' HA ' ' A' ' 102' ' ' THR . 74.3 m -120.49 82.18 32.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.476 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 40.1 Cg_endo -65.79 152.4 81.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.842 1.443 . . . . 10.0 110.347 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 6.8 mtmt 60.72 47.3 8.21 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.82 -0.55 . . . . 10.0 111.027 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.496 HG22 ' HD2' ' A' ' 109' ' ' PRO . 89.0 m -72.97 133.87 81.54 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.496 ' HD2' HG22 ' A' ' 108' ' ' THR . 37.0 Cg_endo -62.37 129.13 25.73 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.529 1.278 . . . . 10.0 109.747 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.476 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 6.6 t80 -136.96 111.34 8.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.358 -0.839 . . . . 10.0 109.722 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.597 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 1.4 mm? -90.99 99.86 12.82 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.722 0.772 . . . . 10.0 111.333 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.564 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.2 mt -74.29 148.92 41.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HB ' ' CB ' ' A' ' 81' ' ' CYS . 2.7 t -147.15 179.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.822 -1.173 . . . . 10.0 111.391 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -122.35 133.41 9.24 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.894 -2.082 . . . . 10.0 107.894 178.514 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 82' ' ' PHE . 28.9 m -100.12 132.82 45.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.92 -1.341 . . . . 10.0 111.393 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 52.12 61.36 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 10.0 111.03 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.766 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -79.38 -19.96 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.045 -1.034 . . . . 10.0 109.249 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.555 ' O ' ' HB3' ' A' ' 119' ' ' LEU . 12.6 p-10 -48.82 61.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.16 0.981 . . . . 10.0 111.22 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 pp 158.56 -24.56 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.722 -1.126 . . . . 10.0 108.462 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 14.5 tpt180 -43.41 -44.31 5.66 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.592 0.71 . . . . 10.0 109.666 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.99 -11.19 7.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 10.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.547 ' O ' HD12 ' A' ' 126' ' ' ILE . 43.7 t0 -104.83 120.31 50.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 10.0 110.534 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.49 24.43 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 10.0 111.035 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -105.85 -50.46 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.065 -1.022 . . . . 10.0 110.93 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.475 HG21 ' HB2' ' A' ' 119' ' ' LEU . 6.0 t -72.09 -30.62 65.28 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.076 -2.194 . . . . 10.0 105.076 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.547 HD12 ' O ' ' A' ' 122' ' ' ASP 0.304 0.8 OUTLIER -48.64 -26.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.211 -1.359 . . . . 10.0 107.862 176.309 . . . . . . . . 4 4 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -54.32 -36.71 64.04 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.181 0.991 . . . . 10.0 109.676 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -21.95 61.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.518 -0.739 . . . . 10.0 110.878 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.577 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 4.0 mp -57.74 -37.79 74.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.292 -0.88 . . . . 10.0 109.627 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.82 82.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.525 -0.734 . . . . 10.0 109.867 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -51.17 -28.55 11.43 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.901 -1.12 . . . . 10.0 108.677 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.565 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 1.3 m120 -90.27 -66.77 0.89 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.228 -0.989 . . . . 10.0 110.553 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.599 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.5 mptp? -140.33 160.5 39.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.8 -0.563 . . . . 10.0 109.548 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.599 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -97.28 1.48 49.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 10.0 111.313 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.513 ' O ' ' CA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -120.52 98.53 48.27 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 10.0 111.188 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.52 ' HA ' ' HA ' ' A' ' 87' ' ' PRO . 42.2 Cg_endo -73.95 160.59 42.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.888 1.725 . . . . 10.0 111.255 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.541 HG22 ' O ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.68 136.95 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.954 -1.091 . . . . 10.0 109.997 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.527 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 73.0 p -128.23 167.78 17.72 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.434 -0.791 . . . . 10.0 110.822 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.527 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -65.37 -12.45 34.94 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.941 1.495 . . . . 10.0 110.907 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 1.5 mt-10 -78.6 -15.61 58.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.094 . . . . 10.0 109.839 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.6 m -94.93 -45.1 7.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.185 -0.947 . . . . 10.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.57 69.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 10.0 110.571 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.456 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 2.8 tt0 -50.24 -34.64 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.853 . . . . 10.0 109.74 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -74.84 -47.4 30.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.338 -0.851 . . . . 10.0 110.284 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.522 HD12 ' HD3' ' A' ' 94' ' ' LYS . 1.1 tp -55.91 -44.7 78.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.02 -1.05 . . . . 10.0 109.409 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.526 ' HA ' ' HB2' ' A' ' 151' ' ' ALA . . . -61.74 -50.22 73.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 10.0 109.951 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -18.01 62.47 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.523 -0.871 . . . . 10.0 109.515 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 144' ' ' LYS . 9.7 m-20 -85.96 -57.65 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 10.0 110.856 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.569 ' O ' ' HB2' ' A' ' 150' ' ' LYS . 0.0 OUTLIER -84.67 4.24 33.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.157 -0.964 . . . . 10.0 110.754 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.569 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.0 mttp 69.49 60.1 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.375 1.084 . . . . 10.0 112.352 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.546 ' N ' HD12 ' A' ' 149' ' ' LEU . . . -96.96 -154.09 0.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.333 -0.849 . . . . 10.0 108.71 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.597 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 15.8 t -100.04 -81.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.207 -0.997 . . . . 10.0 108.657 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.427 ' N ' ' CG1' ' A' ' 152' ' ' VAL . 2.7 tttm -173.73 159.28 3.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.43 -0.908 . . . . 10.0 111.858 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.598 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -82.77 105.04 13.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.541 -0.725 . . . . 10.0 109.466 178.304 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.478 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -102.12 -172.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -148.45 137.11 21.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.821 -1.174 . . . . 10.0 109.973 179.737 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.499 ' SG ' ' CB ' ' A' ' 16' ' ' LYS . 30.1 p -138.15 116.24 11.73 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.422 -0.911 . . . . 10.0 111.484 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.531 ' N ' HD23 ' A' ' 165' ' ' LEU . 6.2 m -102.6 156.73 17.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.572 ' HB1' HD23 ' A' ' 19' ' ' LEU . . . -93.62 -94.0 0.16 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 120.435 -1.416 . . . . 10.0 111.072 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.651 HD22 ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -47.29 -20.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.463 -1.295 . . . . 10.0 109.001 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.516 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -93.42 -44.35 8.3 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.077 -1.015 . . . . 10.0 109.533 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.591 ' HB2' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm0? 61.59 68.91 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 10.0 110.745 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.46 ' HE2' HG23 ' A' ' 161' ' ' THR . 0.4 OUTLIER -97.89 36.86 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.445 -0.902 . . . . 10.0 111.328 -179.91 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.78 30.03 0.72 Allowed Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.623 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.585 ' CD1' ' N ' ' A' ' 20' ' ' LEU . 0.2 OUTLIER -54.7 -47.41 73.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.229 -1.159 . . . . 10.0 110.714 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -71.41 -21.28 62.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.315 -0.865 . . . . 10.0 110.526 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -70.78 -39.4 73.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.021 -1.049 . . . . 10.0 111.275 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.537 HG11 ' CD1' ' A' ' 79' ' ' LEU . 39.6 t -58.48 -50.79 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.811 -1.181 . . . . 10.0 110.212 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.503 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 80.4 t80 -68.27 -36.26 79.12 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.48 -0.762 . . . . 10.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.496 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.8 t0 -53.75 -47.56 70.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.867 -1.146 . . . . 10.0 110.478 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.532 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . 11.4 mm-40 -54.82 -40.46 69.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 10.0 109.857 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.447 ' HB3' HD21 ' A' ' 111' ' ' LEU . . . -59.59 -21.35 60.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.139 -0.976 . . . . 10.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.599 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 37.2 mm -63.25 -40.52 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.254 -0.904 . . . . 10.0 110.038 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.53 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -87.17 -15.71 37.52 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.638 -1.289 . . . . 10.0 110.946 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.585 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.04 -11.08 23.36 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.977 -1.077 . . . . 10.0 110.596 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.526 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -82.35 -42.82 18.2 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.941 -1.099 . . . . 10.0 109.74 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.599 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -96.61 -14.53 22.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.366 -0.834 . . . . 10.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.791 -1.099 . . . . 10.0 110.318 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.443 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . 68.6 m -99.74 37.04 1.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.318 -1.107 . . . . 10.0 110.036 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -64.19 103.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 10.0 110.934 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -128.51 178.02 6.59 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.756 0.789 . . . . 10.0 110.724 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.559 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -67.44 -179.99 0.51 Allowed Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.899 -1.889 . . . . 10.0 105.899 177.11 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.577 ' O ' ' O ' ' B' ' 7' ' ' GLU . 42.8 Cg_endo -69.41 55.28 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 N-CA-C 110.35 -0.673 . . . . 10.0 110.35 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.577 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.8 tp10 15.14 -142.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.693 0.759 . . . . 10.0 112.814 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.653 ' CG2' ' CA ' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -88.25 -110.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.245 -0.909 . . . . 10.0 109.203 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.536 ' N ' HG12 ' B' ' 8' ' ' ILE . 6.1 t -158.12 105.64 1.95 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.081 -1.637 . . . . 10.0 112.031 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.613 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.6 OUTLIER -122.91 103.21 37.1 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.97 . . . . 10.0 109.916 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -66.91 99.12 0.45 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.373 1.196 . . . . 10.0 109.856 179.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.577 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.5 m -157.15 99.39 1.79 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.39 -0.819 . . . . 10.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 11.6 p-10 -148.63 154.86 40.28 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.818 -1.153 . . . . 10.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.61 ' N ' HG11 ' A' ' 42' ' ' VAL . 48.1 m-85 -84.64 -165.29 1.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.274 1.035 . . . . 10.0 113.165 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.541 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.3 tp10 -53.38 -167.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.88 0.848 . . . . 10.0 111.891 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -138.03 -166.94 2.06 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.508 ' HB ' ' HB2' ' A' ' 40' ' ' TYR . 9.8 t -119.24 -171.8 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.933 -1.104 . . . . 10.0 112.05 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.59 HG12 ' CZ ' ' A' ' 37' ' ' PHE . 1.3 pp -112.4 -177.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -101.08 155.91 17.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.062 . . . . 10.0 111.831 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.7 ' CG2' ' CE2' ' B' ' 22' ' ' PHE . 11.2 m -80.0 152.73 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.483 0.658 . . . . 10.0 111.281 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.549 ' CA ' ' HG2' ' A' ' 61' ' ' GLN . . . -87.69 133.39 11.77 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.162 -1.575 . . . . 10.0 109.162 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.7 ' CE2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER 179.0 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.88 -1.365 . . . . 10.0 112.914 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.442 ' C ' ' N ' ' B' ' 25' ' ' VAL . 15.2 t70 -76.99 116.39 17.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.786 -1.196 . . . . 10.0 107.907 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 46.41 26.11 0.45 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.789 -1.194 . . . . 10.0 107.837 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.638 ' O ' ' CG1' ' A' ' 33' ' ' VAL 0.262 2.4 t -109.84 -14.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.564 0.697 . . . . 10.0 109.383 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.648 ' HB ' ' CD2' ' B' ' 22' ' ' PHE . 1.3 t -83.47 32.88 0.46 Allowed 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.798 -0.564 . . . . 10.0 111.181 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.575 ' CA ' ' OG1' ' A' ' 25' ' ' THR . . . -161.31 69.94 0.23 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.642 -1.783 . . . . 10.0 108.642 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.709 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.9 mt-10 -151.47 131.61 13.52 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.964 0.888 . . . . 10.0 111.43 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.621 ' CG ' HD23 ' A' ' 19' ' ' LEU . 1.9 t80 -142.7 142.41 31.99 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.53 ' CG2' ' O ' ' B' ' 29' ' ' PHE . 2.2 p -162.14 -66.13 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 10.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.79 111.5 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.073 -1.611 . . . . 10.0 109.073 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 pt -131.93 158.9 74.22 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.217 . . . . 10.0 110.308 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' B' ' 34' ' ' GLU . 42.2 Cg_endo -70.43 139.99 39.15 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.985 1.519 . . . . 10.0 109.942 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.531 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 3.0 tm-20 56.87 124.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 10.0 110.433 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.501 ' HG2' ' N ' ' B' ' 36' ' ' TRP . 2.3 pm0 -96.31 -30.11 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 10.0 111.244 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.61 ' CG ' ' O ' ' B' ' 36' ' ' TRP . 7.8 t-105 -165.5 27.78 0.05 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.186 0.993 . . . . 10.0 110.099 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.495 ' C ' ' HG3' ' B' ' 34' ' ' GLU . . . -158.48 85.27 0.85 Allowed 'General case' 0 C--N 1.287 -2.113 0 O-C-N 121.798 -0.564 . . . . 10.0 109.64 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.531 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 2.4 ttt180 -83.31 41.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.523 ' CG ' ' HA ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -58.01 -39.18 77.68 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.627 0.727 . . . . 10.0 111.238 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.418 ' O ' ' HG2' ' B' ' 41' ' ' GLN . 0.5 OUTLIER -80.37 19.44 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.645 -0.659 . . . . 10.0 112.293 -177.755 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.418 ' HG2' ' O ' ' B' ' 40' ' ' LEU . 1.9 mm100 -146.39 -84.79 0.12 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.208 -0.932 . . . . 10.0 110.722 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 63.1 p -130.7 -178.53 4.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 10.0 109.791 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' B' ' 44' ' ' ASN . 18.7 p -85.35 19.68 2.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.132 -0.98 . . . . 10.0 109.339 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' SER . 6.4 t30 73.81 86.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 10.0 109.903 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -90.86 155.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.15 -0.969 . . . . 10.0 109.988 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 117.851 -1.071 . . . . 10.0 109.679 178.852 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.458 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 10.0 110.038 . . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mm100 -74.94 -26.86 59.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.595 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.4 m -46.23 106.16 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.907 -0.495 . . . . 10.0 110.941 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.614 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -128.03 119.94 52.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.735 -1.586 . . . . 10.0 111.054 178.115 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.544 ' O ' ' CG2' ' A' ' 75' ' ' THR . 4.5 mttm -103.8 124.55 49.12 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.895 -1.52 . . . . 10.0 106.895 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.513 ' CB ' HD21 ' A' ' 55' ' ' LEU . 2.4 t -89.01 108.0 19.35 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.884 -1.127 . . . . 10.0 110.886 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.539 ' HB ' ' CG2' ' A' ' 75' ' ' THR . 60.0 t -139.17 163.97 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 10.0 109.476 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.494 ' O ' ' O ' ' A' ' 9' ' ' VAL . 36.5 t -73.36 157.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.006 -1.059 . . . . 10.0 109.713 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.569 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -43.58 170.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 10.0 109.984 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -104.94 -29.27 5.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.082 -1.607 . . . . 10.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.459 ' OD2' HG22 ' A' ' 80' ' ' VAL . 42.0 m-20 -42.59 -61.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 10.0 110.039 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' B' ' 35' ' ' GLN . . . 92.2 5.8 65.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' HD11 ' B' ' 32' ' ' ILE . . . -43.76 -30.93 0.71 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -1.109 . . . . 10.0 110.865 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.451 ' HA ' HG13 ' B' ' 32' ' ' ILE . 53.1 t -148.92 -69.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.07 -1.019 . . . . 10.0 110.405 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.06 74.32 0.06 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.545 ' HA ' ' CD2' ' A' ' 19' ' ' LEU . 4.4 tttm -65.15 -13.0 57.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -1.056 . . . . 10.0 109.707 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 14.3 t -50.27 -29.52 9.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 10.0 110.073 -179.935 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.586 ' CB ' ' O ' ' B' ' 26' ' ' THR . 27.3 p -78.4 -2.46 38.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.076 -1.015 . . . . 10.0 111.127 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.598 HD13 ' CE2' ' A' ' 23' ' ' TYR . 1.7 mm? -84.39 -40.22 18.09 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.892 -1.13 . . . . 10.0 109.02 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.473 ' O ' ' OG1' ' A' ' 24' ' ' THR . 0.8 OUTLIER -52.57 -38.73 60.54 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.619 -0.832 . . . . 10.0 109.206 178.772 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.629 ' CG2' ' HA2' ' B' ' 27' ' ' GLY . 3.4 mm -80.42 -45.56 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.418 -0.801 . . . . 10.0 110.399 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.564 ' HA ' ' HA ' ' A' ' 27' ' ' LYS . 19.7 t -45.84 -50.8 13.85 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.026 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.667 ' CD2' HD13 ' A' ' 165' ' ' LEU . 36.6 m-85 -81.49 0.24 38.75 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.847 -1.158 . . . . 10.0 110.43 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.594 ' O ' ' HB ' ' A' ' 25' ' ' THR . 20.1 m -97.93 -54.17 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.404 -1.318 . . . . 10.0 110.779 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.594 ' HB ' ' O ' ' A' ' 24' ' ' THR . 14.6 t 175.75 -39.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.115 -0.991 . . . . 10.0 112.424 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.617 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 65.2 m-20 -85.4 32.39 0.57 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.737 -1.227 . . . . 10.0 111.53 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.564 ' HA ' ' HA ' ' A' ' 22' ' ' SER 0.261 8.7 ttpp -45.26 -167.28 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.846 0.831 . . . . 10.0 112.863 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.621 ' CB ' ' CB ' ' B' ' 28' ' ' GLU . 51.1 t80 -107.14 47.48 0.15 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.242 -0.911 . . . . 10.0 111.523 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.547 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 52.9 Cg_endo -73.55 -93.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 122.951 0.974 . . . . 10.0 109.624 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t -167.25 60.17 0.08 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.365 -0.834 . . . . 10.0 109.033 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.5 pt-20 -155.81 -173.18 4.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.442 -0.787 . . . . 10.0 109.007 -179.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 8.4 m-85 -111.12 105.43 14.15 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.624 -0.673 . . . . 10.0 110.305 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -126.04 158.73 65.09 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.301 -0.874 . . . . 10.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 49.0 Cg_endo -76.67 92.44 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.656 1.345 . . . . 10.0 110.033 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.619 ' O ' ' CG2' ' B' ' 20' ' ' VAL . 4.2 t -94.9 154.02 17.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.203 -0.936 . . . . 10.0 110.017 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.615 ' HB ' ' O ' ' A' ' 35' ' ' THR . 16.9 t 77.56 5.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.019 -0.426 . . . . 10.0 110.664 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.58 ' HA ' ' CG1' ' B' ' 20' ' ' VAL . 73.9 t80 -39.55 161.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.784 0.802 . . . . 10.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.617 ' CB ' ' CD1' ' B' ' 18' ' ' ILE . 3.7 p30 -79.13 -161.08 0.28 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.346 1.07 . . . . 10.0 113.391 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.583 ' O ' ' CG2' ' B' ' 17' ' ' THR . 1.4 m120 -152.9 -171.52 3.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.491 ' CD2' ' CG2' ' B' ' 17' ' ' THR . 69.6 m-85 -121.72 152.87 38.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 10.0 111.647 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.689 ' CB ' ' CZ ' ' A' ' 56' ' ' PHE . . . -131.18 99.51 4.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.302 -0.874 . . . . 10.0 109.715 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.6 ' CB ' ' HB3' ' B' ' 15' ' ' GLU . 1.4 p -131.44 -168.9 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 122.104 0.954 . . . . 10.0 111.182 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.507 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 23.2 m -142.43 151.5 41.85 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.585 0.707 . . . . 10.0 110.005 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.486 HG21 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -136.08 126.2 41.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.456 -0.778 . . . . 10.0 109.527 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.574 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 30.9 mtt -90.87 96.56 10.7 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.69 -1.204 . . . . 10.0 109.625 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.583 ' CG2' ' HG3' ' B' ' 7' ' ' GLU . 1.4 mp -72.03 104.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.548 -0.72 . . . . 10.0 110.049 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.455 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 43.65 35.06 2.89 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.776 -1.202 . . . . 10.0 110.428 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.52 2.17 30.92 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.879 -1.365 . . . . 10.0 110.802 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' ILE . 79.6 mt-10 -117.45 110.73 40.53 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.741 -1.446 . . . . 10.0 110.297 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.488 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.2 Cg_endo -75.13 135.75 19.25 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.566 1.298 . . . . 10.0 110.706 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.507 ' O ' ' HA ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -99.76 122.85 43.36 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 10.0 110.749 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.595 ' CB ' ' HA ' ' A' ' 3' ' ' THR . 30.2 p -84.6 98.32 10.1 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.05 -1.031 . . . . 10.0 109.439 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD13 ' HB3' ' A' ' 51' ' ' TYR . 6.8 mt -121.48 126.67 49.83 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.662 -1.215 . . . . 10.0 109.672 179.571 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.48 ' HA2' ' CB ' ' A' ' 41' ' ' ALA . . . -141.35 100.8 0.27 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.531 -1.828 . . . . 10.0 108.531 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.559 HD13 ' CB ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -115.36 117.24 29.88 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.224 -1.162 . . . . 10.0 110.581 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.689 ' CZ ' ' CB ' ' A' ' 41' ' ' ALA . 20.9 m-85 -134.59 144.4 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.559 ' CB ' ' O ' ' A' ' 37' ' ' PHE . 22.1 m-20 -105.78 160.76 14.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.475 -1.391 . . . . 10.0 110.008 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.569 ' OG1' ' CD1' ' B' ' 36' ' ' TRP . 4.3 t -70.42 -177.94 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.06 . . . . 10.0 110.97 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.59 ' CB ' ' HA ' ' A' ' 62' ' ' GLU . . . -111.04 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.708 -0.62 . . . . 10.0 109.409 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -52.02 -34.51 38.88 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 107.781 -2.128 . . . . 10.0 107.781 179.654 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.54 ' CB ' ' HA3' ' B' ' 21' ' ' GLY . 20.4 tt0 -99.94 -19.19 16.72 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 10.0 109.863 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.59 ' HA ' ' CB ' ' A' ' 59' ' ' ALA . 65.4 mt-10 58.64 84.98 0.1 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.269 -0.895 . . . . 10.0 110.564 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.442 ' OD1' ' HG2' ' A' ' 61' ' ' GLN . 55.6 m-20 -96.4 -10.39 27.74 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 3.9 p90 -140.3 -35.1 0.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 10.0 109.571 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 2.7 p30 38.11 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 10.0 111.074 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' TYR . 1.7 mmm-85 -58.16 -32.59 68.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.066 -1.021 . . . . 10.0 109.287 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.593 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -79.93 7.67 8.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -0.759 . . . . 10.0 110.097 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.664 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -52.16 -36.44 32.03 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.335 -0.853 . . . . 10.0 112.74 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.583 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 48.9 Cg_endo -77.6 10.49 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 122.62 0.8 . . . . 10.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.664 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -45.94 -64.47 0.73 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.935 -1.103 . . . . 10.0 111.954 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.456 ' C ' ' O ' ' A' ' 70' ' ' LEU . 67.4 m 41.06 32.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.899 -1.126 . . . . 10.0 109.969 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 6.7 t80 -171.33 127.8 0.66 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 10.0 110.677 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.96 130.59 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.997 1.525 . . . . 10.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 4.1 mt-30 -138.32 67.35 1.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.232 -0.917 . . . . 10.0 108.943 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.584 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 95.1 m -144.67 92.1 2.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 10.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.482 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.1 m-20 -39.13 -30.46 0.05 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.661 -0.65 . . . . 10.0 111.178 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.533 HG12 ' O ' ' A' ' 5' ' ' LYS . 1.5 p -112.82 118.22 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.819 -1.176 . . . . 10.0 110.021 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.584 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 23.3 m-85 -119.29 133.92 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.429 -0.794 . . . . 10.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.457 HD22 HD22 ' A' ' 111' ' ' LEU . 1.2 mm? -104.36 97.43 7.37 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.53 ' HA ' ' HB ' ' A' ' 9' ' ' VAL . 10.3 p -96.1 147.02 6.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.783 -0.767 . . . . 10.0 110.357 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.532 ' SG ' ' O ' ' A' ' 81' ' ' CYS . 0.0 OUTLIER -113.9 101.89 9.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.078 0.942 . . . . 10.0 110.882 -178.763 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.53 ' CE2' ' CG1' ' A' ' 80' ' ' VAL . 35.9 m-85 -92.44 178.32 5.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -0.977 . . . . 10.0 110.003 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 52.4 m -108.96 158.2 17.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 10.0 109.262 179.112 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.47 ' O ' HG22 ' A' ' 137' ' ' ILE . 4.1 t -99.18 -19.03 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.16 -0.962 . . . . 10.0 111.188 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.546 HG12 ' HB2' ' A' ' 129' ' ' LEU . 4.1 t -96.59 -60.16 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.01 -1.056 . . . . 10.0 110.209 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -73.39 114.84 35.36 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.393 -0.817 . . . . 10.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 52.5 Cg_endo -88.59 -3.45 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.076 1.566 . . . . 10.0 110.495 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.451 ' HB3' ' HG3' ' A' ' 133' ' ' LYS . 4.1 p -75.1 21.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.289 -0.882 . . . . 10.0 112.115 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.517 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 19.5 t -131.4 -31.39 1.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 10.0 109.934 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.561 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -72.8 -53.0 12.69 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.095 -1.003 . . . . 10.0 110.678 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.41 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 9.3 tp10 -49.79 -17.9 0.41 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.029 -1.044 . . . . 10.0 112.037 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.557 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -91.37 -18.96 23.44 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.497 -1.377 . . . . 10.0 110.822 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.616 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 3.6 m -91.06 -18.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 118.39 -1.324 . . . . 10.0 109.306 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.561 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 21.2 mmtt -88.65 -20.38 24.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.924 . . . . 10.0 109.138 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.557 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -95.99 -0.68 50.31 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.442 178.681 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -91.54 -51.69 5.14 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.773 -1.171 . . . . 10.0 112.578 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.616 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 34.3 p-90 -95.37 -26.01 16.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.81 -1.181 . . . . 10.0 111.771 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 56.1 t -53.77 -43.39 96.19 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.705 -1.247 . . . . 10.0 109.777 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.581 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 42.1 Cg_endo -75.93 -24.28 11.54 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.292 1.154 . . . . 10.0 110.147 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 6.3 mm-40 -61.27 -13.17 16.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.907 -1.121 . . . . 10.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.536 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 24.9 mm 71.68 82.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 10.0 111.311 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -16.66 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -56.46 -47.26 79.55 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.65 -1.241 . . . . 10.0 107.65 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -64.85 -40.35 95.01 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.466 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -81.99 -176.6 0.8 Allowed Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.724 -0.61 . . . . 10.0 109.42 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.484 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 50.5 Cg_endo -77.84 19.72 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.832 1.438 . . . . 10.0 112.856 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 58.35 67.1 0.98 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.377 -1.452 . . . . 10.0 108.929 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.492 HG23 ' HD2' ' A' ' 109' ' ' PRO . 21.0 m -45.46 134.89 5.86 Favored Pre-proline 0 N--CA 1.49 1.571 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.915 -179.479 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HD2' HG23 ' A' ' 108' ' ' THR . 42.6 Cg_endo -69.79 140.75 43.33 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.984 1.518 . . . . 10.0 110.997 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.556 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -136.95 113.28 9.96 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.704 0.764 . . . . 10.0 110.939 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.588 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.3 mm? -87.98 97.0 10.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.542 HD11 ' CZ ' ' A' ' 90' ' ' PHE . 1.6 tt -79.14 124.07 27.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.038 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.527 HG21 ' CG1' ' A' ' 168' ' ' VAL . 2.4 t -139.92 164.82 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 10.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.48 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -111.61 156.15 15.74 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.119 -1.993 . . . . 10.0 108.119 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.531 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 9.6 t -138.01 160.91 38.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.365 . . . . 10.0 111.169 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.502 ' HB2' ' O ' ' A' ' 115' ' ' THR . 7.2 mt-30 58.98 36.67 24.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.526 -0.734 . . . . 10.0 109.903 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.729 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -72.63 -19.52 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.351 -0.843 . . . . 10.0 109.751 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.597 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 7.6 t70 -51.75 58.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 122.156 0.979 . . . . 10.0 112.125 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 3.6 tp 162.27 -23.63 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.526 -1.215 . . . . 10.0 108.131 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.487 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -50.88 -33.24 23.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.16 -26.56 60.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 10.0 109.901 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.565 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 1.0 OUTLIER -93.53 132.02 31.11 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.452 -0.78 . . . . 10.0 110.549 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -87.0 23.26 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.471 1.447 . . . . 10.0 110.256 179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 47.5 t -110.68 -50.62 2.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -0.98 . . . . 10.0 111.016 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.528 HG22 ' N ' ' A' ' 126' ' ' ILE . 10.0 t -70.11 -27.22 64.41 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.565 ' CD1' ' O ' ' A' ' 122' ' ' ASP 0.306 1.2 mp -51.91 -25.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 10.0 107.361 176.571 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.443 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 25.6 tt0 -58.46 -42.04 86.55 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.282 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -55.92 -41.64 74.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.529 -0.732 . . . . 10.0 110.665 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.546 ' HB2' HG12 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -75.72 -33.85 60.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 10.0 109.549 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' LYS . . . -52.52 -50.2 63.3 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.326 0.584 . . . . 10.0 110.277 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -28.91 61.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.258 -0.901 . . . . 10.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.483 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.4 t30 -71.56 -52.19 19.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.951 . . . . 10.0 109.985 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.573 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 3.2 mmtt -134.38 155.75 49.74 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.549 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -105.43 24.09 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.005 . . . . 10.0 111.157 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.549 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -148.74 92.95 4.33 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 10.0 109.391 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.72 160.61 48.84 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.183 1.622 . . . . 10.0 110.519 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.47 HG22 ' O ' ' A' ' 84' ' ' VAL . 4.6 tp -102.07 133.68 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.464 -0.939 . . . . 10.0 108.464 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.491 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.9 p -119.67 165.04 18.72 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 121.182 -0.949 . . . . 10.0 110.159 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.491 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.6 Cg_endo -64.13 -32.3 63.72 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.935 1.492 . . . . 10.0 110.369 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.529 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 17.3 pt-20 -74.14 -29.82 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 10.0 109.456 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 81.1 m -80.13 -41.02 26.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.79 . . . . 10.0 110.247 179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.21 68.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.471 -0.768 . . . . 10.0 110.54 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.46 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 18.9 tt0 -57.11 -42.57 81.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 10.0 109.637 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 14.5 mtmt -68.6 -40.33 80.49 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.161 -0.962 . . . . 10.0 109.494 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.508 HD23 ' CE ' ' A' ' 94' ' ' LYS . 6.6 tt -56.0 -43.45 77.67 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.029 -1.044 . . . . 10.0 109.671 179.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -67.45 -51.17 54.73 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 10.0 108.648 178.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -60.6 -30.37 69.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 10.0 109.624 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.503 ' N ' ' O ' ' A' ' 144' ' ' LYS . 32.9 t70 -67.99 -45.06 75.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.307 -0.871 . . . . 10.0 110.301 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.67 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.9 OUTLIER -92.76 14.78 16.23 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.089 0.947 . . . . 10.0 108.964 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 151' ' ' ALA . 8.9 mttp 56.23 38.28 29.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.786 0.803 . . . . 10.0 110.299 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.457 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -60.97 -141.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.198 -0.601 . . . . 10.0 109.563 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.556 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 0.5 OUTLIER -117.43 -57.7 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.959 -1.088 . . . . 10.0 110.477 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.46 ' HD2' ' CD ' ' A' ' 171' ' ' GLU . 0.9 OUTLIER -170.89 145.09 2.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.116 -1.434 . . . . 10.0 111.813 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.49 ' HB2' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -90.79 119.49 31.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.399 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.523 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -124.53 -168.88 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.863 -1.148 . . . . 10.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.497 ' CA ' HG12 ' A' ' 113' ' ' VAL . 6.0 tt0 -146.82 152.7 39.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.975 . . . . 10.0 110.335 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.559 ' CB ' ' CB ' ' A' ' 165' ' ' LEU . 31.1 p -160.36 145.18 14.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 10.0 111.394 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.538 ' HB2' ' HB2' ' A' ' 162' ' ' GLN . 18.4 m -149.91 103.79 3.25 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.586 ' CB ' ' CD1' ' A' ' 19' ' ' LEU . . . -37.02 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.562 0.696 . . . . 10.0 112.316 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.429 ' HA ' ' OE2' ' B' ' 28' ' ' GLU . 0.3 OUTLIER -57.61 -7.9 0.76 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.532 HG23 ' CB ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -134.78 -92.52 0.31 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.069 -1.644 . . . . 10.0 114.669 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.538 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 7.5 mm-40 -11.55 -69.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.817 0.817 . . . . 10.0 112.657 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.628 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 11.7 mttt 62.57 30.35 17.06 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.815 0.817 . . . . 10.0 109.44 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.0 -0.94 5.49 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.97 -1.652 . . . . 10.0 108.97 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.701 ' N ' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -65.89 -7.75 18.32 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.279 -1.13 . . . . 10.0 111.847 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.483 ' N ' HD11 ' A' ' 165' ' ' LEU . 11.5 mtmt -56.77 -33.05 66.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.581 -1.324 . . . . 10.0 109.827 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -70.35 -33.71 71.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 10.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.58 HG22 ' HA ' ' A' ' 165' ' ' LEU . 7.3 t -49.22 -35.84 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.752 -1.218 . . . . 10.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 6.1 t80 -78.91 -40.93 30.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 10.0 110.734 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.472 ' O ' HD21 ' A' ' 174' ' ' LEU . 14.4 m-20 -54.1 -46.7 72.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.185 -0.947 . . . . 10.0 111.429 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.486 ' OE2' ' CG2' ' A' ' 155' ' ' VAL . 6.9 pt-20 -66.15 -35.01 79.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 10.0 112.158 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.569 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -66.86 -17.95 65.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.597 -1.314 . . . . 10.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.533 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 22.1 mt -66.88 -44.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.366 -0.934 . . . . 10.0 109.119 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.565 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -85.09 -17.84 36.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 10.0 111.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.498 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -95.54 -0.49 51.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.906 -1.122 . . . . 10.0 110.141 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.614 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -87.95 -49.09 7.29 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.434 -0.791 . . . . 10.0 109.973 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.542 ' HB3' ' NE2' ' A' ' 2' ' ' GLN . 0.9 OUTLIER -88.55 -16.58 32.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.552 -0.718 . . . . 10.0 109.598 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 177' ' ' LEU . 2.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.035 -0.984 . . . . 10.0 110.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 109.532 -1.427 . . . . 10.0 109.532 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.429 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . 68.7 m -59.66 152.29 22.82 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -1.112 . . . . 10.0 110.328 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 102.05 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.567 -0.708 . . . . 10.0 111.366 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 mm-40 -118.68 159.86 22.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -0.835 . . . . 10.0 110.133 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.657 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.55 -150.02 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.657 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 42.6 Cg_endo -70.88 85.72 0.77 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 N-CA-C 109.844 -0.868 . . . . 10.0 109.844 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.583 ' HG3' ' CG2' ' A' ' 46' ' ' ILE . 17.9 mm-40 -53.53 -164.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.648 -0.657 . . . . 10.0 110.826 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.404 HG13 ' H ' ' B' ' 9' ' ' SER . 1.5 pp -81.3 -51.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 10.0 112.472 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.404 ' H ' HG13 ' B' ' 8' ' ' ILE . 43.7 t -159.09 164.99 34.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.422 -1.424 . . . . 10.0 111.624 -179.502 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -158.89 106.83 1.59 Allowed Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.577 -0.849 . . . . 10.0 111.951 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.543 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 42.6 Cg_endo -69.34 115.07 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.155 1.608 . . . . 10.0 109.607 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.81 178.39 0.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.399 -0.813 . . . . 10.0 111.609 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.412 ' HB2' ' O ' ' A' ' 43' ' ' THR . 1.7 t0 -135.09 -169.32 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.957 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.533 ' N ' ' CD1' ' B' ' 14' ' ' PHE . 5.1 m-85 -99.88 152.71 19.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 10.0 110.435 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -160.7 163.44 32.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.38 -0.825 . . . . 10.0 110.641 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -149.9 167.23 27.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.721 -1.192 . . . . 10.0 112.039 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.583 ' CG2' ' O ' ' A' ' 39' ' ' ASN 0.257 2.4 p -124.34 162.47 23.72 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.676 -0.64 . . . . 10.0 111.115 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.617 ' CD1' ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -93.31 -167.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.932 -1.105 . . . . 10.0 109.153 177.706 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -112.68 157.48 21.21 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.728 -1.233 . . . . 10.0 111.377 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.1 p -122.73 152.7 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.022 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.54 ' HA3' ' CB ' ' A' ' 61' ' ' GLN . . . -147.33 179.16 24.45 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.211 -1.556 . . . . 10.0 109.211 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.502 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 4.4 m-85 62.3 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.298 -1.119 . . . . 10.0 111.417 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.499 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 7.0 p-10 -66.71 157.57 32.37 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.578 0.704 . . . . 10.0 111.915 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 24.98 46.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.318 0.58 . . . . 10.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.438 ' N ' ' O ' ' B' ' 23' ' ' ASP . 1.2 t -104.58 -33.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.596 ' CG2' ' O ' ' B' ' 26' ' ' THR . 0.7 OUTLIER -128.61 17.82 6.34 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.811 0.815 . . . . 10.0 109.411 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.629 ' HA2' ' CG2' ' A' ' 21' ' ' ILE . . . -61.43 -22.3 61.11 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.621 ' CB ' ' CB ' ' A' ' 28' ' ' PHE . 3.0 tt0 -153.09 -151.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.633 -0.922 . . . . 10.0 109.041 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -103.78 115.35 30.32 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 120.922 -1.111 . . . . 10.0 110.32 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.589 ' CG2' ' CD1' ' A' ' 28' ' ' PHE . 34.7 p -130.3 -89.01 0.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 10.0 110.076 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.491 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -80.24 -115.28 0.3 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.481 ' O ' HG23 ' B' ' 32' ' ' ILE . 2.6 tt -173.27 56.14 0.2 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 10.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 44.4 Cg_endo -71.77 155.06 58.85 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.781 1.411 . . . . 10.0 110.883 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.593 ' HG3' ' CG ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -61.19 153.37 26.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.342 -0.849 . . . . 10.0 110.475 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.549 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 0.5 OUTLIER -73.92 -57.37 4.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.349 -0.844 . . . . 10.0 111.234 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.569 ' CD1' ' OG1' ' A' ' 58' ' ' THR . 3.3 t90 174.26 27.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.584 -0.697 . . . . 10.0 109.838 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.609 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . 178.22 15.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.266 -0.896 . . . . 10.0 112.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.593 ' CG ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -62.34 -13.23 26.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 119.974 -1.704 . . . . 10.0 108.109 178.284 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.548 ' CD2' HD23 ' A' ' 70' ' ' LEU . 5.1 mp -55.45 -9.5 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.639 . . . . 10.0 111.667 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.533 ' O ' ' HB2' ' B' ' 41' ' ' GLN . 1.9 pp -83.73 22.51 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 10.0 110.093 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.533 ' HB2' ' O ' ' B' ' 40' ' ' LEU . 6.9 mp0 62.92 63.93 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.046 0.927 . . . . 10.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.522 HG23 ' CD1' ' B' ' 40' ' ' LEU . 63.2 p -82.9 -171.26 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.456 0.646 . . . . 10.0 110.864 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 20.4 m -79.59 51.0 1.2 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.36 -0.837 . . . . 10.0 110.248 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.483 ' OD1' ' HD2' ' B' ' 38' ' ' ARG . 74.8 m-20 -46.36 -36.64 6.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 10.0 109.693 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' O ' ' OG1' ' B' ' 46' ' ' THR . 1.9 pt -115.54 168.32 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 10.0 110.02 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.471 ' OG1' ' O ' ' B' ' 45' ' ' ILE . 16.7 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.947 -1.025 . . . . 10.0 110.089 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.403 ' C ' ' HG2' ' A' ' 2' ' ' GLN . 6.9 mtm . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.963 0.411 . . . . 10.0 110.05 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.504 ' HB3' ' OG1' ' A' ' 52' ' ' THR . 28.9 mm100 -146.21 -33.83 0.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.019 -1.05 . . . . 10.0 109.743 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.537 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 51.8 m -56.54 110.93 0.86 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.324 -0.86 . . . . 10.0 111.01 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.58 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -108.33 128.01 64.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.86 -1.136 . . . . 10.0 110.088 178.018 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.623 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.7 ttmt -112.23 109.54 19.28 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.431 ' HB3' ' HB2' ' A' ' 55' ' ' LEU . 51.7 t -93.94 102.6 14.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.59 -1.319 . . . . 10.0 110.369 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 48.8 t -131.78 163.14 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.71 -1.196 . . . . 10.0 110.765 -179.872 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.551 HG21 ' CG2' ' A' ' 17' ' ' THR . 1.9 t -78.26 154.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.295 -0.878 . . . . 10.0 109.388 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -160.39 174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.854 -1.154 . . . . 10.0 110.353 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.578 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 115.2 173.5 17.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.651 -1.78 . . . . 10.0 108.651 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.13 -29.43 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.712 -1.463 . . . . 10.0 108.894 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 163.7 -81.29 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.721 -1.752 . . . . 10.0 108.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . 39.96 -131.88 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.992 . . . . 10.0 110.937 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.491 HG13 HG23 ' A' ' 115' ' ' THR . 6.1 m -110.72 153.89 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 10.0 111.748 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -111.96 110.13 2.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.229 -1.548 . . . . 10.0 109.229 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.466 ' HG3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.13 -20.63 7.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.761 -1.435 . . . . 10.0 110.896 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.551 ' CG2' HG21 ' A' ' 8' ' ' VAL . 11.4 t -73.82 -32.17 63.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.762 -1.212 . . . . 10.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.551 ' SG ' ' CE1' ' B' ' 29' ' ' PHE . 18.3 p -73.68 -15.68 61.23 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.618 -1.301 . . . . 10.0 107.673 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.678 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 53.7 mt -95.69 -23.42 17.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.534 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -46.85 -43.38 18.58 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.842 0.829 . . . . 10.0 109.046 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.642 ' CG2' ' HB2' ' A' ' 26' ' ' ASN . 4.6 mm -74.72 -39.88 46.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.505 ' OG ' ' O ' ' A' ' 19' ' ' LEU . 4.6 p -52.02 -49.25 63.75 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 119.435 -0.906 . . . . 10.0 110.254 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.757 ' CE2' ' CD1' ' A' ' 165' ' ' LEU . 4.7 m-85 -62.05 -34.09 75.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.377 -1.452 . . . . 10.0 109.706 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.563 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -72.79 -51.99 16.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.562 -0.855 . . . . 10.0 111.048 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.532 HG22 ' ND2' ' A' ' 26' ' ' ASN . 11.8 t -169.49 -20.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.959 -1.896 . . . . 10.0 114.563 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.642 ' HB2' ' CG2' ' A' ' 21' ' ' ILE . 4.8 m-80 -79.29 -8.67 59.22 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.454 -1.404 . . . . 10.0 111.223 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.66 ' HD2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 14.86 -146.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 114.359 1.244 . . . . 10.0 114.359 178.206 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.639 ' CE1' ' CG2' ' B' ' 30' ' ' THR . 1.8 t80 -100.71 -50.9 0.18 Allowed Pre-proline 0 N--CA 1.507 2.408 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.66 ' HD2' ' HD2' ' A' ' 27' ' ' LYS . 32.6 Cg_endo -54.82 -89.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.835 0 N-CA-C 115.216 1.199 . . . . 10.0 115.216 -176.006 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.89 70.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.523 -1.985 . . . . 10.0 112.63 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.597 ' O ' ' N ' ' A' ' 33' ' ' VAL . 41.4 mm-40 -99.82 112.83 25.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.107 -1.071 . . . . 10.0 108.107 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.449 ' HA ' ' OD1' ' B' ' 23' ' ' ASP . 11.7 m-85 -58.4 62.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.276 0.56 . . . . 10.0 111.218 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.597 ' N ' ' O ' ' A' ' 31' ' ' GLU . 9.3 m -117.17 169.77 6.94 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.091 -1.006 . . . . 10.0 109.449 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.557 ' CB ' HG13 ' B' ' 20' ' ' VAL . 49.3 Cg_endo -78.24 137.86 15.51 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.726 1.382 . . . . 10.0 113.551 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.605 ' O ' ' CG2' ' B' ' 20' ' ' VAL . 68.9 p -124.87 158.36 33.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.67 -0.644 . . . . 10.0 109.317 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.535 ' CG2' ' HB ' ' B' ' 26' ' ' THR . 16.5 t 63.1 -6.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.57 -1.331 . . . . 10.0 111.811 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -67.58 95.29 0.47 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 120.474 -1.391 . . . . 10.0 109.368 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.704 ' HA ' HG22 ' B' ' 18' ' ' ILE . 2.3 m-20 -165.78 103.69 0.69 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.308 -1.757 . . . . 10.0 114.278 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.561 ' H ' ' CG2' ' B' ' 18' ' ' ILE . 53.5 t30 -134.59 97.17 3.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.858 -1.151 . . . . 10.0 108.471 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.65 ' CD2' ' CB ' ' B' ' 15' ' ' GLU . 2.9 m-30 -118.76 146.58 44.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.669 -0.644 . . . . 10.0 111.063 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.529 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -171.72 98.07 0.18 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.08 -1.013 . . . . 10.0 109.262 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.581 HG12 ' O ' ' B' ' 14' ' ' PHE . 30.9 m -156.15 -165.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.988 0.899 . . . . 10.0 112.276 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.512 ' O ' ' HB3' ' B' ' 12' ' ' SER . 20.3 m -130.24 155.23 46.63 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.294 0.569 . . . . 10.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.51 ' HA ' ' CB ' ' B' ' 12' ' ' SER . 11.6 t -131.2 150.99 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.589 -0.694 . . . . 10.0 109.215 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.617 ' O ' ' O ' ' B' ' 10' ' ' LEU . 10.6 mtp -110.52 93.14 4.34 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.978 -1.489 . . . . 10.0 107.661 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.542 ' N ' HD11 ' A' ' 46' ' ' ILE . 1.8 mp -72.57 103.01 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 O-C-N 120.594 -1.316 . . . . 10.0 109.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.621 ' CA ' ' HB3' ' B' ' 9' ' ' SER . . . 51.0 30.56 23.26 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.404 -1.379 . . . . 10.0 110.119 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.92 6.12 37.65 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 120.845 -1.385 . . . . 10.0 110.592 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.488 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.6 tp10 -110.87 115.1 53.65 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.234 -1.157 . . . . 10.0 109.758 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.431 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.7 Cg_endo -71.59 139.0 33.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.947 1.498 . . . . 10.0 110.88 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -114.1 163.04 15.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 10.0 111.9 -179.894 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.58 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 3.1 m -122.99 104.75 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 21.2 mt -108.65 147.93 31.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.789 -1.195 . . . . 10.0 110.893 -179.308 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.44 99.98 0.17 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.044 -1.623 . . . . 10.0 109.044 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.564 ' CD2' ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -138.34 139.81 39.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -1.177 . . . . 10.0 110.269 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.564 ' N ' ' CD2' ' A' ' 55' ' ' LEU . 18.4 p90 -162.06 139.96 8.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.136 -0.978 . . . . 10.0 110.139 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 m-20 -104.25 170.1 8.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.097 -1.002 . . . . 10.0 110.476 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.501 HG21 ' CD2' ' B' ' 36' ' ' TRP . 5.5 t -43.55 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 10.0 111.927 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -133.29 90.53 2.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.526 -0.733 . . . . 10.0 110.652 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -66.87 71.14 0.18 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 106.885 -2.486 . . . . 10.0 106.885 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER 64.02 28.69 14.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.541 -0.976 . . . . 10.0 109.216 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.562 ' HG3' ' HA ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -58.95 -58.59 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.834 -1.166 . . . . 10.0 109.768 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.8 OUTLIER 175.09 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.256 -0.903 . . . . 10.0 110.147 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.607 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -151.7 -34.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 10.0 109.917 -179.25 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.8 t0 79.05 20.99 0.7 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.365 0.602 . . . . 10.0 109.616 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.474 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -58.73 -19.11 37.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 178.576 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.48 ' C ' HD22 ' A' ' 70' ' ' LEU . 1.1 pp -55.23 -16.32 3.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.531 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 1.1 ttm180 -99.68 -52.98 0.19 Allowed Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.531 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 45.7 Cg_endo -70.54 -16.51 34.28 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 120.466 0.778 . . . . 10.0 112.625 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.623 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.9 OUTLIER -54.84 -10.91 0.52 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.678 -1.264 . . . . 10.0 111.949 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.616 ' HA ' ' HB2' ' B' ' 39' ' ' LEU . 1.0 OUTLIER -45.83 -31.78 2.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.953 -1.092 . . . . 10.0 110.449 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 134.44 34.42 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 10.0 111.27 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.616 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 43.3 Cg_endo -80.27 159.2 23.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.899 1.473 . . . . 10.0 110.588 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 163.91 78.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.29 0.567 . . . . 10.0 109.586 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.623 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 89.1 m -146.83 99.59 3.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.312 -0.867 . . . . 10.0 109.962 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 75' ' ' THR . 81.5 m-20 -38.86 -30.59 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.487 -0.758 . . . . 10.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.539 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.5 OUTLIER -119.02 120.37 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 10.0 109.337 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.574 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 67.0 m-85 -108.19 129.48 55.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.909 -1.12 . . . . 10.0 111.906 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.548 HD23 ' CD2' ' A' ' 111' ' ' LEU . 2.0 mm? -104.05 97.05 7.09 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.509 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -107.24 145.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.101 -0.999 . . . . 10.0 110.495 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.509 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 39.4 t -141.43 126.17 18.01 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.157 -0.964 . . . . 10.0 111.192 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CA ' ' OG1' ' A' ' 115' ' ' THR . 1.8 p90 -135.01 168.26 19.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.441 -0.787 . . . . 10.0 110.654 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.6 t -77.3 161.06 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 10.0 109.74 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.479 HG13 HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -110.74 14.98 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 10.0 111.118 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.515 HG21 HD22 ' A' ' 129' ' ' LEU . 3.0 m -125.48 -17.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.69 -1.257 . . . . 10.0 111.716 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.63 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.9 OUTLIER -60.66 -159.7 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.992 -1.067 . . . . 10.0 110.096 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.63 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.3 Cg_endo -71.9 178.31 6.01 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 122.804 0.897 . . . . 10.0 110.099 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.84 66.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.246 -0.909 . . . . 10.0 110.087 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' PRO . 66.1 m -89.96 -15.28 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.691 . . . . 10.0 110.537 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.569 ' CE1' HD11 ' A' ' 137' ' ' ILE . 6.1 t80 -86.24 -50.23 7.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 10.0 110.188 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.45 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -65.65 -30.59 71.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.545 -0.722 . . . . 10.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.493 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -79.29 -14.22 59.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.821 -1.174 . . . . 10.0 109.58 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.653 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 2.7 t -83.84 -21.81 8.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.612 -1.305 . . . . 10.0 107.914 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.566 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -72.12 -37.87 69.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 178.583 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 1.4 pt-20 -69.49 -10.53 58.45 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.943 -0.703 . . . . 10.0 109.263 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -87.34 -52.37 5.42 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.316 -0.954 . . . . 10.0 112.582 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.653 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 54.9 p-90 -93.91 -15.93 24.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.752 -1.217 . . . . 10.0 112.444 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.595 HG23 ' CZ3' ' A' ' 97' ' ' TRP . 58.8 t -66.9 -50.78 41.47 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.745 -1.222 . . . . 10.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.543 ' O ' HG13 ' A' ' 101' ' ' ILE . 44.0 Cg_endo -71.58 -20.64 26.7 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.21 1.111 . . . . 10.0 109.761 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 5.7 mm-40 -57.14 -35.97 70.14 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.344 -0.943 . . . . 10.0 109.264 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.543 HG13 ' O ' ' A' ' 99' ' ' PRO . 10.2 mt 55.15 118.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.379 -0.825 . . . . 10.0 110.881 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.623 ' HA ' ' O ' ' A' ' 105' ' ' CYS . 4.2 p -48.66 -24.91 1.52 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.001 -1.062 . . . . 10.0 109.07 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 62.5 m-70 -76.2 -33.13 59.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.528 -0.732 . . . . 10.0 109.843 179.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.459 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 1.4 t-80 -105.91 -16.71 14.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 10.0 110.847 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.623 ' O ' ' HA ' ' A' ' 102' ' ' THR . 1.1 m -166.4 175.51 2.21 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.041 . . . . 10.0 110.085 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 105' ' ' CYS . 43.0 Cg_endo -70.72 86.72 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.641 1.337 . . . . 10.0 111.747 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.611 ' HB3' ' N ' ' A' ' 102' ' ' THR . 8.5 tttp -102.58 4.88 38.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 10.0 109.589 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.58 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 90.8 m -43.02 147.48 0.67 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 10.0 110.309 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.58 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 34.3 Cg_endo -58.22 160.67 15.57 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.019 1.813 . . . . 10.0 112.81 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.56 ' O ' HG11 ' A' ' 152' ' ' VAL . 1.7 p90 -151.01 144.53 24.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.2 1.0 . . . . 10.0 109.417 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.582 ' CD1' ' CG2' ' A' ' 152' ' ' VAL . 1.2 mm? -77.88 99.68 6.07 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.841 0.829 . . . . 10.0 109.745 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.492 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 75.5 mt -62.9 146.87 51.88 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.539 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 3.0 t -148.39 173.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.46 -1.4 . . . . 10.0 111.929 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.468 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -109.66 138.43 14.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.842 -1.703 . . . . 10.0 108.842 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.55 ' OG1' ' CA ' ' A' ' 82' ' ' PHE . 97.1 m -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.003 -1.292 . . . . 10.0 110.626 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.8 tp60 41.9 59.8 2.43 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.432 -0.793 . . . . 10.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.77 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -61.54 -42.05 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.998 -1.482 . . . . 10.0 106.998 179.196 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 4.8 p30 -51.91 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.284 1.04 . . . . 10.0 110.385 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 162.34 -28.07 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.529 ' HD2' ' N ' ' A' ' 121' ' ' ASP . 0.0 OUTLIER -47.47 -41.43 20.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.592 0.711 . . . . 10.0 109.62 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.529 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 77.5 m-20 -67.57 -10.14 49.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.401 -0.812 . . . . 10.0 109.99 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.447 ' N ' ' O ' ' A' ' 119' ' ' LEU . 14.8 t0 -82.3 117.15 67.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.824 . . . . 10.0 109.301 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.62 23.77 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.154 1.607 . . . . 10.0 110.97 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 37.2 t -107.84 -49.35 3.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.167 -0.958 . . . . 10.0 109.932 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.433 HG21 HD12 ' A' ' 126' ' ' ILE . 14.4 t -75.06 -31.25 61.23 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.478 HG21 ' HB3' ' A' ' 130' ' ' ALA 0.295 1.2 mp -56.02 -23.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 176.751 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.47 ' CB ' ' O ' ' A' ' 124' ' ' SER . 12.4 tt0 -47.99 -42.25 27.36 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.382 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -71.13 -49.55 42.95 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.48 -0.763 . . . . 10.0 110.547 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 86' ' ' SER . 4.9 mp -67.3 -43.68 81.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.67 0.748 . . . . 10.0 110.691 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.478 ' HB3' HG21 ' A' ' 126' ' ' ILE . . . -56.22 -42.46 77.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 10.0 110.594 -179.269 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -52.23 -21.3 3.27 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.214 -0.929 . . . . 10.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.583 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 3.1 t30 -85.9 -68.12 0.76 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.381 -0.825 . . . . 10.0 111.242 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.512 ' HD3' ' ND2' ' A' ' 132' ' ' ASN . 0.4 OUTLIER -124.59 129.4 50.51 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.532 -0.73 . . . . 10.0 110.6 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.648 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.6 OUTLIER -84.25 9.05 13.9 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.357 -0.839 . . . . 10.0 109.172 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -118.6 94.03 46.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.415 -0.803 . . . . 10.0 110.368 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 162.35 28.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.586 1.524 . . . . 10.0 110.182 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.569 HD11 ' CE1' ' A' ' 90' ' ' PHE . 2.4 tp -103.98 146.61 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.004 -1.06 . . . . 10.0 110.34 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.512 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.4 p -132.69 171.12 9.7 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 10.0 110.102 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.625 ' CB ' ' CD1' ' A' ' 154' ' ' TYR . 40.0 Cg_endo -71.69 -22.55 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.551 1.29 . . . . 10.0 111.445 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -55.15 21.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.085 . . . . 10.0 109.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -65.4 -39.85 92.7 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.372 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.47 -30.01 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.009 -1.057 . . . . 10.0 111.144 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.38 -49.3 67.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.183 -0.948 . . . . 10.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 148' ' ' ASP . 7.2 ttmt -62.91 -44.01 97.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.347 -0.941 . . . . 10.0 109.078 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.48 HD13 ' HE3' ' A' ' 94' ' ' LYS . 7.0 tt -59.32 -33.51 71.21 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.486 -0.758 . . . . 10.0 109.157 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.559 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -67.34 -50.02 61.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.69 0.757 . . . . 10.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -84.34 -10.12 57.87 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.35 -0.94 . . . . 10.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 144' ' ' LYS . 37.6 t0 -93.77 -37.55 11.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.599 -1.313 . . . . 10.0 110.795 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.618 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.4 mp -101.07 24.75 8.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 10.0 109.735 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.9 mtpt 61.95 39.21 13.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.561 -0.745 . . . . 10.0 112.017 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.559 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -95.26 -156.05 0.5 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.582 ' CG2' ' CD1' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.71 -66.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.473 -1.392 . . . . 10.0 110.259 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.42 ' HD2' ' O ' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -172.68 174.8 3.59 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.679 -1.608 . . . . 10.0 112.003 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.625 ' CD1' ' CB ' ' A' ' 139' ' ' PRO . 41.5 p90 -104.34 133.6 48.97 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.0 OUTLIER -137.71 -169.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.307 -0.871 . . . . 10.0 109.781 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.494 ' CA ' HG11 ' A' ' 113' ' ' VAL . 78.4 mm-40 -144.13 162.86 35.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.016 -1.053 . . . . 10.0 110.138 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 163' ' ' LYS . 15.5 p -164.89 133.82 3.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.282 -0.886 . . . . 10.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.525 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 32.6 t -120.78 173.38 7.25 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.614 ' HA ' ' CD1' ' A' ' 19' ' ' LEU . . . -86.67 -78.76 0.28 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 120.899 -1.126 . . . . 10.0 111.789 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.484 HD11 ' O ' ' A' ' 160' ' ' LEU . 3.8 pp -91.49 -4.25 55.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.434 -1.416 . . . . 10.0 111.108 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.1 m -96.1 -32.41 12.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.087 -1.008 . . . . 10.0 111.466 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.531 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.9 mt-30 75.92 67.84 0.07 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.236 -0.915 . . . . 10.0 109.772 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.561 ' O ' ' N ' ' A' ' 157' ' ' CYS . 0.3 OUTLIER -102.9 102.73 12.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.831 -1.147 . . . . 10.0 109.719 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.472 ' O ' ' CG2' ' A' ' 168' ' ' VAL . . . 78.14 10.51 86.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.36 -1.896 . . . . 10.0 108.36 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.757 ' CD1' ' CE2' ' A' ' 23' ' ' TYR 0.254 0.2 OUTLIER -54.34 -51.84 63.46 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.995 0.902 . . . . 10.0 110.78 -179.658 . . . . . . . . 4 4 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -80.91 -10.56 59.7 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.809 -0.557 . . . . 10.0 111.101 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.465 ' HB3' HG11 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -85.31 -31.57 22.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.193 -0.942 . . . . 10.0 110.342 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.543 HG11 ' CD1' ' A' ' 79' ' ' LEU . 2.8 t -71.92 -25.82 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.02 -1.05 . . . . 10.0 108.219 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.531 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -76.2 -49.68 16.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.314 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 26.2 m-20 -63.03 -49.88 72.88 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.282 -0.886 . . . . 10.0 112.269 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.463 ' O ' HD23 ' A' ' 174' ' ' LEU . 24.2 mm-40 -60.89 -40.79 94.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.896 -1.128 . . . . 10.0 111.25 -179.007 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.552 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -60.54 -22.5 63.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.98 -1.075 . . . . 10.0 109.925 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.531 HG12 ' O ' ' A' ' 169' ' ' PHE . 18.2 mm -61.13 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.219 -0.926 . . . . 10.0 109.864 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.551 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.34 -45.85 65.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.255 -0.903 . . . . 10.0 110.557 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.2 4.42 23.53 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.351 -0.843 . . . . 10.0 110.532 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.552 ' CB ' ' O ' ' A' ' 172' ' ' ALA . . . -84.47 -39.37 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 10.0 110.666 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.524 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -101.83 -14.76 17.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 10.0 110.409 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.877 -1.059 . . . . 10.0 110.68 -179.626 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.411 . . . . 10.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.533 ' O ' ' N ' ' B' ' 4' ' ' GLU . 54.3 m -98.81 33.5 2.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.244 -1.151 . . . . 10.0 110.646 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.464 ' HD3' ' O ' ' A' ' 174' ' ' LEU . 1.3 ttmt -50.15 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 10.0 110.597 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 2' ' ' SER . 31.9 mm-40 -134.74 167.61 20.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.186 -0.946 . . . . 10.0 110.664 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.635 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.03 -153.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.158 -1.052 . . . . 10.0 108.158 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.635 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.3 Cg_endo -69.87 84.22 0.68 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 N-CA-C 109.463 -1.014 . . . . 10.0 109.463 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.512 ' CG ' HG21 ' A' ' 46' ' ' ILE . 1.3 tp10 -44.43 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.79 0.805 . . . . 10.0 111.115 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.615 ' CD1' ' N ' ' B' ' 9' ' ' SER . 1.6 pp -91.56 -23.39 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 122.566 1.174 . . . . 10.0 107.939 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.621 ' HB3' ' CA ' ' A' ' 47' ' ' GLY . 43.3 m -57.24 -166.64 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.68 -1.145 . . . . 10.0 112.205 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.617 ' O ' ' O ' ' A' ' 45' ' ' MET . 0.2 OUTLIER -37.48 117.23 0.82 Allowed Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.478 1.288 . . . . 10.0 114.478 -176.434 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.475 ' HD2' HD11 ' B' ' 10' ' ' LEU . 49.7 Cg_endo -93.95 111.31 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.488 1.459 . . . . 10.0 109.266 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.512 ' HB3' ' O ' ' A' ' 43' ' ' THR . 0.3 OUTLIER -86.51 -168.01 2.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.799 -1.188 . . . . 10.0 110.054 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 147.03 0.97 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.499 -0.75 . . . . 10.0 110.009 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.581 ' O ' HG12 ' A' ' 42' ' ' VAL . 80.2 m-85 -90.88 163.16 14.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 10.0 110.14 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.65 ' CB ' ' CD2' ' A' ' 40' ' ' TYR . 2.3 mp0 -50.59 179.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.991 0.901 . . . . 10.0 112.322 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -81.3 -167.42 1.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.764 0.792 . . . . 10.0 112.719 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.412 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.3 m -85.46 152.81 22.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.688 -0.633 . . . . 10.0 109.843 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.704 HG22 ' HA ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -123.83 129.09 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 10.0 109.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.532 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 17.2 t60 -141.93 151.04 42.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.639 -1.288 . . . . 10.0 112.728 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.605 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.7 p -120.9 154.96 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.331 0.586 . . . . 10.0 111.181 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' B' ' 22' ' ' PHE . . . -124.31 56.64 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 106.93 -2.468 . . . . 10.0 106.93 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.632 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.0 OUTLIER 172.06 101.43 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.534 -0.98 . . . . 10.0 109.529 -177.756 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.449 ' OD1' ' HA ' ' A' ' 32' ' ' TYR . 9.8 t0 -61.77 139.94 58.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.114 -0.991 . . . . 10.0 111.165 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.454 ' O ' ' OE1' ' B' ' 28' ' ' GLU . . . 33.79 61.83 0.46 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.558 -0.714 . . . . 10.0 111.336 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.632 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 19.4 t -113.13 -27.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.163 -0.961 . . . . 10.0 110.818 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.535 ' HB ' ' CG2' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -121.19 -12.25 8.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 10.0 111.181 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.567 ' HA3' ' CB ' ' A' ' 26' ' ' ASN . . . -72.7 -29.91 64.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.239 -1.944 . . . . 10.0 108.239 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.506 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 13.2 mt-10 -83.44 97.63 9.08 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.925 0.869 . . . . 10.0 109.781 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.652 ' CE1' ' CG ' ' B' ' 33' ' ' PRO . 0.8 OUTLIER -110.64 144.52 39.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 120.07 -0.652 . . . . 10.0 109.404 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.639 ' CG2' ' CE1' ' A' ' 28' ' ' PHE . 7.2 p -148.14 -39.25 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.203 -0.936 . . . . 10.0 110.39 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.51 -154.56 11.43 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 120.046 -1.073 . . . . 10.0 110.773 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.07 76.21 6.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.782 -0.834 . . . . 10.0 111.621 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.652 ' CG ' ' CE1' ' B' ' 29' ' ' PHE . 43.9 Cg_endo -74.24 171.32 18.25 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.838 1.441 . . . . 10.0 109.199 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.467 ' OE2' ' HA ' ' B' ' 39' ' ' LEU . 6.2 tt0 -62.38 171.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 10.0 111.642 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.508 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -94.25 16.55 14.62 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.758 -0.589 . . . . 10.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.508 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 53.4 m0 58.85 52.99 6.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 10.0 111.616 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.554 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -177.83 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.358 -0.839 . . . . 10.0 111.593 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -46.41 -36.36 6.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.964 -1.085 . . . . 10.0 110.792 -179.271 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.616 ' HB2' ' HA ' ' A' ' 71' ' ' SER . 11.7 mt 43.03 20.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.025 0.75 . . . . 10.0 113.025 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.478 HD11 ' O ' ' B' ' 42' ' ' THR . 0.7 OUTLIER -122.37 10.03 9.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.513 -1.367 . . . . 10.0 110.75 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.497 ' OE1' ' HA ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER 70.23 -13.27 0.45 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.744 -0.598 . . . . 10.0 112.092 178.834 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.478 ' O ' HD11 ' B' ' 40' ' ' LEU . 92.7 m -132.98 167.31 20.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.705 -1.247 . . . . 10.0 110.101 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.455 ' O ' HD11 ' B' ' 45' ' ' ILE . 7.5 t -88.27 41.33 1.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 10.0 110.547 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 32.8 t-20 -91.79 115.48 28.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 10.0 110.537 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.455 HD11 ' O ' ' B' ' 43' ' ' SER . 3.3 mp -99.39 -36.44 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 10.0 109.867 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 45' ' ' ILE . 5.3 m . . . . . 0 C--N 1.304 -1.412 0 CA-C-O 118.099 -0.953 . . . . 10.0 110.419 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.206 0.527 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.483 ' O ' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -143.91 -14.51 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.224 -0.922 . . . . 10.0 110.542 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.62 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 57.0 m -71.91 112.43 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.302 -0.874 . . . . 10.0 111.758 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.588 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -106.26 121.63 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 118.854 -1.138 . . . . 10.0 108.974 177.214 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.585 ' O ' ' CG2' ' A' ' 75' ' ' THR . 2.3 mmtm -94.0 113.78 25.83 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.791 -1.189 . . . . 10.0 107.791 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 95.3 m -99.69 105.08 16.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.223 -0.923 . . . . 10.0 109.231 -179.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.546 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 39.7 t -143.02 146.8 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.94 -1.104 . . . . 10.0 111.084 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.448 HG21 ' OG1' ' A' ' 17' ' ' THR . 21.8 t -59.77 141.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 10.0 109.961 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.537 HG13 ' N ' ' A' ' 80' ' ' VAL . 25.7 m -72.73 -169.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 10.0 110.925 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . . . . . . . . . . . -129.67 11.06 6.03 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.689 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -49.96 -46.71 52.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.303 -1.116 . . . . 10.0 109.15 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.466 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 134.32 -12.41 4.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 81' ' ' CYS . . . -69.99 172.37 7.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.478 -1.013 . . . . 10.0 109.347 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG21 ' HB2' ' B' ' 29' ' ' PHE . 2.5 p -58.63 161.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.995 -1.066 . . . . 10.0 109.237 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.533 ' N ' ' HG3' ' B' ' 35' ' ' GLN . . . -71.7 112.25 4.02 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.336 . . . . 10.0 109.761 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.421 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.1 OUTLIER -49.75 -29.3 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.035 -1.274 . . . . 10.0 108.593 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.448 ' OG1' HG21 ' A' ' 8' ' ' VAL . 94.6 m -59.84 -33.02 71.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.503 -0.748 . . . . 10.0 109.371 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.555 ' HA ' ' O ' ' B' ' 26' ' ' THR . 1.9 t -81.77 -13.86 57.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.601 -0.84 . . . . 10.0 109.899 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.519 HD22 ' HB2' ' B' ' 29' ' ' PHE . 4.4 mt -92.58 -31.19 15.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 10.0 109.486 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.13 -31.41 72.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 10.0 107.683 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.548 HG21 ' CG2' ' B' ' 26' ' ' THR 0.26 9.3 mm -72.19 -45.86 60.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.33 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 21' ' ' ILE . 20.1 p -48.85 -26.1 2.24 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.905 -1.118 . . . . 10.0 108.611 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.642 ' CE2' ' CD1' ' A' ' 165' ' ' LEU . 2.8 m-85 -86.3 -26.02 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 10.0 108.596 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 21' ' ' ILE . 56.2 m -89.91 -31.15 17.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.667 . . . . 10.0 111.651 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.548 HG22 ' CG2' ' A' ' 33' ' ' VAL . 1.5 p -92.29 -81.32 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.613 -1.304 . . . . 10.0 109.687 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.643 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 8.9 m-80 -148.62 -30.19 0.28 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.931 -0.708 . . . . 10.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.643 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 6.4 pttt 145.96 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 CA-C-O 121.146 0.498 . . . . 10.0 109.815 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.595 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.1 OUTLIER -121.03 -62.2 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 113.076 0.769 . . . . 10.0 113.076 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.585 ' HD3' ' CD2' ' A' ' 28' ' ' PHE . 42.6 Cg_endo -67.98 0.05 4.89 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 122.859 0.926 . . . . 10.0 113.356 -177.452 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.519 ' CB ' ' HE3' ' A' ' 27' ' ' LYS . 3.0 t -162.26 58.75 0.23 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.362 -1.461 . . . . 10.0 111.48 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -141.55 88.44 2.14 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.152 -0.967 . . . . 10.0 110.183 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.475 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 56.1 m-85 -80.07 56.81 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 10.0 109.61 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.548 ' CG2' HG22 ' A' ' 25' ' ' THR . 10.1 m -95.98 125.31 48.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.598 -0.688 . . . . 10.0 110.313 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -71.89 94.48 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.85 1.447 . . . . 10.0 110.633 -179.736 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.59 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.0 OUTLIER -154.58 161.59 41.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 10.0 111.427 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.594 ' CG1' ' N ' ' A' ' 37' ' ' PHE . 1.6 t 158.28 -78.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.594 ' N ' ' CG1' ' A' ' 36' ' ' VAL . 29.9 t80 -61.3 140.22 58.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 10.0 110.96 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' HA ' HG13 ' B' ' 18' ' ' ILE . 35.6 t0 -164.56 85.73 0.44 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 39' ' ' ASN . 4.0 p-10 -104.96 103.46 13.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 10.0 111.421 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.583 ' CG ' ' HA ' ' B' ' 16' ' ' HIS . 0.2 OUTLIER -170.24 -168.4 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 10.0 110.076 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.488 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.04 165.22 28.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.045 -1.035 . . . . 10.0 110.358 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.564 ' CG1' ' HA ' ' B' ' 14' ' ' PHE . 60.2 t -155.57 171.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 10.0 110.972 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.461 HG21 ' N ' ' A' ' 44' ' ' VAL . 85.4 m -140.17 146.24 38.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.816 -0.552 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.551 HG12 ' CD1' ' A' ' 46' ' ' ILE . 0.8 OUTLIER -105.34 170.64 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.007 -1.058 . . . . 10.0 109.443 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.489 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 8.4 mtt -144.0 121.71 11.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.447 -0.783 . . . . 10.0 109.93 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.599 ' CG2' ' HB2' ' B' ' 7' ' ' GLU . 1.4 mp -138.0 130.62 40.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.357 -0.84 . . . . 10.0 109.535 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.403 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 46.72 23.27 1.37 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.34 -1.504 . . . . 10.0 109.34 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.61 2.34 67.57 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.061 -1.258 . . . . 10.0 110.214 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 -94.3 111.58 54.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.049 -1.265 . . . . 10.0 111.163 -179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_endo -70.11 152.35 67.47 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.87 1.458 . . . . 10.0 109.906 178.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.542 ' HB2' ' CB ' ' A' ' 44' ' ' VAL . 0.4 OUTLIER -116.06 163.55 15.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.072 -1.017 . . . . 10.0 110.876 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.62 ' CG2' ' HA ' ' A' ' 3' ' ' THR 0.256 39.0 m -124.21 112.51 17.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.78 -0.575 . . . . 10.0 109.795 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.469 ' HA ' HG23 ' A' ' 4' ' ' ILE . 3.4 pp -146.59 179.94 7.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.9 -1.125 . . . . 10.0 111.445 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 53' ' ' LEU . . . -169.26 133.38 2.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.481 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.8 tm? -124.59 123.97 41.21 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.062 -1.257 . . . . 10.0 110.338 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 58.9 m-85 -133.51 112.95 11.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 10.0 111.001 -179.738 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.1 t0 -92.24 134.78 34.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 10.0 109.658 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.545 ' HB ' ' CD1' ' B' ' 36' ' ' TRP . 12.4 t -84.22 98.24 9.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 10.0 111.982 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.585 ' CB ' ' CG1' ' A' ' 36' ' ' VAL . . . 164.7 62.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.358 -0.839 . . . . 10.0 109.89 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 37' ' ' PHE . . . -40.41 -30.07 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.347 -1.501 . . . . 10.0 109.347 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.499 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 1.9 pt20 -170.82 23.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -1.124 . . . . 10.0 111.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.507 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 8.2 mt-10 -150.63 -93.71 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.881 -1.137 . . . . 10.0 110.606 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' OD1' ' N ' ' A' ' 63' ' ' ASP . 4.5 p30 169.74 47.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.689 -1.257 . . . . 10.0 111.073 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.582 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 55.5 p90 -162.12 -44.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.861 -1.15 . . . . 10.0 111.237 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 1.8 t0 77.06 113.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.32 -0.863 . . . . 10.0 111.901 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -21.88 12.82 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.598 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 18.1 mt -84.26 5.9 24.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.469 -0.769 . . . . 10.0 109.01 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.609 ' CG ' ' HD3' ' A' ' 69' ' ' PRO . 1.8 ptt180 -52.32 -32.48 9.13 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 113.709 1.003 . . . . 10.0 113.709 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.609 ' HD3' ' CG ' ' A' ' 68' ' ' ARG . 53.4 Cg_endo -74.66 76.58 3.21 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 CA-C-N 120.038 1.049 . . . . 10.0 110.325 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.548 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -101.0 -29.98 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.87 -1.144 . . . . 10.0 111.184 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.473 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 43.9 24.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 10.0 110.667 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.406 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.6 OUTLIER -164.3 98.59 0.91 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.915 -1.115 . . . . 10.0 111.678 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' HD21 ' B' ' 39' ' ' LEU . 48.4 Cg_endo -69.76 167.66 23.81 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.925 1.487 . . . . 10.0 111.134 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 67.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.537 -0.727 . . . . 10.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.615 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 52.6 m -145.42 97.85 3.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.398 -0.814 . . . . 10.0 109.493 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.484 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 64.5 m-20 -33.7 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.169 0.509 . . . . 10.0 111.36 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.539 ' N ' ' O ' ' A' ' 75' ' ' THR . 0.4 OUTLIER -122.26 120.25 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.085 -1.01 . . . . 10.0 110.423 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 39.3 m-85 -116.48 140.61 49.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.616 -0.677 . . . . 10.0 109.735 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.497 ' O ' HG11 ' A' ' 9' ' ' VAL . 1.1 mm? -113.96 98.96 7.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.932 -1.105 . . . . 10.0 108.819 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.537 ' N ' HG13 ' A' ' 9' ' ' VAL . 12.9 p -106.31 148.05 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.553 -0.717 . . . . 10.0 110.893 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.581 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 41.2 t -134.59 125.15 26.63 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.863 . . . . 10.0 110.805 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 13.6 p90 -136.66 157.72 46.11 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.242 -0.983 . . . . 10.0 110.345 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.428 ' OG ' HG23 ' A' ' 85' ' ' VAL . 44.0 t -83.4 137.69 33.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 10.0 112.133 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.527 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 18.7 m -90.53 2.32 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.666 -0.646 . . . . 10.0 109.859 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.509 ' O ' HD13 ' A' ' 129' ' ' LEU . 35.0 m -119.21 48.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 10.0 109.187 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.546 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . 21.1 p -133.36 176.69 2.71 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.546 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 42.3 Cg_endo -70.52 158.8 54.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.306 1.161 . . . . 10.0 110.733 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 87' ' ' PRO . 3.6 m -31.3 87.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.477 0.656 . . . . 10.0 111.899 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' PRO . 31.0 t -117.14 -54.2 2.42 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 10.0 109.832 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.609 ' CE1' ' HE2' ' A' ' 94' ' ' LYS . 8.8 t80 -49.41 -38.49 29.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.105 . . . . 10.0 109.303 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -60.84 -35.4 76.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 10.0 109.719 179.222 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.516 ' ND2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -69.96 -15.43 63.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.362 -0.836 . . . . 10.0 109.527 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.534 ' O ' ' NE1' ' A' ' 97' ' ' TRP . 62.1 t -87.76 -16.0 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.209 -0.932 . . . . 10.0 109.405 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.609 ' HE2' ' CE1' ' A' ' 90' ' ' PHE . 2.6 mmtt -85.8 -29.54 23.71 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 5.7 pt-20 -94.4 5.97 50.16 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.481 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -95.92 -51.83 4.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 10.0 112.317 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.534 ' NE1' ' O ' ' A' ' 93' ' ' VAL . 49.6 p-90 -104.06 -25.5 12.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.748 -1.22 . . . . 10.0 111.694 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.0 t -64.87 -41.91 59.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.838 -1.164 . . . . 10.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.7 Cg_endo -82.65 -23.32 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.431 1.227 . . . . 10.0 110.635 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.454 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.5 mm-40 -93.87 7.48 44.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.031 . . . . 10.0 110.363 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.5 HD12 HG23 ' A' ' 101' ' ' ILE . 37.0 mm 59.32 103.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 10.0 111.023 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.495 ' CG2' ' N ' ' A' ' 103' ' ' HIS . 1.6 m -44.7 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.428 -0.952 . . . . 10.0 108.428 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.551 ' O ' ' CB ' ' A' ' 104' ' ' HIS . 21.3 m-70 -113.23 -6.38 13.61 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.497 -0.752 . . . . 10.0 109.295 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.578 ' O ' ' CB ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER 157.07 16.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 -178.267 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.669 ' N ' ' CD ' ' A' ' 106' ' ' PRO . 5.5 t 83.04 34.65 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.853 -0.53 . . . . 10.0 110.026 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.669 ' CD ' ' N ' ' A' ' 105' ' ' CYS . 56.8 Cg_endo -80.85 -18.27 9.15 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 O-C-N 123.177 1.093 . . . . 10.0 109.603 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.554 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 64.0 54.22 1.74 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.596 0.713 . . . . 10.0 110.558 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.516 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 13.5 t -52.29 157.8 2.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.505 -0.747 . . . . 10.0 109.552 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.516 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 42.4 Cg_endo -70.5 140.0 38.91 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.294 1.154 . . . . 10.0 110.404 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' O ' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -135.61 112.41 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.297 -0.877 . . . . 10.0 109.662 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.564 HD12 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -77.08 97.63 4.77 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.106 -0.996 . . . . 10.0 109.242 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.629 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 11.2 mt -69.91 141.01 53.19 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.581 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 47.0 t -140.94 168.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.805 -1.184 . . . . 10.0 112.509 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.517 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -107.52 159.23 14.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.285 -1.926 . . . . 10.0 108.285 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' C ' ' A' ' 82' ' ' PHE . 85.5 m -115.55 120.41 39.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.399 . . . . 10.0 111.341 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.32 55.57 5.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.582 -0.699 . . . . 10.0 111.375 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.723 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -55.74 -22.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.084 . . . . 10.0 108.714 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 21.3 t70 -52.0 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.453 1.12 . . . . 10.0 110.708 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.723 ' N ' ' O ' ' A' ' 117' ' ' ILE . 16.0 tp 159.71 -24.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.447 -1.252 . . . . 10.0 108.381 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -49.12 -42.77 40.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.748 -0.595 . . . . 10.0 109.6 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.404 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m-20 -53.92 -20.2 5.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.021 -1.049 . . . . 10.0 109.234 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.479 ' CB ' HD11 ' A' ' 119' ' ' LEU . 51.8 t0 -82.53 118.0 70.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.688 . . . . 10.0 110.537 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 48.4 Cg_endo -90.58 23.0 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.661 1.574 . . . . 10.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 p -101.36 -49.41 4.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 10.0 110.149 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.435 HG21 HD23 ' A' ' 119' ' ' LEU . 6.1 t -78.89 -26.83 43.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.201 -2.148 . . . . 10.0 105.201 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.54 ' HA ' HD23 ' A' ' 129' ' ' LEU 0.281 1.1 mp -56.66 -26.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 176.858 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.476 ' O ' ' HB2' ' A' ' 130' ' ' ALA . 53.2 tt0 -49.38 -35.07 17.74 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.636 -0.711 . . . . 10.0 111.128 -179.588 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -61.81 -38.31 87.64 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.188 -0.945 . . . . 10.0 110.744 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.567 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -59.03 -32.9 70.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 10.0 110.086 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -56.23 -45.01 80.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 10.0 109.833 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -55.94 -16.89 5.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.337 -0.852 . . . . 10.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.99 -18.3 5.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.922 -1.111 . . . . 10.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -165.57 110.54 0.87 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.014 -1.054 . . . . 10.0 109.998 -179.301 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.52 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -71.91 -24.62 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 10.0 110.511 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -98.12 104.83 24.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 10.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 44.1 Cg_endo -71.54 154.47 60.11 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.793 1.417 . . . . 10.0 110.379 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.527 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.5 tp -94.08 135.38 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 10.0 109.013 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.494 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 16.2 p -124.01 168.81 11.8 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.325 -0.859 . . . . 10.0 109.589 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.505 ' HA ' ' CD1' ' A' ' 154' ' ' TYR . 42.0 Cg_endo -66.3 -15.27 47.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.527 1.278 . . . . 10.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.66 -37.81 22.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 10.0 110.426 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.6 m -79.33 -32.66 43.4 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.538 -0.726 . . . . 10.0 110.821 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.27 -44.86 74.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 10.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HG3' ' N ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -64.52 -27.76 69.19 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.27 -0.972 . . . . 10.0 109.453 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.477 ' N ' ' HG3' ' A' ' 143' ' ' GLU . 2.0 mmtp -67.53 -43.89 79.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.11 -0.994 . . . . 10.0 108.639 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.574 ' CD1' ' HE3' ' A' ' 94' ' ' LYS . 4.3 tt -63.05 -46.22 88.53 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.416 ' HA ' ' HB1' ' A' ' 151' ' ' ALA . . . -52.22 -43.12 64.1 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.816 0.817 . . . . 10.0 109.179 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.46 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 3.8 ttp85 -55.6 -28.74 56.89 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.524 0.678 . . . . 10.0 109.463 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.432 ' HB3' ' CD1' ' A' ' 149' ' ' LEU . 22.9 t70 -78.17 -43.95 27.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.623 -0.673 . . . . 10.0 110.776 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.691 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 5.7 mp -88.06 9.83 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 10.0 108.88 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.499 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 10.2 mttt 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.895 0.855 . . . . 10.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.448 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.9 -151.34 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.197 -0.668 . . . . 10.0 109.197 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.564 ' CG1' HD12 ' A' ' 111' ' ' LEU . 1.4 p -116.86 -64.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.594 -1.316 . . . . 10.0 110.747 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.431 ' HB2' ' O ' ' A' ' 152' ' ' VAL . 0.8 OUTLIER -173.9 140.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.453 -1.404 . . . . 10.0 111.863 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.629 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 29.0 t80 -84.78 108.06 17.27 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.388 -0.925 . . . . 10.0 109.889 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.6 OUTLIER -103.61 -169.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.752 . . . . 10.0 110.174 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.535 ' CG ' ' O ' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -127.74 160.29 32.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.958 . . . . 10.0 110.14 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.634 ' HB2' ' HA ' ' A' ' 165' ' ' LEU 0.251 1.6 t -166.02 135.87 3.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 10.0 110.238 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.556 ' OG ' ' CG ' ' A' ' 163' ' ' LYS . 34.2 m -131.17 83.88 2.14 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.078 -1.453 . . . . 10.0 107.078 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.501 ' HB3' ' CD1' ' A' ' 19' ' ' LEU . . . -29.26 -53.2 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.691 -1.141 . . . . 10.0 113.132 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.407 ' CD1' ' C ' ' A' ' 160' ' ' LEU . 1.8 tp -71.06 -53.75 13.6 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.693 -1.254 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.4 p -84.74 -89.54 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.911 -1.118 . . . . 10.0 111.169 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.6 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 2.4 pt20 159.28 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 10.0 109.364 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.556 ' CG ' ' OG ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -105.33 69.19 0.83 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.026 -1.069 . . . . 10.0 110.591 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.528 ' HA3' ' HG2' ' A' ' 156' ' ' GLU . . . 76.98 0.93 71.24 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.993 -1.643 . . . . 10.0 108.993 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.642 ' CD1' ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -50.12 -44.41 52.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.42 -1.047 . . . . 10.0 109.608 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.474 ' N ' HD12 ' A' ' 165' ' ' LEU . 14.8 tttm -70.69 -25.64 63.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.156 -0.965 . . . . 10.0 109.367 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.436 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 19.3 m120 -75.45 -33.89 60.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 10.0 111.641 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 10.7 t -57.96 -49.75 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.786 -1.197 . . . . 10.0 110.056 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.26 -40.0 88.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.659 -0.651 . . . . 10.0 110.43 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.478 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 20.6 t0 -60.12 -46.41 89.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 10.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.5 -42.63 99.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 10.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.541 ' CB ' ' HG ' ' A' ' 111' ' ' LEU . . . -56.28 -24.52 43.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 10.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.572 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 77.4 mt -63.92 -47.03 92.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.115 -0.99 . . . . 10.0 109.595 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.526 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.07 -41.45 70.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 10.0 111.087 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.51 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -80.71 -2.72 48.0 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.198 -0.938 . . . . 10.0 110.899 -179.325 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.588 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -87.67 -22.5 24.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.045 -1.035 . . . . 10.0 110.821 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.572 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -90.06 -22.19 21.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.077 -1.015 . . . . 10.0 110.138 -179.324 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.025 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.254 -1.538 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -124.23 140.44 52.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.174 -1.192 . . . . 10.0 110.475 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.459 ' HE2' HD12 ' A' ' 174' ' ' LEU . 10.1 tptt -84.26 103.15 13.21 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.204 -0.935 . . . . 10.0 108.511 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -82.66 152.61 25.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.238 -0.914 . . . . 10.0 110.692 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.631 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.76 -48.14 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.77 -0.581 . . . . 10.0 110.555 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.631 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.2 Cg_endo -91.32 24.06 0.58 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.977 -1.201 . . . . 10.0 108.977 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.599 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 2.0 pm0 -39.55 166.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.544 0.688 . . . . 10.0 111.659 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.85 -88.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 10.0 111.192 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 86.5 p -82.37 171.19 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 10.0 111.96 -178.612 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.673 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.96 96.8 0.48 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 10.0 111.818 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.489 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 46.9 Cg_endo -76.1 133.61 15.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.418 1.22 . . . . 10.0 109.117 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 56.4 p -93.16 117.95 30.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 10.0 111.105 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.09 136.45 54.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.523 -0.736 . . . . 10.0 109.303 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.564 ' HA ' ' CG1' ' A' ' 42' ' ' VAL . 11.4 p90 -139.98 166.53 24.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.939 -1.101 . . . . 10.0 110.635 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 2.6 tt0 -164.19 110.88 1.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.087 -1.008 . . . . 10.0 110.78 -179.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.583 ' HA ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 p80 -165.76 137.54 3.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 10.0 110.17 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.508 ' C ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -150.59 98.48 2.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 10.0 110.636 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.573 HG13 ' HA ' ' A' ' 38' ' ' ASP . 0.1 OUTLIER -155.55 -170.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.478 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.4 p-80 -141.81 153.75 44.73 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 117.6 -1.64 . . . . 10.0 112.605 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.585 HG11 ' HA ' ' A' ' 35' ' ' THR . 3.5 m -103.39 152.34 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.461 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.499 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -124.09 73.77 0.4 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.742 -1.218 . . . . 10.0 110.313 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.553 ' CD2' HG22 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 167.4 97.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.385 -1.067 . . . . 10.0 109.189 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.403 ' O ' ' C ' ' B' ' 24' ' ' ALA . 21.1 m-20 -61.33 154.48 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.438 -0.789 . . . . 10.0 111.815 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.475 ' HB2' ' HA ' ' A' ' 32' ' ' TYR . . . 39.76 38.11 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.638 . . . . 10.0 111.065 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.553 HG22 ' CD2' ' B' ' 22' ' ' PHE . 37.1 t -111.39 -23.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 10.0 108.821 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.555 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 10.0 t -88.97 -10.61 47.04 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.36 0.6 . . . . 10.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.63 -0.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.517 -1.433 . . . . 10.0 109.517 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.55 ' O ' ' HG3' ' B' ' 28' ' ' GLU . 6.8 pt-20 -104.51 122.11 44.86 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.969 -1.312 . . . . 10.0 110.733 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.3 OUTLIER -121.59 118.61 29.66 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.736 -0.839 . . . . 10.0 108.736 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.566 HG23 ' CE1' ' A' ' 28' ' ' PHE . 23.0 p -122.19 -4.99 8.93 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.986 -0.685 . . . . 10.0 109.589 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.89 39.09 0.78 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.167 -1.573 . . . . 10.0 109.167 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.494 HG23 HD13 ' B' ' 32' ' ' ILE . 28.4 mm -69.0 142.15 92.94 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.329 -1.1 . . . . 10.0 110.435 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.498 ' O ' ' C ' ' B' ' 34' ' ' GLU . 45.0 Cg_endo -68.9 177.61 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.293 1.681 . . . . 10.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.588 ' HG3' ' O ' ' B' ' 37' ' ' ALA . 5.4 tm-20 -23.09 138.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.437 0.637 . . . . 10.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.533 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 7.6 mm100 -100.81 -71.72 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.67 0.989 . . . . 10.0 113.67 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.546 ' CZ3' HG11 ' A' ' 7' ' ' VAL . 16.5 t90 -108.69 30.36 6.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.357 -0.839 . . . . 10.0 112.611 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.588 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -178.18 89.3 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 118.986 -1.086 . . . . 10.0 111.383 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.546 ' HA ' ' HG3' ' B' ' 34' ' ' GLU . 5.3 ttp180 -82.87 43.3 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.504 HD21 ' HD3' ' A' ' 73' ' ' PRO . 0.6 OUTLIER -50.75 -49.88 56.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.892 -178.541 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.68 13.29 26.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.197 -0.939 . . . . 10.0 110.284 -179.837 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.434 ' CB ' ' HG2' ' B' ' 38' ' ' ARG . 2.6 mt-30 -120.89 10.72 10.93 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.805 -0.559 . . . . 10.0 110.134 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 14.5 t -83.36 173.86 11.19 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.134 -0.979 . . . . 10.0 109.503 179.667 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.76 18.39 0.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 10.0 111.139 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 5.4 m120 -129.2 137.76 51.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.898 -1.126 . . . . 10.0 110.689 179.894 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -39.98 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 10.0 111.271 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 118.039 -0.982 . . . . 10.0 110.33 -178.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.513 ' HE1' ' OE1' ' A' ' 49' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.283 0.563 . . . . 10.0 109.703 . . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -177.9 -160.74 0.05 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 10.0 110.749 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.514 ' N ' ' HG2' ' A' ' 2' ' ' GLN . 85.0 m 41.25 58.29 2.64 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.36 -0.837 . . . . 10.0 111.019 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.615 HG13 ' N ' ' A' ' 5' ' ' LYS . 0.3 OUTLIER -143.16 150.52 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 117.28 -1.768 . . . . 10.0 113.804 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.615 ' N ' HG13 ' A' ' 4' ' ' ILE . 27.9 mtmt -131.32 126.1 34.45 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.279 -0.888 . . . . 10.0 109.601 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.463 ' C ' ' CG2' ' A' ' 7' ' ' VAL . 10.0 t -85.36 129.98 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.133 -0.979 . . . . 10.0 109.336 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.485 HG21 ' HB2' ' A' ' 76' ' ' ASP . 4.1 t -146.97 175.97 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.919 -1.113 . . . . 10.0 110.421 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.516 HG21 ' CG2' ' A' ' 17' ' ' THR . 0.0 OUTLIER -108.93 146.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.537 -1.352 . . . . 10.0 111.178 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.625 ' CG1' ' N ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.27 -168.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.211 -0.93 . . . . 10.0 110.389 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.625 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 114.02 134.9 5.96 Favored Glycine 0 C--N 1.29 -1.994 0 N-CA-C 109.251 -1.54 . . . . 10.0 109.251 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.24 -14.8 19.72 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.507 -0.996 . . . . 10.0 110.054 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.49 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 163.49 -108.17 0.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.941 -1.664 . . . . 10.0 108.941 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 69.54 -130.3 0.08 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.03 -1.277 . . . . 10.0 110.933 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.518 ' C ' ' HG3' ' B' ' 35' ' ' GLN . 17.8 m -110.4 148.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.186 . . . . 10.0 110.618 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.502 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -51.58 137.95 29.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.518 ' NZ ' ' O ' ' A' ' 9' ' ' VAL . 0.1 OUTLIER -103.6 -28.27 11.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.671 -1.488 . . . . 10.0 110.72 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.516 ' CG2' HG21 ' A' ' 8' ' ' VAL . 77.1 p -88.88 -37.44 15.31 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.492 -0.755 . . . . 10.0 110.336 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.547 ' SG ' ' CD2' ' A' ' 19' ' ' LEU . 21.8 p -85.35 -13.46 49.47 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.925 -1.109 . . . . 10.0 109.745 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.644 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 4.4 mm? -81.9 -42.89 18.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.36 -1.463 . . . . 10.0 109.048 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.407 ' C ' ' O ' ' A' ' 19' ' ' LEU . 5.6 tt -46.85 -37.74 9.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.632 -1.248 . . . . 10.0 107.632 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.556 ' CG2' ' CG2' ' A' ' 25' ' ' THR 0.256 5.6 mm -67.86 -46.99 81.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.779 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.472 ' OG ' ' O ' ' A' ' 19' ' ' LEU . 47.5 p -48.3 -31.52 6.11 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.596 -0.842 . . . . 10.0 109.843 -179.279 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.644 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 3.4 m-85 -93.77 -18.86 21.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.785 -1.197 . . . . 10.0 109.399 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.418 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 93.5 m -94.4 -22.5 18.26 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 10.0 112.604 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.556 ' CG2' ' CG2' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -109.16 -77.84 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.033 -1.667 . . . . 10.0 110.891 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.633 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 80.4 m-20 -152.19 -23.68 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.144 -1.423 . . . . 10.0 113.025 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.633 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 49.5 pttt 167.68 -158.7 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 O-C-N 120.855 -1.153 . . . . 10.0 112.481 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.592 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 2.7 p90 -120.5 -15.74 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 115.055 1.502 . . . . 10.0 115.055 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 42.6 Cg_endo -70.31 -63.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 CA-C-N 120.041 1.05 . . . . 10.0 113.335 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -165.5 73.48 0.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.567 -1.333 . . . . 10.0 109.701 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' OE1' ' N ' ' A' ' 26' ' ' ASN . 2.5 pt-20 -108.65 164.71 12.12 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.953 0.882 . . . . 10.0 110.927 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -82.06 99.16 9.01 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.025 0.917 . . . . 10.0 109.03 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.567 HG12 ' HA3' ' B' ' 27' ' ' GLY 0.286 6.6 m -112.5 169.99 5.76 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.935 -177.44 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.519 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 42.0 Cg_endo -63.48 -150.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 124.097 1.577 . . . . 10.0 109.25 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.544 ' HB ' HG12 ' B' ' 20' ' ' VAL . 34.6 p -109.14 134.01 52.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.312 -1.492 . . . . 10.0 113.358 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.629 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 44.3 t -57.07 -74.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.777 -0.577 . . . . 10.0 109.752 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.66 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 19.8 t80 -45.05 123.43 3.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.543 ' HA ' ' CD1' ' B' ' 18' ' ' ILE . 12.1 t0 -149.73 86.59 1.46 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.381 -1.328 . . . . 10.0 111.479 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.486 ' N ' HD13 ' B' ' 18' ' ' ILE . 19.1 t-20 -97.82 99.98 11.33 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.721 -1.215 . . . . 10.0 107.721 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.527 ' CE1' ' O ' ' B' ' 16' ' ' HIS . 2.3 m-85 -122.69 121.44 36.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.661 . . . . 10.0 109.63 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' B' ' 14' ' ' PHE . . . -112.48 116.12 29.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 10.0 110.253 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.452 ' CG2' ' HB3' ' B' ' 15' ' ' GLU . 40.1 t -132.86 173.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.897 -1.127 . . . . 10.0 110.244 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.482 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 67.6 m -155.03 151.27 28.23 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.767 -0.773 . . . . 10.0 110.216 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.505 HG13 ' HA ' ' B' ' 12' ' ' SER . 0.1 OUTLIER -144.83 128.67 12.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.491 -0.883 . . . . 10.0 111.357 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.571 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -86.8 97.57 10.7 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.336 -0.946 . . . . 10.0 109.417 178.628 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.496 ' N ' HD11 ' A' ' 46' ' ' ILE . 2.9 mp -78.96 114.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.073 -1.017 . . . . 10.0 108.27 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.633 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 55.69 19.76 21.84 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 118.654 -1.736 . . . . 10.0 109.189 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.93 -8.13 31.5 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.349 -1.089 . . . . 10.0 110.645 179.623 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.513 ' OE1' ' HE1' ' A' ' 1' ' ' MET . 30.1 mm-40 -96.43 105.33 21.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.28 . . . . 10.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.477 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 44.3 Cg_endo -71.19 130.71 18.0 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.495 1.463 . . . . 10.0 110.387 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.493 ' CE1' HD13 ' A' ' 46' ' ' ILE . 3.8 m-30 -98.18 118.31 34.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.838 -1.163 . . . . 10.0 111.616 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.591 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 1.7 p -92.28 99.23 12.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.077 -1.014 . . . . 10.0 108.568 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.03 147.33 44.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.039 -1.038 . . . . 10.0 110.94 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -129.62 109.52 0.96 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.04 -1.624 . . . . 10.0 109.04 179.278 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.529 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.9 OUTLIER -98.28 127.45 44.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -1.204 . . . . 10.0 110.543 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.413 ' N ' HD21 ' A' ' 55' ' ' LEU . 11.5 t80 -137.92 122.12 18.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.947 . . . . 10.0 111.283 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -107.8 164.73 12.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.902 -1.124 . . . . 10.0 109.719 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' B' ' 36' ' ' TRP . 99.6 m -47.44 164.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.798 -1.189 . . . . 10.0 111.001 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' A' ' 62' ' ' GLU . . . -104.74 91.68 3.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.73 -0.606 . . . . 10.0 109.961 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.553 ' HA3' HG21 ' B' ' 20' ' ' VAL . . . -48.01 -41.47 21.76 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.843 -2.503 . . . . 10.0 106.843 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.495 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 20.3 pt20 -71.87 -31.93 66.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 5.6 mt-10 56.42 81.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.813 0.816 . . . . 10.0 111.681 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.537 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 97.9 m-20 -126.38 3.92 6.98 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.32 0.581 . . . . 10.0 109.513 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 171.46 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 10.0 110.911 -178.915 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 5.4 p-10 -113.83 15.61 18.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.828 -1.17 . . . . 10.0 110.808 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.567 ' HB2' ' HB2' ' B' ' 43' ' ' SER . 11.7 ptt-85 -77.83 -33.99 52.09 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.091 -1.006 . . . . 10.0 110.136 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.581 ' HA ' HD23 ' A' ' 70' ' ' LEU . 4.9 mt -111.41 5.27 19.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.909 -1.12 . . . . 10.0 111.726 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.444 ' NH2' ' HG3' ' A' ' 68' ' ' ARG . 0.0 OUTLIER -97.07 -54.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.474 -1.391 . . . . 10.0 113.296 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.486 ' CD ' ' O ' ' A' ' 65' ' ' ASP . 42.8 Cg_endo -71.46 -62.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.233 1.123 . . . . 10.0 111.335 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.713 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -50.62 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.383 -0.823 . . . . 10.0 111.855 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.627 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 17.4 p -31.37 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.416 0.626 . . . . 10.0 110.371 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 p90 48.13 138.62 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.3 0 N-CA-C 113.383 0.883 . . . . 10.0 113.383 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.97 167.28 27.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.65 1.567 . . . . 10.0 111.205 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -83.39 32.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.19 -0.944 . . . . 10.0 110.588 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 27.7 m -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.599 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 4.6 p-10 160.78 118.69 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.525 HG13 HD13 ' A' ' 4' ' ' ILE . 16.0 m -64.47 157.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.944 -1.872 . . . . 10.0 105.944 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 72' ' ' TYR . 43.9 m-85 -121.86 155.63 35.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.085 -1.634 . . . . 10.0 114.451 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.554 ' CD1' HG13 ' A' ' 168' ' ' VAL . 2.3 mm? -118.71 97.68 5.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.425 ' HB ' HG13 ' A' ' 9' ' ' VAL . 14.3 p -110.03 154.97 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.119 -0.988 . . . . 10.0 109.708 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.519 ' CB ' ' OG1' ' A' ' 115' ' ' THR . 4.7 m -123.3 109.33 13.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.946 -1.096 . . . . 10.0 111.663 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.417 ' CE1' HG22 ' A' ' 93' ' ' VAL . 93.8 m-85 -87.89 168.7 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 10.0 109.918 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.2 m -75.91 157.59 33.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.988 -1.07 . . . . 10.0 108.417 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.477 HG23 ' HG3' ' A' ' 120' ' ' ARG . 3.5 p -81.91 -23.1 9.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.745 -1.222 . . . . 10.0 111.09 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.591 ' CG1' ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -129.86 -88.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.847 -1.158 . . . . 10.0 108.808 178.251 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.575 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 44.52 -171.72 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.497 -0.752 . . . . 10.0 109.675 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.575 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 53.3 Cg_endo -73.34 162.84 39.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.421 1.222 . . . . 10.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -63.03 78.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.117 . . . . 10.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.501 ' N ' ' O ' ' A' ' 87' ' ' PRO . 29.1 t -106.36 -45.83 4.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.848 . . . . 10.0 110.791 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.447 ' O ' HG21 ' A' ' 93' ' ' VAL . 62.5 t80 -49.14 -19.4 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.156 -0.965 . . . . 10.0 110.193 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 7.3 mm-40 -78.79 -19.75 51.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.333 -0.855 . . . . 10.0 111.634 -179.378 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.514 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -93.68 -14.6 26.19 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.388 -1.445 . . . . 10.0 109.38 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.484 HG23 ' N ' ' A' ' 94' ' ' LYS . 31.5 m -85.58 -30.87 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.215 -0.994 . . . . 10.0 108.435 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.517 ' HE2' ' CD1' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.16 -25.68 59.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.118 -0.989 . . . . 10.0 109.801 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.528 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -96.23 3.21 53.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 10.0 111.109 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.26 -50.33 3.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.571 -1.331 . . . . 10.0 111.06 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.64 -40.22 13.48 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.92 -1.112 . . . . 10.0 113.251 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.558 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 55.9 t -70.78 -51.62 11.35 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.33 -1.481 . . . . 10.0 112.806 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 40.1 Cg_endo -64.71 -21.1 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.311 1.164 . . . . 10.0 109.365 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.584 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 64.6 tt0 -51.39 -57.0 10.12 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.127 -0.983 . . . . 10.0 109.999 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.584 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 149.67 119.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 109.743 -0.465 . . . . 10.0 109.743 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 108' ' ' THR . 25.3 m -92.36 -83.97 0.29 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.515 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 36.7 m-70 -107.73 -11.47 15.41 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.515 ' HB3' ' O ' ' A' ' 103' ' ' HIS . 4.5 p80 173.11 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.565 -1.272 . . . . 10.0 107.565 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.444 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 96.9 m -130.98 164.98 38.38 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.456 ' HB2' ' CG1' ' A' ' 98' ' ' VAL . 38.8 Cg_endo -67.88 92.04 0.37 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 123.608 1.32 . . . . 10.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.551 ' CG ' ' O ' ' A' ' 107' ' ' LYS . 1.6 tttt -139.31 9.45 2.49 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.441 -0.787 . . . . 10.0 109.982 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.459 ' OG1' ' OG1' ' A' ' 102' ' ' THR . 23.6 m -46.21 139.95 5.47 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.679 -1.263 . . . . 10.0 109.843 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HG3' HG11 ' A' ' 77' ' ' VAL . 51.2 Cg_endo -70.76 117.65 5.26 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.003 1.528 . . . . 10.0 108.352 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.429 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -126.59 110.23 12.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.289 -0.882 . . . . 10.0 111.711 -177.954 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.588 ' CD1' ' CG1' ' A' ' 152' ' ' VAL . 1.2 mm? -85.6 98.08 10.45 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.526 -1.287 . . . . 10.0 107.526 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.428 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 70.1 mt -84.13 127.87 34.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.042 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.531 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 19.2 t -133.5 165.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.857 . . . . 10.0 110.131 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.409 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -116.28 112.25 2.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -92.89 160.86 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.375 -1.073 . . . . 10.0 111.358 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 59.93 43.72 14.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.497 -0.752 . . . . 10.0 110.481 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.732 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -74.32 -18.97 17.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 179.054 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.537 ' N ' HD12 ' A' ' 117' ' ' ILE . 13.2 m-20 -53.46 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 122.7 1.238 . . . . 10.0 110.499 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.732 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.8 pp 166.44 -27.68 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 114.138 -1.392 . . . . 10.0 107.596 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.518 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.0 OUTLIER -46.12 -41.75 12.81 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.726 0.774 . . . . 10.0 109.07 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.88 -23.31 63.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.549 0.69 . . . . 10.0 110.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.469 ' OD2' ' HB3' ' A' ' 124' ' ' SER . 27.0 t70 -93.04 119.63 67.56 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 10.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.92 21.83 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 124.277 1.672 . . . . 10.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.469 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 32.2 t -107.19 -45.0 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 10.0 110.169 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.401 HG21 HD13 ' A' ' 126' ' ' ILE . 7.1 t -71.63 -30.26 65.57 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 176.271 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.52 HD11 ' CD1' ' A' ' 129' ' ' LEU 0.315 0.9 OUTLIER -50.87 -26.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.188 -1.369 . . . . 10.0 108.315 177.18 . . . . . . . . 4 4 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -54.8 -40.45 69.5 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.509 0.671 . . . . 10.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.484 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -81.86 -36.03 28.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.462 -0.773 . . . . 10.0 109.904 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.534 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 8.5 mt -59.41 -45.29 91.92 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.778 -1.201 . . . . 10.0 108.586 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.46 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -49.01 -39.27 26.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 10.0 110.357 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.484 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -53.95 -19.09 4.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.571 -0.706 . . . . 10.0 111.13 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.548 ' ND2' ' HG2' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -118.36 -2.15 11.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.311 -1.356 . . . . 10.0 111.964 -178.189 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.548 ' HG2' ' ND2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -158.15 -25.51 0.08 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.148 -0.97 . . . . 10.0 111.043 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.523 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 40.79 19.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.753 -0.592 . . . . 10.0 111.595 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' LYS . 1.2 ptmt -153.77 95.1 2.87 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.776 -1.203 . . . . 10.0 110.036 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.591 ' HB3' ' CG1' ' A' ' 85' ' ' VAL . 44.4 Cg_endo -71.07 156.84 59.13 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 O-C-N 124.055 1.555 . . . . 10.0 110.357 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . . . . . . . . . 2.0 mm -93.7 122.35 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 10.0 109.779 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.545 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.1 p -118.95 173.36 3.48 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.515 -0.74 . . . . 10.0 109.219 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.545 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.8 Cg_endo -63.37 -10.17 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.803 0.896 . . . . 10.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -94.12 -44.96 7.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 10.0 109.836 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -48.78 45.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 10.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.431 ' CB ' ' CG ' ' A' ' 154' ' ' TYR . . . -62.47 -40.38 96.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 10.0 111.297 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.403 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 27.0 tt0 -61.18 -39.85 91.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.126 . . . . 10.0 109.526 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -60.61 -49.55 77.07 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.665 -1.214 . . . . 10.0 108.416 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.517 ' CD1' ' HE2' ' A' ' 94' ' ' LYS . 4.3 tt -57.82 -37.79 74.41 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.028 -1.045 . . . . 10.0 109.238 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.519 ' O ' HD13 ' A' ' 149' ' ' LEU . . . -66.57 -35.61 80.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 120.017 -0.673 . . . . 10.0 109.633 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -15.44 60.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.141 -0.975 . . . . 10.0 109.277 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.462 ' OD1' ' O ' ' A' ' 148' ' ' ASP . 11.8 t0 -70.3 -10.41 58.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.436 -0.79 . . . . 10.0 110.928 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.666 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.75 31.06 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 10.0 111.028 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.4 ' HG3' ' C ' ' A' ' 149' ' ' LEU . 3.4 mtpt 60.03 36.65 21.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.82 0.819 . . . . 10.0 110.314 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.49 ' HB2' ' CB ' ' A' ' 146' ' ' ALA . . . -71.19 -176.23 1.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.588 ' CG1' ' CD1' ' A' ' 111' ' ' LEU . 12.7 t -87.48 -81.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.459 ' HD2' ' OE2' ' A' ' 171' ' ' GLU . 1.6 tttp -173.74 159.38 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.549 -0.72 . . . . 10.0 110.072 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CG ' ' CB ' ' A' ' 142' ' ' ALA . 43.1 t80 -93.98 100.37 12.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.714 -1.241 . . . . 10.0 109.886 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.588 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -95.15 -167.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.51 -0.744 . . . . 10.0 109.328 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -136.05 149.65 48.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.66 -1.275 . . . . 10.0 112.262 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.549 ' HB2' ' CB ' ' A' ' 165' ' ' LEU . 0.7 OUTLIER -162.9 138.41 6.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.335 -0.853 . . . . 10.0 109.424 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' LEU . 5.0 t -148.13 114.18 5.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 10.0 110.065 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.67 ' CB ' ' CE2' ' B' ' 29' ' ' PHE . . . 3.21 -65.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.739 1.385 . . . . 10.0 114.739 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.546 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -131.9 -38.51 1.12 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.758 -1.214 . . . . 10.0 112.079 -177.428 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.1 p -60.91 -71.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 10.0 111.788 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.52 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 4.4 mm100 -36.6 -69.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.631 -0.668 . . . . 10.0 111.43 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.629 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER 66.05 25.27 10.92 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.637 -0.825 . . . . 10.0 110.532 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.82 2.89 9.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.192 -1.963 . . . . 10.0 108.192 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.632 HD13 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -58.27 -14.76 7.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.666 -0.902 . . . . 10.0 111.944 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.424 ' H ' HD11 ' A' ' 165' ' ' LEU . 9.4 mtmt -63.15 -36.07 82.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.445 -1.409 . . . . 10.0 110.952 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -63.86 -38.56 91.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 10.0 111.103 -179.243 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.588 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 5.8 t -52.8 -34.38 20.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.815 -1.178 . . . . 10.0 110.412 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.89 -24.28 55.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 10.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.415 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -74.21 -43.89 55.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.042 -1.063 . . . . 10.0 110.088 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.459 ' OE2' ' HD2' ' A' ' 153' ' ' LYS . 36.4 mt-10 -60.58 -32.94 72.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 10.0 109.995 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -61.23 -24.78 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.772 -1.205 . . . . 10.0 109.76 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 18.8 mm -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.08 -1.013 . . . . 10.0 109.736 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.534 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -76.41 -41.88 46.22 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.004 -1.06 . . . . 10.0 109.986 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.531 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -79.81 -4.2 51.08 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.447 -0.783 . . . . 10.0 109.824 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.494 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . . . -76.41 -43.17 41.59 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.191 -0.943 . . . . 10.0 108.95 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.528 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -108.09 -20.6 13.11 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.56 0.695 . . . . 10.0 109.814 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.184 -0.912 . . . . 10.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 108.517 -1.833 . . . . 10.0 108.517 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.525 ' O ' ' HG3' ' B' ' 4' ' ' GLU . 2.0 m -107.75 55.25 0.65 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.218 -1.166 . . . . 10.0 110.476 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -51.64 105.48 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 10.0 110.457 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.525 ' HG3' ' O ' ' B' ' 2' ' ' SER . 1.5 mt-10 -96.01 156.0 16.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.608 -0.682 . . . . 10.0 110.388 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.613 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -108.6 -50.3 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.159 -0.963 . . . . 10.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.613 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 55.6 Cg_endo -95.67 32.3 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 108.298 -1.462 . . . . 10.0 108.298 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.5 pp20? -38.57 158.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.912 -0.493 . . . . 10.0 109.676 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.633 HG13 ' HA2' ' A' ' 47' ' ' GLY . 2.1 pp -81.52 -53.33 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.233 . . . . 10.0 112.184 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.474 ' N ' HD11 ' B' ' 8' ' ' ILE . 30.6 t -160.94 173.81 14.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.325 -1.484 . . . . 10.0 111.462 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.571 ' CB ' ' O ' ' A' ' 45' ' ' MET . 1.2 pp -164.39 99.2 0.89 Allowed Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.119 -1.032 . . . . 10.0 111.929 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 44.2 Cg_endo -72.65 104.95 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.862 1.453 . . . . 10.0 109.343 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.505 ' HA ' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -53.02 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.956 . . . . 10.0 111.037 -179.29 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -138.31 -168.88 2.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' ALA . 21.6 m-85 -97.13 165.21 12.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.7 -1.25 . . . . 10.0 111.796 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.452 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 6.1 pm0 -119.85 171.05 8.69 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.8 -0.562 . . . . 10.0 110.39 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.527 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -92.16 -174.97 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.006 -1.059 . . . . 10.0 110.356 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.434 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -147.1 133.47 19.59 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.122 -0.986 . . . . 10.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.66 ' HB ' ' CE2' ' A' ' 37' ' ' PHE . 0.2 OUTLIER -150.07 -177.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.916 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -142.37 154.91 45.04 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.989 -1.069 . . . . 10.0 110.645 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.629 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 2.8 p -91.11 148.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 10.0 110.503 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -99.42 47.94 1.3 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.55 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -177.74 104.62 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.234 -1.156 . . . . 10.0 109.032 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.39 142.0 49.67 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.808 0.813 . . . . 10.0 112.343 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.51 ' HB2' ' O ' ' A' ' 31' ' ' GLU . . . 51.57 51.71 16.17 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.746 -0.596 . . . . 10.0 112.38 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.55 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 52.1 t -113.32 -39.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.649 -1.282 . . . . 10.0 110.547 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.551 HG22 ' CG2' ' A' ' 33' ' ' VAL . 3.1 t -61.58 -22.78 65.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.137 -0.977 . . . . 10.0 110.18 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.567 ' HA3' HG12 ' A' ' 33' ' ' VAL . . . -106.3 31.12 8.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 106.841 -2.504 . . . . 10.0 106.841 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.585 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 2.8 mp0 -128.55 114.07 16.26 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.261 1.029 . . . . 10.0 110.663 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.67 ' CE2' ' CB ' ' A' ' 159' ' ' ALA . 15.6 t80 -128.67 140.32 51.81 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.707 0.765 . . . . 10.0 109.955 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -146.29 -69.52 0.26 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.97 1.2 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.631 -1.271 . . . . 10.0 111.289 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.5 ' HB ' ' HD3' ' B' ' 33' ' ' PRO . 2.0 mt -63.29 -55.65 34.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.629 -1.512 . . . . 10.0 111.217 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.5 ' HD3' ' HB ' ' B' ' 32' ' ' ILE . 44.1 Cg_endo -70.56 169.38 20.07 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.326 1.172 . . . . 10.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.512 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.4 tp10 -78.63 167.67 20.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.991 -1.068 . . . . 10.0 109.371 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 11.5 mp0 -81.08 19.62 0.88 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.484 -0.76 . . . . 10.0 111.469 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.581 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 4.8 m95 89.9 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 123.074 1.416 . . . . 10.0 107.504 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.617 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . . . -156.81 81.09 0.94 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.217 -1.356 . . . . 10.0 108.613 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.512 ' CA ' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -82.68 35.32 0.46 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.061 -1.025 . . . . 10.0 108.719 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.482 HD23 ' HA ' ' A' ' 71' ' ' SER . 0.5 OUTLIER -58.55 -11.85 3.42 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.951 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.434 HD11 ' HG3' ' B' ' 41' ' ' GLN . 1.2 pp -71.68 -2.32 16.9 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.783 -1.198 . . . . 10.0 111.926 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.434 ' HG3' HD11 ' B' ' 40' ' ' LEU . 5.6 mt-30 -161.05 -89.21 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.379 -0.825 . . . . 10.0 109.73 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 8.8 t -137.8 -170.36 2.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.505 0.669 . . . . 10.0 110.224 179.776 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.567 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 82.6 p -86.97 6.07 34.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.442 -0.786 . . . . 10.0 111.113 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.416 ' O ' ' NH2' ' B' ' 38' ' ' ARG . 9.7 t-20 -87.73 96.76 10.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.051 -1.03 . . . . 10.0 111.413 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' THR . 22.4 mt -87.32 -65.9 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.95 . . . . 10.0 110.777 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.442 ' C ' ' O ' ' B' ' 45' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.932 -1.032 . . . . 10.0 110.08 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.471 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 1.5 mpp? . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.905 0.384 . . . . 10.0 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.558 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 2.3 mt-30 -139.01 -39.99 0.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 10.0 110.249 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.607 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -44.09 101.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.972 . . . . 10.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.555 ' CG2' ' O ' ' A' ' 52' ' ' THR . 2.1 tt -106.47 140.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.658 -1.217 . . . . 10.0 110.302 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.57 ' O ' HG23 ' A' ' 77' ' ' VAL . 2.7 mmtt -112.85 137.05 51.77 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.537 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 18.2 t -118.85 108.42 14.8 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.807 -1.183 . . . . 10.0 110.317 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.484 HG23 ' OG1' ' A' ' 75' ' ' THR . 9.1 t -137.81 163.62 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 10.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.422 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.1 t -87.02 141.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 10.0 110.548 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.417 HG22 ' C ' ' A' ' 8' ' ' VAL . 46.1 t -136.42 174.69 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.374 -0.829 . . . . 10.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.471 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 125.04 130.6 3.52 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.864 -1.295 . . . . 10.0 109.864 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.82 -27.57 43.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -1.075 . . . . 10.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.482 ' O ' ' CB ' ' A' ' 13' ' ' ALA . . . 140.92 127.61 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.02 -1.232 . . . . 10.0 110.02 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.482 ' CB ' ' O ' ' A' ' 12' ' ' GLY . . . 169.59 -67.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 10.0 109.703 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.513 ' HB ' ' CG2' ' A' ' 115' ' ' THR . 13.4 t -147.93 107.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 10.0 109.525 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.47 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -74.08 99.1 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.882 -1.287 . . . . 10.0 109.882 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.476 ' HG3' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -52.64 -36.97 57.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.296 . . . . 10.0 109.709 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 53.2 m -52.71 -39.57 62.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.436 -0.79 . . . . 10.0 110.792 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.49 ' O ' ' HB2' ' A' ' 22' ' ' SER . 14.5 p -81.89 -15.77 52.86 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.673 -1.267 . . . . 10.0 108.988 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.54 ' HB3' ' HA ' ' A' ' 159' ' ' ALA . 10.2 mt -84.34 -30.52 25.43 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.906 0.86 . . . . 10.0 109.12 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.542 ' HA ' HD13 ' A' ' 165' ' ' LEU . 0.6 OUTLIER -54.69 -39.3 67.99 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.488 ' O ' HG21 ' A' ' 25' ' ' THR . 3.5 mm -91.27 -42.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 121.666 0.746 . . . . 10.0 109.911 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.509 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 32.9 t -47.6 -40.5 19.52 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.303 -0.959 . . . . 10.0 109.974 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 160' ' ' LEU . 9.4 t80 -100.83 1.46 40.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.238 -1.385 . . . . 10.0 110.625 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.49 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 6.3 m -107.21 -19.09 13.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.984 -1.072 . . . . 10.0 111.325 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.495 HG22 ' CG ' ' A' ' 34' ' ' PRO . 11.3 t -112.23 -43.04 3.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.731 -1.23 . . . . 10.0 111.16 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.538 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 7.3 m-20 -155.87 -48.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.492 -1.283 . . . . 10.0 112.512 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.661 ' HD3' ' C ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 168.88 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.217 -0.927 . . . . 10.0 111.892 -178.527 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.623 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 22.4 p90 -114.05 -17.14 0.11 Allowed Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 47.3 Cg_endo -69.04 -112.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.483 0.851 . . . . 10.0 112.217 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 p -166.35 68.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.104 -1.623 . . . . 10.0 111.56 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' HG3' ' HE3' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -121.55 -169.39 1.85 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 5.7 t80 -48.01 100.3 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.63 ' CG2' ' HD2' ' A' ' 34' ' ' PRO 0.261 12.1 p -149.8 154.25 37.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.661 -0.649 . . . . 10.0 109.682 -177.87 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.63 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 36.8 Cg_endo -60.43 179.96 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.16 1.084 . . . . 10.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.601 ' O ' ' N ' ' A' ' 37' ' ' PHE . 20.3 p -145.35 166.38 25.74 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.117 -0.989 . . . . 10.0 111.693 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.584 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 89.8 t -28.22 -33.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 121.325 0.583 . . . . 10.0 111.321 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -38.94 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 10.0 109.759 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.2 OUTLIER -170.38 91.07 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 119.879 -1.763 . . . . 10.0 113.776 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.56 ' O ' ' CD2' ' A' ' 40' ' ' TYR . 8.2 t30 -135.88 149.75 49.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 10.0 108.604 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 2.6 m-85 -167.2 113.84 0.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.402 -1.436 . . . . 10.0 111.702 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 15' ' ' GLU . . . -93.69 108.85 20.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.92 -1.141 . . . . 10.0 107.92 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.577 ' CG2' ' O ' ' B' ' 14' ' ' PHE . 44.1 t -135.87 171.93 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.184 -1.407 . . . . 10.0 112.31 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.527 HG22 ' O ' ' A' ' 51' ' ' TYR . 54.7 m -147.28 170.6 16.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.564 ' HA ' ' O ' ' B' ' 12' ' ' SER . 1.3 p -161.35 129.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.89 -1.131 . . . . 10.0 111.561 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.6 ' CB ' ' HB3' ' B' ' 10' ' ' LEU . 1.3 mmt -104.95 129.06 53.44 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.826 -1.15 . . . . 10.0 108.131 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.557 ' CG2' ' O ' ' B' ' 6' ' ' PRO . 33.6 mt -132.05 99.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.913 -1.117 . . . . 10.0 110.194 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.603 ' CA ' ' CG2' ' B' ' 8' ' ' ILE . . . 59.76 24.05 59.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.038 -1.625 . . . . 10.0 109.038 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.72 6.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -127.29 95.47 36.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.17 -1.194 . . . . 10.0 110.538 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.467 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 51.5 Cg_endo -83.19 132.68 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.236 1.65 . . . . 10.0 112.008 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.532 ' HB2' HG11 ' A' ' 44' ' ' VAL . 2.7 m-85 -93.65 150.69 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 10.0 109.29 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.607 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 23.3 m -136.25 100.32 4.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.786 -1.196 . . . . 10.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.552 ' CB ' HG22 ' A' ' 4' ' ' ILE . 3.0 pp -149.3 176.35 10.62 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.393 -1.323 . . . . 10.0 112.813 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.408 ' N ' ' CD1' ' A' ' 53' ' ' LEU . . . -170.82 118.52 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 107.67 -2.172 . . . . 10.0 107.67 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.537 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . 2.0 pp -129.78 159.58 36.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.647 -1.502 . . . . 10.0 111.138 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 15.9 p90 -165.69 131.77 2.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 10.0 110.568 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.484 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -81.38 176.84 9.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 10.0 110.095 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.576 ' OG1' ' CE2' ' B' ' 36' ' ' TRP . 99.1 m -40.2 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 10.0 111.43 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.506 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . . . -146.65 63.01 1.2 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 10.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.19 69.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.275 -1.13 . . . . 10.0 110.275 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' HB2' ' HA3' ' B' ' 21' ' ' GLY . 64.7 tp60 -115.77 -28.79 6.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.065 -1.256 . . . . 10.0 111.23 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.493 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 7.3 tp10 -63.53 -50.02 71.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.871 -1.143 . . . . 10.0 110.572 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.53 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -142.74 0.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 10.0 111.323 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.53 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.2 m-85 65.35 40.26 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.821 -1.178 . . . . 10.0 107.821 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.506 ' HB2' ' HB3' ' A' ' 59' ' ' ALA . 0.2 OUTLIER -78.7 47.72 0.75 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.85 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.534 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 17.4 mtp180 -82.82 -26.28 31.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.437 -0.789 . . . . 10.0 109.53 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.516 ' CD2' ' HG2' ' B' ' 41' ' ' GLN . 1.2 mt -111.77 -6.66 14.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 10.0 111.888 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.532 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -92.75 -54.9 0.25 Allowed Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 120.376 -1.453 . . . . 10.0 113.19 -177.864 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.597 ' CD ' HD23 ' A' ' 70' ' ' LEU . 43.0 Cg_endo -77.61 -5.02 15.17 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.528 1.278 . . . . 10.0 111.987 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.597 HD23 ' CD ' ' A' ' 69' ' ' PRO . 0.5 OUTLIER -101.81 -98.8 0.27 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.773 -1.205 . . . . 10.0 110.966 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.504 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 40.1 m -36.38 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.744 -0.598 . . . . 10.0 110.467 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 70' ' ' LEU . 15.6 m-85 -103.47 91.92 3.66 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 10.0 109.056 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.504 ' HD3' ' O ' ' A' ' 71' ' ' SER . 45.4 Cg_endo -70.62 147.43 57.32 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.787 1.414 . . . . 10.0 110.555 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' CD ' ' O ' ' A' ' 74' ' ' GLN . 3.2 pp0? -169.37 57.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.221 -0.924 . . . . 10.0 110.583 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.571 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 18.0 m -145.01 98.05 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.162 -0.961 . . . . 10.0 110.099 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -34.37 -33.21 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 10.0 110.487 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.574 ' O ' HG23 ' A' ' 77' ' ' VAL . 0.7 OUTLIER -111.25 120.24 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.313 -0.867 . . . . 10.0 109.644 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 47.7 m-85 -115.41 140.92 48.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.906 -1.121 . . . . 10.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.458 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 3.4 mm? -109.39 99.35 8.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 10.0 109.562 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.586 HG21 ' CZ ' ' A' ' 82' ' ' PHE . 7.1 p -103.82 151.02 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 10.0 110.131 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 115' ' ' THR . 3.2 t -126.71 103.8 7.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 10.0 111.496 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.586 ' CZ ' HG21 ' A' ' 80' ' ' VAL . 67.7 m-85 -89.89 140.05 29.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 10.0 111.056 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -92.52 138.59 31.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.214 -0.929 . . . . 10.0 110.169 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.548 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 14.4 m -81.42 -17.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 10.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.496 ' N ' HG21 ' A' ' 84' ' ' VAL . 17.8 m -102.6 38.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.774 0.797 . . . . 10.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.484 ' OG ' ' HD2' ' A' ' 87' ' ' PRO . 47.7 t -110.04 154.34 42.76 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.677 -0.639 . . . . 10.0 109.37 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.564 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 47.9 Cg_endo -68.93 73.62 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.735 1.387 . . . . 10.0 111.099 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.47 ' OG ' ' HG3' ' A' ' 133' ' ' LYS . 43.4 m 39.91 55.04 2.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 10.0 110.429 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.442 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 62.7 p -91.9 -36.74 13.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 10.0 110.547 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.408 ' O ' ' HD3' ' A' ' 94' ' ' LYS . 2.9 p90 -50.3 -29.96 10.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.09 . . . . 10.0 110.338 -179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.421 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -67.47 -35.7 79.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.901 . . . . 10.0 110.036 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.443 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.32 -12.81 61.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 10.0 109.39 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.446 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t -88.87 -12.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.39 -0.819 . . . . 10.0 109.346 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 6.8 mmtt -89.03 -35.75 16.19 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.443 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.0 pt-20 -80.0 -5.05 55.04 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.26 -0.576 . . . . 10.0 110.082 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -102.02 -44.89 5.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.935 -1.103 . . . . 10.0 111.763 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.559 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 35.9 m95 -89.59 -29.05 19.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.294 -0.878 . . . . 10.0 112.028 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.57 ' CG2' ' CD2' ' A' ' 149' ' ' LEU . 62.8 t -62.28 -47.9 88.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.545 -1.347 . . . . 10.0 110.596 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 48.9 Cg_endo -74.68 -15.56 21.53 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 109.115 -1.148 . . . . 10.0 109.115 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.514 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 40.9 tt0 -58.97 -29.25 67.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.754 -0.591 . . . . 10.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.528 ' CG2' ' HA ' ' A' ' 104' ' ' HIS . 3.6 mt 57.57 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 10.0 109.603 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.56 ' CG2' ' HG2' ' A' ' 106' ' ' PRO . 3.9 m -43.29 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.345 -0.847 . . . . 10.0 109.08 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.505 ' O ' ' CB ' ' A' ' 104' ' ' HIS . 4.8 m-70 -110.45 -15.9 13.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.528 ' HA ' ' CG2' ' A' ' 101' ' ' ILE . 0.0 OUTLIER 162.45 -55.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.56 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 6.9 t -168.06 44.58 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.207 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.579 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 56.4 Cg_endo -81.26 -26.1 3.56 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 N-CA-C 109.083 -1.16 . . . . 10.0 109.083 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.579 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 1.6 pttp 55.66 52.85 10.33 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.342 1.067 . . . . 10.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.495 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 10.0 t -45.38 155.17 0.46 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 10.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.495 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 38.9 Cg_endo -66.35 148.77 84.81 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.76 1.4 . . . . 10.0 110.486 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.49 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -139.07 111.9 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 10.0 110.023 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.612 HD11 ' CG1' ' A' ' 152' ' ' VAL . 1.6 mm? -80.84 98.08 7.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.316 -0.865 . . . . 10.0 109.358 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.577 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 56.1 mt -70.22 140.11 52.38 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.464 HG21 ' O ' ' A' ' 111' ' ' LEU . 4.5 t -148.1 168.22 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.809 -1.182 . . . . 10.0 111.679 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.37 150.04 16.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.748 -1.741 . . . . 10.0 108.748 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.531 ' N ' ' O ' ' A' ' 82' ' ' PHE . 24.1 m -103.49 129.94 50.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.353 . . . . 10.0 110.756 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.451 ' HG3' HG23 ' A' ' 14' ' ' VAL . 69.4 mt-30 53.27 50.03 18.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 10.0 110.377 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.796 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -65.29 -25.27 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.028 -1.045 . . . . 10.0 110.017 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.8 p-10 -52.06 59.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.267 1.032 . . . . 10.0 110.051 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.796 ' N ' ' O ' ' A' ' 117' ' ' ILE . 9.8 tp 158.64 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.53 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -50.35 -40.11 48.25 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.81 -0.556 . . . . 10.0 109.928 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -28.77 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 10.0 109.993 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -83.6 130.35 56.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 10.0 110.834 -179.717 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.464 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.3 Cg_endo -86.18 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.664 1.576 . . . . 10.0 110.079 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -98.47 -50.98 4.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 10.0 110.198 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.524 HG23 ' CD2' ' A' ' 119' ' ' LEU . 6.4 t -75.53 -32.37 60.45 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.014 -2.217 . . . . 10.0 105.014 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.525 ' N ' HD13 ' A' ' 126' ' ' ILE 0.293 1.1 mp -50.69 -28.25 5.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 176.856 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -52.18 -29.89 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.65 0.738 . . . . 10.0 110.471 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 6.4 mmtp -55.75 -36.93 67.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.492 -0.755 . . . . 10.0 111.606 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -57.85 -49.81 75.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.685 -1.26 . . . . 10.0 109.566 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -49.56 -41.23 40.97 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.735 -0.603 . . . . 10.0 111.466 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -21.76 56.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.26 -0.9 . . . . 10.0 110.203 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.564 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 12.7 p-10 -128.49 -46.82 1.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 10.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 129' ' ' LEU . 5.2 mmtp -121.74 144.95 48.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.631 -0.668 . . . . 10.0 109.287 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -99.54 6.33 45.85 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.257 -0.902 . . . . 10.0 110.557 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 10.6 mtpt -131.76 94.02 26.34 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 10.0 109.91 179.301 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_endo -70.61 160.65 48.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.128 1.593 . . . . 10.0 110.604 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.548 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 0.2 OUTLIER -75.68 133.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.023 . . . . 10.0 108.649 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.504 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.2 p -131.19 168.84 15.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.152 -0.968 . . . . 10.0 109.744 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.504 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.3 Cg_endo -68.71 -33.11 22.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.758 1.399 . . . . 10.0 109.351 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.48 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 15.6 pt-20 -71.18 -23.87 62.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.822 . . . . 10.0 109.181 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.477 ' OG1' ' OG1' ' A' ' 138' ' ' THR . 57.4 m -80.03 -40.87 26.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 10.0 109.017 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.472 -0.768 . . . . 10.0 109.31 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.448 ' HG3' ' O ' ' A' ' 139' ' ' PRO . 37.4 mt-10 -59.63 -42.84 93.61 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.079 -0.648 . . . . 10.0 109.692 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -61.56 -39.79 92.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.373 -0.829 . . . . 10.0 109.434 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.493 ' O ' HD11 ' A' ' 149' ' ' LEU . 3.8 tp -65.03 -46.45 81.25 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.061 -1.024 . . . . 10.0 108.431 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.439 ' HB1' HD12 ' A' ' 112' ' ' LEU . . . -57.66 -45.1 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 10.0 110.383 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -26.37 64.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.406 -0.809 . . . . 10.0 109.882 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -75.63 -49.95 16.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.324 -0.86 . . . . 10.0 110.574 -179.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.668 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 6.5 mp -90.37 1.68 56.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 10.0 108.975 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.484 ' O ' ' O ' ' A' ' 151' ' ' ALA . 6.2 mtmt 65.49 30.31 10.8 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.639 0.733 . . . . 10.0 109.847 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.484 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -59.34 -146.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.955 -0.698 . . . . 10.0 109.463 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.612 ' CG1' HD11 ' A' ' 111' ' ' LEU . 2.7 p -117.51 -57.15 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.368 -1.458 . . . . 10.0 112.047 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -171.69 151.59 2.93 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 118.148 -1.421 . . . . 10.0 112.291 -179.332 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.577 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.9 p90 -87.54 124.51 33.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 10.0 110.329 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.56 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -126.36 -168.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.355 -0.84 . . . . 10.0 109.879 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.414 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 1.9 mt-10 -143.16 144.44 32.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.016 -1.052 . . . . 10.0 110.502 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.523 ' SG ' ' CG2' ' A' ' 168' ' ' VAL . 79.8 m -144.28 129.8 19.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.898 0.856 . . . . 10.0 111.4 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.541 ' OG ' ' OG1' ' A' ' 161' ' ' THR . 3.9 t -120.74 173.32 7.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.54 ' HA ' ' HB3' ' A' ' 19' ' ' LEU . . . -93.66 -93.44 0.17 Allowed 'General case' 0 C--N 1.29 -1.99 0 O-C-N 120.984 -1.073 . . . . 10.0 110.438 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.639 ' O ' ' CD1' ' A' ' 23' ' ' TYR . 0.2 OUTLIER -54.67 -39.19 67.82 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.067 -1.021 . . . . 10.0 109.49 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.541 ' OG1' ' OG ' ' A' ' 158' ' ' SER . 75.0 p -79.39 -35.34 40.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.152 -1.592 . . . . 10.0 110.953 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.554 ' CG ' ' HG ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 58.02 67.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.785 -1.197 . . . . 10.0 109.858 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.453 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 0.0 OUTLIER -87.3 56.8 4.13 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.64 -0.824 . . . . 10.0 111.047 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.498 ' O ' HG21 ' A' ' 168' ' ' VAL . . . 125.6 11.41 4.09 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.416 -1.374 . . . . 10.0 111.001 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.554 ' HG ' ' CG ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -54.52 -34.18 61.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.718 -1.46 . . . . 10.0 109.556 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -88.15 -25.01 23.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 10.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -70.91 -38.78 72.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 10.0 111.206 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.56 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 3.5 t -68.94 -36.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.833 -1.167 . . . . 10.0 109.325 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 173' ' ' ILE . 60.7 t80 -60.11 -37.76 80.97 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.687 -0.633 . . . . 10.0 110.01 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.429 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 10.7 m-20 -67.66 -46.63 71.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -0.943 . . . . 10.0 111.358 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.07 -30.61 69.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 10.0 110.359 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.543 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -70.56 -24.47 62.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.062 . . . . 10.0 109.324 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.587 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 27.8 mm -64.55 -44.74 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.434 -0.791 . . . . 10.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.541 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.85 -31.91 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.803 -1.185 . . . . 10.0 110.629 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.42 ' O ' ' HG3' ' A' ' 109' ' ' PRO . . . -89.01 0.79 56.37 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.472 -0.768 . . . . 10.0 110.838 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.543 ' CB ' ' O ' ' A' ' 172' ' ' ALA . . . -88.89 -37.23 15.47 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.933 -1.105 . . . . 10.0 110.195 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.587 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.95 -13.54 16.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.385 -0.822 . . . . 10.0 109.716 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.485 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.42 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -89.96 47.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 10.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.2 100.49 4.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.067 -1.021 . . . . 10.0 110.664 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.463 ' CB ' ' OE1' ' B' ' 7' ' ' GLU . 14.3 mm-40 -101.52 175.67 5.49 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.542 0.687 . . . . 10.0 110.168 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.36 -146.49 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -76.11 13.72 1.23 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 CA-C-N 119.277 0.777 . . . . 10.0 111.815 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.513 ' CB ' HG21 ' A' ' 46' ' ' ILE . 0.7 OUTLIER 36.72 -150.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.229 -0.919 . . . . 10.0 110.166 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.603 ' CG2' ' CA ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -82.57 -115.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.943 -1.132 . . . . 10.0 107.943 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.504 ' N ' HG12 ' B' ' 8' ' ' ILE . 7.8 t -159.08 110.11 2.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.084 -1.635 . . . . 10.0 111.348 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.6 ' HB3' ' CB ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -116.94 119.96 34.52 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.146 -0.971 . . . . 10.0 108.869 178.382 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.95 100.09 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.67 1.353 . . . . 10.0 112.928 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.564 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 m -149.17 126.01 11.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.597 -0.69 . . . . 10.0 109.575 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.462 ' HA ' ' O ' ' A' ' 43' ' ' THR . 5.9 p-10 -170.89 148.82 2.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.395 -1.441 . . . . 10.0 113.15 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.577 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 5.4 m-85 -129.63 -176.33 3.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.538 ' HA ' HG21 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -173.81 149.77 1.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.592 -1.318 . . . . 10.0 112.436 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.524 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.9 t60 -171.29 117.34 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.537 -0.727 . . . . 10.0 110.068 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.514 ' HA ' ' HB3' ' A' ' 39' ' ' ASN . 9.3 t -128.82 158.46 38.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.868 -1.145 . . . . 10.0 112.261 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.547 HG13 ' HB3' ' A' ' 39' ' ' ASN . 1.3 pp -121.5 -168.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.642 . . . . 10.0 109.265 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.598 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 63.1 m80 -136.25 157.28 47.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 10.0 111.877 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.584 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 10.2 p -97.63 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.538 -0.726 . . . . 10.0 112.062 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.502 ' HA3' ' HB2' ' A' ' 61' ' ' GLN . . . -108.41 65.48 0.25 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.669 -2.172 . . . . 10.0 107.669 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.587 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 0.3 OUTLIER 175.32 114.24 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.433 -1.039 . . . . 10.0 108.673 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.489 ' HA ' HG23 ' A' ' 35' ' ' THR . 32.4 t70 -62.1 152.4 32.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.28 -0.888 . . . . 10.0 112.349 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.582 ' CB ' ' CG1' ' A' ' 33' ' ' VAL . . . 37.82 71.78 0.14 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.733 -0.604 . . . . 10.0 112.524 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.587 ' CG2' ' HB3' ' B' ' 22' ' ' PHE . 15.4 t -113.15 -46.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.966 -1.084 . . . . 10.0 109.767 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.495 ' HB ' ' N ' ' A' ' 36' ' ' VAL . 1.1 t -82.57 -28.15 31.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.31 0.576 . . . . 10.0 110.51 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 36.35 3.82 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.26 -1.936 . . . . 10.0 108.26 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.483 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 36.4 tt0 -142.18 128.95 20.48 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.554 -0.968 . . . . 10.0 110.953 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.515 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -140.9 114.54 8.87 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 122.233 1.016 . . . . 10.0 109.284 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.446 HG23 ' O ' ' B' ' 29' ' ' PHE . 5.1 p -146.82 -49.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.576 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . 177.83 89.71 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.063 -1.615 . . . . 10.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.516 ' CG2' ' HD2' ' B' ' 33' ' ' PRO . 83.1 mt -120.0 147.11 43.71 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.195 -1.179 . . . . 10.0 110.445 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.516 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 42.7 Cg_endo -69.45 129.26 17.6 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 10.0 109.767 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.498 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.1 tp10 55.92 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 10.0 109.617 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.604 ' O ' ' CE3' ' B' ' 36' ' ' TRP . 72.5 mt-30 -93.08 -27.25 17.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.952 -1.092 . . . . 10.0 112.521 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.604 ' CE3' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 162.61 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.104 -1.073 . . . . 10.0 108.104 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.569 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . -175.19 75.64 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' B' ' 40' ' ' LEU . 3.9 mtm180 -79.17 50.24 1.04 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.295 -1.372 . . . . 10.0 107.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.456 ' C ' ' O ' ' B' ' 38' ' ' ARG . 1.2 mp -38.42 -30.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.105 0.955 . . . . 10.0 108.766 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 42' ' ' THR . 0.9 OUTLIER -80.74 34.05 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.169 178.744 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.516 ' HG2' ' CD2' ' A' ' 67' ' ' LEU . 6.2 tp-100 -33.94 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.395 0.617 . . . . 10.0 110.382 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.803 ' O ' ' N ' ' B' ' 44' ' ' ASN . 20.7 m -110.16 72.17 0.78 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.575 -2.009 . . . . 10.0 105.575 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -44.74 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.517 0.675 . . . . 10.0 111.971 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.803 ' N ' ' O ' ' B' ' 42' ' ' THR . 2.1 m-80 -98.09 141.51 30.94 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.657 -0.652 . . . . 10.0 110.31 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . 0.474 ' O ' ' O ' ' B' ' 44' ' ' ASN . 21.0 mt 48.0 -178.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 10.0 110.456 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 46' ' ' THR . . . . . 0.43 ' OG1' ' C ' ' B' ' 45' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 118.073 -0.965 . . . . 10.0 109.758 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.414 ' O ' ' HG3' ' A' ' 1' ' ' MET . 3.3 ptp . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.807 0.813 . . . . 10.0 109.843 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.465 ' HA ' HD21 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -153.86 -35.63 0.1 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.617 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 89.8 m -53.17 94.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.374 -0.829 . . . . 10.0 110.246 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.497 HG21 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -109.12 132.27 57.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.524 -1.271 . . . . 10.0 110.062 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.569 ' HB2' ' HA ' ' A' ' 75' ' ' THR . 4.4 mtpp -122.85 104.75 9.47 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.518 ' O ' HD22 ' A' ' 55' ' ' LEU . 29.9 p -108.98 152.85 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.143 -0.973 . . . . 10.0 111.75 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.529 HG22 ' CG2' ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.56 162.53 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.759 -0.588 . . . . 10.0 110.102 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.484 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 16.0 m -81.76 137.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 10.0 111.472 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.561 HG13 ' HB2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -152.29 169.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.307 -0.871 . . . . 10.0 109.741 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 150.39 88.88 0.07 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.974 -1.251 . . . . 10.0 109.974 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' GLY . 3.8 t0 40.88 25.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -1.072 . . . . 10.0 111.048 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.586 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 71.63 36.85 62.04 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.499 -1.44 . . . . 10.0 109.499 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.428 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . -108.97 -140.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.532 -0.981 . . . . 10.0 109.657 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.545 HG11 ' CE2' ' B' ' 29' ' ' PHE . 4.7 m -88.27 161.7 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 10.0 109.648 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.484 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -92.2 -174.16 42.09 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.274 -1.13 . . . . 10.0 110.274 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.514 ' CE ' ' HA ' ' A' ' 16' ' ' LYS . 0.1 OUTLIER -110.59 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -1.064 . . . . 10.0 111.001 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.436 ' C ' ' H ' ' A' ' 19' ' ' LEU . 73.7 m -50.8 -36.45 37.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.036 -1.04 . . . . 10.0 109.041 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.716 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 25.3 p -67.22 4.32 0.97 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.128 0.966 . . . . 10.0 109.718 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.795 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 3.8 mt -110.46 -38.82 5.11 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.285 -1.509 . . . . 10.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.468 ' HA ' ' CD2' ' A' ' 165' ' ' LEU . 21.1 tp -44.63 -46.2 10.01 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.853 -1.154 . . . . 10.0 111.227 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.621 HG21 ' CA ' ' A' ' 28' ' ' PHE . 0.7 OUTLIER -90.33 -31.14 5.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 117.093 -1.843 . . . . 10.0 109.858 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.653 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 21.9 t -47.44 -44.14 24.6 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.346 -0.942 . . . . 10.0 110.311 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.493 ' HB2' ' C ' ' A' ' 159' ' ' ALA . 67.0 t80 -86.42 -0.89 56.94 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.55 -1.344 . . . . 10.0 109.951 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.512 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 4.3 m -108.93 -42.87 4.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.851 -1.155 . . . . 10.0 113.984 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.506 ' CG2' ' OD1' ' A' ' 26' ' ' ASN . 60.0 m -117.38 -93.06 0.51 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 119.95 -1.719 . . . . 10.0 111.515 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.577 ' O ' ' CA ' ' B' ' 27' ' ' GLY . 0.1 OUTLIER -135.81 -21.64 1.47 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.277 -0.889 . . . . 10.0 110.34 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.653 ' O ' ' HA ' ' A' ' 22' ' ' SER . 14.4 mttt -148.87 -139.32 0.09 Allowed 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.729 -1.952 . . . . 10.0 105.729 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.716 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -124.25 18.89 0.08 OUTLIER Pre-proline 0 C--N 1.285 -2.203 0 C-N-CA 116.357 -2.137 . . . . 10.0 115.384 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 46.2 Cg_endo -73.61 -94.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 N-CA-C 109.192 -1.118 . . . . 10.0 109.192 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.513 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . 0.3 OUTLIER -155.48 -12.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.878 -1.139 . . . . 10.0 112.55 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.546 ' O ' ' N ' ' A' ' 33' ' ' VAL . 6.2 pt-20 -172.47 -170.76 0.74 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.252 -1.388 . . . . 10.0 107.252 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.464 ' C ' HG21 ' A' ' 33' ' ' VAL . 75.6 t80 -49.19 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.638 -1.616 . . . . 10.0 106.638 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.627 ' CG1' ' HD2' ' A' ' 34' ' ' PRO 0.325 60.9 t -152.99 158.92 32.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.721 -0.612 . . . . 10.0 109.666 -175.325 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.627 ' HD2' ' CG1' ' A' ' 33' ' ' VAL . 39.9 Cg_endo -66.69 171.34 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.155 1.081 . . . . 10.0 110.707 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 28' ' ' PHE . 2.9 m -96.86 146.37 24.99 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.115 -0.991 . . . . 10.0 111.369 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 38.6 t 77.46 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.763 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -33.75 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.141 0.972 . . . . 10.0 110.648 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -170.15 112.22 0.44 Allowed 'General case' 0 C--N 1.289 -2.033 0 O-C-N 119.374 -2.079 . . . . 10.0 112.221 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.565 ' HB3' ' CG1' ' B' ' 18' ' ' ILE . 0.9 OUTLIER -166.4 96.93 0.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.217 -0.927 . . . . 10.0 108.558 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.493 ' HB3' ' O ' ' B' ' 16' ' ' HIS . 17.4 p90 -171.77 176.95 3.5 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.354 -0.938 . . . . 10.0 111.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.522 ' O ' HG12 ' A' ' 42' ' ' VAL . . . -171.23 98.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.615 ' CG2' ' O ' ' B' ' 15' ' ' GLU . 16.6 m -157.5 -166.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 10.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.596 ' O ' ' CB ' ' B' ' 13' ' ' ASP . 24.1 m -105.35 166.83 10.15 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.967 -0.693 . . . . 10.0 111.319 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.471 ' HB ' ' HB2' ' A' ' 51' ' ' TYR . 2.9 t -127.7 139.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.398 -0.964 . . . . 10.0 108.398 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.561 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 3.1 mtt -102.57 102.16 12.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.349 -1.34 . . . . 10.0 110.426 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.494 HG21 ' HB2' ' B' ' 7' ' ' GLU . 2.3 mp -110.24 118.59 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.06 . . . . 10.0 110.167 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 54.41 16.96 7.48 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.178 -1.169 . . . . 10.0 110.178 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.03 18.35 34.45 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 68.2 mm-40 -110.59 115.89 53.21 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.39 -1.065 . . . . 10.0 110.315 -179.818 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 45.8 Cg_endo -69.24 119.4 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.824 1.434 . . . . 10.0 110.272 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.514 ' O ' HG23 ' A' ' 43' ' ' THR . 3.9 m-30 -97.52 179.93 4.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 10.0 110.72 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.617 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 5.0 m -146.27 132.66 19.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 10.0 110.039 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.482 HD12 ' O ' ' A' ' 53' ' ' LEU . 1.3 pp -172.27 174.04 4.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.739 -1.225 . . . . 10.0 111.593 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.87 105.4 0.21 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.163 -1.975 . . . . 10.0 108.163 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.518 HD22 ' O ' ' A' ' 6' ' ' CYS . 0.9 OUTLIER -105.52 135.48 46.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.64 -1.506 . . . . 10.0 110.409 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.515 ' N ' HD23 ' A' ' 55' ' ' LEU . 16.1 m-85 -129.03 103.25 6.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 10.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' THR . 51.1 t0 -105.96 121.04 43.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 10.0 109.421 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.443 ' C ' ' O ' ' A' ' 57' ' ' ASP . 13.7 t -39.4 129.39 1.82 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.074 -1.016 . . . . 10.0 111.466 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -72.17 -73.52 0.19 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.811 -0.556 . . . . 10.0 111.515 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.412 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 69.98 7.4 59.29 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.985 -1.646 . . . . 10.0 108.985 -178.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 177.91 -26.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -1.093 . . . . 10.0 110.903 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.612 ' HG2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -41.87 -71.14 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.858 -1.152 . . . . 10.0 110.383 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.551 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 7.2 t70 164.34 -13.77 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.698 -0.626 . . . . 10.0 110.697 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.509 ' CZ ' ' OD1' ' A' ' 39' ' ' ASN . 38.2 p90 -110.86 17.33 20.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.865 -1.147 . . . . 10.0 109.312 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.507 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 35.1 t70 -49.52 -23.7 1.73 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.434 -0.791 . . . . 10.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -49.92 -36.62 28.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.04 -1.038 . . . . 10.0 109.223 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.568 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 1.6 mt -92.66 11.49 26.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.505 -0.747 . . . . 10.0 110.041 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.658 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -73.37 -22.13 0.48 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.275 -0.891 . . . . 10.0 112.959 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 42.8 Cg_endo -78.21 85.12 1.87 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 CA-C-O 121.944 0.727 . . . . 10.0 110.546 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.578 ' CD1' ' CD1' ' B' ' 39' ' ' LEU . 0.0 OUTLIER -129.27 -47.15 1.2 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.795 0.807 . . . . 10.0 109.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.623 ' N ' ' HB2' ' B' ' 39' ' ' LEU . 5.6 m 59.91 12.78 3.26 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.948 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -101.98 110.4 62.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 10.0 112.038 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.433 ' C ' ' HG3' ' A' ' 74' ' ' GLN . 48.6 Cg_endo -76.93 148.59 28.2 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.107 1.583 . . . . 10.0 110.7 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.559 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.04 67.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 10.0 109.283 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.606 ' O ' ' CD2' ' A' ' 78' ' ' PHE . 0.0 OUTLIER -143.18 87.35 1.96 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.101 -1.0 . . . . 10.0 109.982 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 9.6 m-20 -20.29 -44.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.456 0.91 . . . . 10.0 113.456 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.56 ' N ' ' O ' ' A' ' 75' ' ' THR . 1.1 m -110.5 144.32 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.818 -1.176 . . . . 10.0 111.26 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.606 ' CD2' ' O ' ' A' ' 75' ' ' THR . 0.0 OUTLIER -156.25 157.41 35.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 10.0 110.977 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.585 ' N ' ' CD2' ' A' ' 79' ' ' LEU . 0.2 OUTLIER -107.32 98.65 8.25 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 178.423 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.597 HG13 ' CE2' ' A' ' 82' ' ' PHE . 3.9 p -85.07 148.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 10.0 109.95 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.52 ' C ' ' CG2' ' A' ' 115' ' ' THR . 41.1 m -117.26 103.16 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.767 -1.173 . . . . 10.0 113.516 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.597 ' CE2' HG13 ' A' ' 80' ' ' VAL . 43.8 m-85 -99.84 147.69 25.23 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.293 -0.879 . . . . 10.0 109.232 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.504 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 46.6 t -90.42 141.1 29.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.513 -1.367 . . . . 10.0 108.95 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.529 ' CG2' ' HG3' ' A' ' 120' ' ' ARG . 2.0 t -80.32 5.58 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.905 . . . . 10.0 110.375 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.558 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 33.9 m -143.31 59.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.931 0.872 . . . . 10.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.577 ' CB ' ' CD ' ' A' ' 87' ' ' PRO . 2.7 p -125.13 -165.53 0.08 OUTLIER Pre-proline 0 C--N 1.287 -2.125 0 O-C-N 121.376 -0.828 . . . . 10.0 108.773 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.577 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 43.4 Cg_endo -76.18 60.76 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.277 1.146 . . . . 10.0 109.621 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 87' ' ' PRO . 43.6 p 32.86 51.5 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.104 0.478 . . . . 10.0 111.54 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.1 p -77.02 -25.42 52.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 10.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.508 ' CZ ' ' HB1' ' A' ' 142' ' ' ALA . 73.0 t80 -59.22 -40.21 85.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 10.0 111.51 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.496 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -70.77 -22.87 62.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.914 -1.116 . . . . 10.0 110.828 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -86.13 -20.8 28.12 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.807 -1.183 . . . . 10.0 109.97 179.888 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.507 ' CG2' ' O ' ' A' ' 90' ' ' PHE . 23.1 m -84.23 -29.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.151 -1.02 . . . . 10.0 109.931 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.555 ' HD2' ' N ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -70.87 -34.03 71.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.072 -1.018 . . . . 10.0 109.6 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.555 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 7.2 pt-20 -80.26 -8.22 59.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 10.0 110.971 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.561 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 2.1 mmtm -81.73 -52.75 6.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 10.0 111.655 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -73.24 -9.88 59.17 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.982 -1.073 . . . . 10.0 112.202 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.564 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 77.6 t -76.48 -50.2 2.75 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.621 -1.3 . . . . 10.0 110.828 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.1 Cg_endo -73.42 -25.8 14.96 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.209 1.11 . . . . 10.0 110.647 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.561 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -77.07 -23.74 51.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.287 -0.883 . . . . 10.0 110.998 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.501 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 49.0 mm 60.15 103.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.026 -1.046 . . . . 10.0 110.329 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.489 HG23 ' OG1' ' A' ' 108' ' ' THR . 2.3 m -47.04 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 10.0 108.623 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.521 ' O ' ' CB ' ' A' ' 104' ' ' HIS . 5.5 m170 -112.1 -4.85 14.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.323 -0.861 . . . . 10.0 109.51 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 160.87 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 50.8 t -142.26 137.37 15.61 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 149' ' ' LEU . 44.1 Cg_endo -69.82 80.29 0.91 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.681 1.358 . . . . 10.0 110.68 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' THR . 34.4 mtpt -118.16 -14.44 9.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.469 -0.77 . . . . 10.0 111.181 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.489 ' OG1' HG23 ' A' ' 102' ' ' THR . 52.1 m -46.3 136.08 7.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.718 -1.239 . . . . 10.0 109.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 175' ' ' ALA . 37.5 Cg_endo -64.9 111.9 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 10.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.522 ' O ' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -117.94 103.88 10.37 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.757 0.789 . . . . 10.0 110.209 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.616 HD13 ' CG1' ' A' ' 152' ' ' VAL . 1.7 mm? -77.41 98.57 5.3 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 90.0 mt -74.03 135.82 43.08 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.481 HG22 ' O ' ' A' ' 112' ' ' LEU . 10.8 t -143.28 169.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 10.0 112.552 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.522 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.87 153.88 19.54 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.479 -2.248 . . . . 10.0 107.479 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.52 ' CG2' ' C ' ' A' ' 81' ' ' CYS . 76.3 p -101.04 127.57 47.49 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.497 -1.59 . . . . 10.0 111.057 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.462 ' O ' ' N ' ' A' ' 118' ' ' ASP . 0.8 OUTLIER 40.31 55.06 2.82 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.849 -0.74 . . . . 10.0 110.16 178.317 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.764 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -40.78 -28.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 C-N-CA 119.467 -0.893 . . . . 10.0 110.16 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.526 ' O ' HD12 ' A' ' 119' ' ' LEU . 2.3 p-10 -52.69 60.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.17 0.986 . . . . 10.0 110.524 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.764 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.4 OUTLIER 161.77 -27.95 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -47.09 -38.33 11.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.77 17.75 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 10.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.46 ' O ' ' CG1' ' A' ' 126' ' ' ILE . 6.9 t70 -104.28 110.84 64.81 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 10.0 110.857 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.32 15.46 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.072 1.564 . . . . 10.0 110.779 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.417 ' HB3' ' OD1' ' A' ' 122' ' ' ASP . 47.1 t -109.89 -49.93 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 10.0 109.857 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.496 ' CG2' ' HG ' ' A' ' 119' ' ' LEU . 4.7 t -73.67 -24.39 59.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.515 -2.031 . . . . 10.0 105.515 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.487 ' N ' HD11 ' A' ' 126' ' ' ILE 0.301 0.6 OUTLIER -59.98 -20.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 176.859 . . . . . . . . 4 4 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -48.26 -45.34 34.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.672 -0.642 . . . . 10.0 110.396 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.469 ' O ' ' HG2' ' A' ' 131' ' ' LYS . 36.5 mmtt -84.96 -13.77 49.65 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.425 -0.797 . . . . 10.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.638 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 6.1 mp -95.91 -40.45 9.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.233 -0.917 . . . . 10.0 109.554 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.439 ' HA ' ' HD3' ' A' ' 133' ' ' LYS . . . -57.96 -39.67 78.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.137 -0.977 . . . . 10.0 109.72 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.469 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 11.2 pttt -55.66 -20.31 13.59 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.398 -0.814 . . . . 10.0 109.746 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -118.69 9.64 12.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.351 -0.843 . . . . 10.0 109.299 178.723 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.533 ' CE ' ' HB3' ' A' ' 136' ' ' PRO . 2.3 tmtt? -141.0 82.99 1.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.102 -0.703 . . . . 10.0 109.102 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.486 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 1.3 mp0 -65.39 -24.44 67.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 3.2 mmmm -132.79 115.88 14.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 10.0 109.422 179.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.533 ' HB3' ' CE ' ' A' ' 133' ' ' LYS . 40.1 Cg_endo -67.01 159.4 52.18 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.799 1.421 . . . . 10.0 110.494 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -103.95 134.29 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.289 -0.882 . . . . 10.0 109.564 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.465 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.1 p -125.87 164.46 33.01 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 10.0 109.541 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.465 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.6 Cg_endo -65.64 -13.65 40.86 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.883 1.465 . . . . 10.0 109.823 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.98 -20.86 29.9 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.764 -0.774 . . . . 10.0 110.1 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -96.74 -42.32 8.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 10.0 110.744 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.62 ' HB2' ' CD2' ' A' ' 154' ' ' TYR . . . -73.79 -26.42 60.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 10.0 110.488 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.45 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.9 tt0 -61.22 -39.07 88.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 10.0 109.847 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -65.69 -40.1 91.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.895 . . . . 10.0 109.1 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.44 HD22 ' O ' ' A' ' 145' ' ' LEU . 4.1 tt -63.04 -40.7 98.51 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.367 -0.833 . . . . 10.0 109.238 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.421 ' HA ' ' HB1' ' A' ' 151' ' ' ALA . . . -63.58 -44.84 92.91 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.821 0.819 . . . . 10.0 109.088 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -59.91 -25.8 65.42 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.361 -0.536 . . . . 10.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.419 ' C ' HD13 ' A' ' 149' ' ' LEU . 34.8 t0 -70.26 -48.8 55.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.09 -1.006 . . . . 10.0 110.827 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.653 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.5 mp -93.11 24.55 3.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 10.0 108.931 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 151' ' ' ALA . 1.0 OUTLIER 51.91 27.3 4.21 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.741 0.781 . . . . 10.0 109.389 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -57.04 -160.19 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.616 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.3 p -108.49 -65.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.677 -1.264 . . . . 10.0 111.761 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.474 ' HE3' ' HG3' ' A' ' 171' ' ' GLU . 0.0 OUTLIER -174.02 157.74 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.016 -1.678 . . . . 10.0 112.106 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.62 ' CD2' ' HB2' ' A' ' 142' ' ' ALA . 4.1 t80 -107.61 112.61 25.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 10.0 110.107 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.572 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -103.36 -168.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.429 -0.794 . . . . 10.0 110.604 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 22.4 tt0 -170.28 98.55 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.221 -0.924 . . . . 10.0 109.749 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.616 ' CB ' ' HA ' ' A' ' 165' ' ' LEU . 73.8 m -153.0 156.35 38.65 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.107 -0.996 . . . . 10.0 111.608 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.588 ' O ' ' N ' ' A' ' 162' ' ' GLN . 3.7 m -140.86 114.75 9.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.795 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . . . -74.09 -87.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.428 -1.42 . . . . 10.0 111.025 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.634 HD22 ' HB3' ' B' ' 29' ' ' PHE . 0.0 OUTLIER -31.32 -33.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 122.32 1.057 . . . . 10.0 109.383 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -93.94 -70.79 0.69 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.341 -0.845 . . . . 10.0 112.218 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -109.13 -107.71 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.377 -1.452 . . . . 10.0 112.021 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.544 ' HB3' ' O ' ' A' ' 162' ' ' GLN . 12.2 pttt 174.48 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.425 -0.797 . . . . 10.0 109.521 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.58 49.1 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.145 -1.026 . . . . 10.0 110.75 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.616 ' HA ' ' CB ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -59.39 -2.07 0.28 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.409 -1.054 . . . . 10.0 113.097 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.496 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 8.9 tttt -59.69 -48.84 80.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.39 -1.444 . . . . 10.0 110.432 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -56.45 -39.75 73.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.437 -0.789 . . . . 10.0 111.755 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.572 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 46.3 t -53.74 -48.34 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.819 -1.175 . . . . 10.0 111.034 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -78.6 -37.97 41.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.242 -0.911 . . . . 10.0 111.368 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.505 ' O ' HD22 ' A' ' 174' ' ' LEU . 16.5 m-20 -60.91 -40.26 92.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.876 -1.14 . . . . 10.0 110.946 -179.054 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.474 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 41.0 mm-40 -62.03 -46.05 90.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 10.0 111.28 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.479 ' HB3' ' HG ' ' A' ' 111' ' ' LEU . . . -54.36 -24.45 19.54 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.986 . . . . 10.0 110.379 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.526 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 28.6 mm -63.85 -42.86 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.415 -0.914 . . . . 10.0 109.841 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.587 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.1 OUTLIER -86.17 -17.07 35.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 10.0 111.01 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.75 -1.18 41.13 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.938 -1.101 . . . . 10.0 109.812 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.472 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -87.96 -40.89 13.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 10.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.526 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.23 -11.83 18.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 10.0 109.505 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.04 -0.981 . . . . 10.0 110.025 -179.815 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.439 ' CA ' ' CG ' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -112.37 131.9 55.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 10.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 4.5 mtpt -88.38 99.96 12.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.137 -0.977 . . . . 10.0 110.115 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.2 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.74 -0.6 . . . . 10.0 110.001 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.38 -91.15 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.117 -0.989 . . . . 10.0 109.231 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 53.8 Cg_endo -76.57 -10.45 18.71 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 N-CA-C 108.423 -1.414 . . . . 10.0 108.423 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 3.3 pt-20 41.25 -162.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.776 -0.578 . . . . 10.0 110.121 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.419 HD11 ' CA ' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -134.77 -67.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.034 -1.041 . . . . 10.0 110.579 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 47.5 t -103.32 132.11 49.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 10.0 111.604 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.577 ' O ' ' CD1' ' B' ' 10' ' ' LEU . 1.2 tm? -149.36 101.77 3.32 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 120.598 -1.314 . . . . 10.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.561 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -91.2 -168.5 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.406 2.071 . . . . 10.0 108.15 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 67.0 m -108.97 173.58 6.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.736 -1.228 . . . . 10.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 43' ' ' THR . 5.3 m-20 -134.33 -165.22 1.62 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.799 0.809 . . . . 10.0 111.657 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.567 ' CB ' HG11 ' A' ' 42' ' ' VAL . 18.5 m-85 -45.39 -166.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.25 1.024 . . . . 10.0 112.426 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.615 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 57.1 mt-10 -41.24 154.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.088 -1.008 . . . . 10.0 111.806 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.493 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -139.32 -171.1 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 10.0 110.722 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.453 ' CG2' ' CE1' ' A' ' 40' ' ' TYR . 47.2 p -58.65 156.07 11.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.769 0.795 . . . . 10.0 112.064 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.565 ' CG1' ' HB3' ' A' ' 39' ' ' ASN . 1.3 pp -128.31 -168.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.599 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 74.0 m-70 -109.19 143.89 38.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.503 -1.373 . . . . 10.0 112.277 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.68 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 33.3 t -130.82 152.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.695 -0.628 . . . . 10.0 110.838 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.559 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -112.02 -175.17 19.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.817 -1.313 . . . . 10.0 109.817 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' B' ' 31' ' ' GLY . 46.0 t80 166.37 116.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.711 -0.876 . . . . 10.0 108.752 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.471 ' C ' ' O ' ' B' ' 22' ' ' PHE . 12.6 t70 -39.41 152.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.105 -0.638 . . . . 10.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.452 ' O ' ' CD ' ' B' ' 28' ' ' GLU . . . 63.11 79.85 0.25 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.735 -1.58 . . . . 10.0 106.735 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.589 ' O ' ' CG ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.5 -21.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.882 0.849 . . . . 10.0 110.572 -176.658 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.475 ' C ' ' O ' ' A' ' 26' ' ' ASN . 10.0 t -48.79 -15.96 0.11 Allowed 'General case' 0 C--N 1.286 -2.16 0 O-C-N 120.962 -1.086 . . . . 10.0 112.948 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.577 ' CA ' ' O ' ' A' ' 26' ' ' ASN . . . 148.22 85.64 0.06 OUTLIER Glycine 0 N--CA 1.504 3.178 0 N-CA-C 109.358 -1.497 . . . . 10.0 109.358 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.542 ' OE1' ' N ' ' B' ' 28' ' ' GLU . 19.7 pm0 -129.82 -146.4 0.31 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.746 -0.855 . . . . 10.0 109.422 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.634 ' HB3' HD22 ' A' ' 160' ' ' LEU . 13.9 p90 -135.35 145.23 47.18 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.521 ' CG2' ' C ' ' B' ' 29' ' ' PHE . 1.7 t 30.99 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.082 0.468 . . . . 10.0 110.559 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.58 ' O ' ' CE1' ' B' ' 22' ' ' PHE . . . -153.77 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.694 -1.762 . . . . 10.0 108.694 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.417 HG22 ' C ' ' B' ' 31' ' ' GLY . 10.7 pt -127.83 145.29 54.48 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.519 -0.989 . . . . 10.0 109.187 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.09 83.22 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.562 1.296 . . . . 10.0 109.925 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.542 ' HG3' ' HB2' ' B' ' 38' ' ' ARG . 2.8 tm-20 -160.13 155.6 25.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.568 -0.708 . . . . 10.0 110.315 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.593 ' HG2' ' CD1' ' B' ' 36' ' ' TRP . 2.2 tt0 -91.59 -71.3 0.64 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.027 -1.046 . . . . 10.0 109.7 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.593 ' CD1' ' HG2' ' B' ' 35' ' ' GLN . 0.4 OUTLIER -172.13 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.103 -0.998 . . . . 10.0 112.571 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' SER . . . -130.32 -19.1 3.16 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.478 -0.763 . . . . 10.0 110.468 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.542 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 6.6 mtt180 -78.89 6.54 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.404 -1.435 . . . . 10.0 108.108 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.623 ' HB2' ' N ' ' A' ' 71' ' ' SER . 29.7 mt -43.16 -29.96 0.42 Allowed 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.941 -0.475 . . . . 10.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.498 ' N ' ' OG ' ' A' ' 71' ' ' SER . 1.1 pp -95.72 14.8 21.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.189 -0.944 . . . . 10.0 110.182 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' B' ' 41' ' ' GLN . 5.5 tt0 -158.78 62.52 0.42 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.462 0.648 . . . . 10.0 109.755 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -91.52 -173.63 3.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.369 -0.832 . . . . 10.0 110.234 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 80.0 p -72.32 9.5 1.0 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.373 -0.829 . . . . 10.0 111.36 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -52.96 -26.06 13.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.574 -1.329 . . . . 10.0 109.84 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pt -108.8 168.86 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.211 -0.931 . . . . 10.0 109.616 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 117.946 -1.026 . . . . 10.0 110.356 -179.936 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' CA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.523 ' HA ' ' CD2' ' A' ' 177' ' ' LEU . 7.9 mm100 -133.1 0.87 3.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.002 . . . . 10.0 110.532 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.539 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.9 m -64.74 100.62 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 10.0 110.51 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.544 HG21 ' HA ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -114.65 133.73 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.994 -1.082 . . . . 10.0 111.096 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.595 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 26.2 mmtt -121.23 100.65 7.17 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.517 -0.92 . . . . 10.0 108.517 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.21 106.58 15.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.04 -1.038 . . . . 10.0 109.75 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.492 ' HB ' HG21 ' A' ' 75' ' ' THR . 71.7 t -133.67 147.56 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 10.0 110.11 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.536 ' CG2' ' HA2' ' A' ' 15' ' ' GLY . 14.2 m -91.2 115.72 30.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.424 -0.798 . . . . 10.0 110.295 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.498 HG13 ' CG ' ' A' ' 78' ' ' PHE . 0.5 OUTLIER -139.7 -166.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.277 -0.889 . . . . 10.0 110.045 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.511 ' HA2' ' CG2' ' A' ' 80' ' ' VAL . . . 126.43 -144.83 15.36 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 10.0 109.81 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.88 -37.84 20.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -1.223 . . . . 10.0 109.897 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 133.8 31.88 0.38 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.526 ' O ' HG22 ' B' ' 32' ' ' ILE . . . -61.27 -133.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.991 -1.3 . . . . 10.0 109.066 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.514 HG21 ' CG2' ' B' ' 32' ' ' ILE . 5.0 t -128.93 -24.79 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.546 -1.347 . . . . 10.0 111.144 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.536 ' HA2' ' CG2' ' A' ' 8' ' ' VAL . . . 157.0 128.94 1.09 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.351 -1.404 . . . . 10.0 110.062 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.486 ' HD3' ' CD1' ' A' ' 79' ' ' LEU . 0.3 OUTLIER -57.77 -24.53 57.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.205 -1.173 . . . . 10.0 110.154 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.8 m -59.37 -32.73 70.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 10.0 110.847 -179.755 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.541 ' HB2' ' CB ' ' B' ' 28' ' ' GLU . 16.6 p -61.0 -29.03 69.46 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.138 -0.976 . . . . 10.0 110.388 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.565 ' CD1' ' CB ' ' A' ' 159' ' ' ALA . 0.3 OUTLIER -80.51 -30.31 37.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.941 -1.1 . . . . 10.0 110.718 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.534 ' O ' ' OG1' ' A' ' 24' ' ' THR . 12.8 tp -49.2 -30.65 7.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.101 -0.999 . . . . 10.0 110.122 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.552 ' CG2' ' HB2' ' A' ' 26' ' ' ASN . 3.8 mm -106.74 -44.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 10.0 109.7 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.526 ' HB2' ' CA ' ' B' ' 27' ' ' GLY . 39.6 t -49.7 -40.07 39.12 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.364 -0.934 . . . . 10.0 109.303 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.63 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -82.09 -28.93 32.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.07 . . . . 10.0 109.311 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.534 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 25.2 m -65.58 -50.22 65.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 10.0 110.7 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.555 HG21 ' N ' ' A' ' 26' ' ' ASN . 14.7 t -175.24 -37.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.2 -1.4 . . . . 10.0 112.693 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.567 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.3 m120 -70.75 -9.79 58.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.156 -0.965 . . . . 10.0 111.985 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.618 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 0.8 OUTLIER 33.75 -150.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 10.0 110.661 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.523 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 12.6 p90 -131.31 59.41 45.49 Favored Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.167 -0.958 . . . . 10.0 111.437 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.589 ' HD2' ' CG2' ' B' ' 26' ' ' THR . 55.7 Cg_endo -96.02 -89.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.672 1.581 . . . . 10.0 110.618 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 m -167.26 67.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.063 -1.023 . . . . 10.0 110.92 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.57 ' HG3' ' CG2' ' A' ' 33' ' ' VAL . 12.4 pt-20 -134.72 -172.66 3.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.465 ' C ' HG22 ' A' ' 33' ' ' VAL . 53.6 m-85 -109.98 110.24 21.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.056 -1.028 . . . . 10.0 112.167 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 ' CG2' ' HG3' ' A' ' 31' ' ' GLU . 0.0 OUTLIER -155.36 105.78 2.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 178.55 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.512 ' HA ' HG13 ' B' ' 25' ' ' VAL . 50.0 Cg_endo -72.5 112.78 3.55 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.841 1.694 . . . . 10.0 114.67 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.572 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 16.8 m -157.96 94.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.503 -0.748 . . . . 10.0 109.222 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.572 ' CG2' ' O ' ' A' ' 35' ' ' THR . 54.9 t -163.62 -96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.334 -0.854 . . . . 10.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.577 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 6.8 t80 -57.22 141.11 47.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 10.0 111.122 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.629 ' HA ' HD13 ' B' ' 18' ' ' ILE . 4.8 t70 -164.31 101.37 0.84 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.252 -0.905 . . . . 10.0 110.376 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.58 ' CB ' HG22 ' B' ' 18' ' ' ILE . 0.4 OUTLIER -104.86 118.26 36.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.237 -1.54 . . . . 10.0 109.279 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.618 ' CE2' ' HG3' ' B' ' 15' ' ' GLU . 6.5 m-85 -146.72 113.53 6.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.068 -1.02 . . . . 10.0 111.107 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.455 ' O ' ' HA ' ' B' ' 15' ' ' GLU . . . -118.41 115.29 24.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.72 -1.238 . . . . 10.0 109.976 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.417 HG21 ' O ' ' B' ' 14' ' ' PHE . 0.9 OUTLIER -135.94 -168.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 10.0 111.462 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.481 ' O ' ' HB2' ' B' ' 13' ' ' ASP . 20.2 m -163.71 145.16 9.15 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.493 0.663 . . . . 10.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.48 ' HB ' HD12 ' A' ' 46' ' ' ILE . 0.9 OUTLIER -137.73 123.75 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.381 -0.824 . . . . 10.0 109.771 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.562 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 7.3 mtm -92.06 98.19 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.869 -1.133 . . . . 10.0 109.406 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 1.9 mp -86.36 120.93 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.593 -0.692 . . . . 10.0 109.874 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.552 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 44.6 26.38 1.05 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.486 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 110.02 -24.88 17.79 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.012 -1.287 . . . . 10.0 111.307 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.46 110.98 30.82 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 120.714 -1.462 . . . . 10.0 110.545 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.562 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.3 Cg_endo -73.64 141.06 30.42 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.044 1.549 . . . . 10.0 111.042 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.454 ' O ' ' HA ' ' A' ' 43' ' ' THR . 1.6 t80 -91.9 122.33 34.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.358 -0.839 . . . . 10.0 109.524 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.539 ' CG2' ' HA ' ' A' ' 3' ' ' THR 0.258 56.3 m -107.54 99.69 9.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.8 . . . . 10.0 109.772 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.544 ' HA ' HG21 ' A' ' 4' ' ' ILE . 1.8 pp -144.23 168.63 19.59 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.341 -1.344 . . . . 10.0 112.33 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.479 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.4 126.9 1.32 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.87 -2.092 . . . . 10.0 107.87 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.485 HD13 ' O ' ' A' ' 38' ' ' ASP . 2.0 pp -124.55 142.32 51.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.82 -1.4 . . . . 10.0 110.354 -179.295 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -139.82 104.91 5.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 10.0 110.837 -178.644 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 79.4 m-20 -80.97 -179.66 7.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.172 -0.955 . . . . 10.0 110.497 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 14.0 t -85.33 -175.97 5.93 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.549 1.166 . . . . 10.0 113.361 -177.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -142.0 -70.83 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.527 ' O ' ' HG2' ' A' ' 61' ' ' GLN . . . 40.54 24.09 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.117 -1.193 . . . . 10.0 110.117 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.543 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 1.4 mm-40 -171.47 -35.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.214 -1.168 . . . . 10.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.571 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 2.0 mt-10 -54.6 -80.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 117.813 -1.555 . . . . 10.0 108.861 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER 172.1 27.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 10.0 111.595 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.571 ' CZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.16 -52.43 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.672 -1.267 . . . . 10.0 110.807 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.49 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 24.0 t0 42.0 32.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.472 -0.767 . . . . 10.0 109.361 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.19 1.91 29.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.469 -0.769 . . . . 10.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.58 ' O ' HD23 ' A' ' 70' ' ' LEU . 2.4 mp -103.72 -14.46 16.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.413 -0.804 . . . . 10.0 110.03 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 3.9 ttt180 -82.26 -27.38 0.43 Allowed Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.7 Cg_endo -81.78 5.6 6.2 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.859 0.926 . . . . 10.0 111.072 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.614 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 2.0 pt? -49.34 -40.46 35.45 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.399 -0.813 . . . . 10.0 112.97 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.568 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 34.3 m 49.38 21.03 0.51 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.67 -1.269 . . . . 10.0 110.841 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 71' ' ' SER . 13.2 m-85 -143.92 130.61 10.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.925 -1.109 . . . . 10.0 110.366 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.462 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 50.8 Cg_endo -72.88 150.07 48.7 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.832 1.438 . . . . 10.0 111.276 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -177.48 47.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.047 0.927 . . . . 10.0 109.708 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.595 ' HA ' ' CB ' ' A' ' 5' ' ' LYS . 57.5 m -140.25 89.74 2.31 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.149 -0.97 . . . . 10.0 110.228 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -42.58 -30.72 0.38 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.53 -0.731 . . . . 10.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.495 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 13.6 m -123.19 124.84 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.78 -1.2 . . . . 10.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.58 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 1.7 m-85 -116.5 154.57 30.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.421 -0.799 . . . . 10.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.504 HD22 ' CD2' ' A' ' 111' ' ' LEU . 0.5 OUTLIER -111.0 97.95 7.19 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.843 -1.169 . . . . 10.0 107.843 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.513 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -103.39 125.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.159 -0.963 . . . . 10.0 111.033 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.44 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 4.2 m -127.38 125.96 41.63 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.299 -0.875 . . . . 10.0 109.084 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -135.91 178.85 6.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 10.0 110.245 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 t -81.03 149.5 29.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 10.0 112.059 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 6.1 t -100.48 -2.01 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.704 -0.623 . . . . 10.0 110.125 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.487 ' HB ' ' HG ' ' A' ' 129' ' ' LEU . 22.9 m -132.97 53.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.75 0.786 . . . . 10.0 109.842 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.496 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 19.4 p -121.29 158.39 53.38 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 121.513 -0.742 . . . . 10.0 110.5 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 120.64 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.557 . . . . 10.0 111.647 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m 44.41 64.77 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 10.0 111.612 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -124.22 -43.34 2.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.677 -1.264 . . . . 10.0 110.918 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.631 ' CD1' ' CD1' ' A' ' 137' ' ' ILE . 6.4 t80 -56.12 -50.21 71.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.828 -1.17 . . . . 10.0 110.694 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.96 -15.33 12.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.955 -1.091 . . . . 10.0 111.823 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.54 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -86.9 -20.21 27.74 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.698 -1.251 . . . . 10.0 111.079 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.568 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 19.3 m -90.18 -14.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.552 -1.343 . . . . 10.0 108.896 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HE2' ' CE1' ' A' ' 90' ' ' PHE . 25.9 mmtt -88.14 -33.41 18.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.15 0.976 . . . . 10.0 108.842 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 10.6 pt-20 -78.76 -5.82 54.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.105 -0.702 . . . . 10.0 109.105 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -84.24 -50.23 8.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 10.0 112.27 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 20.7 m95 -80.99 -23.8 38.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.014 -1.054 . . . . 10.0 113.376 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.544 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 4.4 t -69.23 -50.54 20.16 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.048 -1.658 . . . . 10.0 110.676 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.7 Cg_endo -72.84 -6.23 18.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.139 1.073 . . . . 10.0 109.564 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 101' ' ' ILE . 0.5 OUTLIER -68.98 -32.96 72.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 10.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 100' ' ' GLU . 2.7 pt 36.0 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.481 0.658 . . . . 10.0 111.318 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.503 HG23 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -47.11 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 109.416 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.475 ' H ' ' CG2' ' A' ' 102' ' ' THR . 30.4 m80 -106.74 -4.63 19.19 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.432 -0.793 . . . . 10.0 109.395 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -175.8 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 10.0 109.948 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.503 ' O ' HG23 ' A' ' 102' ' ' THR . 20.0 p -134.77 167.46 22.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 10.0 110.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.411 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 54.4 Cg_endo -81.01 72.38 6.55 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.773 1.407 . . . . 10.0 111.411 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -112.84 -10.11 13.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 10.0 112.029 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -52.92 125.39 39.65 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 120.687 -1.258 . . . . 10.0 110.432 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -73.72 153.12 48.43 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.052 1.553 . . . . 10.0 111.952 -179.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.608 ' CZ ' ' HB2' ' A' ' 151' ' ' ALA . 21.8 p90 -165.02 156.57 15.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.231 -1.025 . . . . 10.0 108.231 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.555 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 1.9 mm? -102.9 103.32 13.46 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 122.104 0.954 . . . . 10.0 111.007 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.541 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 88.2 mt -66.33 138.57 57.7 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.179 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.566 ' CG2' HG11 ' A' ' 168' ' ' VAL . 1.4 t -150.42 171.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.792 -1.192 . . . . 10.0 111.776 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . . . . . . . . . . . -133.25 122.11 3.04 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.486 -1.846 . . . . 10.0 108.486 178.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.44 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 31.0 p -100.55 170.96 8.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.165 -1.197 . . . . 10.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.22 33.95 8.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.473 -0.767 . . . . 10.0 109.392 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.769 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -69.05 -21.88 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 10.0 109.688 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.557 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 17.3 t70 -51.45 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.958 0.885 . . . . 10.0 110.282 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.769 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.2 tp 160.33 -30.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.017 -1.105 . . . . 10.0 108.017 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.464 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -47.46 -37.5 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.57 0.7 . . . . 10.0 109.876 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.487 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 64.2 t0 -55.74 -24.83 37.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 10.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 9.0 t0 -90.22 109.4 33.09 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.24 -0.913 . . . . 10.0 111.249 -179.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 51.5 Cg_endo -76.92 24.12 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.592 1.528 . . . . 10.0 112.142 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 m -100.97 -47.05 4.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.748 -1.22 . . . . 10.0 109.728 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.488 HG22 HD12 ' A' ' 126' ' ' ILE . 3.4 t -71.94 -26.34 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.035 -2.209 . . . . 10.0 105.035 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.488 HD12 HG22 ' A' ' 125' ' ' THR 0.301 1.1 mp -50.69 -26.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.15 -38.84 54.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.521 0.677 . . . . 10.0 110.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.534 ' CD ' ' N ' ' A' ' 128' ' ' LYS . 13.0 mptt -75.22 -44.6 45.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.469 -0.769 . . . . 10.0 110.679 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.511 ' N ' HD13 ' A' ' 129' ' ' LEU . 0.3 OUTLIER -60.16 -49.1 78.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.854 0.835 . . . . 10.0 108.971 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . -52.97 -40.92 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.469 0.652 . . . . 10.0 109.582 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -25.21 11.77 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.946 -1.097 . . . . 10.0 110.009 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -88.59 -48.65 7.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 10.0 112.177 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -126.98 0.84 6.58 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.484 -0.76 . . . . 10.0 110.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER 45.52 23.32 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 10.0 111.494 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -154.19 101.06 2.45 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.033 -1.042 . . . . 10.0 111.781 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 48.9 Cg_endo -74.03 160.12 43.43 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.124 1.592 . . . . 10.0 109.919 178.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.631 ' CD1' ' CD1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -81.77 128.19 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.529 -1.357 . . . . 10.0 109.077 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.535 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.5 p -125.37 170.89 8.41 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.475 -0.765 . . . . 10.0 110.404 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.535 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.5 Cg_endo -68.21 -7.27 19.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.786 1.414 . . . . 10.0 110.519 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -92.58 -38.54 11.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 10.0 110.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.565 HG23 ' CZ ' ' A' ' 90' ' ' PHE . 84.3 m -74.68 -44.68 48.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.635 -0.665 . . . . 10.0 111.593 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -77.67 -38.54 47.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 111.581 -178.28 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.439 ' CD ' ' O ' ' A' ' 143' ' ' GLU . 5.4 tm-20 -62.97 -27.04 69.13 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.792 -1.193 . . . . 10.0 108.94 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -49.59 10.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 10.0 109.93 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.482 ' CD1' ' HB3' ' A' ' 94' ' ' LYS . 5.1 tt -56.2 -41.82 76.19 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.237 -0.914 . . . . 10.0 110.022 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.34 73.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 10.0 108.89 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -60.23 -29.07 68.51 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.823 -0.751 . . . . 10.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.03 -47.49 51.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 10.0 110.499 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.731 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.8 OUTLIER -90.05 16.33 8.56 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.075 0.94 . . . . 10.0 108.966 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 27.12 1.99 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.798 0.809 . . . . 10.0 109.525 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.608 ' HB2' ' CZ ' ' A' ' 110' ' ' PHE . . . -63.68 -148.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.137 -0.625 . . . . 10.0 109.877 179.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.556 HG23 ' CB ' ' A' ' 175' ' ' ALA . 19.1 t -98.51 -75.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.231 -0.987 . . . . 10.0 109.963 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 112' ' ' LEU . 0.3 OUTLIER -173.56 -177.18 1.4 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.739 -1.184 . . . . 10.0 111.637 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.541 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -110.69 116.54 31.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.709 -0.619 . . . . 10.0 110.358 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.537 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.1 OUTLIER -122.77 -168.98 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.954 -1.091 . . . . 10.0 110.169 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.1 pt-20 -161.97 143.49 11.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 10.0 111.403 -179.423 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.517 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 28.4 p -159.19 177.28 11.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.472 -0.767 . . . . 10.0 111.301 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.559 ' CB ' ' CB ' ' A' ' 162' ' ' GLN . 47.1 t -144.91 170.58 15.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 10.0 109.725 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.608 ' CB ' ' CD2' ' B' ' 29' ' ' PHE . . . -89.59 -48.77 7.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 10.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.407 HD11 HG21 ' A' ' 161' ' ' THR . 2.0 pp -118.61 -0.7 11.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 10.0 112.176 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.502 ' O ' ' HD2' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -120.13 -80.07 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.429 -1.42 . . . . 10.0 111.968 -178.811 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.559 ' CB ' ' CB ' ' A' ' 158' ' ' SER . 5.7 tp60 -40.73 -63.75 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.991 -1.068 . . . . 10.0 112.071 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 25.2 mttt 70.14 51.01 0.41 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.932 0.872 . . . . 10.0 109.295 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.84 24.37 2.59 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.316 -1.514 . . . . 10.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.58 HD23 ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -78.78 1.43 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -1.224 . . . . 10.0 110.767 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -79.39 -39.47 32.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.851 -1.156 . . . . 10.0 109.596 178.809 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.35 -40.77 97.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.173 -0.954 . . . . 10.0 110.682 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.566 HG11 ' CG2' ' A' ' 113' ' ' VAL . 4.3 t -59.23 -28.21 38.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.185 -0.947 . . . . 10.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 169' ' ' PHE . 4.4 t80 -84.04 -21.34 31.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.488 -0.757 . . . . 10.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.405 ' O ' HD22 ' A' ' 174' ' ' LEU . 53.7 t0 -74.31 -49.45 22.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.091 -1.005 . . . . 10.0 111.135 -179.49 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.471 ' HA ' HD21 ' A' ' 174' ' ' LEU . 1.1 mm-40 -58.22 -37.22 74.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 10.0 110.578 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.535 ' CB ' HD21 ' A' ' 111' ' ' LEU . . . -55.61 -32.71 63.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.158 -0.964 . . . . 10.0 110.045 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.603 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 66.9 mt -60.8 -44.3 97.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.153 -0.967 . . . . 10.0 110.132 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.566 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -70.57 -30.59 67.34 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.732 -1.23 . . . . 10.0 111.567 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.556 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -86.37 -17.78 33.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 10.0 111.234 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.516 ' HB2' ' HB ' ' A' ' 4' ' ' ILE . . . -65.72 -30.97 71.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 10.0 109.318 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.603 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -110.35 -11.68 14.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 10.0 110.188 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.959 -1.019 . . . . 10.0 110.439 -179.866 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 108.809 -1.716 . . . . 10.0 108.809 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -130.14 136.92 49.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.488 -1.007 . . . . 10.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.462 ' O ' ' HG3' ' B' ' 3' ' ' LYS . 5.7 tptt -99.38 103.31 15.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.01 -1.057 . . . . 10.0 108.388 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.495 ' HB3' ' OE2' ' B' ' 7' ' ' GLU . 6.1 mm-40 -104.28 161.03 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.306 -0.871 . . . . 10.0 110.769 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.622 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.07 -153.26 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.564 -1.272 . . . . 10.0 107.564 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.622 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 40.3 Cg_endo -69.85 90.88 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 109.91 -0.842 . . . . 10.0 109.91 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.552 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 39.1 mm-40 -56.6 -152.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.893 -0.505 . . . . 10.0 110.691 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.588 ' CD1' ' N ' ' B' ' 9' ' ' SER . 2.7 pp -79.64 -51.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.756 -1.215 . . . . 10.0 111.406 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.588 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 32.2 t -155.3 171.5 19.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.594 -1.316 . . . . 10.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.601 ' O ' HD11 ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.25 133.33 3.28 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 118.857 -1.137 . . . . 10.0 113.023 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.505 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 46.3 Cg_endo -86.4 177.16 4.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 N-CA-C 108.459 -1.4 . . . . 10.0 108.459 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -133.48 148.75 51.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.633 -1.292 . . . . 10.0 111.655 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.481 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -104.55 -179.65 4.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.64 -0.662 . . . . 10.0 109.471 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.417 ' O ' HG21 ' A' ' 42' ' ' VAL . 21.6 m-85 -91.81 164.4 13.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.987 -1.07 . . . . 10.0 111.113 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.618 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 1.5 pm0 -127.85 177.25 6.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.2 0.524 . . . . 10.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.473 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 7.5 m-70 -95.6 166.23 11.94 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.487 -0.758 . . . . 10.0 111.901 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.527 ' O ' HG21 ' B' ' 18' ' ' ILE . 42.5 m -128.91 146.23 51.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.422 -0.799 . . . . 10.0 110.669 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.63 ' N ' HD12 ' B' ' 18' ' ' ILE . 0.2 OUTLIER -159.42 -171.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 10.0 110.481 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.409 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 64.6 m80 -140.02 156.73 46.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.552 -0.718 . . . . 10.0 109.73 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.496 ' HB ' ' HB ' ' A' ' 36' ' ' VAL . 14.0 m -105.98 143.72 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 10.0 112.658 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -147.85 132.62 4.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.543 ' HA ' ' HG3' ' A' ' 61' ' ' GLN . 0.4 OUTLIER 173.46 114.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.175 -1.191 . . . . 10.0 109.416 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' B' ' 22' ' ' PHE . 83.3 m-20 -39.46 132.74 1.49 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.78 . . . . 10.0 109.121 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.63 70.04 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.289 -1.004 . . . . 10.0 108.289 -176.175 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.537 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 2.0 t -88.16 -17.98 8.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 122.543 1.163 . . . . 10.0 108.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.589 ' CG2' ' HD2' ' A' ' 29' ' ' PRO 0.287 7.2 t -48.72 -19.05 0.32 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.713 -1.131 . . . . 10.0 111.175 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.618 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -154.51 -33.9 0.03 OUTLIER Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.513 -1.835 . . . . 10.0 108.513 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.541 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . 0.1 OUTLIER 52.45 23.96 2.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.769 -0.842 . . . . 10.0 111.394 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.608 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 51.6 t80 -112.35 115.6 28.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 122.093 0.949 . . . . 10.0 109.937 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' B' ' 29' ' ' PHE . 33.5 p -156.51 -70.14 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.509 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.46 118.1 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.033 -1.227 . . . . 10.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.526 HG22 ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -150.95 160.9 31.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -1.158 . . . . 10.0 109.51 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 34' ' ' GLU . 55.8 Cg_endo -76.85 136.91 17.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.906 1.477 . . . . 10.0 111.126 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.574 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 2.6 tt0 55.04 146.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.671 0.748 . . . . 10.0 110.736 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.523 ' HG2' ' N ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -85.85 -63.46 1.32 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.923 -1.111 . . . . 10.0 111.399 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.609 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 65.7 t90 -143.48 21.1 1.87 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.341 -0.85 . . . . 10.0 108.892 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.617 ' HB3' ' CD1' ' B' ' 39' ' ' LEU . . . 167.1 132.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.026 -1.101 . . . . 10.0 108.026 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.595 ' HG3' ' HB2' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -96.77 43.74 1.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.563 1.173 . . . . 10.0 109.63 -178.298 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.672 ' CD1' ' N ' ' B' ' 39' ' ' LEU . 0.1 OUTLIER -61.39 -51.17 69.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.326 -0.852 . . . . 10.0 112.964 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.58 18.15 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.595 ' HB2' ' HG3' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -119.22 -85.01 0.66 Allowed 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.811 -1.18 . . . . 10.0 110.486 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 66.9 p -136.04 54.4 1.9 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.501 ' HB3' ' HA ' ' B' ' 39' ' ' LEU . 81.9 p -74.63 -1.3 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.458 ' OD1' ' C ' ' B' ' 44' ' ' ASN . 42.7 p30 -161.23 168.72 23.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.166 -0.614 . . . . 10.0 109.999 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.15 -49.19 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 10.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 3.0 t . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.958 -1.02 . . . . 10.0 110.261 -179.795 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.496 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.15 0.5 . . . . 10.0 110.056 . . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.525 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 1.7 mt-30 -136.71 2.62 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.29 -0.881 . . . . 10.0 110.03 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.518 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 3.0 m -60.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.364 -0.835 . . . . 10.0 109.555 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.612 HG21 ' HA ' ' A' ' 53' ' ' LEU . 0.0 OUTLIER -108.97 132.32 57.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.705 -1.198 . . . . 10.0 110.425 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -121.07 97.56 5.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.313 -0.867 . . . . 10.0 110.522 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.407 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -79.67 111.49 16.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 10.0 111.003 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.505 HG21 ' CG2' ' A' ' 75' ' ' THR . 56.1 t -131.06 172.47 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 10.0 108.962 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' CG1' ' HB3' ' B' ' 35' ' ' GLN . 46.5 t -92.04 130.83 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.753 -1.217 . . . . 10.0 111.729 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.54 HG11 ' CG1' ' A' ' 80' ' ' VAL . 74.4 t -145.34 179.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.505 ' HA2' ' HB ' ' A' ' 80' ' ' VAL . . . 122.35 170.53 13.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.79 -1.324 . . . . 10.0 109.79 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -50.75 -39.51 52.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.151 . . . . 10.0 109.859 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.631 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 151.14 159.05 8.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.547 -1.421 . . . . 10.0 109.547 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.604 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . 179.82 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -1.097 . . . . 10.0 108.852 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.604 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 1.7 t 149.22 89.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . 42.68 92.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.365 -1.494 . . . . 10.0 109.365 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -49.47 -34.62 17.33 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.918 -1.342 . . . . 10.0 109.296 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.2 m -49.84 -25.22 2.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.738 -1.226 . . . . 10.0 108.724 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.516 ' HA ' ' O ' ' B' ' 26' ' ' THR . 13.7 p -63.73 -18.26 63.85 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.233 -0.987 . . . . 10.0 108.706 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.582 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 1.2 mm? -69.36 -33.31 72.88 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.15 -0.969 . . . . 10.0 108.863 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -48.61 -37.75 19.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 10.0 108.829 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.567 ' CD1' HG23 ' B' ' 26' ' ' THR . 1.5 mm -64.3 -43.6 97.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.68 0.752 . . . . 10.0 110.012 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.515 ' HB3' ' CE2' ' A' ' 23' ' ' TYR . 40.3 t -47.89 -44.26 29.43 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.335 -0.946 . . . . 10.0 109.738 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CZ ' ' CD1' ' A' ' 165' ' ' LEU . 6.9 m-85 -90.98 -3.81 56.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.573 -0.705 . . . . 10.0 109.676 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.44 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 14.4 m -112.41 -33.46 6.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.855 . . . . 10.0 112.403 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 17.3 m -136.58 -82.51 0.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.187 -1.57 . . . . 10.0 113.064 -178.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.512 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 2.3 m120 -153.89 51.42 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.626 -1.296 . . . . 10.0 113.724 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 30.81 -131.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.619 -0.675 . . . . 10.0 112.676 177.609 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.635 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 11.0 p90 -111.83 81.28 3.39 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-O 121.216 0.531 . . . . 10.0 110.765 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.578 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 52.8 Cg_endo -90.61 -169.53 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.717 1.611 . . . . 10.0 110.777 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.28 43.37 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 10.0 110.319 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.39 -176.93 5.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.99 133.07 44.15 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.107 -0.995 . . . . 10.0 111.162 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.584 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -134.71 -177.3 0.68 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.584 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 36.7 Cg_endo -59.28 -176.89 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.061 1.032 . . . . 10.0 109.421 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.673 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 1.3 p -117.26 167.31 11.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.043 -1.036 . . . . 10.0 111.567 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.645 ' HB ' ' CG1' ' B' ' 20' ' ' VAL 0.273 74.1 t -55.77 -8.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 112.46 0.541 . . . . 10.0 112.46 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.73 ' CD1' ' O ' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -32.69 87.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.43 1.11 . . . . 10.0 113.46 -177.45 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' VAL . 11.4 m-20 -157.53 104.74 2.01 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 120.718 -1.239 . . . . 10.0 111.368 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.621 ' CB ' ' CG1' ' B' ' 18' ' ' ILE . 0.6 OUTLIER -170.42 102.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 10.0 108.651 178.969 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.625 ' CD1' ' HB3' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -153.66 175.22 13.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.669 -1.212 . . . . 10.0 112.177 -178.529 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.578 ' O ' ' CG1' ' A' ' 42' ' ' VAL . . . -165.71 148.37 7.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.829 -0.748 . . . . 10.0 110.791 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.603 HG23 ' N ' ' B' ' 15' ' ' GLU . 0.2 OUTLIER -171.52 -165.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.41 -0.806 . . . . 10.0 111.105 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.468 HG23 ' O ' ' A' ' 51' ' ' TYR . 74.9 m -137.38 146.05 44.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 10.0 110.217 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.558 HG11 ' CD1' ' A' ' 46' ' ' ILE . 0.5 OUTLIER -103.6 176.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.244 -0.91 . . . . 10.0 109.467 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.581 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 39.5 mtp -154.37 126.18 7.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 10.0 110.472 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.558 ' CD1' HG11 ' A' ' 44' ' ' VAL . 2.7 mp -139.06 123.43 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 10.0 109.196 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.49 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.93 22.41 6.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.49 6.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.477 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.0 mt-10 -120.81 99.56 47.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.293 -1.122 . . . . 10.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.523 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 43.6 Cg_endo -71.6 136.31 27.99 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.632 1.333 . . . . 10.0 110.319 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' HB2' ' CG1' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -99.88 157.02 16.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.102 -0.999 . . . . 10.0 110.347 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.518 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 40.1 m -126.95 106.62 9.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 10.0 111.973 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.612 ' HA ' HG21 ' A' ' 4' ' ' ILE . 1.9 pt? -148.37 166.71 27.24 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.438 -1.414 . . . . 10.0 111.293 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.16 134.99 3.2 Favored Glycine 0 C--N 1.288 -2.092 0 N-CA-C 108.629 -1.789 . . . . 10.0 108.629 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.407 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . 4.6 pp -153.19 167.45 29.24 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.112 -1.228 . . . . 10.0 110.308 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.475 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 22.4 p90 -170.29 131.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 10.0 110.908 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 5.1 p-10 -99.09 176.83 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 10.0 110.252 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 21.5 m -40.75 162.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.167 0.984 . . . . 10.0 112.638 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.639 ' HA ' ' CG1' ' B' ' 20' ' ' VAL . . . -134.39 68.93 1.47 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.512 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.58 ' HA3' ' CD2' ' B' ' 22' ' ' PHE . . . -43.61 -82.23 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 107.904 -2.078 . . . . 10.0 107.904 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.273 -1.134 . . . . 10.0 107.951 177.121 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.554 ' CG ' ' O ' ' A' ' 61' ' ' GLN . 8.5 pt-20 41.99 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.406 1.098 . . . . 10.0 111.034 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.5 -12.73 57.6 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 1.2 p90 -133.83 -27.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.851 -0.531 . . . . 10.0 109.693 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 68' ' ' ARG . 5.3 t70 43.12 35.98 0.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 10.0 110.496 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.8 -7.83 59.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.986 -1.071 . . . . 10.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.579 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -111.63 4.14 18.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 10.0 110.358 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.589 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 1.7 mmt180 -53.61 -40.53 81.25 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.214 -0.929 . . . . 10.0 111.868 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 52.5 Cg_endo -83.72 78.71 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.414 1.218 . . . . 10.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.584 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -105.61 -105.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 10.0 110.488 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 47.07 35.7 3.66 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -148.26 114.92 3.91 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 120.154 -0.618 . . . . 10.0 110.948 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' GLN . 53.9 Cg_endo -75.52 -151.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.925 1.487 . . . . 10.0 110.004 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 76.64 79.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.79 . . . . 10.0 111.275 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.5 m -139.09 96.67 3.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.517 ' C ' ' O ' ' A' ' 75' ' ' THR . 71.0 m-20 -23.14 -41.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.856 -0.611 . . . . 10.0 112.37 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.583 ' N ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -142.13 130.09 21.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.894 -1.129 . . . . 10.0 110.838 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.476 ' HB2' HG22 ' A' ' 9' ' ' VAL . 3.7 p90 -148.25 170.19 18.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.055 -1.028 . . . . 10.0 110.596 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.5 HD12 HG12 ' A' ' 168' ' ' VAL . 4.1 mt -112.34 102.53 10.67 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.86 . . . . 10.0 110.067 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.565 HG23 ' CE2' ' A' ' 82' ' ' PHE . 1.7 m -98.79 127.52 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.676 -0.861 . . . . 10.0 108.676 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.53 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 0.5 OUTLIER -105.66 100.44 10.0 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.638 -1.288 . . . . 10.0 112.048 -178.322 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.565 ' CE2' HG23 ' A' ' 80' ' ' VAL . 57.6 m-85 -86.86 176.1 7.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.247 -0.908 . . . . 10.0 109.908 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.465 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 47.9 t -100.72 142.67 31.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -0.845 . . . . 10.0 108.878 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.533 ' CG2' ' CG ' ' A' ' 120' ' ' ARG . 34.0 m -56.16 -16.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.041 -1.037 . . . . 10.0 110.675 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.489 HG23 ' CG ' ' A' ' 120' ' ' ARG . 0.0 OUTLIER -112.66 -88.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.868 -1.145 . . . . 10.0 109.293 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 34.25 75.27 0.47 Allowed Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.942 -0.474 . . . . 10.0 110.612 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.467 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 43.6 Cg_endo -69.79 162.12 43.3 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.978 1.515 . . . . 10.0 110.62 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.505 ' OG ' ' HD3' ' A' ' 133' ' ' LYS . 15.8 m 47.42 39.37 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.783 . . . . 10.0 111.402 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.544 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -135.06 -68.6 0.52 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.91 -1.119 . . . . 10.0 110.38 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.548 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 p90 -57.18 -16.67 8.53 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.322 -0.861 . . . . 10.0 110.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.46 ' HG2' ' CZ ' ' A' ' 90' ' ' PHE . 18.1 mt-10 -78.59 -24.54 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 10.0 110.208 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.544 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -80.95 -14.76 57.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 10.0 110.311 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.552 HG22 ' HD3' ' A' ' 94' ' ' LYS . 16.6 m -87.93 -22.74 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 118.288 -1.365 . . . . 10.0 108.486 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.565 ' HE2' ' CD2' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.43 -27.73 63.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.51 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -89.39 -1.27 57.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.746 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.489 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 13.3 mmtm -102.46 -53.16 2.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.948 -1.101 . . . . 10.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.431 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 41.7 m95 -90.32 -38.37 13.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.704 -1.247 . . . . 10.0 112.547 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.534 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 2.7 t -64.22 -51.06 64.51 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.541 -1.349 . . . . 10.0 111.29 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.534 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -67.58 -16.05 46.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.055 1.029 . . . . 10.0 109.556 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ILE . 5.0 tm-20 -55.54 -51.39 67.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.347 -0.846 . . . . 10.0 109.957 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CB ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 163.32 1.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.522 -0.736 . . . . 10.0 112.114 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.672 ' CG2' ' CB ' ' A' ' 107' ' ' LYS . 46.9 p -60.1 -26.84 66.53 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.279 -1.513 . . . . 10.0 111.314 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -10.06 18.54 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.376 -0.828 . . . . 10.0 111.418 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -120.0 -3.42 10.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.718 -1.238 . . . . 10.0 110.926 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.506 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 24.9 p -161.17 166.57 14.93 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.902 -1.124 . . . . 10.0 110.65 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.506 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 38.1 Cg_endo -65.36 110.39 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.741 1.39 . . . . 10.0 109.304 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.672 ' CB ' ' CG2' ' A' ' 102' ' ' THR 0.261 0.0 OUTLIER -92.35 -95.46 0.14 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.89 0.852 . . . . 10.0 111.06 -178.052 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.593 ' H ' ' CG ' ' A' ' 107' ' ' LYS . 1.1 m -167.26 120.36 0.78 Allowed Pre-proline 0 C--N 1.29 -1.992 0 C-N-CA 120.064 -0.655 . . . . 10.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.51 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 42.1 Cg_endo -68.62 149.91 74.24 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.938 1.494 . . . . 10.0 111.052 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.6 ' CE1' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -129.7 119.78 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 10.0 108.89 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.574 HD11 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -75.05 97.24 3.37 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.532 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 51.1 mt -63.81 144.47 57.02 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.81 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.564 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 65.4 t -154.66 157.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 10.0 111.619 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.508 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.1 154.39 19.87 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.78 -1.728 . . . . 10.0 108.78 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.53 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 45.9 p -120.79 136.74 54.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.877 -1.366 . . . . 10.0 110.518 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.0 OUTLIER 39.75 50.86 2.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.944 0.878 . . . . 10.0 108.718 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.763 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -83.29 -32.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.173 -177.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -52.35 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.999 0.904 . . . . 10.0 111.064 -177.244 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.763 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.9 tp 153.03 -33.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.849 -1.167 . . . . 10.0 107.849 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.533 ' CG ' ' CG2' ' A' ' 84' ' ' VAL . 24.6 tpp180 -53.86 -27.83 32.4 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.45 ' OD1' ' O ' ' A' ' 121' ' ' ASP . 19.3 t0 -72.23 -5.76 38.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 10.0 110.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.459 ' OD2' HD12 ' A' ' 119' ' ' LEU . 17.0 m-20 -79.82 157.91 73.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 10.0 110.668 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -83.0 23.04 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.935 1.756 . . . . 10.0 111.507 -178.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.8 p -105.8 -46.97 4.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.043 -1.035 . . . . 10.0 109.324 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.448 HG21 ' HA ' ' A' ' 120' ' ' ARG . 8.2 t -69.98 -27.65 64.89 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.497 ' N ' HD11 ' A' ' 126' ' ' ILE 0.307 0.7 OUTLIER -49.26 -27.53 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.144 -1.389 . . . . 10.0 107.427 177.1 . . . . . . . . 4 4 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.03 -37.44 61.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.049 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -82.52 -50.75 8.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 10.0 111.426 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.491 ' CD2' ' HA ' ' A' ' 126' ' ' ILE . 0.5 OUTLIER -67.92 -20.72 65.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.631 -1.293 . . . . 10.0 109.261 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.434 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -62.07 -40.87 97.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.491 -0.756 . . . . 10.0 109.968 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -62.46 -18.19 61.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 10.0 109.678 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.467 ' OD1' ' HB2' ' A' ' 87' ' ' PRO . 12.3 t-20 -97.99 -72.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 10.0 110.281 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.505 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 1.2 mptp? -149.55 144.35 26.19 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.347 -0.846 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.617 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -86.02 21.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 10.0 110.404 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -112.21 93.92 24.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.124 -0.985 . . . . 10.0 110.633 -179.944 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.446 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 46.1 Cg_endo -83.17 156.67 14.91 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.158 1.609 . . . . 10.0 110.841 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.446 HG12 ' CD2' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -89.25 114.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -0.944 . . . . 10.0 109.057 179.109 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.548 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.6 p -114.72 169.25 6.86 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.386 -0.821 . . . . 10.0 109.631 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.548 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 36.7 Cg_endo -61.84 -19.39 65.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.43 1.226 . . . . 10.0 110.523 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.59 -41.93 44.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 10.0 108.749 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.5 m -83.35 -41.18 18.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.502 ' HB3' ' CD1' ' A' ' 154' ' ' TYR . . . -52.24 -41.8 63.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.6 -0.687 . . . . 10.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.27 -49.6 76.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.429 -0.795 . . . . 10.0 109.259 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' ASP . 22.9 mttm -60.53 -39.93 89.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.487 -0.931 . . . . 10.0 108.487 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.565 ' CD2' ' HE2' ' A' ' 94' ' ' LYS . 10.4 tt -58.67 -39.51 80.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.592 -0.693 . . . . 10.0 109.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -69.76 -48.08 60.6 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.627 -0.829 . . . . 10.0 108.85 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.42 -23.71 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.729 0.776 . . . . 10.0 108.98 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 144' ' ' LYS . 38.2 t70 -54.6 -27.49 39.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.594 -0.691 . . . . 10.0 111.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.629 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.26 38.1 0.79 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.914 -1.116 . . . . 10.0 112.402 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.519 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 18.0 mtpt 64.49 38.08 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.317 -0.864 . . . . 10.0 112.197 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -72.97 -158.39 0.05 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.574 ' CG1' HD11 ' A' ' 111' ' ' LEU . 2.1 p -114.9 -62.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.323 -1.486 . . . . 10.0 111.358 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 6.9 tttt -173.04 156.48 3.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.385 -1.447 . . . . 10.0 112.714 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.532 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 78.9 t80 -101.32 105.73 16.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 10.0 109.521 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.547 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 1.3 t -96.81 -167.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 10.0 110.854 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -132.37 139.53 48.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.477 -0.764 . . . . 10.0 110.463 -179.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.576 ' HB2' ' CB ' ' A' ' 165' ' ' LEU . 2.7 t -166.96 133.0 2.23 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.337 1.065 . . . . 10.0 110.969 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.69 ' C ' ' HB3' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -150.98 80.03 1.32 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.446 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.596 ' HB2' ' CD1' ' B' ' 29' ' ' PHE . . . -21.11 -43.48 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.49 0.922 . . . . 10.0 113.49 -177.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.0 tp -76.56 -59.26 2.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.366 -1.458 . . . . 10.0 110.069 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.543 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -115.3 39.08 3.03 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 123.179 1.466 . . . . 10.0 108.611 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.69 ' HB3' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -59.38 -106.96 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 113.604 -1.634 . . . . 10.0 111.798 -177.649 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 6.6 mttt 71.69 63.02 0.14 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.665 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.31 -21.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.554 -1.308 . . . . 10.0 111.05 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.751 ' CD1' ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -62.59 -8.24 6.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.401 -1.647 . . . . 10.0 110.912 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.54 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.0 ptmt -65.2 -31.57 72.8 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.962 -1.086 . . . . 10.0 109.537 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.58 -27.7 60.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.454 -0.779 . . . . 10.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.547 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 11.9 t -53.32 -48.17 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 10.0 109.676 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.533 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 t80 -73.55 -30.51 63.1 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.866 -0.521 . . . . 10.0 111.259 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.519 ' O ' HD21 ' A' ' 174' ' ' LEU . 6.1 m-20 -69.37 -46.17 67.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 10.0 111.781 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 -25.32 59.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.209 . . . . 10.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.489 ' HB1' HD21 ' A' ' 111' ' ' LEU . . . -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.196 -0.94 . . . . 10.0 109.491 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.562 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 26.3 mm -63.24 -48.03 89.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.299 -0.96 . . . . 10.0 109.305 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.545 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -73.44 -42.97 61.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 10.0 110.784 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.498 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -76.23 -2.08 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 10.0 111.065 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.549 ' HB2' ' CG1' ' A' ' 4' ' ' ILE . . . -87.82 -30.63 20.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.985 -1.072 . . . . 10.0 110.659 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.562 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -85.77 -17.19 36.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -0.855 . . . . 10.0 109.163 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 118.07 -0.967 . . . . 10.0 110.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.464 -1.454 . . . . 10.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -89.43 56.34 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -1.142 . . . . 10.0 110.602 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -77.38 98.21 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 10.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -91.3 155.22 18.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.824 . . . . 10.0 110.192 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.664 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.35 -152.09 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.664 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.7 Cg_endo -69.95 87.35 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 N-CA-C 110.279 -0.701 . . . . 10.0 110.279 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.523 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 22.6 mm-40 -50.92 -175.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 10.0 110.155 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.422 HD11 ' CB ' ' B' ' 9' ' ' SER . 1.7 pp -79.77 -44.43 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.016 -1.053 . . . . 10.0 111.271 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.49 ' O ' ' N ' ' A' ' 47' ' ' GLY . 7.5 t -126.25 163.66 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.659 -1.276 . . . . 10.0 110.828 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.658 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.37 96.79 0.51 Allowed Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.764 -1.174 . . . . 10.0 113.367 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.581 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 40.2 Cg_endo -81.91 157.71 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 N-CA-C 108.007 -1.574 . . . . 10.0 108.007 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -149.02 125.24 10.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.14 -1.6 . . . . 10.0 112.2 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.448 ' HB2' ' O ' ' A' ' 43' ' ' THR . 10.0 m-20 -80.35 156.97 26.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.152 -1.055 . . . . 10.0 108.152 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.546 ' O ' ' CG1' ' A' ' 42' ' ' VAL . 29.0 m-85 -110.34 142.63 41.74 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.411 -1.431 . . . . 10.0 111.301 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.625 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -58.93 143.28 48.45 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.361 0.601 . . . . 10.0 112.335 -177.777 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.616 ' C ' ' HB3' ' A' ' 40' ' ' TYR . 8.1 t60 -88.58 97.6 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.521 -0.737 . . . . 10.0 109.798 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.439 ' HA ' ' HB3' ' A' ' 40' ' ' TYR . 4.2 m -83.85 155.35 22.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.874 0.845 . . . . 10.0 112.934 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.621 ' CG1' ' CB ' ' A' ' 39' ' ' ASN . 1.9 pp -125.98 -167.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.568 ' HA ' ' CB ' ' A' ' 37' ' ' PHE . 22.2 m-70 -123.14 143.87 49.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 10.0 110.605 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.645 ' CG1' ' HB ' ' A' ' 36' ' ' VAL . 41.2 t -135.41 155.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.446 -0.784 . . . . 10.0 110.413 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.548 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -122.67 151.76 16.87 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.0 -1.095 . . . . 10.0 112.737 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.602 ' HB3' ' CB ' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 159.33 112.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' B' ' 24' ' ' ALA . 8.3 m-20 -44.66 143.32 1.41 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.465 -0.772 . . . . 10.0 111.653 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.535 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . . . 19.82 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 120.968 0.413 . . . . 10.0 111.762 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.602 ' CB ' ' HB3' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -112.59 -41.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.438 -0.789 . . . . 10.0 109.322 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.567 HG23 ' CD1' ' A' ' 21' ' ' ILE . 13.2 t -53.58 -18.3 2.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.62 -0.675 . . . . 10.0 109.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.512 ' HA3' ' CG2' ' A' ' 21' ' ' ILE . . . -128.09 25.51 4.89 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 107.78 -2.128 . . . . 10.0 107.78 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.52 ' HB2' ' O ' ' B' ' 24' ' ' ALA . 23.9 tt0 -92.93 110.25 21.71 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.854 -1.38 . . . . 10.0 111.995 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.596 ' CD1' ' HB2' ' A' ' 159' ' ' ALA . 45.7 t80 -140.75 111.06 6.69 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.515 -1.22 . . . . 10.0 109.297 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.466 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 47.6 p -116.67 -79.61 0.59 Allowed 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.465 -0.939 . . . . 10.0 108.465 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.469 ' O ' HG13 ' B' ' 32' ' ' ILE . . . 139.16 97.18 0.37 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.721 -1.228 . . . . 10.0 110.971 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.57 HG23 ' CD ' ' B' ' 33' ' ' PRO . 0.1 OUTLIER 178.51 -51.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.111 -1.229 . . . . 10.0 110.284 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.57 ' CD ' HG23 ' B' ' 32' ' ' ILE . 49.3 Cg_endo -92.44 154.31 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.712 1.375 . . . . 10.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.58 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -49.19 174.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 10.0 108.762 178.889 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.631 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 23.7 mt-30 -88.42 -73.78 0.48 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.457 -1.402 . . . . 10.0 111.946 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.585 ' O ' ' CD2' ' B' ' 36' ' ' TRP . 0.4 OUTLIER -122.61 19.26 10.37 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.311 1.053 . . . . 10.0 108.792 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.545 ' O ' ' CD2' ' B' ' 39' ' ' LEU . . . -112.75 52.34 0.79 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.499 ' CG ' ' HB2' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -75.6 42.95 0.23 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.199 1.0 . . . . 10.0 108.794 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.545 ' CD2' ' O ' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -51.83 -29.39 19.23 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.565 -0.743 . . . . 10.0 111.151 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.2 pp -114.72 13.68 17.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 10.0 109.957 179.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.499 ' HB2' ' CG ' ' B' ' 38' ' ' ARG . 28.3 mt-30 -131.73 35.09 3.82 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.788 -0.57 . . . . 10.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.423 HG22 ' N ' ' B' ' 43' ' ' SER . 44.9 m -102.35 168.39 9.36 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.101 -0.999 . . . . 10.0 110.259 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.423 ' N ' HG22 ' B' ' 42' ' ' THR . 96.6 p -61.6 -7.96 3.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 10.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -123.82 100.84 6.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.806 -1.184 . . . . 10.0 110.025 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.45 160.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 10.0 109.746 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.298 -1.653 0 C-N-CA 119.139 -1.024 . . . . 10.0 110.322 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.401 ' C ' ' HG2' ' A' ' 2' ' ' GLN . 3.8 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.157 0.503 . . . . 10.0 110.503 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.566 ' NE2' HD22 ' A' ' 177' ' ' LEU . 24.9 mm100 -146.61 -38.53 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.332 -0.855 . . . . 10.0 109.607 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.585 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.8 m -47.28 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 10.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.557 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -111.07 130.46 64.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.286 -0.966 . . . . 10.0 108.892 177.101 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER -113.19 98.57 7.21 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.412 -0.915 . . . . 10.0 109.598 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.1 t -84.88 101.31 12.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.283 -0.885 . . . . 10.0 109.072 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.51 ' CG2' HG21 ' A' ' 75' ' ' THR . 48.4 t -121.84 142.46 38.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.135 -1.026 . . . . 10.0 110.739 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.543 ' CG2' ' HA3' ' A' ' 15' ' ' GLY . 2.4 p -63.29 125.86 20.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.671 -0.643 . . . . 10.0 109.994 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.628 ' HB ' ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -141.64 168.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.148 -0.97 . . . . 10.0 109.672 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.542 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 169.97 158.19 13.47 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.7 -1.36 . . . . 10.0 109.7 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -50.03 -22.62 1.67 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.404 -1.056 . . . . 10.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.0 35.4 0.08 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.599 -1.4 . . . . 10.0 109.599 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.496 ' HA ' ' O ' ' B' ' 32' ' ' ILE . . . -125.55 -155.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -1.103 . . . . 10.0 109.661 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.455 HG12 ' HA ' ' B' ' 29' ' ' PHE . 20.1 t -69.71 108.79 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 10.0 109.471 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' HA3' ' CG2' ' A' ' 8' ' ' VAL . . . -52.55 164.51 1.64 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.888 -1.285 . . . . 10.0 109.888 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -87.68 5.89 37.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -1.086 . . . . 10.0 110.267 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.527 ' HB ' ' HB ' ' A' ' 8' ' ' VAL . 14.1 t -75.08 -43.06 55.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.167 -0.958 . . . . 10.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.642 ' HA ' ' O ' ' B' ' 26' ' ' THR . 30.8 p -74.72 -9.23 58.37 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.375 -1.33 . . . . 10.0 108.429 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.576 ' CD1' ' CB ' ' A' ' 159' ' ' ALA . 3.9 mm? -76.8 -36.2 57.11 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.385 -0.822 . . . . 10.0 109.631 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -37.79 49.82 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.197 -1.038 . . . . 10.0 108.197 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.543 HG22 ' CA ' ' B' ' 27' ' ' GLY . 1.4 mm -91.61 -51.76 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.685 0.755 . . . . 10.0 109.912 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.626 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 68.4 m -49.52 -45.59 47.45 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.51 -0.876 . . . . 10.0 109.808 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.556 ' C ' ' CD1' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -67.58 -32.47 73.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 10.0 109.726 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 m -75.77 -51.85 11.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 10.0 112.073 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.513 HG22 ' N ' ' A' ' 26' ' ' ASN . 15.3 t -153.67 -46.15 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.54 -1.664 . . . . 10.0 113.82 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.557 ' HB3' ' CG2' ' A' ' 33' ' ' VAL . 30.5 m120 -67.98 -23.67 65.06 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.907 -1.12 . . . . 10.0 111.596 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.626 ' N ' ' HA ' ' A' ' 22' ' ' SER . 2.6 pttt 24.37 -148.59 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.287 1.042 . . . . 10.0 113.249 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.612 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 15.0 t80 -53.39 149.77 13.63 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.085 -1.01 . . . . 10.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.612 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 36.5 Cg_endo -60.42 100.3 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 O-C-N 123.527 1.278 . . . . 10.0 112.49 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 t -168.09 28.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.695 -0.628 . . . . 10.0 109.632 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.486 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 13.0 pt-20 -171.24 -174.33 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.849 0.833 . . . . 10.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.486 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 11.1 m-85 -72.91 154.49 40.54 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.57 HG23 ' HD2' ' A' ' 34' ' ' PRO . 1.8 p -176.91 153.04 1.07 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.516 -1.365 . . . . 10.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.57 ' HD2' HG23 ' A' ' 33' ' ' VAL . 37.7 Cg_endo -61.79 -175.28 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 124.069 1.563 . . . . 10.0 110.55 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.547 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 82.5 p -126.03 163.11 23.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.177 0.989 . . . . 10.0 112.68 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.748 ' N ' HG13 ' B' ' 20' ' ' VAL . 73.2 t -50.64 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.621 ' CD2' HG13 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -51.64 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.757 -1.214 . . . . 10.0 110.213 -175.597 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' VAL . 57.0 t0 -133.66 85.64 2.22 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.663 -0.698 . . . . 10.0 110.564 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' B' ' 17' ' ' THR . 2.0 t-20 -84.4 99.65 10.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.916 -1.115 . . . . 10.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.97 120.71 41.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 10.0 109.652 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.573 ' O ' ' CB ' ' B' ' 15' ' ' GLU . . . -124.0 137.13 54.64 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.693 -1.203 . . . . 10.0 111.023 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.551 ' CG2' ' O ' ' A' ' 41' ' ' ALA . 55.8 t -157.94 170.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.012 . . . . 10.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.531 ' CG2' ' O ' ' A' ' 51' ' ' TYR . 85.1 m -149.82 146.55 27.21 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.519 HG21 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.95 133.17 10.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 120.912 -1.118 . . . . 10.0 112.133 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.56 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 27.0 mtp -92.4 99.82 12.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 10.0 109.794 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.701 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 5.7 mt -88.16 130.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 10.0 110.636 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.514 ' HA2' ' CD1' ' B' ' 8' ' ' ILE . . . 43.78 25.77 0.65 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.267 -1.533 . . . . 10.0 109.267 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 96.87 21.66 20.36 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.225 -1.15 . . . . 10.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.499 ' C ' ' HA ' ' A' ' 45' ' ' MET . 27.9 mt-10 -126.34 105.43 24.64 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.972 -1.31 . . . . 10.0 110.526 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.53 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 41.4 Cg_endo -67.26 131.45 25.05 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 124.028 1.541 . . . . 10.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.545 ' CE1' HD21 ' A' ' 53' ' ' LEU . 1.5 t80 -88.53 152.26 21.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 10.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.585 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 23.7 m -130.38 98.72 4.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.706 . . . . 10.0 109.267 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.545 HD21 ' CE1' ' A' ' 51' ' ' TYR . 2.3 pp -152.33 173.6 14.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.12 -1.432 . . . . 10.0 112.259 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.423 ' N ' ' CD1' ' A' ' 53' ' ' LEU . . . -172.5 134.38 2.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.151 -1.98 . . . . 10.0 108.151 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.495 ' O ' HD13 ' A' ' 55' ' ' LEU . 4.0 pp -130.32 152.43 49.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.683 -1.481 . . . . 10.0 110.712 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 16.8 p90 -169.81 150.45 3.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 10.0 110.432 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.499 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 63.6 m-20 -93.04 172.96 7.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.222 -0.923 . . . . 10.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.565 ' HA ' ' CZ ' ' A' ' 68' ' ' ARG . 0.9 OUTLIER -64.28 -169.03 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.117 0.961 . . . . 10.0 112.078 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.553 ' CB ' ' HB2' ' A' ' 62' ' ' GLU . . . -111.34 72.11 0.77 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -39.91 -43.69 2.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.675 -1.37 . . . . 10.0 109.675 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -143.81 13.62 1.7 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.259 -1.142 . . . . 10.0 110.864 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.635 ' O ' ' CE1' ' A' ' 64' ' ' TYR . 13.4 mm-40 -53.05 -39.14 63.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.765 -1.209 . . . . 10.0 109.147 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.547 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 35.0 m-20 67.21 10.37 7.66 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 62' ' ' GLU . 4.5 m-85 -101.45 -32.57 10.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 64' ' ' TYR . 9.7 t70 20.45 49.16 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.226 0.536 . . . . 10.0 111.28 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' TYR . 42.8 mtp180 -83.22 -37.06 24.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.328 -0.858 . . . . 10.0 110.419 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.477 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.1 mt -108.13 4.58 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 10.0 110.626 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.719 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -100.27 3.04 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 118.934 -1.107 . . . . 10.0 113.54 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_endo -79.37 52.98 4.51 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 N-CA-C 108.196 -1.502 . . . . 10.0 108.196 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.564 ' HG ' ' N ' ' A' ' 71' ' ' SER . 1.7 pt? -53.28 -52.9 57.57 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 121.572 -0.705 . . . . 10.0 112.225 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.577 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 26.2 t 39.99 27.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.011 . . . . 10.0 109.601 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.47 158.75 0.74 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 10.0 110.017 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 47.1 Cg_endo -72.99 107.75 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.696 1.366 . . . . 10.0 109.44 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -137.69 36.95 2.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.805 -1.184 . . . . 10.0 110.962 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.615 ' O ' ' CE1' ' A' ' 78' ' ' PHE . 97.7 m -144.66 91.99 2.24 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.177 -0.952 . . . . 10.0 108.885 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 75' ' ' THR . 10.0 m-20 -24.25 -48.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.481 HG23 ' O ' ' A' ' 5' ' ' LYS . 2.3 m -114.5 133.61 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.983 -1.073 . . . . 10.0 110.986 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -119.77 131.45 55.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 10.0 112.074 -178.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.433 ' H ' ' CG1' ' A' ' 9' ' ' VAL . 2.6 mm? -103.67 98.33 8.22 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.582 HG13 ' CE2' ' A' ' 82' ' ' PHE . 2.6 p -114.96 161.45 13.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.356 -0.84 . . . . 10.0 110.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 23.0 p -124.74 101.6 7.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 10.0 111.2 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.582 ' CE2' HG13 ' A' ' 80' ' ' VAL . 51.9 m-85 -87.26 174.29 8.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 10.0 110.401 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -118.94 130.83 55.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 10.0 109.852 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.54 ' CG2' ' CG ' ' A' ' 120' ' ' ARG . 27.8 m -67.14 -10.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.132 -0.98 . . . . 10.0 109.913 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.528 ' HA ' ' CD2' ' A' ' 129' ' ' LEU . 35.3 m -115.8 43.17 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 10.0 109.89 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.482 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 36.7 t -105.55 140.06 20.79 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.775 . . . . 10.0 109.784 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.478 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 46.9 Cg_endo -71.38 114.46 3.94 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.04 1.547 . . . . 10.0 111.515 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 87' ' ' PRO . 75.3 m 38.9 60.08 1.49 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.426 -0.796 . . . . 10.0 111.458 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.482 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 3.4 t -100.21 -66.16 0.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.086 . . . . 10.0 110.035 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.539 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -48.52 -26.01 1.97 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.344 -0.847 . . . . 10.0 110.301 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.89 -19.43 65.87 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.029 -1.044 . . . . 10.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.499 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -84.77 -16.24 42.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 10.0 110.067 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.582 ' HB ' ' CE2' ' A' ' 97' ' ' TRP . 18.1 m -88.95 -19.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.821 -1.174 . . . . 10.0 109.005 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.58 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.83 -32.84 57.85 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 178.291 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.529 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.4 OUTLIER -85.16 0.38 51.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -111.38 -51.75 2.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.102 -1.039 . . . . 10.0 111.379 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 15.2 m0 -72.97 -30.61 63.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.347 -0.846 . . . . 10.0 111.81 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.549 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 16.8 t -70.89 -47.89 15.05 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 10.0 111.362 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -70.7 -14.3 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.077 1.041 . . . . 10.0 111.397 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 3.5 mm-40 -67.04 -39.64 86.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.916 -1.115 . . . . 10.0 110.223 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.435 ' C ' ' O ' ' A' ' 100' ' ' GLU . 11.3 mt 44.22 85.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.322 -0.951 . . . . 10.0 109.59 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -44.23 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 10.0 110.133 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.426 ' H ' HG22 ' A' ' 102' ' ' THR . 7.1 t60 -103.57 -13.96 16.35 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.192 -0.943 . . . . 10.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -173.25 -48.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 -179.542 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.551 ' O ' ' CG2' ' A' ' 102' ' ' THR . 73.2 m -119.08 164.75 19.56 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.07 112.98 3.52 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.538 1.283 . . . . 10.0 110.282 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -144.18 0.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.885 -1.134 . . . . 10.0 111.728 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.478 HG22 ' HD2' ' A' ' 109' ' ' PRO . 14.4 m -47.69 134.89 10.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.681 -1.262 . . . . 10.0 108.819 179.76 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.489 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 41.8 Cg_endo -68.38 130.54 21.31 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.561 1.295 . . . . 10.0 109.775 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CE1' ' CZ2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -137.58 113.85 10.09 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.032 0.92 . . . . 10.0 110.931 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.54 ' CD1' HG13 ' A' ' 152' ' ' VAL . 1.8 mm? -82.19 100.29 9.76 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.58 ' CD1' ' HA ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -91.3 117.47 29.68 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.889 0.852 . . . . 10.0 110.352 -178.121 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.538 ' CG2' HG12 ' A' ' 168' ' ' VAL . 1.6 t -126.3 177.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 10.0 111.618 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.48 159.29 14.6 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 82' ' ' PHE . 87.1 m -113.59 140.77 47.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.302 . . . . 10.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 48.61 36.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 10.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.76 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -47.39 -24.82 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.261 -0.976 . . . . 10.0 110.864 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.737 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 3.6 p-10 -52.67 52.33 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 121.397 0.618 . . . . 10.0 112.222 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.76 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 157.34 -53.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.569 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -40.07 -30.16 0.09 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.277 -0.874 . . . . 10.0 110.23 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 37.3 t0 -68.02 -19.04 64.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 10.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.515 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 3.4 m-20 -82.13 148.4 59.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 10.0 110.27 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -86.33 22.74 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.067 1.562 . . . . 10.0 110.226 179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 21.0 p -102.95 -50.25 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 10.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.537 HG23 ' N ' ' A' ' 126' ' ' ILE . 4.0 t -70.55 -30.44 67.16 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.163 -2.162 . . . . 10.0 105.163 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.537 ' N ' HG23 ' A' ' 125' ' ' THR 0.298 0.8 OUTLIER -49.54 -30.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.707 -1.59 . . . . 10.0 106.707 176.515 . . . . . . . . 4 4 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 124' ' ' SER . 1.5 tp10 -52.84 -38.62 61.63 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.876 0.846 . . . . 10.0 109.971 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -56.5 -39.61 73.57 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.922 -0.487 . . . . 10.0 111.041 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.528 ' CD2' ' HA ' ' A' ' 85' ' ' VAL . 3.2 mt -51.41 -47.75 62.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.938 -1.101 . . . . 10.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.53 59.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.569 -0.707 . . . . 10.0 110.397 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.93 -23.83 0.88 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.232 -0.918 . . . . 10.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.478 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 2.1 p-10 -127.95 -25.54 3.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.037 . . . . 10.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.538 ' CE ' ' O ' ' A' ' 135' ' ' LYS . 0.0 OUTLIER -147.79 118.31 7.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.597 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -65.16 -22.36 66.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.61 -0.682 . . . . 10.0 111.855 -178.003 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -108.33 95.24 15.24 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.048 -1.032 . . . . 10.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.502 ' HA ' ' HE2' ' A' ' 133' ' ' LYS . 43.5 Cg_endo -72.49 157.54 52.67 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.977 1.514 . . . . 10.0 109.763 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.472 HG22 ' HA ' ' A' ' 84' ' ' VAL . 5.8 tp -100.49 127.4 53.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 10.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.54 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.6 p -125.1 169.83 10.36 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.507 -0.746 . . . . 10.0 109.223 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -63.1 -11.78 26.65 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.637 1.335 . . . . 10.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -83.95 -51.06 7.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 10.0 110.218 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.7 m -68.55 -39.94 80.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 10.0 110.514 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.53 ' HB2' ' CD1' ' A' ' 112' ' ' LEU . . . -51.16 -27.39 8.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 10.0 110.039 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.402 ' HB2' ' CD1' ' A' ' 154' ' ' TYR . 32.0 tt0 -67.38 -49.95 61.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 10.0 109.732 179.512 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.5 72.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.196 -0.94 . . . . 10.0 108.976 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.517 ' CG ' ' HE2' ' A' ' 94' ' ' LYS . 2.5 tt -64.08 -49.72 71.17 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.398 -0.813 . . . . 10.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -61.71 -41.0 97.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 178.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -57.85 -24.45 57.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.014 -0.674 . . . . 10.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.462 ' HB3' ' O ' ' A' ' 145' ' ' LEU . 51.0 t0 -58.33 -55.19 38.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.34 -0.85 . . . . 10.0 109.428 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.619 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 6.7 mp -96.55 9.23 42.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.007 -1.109 . . . . 10.0 108.007 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.489 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.9 mttp 61.86 35.99 16.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.044 0.926 . . . . 10.0 109.62 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.459 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -58.12 -154.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.476 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.54 HG13 ' CD1' ' A' ' 111' ' ' LEU . 4.3 t -89.08 -76.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.945 -1.097 . . . . 10.0 110.627 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.531 ' O ' ' CD2' ' A' ' 112' ' ' LEU . 2.1 tppt? -174.88 159.83 2.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.281 -1.368 . . . . 10.0 112.125 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' CG ' ' O ' ' A' ' 154' ' ' TYR . 18.0 p90 -84.26 112.57 20.41 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.658 0.742 . . . . 10.0 109.98 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.531 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -115.71 -169.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 10.0 110.637 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.08 144.49 21.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 10.0 109.928 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.625 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 24.0 p -149.42 148.93 30.04 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.023 0.916 . . . . 10.0 111.738 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.503 ' CB ' ' HB ' ' A' ' 161' ' ' THR . 0.2 OUTLIER -149.13 96.06 2.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.599 ' CB ' ' HB3' ' B' ' 29' ' ' PHE . . . -35.73 -56.41 0.68 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.618 -0.676 . . . . 10.0 112.071 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 4.3 pp -99.98 -11.02 20.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.667 -1.271 . . . . 10.0 113.796 -177.538 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.516 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 30.0 m -98.79 -90.19 0.3 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 119.93 -1.731 . . . . 10.0 111.613 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 9.9 mt-30 -52.61 -68.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.731 -1.231 . . . . 10.0 110.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 24.8 mtmm 74.07 57.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.597 0.713 . . . . 10.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 26.77 0.24 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.643 -1.783 . . . . 10.0 108.643 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.625 ' HB3' ' CB ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -72.42 4.85 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -1.037 . . . . 10.0 111.758 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.426 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -52.81 -22.59 5.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 10.0 109.543 178.77 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.446 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 20.2 m120 -69.13 -38.49 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 10.0 110.049 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.538 HG12 ' CG2' ' A' ' 113' ' ' VAL . 17.2 t -49.71 -40.11 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 10.0 109.179 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -79.98 -26.07 40.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 10.0 110.329 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.513 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 21.8 m-20 -58.65 -45.72 88.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.008 . . . . 10.0 110.148 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.464 ' HA ' ' OE1' ' A' ' 171' ' ' GLU . 5.6 mm-40 -74.68 -26.0 59.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.032 . . . . 10.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.49 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -67.11 -31.72 72.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 10.0 109.586 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.57 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 46.3 mt -59.15 -46.99 91.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.462 -0.774 . . . . 10.0 109.977 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.513 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 0.4 OUTLIER -70.13 -35.5 74.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.203 -0.936 . . . . 10.0 110.686 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -88.56 -3.39 58.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.39 -0.819 . . . . 10.0 109.866 179.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.516 ' CB ' HG13 ' A' ' 4' ' ' ILE . . . -77.94 -33.76 51.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 10.0 110.049 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.57 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -98.08 -24.05 15.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 10.0 109.182 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.022 -0.989 . . . . 10.0 110.208 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 10.0 109.723 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.464 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 15.5 m 54.24 49.82 17.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -1.147 . . . . 10.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 105.01 2.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 10.0 109.749 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.464 ' HG2' ' O ' ' B' ' 2' ' ' SER . 15.8 mm-40 -100.81 162.85 12.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.522 -0.736 . . . . 10.0 110.404 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.659 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -69.42 -147.84 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.4 Cg_endo -69.66 87.5 0.54 Allowed 'Trans proline' 0 N--CA 1.481 0.766 0 CA-C-N 119.549 0.874 . . . . 10.0 110.327 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.499 ' O ' ' O ' ' B' ' 6' ' ' PRO . 2.8 mp0 -54.11 -164.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.514 ' CD1' ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -80.41 -71.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.421 -1.424 . . . . 10.0 109.923 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -149.32 -175.2 4.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.375 -1.33 . . . . 10.0 112.2 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.701 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -163.35 138.3 4.97 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 119.223 -0.991 . . . . 10.0 112.846 -178.503 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 50.3 Cg_endo -81.01 153.83 19.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 108.243 -1.484 . . . . 10.0 108.243 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -129.64 151.23 50.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.399 -1.438 . . . . 10.0 111.689 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 19.4 m-20 -108.06 170.26 8.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.667 -0.864 . . . . 10.0 108.667 178.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.11 148.46 48.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.674 -1.266 . . . . 10.0 111.37 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.573 ' CB ' ' O ' ' A' ' 41' ' ' ALA . 3.8 tm-20 -148.0 -179.93 7.27 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -136.98 -175.3 3.99 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 117.267 -1.773 . . . . 10.0 113.511 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 39' ' ' ASN . 15.1 t -121.62 -169.7 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.863 0.84 . . . . 10.0 112.41 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.621 HG13 ' CD2' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -122.28 -168.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.739 -0.6 . . . . 10.0 109.691 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.501 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 17.2 p80 -100.24 155.66 17.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.656 -1.277 . . . . 10.0 113.41 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.748 HG13 ' N ' ' A' ' 36' ' ' VAL 0.255 40.7 t -109.91 155.45 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.22 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.21 54.34 0.59 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.99 -1.644 . . . . 10.0 108.99 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.508 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 177.19 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.263 . . . . 10.0 109.874 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 74.4 m-20 -71.42 152.77 42.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.532 -0.73 . . . . 10.0 111.309 -179.492 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.548 ' CB ' HG12 ' A' ' 33' ' ' VAL . . . 50.06 38.01 15.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.597 -0.689 . . . . 10.0 111.431 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.624 ' CG1' ' CG2' ' A' ' 36' ' ' VAL . 54.8 t -111.0 -22.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.829 -1.175 . . . . 10.0 107.829 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.642 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.6 t -88.18 -26.56 22.34 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.466 0.651 . . . . 10.0 109.902 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -116.42 39.84 2.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.231 -1.948 . . . . 10.0 108.231 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.571 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 9.9 mp0 -140.03 122.26 15.89 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.883 0.849 . . . . 10.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.599 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 8.0 t80 -116.87 128.11 54.93 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.523 HG23 ' CE2' ' A' ' 28' ' ' PHE . 47.1 p -141.13 -44.9 0.38 Allowed 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.649 -0.657 . . . . 10.0 110.45 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.441 ' HA2' HG23 ' A' ' 14' ' ' VAL . . . 130.44 76.7 0.16 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.995 -1.242 . . . . 10.0 109.995 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.496 ' O ' ' HA ' ' A' ' 13' ' ' ALA . 26.5 pt -110.05 160.89 26.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.282 -1.128 . . . . 10.0 109.318 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.572 ' O ' ' C ' ' B' ' 34' ' ' GLU . 47.9 Cg_endo -73.85 175.16 11.16 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.706 1.371 . . . . 10.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.572 ' C ' ' O ' ' B' ' 33' ' ' PRO . 2.3 tm-20 -1.0 114.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 121.203 0.525 . . . . 10.0 112.373 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.436 ' HG3' ' O ' ' A' ' 13' ' ' ALA . 0.0 OUTLIER -97.45 -71.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.041 -1.037 . . . . 10.0 111.89 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.628 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.05 -12.5 19.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.122 0.963 . . . . 10.0 111.247 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.533 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -90.81 60.64 4.51 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.562 ' CG ' ' O ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -81.75 43.37 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 10.0 108.9 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.562 ' CD2' ' HA ' ' A' ' 71' ' ' SER . 2.3 mp -49.62 -44.65 47.48 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.995 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.17 18.03 10.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 10.0 110.687 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.562 ' O ' ' CG ' ' B' ' 38' ' ' ARG . 17.1 mm-40 -123.94 39.65 3.91 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.774 -0.579 . . . . 10.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.431 HG22 ' CG ' ' A' ' 65' ' ' ASP . 21.9 m -99.15 165.44 11.71 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.92 -1.113 . . . . 10.0 110.855 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.412 ' O ' ' C ' ' B' ' 44' ' ' ASN . 52.7 m -62.64 -7.15 4.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 10.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' B' ' 43' ' ' SER . 0.2 OUTLIER 43.09 59.09 3.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.081 -1.012 . . . . 10.0 110.168 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.0 -40.71 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.907 . . . . 10.0 110.665 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 117.932 -1.032 . . . . 10.0 110.514 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.476 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.091 0.472 . . . . 10.0 110.225 . . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.58 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 2.4 mt-30 -130.92 -3.48 4.04 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.104 -0.997 . . . . 10.0 109.9 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.603 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 23.7 m -68.39 106.18 2.42 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 10.0 110.878 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.584 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -109.22 123.75 65.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.057 -1.057 . . . . 10.0 109.397 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.571 ' O ' ' CG2' ' A' ' 75' ' ' THR . 7.4 mmmt -107.71 130.75 54.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.563 ' HB2' ' CB ' ' A' ' 55' ' ' LEU . 60.8 m -109.87 116.62 31.98 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.124 -1.03 . . . . 10.0 110.056 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.471 HG22 ' OG1' ' A' ' 75' ' ' THR . 25.5 t -126.79 166.19 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.688 . . . . 10.0 109.986 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.485 ' HB ' ' O ' ' B' ' 35' ' ' GLN . 0.5 OUTLIER -101.52 125.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 10.0 110.257 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.555 HG21 ' CD1' ' A' ' 78' ' ' PHE . 12.0 t -132.73 -171.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 10.0 109.534 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.522 ' HA2' ' HB ' ' A' ' 80' ' ' VAL . . . 109.26 171.48 20.71 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.411 -1.476 . . . . 10.0 109.411 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.435 ' OD1' ' HB3' ' A' ' 82' ' ' PHE . 1.4 m-20 -45.32 -37.17 4.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 10.0 109.684 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.438 ' HA2' ' OE1' ' B' ' 35' ' ' GLN . . . 150.25 143.28 3.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 33' ' ' PRO . . . -157.32 -130.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -1.125 . . . . 10.0 110.205 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.575 ' O ' ' CZ2' ' B' ' 36' ' ' TRP . 60.5 t -119.78 -44.51 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.957 -1.089 . . . . 10.0 110.974 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -176.65 -177.69 45.82 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.899 -1.28 . . . . 10.0 109.899 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.525 ' HE3' ' CB ' ' A' ' 6' ' ' CYS . 6.0 ttpm? -97.79 -50.49 4.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.18 . . . . 10.0 110.386 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.8 p -72.15 -18.31 61.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 10.0 110.026 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.531 ' O ' ' OG ' ' A' ' 22' ' ' SER . 28.3 p -63.92 -17.2 63.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 10.0 110.79 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.502 ' N ' HD11 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -93.09 -38.59 11.53 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.001 -1.062 . . . . 10.0 110.759 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 50.4 tp -55.19 -38.34 68.24 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.673 -1.211 . . . . 10.0 108.541 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.583 ' HA ' ' HB ' ' A' ' 24' ' ' THR 0.273 6.3 tp -80.98 -30.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.697 0.76 . . . . 10.0 110.039 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.583 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . 38.4 m -46.93 -54.54 9.83 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.793 -1.163 . . . . 10.0 108.724 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.694 ' CG ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.62 3.75 51.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.481 -1.688 . . . . 10.0 111.035 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.583 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 19.2 m -77.1 -52.54 9.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.481 -1.288 . . . . 10.0 107.821 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.447 ' HB ' ' O ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -179.59 -71.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.695 -1.202 . . . . 10.0 113.745 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.515 ' HB3' ' OG1' ' B' ' 26' ' ' THR . 26.1 m-20 -85.78 48.59 1.62 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.806 -1.184 . . . . 10.0 112.076 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.641 ' C ' ' CD ' ' A' ' 29' ' ' PRO . 3.2 pttt -44.92 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.222 1.01 . . . . 10.0 111.872 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.605 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 39.3 t80 -90.08 19.92 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 114.819 1.414 . . . . 10.0 114.819 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.641 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 55.4 Cg_endo -80.77 -118.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.038 0 N-CA-C 109.563 -0.976 . . . . 10.0 109.563 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 29' ' ' PRO . 1.2 m -167.81 68.91 0.08 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.151 -1.593 . . . . 10.0 111.033 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.506 ' OE2' ' HA ' ' A' ' 26' ' ' ASN . 2.9 pt-20 -141.87 -171.04 3.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.884 -1.135 . . . . 10.0 110.033 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.564 ' C ' ' CG2' ' A' ' 33' ' ' VAL . 6.0 t80 -70.2 121.75 18.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.592 0.71 . . . . 10.0 112.004 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.607 ' CG1' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.19 -168.28 0.19 Allowed Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.476 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.607 ' HD2' ' CG1' ' A' ' 33' ' ' VAL . 41.6 Cg_endo -72.05 -178.52 3.25 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 122.611 0.795 . . . . 10.0 111.046 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.597 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 22.5 p -129.85 162.46 28.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 10.0 111.921 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.672 ' N ' HG12 ' B' ' 20' ' ' VAL . 71.6 t -58.66 -90.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 10.0 110.213 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.529 ' CD2' ' HB ' ' B' ' 18' ' ' ILE . 1.7 t80 -47.26 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 10.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' ' CE2' ' A' ' 40' ' ' TYR . 9.4 t0 -141.02 84.2 1.92 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.408 -0.807 . . . . 10.0 109.666 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.523 ' CB ' HD13 ' B' ' 18' ' ' ILE . 9.6 t-20 -79.32 99.26 7.03 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.786 -1.196 . . . . 10.0 109.928 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.599 ' HA ' ' O ' ' B' ' 16' ' ' HIS . 21.1 m-85 -91.93 121.16 33.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.416 -0.802 . . . . 10.0 109.832 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.619 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -145.83 96.72 2.85 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.52 -0.872 . . . . 10.0 111.293 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.626 ' HB ' ' O ' ' B' ' 14' ' ' PHE . 82.4 t -162.64 -165.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.597 ' O ' ' CB ' ' B' ' 13' ' ' ASP . 40.1 m -126.43 165.67 18.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.588 -1.945 . . . . 10.0 112.139 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -123.59 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.56 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 0.5 OUTLIER -101.18 107.31 18.68 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.981 -1.074 . . . . 10.0 109.998 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.567 ' HA ' ' CB ' ' B' ' 10' ' ' LEU . 3.7 mp -121.7 130.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 10.0 110.376 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.539 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.87 25.01 8.88 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.0 13.76 71.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 10.0 109.561 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -116.18 123.52 30.76 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.344 -1.092 . . . . 10.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.08 141.45 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.52 . . . . 10.0 110.709 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.487 ' HB2' ' CB ' ' A' ' 44' ' ' VAL . 2.0 m-30 -109.97 116.32 31.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.317 -0.864 . . . . 10.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.603 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 58.1 m -85.35 106.91 17.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 10.0 109.923 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 4.3 mt -121.58 153.38 38.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 10.0 111.063 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.51 99.4 0.16 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 6' ' ' CYS . 3.3 pp -138.07 167.75 21.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -1.221 . . . . 10.0 110.644 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.518 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 27.1 p90 -169.11 130.03 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.834 . . . . 10.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.458 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 11.0 t0 -82.05 160.95 23.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.92 -1.112 . . . . 10.0 109.045 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.591 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 8.9 m -128.52 159.79 34.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.744 -1.222 . . . . 10.0 111.481 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.524 ' HA ' ' HB2' ' A' ' 62' ' ' GLU . . . 75.04 28.79 1.02 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.973 0.892 . . . . 10.0 109.143 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.59 ' CA ' ' CG1' ' A' ' 36' ' ' VAL . . . -80.88 -75.08 1.1 Allowed Glycine 0 C--N 1.297 -1.588 0 N-CA-C 106.972 -2.451 . . . . 10.0 106.972 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.504 ' HA ' ' N ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER -89.14 20.5 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -1.082 . . . . 10.0 110.098 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' O ' ' CZ ' ' A' ' 64' ' ' TYR . 60.3 mm-40 -104.22 -48.91 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 10.0 110.421 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 31.8 t0 66.12 47.9 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 10.0 109.448 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER 157.16 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.423 0.63 . . . . 10.0 109.553 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.563 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.3 p30 36.92 53.54 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 10.0 111.763 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -52.93 -29.13 26.83 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.582 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.5 mp -82.32 10.9 6.12 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.251 0.548 . . . . 10.0 109.755 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.577 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -63.07 -18.06 0.44 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.582 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -84.04 80.42 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 CA-C-N 120.043 1.051 . . . . 10.0 110.206 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.62 HD21 ' HA ' ' B' ' 37' ' ' ALA . 0.4 OUTLIER -90.73 -28.36 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.75 . . . . 10.0 110.366 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.47 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 30.7 t 42.75 25.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 10.0 110.615 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 16.2 m-85 -120.22 93.06 47.83 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.018 -1.051 . . . . 10.0 110.488 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.89 73.35 6.06 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 10.0 111.168 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.74 65.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 10.0 109.924 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.611 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 48.1 m -143.84 96.18 2.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.4 t70 -33.32 -31.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 120.83 0.348 . . . . 10.0 111.417 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.549 ' N ' ' O ' ' A' ' 75' ' ' THR . 3.1 m -122.69 123.5 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.205 -0.934 . . . . 10.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.611 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 21.3 m-85 -109.56 143.15 39.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.3 -0.875 . . . . 10.0 109.89 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.555 ' CD1' ' CG1' ' A' ' 168' ' ' VAL . 1.1 mm? -108.35 97.99 7.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.108 . . . . 10.0 110.414 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.522 ' HB ' ' HA2' ' A' ' 10' ' ' GLY . 2.1 m -105.45 131.55 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 10.0 108.658 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.457 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 41.3 t -136.98 124.45 22.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.795 -1.19 . . . . 10.0 110.963 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 8.1 p90 -149.55 179.63 7.83 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.458 -0.897 . . . . 10.0 111.35 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 m -75.21 163.14 27.83 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.244 -0.91 . . . . 10.0 111.148 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.52 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 0.6 OUTLIER -127.83 9.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 10.0 112.5 -178.091 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.543 HG23 ' HB3' ' A' ' 129' ' ' LEU . 0.1 OUTLIER -80.49 -72.56 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.127 -1.608 . . . . 10.0 107.751 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.477 ' OG ' ' HB3' ' A' ' 129' ' ' LEU . 60.8 m -76.8 135.26 67.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.665 -1.272 . . . . 10.0 108.496 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.533 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 42.1 Cg_endo -72.37 -23.92 20.03 Favored 'Trans proline' 0 C--N 1.297 -2.139 0 O-C-N 123.662 1.348 . . . . 10.0 110.144 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.505 ' O ' ' HB2' ' A' ' 89' ' ' SER . 66.7 m 41.26 38.96 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.505 ' HB2' ' O ' ' A' ' 88' ' ' SER . 15.3 m 64.13 40.36 6.99 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.377 0.608 . . . . 10.0 110.243 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.576 ' CE1' ' CZ ' ' A' ' 82' ' ' PHE . 7.1 t80 -48.59 -26.34 2.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 10.0 108.761 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.509 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.5 tt0 -56.85 -27.43 60.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 10.0 109.072 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.506 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.12 -22.07 61.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.88 0.848 . . . . 10.0 109.396 179.169 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.53 ' CG1' ' CZ2' ' A' ' 97' ' ' TRP . 6.8 t -82.85 -8.43 11.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.261 -0.899 . . . . 10.0 109.356 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' HD3' ' A' ' 94' ' ' LYS . 4.0 mmtp -86.63 -32.44 20.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.509 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 8.0 pt-20 -84.08 3.13 36.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.846 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -103.37 -50.29 3.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.964 -1.094 . . . . 10.0 111.843 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.667 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 5.6 m0 -86.52 -49.06 7.84 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.98 -1.075 . . . . 10.0 112.022 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.539 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 18.2 t -54.21 -50.39 84.89 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.861 -1.149 . . . . 10.0 111.575 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.539 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 43.2 Cg_endo -70.54 -15.92 34.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.089 1.047 . . . . 10.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.506 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -54.2 -30.25 49.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 10.0 109.119 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.506 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 4.6 mt 60.24 114.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.493 -0.883 . . . . 10.0 110.223 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.528 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -49.83 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 109.632 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.563 ' O ' ' CD2' ' A' ' 104' ' ' HIS . 7.3 p80 -109.49 6.97 24.58 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.367 -0.833 . . . . 10.0 109.546 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.563 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 169.59 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 10.0 109.575 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.528 ' O ' ' CG2' ' A' ' 102' ' ' THR . 75.8 m -119.66 155.71 54.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.51 -0.744 . . . . 10.0 110.205 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.474 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 55.2 Cg_endo -76.6 73.41 5.22 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.149 1.605 . . . . 10.0 111.64 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 18.5 ttpt -126.9 -2.02 6.56 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.698 -1.251 . . . . 10.0 109.826 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.476 ' OG1' ' HB ' ' A' ' 102' ' ' THR . 96.3 m -46.22 129.24 7.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.118 -0.989 . . . . 10.0 109.721 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.549 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 47.0 Cg_endo -71.75 149.22 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.81 1.426 . . . . 10.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.595 ' CZ ' ' HB3' ' A' ' 97' ' ' TRP . 43.6 m-85 -132.99 119.58 20.27 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.081 -1.048 . . . . 10.0 111.772 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.591 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.5 mm? -88.79 93.38 9.56 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.235 -1.395 . . . . 10.0 107.235 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 2.2 mt -70.99 147.2 48.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.469 -0.769 . . . . 10.0 109.617 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.477 HG22 ' O ' ' A' ' 80' ' ' VAL . 1.8 t -146.51 178.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.952 . . . . 10.0 111.32 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -126.3 116.35 2.53 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.814 -1.715 . . . . 10.0 108.814 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.457 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 64.4 m -81.79 123.72 29.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.067 -1.254 . . . . 10.0 109.723 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.552 ' O ' ' CB ' ' A' ' 120' ' ' ARG . 3.6 mt-30 47.1 69.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.741 ' C ' ' CD1' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -93.83 -45.41 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.969 -0.692 . . . . 10.0 111.41 -177.592 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 35.8 t70 -51.43 56.16 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 121.921 0.867 . . . . 10.0 112.86 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 2.5 tp 152.95 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.552 ' CB ' ' O ' ' A' ' 116' ' ' GLN . 17.6 tpp180 -58.66 -17.72 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' CG2' ' A' ' 84' ' ' VAL . 14.6 m-20 -111.54 19.51 18.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.84 -0.537 . . . . 10.0 110.548 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.589 ' O ' ' HB ' ' A' ' 126' ' ' ILE . 21.2 p-10 -80.63 145.41 58.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.025 -1.047 . . . . 10.0 108.994 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.57 24.19 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.382 1.727 . . . . 10.0 112.469 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -110.23 -48.13 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.56 -1.337 . . . . 10.0 110.288 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.515 ' CG2' ' OD1' ' A' ' 122' ' ' ASP . 9.3 t -86.49 -24.68 25.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.09 -1.818 . . . . 10.0 106.09 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.589 ' HB ' ' O ' ' A' ' 122' ' ' ASP 0.278 1.1 mp -62.68 -21.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 176.985 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -47.84 -46.68 31.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.625 0.726 . . . . 10.0 109.636 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 -41.33 12.5 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.509 -0.744 . . . . 10.0 111.192 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.543 ' HB3' HG23 ' A' ' 85' ' ' VAL . 4.6 mt -57.09 -41.58 79.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 10.0 110.999 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.994 -1.067 . . . . 10.0 109.214 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -71.2 -8.51 54.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 10.0 110.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.526 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 57.9 t-20 -65.82 -33.62 76.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 10.0 110.496 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.616 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mptt -117.67 -68.03 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 143.53 -17.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 123.377 0.671 . . . . 10.0 110.023 177.793 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.511 ' O ' ' HB3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -136.48 94.9 13.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.978 -1.077 . . . . 10.0 110.844 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.8 Cg_endo -71.05 161.5 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.028 1.541 . . . . 10.0 110.657 179.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.52 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 7.1 tp -102.76 134.97 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 10.0 109.232 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.543 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.7 p -120.2 172.23 4.84 Favored Pre-proline 0 C--N 1.295 -1.777 0 O-C-N 121.238 -0.914 . . . . 10.0 109.062 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.543 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.65 -17.41 52.69 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.276 1.146 . . . . 10.0 109.703 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.441 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 mt-10 -79.7 -42.78 23.95 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.81 . . . . 10.0 109.945 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 m -73.9 -43.5 58.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.359 -0.838 . . . . 10.0 109.889 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.486 ' HB3' ' HB2' ' A' ' 154' ' ' TYR . . . -57.75 -50.38 73.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 10.0 110.752 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.441 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 3.0 pp20? -65.92 -30.41 70.99 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.209 -0.997 . . . . 10.0 108.966 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -71.22 -35.82 71.64 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.444 HD12 ' HE2' ' A' ' 94' ' ' LYS . 0.1 OUTLIER -60.73 -45.8 92.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.036 -1.098 . . . . 10.0 108.036 178.155 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 151' ' ' ALA . . . -59.66 -50.17 74.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.887 0.851 . . . . 10.0 109.114 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.455 ' O ' ' HG2' ' A' ' 147' ' ' ARG . 4.7 ttm180 -65.55 -17.75 64.81 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.48 0.657 . . . . 10.0 109.729 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -67.92 -18.74 64.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.824 . . . . 10.0 110.97 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.628 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -152.03 38.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.9 -1.125 . . . . 10.0 111.326 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.479 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 8.9 mttp 62.08 53.43 2.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.005 0.907 . . . . 10.0 112.105 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 146' ' ' ALA . . . -105.36 173.15 6.43 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.895 -0.779 . . . . 10.0 108.895 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.558 ' CG1' ' N ' ' A' ' 153' ' ' LYS . 2.9 t -71.23 -87.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.005 -1.06 . . . . 10.0 110.821 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.558 ' N ' ' CG1' ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.12 168.75 4.05 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.088 -1.007 . . . . 10.0 111.006 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.548 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 77.6 t80 -81.04 119.0 22.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 10.0 110.581 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.576 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.7 OUTLIER -118.83 -169.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.141 -0.974 . . . . 10.0 110.463 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 86.7 mt-10 -146.36 138.54 25.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.661 -1.274 . . . . 10.0 111.874 -178.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.606 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 30.1 t -141.2 130.56 23.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.131 0.967 . . . . 10.0 111.373 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 162' ' ' GLN . 18.9 m -148.35 81.15 1.47 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.997 0.903 . . . . 10.0 109.387 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.663 ' HA ' ' CE ' ' A' ' 163' ' ' LYS . . . -52.98 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.995 . . . . 10.0 111.062 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.554 ' HB2' ' CE2' ' B' ' 29' ' ' PHE 0.262 0.4 OUTLIER -48.05 -50.7 27.1 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.961 -1.087 . . . . 10.0 110.288 -179.825 . . . . . . . . 4 4 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.533 ' N ' HD11 ' A' ' 160' ' ' LEU . 1.1 m -76.8 -70.52 0.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.227 0.825 . . . . 10.0 113.227 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.656 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -123.85 -91.16 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.0 -1.688 . . . . 10.0 112.238 -178.341 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.731 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 1.3 mmtt 124.36 -154.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.788 1.235 . . . . 10.0 108.531 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 96.11 14.06 46.89 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.535 -2.626 . . . . 10.0 106.535 -177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.731 ' CD1' ' HA ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -84.34 5.23 27.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.964 -0.618 . . . . 10.0 111.478 -178.832 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 13.8 mttt -50.47 -27.57 6.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 10.0 108.613 179.005 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.515 ' HB3' ' CG1' ' A' ' 155' ' ' VAL . 25.9 t-20 -65.12 -43.95 90.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.526 -0.734 . . . . 10.0 109.813 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.576 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 93.9 t -50.54 -29.39 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 10.0 109.165 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 14.8 m-85 -96.78 -22.14 17.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.74 -0.6 . . . . 10.0 109.958 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.536 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 20.1 t0 -67.54 -51.29 52.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 10.0 111.067 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.504 ' CB ' HG11 ' A' ' 152' ' ' VAL . 4.8 mt-10 -72.34 -40.5 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 10.0 111.097 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.458 ' HB1' ' HG ' ' A' ' 111' ' ' LEU . . . -54.8 -31.77 59.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.988 -1.07 . . . . 10.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.575 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 30.1 mt -58.48 -44.16 88.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.995 -1.065 . . . . 10.0 109.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.536 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 0.5 OUTLIER -76.69 -48.59 18.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 10.0 112.182 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.3 -10.27 22.93 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.354 -0.841 . . . . 10.0 110.865 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.584 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -79.0 -41.41 29.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 10.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.58 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -77.3 -19.91 55.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.402 -0.811 . . . . 10.0 109.164 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 117.982 -1.009 . . . . 10.0 110.341 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.495 -1.442 . . . . 10.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -106.19 138.01 43.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -1.145 . . . . 10.0 110.567 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.44 102.56 9.32 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.42 -0.8 . . . . 10.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -101.56 140.39 35.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.687 -0.633 . . . . 10.0 110.926 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.632 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -98.77 -49.02 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 10.0 110.213 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 51.9 Cg_endo -83.62 -18.15 5.83 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.086 -1.159 . . . . 10.0 109.086 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.549 ' HG3' ' O ' ' B' ' 6' ' ' PRO . 0.5 OUTLIER 32.93 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.521 0.677 . . . . 10.0 111.71 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.519 HG13 ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -141.96 -61.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.071 -1.018 . . . . 10.0 110.117 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 t -134.44 132.09 38.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 10.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.567 ' CB ' ' HA ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -132.33 99.62 15.9 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.546 -0.721 . . . . 10.0 111.176 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 41.6 Cg_endo -72.54 117.06 4.95 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.604 1.318 . . . . 10.0 108.761 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -47.82 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 10.0 111.202 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -151.96 -166.66 2.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.857 -0.527 . . . . 10.0 109.717 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.626 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 24.0 m-85 -109.49 -170.05 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.99 1.108 . . . . 10.0 113.99 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.625 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -160.85 -169.69 2.48 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.599 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 53.8 t60 -136.07 146.93 47.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.022 -1.049 . . . . 10.0 110.837 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.441 ' HB ' ' CE1' ' A' ' 40' ' ' TYR . 2.8 t -150.27 143.33 24.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.173 -1.579 . . . . 10.0 112.203 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.585 ' N ' ' CD1' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -110.99 -167.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.479 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 68.3 t60 -107.38 153.4 22.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.775 -1.203 . . . . 10.0 112.275 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.672 HG12 ' N ' ' A' ' 36' ' ' VAL . 1.6 m -124.98 153.1 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.729 0.776 . . . . 10.0 111.405 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.504 ' N ' ' HA ' ' A' ' 61' ' ' GLN . . . -134.62 98.43 0.31 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.32 -1.912 . . . . 10.0 108.32 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.51 ' O ' ' CG2' ' B' ' 25' ' ' VAL . 1.1 t80 -179.34 117.46 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.014 -1.286 . . . . 10.0 109.314 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 22' ' ' PHE . 16.0 t0 -38.95 156.3 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.643 0.735 . . . . 10.0 111.133 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 60.01 46.73 10.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.667 -0.646 . . . . 10.0 110.512 -178.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.51 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 64.9 t -78.54 -17.59 13.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.586 ' HA ' ' CG2' ' A' ' 33' ' ' VAL 0.256 5.7 t -50.06 -29.87 9.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.874 -1.057 . . . . 10.0 111.747 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.626 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -134.99 4.44 4.23 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.16 -1.976 . . . . 10.0 108.16 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 0.5 OUTLIER 54.08 19.99 2.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.416 -1.05 . . . . 10.0 110.664 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.554 ' CE2' ' HB2' ' A' ' 160' ' ' LEU . 4.2 t80 -113.15 133.08 55.21 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.762 -0.586 . . . . 10.0 109.973 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.532 ' CB ' ' O ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER 161.97 135.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.238 0.542 . . . . 10.0 110.95 179.524 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 -179.61 50.98 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.051 -1.219 . . . . 10.0 110.051 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 1.1 pp -143.17 36.1 0.21 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.26 -1.141 . . . . 10.0 112.055 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 46.2 Cg_endo -73.2 171.64 17.19 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.172 1.091 . . . . 10.0 109.437 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' PRO . 41.8 tp10 -48.96 167.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.699 -1.25 . . . . 10.0 108.788 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.606 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 2.1 mp0 -82.13 20.08 1.08 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.39 -0.819 . . . . 10.0 110.853 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.606 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 3.5 m95 87.84 49.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.62 ' HA ' HD21 ' A' ' 70' ' ' LEU . . . 168.56 99.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.455 -0.942 . . . . 10.0 108.455 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.438 ' HD2' ' HD3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -88.16 44.14 1.18 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.294 -1.743 . . . . 10.0 106.294 177.863 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.481 HD21 ' O ' ' B' ' 37' ' ' ALA . 0.9 OUTLIER -55.39 -21.11 14.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.726 -177.747 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -121.2 10.32 10.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.805 -1.184 . . . . 10.0 111.177 -179.33 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.35 -81.75 0.48 Allowed 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.638 -0.664 . . . . 10.0 109.401 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.487 ' O ' ' N ' ' B' ' 44' ' ' ASN . 83.8 m -128.4 122.04 30.47 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -67.72 50.78 0.06 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.162 -0.961 . . . . 10.0 110.371 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' B' ' 42' ' ' THR . 56.3 t-20 -64.81 130.25 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 10.0 109.965 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -114.54 161.61 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.043 . . . . 10.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.297 -1.692 0 CA-C-O 117.896 -1.05 . . . . 10.0 110.111 178.76 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.539 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 2.5 ttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.478 0.656 . . . . 10.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' O ' ' N ' ' A' ' 4' ' ' ILE . 7.6 mm-40 -149.51 -83.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.545 ' HA ' HG22 ' A' ' 52' ' ' THR . 4.3 m -38.87 91.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.584 -0.697 . . . . 10.0 110.171 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.559 ' CG2' ' O ' ' A' ' 52' ' ' THR . 1.6 tt -135.59 138.76 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.088 -1.008 . . . . 10.0 110.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.587 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.35 122.84 28.64 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.132 0.968 . . . . 10.0 111.313 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.549 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 40.4 t -71.34 126.1 28.73 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.746 0.784 . . . . 10.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . . . . . . . . . 4.3 t -140.43 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.667 . . . . 10.0 109.212 179.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.608 HG22 ' CE3' ' B' ' 36' ' ' TRP . 71.5 t -93.87 143.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.05 -1.031 . . . . 10.0 109.82 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.494 ' HA ' ' HB3' ' B' ' 35' ' ' GLN . 0.3 OUTLIER -132.74 -166.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.505 -0.747 . . . . 10.0 110.397 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.483 ' N ' ' CG1' ' A' ' 9' ' ' VAL . . . 89.49 -158.92 27.95 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.567 -1.413 . . . . 10.0 109.567 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.59 -10.19 57.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.986 -1.302 . . . . 10.0 109.4 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.498 ' CA ' ' HG3' ' B' ' 35' ' ' GLN . . . 112.07 89.68 1.87 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . -166.15 50.03 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.211 -1.17 . . . . 10.0 110.265 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.484 ' CB ' ' O ' ' A' ' 13' ' ' ALA . 0.5 OUTLIER 68.32 157.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.058 -1.026 . . . . 10.0 109.411 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.614 ' O ' ' CD2' ' A' ' 19' ' ' LEU . . . -122.87 -153.32 8.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.756 -1.738 . . . . 10.0 108.756 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.55 ' NZ ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.01 0.36 21.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.523 -0.986 . . . . 10.0 110.873 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 -50.63 18.23 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.315 -0.866 . . . . 10.0 111.493 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.518 ' HA ' ' O ' ' B' ' 26' ' ' THR . 31.9 p -61.88 -17.89 58.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.778 -1.201 . . . . 10.0 109.443 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.614 ' CD2' ' O ' ' A' ' 15' ' ' GLY . 0.4 OUTLIER -79.21 -28.15 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.371 -0.831 . . . . 10.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -49.57 -41.39 41.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.604 -1.31 . . . . 10.0 109.331 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.675 ' HB ' ' HA2' ' B' ' 27' ' ' GLY . 1.2 mm -84.59 -39.97 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.369 1.08 . . . . 10.0 109.09 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 19' ' ' LEU . 16.1 t -46.73 -49.21 19.95 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.359 -0.837 . . . . 10.0 110.546 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.644 ' CE2' ' HA ' ' A' ' 162' ' ' GLN . 29.8 m-85 -79.94 -14.28 58.72 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.002 -1.061 . . . . 10.0 110.316 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 m -100.04 -31.63 11.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 10.0 112.849 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.502 HG21 HD13 ' A' ' 21' ' ' ILE . 82.8 p -110.74 -90.2 0.48 Allowed 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.051 -1.656 . . . . 10.0 112.118 -177.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.573 ' C ' ' HG3' ' A' ' 27' ' ' LYS . 47.7 t-20 -159.85 20.96 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.51 -0.744 . . . . 10.0 111.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.602 ' O ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER 26.86 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.431 0.901 . . . . 10.0 113.431 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.593 ' N ' ' HD2' ' A' ' 27' ' ' LYS . 1.0 OUTLIER -53.24 95.24 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.951 -0.468 . . . . 10.0 110.244 -178.066 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' CD ' ' O ' ' A' ' 27' ' ' LYS . 55.4 Cg_endo -103.92 -160.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.695 1.596 . . . . 10.0 110.179 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -112.65 33.04 5.21 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.429 ' HG3' HG12 ' A' ' 33' ' ' VAL . 11.1 pt-20 -142.36 -171.29 3.37 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.935 0.874 . . . . 10.0 109.434 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.25 73.7 0.94 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.336 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.594 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 1.4 m -60.91 -168.44 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.274 -1.01 . . . . 10.0 108.274 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.594 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 36.8 Cg_endo -66.06 158.19 55.66 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-O 122.044 0.768 . . . . 10.0 112.11 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.567 ' CG2' ' HB2' ' A' ' 37' ' ' PHE . 5.1 t -89.39 165.3 14.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.644 0.735 . . . . 10.0 112.18 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.545 ' O ' ' N ' ' A' ' 38' ' ' ASP . 1.6 t -54.42 -14.18 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.559 -0.713 . . . . 10.0 111.058 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.722 ' N ' ' HA ' ' B' ' 20' ' ' VAL . 0.0 OUTLIER -35.69 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.511 -0.743 . . . . 10.0 109.989 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.545 ' N ' ' O ' ' A' ' 36' ' ' VAL . 68.5 m-20 -137.79 131.96 31.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.913 2.19 . . . . 10.0 116.913 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.706 ' HB3' ' N ' ' B' ' 18' ' ' ILE 0.26 35.1 p-10 -104.9 107.37 18.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.007 -0.997 . . . . 10.0 111.101 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 39' ' ' ASN . 23.8 m-85 -155.21 108.84 2.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 119.368 -2.082 . . . . 10.0 113.101 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.5 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -171.65 99.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.423 -1.325 . . . . 10.0 107.423 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.635 ' CG1' ' N ' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -156.11 -168.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.899 -1.125 . . . . 10.0 111.436 -177.558 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.54 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 27.0 m -151.68 115.55 4.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.648 -0.821 . . . . 10.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.539 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -79.76 152.05 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.556 . . . . 10.0 110.047 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.6 ' O ' ' O ' ' B' ' 10' ' ' LEU . 33.6 mtm -127.43 92.89 3.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.339 -1.344 . . . . 10.0 108.125 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.72 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 38.3 mt -95.6 141.13 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 120.909 0.385 . . . . 10.0 110.249 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.482 ' HA3' ' HB2' ' B' ' 7' ' ' GLU . . . 40.97 26.96 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 86.24 33.33 14.64 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.161 -1.199 . . . . 10.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' HG3' ' CG ' ' B' ' 4' ' ' GLU . 52.7 mm-40 -127.46 102.52 23.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.085 -1.244 . . . . 10.0 110.723 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.539 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 48.0 Cg_endo -74.92 124.2 8.48 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.874 1.46 . . . . 10.0 110.303 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.54 ' O ' ' HA ' ' A' ' 43' ' ' THR . 6.3 m-30 -99.83 110.99 23.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.683 -1.261 . . . . 10.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.559 ' O ' ' CG2' ' A' ' 4' ' ' ILE . 1.4 m -71.69 117.04 12.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.636 -0.665 . . . . 10.0 110.546 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.467 ' HG ' ' C ' ' A' ' 52' ' ' THR . 5.2 mt -137.71 160.72 38.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.884 -1.135 . . . . 10.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 5' ' ' LYS . . . -170.92 110.87 0.38 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.959 -1.256 . . . . 10.0 109.959 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.551 HD13 ' CB ' ' A' ' 40' ' ' TYR . 2.2 pp -138.57 152.53 48.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.97 -1.312 . . . . 10.0 111.924 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.556 ' N ' ' CD1' ' A' ' 56' ' ' PHE . 20.6 p90 -160.27 140.65 11.67 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.307 -0.86 . . . . 10.0 108.766 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.519 ' HA ' ' CZ3' ' B' ' 36' ' ' TRP . 1.7 m-20 -92.8 154.37 18.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.804 -1.185 . . . . 10.0 111.468 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.633 ' HB ' ' CD2' ' B' ' 36' ' ' TRP . 1.6 t -60.55 133.77 56.42 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 10.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.55 ' HA ' ' O ' ' B' ' 20' ' ' VAL . . . -87.12 79.1 8.74 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.677 -0.64 . . . . 10.0 111.439 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.541 ' N ' ' HA2' ' B' ' 21' ' ' GLY . . . -42.94 -50.07 6.14 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.559 -2.617 . . . . 10.0 106.559 177.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.502 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 3.5 mm-40 -62.99 -44.18 96.73 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 4.5 mt-10 65.41 84.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.121 0.962 . . . . 10.0 111.366 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.452 ' OD2' HG11 ' B' ' 20' ' ' VAL . 21.5 m-20 -95.52 -8.86 34.01 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.811 0.815 . . . . 10.0 108.858 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.4 p90 -139.65 10.32 2.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.664 -0.865 . . . . 10.0 108.664 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.525 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.1 p-10 -30.62 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.26 0.552 . . . . 10.0 112.101 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -48.46 -26.88 2.33 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.829 -1.169 . . . . 10.0 109.451 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.558 ' N ' HD11 ' A' ' 67' ' ' LEU . 8.4 mp -97.02 6.68 48.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.432 -0.792 . . . . 10.0 110.273 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.618 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -72.69 -24.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.103 -0.998 . . . . 10.0 112.891 -179.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 38.0 Cg_endo -70.91 71.42 2.1 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 109.275 -1.086 . . . . 10.0 109.275 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.567 ' CD2' ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -69.93 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.793 -0.567 . . . . 10.0 111.519 -178.984 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.494 ' H ' ' CG ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER 54.67 35.21 23.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.805 -1.185 . . . . 10.0 108.482 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.54 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 4.9 m-85 -118.1 -53.48 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.629 -0.669 . . . . 10.0 111.222 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.587 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 55.7 Cg_endo -85.92 76.8 2.7 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 122.978 0.988 . . . . 10.0 111.296 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.16 0.32 52.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.904 -1.122 . . . . 10.0 110.443 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.427 ' O ' ' CG2' ' A' ' 75' ' ' THR . 2.7 m -140.1 84.21 1.96 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.287 -0.883 . . . . 10.0 110.048 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -140.52 -97.62 0.15 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.704 -0.622 . . . . 10.0 109.424 179.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.549 ' CG1' ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -140.78 118.53 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 10.0 108.743 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.448 ' O ' HD23 ' A' ' 111' ' ' LEU . 21.4 m-85 -114.85 125.51 53.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.018 . . . . 10.0 111.443 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.52 HD22 HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -111.47 99.76 8.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 178.647 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.428 ' CG1' ' HA ' ' A' ' 112' ' ' LEU . 1.7 p -82.64 133.79 28.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.618 -0.676 . . . . 10.0 110.457 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.452 ' C ' ' OG1' ' A' ' 115' ' ' THR . 11.3 t -124.27 101.21 7.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.176 -0.953 . . . . 10.0 109.161 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.8 p90 -133.53 162.24 32.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.662 -1.215 . . . . 10.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.445 ' HB3' HG22 ' A' ' 85' ' ' VAL . 63.6 m -75.76 158.64 31.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.648 -0.658 . . . . 10.0 110.328 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.462 ' HB ' HG23 ' A' ' 137' ' ' ILE . 29.7 m -107.9 -11.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.472 -0.767 . . . . 10.0 109.403 179.82 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.491 ' O ' HD23 ' A' ' 129' ' ' LEU . 33.9 m -68.62 -1.93 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.776 . . . . 10.0 109.701 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.2 m -128.08 82.86 67.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.201 -0.937 . . . . 10.0 109.871 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 44.2 Cg_endo -63.81 -19.26 66.71 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.35 1.711 . . . . 10.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.474 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 67.9 m -89.04 22.36 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 10.0 109.122 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.547 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 46.9 t -124.75 -56.23 1.59 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.779 -0.576 . . . . 10.0 109.881 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.531 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.4 p90 -53.38 -39.95 64.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.631 -1.293 . . . . 10.0 109.469 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 17.8 pt-20 -67.55 -26.5 66.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.555 -0.715 . . . . 10.0 109.55 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.547 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -77.13 -14.3 59.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.224 -0.922 . . . . 10.0 108.667 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.415 ' HB ' ' O ' ' A' ' 90' ' ' PHE . 32.9 t -88.5 -16.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.787 0.803 . . . . 10.0 109.601 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.617 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 1.1 mmtt -86.22 -33.48 20.73 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.525 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 5.4 pt-20 -77.02 -9.04 58.44 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.163 -0.615 . . . . 10.0 109.421 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -90.3 -52.4 4.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.844 -1.16 . . . . 10.0 111.976 -178.453 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -93.09 -31.83 14.68 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.563 -1.336 . . . . 10.0 112.487 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.552 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 95.0 t -54.32 -46.75 98.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.572 -1.33 . . . . 10.0 110.863 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 44.4 Cg_endo -73.9 -23.41 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.323 1.17 . . . . 10.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.468 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 29.1 mm-40 -63.46 -16.36 60.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 10.0 110.772 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.499 ' CG2' ' CA ' ' A' ' 104' ' ' HIS . 9.6 mm 56.62 104.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.141 -0.975 . . . . 10.0 110.058 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.554 ' HB ' ' CG ' ' A' ' 106' ' ' PRO . 5.9 m -44.08 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.526 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 4.8 t-160 -112.89 -15.43 12.9 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.524 -0.735 . . . . 10.0 110.23 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.526 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 0.5 OUTLIER 165.91 -49.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.875 -1.528 . . . . 10.0 106.875 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.583 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 19.5 t 179.26 58.92 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 CA-C-N 115.206 -0.906 . . . . 10.0 108.924 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.632 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 52.2 Cg_endo -89.62 -62.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.002 1.527 . . . . 10.0 110.191 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 108.2 51.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 124.972 1.309 . . . . 10.0 110.905 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.487 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 31.2 m -45.88 144.29 2.88 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.892 -1.13 . . . . 10.0 109.319 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 43.7 Cg_endo -69.6 144.49 55.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.763 1.402 . . . . 10.0 110.776 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.448 ' C ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -133.66 113.02 11.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.399 -0.813 . . . . 10.0 111.641 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.565 ' N ' ' CD2' ' A' ' 111' ' ' LEU . 2.6 mm? -83.09 97.41 8.77 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 177.934 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.548 HD22 ' CB ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -77.02 145.68 37.84 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.413 -0.804 . . . . 10.0 110.447 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.503 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.0 t -152.97 176.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.147 -0.97 . . . . 10.0 111.83 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.455 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -112.32 159.82 13.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.42 -1.872 . . . . 10.0 108.42 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.539 ' N ' ' O ' ' A' ' 82' ' ' PHE . 81.8 m -127.03 150.75 49.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.675 -1.485 . . . . 10.0 111.457 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.504 ' N ' HG22 ' A' ' 115' ' ' THR . 4.2 pt20 33.6 57.35 0.54 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.376 0.607 . . . . 10.0 110.97 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.741 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -80.13 -25.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 10.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.528 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 15.7 t0 -52.48 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.566 1.174 . . . . 10.0 110.708 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.741 ' N ' ' O ' ' A' ' 117' ' ' ILE . 4.6 tp 167.42 -30.24 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.035 -1.439 . . . . 10.0 107.634 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.484 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 ttp180 -46.5 -38.56 9.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -55.07 -25.53 31.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 10.0 109.503 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 119' ' ' LEU . 6.8 m-20 -92.63 150.6 40.03 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 10.0 111.526 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.449 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 56.2 Cg_endo -80.79 17.15 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.578 1.831 . . . . 10.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.9 p -96.68 -50.75 4.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.984 -1.072 . . . . 10.0 110.188 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.469 ' O ' ' CD ' ' A' ' 128' ' ' LYS . 15.3 t -71.74 -28.11 63.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.832 -2.284 . . . . 10.0 104.832 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.493 HD12 HD13 ' A' ' 129' ' ' LEU 0.304 0.4 OUTLIER -49.67 -27.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 176.794 . . . . . . . . 4 4 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -50.12 -32.07 14.99 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.495 0.664 . . . . 10.0 109.998 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 125' ' ' THR . 0.3 OUTLIER -65.64 -32.19 73.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.334 -0.854 . . . . 10.0 110.391 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.493 HD13 HD12 ' A' ' 126' ' ' ILE . 7.9 mt -54.71 -38.69 67.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.109 -0.994 . . . . 10.0 109.373 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.559 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -54.15 -51.28 64.78 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.551 -0.86 . . . . 10.0 109.512 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -71.74 -13.28 61.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.014 . . . . 10.0 108.398 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.524 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 17.1 m120 -126.93 46.39 2.51 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.771 -0.581 . . . . 10.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 68.08 135.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 10.0 110.322 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.559 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.74 3.71 21.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 10.0 110.686 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.552 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 27.2 mmtp -101.53 99.49 11.59 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 10.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.66 161.74 44.74 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.862 1.454 . . . . 10.0 112.155 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.462 HG23 ' HB ' ' A' ' 84' ' ' VAL . 2.2 tp -84.71 143.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 10.0 109.011 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.578 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 43.6 p -134.4 171.26 9.34 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 10.0 110.312 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.578 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.1 Cg_endo -65.98 -30.55 47.99 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.556 1.293 . . . . 10.0 110.473 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -67.54 -38.13 83.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 10.0 109.01 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 m -88.79 -38.96 14.24 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.518 0.675 . . . . 10.0 109.484 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -69.05 -36.17 77.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.692 -0.63 . . . . 10.0 110.343 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 5.2 tt0 -65.31 -37.56 87.49 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.351 -0.843 . . . . 10.0 109.403 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.422 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 42.3 tttp -66.79 -36.04 81.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 10.0 108.806 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.484 HD23 ' HE3' ' A' ' 94' ' ' LYS . 2.9 tp -62.56 -48.97 77.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.537 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -63.47 -49.35 73.95 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.564 -0.854 . . . . 10.0 109.435 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -27.1 68.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.281 0.562 . . . . 10.0 109.567 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.422 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 1.9 m-20 -74.68 -47.45 31.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 10.0 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 3.2 mp -88.73 12.07 15.92 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.892 0.853 . . . . 10.0 109.445 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.453 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 19.2 mtmt 59.69 33.11 21.81 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.816 0.817 . . . . 10.0 110.216 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.537 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -61.58 -152.85 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.145 -0.622 . . . . 10.0 110.117 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.593 ' CG2' ' CB ' ' A' ' 175' ' ' ALA . 0.6 OUTLIER -117.97 -51.52 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.035 -1.041 . . . . 10.0 111.471 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -172.52 143.62 1.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.613 -1.235 . . . . 10.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 53.8 p90 -90.32 121.64 32.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 10.0 109.623 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.552 ' CG1' HG23 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -127.14 -169.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 10.0 110.771 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -145.69 148.21 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 10.0 110.033 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.54 ' CB ' ' CB ' ' A' ' 165' ' ' LEU . 27.6 p -156.52 154.11 29.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.326 -0.859 . . . . 10.0 109.171 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.572 ' OG ' ' CG2' ' A' ' 161' ' ' THR . 1.3 t -149.61 88.47 1.56 Allowed 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.066 -1.054 . . . . 10.0 109.933 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.541 ' HB3' HD13 ' A' ' 19' ' ' LEU . . . -42.84 -79.86 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.519 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -31.3 -39.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.216 1.008 . . . . 10.0 109.351 -178.742 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.572 ' CG2' ' OG ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -111.2 -97.91 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.021 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.644 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 158.75 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.833 . . . . 10.0 109.754 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.497 ' HB3' ' CA ' ' A' ' 157' ' ' CYS . 21.8 tptt -105.47 43.59 1.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.851 -1.155 . . . . 10.0 110.221 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.44 40.84 87.17 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.741 -1.344 . . . . 10.0 109.741 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.625 HD13 ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -61.71 -12.27 15.77 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.237 -1.155 . . . . 10.0 110.785 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.458 ' N ' HD12 ' A' ' 165' ' ' LEU . 2.5 mttp -53.24 -29.67 33.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.889 -1.132 . . . . 10.0 109.834 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -70.86 -29.79 66.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 10.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.552 HG23 ' CG1' ' A' ' 155' ' ' VAL . 2.3 t -66.86 -19.37 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 10.0 110.035 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.466 ' O ' HG12 ' A' ' 173' ' ' ILE . 25.4 t80 -96.55 -45.3 6.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.212 -0.93 . . . . 10.0 112.094 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.472 ' O ' HD23 ' A' ' 174' ' ' LEU . 1.3 m-20 -51.22 -49.14 61.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.985 -1.072 . . . . 10.0 110.82 -178.595 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.78 -39.73 76.46 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.087 -1.008 . . . . 10.0 110.137 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.476 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -54.85 -27.24 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.514 ' O ' HD11 ' A' ' 177' ' ' LEU . 34.8 mm -67.14 -45.93 85.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.959 -1.088 . . . . 10.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.509 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -80.49 -27.63 37.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.945 -1.097 . . . . 10.0 109.954 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -85.43 -1.66 57.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.763 . . . . 10.0 109.418 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.518 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -83.11 -42.43 17.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.329 -0.857 . . . . 10.0 110.497 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.539 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -87.73 -19.12 28.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.494 -0.754 . . . . 10.0 109.826 -178.555 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.416 ' CG ' ' HA ' ' A' ' 175' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 120.858 -1.151 . . . . 10.0 109.998 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.661 -1.376 . . . . 10.0 109.661 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.3 m -119.55 157.59 28.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -1.159 . . . . 10.0 110.748 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.08 100.66 13.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.376 -0.828 . . . . 10.0 110.022 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.543 ' CG ' ' HG3' ' A' ' 49' ' ' GLU . 53.4 mm-40 -81.28 157.99 24.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.876 . . . . 10.0 110.669 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.699 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -118.09 -52.32 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.481 -0.762 . . . . 10.0 110.129 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.699 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.7 Cg_endo -89.59 21.37 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.26 1.137 . . . . 10.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.482 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 4.0 pt-20 -55.39 168.44 0.37 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.956 . . . . 10.0 110.353 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.591 ' CG2' ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -80.27 -148.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 10.0 108.649 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.591 ' N ' ' CG2' ' B' ' 8' ' ' ILE . 66.6 m -121.55 98.6 6.04 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.262 -0.899 . . . . 10.0 108.864 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.72 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -132.8 98.06 16.51 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.334 -0.854 . . . . 10.0 111.093 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -90.31 111.39 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.704 1.371 . . . . 10.0 110.25 178.724 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 43' ' ' THR . 14.0 m -142.27 102.81 4.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 10.0 111.151 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.542 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 7.5 p-10 -170.84 132.09 0.87 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.486 -0.759 . . . . 10.0 110.488 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.49 100.02 2.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 10.0 112.389 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.635 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 27.2 tt0 -173.01 123.65 0.42 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.592 -0.693 . . . . 10.0 109.217 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.616 ' HB2' ' HB2' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -163.72 151.13 12.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.538 -1.352 . . . . 10.0 111.639 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.551 ' N ' ' HB2' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -136.48 104.3 5.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.083 -1.011 . . . . 10.0 110.584 179.163 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.706 ' N ' ' HB3' ' A' ' 39' ' ' ASN . 31.7 mm -50.84 106.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.998 -1.064 . . . . 10.0 112.769 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.663 ' C ' ' HA ' ' A' ' 37' ' ' PHE . 55.4 m170 -102.75 116.45 32.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.019 . . . . 10.0 111.096 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.722 ' HA ' ' N ' ' A' ' 37' ' ' PHE . 3.1 p -87.55 149.09 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.219 -0.926 . . . . 10.0 113.461 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.545 ' CA ' ' HA ' ' A' ' 59' ' ' ALA . . . -143.47 -65.65 0.02 OUTLIER Glycine 0 CA--C 1.538 1.491 0 C-N-CA 119.791 -1.195 . . . . 10.0 112.137 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.495 ' O ' ' HB ' ' B' ' 25' ' ' VAL . 5.6 t80 -177.32 126.94 0.15 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 120.674 -1.486 . . . . 10.0 109.227 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 33' ' ' VAL . 9.4 m-20 -38.47 148.27 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.853 0.835 . . . . 10.0 111.471 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.497 ' CB ' ' OE2' ' B' ' 28' ' ' GLU . . . 52.87 31.35 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.37 0.507 . . . . 10.0 112.37 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.495 ' HB ' ' O ' ' B' ' 22' ' ' PHE . 9.8 t -109.63 -31.56 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.518 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 5.4 t -94.21 -0.61 55.04 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.593 0.711 . . . . 10.0 109.145 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.675 ' HA2' ' HB ' ' A' ' 21' ' ' ILE . . . -114.28 2.9 23.78 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.738 -1.22 . . . . 10.0 110.159 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.566 ' HG3' ' HB2' ' A' ' 28' ' ' PHE . 1.7 pm0 -178.12 -158.69 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.982 -1.305 . . . . 10.0 110.602 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.465 ' HB2' HG13 ' A' ' 14' ' ' VAL . 1.2 t80 -131.39 135.29 47.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.72 0.772 . . . . 10.0 109.508 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.562 HG21 ' CD2' ' A' ' 28' ' ' PHE . 15.0 p -151.01 -64.32 0.19 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.461 -0.774 . . . . 10.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.516 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -70.86 171.13 45.62 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.116 -1.193 . . . . 10.0 110.116 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 15.8 mm -125.72 47.79 2.45 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.904 . . . . 10.0 110.198 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 45.7 Cg_endo -71.01 171.97 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.977 1.514 . . . . 10.0 110.385 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' B' ' 35' ' ' GLN . 1.8 tp10 -50.57 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 10.0 109.73 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.632 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -81.62 19.11 1.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.195 -0.94 . . . . 10.0 109.45 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.633 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 37.1 m0 71.1 39.38 0.98 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.492 ' O ' ' HG ' ' B' ' 39' ' ' LEU . . . -172.34 74.06 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 113.386 -1.734 . . . . 10.0 106.887 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.472 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 6.7 mtm180 -72.82 55.17 0.38 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.238 -1.393 . . . . 10.0 107.238 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.492 ' HG ' ' O ' ' B' ' 37' ' ' ALA . 11.9 mt -51.42 -36.44 43.71 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.49 -1.232 . . . . 10.0 111.749 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 1.5 pp -123.35 12.49 9.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.605 -1.309 . . . . 10.0 111.846 -179.313 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.487 ' OE1' ' HA ' ' B' ' 41' ' ' GLN . 1.8 mm100 -91.82 -34.19 14.66 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.235 -0.916 . . . . 10.0 110.433 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.537 ' O ' ' CG2' ' B' ' 42' ' ' THR . 3.7 t -135.49 51.64 2.06 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.33 1.062 . . . . 10.0 108.254 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.7 m -136.89 -34.93 0.72 Allowed 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -125.46 153.72 43.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.995 -0.682 . . . . 10.0 110.366 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -50.03 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 10.0 110.482 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.047 -0.977 . . . . 10.0 110.159 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.178 0.513 . . . . 10.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.592 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -164.72 25.36 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.163 -0.961 . . . . 10.0 109.453 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.554 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 30.2 m -89.47 127.01 35.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.581 -0.699 . . . . 10.0 110.303 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.551 ' CG2' ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.39 136.2 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.281 -0.968 . . . . 10.0 110.266 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.545 ' O ' HG21 ' A' ' 75' ' ' THR . 6.6 mtpt -124.53 98.95 5.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 10.0 109.595 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.445 ' C ' HG22 ' A' ' 7' ' ' VAL . 8.6 t -82.37 99.83 9.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.895 -1.128 . . . . 10.0 110.764 -179.612 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.46 HG21 HG23 ' A' ' 75' ' ' THR . 61.7 t -134.29 144.48 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 10.0 109.442 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.511 ' O ' ' HB3' ' B' ' 37' ' ' ALA . 94.4 t -59.67 166.04 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 10.0 110.925 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.585 ' CG2' ' N ' ' A' ' 79' ' ' LEU . 3.4 t -112.39 -174.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.426 -0.797 . . . . 10.0 109.348 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.508 ' HA2' ' N ' ' B' ' 38' ' ' ARG . . . -63.39 -144.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.014 -1.089 . . . . 10.0 110.417 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . 0.449 ' OD2' HG21 ' A' ' 80' ' ' VAL . 5.9 m-20 62.24 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.416 -1.049 . . . . 10.0 109.951 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.515 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 112.14 54.16 0.49 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.029 -1.228 . . . . 10.0 110.029 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -175.94 68.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -1.22 . . . . 10.0 110.559 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.463 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 10.9 p -179.1 58.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 10.0 109.715 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.571 ' O ' HD22 ' A' ' 19' ' ' LEU . . . -103.95 88.28 0.61 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.832 -1.307 . . . . 10.0 109.832 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.626 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.13 -31.56 63.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.795 -1.415 . . . . 10.0 110.7 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.423 ' HB ' ' OD2' ' A' ' 57' ' ' ASP . 11.3 m -62.47 -41.32 98.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 10.0 111.481 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.535 ' CA ' ' O ' ' B' ' 26' ' ' THR . 17.8 m -95.07 -15.47 23.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.748 -1.22 . . . . 10.0 110.449 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.591 HD22 ' N ' ' A' ' 19' ' ' LEU . 4.6 mm? -93.02 -34.79 13.57 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.145 -0.972 . . . . 10.0 109.808 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.58 -37.18 77.82 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.647 -1.983 . . . . 10.0 105.647 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.521 HG21 ' CA ' ' B' ' 27' ' ' GLY 0.266 0.4 OUTLIER -63.41 -50.19 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.328 -1.36 . . . . 10.0 107.328 176.34 . . . . . . . . 4 4 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.648 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 23.8 m -49.05 -49.72 39.99 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.633 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 33.9 m-85 -72.96 -29.34 63.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.959 -1.088 . . . . 10.0 110.442 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -65.32 -50.37 65.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 10.0 109.396 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 10.2 t -169.6 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.253 -0.979 . . . . 10.0 111.095 179.216 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.559 ' O ' ' CD ' ' A' ' 29' ' ' PRO . 35.8 t-20 -61.15 -20.46 62.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 10.0 111.473 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.648 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 26.13 -134.02 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.873 -0.517 . . . . 10.0 111.994 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.669 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 6.1 t80 -129.53 45.59 1.82 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.02 -1.05 . . . . 10.0 112.924 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.669 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 59.6 Cg_endo -97.11 -119.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.179 0 N-CA-C 108.777 -1.278 . . . . 10.0 108.777 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.416 ' H ' ' HB2' ' A' ' 29' ' ' PRO . 0.4 OUTLIER -168.87 69.79 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.678 -1.264 . . . . 10.0 109.504 179.15 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.414 ' O ' ' CB ' ' B' ' 24' ' ' ALA . 18.0 pt-20 -138.56 -173.73 3.63 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 120.937 -1.102 . . . . 10.0 110.648 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' C ' ' CG2' ' A' ' 33' ' ' VAL . 12.5 t80 -71.65 135.8 47.04 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.991 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.587 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -157.52 -171.42 0.28 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.241 -0.912 . . . . 10.0 109.119 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.587 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 40.1 Cg_endo -65.33 -148.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 122.859 0.926 . . . . 10.0 111.699 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.42 ' C ' ' HB ' ' B' ' 26' ' ' THR . 46.7 p -128.0 162.68 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.696 -1.253 . . . . 10.0 113.47 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.704 ' HB ' ' CG2' ' B' ' 20' ' ' VAL 0.256 6.9 t -70.6 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-N 115.296 -0.865 . . . . 10.0 110.311 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.69 ' H ' ' CG2' ' B' ' 20' ' ' VAL . 0.8 OUTLIER -33.45 129.42 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.572 0.701 . . . . 10.0 110.957 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 10.0 t70 -138.96 83.45 1.95 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.444 ' HB3' HG13 ' B' ' 18' ' ' ILE . 7.4 t-20 -88.42 98.45 11.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -0.932 . . . . 10.0 110.511 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.557 ' CD2' ' HB3' ' B' ' 15' ' ' GLU . 19.6 m-85 -127.69 116.03 19.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.222 -0.923 . . . . 10.0 109.453 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.597 ' O ' ' CG2' ' A' ' 42' ' ' VAL . . . -133.69 100.34 4.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.05 -1.031 . . . . 10.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.716 ' HB ' ' O ' ' B' ' 14' ' ' PHE . 3.1 t -167.33 -166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.601 ' H ' ' CG1' ' A' ' 42' ' ' VAL . 52.0 m -137.15 161.65 35.56 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 119.452 -2.03 . . . . 10.0 113.636 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.738 ' CA ' ' HB3' ' B' ' 13' ' ' ASP . 0.7 OUTLIER -105.25 -176.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.765 -0.585 . . . . 10.0 110.59 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.607 ' O ' ' O ' ' B' ' 10' ' ' LEU . 27.5 mtp -139.74 96.56 3.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.937 -1.105 . . . . 10.0 108.836 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 49' ' ' GLU . 11.6 mt -102.43 131.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.783 -0.573 . . . . 10.0 111.146 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.511 ' HA2' ' CG1' ' B' ' 8' ' ' ILE . . . 38.2 27.81 0.04 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.346 -1.102 . . . . 10.0 110.346 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 98.97 -16.85 58.96 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.958 -1.319 . . . . 10.0 110.652 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -101.74 108.59 56.61 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.283 . . . . 10.0 110.153 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.63 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 42.8 Cg_endo -73.63 156.58 49.17 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.063 1.559 . . . . 10.0 111.668 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.55 ' HB2' ' CG2' ' A' ' 44' ' ' VAL . 1.9 m-85 -105.95 113.96 27.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.034 . . . . 10.0 112.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.554 ' HB ' ' HA ' ' A' ' 3' ' ' THR 0.271 98.2 m -75.82 110.07 9.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 10.0 109.459 178.385 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.542 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 3.7 pp -149.32 173.25 13.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 10.0 112.857 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.54 118.02 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.688 -2.165 . . . . 10.0 107.688 179.766 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.514 ' C ' ' CD2' ' A' ' 56' ' ' PHE . 4.6 pp -129.25 149.55 51.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.728 -1.454 . . . . 10.0 111.332 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.514 ' CD2' ' C ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -172.16 129.38 0.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 10.0 110.088 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.423 ' OD2' ' HB ' ' A' ' 17' ' ' THR . 1.3 m-20 -102.62 158.3 16.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.059 -1.026 . . . . 10.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.601 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 13.9 t -43.55 147.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.011 . . . . 10.0 109.68 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.609 ' CB ' HG11 ' A' ' 36' ' ' VAL . . . 177.57 -72.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.783 . . . . 10.0 112.144 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.499 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 45.38 52.62 8.59 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.154 -1.979 . . . . 10.0 108.154 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.52 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 16.4 mm-40 60.77 40.56 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.679 -0.895 . . . . 10.0 109.869 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.615 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.3 OUTLIER 174.24 -70.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 10.0 111.092 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.572 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.2 OUTLIER 169.14 44.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.897 -1.127 . . . . 10.0 110.314 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.615 ' CE2' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -148.94 -49.93 0.15 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.84 . . . . 10.0 109.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.533 ' HB3' ' CB ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 69.45 80.86 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.681 0.753 . . . . 10.0 109.825 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.492 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 26.6 ttp180 -52.32 -26.81 13.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.642 -0.661 . . . . 10.0 110.371 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.511 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -86.03 -0.62 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 10.0 110.276 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.616 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -110.85 13.24 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 -178.455 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -60.99 126.64 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 N-CA-C 108.613 -1.341 . . . . 10.0 108.613 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.591 ' CD1' ' HA ' ' B' ' 37' ' ' ALA . 0.2 OUTLIER -113.62 -77.38 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 10.0 111.874 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.568 ' HA ' ' N ' ' B' ' 40' ' ' LEU . 19.5 m 61.31 34.39 18.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.148 -0.97 . . . . 10.0 108.482 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.09 131.44 6.44 Favored Pre-proline 0 N--CA 1.487 1.399 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.673 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.31 79.85 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.719 1.378 . . . . 10.0 110.03 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.53 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -131.06 60.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 10.0 110.242 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.596 ' HB ' ' CZ ' ' A' ' 78' ' ' PHE . 9.9 m -144.47 96.91 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.143 -0.973 . . . . 10.0 109.435 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.471 ' O ' ' HD2' ' A' ' 109' ' ' PRO . 84.8 m-20 -38.52 -27.86 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.947 -0.47 . . . . 10.0 111.198 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.514 HG23 ' O ' ' A' ' 5' ' ' LYS . 17.7 m -130.38 116.73 37.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.717 -1.239 . . . . 10.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.596 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-85 -109.2 130.87 55.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.477 -0.764 . . . . 10.0 108.997 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.614 HD12 ' CE1' ' A' ' 169' ' ' PHE . 2.5 mm? -103.21 96.94 7.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.091 . . . . 10.0 109.08 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.455 HG12 ' O ' ' A' ' 80' ' ' VAL . 14.8 p -108.8 143.7 18.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.662 -0.649 . . . . 10.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.461 ' SG ' ' OG1' ' A' ' 115' ' ' THR . 53.7 t -133.75 129.71 37.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.259 -0.976 . . . . 10.0 110.569 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.483 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 24.2 p90 -137.15 178.0 7.43 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.387 -0.82 . . . . 10.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.7 p -76.68 162.54 27.64 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.126 -0.984 . . . . 10.0 111.556 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.477 ' CG1' ' OH ' ' A' ' 154' ' ' TYR . 28.4 m -112.96 -1.5 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 121.325 -0.86 . . . . 10.0 111.69 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.518 ' CG2' ' HG3' ' A' ' 120' ' ' ARG . 14.5 m -128.88 38.05 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.849 -1.157 . . . . 10.0 111.468 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.534 ' O ' ' CD2' ' A' ' 129' ' ' LEU . 59.8 m -95.97 149.23 35.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.057 -1.027 . . . . 10.0 108.964 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' CB ' ' CG ' ' A' ' 132' ' ' ASN . 41.0 Cg_endo -67.49 113.04 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.632 1.333 . . . . 10.0 110.382 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.409 ' HB2' ' O ' ' A' ' 87' ' ' PRO . 41.5 m 54.5 64.13 1.92 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 10.0 109.987 -179.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.508 ' CB ' ' HB2' ' A' ' 86' ' ' SER . 22.1 p -116.55 -60.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 10.0 110.949 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 9.4 t80 -59.96 -38.87 83.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.011 -1.055 . . . . 10.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.48 -17.63 64.9 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.844 -1.16 . . . . 10.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.477 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -77.62 -21.62 52.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 10.0 110.353 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.56 HG22 ' HD3' ' A' ' 94' ' ' LYS . 2.2 m -89.72 -5.09 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.591 -1.243 . . . . 10.0 109.414 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 90' ' ' PHE . 12.9 mmtt -94.49 -32.72 13.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.137 -0.977 . . . . 10.0 108.391 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.487 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 3.6 pt-20 -77.64 -10.85 59.74 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.021 -0.672 . . . . 10.0 109.221 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.404 ' C ' ' HD2' ' A' ' 99' ' ' PRO . 2.7 tttt -112.35 -50.53 2.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 10.0 111.852 -179.286 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.494 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 60.6 m95 -69.39 -47.11 65.21 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.564 -0.71 . . . . 10.0 112.256 -178.008 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.571 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 98.9 t -55.93 -49.28 93.92 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.49 -1.381 . . . . 10.0 110.331 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.571 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.4 Cg_endo -72.86 -12.92 26.55 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.257 1.135 . . . . 10.0 110.643 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.484 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -68.69 -36.68 78.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 10.0 110.601 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.562 ' CG2' ' HA ' ' A' ' 104' ' ' HIS . 78.6 mt 55.11 85.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.206 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.494 HG23 ' N ' ' A' ' 103' ' ' HIS . 1.9 m -39.37 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.681 0.753 . . . . 10.0 110.114 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.557 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 6.0 m170 -109.87 -2.98 16.91 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.5 -0.75 . . . . 10.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.562 ' HA ' ' CG2' ' A' ' 101' ' ' ILE . 66.2 t60 80.37 16.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.622 0.725 . . . . 10.0 109.494 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.603 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.8 OUTLIER -150.76 -65.81 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.808 -0.757 . . . . 10.0 111.44 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 41.6 Cg_endo -68.81 -31.3 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.51 1.268 . . . . 10.0 111.892 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 42.31 63.12 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.367 1.079 . . . . 10.0 108.485 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 76' ' ' ASP . 8.7 t -44.91 141.46 3.03 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.674 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.471 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 43.1 Cg_endo -69.99 163.39 38.65 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.286 1.677 . . . . 10.0 112.068 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.485 ' O ' HG13 ' A' ' 152' ' ' VAL . 86.5 m-85 -127.13 114.69 18.04 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.698 -0.626 . . . . 10.0 109.701 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.588 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -73.95 92.59 2.12 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.569 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 15.8 mt -69.33 139.33 54.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.732 -0.605 . . . . 10.0 109.372 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.505 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.0 t -144.98 -179.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.965 -1.085 . . . . 10.0 111.41 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -118.49 125.14 6.3 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.461 ' OG1' ' SG ' ' A' ' 81' ' ' CYS . 52.9 m -92.42 140.83 29.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.971 -1.311 . . . . 10.0 111.36 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.457 ' C ' ' O ' ' A' ' 115' ' ' THR . 6.9 mm100 40.14 57.44 2.4 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.196 -0.602 . . . . 10.0 109.754 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.2 OUTLIER -76.87 -29.21 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.29 -0.964 . . . . 10.0 110.103 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.64 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 44.2 t0 -51.73 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.459 0.647 . . . . 10.0 111.85 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.7 OUTLIER 147.33 -30.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 CA-C-N 114.858 -1.064 . . . . 10.0 108.572 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.534 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 15.2 tpp180 -55.51 -31.35 61.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.778 -0.577 . . . . 10.0 110.315 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -86.88 4.93 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 10.0 111.044 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.489 ' OD1' ' N ' ' A' ' 122' ' ' ASP . 0.8 OUTLIER -82.29 165.74 40.86 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 10.0 110.403 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.426 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 54.9 Cg_endo -79.2 23.38 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.074 1.565 . . . . 10.0 111.086 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 t -108.45 -50.14 3.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.92 -1.112 . . . . 10.0 110.278 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.493 HG23 ' N ' ' A' ' 126' ' ' ILE . 14.5 t -79.06 -28.09 43.14 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.779 -1.934 . . . . 10.0 105.779 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.534 ' CD1' ' O ' ' A' ' 120' ' ' ARG 0.289 1.4 mp -59.82 -22.59 24.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -48.89 -33.66 11.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.49 0.662 . . . . 10.0 109.864 179.185 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.36 -49.05 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.661 -0.649 . . . . 10.0 110.775 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.534 ' CD2' ' O ' ' A' ' 86' ' ' SER . 1.3 tm? -49.87 -50.48 45.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 10.0 110.963 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.532 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -55.82 -49.94 71.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.201 -0.937 . . . . 10.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 17.9 mttt -60.01 -22.49 62.67 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.612 -0.68 . . . . 10.0 110.027 179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.49 ' CG ' ' CB ' ' A' ' 87' ' ' PRO . 23.0 t-20 -99.68 -62.46 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.934 -1.104 . . . . 10.0 111.337 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.561 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -109.69 -0.36 18.59 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.365 -0.835 . . . . 10.0 111.494 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.561 ' HB2' ' O ' ' A' ' 133' ' ' LYS . 0.6 OUTLIER 64.13 -44.52 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.707 . . . . 10.0 112.334 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.509 ' HD2' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -113.99 128.71 25.49 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 120.94 -1.1 . . . . 10.0 111.087 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.1 161.65 44.07 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.877 1.462 . . . . 10.0 110.527 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.474 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 4.1 tp -95.36 133.19 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.921 -1.112 . . . . 10.0 109.506 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.575 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.6 p -123.8 179.17 1.12 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 10.0 109.399 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.575 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 44.2 Cg_endo -73.52 -26.64 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.228 1.12 . . . . 10.0 110.421 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -66.87 -47.9 70.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 10.0 110.413 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.1 m -74.65 -39.75 61.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.504 -0.747 . . . . 10.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.51 -35.67 77.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 10.0 110.663 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -51.41 -39.74 57.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.351 -0.843 . . . . 10.0 109.955 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -49.21 78.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.333 -0.854 . . . . 10.0 110.422 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.471 ' CD2' HD22 ' A' ' 149' ' ' LEU . 7.7 tt -58.61 -33.17 69.71 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.013 -1.055 . . . . 10.0 109.644 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.495 ' HA ' ' HB1' ' A' ' 151' ' ' ALA . . . -71.32 -48.18 52.03 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.889 0.852 . . . . 10.0 109.471 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -63.46 -26.92 68.95 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.303 -0.559 . . . . 10.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB3' HD11 ' A' ' 149' ' ' LEU . 20.4 t0 -79.61 -40.25 29.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 10.0 110.659 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.3 mp -91.47 20.83 4.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 10.0 109.125 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.412 ' HD3' ' HD2' ' A' ' 107' ' ' LYS . 4.8 mtpt 57.03 20.6 5.57 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.935 0.874 . . . . 10.0 109.41 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.495 ' HB1' ' HA ' ' A' ' 146' ' ' ALA . . . -69.36 -174.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.588 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.2 p -91.59 -72.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.826 -1.172 . . . . 10.0 111.578 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.558 ' H ' ' CG1' ' A' ' 152' ' ' VAL . 5.4 tttt -173.86 173.46 3.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.217 -1.552 . . . . 10.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.593 ' CD2' ' CB ' ' A' ' 142' ' ' ALA . 18.6 t80 -112.26 104.44 12.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 10.0 109.448 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.505 ' O ' ' HA ' ' A' ' 113' ' ' VAL . 0.9 OUTLIER -109.17 -168.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 10.0 110.405 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.421 ' CG ' ' O ' ' A' ' 155' ' ' VAL . 67.3 mt-10 -152.51 135.57 15.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.784 -1.198 . . . . 10.0 111.164 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.457 ' HA ' ' HG2' ' A' ' 162' ' ' GLN . 28.1 p -152.4 172.74 16.03 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.722 0.773 . . . . 10.0 109.563 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.56 ' HB3' ' CB ' ' A' ' 162' ' ' GLN . 34.0 t -140.9 175.17 9.83 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.633 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -73.22 -54.62 7.98 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.409 -0.807 . . . . 10.0 111.97 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.621 ' CD1' ' N ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -129.23 -22.54 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.736 -1.227 . . . . 10.0 113.39 -178.017 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' CD1' ' A' ' 160' ' ' LEU . 10.0 t -90.47 -51.87 5.19 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.312 -1.492 . . . . 10.0 113.637 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.564 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 6.7 tp60 -59.76 -63.21 1.38 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.308 -1.495 . . . . 10.0 111.696 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.6 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 28.4 ttpt 79.47 34.67 0.18 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.513 0.673 . . . . 10.0 109.383 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -118.19 20.64 10.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.886 -1.686 . . . . 10.0 108.886 179.668 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.553 HD22 ' N ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -78.04 4.96 10.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -1.091 . . . . 10.0 110.652 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -93.78 -44.15 8.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.037 -1.039 . . . . 10.0 110.085 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.44 -31.44 72.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 10.0 110.142 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.496 HG21 HG12 ' A' ' 155' ' ' VAL . 14.5 t -65.09 -49.23 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.27 -0.894 . . . . 10.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.626 ' CE1' ' HB2' ' A' ' 16' ' ' LYS . 9.0 m-85 -76.82 -23.65 52.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.389 -0.82 . . . . 10.0 111.302 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.37 -50.3 60.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.896 -1.127 . . . . 10.0 111.766 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.423 ' HG3' HG21 ' A' ' 152' ' ' VAL . 20.0 pt-20 -61.23 -24.59 66.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 10.0 109.825 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.535 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -67.53 -26.54 66.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.244 -0.982 . . . . 10.0 109.045 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.508 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 34.2 mm -60.18 -45.54 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 10.0 110.179 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.531 ' CD1' ' N ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER -74.36 -38.14 63.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 10.0 109.642 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -78.56 -6.59 55.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.489 -0.757 . . . . 10.0 109.712 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.547 ' HB3' ' CB ' ' A' ' 4' ' ' ILE . . . -77.76 -38.15 47.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 10.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.592 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -76.51 -34.79 58.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 10.0 110.286 -178.676 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.893 -1.051 . . . . 10.0 110.159 179.884 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.518 ' CA ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 108.977 -1.649 . . . . 10.0 108.977 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.506 ' O ' ' N ' ' B' ' 4' ' ' GLU . 13.8 m -111.3 44.9 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -1.112 . . . . 10.0 111.211 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 10.0 109.305 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.561 ' HB3' ' HD2' ' B' ' 6' ' ' PRO . 2.2 mm-40 -92.16 144.48 25.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.856 -1.152 . . . . 10.0 110.116 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.32 -41.74 14.36 Favored Pre-proline 0 C--N 1.292 -1.909 0 O-C-N 121.724 -0.61 . . . . 10.0 110.645 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 43.3 Cg_endo -89.39 57.78 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.746 1.393 . . . . 10.0 112.418 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.443 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -97.78 160.72 14.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.69 -1.256 . . . . 10.0 108.327 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.511 ' CG1' ' HA2' ' A' ' 47' ' ' GLY . 5.8 pt -80.39 -117.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.879 -1.138 . . . . 10.0 109.376 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -147.58 104.05 3.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.69 -1.256 . . . . 10.0 109.628 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 45' ' ' MET . 14.2 tp -143.65 97.13 5.52 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 118.957 -1.097 . . . . 10.0 112.092 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -101.37 98.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.166 1.911 . . . . 10.0 108.685 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.62 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.4 m -148.5 99.59 3.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.248 -1.532 . . . . 10.0 112.895 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.738 ' HB3' ' CA ' ' A' ' 44' ' ' VAL . 5.0 p-10 -143.17 153.44 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.984 0.897 . . . . 10.0 112.153 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.716 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 53.6 m-85 -110.37 -172.25 2.0 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.636 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -174.88 -170.5 0.47 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 10.0 110.562 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.544 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 22.8 m170 -104.52 168.98 8.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.454 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 6.7 t -151.5 146.22 25.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.583 -1.323 . . . . 10.0 111.805 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.523 HD11 ' CG ' ' A' ' 37' ' ' PHE . 1.6 pp -149.18 179.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.358 -0.979 . . . . 10.0 108.358 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -134.5 159.27 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 10.0 112.496 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.704 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 54.2 t -104.74 153.34 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.564 0.697 . . . . 10.0 112.394 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.541 ' N ' HG13 ' B' ' 20' ' ' VAL . . . -106.5 63.95 0.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.661 -1.776 . . . . 10.0 108.661 179.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.64 ' CD1' ' CG2' ' B' ' 25' ' ' VAL . 0.3 OUTLIER -170.57 100.74 0.25 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.452 -1.028 . . . . 10.0 109.371 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 11.9 t70 -53.09 150.07 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.822 0.82 . . . . 10.0 111.968 -178.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.527 ' HA ' ' CG2' ' A' ' 33' ' ' VAL . . . 39.21 51.31 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.865 -0.522 . . . . 10.0 112.254 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.64 ' CG2' ' CD1' ' B' ' 22' ' ' PHE . 38.9 t -111.77 -25.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.784 -1.198 . . . . 10.0 108.487 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.535 ' O ' ' CA ' ' A' ' 18' ' ' CYS . 11.3 t -70.64 -20.66 62.71 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.29 53.45 0.74 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 106.902 -2.479 . . . . 10.0 106.902 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.25 58.02 1.69 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.681 -0.893 . . . . 10.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.616 ' CD1' ' HB3' ' A' ' 159' ' ' ALA . 20.4 t80 -85.78 133.17 34.0 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-O 122.059 0.933 . . . . 10.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.619 ' CG2' ' CE1' ' A' ' 28' ' ' PHE . 19.2 p -146.9 -178.83 6.4 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.08 81.13 0.04 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.59 -1.804 . . . . 10.0 108.59 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.498 ' N ' ' O ' ' B' ' 30' ' ' THR . 90.2 mt -111.67 145.5 32.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.366 -1.079 . . . . 10.0 111.474 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.0 Cg_endo -69.91 178.59 4.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.933 1.755 . . . . 10.0 110.462 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.527 ' C ' ' O ' ' B' ' 33' ' ' PRO . 34.3 tt0 -8.0 131.07 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.518 0.932 . . . . 10.0 113.518 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.515 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 0.1 OUTLIER -83.4 -70.52 0.56 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.641 0.734 . . . . 10.0 109.862 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.601 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -172.99 24.64 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.912 -0.715 . . . . 10.0 111.58 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.591 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . -127.36 -28.62 2.79 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.495 -0.753 . . . . 10.0 109.552 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CB ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -56.88 -14.8 3.8 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 177.621 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.507 HD13 ' CG ' ' A' ' 70' ' ' LEU . 23.7 mt -40.03 -25.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.897 -0.502 . . . . 10.0 110.982 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.568 ' N ' ' HA ' ' A' ' 71' ' ' SER . 2.2 pp -93.1 11.76 26.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.014 . . . . 10.0 111.295 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 38' ' ' ARG . 3.0 mt-30 -137.71 -92.05 0.22 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.568 -0.707 . . . . 10.0 109.146 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.458 ' OG1' ' NH1' ' B' ' 38' ' ' ARG . 60.9 p -135.82 169.97 16.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.377 -0.827 . . . . 10.0 109.682 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.458 ' HA ' ' OE1' ' B' ' 34' ' ' GLU . 88.2 p -86.57 18.88 3.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -0.977 . . . . 10.0 110.538 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -157.99 166.9 31.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.019 -1.051 . . . . 10.0 110.595 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 2.9 mp -87.02 -52.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 10.0 109.631 179.593 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 10.0 110.524 -179.874 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.495 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.11 0.481 . . . . 10.0 109.91 . . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.495 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 68.7 79.17 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.891 0.853 . . . . 10.0 109.278 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.568 ' CG2' ' O ' ' A' ' 3' ' ' THR . 1.2 m -175.95 78.56 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.585 ' N ' ' OG1' ' A' ' 52' ' ' THR . 0.2 OUTLIER -115.24 121.51 67.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.764 -1.21 . . . . 10.0 110.615 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.563 ' O ' ' CG2' ' A' ' 75' ' ' THR . 62.0 mttt -128.93 112.66 14.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.481 ' SG ' ' HB2' ' A' ' 55' ' ' LEU . 26.4 p -94.67 141.29 28.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.058 -1.057 . . . . 10.0 110.444 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.402 HG21 ' CZ ' ' A' ' 56' ' ' PHE . 57.9 t -144.72 152.26 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.565 -0.709 . . . . 10.0 109.224 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.558 HG21 ' CE3' ' B' ' 36' ' ' TRP . 35.0 m -65.84 102.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.204 -0.935 . . . . 10.0 111.309 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.459 ' O ' ' O ' ' A' ' 79' ' ' LEU . 21.3 t -109.53 177.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.213 -0.93 . . . . 10.0 109.143 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.496 ' HA2' ' CG2' ' A' ' 80' ' ' VAL . . . 151.74 166.99 14.51 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.502 -1.332 . . . . 10.0 110.062 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -47.79 -27.63 2.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.304 -1.116 . . . . 10.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.531 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 140.83 43.72 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.699 -1.36 . . . . 10.0 109.699 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.8 -114.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.343 -1.092 . . . . 10.0 109.687 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.584 ' O ' ' CH2' ' B' ' 36' ' ' TRP . 80.0 t -113.89 -92.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.736 -1.227 . . . . 10.0 110.657 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.482 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 170.14 144.65 4.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.927 -1.269 . . . . 10.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.552 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.14 -23.17 61.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.977 . . . . 10.0 111.77 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.512 ' OG1' ' CG1' ' A' ' 8' ' ' VAL . 16.6 m -62.66 -50.27 71.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.938 -1.101 . . . . 10.0 112.03 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.565 ' HB3' ' CB ' ' A' ' 35' ' ' THR . 31.3 p -78.59 8.77 4.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.46 -1.4 . . . . 10.0 110.3 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.613 ' CD2' ' HB2' ' B' ' 29' ' ' PHE . 0.7 OUTLIER -88.0 -28.01 21.69 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.553 -1.342 . . . . 10.0 107.622 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.47 ' O ' ' OG1' ' A' ' 24' ' ' THR . 0.4 OUTLIER -69.65 -34.19 73.65 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.532 HG21 ' HA3' ' B' ' 27' ' ' GLY . 6.7 mm -75.25 -48.18 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.518 ' O ' ' HA ' ' A' ' 27' ' ' LYS . 26.9 t -54.29 -43.08 70.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.595 ' CG ' ' CB ' ' A' ' 162' ' ' GLN . 74.8 t80 -77.78 -0.94 29.0 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.743 -1.223 . . . . 10.0 109.442 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.47 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 22.2 m -112.09 -49.1 2.99 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.411 ' CG2' ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.85 -84.66 0.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.011 -1.681 . . . . 10.0 114.032 -176.611 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.535 ' HB3' HG11 ' A' ' 33' ' ' VAL . 2.8 m-20 -67.32 -33.49 75.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 10.0 112.033 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.522 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER 59.96 -144.71 0.52 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.048 -1.061 . . . . 10.0 110.082 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.533 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 2.4 t80 -142.54 57.25 6.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.058 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.533 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 51.3 Cg_endo -82.8 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.767 1.404 . . . . 10.0 110.306 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 44.05 3.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.14 -0.975 . . . . 10.0 110.435 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.461 ' HG3' HG11 ' A' ' 33' ' ' VAL . 7.0 pt-20 -155.63 142.44 18.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 10.0 109.214 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -86.08 104.32 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.49 -0.757 . . . . 10.0 110.735 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.614 ' O ' ' CG2' ' A' ' 33' ' ' VAL . 0.2 OUTLIER -129.03 68.58 80.05 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-O 122.42 1.105 . . . . 10.0 108.194 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' B' ' 25' ' ' VAL . 50.5 Cg_endo -76.44 162.93 32.87 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.13 1.887 . . . . 10.0 112.145 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.614 HG22 ' CZ3' ' B' ' 36' ' ' TRP . 3.7 t -57.01 160.48 3.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.288 -0.882 . . . . 10.0 110.29 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 t -148.45 -114.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.836 -1.165 . . . . 10.0 110.554 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.619 ' CD2' ' HG3' ' A' ' 62' ' ' GLU . 4.4 t80 -102.26 105.87 16.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.831 -1.168 . . . . 10.0 111.928 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.504 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -128.0 93.08 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.311 -0.868 . . . . 10.0 109.433 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.626 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 36.0 t-20 -91.27 98.75 11.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.405 -1.318 . . . . 10.0 110.399 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.504 ' CB ' HD13 ' A' ' 55' ' ' LEU . 16.5 t80 -107.36 126.92 53.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.469 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -153.88 112.88 3.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.807 -1.183 . . . . 10.0 110.454 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.478 ' O ' ' HB2' ' A' ' 53' ' ' LEU . 22.2 t -131.12 172.39 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.779 -0.768 . . . . 10.0 109.724 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.402 HG22 ' N ' ' A' ' 44' ' ' VAL . 63.8 m -135.66 148.97 49.15 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.31 -0.956 . . . . 10.0 110.388 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.582 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 1.1 t -118.88 174.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.536 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 3.8 mtt -149.96 120.67 7.54 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.546 -0.862 . . . . 10.0 109.956 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.582 ' CD1' ' CG1' ' A' ' 44' ' ' VAL . 1.4 mp -134.64 126.75 48.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.305 -0.998 . . . . 10.0 108.305 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 48.08 31.09 8.0 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.271 -1.532 . . . . 10.0 109.271 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.19 31.52 31.18 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.099 -1.236 . . . . 10.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.489 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -119.68 115.77 33.54 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.846 -1.384 . . . . 10.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -76.91 141.54 21.44 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.859 1.452 . . . . 10.0 111.193 -179.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.567 ' CE1' HD21 ' A' ' 177' ' ' LEU . 0.5 OUTLIER -103.45 112.56 25.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 10.0 110.305 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.585 ' OG1' ' N ' ' A' ' 4' ' ' ILE . 27.5 p -78.05 100.28 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 10.0 110.186 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.478 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 22.3 mt -117.58 140.32 49.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.666 -1.271 . . . . 10.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.54 130.23 2.28 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.219 -1.552 . . . . 10.0 109.219 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.527 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 0.0 OUTLIER -137.99 132.29 32.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 10.0 108.863 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.504 ' HA ' ' O ' ' A' ' 38' ' ' ASP . 50.8 p90 -157.26 148.98 22.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 10.0 112.4 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.552 ' O ' ' O ' ' A' ' 58' ' ' THR . 23.7 m-20 -124.05 -169.37 1.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.835 -0.54 . . . . 10.0 110.455 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.555 ' O ' ' O ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -45.85 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.25 1.024 . . . . 10.0 112.532 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.545 ' HB1' ' CB ' ' A' ' 65' ' ' ASP . . . -157.24 42.17 0.33 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.723 -1.236 . . . . 10.0 109.851 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -47.63 -27.45 4.48 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.422 -2.271 . . . . 10.0 107.422 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.588 ' CG ' ' HA3' ' B' ' 21' ' ' GLY . 2.4 tp60 -73.34 -55.85 5.85 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.855 -0.791 . . . . 10.0 109.259 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.619 ' HG3' ' CD2' ' A' ' 37' ' ' PHE . 5.3 mm-40 -59.88 -40.71 89.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.086 -1.046 . . . . 10.0 110.131 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 7.5 t70 75.61 38.85 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.008 0.908 . . . . 10.0 108.588 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -151.96 5.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.943 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.545 ' CB ' ' HB1' ' A' ' 59' ' ' ALA . 19.1 t70 -115.17 25.56 10.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.692 -1.255 . . . . 10.0 111.131 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.471 ' O ' ' CD1' ' A' ' 70' ' ' LEU . 60.3 mtm180 -83.94 -25.44 30.11 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.096 -1.002 . . . . 10.0 109.364 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.528 ' O ' HD21 ' A' ' 70' ' ' LEU . 20.8 mt -111.41 10.34 21.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.558 -0.714 . . . . 10.0 110.35 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.552 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -102.17 -41.91 0.21 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 114.038 1.125 . . . . 10.0 114.038 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.552 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 41.4 Cg_endo -69.4 -42.71 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.842 0.917 . . . . 10.0 111.727 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.618 ' CD2' ' N ' ' A' ' 70' ' ' LEU . 0.0 OUTLIER -48.85 -19.84 0.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.21 -0.931 . . . . 10.0 109.695 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.568 ' N ' HD22 ' A' ' 70' ' ' LEU . 14.2 m -126.83 51.33 1.87 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.538 -0.726 . . . . 10.0 110.059 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -109.68 75.66 0.83 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.215 -0.928 . . . . 10.0 111.987 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.453 ' HD3' ' O ' ' A' ' 71' ' ' SER . 52.2 Cg_endo -77.31 -0.88 11.04 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.957 1.503 . . . . 10.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -81.56 49.69 1.36 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.954 -1.091 . . . . 10.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.578 ' O ' ' CZ ' ' A' ' 78' ' ' PHE . 82.3 m -142.0 84.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.443 -0.785 . . . . 10.0 110.296 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 76' ' ' ASP . 5.2 m-20 -55.09 -22.63 17.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 10.0 109.979 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.551 ' CG1' HD11 ' A' ' 4' ' ' ILE . 2.5 m -118.65 116.75 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.578 ' CZ ' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -107.03 144.47 33.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 10.0 110.137 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.478 ' CD1' ' CG1' ' A' ' 168' ' ' VAL . 1.9 mm? -103.46 97.81 7.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.994 . . . . 10.0 108.866 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.524 HG22 ' CZ ' ' A' ' 82' ' ' PHE . 4.7 p -98.78 130.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.581 -0.699 . . . . 10.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.499 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 28.2 p -133.61 115.09 14.25 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.126 -0.984 . . . . 10.0 110.731 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.524 ' CZ ' HG22 ' A' ' 80' ' ' VAL . 94.6 m-85 -97.21 157.77 15.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.584 -0.697 . . . . 10.0 110.967 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' THR . 57.1 m -85.13 157.06 20.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.427 -0.796 . . . . 10.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 30.4 m -60.71 -10.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.403 -0.81 . . . . 10.0 110.769 -179.704 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.474 HG11 ' CE ' ' A' ' 133' ' ' LYS . 8.6 m -134.54 -53.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 10.0 110.116 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.573 ' CB ' ' CD ' ' A' ' 87' ' ' PRO . 0.1 OUTLIER 44.9 -172.82 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.029 -1.044 . . . . 10.0 111.987 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 53.7 Cg_endo -82.6 41.17 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.194 1.628 . . . . 10.0 111.468 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.471 ' OG ' ' HA ' ' A' ' 133' ' ' LYS . 3.5 m 39.78 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 10.0 110.795 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.538 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 3.4 t -175.63 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.839 -1.163 . . . . 10.0 111.649 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.657 ' CE1' ' CE ' ' A' ' 94' ' ' LYS . 27.2 t80 -90.66 -23.94 20.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.794 -1.191 . . . . 10.0 109.466 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -22.75 28.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.179 -0.951 . . . . 10.0 108.855 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.538 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -83.37 -13.98 53.78 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.258 -0.977 . . . . 10.0 110.151 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.549 HG21 ' HD3' ' A' ' 94' ' ' LYS . 1.6 m -87.72 -16.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 118.162 -1.415 . . . . 10.0 109.28 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.657 ' CE ' ' CE1' ' A' ' 90' ' ' PHE . 0.7 OUTLIER -81.66 -41.54 21.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 10.0 109.271 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.5 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -76.85 -4.62 44.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.993 -0.683 . . . . 10.0 109.172 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.492 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -111.72 -47.51 3.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.05 -1.031 . . . . 10.0 111.688 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 8.0 m0 -77.24 -49.09 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 10.0 112.318 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.544 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 4.6 t -65.67 -46.59 67.46 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.687 -1.258 . . . . 10.0 112.814 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.544 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 39.1 Cg_endo -69.09 -12.79 35.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 N-CA-C 109.338 -1.062 . . . . 10.0 109.338 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.53 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.9 mt-10 -89.36 -58.95 2.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 10.0 109.569 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.53 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER 161.18 80.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 10.0 108.798 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.566 ' CG2' ' HB ' ' A' ' 108' ' ' THR . 2.5 m -48.1 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 10.0 109.744 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.489 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 46.0 t-80 -105.38 -22.45 13.03 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.524 ' NE2' ' SG ' ' A' ' 105' ' ' CYS . 5.5 p80 178.31 -33.49 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.524 ' SG ' ' NE2' ' A' ' 104' ' ' HIS . 4.8 p -144.66 160.04 48.9 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.443 ' HB3' HG13 ' A' ' 98' ' ' VAL . 43.8 Cg_endo -72.4 84.56 1.16 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.645 1.339 . . . . 10.0 109.743 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.429 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 176.02 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.405 -0.809 . . . . 10.0 111.363 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.575 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 99.8 m -51.66 150.98 6.35 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 10.0 110.31 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.575 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 37.6 Cg_endo -63.59 110.21 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.865 1.455 . . . . 10.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.13 100.24 8.94 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.27 0.557 . . . . 10.0 109.631 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.487 ' CD1' HG12 ' A' ' 152' ' ' VAL . 1.6 mm? -78.37 97.92 5.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.508 ' C ' ' CG2' ' A' ' 113' ' ' VAL . 64.5 mt -78.23 154.48 31.0 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.793 -0.567 . . . . 10.0 109.836 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.508 ' CG2' ' C ' ' A' ' 112' ' ' LEU . 6.3 t -156.53 175.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.96 -1.087 . . . . 10.0 111.31 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.452 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -124.3 96.79 0.53 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 116' ' ' GLN . 1.3 m -95.16 170.97 9.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -1.086 . . . . 10.0 110.947 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.535 ' N ' ' CG2' ' A' ' 115' ' ' THR . 36.6 tp60 57.94 38.12 26.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.48 -0.762 . . . . 10.0 110.831 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.752 ' C ' ' CD1' ' A' ' 117' ' ' ILE . 0.1 OUTLIER -95.35 -36.67 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 178.239 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.7 p-10 -52.13 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.554 1.169 . . . . 10.0 110.352 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.752 ' N ' ' O ' ' A' ' 117' ' ' ILE . 13.0 tp 159.25 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.187 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.525 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -45.72 -42.48 11.84 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 178.711 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' ARG . 3.8 m-20 -45.94 -25.73 0.59 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.433 -0.907 . . . . 10.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.472 ' HB3' ' CD1' ' A' ' 119' ' ' LEU . 62.7 t0 -94.84 123.17 58.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.668 -0.645 . . . . 10.0 110.759 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.42 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.9 Cg_endo -80.76 24.73 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.607 1.538 . . . . 10.0 110.536 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 73.1 m -96.52 -50.46 4.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 10.0 110.366 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.443 ' HB ' HD22 ' A' ' 119' ' ' LEU . 1.6 t -72.8 -33.58 66.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.906 -2.257 . . . . 10.0 104.906 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.466 ' N ' HD11 ' A' ' 126' ' ' ILE 0.301 0.9 OUTLIER -49.43 -30.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.267 -1.382 . . . . 10.0 107.267 176.573 . . . . . . . . 4 4 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -51.65 -43.88 62.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.594 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -75.09 -32.25 61.4 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.538 -0.726 . . . . 10.0 110.054 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.491 ' O ' ' HB3' ' A' ' 133' ' ' LYS . 4.3 mt -77.11 -36.95 55.15 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.272 -0.893 . . . . 10.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.25 -49.42 53.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 10.0 110.267 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -26.51 4.97 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.212 -0.93 . . . . 10.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.79 7.69 9.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.378 -0.929 . . . . 10.0 111.56 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.93 82.69 2.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.802 -1.186 . . . . 10.0 109.838 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.49 -17.95 61.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.847 -1.158 . . . . 10.0 109.424 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 113.44 4.41 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.503 ' HB3' ' HE3' ' A' ' 133' ' ' LYS . 40.5 Cg_endo -68.89 157.12 63.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.907 1.477 . . . . 10.0 110.529 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.495 HG21 HD11 ' A' ' 137' ' ' ILE . 0.4 OUTLIER -103.27 132.03 50.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.358 -0.839 . . . . 10.0 109.738 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.514 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.9 p -122.89 167.72 13.8 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.299 -0.876 . . . . 10.0 110.046 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.514 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -66.79 -24.82 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 10.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.43 -35.46 77.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 10.0 109.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.6 m -84.81 -31.28 23.95 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.255 0.55 . . . . 10.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.44 -34.14 65.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 10.0 111.53 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -56.16 -43.5 78.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.927 -1.108 . . . . 10.0 109.369 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.473 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -63.9 -41.02 97.8 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.495 -0.882 . . . . 10.0 108.681 179.338 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.632 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 3.1 tt -59.87 -50.72 72.68 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.56 -0.712 . . . . 10.0 109.34 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.533 ' CA ' ' HB1' ' A' ' 151' ' ' ALA . . . -57.43 -41.38 80.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.156 -0.965 . . . . 10.0 108.632 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -79.49 -0.15 32.01 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.531 -0.731 . . . . 10.0 109.388 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 15.8 t0 -86.51 -10.53 53.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.582 -0.699 . . . . 10.0 110.476 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.587 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.28 32.11 0.47 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 10.0 111.673 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.486 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.3 mttt 62.24 41.2 10.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 10.0 111.649 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.533 ' HB1' ' CA ' ' A' ' 146' ' ' ALA . . . -80.31 -163.38 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.739 -0.601 . . . . 10.0 109.538 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.548 ' CG2' ' CB ' ' A' ' 175' ' ' ALA . 40.3 t -98.04 -79.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.991 . . . . 10.0 109.969 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.438 ' N ' HG11 ' A' ' 152' ' ' VAL . 6.3 tptp -172.57 165.22 5.57 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.759 -0.776 . . . . 10.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.565 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 40.5 p90 -96.33 124.44 40.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.777 . . . . 10.0 109.751 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.516 HG22 ' HA ' ' A' ' 168' ' ' VAL . 0.2 OUTLIER -111.86 -169.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.174 -0.954 . . . . 10.0 110.237 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . 0.413 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 31.4 mt-10 -130.15 135.18 47.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.147 -0.971 . . . . 10.0 109.789 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.478 ' SG ' HD23 ' A' ' 165' ' ' LEU . 6.5 t -150.9 124.76 9.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.962 -1.086 . . . . 10.0 111.205 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.561 ' O ' ' HA ' ' A' ' 162' ' ' GLN . 30.0 m -128.39 154.61 45.82 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 177.697 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.536 ' CB ' HD22 ' A' ' 19' ' ' LEU . . . -99.65 -45.85 5.63 Favored 'General case' 0 C--N 1.283 -2.301 0 O-C-N 120.469 -1.395 . . . . 10.0 108.305 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.549 ' C ' ' CD1' ' A' ' 160' ' ' LEU 0.294 2.7 tm? -61.58 -51.29 69.16 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.751 0.786 . . . . 10.0 109.215 177.799 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 28.6 m -102.94 -18.79 14.87 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 113.204 0.816 . . . . 10.0 113.204 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.595 ' CB ' ' CG ' ' A' ' 23' ' ' TYR . 1.7 tt0 61.01 75.31 0.42 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.367 -1.458 . . . . 10.0 109.203 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.413 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 4.6 tptt -95.08 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.921 -0.711 . . . . 10.0 111.767 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 119.58 31.56 1.34 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.4 -1.381 . . . . 10.0 110.796 178.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.588 HD11 ' CB ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -54.99 -43.2 73.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.965 -1.314 . . . . 10.0 110.512 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.22 -35.78 58.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 10.0 110.825 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.2 m120 -60.83 -32.54 71.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.267 -0.896 . . . . 10.0 111.585 -178.938 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.516 ' HA ' HG22 ' A' ' 155' ' ' VAL . 34.6 t -64.41 -46.75 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.83 -1.169 . . . . 10.0 110.492 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 12.8 t80 -70.35 -28.03 64.81 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.493 -0.754 . . . . 10.0 111.753 -179.327 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.47 ' O ' HD23 ' A' ' 174' ' ' LEU . 19.3 t70 -57.51 -50.02 74.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.771 -1.206 . . . . 10.0 111.992 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.471 ' OE2' HD11 ' A' ' 111' ' ' LEU . 12.7 pt-20 -68.58 -23.9 64.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.903 -1.123 . . . . 10.0 110.814 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.508 ' O ' ' CB ' ' A' ' 176' ' ' ALA . . . -70.77 -21.16 62.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.016 -1.052 . . . . 10.0 109.05 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.577 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 9.8 mm -67.32 -43.34 88.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 10.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.544 HD12 ' N ' ' A' ' 174' ' ' LEU . 0.3 OUTLIER -73.13 -42.35 62.97 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.029 -1.044 . . . . 10.0 111.645 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.548 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -82.56 -2.58 54.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.323 -0.861 . . . . 10.0 109.944 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.555 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -78.47 -43.13 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.302 -0.874 . . . . 10.0 109.704 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.577 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -107.05 -23.34 12.35 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.746 0.784 . . . . 10.0 110.307 -178.598 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.988 -1.006 . . . . 10.0 110.354 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.396 -1.481 . . . . 10.0 109.396 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 1.0 OUTLIER 73.23 137.54 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -1.007 . . . . 10.0 111.173 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -98.33 87.1 3.79 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.174 -0.954 . . . . 10.0 109.374 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.46 ' OE2' ' HB3' ' A' ' 49' ' ' GLU . 41.3 mt-10 -119.38 171.3 8.42 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.747 0.784 . . . . 10.0 110.569 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.614 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.57 -161.55 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 178.38 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.614 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 40.5 Cg_endo -66.89 80.57 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.305 -1.075 . . . . 10.0 109.305 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.494 ' CB ' ' CG2' ' A' ' 46' ' ' ILE . 10.9 pm0 -45.98 175.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.447 0.641 . . . . 10.0 110.666 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.604 ' N ' ' CD1' ' B' ' 8' ' ' ILE . 0.2 OUTLIER -135.19 -39.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 10.0 110.621 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.1 t -123.0 151.41 41.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 10.0 110.985 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.66 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -167.44 97.83 0.63 Allowed Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 120.716 -1.24 . . . . 10.0 112.801 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.516 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 45.2 Cg_endo -73.91 145.51 36.1 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.668 1.351 . . . . 10.0 109.085 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -97.16 154.91 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.936 -1.103 . . . . 10.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -151.91 136.56 17.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 10.0 109.623 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.405 ' HA ' HG13 ' A' ' 42' ' ' VAL . 43.0 m-85 -123.56 143.22 50.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 10.0 110.515 -179.761 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.469 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 42.9 tp10 -146.7 147.21 30.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 10.0 109.896 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 19' ' ' HIS . 2.3 t60 -143.17 129.17 19.59 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 10.0 109.93 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.626 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -96.06 -167.94 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 10.0 110.468 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.599 HG13 ' CE2' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -55.59 179.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 10.0 111.736 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 16' ' ' HIS . 13.2 m80 -122.62 162.65 21.48 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.622 0.725 . . . . 10.0 111.528 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.527 HG11 ' O ' ' A' ' 37' ' ' PHE . 6.4 m -64.49 152.64 8.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.588 ' HA3' ' CG ' ' A' ' 61' ' ' GLN . . . -73.96 151.7 44.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.689 -1.364 . . . . 10.0 109.689 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.585 ' CG ' HG22 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 67.61 97.86 0.06 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.415 -1.05 . . . . 10.0 109.326 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -53.76 143.23 21.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 10.0 110.658 -179.378 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.541 ' O ' HG22 ' A' ' 33' ' ' VAL . . . 59.32 31.03 20.84 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.433 -0.792 . . . . 10.0 111.954 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.585 HG22 ' CG ' ' B' ' 22' ' ' PHE . 21.4 t -113.7 -17.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.917 -1.114 . . . . 10.0 109.997 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.528 ' O ' ' CB ' ' A' ' 18' ' ' CYS . 10.3 t -83.48 31.73 0.46 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.674 -0.641 . . . . 10.0 110.958 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.532 ' HA3' HG21 ' A' ' 21' ' ' ILE . . . -113.07 -91.64 1.95 Allowed Glycine 0 N--CA 1.488 2.111 0 O-C-N 120.85 -1.156 . . . . 10.0 110.225 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.527 ' HB2' HG12 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -1.14 124.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.859 1.314 . . . . 10.0 113.986 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.613 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -120.79 142.79 49.25 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.484 -1.235 . . . . 10.0 109.239 178.383 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.476 ' OG1' HG12 ' B' ' 32' ' ' ILE . 68.7 p -152.33 -137.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 10.0 110.314 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.92 45.77 1.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.494 ' CG2' ' HD2' ' B' ' 33' ' ' PRO . 50.4 mm -68.29 144.21 96.44 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.256 -1.144 . . . . 10.0 109.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.494 ' HD2' ' CG2' ' B' ' 32' ' ' ILE . 41.0 Cg_endo -70.79 141.51 41.21 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.954 1.502 . . . . 10.0 111.699 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.531 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 9.6 tp10 53.58 163.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.012 0.911 . . . . 10.0 112.058 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 4.5 mm100 -89.91 19.4 4.86 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.58 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.623 ' HB2' ' O ' ' B' ' 35' ' ' GLN . 3.8 m-90 87.33 26.86 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-O 122.549 1.166 . . . . 10.0 108.071 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.578 ' CA ' ' HA ' ' A' ' 70' ' ' LEU . . . -160.99 85.87 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.138 -1.431 . . . . 10.0 107.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.473 ' HG2' ' CB ' ' B' ' 41' ' ' GLN . 3.2 ttm180 -82.91 53.25 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.721 1.248 . . . . 10.0 108.537 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.528 ' CG ' ' O ' ' A' ' 70' ' ' LEU . 1.1 mp -44.16 -50.09 8.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.483 -1.235 . . . . 10.0 111.369 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.432 HD21 ' HB2' ' B' ' 39' ' ' LEU . 0.5 OUTLIER -122.97 14.99 9.95 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.449 -0.901 . . . . 10.0 111.78 -178.319 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.473 ' CB ' ' HG2' ' B' ' 38' ' ' ARG . 9.3 mt-30 -115.21 34.51 4.83 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.566 -0.709 . . . . 10.0 110.257 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 33.0 p -77.09 -178.05 4.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.163 -0.961 . . . . 10.0 109.885 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -83.53 26.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 10.0 110.478 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -85.31 115.92 23.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.041 . . . . 10.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -179.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 10.0 111.875 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.149 179.295 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.572 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 15.2 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.306 0.574 . . . . 10.0 110.6 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -144.23 -86.11 0.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.202 -0.936 . . . . 10.0 109.275 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 3' ' ' THR . 3.5 m -41.26 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.943 -0.473 . . . . 10.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.71 ' N ' ' O ' ' A' ' 2' ' ' GLN . 1.9 tt -136.01 154.02 33.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 118.231 -1.388 . . . . 10.0 113.321 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.69 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -135.23 109.66 8.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.816 0.817 . . . . 10.0 110.716 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.502 ' HA ' ' HB3' ' A' ' 76' ' ' ASP . 30.1 m -67.98 142.64 55.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.931 -1.106 . . . . 10.0 109.882 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.488 ' CG2' ' C ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -167.49 -169.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.846 -1.159 . . . . 10.0 111.004 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.0 t -105.47 164.49 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.548 -0.72 . . . . 10.0 110.279 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.651 HG13 ' N ' ' A' ' 80' ' ' VAL . 27.7 m -79.99 -168.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.913 -1.117 . . . . 10.0 111.718 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.544 ' HA3' ' CD2' ' B' ' 39' ' ' LEU . . . -148.27 17.17 1.33 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.54 -34.92 78.07 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.073 -1.251 . . . . 10.0 108.995 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.472 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 141.25 -151.73 22.79 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.985 -1.246 . . . . 10.0 109.985 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . 57.73 160.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -1.094 . . . . 10.0 111.4 179.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.474 ' O ' ' NE2' ' B' ' 35' ' ' GLN . 12.4 p -52.57 152.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.445 -0.784 . . . . 10.0 109.981 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.471 ' N ' HG21 ' A' ' 14' ' ' VAL . . . -65.24 161.32 41.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.48 ' HE2' ' O ' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -88.68 -32.34 18.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 10.0 109.316 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.5 p -67.66 -26.15 66.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.506 -0.746 . . . . 10.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.55 ' HA ' ' O ' ' B' ' 26' ' ' THR . 24.8 p -75.12 -0.1 18.02 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.821 -1.175 . . . . 10.0 110.073 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.647 HD22 ' HB2' ' B' ' 29' ' ' PHE . 6.3 mt -104.19 -21.46 13.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 10.0 109.866 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.51 -35.81 81.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.745 0.784 . . . . 10.0 110.136 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.563 HG21 ' HB2' ' A' ' 26' ' ' ASN . 1.6 mm -97.87 -45.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.858 0.837 . . . . 10.0 109.404 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.574 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 15.9 t -49.33 -46.92 47.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.386 -0.926 . . . . 10.0 109.757 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.602 ' CZ ' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -67.68 -45.68 74.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.354 -1.466 . . . . 10.0 110.628 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.465 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 5.5 p -58.73 -51.19 71.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.647 -1.283 . . . . 10.0 110.442 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -153.65 -59.93 0.13 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 118.001 -1.48 . . . . 10.0 114.218 -179.636 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.563 ' HB2' HG21 ' A' ' 21' ' ' ILE . 20.3 m-20 -49.45 -26.07 3.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.846 -1.159 . . . . 10.0 111.562 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.574 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.4 OUTLIER 29.54 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 112.753 0.649 . . . . 10.0 112.753 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -126.19 65.36 56.96 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.164 . . . . 10.0 111.216 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.55 ' HD3' ' HG3' ' A' ' 27' ' ' LYS . 58.3 Cg_endo -95.39 -93.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.212 1.275 . . . . 10.0 109.691 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.481 ' OG ' ' O ' ' A' ' 29' ' ' PRO . 4.4 m -167.49 59.29 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.346 -0.846 . . . . 10.0 110.488 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -149.02 178.75 8.42 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.858 -1.152 . . . . 10.0 108.936 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.473 ' HA ' ' CB ' ' B' ' 24' ' ' ALA . 16.9 m-85 -121.99 131.94 54.27 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.511 -0.743 . . . . 10.0 110.979 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.559 HG21 ' ND2' ' A' ' 26' ' ' ASN . 4.1 m -132.59 168.89 15.61 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.498 -0.751 . . . . 10.0 109.537 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.468 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 46.7 Cg_endo -71.92 95.78 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.826 1.435 . . . . 10.0 109.106 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.63 ' O ' ' HB ' ' A' ' 36' ' ' VAL . 32.7 p -131.99 163.83 27.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 10.0 111.482 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.63 ' HB ' ' O ' ' A' ' 35' ' ' THR . 27.8 t 80.01 3.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.356 0.598 . . . . 10.0 109.572 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.618 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 45.4 t80 -41.27 124.6 2.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.776 ' CB ' ' HB ' ' B' ' 18' ' ' ILE . 5.5 m-20 -64.46 -153.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.769 -1.172 . . . . 10.0 111.504 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.567 ' CB ' ' CD1' ' A' ' 55' ' ' LEU . 2.5 t-20 -154.09 -163.11 1.55 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.137 -0.977 . . . . 10.0 111.79 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.527 ' CB ' ' HB2' ' B' ' 16' ' ' HIS . 41.3 p90 -131.97 -174.49 3.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.775 0.798 . . . . 10.0 110.974 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.556 ' CB ' ' CA ' ' A' ' 54' ' ' GLY . . . -156.67 139.02 14.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.466 ' CG1' ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -164.75 -176.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.145 . . . . 10.0 110.701 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.472 HG23 ' N ' ' A' ' 44' ' ' VAL . 58.6 m -121.5 144.34 48.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.981 -0.688 . . . . 10.0 109.983 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.525 HG12 ' N ' ' A' ' 45' ' ' MET . 0.9 OUTLIER -111.37 164.32 7.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.314 -0.866 . . . . 10.0 108.844 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.525 ' N ' HG12 ' A' ' 44' ' ' VAL . 0.4 OUTLIER -150.55 103.91 3.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.364 -0.976 . . . . 10.0 108.364 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.498 HG22 ' HB2' ' B' ' 7' ' ' GLU . 4.2 mt -125.02 130.1 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.062 -1.024 . . . . 10.0 110.904 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.513 ' HA2' HG21 ' B' ' 8' ' ' ILE . . . 40.24 27.17 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 95.85 30.4 7.99 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.701 -1.238 . . . . 10.0 110.097 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.492 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -120.98 94.97 49.04 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 120.898 -1.354 . . . . 10.0 110.447 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -75.57 144.52 28.54 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.094 1.576 . . . . 10.0 111.134 179.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.492 ' CE1' ' OE1' ' A' ' 49' ' ' GLU . 1.7 m-85 -126.66 122.62 35.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.466 -0.771 . . . . 10.0 109.092 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.584 ' HB ' ' C ' ' A' ' 2' ' ' GLN 0.265 93.5 m -108.43 97.41 7.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 10.0 109.836 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.563 ' CD2' ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -153.37 174.93 13.7 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.634 -1.626 . . . . 10.0 111.895 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.556 ' CA ' ' CB ' ' A' ' 41' ' ' ALA . . . -172.55 136.54 3.81 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 108.589 -1.804 . . . . 10.0 108.589 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.567 ' CD1' ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -131.71 135.27 46.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.895 -1.356 . . . . 10.0 109.659 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . . . . . . . . . 62.3 m-85 -133.76 158.95 42.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 179.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' THR . 28.7 t0 -124.17 171.17 10.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.887 -1.133 . . . . 10.0 109.787 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.575 ' O ' ' O ' ' A' ' 57' ' ' ASP . 0.0 OUTLIER -45.87 -176.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.122 -1.031 . . . . 10.0 110.647 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.483 ' HB1' ' HB3' ' A' ' 62' ' ' GLU . . . -144.56 75.12 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.864 -1.147 . . . . 10.0 110.517 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -15.41 59.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.305 -1.518 . . . . 10.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.461 ' HB2' ' CA ' ' B' ' 21' ' ' GLY . 26.1 mt-30 -144.53 -16.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.119 -1.224 . . . . 10.0 111.643 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.498 ' HG3' ' HA ' ' B' ' 18' ' ' ILE . 1.8 tt0 -62.52 -48.71 78.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.479 -1.388 . . . . 10.0 109.285 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.5 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 4.3 t0 -134.21 1.28 3.2 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.706 -0.621 . . . . 10.0 109.559 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.5 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 17.4 m-85 66.64 37.65 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.552 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 t0 -137.43 72.83 1.42 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.026 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.478 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 9.6 ptt180 -85.03 -30.61 24.0 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.623 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.478 ' N ' ' HG3' ' A' ' 66' ' ' ARG . 20.6 mt -86.86 -25.58 24.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 10.0 111.29 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.696 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 mtm-85 -109.85 12.68 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.729 -1.232 . . . . 10.0 114.242 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.3 Cg_endo -73.59 0.96 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 110.189 -0.735 . . . . 10.0 110.189 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.592 ' CD2' ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -102.46 -113.94 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.426 -0.796 . . . . 10.0 110.819 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.592 ' N ' ' CD2' ' A' ' 70' ' ' LEU . 0.4 OUTLIER 42.43 44.11 3.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 10.0 110.662 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.699 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -160.16 174.37 4.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 10.0 110.753 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.699 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 36.6 Cg_endo -62.11 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.112 1.059 . . . . 10.0 110.862 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.595 ' HG2' ' CZ ' ' A' ' 72' ' ' TYR . 1.3 mp0 54.21 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.35 -1.469 . . . . 10.0 108.311 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.645 ' HA ' ' CZ ' ' A' ' 78' ' ' PHE . 1.3 m -139.58 86.63 2.12 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.358 -0.839 . . . . 10.0 112.404 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.69 ' HB3' ' O ' ' A' ' 5' ' ' LYS . 1.6 t70 -110.48 -72.72 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.562 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 24.8 m -141.92 112.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.792 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.645 ' CZ ' ' HA ' ' A' ' 75' ' ' THR . 84.0 m-85 -88.65 127.3 35.57 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.711 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.501 ' O ' HG22 ' A' ' 9' ' ' VAL . 4.0 mm? -100.76 97.93 8.51 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.215 -0.928 . . . . 10.0 109.662 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.651 ' N ' HG13 ' A' ' 9' ' ' VAL . 7.5 p -106.65 150.55 9.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.961 -0.695 . . . . 10.0 109.947 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.492 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.6 m -133.13 118.86 19.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.924 -1.11 . . . . 10.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.526 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 31.4 p90 -127.03 166.66 17.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.457 -0.777 . . . . 10.0 110.431 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -78.93 158.51 28.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.63 -1.293 . . . . 10.0 111.852 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.504 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 28.4 m -114.39 2.9 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.607 -0.683 . . . . 10.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.539 ' CA ' HD12 ' A' ' 129' ' ' LEU . 19.2 m -105.58 39.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 10.0 109.761 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.558 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 73.0 m -114.94 172.13 3.88 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.558 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 40.2 Cg_endo -68.71 81.1 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.048 1.026 . . . . 10.0 110.771 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 37.76 39.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.206 0.527 . . . . 10.0 110.844 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.8 m -62.0 -38.26 87.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.047 -1.033 . . . . 10.0 110.81 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.572 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 16.3 p90 -48.46 -38.15 19.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 10.0 111.071 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 9.6 tt0 -59.22 -37.93 78.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.345 -0.847 . . . . 10.0 110.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.525 ' ND2' HG22 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -68.62 -18.32 64.28 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.223 -0.923 . . . . 10.0 109.771 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.525 HG22 ' ND2' ' A' ' 92' ' ' ASN . 64.6 t -89.62 -7.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 10.0 109.449 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.572 ' HG2' ' O ' ' A' ' 90' ' ' PHE . 0.5 OUTLIER -93.29 -25.58 17.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 8.3 pt-20 -94.78 2.67 55.52 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.403 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.527 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -110.08 -49.03 3.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.989 -1.069 . . . . 10.0 111.79 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.57 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 24.5 m95 -89.9 -33.21 16.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.751 -1.218 . . . . 10.0 111.643 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.558 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 96.3 t -71.7 -49.96 10.52 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.658 -1.276 . . . . 10.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -70.57 -10.49 28.02 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.178 1.094 . . . . 10.0 109.764 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.457 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 22.4 tt0 -64.06 -48.58 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 10.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.485 ' O ' ' HD2' ' A' ' 106' ' ' PRO . 20.9 tt -176.43 -29.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.053 -1.029 . . . . 10.0 110.395 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.529 ' HA ' ' HG2' ' A' ' 106' ' ' PRO . 58.3 p -61.76 -11.95 14.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.272 -0.892 . . . . 10.0 109.977 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.429 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -55.62 -35.21 65.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.337 -0.852 . . . . 10.0 110.59 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -152.1 10.18 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.965 -1.094 . . . . 10.0 111.937 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . 0.67 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 1.7 m -113.12 -81.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.452 -1.405 . . . . 10.0 111.103 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.67 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 55.2 Cg_endo -74.84 -22.99 14.61 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 122.557 0.767 . . . . 10.0 112.029 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 106' ' ' PRO . 6.0 tttt 45.8 42.93 9.38 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.729 -1.232 . . . . 10.0 109.85 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.519 HG23 HG22 ' A' ' 75' ' ' THR . 18.5 m -67.1 139.37 95.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.433 -0.792 . . . . 10.0 110.573 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 48.8 Cg_endo -71.94 125.14 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.091 1.574 . . . . 10.0 110.067 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.492 ' N ' HG11 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -100.06 99.79 10.57 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.548 -0.72 . . . . 10.0 110.224 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.67 HD11 ' CG1' ' A' ' 152' ' ' VAL . 2.7 mm? -75.67 96.89 3.67 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.665 -1.235 . . . . 10.0 107.665 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.0 mt -80.02 113.44 18.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.643 -0.708 . . . . 10.0 110.114 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.502 HG23 ' O ' ' A' ' 80' ' ' VAL . 1.6 t -120.01 -175.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.087 -1.008 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.526 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -147.09 101.56 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.504 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 4.8 t -99.73 178.09 4.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.246 . . . . 10.0 110.955 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.504 ' HB2' ' O ' ' A' ' 115' ' ' THR . 31.2 mt-30 58.88 30.09 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 10.0 109.17 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.756 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.7 OUTLIER -80.17 -13.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.951 -0.7 . . . . 10.0 110.581 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.536 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 5.5 p-10 -51.59 58.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 122.493 1.139 . . . . 10.0 111.544 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER 165.72 -28.54 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.503 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -50.82 -29.54 11.97 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.729 -0.607 . . . . 10.0 109.367 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.28 -26.76 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 10.0 109.709 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . . . . . . . . . 22.2 m-20 -93.3 123.57 60.22 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.568 -0.708 . . . . 10.0 109.939 179.713 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.447 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.0 Cg_endo -78.15 24.35 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.89 1.468 . . . . 10.0 111.41 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.486 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 15.6 m -98.09 -50.55 4.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.967 -1.083 . . . . 10.0 110.39 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.435 ' CG2' HD12 ' A' ' 126' ' ' ILE . 14.3 t -72.22 -29.73 64.24 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 176.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.572 HD12 ' N ' ' A' ' 126' ' ' ILE 0.306 1.1 mp -51.82 -26.51 7.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.109 -1.405 . . . . 10.0 107.365 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.486 ' HB2' ' O ' ' A' ' 124' ' ' SER . 28.9 tt0 -50.6 -29.35 10.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.926 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -61.39 -29.08 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.709 . . . . 10.0 111.345 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.559 ' N ' HD11 ' A' ' 129' ' ' LEU . 9.2 mp -65.12 -42.92 93.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.804 -1.185 . . . . 10.0 109.835 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.66 -30.4 65.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.762 -0.586 . . . . 10.0 110.662 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.406 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 8.5 mmtp -64.85 -15.06 61.36 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.551 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -127.64 -41.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 10.0 110.739 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.466 ' HD2' ' HB2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -149.66 136.46 19.45 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.401 -0.812 . . . . 10.0 110.213 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.595 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -82.15 -10.11 59.29 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.362 0.601 . . . . 10.0 110.315 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -110.72 98.47 37.74 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 10.0 111.764 -179.352 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.521 ' HB3' HD23 ' A' ' 129' ' ' LEU . 45.1 Cg_endo -71.56 161.79 44.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.372 1.722 . . . . 10.0 109.904 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.504 ' CG2' ' HB ' ' A' ' 84' ' ' VAL . 1.5 tp -77.84 116.67 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.626 -1.296 . . . . 10.0 109.682 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.551 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 42.9 p -121.8 172.19 5.34 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.551 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -67.66 -16.56 46.87 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.25 1.132 . . . . 10.0 111.331 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.516 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -79.62 -24.78 41.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 10.0 109.263 178.897 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' THR . . . . . 0.45 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.3 m -97.21 -35.0 10.9 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.662 0.744 . . . . 10.0 109.341 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.491 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -72.3 -39.9 67.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.778 -0.576 . . . . 10.0 110.904 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.407 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 25.7 mt-10 -62.23 -50.22 72.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.569 -0.852 . . . . 10.0 109.597 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.451 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -61.24 -42.18 98.17 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.562 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 4.8 tt -58.8 -45.68 89.35 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.33 -0.856 . . . . 10.0 109.399 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.493 ' O ' ' HB1' ' A' ' 151' ' ' ALA . . . -60.33 -48.7 80.6 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.522 0.677 . . . . 10.0 109.629 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.407 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 10.3 mtm-85 -71.13 -14.36 62.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.231 -0.918 . . . . 10.0 109.314 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.451 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 9.4 t0 -69.3 -13.33 62.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 10.0 111.115 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.6 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.51 26.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.025 -1.047 . . . . 10.0 110.155 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.428 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER 64.45 36.27 8.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.684 0.754 . . . . 10.0 110.637 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 146' ' ' ALA . . . -69.4 -155.59 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.67 ' CG1' HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -118.77 -62.29 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.781 -1.199 . . . . 10.0 111.112 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.9 ttmt -171.99 154.73 3.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.521 -1.362 . . . . 10.0 112.041 179.287 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.537 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 54.3 t80 -106.8 101.4 10.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 10.0 108.981 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.536 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -107.42 -170.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.469 -0.769 . . . . 10.0 110.139 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -152.56 133.39 14.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.08 -1.013 . . . . 10.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.49 ' O ' ' HA ' ' A' ' 115' ' ' THR . 26.9 p -153.63 157.75 40.11 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.557 -0.905 . . . . 10.0 108.557 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.488 ' HB2' ' H ' ' A' ' 162' ' ' GLN . 54.0 m -138.68 164.32 29.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.185 -1.042 . . . . 10.0 108.185 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.612 ' CB ' ' CD2' ' B' ' 29' ' ' PHE . . . -62.06 -59.26 5.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.631 -1.293 . . . . 10.0 112.33 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.58 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 2.6 pp -121.16 4.7 10.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.454 -1.404 . . . . 10.0 112.898 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.493 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -104.07 -47.34 4.2 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.333 -1.479 . . . . 10.0 113.544 -178.021 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.567 ' O ' ' HB3' ' A' ' 163' ' ' LYS . 10.7 mm100 -91.51 -44.38 9.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.444 -1.41 . . . . 10.0 112.026 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.602 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 15.4 ttpt 63.95 28.73 14.5 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.205 1.002 . . . . 10.0 109.325 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -109.45 15.86 32.18 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.088 -1.605 . . . . 10.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.622 ' N ' HD23 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -69.51 -3.17 13.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.541 -0.976 . . . . 10.0 110.471 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -89.65 -25.32 21.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 10.0 109.946 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -34.92 23.39 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.092 -1.005 . . . . 10.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.536 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 16.2 t -59.62 -38.77 77.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 10.0 110.692 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.464 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 t80 -80.17 -44.05 20.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 10.0 111.796 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.543 ' O ' ' CD2' ' A' ' 174' ' ' LEU . 29.7 t70 -52.51 -44.08 65.47 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.528 -1.358 . . . . 10.0 110.688 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 14.5 mt-10 -60.62 -41.82 95.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.237 -0.914 . . . . 10.0 111.466 -179.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.581 ' HB3' HD21 ' A' ' 111' ' ' LEU . . . -56.14 -33.21 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 10.0 111.092 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.545 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 20.8 mm -61.01 -44.68 98.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 118.316 -1.354 . . . . 10.0 108.423 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.543 ' CD2' ' O ' ' A' ' 170' ' ' ASP . 0.2 OUTLIER -70.84 -21.04 62.48 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.375 -0.828 . . . . 10.0 109.839 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.548 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -95.95 -7.5 36.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.397 -0.814 . . . . 10.0 111.005 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.562 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -85.97 -33.65 21.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.017 . . . . 10.0 111.343 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.572 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.4 OUTLIER -100.31 -10.65 21.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.767 -1.208 . . . . 10.0 109.418 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.407 ' OE1' ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.191 . . . . 10.0 109.138 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 10.0 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 2' ' ' SER . . . . . 0.432 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 56.9 m -80.39 36.82 0.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.09 -1.241 . . . . 10.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.489 ' NZ ' ' HB3' ' A' ' 174' ' ' LEU . 9.4 mtpp -61.0 100.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 10.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.432 ' HG2' ' O ' ' B' ' 2' ' ' SER . 9.2 mm-40 -108.43 161.97 14.54 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.588 0.709 . . . . 10.0 111.262 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.681 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.48 -143.17 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.202 -1.036 . . . . 10.0 108.202 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.681 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 43.9 Cg_endo -74.27 7.31 2.62 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 CA-C-N 119.448 0.839 . . . . 10.0 110.626 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.525 ' OE1' ' CA ' ' B' ' 7' ' ' GLU . 0.0 OUTLIER 41.81 -149.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 10.0 110.517 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.523 ' N ' ' OE1' ' B' ' 7' ' ' GLU . 0.0 OUTLIER -100.48 -99.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.46 -0.775 . . . . 10.0 109.951 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.488 ' N ' HG12 ' B' ' 8' ' ' ILE . 31.1 m -78.12 151.96 33.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.592 -1.317 . . . . 10.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.522 ' HG ' ' O ' ' B' ' 10' ' ' LEU . 0.8 OUTLIER -164.89 98.81 0.84 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.459 -1.401 . . . . 10.0 112.348 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.492 ' HD2' ' O ' ' A' ' 45' ' ' MET . 45.0 Cg_endo -75.72 124.18 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.771 1.406 . . . . 10.0 108.893 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.8 m -93.14 166.37 12.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.44 174.99 10.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 47.1 p90 -149.23 150.04 31.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.724 -1.235 . . . . 10.0 111.62 -179.691 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -170.85 117.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.67 -0.644 . . . . 10.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . 0.527 ' HB2' ' CB ' ' A' ' 40' ' ' TYR . 2.3 p-80 -162.83 156.42 20.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.624 -1.297 . . . . 10.0 111.737 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.531 ' O ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -166.95 96.25 0.51 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.297 -0.877 . . . . 10.0 110.226 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.776 ' HB ' ' CB ' ' A' ' 38' ' ' ASP . 0.6 OUTLIER -172.9 167.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.605 . . . . 10.0 109.466 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.42 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 50.0 t60 -145.75 159.6 42.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.211 -1.556 . . . . 10.0 114.551 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.618 ' HB ' ' HA ' ' A' ' 37' ' ' PHE . 4.8 p -69.08 146.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.648 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.515 ' N ' HG23 ' B' ' 20' ' ' VAL . . . -146.48 155.84 26.71 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.364 -1.894 . . . . 10.0 108.364 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.598 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 8.1 m-30 58.81 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.213 -1.169 . . . . 10.0 110.359 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 72.1 m-20 -60.65 157.55 14.33 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.634 0.73 . . . . 10.0 111.764 -179.374 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.497 ' HA ' HG22 ' A' ' 33' ' ' VAL . . . 43.89 43.89 5.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.69 -0.631 . . . . 10.0 111.331 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.598 ' CG2' ' HB3' ' B' ' 22' ' ' PHE . 6.7 t -111.7 -35.1 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 119.356 -0.938 . . . . 10.0 108.663 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.568 ' HB ' ' N ' ' A' ' 36' ' ' VAL . 0.6 OUTLIER -101.93 7.44 41.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 177.584 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.56 ' CA ' HG21 ' A' ' 21' ' ' ILE . . . -125.14 24.87 5.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.881 -2.088 . . . . 10.0 107.881 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.517 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 11.3 tt0 -158.66 132.59 7.71 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.647 ' HB2' HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -110.04 118.92 37.69 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.238 1.018 . . . . 10.0 110.7 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.432 HG23 ' C ' ' B' ' 29' ' ' PHE . 71.7 p -143.07 162.31 35.87 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.575 -0.739 . . . . 10.0 109.664 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.467 ' O ' HG22 ' B' ' 32' ' ' ILE . . . 45.43 -165.9 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.205 -1.158 . . . . 10.0 110.205 179.26 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.467 HG22 ' O ' ' B' ' 31' ' ' GLY . 24.2 pt -143.01 52.87 2.35 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.372 -1.075 . . . . 10.0 110.458 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 55.5 Cg_endo -74.72 163.14 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.83 1.437 . . . . 10.0 111.05 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.499 ' OE1' HD22 ' B' ' 40' ' ' LEU . 3.6 tp10 -43.7 155.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.963 . . . . 10.0 109.97 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 14' ' ' VAL . 4.1 mm-40 -67.83 -66.76 0.52 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.238 -0.985 . . . . 10.0 111.141 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.625 ' O ' ' CD2' ' B' ' 36' ' ' TRP . 9.4 t90 -161.96 21.05 0.11 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 122.51 1.148 . . . . 10.0 108.114 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.547 ' HA ' ' CG ' ' A' ' 70' ' ' LEU . . . -155.95 93.92 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.081 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.413 ' HG3' ' O ' ' B' ' 42' ' ' THR . 0.0 OUTLIER -88.78 45.13 1.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.466 -1.309 . . . . 10.0 107.466 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.544 ' CD2' ' HA3' ' A' ' 10' ' ' GLY . 0.6 OUTLIER -51.13 -20.79 1.63 Allowed 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.832 -1.076 . . . . 10.0 111.727 -178.095 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.519 ' N ' ' HG ' ' B' ' 39' ' ' LEU . 0.6 OUTLIER -79.22 9.38 4.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.745 -1.222 . . . . 10.0 110.502 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.51 ' OE1' ' HA ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER 73.63 -20.92 0.28 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.992 -0.442 . . . . 10.0 111.707 179.126 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.471 ' OG1' HD13 ' B' ' 40' ' ' LEU . 26.9 p -134.33 178.01 7.31 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.213 . . . . 10.0 109.87 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 88.3 p -93.06 15.57 14.83 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.422 -0.798 . . . . 10.0 109.018 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.468 ' O ' ' CD1' ' B' ' 40' ' ' LEU . 27.2 t-20 -85.09 115.9 23.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 10.0 110.724 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.94 -45.24 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 10.0 109.5 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.942 -1.028 . . . . 10.0 110.031 -179.769 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.085 0.469 . . . . 10.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 4' ' ' ILE . 2.8 mm100 -78.72 -48.54 14.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.236 -0.915 . . . . 10.0 108.776 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.56 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -40.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.976 -0.75 . . . . 10.0 108.976 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.598 ' CD1' ' CB ' ' A' ' 176' ' ' ALA . 1.2 tt -134.55 149.06 29.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.001 -1.079 . . . . 10.0 111.935 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.466 ' HG3' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -126.95 119.38 26.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.558 ' HA ' ' CG1' ' A' ' 77' ' ' VAL . 7.5 m -89.32 135.31 33.65 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.732 0.777 . . . . 10.0 109.479 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.506 ' O ' HG22 ' A' ' 9' ' ' VAL . 11.0 t -144.31 158.5 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.46 -0.775 . . . . 10.0 109.972 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.577 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 30.5 m -63.83 136.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.44 -0.787 . . . . 10.0 111.235 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.532 HG12 ' CG1' ' A' ' 80' ' ' VAL . 7.6 t -145.27 -173.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.558 -0.714 . . . . 10.0 109.242 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.57 ' CA ' ' HA ' ' A' ' 80' ' ' VAL . . . 126.93 -129.05 6.42 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.942 -1.263 . . . . 10.0 109.942 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.98 22.95 14.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.435 -1.038 . . . . 10.0 109.224 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' B' ' 33' ' ' PRO . . . 100.82 90.07 2.07 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.644 -1.782 . . . . 10.0 108.644 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . 0.49 ' C ' ' HA ' ' B' ' 35' ' ' GLN . . . -141.18 96.16 2.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 10.0 110.659 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.468 HG22 ' OE1' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -82.91 133.59 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.918 -1.114 . . . . 10.0 109.684 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.545 ' O ' HD22 ' A' ' 19' ' ' LEU . . . 98.75 2.42 57.35 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.914 -1.136 . . . . 10.0 110.356 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.577 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.2 tttt -51.0 -47.73 61.52 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.024 -1.28 . . . . 10.0 111.013 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.488 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 22.7 m -62.06 -30.94 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.283 -1.511 . . . . 10.0 109.645 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.56 ' O ' ' HB ' ' A' ' 21' ' ' ILE . 14.9 m -70.18 -11.8 61.15 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.742 -1.224 . . . . 10.0 108.916 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.651 ' O ' ' CD2' ' A' ' 23' ' ' TYR . 4.3 mm? -70.26 -30.67 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.575 ' N ' ' CD2' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -49.29 -40.36 34.45 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.841 -1.541 . . . . 10.0 106.841 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.7 mm -67.54 -36.5 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 122.349 1.071 . . . . 10.0 108.948 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.573 ' HA ' ' CA ' ' A' ' 27' ' ' LYS . 3.5 p -60.05 -42.29 94.16 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.883 -0.727 . . . . 10.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.651 ' CD2' ' O ' ' A' ' 19' ' ' LEU . 31.7 m-85 -71.52 -7.45 47.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.824 -1.172 . . . . 10.0 108.768 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.497 HG23 ' O ' ' A' ' 20' ' ' LEU . 66.5 p -107.65 -44.31 4.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.531 -0.867 . . . . 10.0 110.143 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.419 ' CG2' ' H ' ' A' ' 26' ' ' ASN . 1.9 t -166.2 -65.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 116.798 -1.961 . . . . 10.0 115.361 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.552 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 15.9 t-20 -79.0 45.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.018 -1.676 . . . . 10.0 113.181 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.699 ' C ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -56.04 -126.71 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.577 -0.702 . . . . 10.0 111.392 179.022 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.619 ' CG ' ' O ' ' A' ' 28' ' ' PHE . 3.8 t80 -106.91 55.11 0.19 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.699 ' HD3' ' C ' ' A' ' 27' ' ' LYS . 60.9 Cg_endo -95.87 -104.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 120.827 1.018 . . . . 10.0 110.042 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -168.87 67.34 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.711 -1.243 . . . . 10.0 111.564 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.528 ' HG3' ' ND2' ' A' ' 26' ' ' ASN . 22.0 pt-20 -147.45 -173.81 4.36 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.808 -1.183 . . . . 10.0 108.294 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.457 ' O ' HG12 ' A' ' 33' ' ' VAL . 87.0 m-85 -123.64 138.4 54.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.851 -1.156 . . . . 10.0 111.705 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.527 ' CG2' ' OD1' ' A' ' 26' ' ' ASN 0.263 12.3 m -149.1 133.19 8.77 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.476 ' O ' HG22 ' A' ' 35' ' ' THR . 50.3 Cg_endo -73.67 89.18 0.99 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.05 1.027 . . . . 10.0 110.567 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.558 ' O ' ' CG2' ' A' ' 36' ' ' VAL . 0.3 OUTLIER -158.34 101.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 179.167 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.558 ' CG2' ' O ' ' A' ' 35' ' ' THR . 91.2 t -156.88 -97.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.636 -1.29 . . . . 10.0 111.995 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.551 ' CD2' ' O ' ' B' ' 19' ' ' HIS . 1.7 t80 -70.86 126.94 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 10.0 110.522 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.603 ' HB3' ' CG ' ' A' ' 56' ' ' PHE . 3.2 t70 -160.89 -177.82 6.4 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.055 -1.028 . . . . 10.0 110.103 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.507 ' HB3' ' CG2' ' B' ' 18' ' ' ILE . 1.2 t-20 -167.63 102.65 0.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 10.0 109.125 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.675 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 7.3 t80 -92.76 141.73 28.12 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.989 -1.07 . . . . 10.0 110.577 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -159.58 98.16 1.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 10.0 109.38 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . 0.675 ' CG2' ' CE2' ' A' ' 40' ' ' TYR . 0.0 OUTLIER -144.79 -174.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 10.0 110.622 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.57 ' O ' ' CB ' ' B' ' 13' ' ' ASP . 6.8 m -142.07 146.66 35.69 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.53 ' HA ' ' O ' ' B' ' 12' ' ' SER . 18.1 t -120.91 136.86 56.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.629 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 10.3 mtt -89.36 109.45 20.36 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 117.736 -1.586 . . . . 10.0 109.181 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.25 109.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.185 -1.572 . . . . 10.0 109.544 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.419 ' HA2' ' CG2' ' B' ' 8' ' ' ILE . . . 50.02 28.09 11.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.476 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.07 -28.0 17.09 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 111.15 16.15 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.246 . . . . 10.0 110.475 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 56.0 Cg_endo -73.04 134.64 21.73 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.159 1.61 . . . . 10.0 109.561 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.481 ' OH ' HG21 ' A' ' 173' ' ' ILE . 1.4 t80 -89.34 139.97 29.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.752 -1.218 . . . . 10.0 109.549 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.56 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -122.06 97.88 5.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 10.0 110.343 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.534 ' C ' ' CD1' ' A' ' 53' ' ' LEU . 3.8 pp -148.85 171.36 16.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.733 -1.229 . . . . 10.0 111.621 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -173.28 120.85 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.377 -1.889 . . . . 10.0 108.377 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.613 ' C ' ' CD1' ' A' ' 55' ' ' LEU . 1.5 pp -157.58 144.69 18.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.408 -1.643 . . . . 10.0 112.845 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.603 ' CG ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -174.66 172.34 3.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.251 -0.905 . . . . 10.0 110.384 175.093 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -90.82 157.33 17.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 10.0 110.187 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.5 m -129.29 135.74 49.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.028 . . . . 10.0 111.662 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.419 ' O ' HG12 ' A' ' 36' ' ' VAL . . . 55.85 -152.44 0.37 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.39 -0.819 . . . . 10.0 110.934 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.428 ' O ' HG12 ' B' ' 25' ' ' VAL . . . 96.09 -7.84 67.22 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.236 -1.946 . . . . 10.0 108.236 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.557 ' CG ' ' HB2' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -152.84 -41.76 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.509 -0.994 . . . . 10.0 110.444 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.627 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 8.7 mm-40 -73.1 -43.25 62.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.502 -1.279 . . . . 10.0 109.386 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 2.1 t70 73.46 52.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.627 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -165.24 0.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.195 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.532 ' C ' ' O ' ' A' ' 64' ' ' TYR . 6.1 p30 -22.53 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.493 0.663 . . . . 10.0 112.487 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.462 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -54.29 -34.16 60.26 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 178.483 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.59 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 83.7 mt -76.43 6.24 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.442 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.574 ' CG ' ' HD3' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -57.82 -31.29 9.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.826 -1.171 . . . . 10.0 113.651 -179.012 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.59 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 52.0 Cg_endo -72.47 81.11 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 CA-C-N 119.36 0.807 . . . . 10.0 110.037 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.554 ' O ' ' CB ' ' A' ' 71' ' ' SER . 0.7 OUTLIER -108.72 -34.14 6.78 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.751 -1.218 . . . . 10.0 110.913 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.657 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 77.16 -17.3 0.57 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 10.0 110.808 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.657 ' CB ' ' O ' ' A' ' 71' ' ' SER . 79.2 t80 104.29 115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.838 0 C-N-CA 123.682 0.793 . . . . 10.0 111.181 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 43.9 Cg_endo -71.58 164.7 34.86 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.89 1.469 . . . . 10.0 109.307 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 1.1 mt-30 -139.35 7.01 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.821 -1.174 . . . . 10.0 111.11 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -141.78 84.89 1.91 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.852 -1.155 . . . . 10.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.466 ' CB ' ' HG3' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -174.15 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.516 -0.74 . . . . 10.0 109.015 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.582 HG11 ' CG1' ' A' ' 4' ' ' ILE . 0.2 OUTLIER -163.91 143.19 2.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.19 -0.944 . . . . 10.0 108.801 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.567 ' N ' ' CD1' ' A' ' 78' ' ' PHE . 14.0 m-85 -131.72 119.56 21.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.899 -1.126 . . . . 10.0 111.942 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.513 HD12 ' CB ' ' A' ' 111' ' ' LEU . 1.1 mm? -90.58 97.85 11.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 10.0 109.043 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.57 ' HA ' ' CA ' ' A' ' 10' ' ' GLY . 11.0 m -99.38 150.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 10.0 110.35 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.6 p -123.66 108.41 12.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 10.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.495 ' CE2' HG22 ' A' ' 80' ' ' VAL . 97.9 m-85 -91.96 139.54 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.207 -0.933 . . . . 10.0 111.058 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.5 p -77.98 163.64 25.78 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.55 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 1.9 m -119.43 -14.64 8.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 10.0 110.321 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.54 ' O ' ' HG ' ' A' ' 129' ' ' LEU . 32.7 m -115.11 44.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.798 0.809 . . . . 10.0 109.868 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.603 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -133.83 -159.13 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 41.6 Cg_endo -73.26 142.85 34.44 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 122.715 0.85 . . . . 10.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 m -65.29 77.15 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.007 -1.077 . . . . 10.0 109.695 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' PRO . 80.1 p -105.05 -15.71 15.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 10.0 111.642 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.5 p90 -49.79 -39.73 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.258 . . . . 10.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 1.5 tt0 -62.21 -34.17 75.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 10.0 110.269 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.503 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -72.11 -14.01 61.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.063 -1.023 . . . . 10.0 109.682 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.517 HG12 ' CD1' ' A' ' 97' ' ' TRP . 21.2 t -87.95 -18.03 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 10.0 109.444 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.629 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 3.7 mmtt -85.42 -35.53 21.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.519 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -82.74 -1.03 50.32 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.162 0.506 . . . . 10.0 109.847 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.598 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -111.24 -50.01 2.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.832 -1.167 . . . . 10.0 112.052 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.598 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 50.1 m95 -84.77 -49.36 8.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 10.0 112.339 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.608 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 23.2 t -52.79 -46.48 96.58 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.657 -1.277 . . . . 10.0 109.951 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.608 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.0 Cg_endo -71.75 -16.3 29.88 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.392 1.206 . . . . 10.0 109.779 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.548 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 43.5 tt0 -63.36 -16.55 60.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 10.0 109.72 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.548 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt 69.02 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.472 0.653 . . . . 10.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.503 ' CG2' ' N ' ' A' ' 103' ' ' HIS . 2.1 m -52.39 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.868 . . . . 10.0 108.916 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . 0.503 ' N ' ' CG2' ' A' ' 102' ' ' THR . 10.9 p-80 -110.54 -4.2 15.61 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 10.0 108.174 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.5 OUTLIER 162.58 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 35.6 t -138.15 131.49 16.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . 0.402 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 42.7 Cg_endo -69.84 67.67 1.77 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.757 1.399 . . . . 10.0 111.256 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 -11.04 15.08 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.057 -1.027 . . . . 10.0 110.659 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.471 ' HB ' HG23 ' A' ' 102' ' ' THR . 12.9 t -49.21 147.3 5.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.653 -1.279 . . . . 10.0 109.715 -179.12 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.62 130.42 26.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.852 1.448 . . . . 10.0 110.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.457 ' O ' HG13 ' A' ' 152' ' ' VAL . 0.6 OUTLIER -112.8 102.21 10.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.44 -0.787 . . . . 10.0 109.667 179.788 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.599 HD12 ' CG1' ' A' ' 152' ' ' VAL . 2.6 mm? -78.62 95.41 5.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.817 -1.153 . . . . 10.0 108.026 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.561 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 12.5 mt -72.31 137.91 47.0 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.523 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 22.8 t -148.43 158.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.787 -1.196 . . . . 10.0 111.594 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.402 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -96.56 148.21 18.92 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.765 -1.734 . . . . 10.0 108.765 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 81' ' ' CYS . 30.5 m -111.35 126.71 55.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.167 -1.196 . . . . 10.0 110.638 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 44.17 62.18 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.438 -0.789 . . . . 10.0 110.412 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.766 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.1 OUTLIER -83.89 -29.24 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.206 -0.997 . . . . 10.0 109.542 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.576 ' O ' ' CD2' ' A' ' 119' ' ' LEU . 0.3 OUTLIER -52.47 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.427 1.108 . . . . 10.0 110.175 -177.58 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER 166.73 -26.66 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.219 -1.355 . . . . 10.0 107.827 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.519 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -51.14 -33.21 25.73 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.307 0.575 . . . . 10.0 109.731 178.631 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . 0.431 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 75.7 m-20 -73.77 -11.46 60.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.027 . . . . 10.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.447 ' O ' ' CD1' ' A' ' 126' ' ' ILE . 38.0 t0 -86.4 115.86 63.73 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 10.0 110.162 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.47 21.65 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.734 1.386 . . . . 10.0 111.447 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 38.7 t -105.59 -51.24 3.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 10.0 109.993 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.452 ' CG2' HD11 ' A' ' 126' ' ' ILE . 14.3 t -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.967 -2.235 . . . . 10.0 104.967 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.47 ' O ' ' CB ' ' A' ' 130' ' ' ALA 0.296 1.3 mp -54.47 -23.56 11.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.227 -1.351 . . . . 10.0 107.79 176.474 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . 0.483 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -49.21 -41.73 37.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.583 0.706 . . . . 10.0 110.172 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 1.8 mmmm -92.44 -41.32 10.37 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.603 -0.686 . . . . 10.0 109.994 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.599 ' CD1' ' N ' ' A' ' 129' ' ' LEU . 6.0 mp -65.83 -32.75 74.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.761 . . . . 10.0 109.403 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -59.88 -51.51 69.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 10.0 109.869 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HD3' ' O ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -64.62 -25.33 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.196 -1.002 . . . . 10.0 108.903 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.57 ' ND2' ' N ' ' A' ' 87' ' ' PRO . 2.2 t30 -69.38 -8.64 48.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 10.0 110.583 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.485 ' O ' ' HG2' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -167.67 115.3 0.75 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 10.0 108.557 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.511 ' NE2' ' N ' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -64.51 -19.9 65.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 10.0 111.904 -178.262 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 4.8 mptt -137.67 106.34 8.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.747 -1.221 . . . . 10.0 110.284 179.665 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -66.74 160.45 46.45 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.487 . . . . 10.0 109.654 179.42 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.55 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.4 tp -86.86 138.35 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.782 -1.199 . . . . 10.0 109.704 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.487 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 55.8 p -131.43 166.33 28.79 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.463 -0.773 . . . . 10.0 109.813 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.549 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 42.4 Cg_endo -67.8 -11.5 32.31 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.737 1.388 . . . . 10.0 110.965 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . 0.451 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 75.2 mt-10 -75.16 -44.3 47.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.946 -1.096 . . . . 10.0 109.405 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -77.72 -36.55 50.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.662 0.744 . . . . 10.0 109.388 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.47 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -64.93 -49.94 68.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 10.0 111.476 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.3 -46.94 62.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.009 -1.057 . . . . 10.0 109.578 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . 0.457 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 3.2 mtpm? -70.68 -30.05 66.53 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.542 -0.863 . . . . 10.0 109.439 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.513 ' CD1' ' HG3' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -69.53 -38.95 77.73 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.332 -0.855 . . . . 10.0 109.693 178.87 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . 0.525 ' CB ' ' HB1' ' A' ' 151' ' ' ALA . . . -65.71 -49.67 67.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 10.0 108.263 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -24.07 67.53 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.852 -0.739 . . . . 10.0 109.166 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . 0.457 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 21.1 t70 -59.97 -30.93 69.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 10.0 111.177 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.591 ' CD2' ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -132.87 29.9 4.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.888 -1.132 . . . . 10.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.494 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 31.9 mttt 67.45 36.08 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 10.0 112.176 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.525 ' HB1' ' CB ' ' A' ' 146' ' ' ALA . . . -69.68 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.221 -0.991 . . . . 10.0 108.929 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.599 ' CG1' HD12 ' A' ' 111' ' ' LEU . 2.4 p -114.57 -58.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.596 -1.315 . . . . 10.0 112.014 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . 0.437 ' HB3' ' OE2' ' A' ' 171' ' ' GLU . 2.8 ttmm -172.3 148.72 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.367 -1.458 . . . . 10.0 111.675 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.561 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 83.9 t80 -86.0 121.7 29.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 10.0 110.466 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.51 ' HB ' HG21 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -130.03 -174.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.868 -1.145 . . . . 10.0 110.169 179.4 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -148.09 149.23 31.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.862 -1.149 . . . . 10.0 112.195 -178.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.555 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.0 p -148.22 156.09 42.14 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.905 0.859 . . . . 10.0 110.894 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.571 ' HB2' ' CG ' ' A' ' 163' ' ' LYS . 1.7 t -139.38 89.8 2.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.627 0.727 . . . . 10.0 109.495 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.525 ' C ' ' O ' ' A' ' 158' ' ' SER . . . -12.05 -58.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.554 0.946 . . . . 10.0 113.554 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.493 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -106.99 -43.12 4.72 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.056 -1.028 . . . . 10.0 112.84 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.57 ' OG1' ' CB ' ' A' ' 158' ' ' SER . 6.3 p -65.25 -23.58 67.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.264 -1.523 . . . . 10.0 109.577 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' OE1' ' A' ' 162' ' ' GLN . 0.3 OUTLIER 71.19 77.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.457 -0.777 . . . . 10.0 110.946 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.571 ' CG ' ' HB2' ' A' ' 158' ' ' SER . 12.6 mmmt -80.86 23.43 0.55 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.529 -0.868 . . . . 10.0 111.865 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.27 45.41 11.43 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.101 -1.2 . . . . 10.0 110.101 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.644 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -74.96 -3.37 31.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.339 -1.095 . . . . 10.0 112.774 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . 0.501 ' N ' HD12 ' A' ' 165' ' ' LEU . 5.7 ttmt -53.62 -38.99 64.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.57 -1.331 . . . . 10.0 110.223 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -75.6 -26.1 57.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 10.0 111.684 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.583 HG22 ' HA ' ' A' ' 165' ' ' LEU . 87.7 t -52.88 -51.49 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 10.0 111.353 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CZ ' ' OD1' ' A' ' 170' ' ' ASP . 2.3 p90 -85.16 -32.23 22.83 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.699 -0.801 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.58 ' OD1' ' CZ ' ' A' ' 169' ' ' PHE . 1.0 OUTLIER -56.45 -41.54 76.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.993 -1.067 . . . . 10.0 110.972 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.44 ' OE1' HG13 ' A' ' 155' ' ' VAL . 9.0 pt-20 -69.8 -30.64 68.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.991 -1.068 . . . . 10.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . 0.547 ' CB ' HD11 ' A' ' 111' ' ' LEU . . . -71.49 -4.61 27.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.012 -1.055 . . . . 10.0 109.457 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.547 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 44.9 mm -82.52 -46.0 19.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.549 -0.861 . . . . 10.0 108.967 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.477 HD22 ' O ' ' A' ' 170' ' ' ASP . 0.3 OUTLIER -83.63 -30.97 26.48 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.738 -1.185 . . . . 10.0 108.679 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . 0.557 ' CB ' HG21 ' A' ' 152' ' ' VAL . . . -77.03 -0.28 23.95 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.393 -0.817 . . . . 10.0 108.97 178.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.598 ' CB ' ' CD1' ' A' ' 4' ' ' ILE . . . -90.04 -39.25 13.04 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.378 -0.826 . . . . 10.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -89.74 -19.94 24.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 10.0 109.393 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.411 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.283 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . 0.405 ' HA2' ' OE1' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 55.43 33.28 20.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -1.012 . . . . 10.0 110.767 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.76 89.39 5.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.099 -1.001 . . . . 10.0 110.274 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.486 ' C ' ' HD2' ' B' ' 6' ' ' PRO . 3.1 mt-10 -92.81 118.83 31.52 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.209 -0.932 . . . . 10.0 110.245 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.716 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -71.72 -21.38 0.5 Allowed Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 121.38 -0.825 . . . . 10.0 111.903 178.516 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 44.3 Cg_endo -88.06 -9.77 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 O-C-N 122.597 0.788 . . . . 10.0 111.044 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.466 ' OE1' ' CB ' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -53.57 171.27 0.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 118.47 -1.292 . . . . 10.0 109.713 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . 0.619 ' CG2' ' N ' ' B' ' 9' ' ' SER . 0.4 OUTLIER -78.16 -169.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.011 -1.477 . . . . 10.0 107.011 177.909 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.619 ' N ' ' CG2' ' B' ' 8' ' ' ILE . 33.3 t -129.02 98.9 5.08 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 118.994 -1.082 . . . . 10.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.629 ' HB3' ' O ' ' A' ' 45' ' ' MET . 41.1 tp -92.5 99.89 3.27 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 118.558 -1.257 . . . . 10.0 108.994 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.512 ' HD3' ' O ' ' B' ' 9' ' ' SER . 37.8 Cg_endo -61.29 99.43 0.16 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.194 1.102 . . . . 10.0 110.795 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 12' ' ' SER . . . . . 0.53 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 4.9 m -152.36 99.83 2.53 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.327 -0.858 . . . . 10.0 111.422 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -169.17 121.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.62 -0.675 . . . . 10.0 110.353 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -159.42 102.93 1.58 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.005 -1.059 . . . . 10.0 110.558 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.571 ' N ' ' CG1' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.64 106.5 0.22 Allowed 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.273 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -166.82 123.24 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 10.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 17' ' ' THR . . . . . 0.488 ' O ' HG22 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -161.97 111.28 1.51 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.92 . . . . 10.0 110.183 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.507 ' CG2' ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -153.43 -173.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.044 -1.035 . . . . 10.0 110.296 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 64.2 m80 -115.35 142.8 46.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.082 -1.011 . . . . 10.0 110.569 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.528 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 1.1 p -142.88 149.11 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.485 -0.76 . . . . 10.0 111.346 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.514 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -87.95 -124.67 2.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.254 -1.938 . . . . 10.0 108.254 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.589 ' N ' ' CD1' ' B' ' 22' ' ' PHE . 0.0 OUTLIER 173.54 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -1.152 . . . . 10.0 111.363 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.557 ' HB2' ' CG ' ' A' ' 61' ' ' GLN . 9.4 t70 -144.05 159.41 42.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.683 -0.635 . . . . 10.0 109.537 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.557 ' CB ' ' HG3' ' B' ' 28' ' ' GLU . . . -61.03 -5.54 1.46 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.905 -1.122 . . . . 10.0 109.913 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.541 ' HA ' ' HB2' ' B' ' 28' ' ' GLU 0.276 0.5 OUTLIER -49.67 -34.98 9.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.883 1.325 . . . . 10.0 107.566 178.878 . . . . . . . . 4 4 . 1 . 019 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.544 ' HA ' ' HB3' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -52.63 -32.59 42.59 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.111 -1.404 . . . . 10.0 111.064 -179.133 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.552 ' HA3' ' O ' ' A' ' 26' ' ' ASN . . . -123.79 -7.92 6.48 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.655 -1.778 . . . . 10.0 108.655 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.557 ' HG3' ' CB ' ' B' ' 24' ' ' ALA . 18.3 mt-10 -83.74 39.94 0.71 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.68 -0.894 . . . . 10.0 110.453 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.558 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 46.3 t80 -76.07 94.97 3.53 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.756 -1.202 . . . . 10.0 107.756 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.584 HG23 ' CD2' ' A' ' 28' ' ' PHE . 34.3 p -112.89 -19.22 12.04 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.19 -0.914 . . . . 10.0 110.491 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.62 -167.53 14.68 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.129 -1.588 . . . . 10.0 109.129 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.442 ' CD1' ' N ' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -133.59 69.47 76.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.239 -1.153 . . . . 10.0 110.811 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.4 Cg_endo -74.22 156.57 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.088 1.572 . . . . 10.0 108.464 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -35.21 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.268 -0.895 . . . . 10.0 111.003 -178.522 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -73.26 -71.22 0.32 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.496 0.665 . . . . 10.0 112.039 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.542 ' O ' HD13 ' A' ' 70' ' ' LEU . 41.1 t90 -157.26 34.65 0.28 Allowed 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.53 ' CB ' HD12 ' A' ' 70' ' ' LEU . . . -157.8 83.69 0.88 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -81.19 51.13 1.54 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.51 HD11 ' O ' ' B' ' 37' ' ' ALA . 1.2 mp -39.13 -29.49 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.86 0.838 . . . . 10.0 109.197 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 42' ' ' THR . 0.8 OUTLIER -87.39 32.45 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.791 -0.568 . . . . 10.0 109.716 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' B' ' 38' ' ' ARG . 15.7 tp60 -33.39 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.468 0.651 . . . . 10.0 110.133 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 42' ' ' THR . . . . . 0.793 ' O ' ' N ' ' B' ' 44' ' ' ASN . 69.1 p -120.26 65.18 0.83 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' B' ' 40' ' ' LEU . 10.4 t -41.28 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.744 0.783 . . . . 10.0 112.282 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.793 ' N ' ' O ' ' B' ' 42' ' ' THR . 0.8 OUTLIER 52.53 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.603 0.716 . . . . 10.0 110.947 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.3 -29.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.446 -0.784 . . . . 10.0 108.927 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 117.949 -1.024 . . . . 10.0 110.169 -179.461 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.533 ' O ' ' CG ' ' A' ' 1' ' ' MET . 2.2 ptm . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.401 0.62 . . . . 10.0 110.149 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLN . . . . . 0.546 ' HA ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -74.92 -33.66 62.02 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.676 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.2 m -40.79 118.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' ILE . . . . . 0.538 HG13 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -104.16 127.27 58.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.16 -1.816 . . . . 10.0 110.77 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LYS . . . . . 0.584 ' O ' ' CG2' ' A' ' 75' ' ' THR . 1.8 mttp -121.42 97.78 5.67 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.493 ' SG ' HD11 ' A' ' 4' ' ' ILE . 19.6 m -118.19 120.43 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.848 -1.141 . . . . 10.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' VAL . . . . . 0.553 ' CG2' HG22 ' A' ' 75' ' ' THR . 47.1 t -127.55 144.6 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.488 -0.93 . . . . 10.0 108.488 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.586 ' CG2' ' CB ' ' B' ' 36' ' ' TRP . 33.6 m -62.73 116.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.287 -0.883 . . . . 10.0 110.709 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' VAL . . . . . 0.452 ' O ' ' O ' ' A' ' 79' ' ' LEU . 77.2 t -115.72 177.69 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.182 -0.949 . . . . 10.0 109.136 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' GLY . . . . . 0.482 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 167.78 172.64 35.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.23 18.49 13.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.118 -1.225 . . . . 10.0 109.731 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLY . . . . . 0.54 ' CA ' ' OE1' ' B' ' 34' ' ' GLU . . . 74.61 51.74 7.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 -54.41 2.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.529 -0.983 . . . . 10.0 110.785 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.464 HG13 ' OE1' ' A' ' 116' ' ' GLN . 6.3 m -136.26 -7.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 10.0 111.586 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . 0.413 ' HA2' ' HB3' ' B' ' 35' ' ' GLN . . . 81.64 81.63 0.86 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.524 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 3.8 tptt -63.04 -27.24 69.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.54 -0.977 . . . . 10.0 112.008 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.531 ' OG1' ' CG2' ' A' ' 8' ' ' VAL . 93.9 m -55.15 -51.85 65.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.399 -1.438 . . . . 10.0 110.188 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' CB ' ' HA ' ' B' ' 26' ' ' THR . 31.0 p -74.81 0.23 16.14 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.44 -0.904 . . . . 10.0 109.985 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' LEU . . . . . 0.624 HD21 ' N ' ' A' ' 19' ' ' LEU . 0.1 OUTLIER -88.16 -36.07 17.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.003 -1.061 . . . . 10.0 109.097 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LEU . . . . . 0.496 HD22 ' O ' ' A' ' 16' ' ' LYS . 4.3 mm? -51.68 -38.55 55.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ILE . . . . . 0.614 ' O ' ' N ' ' A' ' 25' ' ' THR . 0.5 OUTLIER -76.67 -51.34 19.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.641 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' SER . . . . . 0.519 ' N ' HG23 ' A' ' 21' ' ' ILE . 49.3 m -46.27 -40.85 12.22 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 119.077 -1.049 . . . . 10.0 108.846 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' TYR . . . . . 0.597 ' CE2' ' HB2' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -64.22 -23.28 67.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.187 -0.946 . . . . 10.0 109.461 177.774 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' ILE . 63.2 m -105.04 -29.97 10.07 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.686 0.755 . . . . 10.0 109.889 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -137.73 64.5 1.51 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.73 -1.581 . . . . 10.0 106.73 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . 0.488 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -33.96 49.75 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.583 1.553 . . . . 10.0 114.406 -177.638 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.802 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -67.22 109.12 2.96 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.381 -0.824 . . . . 10.0 110.749 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PHE . . . . . 0.562 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 43.4 t80 -176.12 -56.52 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.237 -0.914 . . . . 10.0 110.406 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PRO . . . . . 0.562 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 41.2 Cg_endo -69.69 -67.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.126 1.066 . . . . 10.0 110.58 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 p -166.29 58.67 0.1 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.271 -0.893 . . . . 10.0 109.714 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.522 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 59.0 mm-40 -127.45 114.77 17.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -0.964 . . . . 10.0 110.271 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' TYR . . . . . 0.455 ' C ' ' HD3' ' A' ' 34' ' ' PRO . 5.9 t80 -73.39 59.98 0.61 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.725 -0.609 . . . . 10.0 110.358 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.581 ' HB ' ' CG2' ' A' ' 25' ' ' THR . 20.3 m -119.99 76.11 22.01 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.172 -0.955 . . . . 10.0 110.912 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PRO . . . . . 0.494 ' HG2' ' OD2' ' B' ' 23' ' ' ASP . 44.2 Cg_endo -87.7 132.84 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.809 1.673 . . . . 10.0 110.99 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' THR . . . . . 0.492 ' O ' HG13 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -157.02 102.64 1.99 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.729 -1.232 . . . . 10.0 111.9 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' VAL . . . . . 0.543 HG12 ' CG2' ' A' ' 58' ' ' THR . 78.6 t -95.29 10.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.654 -1.279 . . . . 10.0 109.017 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' CG ' ' CG2' ' B' ' 18' ' ' ILE . 1.3 m-30 -33.91 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.087 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASP . . . . . 0.788 ' HB2' ' HA ' ' B' ' 18' ' ' ILE . 1.5 m-20 -85.81 -149.02 0.13 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.903 -1.519 . . . . 10.0 108.594 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ASN . . . . . 0.495 ' HB3' ' O ' ' A' ' 55' ' ' LEU . 1.3 t-20 -133.7 -163.62 1.38 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -128.05 163.27 24.94 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.605 -1.31 . . . . 10.0 112.194 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' ALA . . . . . 0.568 ' HB1' ' CE2' ' A' ' 56' ' ' PHE . . . -153.65 153.72 32.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -172.34 -168.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 120.528 -1.357 . . . . 10.0 111.625 -179.019 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' THR . . . . . 0.462 HG21 ' O ' ' A' ' 51' ' ' TYR . 92.3 m -132.39 153.31 50.92 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.503 -0.771 . . . . 10.0 109.887 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . 0.522 HG13 ' CG ' ' A' ' 51' ' ' TYR . 0.3 OUTLIER -142.07 -171.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.039 . . . . 10.0 110.395 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' MET . . . . . 0.54 ' HB2' ' HG2' ' B' ' 11' ' ' PRO . 85.6 mtp -142.65 138.45 30.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.647 . . . . 10.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . 0.564 HG13 ' HB2' ' B' ' 10' ' ' LEU . 1.1 mp -146.91 115.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.222 -0.924 . . . . 10.0 109.714 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLY . . . . . 0.469 ' C ' ' O ' ' A' ' 46' ' ' ILE . . . 41.01 27.58 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.656 -1.259 . . . . 10.0 109.98 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLY . . . . . 0.521 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.37 -16.18 49.22 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.189 -1.183 . . . . 10.0 111.412 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' GLU . . . . . 0.447 ' OE2' ' HB2' ' B' ' 4' ' ' GLU . 1.7 mp0 -98.69 105.04 28.0 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.553 -1.557 . . . . 10.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' PRO . . . . . 0.521 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 52.2 Cg_endo -82.91 151.74 14.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.894 1.471 . . . . 10.0 112.269 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.522 ' CG ' HG13 ' A' ' 44' ' ' VAL . 2.8 m-30 -81.52 174.07 11.79 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . 0.676 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 16.2 m -152.73 124.1 7.67 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.611 -1.306 . . . . 10.0 112.249 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . 0.518 ' C ' ' CG2' ' A' ' 4' ' ' ILE . 0.3 OUTLIER 64.65 -169.21 0.2 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.93 0.871 . . . . 10.0 113.282 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . 0.505 ' HA3' ' HA ' ' A' ' 41' ' ' ALA . . . -169.72 -167.17 29.86 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.054 -1.618 . . . . 10.0 109.054 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . 0.495 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -111.22 156.57 21.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -1.116 . . . . 10.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PHE . . . . . 0.568 ' CE2' ' HB1' ' A' ' 41' ' ' ALA . 56.9 m-85 -132.88 166.03 23.26 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.346 -0.613 . . . . 10.0 109.346 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . 0.539 ' O ' ' O ' ' A' ' 58' ' ' THR . 8.1 t70 -104.57 179.69 4.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.772 -1.205 . . . . 10.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' THR . . . . . 0.543 ' CG2' HG12 ' A' ' 36' ' ' VAL . 12.0 t -45.26 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.469 1.128 . . . . 10.0 112.425 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -132.94 63.35 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 10.0 109.114 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' GLY . . . . . 0.419 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -49.42 -39.94 30.04 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.646 -2.582 . . . . 10.0 106.646 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 2.7 tp60 -63.92 -35.62 81.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.7 mt-10 55.63 32.76 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.939 0.876 . . . . 10.0 109.819 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . 0.586 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 5.6 t70 -90.08 -5.68 56.29 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.527 -0.916 . . . . 10.0 108.527 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' TYR . . . . . 0.586 ' CZ ' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -139.23 -38.33 0.49 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.13 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.2 p30 38.9 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.187 -0.605 . . . . 10.0 109.998 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -58.17 -36.87 73.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.745 -1.222 . . . . 10.0 109.173 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.631 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 5.1 mt -91.77 13.86 17.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.331 0.586 . . . . 10.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -81.47 -13.12 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 114.341 1.238 . . . . 10.0 114.341 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.631 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -69.71 67.76 1.7 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 109.031 -1.18 . . . . 10.0 109.031 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.612 ' HB3' ' HA ' ' B' ' 37' ' ' ALA . 4.9 mt -50.46 -71.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.559 0.695 . . . . 10.0 111.665 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . 0.56 ' HA ' ' HA ' ' B' ' 39' ' ' LEU . 21.7 p -35.31 -29.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.958 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -98.29 105.83 31.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.415 -0.803 . . . . 10.0 108.859 178.67 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' PRO . . . . . 0.476 ' HD3' ' O ' ' A' ' 71' ' ' SER . 43.4 Cg_endo -77.83 113.93 3.55 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.859 1.452 . . . . 10.0 110.721 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -133.77 60.61 1.7 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.477 -0.764 . . . . 10.0 110.288 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' THR . . . . . 0.584 ' CG2' ' O ' ' A' ' 5' ' ' LYS . 3.8 m -144.25 97.33 3.03 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.934 -1.104 . . . . 10.0 109.545 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' THR . 14.5 t70 -28.83 -38.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.662 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' VAL . . . . . 0.579 HG13 ' O ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -121.09 136.96 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.269 -0.894 . . . . 10.0 109.706 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' PHE . . . . . 0.571 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 41.8 m-85 -115.7 144.67 43.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LEU . . . . . 0.486 HD11 ' CG1' ' A' ' 168' ' ' VAL . 0.5 OUTLIER -114.01 102.34 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 10.0 109.129 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' VAL . . . . . 0.519 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 4.4 p -96.8 151.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.982 . . . . 10.0 108.812 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' CYS . . . . . 0.505 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 19.8 t -134.8 100.37 4.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.847 -1.158 . . . . 10.0 112.496 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 47.8 m-85 -88.45 156.18 19.26 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.316 -0.865 . . . . 10.0 109.884 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' SER . . . . . 0.581 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 18.8 m -85.01 147.12 26.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.843 -1.161 . . . . 10.0 109.282 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' VAL . . . . . 0.492 HG23 ' HB ' ' A' ' 117' ' ' ILE . 43.7 t -47.62 -60.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.077 -1.014 . . . . 10.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . 0.52 ' HB ' ' CD2' ' A' ' 129' ' ' LEU . 3.8 t -78.75 -62.52 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.581 ' CB ' ' HB2' ' A' ' 83' ' ' SER . 0.7 OUTLIER 44.8 179.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.847 0 CA-C-O 121.58 0.705 . . . . 10.0 112.375 178.218 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . 0.49 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 52.2 Cg_endo -78.72 145.99 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.462 1.77 . . . . 10.0 109.985 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' SER . . . . . 0.463 ' HB3' ' HG2' ' A' ' 135' ' ' LYS . 95.2 p -68.38 67.81 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 10.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.3 OUTLIER -136.69 13.37 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 10.0 111.666 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 82' ' ' PHE . 16.9 t80 -71.33 -34.15 70.29 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.619 -1.301 . . . . 10.0 110.64 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -74.69 -29.89 61.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.026 -1.046 . . . . 10.0 110.982 -179.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -86.89 -9.69 55.12 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.741 -1.183 . . . . 10.0 109.496 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . 0.406 ' O ' ' HB2' ' A' ' 97' ' ' TRP . 14.4 t -90.35 -36.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.996 -1.065 . . . . 10.0 109.102 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' LYS . . . . . 0.527 ' HE2' ' CD1' ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.26 -25.39 62.45 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 10.0 110.095 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' GLU . . . . . 0.488 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 12.9 pt-20 -78.52 -25.06 45.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 10.0 111.616 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' LYS . . . . . 0.524 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 25.2 mttp -110.93 -50.65 2.93 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.892 -1.13 . . . . 10.0 111.998 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' TRP . . . . . 0.629 ' CH2' ' CD1' ' B' ' 40' ' ' LEU . 23.1 m0 -64.42 -17.19 63.55 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.297 -0.877 . . . . 10.0 112.405 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' VAL . . . . . 0.528 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 53.8 t -82.91 -50.7 0.72 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.772 -1.205 . . . . 10.0 112.033 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.528 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.8 Cg_endo -68.58 -6.47 17.83 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.119 1.063 . . . . 10.0 111.209 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' GLU . . . . . 0.524 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 mm-40 -90.48 -32.0 16.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.876 -1.14 . . . . 10.0 110.464 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ILE . . . . . 0.451 ' CD1' ' O ' ' A' ' 101' ' ' ILE . 0.2 OUTLIER -91.96 -29.14 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.038 -1.039 . . . . 10.0 110.239 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . 0.457 HG23 ' O ' ' A' ' 98' ' ' VAL . 69.9 p -62.26 -12.18 19.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 10.0 109.915 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -57.56 -40.68 79.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.558 -0.714 . . . . 10.0 110.639 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.96 -33.76 39.29 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 10.0 110.803 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.3 t -136.29 128.49 17.37 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 10.0 110.092 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.29 126.5 13.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.117 1.588 . . . . 10.0 111.851 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER 55.84 52.07 11.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.37 -0.831 . . . . 10.0 111.119 178.707 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' THR . . . . . 0.474 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 22.4 m -63.31 145.17 97.24 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 10.0 109.61 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' PRO . . . . . 0.474 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 41.1 Cg_endo -68.37 157.63 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.642 1.338 . . . . 10.0 109.365 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' PHE . . . . . 0.583 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -159.95 121.97 3.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.94 -1.1 . . . . 10.0 111.237 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.534 HD13 ' CG1' ' A' ' 152' ' ' VAL . 1.0 OUTLIER -92.29 102.51 15.01 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.149 0.975 . . . . 10.0 110.682 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' LEU . . . . . 0.534 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 71.2 mt -75.56 135.24 40.58 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.817 -0.809 . . . . 10.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' VAL . . . . . 0.575 ' CG1' ' N ' ' A' ' 114' ' ' GLY . 19.4 t -133.75 169.96 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.654 -1.279 . . . . 10.0 112.694 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -140.35 107.11 0.52 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.583 -2.207 . . . . 10.0 107.583 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.486 ' O ' ' HB2' ' A' ' 116' ' ' GLN . 2.8 t -106.75 -179.51 3.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.267 . . . . 10.0 111.708 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' GLN . . . . . 0.541 ' NE2' ' HB3' ' A' ' 83' ' ' SER . 16.9 mt-30 61.56 48.16 5.98 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.798 -0.564 . . . . 10.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ILE . . . . . 0.792 ' O ' ' N ' ' A' ' 119' ' ' LEU . 0.0 OUTLIER -107.37 -50.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.167 -0.958 . . . . 10.0 110.118 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 11.6 t0 -52.7 61.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.191 0.996 . . . . 10.0 109.947 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER 152.57 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.339 -1.3 . . . . 10.0 108.41 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -46.73 -37.4 8.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 10.0 109.135 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.0 -21.99 9.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.42 -0.8 . . . . 10.0 109.542 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ASP . . . . . 0.521 ' OD1' ' HD2' ' A' ' 123' ' ' PRO . 22.9 t0 -84.28 131.77 49.63 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 10.0 110.889 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.521 ' HD2' ' OD1' ' A' ' 122' ' ' ASP . 51.7 Cg_endo -78.22 24.66 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.925 1.487 . . . . 10.0 111.265 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' SER . . . . . 0.488 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 37.1 m -102.76 -46.96 4.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.002 -1.061 . . . . 10.0 109.843 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' THR . . . . . 0.543 HG21 ' N ' ' A' ' 126' ' ' ILE . 6.8 t -78.41 -27.42 46.65 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.493 -2.039 . . . . 10.0 105.493 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ILE . . . . . 0.543 ' N ' HG21 ' A' ' 125' ' ' THR 0.29 1.1 mp -57.06 -25.26 22.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 177.072 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.4 tm-20 -50.24 -50.18 50.65 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.747 0.784 . . . . 10.0 110.284 179.554 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -65.06 -44.77 87.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.691 -0.63 . . . . 10.0 111.062 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' LEU . . . . . 0.526 ' CB ' ' OE1' ' A' ' 134' ' ' GLN . 5.6 mt -59.92 -35.51 75.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.235 -0.916 . . . . 10.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' ALA . . . . . 0.631 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -49.62 -42.24 44.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.606 -0.684 . . . . 10.0 110.294 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -19.9 42.17 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.46 -0.775 . . . . 10.0 110.498 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ASN . . . . . 0.482 ' OD1' ' HA ' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -123.07 43.89 2.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.953 -1.092 . . . . 10.0 112.348 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.1 mptm? 67.72 150.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 10.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' GLN . . . . . 0.631 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -116.77 66.24 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 10.0 111.387 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' LYS . . . . . 0.463 ' HG2' ' HB3' ' A' ' 88' ' ' SER . 5.0 mmmt -104.83 94.68 7.8 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.112 -0.992 . . . . 10.0 108.958 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' PRO . . . . . 0.487 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 43.7 Cg_endo -71.22 161.43 45.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.075 1.566 . . . . 10.0 110.681 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ILE . . . . . 0.5 HG23 ' O ' ' A' ' 137' ' ' ILE . 3.9 tp -120.13 121.41 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.215 -0.928 . . . . 10.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' THR . . . . . 0.455 ' O ' ' HB3' ' A' ' 142' ' ' ALA . 19.4 p -108.46 164.29 15.06 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.22 -0.925 . . . . 10.0 109.206 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 38.3 Cg_endo -67.51 -29.16 37.61 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.589 1.31 . . . . 10.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.78 -34.12 72.6 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.5 m -93.38 -33.51 13.84 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.746 0.784 . . . . 10.0 109.054 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . 0.492 ' CB ' ' CD1' ' A' ' 154' ' ' TYR . . . -75.38 -38.56 59.93 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.601 -0.687 . . . . 10.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLU . . . . . 0.483 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.0 mt-10 -59.54 -49.23 78.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.258 -0.901 . . . . 10.0 109.836 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -45.26 93.42 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 10.0 109.156 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' LEU . . . . . 0.545 ' O ' HD13 ' A' ' 149' ' ' LEU . 2.8 tt -60.05 -49.37 77.93 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.228 -1.026 . . . . 10.0 108.228 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -55.25 -38.71 68.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 10.0 109.128 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.443 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 1.6 mtp-105 -72.23 -4.85 31.89 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.603 -0.686 . . . . 10.0 109.873 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.15 -52.04 7.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 10.0 110.278 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' LEU . . . . . 0.545 HD13 ' O ' ' A' ' 145' ' ' LEU . 0.2 OUTLIER -89.94 4.86 48.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 10.0 109.309 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 1.8 mttp 73.16 31.17 1.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -55.89 -159.82 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.952 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' VAL . . . . . 0.583 ' CG1' ' O ' ' A' ' 110' ' ' PHE . 0.8 OUTLIER -119.08 -54.74 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 118.941 -1.103 . . . . 10.0 111.516 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -171.53 147.14 2.32 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.934 -1.506 . . . . 10.0 112.621 -179.512 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' TYR . . . . . 0.534 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 43.2 t80 -97.64 100.05 11.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.735 -0.603 . . . . 10.0 109.45 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' VAL . . . . . 0.53 ' HB ' ' CG2' ' A' ' 168' ' ' VAL . 1.9 t -101.39 -170.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 10.0 110.367 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -148.22 168.2 23.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 10.0 110.184 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 115' ' ' THR . 7.3 p -176.99 164.8 2.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.157 -0.965 . . . . 10.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' SER . . . . . 0.503 ' N ' HD13 ' A' ' 165' ' ' LEU . 60.2 m -146.27 128.23 15.49 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.605 -0.685 . . . . 10.0 109.939 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ALA . . . . . 0.529 ' O ' ' C ' ' A' ' 160' ' ' LEU . . . -63.86 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.621 -0.674 . . . . 10.0 111.597 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.561 ' CD2' ' CD2' ' B' ' 29' ' ' PHE . 0.4 OUTLIER -28.06 -52.95 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.57 1.176 . . . . 10.0 109.481 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' THR . . . . . 0.541 HG23 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -95.74 -102.28 0.16 Allowed 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.731 -1.122 . . . . 10.0 110.43 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' GLN . . . . . 0.597 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 159.27 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 -178.989 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' LYS . . . . . 0.502 ' HD2' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -97.35 27.37 4.25 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.566 -1.254 . . . . 10.0 112.545 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' GLY . . . . . 0.44 ' C ' ' HB3' ' A' ' 157' ' ' CYS . . . 135.95 14.96 0.95 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 118.708 -1.711 . . . . 10.0 111.99 177.945 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' LEU . . . . . 0.58 ' CD2' ' CB ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -49.36 -53.44 22.34 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.177 -1.778 . . . . 10.0 109.833 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -67.14 -29.49 69.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.463 0.649 . . . . 10.0 109.588 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ASN . . . . . 0.482 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 1.3 m120 -62.3 -32.11 72.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 10.0 111.4 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' VAL . . . . . 0.53 ' CG2' ' HB ' ' A' ' 155' ' ' VAL . 46.5 t -70.88 -49.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.448 -1.408 . . . . 10.0 109.171 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' PHE . . . . . 0.425 ' O ' HG13 ' A' ' 173' ' ' ILE . 92.4 t80 -59.31 -22.92 61.97 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.762 -0.586 . . . . 10.0 110.452 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.506 ' O ' HD23 ' A' ' 174' ' ' LEU . 80.8 m-20 -59.17 -50.93 72.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 10.0 110.416 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' GLU . . . . . 0.495 ' HA ' HD22 ' A' ' 174' ' ' LEU . 51.2 mp0 -65.88 -31.52 72.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.036 -1.04 . . . . 10.0 108.883 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' ALA . . . . . . . . . . . . . . . -63.63 -24.19 67.69 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.814 -0.554 . . . . 10.0 109.625 179.815 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ILE . . . . . 0.528 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 72.1 mt -63.61 -43.71 98.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.091 -1.044 . . . . 10.0 108.542 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' LEU . . . . . 0.532 ' N ' HD11 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.75 -42.33 67.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.188 -0.945 . . . . 10.0 110.179 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.1 -0.12 30.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.526 -0.733 . . . . 10.0 109.985 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' ALA . . . . . 0.538 ' CB ' HG13 ' A' ' 4' ' ' ILE . . . -83.33 -44.57 14.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.898 . . . . 10.0 109.851 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LEU . . . . . 0.546 ' HA ' ' HA ' ' A' ' 2' ' ' GLN . 0.6 OUTLIER -98.85 -17.56 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.822 . . . . 10.0 109.302 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLU . . . . . 0.429 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 118.003 -0.998 . . . . 10.0 110.028 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -126.54 150.2 48.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -1.131 . . . . 10.0 110.196 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 3' ' ' LYS . . . . . 0.449 ' O ' ' CG ' ' B' ' 3' ' ' LYS . 0.0 OUTLIER -117.96 88.41 2.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.365 -0.835 . . . . 10.0 109.272 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 4' ' ' GLU . . . . . 0.447 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 2.8 mm-40 -87.36 178.18 6.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.84 0.828 . . . . 10.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 5' ' ' ARG . . . . . 0.632 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.12 -149.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 6' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -72.14 0.37 7.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 CA-C-N 119.325 0.795 . . . . 10.0 110.589 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 7' ' ' GLU . . . . . 0.464 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.8 mm-40 46.21 -165.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 10.0 110.427 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 1.4 pp -80.35 -45.01 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 10.0 111.661 -179.412 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 9' ' ' SER . . . . . 0.446 ' O ' ' N ' ' A' ' 47' ' ' GLY . 67.4 m -122.08 151.32 41.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.221 . . . . 10.0 112.137 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 10' ' ' LEU . . . . . 0.71 ' N ' ' CD1' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -170.84 97.53 0.43 Allowed Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.363 -0.836 . . . . 10.0 113.153 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 11' ' ' PRO . . . . . 0.54 ' HG2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -77.35 156.08 32.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 N-CA-C 107.877 -1.624 . . . . 10.0 107.877 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -117.68 163.49 16.39 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.587 -1.321 . . . . 10.0 111.966 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.32 176.46 10.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.073 -1.084 . . . . 10.0 108.073 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -170.63 144.61 2.38 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.784 -1.198 . . . . 10.0 110.792 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 15' ' ' GLU . . . . . 0.418 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 59.8 tt0 -141.02 137.48 32.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -121.77 129.44 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.036 -1.04 . . . . 10.0 112.103 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.54 98.22 3.31 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 18' ' ' ILE . . . . . 0.788 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.4 mp -106.45 140.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 19' ' ' HIS . . . . . 0.572 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 33.8 m170 -132.89 123.59 26.29 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.353 -0.842 . . . . 10.0 110.94 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 20' ' ' VAL . . . . . 0.511 HG23 ' HB ' ' A' ' 36' ' ' VAL . 1.4 p -140.37 130.18 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 10.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 21' ' ' GLY . . . . . 0.545 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -145.56 10.87 1.71 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.846 -1.302 . . . . 10.0 109.846 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 22' ' ' PHE . . . . . 0.43 ' HB3' ' CG2' ' B' ' 25' ' ' VAL . 0.4 OUTLIER -143.93 85.26 1.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.334 -1.098 . . . . 10.0 109.794 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 23' ' ' ASP . . . . . 0.494 ' OD2' ' HG2' ' A' ' 34' ' ' PRO . 10.7 t70 -56.97 151.88 14.01 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.565 0.698 . . . . 10.0 111.416 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 24' ' ' ALA . . . . . 0.48 ' CB ' ' O ' ' B' ' 23' ' ' ASP . . . 69.98 19.84 6.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.557 -0.714 . . . . 10.0 111.099 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 25' ' ' VAL . . . . . 0.43 ' CG2' ' HB3' ' B' ' 22' ' ' PHE . 25.3 t -110.47 -39.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.057 -1.027 . . . . 10.0 110.281 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 26' ' ' THR . . . . . 0.562 ' HA ' ' CB ' ' A' ' 18' ' ' CYS . 6.5 m -94.95 -10.04 32.23 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.314 -0.866 . . . . 10.0 112.605 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' CG ' ' A' ' 27' ' ' LYS . . . -111.59 -15.89 9.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.629 -1.788 . . . . 10.0 108.629 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 28' ' ' GLU . . . . . 0.413 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -86.3 108.44 18.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.638 1.209 . . . . 10.0 110.683 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 29' ' ' PHE . . . . . 0.576 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.4 OUTLIER -117.8 113.65 22.11 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.31 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 30' ' ' THR . . . . . 0.547 HG23 ' CD1' ' A' ' 28' ' ' PHE . 42.3 p -154.78 -61.94 0.12 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.483 -0.78 . . . . 10.0 109.78 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 31' ' ' GLY . . . . . 0.468 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -165.52 66.62 0.21 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.611 -1.796 . . . . 10.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 32' ' ' ILE . . . . . 0.554 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 11.2 pt -102.77 168.26 9.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.349 -1.089 . . . . 10.0 110.947 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 33' ' ' PRO . . . . . 0.554 ' HD2' ' HB ' ' B' ' 32' ' ' ILE . 38.6 Cg_endo -65.42 178.12 2.27 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.004 1.528 . . . . 10.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 34' ' ' GLU . . . . . 0.54 ' OE1' ' CA ' ' A' ' 12' ' ' GLY . 6.6 tp10 -36.56 160.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.744 0.783 . . . . 10.0 111.89 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 35' ' ' GLN . . . . . 0.428 ' HB2' ' OG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -72.63 -70.68 0.33 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.583 -0.698 . . . . 10.0 112.768 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 36' ' ' TRP . . . . . 0.586 ' CB ' ' CG2' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -141.27 22.44 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 10.0 110.101 -179.003 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 37' ' ' ALA . . . . . 0.612 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . . . 178.96 99.7 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.817 0.818 . . . . 10.0 110.026 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 38' ' ' ARG . . . . . 0.528 ' CG ' ' HB3' ' B' ' 41' ' ' GLN . 1.8 ttt180 -84.16 45.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.902 -1.518 . . . . 10.0 106.902 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 39' ' ' LEU . . . . . 0.56 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -50.63 -39.0 49.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.981 -1.009 . . . . 10.0 112.081 -177.466 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' B' B ' 40' ' ' LEU . . . . . 0.629 ' CD1' ' CH2' ' A' ' 97' ' ' TRP . 1.8 pp -105.56 16.9 24.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 10.0 111.174 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 41' ' ' GLN . . . . . 0.528 ' HB3' ' CG ' ' B' ' 38' ' ' ARG . 2.3 mt-30 -142.4 26.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.425 -0.797 . . . . 10.0 110.545 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 11.4 t -121.81 -171.06 2.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 10.0 110.158 179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -93.19 33.67 1.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.012 . . . . 10.0 110.76 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 44' ' ' ASN . . . . . 0.455 ' HB2' ' HB2' ' A' ' 71' ' ' SER . 64.3 t30 -51.81 -64.45 0.81 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 10.0 110.385 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 82.2 mt -109.98 -70.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 10.0 109.972 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.558 0 CA-C-O 118.099 -0.953 . . . . 10.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.431 0.634 . . . . 10.0 110.088 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 98.7 mm-40 -129.57 -24.32 2.77 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.552 -0.717 . . . . 10.0 109.997 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 95.1 m -57.84 115.93 3.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 10.0 111.289 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.588 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -122.85 132.77 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.592 -0.843 . . . . 10.0 109.898 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.888 ' HB3' HG22 ' A' ' 75' ' ' THR . 46.4 mmtt -123.2 101.65 7.5 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.4 t -113.24 145.17 41.47 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.885 0.85 . . . . 10.0 112.801 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -151.59 -176.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HD1' ' B' ' 36' ' ' TRP . 22.7 m -91.59 108.55 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 10.0 109.877 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 10' ' ' GLY . 2.1 t -113.47 -170.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.977 -1.077 . . . . 10.0 110.19 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 137.62 -144.77 16.26 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.73 20.22 16.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 10.0 109.637 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.19 75.87 0.99 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.034 -1.626 . . . . 10.0 109.034 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.63 -174.59 3.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.427 -1.043 . . . . 10.0 109.766 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.534 ' HB ' ' CD2' ' B' ' 29' ' ' PHE . 40.6 t -67.13 161.77 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 10.0 110.647 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -53.02 111.97 1.98 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.427 -1.869 . . . . 10.0 108.427 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -48.61 -28.0 3.18 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.179 -1.189 . . . . 10.0 110.428 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.489 HG23 HD12 ' A' ' 20' ' ' LEU . 26.1 m -66.01 -30.62 71.2 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.15 -0.969 . . . . 10.0 111.072 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 16.3 p -63.2 -9.89 13.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.175 . . . . 10.0 109.733 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' B' ' 29' ' ' PHE . 5.3 mt -94.81 -34.08 12.62 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.424 -0.797 . . . . 10.0 110.184 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD12 HG23 ' A' ' 17' ' ' THR . 79.4 mt -46.49 -30.46 2.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 26' ' ' ASN 0.251 1.7 mm -85.76 -47.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.749 0.785 . . . . 10.0 109.552 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 21' ' ' ILE . 57.1 m -48.26 -38.34 18.4 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.887 -1.125 . . . . 10.0 108.115 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.778 ' CG ' HD11 ' A' ' 165' ' ' LEU . 20.2 m-85 -68.06 -31.0 70.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 25' ' ' THR . 95.9 m -76.83 -51.87 10.52 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.847 -0.533 . . . . 10.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 24' ' ' THR . 2.9 t -178.99 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 115.875 1.805 . . . . 10.0 115.875 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.699 ' OD1' HG23 ' A' ' 21' ' ' ILE . 15.4 m120 -67.47 -8.32 32.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.088 -1.632 . . . . 10.0 113.085 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' O ' ' O ' ' B' ' 27' ' ' GLY . 26.4 pttt 33.59 -131.6 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 121.195 -0.941 . . . . 10.0 111.262 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.7 p90 . . . . . 0 N--CA 1.507 2.381 0 O-C-N 120.5 -1.375 . . . . 10.0 112.815 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' B' ' 19' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 123.266 1.507 . . . . 10.0 114.945 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.978 ' CG2' HG11 ' B' ' 25' ' ' VAL 0.279 2.5 t -45.99 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 116.226 1.936 . . . . 10.0 116.226 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.855 ' N ' HG12 ' A' ' 36' ' ' VAL . 4.6 t80 -32.29 154.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.944 0.878 . . . . 10.0 111.603 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -168.03 83.0 0.18 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.565 ' HB3' HD13 ' B' ' 18' ' ' ILE . 50.8 t30 -113.66 109.11 18.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.159 -0.963 . . . . 10.0 110.017 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.718 ' CD2' ' HA ' ' B' ' 16' ' ' HIS . 3.6 t80 -128.43 128.35 44.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.694 -0.629 . . . . 10.0 110.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -141.58 94.68 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG13 ' HB2' ' B' ' 14' ' ' PHE 0.296 51.6 t -163.94 178.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.394 0.616 . . . . 10.0 110.227 -176.845 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 18.9 m -125.24 126.47 45.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.522 -0.736 . . . . 10.0 109.502 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.939 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -73.76 165.71 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 10.0 110.024 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.548 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 51.5 mtt -137.69 104.79 5.41 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.199 -1.0 . . . . 10.0 109.531 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' B' ' 7' ' ' GLU . 38.7 mt -123.75 128.79 74.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.751 -0.593 . . . . 10.0 109.734 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 52.18 21.39 8.13 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 8.61 67.87 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.155 -1.203 . . . . 10.0 110.302 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.47 112.56 65.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.836 -1.39 . . . . 10.0 110.976 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 44.1 Cg_endo -74.4 139.35 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.951 1.501 . . . . 10.0 110.251 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.939 ' HB2' HG12 ' A' ' 44' ' ' VAL . 3.6 t80 -117.49 121.37 40.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -0.95 . . . . 10.0 109.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -74.82 119.82 19.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.625 -1.297 . . . . 10.0 110.151 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 13.3 mt -123.11 149.31 44.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.915 . . . . 10.0 110.592 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 5' ' ' LYS . . . -170.89 110.47 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.752 -1.213 . . . . 10.0 110.332 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -150.41 168.43 24.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -1.211 . . . . 10.0 110.076 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 67' ' ' LEU . 32.9 p90 -166.36 140.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.882 -1.136 . . . . 10.0 111.218 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 3.8 t70 -119.72 159.99 23.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.394 -0.816 . . . . 10.0 110.444 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -56.31 -168.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.841 0.829 . . . . 10.0 112.131 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.735 ' HB2' ' CD1' ' A' ' 64' ' ' TYR . . . 53.5 70.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.637 -0.664 . . . . 10.0 110.865 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 66' ' ' ARG . . . -75.33 -9.04 84.3 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.326 -1.91 . . . . 10.0 108.326 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.602 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 8.9 tt0 -156.45 24.51 0.35 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.422 -1.046 . . . . 10.0 110.22 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 4.4 tt0 79.3 -7.63 1.71 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.494 -0.754 . . . . 10.0 109.963 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 1.1 m-20 -94.28 -11.47 30.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 10.0 108.759 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.735 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 46.7 m-85 62.65 26.67 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.142 -1.059 . . . . 10.0 108.142 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 30.5 t0 -114.88 -36.49 4.45 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.111 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 6.3 mmt85 -56.4 -26.18 52.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.905 -1.122 . . . . 10.0 108.934 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.67 HD11 ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.81 10.88 36.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.827 -0.546 . . . . 10.0 109.751 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.666 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -82.79 -20.37 0.28 Allowed Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 113.356 0.873 . . . . 10.0 113.356 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 45.9 Cg_endo -75.33 2.07 7.2 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 N-CA-C 110.37 -0.665 . . . . 10.0 110.37 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.638 ' N ' HD23 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -52.78 -64.47 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.199 -0.938 . . . . 10.0 112.184 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.497 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 24.8 t 41.98 27.08 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.367 -1.458 . . . . 10.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 71' ' ' SER . 2.1 t80 -179.84 120.6 0.22 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 10.0 110.744 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.28 118.33 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.838 1.441 . . . . 10.0 110.225 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.71 66.74 1.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.964 -1.085 . . . . 10.0 110.584 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -145.33 99.99 3.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.16 -0.963 . . . . 10.0 109.703 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.66 ' CA ' HG21 ' A' ' 108' ' ' THR . 21.6 m-20 -24.63 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.953 0.724 . . . . 10.0 112.953 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.542 HG11 ' CB ' ' A' ' 176' ' ' ALA . 1.0 OUTLIER -94.03 118.0 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.964 -1.085 . . . . 10.0 110.781 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.504 ' CB ' HG21 ' A' ' 9' ' ' VAL . 97.3 m-85 -111.33 127.6 55.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 10.0 111.203 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 111' ' ' LEU . 1.9 mm? -95.44 97.69 9.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 10.0 108.342 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' HB ' ' A' ' 9' ' ' VAL . 1.6 m -106.41 148.18 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.397 -0.814 . . . . 10.0 109.822 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 7.2 t -138.17 122.37 18.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.855 -1.153 . . . . 10.0 110.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 43.0 p90 -124.46 172.95 8.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.239 -0.913 . . . . 10.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.851 ' OG ' HG22 ' A' ' 85' ' ' VAL . 47.3 t -105.24 148.81 26.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.7 -1.25 . . . . 10.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 19.4 m -86.79 19.02 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.478 -0.764 . . . . 10.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.851 HG22 ' OG ' ' A' ' 83' ' ' SER . 35.3 m -128.0 48.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.39 -0.819 . . . . 10.0 110.513 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.53 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 49.6 m -123.2 166.18 19.27 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.287 -0.883 . . . . 10.0 110.358 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 48.2 Cg_endo -72.44 105.9 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.965 1.508 . . . . 10.0 111.056 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 39.46 42.9 0.93 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.304 -0.873 . . . . 10.0 110.836 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 86' ' ' SER . 65.6 m -79.15 -49.51 12.47 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.022 . . . . 10.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.652 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 34.9 t80 -57.53 -30.38 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.336 -0.853 . . . . 10.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 57.4 mm-40 -70.47 -15.09 62.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.051 -1.031 . . . . 10.0 110.504 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.697 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.63 -21.46 30.28 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.18 -1.008 . . . . 10.0 111.38 -178.796 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.697 HG13 ' ND2' ' A' ' 92' ' ' ASN . 4.2 m -87.68 -16.38 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 117.765 -1.574 . . . . 10.0 108.544 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.816 ' HE2' HD22 ' A' ' 145' ' ' LEU . 1.2 mmtp -68.68 -37.45 79.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 4.4 pt-20 -95.51 8.29 43.73 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.306 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -111.18 -52.09 2.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.58 -1.248 . . . . 10.0 112.595 -178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 19.7 m95 -95.59 -18.79 20.29 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.502 -0.749 . . . . 10.0 111.527 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.1 t -85.45 -46.85 0.61 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 120.97 -1.081 . . . . 10.0 111.5 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 51.4 Cg_endo -74.85 -24.15 13.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 108.759 -1.285 . . . . 10.0 108.759 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.526 ' C ' HG12 ' A' ' 101' ' ' ILE . 8.6 tt0 -87.59 -22.53 24.72 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.526 HG12 ' C ' ' A' ' 100' ' ' GLU . 4.2 mm 60.55 125.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.825 HG21 ' OG1' ' A' ' 108' ' ' THR . 1.2 m -40.84 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.04 -1.037 . . . . 10.0 109.761 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.7 ' N ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -108.32 10.74 27.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.222 -0.924 . . . . 10.0 109.778 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 17.5 m80 82.52 14.08 0.47 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.902 0.382 . . . . 10.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.537 ' HB3' ' CD ' ' A' ' 106' ' ' PRO . 1.6 t -170.65 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 118.814 -1.154 . . . . 10.0 112.029 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 105' ' ' CYS . 37.7 Cg_endo -63.77 -21.74 69.51 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.338 1.178 . . . . 10.0 111.532 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 106' ' ' PRO . 2.0 mttt 47.49 51.13 14.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.733 -1.229 . . . . 10.0 108.843 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.825 ' OG1' HG21 ' A' ' 102' ' ' THR . 1.4 m -45.65 150.48 0.93 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 108' ' ' THR . 39.6 Cg_endo -63.66 149.92 89.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.746 1.393 . . . . 10.0 112.748 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -131.73 109.5 10.21 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.068 HD13 HG11 ' A' ' 152' ' ' VAL . 1.9 mm? -77.2 95.4 4.29 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.028 -1.069 . . . . 10.0 109.388 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' C ' ' CG2' ' A' ' 113' ' ' VAL . 19.1 mt -75.62 142.02 42.73 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.154 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -148.32 -177.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.596 -1.315 . . . . 10.0 112.332 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -125.4 120.61 3.95 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.752 -1.739 . . . . 10.0 108.752 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 23.4 p -78.32 139.2 38.85 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.829 -1.395 . . . . 10.0 110.952 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 115' ' ' THR . 56.7 mt-30 34.41 57.38 0.67 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.204 0.526 . . . . 10.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -79.75 -27.72 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 10.0 110.592 -178.822 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.813 ' OD2' HG21 ' A' ' 161' ' ' THR . 25.1 t0 -51.88 61.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.835 0.826 . . . . 10.0 111.966 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.706 ' N ' ' O ' ' A' ' 117' ' ' ILE . 20.1 tp 152.79 -39.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.705 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 1.2 mpt_? -46.04 -25.66 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.855 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 4.1 p30 -84.69 -0.13 52.4 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.306 -0.872 . . . . 10.0 111.145 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.831 ' O ' HD13 ' A' ' 126' ' ' ILE . 5.8 p-10 -83.32 160.14 60.35 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.88 -1.138 . . . . 10.0 109.944 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.83 22.73 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.55 1.289 . . . . 10.0 111.769 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.479 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 4.2 m -109.68 -47.6 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.976 -1.078 . . . . 10.0 109.79 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.809 HG22 ' OD1' ' A' ' 122' ' ' ASP . 6.6 t -78.44 -27.14 46.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.828 -1.915 . . . . 10.0 105.828 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 122' ' ' ASP 0.283 1.0 OUTLIER -53.19 -28.82 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.391 -1.337 . . . . 10.0 107.391 177.02 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -52.99 -40.41 63.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.578 0.704 . . . . 10.0 111.308 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -60.4 -34.13 73.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.472 -0.767 . . . . 10.0 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.79 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -61.89 -39.16 90.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.831 -1.168 . . . . 10.0 109.659 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -44.56 66.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.568 -0.708 . . . . 10.0 111.232 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -54.66 -18.12 4.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.149 -0.97 . . . . 10.0 110.376 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 133' ' ' LYS . 2.6 t-20 -126.9 -53.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.735 -1.228 . . . . 10.0 110.279 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -137.03 116.01 12.36 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.596 -0.69 . . . . 10.0 110.518 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -74.97 -3.02 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.697 -0.627 . . . . 10.0 110.5 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 93.97 6.55 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.579 -0.701 . . . . 10.0 109.277 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 49.3 Cg_endo -73.75 161.71 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.898 1.473 . . . . 10.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.53 HG12 ' CG ' ' A' ' 90' ' ' PHE . 1.5 tp -100.83 134.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.266 -0.896 . . . . 10.0 109.505 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.513 ' H ' HD12 ' A' ' 137' ' ' ILE . 20.1 p -120.04 165.56 17.59 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.352 -0.843 . . . . 10.0 109.807 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.71 -35.13 29.41 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.829 1.436 . . . . 10.0 111.063 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.09 -15.81 63.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.113 -0.992 . . . . 10.0 110.999 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.3 m -98.36 -36.54 9.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -64.57 -29.12 70.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.802 . . . . 10.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.81 -41.47 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.019 -1.05 . . . . 10.0 109.314 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -56.16 -36.96 68.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 10.0 109.465 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.816 HD22 ' HE2' ' A' ' 94' ' ' LYS . 4.2 tp -62.06 -49.55 75.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.116 -0.99 . . . . 10.0 108.902 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.11 -44.44 94.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.036 . . . . 10.0 109.406 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -78.04 -7.96 57.58 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.525 -0.734 . . . . 10.0 110.297 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.9 t70 -98.6 -37.88 9.36 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.388 1.09 . . . . 10.0 109.235 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.033 HD22 ' O ' ' A' ' 149' ' ' LEU 0.26 0.0 OUTLIER -103.07 -1.15 29.64 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.513 -178.658 . . . . . . . . 4 4 . 1 . 001 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 24.4 mttm 67.78 54.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 10.0 111.359 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -86.24 -150.36 0.15 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.068 HG11 HD13 ' A' ' 111' ' ' LEU . 9.9 p -116.54 -51.56 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.567 -1.333 . . . . 10.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.893 ' HD3' HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -172.42 142.31 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.603 -1.31 . . . . 10.0 111.238 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 142' ' ' ALA . 46.6 t80 -94.26 110.15 21.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 10.0 109.069 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.893 HG13 ' HD3' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -116.19 -168.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.973 -1.08 . . . . 10.0 112.087 -178.595 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -153.27 147.04 25.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 10.0 110.781 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 25.6 p -148.07 152.51 37.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 10.0 111.275 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' ' OG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -135.14 86.23 2.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.192 -1.41 . . . . 10.0 107.192 178.66 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.643 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . . . -24.37 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.7 tp -94.12 -55.05 3.34 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.403 -1.436 . . . . 10.0 112.196 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.813 HG21 ' OD2' ' A' ' 118' ' ' ASP . 24.5 p -64.68 -26.68 68.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.96 -1.087 . . . . 10.0 111.008 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.536 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.8 mt-30 79.26 77.05 0.05 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.528 -0.732 . . . . 10.0 112.024 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.523 ' HD2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -78.35 47.99 0.73 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 10.0 110.006 178.319 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 163' ' ' LYS . . . 43.49 41.68 5.46 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.706 -1.358 . . . . 10.0 109.706 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.778 HD11 ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.11 2.51 3.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 10.0 112.704 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 165' ' ' LEU . 26.9 tttp -58.47 -23.64 58.28 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.782 -1.199 . . . . 10.0 108.694 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -76.86 -17.61 58.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.692 -0.63 . . . . 10.0 111.038 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.825 HG22 ' HB ' ' A' ' 155' ' ' VAL . 42.8 t -67.9 -41.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.822 -1.174 . . . . 10.0 108.775 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -86.55 -47.57 9.12 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.599 0.714 . . . . 10.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.867 ' HA ' HD12 ' A' ' 173' ' ' ILE . 22.1 t0 -51.88 -35.14 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.336 -0.852 . . . . 10.0 111.789 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.6 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.3 mm-40 -90.02 -11.28 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.058 . . . . 10.0 110.771 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.831 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -91.74 -15.27 28.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.038 -1.097 . . . . 10.0 108.038 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 170' ' ' ASP . 53.9 mt -73.63 -49.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.097 -0.641 . . . . 10.0 109.322 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 171' ' ' GLU . 2.1 pt? -76.35 -19.12 58.5 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 118.813 -1.155 . . . . 10.0 111.113 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.41 -14.78 34.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 10.0 110.085 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.542 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -70.25 -44.87 67.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 10.0 109.653 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.7 OUTLIER -74.64 -29.09 61.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.744 0.783 . . . . 10.0 109.055 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -129.81 151.77 50.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 10.0 110.601 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.44 92.49 4.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 10.0 110.065 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.02 165.94 12.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.499 -0.75 . . . . 10.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.664 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.62 -149.76 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.664 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -73.23 96.18 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 N-CA-C 109.772 -0.896 . . . . 10.0 109.772 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.751 ' HB2' HG22 ' A' ' 46' ' ' ILE . 19.6 mm-40 -49.56 -169.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.605 0.717 . . . . 10.0 110.249 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.706 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -77.64 -42.47 29.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.756 -1.215 . . . . 10.0 111.949 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.66 ' N ' HG12 ' B' ' 8' ' ' ILE . 20.7 t -134.78 172.67 12.65 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.06 -1.025 . . . . 10.0 111.348 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.644 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.5 pp -167.25 98.02 0.64 Allowed Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.293 -0.963 . . . . 10.0 111.805 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 38.4 Cg_endo -69.19 134.69 29.85 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 N-CA-C 108.001 -1.577 . . . . 10.0 108.001 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' B' ' 11' ' ' PRO . 0.9 OUTLIER -53.13 -169.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.689 -1.257 . . . . 10.0 111.388 -178.465 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.69 ' OD1' HG11 ' A' ' 42' ' ' VAL . 6.0 p30 -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.992 0.901 . . . . 10.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.878 ' HB2' HG13 ' A' ' 42' ' ' VAL . 49.9 m-85 -54.92 -165.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.8 0.81 . . . . 10.0 111.547 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.682 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.5 tt0 -43.59 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.718 ' HA ' ' CD2' ' A' ' 40' ' ' TYR . 14.2 p80 -146.58 -169.41 3.27 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.569 0.699 . . . . 10.0 111.871 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -79.85 163.17 24.59 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.972 0.891 . . . . 10.0 112.423 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.785 ' N ' HD12 ' B' ' 18' ' ' ILE . 3.3 mp -126.19 175.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.798 -0.816 . . . . 10.0 108.798 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.549 ' CB ' ' OG1' ' A' ' 35' ' ' THR . 79.3 m-70 -141.59 115.55 9.24 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.491 -1.38 . . . . 10.0 112.094 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.612 ' H ' ' N ' ' A' ' 37' ' ' PHE . 18.4 t -144.96 103.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 114.055 1.132 . . . . 10.0 114.055 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.684 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . -150.69 -72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.614 -0.995 . . . . 10.0 110.614 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.827 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.1 t80 175.86 134.02 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.66 -1.607 . . . . 10.0 106.66 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 89.0 m-20 -39.0 131.37 1.41 Allowed 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 122.043 0.925 . . . . 10.0 111.252 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.586 ' HB1' ' OE2' ' B' ' 28' ' ' GLU . . . 69.47 46.41 0.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.865 -0.522 . . . . 10.0 111.383 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.978 HG11 ' CG2' ' A' ' 36' ' ' VAL . 25.4 t -111.0 -57.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.919 -1.113 . . . . 10.0 109.181 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 38.6 m -51.85 -24.84 6.72 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.176 0.988 . . . . 10.0 109.228 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.667 ' HA3' ' HB2' ' A' ' 26' ' ' ASN . . . -115.63 46.25 1.19 Allowed Glycine 0 N--CA 1.482 1.757 0 N-CA-C 107.727 -2.149 . . . . 10.0 107.727 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.586 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 2.2 mt-10 -162.58 123.54 2.51 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.643 0.735 . . . . 10.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.751 ' HB2' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -122.24 129.26 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 178.643 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' GLY . 16.6 p -143.85 174.16 11.07 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.587 -0.696 . . . . 10.0 111.032 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' THR . . . 35.78 -152.65 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.448 -1.061 . . . . 10.0 110.448 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.425 ' O ' HG23 ' B' ' 32' ' ' ILE . 0.5 OUTLIER -150.81 70.45 8.69 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.99 . . . . 10.0 109.473 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.522 ' HB2' ' CH2' ' B' ' 36' ' ' TRP . 51.0 Cg_endo -73.61 177.85 7.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.573 1.828 . . . . 10.0 111.92 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' CZ3' ' B' ' 36' ' ' TRP . 24.3 tt0 -57.83 159.45 5.4 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 10.0 111.006 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 21.2 pt20 -83.51 11.82 6.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.719 -0.613 . . . . 10.0 111.376 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.753 ' HD1' HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER 70.18 36.53 1.85 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.768 0.794 . . . . 10.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -168.57 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.66 -0.65 . . . . 10.0 110.904 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CG ' ' OE1' ' B' ' 35' ' ' GLN . 2.2 mmt180 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 120.676 -1.265 . . . . 10.0 110.131 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.066 0.46 . . . . 10.0 110.122 . . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.714 ' HB3' HD23 ' A' ' 177' ' ' LEU . 1.8 mt-30 -95.75 -17.94 20.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -43.2 99.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.631 -0.668 . . . . 10.0 110.54 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.071 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -116.45 121.03 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 10.0 110.595 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.957 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -93.47 131.27 38.84 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.016 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.805 ' HB3' HD23 ' A' ' 55' ' ' LEU . 94.4 m -110.36 103.79 12.48 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.743 -1.223 . . . . 10.0 110.39 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 56' ' ' PHE . 46.1 t -142.82 162.8 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.229 -0.988 . . . . 10.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -80.46 152.14 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.157 -1.017 . . . . 10.0 109.432 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 10' ' ' GLY . 3.3 t -83.13 -170.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.255 -0.903 . . . . 10.0 110.193 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -95.58 42.16 2.36 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.776 -1.202 . . . . 10.0 111.218 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 80' ' ' VAL . 2.5 t0 -82.16 -31.35 30.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.707 -1.467 . . . . 10.0 109.006 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.551 ' HA2' ' C ' ' B' ' 34' ' ' GLU . . . 61.48 51.53 57.18 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.236 -1.546 . . . . 10.0 109.236 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.622 ' HB1' ' OE1' ' A' ' 116' ' ' GLN . . . -160.32 -77.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 10.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.883 HG13 ' HG ' ' A' ' 19' ' ' LEU . 89.5 t -112.17 117.94 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 10.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CZ2' ' B' ' 36' ' ' TRP . . . -98.95 143.79 16.82 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.784 -1.326 . . . . 10.0 109.784 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -65.4 -21.42 66.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 10.0 112.283 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -99.52 -36.14 9.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.389 -1.444 . . . . 10.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' B' ' 28' ' ' GLU . 26.2 p -73.71 -29.91 62.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.024 -1.047 . . . . 10.0 109.798 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.883 ' HG ' HG13 ' A' ' 14' ' ' VAL . 3.7 mm? -86.78 -18.02 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.868 -1.145 . . . . 10.0 110.49 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.52 -41.4 76.69 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.038 0.923 . . . . 10.0 108.878 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' B' ' 28' ' ' GLU . 7.3 mm -69.04 -39.78 80.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.71 0.767 . . . . 10.0 110.205 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -47.16 -45.93 23.15 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.585 -0.846 . . . . 10.0 109.814 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.648 ' CZ ' ' O ' ' A' ' 159' ' ' ALA . 4.9 m-85 -93.58 3.76 55.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.651 -1.281 . . . . 10.0 110.184 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 2.9 m -110.94 -21.25 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.816 -1.177 . . . . 10.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -88.07 -76.25 0.39 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.456 -1.403 . . . . 10.0 108.647 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 19.1 m120 -156.17 -33.66 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.563 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.575 ' HD2' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 175.03 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.188 0.518 . . . . 10.0 109.95 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.683 0 O-C-N 121.183 -0.948 . . . . 10.0 112.26 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 5.8 t . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.352 0.596 . . . . 10.0 110.865 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 62' ' ' GLU . 65.3 t 61.57 5.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.747 -0.595 . . . . 10.0 111.101 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' O ' ' O ' ' A' ' 38' ' ' ASP . 1.7 t80 -42.29 100.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.476 -0.765 . . . . 10.0 109.829 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.767 ' H ' ' H ' ' B' ' 19' ' ' HIS . 0.5 OUTLIER -47.19 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.884 0.85 . . . . 10.0 111.648 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.796 ' HB3' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -156.55 -167.61 2.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.932 -1.73 . . . . 10.0 111.417 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.632 ' CE1' HD13 ' B' ' 18' ' ' ILE . 7.8 m-30 -112.96 153.48 27.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.411 -0.805 . . . . 10.0 112.852 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.627 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . . . -135.64 119.69 17.57 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' B' ' 15' ' ' GLU . 0.5 OUTLIER -171.81 176.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.368 -1.458 . . . . 10.0 111.709 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' TYR . 66.1 m -129.49 130.92 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.773 -0.58 . . . . 10.0 110.21 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 46' ' ' ILE . 13.2 t -105.17 150.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 10.0 109.42 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.716 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 94.7 mtp -117.65 95.62 5.02 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.798 -1.556 . . . . 10.0 106.798 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.75 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 3.2 mp -102.8 130.46 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.136 0.493 . . . . 10.0 111.513 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 40.1 27.69 0.14 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.837 -1.173 . . . . 10.0 110.745 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.76 18.18 45.41 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.011 -1.288 . . . . 10.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.0 mm-40 -114.87 98.98 51.35 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.294 . . . . 10.0 109.87 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 53.3 Cg_endo -77.89 118.34 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.972 1.511 . . . . 10.0 110.94 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.926 ' O ' HG23 ' A' ' 43' ' ' THR . 2.7 m-85 -89.05 117.6 28.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.992 -1.068 . . . . 10.0 109.385 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -100.56 104.19 15.53 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.065 -1.022 . . . . 10.0 111.029 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -158.08 178.44 10.2 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.444 -1.302 . . . . 10.0 111.381 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.851 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.32 111.46 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.965 -1.654 . . . . 10.0 108.965 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 6' ' ' CYS . 1.8 tm? -130.47 132.8 45.85 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.846 -1.385 . . . . 10.0 110.781 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.766 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 p90 -152.57 155.31 37.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 10.0 109.789 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 15.8 t0 -99.15 179.8 4.49 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.631 -1.293 . . . . 10.0 110.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.7 m -104.81 117.3 33.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 10.0 111.137 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . . . -65.7 91.2 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 10.0 110.256 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -68.92 63.07 0.5 Allowed Glycine 0 N--CA 1.485 1.908 0 N-CA-C 107.816 -2.114 . . . . 10.0 107.816 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ALA . 22.0 tt0 75.03 21.03 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.985 -0.715 . . . . 10.0 110.569 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 36' ' ' VAL . 9.0 mm-40 -50.07 -46.08 53.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.338 -1.345 . . . . 10.0 109.68 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER 162.37 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.163 -0.961 . . . . 10.0 110.923 178.839 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -178.06 44.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.916 -1.115 . . . . 10.0 109.3 -179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 13.9 p-10 -81.4 38.5 0.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.306 -0.871 . . . . 10.0 110.169 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -49.91 -28.06 6.13 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.272 -0.892 . . . . 10.0 109.111 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 67' ' ' LEU . 3.1 mp -81.67 11.12 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 10.0 109.361 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.635 ' C ' HD23 ' A' ' 70' ' ' LEU . 4.5 ptt85 -60.19 -24.76 1.63 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.852 . . . . 10.0 112.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 47.9 Cg_endo -89.92 86.57 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 109.523 -0.991 . . . . 10.0 109.523 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.1 OUTLIER -117.64 -78.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.965 . . . . 10.0 111.831 -178.617 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.5 m 62.03 39.62 13.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 10.0 109.365 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 76.79 41.94 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 10.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.43 113.44 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.135 1.598 . . . . 10.0 110.385 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -163.62 89.59 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 10.0 110.184 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 5' ' ' LYS . 23.0 m -145.89 98.64 3.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.104 -0.997 . . . . 10.0 109.173 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 19.9 t70 -25.77 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.046 0.45 . . . . 10.0 112.15 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -107.68 126.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.947 -1.096 . . . . 10.0 109.897 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.4 m-85 -130.33 139.41 50.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 10.0 110.921 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.708 ' CD1' HG13 ' A' ' 168' ' ' VAL . 1.9 mm? -113.6 98.54 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 11' ' ' ASP . 9.3 p -97.37 137.47 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 10.0 110.846 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 115' ' ' THR . 65.3 m -121.47 112.15 18.16 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.263 -0.898 . . . . 10.0 110.609 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CZ ' ' HD1' ' A' ' 90' ' ' PHE . 35.1 p90 -129.24 160.37 33.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.214 -0.928 . . . . 10.0 110.538 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 116' ' ' GLN . 51.0 m -79.16 162.54 25.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.34 -0.85 . . . . 10.0 111.277 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 137' ' ' ILE . 30.7 m -102.15 23.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.672 -0.643 . . . . 10.0 110.349 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.74 ' CG2' HD23 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -142.02 28.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.201 -0.937 . . . . 10.0 109.875 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.586 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -85.93 -173.84 0.46 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.03 . . . . 10.0 110.294 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.637 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . 50.4 Cg_endo -75.2 72.09 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.889 1.468 . . . . 10.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 m 46.87 40.64 9.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.351 -0.843 . . . . 10.0 110.189 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.602 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 11.8 p -76.46 -25.68 54.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 10.0 110.689 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 74.1 t80 -75.1 -18.7 60.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.475 -0.765 . . . . 10.0 112.617 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.79 -17.34 36.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.458 -1.401 . . . . 10.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.674 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -88.84 -14.9 35.85 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.051 -1.03 . . . . 10.0 109.673 179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 1.086 HG23 ' HD3' ' A' ' 94' ' ' LYS . 12.8 m -84.76 -20.8 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 118.863 -1.135 . . . . 10.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 1.086 ' HD3' HG23 ' A' ' 93' ' ' VAL . 20.8 mmtt -80.08 -30.54 39.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.919 0.866 . . . . 10.0 109.544 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -96.88 9.44 41.87 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.65 -0.82 . . . . 10.0 109.415 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.8 -51.43 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.094 -1.042 . . . . 10.0 111.044 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 35.5 m95 -90.53 -40.52 11.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.187 -0.946 . . . . 10.0 112.376 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 92.0 t -53.0 -47.75 94.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.581 -1.324 . . . . 10.0 111.135 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.3 Cg_endo -75.14 -17.26 19.39 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.215 1.113 . . . . 10.0 110.644 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -69.52 -23.95 63.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.097 -1.002 . . . . 10.0 111.551 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 18.0 mt 54.75 99.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.564 -1.335 . . . . 10.0 109.776 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.58 HG21 ' HG2' ' A' ' 106' ' ' PRO . 21.0 m -46.89 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 10.0 109.6 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 37.6 t60 -110.46 -6.73 14.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.269 -0.894 . . . . 10.0 108.752 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 154.79 -49.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.61 ' H ' ' HD3' ' A' ' 106' ' ' PRO . 0.6 OUTLIER -176.14 46.19 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.716 -0.675 . . . . 10.0 110.746 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' H ' ' A' ' 105' ' ' CYS . 57.0 Cg_endo -78.94 -29.47 3.33 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.288 1.152 . . . . 10.0 109.539 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 71.1 57.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.53 0.681 . . . . 10.0 110.511 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.574 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 2.9 m -46.55 149.6 1.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 10.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 38.4 Cg_endo -63.56 114.22 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.683 1.359 . . . . 10.0 110.762 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 2.2 t80 -115.11 107.6 15.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.458 -0.776 . . . . 10.0 109.173 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.0 ' CD1' HG11 ' A' ' 152' ' ' VAL . 2.0 mm? -96.32 103.69 15.61 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.59 0.71 . . . . 10.0 109.61 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 83.7 mt -85.88 143.29 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.663 -0.648 . . . . 10.0 111.029 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.6 t -141.86 170.53 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.992 -1.068 . . . . 10.0 111.482 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -134.93 98.13 0.3 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 106.934 -2.467 . . . . 10.0 106.934 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.712 HG22 ' SG ' ' A' ' 157' ' ' CYS . 27.1 p -114.55 -171.12 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 10.0 111.501 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.622 ' OE1' ' HB1' ' A' ' 13' ' ' ALA . 13.4 mt-30 56.55 18.44 3.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.53 -0.731 . . . . 10.0 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.007 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -82.94 -22.01 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.934 -0.706 . . . . 10.0 109.297 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 7.7 p-10 -51.52 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 122.051 0.929 . . . . 10.0 111.057 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.744 ' N ' ' O ' ' A' ' 117' ' ' ILE . 17.3 tp 157.85 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.681 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.03 -43.01 14.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.0 p-10 -50.29 -23.49 2.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.507 0.67 . . . . 10.0 109.682 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 76.9 m-20 -87.59 138.08 31.87 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.993 -0.683 . . . . 10.0 110.201 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.4 Cg_endo -80.09 23.37 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.174 1.618 . . . . 10.0 110.865 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 t -102.52 -50.65 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.882 -1.136 . . . . 10.0 110.285 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.624 ' HB ' HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.57 -26.45 45.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.295 1.1 mp -61.24 -23.22 29.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.555 -1.202 . . . . 10.0 107.801 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -49.09 -41.06 34.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.586 0.708 . . . . 10.0 110.501 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -89.26 -30.59 18.38 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.608 0.718 . . . . 10.0 110.397 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.8 mp -74.73 -49.85 19.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 10.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.416 ' HB2' HG23 ' A' ' 126' ' ' ILE . . . -61.74 -42.68 99.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.599 -0.688 . . . . 10.0 110.394 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -53.69 -20.07 4.92 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.007 -1.077 . . . . 10.0 108.997 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.637 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 1.2 t-20 -85.16 -44.09 13.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 10.0 109.648 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 133.95 19.79 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.538 0.685 . . . . 10.0 109.926 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.23 -4.16 58.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 10.0 110.269 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -119.18 103.04 48.02 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 10.0 111.54 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.1 Cg_endo -69.92 162.4 42.3 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.033 1.544 . . . . 10.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.591 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -99.55 138.28 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 10.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.8 p -126.07 170.21 10.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 10.0 109.737 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 43.3 Cg_endo -68.63 -15.02 40.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.531 1.279 . . . . 10.0 110.46 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.38 -42.04 54.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 10.0 109.762 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -75.52 -40.95 56.31 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.732 -0.605 . . . . 10.0 110.553 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.89 -44.94 65.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 10.0 111.269 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.8 -43.93 48.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 10.0 109.619 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 67.4 tttt -66.42 -40.32 89.48 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.508 -0.745 . . . . 10.0 109.294 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 148' ' ' ASP . 2.1 tt -63.66 -48.26 77.94 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.559 -0.856 . . . . 10.0 109.42 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.645 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.42 -42.12 86.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 10.0 108.93 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -80.66 1.86 28.26 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.679 -0.808 . . . . 10.0 108.991 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.607 ' HB3' HD13 ' A' ' 149' ' ' LEU . 14.4 t70 -79.21 -31.82 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.48 -0.763 . . . . 10.0 112.214 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.921 HD13 ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -135.65 -8.17 2.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.032 -1.668 . . . . 10.0 113.088 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.676 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 6.2 pttt 125.93 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.899 0.88 . . . . 10.0 111.703 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.645 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -116.83 -177.44 3.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.882 -1.136 . . . . 10.0 109.65 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.0 HG11 ' CD1' ' A' ' 111' ' ' LEU . 1.1 t -90.16 -78.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.766 -1.208 . . . . 10.0 109.531 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.833 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -171.93 164.53 6.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.023 -1.048 . . . . 10.0 111.093 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 57.8 t80 -104.76 101.1 10.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.411 -0.806 . . . . 10.0 109.562 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' A' ' 168' ' ' VAL . 38.2 t -87.76 169.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 10.0 109.137 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' N ' HG12 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -134.64 121.67 21.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.929 -1.107 . . . . 10.0 109.737 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG22 ' A' ' 115' ' ' THR . 25.6 p -141.23 169.99 16.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.051 -1.031 . . . . 10.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.583 ' N ' ' HB2' ' A' ' 162' ' ' GLN . 1.1 t -143.76 118.6 9.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.691 -0.631 . . . . 10.0 109.576 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.893 ' HB1' ' CZ ' ' B' ' 29' ' ' PHE . . . -12.25 -54.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.569 0.951 . . . . 10.0 113.569 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.5 pp -131.9 -3.82 3.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.471 -1.393 . . . . 10.0 111.788 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 158' ' ' SER . 59.5 m -98.05 -90.17 0.28 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.664 -1.273 . . . . 10.0 111.995 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB2' ' N ' ' A' ' 158' ' ' SER . 1.7 mm-40 -38.3 -39.44 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.945 . . . . 10.0 111.98 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.62 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 18.4 ttpt 49.5 26.29 1.65 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.056 -1.058 . . . . 10.0 108.938 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -94.62 -8.3 59.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.008 -1.637 . . . . 10.0 109.008 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -49.81 -9.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.414 -1.051 . . . . 10.0 112.306 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.775 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.17 -46.19 65.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.352 -1.468 . . . . 10.0 111.061 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.405 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 3.0 m120 -59.39 -27.97 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 10.0 108.298 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' A' ' 155' ' ' VAL . 0.5 OUTLIER -51.48 -50.68 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.576 0.703 . . . . 10.0 110.897 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.584 ' N ' HG12 ' A' ' 168' ' ' VAL . 18.4 t80 -87.14 -25.74 23.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.499 -0.751 . . . . 10.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.0 t70 -50.39 -49.55 54.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 10.0 109.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.0 mp0 -67.12 -45.02 78.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 10.0 110.257 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.954 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -50.95 -21.21 1.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 10.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 177' ' ' LEU . 24.4 mm -70.07 -43.86 78.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 10.0 110.338 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.899 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.42 -23.82 34.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.577 -1.327 . . . . 10.0 111.068 -178.99 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.46 -11.55 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 10.0 111.322 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.071 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -80.42 -45.92 16.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.229 . . . . 10.0 109.991 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 173' ' ' ILE . 1.1 mp -89.99 -19.62 24.24 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.96 0.886 . . . . 10.0 108.917 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 10.0 110.337 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.473 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.576 -1.41 . . . . 10.0 109.576 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -75.89 145.08 40.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 10.0 109.99 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.543 ' CD ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -98.85 93.36 6.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.056 -1.028 . . . . 10.0 110.614 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.421 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 30.2 mm-40 -129.75 159.64 35.88 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.439 0.638 . . . . 10.0 110.49 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.26 -158.18 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 106.834 -1.543 . . . . 10.0 106.834 177.697 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -67.41 112.47 2.59 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 N-CA-C 109.236 -1.101 . . . . 10.0 109.236 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' HG22 ' A' ' 46' ' ' ILE . 12.1 tp10 -55.29 -128.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.605 0.717 . . . . 10.0 110.717 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -78.97 -101.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.892 -1.13 . . . . 10.0 109.682 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.666 ' H ' HG23 ' B' ' 8' ' ' ILE . 25.3 t -142.91 112.2 6.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.341 -1.475 . . . . 10.0 111.895 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -171.04 97.54 0.42 Allowed Pre-proline 0 N--CA 1.489 1.517 0 CA-C-O 121.632 0.73 . . . . 10.0 109.605 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.69 99.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.074 1.849 . . . . 10.0 111.214 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.4 m -136.62 98.41 3.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.691 -1.255 . . . . 10.0 109.748 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -167.4 138.79 3.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.63 -1.228 . . . . 10.0 112.364 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.579 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 58.3 m-85 -115.71 107.31 14.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.695 . . . . 10.0 110.305 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.655 ' HB3' HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -88.81 174.19 8.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.782 1.277 . . . . 10.0 113.242 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -90.0 -165.75 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.552 -1.204 . . . . 10.0 112.317 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -119.41 146.12 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.669 -0.645 . . . . 10.0 109.816 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.632 HD13 ' CE1' ' A' ' 40' ' ' TYR . 1.3 mp -76.77 173.06 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 10.0 112.463 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.767 ' H ' ' H ' ' A' ' 38' ' ' ASP . 27.4 m170 -141.95 117.28 10.16 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.436 0.902 . . . . 10.0 113.436 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.519 ' HB ' ' HD1' ' A' ' 37' ' ' PHE . 2.8 p -144.93 143.58 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.237 -0.914 . . . . 10.0 110.562 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 62' ' ' GLU . . . -148.12 30.69 1.33 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.668 -1.253 . . . . 10.0 110.178 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.699 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -171.69 91.26 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.021 -1.282 . . . . 10.0 110.392 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' B' ' 24' ' ' ALA . 4.1 m-20 -67.39 151.78 46.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.852 -1.155 . . . . 10.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.71 54.92 0.69 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.671 -0.643 . . . . 10.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.699 HG21 ' CD1' ' B' ' 22' ' ' PHE . 0.9 OUTLIER -113.61 -36.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.239 -0.984 . . . . 10.0 108.687 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.832 HG23 ' N ' ' B' ' 29' ' ' PHE 0.262 0.5 OUTLIER -149.62 11.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.125 -1.03 . . . . 10.0 112.946 -178.148 . . . . . . . . 4 4 . 1 . 002 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 59.09 30.56 67.17 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.719 -2.952 . . . . 10.0 105.719 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.602 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER 59.34 16.68 5.23 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.692 0.758 . . . . 10.0 109.328 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.893 ' CZ ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -143.26 147.82 35.41 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.211 0.529 . . . . 10.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.794 HG22 ' OG1' ' B' ' 26' ' ' THR . 19.0 p -134.81 -178.55 5.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.163 . . . . 10.0 110.213 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.19 -28.73 9.56 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.013 -1.089 . . . . 10.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.723 HG22 ' O ' ' B' ' 32' ' ' ILE . 31.4 mm -132.97 50.76 5.99 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.605 -1.527 . . . . 10.0 111.56 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.551 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 55.8 Cg_endo -75.5 150.58 36.28 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.615 1.324 . . . . 10.0 110.651 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.551 ' C ' ' HA2' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -75.12 -169.75 1.0 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.998 -1.064 . . . . 10.0 109.226 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 1.2 mp0 -76.43 20.4 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.19 -0.944 . . . . 10.0 110.779 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.639 ' CD2' HG11 ' A' ' 8' ' ' VAL . 8.5 m-90 65.7 20.71 11.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.802 -1.555 . . . . 10.0 106.802 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.862 ' HA ' HD11 ' A' ' 70' ' ' LEU . . . -155.02 83.06 1.08 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.482 ' HD2' ' OE2' ' B' ' 34' ' ' GLU . 22.2 tpt180 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 122.751 1.262 . . . . 10.0 107.988 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.602 ' CG ' HD22 ' A' ' 177' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.705 0.288 . . . . 10.0 110.41 . . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.588 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.1 pm0 -179.19 152.78 0.56 Allowed 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.166 -0.959 . . . . 10.0 110.002 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 52' ' ' THR . 85.1 m 61.42 48.43 5.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 113.707 1.003 . . . . 10.0 113.707 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -112.66 128.86 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.159 -1.588 . . . . 10.0 110.942 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 1.041 ' CB ' HG23 ' A' ' 75' ' ' THR . 4.1 mmtm -118.11 147.53 43.2 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.3 t -119.26 106.05 11.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.837 -1.165 . . . . 10.0 109.993 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 8' ' ' VAL . 4.0 t -128.41 170.88 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.769 -1.207 . . . . 10.0 110.966 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 16' ' ' LYS . 8.5 t -85.25 129.92 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.469 -0.769 . . . . 10.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 10' ' ' GLY . 40.6 t -132.46 176.55 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.972 -1.08 . . . . 10.0 111.567 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 131.95 -173.27 20.7 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.067 -1.613 . . . . 10.0 109.067 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 11' ' ' ASP . 2.3 p30 -84.67 15.43 3.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.432 . . . . 10.0 109.559 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.635 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 89.27 52.8 2.63 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.588 -1.805 . . . . 10.0 108.588 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -133.13 105.2 6.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.721 -0.87 . . . . 10.0 109.19 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 4.5 t 66.71 119.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -0.806 . . . . 10.0 109.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.503 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -90.13 115.07 4.5 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.912 -1.675 . . . . 10.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.54 -19.98 2.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.65 -1.5 . . . . 10.0 111.482 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.681 HG21 ' CG ' ' A' ' 57' ' ' ASP . 88.9 m -82.1 -41.8 20.03 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.721 -1.237 . . . . 10.0 111.809 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HA ' HG23 ' B' ' 26' ' ' THR . 23.7 p -79.73 1.79 25.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.809 -1.182 . . . . 10.0 109.909 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 159' ' ' ALA . 3.2 mm? -109.11 -41.31 4.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.843 -1.161 . . . . 10.0 109.52 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.804 HD12 HD21 ' A' ' 165' ' ' LEU . 1.5 tp -48.14 -34.07 9.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.629 HG13 HG22 ' B' ' 26' ' ' THR . 2.5 mm -73.83 -41.7 53.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.409 -0.959 . . . . 10.0 108.409 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 23.0 t -48.55 -41.76 31.36 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.445 -0.902 . . . . 10.0 110.117 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -97.26 -0.63 46.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.556 -1.34 . . . . 10.0 109.405 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 17.5 m -109.99 -19.01 13.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.012 . . . . 10.0 112.58 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -116.76 -72.34 0.69 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.231 -1.543 . . . . 10.0 111.544 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 34.1 m-20 -147.73 -33.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.311 -1.356 . . . . 10.0 112.773 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 165.83 -138.8 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 O-C-N 121.331 -0.856 . . . . 10.0 111.606 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.131 -0.981 . . . . 10.0 113.457 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG23 ' B' ' 20' ' ' VAL . 22.3 p . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 58' ' ' THR . 58.1 t 62.99 -43.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.72 -0.613 . . . . 10.0 111.358 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.724 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 7.8 p90 -36.38 100.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.161 0.981 . . . . 10.0 110.374 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.952 ' HB3' HD11 ' A' ' 55' ' ' LEU . 1.5 m-20 -167.71 102.92 0.49 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 117.297 -1.761 . . . . 10.0 112.489 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.623 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 61.4 t30 -147.8 98.78 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.069 -1.019 . . . . 10.0 108.361 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 75.6 m-85 -139.73 147.05 40.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.86 -1.136 . . . . 10.0 112.65 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' B' ' 16' ' ' HIS . . . -140.85 98.55 3.42 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.835 HG23 ' O ' ' B' ' 14' ' ' PHE . 7.5 p -135.23 -173.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -0.854 . . . . 10.0 110.269 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 42' ' ' VAL . 94.1 m -136.72 167.29 21.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.48 152.24 37.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.215 -1.031 . . . . 10.0 108.215 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.737 ' C ' HD12 ' A' ' 46' ' ' ILE . 7.1 mtm -144.67 131.15 19.82 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.001 -0.68 . . . . 10.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.737 HD12 ' C ' ' A' ' 45' ' ' MET . 1.4 mp -147.94 114.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.204 -0.935 . . . . 10.0 110.693 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 67.51 6.5 42.14 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.934 -1.267 . . . . 10.0 109.934 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.54 24.06 6.31 Favored Glycine 0 N--CA 1.489 2.179 0 O-C-N 121.064 -1.257 . . . . 10.0 110.008 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 13.7 pt-20 -118.67 111.33 37.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.33 . . . . 10.0 109.723 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.49 146.94 57.03 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.87 1.458 . . . . 10.0 111.542 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 44' ' ' VAL . 2.8 m-85 -136.71 107.12 6.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.348 -0.845 . . . . 10.0 111.122 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.818 HG21 ' H ' ' A' ' 3' ' ' THR . 47.3 m -83.64 153.04 24.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.164 -0.96 . . . . 10.0 109.169 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 53' ' ' LEU . 1.4 pp -167.26 166.34 14.81 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.716 -1.24 . . . . 10.0 110.765 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.61 131.92 2.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.405 -1.478 . . . . 10.0 109.405 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.041 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.63 124.03 49.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -1.034 . . . . 10.0 109.403 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.913 ' N ' HD22 ' A' ' 55' ' ' LEU . 5.1 m-85 -135.96 104.51 5.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.11 -0.994 . . . . 10.0 110.259 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.681 ' CG ' HG21 ' A' ' 17' ' ' THR . 23.5 t0 -105.34 146.36 29.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.141 -0.975 . . . . 10.0 110.231 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.735 ' O ' HG13 ' A' ' 36' ' ' VAL . 66.5 m -45.72 131.15 9.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.345 -0.847 . . . . 10.0 109.283 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -101.26 89.75 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.607 -0.683 . . . . 10.0 111.305 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . -53.41 -23.78 20.49 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.558 -2.217 . . . . 10.0 107.558 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' B' ' 21' ' ' GLY . 29.1 tt0 178.02 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 122.004 -0.704 . . . . 10.0 109.516 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 64' ' ' TYR . 9.6 tm-20 -53.62 -51.95 61.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.129 -0.982 . . . . 10.0 110.687 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER 177.05 -17.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.275 -0.891 . . . . 10.0 110.988 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.54 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 19.9 p90 -119.74 16.53 12.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.004 -1.06 . . . . 10.0 109.395 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 38.0 t0 -37.42 -30.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.729 -0.607 . . . . 10.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.517 ' HG3' HD23 ' A' ' 67' ' ' LEU . 12.6 ptp180 -51.03 -22.22 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 10.0 110.004 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.9 mm? -106.95 11.41 29.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 10.0 109.048 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 10.6 ttp-105 -54.48 -37.98 60.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.775 -0.578 . . . . 10.0 111.641 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 39.8 Cg_endo -68.06 59.19 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 109.953 -0.826 . . . . 10.0 109.953 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -92.72 -57.34 2.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.61 -0.681 . . . . 10.0 109.986 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.584 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 1.5 t 58.44 53.24 6.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.245 -0.909 . . . . 10.0 109.628 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.638 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 1.2 p90 -149.11 113.72 3.6 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 118.564 -1.254 . . . . 10.0 112.542 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.23 94.65 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.509 1.473 . . . . 10.0 109.971 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.98 76.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.791 -1.193 . . . . 10.0 110.791 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 75' ' ' THR . . . . . 1.041 HG23 ' CB ' ' A' ' 5' ' ' LYS . 54.1 m -144.83 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.179 -0.951 . . . . 10.0 109.626 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 75' ' ' THR . 2.3 m-20 -18.95 -53.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.449 0.642 . . . . 10.0 111.843 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -88.84 123.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.442 -0.903 . . . . 10.0 109.352 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.497 ' CD2' HG21 ' A' ' 9' ' ' VAL . 93.8 m-85 -116.01 139.96 49.74 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.403 -0.81 . . . . 10.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 168' ' ' VAL . 1.6 mm? -108.15 98.17 7.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.621 HG23 ' HA2' ' A' ' 10' ' ' GLY . 9.2 p -92.84 122.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.619 -0.832 . . . . 10.0 110.708 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.82 104.3 11.19 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.564 -0.71 . . . . 10.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.499 ' C ' HG22 ' A' ' 115' ' ' THR . 13.0 p90 -136.57 179.82 6.14 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.221 -0.925 . . . . 10.0 109.239 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.433 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 90.2 p -75.28 161.5 29.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.861 -1.149 . . . . 10.0 111.333 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' OH ' ' A' ' 154' ' ' TYR . 6.6 m -78.78 -9.87 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.616 . . . . 10.0 111.134 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.929 HG11 HD23 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -115.17 -82.29 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.99 -1.069 . . . . 10.0 108.116 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.5 t 66.38 147.66 0.11 Allowed Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 120.407 -1.433 . . . . 10.0 111.79 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 134' ' ' GLN . 49.9 Cg_endo -76.76 167.78 24.73 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 124.384 1.728 . . . . 10.0 112.247 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 1.0 OUTLIER 71.77 15.35 5.87 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.985 178.855 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 90' ' ' PHE . 1.5 t 61.64 102.01 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.023 -1.048 . . . . 10.0 110.474 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -46.76 -31.77 3.2 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.395 -0.922 . . . . 10.0 109.046 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 73.9 tt0 -53.55 -29.39 36.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 10.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.665 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -82.17 -11.82 58.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 10.0 109.535 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.66 HG23 ' OD1' ' A' ' 92' ' ' ASN . 89.1 t -89.63 -36.04 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.181 -0.949 . . . . 10.0 109.391 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.67 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.14 -17.75 62.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.458 -0.897 . . . . 10.0 109.285 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.84 -4.82 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.111 -0.993 . . . . 10.0 110.804 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -78.37 -41.63 32.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 10.0 110.469 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.501 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 24.2 m95 -80.52 -27.84 37.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.428 -0.795 . . . . 10.0 110.195 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.716 HG22 HD22 ' A' ' 149' ' ' LEU . 93.9 t -52.83 -50.77 79.47 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.159 -0.963 . . . . 10.0 110.861 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.5 Cg_endo -68.35 -17.95 44.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.277 1.146 . . . . 10.0 109.731 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.553 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -58.02 -29.57 65.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 10.0 110.142 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 7.0 mt 63.01 106.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.301 -0.874 . . . . 10.0 111.417 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -49.17 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.363 -0.977 . . . . 10.0 108.363 178.653 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.699 ' H ' HG23 ' A' ' 102' ' ' THR . 40.4 m170 -105.19 -7.62 18.9 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.162 -0.961 . . . . 10.0 110.181 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER 174.68 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 10.0 109.764 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.832 ' O ' HG22 ' A' ' 102' ' ' THR . 81.3 m -119.2 144.91 37.16 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.058 . . . . 10.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.05 91.67 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 123.679 1.358 . . . . 10.0 110.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.561 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -153.36 18.31 0.55 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.201 -0.937 . . . . 10.0 109.591 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -56.25 131.58 75.4 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.254 -0.904 . . . . 10.0 109.634 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 135.69 25.7 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.557 1.293 . . . . 10.0 109.637 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.505 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -132.48 106.01 7.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.288 -0.882 . . . . 10.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 152' ' ' VAL . 3.1 mm? -74.91 95.61 2.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.972 -1.862 . . . . 10.0 105.972 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 46.2 mt -70.08 139.07 52.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.558 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.9 t -149.6 167.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.141 . . . . 10.0 111.454 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.463 ' O ' ' CG2' ' A' ' 117' ' ' ILE . . . -124.52 107.27 1.0 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.956 -2.057 . . . . 10.0 107.956 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.499 HG22 ' C ' ' A' ' 82' ' ' PHE . 3.5 t -93.88 155.62 17.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -1.189 . . . . 10.0 110.543 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 48.73 48.65 19.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.832 . . . . 10.0 109.894 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.988 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -82.62 -13.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 10.0 110.662 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 51.3 p30 -52.01 51.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 112.3 0.481 . . . . 10.0 112.3 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.738 ' N ' ' O ' ' A' ' 117' ' ' ILE . 12.3 tp 152.47 -34.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' A' ' 84' ' ' VAL . 10.9 tpp180 -55.54 -33.87 64.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.504 0.669 . . . . 10.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.15 -14.43 60.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 10.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.738 ' O ' HD13 ' A' ' 126' ' ' ILE . 70.9 m-20 -82.7 142.12 45.33 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.233 -0.917 . . . . 10.0 110.837 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.5 Cg_endo -75.44 22.99 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.12 1.59 . . . . 10.0 111.558 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -103.07 -50.57 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.757 -1.214 . . . . 10.0 109.967 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 t -74.26 -28.16 61.09 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.411 -2.07 . . . . 10.0 105.411 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 122' ' ' ASP 0.29 0.6 OUTLIER -51.1 -30.88 10.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 176.888 . . . . . . . . 4 4 . 1 . 003 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.3 -47.82 46.72 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.885 0.85 . . . . 10.0 110.235 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -37.29 62.58 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.466 0.651 . . . . 10.0 110.005 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.929 HD23 HG11 ' A' ' 85' ' ' VAL . 3.4 mp -55.64 -27.1 47.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.114 0.959 . . . . 10.0 109.942 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.25 -28.39 57.1 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.405 -1.434 . . . . 10.0 109.022 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -69.94 -17.31 63.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.015 -0.674 . . . . 10.0 109.982 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.486 ' HB3' ' CD ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -129.25 34.28 4.42 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.204 -1.398 . . . . 10.0 112.589 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 55.91 63.94 1.88 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.135 -0.978 . . . . 10.0 110.225 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.834 ' O ' HG12 ' A' ' 85' ' ' VAL . 5.9 mt-30 -128.86 80.99 2.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 140.13 39.44 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.78 . . . . 10.0 109.901 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.48 ' N ' HG13 ' A' ' 85' ' ' VAL . 42.6 Cg_endo -66.53 161.65 40.31 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.203 1.633 . . . . 10.0 111.741 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.574 HG12 ' CE2' ' A' ' 90' ' ' PHE . 3.5 tp -126.64 139.92 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 10.0 109.479 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -118.78 165.42 16.84 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.323 -0.86 . . . . 10.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.9 Cg_endo -65.67 -21.57 58.72 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.8 1.421 . . . . 10.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -70.54 -47.66 59.29 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.283 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -77.9 -42.15 34.24 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.916 -0.714 . . . . 10.0 110.292 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.88 90.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.912 -1.118 . . . . 10.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 139' ' ' PRO . 20.4 mm-40 -52.95 -48.19 67.55 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.483 -0.887 . . . . 10.0 110.132 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -62.18 -34.63 76.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.175 -0.953 . . . . 10.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 8.8 tp -66.46 -50.08 64.52 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.905 -1.122 . . . . 10.0 108.222 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.965 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.09 -41.62 88.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.284 -0.885 . . . . 10.0 109.95 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 147' ' ' ARG . 40.3 mmm-85 -78.61 -7.29 57.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.344 -0.847 . . . . 10.0 110.18 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 2.5 m-20 -76.88 -48.66 17.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.028 -1.045 . . . . 10.0 110.806 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.798 HD12 ' H ' ' A' ' 149' ' ' LEU . 2.2 mp -102.09 9.84 39.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 10.0 109.819 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 5.6 mtpt 81.51 23.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.028 0.918 . . . . 10.0 110.512 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.26 -176.34 0.21 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 111' ' ' LEU . 2.5 p -84.99 -77.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.773 -1.204 . . . . 10.0 111.83 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.877 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -173.66 -179.04 1.72 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.437 -1.414 . . . . 10.0 110.889 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.713 ' OH ' HG12 ' A' ' 84' ' ' VAL . 68.1 t80 -108.7 120.86 43.7 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 10.0 109.778 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -124.51 -169.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.226 -0.922 . . . . 10.0 109.349 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -157.2 144.42 18.62 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.291 -1.364 . . . . 10.0 112.679 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 27.4 p -157.49 162.43 38.89 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.448 0.642 . . . . 10.0 110.133 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.6 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 18.9 p -133.14 172.84 12.12 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 108.49 -0.93 . . . . 10.0 108.49 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.737 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -54.96 -64.85 0.7 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.894 0.702 . . . . 10.0 112.894 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.0 pp -132.91 -3.83 3.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.66 -1.275 . . . . 10.0 112.13 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.539 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.4 m -96.33 -53.56 3.57 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.65 -1.282 . . . . 10.0 113.167 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.565 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -63.25 -53.03 59.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.757 -1.215 . . . . 10.0 111.327 -178.406 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' THR . 0.4 OUTLIER 66.19 27.78 10.25 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 -177.728 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.51 -17.23 42.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -49.98 -18.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.186 . . . . 10.0 110.796 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.836 ' N ' HD22 ' A' ' 165' ' ' LEU . 1.5 tttt -71.97 -31.44 66.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.681 -1.262 . . . . 10.0 109.658 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -69.38 -45.1 70.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 10.0 109.582 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.019 HG22 ' HB ' ' A' ' 155' ' ' VAL . 31.1 t -53.31 -18.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.661 0.743 . . . . 10.0 110.2 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 m-85 -84.3 -40.52 17.87 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 10.0 111.902 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.62 ' O ' HD22 ' A' ' 174' ' ' LEU . 22.8 t70 -65.69 -52.19 53.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.89 -1.131 . . . . 10.0 112.268 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.748 ' OE2' HD12 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -63.92 -25.53 68.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.773 -1.204 . . . . 10.0 109.972 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -66.87 -32.07 73.09 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.264 -0.897 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 49.0 mm -62.74 -50.27 80.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.413 -0.804 . . . . 10.0 109.696 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.854 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -72.63 -34.07 67.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.56 -0.712 . . . . 10.0 111.073 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.662 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -85.24 -2.35 57.95 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.154 -0.966 . . . . 10.0 110.202 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -87.12 -22.31 25.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.052 -1.03 . . . . 10.0 110.129 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -100.22 -20.38 15.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 10.0 108.793 179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 118.09 -0.957 . . . . 10.0 110.426 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' ' 49' ' ' GLU . 46.4 m -128.4 156.65 42.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.297 -1.119 . . . . 10.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -81.66 97.66 8.01 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.151 -0.968 . . . . 10.0 108.582 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.055 . . . . 10.0 111.024 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.722 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -72.24 -154.47 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.722 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 38.2 Cg_endo -65.74 73.87 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-N 119.062 0.701 . . . . 10.0 110.523 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.53 ' HB2' HG22 ' A' ' 46' ' ' ILE . 3.3 tp10 -53.32 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.591 -0.693 . . . . 10.0 110.073 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.692 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -79.56 -50.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.7 -1.25 . . . . 10.0 112.25 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.658 ' N ' HG12 ' B' ' 8' ' ' ILE . 61.0 m -88.82 146.72 24.81 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.808 -1.182 . . . . 10.0 110.994 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.44 HD23 ' O ' ' B' ' 8' ' ' ILE . 0.7 OUTLIER -170.8 98.05 0.43 Allowed Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.359 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 45' ' ' MET . 51.4 Cg_endo -86.16 97.56 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.229 1.647 . . . . 10.0 109.073 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.1 p -68.37 160.61 29.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.07 -1.019 . . . . 10.0 111.894 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.537 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.2 m-20 -124.14 155.86 37.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' VAL . 69.0 m-85 -85.33 156.09 21.05 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.028 0.918 . . . . 10.0 112.672 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 15.9 pt-20 -120.09 154.71 34.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.609 0.719 . . . . 10.0 110.316 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -49.87 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 10.0 111.142 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.67 ' O ' HG23 ' B' ' 18' ' ' ILE . 4.3 t -159.5 144.37 15.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.672 -1.268 . . . . 10.0 110.685 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.67 HG23 ' O ' ' B' ' 17' ' ' THR . 0.8 OUTLIER -160.67 177.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.721 -0.612 . . . . 10.0 109.613 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.2 t-80 -143.07 160.23 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.675 -1.266 . . . . 10.0 111.548 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.791 HG22 ' H ' ' B' ' 22' ' ' PHE . 5.8 p -69.74 148.46 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.192 0.996 . . . . 10.0 112.711 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -127.31 42.68 1.43 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.132 -2.387 . . . . 10.0 107.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -178.94 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.528 -0.983 . . . . 10.0 109.705 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.631 ' O ' HG23 ' B' ' 25' ' ' VAL . 17.3 p-10 -57.95 155.12 11.18 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.85 0.833 . . . . 10.0 112.688 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.21 57.98 0.63 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.781 -0.575 . . . . 10.0 112.37 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' B' ' 22' ' ' PHE . 42.5 t -113.01 -26.83 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.987 -1.071 . . . . 10.0 109.72 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.629 HG22 HG13 ' A' ' 21' ' ' ILE . 3.3 m -107.91 -22.23 12.52 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.611 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -90.49 35.2 3.9 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 106.923 -2.471 . . . . 10.0 106.923 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 28' ' ' PHE . 19.6 mt-10 -149.92 120.41 7.43 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.475 -1.014 . . . . 10.0 110.304 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.667 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 3.8 t80 -124.21 142.71 51.01 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.25 -0.906 . . . . 10.0 108.701 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.5 p -141.06 -46.59 0.39 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.153 -0.967 . . . . 10.0 109.566 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.11 51.02 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.449 -1.86 . . . . 10.0 108.449 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 21.1 mm -73.55 132.64 80.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.835 -0.803 . . . . 10.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 56.3 Cg_endo -80.54 79.88 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.718 1.378 . . . . 10.0 112.243 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' B' ' 33' ' ' PRO . 33.7 tt0 173.61 122.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.005 -1.059 . . . . 10.0 111.126 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.635 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 10.4 pt20 -78.3 -37.73 44.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.706 -0.622 . . . . 10.0 109.658 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.619 ' CG ' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 152.52 33.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.752 0.787 . . . . 10.0 109.066 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -139.97 -21.74 0.87 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.716 -0.615 . . . . 10.0 110.096 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.467 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 10.0 mmm180 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.128 . . . . 10.0 109.397 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.555 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 6.4 tmm? . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.14 0.495 . . . . 10.0 109.943 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 75.17 51.09 0.08 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 -178.935 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.86 ' HA ' HG21 ' A' ' 52' ' ' THR . 2.2 m -173.13 75.0 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.467 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -105.3 136.36 39.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.167 -1.583 . . . . 10.0 110.026 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -118.33 114.25 22.67 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.82 105.3 17.3 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.518 -1.363 . . . . 10.0 110.734 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.721 ' HB ' HG21 ' A' ' 75' ' ' THR . 45.7 t -136.3 145.45 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.315 -0.954 . . . . 10.0 110.675 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 17' ' ' THR . 29.6 m -77.96 141.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.657 -0.652 . . . . 10.0 109.278 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.893 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.5 p -161.38 172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.138 -0.976 . . . . 10.0 110.205 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.579 ' N ' HG22 ' A' ' 9' ' ' VAL . . . 149.54 176.22 22.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -49.34 -21.94 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.252 . . . . 10.0 110.373 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 139.28 45.84 0.07 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.556 -1.418 . . . . 10.0 109.556 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.2 -91.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -1.193 . . . . 10.0 110.039 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.893 HG21 ' O ' ' A' ' 9' ' ' VAL . 2.8 t 50.26 -125.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 10.0 111.148 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 96.53 7.47 57.96 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 108.378 -1.889 . . . . 10.0 108.378 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.792 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -57.96 -18.6 24.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.038 -1.272 . . . . 10.0 109.477 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.479 HG21 HG11 ' A' ' 8' ' ' VAL . 4.9 t -86.48 -24.9 25.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 15' ' ' GLY . 26.9 p -97.7 -8.22 29.18 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.029 -1.044 . . . . 10.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt -74.6 -38.36 62.62 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -59.29 -37.81 78.62 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 177.204 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.044 HG23 HG21 ' A' ' 25' ' ' THR . 7.2 mm -70.59 -51.38 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 115.032 -0.985 . . . . 10.0 108.651 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.69 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 17.3 p -51.3 -40.41 58.94 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.178 -0.952 . . . . 10.0 109.546 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.618 ' CE1' ' O ' ' A' ' 160' ' ' LEU . 10.7 t80 -79.89 -32.71 40.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.9 -1.125 . . . . 10.0 110.862 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' LEU . 33.9 p -97.04 -9.63 27.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 10.0 112.789 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' THR . . . . . 1.044 HG21 HG23 ' A' ' 21' ' ' ILE . 81.1 p -102.18 -88.07 0.39 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.133 -1.604 . . . . 10.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.72 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.2 p30 -123.55 -33.21 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 116.997 -1.881 . . . . 10.0 113.029 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 152.94 -141.84 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 CA-C-N 119.052 0.842 . . . . 10.0 111.638 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.768 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.191 0.996 . . . . 10.0 110.505 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 105.577 -2.009 . . . . 10.0 105.577 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 HG23 ' A' ' 58' ' ' THR . 3.2 t -79.36 -96.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.485 -0.759 . . . . 10.0 111.2 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' B' ' 18' ' ' ILE . 3.5 t80 -62.78 112.26 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 119.635 -1.915 . . . . 10.0 108.148 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 55' ' ' LEU . 3.0 t0 -150.79 111.27 4.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 10.0 111.488 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.553 ' HA ' ' CE1' ' A' ' 56' ' ' PHE . 7.8 m-20 -120.65 97.93 5.79 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 12.2 t80 -132.37 125.48 30.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.399 -0.813 . . . . 10.0 110.972 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' C ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.38 96.38 2.98 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.466 -2.05 . . . . 10.0 105.466 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 43' ' ' THR . 2.2 t -149.76 -177.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.895 -1.122 . . . . 10.0 111.864 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.61 ' H ' HG12 ' A' ' 42' ' ' VAL . 18.6 m -163.16 176.78 9.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.457 -0.571 . . . . 10.0 109.457 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.83 HG12 ' CD1' ' A' ' 46' ' ' ILE . 98.5 t -145.49 134.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.921 -1.112 . . . . 10.0 108.871 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.636 ' HB3' HD13 ' B' ' 10' ' ' LEU . 58.0 mtp -85.31 128.23 34.62 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 117.362 -1.735 . . . . 10.0 107.698 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -124.84 94.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.751 -1.218 . . . . 10.0 108.97 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 62.73 19.88 61.19 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.51 34.32 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.392 -1.483 . . . . 10.0 109.392 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' ILE . 4.6 tt0 -112.64 95.91 34.6 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.391 -1.064 . . . . 10.0 110.84 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.7 138.64 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.867 1.456 . . . . 10.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 4.7 t80 -110.75 110.87 21.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 10.0 109.56 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 3' ' ' THR . 89.4 m -68.49 128.33 36.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.217 -0.927 . . . . 10.0 111.749 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 52' ' ' THR . 13.3 mt -134.59 138.67 44.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.249 -0.907 . . . . 10.0 109.864 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -170.43 126.52 1.35 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.853 HD11 ' OD1' ' A' ' 38' ' ' ASP . 3.0 pp -144.45 160.28 41.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 10.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 17.7 m-85 -158.5 146.72 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 10.0 109.053 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 10.7 t0 -153.89 175.75 12.97 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.945 -1.097 . . . . 10.0 110.938 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' THR . . . . . 1.027 HG23 HG13 ' A' ' 36' ' ' VAL . 1.8 t -45.89 166.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.646 -0.659 . . . . 10.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -100.5 89.76 4.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.458 -0.776 . . . . 10.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -62.33 -57.33 17.24 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 106.704 -2.558 . . . . 10.0 106.704 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.578 ' HG2' ' CA ' ' B' ' 21' ' ' GLY . 17.8 mt-30 -62.52 -21.48 65.56 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.658 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 51.02 66.97 1.02 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.669 0.747 . . . . 10.0 111.33 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 37' ' ' PHE . 13.1 p-10 -119.18 23.59 11.24 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.654 -0.654 . . . . 10.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 1.2 p90 -177.4 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 10.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 51.39 21.02 1.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.064 . . . . 10.0 111.271 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 9.6 mmt180 -56.61 -30.27 63.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.697 -1.252 . . . . 10.0 108.971 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.607 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 4.6 mm? -79.03 7.69 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.68 -0.638 . . . . 10.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.686 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 9.8 ttp180 -60.35 -22.86 1.03 Allowed Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.118 -0.989 . . . . 10.0 112.195 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 44.2 Cg_endo -90.01 22.95 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 N-CA-C 109.263 -1.091 . . . . 10.0 109.263 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? -33.68 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.741 -0.6 . . . . 10.0 111.335 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.537 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 58.3 m -37.46 -34.22 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.554 0.693 . . . . 10.0 110.213 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' LEU . 28.4 t80 -84.71 115.93 62.98 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.387 -0.821 . . . . 10.0 109.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.89 150.09 33.99 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.722 1.38 . . . . 10.0 111.395 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.4 56.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 10.0 110.257 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 5' ' ' LYS . 99.3 m -143.5 92.73 2.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.251 -0.906 . . . . 10.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 75' ' ' THR . 11.8 m-20 -31.9 -39.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.98 0.419 . . . . 10.0 111.913 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.4 m -114.26 135.05 55.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.332 1.063 . . . . 10.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . 71.3 m-85 -121.66 149.7 42.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.688 -0.632 . . . . 10.0 110.488 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.4 mm? -119.75 97.98 5.89 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.175 -0.953 . . . . 10.0 108.466 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 p -108.07 144.65 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.012 -1.055 . . . . 10.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 14' ' ' VAL . 42.0 t -144.7 134.94 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.235 -0.916 . . . . 10.0 110.627 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 19.1 p90 -142.08 171.66 13.75 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 85' ' ' VAL . 43.8 t -79.08 150.29 31.87 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.816 -1.178 . . . . 10.0 111.611 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 137' ' ' ILE . 27.3 m -102.54 -14.72 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.498 -0.751 . . . . 10.0 110.681 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.912 ' HB ' HD21 ' A' ' 129' ' ' LEU . 3.5 m -81.81 -41.83 18.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.701 -1.249 . . . . 10.0 108.676 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.7 m -54.31 120.3 25.11 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.382 -0.824 . . . . 10.0 110.28 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 55.7 Cg_endo -82.39 25.09 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.815 1.429 . . . . 10.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 9.0 t -62.64 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.99 -1.069 . . . . 10.0 109.898 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -122.53 65.61 0.95 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 10.0 111.683 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 1.8 t80 -64.54 -19.29 65.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.85 -1.156 . . . . 10.0 109.521 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' A' ' 94' ' ' LYS . 8.5 tt0 -69.65 -29.26 66.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.447 -0.783 . . . . 10.0 111.042 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.722 ' OD1' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -83.56 -15.07 50.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.177 . . . . 10.0 111.025 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.722 HG13 ' OD1' ' A' ' 92' ' ' ASN . 29.2 m -94.55 -26.69 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.827 -1.171 . . . . 10.0 108.998 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.809 ' CE ' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.66 -29.22 36.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.431 -0.907 . . . . 10.0 109.167 178.917 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -89.14 -4.77 58.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 10.0 110.603 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -83.97 -50.01 8.42 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.019 -1.051 . . . . 10.0 112.547 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 39.6 m95 -76.9 -24.08 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.055 -1.028 . . . . 10.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 149' ' ' LEU . 62.7 t -67.41 -51.89 30.96 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.646 -1.283 . . . . 10.0 111.606 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -72.85 -8.27 22.07 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.289 1.152 . . . . 10.0 110.416 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -81.38 -31.58 33.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 10.0 112.607 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 108' ' ' THR . 8.0 pt -129.25 -10.17 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.352 -1.468 . . . . 10.0 113.022 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.7 p -72.57 -5.23 35.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.492 -1.38 . . . . 10.0 110.656 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -64.61 -43.13 94.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.045 -1.034 . . . . 10.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -100.67 -27.84 13.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.485 -0.759 . . . . 10.0 109.355 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 102' ' ' THR . 74.3 m -120.49 82.18 32.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 40.1 Cg_endo -65.79 152.4 81.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.842 1.443 . . . . 10.0 110.347 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 6.8 mtmt 60.72 47.3 8.21 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.82 -0.55 . . . . 10.0 111.027 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 101' ' ' ILE . 89.0 m -72.97 133.87 81.54 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 37.0 Cg_endo -62.37 129.13 25.73 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.529 1.278 . . . . 10.0 109.747 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 6.6 t80 -136.96 111.34 8.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.358 -0.839 . . . . 10.0 109.722 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.917 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.4 mm? -90.99 99.86 12.82 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.722 0.772 . . . . 10.0 111.333 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.2 mt -74.29 148.92 41.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -147.15 179.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.822 -1.173 . . . . 10.0 111.391 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.626 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -122.35 133.41 9.24 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.894 -2.082 . . . . 10.0 107.894 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 82' ' ' PHE . 28.9 m -100.12 132.82 45.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.92 -1.341 . . . . 10.0 111.393 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 52.12 61.36 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 10.0 111.03 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -79.38 -19.96 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.045 -1.034 . . . . 10.0 109.249 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 119' ' ' LEU . 12.6 p-10 -48.82 61.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.16 0.981 . . . . 10.0 111.22 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 pp 158.56 -24.56 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.722 -1.126 . . . . 10.0 108.462 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 14.5 tpt180 -43.41 -44.31 5.66 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.592 0.71 . . . . 10.0 109.666 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.99 -11.19 7.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 10.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 43.7 t0 -104.83 120.31 50.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 10.0 110.534 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.49 24.43 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 10.0 111.035 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -105.85 -50.46 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.065 -1.022 . . . . 10.0 110.93 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 126' ' ' ILE . 6.0 t -72.09 -30.62 65.28 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.076 -2.194 . . . . 10.0 105.076 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.547 HG23 HD22 ' A' ' 129' ' ' LEU 0.304 0.8 OUTLIER -48.64 -26.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.211 -1.359 . . . . 10.0 107.862 176.309 . . . . . . . . 4 4 . 1 . 004 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -54.32 -36.71 64.04 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.181 0.991 . . . . 10.0 109.676 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -21.95 61.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.518 -0.739 . . . . 10.0 110.878 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HB ' ' A' ' 85' ' ' VAL . 4.0 mp -57.74 -37.79 74.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.292 -0.88 . . . . 10.0 109.627 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.82 82.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.525 -0.734 . . . . 10.0 109.867 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -51.17 -28.55 11.43 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.901 -1.12 . . . . 10.0 108.677 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.598 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 1.3 m120 -90.27 -66.77 0.89 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.228 -0.989 . . . . 10.0 110.553 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.599 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.5 mptp? -140.33 160.5 39.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.8 -0.563 . . . . 10.0 109.548 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.599 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -97.28 1.48 49.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 10.0 111.313 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -120.52 98.53 48.27 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 10.0 111.188 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' PRO . 42.2 Cg_endo -73.95 160.59 42.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.888 1.725 . . . . 10.0 111.255 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.68 136.95 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.954 -1.091 . . . . 10.0 109.997 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.536 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 73.0 p -128.23 167.78 17.72 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.434 -0.791 . . . . 10.0 110.822 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 39.2 Cg_endo -65.37 -12.45 34.94 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.941 1.495 . . . . 10.0 110.907 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 1.5 mt-10 -78.6 -15.61 58.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.094 . . . . 10.0 109.839 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.6 m -94.93 -45.1 7.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.185 -0.947 . . . . 10.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.57 69.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 10.0 110.571 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 2.8 tt0 -50.24 -34.64 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.853 . . . . 10.0 109.74 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -74.84 -47.4 30.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.338 -0.851 . . . . 10.0 110.284 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 1.035 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.1 tp -55.91 -44.7 78.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.02 -1.05 . . . . 10.0 109.409 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -61.74 -50.22 73.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 10.0 109.951 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -18.01 62.47 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.523 -0.871 . . . . 10.0 109.515 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 144' ' ' LYS . 9.7 m-20 -85.96 -57.65 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 10.0 110.856 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.061 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -84.67 4.24 33.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.157 -0.964 . . . . 10.0 110.754 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.84 ' N ' HD13 ' A' ' 149' ' ' LEU . 11.0 mttp 69.49 60.1 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.375 1.084 . . . . 10.0 112.352 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.967 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -96.96 -154.09 0.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.333 -0.849 . . . . 10.0 108.71 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.917 HG11 ' CD1' ' A' ' 111' ' ' LEU . 15.8 t -100.04 -81.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.207 -0.997 . . . . 10.0 108.657 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.641 ' N ' HG12 ' A' ' 152' ' ' VAL . 2.7 tttm -173.73 159.28 3.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.43 -0.908 . . . . 10.0 111.858 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -82.77 105.04 13.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.541 -0.725 . . . . 10.0 109.466 178.304 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.711 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -102.12 -172.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.757 ' HG3' HG21 ' A' ' 117' ' ' ILE . 18.2 tt0 -148.45 137.11 21.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.821 -1.174 . . . . 10.0 109.973 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 165' ' ' LEU . 30.1 p -138.15 116.24 11.73 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.422 -0.911 . . . . 10.0 111.484 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.924 ' O ' HD21 ' A' ' 165' ' ' LEU . 6.2 m -102.6 156.73 17.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.781 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -93.62 -94.0 0.16 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 120.435 -1.416 . . . . 10.0 111.072 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -47.29 -20.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.463 -1.295 . . . . 10.0 109.001 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -93.42 -44.35 8.3 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.077 -1.015 . . . . 10.0 109.533 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm0? 61.59 68.91 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 10.0 110.745 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.89 36.86 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.445 -0.902 . . . . 10.0 111.328 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.78 30.03 0.72 Allowed Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.623 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.924 HD21 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.7 -47.41 73.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.229 -1.159 . . . . 10.0 110.714 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -71.41 -21.28 62.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.315 -0.865 . . . . 10.0 110.526 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -70.78 -39.4 73.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.021 -1.049 . . . . 10.0 111.275 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 155' ' ' VAL . 39.6 t -58.48 -50.79 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.811 -1.181 . . . . 10.0 110.212 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 80.4 t80 -68.27 -36.26 79.12 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.48 -0.762 . . . . 10.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.8 t0 -53.75 -47.56 70.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.867 -1.146 . . . . 10.0 110.478 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.55 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . 11.4 mm-40 -54.82 -40.46 69.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 10.0 109.857 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.445 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.59 -21.35 60.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.139 -0.976 . . . . 10.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.789 ' O ' HD12 ' A' ' 177' ' ' LEU . 37.2 mm -63.25 -40.52 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.254 -0.904 . . . . 10.0 110.038 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -87.17 -15.71 37.52 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.638 -1.289 . . . . 10.0 110.946 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 152' ' ' VAL . . . -98.04 -11.08 23.36 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.977 -1.077 . . . . 10.0 110.596 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.814 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -82.35 -42.82 18.2 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.941 -1.099 . . . . 10.0 109.74 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -96.61 -14.53 22.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.366 -0.834 . . . . 10.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.467 ' OXT' ' O ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.791 -1.099 . . . . 10.0 110.318 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.461 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . 68.6 m -99.74 37.04 1.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.318 -1.107 . . . . 10.0 110.036 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -64.19 103.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 10.0 110.934 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -128.51 178.02 6.59 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.756 0.789 . . . . 10.0 110.724 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.589 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -67.44 -179.99 0.51 Allowed Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.899 -1.889 . . . . 10.0 105.899 177.11 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.589 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 42.8 Cg_endo -69.41 55.28 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 N-CA-C 110.35 -0.673 . . . . 10.0 110.35 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.577 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.8 tp10 15.14 -142.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.693 0.759 . . . . 10.0 112.814 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.772 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -88.25 -110.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.245 -0.909 . . . . 10.0 109.203 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.651 ' H ' HG23 ' B' ' 8' ' ' ILE . 6.1 t -158.12 105.64 1.95 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.081 -1.637 . . . . 10.0 112.031 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -122.91 103.21 37.1 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.97 . . . . 10.0 109.916 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.447 ' HD2' HD23 ' B' ' 10' ' ' LEU . 38.0 Cg_endo -66.91 99.12 0.45 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.373 1.196 . . . . 10.0 109.856 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.5 m -157.15 99.39 1.79 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.39 -0.819 . . . . 10.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 11.6 p-10 -148.63 154.86 40.28 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.818 -1.153 . . . . 10.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 48.1 m-85 -84.64 -165.29 1.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.274 1.035 . . . . 10.0 113.165 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.541 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.3 tp10 -53.38 -167.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.88 0.848 . . . . 10.0 111.891 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -138.03 -166.94 2.06 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 40' ' ' TYR . 9.8 t -119.24 -171.8 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.933 -1.104 . . . . 10.0 112.05 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.725 HD13 ' CD2' ' A' ' 37' ' ' PHE . 1.3 pp -112.4 -177.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -101.08 155.91 17.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.062 . . . . 10.0 111.831 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.7 ' CG2' ' CE2' ' B' ' 22' ' ' PHE . 11.2 m -80.0 152.73 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.483 0.658 . . . . 10.0 111.281 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HG2' ' A' ' 61' ' ' GLN . . . -87.69 133.39 11.77 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.162 -1.575 . . . . 10.0 109.162 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.7 ' CE2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER 179.0 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.88 -1.365 . . . . 10.0 112.914 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.551 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.2 t70 -76.99 116.39 17.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.786 -1.196 . . . . 10.0 107.907 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 46.41 26.11 0.45 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.789 -1.194 . . . . 10.0 107.837 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.551 HG23 ' O ' ' B' ' 23' ' ' ASP 0.262 2.4 t -109.84 -14.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.564 0.697 . . . . 10.0 109.383 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.748 ' O ' HG21 ' A' ' 25' ' ' THR . 1.3 t -83.47 32.88 0.46 Allowed 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.798 -0.564 . . . . 10.0 111.181 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.575 ' CA ' ' OG1' ' A' ' 25' ' ' THR . . . -161.31 69.94 0.23 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.642 -1.783 . . . . 10.0 108.642 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.768 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.9 mt-10 -151.47 131.61 13.52 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.964 0.888 . . . . 10.0 111.43 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.812 ' O ' HG23 ' B' ' 30' ' ' THR . 1.9 t80 -142.7 142.41 31.99 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 29' ' ' PHE . 2.2 p -162.14 -66.13 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 10.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.79 111.5 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.073 -1.611 . . . . 10.0 109.073 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 pt -131.93 158.9 74.22 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.217 . . . . 10.0 110.308 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' B' ' 34' ' ' GLU . 42.2 Cg_endo -70.43 139.99 39.15 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.985 1.519 . . . . 10.0 109.942 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.541 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 3.0 tm-20 56.87 124.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 10.0 110.433 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' B' ' 36' ' ' TRP . 2.3 pm0 -96.31 -30.11 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 10.0 111.244 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.61 ' O ' ' CG ' ' B' ' 36' ' ' TRP . 7.8 t-105 -165.5 27.78 0.05 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.186 0.993 . . . . 10.0 110.099 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.519 ' C ' ' HG3' ' B' ' 34' ' ' GLU . . . -158.48 85.27 0.85 Allowed 'General case' 0 C--N 1.287 -2.113 0 O-C-N 121.798 -0.564 . . . . 10.0 109.64 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.541 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 2.4 ttt180 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 10.0 110.038 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mm100 -74.94 -26.86 59.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.64 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.4 m -46.23 106.16 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.907 -0.495 . . . . 10.0 110.941 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -128.03 119.94 52.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.735 -1.586 . . . . 10.0 111.054 178.115 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.822 ' O ' HG23 ' A' ' 75' ' ' THR . 4.5 mttm -103.8 124.55 49.12 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.895 -1.52 . . . . 10.0 106.895 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.934 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.4 t -89.01 108.0 19.35 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.884 -1.127 . . . . 10.0 110.886 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.776 ' HB ' HG21 ' A' ' 75' ' ' THR . 60.0 t -139.17 163.97 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 10.0 109.476 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG21 ' HB ' ' A' ' 17' ' ' THR . 36.5 t -73.36 157.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.006 -1.059 . . . . 10.0 109.713 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.969 HG13 ' NE2' ' B' ' 35' ' ' GLN . 0.3 OUTLIER -43.58 170.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 10.0 109.984 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -104.94 -29.27 5.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.082 -1.607 . . . . 10.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 9' ' ' VAL . 42.0 m-20 -42.59 -61.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 10.0 110.039 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' B' ' 35' ' ' GLN . . . 92.2 5.8 65.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HD11 ' B' ' 32' ' ' ILE . . . -43.76 -30.93 0.71 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -1.109 . . . . 10.0 110.865 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' B' ' 32' ' ' ILE . 53.1 t -148.92 -69.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.07 -1.019 . . . . 10.0 110.405 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.06 74.32 0.06 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.982 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.4 tttm -65.15 -13.0 57.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -1.056 . . . . 10.0 109.707 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 8' ' ' VAL . 14.3 t -50.27 -29.52 9.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 10.0 110.073 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.614 ' SG ' HD22 ' A' ' 19' ' ' LEU . 27.3 p -78.4 -2.46 38.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.076 -1.015 . . . . 10.0 111.127 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.7 mm? -84.39 -40.22 18.09 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.892 -1.13 . . . . 10.0 109.02 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -38.73 60.54 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.619 -0.832 . . . . 10.0 109.206 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.706 HG21 ' HA2' ' B' ' 27' ' ' GLY . 3.4 mm -80.42 -45.56 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.418 -0.801 . . . . 10.0 110.399 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' B' ' 28' ' ' GLU . 19.7 t -45.84 -50.8 13.85 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.026 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 165' ' ' LEU . 36.6 m-85 -81.49 0.24 38.75 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.847 -1.158 . . . . 10.0 110.43 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.609 ' O ' ' HB ' ' A' ' 25' ' ' THR . 20.1 m -97.93 -54.17 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.404 -1.318 . . . . 10.0 110.779 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 24' ' ' THR . 14.6 t 175.75 -39.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.115 -0.991 . . . . 10.0 112.424 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.671 ' HB2' HG23 ' A' ' 21' ' ' ILE . 65.2 m-20 -85.4 32.39 0.57 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.737 -1.227 . . . . 10.0 111.53 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 26' ' ' ASN 0.261 8.7 ttpp -45.26 -167.28 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.846 0.831 . . . . 10.0 112.863 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.662 ' CD1' HG21 ' B' ' 30' ' ' THR . 51.1 t80 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.242 -0.911 . . . . 10.0 111.523 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.917 HG21 ' H ' ' B' ' 25' ' ' VAL . 4.2 t . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 110.017 -0.364 . . . . 10.0 110.017 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.885 HG22 HG21 ' B' ' 26' ' ' THR . 16.9 t 77.56 5.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.019 -0.426 . . . . 10.0 110.664 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 73.9 t80 -39.55 161.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.784 0.802 . . . . 10.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 1.051 ' CB ' HD12 ' B' ' 18' ' ' ILE . 3.7 p30 -79.13 -161.08 0.28 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.346 1.07 . . . . 10.0 113.391 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.755 ' O ' HG22 ' B' ' 17' ' ' THR . 1.4 m120 -152.9 -171.52 3.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.58 ' CE2' HG21 ' B' ' 17' ' ' THR . 69.6 m-85 -121.72 152.87 38.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 10.0 111.647 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -131.18 99.51 4.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.302 -0.874 . . . . 10.0 109.715 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 43' ' ' THR . 1.4 p -131.44 -168.9 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 122.104 0.954 . . . . 10.0 111.182 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.743 ' H ' HG22 ' A' ' 42' ' ' VAL . 23.2 m -142.43 151.5 41.85 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.585 0.707 . . . . 10.0 110.005 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -136.08 126.2 41.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.456 -0.778 . . . . 10.0 109.527 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.574 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 30.9 mtt -90.87 96.56 10.7 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.69 -1.204 . . . . 10.0 109.625 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.727 HG22 ' HG3' ' B' ' 7' ' ' GLU . 1.4 mp -72.03 104.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.548 -0.72 . . . . 10.0 110.049 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 43.65 35.06 2.89 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.776 -1.202 . . . . 10.0 110.428 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.52 2.17 30.92 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.879 -1.365 . . . . 10.0 110.802 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' ILE . 79.6 mt-10 -117.45 110.73 40.53 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.741 -1.446 . . . . 10.0 110.297 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.2 Cg_endo -75.13 135.75 19.25 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.566 1.298 . . . . 10.0 110.706 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' HB2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -99.76 122.85 43.36 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 10.0 110.749 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 4' ' ' ILE . 30.2 p -84.6 98.32 10.1 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.05 -1.031 . . . . 10.0 109.439 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -121.48 126.67 49.83 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.662 -1.215 . . . . 10.0 109.672 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 41' ' ' ALA . . . -141.35 100.8 0.27 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.531 -1.828 . . . . 10.0 108.531 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD22 ' CB ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -115.36 117.24 29.88 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.224 -1.162 . . . . 10.0 110.581 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.797 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 20.9 m-85 -134.59 144.4 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.916 ' H ' HD11 ' B' ' 18' ' ' ILE . 22.1 m-20 -105.78 160.76 14.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.475 -1.391 . . . . 10.0 110.008 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CD1' ' B' ' 36' ' ' TRP . 4.3 t -70.42 -177.94 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.06 . . . . 10.0 110.97 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -111.04 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.708 -0.62 . . . . 10.0 109.409 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.587 ' H ' HG11 ' A' ' 36' ' ' VAL . . . -52.02 -34.51 38.88 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 107.781 -2.128 . . . . 10.0 107.781 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.74 HE21 ' HD1' ' B' ' 22' ' ' PHE . 5.9 tt0 -99.94 -19.19 16.72 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 10.0 109.863 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.624 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 65.4 mt-10 58.64 84.98 0.1 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.269 -0.895 . . . . 10.0 110.564 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 61' ' ' GLN . 55.6 m-20 -96.4 -10.39 27.74 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 3.9 p90 -140.3 -35.1 0.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 10.0 109.571 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 2.7 p30 38.11 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 10.0 111.074 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' TYR . 1.7 mmm-85 -58.16 -32.59 68.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.066 -1.021 . . . . 10.0 109.287 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.779 HD12 ' HB3' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -79.93 7.67 8.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -0.759 . . . . 10.0 110.097 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.664 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -52.16 -36.44 32.03 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.335 -0.853 . . . . 10.0 112.74 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 48.9 Cg_endo -77.6 10.49 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 122.62 0.8 . . . . 10.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.779 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.94 -64.47 0.73 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.935 -1.103 . . . . 10.0 111.954 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 67.4 m 41.06 32.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.899 -1.126 . . . . 10.0 109.969 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 6.7 t80 -171.33 127.8 0.66 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 10.0 110.677 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.96 130.59 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.997 1.525 . . . . 10.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 4.1 mt-30 -138.32 67.35 1.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.232 -0.917 . . . . 10.0 108.943 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.1 m -144.67 92.1 2.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 10.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.1 m-20 -39.13 -30.46 0.05 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.661 -0.65 . . . . 10.0 111.178 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 75' ' ' THR . 1.5 p -112.82 118.22 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.819 -1.176 . . . . 10.0 110.021 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.597 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 23.3 m-85 -119.29 133.92 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.429 -0.794 . . . . 10.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.712 HD22 HD23 ' A' ' 111' ' ' LEU . 1.2 mm? -104.36 97.43 7.37 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.844 HG23 HG21 ' A' ' 9' ' ' VAL . 10.3 p -96.1 147.02 6.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.783 -0.767 . . . . 10.0 110.357 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.726 ' SG ' HG21 ' A' ' 115' ' ' THR . 0.0 OUTLIER -113.9 101.89 9.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.078 0.942 . . . . 10.0 110.882 -178.763 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.765 ' CE1' HG11 ' A' ' 93' ' ' VAL . 35.9 m-85 -92.44 178.32 5.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -0.977 . . . . 10.0 110.003 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.426 ' O ' HG21 ' A' ' 137' ' ' ILE . 52.4 m -108.96 158.2 17.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 10.0 109.262 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.605 ' HA ' HG23 ' A' ' 137' ' ' ILE . 4.1 t -99.18 -19.03 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.16 -0.962 . . . . 10.0 111.188 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.007 HG11 HD23 ' A' ' 129' ' ' LEU . 4.1 t -96.59 -60.16 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.01 -1.056 . . . . 10.0 110.209 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -73.39 114.84 35.36 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.393 -0.817 . . . . 10.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 52.5 Cg_endo -88.59 -3.45 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.076 1.566 . . . . 10.0 110.495 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 133' ' ' LYS . 4.1 p -75.1 21.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.289 -0.882 . . . . 10.0 112.115 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.57 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.5 t -131.4 -31.39 1.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 10.0 109.934 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -72.8 -53.0 12.69 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.095 -1.003 . . . . 10.0 110.678 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 9.3 tp10 -49.79 -17.9 0.41 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.029 -1.044 . . . . 10.0 112.037 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.716 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -91.37 -18.96 23.44 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.497 -1.377 . . . . 10.0 110.822 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.765 HG11 ' CE1' ' A' ' 82' ' ' PHE . 3.6 m -91.06 -18.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 118.39 -1.324 . . . . 10.0 109.306 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.694 ' HD3' HG23 ' A' ' 93' ' ' VAL . 21.2 mmtt -88.65 -20.38 24.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.924 . . . . 10.0 109.138 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -95.99 -0.68 50.31 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.442 178.681 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -91.54 -51.69 5.14 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.773 -1.171 . . . . 10.0 112.578 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.723 ' CH2' HD23 ' A' ' 149' ' ' LEU . 34.3 p-90 -95.37 -26.01 16.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.81 -1.181 . . . . 10.0 111.771 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 56.1 t -53.77 -43.39 96.19 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.705 -1.247 . . . . 10.0 109.777 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 42.1 Cg_endo -75.93 -24.28 11.54 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.292 1.154 . . . . 10.0 110.147 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 6.3 mm-40 -61.27 -13.17 16.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.907 -1.121 . . . . 10.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 24.9 mm 71.68 82.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 10.0 111.311 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -16.66 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -56.46 -47.26 79.55 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.65 -1.241 . . . . 10.0 107.65 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -64.85 -40.35 95.01 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -81.99 -176.6 0.8 Allowed Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.724 -0.61 . . . . 10.0 109.42 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD2' ' SG ' ' A' ' 105' ' ' CYS . 50.5 Cg_endo -77.84 19.72 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.832 1.438 . . . . 10.0 112.856 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 58.35 67.1 0.98 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.377 -1.452 . . . . 10.0 108.929 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 m -45.46 134.89 5.86 Favored Pre-proline 0 N--CA 1.49 1.571 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.915 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 42.6 Cg_endo -69.79 140.75 43.33 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.984 1.518 . . . . 10.0 110.997 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 152' ' ' VAL . 1.3 m-85 -136.95 113.28 9.96 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.704 0.764 . . . . 10.0 110.939 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.825 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.3 mm? -87.98 97.0 10.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.631 HD11 ' HZ ' ' A' ' 90' ' ' PHE . 1.6 tt -79.14 124.07 27.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.038 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.793 HG21 HG11 ' A' ' 168' ' ' VAL . 2.4 t -139.92 164.82 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 10.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -111.61 156.15 15.74 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.119 -1.993 . . . . 10.0 108.119 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.726 HG21 ' SG ' ' A' ' 81' ' ' CYS . 9.6 t -138.01 160.91 38.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.365 . . . . 10.0 111.169 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 115' ' ' THR . 7.2 mt-30 58.98 36.67 24.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.526 -0.734 . . . . 10.0 109.903 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -72.63 -19.52 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.351 -0.843 . . . . 10.0 109.751 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 161' ' ' THR . 7.6 t70 -51.75 58.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 122.156 0.979 . . . . 10.0 112.125 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 3.6 tp 162.27 -23.63 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.526 -1.215 . . . . 10.0 108.131 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.865 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.88 -33.24 23.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.16 -26.56 60.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 10.0 109.901 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.984 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -93.53 132.02 31.11 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.452 -0.78 . . . . 10.0 110.549 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 58.5 Cg_endo -87.0 23.26 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.471 1.447 . . . . 10.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 47.5 t -110.68 -50.62 2.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -0.98 . . . . 10.0 111.016 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.658 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.0 t -70.11 -27.22 64.41 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.984 HD13 ' O ' ' A' ' 122' ' ' ASP 0.306 1.2 mp -51.91 -25.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 10.0 107.361 176.571 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 124' ' ' SER . 25.6 tt0 -58.46 -42.04 86.55 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.282 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -55.92 -41.64 74.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.529 -0.732 . . . . 10.0 110.665 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.007 HD23 HG11 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -75.72 -33.85 60.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 10.0 109.549 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' LYS . . . -52.52 -50.2 63.3 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.326 0.584 . . . . 10.0 110.277 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -28.91 61.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.258 -0.901 . . . . 10.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.4 t30 -71.56 -52.19 19.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.951 . . . . 10.0 109.985 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.594 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 3.2 mmtt -134.38 155.75 49.74 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.43 24.09 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.005 . . . . 10.0 111.157 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -148.74 92.95 4.33 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 10.0 109.391 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.72 160.61 48.84 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.183 1.622 . . . . 10.0 110.519 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.605 HG23 ' HA ' ' A' ' 84' ' ' VAL . 4.6 tp -102.07 133.68 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.464 -0.939 . . . . 10.0 108.464 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.9 p -119.67 165.04 18.72 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 121.182 -0.949 . . . . 10.0 110.159 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -64.13 -32.3 63.72 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.935 1.492 . . . . 10.0 110.369 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.529 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 17.3 pt-20 -74.14 -29.82 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 10.0 109.456 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.441 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 81.1 m -80.13 -41.02 26.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.79 . . . . 10.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.21 68.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.471 -0.768 . . . . 10.0 110.54 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 18.9 tt0 -57.11 -42.57 81.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 10.0 109.637 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 14.5 mtmt -68.6 -40.33 80.49 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.161 -0.962 . . . . 10.0 109.494 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.6 tt -56.0 -43.45 77.67 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.029 -1.044 . . . . 10.0 109.671 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -67.45 -51.17 54.73 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 10.0 108.648 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -60.6 -30.37 69.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 10.0 109.624 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 149' ' ' LEU . 32.9 t70 -67.99 -45.06 75.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.307 -0.871 . . . . 10.0 110.301 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.723 HD23 ' CH2' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -92.76 14.78 16.23 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.089 0.947 . . . . 10.0 108.964 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 151' ' ' ALA . 8.9 mttp 56.23 38.28 29.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.786 0.803 . . . . 10.0 110.299 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -60.97 -141.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.198 -0.601 . . . . 10.0 109.563 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.753 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -117.43 -57.7 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.959 -1.088 . . . . 10.0 110.477 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HD2' ' CD ' ' A' ' 171' ' ' GLU . 0.9 OUTLIER -170.89 145.09 2.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.116 -1.434 . . . . 10.0 111.813 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -90.79 119.49 31.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.399 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.947 ' CG2' HG13 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -124.53 -168.88 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.863 -1.148 . . . . 10.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 113' ' ' VAL . 6.0 tt0 -146.82 152.7 39.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.975 . . . . 10.0 110.335 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 31.1 p -160.36 145.18 14.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 10.0 111.394 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.865 ' CB ' HG23 ' A' ' 161' ' ' THR . 18.4 m -149.91 103.79 3.25 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 1.086 ' HB1' ' HG2' ' B' ' 28' ' ' GLU . . . -37.02 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.562 0.696 . . . . 10.0 112.316 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -57.61 -7.9 0.76 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.865 HG23 ' CB ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -134.78 -92.52 0.31 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.069 -1.644 . . . . 10.0 114.669 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.54 ' H ' HG23 ' A' ' 161' ' ' THR . 7.5 mm-40 -11.55 -69.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.817 0.817 . . . . 10.0 112.657 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 11.7 mttt 62.57 30.35 17.06 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.815 0.817 . . . . 10.0 109.44 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.0 -0.94 5.49 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.97 -1.652 . . . . 10.0 108.97 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -65.89 -7.75 18.32 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.279 -1.13 . . . . 10.0 111.847 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.688 ' N ' HD13 ' A' ' 165' ' ' LEU . 11.5 mtmt -56.77 -33.05 66.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.581 -1.324 . . . . 10.0 109.827 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -70.35 -33.71 71.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 10.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.947 HG13 ' CG2' ' A' ' 155' ' ' VAL . 7.3 t -49.22 -35.84 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.752 -1.218 . . . . 10.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 173' ' ' ILE . 6.1 t80 -78.91 -40.93 30.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 10.0 110.734 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 174' ' ' LEU . 14.4 m-20 -54.1 -46.7 72.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.185 -0.947 . . . . 10.0 111.429 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.486 ' OE2' ' CG2' ' A' ' 155' ' ' VAL . 6.9 pt-20 -66.15 -35.01 79.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 10.0 112.158 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -66.86 -17.95 65.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.597 -1.314 . . . . 10.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.657 ' O ' HD12 ' A' ' 177' ' ' LEU . 22.1 mt -66.88 -44.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.366 -0.934 . . . . 10.0 109.119 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -85.09 -17.84 36.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 10.0 111.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.563 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.54 -0.49 51.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.906 -1.122 . . . . 10.0 110.141 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.684 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.95 -49.09 7.29 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.434 -0.791 . . . . 10.0 109.973 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -88.55 -16.58 32.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.552 -0.718 . . . . 10.0 109.598 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 177' ' ' LEU . 2.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.035 -0.984 . . . . 10.0 110.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 109.532 -1.427 . . . . 10.0 109.532 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . 68.7 m -59.66 152.29 22.82 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -1.112 . . . . 10.0 110.328 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 102.05 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.567 -0.708 . . . . 10.0 111.366 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.41 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 8.7 mm-40 -118.68 159.86 22.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -0.835 . . . . 10.0 110.133 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.691 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.55 -150.02 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.691 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 42.6 Cg_endo -70.88 85.72 0.77 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 N-CA-C 109.844 -0.868 . . . . 10.0 109.844 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 46' ' ' ILE . 17.9 mm-40 -53.53 -164.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.648 -0.657 . . . . 10.0 110.826 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 1.5 pp -81.3 -51.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 10.0 112.472 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.7 t -159.09 164.99 34.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.422 -1.424 . . . . 10.0 111.624 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -158.89 106.83 1.59 Allowed Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.577 -0.849 . . . . 10.0 111.951 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 42.6 Cg_endo -69.34 115.07 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.155 1.608 . . . . 10.0 109.607 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.81 178.39 0.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.399 -0.813 . . . . 10.0 111.609 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 43' ' ' THR . 1.7 t0 -135.09 -169.32 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.957 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 5.1 m-85 -99.88 152.71 19.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 10.0 110.435 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -160.7 163.44 32.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.38 -0.825 . . . . 10.0 110.641 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.9 167.23 27.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.721 -1.192 . . . . 10.0 112.039 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 39' ' ' ASN 0.257 2.4 p -124.34 162.47 23.72 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.676 -0.64 . . . . 10.0 111.115 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 1.051 HD12 ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -93.31 -167.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.932 -1.105 . . . . 10.0 109.153 177.706 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -112.68 157.48 21.21 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.728 -1.233 . . . . 10.0 111.377 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.1 p -122.73 152.7 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.022 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 61' ' ' GLN . . . -147.33 179.16 24.45 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.211 -1.556 . . . . 10.0 109.211 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.74 ' HD1' HE21 ' A' ' 61' ' ' GLN . 4.4 m-85 62.3 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.298 -1.119 . . . . 10.0 111.417 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.469 ' O ' ' C ' ' B' ' 24' ' ' ALA . 7.0 p-10 -66.71 157.57 32.37 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.578 0.704 . . . . 10.0 111.915 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 24.98 46.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.318 0.58 . . . . 10.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.917 ' H ' HG21 ' A' ' 35' ' ' THR . 1.2 t -104.58 -33.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.885 HG21 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -128.61 17.82 6.34 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.811 0.815 . . . . 10.0 109.411 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 21' ' ' ILE . . . -61.43 -22.3 61.11 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 1.086 ' HG2' ' HB1' ' A' ' 159' ' ' ALA . 3.0 tt0 -153.09 -151.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.633 -0.922 . . . . 10.0 109.041 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -103.78 115.35 30.32 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 120.922 -1.111 . . . . 10.0 110.32 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.662 HG21 ' CD1' ' A' ' 28' ' ' PHE . 34.7 p -130.3 -89.01 0.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 10.0 110.076 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.536 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -80.24 -115.28 0.3 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 13' ' ' ALA . 2.6 tt -173.27 56.14 0.2 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 10.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 44.4 Cg_endo -71.77 155.06 58.85 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.781 1.411 . . . . 10.0 110.883 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.613 ' HG3' ' CG ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -61.19 153.37 26.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.342 -0.849 . . . . 10.0 110.475 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.969 ' NE2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -73.92 -57.37 4.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.349 -0.844 . . . . 10.0 111.234 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.3 t90 174.26 27.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.584 -0.697 . . . . 10.0 109.838 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . 178.22 15.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.266 -0.896 . . . . 10.0 112.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.613 ' CG ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 119.974 -1.704 . . . . 10.0 108.109 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtm . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.963 0.411 . . . . 10.0 110.05 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.55 ' HA ' HD23 ' A' ' 177' ' ' LEU . 98.2 mm-40 -146.21 -33.83 0.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.019 -1.05 . . . . 10.0 109.743 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.511 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 51.8 m -56.54 110.93 0.86 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.324 -0.86 . . . . 10.0 111.01 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.885 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -108.33 128.01 64.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.86 -1.136 . . . . 10.0 110.088 178.018 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.623 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.7 ttmt -112.23 109.54 19.28 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' HB3' HD23 ' A' ' 55' ' ' LEU . 51.7 t -93.94 102.6 14.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.59 -1.319 . . . . 10.0 110.369 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 8' ' ' VAL . 48.8 t -131.78 163.14 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.71 -1.196 . . . . 10.0 110.765 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.858 HG12 ' HG2' ' B' ' 35' ' ' GLN . 1.9 t -78.26 154.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.295 -0.878 . . . . 10.0 109.388 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -160.39 174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.854 -1.154 . . . . 10.0 110.353 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.593 ' O ' ' NE2' ' B' ' 35' ' ' GLN . . . 115.2 173.5 17.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.651 -1.78 . . . . 10.0 108.651 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.13 -29.43 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.712 -1.463 . . . . 10.0 108.894 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 163.7 -81.29 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.721 -1.752 . . . . 10.0 108.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . 39.96 -131.88 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.992 . . . . 10.0 110.937 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.728 ' CG1' HG23 ' A' ' 115' ' ' THR . 6.1 m -110.72 153.89 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 10.0 111.748 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -111.96 110.13 2.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.229 -1.548 . . . . 10.0 109.229 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.13 -20.63 7.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.761 -1.435 . . . . 10.0 110.896 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.499 HG21 ' CG2' ' A' ' 8' ' ' VAL . 11.4 t -73.82 -32.17 63.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.762 -1.212 . . . . 10.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.664 ' HA ' HG23 ' B' ' 26' ' ' THR . 18.3 p -73.68 -15.68 61.23 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.618 -1.301 . . . . 10.0 107.673 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.834 HD13 ' CA ' ' A' ' 159' ' ' ALA . 53.7 mt -95.69 -23.42 17.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -46.85 -43.38 18.58 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.842 0.829 . . . . 10.0 109.046 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.045 HG22 ' HB2' ' A' ' 26' ' ' ASN . 4.6 mm -74.72 -39.88 46.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.546 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 4.6 p -52.02 -49.25 63.75 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 119.435 -0.906 . . . . 10.0 110.254 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 1.241 ' CE2' HD11 ' A' ' 165' ' ' LEU . 4.7 m-85 -62.05 -34.09 75.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.377 -1.452 . . . . 10.0 109.706 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -72.79 -51.99 16.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.562 -0.855 . . . . 10.0 111.048 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 11.8 t -169.49 -20.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.959 -1.896 . . . . 10.0 114.563 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 1.045 ' HB2' HG22 ' A' ' 21' ' ' ILE . 9.1 m120 -79.29 -8.67 59.22 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.454 -1.404 . . . . 10.0 111.223 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 14.86 -146.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 114.359 1.244 . . . . 10.0 114.359 178.206 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.668 ' CE1' HG22 ' B' ' 30' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.507 2.408 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.688 ' CG2' ' ND2' ' A' ' 26' ' ' ASN . 68.9 p . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.677 HG23 ' HB ' ' B' ' 26' ' ' THR . 16.5 t 63.1 -6.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.57 -1.331 . . . . 10.0 111.811 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -67.58 95.29 0.47 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 120.474 -1.391 . . . . 10.0 109.368 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.699 ' HA ' ' CG2' ' B' ' 18' ' ' ILE . 2.3 m-20 -165.78 103.69 0.69 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.308 -1.757 . . . . 10.0 114.278 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.784 ' N ' HG22 ' B' ' 18' ' ' ILE . 53.5 t30 -134.59 97.17 3.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.858 -1.151 . . . . 10.0 108.471 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.747 ' CE1' HG23 ' B' ' 18' ' ' ILE . 2.9 m-30 -118.76 146.58 44.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.669 -0.644 . . . . 10.0 111.063 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.629 ' C ' HG13 ' A' ' 42' ' ' VAL . . . -171.72 98.07 0.18 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.08 -1.013 . . . . 10.0 109.262 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.629 HG13 ' C ' ' A' ' 41' ' ' ALA . 30.9 m -156.15 -165.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.988 0.899 . . . . 10.0 112.276 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' TYR . 20.3 m -130.24 155.23 46.63 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.294 0.569 . . . . 10.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' B' ' 12' ' ' SER . 11.6 t -131.2 150.99 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.589 -0.694 . . . . 10.0 109.215 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.637 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 10.6 mtp -110.52 93.14 4.34 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.978 -1.489 . . . . 10.0 107.661 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.731 HG23 ' CG ' ' B' ' 7' ' ' GLU . 1.8 mp -72.57 103.01 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 O-C-N 120.594 -1.316 . . . . 10.0 109.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' B' ' 9' ' ' SER . . . 51.0 30.56 23.26 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.404 -1.379 . . . . 10.0 110.119 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.92 6.12 37.65 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 120.845 -1.385 . . . . 10.0 110.592 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.6 tp10 -110.87 115.1 53.65 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.234 -1.157 . . . . 10.0 109.758 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.7 Cg_endo -71.59 139.0 33.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.947 1.498 . . . . 10.0 110.88 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -114.1 163.04 15.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 10.0 111.9 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.752 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -122.99 104.75 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HA ' HG23 ' A' ' 4' ' ' ILE . 21.2 mt -108.65 147.93 31.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.789 -1.195 . . . . 10.0 110.893 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.44 99.98 0.17 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.044 -1.623 . . . . 10.0 109.044 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -138.34 139.81 39.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -1.177 . . . . 10.0 110.269 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 1.086 ' N ' HD22 ' A' ' 55' ' ' LEU . 18.4 p90 -162.06 139.96 8.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.136 -0.978 . . . . 10.0 110.139 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 m-20 -104.25 170.1 8.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.097 -1.002 . . . . 10.0 110.476 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 5.5 t -43.55 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 10.0 111.927 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -133.29 90.53 2.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.526 -0.733 . . . . 10.0 110.652 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -66.87 71.14 0.18 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 106.885 -2.486 . . . . 10.0 106.885 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER 64.02 28.69 14.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.541 -0.976 . . . . 10.0 109.216 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -58.95 -58.59 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.834 -1.166 . . . . 10.0 109.768 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.8 OUTLIER 175.09 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.256 -0.903 . . . . 10.0 110.147 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.607 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -151.7 -34.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 10.0 109.917 -179.25 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.8 t0 79.05 20.99 0.7 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.365 0.602 . . . . 10.0 109.616 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -58.73 -19.11 37.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 178.576 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' C ' HD22 ' A' ' 70' ' ' LEU . 1.1 pp -55.23 -16.32 3.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 1.1 ttm180 -99.68 -52.98 0.19 Allowed Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 45.7 Cg_endo -70.54 -16.51 34.28 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 120.466 0.778 . . . . 10.0 112.625 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.862 HD12 ' C ' ' B' ' 36' ' ' TRP . 0.9 OUTLIER -54.84 -10.91 0.52 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.678 -1.264 . . . . 10.0 111.949 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' B' ' 37' ' ' ALA . 1.0 OUTLIER -45.83 -31.78 2.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.953 -1.092 . . . . 10.0 110.449 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 134.44 34.42 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 10.0 111.27 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.602 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 43.3 Cg_endo -80.27 159.2 23.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.899 1.473 . . . . 10.0 110.588 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 163.91 78.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.29 0.567 . . . . 10.0 109.586 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 77' ' ' VAL . 89.1 m -146.83 99.59 3.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.312 -0.867 . . . . 10.0 109.962 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 75' ' ' THR . 81.5 m-20 -38.86 -30.59 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.487 -0.758 . . . . 10.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 75' ' ' THR . 0.5 OUTLIER -119.02 120.37 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 10.0 109.337 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 67.0 m-85 -108.19 129.48 55.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.909 -1.12 . . . . 10.0 111.906 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.98 HD22 HD23 ' A' ' 111' ' ' LEU . 2.0 mm? -104.05 97.05 7.09 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -107.24 145.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.101 -0.999 . . . . 10.0 110.495 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 39.4 t -141.43 126.17 18.01 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.157 -0.964 . . . . 10.0 111.192 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CA ' ' OG1' ' A' ' 115' ' ' THR . 1.8 p90 -135.01 168.26 19.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.441 -0.787 . . . . 10.0 110.654 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.6 t -77.3 161.06 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 10.0 109.74 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -110.74 14.98 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 10.0 111.118 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 129' ' ' LEU . 3.0 m -125.48 -17.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.69 -1.257 . . . . 10.0 111.716 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.887 ' CA ' HD23 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -60.66 -159.7 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.992 -1.067 . . . . 10.0 110.096 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.3 Cg_endo -71.9 178.31 6.01 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 122.804 0.897 . . . . 10.0 110.099 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.84 66.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.246 -0.909 . . . . 10.0 110.087 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' PRO . 66.1 m -89.96 -15.28 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.691 . . . . 10.0 110.537 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.587 ' CZ ' ' HE3' ' A' ' 94' ' ' LYS . 6.1 t80 -86.24 -50.23 7.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 10.0 110.188 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -65.65 -30.59 71.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.545 -0.722 . . . . 10.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -79.29 -14.22 59.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.821 -1.174 . . . . 10.0 109.58 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.653 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 2.7 t -83.84 -21.81 8.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.612 -1.305 . . . . 10.0 107.914 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.587 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -72.12 -37.87 69.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 178.583 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 1.4 pt-20 -69.49 -10.53 58.45 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.943 -0.703 . . . . 10.0 109.263 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -87.34 -52.37 5.42 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.316 -0.954 . . . . 10.0 112.582 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 98' ' ' VAL . 54.9 p-90 -93.91 -15.93 24.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.752 -1.217 . . . . 10.0 112.444 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 58.8 t -66.9 -50.78 41.47 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.745 -1.222 . . . . 10.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.0 Cg_endo -71.58 -20.64 26.7 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.21 1.111 . . . . 10.0 109.761 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 5.7 mm-40 -57.14 -35.97 70.14 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.344 -0.943 . . . . 10.0 109.264 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 99' ' ' PRO . 10.2 mt 55.15 118.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.379 -0.825 . . . . 10.0 110.881 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 105' ' ' CYS . 4.2 p -48.66 -24.91 1.52 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.001 -1.062 . . . . 10.0 109.07 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.469 ' HB2' HG22 ' A' ' 101' ' ' ILE . 62.5 m-70 -76.2 -33.13 59.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.528 -0.732 . . . . 10.0 109.843 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 1.4 t-80 -105.91 -16.71 14.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 10.0 110.847 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 102' ' ' THR . 1.1 m -166.4 175.51 2.21 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.041 . . . . 10.0 110.085 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 105' ' ' CYS . 43.0 Cg_endo -70.72 86.72 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.641 1.337 . . . . 10.0 111.747 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.635 ' HB3' ' N ' ' A' ' 102' ' ' THR . 8.5 tttp -102.58 4.88 38.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 10.0 109.589 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 109' ' ' PRO . 90.8 m -43.02 147.48 0.67 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 10.0 110.309 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 108' ' ' THR . 34.3 Cg_endo -58.22 160.67 15.57 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.019 1.813 . . . . 10.0 112.81 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.587 ' O ' HG13 ' A' ' 152' ' ' VAL . 1.7 p90 -151.01 144.53 24.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.2 1.0 . . . . 10.0 109.417 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 HD22 ' A' ' 79' ' ' LEU . 1.2 mm? -77.88 99.68 6.07 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.841 0.829 . . . . 10.0 109.745 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 75.5 mt -62.9 146.87 51.88 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 80' ' ' VAL . 3.0 t -148.39 173.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.46 -1.4 . . . . 10.0 111.929 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -109.66 138.43 14.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.842 -1.703 . . . . 10.0 108.842 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.728 HG23 ' CG1' ' A' ' 14' ' ' VAL . 97.1 m -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.003 -1.292 . . . . 10.0 110.626 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.8 tp60 41.9 59.8 2.43 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.432 -0.793 . . . . 10.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.03 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.54 -42.05 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.998 -1.482 . . . . 10.0 106.998 179.196 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 4.8 p30 -51.91 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.284 1.04 . . . . 10.0 110.385 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 162.34 -28.07 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.47 -41.43 20.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.592 0.711 . . . . 10.0 109.62 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 77.5 m-20 -67.57 -10.14 49.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.401 -0.812 . . . . 10.0 109.99 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 126' ' ' ILE . 14.8 t0 -82.3 117.15 67.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.824 . . . . 10.0 109.301 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.62 23.77 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.154 1.607 . . . . 10.0 110.97 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 37.2 t -107.84 -49.35 3.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.167 -0.958 . . . . 10.0 109.932 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 119' ' ' LEU . 14.4 t -75.06 -31.25 61.23 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 122' ' ' ASP 0.295 1.2 mp -56.02 -23.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 176.751 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.4 tt0 -47.99 -42.25 27.36 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.382 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -71.13 -49.55 42.95 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.48 -0.763 . . . . 10.0 110.547 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 85' ' ' VAL . 4.9 mp -67.3 -43.68 81.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.67 0.748 . . . . 10.0 110.691 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.46 77.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 10.0 110.594 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -52.23 -21.3 3.27 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.214 -0.929 . . . . 10.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.464 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 22.0 t-20 -85.9 -68.12 0.76 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.381 -0.825 . . . . 10.0 111.242 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 132' ' ' ASN . 0.4 OUTLIER -124.59 129.4 50.51 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.532 -0.73 . . . . 10.0 110.6 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 1.1 mp0 -84.25 9.05 13.9 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.357 -0.839 . . . . 10.0 109.172 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -118.6 94.03 46.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.415 -0.803 . . . . 10.0 110.368 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 162.35 28.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.586 1.524 . . . . 10.0 110.182 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.975 HG23 HG12 ' A' ' 84' ' ' VAL . 2.4 tp -103.98 146.61 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.004 -1.06 . . . . 10.0 110.34 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.4 p -132.69 171.12 9.7 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 10.0 110.102 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.646 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . 40.0 Cg_endo -71.69 -22.55 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.551 1.29 . . . . 10.0 111.445 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -55.15 21.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.085 . . . . 10.0 109.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -65.4 -39.85 92.7 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.372 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.47 -30.01 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.009 -1.057 . . . . 10.0 111.144 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.38 -49.3 67.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.183 -0.948 . . . . 10.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 148' ' ' ASP . 7.2 ttmt -62.91 -44.01 97.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.347 -0.941 . . . . 10.0 109.078 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.827 ' HG ' HD22 ' A' ' 149' ' ' LEU . 7.0 tt -59.32 -33.51 71.21 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.486 -0.758 . . . . 10.0 109.157 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 1.011 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -67.34 -50.02 61.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.69 0.757 . . . . 10.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -84.34 -10.12 57.87 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.35 -0.94 . . . . 10.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 144' ' ' LYS . 37.6 t0 -93.77 -37.55 11.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.599 -1.313 . . . . 10.0 110.795 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.827 HD22 ' HG ' ' A' ' 145' ' ' LEU . 1.4 mp -101.07 24.75 8.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 10.0 109.735 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.9 mtpt 61.95 39.21 13.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.561 -0.745 . . . . 10.0 112.017 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 1.011 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -95.26 -156.05 0.5 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.71 -66.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.473 -1.392 . . . . 10.0 110.259 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.576 ' N ' HG22 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -172.68 174.8 3.59 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.679 -1.608 . . . . 10.0 112.003 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 139' ' ' PRO . 41.5 p90 -104.34 133.6 48.97 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -137.71 -169.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.307 -0.871 . . . . 10.0 109.781 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 164' ' ' GLY . 78.4 mm-40 -144.13 162.86 35.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.016 -1.053 . . . . 10.0 110.138 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 163' ' ' LYS . 15.5 p -164.89 133.82 3.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.282 -0.886 . . . . 10.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.582 ' H ' HD23 ' A' ' 165' ' ' LEU . 32.6 t -120.78 173.38 7.25 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.834 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -86.67 -78.76 0.28 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 120.899 -1.126 . . . . 10.0 111.789 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.8 pp -91.49 -4.25 55.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.434 -1.416 . . . . 10.0 111.108 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.1 m -96.1 -32.41 12.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.087 -1.008 . . . . 10.0 111.466 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.54 ' HA ' ' HG ' ' A' ' 165' ' ' LEU . 3.9 mt-30 75.92 67.84 0.07 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.236 -0.915 . . . . 10.0 109.772 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.565 ' HG2' HG12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -102.9 102.73 12.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.831 -1.147 . . . . 10.0 109.719 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.971 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 78.14 10.51 86.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.36 -1.896 . . . . 10.0 108.36 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.241 HD11 ' CE2' ' A' ' 23' ' ' TYR 0.254 0.2 OUTLIER -54.34 -51.84 63.46 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.995 0.902 . . . . 10.0 110.78 -179.658 . . . . . . . . 4 4 . 1 . 006 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -80.91 -10.56 59.7 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.809 -0.557 . . . . 10.0 111.101 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.535 ' HB3' HG12 ' A' ' 155' ' ' VAL . 1.9 t-20 -85.31 -31.57 22.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.193 -0.942 . . . . 10.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 164' ' ' GLY . 2.8 t -71.92 -25.82 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.02 -1.05 . . . . 10.0 108.219 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.556 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -76.2 -49.68 16.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.314 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 26.2 m-20 -63.03 -49.88 72.88 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.282 -0.886 . . . . 10.0 112.269 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.89 -40.79 94.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.896 -1.128 . . . . 10.0 111.25 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -60.54 -22.5 63.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.98 -1.075 . . . . 10.0 109.925 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.595 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.2 mm -61.13 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.219 -0.926 . . . . 10.0 109.864 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.34 -45.85 65.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.255 -0.903 . . . . 10.0 110.557 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.2 4.42 23.53 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.351 -0.843 . . . . 10.0 110.532 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -84.47 -39.37 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 10.0 110.666 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -101.83 -14.76 17.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 10.0 110.409 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.877 -1.059 . . . . 10.0 110.68 -179.626 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.411 . . . . 10.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.533 ' O ' ' N ' ' B' ' 4' ' ' GLU . 54.3 m -98.81 33.5 2.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.244 -1.151 . . . . 10.0 110.646 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 174' ' ' LEU . 1.3 ttmt -50.15 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 10.0 110.597 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 2' ' ' SER . 31.9 mm-40 -134.74 167.61 20.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.186 -0.946 . . . . 10.0 110.664 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.671 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.03 -153.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.158 -1.052 . . . . 10.0 108.158 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.671 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.3 Cg_endo -69.87 84.22 0.68 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 N-CA-C 109.463 -1.014 . . . . 10.0 109.463 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.731 ' CG ' HG23 ' A' ' 46' ' ' ILE . 1.3 tp10 -44.43 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.79 0.805 . . . . 10.0 111.115 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 1.069 HD12 ' N ' ' B' ' 9' ' ' SER . 1.6 pp -91.56 -23.39 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 122.566 1.174 . . . . 10.0 107.939 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 9' ' ' SER . . . . . 1.069 ' N ' HD12 ' B' ' 8' ' ' ILE . 43.3 m -57.24 -166.64 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.68 -1.145 . . . . 10.0 112.205 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.637 ' HB3' ' O ' ' A' ' 45' ' ' MET . 0.2 OUTLIER -37.48 117.23 0.82 Allowed Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.478 1.288 . . . . 10.0 114.478 -176.434 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.541 ' HD2' HD13 ' B' ' 10' ' ' LEU . 49.7 Cg_endo -93.95 111.31 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.488 1.459 . . . . 10.0 109.266 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -86.51 -168.01 2.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.799 -1.188 . . . . 10.0 110.054 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 147.03 0.97 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.499 -0.75 . . . . 10.0 110.009 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.621 ' O ' HG11 ' A' ' 42' ' ' VAL . 80.2 m-85 -90.88 163.16 14.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 10.0 110.14 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.658 ' HB3' ' CG ' ' A' ' 40' ' ' TYR . 2.3 mp0 -50.59 179.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.991 0.901 . . . . 10.0 112.322 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -81.3 -167.42 1.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.764 0.792 . . . . 10.0 112.719 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.3 m -85.46 152.81 22.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.688 -0.633 . . . . 10.0 109.843 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.784 HG22 ' N ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -123.83 129.09 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 10.0 109.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 17.2 t60 -141.93 151.04 42.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.639 -1.288 . . . . 10.0 112.728 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.68 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.7 p -120.9 154.96 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.331 0.586 . . . . 10.0 111.181 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' B' ' 22' ' ' PHE . . . -124.31 56.64 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 106.93 -2.468 . . . . 10.0 106.93 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.047 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 172.06 101.43 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.534 -0.98 . . . . 10.0 109.529 -177.756 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.625 ' O ' HG23 ' B' ' 25' ' ' VAL . 9.8 t0 -61.77 139.94 58.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.114 -0.991 . . . . 10.0 111.165 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' THR . . . 33.79 61.83 0.46 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.558 -0.714 . . . . 10.0 111.336 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 1.047 HG21 ' CD1' ' B' ' 22' ' ' PHE . 19.4 t -113.13 -27.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.163 -0.961 . . . . 10.0 110.818 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.677 ' HB ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -121.19 -12.25 8.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 10.0 111.181 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 26' ' ' ASN . . . -72.7 -29.91 64.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.239 -1.944 . . . . 10.0 108.239 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 13.2 mt-10 -83.44 97.63 9.08 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.925 0.869 . . . . 10.0 109.781 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.816 ' CB ' HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -110.64 144.52 39.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 120.07 -0.652 . . . . 10.0 109.404 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.668 HG22 ' CE1' ' A' ' 28' ' ' PHE . 7.2 p -148.14 -39.25 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.203 -0.936 . . . . 10.0 110.39 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.51 -154.56 11.43 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 120.046 -1.073 . . . . 10.0 110.773 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.07 76.21 6.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.782 -0.834 . . . . 10.0 111.621 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.652 ' CG ' ' CE1' ' B' ' 29' ' ' PHE . 43.9 Cg_endo -74.24 171.32 18.25 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.838 1.441 . . . . 10.0 109.199 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.38 171.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 10.0 111.642 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.858 ' HG2' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -94.25 16.55 14.62 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.758 -0.589 . . . . 10.0 110.786 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.862 ' C ' HD12 ' A' ' 70' ' ' LEU . 53.4 m0 58.85 52.99 6.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 10.0 111.616 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -177.83 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.358 -0.839 . . . . 10.0 111.593 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 73' ' ' PRO . 1.2 mpt_? . . . . . 0 N--CA 1.499 1.998 0 O-C-N 120.964 -1.085 . . . . 10.0 110.792 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.206 0.527 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -143.91 -14.51 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.224 -0.922 . . . . 10.0 110.542 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 57.0 m -71.91 112.43 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.302 -0.874 . . . . 10.0 111.758 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.048 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -106.26 121.63 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 118.854 -1.138 . . . . 10.0 108.974 177.214 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.3 mmtm -94.0 113.78 25.83 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.791 -1.189 . . . . 10.0 107.791 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.431 ' C ' HG23 ' A' ' 7' ' ' VAL . 95.3 m -99.69 105.08 16.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.223 -0.923 . . . . 10.0 109.231 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.724 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 39.7 t -143.02 146.8 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.94 -1.104 . . . . 10.0 111.084 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.617 HG22 ' OG1' ' A' ' 17' ' ' THR . 21.8 t -59.77 141.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 10.0 109.961 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 80' ' ' VAL . 25.7 m -72.73 -169.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 10.0 110.925 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' B' ' 37' ' ' ALA . . . -129.67 11.06 6.03 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -49.96 -46.71 52.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.303 -1.116 . . . . 10.0 109.15 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 134.32 -12.41 4.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 81' ' ' CYS . . . -69.99 172.37 7.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.478 -1.013 . . . . 10.0 109.347 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 19' ' ' LEU . 2.5 p -58.63 161.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.995 -1.066 . . . . 10.0 109.237 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.546 ' N ' ' HG3' ' B' ' 35' ' ' GLN . . . -71.7 112.25 4.02 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.336 . . . . 10.0 109.761 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.921 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -49.75 -29.3 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.035 -1.274 . . . . 10.0 108.593 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 8' ' ' VAL . 94.6 m -59.84 -33.02 71.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.503 -0.748 . . . . 10.0 109.371 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 1.9 t -81.77 -13.86 57.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.601 -0.84 . . . . 10.0 109.899 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 159' ' ' ALA . 4.4 mt -92.58 -31.19 15.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 10.0 109.486 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.13 -31.41 72.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 10.0 107.683 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.84 HG21 HG23 ' B' ' 26' ' ' THR 0.26 9.3 mm -72.19 -45.86 60.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.33 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 21' ' ' ILE . 20.1 p -48.85 -26.1 2.24 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.905 -1.118 . . . . 10.0 108.611 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 1.183 ' CE2' HD12 ' A' ' 165' ' ' LEU . 2.8 m-85 -86.3 -26.02 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 10.0 108.596 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 21' ' ' ILE . 56.2 m -89.91 -31.15 17.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.667 . . . . 10.0 111.651 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -92.29 -81.32 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.613 -1.304 . . . . 10.0 109.687 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 8.9 m-80 -148.62 -30.19 0.28 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.931 -0.708 . . . . 10.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 6.4 pttt 145.96 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 CA-C-O 121.146 0.498 . . . . 10.0 109.815 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.887 ' CZ ' HG22 ' B' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 113.076 0.769 . . . . 10.0 113.076 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' THR . . . . . 1.045 ' CB ' HG21 ' B' ' 26' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.995 0.426 . . . . 10.0 111.427 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.869 HG12 ' N ' ' A' ' 37' ' ' PHE . 1.6 t 158.28 -78.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.869 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.9 t80 -61.3 140.22 58.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 10.0 110.96 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HA ' HG13 ' B' ' 18' ' ' ILE . 35.6 t0 -164.56 85.73 0.44 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 39' ' ' ASN . 4.0 p-10 -104.96 103.46 13.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 10.0 111.421 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' B' ' 16' ' ' HIS . 0.2 OUTLIER -170.24 -168.4 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 10.0 110.076 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.574 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -141.04 165.22 28.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.045 -1.035 . . . . 10.0 110.358 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HA ' ' B' ' 14' ' ' PHE . 60.2 t -155.57 171.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 10.0 110.972 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.4 m -140.17 146.24 38.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.816 -0.552 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.696 ' CG1' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -105.34 170.64 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.007 -1.058 . . . . 10.0 109.443 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 8.4 mtt -144.0 121.71 11.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.447 -0.783 . . . . 10.0 109.93 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 ' CG1' ' A' ' 44' ' ' VAL . 1.4 mp -138.0 130.62 40.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.357 -0.84 . . . . 10.0 109.535 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 46.72 23.27 1.37 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.34 -1.504 . . . . 10.0 109.34 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.61 2.34 67.57 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.061 -1.258 . . . . 10.0 110.214 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 4.3 mm-40 -94.3 111.58 54.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.049 -1.265 . . . . 10.0 111.163 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 45.2 Cg_endo -70.11 152.35 67.47 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.87 1.458 . . . . 10.0 109.906 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.789 ' O ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -116.06 163.55 15.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.072 -1.017 . . . . 10.0 110.876 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.647 ' O ' HG22 ' A' ' 4' ' ' ILE 0.256 39.0 m -124.21 112.51 17.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.78 -0.575 . . . . 10.0 109.795 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.4 pp -146.59 179.94 7.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.9 -1.125 . . . . 10.0 111.445 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.826 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -169.26 133.38 2.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 55' ' ' LEU . 1.8 tm? -124.59 123.97 41.21 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.062 -1.257 . . . . 10.0 110.338 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 55' ' ' LEU . 58.9 m-85 -133.51 112.95 11.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 10.0 111.001 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.1 t0 -92.24 134.78 34.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 10.0 109.658 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.77 ' O ' HG23 ' A' ' 58' ' ' THR . 12.4 t -84.22 98.24 9.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 10.0 111.982 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . . . 164.7 62.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.358 -0.839 . . . . 10.0 109.89 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 37' ' ' PHE . . . -40.41 -30.07 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.347 -1.501 . . . . 10.0 109.347 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 1.9 pt20 -170.82 23.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -1.124 . . . . 10.0 111.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 8.2 mt-10 -150.63 -93.71 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.881 -1.137 . . . . 10.0 110.606 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p30 169.74 47.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.689 -1.257 . . . . 10.0 111.073 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.582 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 55.5 p90 -162.12 -44.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.861 -1.15 . . . . 10.0 111.237 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 1.8 t0 77.06 113.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.32 -0.863 . . . . 10.0 111.901 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -21.88 12.82 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.622 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 18.1 mt -84.26 5.9 24.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.469 -0.769 . . . . 10.0 109.01 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.982 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.8 ptt180 -52.32 -32.48 9.13 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 113.709 1.003 . . . . 10.0 113.709 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.624 ' HD3' ' CG ' ' A' ' 68' ' ' ARG . 53.4 Cg_endo -74.66 76.58 3.21 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 CA-C-N 120.038 1.049 . . . . 10.0 110.325 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -101.0 -29.98 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.87 -1.144 . . . . 10.0 111.184 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 43.9 24.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 10.0 110.667 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -164.3 98.59 0.91 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.915 -1.115 . . . . 10.0 111.678 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 48.4 Cg_endo -69.76 167.66 23.81 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.925 1.487 . . . . 10.0 111.134 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 67.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.537 -0.727 . . . . 10.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.82 HG23 ' CB ' ' A' ' 5' ' ' LYS . 52.6 m -145.42 97.85 3.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.398 -0.814 . . . . 10.0 109.493 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 64.5 m-20 -33.7 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.169 0.509 . . . . 10.0 111.36 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 75' ' ' THR . 0.4 OUTLIER -122.26 120.25 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.085 -1.01 . . . . 10.0 110.423 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 39.3 m-85 -116.48 140.61 49.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.616 -0.677 . . . . 10.0 109.735 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.921 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.1 mm? -113.96 98.96 7.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.932 -1.105 . . . . 10.0 108.819 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HA ' HG21 ' A' ' 9' ' ' VAL . 12.9 p -106.31 148.05 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.553 -0.717 . . . . 10.0 110.893 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 41.2 t -134.59 125.15 26.63 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.863 . . . . 10.0 110.805 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 13.6 p90 -136.66 157.72 46.11 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.242 -0.983 . . . . 10.0 110.345 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.424 ' OG ' HG22 ' A' ' 85' ' ' VAL . 44.0 t -83.4 137.69 33.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 10.0 112.133 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 HG13 ' A' ' 85' ' ' VAL . 18.7 m -90.53 2.32 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.666 -0.646 . . . . 10.0 109.859 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.647 HG13 HG23 ' A' ' 84' ' ' VAL . 35.0 m -119.21 48.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 10.0 109.187 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . 21.1 p -133.36 176.69 2.71 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 42.3 Cg_endo -70.52 158.8 54.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.306 1.161 . . . . 10.0 110.733 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 87' ' ' PRO . 3.6 m -31.3 87.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.477 0.656 . . . . 10.0 111.899 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' PRO . 31.0 t -117.14 -54.2 2.42 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 10.0 109.832 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.612 ' CE1' ' HE2' ' A' ' 94' ' ' LYS . 8.8 t80 -49.41 -38.49 29.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.105 . . . . 10.0 109.303 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 34.7 tt0 -60.84 -35.4 76.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 10.0 109.719 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.543 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -69.96 -15.43 63.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.362 -0.836 . . . . 10.0 109.527 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.534 ' O ' ' NE1' ' A' ' 97' ' ' TRP . 62.1 t -87.76 -16.0 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.209 -0.932 . . . . 10.0 109.405 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE3' HD13 ' A' ' 145' ' ' LEU . 2.6 mmtt -85.8 -29.54 23.71 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.7 pt-20 -94.4 5.97 50.16 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.481 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -95.92 -51.83 4.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 10.0 112.317 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.914 ' CH2' HD23 ' A' ' 149' ' ' LEU . 49.6 p-90 -104.06 -25.5 12.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.748 -1.22 . . . . 10.0 111.694 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.0 t -64.87 -41.91 59.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.838 -1.164 . . . . 10.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.7 Cg_endo -82.65 -23.32 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.431 1.227 . . . . 10.0 110.635 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.5 mm-40 -93.87 7.48 44.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.031 . . . . 10.0 110.363 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 37.0 mm 59.32 103.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 10.0 111.023 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.768 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.6 m -44.7 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.428 -0.952 . . . . 10.0 108.428 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.768 ' N ' HG22 ' A' ' 102' ' ' THR . 21.3 m-70 -113.23 -6.38 13.61 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.497 -0.752 . . . . 10.0 109.295 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.578 ' O ' ' CB ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER 157.07 16.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 -178.267 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 5.5 t 83.04 34.65 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.853 -0.53 . . . . 10.0 110.026 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.8 Cg_endo -80.85 -18.27 9.15 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 O-C-N 123.177 1.093 . . . . 10.0 109.603 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 64.0 54.22 1.74 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.596 0.713 . . . . 10.0 110.558 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.527 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 13.5 t -52.29 157.8 2.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.505 -0.747 . . . . 10.0 109.552 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.527 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 42.4 Cg_endo -70.5 140.0 38.91 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.294 1.154 . . . . 10.0 110.404 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -135.61 112.41 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.297 -0.877 . . . . 10.0 109.662 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.986 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 3.0 mm? -77.08 97.63 4.77 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.106 -0.996 . . . . 10.0 109.242 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 11.2 mt -69.91 141.01 53.19 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.926 ' CG2' HG11 ' A' ' 168' ' ' VAL . 47.0 t -140.94 168.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.805 -1.184 . . . . 10.0 112.509 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -107.52 159.23 14.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.285 -1.926 . . . . 10.0 108.285 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' C ' ' A' ' 82' ' ' PHE . 85.5 m -115.55 120.41 39.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.399 . . . . 10.0 111.341 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.32 55.57 5.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.582 -0.699 . . . . 10.0 111.375 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -55.74 -22.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.084 . . . . 10.0 108.714 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 21.3 t70 -52.0 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.453 1.12 . . . . 10.0 110.708 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.723 ' N ' ' O ' ' A' ' 117' ' ' ILE . 16.0 tp 159.71 -24.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.447 -1.252 . . . . 10.0 108.381 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -49.12 -42.77 40.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.748 -0.595 . . . . 10.0 109.6 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m-20 -53.92 -20.2 5.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.021 -1.049 . . . . 10.0 109.234 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.8 t0 -82.53 118.0 70.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.688 . . . . 10.0 110.537 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 48.4 Cg_endo -90.58 23.0 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.661 1.574 . . . . 10.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 p -101.36 -49.41 4.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 10.0 110.149 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.714 HG21 HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.89 -26.83 43.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.201 -2.148 . . . . 10.0 105.201 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.815 ' HA ' HD22 ' A' ' 129' ' ' LEU 0.281 1.1 mp -56.66 -26.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 176.858 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -49.38 -35.07 17.74 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.636 -0.711 . . . . 10.0 111.128 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -61.81 -38.31 87.64 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.188 -0.945 . . . . 10.0 110.744 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -59.03 -32.9 70.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 10.0 110.086 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -56.23 -45.01 80.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 10.0 109.833 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -55.94 -16.89 5.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.337 -0.852 . . . . 10.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.99 -18.3 5.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.922 -1.111 . . . . 10.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -165.57 110.54 0.87 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.014 -1.054 . . . . 10.0 109.998 -179.301 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.52 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -71.91 -24.62 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 10.0 110.511 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -98.12 104.83 24.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 10.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 44.1 Cg_endo -71.54 154.47 60.11 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.793 1.417 . . . . 10.0 110.379 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.5 tp -94.08 135.38 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 10.0 109.013 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 16.2 p -124.01 168.81 11.8 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.325 -0.859 . . . . 10.0 109.589 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -66.3 -15.27 47.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.527 1.278 . . . . 10.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.66 -37.81 22.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 10.0 110.426 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.6 m -79.33 -32.66 43.4 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.538 -0.726 . . . . 10.0 110.821 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.27 -44.86 74.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 10.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -64.52 -27.76 69.19 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.27 -0.972 . . . . 10.0 109.453 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 147' ' ' ARG . 2.0 mmtp -67.53 -43.89 79.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.11 -0.994 . . . . 10.0 108.639 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.877 HD13 ' HE3' ' A' ' 94' ' ' LYS . 4.3 tt -63.05 -46.22 88.53 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -52.22 -43.12 64.1 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.816 0.817 . . . . 10.0 109.179 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 3.8 ttp85 -55.6 -28.74 56.89 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.524 0.678 . . . . 10.0 109.463 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.489 ' C ' HD12 ' A' ' 149' ' ' LEU . 22.9 t70 -78.17 -43.95 27.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.623 -0.673 . . . . 10.0 110.776 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.914 HD23 ' CH2' ' A' ' 97' ' ' TRP . 5.7 mp -88.06 9.83 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 10.0 108.88 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 10.2 mttt 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.895 0.855 . . . . 10.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.805 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -59.9 -151.34 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.197 -0.668 . . . . 10.0 109.197 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.913 ' CG1' HD13 ' A' ' 111' ' ' LEU . 1.4 p -116.86 -64.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.594 -1.316 . . . . 10.0 110.747 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.603 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -173.9 140.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.453 -1.404 . . . . 10.0 111.863 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 29.0 t80 -84.78 108.06 17.27 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.388 -0.925 . . . . 10.0 109.889 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.957 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -103.61 -169.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.752 . . . . 10.0 110.174 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' HA3' ' A' ' 164' ' ' GLY . 0.5 OUTLIER -127.74 160.29 32.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.958 . . . . 10.0 110.14 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.925 ' SG ' HD23 ' A' ' 165' ' ' LEU 0.251 1.6 t -166.02 135.87 3.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 10.0 110.238 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.556 ' OG ' ' CG ' ' A' ' 163' ' ' LYS . 34.2 m -131.17 83.88 2.14 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.078 -1.453 . . . . 10.0 107.078 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 1.052 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -29.26 -53.2 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.691 -1.141 . . . . 10.0 113.132 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.8 tp -71.06 -53.75 13.6 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.693 -1.254 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.4 p -84.74 -89.54 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.911 -1.118 . . . . 10.0 111.169 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.605 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 2.4 pt20 159.28 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 10.0 109.364 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.556 ' CG ' ' OG ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -105.33 69.19 0.83 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.026 -1.069 . . . . 10.0 110.591 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 76.98 0.93 71.24 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.993 -1.643 . . . . 10.0 108.993 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.183 HD12 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -50.12 -44.41 52.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.42 -1.047 . . . . 10.0 109.608 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.879 ' N ' HD13 ' A' ' 165' ' ' LEU . 14.8 tttm -70.69 -25.64 63.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.156 -0.965 . . . . 10.0 109.367 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 19.3 m120 -75.45 -33.89 60.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 10.0 111.641 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.957 HG22 ' HB ' ' A' ' 155' ' ' VAL . 10.7 t -57.96 -49.75 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.786 -1.197 . . . . 10.0 110.056 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.26 -40.0 88.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.659 -0.651 . . . . 10.0 110.43 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.6 t0 -60.12 -46.41 89.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 10.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.5 -42.63 99.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 10.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.986 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.28 -24.52 43.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 10.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.639 ' O ' HD11 ' A' ' 177' ' ' LEU . 77.4 mt -63.92 -47.03 92.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.115 -0.99 . . . . 10.0 109.595 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.802 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.07 -41.45 70.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 10.0 111.087 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -80.71 -2.72 48.0 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.198 -0.938 . . . . 10.0 110.899 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.048 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.67 -22.5 24.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.045 -1.035 . . . . 10.0 110.821 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -90.06 -22.19 21.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.077 -1.015 . . . . 10.0 110.138 -179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.025 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.254 -1.538 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -124.23 140.44 52.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.174 -1.192 . . . . 10.0 110.475 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.747 ' HE2' HD12 ' A' ' 174' ' ' LEU . 10.1 tptt -84.26 103.15 13.21 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.204 -0.935 . . . . 10.0 108.511 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -82.66 152.61 25.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.238 -0.914 . . . . 10.0 110.692 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.632 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.76 -48.14 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.77 -0.581 . . . . 10.0 110.555 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.2 Cg_endo -91.32 24.06 0.58 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.977 -1.201 . . . . 10.0 108.977 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.628 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 2.0 pm0 -39.55 166.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.544 0.688 . . . . 10.0 111.659 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.85 -88.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 10.0 111.192 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.5 p -82.37 171.19 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 10.0 111.96 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.909 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.96 96.8 0.48 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 10.0 111.818 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.49 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 46.9 Cg_endo -76.1 133.61 15.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.418 1.22 . . . . 10.0 109.117 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 56.4 p -93.16 117.95 30.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 10.0 111.105 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.09 136.45 54.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.523 -0.736 . . . . 10.0 109.303 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.794 ' HA ' HG13 ' A' ' 42' ' ' VAL . 11.4 p90 -139.98 166.53 24.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.939 -1.101 . . . . 10.0 110.635 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.6 tt0 -164.19 110.88 1.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.087 -1.008 . . . . 10.0 110.78 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 40' ' ' TYR . 6.4 p-80 -165.76 137.54 3.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 10.0 110.17 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.508 ' C ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -150.59 98.48 2.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 10.0 110.636 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.729 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -155.55 -170.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.4 p-80 -141.81 153.75 44.73 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 117.6 -1.64 . . . . 10.0 112.605 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.985 HG21 ' CA ' ' A' ' 35' ' ' THR . 3.5 m -103.39 152.34 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.461 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -124.09 73.77 0.4 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.742 -1.218 . . . . 10.0 110.313 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.858 ' CD2' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 167.4 97.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.385 -1.067 . . . . 10.0 109.189 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.777 ' O ' HG23 ' B' ' 25' ' ' VAL . 21.1 m-20 -61.33 154.48 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.438 -0.789 . . . . 10.0 111.815 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 39.76 38.11 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.638 . . . . 10.0 111.065 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.858 HG21 ' CD2' ' B' ' 22' ' ' PHE . 37.1 t -111.39 -23.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 10.0 108.821 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 26' ' ' THR . . . . . 1.045 HG21 ' CB ' ' A' ' 35' ' ' THR . 10.0 t -88.97 -10.61 47.04 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.36 0.6 . . . . 10.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.63 -0.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.517 -1.433 . . . . 10.0 109.517 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' B' ' 28' ' ' GLU . 6.8 pt-20 -104.51 122.11 44.86 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.969 -1.312 . . . . 10.0 110.733 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.3 OUTLIER -121.59 118.61 29.66 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.736 -0.839 . . . . 10.0 108.736 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.887 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 23.0 p -122.19 -4.99 8.93 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.986 -0.685 . . . . 10.0 109.589 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.89 39.09 0.78 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.167 -1.573 . . . . 10.0 109.167 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' B' ' 33' ' ' PRO . 28.4 mm -69.0 142.15 92.94 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.329 -1.1 . . . . 10.0 110.435 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' B' ' 32' ' ' ILE . 45.0 Cg_endo -68.9 177.61 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.293 1.681 . . . . 10.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' B' ' 37' ' ' ALA . 5.4 tm-20 -23.09 138.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.437 0.637 . . . . 10.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.546 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 7.6 mm100 -100.81 -71.72 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.67 0.989 . . . . 10.0 113.67 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.724 ' CZ3' HG11 ' A' ' 7' ' ' VAL . 16.5 t90 -108.69 30.36 6.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.357 -0.839 . . . . 10.0 112.611 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.746 ' HA ' HD21 ' A' ' 70' ' ' LEU . . . -178.18 89.3 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 118.986 -1.086 . . . . 10.0 111.383 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.505 ' HA ' ' HG3' ' B' ' 34' ' ' GLU . 5.3 ttp180 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.283 0.563 . . . . 10.0 109.703 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 3' ' ' THR . 0.7 OUTLIER -177.9 -160.74 0.05 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 10.0 110.749 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 3' ' ' THR . 85.0 m 41.25 58.29 2.64 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.36 -0.837 . . . . 10.0 111.019 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -143.16 150.52 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 117.28 -1.768 . . . . 10.0 113.804 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.629 ' N ' HG13 ' A' ' 4' ' ' ILE . 27.9 mtmt -131.32 126.1 34.45 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.279 -0.888 . . . . 10.0 109.601 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' C ' HG23 ' A' ' 7' ' ' VAL . 10.0 t -85.36 129.98 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.133 -0.979 . . . . 10.0 109.336 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 6' ' ' CYS . 4.1 t -146.97 175.97 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.919 -1.113 . . . . 10.0 110.421 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG21 HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER -108.93 146.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.537 -1.352 . . . . 10.0 111.178 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.27 -168.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.211 -0.93 . . . . 10.0 110.389 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.753 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 114.02 134.9 5.96 Favored Glycine 0 C--N 1.29 -1.994 0 N-CA-C 109.251 -1.54 . . . . 10.0 109.251 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.24 -14.8 19.72 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.507 -0.996 . . . . 10.0 110.054 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.49 -108.17 0.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.941 -1.664 . . . . 10.0 108.941 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.54 -130.3 0.08 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.03 -1.277 . . . . 10.0 110.933 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' C ' ' HG3' ' B' ' 35' ' ' GLN . 17.8 m -110.4 148.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.186 . . . . 10.0 110.618 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -51.58 137.95 29.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.6 -28.27 11.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.671 -1.488 . . . . 10.0 110.72 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.536 HG21 HG21 ' A' ' 8' ' ' VAL . 77.1 p -88.88 -37.44 15.31 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.492 -0.755 . . . . 10.0 110.336 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 19' ' ' LEU . 21.8 p -85.35 -13.46 49.47 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.925 -1.109 . . . . 10.0 109.745 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' B' ' 29' ' ' PHE . 4.4 mm? -81.9 -42.89 18.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.36 -1.463 . . . . 10.0 109.048 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 165' ' ' LEU . 5.6 tt -46.85 -37.74 9.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.632 -1.248 . . . . 10.0 107.632 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.868 HG21 HG23 ' B' ' 26' ' ' THR 0.256 5.6 mm -67.86 -46.99 81.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.779 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 p -48.3 -31.52 6.11 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.596 -0.842 . . . . 10.0 109.843 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.699 ' CD2' HD11 ' A' ' 165' ' ' LEU . 3.4 m-85 -93.77 -18.86 21.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.785 -1.197 . . . . 10.0 109.399 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 93.5 m -94.4 -22.5 18.26 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 10.0 112.604 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -109.16 -77.84 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.033 -1.667 . . . . 10.0 110.891 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 80.4 m-20 -152.19 -23.68 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.144 -1.423 . . . . 10.0 113.025 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 49.5 pttt 167.68 -158.7 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 O-C-N 120.855 -1.153 . . . . 10.0 112.481 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 2.7 p90 . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 115.055 1.502 . . . . 10.0 115.055 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.429 ' HB ' HG12 ' B' ' 20' ' ' VAL . 34.6 p . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.643 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 44.3 t -57.07 -74.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.777 -0.577 . . . . 10.0 109.752 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.68 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 19.8 t80 -45.05 123.43 3.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.712 ' HA ' HD11 ' B' ' 18' ' ' ILE . 12.1 t0 -149.73 86.59 1.46 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.381 -1.328 . . . . 10.0 111.479 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 16' ' ' HIS . 19.1 t-20 -97.82 99.98 11.33 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.721 -1.215 . . . . 10.0 107.721 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 2.3 m-85 -122.69 121.44 36.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.661 . . . . 10.0 109.63 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' B' ' 14' ' ' PHE . . . -112.48 116.12 29.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 10.0 110.253 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 43' ' ' THR . 40.1 t -132.86 173.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.897 -1.127 . . . . 10.0 110.244 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 51' ' ' TYR . 67.6 m -155.03 151.27 28.23 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.767 -0.773 . . . . 10.0 110.216 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -144.83 128.67 12.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.491 -0.883 . . . . 10.0 111.357 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.571 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -86.8 97.57 10.7 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.336 -0.946 . . . . 10.0 109.417 178.628 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 51' ' ' TYR . 2.9 mp -78.96 114.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.073 -1.017 . . . . 10.0 108.27 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 55.69 19.76 21.84 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 118.654 -1.736 . . . . 10.0 109.189 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 109.93 -8.13 31.5 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.349 -1.089 . . . . 10.0 110.645 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' C ' ' HA ' ' A' ' 45' ' ' MET . 30.1 mm-40 -96.43 105.33 21.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.28 . . . . 10.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 44.3 Cg_endo -71.19 130.71 18.0 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.495 1.463 . . . . 10.0 110.387 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.572 ' CE1' HD13 ' A' ' 46' ' ' ILE . 3.8 m-30 -98.18 118.31 34.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.838 -1.163 . . . . 10.0 111.616 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.7 p -92.28 99.23 12.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.077 -1.014 . . . . 10.0 108.568 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.03 147.33 44.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.039 -1.038 . . . . 10.0 110.94 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -129.62 109.52 0.96 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.04 -1.624 . . . . 10.0 109.04 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.807 ' C ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -98.28 127.45 44.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -1.204 . . . . 10.0 110.543 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.745 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.5 t80 -137.92 122.12 18.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.947 . . . . 10.0 111.283 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -107.8 164.73 12.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.902 -1.124 . . . . 10.0 109.719 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' B' ' 36' ' ' TRP . 99.6 m -47.44 164.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.798 -1.189 . . . . 10.0 111.001 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' A' ' 62' ' ' GLU . . . -104.74 91.68 3.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.73 -0.606 . . . . 10.0 109.961 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.574 ' HA3' HG23 ' B' ' 20' ' ' VAL . . . -48.01 -41.47 21.76 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.843 -2.503 . . . . 10.0 106.843 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 20.3 pt20 -71.87 -31.93 66.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 5.6 mt-10 56.42 81.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.813 0.816 . . . . 10.0 111.681 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.537 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 97.9 m-20 -126.38 3.92 6.98 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.32 0.581 . . . . 10.0 109.513 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 171.46 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 10.0 110.911 -178.915 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 5.4 p-10 -113.83 15.61 18.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.828 -1.17 . . . . 10.0 110.808 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.7 ptt-85 -77.83 -33.99 52.09 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.091 -1.006 . . . . 10.0 110.136 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.551 ' CA ' HD21 ' A' ' 70' ' ' LEU . 4.9 mt -111.41 5.27 19.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.909 -1.12 . . . . 10.0 111.726 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -97.07 -54.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.474 -1.391 . . . . 10.0 113.296 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.749 ' HG2' HD13 ' A' ' 70' ' ' LEU . 42.8 Cg_endo -71.46 -62.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.233 1.123 . . . . 10.0 111.335 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.957 ' N ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -50.62 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.383 -0.823 . . . . 10.0 111.855 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.627 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 17.4 p -31.37 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.416 0.626 . . . . 10.0 110.371 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 p90 48.13 138.62 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.3 0 N-CA-C 113.383 0.883 . . . . 10.0 113.383 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.97 167.28 27.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.65 1.567 . . . . 10.0 111.205 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -83.39 32.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.19 -0.944 . . . . 10.0 110.588 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 27.7 m -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 4.6 p-10 160.78 118.69 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.972 HG11 ' HA ' ' A' ' 176' ' ' ALA . 16.0 m -64.47 157.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.944 -1.872 . . . . 10.0 105.944 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 72' ' ' TYR . 43.9 m-85 -121.86 155.63 35.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.085 -1.634 . . . . 10.0 114.451 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 HG12 ' A' ' 168' ' ' VAL . 2.3 mm? -118.71 97.68 5.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 10' ' ' GLY . 14.3 p -110.03 154.97 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.119 -0.988 . . . . 10.0 109.708 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.519 ' CB ' ' OG1' ' A' ' 115' ' ' THR . 4.7 m -123.3 109.33 13.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.946 -1.096 . . . . 10.0 111.663 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CE1' HG21 ' A' ' 93' ' ' VAL . 93.8 m-85 -87.89 168.7 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 10.0 109.918 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.2 m -75.91 157.59 33.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.988 -1.07 . . . . 10.0 108.417 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 85' ' ' VAL . 3.5 p -81.91 -23.1 9.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.745 -1.222 . . . . 10.0 111.09 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -129.86 -88.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.847 -1.158 . . . . 10.0 108.808 178.251 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.603 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 44.52 -171.72 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.497 -0.752 . . . . 10.0 109.675 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 53.3 Cg_endo -73.34 162.84 39.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.421 1.222 . . . . 10.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -63.03 78.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.117 . . . . 10.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 29.1 t -106.36 -45.83 4.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.848 . . . . 10.0 110.791 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 112' ' ' LEU . 62.5 t80 -49.14 -19.4 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.156 -0.965 . . . . 10.0 110.193 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 7.3 mm-40 -78.79 -19.75 51.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.333 -0.855 . . . . 10.0 111.634 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.75 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -93.68 -14.6 26.19 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.388 -1.445 . . . . 10.0 109.38 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.75 HG13 ' ND2' ' A' ' 92' ' ' ASN . 31.5 m -85.58 -30.87 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.215 -0.994 . . . . 10.0 108.435 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.892 ' CE ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.16 -25.68 59.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.118 -0.989 . . . . 10.0 109.801 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.58 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -96.23 3.21 53.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 10.0 111.109 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.26 -50.33 3.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.571 -1.331 . . . . 10.0 111.06 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.64 -40.22 13.48 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.92 -1.112 . . . . 10.0 113.251 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 ' HG ' ' A' ' 149' ' ' LEU . 55.9 t -70.78 -51.62 11.35 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.33 -1.481 . . . . 10.0 112.806 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 95' ' ' GLU . 40.1 Cg_endo -64.71 -21.1 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.311 1.164 . . . . 10.0 109.365 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.783 ' HG2' HG22 ' A' ' 101' ' ' ILE . 64.6 tt0 -51.39 -57.0 10.12 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.127 -0.983 . . . . 10.0 109.999 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 149.67 119.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 109.743 -0.465 . . . . 10.0 109.743 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 108' ' ' THR . 25.3 m -92.36 -83.97 0.29 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 17.7 m80 -107.73 -11.47 15.41 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 103' ' ' HIS . 4.5 p80 173.11 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.565 -1.272 . . . . 10.0 107.565 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 96.9 m -130.98 164.98 38.38 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HB2' HG12 ' A' ' 98' ' ' VAL . 38.8 Cg_endo -67.88 92.04 0.37 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 123.608 1.32 . . . . 10.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 1.6 tttt -139.31 9.45 2.49 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.441 -0.787 . . . . 10.0 109.982 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.454 ' N ' ' OG1' ' A' ' 102' ' ' THR . 23.6 m -46.21 139.95 5.47 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.679 -1.263 . . . . 10.0 109.843 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.891 ' CG ' HG12 ' A' ' 77' ' ' VAL . 51.2 Cg_endo -70.76 117.65 5.26 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.003 1.528 . . . . 10.0 108.352 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.439 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -126.59 110.23 12.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.289 -0.882 . . . . 10.0 111.711 -177.954 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.033 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.2 mm? -85.6 98.08 10.45 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.526 -1.287 . . . . 10.0 107.526 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 90' ' ' PHE . 70.1 mt -84.13 127.87 34.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.042 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.814 HG11 ' HB3' ' A' ' 157' ' ' CYS . 19.2 t -133.5 165.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.857 . . . . 10.0 110.131 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -116.28 112.25 2.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -92.89 160.86 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.375 -1.073 . . . . 10.0 111.358 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 59.93 43.72 14.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.497 -0.752 . . . . 10.0 110.481 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -74.32 -18.97 17.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 179.054 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 117' ' ' ILE . 13.2 m-20 -53.46 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 122.7 1.238 . . . . 10.0 110.499 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 120' ' ' ARG . 1.8 pp 166.44 -27.68 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 114.138 -1.392 . . . . 10.0 107.596 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.739 ' N ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.12 -41.75 12.81 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.726 0.774 . . . . 10.0 109.07 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.88 -23.31 63.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.549 0.69 . . . . 10.0 110.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.485 ' O ' HD13 ' A' ' 126' ' ' ILE . 27.0 t70 -93.04 119.63 67.56 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 10.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.92 21.83 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 124.277 1.672 . . . . 10.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.475 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 32.2 t -107.19 -45.0 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 10.0 110.169 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 t -71.63 -30.26 65.57 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.8 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.315 0.9 OUTLIER -50.87 -26.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.188 -1.369 . . . . 10.0 108.315 177.18 . . . . . . . . 4 4 . 1 . 008 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -54.8 -40.45 69.5 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.509 0.671 . . . . 10.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -81.86 -36.03 28.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.462 -0.773 . . . . 10.0 109.904 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.847 ' HA ' HD22 ' A' ' 132' ' ' ASN . 8.5 mt -59.41 -45.29 91.92 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.778 -1.201 . . . . 10.0 108.586 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -49.01 -39.27 26.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 10.0 110.357 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -53.95 -19.09 4.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.571 -0.706 . . . . 10.0 111.13 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.847 HD22 ' HA ' ' A' ' 129' ' ' LEU . 8.4 p30 -118.36 -2.15 11.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.311 -1.356 . . . . 10.0 111.964 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -158.15 -25.51 0.08 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.148 -0.97 . . . . 10.0 111.043 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 9.0 pm0 40.79 19.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.753 -0.592 . . . . 10.0 111.595 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' LYS . 1.2 ptmt -153.77 95.1 2.87 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.776 -1.203 . . . . 10.0 110.036 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.939 ' HB3' HG12 ' A' ' 85' ' ' VAL . 44.4 Cg_endo -71.07 156.84 59.13 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 O-C-N 124.055 1.555 . . . . 10.0 110.357 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' A' ' 142' ' ' ALA . 2.0 mm -93.7 122.35 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 10.0 109.779 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.1 p -118.95 173.36 3.48 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.515 -0.74 . . . . 10.0 109.219 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.568 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.8 Cg_endo -63.37 -10.17 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.803 0.896 . . . . 10.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -94.12 -44.96 7.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 10.0 109.836 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -48.78 45.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 10.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 137' ' ' ILE . . . -62.47 -40.38 96.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 10.0 111.297 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 27.0 tt0 -61.18 -39.85 91.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.126 . . . . 10.0 109.526 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -60.61 -49.55 77.07 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.665 -1.214 . . . . 10.0 108.416 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.892 HD11 ' CE ' ' A' ' 94' ' ' LYS . 4.3 tt -57.82 -37.79 74.41 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.028 -1.045 . . . . 10.0 109.238 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.702 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -66.57 -35.61 80.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 120.017 -0.673 . . . . 10.0 109.633 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -15.44 60.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.141 -0.975 . . . . 10.0 109.277 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 11.8 t0 -70.3 -10.41 58.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.436 -0.79 . . . . 10.0 110.928 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.75 31.06 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 10.0 111.028 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt 60.03 36.65 21.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.82 0.819 . . . . 10.0 110.314 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -71.19 -176.23 1.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.033 HG11 ' CD1' ' A' ' 111' ' ' LEU . 12.7 t -87.48 -81.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.659 ' N ' HG12 ' A' ' 152' ' ' VAL . 1.6 tttp -173.74 159.38 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.549 -0.72 . . . . 10.0 110.072 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CG ' ' CB ' ' A' ' 142' ' ' ALA . 43.1 t80 -93.98 100.37 12.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.714 -1.241 . . . . 10.0 109.886 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.06 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -95.15 -167.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.51 -0.744 . . . . 10.0 109.328 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -136.05 149.65 48.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.66 -1.275 . . . . 10.0 112.262 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.814 ' HB3' HG11 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -162.9 138.41 6.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.335 -0.853 . . . . 10.0 109.424 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' LEU . 5.0 t -148.13 114.18 5.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 10.0 110.065 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.817 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 3.21 -65.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.739 1.385 . . . . 10.0 114.739 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.9 -38.51 1.12 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.758 -1.214 . . . . 10.0 112.079 -177.428 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.1 p -60.91 -71.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 10.0 111.788 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 158' ' ' SER . 4.4 mm100 -36.6 -69.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.631 -0.668 . . . . 10.0 111.43 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER 66.05 25.27 10.92 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.637 -0.825 . . . . 10.0 110.532 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.82 2.89 9.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.192 -1.963 . . . . 10.0 108.192 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -58.27 -14.76 7.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.666 -0.902 . . . . 10.0 111.944 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.654 ' N ' HD22 ' A' ' 165' ' ' LEU . 9.4 mtmt -63.15 -36.07 82.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.445 -1.409 . . . . 10.0 110.952 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -63.86 -38.56 91.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 10.0 111.103 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.06 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.8 t -52.8 -34.38 20.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.815 -1.178 . . . . 10.0 110.412 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.89 -24.28 55.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 10.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -74.21 -43.89 55.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.042 -1.063 . . . . 10.0 110.088 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 153' ' ' LYS . 36.4 mt-10 -60.58 -32.94 72.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 10.0 109.995 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.763 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -61.23 -24.78 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.772 -1.205 . . . . 10.0 109.76 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.741 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.8 mm -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.08 -1.013 . . . . 10.0 109.736 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.776 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -76.41 -41.88 46.22 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.004 -1.06 . . . . 10.0 109.986 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.835 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -79.81 -4.2 51.08 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.447 -0.783 . . . . 10.0 109.824 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.972 ' HA ' HG11 ' A' ' 77' ' ' VAL . . . -76.41 -43.17 41.59 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.191 -0.943 . . . . 10.0 108.95 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -108.09 -20.6 13.11 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.56 0.695 . . . . 10.0 109.814 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.184 -0.912 . . . . 10.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 108.517 -1.833 . . . . 10.0 108.517 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' B' ' 4' ' ' GLU . 2.0 m -107.75 55.25 0.65 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.218 -1.166 . . . . 10.0 110.476 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -51.64 105.48 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 10.0 110.457 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' B' ' 2' ' ' SER . 1.5 mt-10 -96.01 156.0 16.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.608 -0.682 . . . . 10.0 110.388 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.61 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -108.6 -50.3 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.159 -0.963 . . . . 10.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 55.6 Cg_endo -95.67 32.3 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 108.298 -1.462 . . . . 10.0 108.298 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.5 pp20? -38.57 158.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.912 -0.493 . . . . 10.0 109.676 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.677 HG13 ' HA2' ' A' ' 47' ' ' GLY . 2.1 pp -81.52 -53.33 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.233 . . . . 10.0 112.184 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.559 ' N ' HD12 ' B' ' 8' ' ' ILE . 30.6 t -160.94 173.81 14.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.325 -1.484 . . . . 10.0 111.462 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.666 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.2 pp -164.39 99.2 0.89 Allowed Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.119 -1.032 . . . . 10.0 111.929 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 44.2 Cg_endo -72.65 104.95 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.862 1.453 . . . . 10.0 109.343 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.51 ' HA ' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -53.02 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.956 . . . . 10.0 111.037 -179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -138.31 -168.88 2.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' ALA . 21.6 m-85 -97.13 165.21 12.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.7 -1.25 . . . . 10.0 111.796 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 6.1 pm0 -119.85 171.05 8.69 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.8 -0.562 . . . . 10.0 110.39 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -92.16 -174.97 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.006 -1.059 . . . . 10.0 110.356 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.511 ' C ' HG23 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -147.1 133.47 19.59 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.122 -0.986 . . . . 10.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.835 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -150.07 -177.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.916 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -142.37 154.91 45.04 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.989 -1.069 . . . . 10.0 110.645 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.643 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 2.8 p -91.11 148.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 10.0 110.503 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' A' ' 61' ' ' GLN . . . -99.42 47.94 1.3 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.874 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -177.74 104.62 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.234 -1.156 . . . . 10.0 109.032 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.39 142.0 49.67 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.808 0.813 . . . . 10.0 112.343 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' B' ' 28' ' ' GLU . . . 51.57 51.71 16.17 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.746 -0.596 . . . . 10.0 112.38 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.874 HG21 ' HB3' ' B' ' 22' ' ' PHE . 52.1 t -113.32 -39.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.649 -1.282 . . . . 10.0 110.547 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.868 HG23 HG21 ' A' ' 21' ' ' ILE . 3.1 t -61.58 -22.78 65.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.137 -0.977 . . . . 10.0 110.18 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.592 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -106.3 31.12 8.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 106.841 -2.504 . . . . 10.0 106.841 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 2.8 mp0 -128.55 114.07 16.26 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.261 1.029 . . . . 10.0 110.663 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.822 ' CG ' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -128.67 140.32 51.81 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.707 0.765 . . . . 10.0 109.955 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -146.29 -69.52 0.26 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.97 1.2 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.631 -1.271 . . . . 10.0 111.289 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.56 ' HB ' ' HD3' ' B' ' 33' ' ' PRO . 2.0 mt -63.29 -55.65 34.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.629 -1.512 . . . . 10.0 111.217 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' B' ' 32' ' ' ILE . 44.1 Cg_endo -70.56 169.38 20.07 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.326 1.172 . . . . 10.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.519 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.4 tp10 -78.63 167.67 20.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.991 -1.068 . . . . 10.0 109.371 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 11.5 mp0 -81.08 19.62 0.88 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.484 -0.76 . . . . 10.0 111.469 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.581 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 4.8 m95 89.9 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 123.074 1.416 . . . . 10.0 107.504 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . . . -156.81 81.09 0.94 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.217 -1.356 . . . . 10.0 108.613 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.519 ' CA ' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.061 -1.025 . . . . 10.0 108.719 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 1.5 mpp? . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.905 0.384 . . . . 10.0 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.622 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.3 mt-30 -139.01 -39.99 0.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 10.0 110.249 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -44.09 101.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.972 . . . . 10.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.891 HD12 ' CB ' ' A' ' 176' ' ' ALA . 2.1 tt -106.47 140.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.658 -1.217 . . . . 10.0 110.302 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 mmtt -112.85 137.05 51.77 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 18.2 t -118.85 108.42 14.8 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.807 -1.183 . . . . 10.0 110.317 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.601 ' N ' HG21 ' A' ' 75' ' ' THR . 9.1 t -137.81 163.62 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 10.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.612 HG22 ' OG1' ' A' ' 17' ' ' THR . 3.1 t -87.02 141.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 10.0 110.548 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 78' ' ' PHE . 46.1 t -136.42 174.69 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.374 -0.829 . . . . 10.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.762 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 125.04 130.6 3.52 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.864 -1.295 . . . . 10.0 109.864 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.82 -27.57 43.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -1.075 . . . . 10.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 140.92 127.61 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.02 -1.232 . . . . 10.0 110.02 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 169.59 -67.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 10.0 109.703 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.966 ' HB ' HG23 ' A' ' 115' ' ' THR . 13.4 t -147.93 107.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 10.0 109.525 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' B' ' 35' ' ' GLN . . . -74.08 99.1 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.882 -1.287 . . . . 10.0 109.882 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -52.64 -36.97 57.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.296 . . . . 10.0 109.709 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 8' ' ' VAL . 53.2 m -52.71 -39.57 62.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.436 -0.79 . . . . 10.0 110.792 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 22' ' ' SER . 14.5 p -81.89 -15.77 52.86 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.673 -1.267 . . . . 10.0 108.988 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.771 HD11 HG13 ' A' ' 14' ' ' VAL . 10.2 mt -84.34 -30.52 25.43 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.906 0.86 . . . . 10.0 109.12 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -54.69 -39.3 67.99 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.788 HG21 HG23 ' B' ' 26' ' ' THR . 3.5 mm -91.27 -42.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 121.666 0.746 . . . . 10.0 109.911 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.576 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 32.9 t -47.6 -40.5 19.52 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.303 -0.959 . . . . 10.0 109.974 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 160' ' ' LEU . 9.4 t80 -100.83 1.46 40.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.238 -1.385 . . . . 10.0 110.625 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 6.3 m -107.21 -19.09 13.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.984 -1.072 . . . . 10.0 111.325 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 21' ' ' ILE . 11.3 t -112.23 -43.04 3.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.731 -1.23 . . . . 10.0 111.16 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.553 ' N ' HG23 ' A' ' 25' ' ' THR . 7.3 m-20 -155.87 -48.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.492 -1.283 . . . . 10.0 112.512 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.698 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 168.88 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.217 -0.927 . . . . 10.0 111.892 -178.527 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 22.4 p90 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.966 ' HB ' HG11 ' B' ' 20' ' ' VAL . 20.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.0 0.429 . . . . 10.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' B' ' 25' ' ' VAL . 89.8 t -28.22 -33.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 121.325 0.583 . . . . 10.0 111.321 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -38.94 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 10.0 109.759 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -170.38 91.07 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 119.879 -1.763 . . . . 10.0 113.776 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.581 ' HB3' HG13 ' B' ' 18' ' ' ILE . 8.2 t30 -135.88 149.75 49.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 10.0 108.604 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 2.6 m-85 -167.2 113.84 0.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.402 -1.436 . . . . 10.0 111.702 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 15' ' ' GLU . . . -93.69 108.85 20.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.92 -1.141 . . . . 10.0 107.92 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' O ' ' B' ' 14' ' ' PHE . 44.1 t -135.87 171.93 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.184 -1.407 . . . . 10.0 112.31 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 51' ' ' TYR . 54.7 m -147.28 170.6 16.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 51' ' ' TYR . 1.3 p -161.35 129.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.89 -1.131 . . . . 10.0 111.561 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.681 ' CB ' HD22 ' B' ' 10' ' ' LEU . 1.3 mmt -104.95 129.06 53.44 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.826 -1.15 . . . . 10.0 108.131 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.995 HG22 ' HB3' ' B' ' 7' ' ' GLU . 33.6 mt -132.05 99.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.913 -1.117 . . . . 10.0 110.194 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.71 ' CA ' HG22 ' B' ' 8' ' ' ILE . . . 59.76 24.05 59.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.038 -1.625 . . . . 10.0 109.038 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.72 6.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -127.29 95.47 36.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.17 -1.194 . . . . 10.0 110.538 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 51.5 Cg_endo -83.19 132.68 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.236 1.65 . . . . 10.0 112.008 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.852 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.7 m-85 -93.65 150.69 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 10.0 109.29 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.3 m -136.25 100.32 4.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.786 -1.196 . . . . 10.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -149.3 176.35 10.62 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.393 -1.323 . . . . 10.0 112.813 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.82 118.52 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 107.67 -2.172 . . . . 10.0 107.67 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . 2.0 pp -129.78 159.58 36.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.647 -1.502 . . . . 10.0 111.138 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 15.9 p90 -165.69 131.77 2.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 10.0 110.568 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -81.38 176.84 9.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 10.0 110.095 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.518 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 99.1 m -40.2 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 10.0 111.43 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . . . -146.65 63.01 1.2 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 10.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.19 69.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.275 -1.13 . . . . 10.0 110.275 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.528 ' HB2' ' HA3' ' B' ' 21' ' ' GLY . 64.7 tp60 -115.77 -28.79 6.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.065 -1.256 . . . . 10.0 111.23 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 7.3 tp10 -63.53 -50.02 71.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.871 -1.143 . . . . 10.0 110.572 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -142.74 0.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 10.0 111.323 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.2 m-85 65.35 40.26 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.821 -1.178 . . . . 10.0 107.821 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.621 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -78.7 47.72 0.75 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.85 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.932 ' O ' HD23 ' A' ' 70' ' ' LEU . 17.4 mtp180 -82.82 -26.28 31.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.437 -0.789 . . . . 10.0 109.53 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.77 -6.66 14.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 10.0 111.888 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -92.75 -54.9 0.25 Allowed Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 120.376 -1.453 . . . . 10.0 113.19 -177.864 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.625 ' C ' HD13 ' A' ' 70' ' ' LEU . 43.0 Cg_endo -77.61 -5.02 15.17 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.528 1.278 . . . . 10.0 111.987 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.932 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -101.81 -98.8 0.27 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.773 -1.205 . . . . 10.0 110.966 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 40.1 m -36.38 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.744 -0.598 . . . . 10.0 110.467 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 70' ' ' LEU . 15.6 m-85 -103.47 91.92 3.66 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 10.0 109.056 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 71' ' ' SER . 45.4 Cg_endo -70.62 147.43 57.32 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.787 1.414 . . . . 10.0 110.555 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CD ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -169.37 57.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.221 -0.924 . . . . 10.0 110.583 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.655 HG23 ' CB ' ' A' ' 5' ' ' LYS . 18.0 m -145.01 98.05 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.162 -0.961 . . . . 10.0 110.099 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -34.37 -33.21 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 10.0 110.487 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -111.25 120.24 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.313 -0.867 . . . . 10.0 109.644 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.7 m-85 -115.41 140.92 48.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.906 -1.121 . . . . 10.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 111' ' ' LEU . 3.4 mm? -109.39 99.35 8.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 10.0 109.562 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG23 ' HA2' ' A' ' 10' ' ' GLY . 7.1 p -103.82 151.02 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 10.0 110.131 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 115' ' ' THR . 3.2 t -126.71 103.8 7.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 10.0 111.496 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 115' ' ' THR . 67.7 m-85 -89.89 140.05 29.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 10.0 111.056 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -92.52 138.59 31.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.214 -0.929 . . . . 10.0 110.169 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.871 HG11 ' HG3' ' A' ' 120' ' ' ARG . 14.4 m -81.42 -17.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 10.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 84' ' ' VAL . 17.8 m -102.6 38.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.774 0.797 . . . . 10.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 87' ' ' PRO . 47.7 t -110.04 154.34 42.76 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.677 -0.639 . . . . 10.0 109.37 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.535 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 47.9 Cg_endo -68.93 73.62 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.735 1.387 . . . . 10.0 111.099 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 133' ' ' LYS . 43.4 m 39.91 55.04 2.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 10.0 110.429 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 93' ' ' VAL . 62.7 p -91.9 -36.74 13.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 10.0 110.547 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -50.3 -29.96 10.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.09 . . . . 10.0 110.338 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -67.47 -35.7 79.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.901 . . . . 10.0 110.036 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -71.32 -12.81 61.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 10.0 109.39 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t -88.87 -12.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.39 -0.819 . . . . 10.0 109.346 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 6.8 mmtt -89.03 -35.75 16.19 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.0 pt-20 -80.0 -5.05 55.04 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.26 -0.576 . . . . 10.0 110.082 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -102.02 -44.89 5.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.935 -1.103 . . . . 10.0 111.763 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.559 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 35.9 m95 -89.59 -29.05 19.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.294 -0.878 . . . . 10.0 112.028 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.929 ' CG2' HD21 ' A' ' 149' ' ' LEU . 62.8 t -62.28 -47.9 88.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.545 -1.347 . . . . 10.0 110.596 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.765 ' O ' HD12 ' A' ' 101' ' ' ILE . 48.9 Cg_endo -74.68 -15.56 21.53 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 109.115 -1.148 . . . . 10.0 109.115 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 40.9 tt0 -58.97 -29.25 67.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.754 -0.591 . . . . 10.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 99' ' ' PRO . 3.6 mt 57.57 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 10.0 109.603 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.59 ' CG2' ' HG2' ' A' ' 106' ' ' PRO . 3.9 m -43.29 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.345 -0.847 . . . . 10.0 109.08 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.547 ' N ' HG22 ' A' ' 102' ' ' THR . 4.8 m-70 -110.45 -15.9 13.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 162.45 -55.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.592 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 6.9 t -168.06 44.58 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.207 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.4 Cg_endo -81.26 -26.1 3.56 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 N-CA-C 109.083 -1.16 . . . . 10.0 109.083 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.579 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 1.6 pttp 55.66 52.85 10.33 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.342 1.067 . . . . 10.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 10.0 t -45.38 155.17 0.46 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 10.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 38.9 Cg_endo -66.35 148.77 84.81 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.76 1.4 . . . . 10.0 110.486 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -139.07 111.9 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 10.0 110.023 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.849 HD13 HG11 ' A' ' 152' ' ' VAL . 1.6 mm? -80.84 98.08 7.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.316 -0.865 . . . . 10.0 109.358 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 56.1 mt -70.22 140.11 52.38 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 111' ' ' LEU . 4.5 t -148.1 168.22 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.809 -1.182 . . . . 10.0 111.679 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.37 150.04 16.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.748 -1.741 . . . . 10.0 108.748 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.966 HG23 ' HB ' ' A' ' 14' ' ' VAL . 24.1 m -103.49 129.94 50.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.353 . . . . 10.0 110.756 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 14' ' ' VAL . 69.4 mt-30 53.27 50.03 18.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 10.0 110.377 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.995 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -65.29 -25.27 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.028 -1.045 . . . . 10.0 110.017 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.8 p-10 -52.06 59.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.267 1.032 . . . . 10.0 110.051 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.796 ' N ' ' O ' ' A' ' 117' ' ' ILE . 9.8 tp 158.64 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.871 ' HG3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.35 -40.11 48.25 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.81 -0.556 . . . . 10.0 109.928 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -28.77 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 10.0 109.993 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.6 m-20 -83.6 130.35 56.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 10.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.3 Cg_endo -86.18 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.664 1.576 . . . . 10.0 110.079 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -98.47 -50.98 4.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 10.0 110.198 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.552 HG21 HD21 ' A' ' 119' ' ' LEU . 6.4 t -75.53 -32.37 60.45 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.014 -2.217 . . . . 10.0 105.014 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 123' ' ' PRO 0.293 1.1 mp -50.69 -28.25 5.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 176.856 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -52.18 -29.89 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.65 0.738 . . . . 10.0 110.471 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 6.4 mmtp -55.75 -36.93 67.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.492 -0.755 . . . . 10.0 111.606 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -57.85 -49.81 75.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.685 -1.26 . . . . 10.0 109.566 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -49.56 -41.23 40.97 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.735 -0.603 . . . . 10.0 111.466 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -21.76 56.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.26 -0.9 . . . . 10.0 110.203 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 12.7 p-10 -128.49 -46.82 1.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 10.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 129' ' ' LEU . 5.2 mmtp -121.74 144.95 48.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.631 -0.668 . . . . 10.0 109.287 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -99.54 6.33 45.85 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.257 -0.902 . . . . 10.0 110.557 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 10.6 mtpt -131.76 94.02 26.34 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 10.0 109.91 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.3 Cg_endo -70.61 160.65 48.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.128 1.593 . . . . 10.0 110.604 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.698 HG22 HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -75.68 133.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.023 . . . . 10.0 108.649 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.2 p -131.19 168.84 15.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.152 -0.968 . . . . 10.0 109.744 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.3 Cg_endo -68.71 -33.11 22.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.758 1.399 . . . . 10.0 109.351 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 15.6 pt-20 -71.18 -23.87 62.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.822 . . . . 10.0 109.181 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 57.4 m -80.03 -40.87 26.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 10.0 109.017 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.472 -0.768 . . . . 10.0 109.31 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' PRO . 37.4 mt-10 -59.63 -42.84 93.61 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.079 -0.648 . . . . 10.0 109.692 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -61.56 -39.79 92.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.373 -0.829 . . . . 10.0 109.434 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.558 HD13 ' HE3' ' A' ' 94' ' ' LYS . 3.8 tp -65.03 -46.45 81.25 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.061 -1.024 . . . . 10.0 108.431 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -57.66 -45.1 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 10.0 110.383 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -26.37 64.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.406 -0.809 . . . . 10.0 109.882 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.495 ' C ' HD12 ' A' ' 149' ' ' LEU . 12.8 m-20 -75.63 -49.95 16.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.324 -0.86 . . . . 10.0 110.574 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.929 HD21 ' CG2' ' A' ' 98' ' ' VAL . 6.5 mp -90.37 1.68 56.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 10.0 108.975 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 6.2 mtmt 65.49 30.31 10.8 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.639 0.733 . . . . 10.0 109.847 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -59.34 -146.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.955 -0.698 . . . . 10.0 109.463 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.849 HG11 HD13 ' A' ' 111' ' ' LEU . 2.7 p -117.51 -57.15 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.368 -1.458 . . . . 10.0 112.047 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.584 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -171.69 151.59 2.93 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 118.148 -1.421 . . . . 10.0 112.291 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.9 p90 -87.54 124.51 33.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 10.0 110.329 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.016 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -126.36 -168.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.355 -0.84 . . . . 10.0 109.879 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 1.9 mt-10 -143.16 144.44 32.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.016 -1.052 . . . . 10.0 110.502 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 168' ' ' VAL . 79.8 m -144.28 129.8 19.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.898 0.856 . . . . 10.0 111.4 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.563 ' N ' HD21 ' A' ' 165' ' ' LEU . 3.9 t -120.74 173.32 7.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.684 ' CB ' HD22 ' A' ' 19' ' ' LEU . . . -93.66 -93.44 0.17 Allowed 'General case' 0 C--N 1.29 -1.99 0 O-C-N 120.984 -1.073 . . . . 10.0 110.438 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.036 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -54.67 -39.19 67.82 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.067 -1.021 . . . . 10.0 109.49 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.54 ' OG1' ' OG ' ' A' ' 158' ' ' SER . 75.0 p -79.39 -35.34 40.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.152 -1.592 . . . . 10.0 110.953 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.583 ' CG ' ' HG ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 58.02 67.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.785 -1.197 . . . . 10.0 109.858 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.591 ' HG2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -87.3 56.8 4.13 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.64 -0.824 . . . . 10.0 111.047 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 125.6 11.41 4.09 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.416 -1.374 . . . . 10.0 111.001 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.583 ' HG ' ' CG ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -54.52 -34.18 61.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.718 -1.46 . . . . 10.0 109.556 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -88.15 -25.01 23.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 10.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -70.91 -38.78 72.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 10.0 111.206 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 155' ' ' VAL . 3.5 t -68.94 -36.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.833 -1.167 . . . . 10.0 109.325 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 173' ' ' ILE . 60.7 t80 -60.11 -37.76 80.97 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.687 -0.633 . . . . 10.0 110.01 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.7 m-20 -67.66 -46.63 71.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -0.943 . . . . 10.0 111.358 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.07 -30.61 69.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 10.0 110.359 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -70.56 -24.47 62.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.062 . . . . 10.0 109.324 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.691 ' O ' HD12 ' A' ' 177' ' ' LEU . 27.8 mm -64.55 -44.74 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.434 -0.791 . . . . 10.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.85 -31.91 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.803 -1.185 . . . . 10.0 110.629 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.462 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . . . -89.01 0.79 56.37 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.472 -0.768 . . . . 10.0 110.838 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.891 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -88.89 -37.23 15.47 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.933 -1.105 . . . . 10.0 110.195 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.95 -13.54 16.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.385 -0.822 . . . . 10.0 109.716 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.42 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -89.96 47.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 10.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.2 100.49 4.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.067 -1.021 . . . . 10.0 110.664 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.469 ' HB2' ' OE1' ' B' ' 7' ' ' GLU . 14.3 mm-40 -101.52 175.67 5.49 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.542 0.687 . . . . 10.0 110.168 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.36 -146.49 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -76.11 13.72 1.23 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 CA-C-N 119.277 0.777 . . . . 10.0 111.815 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.995 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER 36.72 -150.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.229 -0.919 . . . . 10.0 110.166 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.71 HG22 ' CA ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -82.57 -115.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.943 -1.132 . . . . 10.0 107.943 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.648 ' H ' HG23 ' B' ' 8' ' ' ILE . 7.8 t -159.08 110.11 2.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.084 -1.635 . . . . 10.0 111.348 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -116.94 119.96 34.52 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.146 -0.971 . . . . 10.0 108.869 178.382 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.95 100.09 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.67 1.353 . . . . 10.0 112.928 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 m -149.17 126.01 11.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.597 -0.69 . . . . 10.0 109.575 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 43' ' ' THR . 5.9 p-10 -170.89 148.82 2.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.395 -1.441 . . . . 10.0 113.15 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 1.056 ' O ' HG22 ' A' ' 42' ' ' VAL . 5.4 m-85 -129.63 -176.33 3.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.81 149.77 1.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.592 -1.318 . . . . 10.0 112.436 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.9 t60 -171.29 117.34 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.537 -0.727 . . . . 10.0 110.068 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' A' ' 39' ' ' ASN . 9.3 t -128.82 158.46 38.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.868 -1.145 . . . . 10.0 112.261 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.647 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -121.5 -168.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.642 . . . . 10.0 109.265 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.642 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 63.1 m80 -136.25 157.28 47.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 10.0 111.877 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.966 HG11 ' HB ' ' A' ' 35' ' ' THR . 10.2 p -97.63 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.538 -0.726 . . . . 10.0 112.062 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 61' ' ' GLN . . . -108.41 65.48 0.25 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.669 -2.172 . . . . 10.0 107.669 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.741 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER 175.32 114.24 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.433 -1.039 . . . . 10.0 108.673 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.541 ' HA ' HG21 ' A' ' 35' ' ' THR . 32.4 t70 -62.1 152.4 32.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.28 -0.888 . . . . 10.0 112.349 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.612 ' N ' HG22 ' A' ' 35' ' ' THR . . . 37.82 71.78 0.14 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.733 -0.604 . . . . 10.0 112.524 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 36' ' ' VAL . 15.4 t -113.15 -46.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.966 -1.084 . . . . 10.0 109.767 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.788 HG23 HG21 ' A' ' 21' ' ' ILE . 1.1 t -82.57 -28.15 31.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.31 0.576 . . . . 10.0 110.51 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 36.35 3.82 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.26 -1.936 . . . . 10.0 108.26 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 36.4 tt0 -142.18 128.95 20.48 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.554 -0.968 . . . . 10.0 110.953 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -140.9 114.54 8.87 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 122.233 1.016 . . . . 10.0 109.284 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' B' ' 31' ' ' GLY . 5.1 p -146.82 -49.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.576 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . 177.83 89.71 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.063 -1.615 . . . . 10.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.614 HG23 ' HD2' ' B' ' 33' ' ' PRO . 83.1 mt -120.0 147.11 43.71 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.195 -1.179 . . . . 10.0 110.445 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.7 Cg_endo -69.45 129.26 17.6 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 10.0 109.767 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' B' ' 38' ' ' ARG . 25.1 tp10 55.92 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 10.0 109.617 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.604 ' O ' ' CE3' ' B' ' 36' ' ' TRP . 72.5 mt-30 -93.08 -27.25 17.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.952 -1.092 . . . . 10.0 112.521 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.693 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER 162.61 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.104 -1.073 . . . . 10.0 108.104 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 70' ' ' LEU . . . -175.19 75.64 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.501 ' N ' ' HG2' ' B' ' 34' ' ' GLU . 3.9 mtm180 . . . . . 0 C--N 1.293 -1.876 0 N-CA-C 107.295 -1.372 . . . . 10.0 107.295 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 1' ' ' MET . 3.3 ptp . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.807 0.813 . . . . 10.0 109.843 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -153.86 -35.63 0.1 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.606 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 89.8 m -53.17 94.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.374 -0.829 . . . . 10.0 110.246 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.697 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -109.12 132.27 57.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.524 -1.271 . . . . 10.0 110.062 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' THR . 4.4 mtpp -122.85 104.75 9.47 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.565 ' C ' HG22 ' A' ' 7' ' ' VAL . 29.9 p -108.98 152.85 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.143 -0.973 . . . . 10.0 111.75 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.56 162.53 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.759 -0.588 . . . . 10.0 110.102 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 16.0 m -81.76 137.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 10.0 111.472 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -152.29 169.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.307 -0.871 . . . . 10.0 109.741 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.535 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 150.39 88.88 0.07 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.974 -1.251 . . . . 10.0 109.974 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' GLY . 3.8 t0 40.88 25.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -1.072 . . . . 10.0 111.048 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 71.63 36.85 62.04 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.499 -1.44 . . . . 10.0 109.499 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . -108.97 -140.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.532 -0.981 . . . . 10.0 109.657 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.602 HG12 ' CE2' ' B' ' 29' ' ' PHE . 4.7 m -88.27 161.7 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 10.0 109.648 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.517 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -92.2 -174.16 42.09 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.274 -1.13 . . . . 10.0 110.274 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG11 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -110.59 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -1.064 . . . . 10.0 111.001 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 19' ' ' LEU . 73.7 m -50.8 -36.45 37.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.036 -1.04 . . . . 10.0 109.041 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 25.3 p -67.22 4.32 0.97 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.128 0.966 . . . . 10.0 109.718 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 160' ' ' LEU . 3.8 mt -110.46 -38.82 5.11 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.285 -1.509 . . . . 10.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 166' ' ' LYS . 21.1 tp -44.63 -46.2 10.01 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.853 -1.154 . . . . 10.0 111.227 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 1.065 HG22 ' O ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -90.33 -31.14 5.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 117.093 -1.843 . . . . 10.0 109.858 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.805 ' OG ' HD23 ' A' ' 160' ' ' LEU . 21.9 t -47.44 -44.14 24.6 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.346 -0.942 . . . . 10.0 110.311 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.511 ' HB2' ' C ' ' A' ' 159' ' ' ALA . 67.0 t80 -86.42 -0.89 56.94 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.55 -1.344 . . . . 10.0 109.951 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 4.3 m -108.93 -42.87 4.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.851 -1.155 . . . . 10.0 113.984 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 26' ' ' ASN . 60.0 m -117.38 -93.06 0.51 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 119.95 -1.719 . . . . 10.0 111.515 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.841 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.1 OUTLIER -135.81 -21.64 1.47 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.277 -0.889 . . . . 10.0 110.34 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 1.065 ' O ' HG22 ' A' ' 21' ' ' ILE . 14.4 mttt -148.87 -139.32 0.09 Allowed 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.729 -1.952 . . . . 10.0 105.729 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.285 -2.203 0 C-N-CA 116.357 -2.137 . . . . 10.0 115.384 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 28' ' ' PHE . 2.9 m . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 120.93 0.395 . . . . 10.0 111.369 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.852 ' CG1' HG11 ' B' ' 20' ' ' VAL . 38.6 t 77.46 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.763 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -33.75 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.141 0.972 . . . . 10.0 110.648 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -170.15 112.22 0.44 Allowed 'General case' 0 C--N 1.289 -2.033 0 O-C-N 119.374 -2.079 . . . . 10.0 112.221 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.594 ' HB3' ' CG1' ' B' ' 18' ' ' ILE . 0.9 OUTLIER -166.4 96.93 0.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.217 -0.927 . . . . 10.0 108.558 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' B' ' 17' ' ' THR . 17.4 p90 -171.77 176.95 3.5 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.354 -0.938 . . . . 10.0 111.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -171.23 98.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.773 HG21 ' O ' ' B' ' 15' ' ' GLU . 16.6 m -157.5 -166.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 10.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 51' ' ' TYR . 24.1 m -105.35 166.83 10.15 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.967 -0.693 . . . . 10.0 111.319 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.58 ' CG1' HD11 ' A' ' 46' ' ' ILE . 2.9 t -127.7 139.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.398 -0.964 . . . . 10.0 108.398 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.738 ' O ' HD23 ' B' ' 10' ' ' LEU . 3.1 mtt -102.57 102.16 12.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.349 -1.34 . . . . 10.0 110.426 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.58 HD11 ' CG1' ' A' ' 44' ' ' VAL . 2.3 mp -110.24 118.59 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.06 . . . . 10.0 110.167 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 54.41 16.96 7.48 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.178 -1.169 . . . . 10.0 110.178 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.03 18.35 34.45 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 68.2 mm-40 -110.59 115.89 53.21 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.39 -1.065 . . . . 10.0 110.315 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 45.8 Cg_endo -69.24 119.4 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.824 1.434 . . . . 10.0 110.272 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 43' ' ' THR . 3.9 m-30 -97.52 179.93 4.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 10.0 110.72 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 4' ' ' ILE . 5.0 m -146.27 132.66 19.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 10.0 110.039 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -172.27 174.04 4.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.739 -1.225 . . . . 10.0 111.593 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.87 105.4 0.21 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.163 -1.975 . . . . 10.0 108.163 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.942 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -105.52 135.48 46.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.64 -1.506 . . . . 10.0 110.409 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.942 ' N ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -129.03 103.25 6.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 10.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' THR . 51.1 t0 -105.96 121.04 43.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 10.0 109.421 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 13.7 t -39.4 129.39 1.82 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.074 -1.016 . . . . 10.0 111.466 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . . . -72.17 -73.52 0.19 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.811 -0.556 . . . . 10.0 111.515 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.98 7.4 59.29 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.985 -1.646 . . . . 10.0 108.985 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 177.91 -26.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -1.093 . . . . 10.0 110.903 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.999 ' HG2' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -41.87 -71.14 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.858 -1.152 . . . . 10.0 110.383 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 7.2 t70 164.34 -13.77 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.698 -0.626 . . . . 10.0 110.697 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 38.2 p90 -110.86 17.33 20.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.865 -1.147 . . . . 10.0 109.312 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 68' ' ' ARG . 35.1 t70 -49.52 -23.7 1.73 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.434 -0.791 . . . . 10.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -49.92 -36.62 28.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.04 -1.038 . . . . 10.0 109.223 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.6 mt -92.66 11.49 26.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.505 -0.747 . . . . 10.0 110.041 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.658 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -73.37 -22.13 0.48 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.275 -0.891 . . . . 10.0 112.959 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 42.8 Cg_endo -78.21 85.12 1.87 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 CA-C-O 121.944 0.727 . . . . 10.0 110.546 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.568 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.27 -47.15 1.2 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.795 0.807 . . . . 10.0 109.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' B' ' 37' ' ' ALA . 5.6 m 59.91 12.78 3.26 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.948 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -101.98 110.4 62.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 10.0 112.038 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' C ' ' HG3' ' A' ' 74' ' ' GLN . 48.6 Cg_endo -76.93 148.59 28.2 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.107 1.583 . . . . 10.0 110.7 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.04 67.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 10.0 109.283 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -143.18 87.35 1.96 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.101 -1.0 . . . . 10.0 109.982 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 9.6 m-20 -20.29 -44.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.456 0.91 . . . . 10.0 113.456 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 109' ' ' PRO . 1.1 m -110.5 144.32 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.818 -1.176 . . . . 10.0 111.26 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -156.25 157.41 35.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 10.0 110.977 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.668 ' CD1' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -107.32 98.65 8.25 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 178.423 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 3.9 p -85.07 148.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 10.0 109.95 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB3' HG22 ' A' ' 115' ' ' THR . 41.1 m -117.26 103.16 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.767 -1.173 . . . . 10.0 113.516 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.859 ' C ' HG23 ' A' ' 115' ' ' THR . 43.8 m-85 -99.84 147.69 25.23 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.293 -0.879 . . . . 10.0 109.232 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 46.6 t -90.42 141.1 29.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.513 -1.367 . . . . 10.0 108.95 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG21 ' HG3' ' A' ' 120' ' ' ARG . 2.0 t -80.32 5.58 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.905 . . . . 10.0 110.375 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 1.021 HG23 HD23 ' A' ' 129' ' ' LEU . 33.9 m -143.31 59.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.931 0.872 . . . . 10.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.588 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 2.7 p -125.13 -165.53 0.08 OUTLIER Pre-proline 0 C--N 1.287 -2.125 0 O-C-N 121.376 -0.828 . . . . 10.0 108.773 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.4 Cg_endo -76.18 60.76 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.277 1.146 . . . . 10.0 109.621 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 87' ' ' PRO . 43.6 p 32.86 51.5 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.104 0.478 . . . . 10.0 111.54 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.1 p -77.02 -25.42 52.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 10.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 73.0 t80 -59.22 -40.21 85.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 10.0 111.51 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -70.77 -22.87 62.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.914 -1.116 . . . . 10.0 110.828 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.564 ' OD1' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -86.13 -20.8 28.12 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.807 -1.183 . . . . 10.0 109.97 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 90' ' ' PHE . 23.1 m -84.23 -29.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.151 -1.02 . . . . 10.0 109.931 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -70.87 -34.03 71.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.072 -1.018 . . . . 10.0 109.6 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 7.2 pt-20 -80.26 -8.22 59.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 10.0 110.971 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 2.1 mmtm -81.73 -52.75 6.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 10.0 111.655 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -73.24 -9.88 59.17 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.982 -1.073 . . . . 10.0 112.202 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 149' ' ' LEU . 77.6 t -76.48 -50.2 2.75 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.621 -1.3 . . . . 10.0 110.828 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.1 Cg_endo -73.42 -25.8 14.96 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.209 1.11 . . . . 10.0 110.647 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -77.07 -23.74 51.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.287 -0.883 . . . . 10.0 110.998 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 49.0 mm 60.15 103.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.026 -1.046 . . . . 10.0 110.329 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.3 m -47.04 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 10.0 108.623 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.667 ' N ' HG22 ' A' ' 102' ' ' THR . 5.5 m170 -112.1 -4.85 14.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.323 -0.861 . . . . 10.0 109.51 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 160.87 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 50.8 t -142.26 137.37 15.61 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 149' ' ' LEU . 44.1 Cg_endo -69.82 80.29 0.91 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.681 1.358 . . . . 10.0 110.68 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' THR . 34.4 mtpt -118.16 -14.44 9.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.469 -0.77 . . . . 10.0 111.181 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 102' ' ' THR . 52.1 m -46.3 136.08 7.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.718 -1.239 . . . . 10.0 109.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.804 ' CG ' HG12 ' A' ' 77' ' ' VAL . 37.5 Cg_endo -64.9 111.9 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 10.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -117.94 103.88 10.37 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.757 0.789 . . . . 10.0 110.209 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.132 HD13 HG11 ' A' ' 152' ' ' VAL . 1.7 mm? -77.41 98.57 5.3 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 90.0 mt -74.03 135.82 43.08 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.693 HG22 HG23 ' A' ' 155' ' ' VAL . 10.8 t -143.28 169.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 10.0 112.552 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.87 153.88 19.54 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.479 -2.248 . . . . 10.0 107.479 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.859 HG23 ' C ' ' A' ' 82' ' ' PHE . 76.3 p -101.04 127.57 47.49 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.497 -1.59 . . . . 10.0 111.057 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.471 ' HG2' ' OD2' ' A' ' 118' ' ' ASP . 0.8 OUTLIER 40.31 55.06 2.82 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.849 -0.74 . . . . 10.0 110.16 178.317 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -40.78 -28.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 C-N-CA 119.467 -0.893 . . . . 10.0 110.16 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.671 ' O ' HD13 ' A' ' 119' ' ' LEU . 2.3 p-10 -52.69 60.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.17 0.986 . . . . 10.0 110.524 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 1.052 ' HG ' HG21 ' A' ' 125' ' ' THR . 0.4 OUTLIER 161.77 -27.95 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HG3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.09 -38.33 11.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.77 17.75 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 10.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.69 ' OD1' HG22 ' A' ' 125' ' ' THR . 6.9 t70 -104.28 110.84 64.81 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 10.0 110.857 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.32 15.46 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.072 1.564 . . . . 10.0 110.779 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 122' ' ' ASP . 47.1 t -109.89 -49.93 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 10.0 109.857 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' THR . . . . . 1.052 HG21 ' HG ' ' A' ' 119' ' ' LEU . 4.7 t -73.67 -24.39 59.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.515 -2.031 . . . . 10.0 105.515 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.738 HD11 HG11 ' A' ' 85' ' ' VAL 0.301 0.6 OUTLIER -59.98 -20.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 176.859 . . . . . . . . 4 4 . 1 . 010 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -48.26 -45.34 34.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.672 -0.642 . . . . 10.0 110.396 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.556 ' C ' HD12 ' A' ' 129' ' ' LEU . 36.5 mmtt -84.96 -13.77 49.65 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.425 -0.797 . . . . 10.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 1.021 HD23 HG23 ' A' ' 85' ' ' VAL . 6.1 mp -95.91 -40.45 9.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.233 -0.917 . . . . 10.0 109.554 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 126' ' ' ILE . . . -57.96 -39.67 78.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.137 -0.977 . . . . 10.0 109.72 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 11.2 pttt -55.66 -20.31 13.59 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.398 -0.814 . . . . 10.0 109.746 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -118.69 9.64 12.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.351 -0.843 . . . . 10.0 109.299 178.723 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' CE ' ' HB3' ' A' ' 136' ' ' PRO . 2.3 tmtt? -141.0 82.99 1.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.102 -0.703 . . . . 10.0 109.102 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.39 -24.44 67.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 10.0 110.409 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 3.2 mmmm -132.79 115.88 14.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 10.0 109.422 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.524 ' HB3' ' CE ' ' A' ' 133' ' ' LYS . 40.1 Cg_endo -67.01 159.4 52.18 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.799 1.421 . . . . 10.0 110.494 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -103.95 134.29 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.289 -0.882 . . . . 10.0 109.564 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.1 p -125.87 164.46 33.01 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 10.0 109.541 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 38.6 Cg_endo -65.64 -13.65 40.86 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.883 1.465 . . . . 10.0 109.823 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.98 -20.86 29.9 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.764 -0.774 . . . . 10.0 110.1 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -96.74 -42.32 8.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 10.0 110.744 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.897 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -73.79 -26.42 60.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 10.0 110.488 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.9 tt0 -61.22 -39.07 88.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 10.0 109.847 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -65.69 -40.1 91.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.895 . . . . 10.0 109.1 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 145' ' ' LEU . 4.1 tt -63.04 -40.7 98.51 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.367 -0.833 . . . . 10.0 109.238 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.465 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -63.58 -44.84 92.91 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.821 0.819 . . . . 10.0 109.088 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -59.91 -25.8 65.42 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.361 -0.536 . . . . 10.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 149' ' ' LEU . 34.8 t0 -70.26 -48.8 55.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.09 -1.006 . . . . 10.0 110.827 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 98' ' ' VAL . 1.5 mp -93.11 24.55 3.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 10.0 108.931 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 151' ' ' ALA . 1.0 OUTLIER 51.91 27.3 4.21 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.741 0.781 . . . . 10.0 109.389 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -57.04 -160.19 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.132 HG11 HD13 ' A' ' 111' ' ' LEU . 7.3 p -108.49 -65.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.677 -1.264 . . . . 10.0 111.761 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.763 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.02 157.74 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.016 -1.678 . . . . 10.0 112.106 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.897 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.1 t80 -107.61 112.61 25.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 10.0 110.107 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -103.36 -168.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.429 -0.794 . . . . 10.0 110.604 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 22.4 tt0 -170.28 98.55 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.221 -0.924 . . . . 10.0 109.749 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.547 ' CB ' ' CA ' ' A' ' 165' ' ' LEU . 73.8 m -153.0 156.35 38.65 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.107 -0.996 . . . . 10.0 111.608 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.686 ' OG ' HG23 ' A' ' 117' ' ' ILE . 3.7 m -140.86 114.75 9.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.835 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . . . -74.09 -87.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.428 -1.42 . . . . 10.0 111.025 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -31.32 -33.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 122.32 1.057 . . . . 10.0 109.383 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -93.94 -70.79 0.69 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.341 -0.845 . . . . 10.0 112.218 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -109.13 -107.71 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.377 -1.452 . . . . 10.0 112.021 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 162' ' ' GLN . 12.2 pttt 174.48 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.425 -0.797 . . . . 10.0 109.521 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.58 49.1 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.145 -1.026 . . . . 10.0 110.75 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -59.39 -2.07 0.28 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.409 -1.054 . . . . 10.0 113.097 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 20' ' ' LEU . 8.9 tttt -59.69 -48.84 80.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.39 -1.444 . . . . 10.0 110.432 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -56.45 -39.75 73.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.437 -0.789 . . . . 10.0 111.755 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.95 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.3 t -53.74 -48.34 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.819 -1.175 . . . . 10.0 111.034 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -78.6 -37.97 41.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.242 -0.911 . . . . 10.0 111.368 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.91 -40.26 92.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.876 -1.14 . . . . 10.0 110.946 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 41.0 mm-40 -62.03 -46.05 90.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 10.0 111.28 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.748 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.36 -24.45 19.54 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.986 . . . . 10.0 110.379 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.671 ' O ' HD12 ' A' ' 177' ' ' LEU . 28.6 mm -63.85 -42.86 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.415 -0.914 . . . . 10.0 109.841 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.846 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -86.17 -17.07 35.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 10.0 111.01 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.75 -1.18 41.13 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.938 -1.101 . . . . 10.0 109.812 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.96 -40.89 13.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 10.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.23 -11.83 18.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 10.0 109.505 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.04 -0.981 . . . . 10.0 110.025 -179.815 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -112.37 131.9 55.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 10.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.509 ' HG2' HD12 ' A' ' 174' ' ' LEU . 4.5 mtpt -88.38 99.96 12.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.137 -0.977 . . . . 10.0 110.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.2 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.74 -0.6 . . . . 10.0 110.001 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.38 -91.15 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.117 -0.989 . . . . 10.0 109.231 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 53.8 Cg_endo -76.57 -10.45 18.71 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 N-CA-C 108.423 -1.414 . . . . 10.0 108.423 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 3.3 pt-20 41.25 -162.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.776 -0.578 . . . . 10.0 110.121 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.559 ' H ' HD12 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -134.77 -67.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.034 -1.041 . . . . 10.0 110.579 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 47.5 t -103.32 132.11 49.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 10.0 111.604 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.961 ' O ' HD13 ' B' ' 10' ' ' LEU . 1.2 tm? -149.36 101.77 3.32 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 120.598 -1.314 . . . . 10.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -91.2 -168.5 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.406 2.071 . . . . 10.0 108.15 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 67.0 m -108.97 173.58 6.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.736 -1.228 . . . . 10.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 43' ' ' THR . 5.3 m-20 -134.33 -165.22 1.62 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.799 0.809 . . . . 10.0 111.657 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.566 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 18.5 m-85 -45.39 -166.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.25 1.024 . . . . 10.0 112.426 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.773 ' O ' HG21 ' A' ' 42' ' ' VAL . 57.1 mt-10 -41.24 154.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.088 -1.008 . . . . 10.0 111.806 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -139.32 -171.1 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 10.0 110.722 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.592 HG22 ' CE1' ' A' ' 40' ' ' TYR . 47.2 p -58.65 156.07 11.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.769 0.795 . . . . 10.0 112.064 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.602 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -128.31 -168.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 74.0 m-70 -109.19 143.89 38.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.503 -1.373 . . . . 10.0 112.277 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.999 HG22 ' HG2' ' A' ' 62' ' ' GLU . 33.3 t -130.82 152.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.695 -0.628 . . . . 10.0 110.838 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -112.02 -175.17 19.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.817 -1.313 . . . . 10.0 109.817 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' B' ' 31' ' ' GLY . 46.0 t80 166.37 116.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.711 -0.876 . . . . 10.0 108.752 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 12.6 t70 -39.41 152.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.105 -0.638 . . . . 10.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 63.11 79.85 0.25 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.735 -1.58 . . . . 10.0 106.735 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.614 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.5 -21.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.882 0.849 . . . . 10.0 110.572 -176.658 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.475 ' C ' ' O ' ' A' ' 26' ' ' ASN . 10.0 t -48.79 -15.96 0.11 Allowed 'General case' 0 C--N 1.286 -2.16 0 O-C-N 120.962 -1.086 . . . . 10.0 112.948 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 26' ' ' ASN . . . 148.22 85.64 0.06 OUTLIER Glycine 0 N--CA 1.504 3.178 0 N-CA-C 109.358 -1.497 . . . . 10.0 109.358 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.579 ' O ' HD22 ' A' ' 160' ' ' LEU . 19.7 pm0 -129.82 -146.4 0.31 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.746 -0.855 . . . . 10.0 109.422 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 14' ' ' VAL . 13.9 p90 -135.35 145.23 47.18 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' C ' ' B' ' 29' ' ' PHE . 1.7 t 30.99 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.082 0.468 . . . . 10.0 110.559 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.58 ' O ' ' CE1' ' B' ' 22' ' ' PHE . . . -153.77 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.694 -1.762 . . . . 10.0 108.694 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.415 HD11 ' OE1' ' B' ' 34' ' ' GLU . 10.7 pt -127.83 145.29 54.48 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.519 -0.989 . . . . 10.0 109.187 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.09 83.22 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.562 1.296 . . . . 10.0 109.925 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' B' ' 38' ' ' ARG . 2.8 tm-20 -160.13 155.6 25.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.568 -0.708 . . . . 10.0 110.315 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.597 ' HG2' ' CG ' ' B' ' 36' ' ' TRP . 2.2 tt0 -91.59 -71.3 0.64 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.027 -1.046 . . . . 10.0 109.7 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.597 ' CG ' ' HG2' ' B' ' 35' ' ' GLN . 0.4 OUTLIER -172.13 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.103 -0.998 . . . . 10.0 112.571 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' SER . . . -130.32 -19.1 3.16 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.478 -0.763 . . . . 10.0 110.468 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 6.6 mtt180 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.404 -1.435 . . . . 10.0 108.108 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' CA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.834 ' HA ' HD23 ' A' ' 177' ' ' LEU . 7.9 mm100 -133.1 0.87 3.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.002 . . . . 10.0 110.532 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.53 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.9 m -64.74 100.62 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 10.0 110.51 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.804 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -114.65 133.73 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.994 -1.082 . . . . 10.0 111.096 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 26.2 mmtt -121.23 100.65 7.17 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.517 -0.92 . . . . 10.0 108.517 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.21 106.58 15.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.04 -1.038 . . . . 10.0 109.75 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.825 ' HB ' HG21 ' A' ' 75' ' ' THR . 71.7 t -133.67 147.56 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 10.0 110.11 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.2 m -91.2 115.72 30.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.424 -0.798 . . . . 10.0 110.295 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.7 -166.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.277 -0.889 . . . . 10.0 110.045 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 1.04 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 126.43 -144.83 15.36 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 10.0 109.81 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.88 -37.84 20.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -1.223 . . . . 10.0 109.897 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 133.8 31.88 0.38 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' HG22 ' B' ' 32' ' ' ILE . . . -61.27 -133.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.991 -1.3 . . . . 10.0 109.066 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.75 HG22 ' CG2' ' B' ' 32' ' ' ILE . 5.0 t -128.93 -24.79 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.546 -1.347 . . . . 10.0 111.144 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 8' ' ' VAL . . . 157.0 128.94 1.09 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.351 -1.404 . . . . 10.0 110.062 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.973 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -57.77 -24.53 57.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.205 -1.173 . . . . 10.0 110.154 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 35' ' ' THR . 24.8 m -59.37 -32.73 70.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 10.0 110.847 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.708 ' SG ' HD22 ' A' ' 19' ' ' LEU . 16.6 p -61.0 -29.03 69.46 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.138 -0.976 . . . . 10.0 110.388 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.708 HD22 ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -80.51 -30.31 37.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.941 -1.1 . . . . 10.0 110.718 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 24' ' ' THR . 12.8 tp -49.2 -30.65 7.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.101 -0.999 . . . . 10.0 110.122 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 26' ' ' THR . 3.8 mm -106.74 -44.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 10.0 109.7 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 39.6 t -49.7 -40.07 39.12 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.364 -0.934 . . . . 10.0 109.303 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.681 ' CE2' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -82.09 -28.93 32.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.07 . . . . 10.0 109.311 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 25.2 m -65.58 -50.22 65.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 10.0 110.7 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' N ' ' A' ' 26' ' ' ASN . 14.7 t -175.24 -37.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.2 -1.4 . . . . 10.0 112.693 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.3 m120 -70.75 -9.79 58.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.156 -0.965 . . . . 10.0 111.985 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.636 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 0.8 OUTLIER 33.75 -150.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 10.0 110.661 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HE1' HD22 ' A' ' 160' ' ' LEU . 12.6 p90 . . . . . 0 C--N 1.298 -1.658 0 O-C-N 121.167 -0.958 . . . . 10.0 111.437 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.8 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 35' ' ' THR . 54.9 t -163.62 -96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.334 -0.854 . . . . 10.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 36' ' ' VAL . 6.8 t80 -57.22 141.11 47.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 10.0 111.122 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.615 ' HA ' HD11 ' B' ' 18' ' ' ILE . 4.8 t70 -164.31 101.37 0.84 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.252 -0.905 . . . . 10.0 110.376 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.642 ' CB ' HG21 ' B' ' 18' ' ' ILE . 11.4 t-20 -104.86 118.26 36.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.237 -1.54 . . . . 10.0 109.279 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.64 ' CE2' ' HG3' ' B' ' 15' ' ' GLU . 6.5 m-85 -146.72 113.53 6.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.068 -1.02 . . . . 10.0 111.107 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' B' ' 15' ' ' GLU . . . -118.41 115.29 24.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.72 -1.238 . . . . 10.0 109.976 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.94 -168.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 10.0 111.462 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.714 ' H ' HG22 ' A' ' 42' ' ' VAL . 20.2 m -163.71 145.16 9.15 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.493 0.663 . . . . 10.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 HD23 ' B' ' 10' ' ' LEU . 0.9 OUTLIER -137.73 123.75 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.381 -0.824 . . . . 10.0 109.771 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 7.3 mtm -92.06 98.19 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.869 -1.133 . . . . 10.0 109.406 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.9 mp -86.36 120.93 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.593 -0.692 . . . . 10.0 109.874 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 44.6 26.38 1.05 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 110.02 -24.88 17.79 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.012 -1.287 . . . . 10.0 111.307 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.46 110.98 30.82 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 120.714 -1.462 . . . . 10.0 110.545 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.3 Cg_endo -73.64 141.06 30.42 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.044 1.549 . . . . 10.0 111.042 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 53' ' ' LEU . 1.6 t80 -91.9 122.33 34.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.358 -0.839 . . . . 10.0 109.524 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.733 ' O ' HG22 ' A' ' 4' ' ' ILE 0.258 56.3 m -107.54 99.69 9.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.8 . . . . 10.0 109.772 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 54' ' ' GLY . 1.8 pp -144.23 168.63 19.59 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.341 -1.344 . . . . 10.0 112.33 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.738 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.4 126.9 1.32 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.87 -2.092 . . . . 10.0 107.87 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -124.55 142.32 51.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.82 -1.4 . . . . 10.0 110.354 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -139.82 104.91 5.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 10.0 110.837 -178.644 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 79.4 m-20 -80.97 -179.66 7.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.172 -0.955 . . . . 10.0 110.497 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 14' ' ' VAL . 14.0 t -85.33 -175.97 5.93 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.549 1.166 . . . . 10.0 113.361 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -142.0 -70.83 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 61' ' ' GLN . . . 40.54 24.09 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.117 -1.193 . . . . 10.0 110.117 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.566 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 1.4 mm-40 -171.47 -35.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.214 -1.168 . . . . 10.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 2.0 mt-10 -54.6 -80.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 117.813 -1.555 . . . . 10.0 108.861 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER 172.1 27.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 10.0 111.595 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.16 -52.43 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.672 -1.267 . . . . 10.0 110.807 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 24.0 t0 42.0 32.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.472 -0.767 . . . . 10.0 109.361 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.19 1.91 29.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.469 -0.769 . . . . 10.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.607 ' O ' HD22 ' A' ' 70' ' ' LEU . 2.4 mp -103.72 -14.46 16.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.413 -0.804 . . . . 10.0 110.03 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 3.9 ttt180 -82.26 -27.38 0.43 Allowed Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.7 Cg_endo -81.78 5.6 6.2 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.859 0.926 . . . . 10.0 111.072 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.898 HD11 ' CB ' ' B' ' 37' ' ' ALA . 2.0 pt? -49.34 -40.46 35.45 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.399 -0.813 . . . . 10.0 112.97 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 34.3 m 49.38 21.03 0.51 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.67 -1.269 . . . . 10.0 110.841 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 71' ' ' SER . 13.2 m-85 -143.92 130.61 10.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.925 -1.109 . . . . 10.0 110.366 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 50.8 Cg_endo -72.88 150.07 48.7 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.832 1.438 . . . . 10.0 111.276 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -177.48 47.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.047 0.927 . . . . 10.0 109.708 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' HB ' ' A' ' 7' ' ' VAL . 57.5 m -140.25 89.74 2.31 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.149 -0.97 . . . . 10.0 110.228 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -42.58 -30.72 0.38 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.53 -0.731 . . . . 10.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 75' ' ' THR . 13.6 m -123.19 124.84 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.78 -1.2 . . . . 10.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 1.7 m-85 -116.5 154.57 30.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.421 -0.799 . . . . 10.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.979 HD22 HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -111.0 97.95 7.19 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.843 -1.169 . . . . 10.0 107.843 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.04 HG23 ' HA2' ' A' ' 10' ' ' GLY . 8.2 p -103.39 125.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.159 -0.963 . . . . 10.0 111.033 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.464 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 4.2 m -127.38 125.96 41.63 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.299 -0.875 . . . . 10.0 109.084 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -135.91 178.85 6.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 10.0 110.245 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 t -81.03 149.5 29.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 10.0 112.059 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HE ' ' A' ' 120' ' ' ARG . 6.1 t -100.48 -2.01 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.704 -0.623 . . . . 10.0 110.125 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.9 m -132.97 53.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.75 0.786 . . . . 10.0 109.842 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 19.4 p -121.29 158.39 53.38 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 121.513 -0.742 . . . . 10.0 110.5 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 120.64 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.557 . . . . 10.0 111.647 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m 44.41 64.77 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 10.0 111.612 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -124.22 -43.34 2.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.677 -1.264 . . . . 10.0 110.918 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 1.102 ' CE1' HD11 ' A' ' 137' ' ' ILE . 6.4 t80 -56.12 -50.21 71.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.828 -1.17 . . . . 10.0 110.694 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.96 -15.33 12.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.955 -1.091 . . . . 10.0 111.823 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.804 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -86.9 -20.21 27.74 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.698 -1.251 . . . . 10.0 111.079 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 94' ' ' LYS . 19.3 m -90.18 -14.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.552 -1.343 . . . . 10.0 108.896 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 93' ' ' VAL . 25.9 mmtt -88.14 -33.41 18.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.15 0.976 . . . . 10.0 108.842 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 10.6 pt-20 -78.76 -5.82 54.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.105 -0.702 . . . . 10.0 109.105 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -84.24 -50.23 8.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 10.0 112.27 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 20.7 m95 -80.99 -23.8 38.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.014 -1.054 . . . . 10.0 113.376 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.786 HG22 HD21 ' A' ' 149' ' ' LEU . 4.4 t -69.23 -50.54 20.16 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.048 -1.658 . . . . 10.0 110.676 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.7 Cg_endo -72.84 -6.23 18.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.139 1.073 . . . . 10.0 109.564 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 101' ' ' ILE . 0.5 OUTLIER -68.98 -32.96 72.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 10.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 100' ' ' GLU . 2.7 pt 36.0 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.481 0.658 . . . . 10.0 111.318 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -47.11 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 109.416 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.686 ' H ' HG23 ' A' ' 102' ' ' THR . 30.4 m80 -106.74 -4.63 19.19 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.432 -0.793 . . . . 10.0 109.395 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -175.8 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 10.0 109.948 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.894 ' O ' HG22 ' A' ' 102' ' ' THR . 20.0 p -134.77 167.46 22.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 10.0 110.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 54.4 Cg_endo -81.01 72.38 6.55 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.773 1.407 . . . . 10.0 111.411 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -112.84 -10.11 13.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 10.0 112.029 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -52.92 125.39 39.65 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 120.687 -1.258 . . . . 10.0 110.432 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 77' ' ' VAL . 54.5 Cg_endo -73.72 153.12 48.43 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.052 1.553 . . . . 10.0 111.952 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.531 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 21.8 p90 -165.02 156.57 15.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.231 -1.025 . . . . 10.0 108.231 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.979 HD23 HD22 ' A' ' 79' ' ' LEU . 1.9 mm? -102.9 103.32 13.46 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 122.104 0.954 . . . . 10.0 111.007 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 155' ' ' VAL . 88.2 mt -66.33 138.57 57.7 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.179 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.611 ' CG2' HG11 ' A' ' 168' ' ' VAL . 1.4 t -150.42 171.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.792 -1.192 . . . . 10.0 111.776 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -133.25 122.11 3.04 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.486 -1.846 . . . . 10.0 108.486 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 31.0 p -100.55 170.96 8.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.165 -1.197 . . . . 10.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 50.22 33.95 8.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.473 -0.767 . . . . 10.0 109.392 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.979 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -69.05 -21.88 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 10.0 109.688 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.649 ' CG ' HG21 ' A' ' 161' ' ' THR . 17.3 t70 -51.45 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.958 0.885 . . . . 10.0 110.282 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.769 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.2 tp 160.33 -30.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.017 -1.105 . . . . 10.0 108.017 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HE ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.46 -37.5 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.57 0.7 . . . . 10.0 109.876 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 64.2 t0 -55.74 -24.83 37.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 10.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD13 ' A' ' 126' ' ' ILE . 9.0 t0 -90.22 109.4 33.09 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.24 -0.913 . . . . 10.0 111.249 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 51.5 Cg_endo -76.92 24.12 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.592 1.528 . . . . 10.0 112.142 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 m -100.97 -47.05 4.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.748 -1.22 . . . . 10.0 109.728 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.436 ' O ' HD22 ' A' ' 129' ' ' LEU . 3.4 t -71.94 -26.34 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.035 -2.209 . . . . 10.0 105.035 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 122' ' ' ASP 0.301 1.1 mp -50.69 -26.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.15 -38.84 54.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.521 0.677 . . . . 10.0 110.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.534 ' N ' ' CD ' ' A' ' 128' ' ' LYS . 13.0 mptt -75.22 -44.6 45.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.469 -0.769 . . . . 10.0 110.679 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -60.16 -49.1 78.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.854 0.835 . . . . 10.0 108.971 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . -52.97 -40.92 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.469 0.652 . . . . 10.0 109.582 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -25.21 11.77 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.946 -1.097 . . . . 10.0 110.009 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -48.65 7.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 10.0 112.177 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -126.98 0.84 6.58 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.484 -0.76 . . . . 10.0 110.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER 45.52 23.32 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 10.0 111.494 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -154.19 101.06 2.45 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.033 -1.042 . . . . 10.0 111.781 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.9 Cg_endo -74.03 160.12 43.43 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.124 1.592 . . . . 10.0 109.919 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 1.102 HD11 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -81.77 128.19 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.529 -1.357 . . . . 10.0 109.077 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.5 p -125.37 170.89 8.41 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.475 -0.765 . . . . 10.0 110.404 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.5 Cg_endo -68.21 -7.27 19.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.786 1.414 . . . . 10.0 110.519 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -92.58 -38.54 11.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 10.0 110.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.436 ' CG2' ' CZ ' ' A' ' 90' ' ' PHE . 84.3 m -74.68 -44.68 48.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.635 -0.665 . . . . 10.0 111.593 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 154' ' ' TYR . . . -77.67 -38.54 47.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 111.581 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 143' ' ' GLU . 5.4 tm-20 -62.97 -27.04 69.13 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.792 -1.193 . . . . 10.0 108.94 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -49.59 10.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 10.0 109.93 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 94' ' ' LYS . 5.1 tt -56.2 -41.82 76.19 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.237 -0.914 . . . . 10.0 110.022 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.34 73.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 10.0 108.89 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -60.23 -29.07 68.51 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.823 -0.751 . . . . 10.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.03 -47.49 51.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 10.0 110.499 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.786 HD21 HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -90.05 16.33 8.56 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.075 0.94 . . . . 10.0 108.966 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 27.12 1.99 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.798 0.809 . . . . 10.0 109.525 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.68 -148.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.137 -0.625 . . . . 10.0 109.877 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 ' CD1' ' A' ' 111' ' ' LEU . 19.1 t -98.51 -75.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.231 -0.987 . . . . 10.0 109.963 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -173.56 -177.18 1.4 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.739 -1.184 . . . . 10.0 111.637 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -110.69 116.54 31.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.709 -0.619 . . . . 10.0 110.358 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.994 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -122.77 -168.98 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.954 -1.091 . . . . 10.0 110.169 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.422 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 1.1 pt-20 -161.97 143.49 11.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 10.0 111.403 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 162' ' ' GLN . 28.4 p -159.19 177.28 11.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.472 -0.767 . . . . 10.0 111.301 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 162' ' ' GLN . 47.1 t -144.91 170.58 15.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 10.0 109.725 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.644 ' CB ' HD12 ' A' ' 19' ' ' LEU . . . -89.59 -48.77 7.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 10.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.549 HD22 ' HE1' ' A' ' 28' ' ' PHE . 2.0 pp -118.61 -0.7 11.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 10.0 112.176 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.649 HG21 ' CG ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -120.13 -80.07 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.429 -1.42 . . . . 10.0 111.968 -178.811 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 5.7 tp60 -40.73 -63.75 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.991 -1.068 . . . . 10.0 112.071 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 25.2 mttt 70.14 51.01 0.41 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.932 0.872 . . . . 10.0 109.295 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.84 24.37 2.59 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.316 -1.514 . . . . 10.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -78.78 1.43 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -1.224 . . . . 10.0 110.767 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.422 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -79.39 -39.47 32.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.851 -1.156 . . . . 10.0 109.596 178.809 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.35 -40.77 97.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.173 -0.954 . . . . 10.0 110.682 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 155' ' ' VAL . 4.3 t -59.23 -28.21 38.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.185 -0.947 . . . . 10.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 169' ' ' PHE . 4.4 t80 -84.04 -21.34 31.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.488 -0.757 . . . . 10.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -74.31 -49.45 22.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.091 -1.005 . . . . 10.0 111.135 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.52 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.1 mm-40 -58.22 -37.22 74.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 10.0 110.578 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -55.61 -32.71 63.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.158 -0.964 . . . . 10.0 110.045 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.708 ' O ' HD12 ' A' ' 177' ' ' LEU . 66.9 mt -60.8 -44.3 97.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.153 -0.967 . . . . 10.0 110.132 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -70.57 -30.59 67.34 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.732 -1.23 . . . . 10.0 111.567 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -86.37 -17.78 33.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 10.0 111.234 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.804 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -65.72 -30.97 71.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 10.0 109.318 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -110.35 -11.68 14.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 10.0 110.188 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.959 -1.019 . . . . 10.0 110.439 -179.866 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 108.809 -1.716 . . . . 10.0 108.809 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -130.14 136.92 49.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.488 -1.007 . . . . 10.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' B' ' 3' ' ' LYS . 5.7 tptt -99.38 103.31 15.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.01 -1.057 . . . . 10.0 108.388 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.515 ' HB3' ' OE2' ' B' ' 7' ' ' GLU . 6.1 mm-40 -104.28 161.03 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.306 -0.871 . . . . 10.0 110.769 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.659 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.07 -153.26 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.564 -1.272 . . . . 10.0 107.564 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 40.3 Cg_endo -69.85 90.88 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 109.91 -0.842 . . . . 10.0 109.91 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 39.1 mm-40 -56.6 -152.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.893 -0.505 . . . . 10.0 110.691 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.892 HD12 ' N ' ' B' ' 9' ' ' SER . 2.7 pp -79.64 -51.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.756 -1.215 . . . . 10.0 111.406 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.892 ' N ' HD12 ' B' ' 8' ' ' ILE . 32.2 t -155.3 171.5 19.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.594 -1.316 . . . . 10.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.953 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.25 133.33 3.28 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 118.857 -1.137 . . . . 10.0 113.023 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 46.3 Cg_endo -86.4 177.16 4.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 N-CA-C 108.459 -1.4 . . . . 10.0 108.459 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -133.48 148.75 51.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.633 -1.292 . . . . 10.0 111.655 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -104.55 -179.65 4.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.64 -0.662 . . . . 10.0 109.471 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.6 m-85 -91.81 164.4 13.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.987 -1.07 . . . . 10.0 111.113 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.64 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 1.5 pm0 -127.85 177.25 6.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.2 0.524 . . . . 10.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.617 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 7.5 m-70 -95.6 166.23 11.94 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.487 -0.758 . . . . 10.0 111.901 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.555 ' C ' HG23 ' B' ' 18' ' ' ILE . 42.5 m -128.91 146.23 51.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.422 -0.799 . . . . 10.0 110.669 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.755 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -159.42 -171.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 10.0 110.481 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 64.6 m80 -140.02 156.73 46.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.552 -0.718 . . . . 10.0 109.73 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 37' ' ' PHE . 14.0 m -105.98 143.72 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 10.0 112.658 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -147.85 132.62 4.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.894 ' O ' HG22 ' B' ' 25' ' ' VAL . 0.4 OUTLIER 173.46 114.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.175 -1.191 . . . . 10.0 109.416 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' B' ' 22' ' ' PHE . 83.3 m-20 -39.46 132.74 1.49 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.78 . . . . 10.0 109.121 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.63 70.04 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.289 -1.004 . . . . 10.0 108.289 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.894 HG22 ' O ' ' B' ' 22' ' ' PHE . 2.0 t -88.16 -17.98 8.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 122.543 1.163 . . . . 10.0 108.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.583 ' O ' HG22 ' A' ' 21' ' ' ILE 0.287 7.2 t -48.72 -19.05 0.32 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.713 -1.131 . . . . 10.0 111.175 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -154.51 -33.9 0.03 OUTLIER Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.513 -1.835 . . . . 10.0 108.513 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . 0.1 OUTLIER 52.45 23.96 2.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.769 -0.842 . . . . 10.0 111.394 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.608 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 51.6 t80 -112.35 115.6 28.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 122.093 0.949 . . . . 10.0 109.937 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.529 HG23 ' O ' ' B' ' 29' ' ' PHE . 33.5 p -156.51 -70.14 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.509 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.46 118.1 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.033 -1.227 . . . . 10.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.75 ' CG2' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -150.95 160.9 31.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -1.158 . . . . 10.0 109.51 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 34' ' ' GLU . 55.8 Cg_endo -76.85 136.91 17.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.906 1.477 . . . . 10.0 111.126 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.584 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 2.6 tt0 55.04 146.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.671 0.748 . . . . 10.0 110.736 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.549 ' HG2' ' N ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -85.85 -63.46 1.32 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.923 -1.111 . . . . 10.0 111.399 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.692 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 65.7 t90 -143.48 21.1 1.87 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.341 -0.85 . . . . 10.0 108.892 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.898 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . 167.1 132.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.026 -1.101 . . . . 10.0 108.026 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.584 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 CA-C-O 122.563 1.173 . . . . 10.0 109.63 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.15 0.5 . . . . 10.0 110.056 . . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.622 ' OE1' HD22 ' A' ' 177' ' ' LEU . 4.4 mt-30 -136.71 2.62 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.29 -0.881 . . . . 10.0 110.03 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 3.0 m -60.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.364 -0.835 . . . . 10.0 109.555 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -108.97 132.32 57.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.705 -1.198 . . . . 10.0 110.425 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -121.07 97.56 5.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.313 -0.867 . . . . 10.0 110.522 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -79.67 111.49 16.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 10.0 111.003 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HG21 ' A' ' 75' ' ' THR . 56.1 t -131.06 172.47 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 10.0 108.962 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.591 ' CG1' ' HB3' ' B' ' 35' ' ' GLN . 46.5 t -92.04 130.83 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.753 -1.217 . . . . 10.0 111.729 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.771 ' CG1' HG12 ' A' ' 80' ' ' VAL . 74.4 t -145.34 179.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.647 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 122.35 170.53 13.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.79 -1.324 . . . . 10.0 109.79 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -50.75 -39.51 52.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.151 . . . . 10.0 109.859 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.653 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 151.14 159.05 8.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.547 -1.421 . . . . 10.0 109.547 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.742 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 179.82 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -1.097 . . . . 10.0 108.852 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.808 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.7 t 149.22 89.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . 42.68 92.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.365 -1.494 . . . . 10.0 109.365 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -49.47 -34.62 17.33 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.918 -1.342 . . . . 10.0 109.296 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.2 m -49.84 -25.22 2.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.738 -1.226 . . . . 10.0 108.724 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 26' ' ' THR . 13.7 p -63.73 -18.26 63.85 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.233 -0.987 . . . . 10.0 108.706 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.2 mm? -69.36 -33.31 72.88 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.15 -0.969 . . . . 10.0 108.863 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -48.61 -37.75 19.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 10.0 108.829 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.643 HG21 ' HA3' ' B' ' 27' ' ' GLY . 1.5 mm -64.3 -43.6 97.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.68 0.752 . . . . 10.0 110.012 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' A' ' 27' ' ' LYS . 40.3 t -47.89 -44.26 29.43 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.335 -0.946 . . . . 10.0 109.738 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CZ ' ' CD1' ' A' ' 165' ' ' LEU . 6.9 m-85 -90.98 -3.81 56.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.573 -0.705 . . . . 10.0 109.676 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 14.4 m -112.41 -33.46 6.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.855 . . . . 10.0 112.403 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.569 HG22 ' N ' ' A' ' 26' ' ' ASN . 17.3 m -136.58 -82.51 0.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.187 -1.57 . . . . 10.0 113.064 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 25' ' ' THR . 2.3 m120 -153.89 51.42 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.626 -1.296 . . . . 10.0 113.724 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HG2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 30.81 -131.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.619 -0.675 . . . . 10.0 112.676 177.609 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.635 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 11.0 p90 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.216 0.531 . . . . 10.0 110.765 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.673 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 1.3 p . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.806 0.812 . . . . 10.0 111.567 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HB ' ' CG1' ' B' ' 20' ' ' VAL 0.273 74.1 t -55.77 -8.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 112.46 0.541 . . . . 10.0 112.46 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -32.69 87.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.43 1.11 . . . . 10.0 113.46 -177.45 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' VAL . 11.4 m-20 -157.53 104.74 2.01 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 120.718 -1.239 . . . . 10.0 111.368 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' B' ' 18' ' ' ILE . 0.6 OUTLIER -170.42 102.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 10.0 108.651 178.969 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.826 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -153.66 175.22 13.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.669 -1.212 . . . . 10.0 112.177 -178.529 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.944 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -165.71 148.37 7.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.829 -0.748 . . . . 10.0 110.791 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 1.013 HG11 ' O ' ' B' ' 14' ' ' PHE . 0.2 OUTLIER -171.52 -165.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.41 -0.806 . . . . 10.0 111.105 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 51' ' ' TYR . 74.9 m -137.38 146.05 44.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 10.0 110.217 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -103.6 176.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.244 -0.91 . . . . 10.0 109.467 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.583 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 39.5 mtp -154.37 126.18 7.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 10.0 110.472 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 mp -139.06 123.43 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 10.0 109.196 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.93 22.41 6.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.49 6.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.0 mt-10 -120.81 99.56 47.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.293 -1.122 . . . . 10.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 43.6 Cg_endo -71.6 136.31 27.99 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.632 1.333 . . . . 10.0 110.319 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -99.88 157.02 16.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.102 -0.999 . . . . 10.0 110.347 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 4' ' ' ILE . 40.1 m -126.95 106.62 9.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 10.0 111.973 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -148.37 166.71 27.24 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.438 -1.414 . . . . 10.0 111.293 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.16 134.99 3.2 Favored Glycine 0 C--N 1.288 -2.092 0 N-CA-C 108.629 -1.789 . . . . 10.0 108.629 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.826 HD11 ' CE1' ' A' ' 40' ' ' TYR . 4.6 pp -153.19 167.45 29.24 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.112 -1.228 . . . . 10.0 110.308 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.494 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 22.4 p90 -170.29 131.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 10.0 110.908 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 5.1 p-10 -99.09 176.83 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 10.0 110.252 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.409 HG22 ' N ' ' A' ' 59' ' ' ALA . 21.5 m -40.75 162.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.167 0.984 . . . . 10.0 112.638 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.987 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -134.39 68.93 1.47 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.512 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.613 ' HA3' ' CD2' ' B' ' 22' ' ' PHE . . . -43.61 -82.23 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 107.904 -2.078 . . . . 10.0 107.904 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.273 -1.134 . . . . 10.0 107.951 177.121 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.987 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.5 pt-20 41.99 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.406 1.098 . . . . 10.0 111.034 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.5 -12.73 57.6 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 1.2 p90 -133.83 -27.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.851 -0.531 . . . . 10.0 109.693 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 68' ' ' ARG . 5.3 t70 43.12 35.98 0.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 10.0 110.496 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.8 -7.83 59.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.986 -1.071 . . . . 10.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.71 HD12 ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -111.63 4.14 18.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 10.0 110.358 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.733 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.7 mmt180 -53.61 -40.53 81.25 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.214 -0.929 . . . . 10.0 111.868 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 52.5 Cg_endo -83.72 78.71 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.414 1.218 . . . . 10.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -105.61 -105.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 10.0 110.488 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 47.07 35.7 3.66 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -148.26 114.92 3.91 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 120.154 -0.618 . . . . 10.0 110.948 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' GLN . 53.9 Cg_endo -75.52 -151.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.925 1.487 . . . . 10.0 110.004 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 76.64 79.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.79 . . . . 10.0 111.275 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.5 m -139.09 96.67 3.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 71.0 m-20 -23.14 -41.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.856 -0.611 . . . . 10.0 112.37 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.71 HG21 HG12 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -142.13 130.09 21.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.894 -1.129 . . . . 10.0 110.838 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.84 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.7 p90 -148.25 170.19 18.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.055 -1.028 . . . . 10.0 110.596 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.968 HD13 HG12 ' A' ' 168' ' ' VAL . 4.1 mt -112.34 102.53 10.67 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.86 . . . . 10.0 110.067 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.771 HG12 ' CG1' ' A' ' 9' ' ' VAL . 1.7 m -98.79 127.52 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.676 -0.861 . . . . 10.0 108.676 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 115' ' ' THR . 0.5 OUTLIER -105.66 100.44 10.0 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.638 -1.288 . . . . 10.0 112.048 -178.322 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' A' ' 80' ' ' VAL . 57.6 m-85 -86.86 176.1 7.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.247 -0.908 . . . . 10.0 109.908 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 47.9 t -100.72 142.67 31.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -0.845 . . . . 10.0 108.878 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG22 ' HG2' ' A' ' 120' ' ' ARG . 34.0 m -56.16 -16.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.041 -1.037 . . . . 10.0 110.675 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.657 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -112.66 -88.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.868 -1.145 . . . . 10.0 109.293 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 34.25 75.27 0.47 Allowed Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.942 -0.474 . . . . 10.0 110.612 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 43.6 Cg_endo -69.79 162.12 43.3 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.978 1.515 . . . . 10.0 110.62 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 133' ' ' LYS . 15.8 m 47.42 39.37 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.783 . . . . 10.0 111.402 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.06 -68.6 0.52 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.91 -1.119 . . . . 10.0 110.38 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 p90 -57.18 -16.67 8.53 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.322 -0.861 . . . . 10.0 110.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 90' ' ' PHE . 18.1 mt-10 -78.59 -24.54 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 10.0 110.208 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.618 ' OD1' HG13 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -80.95 -14.76 57.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 10.0 110.311 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.875 HG23 ' HD3' ' A' ' 94' ' ' LYS . 16.6 m -87.93 -22.74 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 118.288 -1.365 . . . . 10.0 108.486 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.968 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.43 -27.73 63.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -89.39 -1.27 57.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.746 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 13.3 mmtm -102.46 -53.16 2.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.948 -1.101 . . . . 10.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.453 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 41.7 m95 -90.32 -38.37 13.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.704 -1.247 . . . . 10.0 112.547 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.7 t -64.22 -51.06 64.51 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.541 -1.349 . . . . 10.0 111.29 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 42.0 Cg_endo -67.58 -16.05 46.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.055 1.029 . . . . 10.0 109.556 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ILE . 5.0 tm-20 -55.54 -51.39 67.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.347 -0.846 . . . . 10.0 109.957 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CB ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 163.32 1.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.522 -0.736 . . . . 10.0 112.114 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.97 HG22 ' CB ' ' A' ' 107' ' ' LYS . 46.9 p -60.1 -26.84 66.53 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.279 -1.513 . . . . 10.0 111.314 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -10.06 18.54 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.376 -0.828 . . . . 10.0 111.418 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -120.0 -3.42 10.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.718 -1.238 . . . . 10.0 110.926 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.514 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 24.9 p -161.17 166.57 14.93 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.902 -1.124 . . . . 10.0 110.65 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 38.1 Cg_endo -65.36 110.39 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.741 1.39 . . . . 10.0 109.304 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.97 ' CB ' HG22 ' A' ' 102' ' ' THR 0.261 0.0 OUTLIER -92.35 -95.46 0.14 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.89 0.852 . . . . 10.0 111.06 -178.052 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' ASP . 1.1 m -167.26 120.36 0.78 Allowed Pre-proline 0 C--N 1.29 -1.992 0 C-N-CA 120.064 -0.655 . . . . 10.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 42.1 Cg_endo -68.62 149.91 74.24 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.938 1.494 . . . . 10.0 111.052 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.623 ' CE1' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -129.7 119.78 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 10.0 108.89 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -75.05 97.24 3.37 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.572 ' C ' HG23 ' A' ' 113' ' ' VAL . 51.1 mt -63.81 144.47 57.02 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.81 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 65.4 t -154.66 157.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 10.0 111.619 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.1 154.39 19.87 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.78 -1.728 . . . . 10.0 108.78 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.709 HG22 ' SG ' ' A' ' 81' ' ' CYS . 45.9 p -120.79 136.74 54.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.877 -1.366 . . . . 10.0 110.518 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.0 tt0 39.75 50.86 2.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.944 0.878 . . . . 10.0 108.718 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.011 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.29 -32.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.173 -177.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -52.35 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.999 0.904 . . . . 10.0 111.064 -177.244 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.763 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.9 tp 153.03 -33.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.849 -1.167 . . . . 10.0 107.849 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.6 tpp180 -53.86 -27.83 32.4 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 19.3 t0 -72.23 -5.76 38.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 10.0 110.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.684 ' O ' HD13 ' A' ' 126' ' ' ILE . 17.0 m-20 -79.82 157.91 73.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 10.0 110.668 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.5 Cg_endo -83.0 23.04 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.935 1.756 . . . . 10.0 111.507 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.8 p -105.8 -46.97 4.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.043 -1.035 . . . . 10.0 109.324 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 120' ' ' ARG . 8.2 t -69.98 -27.65 64.89 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.684 HD13 ' O ' ' A' ' 122' ' ' ASP 0.307 0.7 OUTLIER -49.26 -27.53 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.144 -1.389 . . . . 10.0 107.427 177.1 . . . . . . . . 4 4 . 1 . 012 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.03 -37.44 61.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.049 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -82.52 -50.75 8.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 10.0 111.426 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -67.92 -20.72 65.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.631 -1.293 . . . . 10.0 109.261 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -62.07 -40.87 97.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.491 -0.756 . . . . 10.0 109.968 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -62.46 -18.19 61.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 10.0 109.678 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 12.3 t-20 -97.99 -72.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 10.0 110.281 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 1.2 mptp? -149.55 144.35 26.19 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.347 -0.846 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -86.02 21.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 10.0 110.404 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -112.21 93.92 24.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.124 -0.985 . . . . 10.0 110.633 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.657 ' HB3' HG12 ' A' ' 85' ' ' VAL . 46.1 Cg_endo -83.17 156.67 14.91 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.158 1.609 . . . . 10.0 110.841 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -89.25 114.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -0.944 . . . . 10.0 109.057 179.109 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.6 p -114.72 169.25 6.86 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.386 -0.821 . . . . 10.0 109.631 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 36.7 Cg_endo -61.84 -19.39 65.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.43 1.226 . . . . 10.0 110.523 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.59 -41.93 44.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 10.0 108.749 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.5 m -83.35 -41.18 18.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.664 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -52.24 -41.8 63.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.6 -0.687 . . . . 10.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.27 -49.6 76.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.429 -0.795 . . . . 10.0 109.259 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' ASP . 22.9 mttm -60.53 -39.93 89.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.487 -0.931 . . . . 10.0 108.487 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.968 HD21 ' HE2' ' A' ' 94' ' ' LYS . 10.4 tt -58.67 -39.51 80.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.592 -0.693 . . . . 10.0 109.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.691 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -69.76 -48.08 60.6 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.627 -0.829 . . . . 10.0 108.85 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.42 -23.71 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.729 0.776 . . . . 10.0 108.98 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 144' ' ' LYS . 38.2 t70 -54.6 -27.49 39.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.594 -0.691 . . . . 10.0 111.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.979 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.26 38.1 0.79 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.914 -1.116 . . . . 10.0 112.402 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 18.0 mtpt 64.49 38.08 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.317 -0.864 . . . . 10.0 112.197 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.691 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -72.97 -158.39 0.05 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 111' ' ' LEU . 2.1 p -114.9 -62.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.323 -1.486 . . . . 10.0 111.358 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.59 ' H ' HG13 ' A' ' 152' ' ' VAL . 6.9 tttt -173.04 156.48 3.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.385 -1.447 . . . . 10.0 112.714 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.664 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 78.9 t80 -101.32 105.73 16.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 10.0 109.521 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 168' ' ' VAL . 1.3 t -96.81 -167.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 10.0 110.854 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.648 ' H ' HG12 ' A' ' 155' ' ' VAL . 46.1 mt-10 -132.37 139.53 48.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.477 -0.764 . . . . 10.0 110.463 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 2.7 t -166.96 133.0 2.23 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.337 1.065 . . . . 10.0 110.969 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.7 ' C ' ' HB3' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -150.98 80.03 1.32 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.446 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -21.11 -43.48 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.49 0.922 . . . . 10.0 113.49 -177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.0 tp -76.56 -59.26 2.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.366 -1.458 . . . . 10.0 110.069 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -115.3 39.08 3.03 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 123.179 1.466 . . . . 10.0 108.611 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.7 ' HB3' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -59.38 -106.96 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 113.604 -1.634 . . . . 10.0 111.798 -177.649 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 6.6 mttt 71.69 63.02 0.14 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.665 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.31 -21.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.554 -1.308 . . . . 10.0 111.05 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.851 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -62.59 -8.24 6.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.401 -1.647 . . . . 10.0 110.912 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.558 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.0 ptmt -65.2 -31.57 72.8 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.962 -1.086 . . . . 10.0 109.537 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.58 -27.7 60.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.454 -0.779 . . . . 10.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 79' ' ' LEU . 11.9 t -53.32 -48.17 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 10.0 109.676 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 t80 -73.55 -30.51 63.1 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.866 -0.521 . . . . 10.0 111.259 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.502 ' O ' HD22 ' A' ' 174' ' ' LEU . 6.1 m-20 -69.37 -46.17 67.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 10.0 111.781 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 -25.32 59.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.209 . . . . 10.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.196 -0.94 . . . . 10.0 109.491 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.633 ' O ' HD11 ' A' ' 177' ' ' LEU . 26.3 mm -63.24 -48.03 89.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.299 -0.96 . . . . 10.0 109.305 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -73.44 -42.97 61.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 10.0 110.784 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 109' ' ' PRO . . . -76.23 -2.08 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 10.0 111.065 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.82 -30.63 20.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.985 -1.072 . . . . 10.0 110.659 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -85.77 -17.19 36.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -0.855 . . . . 10.0 109.163 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 118.07 -0.967 . . . . 10.0 110.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.464 -1.454 . . . . 10.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -89.43 56.34 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -1.142 . . . . 10.0 110.602 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -77.38 98.21 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 10.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -91.3 155.22 18.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.824 . . . . 10.0 110.192 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.702 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.35 -152.09 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.702 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.7 Cg_endo -69.95 87.35 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 N-CA-C 110.279 -0.701 . . . . 10.0 110.279 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 22.6 mm-40 -50.92 -175.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 10.0 110.155 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 9' ' ' SER . 1.7 pp -79.77 -44.43 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.016 -1.053 . . . . 10.0 111.271 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.649 ' HB2' HD12 ' B' ' 8' ' ' ILE . 7.5 t -126.25 163.66 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.659 -1.276 . . . . 10.0 110.828 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.935 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.37 96.79 0.51 Allowed Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.764 -1.174 . . . . 10.0 113.367 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.583 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 40.2 Cg_endo -81.91 157.71 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 N-CA-C 108.007 -1.574 . . . . 10.0 108.007 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -149.02 125.24 10.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.14 -1.6 . . . . 10.0 112.2 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 43' ' ' THR . 10.0 m-20 -80.35 156.97 26.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.152 -1.055 . . . . 10.0 108.152 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 1.013 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.0 m-85 -110.34 142.63 41.74 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.411 -1.431 . . . . 10.0 111.301 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -58.93 143.28 48.45 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.361 0.601 . . . . 10.0 112.335 -177.777 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.661 ' C ' ' HB3' ' A' ' 40' ' ' TYR . 8.1 t60 -88.58 97.6 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.521 -0.737 . . . . 10.0 109.798 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.42 ' N ' ' HB3' ' A' ' 40' ' ' TYR . 4.2 m -83.85 155.35 22.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.874 0.845 . . . . 10.0 112.934 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.71 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.9 pp -125.98 -167.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.596 ' HA ' ' CB ' ' A' ' 37' ' ' PHE . 22.2 m-70 -123.14 143.87 49.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 10.0 110.605 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.684 ' CG1' ' HA ' ' A' ' 59' ' ' ALA . 41.2 t -135.41 155.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.446 -0.784 . . . . 10.0 110.413 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -122.67 151.76 16.87 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.0 -1.095 . . . . 10.0 112.737 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.628 ' HB3' ' CB ' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 159.33 112.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' B' ' 24' ' ' ALA . 8.3 m-20 -44.66 143.32 1.41 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.465 -0.772 . . . . 10.0 111.653 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 19.82 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 120.968 0.413 . . . . 10.0 111.762 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.628 ' CB ' ' HB3' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -112.59 -41.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.438 -0.789 . . . . 10.0 109.322 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.2 t -53.58 -18.3 2.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.62 -0.675 . . . . 10.0 109.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.643 ' HA3' HG21 ' A' ' 21' ' ' ILE . . . -128.09 25.51 4.89 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 107.78 -2.128 . . . . 10.0 107.78 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.581 ' OE1' HG22 ' B' ' 25' ' ' VAL . 23.9 tt0 -92.93 110.25 21.71 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.854 -1.38 . . . . 10.0 111.995 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 159' ' ' ALA . 45.7 t80 -140.75 111.06 6.69 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.515 -1.22 . . . . 10.0 109.297 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 47.6 p -116.67 -79.61 0.59 Allowed 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.465 -0.939 . . . . 10.0 108.465 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.454 ' O ' HG13 ' B' ' 32' ' ' ILE . . . 139.16 97.18 0.37 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.721 -1.228 . . . . 10.0 110.971 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.582 HG22 ' CD ' ' B' ' 33' ' ' PRO . 0.1 OUTLIER 178.51 -51.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.111 -1.229 . . . . 10.0 110.284 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' B' ' 32' ' ' ILE . 49.3 Cg_endo -92.44 154.31 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.712 1.375 . . . . 10.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.63 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -49.19 174.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 10.0 108.762 178.889 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.653 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 23.7 mt-30 -88.42 -73.78 0.48 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.457 -1.402 . . . . 10.0 111.946 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -122.61 19.26 10.37 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.311 1.053 . . . . 10.0 108.792 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -112.75 52.34 0.79 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 122.199 1.0 . . . . 10.0 108.794 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.157 0.503 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.667 ' HA ' HD23 ' A' ' 177' ' ' LEU . 96.5 mm-40 -146.61 -38.53 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.332 -0.855 . . . . 10.0 109.607 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -47.28 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 10.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -111.07 130.46 64.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.286 -0.966 . . . . 10.0 108.892 177.101 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER -113.19 98.57 7.21 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.412 -0.915 . . . . 10.0 109.598 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.1 t -84.88 101.31 12.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.283 -0.885 . . . . 10.0 109.072 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.71 ' HB ' HG21 ' A' ' 75' ' ' THR . 48.4 t -121.84 142.46 38.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.135 -1.026 . . . . 10.0 110.739 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.731 HG23 ' HA3' ' A' ' 15' ' ' GLY . 2.4 p -63.29 125.86 20.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.671 -0.643 . . . . 10.0 109.994 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -141.64 168.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.148 -0.97 . . . . 10.0 109.672 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.791 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 169.97 158.19 13.47 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.7 -1.36 . . . . 10.0 109.7 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -50.03 -22.62 1.67 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.404 -1.056 . . . . 10.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.0 35.4 0.08 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.599 -1.4 . . . . 10.0 109.599 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 32' ' ' ILE . . . -125.55 -155.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -1.103 . . . . 10.0 109.661 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' ' 29' ' ' PHE . 20.1 t -69.71 108.79 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 10.0 109.471 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.731 ' HA3' HG23 ' A' ' 8' ' ' VAL . . . -52.55 164.51 1.64 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.888 -1.285 . . . . 10.0 109.888 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -87.68 5.89 37.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -1.086 . . . . 10.0 110.267 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.579 HG23 ' N ' ' A' ' 18' ' ' CYS . 14.1 t -75.08 -43.06 55.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.167 -0.958 . . . . 10.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' B' ' 26' ' ' THR . 30.8 p -74.72 -9.23 58.37 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.375 -1.33 . . . . 10.0 108.429 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 159' ' ' ALA . 3.9 mm? -76.8 -36.2 57.11 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.385 -0.822 . . . . 10.0 109.631 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -37.79 49.82 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.197 -1.038 . . . . 10.0 108.197 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.522 ' CG2' ' HA3' ' B' ' 27' ' ' GLY . 1.4 mm -91.61 -51.76 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.685 0.755 . . . . 10.0 109.912 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.686 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 68.4 m -49.52 -45.59 47.45 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.51 -0.876 . . . . 10.0 109.808 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CB ' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.58 -32.47 73.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 10.0 109.726 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 m -75.77 -51.85 11.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 10.0 112.073 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' N ' ' A' ' 26' ' ' ASN . 15.3 t -153.67 -46.15 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.54 -1.664 . . . . 10.0 113.82 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.634 ' N ' HG23 ' A' ' 25' ' ' THR . 30.5 m120 -67.98 -23.67 65.06 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.907 -1.12 . . . . 10.0 111.596 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.686 ' N ' ' HA ' ' A' ' 22' ' ' SER . 2.6 pttt 24.37 -148.59 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.287 1.042 . . . . 10.0 113.249 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' B' ' 30' ' ' THR . 15.0 t80 . . . . . 0 C--N 1.299 -1.612 0 O-C-N 121.085 -1.01 . . . . 10.0 109.504 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 82.5 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 122.177 0.989 . . . . 10.0 112.68 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.824 ' N ' HG11 ' B' ' 20' ' ' VAL . 73.2 t -50.64 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.002 ' N ' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -51.64 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.757 -1.214 . . . . 10.0 110.213 -175.597 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' VAL . 57.0 t0 -133.66 85.64 2.22 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.663 -0.698 . . . . 10.0 110.564 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' B' ' 17' ' ' THR . 48.5 t30 -84.4 99.65 10.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.916 -1.115 . . . . 10.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.97 120.71 41.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 10.0 109.652 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' OE1' ' B' ' 15' ' ' GLU . . . -124.0 137.13 54.64 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.693 -1.203 . . . . 10.0 111.023 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 43' ' ' THR . 55.8 t -157.94 170.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.012 . . . . 10.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' THR . . . . . 1.069 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.1 m -149.82 146.55 27.21 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.95 133.17 10.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 120.912 -1.118 . . . . 10.0 112.133 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.577 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 27.0 mtp -92.4 99.82 12.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 10.0 109.794 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 5.7 mt -88.16 130.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 10.0 110.636 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' B' ' 8' ' ' ILE . . . 43.78 25.77 0.65 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.267 -1.533 . . . . 10.0 109.267 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 96.87 21.66 20.36 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.225 -1.15 . . . . 10.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' C ' ' HA ' ' A' ' 45' ' ' MET . 27.9 mt-10 -126.34 105.43 24.64 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.972 -1.31 . . . . 10.0 110.526 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 41.4 Cg_endo -67.26 131.45 25.05 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 124.028 1.541 . . . . 10.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 1.069 ' O ' HG23 ' A' ' 43' ' ' THR . 1.5 t80 -88.53 152.26 21.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 10.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.84 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.7 m -130.38 98.72 4.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.706 . . . . 10.0 109.267 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 54' ' ' GLY . 2.3 pp -152.33 173.6 14.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.12 -1.432 . . . . 10.0 112.259 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.5 134.38 2.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.151 -1.98 . . . . 10.0 108.151 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 55' ' ' LEU . 4.0 pp -130.32 152.43 49.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.683 -1.481 . . . . 10.0 110.712 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.524 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 16.8 p90 -169.81 150.45 3.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 10.0 110.432 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 63.6 m-20 -93.04 172.96 7.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.222 -0.923 . . . . 10.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -64.28 -169.03 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.117 0.961 . . . . 10.0 112.078 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.981 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -111.34 72.11 0.77 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -39.91 -43.69 2.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.675 -1.37 . . . . 10.0 109.675 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -143.81 13.62 1.7 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.259 -1.142 . . . . 10.0 110.864 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.981 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 mm-40 -53.05 -39.14 63.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.765 -1.209 . . . . 10.0 109.147 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 35.0 m-20 67.21 10.37 7.66 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 62' ' ' GLU . 4.5 m-85 -101.45 -32.57 10.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 64' ' ' TYR . 9.7 t70 20.45 49.16 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.226 0.536 . . . . 10.0 111.28 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' TYR . 42.8 mtp180 -83.22 -37.06 24.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.328 -0.858 . . . . 10.0 110.419 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.1 mt -108.13 4.58 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 10.0 110.626 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.719 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -100.27 3.04 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 118.934 -1.107 . . . . 10.0 113.54 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_endo -79.37 52.98 4.51 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 N-CA-C 108.196 -1.502 . . . . 10.0 108.196 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.7 pt? -53.28 -52.9 57.57 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 121.572 -0.705 . . . . 10.0 112.225 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 26.2 t 39.99 27.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.011 . . . . 10.0 109.601 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.47 158.75 0.74 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 10.0 110.017 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.99 107.75 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.696 1.366 . . . . 10.0 109.44 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -137.69 36.95 2.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.805 -1.184 . . . . 10.0 110.962 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.71 HG21 ' HB ' ' A' ' 7' ' ' VAL . 97.7 m -144.66 91.99 2.24 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.177 -0.952 . . . . 10.0 108.885 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 75' ' ' THR . 10.0 m-20 -24.25 -48.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 5' ' ' LYS . 2.3 m -114.5 133.61 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.983 -1.073 . . . . 10.0 110.986 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -119.77 131.45 55.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 10.0 112.074 -178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 HD23 ' A' ' 111' ' ' LEU . 2.6 mm? -103.67 98.33 8.22 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.791 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.6 p -114.96 161.45 13.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.356 -0.84 . . . . 10.0 110.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 23.0 p -124.74 101.6 7.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 10.0 111.2 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 115' ' ' THR . 51.9 m-85 -87.26 174.29 8.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 10.0 110.401 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -118.94 130.83 55.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 10.0 109.852 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' HG2' ' A' ' 120' ' ' ARG . 27.8 m -67.14 -10.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.132 -0.98 . . . . 10.0 109.913 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 84' ' ' VAL . 35.3 m -115.8 43.17 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 10.0 109.89 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 36.7 t -105.55 140.06 20.79 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.775 . . . . 10.0 109.784 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 46.9 Cg_endo -71.38 114.46 3.94 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.04 1.547 . . . . 10.0 111.515 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 87' ' ' PRO . 75.3 m 38.9 60.08 1.49 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.426 -0.796 . . . . 10.0 111.458 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.512 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 3.4 t -100.21 -66.16 0.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.086 . . . . 10.0 110.035 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.993 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -48.52 -26.01 1.97 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.344 -0.847 . . . . 10.0 110.301 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.89 -19.43 65.87 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.029 -1.044 . . . . 10.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.654 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.77 -16.24 42.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 10.0 110.067 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 90' ' ' PHE . 18.1 m -88.95 -19.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.821 -1.174 . . . . 10.0 109.005 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.71 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.83 -32.84 57.85 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 178.291 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -85.16 0.38 51.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -111.38 -51.75 2.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.102 -1.039 . . . . 10.0 111.379 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 15.2 m0 -72.97 -30.61 63.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.347 -0.846 . . . . 10.0 111.81 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 149' ' ' LEU . 16.8 t -70.89 -47.89 15.05 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 10.0 111.362 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -70.7 -14.3 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.077 1.041 . . . . 10.0 111.397 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 3.5 mm-40 -67.04 -39.64 86.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.916 -1.115 . . . . 10.0 110.223 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 101' ' ' ILE . 11.3 mt 44.22 85.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.322 -0.951 . . . . 10.0 109.59 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -44.23 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 10.0 110.133 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.525 ' H ' HG23 ' A' ' 102' ' ' THR . 7.1 t60 -103.57 -13.96 16.35 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.192 -0.943 . . . . 10.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.654 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -173.25 -48.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.551 ' O ' ' CG2' ' A' ' 102' ' ' THR . 73.2 m -119.08 164.75 19.56 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.07 112.98 3.52 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.538 1.283 . . . . 10.0 110.282 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -144.18 0.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.885 -1.134 . . . . 10.0 111.728 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 m -47.69 134.89 10.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.681 -1.262 . . . . 10.0 108.819 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.53 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 41.8 Cg_endo -68.38 130.54 21.31 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.561 1.295 . . . . 10.0 109.775 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CE1' ' CZ2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -137.58 113.85 10.09 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.032 0.92 . . . . 10.0 110.931 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.919 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.8 mm? -82.19 100.29 9.76 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.669 HD21 ' C ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -91.3 117.47 29.68 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.889 0.852 . . . . 10.0 110.352 -178.121 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 168' ' ' VAL . 1.6 t -126.3 177.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 10.0 111.618 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.48 159.29 14.6 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 82' ' ' PHE . 87.1 m -113.59 140.77 47.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.302 . . . . 10.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 48.61 36.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 10.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -47.39 -24.82 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.261 -0.976 . . . . 10.0 110.864 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.753 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 3.6 p-10 -52.67 52.33 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 121.397 0.618 . . . . 10.0 112.222 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.76 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 157.34 -53.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -40.07 -30.16 0.09 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.277 -0.874 . . . . 10.0 110.23 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 37.3 t0 -68.02 -19.04 64.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 10.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.975 ' O ' HD13 ' A' ' 126' ' ' ILE . 3.4 m-20 -82.13 148.4 59.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 10.0 110.27 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.3 Cg_endo -86.33 22.74 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.067 1.562 . . . . 10.0 110.226 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 21.0 p -102.95 -50.25 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 10.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.711 HG21 HD12 ' A' ' 119' ' ' LEU . 4.0 t -70.55 -30.44 67.16 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.163 -2.162 . . . . 10.0 105.163 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 122' ' ' ASP 0.298 0.8 OUTLIER -49.54 -30.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.707 -1.59 . . . . 10.0 106.707 176.515 . . . . . . . . 4 4 . 1 . 013 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 124' ' ' SER . 1.5 tp10 -52.84 -38.62 61.63 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.876 0.846 . . . . 10.0 109.971 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -56.5 -39.61 73.57 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.922 -0.487 . . . . 10.0 111.041 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -51.41 -47.75 62.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.938 -1.101 . . . . 10.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.53 59.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.569 -0.707 . . . . 10.0 110.397 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.93 -23.83 0.88 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.232 -0.918 . . . . 10.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 2.1 p-10 -127.95 -25.54 3.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.037 . . . . 10.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -147.79 118.31 7.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -65.16 -22.36 66.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.61 -0.682 . . . . 10.0 111.855 -178.003 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -108.33 95.24 15.24 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.048 -1.032 . . . . 10.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.747 ' CB ' HD13 ' A' ' 129' ' ' LEU . 43.5 Cg_endo -72.49 157.54 52.67 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.977 1.514 . . . . 10.0 109.763 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 84' ' ' VAL . 5.8 tp -100.49 127.4 53.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 10.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.6 p -125.1 169.83 10.36 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.507 -0.746 . . . . 10.0 109.223 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -63.1 -11.78 26.65 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.637 1.335 . . . . 10.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -83.95 -51.06 7.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 10.0 110.218 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.7 m -68.55 -39.94 80.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 10.0 110.514 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -51.16 -27.39 8.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 10.0 110.039 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.38 -49.95 61.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 10.0 109.732 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.5 72.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.196 -0.94 . . . . 10.0 108.976 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.55 ' CG ' ' HE2' ' A' ' 94' ' ' LYS . 2.5 tt -64.08 -49.72 71.17 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.398 -0.813 . . . . 10.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -61.71 -41.0 97.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -57.85 -24.45 57.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.014 -0.674 . . . . 10.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.526 ' C ' HD12 ' A' ' 149' ' ' LEU . 51.0 t0 -58.33 -55.19 38.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.34 -0.85 . . . . 10.0 109.428 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 98' ' ' VAL . 6.7 mp -96.55 9.23 42.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.007 -1.109 . . . . 10.0 108.007 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.9 mttp 61.86 35.99 16.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.044 0.926 . . . . 10.0 109.62 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -58.12 -154.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.476 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.919 HG11 ' CD1' ' A' ' 111' ' ' LEU . 4.3 t -89.08 -76.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.945 -1.097 . . . . 10.0 110.627 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.669 ' C ' HD21 ' A' ' 112' ' ' LEU . 2.1 tppt? -174.88 159.83 2.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.281 -1.368 . . . . 10.0 112.125 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 18.0 p90 -84.26 112.57 20.41 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.658 0.742 . . . . 10.0 109.98 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.009 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -115.71 -169.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 10.0 110.637 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.08 144.49 21.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 10.0 109.928 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.66 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 24.0 p -149.42 148.93 30.04 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.023 0.916 . . . . 10.0 111.738 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.533 ' HB3' ' H ' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -149.13 96.06 2.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -35.73 -56.41 0.68 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.618 -0.676 . . . . 10.0 112.071 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.496 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.3 pp -99.98 -11.02 20.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.667 -1.271 . . . . 10.0 113.796 -177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.562 HG21 ' CB ' ' A' ' 118' ' ' ASP . 30.0 m -98.79 -90.19 0.3 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 119.93 -1.731 . . . . 10.0 111.613 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 43.7 mt-30 -52.61 -68.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.731 -1.231 . . . . 10.0 110.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 24.8 mtmm 74.07 57.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.597 0.713 . . . . 10.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 26.77 0.24 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.643 -1.783 . . . . 10.0 108.643 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.807 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.42 4.85 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -1.037 . . . . 10.0 111.758 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.464 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -52.81 -22.59 5.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 10.0 109.543 178.77 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 71.5 m-20 -69.13 -38.49 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 10.0 110.049 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.009 HG22 ' HB ' ' A' ' 155' ' ' VAL . 17.2 t -49.71 -40.11 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 10.0 109.179 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -79.98 -26.07 40.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 10.0 110.329 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.693 ' HA ' HD12 ' A' ' 173' ' ' ILE . 21.8 m-20 -58.65 -45.72 88.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.008 . . . . 10.0 110.148 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.53 ' HB3' HG13 ' A' ' 152' ' ' VAL . 5.6 mm-40 -74.68 -26.0 59.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.032 . . . . 10.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -67.11 -31.72 72.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 10.0 109.586 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.737 HG23 ' OH ' ' A' ' 51' ' ' TYR . 46.3 mt -59.15 -46.99 91.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.462 -0.774 . . . . 10.0 109.977 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -70.13 -35.5 74.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.203 -0.936 . . . . 10.0 110.686 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 109' ' ' PRO . . . -88.56 -3.39 58.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.39 -0.819 . . . . 10.0 109.866 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.736 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -77.94 -33.76 51.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 10.0 110.049 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -98.08 -24.05 15.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 10.0 109.182 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.022 -0.989 . . . . 10.0 110.208 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 10.0 109.723 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 15.5 m 54.24 49.82 17.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -1.147 . . . . 10.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 105.01 2.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 10.0 109.749 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' B' ' 2' ' ' SER . 15.8 mm-40 -100.81 162.85 12.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.522 -0.736 . . . . 10.0 110.404 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.696 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -69.42 -147.84 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.4 Cg_endo -69.66 87.5 0.54 Allowed 'Trans proline' 0 N--CA 1.481 0.766 0 CA-C-N 119.549 0.874 . . . . 10.0 110.327 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.577 ' CD ' HG22 ' A' ' 46' ' ' ILE . 2.8 mp0 -54.11 -164.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.666 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -80.41 -71.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.421 -1.424 . . . . 10.0 109.923 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -149.32 -175.2 4.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.375 -1.33 . . . . 10.0 112.2 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.943 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.35 138.3 4.97 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 119.223 -0.991 . . . . 10.0 112.846 -178.503 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 50.3 Cg_endo -81.01 153.83 19.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 108.243 -1.484 . . . . 10.0 108.243 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -129.64 151.23 50.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.399 -1.438 . . . . 10.0 111.689 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 42' ' ' VAL . 19.4 m-20 -108.06 170.26 8.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.667 -0.864 . . . . 10.0 108.667 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.11 148.46 48.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.674 -1.266 . . . . 10.0 111.37 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.727 ' OE1' ' HB3' ' A' ' 41' ' ' ALA . 3.8 tm-20 -148.0 -179.93 7.27 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -136.98 -175.3 3.99 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 117.267 -1.773 . . . . 10.0 113.511 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 39' ' ' ASN . 15.1 t -121.62 -169.7 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.863 0.84 . . . . 10.0 112.41 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.906 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.3 OUTLIER -122.28 -168.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.739 -0.6 . . . . 10.0 109.691 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 17.2 p80 -100.24 155.66 17.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.656 -1.277 . . . . 10.0 113.41 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 1.002 HG22 ' N ' ' A' ' 37' ' ' PHE 0.255 40.7 t -109.91 155.45 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.22 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.21 54.34 0.59 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.99 -1.644 . . . . 10.0 108.99 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 177.19 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.263 . . . . 10.0 109.874 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 25' ' ' VAL . 74.4 m-20 -71.42 152.77 42.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.532 -0.73 . . . . 10.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 50.06 38.01 15.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.597 -0.689 . . . . 10.0 111.431 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' B' ' 22' ' ' PHE . 54.8 t -111.0 -22.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.829 -1.175 . . . . 10.0 107.829 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.6 t -88.18 -26.56 22.34 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.466 0.651 . . . . 10.0 109.902 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -116.42 39.84 2.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.231 -1.948 . . . . 10.0 108.231 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 9.9 mp0 -140.03 122.26 15.89 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.883 0.849 . . . . 10.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 8.0 t80 -116.87 128.11 54.93 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 ' CE2' ' A' ' 28' ' ' PHE . 47.1 p -141.13 -44.9 0.38 Allowed 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.649 -0.657 . . . . 10.0 110.45 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.421 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 130.44 76.7 0.16 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.995 -1.242 . . . . 10.0 109.995 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.6 HD11 ' HG2' ' B' ' 35' ' ' GLN . 26.5 pt -110.05 160.89 26.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.282 -1.128 . . . . 10.0 109.318 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.572 ' O ' ' C ' ' B' ' 34' ' ' GLU . 47.9 Cg_endo -73.85 175.16 11.16 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.706 1.371 . . . . 10.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.572 ' C ' ' O ' ' B' ' 33' ' ' PRO . 2.3 tm-20 -1.0 114.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 121.203 0.525 . . . . 10.0 112.373 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.6 ' HG2' HD11 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -97.45 -71.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.041 -1.037 . . . . 10.0 111.89 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.05 -12.5 19.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.122 0.963 . . . . 10.0 111.247 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -90.81 60.64 4.51 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 10.0 108.9 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.091 0.472 . . . . 10.0 110.225 . . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.58 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.4 mt-30 -130.92 -3.48 4.04 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.104 -0.997 . . . . 10.0 109.9 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.583 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 23.7 m -68.39 106.18 2.42 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 10.0 110.878 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.041 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -109.22 123.75 65.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.057 -1.057 . . . . 10.0 109.397 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.4 mmmt -107.71 130.75 54.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 55' ' ' LEU . 60.8 m -109.87 116.62 31.98 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.124 -1.03 . . . . 10.0 110.056 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.574 HG21 ' OG1' ' A' ' 75' ' ' THR . 25.5 t -126.79 166.19 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.688 . . . . 10.0 109.986 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -101.52 125.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 10.0 110.257 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 10' ' ' GLY . 12.0 t -132.73 -171.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 10.0 109.534 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.74 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 109.26 171.48 20.71 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.411 -1.476 . . . . 10.0 109.411 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 82' ' ' PHE . 1.4 m-20 -45.32 -37.17 4.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 10.0 109.684 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' B' ' 35' ' ' GLN . . . 150.25 143.28 3.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 33' ' ' PRO . . . -157.32 -130.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -1.125 . . . . 10.0 110.205 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.578 HG21 ' H ' ' B' ' 30' ' ' THR . 60.5 t -119.78 -44.51 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.957 -1.089 . . . . 10.0 110.974 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -176.65 -177.69 45.82 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.899 -1.28 . . . . 10.0 109.899 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.744 ' HB2' HG22 ' A' ' 8' ' ' VAL . 6.0 ttpm? -97.79 -50.49 4.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.18 . . . . 10.0 110.386 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.8 p -72.15 -18.31 61.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 10.0 110.026 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' B' ' 28' ' ' GLU . 28.3 p -63.92 -17.2 63.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 10.0 110.79 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' CA ' ' HZ2' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -93.09 -38.59 11.53 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.001 -1.062 . . . . 10.0 110.759 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 50.4 tp -55.19 -38.34 68.24 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.673 -1.211 . . . . 10.0 108.541 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.674 ' HA ' ' HB ' ' A' ' 24' ' ' THR 0.273 6.3 tp -80.98 -30.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.697 0.76 . . . . 10.0 110.039 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 38.4 m -46.93 -54.54 9.83 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.793 -1.163 . . . . 10.0 108.724 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.694 ' CG ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.62 3.75 51.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.481 -1.688 . . . . 10.0 111.035 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 24' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 25' ' ' THR . 19.2 m -77.1 -52.54 9.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.481 -1.288 . . . . 10.0 107.821 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 24' ' ' THR . 0.6 OUTLIER -179.59 -71.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.695 -1.202 . . . . 10.0 113.745 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.763 ' H ' HG23 ' A' ' 25' ' ' THR . 26.1 m-20 -85.78 48.59 1.62 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.806 -1.184 . . . . 10.0 112.076 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' HG23 ' B' ' 26' ' ' THR . 3.2 pttt -44.92 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.222 1.01 . . . . 10.0 111.872 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 39.3 t80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 114.819 1.414 . . . . 10.0 114.819 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 22.5 p . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.35 0.595 . . . . 10.0 111.921 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' CA ' ' A' ' 60' ' ' GLY . 71.6 t -58.66 -90.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 10.0 110.213 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.611 ' N ' HG12 ' B' ' 20' ' ' VAL . 1.7 t80 -47.26 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 10.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' ' CE2' ' A' ' 40' ' ' TYR . 9.4 t0 -141.02 84.2 1.92 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.408 -0.807 . . . . 10.0 109.666 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.823 ' CB ' HD11 ' B' ' 18' ' ' ILE . 9.6 t-20 -79.32 99.26 7.03 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.786 -1.196 . . . . 10.0 109.928 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' B' ' 16' ' ' HIS . 21.1 m-85 -91.93 121.16 33.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.416 -0.802 . . . . 10.0 109.832 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -145.83 96.72 2.85 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.52 -0.872 . . . . 10.0 111.293 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 43' ' ' THR . 82.4 t -162.64 -165.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.816 ' H ' HG12 ' A' ' 42' ' ' VAL . 40.1 m -126.43 165.67 18.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.588 -1.945 . . . . 10.0 112.139 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -123.59 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.565 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 0.5 OUTLIER -101.18 107.31 18.68 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.981 -1.074 . . . . 10.0 109.998 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' B' ' 10' ' ' LEU . 3.7 mp -121.7 130.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 10.0 110.376 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 50.87 25.01 8.88 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.0 13.76 71.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 10.0 109.561 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -116.18 123.52 30.76 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.344 -1.092 . . . . 10.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.08 141.45 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.52 . . . . 10.0 110.709 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 m-30 -109.97 116.32 31.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.317 -0.864 . . . . 10.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 58.1 m -85.35 106.91 17.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 10.0 109.923 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 4.3 mt -121.58 153.38 38.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 10.0 111.063 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.51 99.4 0.16 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 6' ' ' CYS . 3.3 pp -138.07 167.75 21.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -1.221 . . . . 10.0 110.644 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.541 ' N ' HD12 ' A' ' 55' ' ' LEU . 27.1 p90 -169.11 130.03 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.834 . . . . 10.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 11.0 t0 -82.05 160.95 23.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.92 -1.112 . . . . 10.0 109.045 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.713 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 8.9 m -128.52 159.79 34.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.744 -1.222 . . . . 10.0 111.481 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 75.04 28.79 1.02 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.973 0.892 . . . . 10.0 109.143 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.684 ' CA ' HG11 ' A' ' 36' ' ' VAL . . . -80.88 -75.08 1.1 Allowed Glycine 0 C--N 1.297 -1.588 0 N-CA-C 106.972 -2.451 . . . . 10.0 106.972 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HA ' ' N ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER -89.14 20.5 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -1.082 . . . . 10.0 110.098 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.613 ' O ' ' CZ ' ' A' ' 64' ' ' TYR . 60.3 mm-40 -104.22 -48.91 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 10.0 110.421 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 31.8 t0 66.12 47.9 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 10.0 109.448 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.613 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER 157.16 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.423 0.63 . . . . 10.0 109.553 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 2.3 p30 36.92 53.54 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 10.0 111.763 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -52.93 -29.13 26.83 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.623 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.5 mp -82.32 10.9 6.12 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.251 0.548 . . . . 10.0 109.755 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.782 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -63.07 -18.06 0.44 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -84.04 80.42 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 CA-C-N 120.043 1.051 . . . . 10.0 110.206 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -90.73 -28.36 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.75 . . . . 10.0 110.366 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 30.7 t 42.75 25.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 10.0 110.615 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 16.2 m-85 -120.22 93.06 47.83 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.018 -1.051 . . . . 10.0 110.488 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.89 73.35 6.06 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 10.0 111.168 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.74 65.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 10.0 109.924 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.626 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 48.1 m -143.84 96.18 2.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.569 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.4 t70 -33.32 -31.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 120.83 0.348 . . . . 10.0 111.417 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.979 HG11 ' HB2' ' A' ' 176' ' ' ALA . 3.1 m -122.69 123.5 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.205 -0.934 . . . . 10.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.652 ' CD1' HG21 ' A' ' 9' ' ' VAL . 21.3 m-85 -109.56 143.15 39.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.3 -0.875 . . . . 10.0 109.89 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 168' ' ' VAL . 1.1 mm? -108.35 97.99 7.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.108 . . . . 10.0 110.414 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.586 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 2.1 m -105.45 131.55 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 10.0 108.658 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 113' ' ' VAL . 41.3 t -136.98 124.45 22.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.795 -1.19 . . . . 10.0 110.963 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 8.1 p90 -149.55 179.63 7.83 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.458 -0.897 . . . . 10.0 111.35 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 m -75.21 163.14 27.83 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.244 -0.91 . . . . 10.0 111.148 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.637 ' O ' HG22 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -127.83 9.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 10.0 112.5 -178.091 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -80.49 -72.56 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.127 -1.608 . . . . 10.0 107.751 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 85' ' ' VAL . 60.8 m -76.8 135.26 67.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.665 -1.272 . . . . 10.0 108.496 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 42.1 Cg_endo -72.37 -23.92 20.03 Favored 'Trans proline' 0 C--N 1.297 -2.139 0 O-C-N 123.662 1.348 . . . . 10.0 110.144 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 89' ' ' SER . 66.7 m 41.26 38.96 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 88' ' ' SER . 15.3 m 64.13 40.36 6.99 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.377 0.608 . . . . 10.0 110.243 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' ' HE2' ' A' ' 94' ' ' LYS . 7.1 t80 -48.59 -26.34 2.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 10.0 108.761 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.5 tt0 -56.85 -27.43 60.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 10.0 109.072 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.12 -22.07 61.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.88 0.848 . . . . 10.0 109.396 179.169 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.833 HG13 ' CZ2' ' A' ' 97' ' ' TRP . 6.8 t -82.85 -8.43 11.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.261 -0.899 . . . . 10.0 109.356 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HE2' ' CE2' ' A' ' 90' ' ' PHE . 4.0 mmtp -86.63 -32.44 20.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 8.0 pt-20 -84.08 3.13 36.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.846 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -103.37 -50.29 3.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.964 -1.094 . . . . 10.0 111.843 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.833 ' CZ2' HG13 ' A' ' 93' ' ' VAL . 5.6 m0 -86.52 -49.06 7.84 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.98 -1.075 . . . . 10.0 112.022 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.564 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 18.2 t -54.21 -50.39 84.89 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.861 -1.149 . . . . 10.0 111.575 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 43.2 Cg_endo -70.54 -15.92 34.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.089 1.047 . . . . 10.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -54.2 -30.25 49.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 10.0 109.119 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 104' ' ' HIS . 4.6 mt 60.24 114.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.493 -0.883 . . . . 10.0 110.223 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -49.83 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 109.632 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.656 ' H ' HG23 ' A' ' 102' ' ' THR . 6.0 p-80 -109.49 6.97 24.58 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.367 -0.833 . . . . 10.0 109.546 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.79 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.1 OUTLIER 169.59 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 10.0 109.575 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.901 ' O ' HG22 ' A' ' 102' ' ' THR . 75.8 m -119.66 155.71 54.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.51 -0.744 . . . . 10.0 110.205 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 55.2 Cg_endo -76.6 73.41 5.22 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.149 1.605 . . . . 10.0 111.64 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 18.5 ttpt -126.9 -2.02 6.56 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.698 -1.251 . . . . 10.0 109.826 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 102' ' ' THR . 96.3 m -46.22 129.24 7.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.118 -0.989 . . . . 10.0 109.721 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 47.0 Cg_endo -71.75 149.22 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.81 1.426 . . . . 10.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 97' ' ' TRP . 43.6 m-85 -132.99 119.58 20.27 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.081 -1.048 . . . . 10.0 111.772 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.889 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.5 mm? -88.79 93.38 9.56 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.235 -1.395 . . . . 10.0 107.235 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 2.2 mt -70.99 147.2 48.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.469 -0.769 . . . . 10.0 109.617 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 168' ' ' VAL . 1.8 t -146.51 178.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.952 . . . . 10.0 111.32 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -126.3 116.35 2.53 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.814 -1.715 . . . . 10.0 108.814 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.832 HG22 ' HG3' ' A' ' 116' ' ' GLN . 64.4 m -81.79 123.72 29.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.067 -1.254 . . . . 10.0 109.723 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.6 mt-30 47.1 69.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -93.83 -45.41 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.969 -0.692 . . . . 10.0 111.41 -177.592 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 35.8 t70 -51.43 56.16 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 121.921 0.867 . . . . 10.0 112.86 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 2.5 tp 152.95 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' ILE . 17.6 tpp180 -58.66 -17.72 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' CG2' ' A' ' 84' ' ' VAL . 14.6 m-20 -111.54 19.51 18.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.84 -0.537 . . . . 10.0 110.548 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.847 ' OD1' HG22 ' A' ' 125' ' ' THR . 21.2 p-10 -80.63 145.41 58.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.025 -1.047 . . . . 10.0 108.994 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.57 24.19 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.382 1.727 . . . . 10.0 112.469 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -110.23 -48.13 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.56 -1.337 . . . . 10.0 110.288 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.847 HG22 ' OD1' ' A' ' 122' ' ' ASP . 9.3 t -86.49 -24.68 25.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.09 -1.818 . . . . 10.0 106.09 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 120' ' ' ARG 0.278 1.1 mp -62.68 -21.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 176.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -47.84 -46.68 31.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.625 0.726 . . . . 10.0 109.636 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 -41.33 12.5 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.509 -0.744 . . . . 10.0 111.192 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 125' ' ' THR . 4.6 mt -57.09 -41.58 79.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 10.0 110.999 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.994 -1.067 . . . . 10.0 109.214 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -71.2 -8.51 54.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 10.0 110.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.547 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 57.9 t-20 -65.82 -33.62 76.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 10.0 110.496 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.616 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mptt -117.67 -68.03 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 143.53 -17.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 123.377 0.671 . . . . 10.0 110.023 177.793 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -136.48 94.9 13.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.978 -1.077 . . . . 10.0 110.844 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.8 Cg_endo -71.05 161.5 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.028 1.541 . . . . 10.0 110.657 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' VAL . 7.1 tp -102.76 134.97 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 10.0 109.232 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.7 p -120.2 172.23 4.84 Favored Pre-proline 0 C--N 1.295 -1.777 0 O-C-N 121.238 -0.914 . . . . 10.0 109.062 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.65 -17.41 52.69 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.276 1.146 . . . . 10.0 109.703 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 mt-10 -79.7 -42.78 23.95 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.81 . . . . 10.0 109.945 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 m -73.9 -43.5 58.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.359 -0.838 . . . . 10.0 109.889 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -57.75 -50.38 73.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 10.0 110.752 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 3.0 pp20? -65.92 -30.41 70.99 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.209 -0.997 . . . . 10.0 108.966 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -71.22 -35.82 71.64 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -60.73 -45.8 92.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.036 -1.098 . . . . 10.0 108.036 178.155 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.911 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.66 -50.17 74.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.887 0.851 . . . . 10.0 109.114 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 147' ' ' ARG . 4.7 ttm180 -65.55 -17.75 64.81 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.48 0.657 . . . . 10.0 109.729 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -67.92 -18.74 64.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.824 . . . . 10.0 110.97 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -152.03 38.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.9 -1.125 . . . . 10.0 111.326 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 8.9 mttp 62.08 53.43 2.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.005 0.907 . . . . 10.0 112.105 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.911 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -105.36 173.15 6.43 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.895 -0.779 . . . . 10.0 108.895 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.862 HG21 HD11 ' A' ' 111' ' ' LEU . 2.9 t -71.23 -87.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.005 -1.06 . . . . 10.0 110.821 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.832 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.12 168.75 4.05 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.088 -1.007 . . . . 10.0 111.006 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.636 ' OH ' HG11 ' A' ' 84' ' ' VAL . 77.6 t80 -81.04 119.0 22.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 10.0 110.581 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.758 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.7 OUTLIER -118.83 -169.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.141 -0.974 . . . . 10.0 110.463 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 86.7 mt-10 -146.36 138.54 25.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.661 -1.274 . . . . 10.0 111.874 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 30.1 t -141.2 130.56 23.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.131 0.967 . . . . 10.0 111.373 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 162' ' ' GLN . 18.9 m -148.35 81.15 1.47 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.997 0.903 . . . . 10.0 109.387 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.652 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . . . -52.98 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.995 . . . . 10.0 111.062 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 161' ' ' THR 0.262 0.4 OUTLIER -48.05 -50.7 27.1 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.961 -1.087 . . . . 10.0 110.288 -179.825 . . . . . . . . 4 4 . 1 . 014 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.896 ' N ' HD13 ' A' ' 160' ' ' LEU . 1.1 m -76.8 -70.52 0.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.227 0.825 . . . . 10.0 113.227 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.656 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 2.7 mm-40 -123.85 -91.16 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.0 -1.688 . . . . 10.0 112.238 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.771 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 1.3 mmtt 124.36 -154.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.788 1.235 . . . . 10.0 108.531 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.615 ' N ' HD13 ' A' ' 165' ' ' LEU . . . 96.11 14.06 46.89 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.535 -2.626 . . . . 10.0 106.535 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.908 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -84.34 5.23 27.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.964 -0.618 . . . . 10.0 111.478 -178.832 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.526 ' N ' HD22 ' A' ' 165' ' ' LEU . 13.8 mttt -50.47 -27.57 6.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 10.0 108.613 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' HB3' HG11 ' A' ' 155' ' ' VAL . 25.9 t-20 -65.12 -43.95 90.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.526 -0.734 . . . . 10.0 109.813 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.831 HG12 ' CD1' ' A' ' 79' ' ' LEU . 93.9 t -50.54 -29.39 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 10.0 109.165 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 14.8 m-85 -96.78 -22.14 17.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.74 -0.6 . . . . 10.0 109.958 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.1 t0 -67.54 -51.29 52.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 10.0 111.067 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.407 ' HA ' HD23 ' A' ' 174' ' ' LEU . 4.8 mt-10 -72.34 -40.5 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 10.0 111.097 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.889 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.8 -31.77 59.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.988 -1.07 . . . . 10.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.667 ' O ' HD11 ' A' ' 177' ' ' LEU . 30.1 mt -58.48 -44.16 88.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.995 -1.065 . . . . 10.0 109.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -76.69 -48.59 18.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 10.0 112.182 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.3 -10.27 22.93 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.354 -0.841 . . . . 10.0 110.865 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.041 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -79.0 -41.41 29.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 10.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.667 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -77.3 -19.91 55.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.402 -0.811 . . . . 10.0 109.164 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 117.982 -1.009 . . . . 10.0 110.341 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.495 -1.442 . . . . 10.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -106.19 138.01 43.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -1.145 . . . . 10.0 110.567 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.44 102.56 9.32 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.42 -0.8 . . . . 10.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -101.56 140.39 35.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.687 -0.633 . . . . 10.0 110.926 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.634 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -98.77 -49.02 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 10.0 110.213 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 51.9 Cg_endo -83.62 -18.15 5.83 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.086 -1.159 . . . . 10.0 109.086 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.761 ' OE2' HD23 ' B' ' 10' ' ' LEU . 0.5 OUTLIER 32.93 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.521 0.677 . . . . 10.0 111.71 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -141.96 -61.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.071 -1.018 . . . . 10.0 110.117 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 t -134.44 132.09 38.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 10.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.761 HD23 ' OE2' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -132.33 99.62 15.9 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.546 -0.721 . . . . 10.0 111.176 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 41.6 Cg_endo -72.54 117.06 4.95 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.604 1.318 . . . . 10.0 108.761 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -47.82 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 10.0 111.202 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -151.96 -166.66 2.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.857 -0.527 . . . . 10.0 109.717 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.745 ' C ' HG11 ' A' ' 42' ' ' VAL . 24.0 m-85 -109.49 -170.05 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.99 1.108 . . . . 10.0 113.99 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.652 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -160.85 -169.69 2.48 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 53.8 t60 -136.07 146.93 47.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.022 -1.049 . . . . 10.0 110.837 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.644 ' C ' HD13 ' B' ' 18' ' ' ILE . 2.8 t -150.27 143.33 24.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.173 -1.579 . . . . 10.0 112.203 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.823 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -110.99 -167.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 68.3 t60 -107.38 153.4 22.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.775 -1.203 . . . . 10.0 112.275 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.66 HG11 ' N ' ' A' ' 36' ' ' VAL . 1.6 m -124.98 153.1 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.729 0.776 . . . . 10.0 111.405 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 60' ' ' GLY . . . -134.62 98.43 0.31 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.32 -1.912 . . . . 10.0 108.32 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.725 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.1 t80 -179.34 117.46 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.014 -1.286 . . . . 10.0 109.314 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 22' ' ' PHE . 16.0 t0 -38.95 156.3 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.643 0.735 . . . . 10.0 111.133 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.01 46.73 10.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.667 -0.646 . . . . 10.0 110.512 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 22' ' ' PHE . 64.9 t -78.54 -17.59 13.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 27' ' ' LYS 0.256 5.7 t -50.06 -29.87 9.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.874 -1.057 . . . . 10.0 111.747 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -134.99 4.44 4.23 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.16 -1.976 . . . . 10.0 108.16 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 0.5 OUTLIER 54.08 19.99 2.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.416 -1.05 . . . . 10.0 110.664 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.709 ' C ' HG22 ' B' ' 30' ' ' THR . 4.2 t80 -113.15 133.08 55.21 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.762 -0.586 . . . . 10.0 109.973 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.709 HG22 ' C ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER 161.97 135.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.238 0.542 . . . . 10.0 110.95 179.524 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 -179.61 50.98 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.051 -1.219 . . . . 10.0 110.051 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 1.1 pp -143.17 36.1 0.21 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.26 -1.141 . . . . 10.0 112.055 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 46.2 Cg_endo -73.2 171.64 17.19 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.172 1.091 . . . . 10.0 109.437 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' PRO . 41.8 tp10 -48.96 167.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.699 -1.25 . . . . 10.0 108.788 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.606 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 2.1 mp0 -82.13 20.08 1.08 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.39 -0.819 . . . . 10.0 110.853 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.679 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.5 m95 87.84 49.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 36' ' ' TRP . . . 168.56 99.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.455 -0.942 . . . . 10.0 108.455 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HD2' ' HD3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.291 -1.971 0 N-CA-C 106.294 -1.743 . . . . 10.0 106.294 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 2.5 ttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.478 0.656 . . . . 10.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.563 ' O ' HG22 ' A' ' 4' ' ' ILE . 7.6 mm-40 -149.51 -83.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.734 ' N ' HG21 ' A' ' 52' ' ' THR . 4.3 m -38.87 91.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.584 -0.697 . . . . 10.0 110.171 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.823 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 1.6 tt -135.59 138.76 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.088 -1.008 . . . . 10.0 110.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.615 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.35 122.84 28.64 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.132 0.968 . . . . 10.0 111.313 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.739 ' HA ' HG13 ' A' ' 77' ' ' VAL . 40.4 t -71.34 126.1 28.73 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.746 0.784 . . . . 10.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 8' ' ' VAL . 4.3 t -140.43 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.667 . . . . 10.0 109.212 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.716 ' H ' HG12 ' A' ' 7' ' ' VAL . 71.5 t -93.87 143.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.05 -1.031 . . . . 10.0 109.82 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -132.74 -166.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.505 -0.747 . . . . 10.0 110.397 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.698 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 89.49 -158.92 27.95 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.567 -1.413 . . . . 10.0 109.567 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.59 -10.19 57.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.986 -1.302 . . . . 10.0 109.4 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.525 ' HA2' ' HG3' ' B' ' 35' ' ' GLN . . . 112.07 89.68 1.87 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . -166.15 50.03 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.211 -1.17 . . . . 10.0 110.265 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.618 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER 68.32 157.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.058 -1.026 . . . . 10.0 109.411 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.685 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -122.87 -153.32 8.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.756 -1.738 . . . . 10.0 108.756 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 1.016 ' HA ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.01 0.36 21.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.523 -0.986 . . . . 10.0 110.873 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 -50.63 18.23 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.315 -0.866 . . . . 10.0 111.493 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' SG ' HD22 ' A' ' 19' ' ' LEU . 31.9 p -61.88 -17.89 58.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.778 -1.201 . . . . 10.0 109.443 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.21 -28.15 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.371 -0.831 . . . . 10.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -49.57 -41.39 41.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.604 -1.31 . . . . 10.0 109.331 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.724 ' HB ' ' HA2' ' B' ' 27' ' ' GLY . 1.2 mm -84.59 -39.97 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.369 1.08 . . . . 10.0 109.09 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 19' ' ' LEU . 16.1 t -46.73 -49.21 19.95 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.359 -0.837 . . . . 10.0 110.546 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.939 ' CZ ' HD12 ' A' ' 165' ' ' LEU . 29.8 m-85 -79.94 -14.28 58.72 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.002 -1.061 . . . . 10.0 110.316 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 m -100.04 -31.63 11.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 10.0 112.849 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.419 ' OG1' HG23 ' A' ' 21' ' ' ILE . 82.8 p -110.74 -90.2 0.48 Allowed 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.051 -1.656 . . . . 10.0 112.118 -177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.586 ' C ' ' HG3' ' A' ' 27' ' ' LYS . 47.7 t-20 -159.85 20.96 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.51 -0.744 . . . . 10.0 111.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER 26.86 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.431 0.901 . . . . 10.0 113.431 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CD2' HG22 ' B' ' 30' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.502 2.141 0 O-C-N 121.951 -0.468 . . . . 10.0 110.244 -178.066 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.956 HG23 ' HB2' ' A' ' 37' ' ' PHE . 5.1 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.644 0.735 . . . . 10.0 112.18 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 58' ' ' THR . 1.6 t -54.42 -14.18 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.559 -0.713 . . . . 10.0 111.058 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 1.121 ' CD1' HG22 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -35.69 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.511 -0.743 . . . . 10.0 109.989 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.613 ' C ' ' HA ' ' B' ' 18' ' ' ILE . 68.5 m-20 -137.79 131.96 31.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.913 2.19 . . . . 10.0 116.913 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.805 ' HB3' HD13 ' B' ' 18' ' ' ILE 0.26 35.1 p-10 -104.9 107.37 18.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.007 -0.997 . . . . 10.0 111.101 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 39' ' ' ASN . 23.8 m-85 -155.21 108.84 2.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 119.368 -2.082 . . . . 10.0 113.101 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -171.65 99.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.423 -1.325 . . . . 10.0 107.423 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -156.11 -168.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.899 -1.125 . . . . 10.0 111.436 -177.558 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.942 HG23 ' C ' ' A' ' 51' ' ' TYR . 27.0 m -151.68 115.55 4.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.648 -0.821 . . . . 10.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -79.76 152.05 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.556 . . . . 10.0 110.047 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.6 ' O ' ' O ' ' B' ' 10' ' ' LEU . 33.6 mtm -127.43 92.89 3.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.339 -1.344 . . . . 10.0 108.125 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 38.3 mt -95.6 141.13 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 120.909 0.385 . . . . 10.0 110.249 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.792 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 40.97 26.96 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 86.24 33.33 14.64 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.161 -1.199 . . . . 10.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' CG ' ' B' ' 4' ' ' GLU . 52.7 mm-40 -127.46 102.52 23.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.085 -1.244 . . . . 10.0 110.723 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 48.0 Cg_endo -74.92 124.2 8.48 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.874 1.46 . . . . 10.0 110.303 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.942 ' C ' HG23 ' A' ' 43' ' ' THR . 6.3 m-30 -99.83 110.99 23.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.683 -1.261 . . . . 10.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.734 HG21 ' N ' ' A' ' 3' ' ' THR . 1.4 m -71.69 117.04 12.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.636 -0.665 . . . . 10.0 110.546 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' HG ' ' C ' ' A' ' 52' ' ' THR . 5.2 mt -137.71 160.72 38.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.884 -1.135 . . . . 10.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 5' ' ' LYS . . . -170.92 110.87 0.38 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.959 -1.256 . . . . 10.0 109.959 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 ' CB ' ' A' ' 40' ' ' TYR . 2.2 pp -138.57 152.53 48.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.97 -1.312 . . . . 10.0 111.924 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 20.6 p90 -160.27 140.65 11.67 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.307 -0.86 . . . . 10.0 108.766 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.676 ' HB2' HG13 ' A' ' 36' ' ' VAL . 1.7 m-20 -92.8 154.37 18.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.804 -1.185 . . . . 10.0 111.468 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 36' ' ' VAL . 1.6 t -60.55 133.77 56.42 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 10.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HA ' ' CA ' ' B' ' 21' ' ' GLY . . . -87.12 79.1 8.74 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.677 -0.64 . . . . 10.0 111.439 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.572 ' N ' ' HA2' ' B' ' 21' ' ' GLY . . . -42.94 -50.07 6.14 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.559 -2.617 . . . . 10.0 106.559 177.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 3.5 mm-40 -62.99 -44.18 96.73 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 4.5 mt-10 65.41 84.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.121 0.962 . . . . 10.0 111.366 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.709 ' OD2' HG11 ' B' ' 20' ' ' VAL . 21.5 m-20 -95.52 -8.86 34.01 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.811 0.815 . . . . 10.0 108.858 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.4 p90 -139.65 10.32 2.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.664 -0.865 . . . . 10.0 108.664 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.1 p-10 -30.62 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.26 0.552 . . . . 10.0 112.101 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -48.46 -26.88 2.33 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.829 -1.169 . . . . 10.0 109.451 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 mp -97.02 6.68 48.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.432 -0.792 . . . . 10.0 110.273 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 1.048 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -72.69 -24.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.103 -0.998 . . . . 10.0 112.891 -179.362 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 38.0 Cg_endo -70.91 71.42 2.1 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 109.275 -1.086 . . . . 10.0 109.275 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 1.048 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -69.93 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.793 -0.567 . . . . 10.0 111.519 -178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER 54.67 35.21 23.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.805 -1.185 . . . . 10.0 108.482 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 4.9 m-85 -118.1 -53.48 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.629 -0.669 . . . . 10.0 111.222 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.615 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 55.7 Cg_endo -85.92 76.8 2.7 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 122.978 0.988 . . . . 10.0 111.296 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.16 0.32 52.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.904 -1.122 . . . . 10.0 110.443 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 75' ' ' THR . 2.7 m -140.1 84.21 1.96 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.287 -0.883 . . . . 10.0 110.048 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 4' ' ' ILE . 1.9 m-20 -140.52 -97.62 0.15 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.704 -0.622 . . . . 10.0 109.424 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.739 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -140.78 118.53 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 10.0 108.743 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 21.4 m-85 -114.85 125.51 53.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.018 . . . . 10.0 111.443 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.603 HD22 HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -111.47 99.76 8.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 178.647 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 112' ' ' LEU . 1.7 p -82.64 133.79 28.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.618 -0.676 . . . . 10.0 110.457 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.452 ' C ' ' OG1' ' A' ' 115' ' ' THR . 11.3 t -124.27 101.21 7.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.176 -0.953 . . . . 10.0 109.161 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.8 p90 -133.53 162.24 32.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.662 -1.215 . . . . 10.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB3' HG22 ' A' ' 85' ' ' VAL . 63.6 m -75.76 158.64 31.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.648 -0.658 . . . . 10.0 110.328 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 -11.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.472 -0.767 . . . . 10.0 109.403 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 129' ' ' LEU . 33.9 m -68.62 -1.93 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.776 . . . . 10.0 109.701 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.2 m -128.08 82.86 67.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.201 -0.937 . . . . 10.0 109.871 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 44.2 Cg_endo -63.81 -19.26 66.71 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.35 1.711 . . . . 10.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.507 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 67.9 m -89.04 22.36 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 10.0 109.122 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -124.75 -56.23 1.59 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.779 -0.576 . . . . 10.0 109.881 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.531 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.4 p90 -53.38 -39.95 64.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.631 -1.293 . . . . 10.0 109.469 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 17.8 pt-20 -67.55 -26.5 66.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.555 -0.715 . . . . 10.0 109.55 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.661 ' OD1' HG23 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -77.13 -14.3 59.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.224 -0.922 . . . . 10.0 108.667 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.661 HG23 ' OD1' ' A' ' 92' ' ' ASN . 32.9 t -88.5 -16.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.787 0.803 . . . . 10.0 109.601 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 145' ' ' LEU . 1.1 mmtt -86.22 -33.48 20.73 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 5.4 pt-20 -77.02 -9.04 58.44 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.163 -0.615 . . . . 10.0 109.421 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -90.3 -52.4 4.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.844 -1.16 . . . . 10.0 111.976 -178.453 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -93.09 -31.83 14.68 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.563 -1.336 . . . . 10.0 112.487 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 95.0 t -54.32 -46.75 98.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.572 -1.33 . . . . 10.0 110.863 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.4 Cg_endo -73.9 -23.41 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.323 1.17 . . . . 10.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 29.1 mm-40 -63.46 -16.36 60.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 10.0 110.772 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 104' ' ' HIS . 9.6 mm 56.62 104.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.141 -0.975 . . . . 10.0 110.058 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.565 ' HB ' ' CG ' ' A' ' 106' ' ' PRO . 5.9 m -44.08 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 4.8 t-160 -112.89 -15.43 12.9 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.524 -0.735 . . . . 10.0 110.23 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.603 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER 165.91 -49.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.875 -1.528 . . . . 10.0 106.875 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.585 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 19.5 t 179.26 58.92 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 CA-C-N 115.206 -0.906 . . . . 10.0 108.924 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.632 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 52.2 Cg_endo -89.62 -62.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.002 1.527 . . . . 10.0 110.191 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 108.2 51.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 124.972 1.309 . . . . 10.0 110.905 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.487 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 31.2 m -45.88 144.29 2.88 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.892 -1.13 . . . . 10.0 109.319 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 43.7 Cg_endo -69.6 144.49 55.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.763 1.402 . . . . 10.0 110.776 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.448 ' C ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -133.66 113.02 11.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.399 -0.813 . . . . 10.0 111.641 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 152' ' ' VAL . 2.6 mm? -83.09 97.41 8.77 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -77.02 145.68 37.84 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.413 -0.804 . . . . 10.0 110.447 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.0 t -152.97 176.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.147 -0.97 . . . . 10.0 111.83 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -112.32 159.82 13.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.42 -1.872 . . . . 10.0 108.42 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.696 HG22 ' HG2' ' A' ' 116' ' ' GLN . 81.8 m -127.03 150.75 49.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.675 -1.485 . . . . 10.0 111.457 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.696 ' HG2' HG22 ' A' ' 115' ' ' THR . 4.2 pt20 33.6 57.35 0.54 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.376 0.607 . . . . 10.0 110.97 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.964 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -80.13 -25.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 10.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.862 ' HB2' HG21 ' A' ' 161' ' ' THR . 15.7 t0 -52.48 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.566 1.174 . . . . 10.0 110.708 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.741 ' N ' ' O ' ' A' ' 117' ' ' ILE . 4.6 tp 167.42 -30.24 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.035 -1.439 . . . . 10.0 107.634 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 ttp180 -46.5 -38.56 9.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -55.07 -25.53 31.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 10.0 109.503 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 119' ' ' LEU . 6.8 m-20 -92.63 150.6 40.03 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 10.0 111.526 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.525 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 56.2 Cg_endo -80.79 17.15 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.578 1.831 . . . . 10.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.9 p -96.68 -50.75 4.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.984 -1.072 . . . . 10.0 110.188 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.469 ' O ' ' CD ' ' A' ' 128' ' ' LYS . 15.3 t -71.74 -28.11 63.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.832 -2.284 . . . . 10.0 104.832 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.304 0.4 OUTLIER -49.67 -27.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 176.794 . . . . . . . . 4 4 . 1 . 015 nuclear build core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -50.12 -32.07 14.99 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.495 0.664 . . . . 10.0 109.998 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 125' ' ' THR . 0.3 OUTLIER -65.64 -32.19 73.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.334 -0.854 . . . . 10.0 110.391 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -54.71 -38.69 67.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.109 -0.994 . . . . 10.0 109.373 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -54.15 -51.28 64.78 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.551 -0.86 . . . . 10.0 109.512 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -71.74 -13.28 61.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.014 . . . . 10.0 108.398 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 17.1 m120 -126.93 46.39 2.51 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.771 -0.581 . . . . 10.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 68.08 135.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 10.0 110.322 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 130' ' ' ALA . 1.2 mp0 -80.74 3.71 21.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 10.0 110.686 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 27.2 mmtp -101.53 99.49 11.59 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 10.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.66 161.74 44.74 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.862 1.454 . . . . 10.0 112.155 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 137' ' ' ILE . 2.2 tp -84.71 143.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 10.0 109.011 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 43.6 p -134.4 171.26 9.34 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 10.0 110.312 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.1 Cg_endo -65.98 -30.55 47.99 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.556 1.293 . . . . 10.0 110.473 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -67.54 -38.13 83.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 10.0 109.01 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 m -88.79 -38.96 14.24 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.518 0.675 . . . . 10.0 109.484 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -69.05 -36.17 77.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.692 -0.63 . . . . 10.0 110.343 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 5.2 tt0 -65.31 -37.56 87.49 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.351 -0.843 . . . . 10.0 109.403 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 42.3 tttp -66.79 -36.04 81.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 10.0 108.806 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 94' ' ' LYS . 2.9 tp -62.56 -48.97 77.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -63.47 -49.35 73.95 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.564 -0.854 . . . . 10.0 109.435 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -27.1 68.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.281 0.562 . . . . 10.0 109.567 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 149' ' ' LEU . 1.9 m-20 -74.68 -47.45 31.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 10.0 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 3.2 mp -88.73 12.07 15.92 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.892 0.853 . . . . 10.0 109.445 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 19.2 mtmt 59.69 33.11 21.81 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.816 0.817 . . . . 10.0 110.216 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.493 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -61.58 -152.85 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.145 -0.622 . . . . 10.0 110.117 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -117.97 -51.52 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.035 -1.041 . . . . 10.0 111.471 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -172.52 143.62 1.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.613 -1.235 . . . . 10.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 53.8 p90 -90.32 121.64 32.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 10.0 109.623 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -127.14 -169.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 10.0 110.771 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -145.69 148.21 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 10.0 110.033 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.57 ' SG ' HG11 ' A' ' 113' ' ' VAL . 27.6 p -156.52 154.11 29.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.326 -0.859 . . . . 10.0 109.171 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.928 ' HB3' HG23 ' A' ' 161' ' ' THR . 1.3 t -149.61 88.47 1.56 Allowed 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.066 -1.054 . . . . 10.0 109.933 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.744 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -42.84 -79.86 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.519 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -31.3 -39.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.216 1.008 . . . . 10.0 109.351 -178.742 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.928 HG23 ' HB3' ' A' ' 158' ' ' SER . 0.0 OUTLIER -111.2 -97.91 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.021 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 158.75 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.833 . . . . 10.0 109.754 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 157' ' ' CYS . 21.8 tptt -105.47 43.59 1.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.851 -1.155 . . . . 10.0 110.221 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.44 40.84 87.17 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.741 -1.344 . . . . 10.0 109.741 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.939 HD12 ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -61.71 -12.27 15.77 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.237 -1.155 . . . . 10.0 110.785 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.581 ' N ' HD13 ' A' ' 165' ' ' LEU . 2.5 mttp -53.24 -29.67 33.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.889 -1.132 . . . . 10.0 109.834 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -70.86 -29.79 66.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 10.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 155' ' ' VAL . 2.3 t -66.86 -19.37 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 10.0 110.035 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 25.4 t80 -96.55 -45.3 6.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.212 -0.93 . . . . 10.0 112.094 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.22 -49.14 61.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.985 -1.072 . . . . 10.0 110.82 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.78 -39.73 76.46 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.087 -1.008 . . . . 10.0 110.137 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -54.85 -27.24 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.765 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 34.8 mm -67.14 -45.93 85.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.959 -1.088 . . . . 10.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.831 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -80.49 -27.63 37.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.945 -1.097 . . . . 10.0 109.954 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -85.43 -1.66 57.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.763 . . . . 10.0 109.418 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -83.11 -42.43 17.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.329 -0.857 . . . . 10.0 110.497 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -87.73 -19.12 28.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.494 -0.754 . . . . 10.0 109.826 -178.555 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 175' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 120.858 -1.151 . . . . 10.0 109.998 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.661 -1.376 . . . . 10.0 109.661 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.3 m -119.55 157.59 28.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -1.159 . . . . 10.0 110.748 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.08 100.66 13.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.376 -0.828 . . . . 10.0 110.022 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 49' ' ' GLU . 53.4 mm-40 -81.28 157.99 24.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.876 . . . . 10.0 110.669 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.708 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -118.09 -52.32 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.481 -0.762 . . . . 10.0 110.129 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.7 Cg_endo -89.59 21.37 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.26 1.137 . . . . 10.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 46' ' ' ILE . 4.0 pt-20 -55.39 168.44 0.37 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.956 . . . . 10.0 110.353 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.837 HG23 ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -80.27 -148.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 10.0 108.649 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.837 ' N ' HG23 ' B' ' 8' ' ' ILE . 66.6 m -121.55 98.6 6.04 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.262 -0.899 . . . . 10.0 108.864 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.793 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -132.8 98.06 16.51 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.334 -0.854 . . . . 10.0 111.093 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.513 ' HA ' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_endo -90.31 111.39 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.704 1.371 . . . . 10.0 110.25 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 43' ' ' THR . 14.0 m -142.27 102.81 4.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 10.0 111.151 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.557 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 7.5 p-10 -170.84 132.09 0.87 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.486 -0.759 . . . . 10.0 110.488 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.49 100.02 2.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 10.0 112.389 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 42' ' ' VAL . 27.2 tt0 -173.01 123.65 0.42 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.592 -0.693 . . . . 10.0 109.217 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.615 ' C ' ' HB2' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -163.72 151.13 12.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.538 -1.352 . . . . 10.0 111.639 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.573 ' N ' ' HB2' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -136.48 104.3 5.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.083 -1.011 . . . . 10.0 110.584 179.163 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 1.121 HG22 ' CD1' ' A' ' 37' ' ' PHE . 31.7 mm -50.84 106.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.998 -1.064 . . . . 10.0 112.769 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.706 ' C ' ' HA ' ' A' ' 37' ' ' PHE . 55.4 m170 -102.75 116.45 32.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.019 . . . . 10.0 111.096 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.743 ' HA ' ' N ' ' A' ' 37' ' ' PHE . 3.1 p -87.55 149.09 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.219 -0.926 . . . . 10.0 113.461 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' A' ' 59' ' ' ALA . . . -143.47 -65.65 0.02 OUTLIER Glycine 0 CA--C 1.538 1.491 0 C-N-CA 119.791 -1.195 . . . . 10.0 112.137 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.798 ' HB3' HG21 ' B' ' 25' ' ' VAL . 5.6 t80 -177.32 126.94 0.15 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 120.674 -1.486 . . . . 10.0 109.227 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' B' ' 22' ' ' PHE . 9.4 m-20 -38.47 148.27 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.853 0.835 . . . . 10.0 111.471 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' OE2' ' B' ' 28' ' ' GLU . . . 52.87 31.35 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.37 0.507 . . . . 10.0 112.37 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.798 HG21 ' HB3' ' B' ' 22' ' ' PHE . 9.8 t -109.63 -31.56 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 5.4 t -94.21 -0.61 55.04 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.593 0.711 . . . . 10.0 109.145 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.724 ' HA2' ' HB ' ' A' ' 21' ' ' ILE . . . -114.28 2.9 23.78 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.738 -1.22 . . . . 10.0 110.159 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.64 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 1.7 pm0 -178.12 -158.69 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.982 -1.305 . . . . 10.0 110.602 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.59 ' HB2' HG11 ' A' ' 14' ' ' VAL . 1.2 t80 -131.39 135.29 47.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.72 0.772 . . . . 10.0 109.508 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.664 HG22 ' CD2' ' A' ' 28' ' ' PHE . 15.0 p -151.01 -64.32 0.19 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.461 -0.774 . . . . 10.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.528 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -70.86 171.13 45.62 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.116 -1.193 . . . . 10.0 110.116 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 15.8 mm -125.72 47.79 2.45 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.904 . . . . 10.0 110.198 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 45.7 Cg_endo -71.01 171.97 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.977 1.514 . . . . 10.0 110.385 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' B' ' 35' ' ' GLN . 1.8 tp10 -50.57 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 10.0 109.73 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -81.62 19.11 1.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.195 -0.94 . . . . 10.0 109.45 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.65 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 37.1 m0 71.1 39.38 0.98 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -172.34 74.06 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 113.386 -1.734 . . . . 10.0 106.887 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 6.7 mtm180 . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 107.238 -1.393 . . . . 10.0 107.238 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.178 0.513 . . . . 10.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.631 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -164.72 25.36 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.163 -0.961 . . . . 10.0 109.453 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.571 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 30.2 m -89.47 127.01 35.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.581 -0.699 . . . . 10.0 110.303 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.39 136.2 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.281 -0.968 . . . . 10.0 110.266 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.6 mtpt -124.53 98.95 5.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 10.0 109.595 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.37 99.83 9.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.895 -1.128 . . . . 10.0 110.764 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 75' ' ' THR . 61.7 t -134.29 144.48 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 10.0 109.442 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.779 HG11 ' HB3' ' B' ' 35' ' ' GLN . 94.4 t -59.67 166.04 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 10.0 110.925 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.937 ' C ' ' HB3' ' B' ' 37' ' ' ALA . 3.4 t -112.39 -174.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.426 -0.797 . . . . 10.0 109.348 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.711 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -63.39 -144.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.014 -1.089 . . . . 10.0 110.417 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' ASP . . . . . 0.632 ' OD2' HG23 ' A' ' 80' ' ' VAL . 5.9 m-20 62.24 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.416 -1.049 . . . . 10.0 109.951 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 112.14 54.16 0.49 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.029 -1.228 . . . . 10.0 110.029 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -175.94 68.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -1.22 . . . . 10.0 110.559 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 14' ' ' VAL . 10.9 p -179.1 58.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 10.0 109.715 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -103.95 88.28 0.61 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.832 -1.307 . . . . 10.0 109.832 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.647 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.13 -31.56 63.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.795 -1.415 . . . . 10.0 110.7 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HB ' ' OD2' ' A' ' 57' ' ' ASP . 11.3 m -62.47 -41.32 98.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 10.0 111.481 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 26' ' ' THR . 17.8 m -95.07 -15.47 23.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.748 -1.22 . . . . 10.0 110.449 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.903 HD11 ' CB ' ' B' ' 29' ' ' PHE . 4.6 mm? -93.02 -34.79 13.57 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.145 -0.972 . . . . 10.0 109.808 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.58 -37.18 77.82 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.647 -1.983 . . . . 10.0 105.647 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 26' ' ' THR 0.266 0.4 OUTLIER -63.41 -50.19 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.328 -1.36 . . . . 10.0 107.328 176.34 . . . . . . . . 4 4 . 1 . 016 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.713 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 23.8 m -49.05 -49.72 39.99 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.869 ' CD2' HD11 ' A' ' 165' ' ' LEU . 33.9 m-85 -72.96 -29.34 63.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.959 -1.088 . . . . 10.0 110.442 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -65.32 -50.37 65.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 10.0 109.396 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 26' ' ' ASN . 10.2 t -169.6 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.253 -0.979 . . . . 10.0 111.095 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HB3' ' CG2' ' A' ' 21' ' ' ILE . 0.2 OUTLIER -61.15 -20.46 62.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 10.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.713 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 26.13 -134.02 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.873 -0.517 . . . . 10.0 111.994 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' B' ' 30' ' ' THR . 6.1 t80 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.02 -1.05 . . . . 10.0 112.924 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.436 ' C ' ' HB ' ' B' ' 26' ' ' THR . 46.7 p . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 122.38 1.086 . . . . 10.0 113.47 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.998 HG12 ' HB2' ' A' ' 59' ' ' ALA 0.256 6.9 t -70.6 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-N 115.296 -0.865 . . . . 10.0 110.311 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.733 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -33.45 129.42 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.572 0.701 . . . . 10.0 110.957 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 10.0 t70 -138.96 83.45 1.95 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' B' ' 18' ' ' ILE . 7.4 t-20 -88.42 98.45 11.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -0.932 . . . . 10.0 110.511 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.679 ' HA ' ' H ' ' B' ' 16' ' ' HIS . 19.6 m-85 -127.69 116.03 19.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.222 -0.923 . . . . 10.0 109.453 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.948 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -133.69 100.34 4.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.05 -1.031 . . . . 10.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 41' ' ' ALA . 3.1 t -167.33 -166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 51' ' ' TYR . 52.0 m -137.15 161.65 35.56 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 119.452 -2.03 . . . . 10.0 113.636 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.812 HG22 ' HB2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -105.25 -176.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.765 -0.585 . . . . 10.0 110.59 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.607 ' O ' ' O ' ' B' ' 10' ' ' LEU . 27.5 mtp -139.74 96.56 3.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.937 -1.105 . . . . 10.0 108.836 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 11.6 mt -102.43 131.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.783 -0.573 . . . . 10.0 111.146 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 8' ' ' ILE . . . 38.2 27.81 0.04 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.346 -1.102 . . . . 10.0 110.346 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 98.97 -16.85 58.96 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.958 -1.319 . . . . 10.0 110.652 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -101.74 108.59 56.61 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.283 . . . . 10.0 110.153 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 42.8 Cg_endo -73.63 156.58 49.17 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.063 1.559 . . . . 10.0 111.668 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.812 ' HB2' HG22 ' A' ' 44' ' ' VAL . 1.9 m-85 -105.95 113.96 27.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.034 . . . . 10.0 112.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.869 ' O ' HG22 ' A' ' 4' ' ' ILE 0.271 98.2 m -75.82 110.07 9.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 10.0 109.459 178.385 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.7 pp -149.32 173.25 13.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 10.0 112.857 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.54 118.02 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.688 -2.165 . . . . 10.0 107.688 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.6 pp -129.25 149.55 51.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.728 -1.454 . . . . 10.0 111.332 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.514 ' CD2' ' C ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -172.16 129.38 0.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 10.0 110.088 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD2' ' HB ' ' A' ' 17' ' ' THR . 1.3 m-20 -102.62 158.3 16.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.059 -1.026 . . . . 10.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 13.9 t -43.55 147.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.011 . . . . 10.0 109.68 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . 177.57 -72.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.783 . . . . 10.0 112.144 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 45.38 52.62 8.59 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.154 -1.979 . . . . 10.0 108.154 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 20' ' ' VAL . 16.4 mm-40 60.77 40.56 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.679 -0.895 . . . . 10.0 109.869 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.643 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.3 OUTLIER 174.24 -70.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 10.0 111.092 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 169.14 44.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.897 -1.127 . . . . 10.0 110.314 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -148.94 -49.93 0.15 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.84 . . . . 10.0 109.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 69.45 80.86 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.681 0.753 . . . . 10.0 109.825 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 26.6 ttp180 -52.32 -26.81 13.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.642 -0.661 . . . . 10.0 110.371 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -86.03 -0.62 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 10.0 110.276 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.744 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -110.85 13.24 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 -178.455 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -60.99 126.64 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 N-CA-C 108.613 -1.341 . . . . 10.0 108.613 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.2 OUTLIER -113.62 -77.38 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 10.0 111.874 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.511 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 19.5 m 61.31 34.39 18.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.148 -0.97 . . . . 10.0 108.482 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.09 131.44 6.44 Favored Pre-proline 0 N--CA 1.487 1.399 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.673 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.31 79.85 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.719 1.378 . . . . 10.0 110.03 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -131.06 60.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 10.0 110.242 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 ' HB ' ' A' ' 7' ' ' VAL . 9.9 m -144.47 96.91 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.143 -0.973 . . . . 10.0 109.435 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 108' ' ' THR . 84.8 m-20 -38.52 -27.86 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.947 -0.47 . . . . 10.0 111.198 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.797 HG11 ' HB2' ' A' ' 176' ' ' ALA . 17.7 m -130.38 116.73 37.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.717 -1.239 . . . . 10.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-85 -109.2 130.87 55.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.477 -0.764 . . . . 10.0 108.997 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.906 HD12 ' CE1' ' A' ' 169' ' ' PHE . 2.5 mm? -103.21 96.94 7.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.091 . . . . 10.0 109.08 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.632 HG23 ' OD2' ' A' ' 11' ' ' ASP . 14.8 p -108.8 143.7 18.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.662 -0.649 . . . . 10.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.458 ' C ' ' OG1' ' A' ' 115' ' ' THR . 53.7 t -133.75 129.71 37.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.259 -0.976 . . . . 10.0 110.569 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 24.2 p90 -137.15 178.0 7.43 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.387 -0.82 . . . . 10.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.7 p -76.68 162.54 27.64 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.126 -0.984 . . . . 10.0 111.556 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.963 HG23 HG13 ' A' ' 85' ' ' VAL . 28.4 m -112.96 -1.5 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 121.325 -0.86 . . . . 10.0 111.69 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.963 HG13 HG23 ' A' ' 84' ' ' VAL . 14.5 m -128.88 38.05 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.849 -1.157 . . . . 10.0 111.468 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.556 ' N ' HD23 ' A' ' 129' ' ' LEU . 59.8 m -95.97 149.23 35.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.057 -1.027 . . . . 10.0 108.964 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 41.0 Cg_endo -67.49 113.04 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.632 1.333 . . . . 10.0 110.382 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.5 m 54.5 64.13 1.92 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 10.0 109.987 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 86' ' ' SER . 22.1 p -116.55 -60.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 10.0 110.949 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 9.4 t80 -59.96 -38.87 83.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.011 -1.055 . . . . 10.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.48 -17.63 64.9 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.844 -1.16 . . . . 10.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.589 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -77.62 -21.62 52.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 10.0 110.353 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG13 ' ND2' ' A' ' 92' ' ' ASN . 2.2 m -89.72 -5.09 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.591 -1.243 . . . . 10.0 109.414 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 90' ' ' PHE . 12.9 mmtt -94.49 -32.72 13.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.137 -0.977 . . . . 10.0 108.391 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 3.6 pt-20 -77.64 -10.85 59.74 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.021 -0.672 . . . . 10.0 109.221 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -112.35 -50.53 2.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 10.0 111.852 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.492 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 60.6 m95 -69.39 -47.11 65.21 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.564 -0.71 . . . . 10.0 112.256 -178.008 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 98.9 t -55.93 -49.28 93.92 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.49 -1.381 . . . . 10.0 110.331 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.4 Cg_endo -72.86 -12.92 26.55 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.257 1.135 . . . . 10.0 110.643 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -68.69 -36.68 78.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 10.0 110.601 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 104' ' ' HIS . 78.6 mt 55.11 85.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.206 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.9 m -39.37 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.681 0.753 . . . . 10.0 110.114 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.691 ' N ' HG22 ' A' ' 102' ' ' THR . 6.0 m170 -109.87 -2.98 16.91 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.5 -0.75 . . . . 10.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.706 ' HA ' HG23 ' A' ' 101' ' ' ILE . 66.2 t60 80.37 16.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.622 0.725 . . . . 10.0 109.494 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.603 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.8 OUTLIER -150.76 -65.81 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.808 -0.757 . . . . 10.0 111.44 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 41.6 Cg_endo -68.81 -31.3 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.51 1.268 . . . . 10.0 111.892 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 42.31 63.12 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.367 1.079 . . . . 10.0 108.485 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 76' ' ' ASP . 8.7 t -44.91 141.46 3.03 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.674 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 43.1 Cg_endo -69.99 163.39 38.65 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.286 1.677 . . . . 10.0 112.068 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.5 m-85 -127.13 114.69 18.04 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.698 -0.626 . . . . 10.0 109.701 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.027 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -73.95 92.59 2.12 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 15.8 mt -69.33 139.33 54.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.732 -0.605 . . . . 10.0 109.372 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -144.98 -179.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.965 -1.085 . . . . 10.0 111.41 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -118.49 125.14 6.3 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.681 HG22 ' HG2' ' A' ' 116' ' ' GLN . 52.9 m -92.42 140.83 29.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.971 -1.311 . . . . 10.0 111.36 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 115' ' ' THR . 6.9 mm100 40.14 57.44 2.4 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.196 -0.602 . . . . 10.0 109.754 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.008 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -76.87 -29.21 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.29 -0.964 . . . . 10.0 110.103 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.839 ' O ' HD23 ' A' ' 119' ' ' LEU . 44.2 t0 -51.73 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.459 0.647 . . . . 10.0 111.85 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER 147.33 -30.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 CA-C-N 114.858 -1.064 . . . . 10.0 108.572 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.694 ' HG3' HG22 ' A' ' 85' ' ' VAL . 15.2 tpp180 -55.51 -31.35 61.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.778 -0.577 . . . . 10.0 110.315 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -86.88 4.93 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 10.0 111.044 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.825 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -82.29 165.74 40.86 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 10.0 110.403 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 54.9 Cg_endo -79.2 23.38 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.074 1.565 . . . . 10.0 111.086 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 t -108.45 -50.14 3.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.92 -1.112 . . . . 10.0 110.278 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.66 HG21 ' HA ' ' A' ' 120' ' ' ARG . 14.5 t -79.06 -28.09 43.14 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.779 -1.934 . . . . 10.0 105.779 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 122' ' ' ASP 0.289 1.4 mp -59.82 -22.59 24.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 20.1 tt0 -48.89 -33.66 11.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.49 0.662 . . . . 10.0 109.864 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.36 -49.05 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.661 -0.649 . . . . 10.0 110.775 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.836 HD23 ' C ' ' A' ' 85' ' ' VAL . 1.3 tm? -49.87 -50.48 45.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 10.0 110.963 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -55.82 -49.94 71.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.201 -0.937 . . . . 10.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 17.9 mttt -60.01 -22.49 62.67 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.612 -0.68 . . . . 10.0 110.027 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.492 ' CB ' ' HB3' ' A' ' 87' ' ' PRO . 23.0 t-20 -99.68 -62.46 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.934 -1.104 . . . . 10.0 111.337 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -109.69 -0.36 18.59 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.365 -0.835 . . . . 10.0 111.494 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER 64.13 -44.52 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.707 . . . . 10.0 112.334 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.531 ' HD2' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -113.99 128.71 25.49 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 120.94 -1.1 . . . . 10.0 111.087 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.1 161.65 44.07 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.877 1.462 . . . . 10.0 110.527 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 84' ' ' VAL . 4.1 tp -95.36 133.19 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.921 -1.112 . . . . 10.0 109.506 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.6 p -123.8 179.17 1.12 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 10.0 109.399 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 44.2 Cg_endo -73.52 -26.64 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.228 1.12 . . . . 10.0 110.421 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -66.87 -47.9 70.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 10.0 110.413 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.1 m -74.65 -39.75 61.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.504 -0.747 . . . . 10.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.51 -35.67 77.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 10.0 110.663 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -51.41 -39.74 57.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.351 -0.843 . . . . 10.0 109.955 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -49.21 78.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.333 -0.854 . . . . 10.0 110.422 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.532 ' CD2' HD22 ' A' ' 149' ' ' LEU . 7.7 tt -58.61 -33.17 69.71 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.013 -1.055 . . . . 10.0 109.644 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.836 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -71.32 -48.18 52.03 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.889 0.852 . . . . 10.0 109.471 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -63.46 -26.92 68.95 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.303 -0.559 . . . . 10.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB3' HD13 ' A' ' 149' ' ' LEU . 20.4 t0 -79.61 -40.25 29.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 10.0 110.659 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.3 mp -91.47 20.83 4.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 10.0 109.125 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' HD2' ' A' ' 107' ' ' LYS . 4.8 mtpt 57.03 20.6 5.57 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.935 0.874 . . . . 10.0 109.41 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -69.36 -174.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.027 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.2 p -91.59 -72.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.826 -1.172 . . . . 10.0 111.578 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.915 ' H ' HG13 ' A' ' 152' ' ' VAL . 5.4 tttt -173.86 173.46 3.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.217 -1.552 . . . . 10.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.934 ' OH ' HG12 ' A' ' 84' ' ' VAL . 18.6 t80 -112.26 104.44 12.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 10.0 109.448 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.835 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -109.17 -168.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 10.0 110.405 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 155' ' ' VAL . 67.3 mt-10 -152.51 135.57 15.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.784 -1.198 . . . . 10.0 111.164 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.505 ' SG ' HG11 ' A' ' 113' ' ' VAL . 28.1 p -152.4 172.74 16.03 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.722 0.773 . . . . 10.0 109.563 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.584 ' HB3' ' CB ' ' A' ' 162' ' ' GLN . 34.0 t -140.9 175.17 9.83 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -73.22 -54.62 7.98 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.409 -0.807 . . . . 10.0 111.97 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 1.131 HD13 ' N ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -129.23 -22.54 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.736 -1.227 . . . . 10.0 113.39 -178.017 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 161' ' ' THR . . . . . 1.131 ' N ' HD13 ' A' ' 160' ' ' LEU . 10.0 t -90.47 -51.87 5.19 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.312 -1.492 . . . . 10.0 113.637 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.602 ' N ' HG23 ' A' ' 161' ' ' THR . 6.7 tp60 -59.76 -63.21 1.38 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.308 -1.495 . . . . 10.0 111.696 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 28.4 ttpt 79.47 34.67 0.18 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.513 0.673 . . . . 10.0 109.383 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -118.19 20.64 10.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.886 -1.686 . . . . 10.0 108.886 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.869 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -78.04 4.96 10.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -1.091 . . . . 10.0 110.652 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -93.78 -44.15 8.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.037 -1.039 . . . . 10.0 110.085 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.44 -31.44 72.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 10.0 110.142 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.835 HG22 ' HB ' ' A' ' 155' ' ' VAL . 14.5 t -65.09 -49.23 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.27 -0.894 . . . . 10.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE1' HD12 ' A' ' 79' ' ' LEU . 9.0 m-85 -76.82 -23.65 52.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.389 -0.82 . . . . 10.0 111.302 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.37 -50.3 60.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.896 -1.127 . . . . 10.0 111.766 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 153' ' ' LYS . 20.0 pt-20 -61.23 -24.59 66.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 10.0 109.825 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.654 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -67.53 -26.54 66.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.244 -0.982 . . . . 10.0 109.045 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.538 ' O ' HD11 ' A' ' 177' ' ' LEU . 34.2 mm -60.18 -45.54 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 10.0 110.179 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.855 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -74.36 -38.14 63.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 10.0 109.642 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -78.56 -6.59 55.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.489 -0.757 . . . . 10.0 109.712 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.797 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.76 -38.15 47.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 10.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.631 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -76.51 -34.79 58.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 10.0 110.286 -178.676 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.893 -1.051 . . . . 10.0 110.159 179.884 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 108.977 -1.649 . . . . 10.0 108.977 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.506 ' O ' ' N ' ' B' ' 4' ' ' GLU . 13.8 m -111.3 44.9 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -1.112 . . . . 10.0 111.211 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 10.0 109.305 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' B' ' 6' ' ' PRO . 2.2 mm-40 -92.16 144.48 25.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.856 -1.152 . . . . 10.0 110.116 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.32 -41.74 14.36 Favored Pre-proline 0 C--N 1.292 -1.909 0 O-C-N 121.724 -0.61 . . . . 10.0 110.645 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 43.3 Cg_endo -89.39 57.78 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.746 1.393 . . . . 10.0 112.418 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.451 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -97.78 160.72 14.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.69 -1.256 . . . . 10.0 108.327 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.53 ' CG1' ' HA2' ' A' ' 47' ' ' GLY . 5.8 pt -80.39 -117.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.879 -1.138 . . . . 10.0 109.376 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -147.58 104.05 3.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.69 -1.256 . . . . 10.0 109.628 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 45' ' ' MET . 14.2 tp -143.65 97.13 5.52 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 118.957 -1.097 . . . . 10.0 112.092 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -101.37 98.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.166 1.911 . . . . 10.0 108.685 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.4 m -148.5 99.59 3.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.248 -1.532 . . . . 10.0 112.895 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.768 ' HB3' ' CA ' ' A' ' 44' ' ' VAL . 5.0 p-10 -143.17 153.44 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.984 0.897 . . . . 10.0 112.153 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.742 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 53.6 m-85 -110.37 -172.25 2.0 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.694 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -174.88 -170.5 0.47 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 10.0 110.562 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.679 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -104.52 168.98 8.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.784 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 6.7 t -151.5 146.22 25.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.583 -1.323 . . . . 10.0 111.805 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 37' ' ' PHE . 1.6 pp -149.18 179.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.358 -0.979 . . . . 10.0 108.358 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -134.5 159.27 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 10.0 112.496 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 36' ' ' VAL . 54.2 t -104.74 153.34 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.564 0.697 . . . . 10.0 112.394 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.5 63.95 0.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.661 -1.776 . . . . 10.0 108.661 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.83 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -170.57 100.74 0.25 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.452 -1.028 . . . . 10.0 109.371 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 25' ' ' VAL . 11.9 t70 -53.09 150.07 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.822 0.82 . . . . 10.0 111.968 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 39.21 51.31 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.865 -0.522 . . . . 10.0 112.254 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.904 HG12 ' CG2' ' A' ' 36' ' ' VAL . 38.9 t -111.77 -25.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.784 -1.198 . . . . 10.0 108.487 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.628 HG23 HG21 ' A' ' 21' ' ' ILE . 11.3 t -70.64 -20.66 62.71 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.29 53.45 0.74 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 106.902 -2.479 . . . . 10.0 106.902 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.25 58.02 1.69 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.681 -0.893 . . . . 10.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 19' ' ' LEU . 20.4 t80 -85.78 133.17 34.0 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-O 122.059 0.933 . . . . 10.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 19.2 p -146.9 -178.83 6.4 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.08 81.13 0.04 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.59 -1.804 . . . . 10.0 108.59 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.7 HG23 ' HD2' ' B' ' 33' ' ' PRO . 90.2 mt -111.67 145.5 32.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.366 -1.079 . . . . 10.0 111.474 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.0 Cg_endo -69.91 178.59 4.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.933 1.755 . . . . 10.0 110.462 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' B' ' 38' ' ' ARG . 34.3 tt0 -8.0 131.07 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.518 0.932 . . . . 10.0 113.518 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.779 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -83.4 -70.52 0.56 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.641 0.734 . . . . 10.0 109.862 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.615 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -172.99 24.64 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.912 -0.715 . . . . 10.0 111.58 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.937 ' HB3' ' C ' ' A' ' 9' ' ' VAL . . . -127.36 -28.62 2.79 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.495 -0.753 . . . . 10.0 109.552 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.532 ' HB3' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.11 0.481 . . . . 10.0 109.91 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.904 ' O ' HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER 68.7 79.17 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.891 0.853 . . . . 10.0 109.278 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 3' ' ' THR . 1.2 m -175.95 78.56 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.984 HD13 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -115.24 121.51 67.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.764 -1.21 . . . . 10.0 110.615 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 1.082 ' O ' HG23 ' A' ' 75' ' ' THR . 62.0 mttt -128.93 112.66 14.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 55' ' ' LEU . 26.4 p -94.67 141.29 28.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.058 -1.057 . . . . 10.0 110.444 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 9' ' ' VAL . 57.9 t -144.72 152.26 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.565 -0.709 . . . . 10.0 109.224 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.846 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 35.0 m -65.84 102.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.204 -0.935 . . . . 10.0 111.309 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 78' ' ' PHE . 21.3 t -109.53 177.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.213 -0.93 . . . . 10.0 109.143 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.777 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 151.74 166.99 14.51 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.502 -1.332 . . . . 10.0 110.062 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -47.79 -27.63 2.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.304 -1.116 . . . . 10.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 140.83 43.72 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.699 -1.36 . . . . 10.0 109.699 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.8 -114.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.343 -1.092 . . . . 10.0 109.687 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.825 HG21 ' H ' ' B' ' 30' ' ' THR . 80.0 t -113.89 -92.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.736 -1.227 . . . . 10.0 110.657 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.529 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 170.14 144.65 4.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.927 -1.269 . . . . 10.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.14 -23.17 61.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.977 . . . . 10.0 111.77 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.698 HG21 ' OD2' ' A' ' 57' ' ' ASP . 16.6 m -62.66 -50.27 71.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.938 -1.101 . . . . 10.0 112.03 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.58 ' HB3' ' CB ' ' A' ' 35' ' ' THR . 31.3 p -78.59 8.77 4.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.46 -1.4 . . . . 10.0 110.3 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -88.0 -28.01 21.69 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.553 -1.342 . . . . 10.0 107.622 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -69.65 -34.19 73.65 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.82 HG13 HG23 ' B' ' 26' ' ' THR . 6.7 mm -75.25 -48.18 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' LYS . 26.9 t -54.29 -43.08 70.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.622 ' CG ' ' HB2' ' A' ' 162' ' ' GLN . 74.8 t80 -77.78 -0.94 29.0 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.743 -1.223 . . . . 10.0 109.442 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 22.2 m -112.09 -49.1 2.99 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.85 -84.66 0.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.011 -1.681 . . . . 10.0 114.032 -176.611 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.676 ' H ' HG23 ' A' ' 25' ' ' THR . 2.8 m-20 -67.32 -33.49 75.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 10.0 112.033 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER 59.96 -144.71 0.52 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.048 -1.061 . . . . 10.0 110.082 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.4 t80 . . . . . 0 N--CA 1.491 1.579 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.058 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.655 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 3.7 t . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 120.853 0.359 . . . . 10.0 110.29 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 t -148.45 -114.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.836 -1.165 . . . . 10.0 110.554 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.751 ' C ' HG12 ' B' ' 20' ' ' VAL . 4.4 t80 -102.26 105.87 16.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.831 -1.168 . . . . 10.0 111.928 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -128.0 93.08 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.311 -0.868 . . . . 10.0 109.433 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 36.0 t-20 -91.27 98.75 11.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.405 -1.318 . . . . 10.0 110.399 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CB ' HD12 ' A' ' 55' ' ' LEU . 16.5 t80 -107.36 126.92 53.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -153.88 112.88 3.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.807 -1.183 . . . . 10.0 110.454 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 43' ' ' THR . 22.2 t -131.12 172.39 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.779 -0.768 . . . . 10.0 109.724 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.541 ' N ' HG12 ' A' ' 42' ' ' VAL . 63.8 m -135.66 148.97 49.15 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.31 -0.956 . . . . 10.0 110.388 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.635 HG13 HD12 ' A' ' 46' ' ' ILE . 1.1 t -118.88 174.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 3.8 mtt -149.96 120.67 7.54 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.546 -0.862 . . . . 10.0 109.956 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HG13 ' A' ' 44' ' ' VAL . 1.4 mp -134.64 126.75 48.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.305 -0.998 . . . . 10.0 108.305 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 48.08 31.09 8.0 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.271 -1.532 . . . . 10.0 109.271 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.19 31.52 31.18 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.099 -1.236 . . . . 10.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.55 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -119.68 115.77 33.54 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.846 -1.384 . . . . 10.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 52.7 Cg_endo -76.91 141.54 21.44 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.859 1.452 . . . . 10.0 111.193 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.93 ' OH ' HG23 ' A' ' 173' ' ' ILE . 0.5 OUTLIER -103.45 112.56 25.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 10.0 110.305 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 2' ' ' GLN . 27.5 p -78.05 100.28 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 10.0 110.186 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 22.3 mt -117.58 140.32 49.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.666 -1.271 . . . . 10.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.54 130.23 2.28 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.219 -1.552 . . . . 10.0 109.219 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -137.99 132.29 32.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 10.0 108.863 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.974 ' N ' HD22 ' A' ' 55' ' ' LEU . 50.8 p90 -157.26 148.98 22.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 10.0 112.4 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.698 ' OD2' HG21 ' A' ' 17' ' ' THR . 23.7 m-20 -124.05 -169.37 1.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.835 -0.54 . . . . 10.0 110.455 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -45.85 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.25 1.024 . . . . 10.0 112.532 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -157.24 42.17 0.33 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.723 -1.236 . . . . 10.0 109.851 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -47.63 -27.45 4.48 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.422 -2.271 . . . . 10.0 107.422 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.61 ' CG ' ' HA3' ' B' ' 21' ' ' GLY . 2.4 tp60 -73.34 -55.85 5.85 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.855 -0.791 . . . . 10.0 109.259 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.846 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 5.3 mm-40 -59.88 -40.71 89.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.086 -1.046 . . . . 10.0 110.131 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 7.5 t70 75.61 38.85 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.008 0.908 . . . . 10.0 108.588 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -151.96 5.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.943 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.691 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 19.1 t70 -115.17 25.56 10.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.692 -1.255 . . . . 10.0 111.131 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.944 ' O ' HD11 ' A' ' 70' ' ' LEU . 60.3 mtm180 -83.94 -25.44 30.11 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.096 -1.002 . . . . 10.0 109.364 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.986 ' C ' HD21 ' A' ' 70' ' ' LEU . 20.8 mt -111.41 10.34 21.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.558 -0.714 . . . . 10.0 110.35 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.583 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -102.17 -41.91 0.21 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 114.038 1.125 . . . . 10.0 114.038 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 41.4 Cg_endo -69.4 -42.71 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.842 0.917 . . . . 10.0 111.727 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.986 HD21 ' C ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -48.85 -19.84 0.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.21 -0.931 . . . . 10.0 109.695 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 14.2 m -126.83 51.33 1.87 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.538 -0.726 . . . . 10.0 110.059 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -109.68 75.66 0.83 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.215 -0.928 . . . . 10.0 111.987 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 52.2 Cg_endo -77.31 -0.88 11.04 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.957 1.503 . . . . 10.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -81.56 49.69 1.36 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.954 -1.091 . . . . 10.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 75' ' ' THR . . . . . 1.082 HG23 ' O ' ' A' ' 5' ' ' LYS . 82.3 m -142.0 84.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.443 -0.785 . . . . 10.0 110.296 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 5.2 m-20 -55.09 -22.63 17.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 10.0 109.979 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 4' ' ' ILE . 2.5 m -118.65 116.75 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 9' ' ' VAL . 87.4 m-85 -107.03 144.47 33.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 10.0 110.137 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.714 HD11 HG12 ' A' ' 168' ' ' VAL . 1.9 mm? -103.46 97.81 7.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.994 . . . . 10.0 108.866 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG23 ' HA2' ' A' ' 10' ' ' GLY . 4.7 p -98.78 130.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.581 -0.699 . . . . 10.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 28.2 p -133.61 115.09 14.25 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.126 -0.984 . . . . 10.0 110.731 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 80' ' ' VAL . 94.6 m-85 -97.21 157.77 15.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.584 -0.697 . . . . 10.0 110.967 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' THR . 57.1 m -85.13 157.06 20.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.427 -0.796 . . . . 10.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 84' ' ' VAL . 30.4 m -60.71 -10.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.403 -0.81 . . . . 10.0 110.769 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 HD22 ' A' ' 129' ' ' LEU . 8.6 m -134.54 -53.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 10.0 110.116 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 44.9 -172.82 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.029 -1.044 . . . . 10.0 111.987 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 53.7 Cg_endo -82.6 41.17 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.194 1.628 . . . . 10.0 111.468 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 133' ' ' LYS . 3.5 m 39.78 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 10.0 110.795 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.4 t -175.63 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.839 -1.163 . . . . 10.0 111.649 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.745 ' CE2' HD13 ' A' ' 145' ' ' LEU . 27.2 t80 -90.66 -23.94 20.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.794 -1.191 . . . . 10.0 109.466 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -22.75 28.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.179 -0.951 . . . . 10.0 108.855 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.423 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -83.37 -13.98 53.78 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.258 -0.977 . . . . 10.0 110.151 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' HD3' ' A' ' 94' ' ' LYS . 1.6 m -87.72 -16.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 118.162 -1.415 . . . . 10.0 109.28 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.922 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -81.66 -41.54 21.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 10.0 109.271 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -76.85 -4.62 44.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.993 -0.683 . . . . 10.0 109.172 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -111.72 -47.51 3.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.05 -1.031 . . . . 10.0 111.688 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 8.0 m0 -77.24 -49.09 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 10.0 112.318 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 149' ' ' LEU . 4.6 t -65.67 -46.59 67.46 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.687 -1.258 . . . . 10.0 112.814 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 39.1 Cg_endo -69.09 -12.79 35.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 N-CA-C 109.338 -1.062 . . . . 10.0 109.338 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.629 ' C ' HG22 ' A' ' 101' ' ' ILE . 1.9 mt-10 -89.36 -58.95 2.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 10.0 109.569 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 ' C ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER 161.18 80.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 10.0 108.798 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.857 HG21 ' HB ' ' A' ' 108' ' ' THR . 2.5 m -48.1 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 10.0 109.744 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.708 ' N ' HG22 ' A' ' 102' ' ' THR . 46.0 t-80 -105.38 -22.45 13.03 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' CE1' ' HG ' ' A' ' 105' ' ' CYS . 5.5 p80 178.31 -33.49 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.49 ' HG ' ' CE1' ' A' ' 104' ' ' HIS . 4.8 p -144.66 160.04 48.9 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HB3' HG12 ' A' ' 98' ' ' VAL . 43.8 Cg_endo -72.4 84.56 1.16 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.645 1.339 . . . . 10.0 109.743 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 176.02 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.405 -0.809 . . . . 10.0 111.363 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.857 ' HB ' HG21 ' A' ' 102' ' ' THR . 99.8 m -51.66 150.98 6.35 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 10.0 110.31 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 108' ' ' THR . 37.6 Cg_endo -63.59 110.21 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.865 1.455 . . . . 10.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.13 100.24 8.94 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.27 0.557 . . . . 10.0 109.631 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.927 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 1.6 mm? -78.37 97.92 5.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 146' ' ' ALA . 64.5 mt -78.23 154.48 31.0 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.793 -0.567 . . . . 10.0 109.836 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 114' ' ' GLY . 6.3 t -156.53 175.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.96 -1.087 . . . . 10.0 111.31 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -124.3 96.79 0.53 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 116' ' ' GLN . 1.3 m -95.16 170.97 9.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -1.086 . . . . 10.0 110.947 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.535 ' N ' ' CG2' ' A' ' 115' ' ' THR . 36.6 tp60 57.94 38.12 26.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.48 -0.762 . . . . 10.0 110.831 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.042 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -95.35 -36.67 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 178.239 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.7 p-10 -52.13 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.554 1.169 . . . . 10.0 110.352 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.752 ' N ' ' O ' ' A' ' 117' ' ' ILE . 13.0 tp 159.25 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.187 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -45.72 -42.48 11.84 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' ARG . 3.8 m-20 -45.94 -25.73 0.59 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.433 -0.907 . . . . 10.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.569 ' HB3' HD12 ' A' ' 119' ' ' LEU . 62.7 t0 -94.84 123.17 58.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.668 -0.645 . . . . 10.0 110.759 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.9 Cg_endo -80.76 24.73 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.607 1.538 . . . . 10.0 110.536 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 73.1 m -96.52 -50.46 4.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 10.0 110.366 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.615 ' HB ' HD21 ' A' ' 119' ' ' LEU . 1.6 t -72.8 -33.58 66.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.906 -2.257 . . . . 10.0 104.906 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.667 HD11 ' HD2' ' A' ' 120' ' ' ARG 0.301 0.9 OUTLIER -49.43 -30.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.267 -1.382 . . . . 10.0 107.267 176.573 . . . . . . . . 4 4 . 1 . 017 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -51.65 -43.88 62.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.594 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -75.09 -32.25 61.4 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.538 -0.726 . . . . 10.0 110.054 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.782 HD22 HG23 ' A' ' 85' ' ' VAL . 4.3 mt -77.11 -36.95 55.15 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.272 -0.893 . . . . 10.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.25 -49.42 53.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 10.0 110.267 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -26.51 4.97 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.212 -0.93 . . . . 10.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.637 HD22 ' HA ' ' A' ' 129' ' ' LEU . 19.8 p30 -121.79 7.69 9.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.378 -0.929 . . . . 10.0 111.56 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.93 82.69 2.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.802 -1.186 . . . . 10.0 109.838 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.49 -17.95 61.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.847 -1.158 . . . . 10.0 109.424 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 113.44 4.41 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.484 ' HB3' ' HE3' ' A' ' 133' ' ' LYS . 40.5 Cg_endo -68.89 157.12 63.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.907 1.477 . . . . 10.0 110.529 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -103.27 132.03 50.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.358 -0.839 . . . . 10.0 109.738 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.9 p -122.89 167.72 13.8 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.299 -0.876 . . . . 10.0 110.046 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -66.79 -24.82 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 10.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.43 -35.46 77.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 10.0 109.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.6 m -84.81 -31.28 23.95 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.255 0.55 . . . . 10.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.44 -34.14 65.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 10.0 111.53 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -56.16 -43.5 78.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.927 -1.108 . . . . 10.0 109.369 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -63.9 -41.02 97.8 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.495 -0.882 . . . . 10.0 108.681 179.338 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.919 HD11 ' HG3' ' A' ' 94' ' ' LYS . 3.1 tt -59.87 -50.72 72.68 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.56 -0.712 . . . . 10.0 109.34 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.43 -41.38 80.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.156 -0.965 . . . . 10.0 108.632 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -79.49 -0.15 32.01 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.531 -0.731 . . . . 10.0 109.388 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 15.8 t0 -86.51 -10.53 53.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.582 -0.699 . . . . 10.0 110.476 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.988 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.28 32.11 0.47 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 10.0 111.673 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.3 mttt 62.24 41.2 10.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 10.0 111.649 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -80.31 -163.38 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.739 -0.601 . . . . 10.0 109.538 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.752 HG22 ' CB ' ' A' ' 175' ' ' ALA . 40.3 t -98.04 -79.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.991 . . . . 10.0 109.969 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 6.3 tptp -172.57 165.22 5.57 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.759 -0.776 . . . . 10.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 40.5 p90 -96.33 124.44 40.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.777 . . . . 10.0 109.751 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.884 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -111.86 -169.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.174 -0.954 . . . . 10.0 110.237 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 31.4 mt-10 -130.15 135.18 47.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.147 -0.971 . . . . 10.0 109.789 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.663 ' SG ' HD22 ' A' ' 165' ' ' LEU . 6.5 t -150.9 124.76 9.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.962 -1.086 . . . . 10.0 111.205 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 165' ' ' LEU . 30.0 m -128.39 154.61 45.82 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 177.697 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 19' ' ' LEU . . . -99.65 -45.85 5.63 Favored 'General case' 0 C--N 1.283 -2.301 0 O-C-N 120.469 -1.395 . . . . 10.0 108.305 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 160' ' ' LEU 0.294 2.7 tm? -61.58 -51.29 69.16 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.751 0.786 . . . . 10.0 109.215 177.799 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 28.6 m -102.94 -18.79 14.87 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 113.204 0.816 . . . . 10.0 113.204 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 23' ' ' TYR . 6.3 tt0 61.01 75.31 0.42 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.367 -1.458 . . . . 10.0 109.203 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 4.6 tptt -95.08 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.921 -0.711 . . . . 10.0 111.767 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 119.58 31.56 1.34 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.4 -1.381 . . . . 10.0 110.796 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.99 -43.2 73.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.965 -1.314 . . . . 10.0 110.512 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.22 -35.78 58.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 10.0 110.825 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.625 ' C ' HG11 ' A' ' 155' ' ' VAL . 5.2 m120 -60.83 -32.54 71.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.267 -0.896 . . . . 10.0 111.585 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' A' ' 155' ' ' VAL . 34.6 t -64.41 -46.75 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.83 -1.169 . . . . 10.0 110.492 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 12.8 t80 -70.35 -28.03 64.81 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.493 -0.754 . . . . 10.0 111.753 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 19.3 t70 -57.51 -50.02 74.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.771 -1.206 . . . . 10.0 111.992 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.788 ' OE1' HG22 ' A' ' 155' ' ' VAL . 12.7 pt-20 -68.58 -23.9 64.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.903 -1.123 . . . . 10.0 110.814 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.927 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -70.77 -21.16 62.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.016 -1.052 . . . . 10.0 109.05 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.93 HG23 ' OH ' ' A' ' 51' ' ' TYR . 9.8 mm -67.32 -43.34 88.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 10.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -73.13 -42.35 62.97 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.029 -1.044 . . . . 10.0 111.645 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -82.56 -2.58 54.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.323 -0.861 . . . . 10.0 109.944 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -78.47 -43.13 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.302 -0.874 . . . . 10.0 109.704 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.832 HD21 ' HE1' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -107.05 -23.34 12.35 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.746 0.784 . . . . 10.0 110.307 -178.598 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.988 -1.006 . . . . 10.0 110.354 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 1' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.396 -1.481 . . . . 10.0 109.396 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 1.0 OUTLIER 73.23 137.54 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -1.007 . . . . 10.0 111.173 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -98.33 87.1 3.79 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.174 -0.954 . . . . 10.0 109.374 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 49' ' ' GLU . 41.3 mt-10 -119.38 171.3 8.42 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.747 0.784 . . . . 10.0 110.569 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.57 -161.55 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 178.38 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 40.5 Cg_endo -66.89 80.57 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.305 -1.075 . . . . 10.0 109.305 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.494 ' CB ' ' CG2' ' A' ' 46' ' ' ILE . 10.9 pm0 -45.98 175.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.447 0.641 . . . . 10.0 110.666 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.89 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -135.19 -39.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 10.0 110.621 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.1 t -123.0 151.41 41.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 10.0 110.985 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -167.44 97.83 0.63 Allowed Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 120.716 -1.24 . . . . 10.0 112.801 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 45' ' ' MET . 45.2 Cg_endo -73.91 145.51 36.1 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.668 1.351 . . . . 10.0 109.085 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -97.16 154.91 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.936 -1.103 . . . . 10.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -151.91 136.56 17.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 10.0 109.623 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.56 143.22 50.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 10.0 110.515 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 42.9 tp10 -146.7 147.21 30.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 10.0 109.896 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 19' ' ' HIS . 2.3 t60 -143.17 129.17 19.59 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 10.0 109.93 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -96.06 -167.94 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 10.0 110.468 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.633 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -55.59 179.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 10.0 111.736 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 16' ' ' HIS . 13.2 m80 -122.62 162.65 21.48 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.622 0.725 . . . . 10.0 111.528 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 37' ' ' PHE . 6.4 m -64.49 152.64 8.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.61 ' HA3' ' CG ' ' A' ' 61' ' ' GLN . . . -73.96 151.7 44.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.689 -1.364 . . . . 10.0 109.689 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.062 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 67.61 97.86 0.06 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.415 -1.05 . . . . 10.0 109.326 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 70.8 m-20 -53.76 143.23 21.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 10.0 110.658 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 59.32 31.03 20.84 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.433 -0.792 . . . . 10.0 111.954 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 1.062 HG21 ' CG ' ' B' ' 22' ' ' PHE . 21.4 t -113.7 -17.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.917 -1.114 . . . . 10.0 109.997 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.82 HG23 HG13 ' A' ' 21' ' ' ILE . 10.3 t -83.48 31.73 0.46 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.674 -0.641 . . . . 10.0 110.958 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.789 ' HA3' HG22 ' A' ' 21' ' ' ILE . . . -113.07 -91.64 1.95 Allowed Glycine 0 N--CA 1.488 2.111 0 O-C-N 120.85 -1.156 . . . . 10.0 110.225 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.52 ' OE2' ' CD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -1.14 124.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.859 1.314 . . . . 10.0 113.986 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.643 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -120.79 142.79 49.25 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.484 -1.235 . . . . 10.0 109.239 178.383 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 14' ' ' VAL . 68.7 p -152.33 -137.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 10.0 110.314 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.92 45.77 1.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' B' ' 33' ' ' PRO . 50.4 mm -68.29 144.21 96.44 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.256 -1.144 . . . . 10.0 109.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' B' ' 32' ' ' ILE . 41.0 Cg_endo -70.79 141.51 41.21 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.954 1.502 . . . . 10.0 111.699 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 9.6 tp10 53.58 163.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.012 0.911 . . . . 10.0 112.058 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 4.5 mm100 -89.91 19.4 4.86 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.58 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.846 ' CZ3' HG21 ' A' ' 8' ' ' VAL . 3.8 m-90 87.33 26.86 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-O 122.549 1.166 . . . . 10.0 108.071 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.589 ' CA ' ' HA ' ' A' ' 70' ' ' LEU . . . -160.99 85.87 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.138 -1.431 . . . . 10.0 107.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.462 ' HA ' ' OE2' ' B' ' 34' ' ' GLU . 3.2 ttm180 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 122.721 1.248 . . . . 10.0 108.537 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.562 ' HA ' ' CA ' ' A' ' 177' ' ' LEU . 15.2 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.306 0.574 . . . . 10.0 110.6 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -144.23 -86.11 0.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.202 -0.936 . . . . 10.0 109.275 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 3' ' ' THR . 3.5 m -41.26 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.943 -0.473 . . . . 10.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.983 HG22 ' O ' ' A' ' 52' ' ' THR . 1.9 tt -136.01 154.02 33.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 118.231 -1.388 . . . . 10.0 113.321 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.747 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -135.23 109.66 8.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.816 0.817 . . . . 10.0 110.716 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.674 ' C ' HG22 ' A' ' 7' ' ' VAL . 30.1 m -67.98 142.64 55.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.931 -1.106 . . . . 10.0 109.882 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.674 HG22 ' C ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -167.49 -169.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.846 -1.159 . . . . 10.0 111.004 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.0 t -105.47 164.49 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.548 -0.72 . . . . 10.0 110.279 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 1.029 HG11 ' HB ' ' A' ' 80' ' ' VAL . 27.7 m -79.99 -168.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.913 -1.117 . . . . 10.0 111.718 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' CA ' ' HB3' ' B' ' 37' ' ' ALA . . . -148.27 17.17 1.33 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.54 -34.92 78.07 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.073 -1.251 . . . . 10.0 108.995 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 141.25 -151.73 22.79 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.985 -1.246 . . . . 10.0 109.985 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 57.73 160.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -1.094 . . . . 10.0 111.4 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.623 HG22 ' SG ' ' A' ' 18' ' ' CYS . 12.4 p -52.57 152.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.445 -0.784 . . . . 10.0 109.981 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -65.24 161.32 41.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.482 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -88.68 -32.34 18.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 10.0 109.316 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.5 p -67.66 -26.15 66.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.506 -0.746 . . . . 10.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG22 ' A' ' 14' ' ' VAL . 24.8 p -75.12 -0.1 18.02 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.821 -1.175 . . . . 10.0 110.073 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.905 HD13 ' CA ' ' A' ' 159' ' ' ALA . 6.3 mt -104.19 -21.46 13.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 10.0 109.866 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.51 -35.81 81.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.745 0.784 . . . . 10.0 110.136 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.72 HG22 ' CA ' ' B' ' 27' ' ' GLY . 1.6 mm -97.87 -45.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.858 0.837 . . . . 10.0 109.404 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.627 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 15.9 t -49.33 -46.92 47.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.386 -0.926 . . . . 10.0 109.757 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -67.68 -45.68 74.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.354 -1.466 . . . . 10.0 110.628 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 5.5 p -58.73 -51.19 71.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.647 -1.283 . . . . 10.0 110.442 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -153.65 -59.93 0.13 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 118.001 -1.48 . . . . 10.0 114.218 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.632 ' H ' HG23 ' A' ' 25' ' ' THR . 20.3 m-20 -49.45 -26.07 3.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.846 -1.159 . . . . 10.0 111.562 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.4 OUTLIER 29.54 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 112.753 0.649 . . . . 10.0 112.753 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.164 . . . . 10.0 111.216 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.827 ' O ' HG23 ' B' ' 20' ' ' VAL . 32.7 p . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.252 0.549 . . . . 10.0 111.482 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.827 HG13 HG23 ' A' ' 58' ' ' THR . 27.8 t 80.01 3.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.356 0.598 . . . . 10.0 109.572 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 45.4 t80 -41.27 124.6 2.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.811 ' CB ' ' HB ' ' B' ' 18' ' ' ILE . 5.5 m-20 -64.46 -153.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.769 -1.172 . . . . 10.0 111.504 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.798 ' CB ' HD11 ' A' ' 55' ' ' LEU . 2.5 t-20 -154.09 -163.11 1.55 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.137 -0.977 . . . . 10.0 111.79 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' B' ' 16' ' ' HIS . 41.3 p90 -131.97 -174.49 3.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.775 0.798 . . . . 10.0 110.974 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.8 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -156.67 139.02 14.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -164.75 -176.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.145 . . . . 10.0 110.701 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 51' ' ' TYR . 58.6 m -121.5 144.34 48.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.981 -0.688 . . . . 10.0 109.983 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -111.37 164.32 7.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.314 -0.866 . . . . 10.0 108.844 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 0.4 OUTLIER -150.55 103.91 3.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.364 -0.976 . . . . 10.0 108.364 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.892 HG23 ' HB3' ' B' ' 10' ' ' LEU . 4.2 mt -125.02 130.1 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.062 -1.024 . . . . 10.0 110.904 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 40.24 27.17 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 95.85 30.4 7.99 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.701 -1.238 . . . . 10.0 110.097 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.492 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -120.98 94.97 49.04 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 120.898 -1.354 . . . . 10.0 110.447 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.4 Cg_endo -75.57 144.52 28.54 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.094 1.576 . . . . 10.0 111.134 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' THR . 1.7 m-85 -126.66 122.62 35.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.466 -0.771 . . . . 10.0 109.092 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.983 ' O ' HG22 ' A' ' 4' ' ' ILE 0.265 93.5 m -108.43 97.41 7.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 10.0 109.836 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -153.37 174.93 13.7 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.634 -1.626 . . . . 10.0 111.895 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.644 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . -172.55 136.54 3.81 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 108.589 -1.804 . . . . 10.0 108.589 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -131.71 135.27 46.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.895 -1.356 . . . . 10.0 109.659 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 55' ' ' LEU . 62.3 m-85 -133.76 158.95 42.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' THR . 28.7 t0 -124.17 171.17 10.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.887 -1.133 . . . . 10.0 109.787 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.827 HG23 HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.87 -176.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.122 -1.031 . . . . 10.0 110.647 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 62' ' ' GLU . . . -144.56 75.12 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.864 -1.147 . . . . 10.0 110.517 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -15.41 59.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.305 -1.518 . . . . 10.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.475 ' N ' ' HA3' ' B' ' 21' ' ' GLY . 26.1 mt-30 -144.53 -16.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.119 -1.224 . . . . 10.0 111.643 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.734 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 1.8 tt0 -62.52 -48.71 78.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.479 -1.388 . . . . 10.0 109.285 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 4.3 t0 -134.21 1.28 3.2 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.706 -0.621 . . . . 10.0 109.559 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 17.4 m-85 66.64 37.65 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 t0 -137.43 72.83 1.42 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.026 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 9.6 ptt180 -85.03 -30.61 24.0 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.623 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD11 ' A' ' 70' ' ' LEU . 20.6 mt -86.86 -25.58 24.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 10.0 111.29 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.696 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 mtm-85 -109.85 12.68 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.729 -1.232 . . . . 10.0 114.242 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.3 Cg_endo -73.59 0.96 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 110.189 -0.735 . . . . 10.0 110.189 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -102.46 -113.94 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.426 -0.796 . . . . 10.0 110.819 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.785 ' N ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER 42.43 44.11 3.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 10.0 110.662 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -160.16 174.37 4.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 10.0 110.753 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.743 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 36.6 Cg_endo -62.11 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.112 1.059 . . . . 10.0 110.862 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.607 ' HG3' ' CD ' ' A' ' 5' ' ' LYS . 15.1 mp0 54.21 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.35 -1.469 . . . . 10.0 108.311 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 75' ' ' THR . 1.3 m -139.58 86.63 2.12 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.358 -0.839 . . . . 10.0 112.404 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.854 ' OD2' HG22 ' A' ' 77' ' ' VAL . 1.6 t70 -110.48 -72.72 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 1.056 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 24.8 m -141.92 112.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.792 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.986 ' HB3' HG12 ' A' ' 9' ' ' VAL . 84.0 m-85 -88.65 127.3 35.57 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.711 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' HA ' ' A' ' 169' ' ' PHE . 4.0 mm? -100.76 97.93 8.51 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.215 -0.928 . . . . 10.0 109.662 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 1.029 ' HB ' HG11 ' A' ' 9' ' ' VAL . 7.5 p -106.65 150.55 9.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.961 -0.695 . . . . 10.0 109.947 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.6 m -133.13 118.86 19.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.924 -1.11 . . . . 10.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.536 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 31.4 p90 -127.03 166.66 17.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.457 -0.777 . . . . 10.0 110.431 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -78.93 158.51 28.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.63 -1.293 . . . . 10.0 111.852 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.506 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 28.4 m -114.39 2.9 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.607 -0.683 . . . . 10.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.853 ' HA ' HD21 ' A' ' 129' ' ' LEU . 19.2 m -105.58 39.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 10.0 109.761 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 73.0 m -114.94 172.13 3.88 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 40.2 Cg_endo -68.71 81.1 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.048 1.026 . . . . 10.0 110.771 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 37.76 39.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.206 0.527 . . . . 10.0 110.844 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.8 m -62.0 -38.26 87.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.047 -1.033 . . . . 10.0 110.81 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 16.3 p90 -48.46 -38.15 19.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 10.0 111.071 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 9.6 tt0 -59.22 -37.93 78.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.345 -0.847 . . . . 10.0 110.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.833 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -68.62 -18.32 64.28 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.223 -0.923 . . . . 10.0 109.771 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.833 HG23 ' ND2' ' A' ' 92' ' ' ASN . 64.6 t -89.62 -7.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 10.0 109.449 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.983 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -93.29 -25.58 17.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 8.3 pt-20 -94.78 2.67 55.52 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.403 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -110.08 -49.03 3.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.989 -1.069 . . . . 10.0 111.79 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.57 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 24.5 m95 -89.9 -33.21 16.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.751 -1.218 . . . . 10.0 111.643 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 96.3 t -71.7 -49.96 10.52 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.658 -1.276 . . . . 10.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -70.57 -10.49 28.02 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.178 1.094 . . . . 10.0 109.764 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 22.4 tt0 -64.06 -48.58 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 10.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 106' ' ' PRO . 20.9 tt -176.43 -29.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.053 -1.029 . . . . 10.0 110.395 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 106' ' ' PRO . 58.3 p -61.76 -11.95 14.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.272 -0.892 . . . . 10.0 109.977 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -55.62 -35.21 65.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.337 -0.852 . . . . 10.0 110.59 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -152.1 10.18 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.965 -1.094 . . . . 10.0 111.937 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' CYS . . . . . 0.67 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 1.7 m -113.12 -81.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.452 -1.405 . . . . 10.0 111.103 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 102' ' ' THR . 55.2 Cg_endo -74.84 -22.99 14.61 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 122.557 0.767 . . . . 10.0 112.029 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 106' ' ' PRO . 6.0 tttt 45.8 42.93 9.38 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.729 -1.232 . . . . 10.0 109.85 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.564 HG23 HG23 ' A' ' 75' ' ' THR . 18.5 m -67.1 139.37 95.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.433 -0.792 . . . . 10.0 110.573 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 48.8 Cg_endo -71.94 125.14 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.091 1.574 . . . . 10.0 110.067 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.579 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -100.06 99.79 10.57 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.548 -0.72 . . . . 10.0 110.224 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.7 mm? -75.67 96.89 3.67 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.665 -1.235 . . . . 10.0 107.665 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 154' ' ' TYR . 96.0 mt -80.02 113.44 18.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.643 -0.708 . . . . 10.0 110.114 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 114' ' ' GLY . 1.6 t -120.01 -175.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.087 -1.008 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -147.09 101.56 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 4.8 t -99.73 178.09 4.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.246 . . . . 10.0 110.955 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 115' ' ' THR . 31.2 mt-30 58.88 30.09 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 10.0 109.17 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 0.978 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -80.17 -13.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.951 -0.7 . . . . 10.0 110.581 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.658 ' CB ' HG21 ' A' ' 161' ' ' THR . 5.5 p-10 -51.59 58.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 122.493 1.139 . . . . 10.0 111.544 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER 165.72 -28.54 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.82 -29.54 11.97 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.729 -0.607 . . . . 10.0 109.367 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.28 -26.76 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 10.0 109.709 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.476 ' O ' HD13 ' A' ' 126' ' ' ILE . 22.2 m-20 -93.3 123.57 60.22 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.568 -0.708 . . . . 10.0 109.939 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.0 Cg_endo -78.15 24.35 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.89 1.468 . . . . 10.0 111.41 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 15.6 m -98.09 -50.55 4.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.967 -1.083 . . . . 10.0 110.39 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -29.73 64.24 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.306 1.1 mp -51.82 -26.51 7.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.109 -1.405 . . . . 10.0 107.365 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 124' ' ' SER . 28.9 tt0 -50.6 -29.35 10.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.926 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.463 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 10.3 mmtp -61.39 -29.08 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.709 . . . . 10.0 111.345 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.853 HD21 ' HA ' ' A' ' 85' ' ' VAL . 9.2 mp -65.12 -42.92 93.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.804 -1.185 . . . . 10.0 109.835 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.66 -30.4 65.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.762 -0.586 . . . . 10.0 110.662 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 8.5 mmtp -64.85 -15.06 61.36 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.473 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 1.5 p30 -127.64 -41.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 10.0 110.739 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -149.66 136.46 19.45 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.401 -0.812 . . . . 10.0 110.213 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.455 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -82.15 -10.11 59.29 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.362 0.601 . . . . 10.0 110.315 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.8 OUTLIER -110.72 98.47 37.74 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 10.0 111.764 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.832 ' HB3' HD23 ' A' ' 129' ' ' LEU . 45.1 Cg_endo -71.56 161.79 44.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.372 1.722 . . . . 10.0 109.904 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 137' ' ' ILE . 1.5 tp -77.84 116.67 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.626 -1.296 . . . . 10.0 109.682 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 42.9 p -121.8 172.19 5.34 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -67.66 -16.56 46.87 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.25 1.132 . . . . 10.0 111.331 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -79.62 -24.78 41.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 10.0 109.263 178.897 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 141' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.3 m -97.21 -35.0 10.9 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.662 0.744 . . . . 10.0 109.341 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -72.3 -39.9 67.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.778 -0.576 . . . . 10.0 110.904 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 25.7 mt-10 -62.23 -50.22 72.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.569 -0.852 . . . . 10.0 109.597 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -61.24 -42.18 98.17 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.983 HD11 ' HG3' ' A' ' 94' ' ' LYS . 4.8 tt -58.8 -45.68 89.35 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.33 -0.856 . . . . 10.0 109.399 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.541 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.33 -48.7 80.6 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.522 0.677 . . . . 10.0 109.629 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 10.3 mtm-85 -71.13 -14.36 62.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.231 -0.918 . . . . 10.0 109.314 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 9.4 t0 -69.3 -13.33 62.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 10.0 111.115 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.998 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.51 26.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.025 -1.047 . . . . 10.0 110.155 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER 64.45 36.27 8.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.684 0.754 . . . . 10.0 110.637 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -69.4 -155.59 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -118.77 -62.29 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.781 -1.199 . . . . 10.0 111.112 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttmt -171.99 154.73 3.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.521 -1.362 . . . . 10.0 112.041 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 54.3 t80 -106.8 101.4 10.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 10.0 108.981 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.949 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -107.42 -170.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.469 -0.769 . . . . 10.0 110.139 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -152.56 133.39 14.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.08 -1.013 . . . . 10.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.607 ' SG ' HG11 ' A' ' 113' ' ' VAL . 26.9 p -153.63 157.75 40.11 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.557 -0.905 . . . . 10.0 108.557 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.578 ' HB2' ' H ' ' A' ' 162' ' ' GLN . 54.0 m -138.68 164.32 29.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.185 -1.042 . . . . 10.0 108.185 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.905 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -62.06 -59.26 5.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.631 -1.293 . . . . 10.0 112.33 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.58 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 2.6 pp -121.16 4.7 10.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.454 -1.404 . . . . 10.0 112.898 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -104.07 -47.34 4.2 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.333 -1.479 . . . . 10.0 113.544 -178.021 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.578 ' H ' ' HB2' ' A' ' 158' ' ' SER . 10.7 mm100 -91.51 -44.38 9.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.444 -1.41 . . . . 10.0 112.026 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 15.4 ttpt 63.95 28.73 14.5 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.205 1.002 . . . . 10.0 109.325 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -109.45 15.86 32.18 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.088 -1.605 . . . . 10.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -69.51 -3.17 13.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.541 -0.976 . . . . 10.0 110.471 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -89.65 -25.32 21.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 10.0 109.946 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -34.92 23.39 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.092 -1.005 . . . . 10.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.949 HG22 ' HB ' ' A' ' 155' ' ' VAL . 16.2 t -59.62 -38.77 77.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 10.0 110.692 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.56 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 t80 -80.17 -44.05 20.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 10.0 111.796 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.696 ' O ' HD22 ' A' ' 174' ' ' LEU . 29.7 t70 -52.51 -44.08 65.47 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.528 -1.358 . . . . 10.0 110.688 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.598 ' HA ' HD23 ' A' ' 174' ' ' LEU . 14.5 mt-10 -60.62 -41.82 95.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.237 -0.914 . . . . 10.0 111.466 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.931 ' HB1' ' HB ' ' A' ' 77' ' ' VAL . . . -56.14 -33.21 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 10.0 111.092 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 177' ' ' LEU . 20.8 mm -61.01 -44.68 98.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 118.316 -1.354 . . . . 10.0 108.423 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.84 -21.04 62.48 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.375 -0.828 . . . . 10.0 109.839 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.95 -7.5 36.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.397 -0.814 . . . . 10.0 111.005 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.056 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -85.97 -33.65 21.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.017 . . . . 10.0 111.343 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -100.31 -10.65 21.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.767 -1.208 . . . . 10.0 109.418 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.191 . . . . 10.0 109.138 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 10.0 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 2' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 56.9 m -80.39 36.82 0.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.09 -1.241 . . . . 10.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 174' ' ' LEU . 9.4 mtpp -61.0 100.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 10.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' B' ' 2' ' ' SER . 9.2 mm-40 -108.43 161.97 14.54 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.588 0.709 . . . . 10.0 111.262 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.681 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.48 -143.17 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.202 -1.036 . . . . 10.0 108.202 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.681 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 43.9 Cg_endo -74.27 7.31 2.62 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 CA-C-N 119.448 0.839 . . . . 10.0 110.626 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.829 ' CB ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER 41.81 -149.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 10.0 110.517 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.561 HG23 ' H ' ' B' ' 9' ' ' SER . 0.0 OUTLIER -100.48 -99.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.46 -0.775 . . . . 10.0 109.951 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.561 ' H ' HG23 ' B' ' 8' ' ' ILE . 31.1 m -78.12 151.96 33.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.592 -1.317 . . . . 10.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.892 ' HB3' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -164.89 98.81 0.84 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.459 -1.401 . . . . 10.0 112.348 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 45' ' ' MET . 45.0 Cg_endo -75.72 124.18 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.771 1.406 . . . . 10.0 108.893 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.8 m -93.14 166.37 12.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.44 174.99 10.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.465 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.1 p90 -149.23 150.04 31.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.724 -1.235 . . . . 10.0 111.62 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -170.85 117.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.67 -0.644 . . . . 10.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 16' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 p-80 -162.83 156.42 20.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.624 -1.297 . . . . 10.0 111.737 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.928 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -166.95 96.25 0.51 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.297 -0.877 . . . . 10.0 110.226 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.928 HG23 ' O ' ' B' ' 17' ' ' THR . 0.6 OUTLIER -172.9 167.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.605 . . . . 10.0 109.466 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.42 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 50.0 t60 -145.75 159.6 42.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.211 -1.556 . . . . 10.0 114.551 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 35' ' ' THR . 4.8 p -69.08 146.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.648 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -146.48 155.84 26.71 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.364 -1.894 . . . . 10.0 108.364 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 1.06 ' HB3' HG21 ' B' ' 25' ' ' VAL . 8.1 m-30 58.81 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.213 -1.169 . . . . 10.0 110.359 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.498 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.1 m-20 -60.65 157.55 14.33 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.634 0.73 . . . . 10.0 111.764 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.89 43.89 5.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.69 -0.631 . . . . 10.0 111.331 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 1.06 HG21 ' HB3' ' B' ' 22' ' ' PHE . 6.7 t -111.7 -35.1 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 119.356 -0.938 . . . . 10.0 108.663 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -101.93 7.44 41.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 177.584 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.72 ' CA ' HG22 ' A' ' 21' ' ' ILE . . . -125.14 24.87 5.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.881 -2.088 . . . . 10.0 107.881 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 11.3 tt0 -158.66 132.59 7.71 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.768 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -110.04 118.92 37.69 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.238 1.018 . . . . 10.0 110.7 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -143.07 162.31 35.87 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.575 -0.739 . . . . 10.0 109.664 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.43 -165.9 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.205 -1.158 . . . . 10.0 110.205 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.461 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 24.2 pt -143.01 52.87 2.35 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.372 -1.075 . . . . 10.0 110.458 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 55.5 Cg_endo -74.72 163.14 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.83 1.437 . . . . 10.0 111.05 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.489 ' OE2' ' O ' ' A' ' 10' ' ' GLY . 3.6 tp10 -43.7 155.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.963 . . . . 10.0 109.97 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 14' ' ' VAL . 4.1 mm-40 -67.83 -66.76 0.52 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.238 -0.985 . . . . 10.0 111.141 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.625 ' CD2' ' O ' ' B' ' 36' ' ' TRP . 9.4 t90 -161.96 21.05 0.11 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 122.51 1.148 . . . . 10.0 108.114 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.568 ' HA ' ' CG ' ' A' ' 70' ' ' LEU . . . -155.95 93.92 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.081 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.411 ' HA ' ' CD ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.466 -1.309 . . . . 10.0 107.466 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.085 0.469 . . . . 10.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 4' ' ' ILE . 2.8 mm100 -78.72 -48.54 14.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.236 -0.915 . . . . 10.0 108.776 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.59 ' HA ' HG22 ' A' ' 52' ' ' THR . 1.4 m -40.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.976 -0.75 . . . . 10.0 108.976 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 1.011 HD13 ' HB1' ' A' ' 176' ' ' ALA . 1.2 tt -134.55 149.06 29.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.001 -1.079 . . . . 10.0 111.935 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HG3' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -126.95 119.38 26.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.823 ' HA ' HG13 ' A' ' 77' ' ' VAL . 7.5 m -89.32 135.31 33.65 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.732 0.777 . . . . 10.0 109.479 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' B' ' 36' ' ' TRP . 11.0 t -144.31 158.5 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.46 -0.775 . . . . 10.0 109.972 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 30.5 m -63.83 136.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.44 -0.787 . . . . 10.0 111.235 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.88 HG11 ' HB3' ' A' ' 78' ' ' PHE . 7.6 t -145.27 -173.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.558 -0.714 . . . . 10.0 109.242 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.712 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 126.93 -129.05 6.42 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.942 -1.263 . . . . 10.0 109.942 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.98 22.95 14.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.435 -1.038 . . . . 10.0 109.224 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' B' ' 33' ' ' PRO . . . 100.82 90.07 2.07 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.644 -1.782 . . . . 10.0 108.644 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' B' ' 35' ' ' GLN . . . -141.18 96.16 2.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 10.0 110.659 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 35' ' ' GLN . 0.6 OUTLIER -82.91 133.59 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.918 -1.114 . . . . 10.0 109.684 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 19' ' ' LEU . . . 98.75 2.42 57.35 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.914 -1.136 . . . . 10.0 110.356 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.2 tttt -51.0 -47.73 61.52 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.024 -1.28 . . . . 10.0 111.013 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 22.7 m -62.06 -30.94 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.283 -1.511 . . . . 10.0 109.645 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' B' ' 26' ' ' THR . 14.9 m -70.18 -11.8 61.15 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.742 -1.224 . . . . 10.0 108.916 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' B' ' 29' ' ' PHE . 4.3 mm? -70.26 -30.67 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -49.29 -40.36 34.45 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.841 -1.541 . . . . 10.0 106.841 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.7 mm -67.54 -36.5 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 122.349 1.071 . . . . 10.0 108.948 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.578 ' HA ' ' CA ' ' A' ' 27' ' ' LYS . 3.5 p -60.05 -42.29 94.16 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.883 -0.727 . . . . 10.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 165' ' ' LEU . 31.7 m-85 -71.52 -7.45 47.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.824 -1.172 . . . . 10.0 108.768 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 66.5 p -107.65 -44.31 4.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.531 -0.867 . . . . 10.0 110.143 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.78 HG23 ' H ' ' A' ' 26' ' ' ASN . 1.9 t -166.2 -65.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 116.798 -1.961 . . . . 10.0 115.361 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.78 ' H ' HG23 ' A' ' 25' ' ' THR . 15.9 t-20 -79.0 45.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.018 -1.676 . . . . 10.0 113.181 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HA ' ' HA3' ' B' ' 27' ' ' GLY . 0.0 OUTLIER -56.04 -126.71 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.577 -0.702 . . . . 10.0 111.392 179.022 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 3.8 t80 . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.615 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 35' ' ' THR . 91.2 t -156.88 -97.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.636 -1.29 . . . . 10.0 111.995 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.604 ' N ' HG12 ' A' ' 36' ' ' VAL . 1.7 t80 -70.86 126.94 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 10.0 110.522 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.604 ' HB3' ' CG ' ' A' ' 56' ' ' PHE . 3.2 t70 -160.89 -177.82 6.4 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.055 -1.028 . . . . 10.0 110.103 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.776 ' HB3' HG21 ' B' ' 18' ' ' ILE . 50.4 t30 -167.63 102.65 0.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 10.0 109.125 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.675 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 7.3 t80 -92.76 141.73 28.12 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.989 -1.07 . . . . 10.0 110.577 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -159.58 98.16 1.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 10.0 109.38 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -144.79 -174.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 10.0 110.622 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 51' ' ' TYR . 6.8 m -142.07 146.66 35.69 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' B' ' 12' ' ' SER . 18.1 t -120.91 136.86 56.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.652 ' HB3' HD23 ' B' ' 10' ' ' LEU . 10.3 mtt -89.36 109.45 20.36 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 117.736 -1.586 . . . . 10.0 109.181 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.25 109.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.185 -1.572 . . . . 10.0 109.544 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 50.02 28.09 11.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.07 -28.0 17.09 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 111.15 16.15 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.246 . . . . 10.0 110.475 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 56.0 Cg_endo -73.04 134.64 21.73 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.159 1.61 . . . . 10.0 109.561 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.4 t80 -89.34 139.97 29.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.752 -1.218 . . . . 10.0 109.549 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' HG22 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -122.06 97.88 5.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 10.0 110.343 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.8 pp -148.85 171.36 16.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.733 -1.229 . . . . 10.0 111.621 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -173.28 120.85 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.377 -1.889 . . . . 10.0 108.377 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.849 HD12 ' C ' ' A' ' 55' ' ' LEU . 1.5 pp -157.58 144.69 18.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.408 -1.643 . . . . 10.0 112.845 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' CG ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -174.66 172.34 3.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.251 -0.905 . . . . 10.0 110.384 175.093 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -90.82 157.33 17.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 10.0 110.187 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.5 m -129.29 135.74 49.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.028 . . . . 10.0 111.662 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . . . 55.85 -152.44 0.37 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.39 -0.819 . . . . 10.0 110.934 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HG21 ' B' ' 25' ' ' VAL . . . 96.09 -7.84 67.22 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.236 -1.946 . . . . 10.0 108.236 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.586 ' CG ' ' HB2' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -152.84 -41.76 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.509 -0.994 . . . . 10.0 110.444 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 8.7 mm-40 -73.1 -43.25 62.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.502 -1.279 . . . . 10.0 109.386 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 2.1 t70 73.46 52.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.668 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -165.24 0.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.195 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 6.1 p30 -22.53 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.493 0.663 . . . . 10.0 112.487 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.477 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -54.29 -34.16 60.26 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 178.483 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.614 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 83.7 mt -76.43 6.24 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.442 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.756 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -57.82 -31.29 9.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.826 -1.171 . . . . 10.0 113.651 -179.012 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.614 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 52.0 Cg_endo -72.47 81.11 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 CA-C-N 119.36 0.807 . . . . 10.0 110.037 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.772 HD11 ' CB ' ' B' ' 37' ' ' ALA . 0.7 OUTLIER -108.72 -34.14 6.78 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.751 -1.218 . . . . 10.0 110.913 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.657 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 77.16 -17.3 0.57 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 10.0 110.808 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.663 ' N ' HD12 ' A' ' 70' ' ' LEU . 79.2 t80 104.29 115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.838 0 C-N-CA 123.682 0.793 . . . . 10.0 111.181 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 43.9 Cg_endo -71.58 164.7 34.86 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.89 1.469 . . . . 10.0 109.307 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 1.1 mt-30 -139.35 7.01 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.821 -1.174 . . . . 10.0 111.11 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -141.78 84.89 1.91 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.852 -1.155 . . . . 10.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.645 ' O ' HD11 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -174.15 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.516 -0.74 . . . . 10.0 109.015 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -163.91 143.19 2.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.19 -0.944 . . . . 10.0 108.801 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.88 ' HB3' HG11 ' A' ' 9' ' ' VAL . 14.0 m-85 -131.72 119.56 21.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.899 -1.126 . . . . 10.0 111.942 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 111' ' ' LEU . 1.1 mm? -90.58 97.85 11.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 10.0 109.043 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 10' ' ' GLY . 11.0 m -99.38 150.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 10.0 110.35 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.6 p -123.66 108.41 12.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 10.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 97.9 m-85 -91.96 139.54 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.207 -0.933 . . . . 10.0 111.058 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.5 p -77.98 163.64 25.78 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 137' ' ' ILE . 1.9 m -119.43 -14.64 8.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 10.0 110.321 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 120' ' ' ARG . 32.7 m -115.11 44.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.798 0.809 . . . . 10.0 109.868 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.638 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -133.83 -159.13 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 41.6 Cg_endo -73.26 142.85 34.44 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 122.715 0.85 . . . . 10.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 m -65.29 77.15 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.007 -1.077 . . . . 10.0 109.695 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' PRO . 80.1 p -105.05 -15.71 15.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 10.0 111.642 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.5 p90 -49.79 -39.73 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.258 . . . . 10.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 1.5 tt0 -62.21 -34.17 75.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 10.0 110.269 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.551 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.11 -14.01 61.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.063 -1.023 . . . . 10.0 109.682 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 21.2 t -87.95 -18.03 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 10.0 109.444 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.857 ' HG3' HD11 ' A' ' 145' ' ' LEU . 3.7 mmtt -85.42 -35.53 21.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -82.74 -1.03 50.32 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.162 0.506 . . . . 10.0 109.847 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -111.24 -50.01 2.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.832 -1.167 . . . . 10.0 112.052 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 50.1 m95 -84.77 -49.36 8.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 10.0 112.339 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 23.2 t -52.79 -46.48 96.58 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.657 -1.277 . . . . 10.0 109.951 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.0 Cg_endo -71.75 -16.3 29.88 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.392 1.206 . . . . 10.0 109.779 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 43.5 tt0 -63.36 -16.55 60.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 10.0 109.72 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt 69.02 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.472 0.653 . . . . 10.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.723 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.1 m -52.39 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.868 . . . . 10.0 108.916 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' HIS . . . . . 0.723 ' N ' HG22 ' A' ' 102' ' ' THR . 10.9 p-80 -110.54 -4.2 15.61 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 10.0 108.174 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 104' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER 162.58 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 35.6 t -138.15 131.49 16.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 42.7 Cg_endo -69.84 67.67 1.77 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.757 1.399 . . . . 10.0 111.256 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 -11.04 15.08 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.057 -1.027 . . . . 10.0 110.659 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.9 t -49.21 147.3 5.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.653 -1.279 . . . . 10.0 109.715 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.62 130.42 26.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.852 1.448 . . . . 10.0 110.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.8 102.21 10.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.44 -0.787 . . . . 10.0 109.667 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 152' ' ' VAL . 2.6 mm? -78.62 95.41 5.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.817 -1.153 . . . . 10.0 108.026 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 145' ' ' LEU . 12.5 mt -72.31 137.91 47.0 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 22.8 t -148.43 158.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.787 -1.196 . . . . 10.0 111.594 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.433 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -96.56 148.21 18.92 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.765 -1.734 . . . . 10.0 108.765 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 81' ' ' CYS . 30.5 m -111.35 126.71 55.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.167 -1.196 . . . . 10.0 110.638 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 44.17 62.18 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.438 -0.789 . . . . 10.0 110.412 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.021 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.89 -29.24 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.206 -0.997 . . . . 10.0 109.542 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -52.47 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.427 1.108 . . . . 10.0 110.175 -177.58 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER 166.73 -26.66 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.219 -1.355 . . . . 10.0 107.827 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.76 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -51.14 -33.21 25.73 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.307 0.575 . . . . 10.0 109.731 178.631 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ASP . . . . . 0.458 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 75.7 m-20 -73.77 -11.46 60.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.027 . . . . 10.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.868 ' O ' HD13 ' A' ' 126' ' ' ILE . 38.0 t0 -86.4 115.86 63.73 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 10.0 110.162 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.47 21.65 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.734 1.386 . . . . 10.0 111.447 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 38.7 t -105.59 -51.24 3.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 10.0 109.993 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.52 HG21 HD12 ' A' ' 119' ' ' LEU . 14.3 t -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.967 -2.235 . . . . 10.0 104.967 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 122' ' ' ASP 0.296 1.3 mp -54.47 -23.56 11.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.227 -1.351 . . . . 10.0 107.79 176.474 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -49.21 -41.73 37.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.583 0.706 . . . . 10.0 110.172 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 1.8 mmmm -92.44 -41.32 10.37 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.603 -0.686 . . . . 10.0 109.994 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 85' ' ' VAL . 6.0 mp -65.83 -32.75 74.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.761 . . . . 10.0 109.403 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -59.88 -51.51 69.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 10.0 109.869 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -64.62 -25.33 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.196 -1.002 . . . . 10.0 108.903 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 87' ' ' PRO . 23.3 t-20 -69.38 -8.64 48.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 10.0 110.583 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -167.67 115.3 0.75 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 10.0 108.557 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -19.9 65.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 10.0 111.904 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 4.8 mptt -137.67 106.34 8.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.747 -1.221 . . . . 10.0 110.284 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 41.9 Cg_endo -66.74 160.45 46.45 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.487 . . . . 10.0 109.654 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 84' ' ' VAL . 3.4 tp -86.86 138.35 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.782 -1.199 . . . . 10.0 109.704 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 55.8 p -131.43 166.33 28.79 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.463 -0.773 . . . . 10.0 109.813 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 42.4 Cg_endo -67.8 -11.5 32.31 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.737 1.388 . . . . 10.0 110.965 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 75.2 mt-10 -75.16 -44.3 47.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.946 -1.096 . . . . 10.0 109.405 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -77.72 -36.55 50.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.662 0.744 . . . . 10.0 109.388 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 145' ' ' LEU . . . -64.93 -49.94 68.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 10.0 111.476 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.3 -46.94 62.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.009 -1.057 . . . . 10.0 109.578 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 140' ' ' GLU . 3.2 mtpm? -70.68 -30.05 66.53 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.542 -0.863 . . . . 10.0 109.439 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -69.53 -38.95 77.73 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.332 -0.855 . . . . 10.0 109.693 178.87 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -65.71 -49.67 67.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 10.0 108.263 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -24.07 67.53 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.852 -0.739 . . . . 10.0 109.166 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 21.1 t70 -59.97 -30.93 69.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 10.0 111.177 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 1.029 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -132.87 29.9 4.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.888 -1.132 . . . . 10.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 31.9 mttt 67.45 36.08 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 10.0 112.176 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -69.68 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.221 -0.991 . . . . 10.0 108.929 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 111' ' ' LEU . 2.4 p -114.57 -58.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.596 -1.315 . . . . 10.0 112.014 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.618 ' H ' HG13 ' A' ' 152' ' ' VAL . 2.8 ttmm -172.3 148.72 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.367 -1.458 . . . . 10.0 111.675 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 83.9 t80 -86.0 121.7 29.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 10.0 110.466 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 0.995 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -130.03 -174.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.868 -1.145 . . . . 10.0 110.169 179.4 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 48.8 mt-10 -148.09 149.23 31.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.862 -1.149 . . . . 10.0 112.195 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.0 p -148.22 156.09 42.14 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.905 0.859 . . . . 10.0 110.894 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 163' ' ' LYS . 1.7 t -139.38 89.8 2.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.627 0.727 . . . . 10.0 109.495 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.787 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -12.05 -58.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.554 0.946 . . . . 10.0 113.554 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -106.99 -43.12 4.72 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.056 -1.028 . . . . 10.0 112.84 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.647 HG21 ' CB ' ' A' ' 118' ' ' ASP . 6.3 p -65.25 -23.58 67.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.264 -1.523 . . . . 10.0 109.577 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' OE1' ' A' ' 162' ' ' GLN . 0.3 OUTLIER 71.19 77.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.457 -0.777 . . . . 10.0 110.946 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 158' ' ' SER . 12.6 mmmt -80.86 23.43 0.55 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.529 -0.868 . . . . 10.0 111.865 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.27 45.41 11.43 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.101 -1.2 . . . . 10.0 110.101 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -74.96 -3.37 31.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.339 -1.095 . . . . 10.0 112.774 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 166' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.7 ttmt -53.62 -38.99 64.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.57 -1.331 . . . . 10.0 110.223 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -75.6 -26.1 57.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 10.0 111.684 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 155' ' ' VAL . 87.7 t -52.88 -51.49 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 10.0 111.353 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CZ ' ' OD1' ' A' ' 170' ' ' ASP . 2.3 p90 -85.16 -32.23 22.83 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.699 -0.801 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.58 ' OD1' ' CZ ' ' A' ' 169' ' ' PHE . 1.0 OUTLIER -56.45 -41.54 76.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.993 -1.067 . . . . 10.0 110.972 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.611 ' HA ' HD21 ' A' ' 174' ' ' LEU . 9.0 pt-20 -69.8 -30.64 68.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.991 -1.068 . . . . 10.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.832 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -71.49 -4.61 27.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.012 -1.055 . . . . 10.0 109.457 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 169' ' ' PHE . 44.9 mm -82.52 -46.0 19.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.549 -0.861 . . . . 10.0 108.967 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -83.63 -30.97 26.48 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.738 -1.185 . . . . 10.0 108.679 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -77.03 -0.28 23.95 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.393 -0.817 . . . . 10.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 1.011 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -90.04 -39.25 13.04 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.378 -0.826 . . . . 10.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -89.74 -19.94 24.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 10.0 109.393 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.283 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 55.43 33.28 20.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -1.012 . . . . 10.0 110.767 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.76 89.39 5.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.099 -1.001 . . . . 10.0 110.274 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.515 ' C ' ' HD2' ' B' ' 6' ' ' PRO . 3.1 mt-10 -92.81 118.83 31.52 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.209 -0.932 . . . . 10.0 110.245 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.716 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -71.72 -21.38 0.5 Allowed Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 121.38 -0.825 . . . . 10.0 111.903 178.516 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 44.3 Cg_endo -88.06 -9.77 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 O-C-N 122.597 0.788 . . . . 10.0 111.044 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.483 ' OE1' ' HB2' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -53.57 171.27 0.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 118.47 -1.292 . . . . 10.0 109.713 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.709 HG23 ' N ' ' B' ' 9' ' ' SER . 0.4 OUTLIER -78.16 -169.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.011 -1.477 . . . . 10.0 107.011 177.909 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.709 ' N ' HG23 ' B' ' 8' ' ' ILE . 33.3 t -129.02 98.9 5.08 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 118.994 -1.082 . . . . 10.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 45' ' ' MET . 41.1 tp -92.5 99.89 3.27 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 118.558 -1.257 . . . . 10.0 108.994 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' B' ' 9' ' ' SER . 37.8 Cg_endo -61.29 99.43 0.16 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.194 1.102 . . . . 10.0 110.795 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 12' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 4.9 m -152.36 99.83 2.53 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.327 -0.858 . . . . 10.0 111.422 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 13' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -169.17 121.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.62 -0.675 . . . . 10.0 110.353 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 14' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -159.42 102.93 1.58 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.005 -1.059 . . . . 10.0 110.558 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.69 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.64 106.5 0.22 Allowed 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.273 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -166.82 123.24 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 10.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.507 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -161.97 111.28 1.51 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.92 . . . . 10.0 110.183 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.776 HG21 ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -153.43 -173.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.044 -1.035 . . . . 10.0 110.296 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 64.2 m80 -115.35 142.8 46.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.082 -1.011 . . . . 10.0 110.569 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 1.1 p -142.88 149.11 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.485 -0.76 . . . . 10.0 111.346 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -87.95 -124.67 2.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.254 -1.938 . . . . 10.0 108.254 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER 173.54 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -1.152 . . . . 10.0 111.363 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 61' ' ' GLN . 9.4 t70 -144.05 159.41 42.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.683 -0.635 . . . . 10.0 109.537 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.626 ' HB1' ' HG3' ' B' ' 28' ' ' GLU . . . -61.03 -5.54 1.46 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.905 -1.122 . . . . 10.0 109.913 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.548 ' HA ' ' HB2' ' B' ' 28' ' ' GLU 0.276 0.5 OUTLIER -49.67 -34.98 9.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.883 1.325 . . . . 10.0 107.566 178.878 . . . . . . . . 4 4 . 1 . 019 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.644 ' HA ' ' HB3' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -52.63 -32.59 42.59 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.111 -1.404 . . . . 10.0 111.064 -179.133 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 27' ' ' LYS . . . -123.79 -7.92 6.48 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.655 -1.778 . . . . 10.0 108.655 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.626 ' HG3' ' HB1' ' B' ' 24' ' ' ALA . 18.3 mt-10 -83.74 39.94 0.71 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.68 -0.894 . . . . 10.0 110.453 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.992 ' HB2' HD21 ' A' ' 19' ' ' LEU . 46.3 t80 -76.07 94.97 3.53 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.756 -1.202 . . . . 10.0 107.756 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.605 HG21 ' CE1' ' A' ' 28' ' ' PHE . 34.3 p -112.89 -19.22 12.04 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.19 -0.914 . . . . 10.0 110.491 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.62 -167.53 14.68 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.129 -1.588 . . . . 10.0 109.129 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.632 HD13 ' N ' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -133.59 69.47 76.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.239 -1.153 . . . . 10.0 110.811 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.4 Cg_endo -74.22 156.57 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.088 1.572 . . . . 10.0 108.464 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -35.21 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.268 -0.895 . . . . 10.0 111.003 -178.522 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -73.26 -71.22 0.32 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.496 0.665 . . . . 10.0 112.039 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 7' ' ' VAL . 41.1 t90 -157.26 34.65 0.28 Allowed 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.772 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -157.8 83.69 0.88 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.543 ' HD3' ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.2 ptm . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.401 0.62 . . . . 10.0 110.149 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' LEU . 3.6 mt-30 -74.92 -33.66 62.02 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.849 HG23 HD13 ' A' ' 53' ' ' LEU . 1.2 m -40.79 118.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 4' ' ' ILE . . . . . 0.955 HG13 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -104.16 127.27 58.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.16 -1.816 . . . . 10.0 110.77 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mttp -121.42 97.78 5.67 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' HG11 ' A' ' 77' ' ' VAL . 19.6 m -118.19 120.43 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.848 -1.141 . . . . 10.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' VAL . . . . . 0.661 ' N ' HG21 ' A' ' 75' ' ' THR . 47.1 t -127.55 144.6 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.488 -0.93 . . . . 10.0 108.488 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 8' ' ' VAL . . . . . 0.867 HG21 ' OG1' ' A' ' 17' ' ' THR . 33.6 m -62.73 116.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.287 -0.883 . . . . 10.0 110.709 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 10' ' ' GLY . 77.2 t -115.72 177.69 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.182 -0.949 . . . . 10.0 109.136 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 10' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 167.78 172.64 35.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.23 18.49 13.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.118 -1.225 . . . . 10.0 109.731 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLY . . . . . 0.54 ' CA ' ' OE1' ' B' ' 34' ' ' GLU . . . 74.61 51.74 7.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 -54.41 2.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.529 -0.983 . . . . 10.0 110.785 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' B' ' 29' ' ' PHE . 6.3 m -136.26 -7.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 10.0 111.586 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' B' ' 32' ' ' ILE . . . 81.64 81.63 0.86 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 3.8 tptt -63.04 -27.24 69.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.54 -0.977 . . . . 10.0 112.008 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.867 ' OG1' HG21 ' A' ' 8' ' ' VAL . 93.9 m -55.15 -51.85 65.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.399 -1.438 . . . . 10.0 110.188 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . 0.666 ' CB ' ' HA ' ' B' ' 26' ' ' THR . 31.0 p -74.81 0.23 16.14 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.44 -0.904 . . . . 10.0 109.985 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' LEU . . . . . 0.992 HD13 ' CB ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -88.16 -36.07 17.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.003 -1.061 . . . . 10.0 109.097 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 16' ' ' LYS . 4.3 mm? -51.68 -38.55 55.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ILE . . . . . 0.627 HG22 ' HA2' ' B' ' 27' ' ' GLY . 0.5 OUTLIER -76.67 -51.34 19.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.641 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' SER . . . . . 0.728 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 49.3 m -46.27 -40.85 12.22 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 119.077 -1.049 . . . . 10.0 108.846 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' TYR . . . . . 1.021 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -64.22 -23.28 67.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.187 -0.946 . . . . 10.0 109.461 177.774 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 24' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' ILE . 63.2 m -105.04 -29.97 10.07 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.686 0.755 . . . . 10.0 109.889 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -137.73 64.5 1.51 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.73 -1.581 . . . . 10.0 106.73 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 22' ' ' SER . 43.2 p30 -33.96 49.75 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.583 1.553 . . . . 10.0 114.406 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.802 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -67.22 109.12 2.96 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.381 -0.824 . . . . 10.0 110.749 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 28' ' ' PHE . . . . . 0.583 ' CE1' HG22 ' B' ' 30' ' ' THR . 43.4 t80 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.237 -0.914 . . . . 10.0 110.406 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' THR . . . . . 0.609 ' OG1' HD12 ' A' ' 21' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 120.823 0.345 . . . . 10.0 111.9 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' B' ' 20' ' ' VAL . 78.6 t -95.29 10.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.654 -1.279 . . . . 10.0 109.017 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' B' ' 18' ' ' ILE . 1.3 m-30 -33.91 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.087 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASP . . . . . 0.927 ' HB2' ' HA ' ' B' ' 18' ' ' ILE . 1.5 m-20 -85.81 -149.02 0.13 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.903 -1.519 . . . . 10.0 108.594 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ASN . . . . . 0.749 ' CG ' HD11 ' A' ' 55' ' ' LEU . 1.3 t-20 -133.7 -163.62 1.38 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -128.05 163.27 24.94 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.605 -1.31 . . . . 10.0 112.194 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . . . -153.65 153.72 32.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -172.34 -168.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 120.528 -1.357 . . . . 10.0 111.625 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 43' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 42' ' ' VAL . 92.3 m -132.39 153.31 50.92 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.503 -0.771 . . . . 10.0 109.887 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -142.07 -171.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.039 . . . . 10.0 110.395 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 45' ' ' MET . . . . . 0.575 ' HB2' ' HG2' ' B' ' 11' ' ' PRO . 85.6 mtp -142.65 138.45 30.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.647 . . . . 10.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . 0.714 HD12 HG13 ' A' ' 44' ' ' VAL . 1.1 mp -146.91 115.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.222 -0.924 . . . . 10.0 109.714 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 41.01 27.58 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.656 -1.259 . . . . 10.0 109.98 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.37 -16.18 49.22 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.189 -1.183 . . . . 10.0 111.412 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' OE2' ' HB2' ' B' ' 4' ' ' GLU . 1.7 mp0 -98.69 105.04 28.0 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.553 -1.557 . . . . 10.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 52.2 Cg_endo -82.91 151.74 14.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.894 1.471 . . . . 10.0 112.269 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.624 ' CG ' HG12 ' A' ' 44' ' ' VAL . 2.8 m-30 -81.52 174.07 11.79 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.919 ' O ' HG22 ' A' ' 4' ' ' ILE . 16.2 m -152.73 124.1 7.67 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.611 -1.306 . . . . 10.0 112.249 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER 64.65 -169.21 0.2 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.93 0.871 . . . . 10.0 113.282 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 41' ' ' ALA . . . -169.72 -167.17 29.86 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.054 -1.618 . . . . 10.0 109.054 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.749 HD11 ' CG ' ' A' ' 39' ' ' ASN . 1.6 pp -111.22 156.57 21.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -1.116 . . . . 10.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' LEU . 56.9 m-85 -132.88 166.03 23.26 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.346 -0.613 . . . . 10.0 109.346 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 8.1 t70 -104.57 179.69 4.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.772 -1.205 . . . . 10.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' ASP . 12.0 t -45.26 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.469 1.128 . . . . 10.0 112.425 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -132.94 63.35 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 10.0 109.114 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . -49.42 -39.94 30.04 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.646 -2.582 . . . . 10.0 106.646 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . 0.553 ' CG ' ' HB2' ' A' ' 63' ' ' ASP . 2.7 tp60 -63.92 -35.62 81.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.7 mt-10 55.63 32.76 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.939 0.876 . . . . 10.0 109.819 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 5.6 t70 -90.08 -5.68 56.29 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.527 -0.916 . . . . 10.0 108.527 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -139.23 -38.33 0.49 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.13 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.2 p30 38.9 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.187 -0.605 . . . . 10.0 109.998 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -58.17 -36.87 73.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.745 -1.222 . . . . 10.0 109.173 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.671 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 5.1 mt -91.77 13.86 17.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.331 0.586 . . . . 10.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -81.47 -13.12 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 114.341 1.238 . . . . 10.0 114.341 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -69.71 67.76 1.7 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 109.031 -1.18 . . . . 10.0 109.031 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' B' ' 37' ' ' ALA . 4.9 mt -50.46 -71.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.559 0.695 . . . . 10.0 111.665 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 21.7 p -35.31 -29.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.958 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -98.29 105.83 31.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.415 -0.803 . . . . 10.0 108.859 178.67 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 43.4 Cg_endo -77.83 113.93 3.55 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.859 1.452 . . . . 10.0 110.721 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 72' ' ' TYR . 4.9 mt-30 -133.77 60.61 1.7 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.477 -0.764 . . . . 10.0 110.288 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.8 m -144.25 97.33 3.03 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.934 -1.104 . . . . 10.0 109.545 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 76' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' THR . 14.5 t70 -28.83 -38.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.662 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 77' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -121.09 136.96 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.269 -0.894 . . . . 10.0 109.706 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 41.8 m-85 -115.7 144.67 43.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LEU . . . . . 0.923 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -114.01 102.34 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 10.0 109.129 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 4.4 p -96.8 151.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.982 . . . . 10.0 108.812 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' CYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 19.8 t -134.8 100.37 4.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.847 -1.158 . . . . 10.0 112.496 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 47.8 m-85 -88.45 156.18 19.26 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.316 -0.865 . . . . 10.0 109.884 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 18.8 m -85.01 147.12 26.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.843 -1.161 . . . . 10.0 109.282 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 115' ' ' THR . 43.7 t -47.62 -60.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.077 -1.014 . . . . 10.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 129' ' ' LEU . 3.8 t -78.75 -62.52 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . 0.618 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER 44.8 179.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.847 0 CA-C-O 121.58 0.705 . . . . 10.0 112.375 178.218 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 52.2 Cg_endo -78.72 145.99 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.462 1.77 . . . . 10.0 109.985 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 88' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 135' ' ' LYS . 95.2 p -68.38 67.81 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 10.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -136.69 13.37 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 10.0 111.666 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 82' ' ' PHE . 16.9 t80 -71.33 -34.15 70.29 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.619 -1.301 . . . . 10.0 110.64 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 4.5 mt-10 -74.69 -29.89 61.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.026 -1.046 . . . . 10.0 110.982 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' ASN . . . . . 0.491 ' C ' ' HG2' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -86.89 -9.69 55.12 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.741 -1.183 . . . . 10.0 109.496 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 93' ' ' VAL . . . . . 0.544 HG13 ' CD2' ' A' ' 97' ' ' TRP . 14.4 t -90.35 -36.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.996 -1.065 . . . . 10.0 109.102 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' LYS . . . . . 0.817 ' HE2' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.26 -25.39 62.45 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 10.0 110.095 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 12.9 pt-20 -78.52 -25.06 45.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 10.0 111.616 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 25.2 mttp -110.93 -50.65 2.93 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.892 -1.13 . . . . 10.0 111.998 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 97' ' ' TRP . . . . . 0.595 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 23.1 m0 -64.42 -17.19 63.55 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.297 -0.877 . . . . 10.0 112.405 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' VAL . . . . . 0.871 HG11 ' CD2' ' A' ' 149' ' ' LEU . 53.8 t -82.91 -50.7 0.72 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.772 -1.205 . . . . 10.0 112.033 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.8 Cg_endo -68.58 -6.47 17.83 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.119 1.063 . . . . 10.0 111.209 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 mm-40 -90.48 -32.0 16.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.876 -1.14 . . . . 10.0 110.464 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ILE . . . . . 0.744 ' O ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -91.96 -29.14 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.038 -1.039 . . . . 10.0 110.239 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 98' ' ' VAL . 69.9 p -62.26 -12.18 19.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 10.0 109.915 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -57.56 -40.68 79.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.558 -0.714 . . . . 10.0 110.639 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.96 -33.76 39.29 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 10.0 110.803 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.3 t -136.29 128.49 17.37 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 10.0 110.092 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.29 126.5 13.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.117 1.588 . . . . 10.0 111.851 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER 55.84 52.07 11.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.37 -0.831 . . . . 10.0 111.119 178.707 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 108' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 22.4 m -63.31 145.17 97.24 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 10.0 109.61 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 41.1 Cg_endo -68.37 157.63 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.642 1.338 . . . . 10.0 109.365 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' PHE . . . . . 0.59 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -159.95 121.97 3.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.94 -1.1 . . . . 10.0 111.237 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -92.29 102.51 15.01 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.149 0.975 . . . . 10.0 110.682 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 112' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 71.2 mt -75.56 135.24 40.58 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.817 -0.809 . . . . 10.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 113' ' ' VAL . . . . . 0.684 ' CG2' HG11 ' A' ' 168' ' ' VAL . 19.4 t -133.75 169.96 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.654 -1.279 . . . . 10.0 112.694 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -140.35 107.11 0.52 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.583 -2.207 . . . . 10.0 107.583 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 t -106.75 -179.51 3.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.267 . . . . 10.0 111.708 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 116' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 83' ' ' SER . 16.9 mt-30 61.56 48.16 5.98 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.798 -0.564 . . . . 10.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ILE . . . . . 1.068 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -107.37 -50.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.167 -0.958 . . . . 10.0 110.118 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ASP . . . . . 0.982 ' CB ' HG21 ' A' ' 161' ' ' THR . 11.6 t0 -52.7 61.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.191 0.996 . . . . 10.0 109.947 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 119' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER 152.57 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.339 -1.3 . . . . 10.0 108.41 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -46.73 -37.4 8.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 10.0 109.135 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.0 -21.99 9.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.42 -0.8 . . . . 10.0 109.542 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 123' ' ' PRO . 22.9 t0 -84.28 131.77 49.63 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 10.0 110.889 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.534 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.7 Cg_endo -78.22 24.66 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.925 1.487 . . . . 10.0 111.265 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' SER . . . . . 0.482 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 37.1 m -102.76 -46.96 4.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.002 -1.061 . . . . 10.0 109.843 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 125' ' ' THR . . . . . 0.597 HG21 HD12 ' A' ' 119' ' ' LEU . 6.8 t -78.41 -27.42 46.65 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.493 -2.039 . . . . 10.0 105.493 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.29 1.1 mp -57.06 -25.26 22.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 177.072 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 127' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 5.4 tm-20 -50.24 -50.18 50.65 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.747 0.784 . . . . 10.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -65.06 -44.77 87.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.691 -0.63 . . . . 10.0 111.062 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 85' ' ' VAL . 5.6 mt -59.92 -35.51 75.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.235 -0.916 . . . . 10.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 130' ' ' ALA . . . . . 0.66 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -49.62 -42.24 44.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.606 -0.684 . . . . 10.0 110.294 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -19.9 42.17 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.46 -0.775 . . . . 10.0 110.498 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ASN . . . . . 0.527 ' OD1' ' HA ' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -123.07 43.89 2.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.953 -1.092 . . . . 10.0 112.348 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.1 mptm? 67.72 150.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 10.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -116.77 66.24 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 10.0 111.387 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 88' ' ' SER . 5.0 mmmt -104.83 94.68 7.8 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.112 -0.992 . . . . 10.0 108.958 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 43.7 Cg_endo -71.22 161.43 45.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.075 1.566 . . . . 10.0 110.681 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 137' ' ' ILE . 3.9 tp -120.13 121.41 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.215 -0.928 . . . . 10.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.4 p -108.46 164.29 15.06 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.22 -0.925 . . . . 10.0 109.206 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 38.3 Cg_endo -67.51 -29.16 37.61 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.589 1.31 . . . . 10.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.78 -34.12 72.6 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.5 m -93.38 -33.51 13.84 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.746 0.784 . . . . 10.0 109.054 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -75.38 -38.56 59.93 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.601 -0.687 . . . . 10.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.0 mt-10 -59.54 -49.23 78.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.258 -0.901 . . . . 10.0 109.836 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -45.26 93.42 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 10.0 109.156 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' HE2' ' A' ' 94' ' ' LYS . 2.8 tt -60.05 -49.37 77.93 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.228 -1.026 . . . . 10.0 108.228 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -55.25 -38.71 68.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 10.0 109.128 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 1.6 mtp-105 -72.23 -4.85 31.89 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.603 -0.686 . . . . 10.0 109.873 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.15 -52.04 7.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 10.0 110.278 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' LEU . . . . . 0.871 ' CD2' HG11 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -89.94 4.86 48.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 10.0 109.309 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 150' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 1.8 mttp 73.16 31.17 1.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 151' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -55.89 -159.82 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.952 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' VAL . . . . . 0.593 HG11 HD13 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -119.08 -54.74 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 118.941 -1.103 . . . . 10.0 111.516 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 153' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -171.53 147.14 2.32 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.934 -1.506 . . . . 10.0 112.621 -179.512 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 154' ' ' TYR . . . . . 0.555 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 43.2 t80 -97.64 100.05 11.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.735 -0.603 . . . . 10.0 109.45 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 155' ' ' VAL . . . . . 1.007 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.9 t -101.39 -170.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 10.0 110.367 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 156' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 155' ' ' VAL . 12.8 pt-20 -148.22 168.2 23.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 10.0 110.184 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 157' ' ' CYS . . . . . 0.594 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.3 p -176.99 164.8 2.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.157 -0.965 . . . . 10.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 158' ' ' SER . . . . . 0.628 ' CB ' HG23 ' A' ' 161' ' ' THR . 60.2 m -146.27 128.23 15.49 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.605 -0.685 . . . . 10.0 109.939 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ALA . . . . . 0.992 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -63.86 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.621 -0.674 . . . . 10.0 111.597 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' B' ' 29' ' ' PHE . 0.4 OUTLIER -28.06 -52.95 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.57 1.176 . . . . 10.0 109.481 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 161' ' ' THR . . . . . 0.982 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -95.74 -102.28 0.16 Allowed 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.731 -1.122 . . . . 10.0 110.43 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 162' ' ' GLN . . . . . 0.626 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 159.27 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 -178.989 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 163' ' ' LYS . . . . . 0.552 ' HD2' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -97.35 27.37 4.25 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.566 -1.254 . . . . 10.0 112.545 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 164' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 157' ' ' CYS . . . 135.95 14.96 0.95 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 118.708 -1.711 . . . . 10.0 111.99 177.945 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' LEU . . . . . 1.021 HD22 ' CB ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -49.36 -53.44 22.34 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.177 -1.778 . . . . 10.0 109.833 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -67.14 -29.49 69.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.463 0.649 . . . . 10.0 109.588 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ASN . . . . . 0.589 ' C ' HG11 ' A' ' 155' ' ' VAL . 14.3 m-20 -62.3 -32.11 72.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 10.0 111.4 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.5 t -70.88 -49.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.448 -1.408 . . . . 10.0 109.171 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' O ' HG13 ' A' ' 173' ' ' ILE . 92.4 t80 -59.31 -22.92 61.97 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.762 -0.586 . . . . 10.0 110.452 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 167' ' ' ASN . 80.8 m-20 -59.17 -50.93 72.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 10.0 110.416 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 51.2 mp0 -65.88 -31.52 72.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.036 -1.04 . . . . 10.0 108.883 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 172' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -63.63 -24.19 67.69 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.814 -0.554 . . . . 10.0 109.625 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 177' ' ' LEU . 72.1 mt -63.61 -43.71 98.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.091 -1.044 . . . . 10.0 108.542 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' LEU . . . . . 0.799 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.75 -42.33 67.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.188 -0.945 . . . . 10.0 110.179 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.1 -0.12 30.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.526 -0.733 . . . . 10.0 109.985 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 176' ' ' ALA . . . . . 0.955 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -83.33 -44.57 14.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.898 . . . . 10.0 109.851 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -98.85 -17.56 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.822 . . . . 10.0 109.302 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 118.003 -0.998 . . . . 10.0 110.028 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -126.54 150.2 48.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -1.131 . . . . 10.0 110.196 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -117.96 88.41 2.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.365 -0.835 . . . . 10.0 109.272 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 4' ' ' GLU . . . . . 0.442 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 2.8 mm-40 -87.36 178.18 6.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.84 0.828 . . . . 10.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 5' ' ' ARG . . . . . 0.632 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.12 -149.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 6' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -72.14 0.37 7.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 CA-C-N 119.325 0.795 . . . . 10.0 110.589 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 7' ' ' GLU . . . . . 0.486 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.8 mm-40 46.21 -165.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 10.0 110.427 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 8' ' ' ILE . . . . . 0.663 HD12 ' OG ' ' B' ' 9' ' ' SER . 1.4 pp -80.35 -45.01 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 10.0 111.661 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 9' ' ' SER . . . . . 0.663 ' OG ' HD12 ' B' ' 8' ' ' ILE . 67.4 m -122.08 151.32 41.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.221 . . . . 10.0 112.137 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 10' ' ' LEU . . . . . 0.875 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -170.84 97.53 0.43 Allowed Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.363 -0.836 . . . . 10.0 113.153 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 11' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -77.35 156.08 32.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 N-CA-C 107.877 -1.624 . . . . 10.0 107.877 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -117.68 163.49 16.39 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.587 -1.321 . . . . 10.0 111.966 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.32 176.46 10.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.073 -1.084 . . . . 10.0 108.073 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -170.63 144.61 2.38 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.784 -1.198 . . . . 10.0 110.792 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 59.8 tt0 -141.02 137.48 32.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -121.77 129.44 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.036 -1.04 . . . . 10.0 112.103 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 17' ' ' THR . . . . . 0.647 ' C ' HD12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -141.54 98.22 3.31 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.223 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 18' ' ' ILE . . . . . 0.927 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.4 mp -106.45 140.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 19' ' ' HIS . . . . . 0.585 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 m-70 -132.89 123.59 26.29 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.353 -0.842 . . . . 10.0 110.94 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 20' ' ' VAL . . . . . 0.71 HG23 ' HB ' ' A' ' 36' ' ' VAL . 1.4 p -140.37 130.18 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 10.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -145.56 10.87 1.71 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.846 -1.302 . . . . 10.0 109.846 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 22' ' ' PHE . . . . . 0.769 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -143.93 85.26 1.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.334 -1.098 . . . . 10.0 109.794 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 23' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 10.7 t70 -56.97 151.88 14.01 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.565 0.698 . . . . 10.0 111.416 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 24' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 69.98 19.84 6.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.557 -0.714 . . . . 10.0 111.099 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 25' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' B' ' 22' ' ' PHE . 25.3 t -110.47 -39.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.057 -1.027 . . . . 10.0 110.281 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CB ' ' A' ' 18' ' ' CYS . 6.5 m -94.95 -10.04 32.23 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.314 -0.866 . . . . 10.0 112.605 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 27' ' ' GLY . . . . . 0.627 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -111.59 -15.89 9.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.629 -1.788 . . . . 10.0 108.629 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -86.3 108.44 18.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.638 1.209 . . . . 10.0 110.683 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 29' ' ' PHE . . . . . 0.94 ' CE2' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -117.8 113.65 22.11 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.31 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' CE1' ' A' ' 28' ' ' PHE . 42.3 p -154.78 -61.94 0.12 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.483 -0.78 . . . . 10.0 109.78 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 31' ' ' GLY . . . . . 0.468 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -165.52 66.62 0.21 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.611 -1.796 . . . . 10.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 32' ' ' ILE . . . . . 0.572 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 11.2 pt -102.77 168.26 9.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.349 -1.089 . . . . 10.0 110.947 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 33' ' ' PRO . . . . . 0.572 ' HD2' ' HB ' ' B' ' 32' ' ' ILE . 38.6 Cg_endo -65.42 178.12 2.27 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.004 1.528 . . . . 10.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 34' ' ' GLU . . . . . 0.54 ' OE1' ' CA ' ' A' ' 12' ' ' GLY . 6.6 tp10 -36.56 160.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.744 0.783 . . . . 10.0 111.89 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -72.63 -70.68 0.33 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.583 -0.698 . . . . 10.0 112.768 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 36' ' ' TRP . . . . . 0.653 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.27 22.44 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 10.0 110.101 -179.003 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' B' B ' 37' ' ' ALA . . . . . 0.667 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . 178.96 99.7 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.817 0.818 . . . . 10.0 110.026 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 38' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.8 ttt180 . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 106.902 -1.518 . . . . 10.0 106.902 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.431 0.634 . . . . 10.0 110.088 . . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 98.7 mm-40 -129.57 -24.32 2.77 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.552 -0.717 . . . . 10.0 109.997 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 95.1 m -57.84 115.93 3.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 10.0 111.289 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.588 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -122.85 132.77 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.592 -0.843 . . . . 10.0 109.898 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.888 ' HB3' HG22 ' A' ' 75' ' ' THR . 46.4 mmtt -123.2 101.65 7.5 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.4 t -113.24 145.17 41.47 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.885 0.85 . . . . 10.0 112.801 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -151.59 -176.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HD1' ' B' ' 36' ' ' TRP . 22.7 m -91.59 108.55 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 10.0 109.877 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 10' ' ' GLY . 2.1 t -113.47 -170.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.977 -1.077 . . . . 10.0 110.19 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 137.62 -144.77 16.26 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.73 20.22 16.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 10.0 109.637 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.19 75.87 0.99 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.034 -1.626 . . . . 10.0 109.034 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.63 -174.59 3.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.427 -1.043 . . . . 10.0 109.766 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.534 ' HB ' ' CD2' ' B' ' 29' ' ' PHE . 40.6 t -67.13 161.77 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 10.0 110.647 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -53.02 111.97 1.98 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.427 -1.869 . . . . 10.0 108.427 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -48.61 -28.0 3.18 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.179 -1.189 . . . . 10.0 110.428 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.489 HG23 HD12 ' A' ' 20' ' ' LEU . 26.1 m -66.01 -30.62 71.2 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.15 -0.969 . . . . 10.0 111.072 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 16.3 p -63.2 -9.89 13.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.175 . . . . 10.0 109.733 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' B' ' 29' ' ' PHE . 5.3 mt -94.81 -34.08 12.62 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.424 -0.797 . . . . 10.0 110.184 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD12 HG23 ' A' ' 17' ' ' THR . 79.4 mt -46.49 -30.46 2.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 26' ' ' ASN 0.251 1.7 mm -85.76 -47.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.749 0.785 . . . . 10.0 109.552 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 21' ' ' ILE . 57.1 m -48.26 -38.34 18.4 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.887 -1.125 . . . . 10.0 108.115 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.778 ' CG ' HD11 ' A' ' 165' ' ' LEU . 20.2 m-85 -68.06 -31.0 70.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 25' ' ' THR . 95.9 m -76.83 -51.87 10.52 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.847 -0.533 . . . . 10.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 24' ' ' THR . 2.9 t -178.99 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 115.875 1.805 . . . . 10.0 115.875 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 33' ' ' VAL . 15.4 m120 -67.47 -8.32 32.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.088 -1.632 . . . . 10.0 113.085 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.644 ' HG3' ' HD3' ' A' ' 29' ' ' PRO . 26.4 pttt 33.59 -131.6 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 121.195 -0.941 . . . . 10.0 111.262 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.7 p90 -145.33 50.65 1.14 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 120.5 -1.375 . . . . 10.0 112.815 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.644 ' HD3' ' HG3' ' A' ' 27' ' ' LYS . 46.4 Cg_endo -103.53 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.775 1.65 . . . . 10.0 110.396 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.2 p -166.98 36.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 10.0 110.149 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.798 ' O ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -78.61 -169.65 1.8 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.571 1.176 . . . . 10.0 111.853 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 5.8 t80 -109.33 120.07 41.38 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.825 -1.079 . . . . 10.0 109.006 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' HD2' ' A' ' 34' ' ' PRO 0.286 2.4 p -145.42 161.59 40.68 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.191 -0.943 . . . . 10.0 109.688 -177.926 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.827 ' HD2' HG22 ' A' ' 33' ' ' VAL . 33.5 Cg_endo -55.65 168.76 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 122.935 0.966 . . . . 10.0 110.63 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' B' ' 19' ' ' HIS . 0.3 OUTLIER -92.96 165.23 12.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 123.266 1.507 . . . . 10.0 114.945 -176.373 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.978 ' CG2' HG11 ' B' ' 25' ' ' VAL 0.279 2.5 t -45.99 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 116.226 1.936 . . . . 10.0 116.226 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.855 ' N ' HG12 ' A' ' 36' ' ' VAL . 4.6 t80 -32.29 154.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.944 0.878 . . . . 10.0 111.603 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -168.03 83.0 0.18 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.565 ' HB3' HD13 ' B' ' 18' ' ' ILE . 50.8 t30 -113.66 109.11 18.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.159 -0.963 . . . . 10.0 110.017 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.718 ' CD2' ' HA ' ' B' ' 16' ' ' HIS . 3.6 t80 -128.43 128.35 44.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.694 -0.629 . . . . 10.0 110.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -141.58 94.68 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG13 ' HB2' ' B' ' 14' ' ' PHE 0.296 51.6 t -163.94 178.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.394 0.616 . . . . 10.0 110.227 -176.845 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 18.9 m -125.24 126.47 45.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.522 -0.736 . . . . 10.0 109.502 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.939 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -73.76 165.71 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 10.0 110.024 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.548 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 51.5 mtt -137.69 104.79 5.41 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.199 -1.0 . . . . 10.0 109.531 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' B' ' 7' ' ' GLU . 38.7 mt -123.75 128.79 74.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.751 -0.593 . . . . 10.0 109.734 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 52.18 21.39 8.13 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 8.61 67.87 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.155 -1.203 . . . . 10.0 110.302 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.47 112.56 65.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.836 -1.39 . . . . 10.0 110.976 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 44.1 Cg_endo -74.4 139.35 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.951 1.501 . . . . 10.0 110.251 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.939 ' HB2' HG12 ' A' ' 44' ' ' VAL . 3.6 t80 -117.49 121.37 40.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -0.95 . . . . 10.0 109.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -74.82 119.82 19.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.625 -1.297 . . . . 10.0 110.151 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 13.3 mt -123.11 149.31 44.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.915 . . . . 10.0 110.592 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 5' ' ' LYS . . . -170.89 110.47 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.752 -1.213 . . . . 10.0 110.332 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -150.41 168.43 24.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -1.211 . . . . 10.0 110.076 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 67' ' ' LEU . 32.9 p90 -166.36 140.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.882 -1.136 . . . . 10.0 111.218 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 3.8 t70 -119.72 159.99 23.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.394 -0.816 . . . . 10.0 110.444 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -56.31 -168.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.841 0.829 . . . . 10.0 112.131 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.735 ' HB2' ' CD1' ' A' ' 64' ' ' TYR . . . 53.5 70.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.637 -0.664 . . . . 10.0 110.865 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 66' ' ' ARG . . . -75.33 -9.04 84.3 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.326 -1.91 . . . . 10.0 108.326 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.602 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 8.9 tt0 -156.45 24.51 0.35 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.422 -1.046 . . . . 10.0 110.22 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 4.4 tt0 79.3 -7.63 1.71 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.494 -0.754 . . . . 10.0 109.963 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 1.1 m-20 -94.28 -11.47 30.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 10.0 108.759 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.735 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 46.7 m-85 62.65 26.67 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.142 -1.059 . . . . 10.0 108.142 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 30.5 t0 -114.88 -36.49 4.45 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.111 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 6.3 mmt85 -56.4 -26.18 52.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.905 -1.122 . . . . 10.0 108.934 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.67 HD11 ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.81 10.88 36.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.827 -0.546 . . . . 10.0 109.751 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.666 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -82.79 -20.37 0.28 Allowed Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 113.356 0.873 . . . . 10.0 113.356 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 45.9 Cg_endo -75.33 2.07 7.2 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 N-CA-C 110.37 -0.665 . . . . 10.0 110.37 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.002 HD11 HD13 ' B' ' 39' ' ' LEU . 0.5 OUTLIER -52.78 -64.47 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.199 -0.938 . . . . 10.0 112.184 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.552 ' HA ' ' N ' ' B' ' 40' ' ' LEU . 24.8 t 41.98 27.08 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.367 -1.458 . . . . 10.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 71' ' ' SER . 2.1 t80 -179.84 120.6 0.22 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 10.0 110.744 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.28 118.33 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.838 1.441 . . . . 10.0 110.225 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.71 66.74 1.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.964 -1.085 . . . . 10.0 110.584 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -145.33 99.99 3.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.16 -0.963 . . . . 10.0 109.703 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.66 ' CA ' HG21 ' A' ' 108' ' ' THR . 21.6 m-20 -24.63 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.953 0.724 . . . . 10.0 112.953 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.542 HG11 ' CB ' ' A' ' 176' ' ' ALA . 1.0 OUTLIER -94.03 118.0 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.964 -1.085 . . . . 10.0 110.781 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.504 ' CB ' HG21 ' A' ' 9' ' ' VAL . 97.3 m-85 -111.33 127.6 55.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 10.0 111.203 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 111' ' ' LEU . 1.9 mm? -95.44 97.69 9.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 10.0 108.342 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' HB ' ' A' ' 9' ' ' VAL . 1.6 m -106.41 148.18 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.397 -0.814 . . . . 10.0 109.822 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 7.2 t -138.17 122.37 18.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.855 -1.153 . . . . 10.0 110.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 43.0 p90 -124.46 172.95 8.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.239 -0.913 . . . . 10.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.851 ' OG ' HG22 ' A' ' 85' ' ' VAL . 47.3 t -105.24 148.81 26.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.7 -1.25 . . . . 10.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 19.4 m -86.79 19.02 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.478 -0.764 . . . . 10.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG22 ' OG ' ' A' ' 83' ' ' SER . 35.3 m -128.0 48.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.39 -0.819 . . . . 10.0 110.513 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.53 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 49.6 m -123.2 166.18 19.27 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.287 -0.883 . . . . 10.0 110.358 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.514 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 48.2 Cg_endo -72.44 105.9 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.965 1.508 . . . . 10.0 111.056 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 39.46 42.9 0.93 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.304 -0.873 . . . . 10.0 110.836 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 86' ' ' SER . 65.6 m -79.15 -49.51 12.47 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.022 . . . . 10.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.652 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 34.9 t80 -57.53 -30.38 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.336 -0.853 . . . . 10.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 57.4 mm-40 -70.47 -15.09 62.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.051 -1.031 . . . . 10.0 110.504 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.697 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.63 -21.46 30.28 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.18 -1.008 . . . . 10.0 111.38 -178.796 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.697 HG13 ' ND2' ' A' ' 92' ' ' ASN . 4.2 m -87.68 -16.38 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 117.765 -1.574 . . . . 10.0 108.544 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.816 ' HE2' HD22 ' A' ' 145' ' ' LEU . 1.2 mmtp -68.68 -37.45 79.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 4.4 pt-20 -95.51 8.29 43.73 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.306 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -111.18 -52.09 2.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.58 -1.248 . . . . 10.0 112.595 -178.951 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 19.7 m95 -95.59 -18.79 20.29 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.502 -0.749 . . . . 10.0 111.527 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.1 t -85.45 -46.85 0.61 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 120.97 -1.081 . . . . 10.0 111.5 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 51.4 Cg_endo -74.85 -24.15 13.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 108.759 -1.285 . . . . 10.0 108.759 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' C ' HG12 ' A' ' 101' ' ' ILE . 8.6 tt0 -87.59 -22.53 24.72 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.526 HG12 ' C ' ' A' ' 100' ' ' GLU . 4.2 mm 60.55 125.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.825 HG21 ' OG1' ' A' ' 108' ' ' THR . 1.2 m -40.84 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.04 -1.037 . . . . 10.0 109.761 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.7 ' N ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -108.32 10.74 27.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.222 -0.924 . . . . 10.0 109.778 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 17.5 m80 82.52 14.08 0.47 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.902 0.382 . . . . 10.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.537 ' HB3' ' CD ' ' A' ' 106' ' ' PRO . 1.6 t -170.65 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 118.814 -1.154 . . . . 10.0 112.029 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 105' ' ' CYS . 37.7 Cg_endo -63.77 -21.74 69.51 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.338 1.178 . . . . 10.0 111.532 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 106' ' ' PRO . 2.0 mttt 47.49 51.13 14.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.733 -1.229 . . . . 10.0 108.843 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.825 ' OG1' HG21 ' A' ' 102' ' ' THR . 1.4 m -45.65 150.48 0.93 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 108' ' ' THR . 39.6 Cg_endo -63.66 149.92 89.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.746 1.393 . . . . 10.0 112.748 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -131.73 109.5 10.21 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.068 HD13 HG11 ' A' ' 152' ' ' VAL . 1.9 mm? -77.2 95.4 4.29 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.028 -1.069 . . . . 10.0 109.388 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' C ' ' CG2' ' A' ' 113' ' ' VAL . 19.1 mt -75.62 142.02 42.73 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.154 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -148.32 -177.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.596 -1.315 . . . . 10.0 112.332 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -125.4 120.61 3.95 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.752 -1.739 . . . . 10.0 108.752 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 23.4 p -78.32 139.2 38.85 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.829 -1.395 . . . . 10.0 110.952 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 115' ' ' THR . 56.7 mt-30 34.41 57.38 0.67 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.204 0.526 . . . . 10.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -79.75 -27.72 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 10.0 110.592 -178.822 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.813 ' OD2' HG21 ' A' ' 161' ' ' THR . 25.1 t0 -51.88 61.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.835 0.826 . . . . 10.0 111.966 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.706 ' N ' ' O ' ' A' ' 117' ' ' ILE . 20.1 tp 152.79 -39.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.705 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 1.2 mpt_? -46.04 -25.66 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.855 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 4.1 p30 -84.69 -0.13 52.4 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.306 -0.872 . . . . 10.0 111.145 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.831 ' O ' HD13 ' A' ' 126' ' ' ILE . 5.8 p-10 -83.32 160.14 60.35 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.88 -1.138 . . . . 10.0 109.944 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.83 22.73 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.55 1.289 . . . . 10.0 111.769 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.479 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 4.2 m -109.68 -47.6 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.976 -1.078 . . . . 10.0 109.79 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.809 HG22 ' OD1' ' A' ' 122' ' ' ASP . 6.6 t -78.44 -27.14 46.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.828 -1.915 . . . . 10.0 105.828 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 122' ' ' ASP 0.283 1.0 OUTLIER -53.19 -28.82 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.391 -1.337 . . . . 10.0 107.391 177.02 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -52.99 -40.41 63.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.578 0.704 . . . . 10.0 111.308 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -60.4 -34.13 73.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.472 -0.767 . . . . 10.0 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.79 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -61.89 -39.16 90.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.831 -1.168 . . . . 10.0 109.659 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -52.83 -44.56 66.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.568 -0.708 . . . . 10.0 111.232 -179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -54.66 -18.12 4.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.149 -0.97 . . . . 10.0 110.376 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.433 ' C ' ' HD2' ' A' ' 133' ' ' LYS . 2.6 t-20 -126.9 -53.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.735 -1.228 . . . . 10.0 110.279 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -137.03 116.01 12.36 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.596 -0.69 . . . . 10.0 110.518 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.535 ' O ' ' HD3' ' A' ' 136' ' ' PRO . 0.9 OUTLIER -74.97 -3.02 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.697 -0.627 . . . . 10.0 110.5 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 93.97 6.55 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.579 -0.701 . . . . 10.0 109.277 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 49.3 Cg_endo -73.75 161.71 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.898 1.473 . . . . 10.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.53 HG12 ' CG ' ' A' ' 90' ' ' PHE . 1.5 tp -100.83 134.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.266 -0.896 . . . . 10.0 109.505 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.513 ' H ' HD12 ' A' ' 137' ' ' ILE . 20.1 p -120.04 165.56 17.59 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.352 -0.843 . . . . 10.0 109.807 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.71 -35.13 29.41 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.829 1.436 . . . . 10.0 111.063 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.09 -15.81 63.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.113 -0.992 . . . . 10.0 110.999 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.3 m -98.36 -36.54 9.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -64.57 -29.12 70.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.802 . . . . 10.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.81 -41.47 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.019 -1.05 . . . . 10.0 109.314 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -56.16 -36.96 68.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 10.0 109.465 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.816 HD22 ' HE2' ' A' ' 94' ' ' LYS . 4.2 tp -62.06 -49.55 75.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.116 -0.99 . . . . 10.0 108.902 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.11 -44.44 94.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.036 . . . . 10.0 109.406 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -78.04 -7.96 57.58 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.525 -0.734 . . . . 10.0 110.297 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.9 t70 -98.6 -37.88 9.36 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.388 1.09 . . . . 10.0 109.235 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.033 HD22 ' O ' ' A' ' 149' ' ' LEU 0.26 0.0 OUTLIER -103.07 -1.15 29.64 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.513 -178.658 . . . . . . . . 4 4 . 1 . 001 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 24.4 mttm 67.78 54.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 10.0 111.359 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -86.24 -150.36 0.15 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.068 HG11 HD13 ' A' ' 111' ' ' LEU . 9.9 p -116.54 -51.56 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.567 -1.333 . . . . 10.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.893 ' HD3' HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -172.42 142.31 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.603 -1.31 . . . . 10.0 111.238 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 142' ' ' ALA . 46.6 t80 -94.26 110.15 21.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 10.0 109.069 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.893 HG13 ' HD3' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -116.19 -168.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.973 -1.08 . . . . 10.0 112.087 -178.595 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -153.27 147.04 25.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 10.0 110.781 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 25.6 p -148.07 152.51 37.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 10.0 111.275 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' ' OG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -135.14 86.23 2.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.192 -1.41 . . . . 10.0 107.192 178.66 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.643 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . . . -24.37 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.7 tp -94.12 -55.05 3.34 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.403 -1.436 . . . . 10.0 112.196 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.813 HG21 ' OD2' ' A' ' 118' ' ' ASP . 24.5 p -64.68 -26.68 68.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.96 -1.087 . . . . 10.0 111.008 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.536 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.8 mt-30 79.26 77.05 0.05 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.528 -0.732 . . . . 10.0 112.024 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.523 ' HD2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -78.35 47.99 0.73 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 10.0 110.006 178.319 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 163' ' ' LYS . . . 43.49 41.68 5.46 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.706 -1.358 . . . . 10.0 109.706 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.778 HD11 ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.11 2.51 3.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 10.0 112.704 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 165' ' ' LEU . 26.9 tttp -58.47 -23.64 58.28 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.782 -1.199 . . . . 10.0 108.694 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -76.86 -17.61 58.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.692 -0.63 . . . . 10.0 111.038 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.825 HG22 ' HB ' ' A' ' 155' ' ' VAL . 42.8 t -67.9 -41.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.822 -1.174 . . . . 10.0 108.775 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -86.55 -47.57 9.12 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.599 0.714 . . . . 10.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.867 ' HA ' HD12 ' A' ' 173' ' ' ILE . 22.1 t0 -51.88 -35.14 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.336 -0.852 . . . . 10.0 111.789 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.6 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.3 mm-40 -90.02 -11.28 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.058 . . . . 10.0 110.771 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.831 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -91.74 -15.27 28.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.038 -1.097 . . . . 10.0 108.038 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 170' ' ' ASP . 53.9 mt -73.63 -49.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.097 -0.641 . . . . 10.0 109.322 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 171' ' ' GLU . 2.1 pt? -76.35 -19.12 58.5 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 118.813 -1.155 . . . . 10.0 111.113 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.41 -14.78 34.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 10.0 110.085 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.542 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -70.25 -44.87 67.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 10.0 109.653 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.7 OUTLIER -74.64 -29.09 61.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.744 0.783 . . . . 10.0 109.055 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -129.81 151.77 50.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 10.0 110.601 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.44 92.49 4.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 10.0 110.065 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.02 165.94 12.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.499 -0.75 . . . . 10.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.664 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.62 -149.76 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.664 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -73.23 96.18 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 N-CA-C 109.772 -0.896 . . . . 10.0 109.772 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.751 ' HB2' HG22 ' A' ' 46' ' ' ILE . 19.6 mm-40 -49.56 -169.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.605 0.717 . . . . 10.0 110.249 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.706 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -77.64 -42.47 29.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.756 -1.215 . . . . 10.0 111.949 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.66 ' N ' HG12 ' B' ' 8' ' ' ILE . 20.7 t -134.78 172.67 12.65 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.06 -1.025 . . . . 10.0 111.348 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.644 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.5 pp -167.25 98.02 0.64 Allowed Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.293 -0.963 . . . . 10.0 111.805 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 38.4 Cg_endo -69.19 134.69 29.85 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 N-CA-C 108.001 -1.577 . . . . 10.0 108.001 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' B' ' 11' ' ' PRO . 0.9 OUTLIER -53.13 -169.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.689 -1.257 . . . . 10.0 111.388 -178.465 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.69 ' OD1' HG11 ' A' ' 42' ' ' VAL . 6.0 p30 -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.992 0.901 . . . . 10.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.878 ' HB2' HG13 ' A' ' 42' ' ' VAL . 49.9 m-85 -54.92 -165.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.8 0.81 . . . . 10.0 111.547 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.682 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.5 tt0 -43.59 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.718 ' HA ' ' CD2' ' A' ' 40' ' ' TYR . 14.2 p80 -146.58 -169.41 3.27 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.569 0.699 . . . . 10.0 111.871 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -79.85 163.17 24.59 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.972 0.891 . . . . 10.0 112.423 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.785 ' N ' HD12 ' B' ' 18' ' ' ILE . 3.3 mp -126.19 175.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.798 -0.816 . . . . 10.0 108.798 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.549 ' CB ' ' OG1' ' A' ' 35' ' ' THR . 79.3 m-70 -141.59 115.55 9.24 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.491 -1.38 . . . . 10.0 112.094 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.612 ' H ' ' N ' ' A' ' 37' ' ' PHE . 18.4 t -144.96 103.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 114.055 1.132 . . . . 10.0 114.055 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.684 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . -150.69 -72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.614 -0.995 . . . . 10.0 110.614 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.827 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.1 t80 175.86 134.02 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.66 -1.607 . . . . 10.0 106.66 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 89.0 m-20 -39.0 131.37 1.41 Allowed 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 122.043 0.925 . . . . 10.0 111.252 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 31' ' ' GLU . . . 69.47 46.41 0.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.865 -0.522 . . . . 10.0 111.383 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.978 HG11 ' CG2' ' A' ' 36' ' ' VAL . 25.4 t -111.0 -57.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.919 -1.113 . . . . 10.0 109.181 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 38.6 m -51.85 -24.84 6.72 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.176 0.988 . . . . 10.0 109.228 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.676 ' H ' HG11 ' A' ' 33' ' ' VAL . . . -115.63 46.25 1.19 Allowed Glycine 0 N--CA 1.482 1.757 0 N-CA-C 107.727 -2.149 . . . . 10.0 107.727 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.586 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 2.2 mt-10 -162.58 123.54 2.51 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.643 0.735 . . . . 10.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.751 ' HB2' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -122.24 129.26 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 178.643 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' GLY . 16.6 p -143.85 174.16 11.07 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.587 -0.696 . . . . 10.0 111.032 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' THR . . . 35.78 -152.65 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.448 -1.061 . . . . 10.0 110.448 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.425 ' O ' HG23 ' B' ' 32' ' ' ILE . 0.5 OUTLIER -150.81 70.45 8.69 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.99 . . . . 10.0 109.473 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.522 ' HB2' ' CH2' ' B' ' 36' ' ' TRP . 51.0 Cg_endo -73.61 177.85 7.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.573 1.828 . . . . 10.0 111.92 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' CZ3' ' B' ' 36' ' ' TRP . 24.3 tt0 -57.83 159.45 5.4 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 10.0 111.006 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 21.2 pt20 -83.51 11.82 6.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.719 -0.613 . . . . 10.0 111.376 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.753 ' HD1' HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER 70.18 36.53 1.85 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.768 0.794 . . . . 10.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.602 ' O ' HD23 ' B' ' 40' ' ' LEU . . . -168.57 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.66 -0.65 . . . . 10.0 110.904 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CG ' ' OE1' ' B' ' 35' ' ' GLN . 2.2 mmt180 -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.676 -1.265 . . . . 10.0 110.131 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 1.002 HD13 HD11 ' A' ' 70' ' ' LEU . 2.5 mp -50.3 -13.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -0.994 . . . . 10.0 111.696 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.602 HD23 ' O ' ' B' ' 37' ' ' ALA . 0.9 OUTLIER -65.58 -8.76 21.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.648 -1.283 . . . . 10.0 110.771 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.68 47.53 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.598 0.713 . . . . 10.0 109.495 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 3.7 t -104.91 -168.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.618 -0.676 . . . . 10.0 110.177 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.7 m -85.49 54.37 3.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 10.0 110.099 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -62.02 174.04 0.96 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 10.0 110.291 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' B' ' 46' ' ' THR . 48.1 mt -88.26 -65.92 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.412 -0.805 . . . . 10.0 110.904 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.448 ' O ' ' O ' ' B' ' 45' ' ' ILE . 50.1 m . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 118.016 -0.992 . . . . 10.0 110.126 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.066 0.46 . . . . 10.0 110.122 . . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.714 ' HB3' HD23 ' A' ' 177' ' ' LEU . 1.8 mt-30 -95.75 -17.94 20.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -43.2 99.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.631 -0.668 . . . . 10.0 110.54 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.071 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -116.45 121.03 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 10.0 110.595 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.957 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -93.47 131.27 38.84 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.016 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.805 ' HB3' HD23 ' A' ' 55' ' ' LEU . 94.4 m -110.36 103.79 12.48 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.743 -1.223 . . . . 10.0 110.39 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 56' ' ' PHE . 46.1 t -142.82 162.8 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.229 -0.988 . . . . 10.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -80.46 152.14 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.157 -1.017 . . . . 10.0 109.432 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 10' ' ' GLY . 3.3 t -83.13 -170.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.255 -0.903 . . . . 10.0 110.193 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -95.58 42.16 2.36 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.776 -1.202 . . . . 10.0 111.218 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 80' ' ' VAL . 2.5 t0 -82.16 -31.35 30.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.707 -1.467 . . . . 10.0 109.006 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.551 ' HA2' ' C ' ' B' ' 34' ' ' GLU . . . 61.48 51.53 57.18 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.236 -1.546 . . . . 10.0 109.236 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.622 ' HB1' ' OE1' ' A' ' 116' ' ' GLN . . . -160.32 -77.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 10.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.883 HG13 ' HG ' ' A' ' 19' ' ' LEU . 89.5 t -112.17 117.94 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 10.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CZ2' ' B' ' 36' ' ' TRP . . . -98.95 143.79 16.82 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.784 -1.326 . . . . 10.0 109.784 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -65.4 -21.42 66.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 10.0 112.283 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -99.52 -36.14 9.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.389 -1.444 . . . . 10.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' B' ' 28' ' ' GLU . 26.2 p -73.71 -29.91 62.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.024 -1.047 . . . . 10.0 109.798 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.883 ' HG ' HG13 ' A' ' 14' ' ' VAL . 3.7 mm? -86.78 -18.02 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.868 -1.145 . . . . 10.0 110.49 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.52 -41.4 76.69 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.038 0.923 . . . . 10.0 108.878 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' B' ' 28' ' ' GLU . 7.3 mm -69.04 -39.78 80.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.71 0.767 . . . . 10.0 110.205 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -47.16 -45.93 23.15 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.585 -0.846 . . . . 10.0 109.814 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.648 ' CZ ' ' O ' ' A' ' 159' ' ' ALA . 4.9 m-85 -93.58 3.76 55.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.651 -1.281 . . . . 10.0 110.184 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 2.9 m -110.94 -21.25 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.816 -1.177 . . . . 10.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.865 ' HB ' HG11 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -88.07 -76.25 0.39 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.456 -1.403 . . . . 10.0 108.647 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 19.1 m120 -156.17 -33.66 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.563 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER 175.03 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.188 0.518 . . . . 10.0 109.95 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -139.68 -62.63 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.183 -0.948 . . . . 10.0 112.26 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -74.58 0.4 8.72 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.101 1.053 . . . . 10.0 113.02 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 25.4 m -161.17 51.41 0.25 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.321 -1.487 . . . . 10.0 111.507 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -115.45 103.51 10.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.072 -1.018 . . . . 10.0 110.84 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 2.1 t80 -63.59 59.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.718 . . . . 10.0 110.322 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.865 HG11 ' HB ' ' A' ' 25' ' ' THR . 3.7 m -127.23 167.43 17.89 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.375 -0.828 . . . . 10.0 109.912 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 40.9 Cg_endo -70.16 146.1 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.709 1.373 . . . . 10.0 109.57 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 5.8 t -118.81 156.26 29.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.841 -1.162 . . . . 10.0 110.865 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 62' ' ' GLU . 65.3 t 61.57 5.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.747 -0.595 . . . . 10.0 111.101 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' O ' ' O ' ' A' ' 38' ' ' ASP . 1.7 t80 -42.29 100.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.476 -0.765 . . . . 10.0 109.829 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.767 ' H ' ' H ' ' B' ' 19' ' ' HIS . 0.5 OUTLIER -47.19 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.884 0.85 . . . . 10.0 111.648 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.796 ' HB3' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -156.55 -167.61 2.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.932 -1.73 . . . . 10.0 111.417 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.632 ' CE1' HD13 ' B' ' 18' ' ' ILE . 7.8 m-30 -112.96 153.48 27.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.411 -0.805 . . . . 10.0 112.852 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.627 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . . . -135.64 119.69 17.57 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' B' ' 15' ' ' GLU . 0.5 OUTLIER -171.81 176.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.368 -1.458 . . . . 10.0 111.709 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' TYR . 66.1 m -129.49 130.92 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.773 -0.58 . . . . 10.0 110.21 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 46' ' ' ILE . 13.2 t -105.17 150.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 10.0 109.42 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.716 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 94.7 mtp -117.65 95.62 5.02 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.798 -1.556 . . . . 10.0 106.798 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.75 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 3.2 mp -102.8 130.46 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.136 0.493 . . . . 10.0 111.513 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 40.1 27.69 0.14 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.837 -1.173 . . . . 10.0 110.745 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.76 18.18 45.41 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.011 -1.288 . . . . 10.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.0 mm-40 -114.87 98.98 51.35 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.294 . . . . 10.0 109.87 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 53.3 Cg_endo -77.89 118.34 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.972 1.511 . . . . 10.0 110.94 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.926 ' O ' HG23 ' A' ' 43' ' ' THR . 2.7 m-85 -89.05 117.6 28.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.992 -1.068 . . . . 10.0 109.385 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -100.56 104.19 15.53 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.065 -1.022 . . . . 10.0 111.029 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -158.08 178.44 10.2 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.444 -1.302 . . . . 10.0 111.381 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.851 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.32 111.46 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.965 -1.654 . . . . 10.0 108.965 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 6' ' ' CYS . 1.8 tm? -130.47 132.8 45.85 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.846 -1.385 . . . . 10.0 110.781 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.766 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 p90 -152.57 155.31 37.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 10.0 109.789 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 15.8 t0 -99.15 179.8 4.49 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.631 -1.293 . . . . 10.0 110.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.7 m -104.81 117.3 33.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 10.0 111.137 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . . . -65.7 91.2 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 10.0 110.256 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.944 ' HA2' HD12 ' B' ' 45' ' ' ILE . . . -68.92 63.07 0.5 Allowed Glycine 0 N--CA 1.485 1.908 0 N-CA-C 107.816 -2.114 . . . . 10.0 107.816 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ALA . 22.0 tt0 75.03 21.03 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.985 -0.715 . . . . 10.0 110.569 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 36' ' ' VAL . 9.0 mm-40 -50.07 -46.08 53.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.338 -1.345 . . . . 10.0 109.68 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER 162.37 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.163 -0.961 . . . . 10.0 110.923 178.839 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -178.06 44.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.916 -1.115 . . . . 10.0 109.3 -179.351 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 13.9 p-10 -81.4 38.5 0.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.306 -0.871 . . . . 10.0 110.169 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -49.91 -28.06 6.13 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.272 -0.892 . . . . 10.0 109.111 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 67' ' ' LEU . 3.1 mp -81.67 11.12 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 10.0 109.361 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.635 ' C ' HD23 ' A' ' 70' ' ' LEU . 4.5 ptt85 -60.19 -24.76 1.63 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.852 . . . . 10.0 112.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 47.9 Cg_endo -89.92 86.57 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 109.523 -0.991 . . . . 10.0 109.523 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.1 OUTLIER -117.64 -78.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.965 . . . . 10.0 111.831 -178.617 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.5 m 62.03 39.62 13.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 10.0 109.365 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 76.79 41.94 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 10.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.43 113.44 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.135 1.598 . . . . 10.0 110.385 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -163.62 89.59 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 10.0 110.184 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 5' ' ' LYS . 23.0 m -145.89 98.64 3.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.104 -0.997 . . . . 10.0 109.173 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 19.9 t70 -25.77 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.046 0.45 . . . . 10.0 112.15 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -107.68 126.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.947 -1.096 . . . . 10.0 109.897 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.4 m-85 -130.33 139.41 50.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 10.0 110.921 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.708 ' CD1' HG13 ' A' ' 168' ' ' VAL . 1.9 mm? -113.6 98.54 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 11' ' ' ASP . 9.3 p -97.37 137.47 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 10.0 110.846 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 115' ' ' THR . 65.3 m -121.47 112.15 18.16 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.263 -0.898 . . . . 10.0 110.609 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CZ ' ' HD1' ' A' ' 90' ' ' PHE . 35.1 p90 -129.24 160.37 33.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.214 -0.928 . . . . 10.0 110.538 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 116' ' ' GLN . 51.0 m -79.16 162.54 25.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.34 -0.85 . . . . 10.0 111.277 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 137' ' ' ILE . 30.7 m -102.15 23.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.672 -0.643 . . . . 10.0 110.349 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.74 ' CG2' HD23 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -142.02 28.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.201 -0.937 . . . . 10.0 109.875 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.586 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -85.93 -173.84 0.46 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.03 . . . . 10.0 110.294 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.637 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . 50.4 Cg_endo -75.2 72.09 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.889 1.468 . . . . 10.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 m 46.87 40.64 9.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.351 -0.843 . . . . 10.0 110.189 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.602 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 11.8 p -76.46 -25.68 54.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 10.0 110.689 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 74.1 t80 -75.1 -18.7 60.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.475 -0.765 . . . . 10.0 112.617 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.79 -17.34 36.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.458 -1.401 . . . . 10.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.674 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -88.84 -14.9 35.85 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.051 -1.03 . . . . 10.0 109.673 179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 1.086 HG23 ' HD3' ' A' ' 94' ' ' LYS . 12.8 m -84.76 -20.8 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 118.863 -1.135 . . . . 10.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 1.086 ' HD3' HG23 ' A' ' 93' ' ' VAL . 20.8 mmtt -80.08 -30.54 39.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.919 0.866 . . . . 10.0 109.544 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -96.88 9.44 41.87 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.65 -0.82 . . . . 10.0 109.415 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.8 -51.43 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.094 -1.042 . . . . 10.0 111.044 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 35.5 m95 -90.53 -40.52 11.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.187 -0.946 . . . . 10.0 112.376 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 92.0 t -53.0 -47.75 94.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.581 -1.324 . . . . 10.0 111.135 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.3 Cg_endo -75.14 -17.26 19.39 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.215 1.113 . . . . 10.0 110.644 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -69.52 -23.95 63.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.097 -1.002 . . . . 10.0 111.551 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 18.0 mt 54.75 99.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.564 -1.335 . . . . 10.0 109.776 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.58 HG21 ' HG2' ' A' ' 106' ' ' PRO . 21.0 m -46.89 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 10.0 109.6 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 37.6 t60 -110.46 -6.73 14.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.269 -0.894 . . . . 10.0 108.752 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 154.79 -49.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.61 ' H ' ' HD3' ' A' ' 106' ' ' PRO . 0.6 OUTLIER -176.14 46.19 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.716 -0.675 . . . . 10.0 110.746 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' H ' ' A' ' 105' ' ' CYS . 57.0 Cg_endo -78.94 -29.47 3.33 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.288 1.152 . . . . 10.0 109.539 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 71.1 57.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.53 0.681 . . . . 10.0 110.511 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.574 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 2.9 m -46.55 149.6 1.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 10.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 38.4 Cg_endo -63.56 114.22 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.683 1.359 . . . . 10.0 110.762 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 2.2 t80 -115.11 107.6 15.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.458 -0.776 . . . . 10.0 109.173 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.0 ' CD1' HG11 ' A' ' 152' ' ' VAL . 2.0 mm? -96.32 103.69 15.61 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.59 0.71 . . . . 10.0 109.61 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 83.7 mt -85.88 143.29 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.663 -0.648 . . . . 10.0 111.029 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.6 t -141.86 170.53 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.992 -1.068 . . . . 10.0 111.482 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -134.93 98.13 0.3 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 106.934 -2.467 . . . . 10.0 106.934 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.712 HG22 ' SG ' ' A' ' 157' ' ' CYS . 27.1 p -114.55 -171.12 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 10.0 111.501 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.622 ' OE1' ' HB1' ' A' ' 13' ' ' ALA . 13.4 mt-30 56.55 18.44 3.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.53 -0.731 . . . . 10.0 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.007 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -82.94 -22.01 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.934 -0.706 . . . . 10.0 109.297 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 7.7 p-10 -51.52 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 122.051 0.929 . . . . 10.0 111.057 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.744 ' N ' ' O ' ' A' ' 117' ' ' ILE . 17.3 tp 157.85 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.681 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.03 -43.01 14.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.0 p-10 -50.29 -23.49 2.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.507 0.67 . . . . 10.0 109.682 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 76.9 m-20 -87.59 138.08 31.87 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.993 -0.683 . . . . 10.0 110.201 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.4 Cg_endo -80.09 23.37 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.174 1.618 . . . . 10.0 110.865 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 t -102.52 -50.65 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.882 -1.136 . . . . 10.0 110.285 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.624 ' HB ' HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.57 -26.45 45.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.295 1.1 mp -61.24 -23.22 29.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.555 -1.202 . . . . 10.0 107.801 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -49.09 -41.06 34.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.586 0.708 . . . . 10.0 110.501 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -89.26 -30.59 18.38 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.608 0.718 . . . . 10.0 110.397 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.8 mp -74.73 -49.85 19.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 10.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.416 ' HB2' HG23 ' A' ' 126' ' ' ILE . . . -61.74 -42.68 99.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.599 -0.688 . . . . 10.0 110.394 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -53.69 -20.07 4.92 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.007 -1.077 . . . . 10.0 108.997 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.637 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 1.2 t-20 -85.16 -44.09 13.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 10.0 109.648 179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 133.95 19.79 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.538 0.685 . . . . 10.0 109.926 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -83.23 -4.16 58.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 10.0 110.269 179.9 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -119.18 103.04 48.02 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 10.0 111.54 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.1 Cg_endo -69.92 162.4 42.3 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.033 1.544 . . . . 10.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.591 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -99.55 138.28 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 10.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.8 p -126.07 170.21 10.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 10.0 109.737 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 43.3 Cg_endo -68.63 -15.02 40.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.531 1.279 . . . . 10.0 110.46 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.38 -42.04 54.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 10.0 109.762 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -75.52 -40.95 56.31 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.732 -0.605 . . . . 10.0 110.553 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.89 -44.94 65.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 10.0 111.269 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.8 -43.93 48.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 10.0 109.619 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 67.4 tttt -66.42 -40.32 89.48 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.508 -0.745 . . . . 10.0 109.294 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 148' ' ' ASP . 2.1 tt -63.66 -48.26 77.94 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.559 -0.856 . . . . 10.0 109.42 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.645 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.42 -42.12 86.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 10.0 108.93 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -80.66 1.86 28.26 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.679 -0.808 . . . . 10.0 108.991 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.607 ' HB3' HD13 ' A' ' 149' ' ' LEU . 14.4 t70 -79.21 -31.82 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.48 -0.763 . . . . 10.0 112.214 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.921 HD13 ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -135.65 -8.17 2.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.032 -1.668 . . . . 10.0 113.088 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.676 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 6.2 pttt 125.93 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.899 0.88 . . . . 10.0 111.703 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.645 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -116.83 -177.44 3.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.882 -1.136 . . . . 10.0 109.65 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.0 HG11 ' CD1' ' A' ' 111' ' ' LEU . 1.1 t -90.16 -78.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.766 -1.208 . . . . 10.0 109.531 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.833 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -171.93 164.53 6.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.023 -1.048 . . . . 10.0 111.093 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 57.8 t80 -104.76 101.1 10.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.411 -0.806 . . . . 10.0 109.562 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' A' ' 168' ' ' VAL . 38.2 t -87.76 169.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 10.0 109.137 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' N ' HG12 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -134.64 121.67 21.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.929 -1.107 . . . . 10.0 109.737 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG22 ' A' ' 115' ' ' THR . 25.6 p -141.23 169.99 16.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.051 -1.031 . . . . 10.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.583 ' N ' ' HB2' ' A' ' 162' ' ' GLN . 1.1 t -143.76 118.6 9.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.691 -0.631 . . . . 10.0 109.576 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.893 ' HB1' ' CZ ' ' B' ' 29' ' ' PHE . . . -12.25 -54.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.569 0.951 . . . . 10.0 113.569 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.5 pp -131.9 -3.82 3.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.471 -1.393 . . . . 10.0 111.788 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 158' ' ' SER . 59.5 m -98.05 -90.17 0.28 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.664 -1.273 . . . . 10.0 111.995 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB2' ' N ' ' A' ' 158' ' ' SER . 1.7 mm-40 -38.3 -39.44 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.945 . . . . 10.0 111.98 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.62 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 18.4 ttpt 49.5 26.29 1.65 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.056 -1.058 . . . . 10.0 108.938 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -94.62 -8.3 59.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.008 -1.637 . . . . 10.0 109.008 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -49.81 -9.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.414 -1.051 . . . . 10.0 112.306 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.775 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.17 -46.19 65.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.352 -1.468 . . . . 10.0 111.061 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.405 ' O ' ' OE1' ' A' ' 171' ' ' GLU . 3.0 m120 -59.39 -27.97 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 10.0 108.298 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' A' ' 155' ' ' VAL . 0.5 OUTLIER -51.48 -50.68 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.576 0.703 . . . . 10.0 110.897 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.584 ' N ' HG12 ' A' ' 168' ' ' VAL . 18.4 t80 -87.14 -25.74 23.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.499 -0.751 . . . . 10.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.0 t70 -50.39 -49.55 54.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 10.0 109.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.0 mp0 -67.12 -45.02 78.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 10.0 110.257 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.954 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -50.95 -21.21 1.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 10.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 177' ' ' LEU . 24.4 mm -70.07 -43.86 78.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 10.0 110.338 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.899 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.42 -23.82 34.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.577 -1.327 . . . . 10.0 111.068 -178.99 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.46 -11.55 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 10.0 111.322 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.071 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -80.42 -45.92 16.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.229 . . . . 10.0 109.991 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 173' ' ' ILE . 1.1 mp -89.99 -19.62 24.24 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.96 0.886 . . . . 10.0 108.917 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 10.0 110.337 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.473 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.576 -1.41 . . . . 10.0 109.576 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -75.89 145.08 40.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 10.0 109.99 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.543 ' CD ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -98.85 93.36 6.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.056 -1.028 . . . . 10.0 110.614 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.421 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 30.2 mm-40 -129.75 159.64 35.88 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.439 0.638 . . . . 10.0 110.49 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.26 -158.18 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 106.834 -1.543 . . . . 10.0 106.834 177.697 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -67.41 112.47 2.59 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 N-CA-C 109.236 -1.101 . . . . 10.0 109.236 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' HG22 ' A' ' 46' ' ' ILE . 12.1 tp10 -55.29 -128.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.605 0.717 . . . . 10.0 110.717 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -78.97 -101.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.892 -1.13 . . . . 10.0 109.682 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.666 ' H ' HG23 ' B' ' 8' ' ' ILE . 25.3 t -142.91 112.2 6.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.341 -1.475 . . . . 10.0 111.895 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -171.04 97.54 0.42 Allowed Pre-proline 0 N--CA 1.489 1.517 0 CA-C-O 121.632 0.73 . . . . 10.0 109.605 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.69 99.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.074 1.849 . . . . 10.0 111.214 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.4 m -136.62 98.41 3.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.691 -1.255 . . . . 10.0 109.748 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -167.4 138.79 3.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.63 -1.228 . . . . 10.0 112.364 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.579 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 58.3 m-85 -115.71 107.31 14.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.695 . . . . 10.0 110.305 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.655 ' HB3' HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -88.81 174.19 8.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.782 1.277 . . . . 10.0 113.242 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -90.0 -165.75 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.552 -1.204 . . . . 10.0 112.317 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -119.41 146.12 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.669 -0.645 . . . . 10.0 109.816 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.632 HD13 ' CE1' ' A' ' 40' ' ' TYR . 1.3 mp -76.77 173.06 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 10.0 112.463 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.767 ' H ' ' H ' ' A' ' 38' ' ' ASP . 27.4 m170 -141.95 117.28 10.16 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.436 0.902 . . . . 10.0 113.436 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.519 ' HB ' ' HD1' ' A' ' 37' ' ' PHE . 2.8 p -144.93 143.58 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.237 -0.914 . . . . 10.0 110.562 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 62' ' ' GLU . . . -148.12 30.69 1.33 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.668 -1.253 . . . . 10.0 110.178 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.699 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -171.69 91.26 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.021 -1.282 . . . . 10.0 110.392 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' B' ' 24' ' ' ALA . 4.1 m-20 -67.39 151.78 46.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.852 -1.155 . . . . 10.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 1.047 ' HB2' ' HA ' ' A' ' 32' ' ' TYR . . . 34.71 54.92 0.69 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.671 -0.643 . . . . 10.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.699 HG21 ' CD1' ' B' ' 22' ' ' PHE . 0.9 OUTLIER -113.61 -36.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.239 -0.984 . . . . 10.0 108.687 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.832 HG23 ' N ' ' B' ' 29' ' ' PHE 0.262 0.5 OUTLIER -149.62 11.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.125 -1.03 . . . . 10.0 112.946 -178.148 . . . . . . . . 4 4 . 1 . 002 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 59.09 30.56 67.17 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.719 -2.952 . . . . 10.0 105.719 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.602 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER 59.34 16.68 5.23 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.692 0.758 . . . . 10.0 109.328 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.893 ' CZ ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -143.26 147.82 35.41 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.211 0.529 . . . . 10.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.794 HG22 ' OG1' ' B' ' 26' ' ' THR . 19.0 p -134.81 -178.55 5.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.163 . . . . 10.0 110.213 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.19 -28.73 9.56 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.013 -1.089 . . . . 10.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.723 HG22 ' O ' ' B' ' 32' ' ' ILE . 31.4 mm -132.97 50.76 5.99 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.605 -1.527 . . . . 10.0 111.56 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.551 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 55.8 Cg_endo -75.5 150.58 36.28 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.615 1.324 . . . . 10.0 110.651 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.551 ' C ' ' HA2' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -75.12 -169.75 1.0 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.998 -1.064 . . . . 10.0 109.226 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 0.0 OUTLIER -76.43 20.4 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.19 -0.944 . . . . 10.0 110.779 179.808 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.639 ' CD2' HG11 ' A' ' 8' ' ' VAL . 8.5 m-90 65.7 20.71 11.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.802 -1.555 . . . . 10.0 106.802 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.862 ' HA ' HD11 ' A' ' 70' ' ' LEU . . . -155.02 83.06 1.08 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' B' ' 42' ' ' THR . 22.2 tpt180 -70.27 55.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.751 1.262 . . . . 10.0 107.988 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.808 HD23 ' HB1' ' B' ' 37' ' ' ALA . 2.8 pp -91.55 -21.46 20.85 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.553 -1.203 . . . . 10.0 111.219 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.719 ' O ' HD12 ' B' ' 40' ' ' LEU . 3.8 pp -77.84 5.18 10.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.998 -1.064 . . . . 10.0 111.771 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' B' ' 42' ' ' THR . 0.3 OUTLIER -154.35 -85.79 0.06 Allowed 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.124 -0.985 . . . . 10.0 111.3 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.685 HG23 ' HG3' ' B' ' 41' ' ' GLN . 72.6 p -129.87 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 10.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 53.0 m -79.07 7.51 7.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.494 -0.754 . . . . 10.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 10.3 p30 -117.36 134.44 54.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.01 . . . . 10.0 110.945 -179.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.944 HD12 ' HA2' ' A' ' 60' ' ' GLY . 7.0 mt -97.5 176.28 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.606 -0.684 . . . . 10.0 109.31 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.474 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.291 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.602 ' CG ' HD22 ' A' ' 177' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.705 0.288 . . . . 10.0 110.41 . . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.588 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.1 pm0 -179.19 152.78 0.56 Allowed 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.166 -0.959 . . . . 10.0 110.002 179.385 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 52' ' ' THR . 85.1 m 61.42 48.43 5.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 113.707 1.003 . . . . 10.0 113.707 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -112.66 128.86 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.159 -1.588 . . . . 10.0 110.942 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 1.041 ' CB ' HG23 ' A' ' 75' ' ' THR . 4.1 mmtm -118.11 147.53 43.2 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.3 t -119.26 106.05 11.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.837 -1.165 . . . . 10.0 109.993 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 8' ' ' VAL . 4.0 t -128.41 170.88 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.769 -1.207 . . . . 10.0 110.966 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 16' ' ' LYS . 8.5 t -85.25 129.92 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.469 -0.769 . . . . 10.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 10' ' ' GLY . 40.6 t -132.46 176.55 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.972 -1.08 . . . . 10.0 111.567 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 131.95 -173.27 20.7 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.067 -1.613 . . . . 10.0 109.067 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 11' ' ' ASP . 2.3 p30 -84.67 15.43 3.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.432 . . . . 10.0 109.559 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.635 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 89.27 52.8 2.63 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.588 -1.805 . . . . 10.0 108.588 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -133.13 105.2 6.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.721 -0.87 . . . . 10.0 109.19 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 4.5 t 66.71 119.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -0.806 . . . . 10.0 109.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.503 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -90.13 115.07 4.5 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.912 -1.675 . . . . 10.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.54 -19.98 2.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.65 -1.5 . . . . 10.0 111.482 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.681 HG21 ' CG ' ' A' ' 57' ' ' ASP . 88.9 m -82.1 -41.8 20.03 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.721 -1.237 . . . . 10.0 111.809 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HA ' HG23 ' B' ' 26' ' ' THR . 23.7 p -79.73 1.79 25.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.809 -1.182 . . . . 10.0 109.909 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 159' ' ' ALA . 3.2 mm? -109.11 -41.31 4.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.843 -1.161 . . . . 10.0 109.52 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.804 HD12 HD21 ' A' ' 165' ' ' LEU . 1.5 tp -48.14 -34.07 9.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.629 HG13 HG22 ' B' ' 26' ' ' THR . 2.5 mm -73.83 -41.7 53.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.409 -0.959 . . . . 10.0 108.409 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 23.0 t -48.55 -41.76 31.36 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.445 -0.902 . . . . 10.0 110.117 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -97.26 -0.63 46.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.556 -1.34 . . . . 10.0 109.405 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 17.5 m -109.99 -19.01 13.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.012 . . . . 10.0 112.58 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' THR . . . . . 1.002 HG21 HG21 ' A' ' 33' ' ' VAL . 37.8 m -116.76 -72.34 0.69 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.231 -1.543 . . . . 10.0 111.544 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 34.1 m-20 -147.73 -33.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.311 -1.356 . . . . 10.0 112.773 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 165.83 -138.8 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 O-C-N 121.331 -0.856 . . . . 10.0 111.606 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.648 ' H ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -137.62 -45.14 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.131 -0.981 . . . . 10.0 113.457 -177.731 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 28' ' ' PHE . 42.7 Cg_endo -91.17 4.21 4.24 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 N-CA-C 114.739 1.015 . . . . 10.0 114.739 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 9.1 t -172.38 71.95 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.605 -1.935 . . . . 10.0 112.312 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.587 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 13.2 pt-20 -148.93 126.2 11.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.835 -1.166 . . . . 10.0 111.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' C ' HG12 ' A' ' 33' ' ' VAL . 33.9 t80 -89.08 116.27 27.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 10.0 108.82 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -162.01 160.33 21.82 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.342 -0.849 . . . . 10.0 110.133 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.778 ' HD2' HG23 ' A' ' 33' ' ' VAL . 36.9 Cg_endo -61.28 131.89 38.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.758 1.399 . . . . 10.0 109.09 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG23 ' B' ' 20' ' ' VAL . 22.3 p -137.99 154.63 49.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.604 -1.31 . . . . 10.0 113.24 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 58' ' ' THR . 58.1 t 62.99 -43.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.72 -0.613 . . . . 10.0 111.358 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.724 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 7.8 p90 -36.38 100.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.161 0.981 . . . . 10.0 110.374 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.952 ' HB3' HD11 ' A' ' 55' ' ' LEU . 1.5 m-20 -167.71 102.92 0.49 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 117.297 -1.761 . . . . 10.0 112.489 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.623 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 61.4 t30 -147.8 98.78 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.069 -1.019 . . . . 10.0 108.361 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 75.6 m-85 -139.73 147.05 40.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.86 -1.136 . . . . 10.0 112.65 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' B' ' 16' ' ' HIS . . . -140.85 98.55 3.42 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.835 HG23 ' O ' ' B' ' 14' ' ' PHE . 7.5 p -135.23 -173.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -0.854 . . . . 10.0 110.269 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 42' ' ' VAL . 94.1 m -136.72 167.29 21.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.48 152.24 37.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.215 -1.031 . . . . 10.0 108.215 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.737 ' C ' HD12 ' A' ' 46' ' ' ILE . 7.1 mtm -144.67 131.15 19.82 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.001 -0.68 . . . . 10.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.737 HD12 ' C ' ' A' ' 45' ' ' MET . 1.4 mp -147.94 114.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.204 -0.935 . . . . 10.0 110.693 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 67.51 6.5 42.14 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.934 -1.267 . . . . 10.0 109.934 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.54 24.06 6.31 Favored Glycine 0 N--CA 1.489 2.179 0 O-C-N 121.064 -1.257 . . . . 10.0 110.008 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 13.7 pt-20 -118.67 111.33 37.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.33 . . . . 10.0 109.723 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.49 146.94 57.03 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.87 1.458 . . . . 10.0 111.542 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 44' ' ' VAL . 2.8 m-85 -136.71 107.12 6.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.348 -0.845 . . . . 10.0 111.122 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.818 HG21 ' H ' ' A' ' 3' ' ' THR . 47.3 m -83.64 153.04 24.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.164 -0.96 . . . . 10.0 109.169 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 53' ' ' LEU . 1.4 pp -167.26 166.34 14.81 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.716 -1.24 . . . . 10.0 110.765 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.61 131.92 2.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.405 -1.478 . . . . 10.0 109.405 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.041 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.63 124.03 49.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -1.034 . . . . 10.0 109.403 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.913 ' N ' HD22 ' A' ' 55' ' ' LEU . 5.1 m-85 -135.96 104.51 5.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.11 -0.994 . . . . 10.0 110.259 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.681 ' CG ' HG21 ' A' ' 17' ' ' THR . 23.5 t0 -105.34 146.36 29.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.141 -0.975 . . . . 10.0 110.231 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.735 ' O ' HG13 ' A' ' 36' ' ' VAL . 66.5 m -45.72 131.15 9.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.345 -0.847 . . . . 10.0 109.283 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -101.26 89.75 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.607 -0.683 . . . . 10.0 111.305 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . -53.41 -23.78 20.49 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.558 -2.217 . . . . 10.0 107.558 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' B' ' 21' ' ' GLY . 29.1 tt0 178.02 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 122.004 -0.704 . . . . 10.0 109.516 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 64' ' ' TYR . 9.6 tm-20 -53.62 -51.95 61.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.129 -0.982 . . . . 10.0 110.687 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER 177.05 -17.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.275 -0.891 . . . . 10.0 110.988 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.54 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 19.9 p90 -119.74 16.53 12.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.004 -1.06 . . . . 10.0 109.395 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 38.0 t0 -37.42 -30.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.729 -0.607 . . . . 10.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.517 ' HG3' HD23 ' A' ' 67' ' ' LEU . 12.6 ptp180 -51.03 -22.22 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 10.0 110.004 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.9 mm? -106.95 11.41 29.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 10.0 109.048 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 10.6 ttp-105 -54.48 -37.98 60.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.775 -0.578 . . . . 10.0 111.641 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 39.8 Cg_endo -68.06 59.19 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 109.953 -0.826 . . . . 10.0 109.953 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.884 ' HG ' HD12 ' B' ' 39' ' ' LEU . 0.3 OUTLIER -92.72 -57.34 2.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.61 -0.681 . . . . 10.0 109.986 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.769 ' OG ' HD23 ' B' ' 40' ' ' LEU . 1.5 t 58.44 53.24 6.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.245 -0.909 . . . . 10.0 109.628 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.638 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 1.2 p90 -149.11 113.72 3.6 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 118.564 -1.254 . . . . 10.0 112.542 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.23 94.65 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.509 1.473 . . . . 10.0 109.971 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -129.98 76.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.791 -1.193 . . . . 10.0 110.791 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 75' ' ' THR . . . . . 1.041 HG23 ' CB ' ' A' ' 5' ' ' LYS . 54.1 m -144.83 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.179 -0.951 . . . . 10.0 109.626 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 75' ' ' THR . 2.3 m-20 -18.95 -53.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.449 0.642 . . . . 10.0 111.843 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -88.84 123.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.442 -0.903 . . . . 10.0 109.352 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.497 ' CD2' HG21 ' A' ' 9' ' ' VAL . 93.8 m-85 -116.01 139.96 49.74 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.403 -0.81 . . . . 10.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 168' ' ' VAL . 1.6 mm? -108.15 98.17 7.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.621 HG23 ' HA2' ' A' ' 10' ' ' GLY . 9.2 p -92.84 122.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.619 -0.832 . . . . 10.0 110.708 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.82 104.3 11.19 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.564 -0.71 . . . . 10.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.499 ' C ' HG22 ' A' ' 115' ' ' THR . 13.0 p90 -136.57 179.82 6.14 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.221 -0.925 . . . . 10.0 109.239 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.433 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 90.2 p -75.28 161.5 29.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.861 -1.149 . . . . 10.0 111.333 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' OH ' ' A' ' 154' ' ' TYR . 6.6 m -78.78 -9.87 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.616 . . . . 10.0 111.134 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.929 HG11 HD23 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -115.17 -82.29 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.99 -1.069 . . . . 10.0 108.116 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.5 t 66.38 147.66 0.11 Allowed Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 120.407 -1.433 . . . . 10.0 111.79 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 134' ' ' GLN . 49.9 Cg_endo -76.76 167.78 24.73 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 124.384 1.728 . . . . 10.0 112.247 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 1.0 OUTLIER 71.77 15.35 5.87 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.985 178.855 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.401 ' O ' ' C ' ' A' ' 90' ' ' PHE . 1.5 t 61.64 102.01 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.023 -1.048 . . . . 10.0 110.474 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -46.76 -31.77 3.2 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.395 -0.922 . . . . 10.0 109.046 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 73.9 tt0 -53.55 -29.39 36.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 10.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.665 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -82.17 -11.82 58.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 10.0 109.535 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.66 HG23 ' OD1' ' A' ' 92' ' ' ASN . 89.1 t -89.63 -36.04 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.181 -0.949 . . . . 10.0 109.391 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.14 -17.75 62.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.458 -0.897 . . . . 10.0 109.285 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.84 -4.82 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.111 -0.993 . . . . 10.0 110.804 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -78.37 -41.63 32.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 10.0 110.469 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.501 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 24.2 m95 -80.52 -27.84 37.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.428 -0.795 . . . . 10.0 110.195 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.716 HG22 HD22 ' A' ' 149' ' ' LEU . 93.9 t -52.83 -50.77 79.47 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.159 -0.963 . . . . 10.0 110.861 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.5 Cg_endo -68.35 -17.95 44.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.277 1.146 . . . . 10.0 109.731 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -58.02 -29.57 65.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 10.0 110.142 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 7.0 mt 63.01 106.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.301 -0.874 . . . . 10.0 111.417 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -49.17 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.363 -0.977 . . . . 10.0 108.363 178.653 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.699 ' H ' HG23 ' A' ' 102' ' ' THR . 40.4 m170 -105.19 -7.62 18.9 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.162 -0.961 . . . . 10.0 110.181 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.555 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.2 OUTLIER 174.68 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 10.0 109.764 -179.778 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.832 ' O ' HG22 ' A' ' 102' ' ' THR . 81.3 m -119.2 144.91 37.16 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.058 . . . . 10.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.05 91.67 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 123.679 1.358 . . . . 10.0 110.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -153.36 18.31 0.55 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.201 -0.937 . . . . 10.0 109.591 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -56.25 131.58 75.4 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.254 -0.904 . . . . 10.0 109.634 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 135.69 25.7 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.557 1.293 . . . . 10.0 109.637 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.505 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -132.48 106.01 7.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.288 -0.882 . . . . 10.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 152' ' ' VAL . 3.1 mm? -74.91 95.61 2.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.972 -1.862 . . . . 10.0 105.972 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 46.2 mt -70.08 139.07 52.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.558 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.9 t -149.6 167.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.141 . . . . 10.0 111.454 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.463 ' O ' ' CG2' ' A' ' 117' ' ' ILE . . . -124.52 107.27 1.0 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.956 -2.057 . . . . 10.0 107.956 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.499 HG22 ' C ' ' A' ' 82' ' ' PHE . 3.5 t -93.88 155.62 17.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -1.189 . . . . 10.0 110.543 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 48.73 48.65 19.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.832 . . . . 10.0 109.894 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.988 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -82.62 -13.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 10.0 110.662 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 51.3 p30 -52.01 51.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 112.3 0.481 . . . . 10.0 112.3 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.738 ' N ' ' O ' ' A' ' 117' ' ' ILE . 12.3 tp 152.47 -34.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' A' ' 84' ' ' VAL . 10.9 tpp180 -55.54 -33.87 64.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.504 0.669 . . . . 10.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.15 -14.43 60.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 10.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.738 ' O ' HD13 ' A' ' 126' ' ' ILE . 70.9 m-20 -82.7 142.12 45.33 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.233 -0.917 . . . . 10.0 110.837 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.5 Cg_endo -75.44 22.99 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.12 1.59 . . . . 10.0 111.558 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -103.07 -50.57 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.757 -1.214 . . . . 10.0 109.967 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 t -74.26 -28.16 61.09 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.411 -2.07 . . . . 10.0 105.411 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 122' ' ' ASP 0.29 0.6 OUTLIER -51.1 -30.88 10.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 176.888 . . . . . . . . 4 4 . 1 . 003 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.3 -47.82 46.72 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.885 0.85 . . . . 10.0 110.235 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -37.29 62.58 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.466 0.651 . . . . 10.0 110.005 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.929 HD23 HG11 ' A' ' 85' ' ' VAL . 3.4 mp -55.64 -27.1 47.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.114 0.959 . . . . 10.0 109.942 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.25 -28.39 57.1 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.405 -1.434 . . . . 10.0 109.022 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -69.94 -17.31 63.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.015 -0.674 . . . . 10.0 109.982 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.486 ' HB3' ' CD ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -129.25 34.28 4.42 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.204 -1.398 . . . . 10.0 112.589 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 55.91 63.94 1.88 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.135 -0.978 . . . . 10.0 110.225 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.834 ' O ' HG12 ' A' ' 85' ' ' VAL . 5.9 mt-30 -128.86 80.99 2.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 140.13 39.44 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.78 . . . . 10.0 109.901 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.48 ' N ' HG13 ' A' ' 85' ' ' VAL . 42.6 Cg_endo -66.53 161.65 40.31 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.203 1.633 . . . . 10.0 111.741 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.574 HG12 ' CE2' ' A' ' 90' ' ' PHE . 3.5 tp -126.64 139.92 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 10.0 109.479 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -118.78 165.42 16.84 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.323 -0.86 . . . . 10.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.9 Cg_endo -65.67 -21.57 58.72 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.8 1.421 . . . . 10.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -70.54 -47.66 59.29 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.283 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -77.9 -42.15 34.24 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.916 -0.714 . . . . 10.0 110.292 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.88 90.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.912 -1.118 . . . . 10.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 139' ' ' PRO . 20.4 mm-40 -52.95 -48.19 67.55 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.483 -0.887 . . . . 10.0 110.132 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -62.18 -34.63 76.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.175 -0.953 . . . . 10.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 8.8 tp -66.46 -50.08 64.52 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.905 -1.122 . . . . 10.0 108.222 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.965 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.09 -41.62 88.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.284 -0.885 . . . . 10.0 109.95 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 147' ' ' ARG . 40.3 mmm-85 -78.61 -7.29 57.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.344 -0.847 . . . . 10.0 110.18 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 2.5 m-20 -76.88 -48.66 17.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.028 -1.045 . . . . 10.0 110.806 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.798 HD12 ' H ' ' A' ' 149' ' ' LEU . 2.2 mp -102.09 9.84 39.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 10.0 109.819 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 5.6 mtpt 81.51 23.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.028 0.918 . . . . 10.0 110.512 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.26 -176.34 0.21 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 111' ' ' LEU . 2.5 p -84.99 -77.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.773 -1.204 . . . . 10.0 111.83 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.877 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -173.66 -179.04 1.72 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.437 -1.414 . . . . 10.0 110.889 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.713 ' OH ' HG12 ' A' ' 84' ' ' VAL . 68.1 t80 -108.7 120.86 43.7 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 10.0 109.778 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -124.51 -169.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.226 -0.922 . . . . 10.0 109.349 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -157.2 144.42 18.62 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.291 -1.364 . . . . 10.0 112.679 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 27.4 p -157.49 162.43 38.89 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.448 0.642 . . . . 10.0 110.133 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.6 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 18.9 p -133.14 172.84 12.12 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 108.49 -0.93 . . . . 10.0 108.49 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.737 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -54.96 -64.85 0.7 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.894 0.702 . . . . 10.0 112.894 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.0 pp -132.91 -3.83 3.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.66 -1.275 . . . . 10.0 112.13 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.539 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.4 m -96.33 -53.56 3.57 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.65 -1.282 . . . . 10.0 113.167 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.565 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -63.25 -53.03 59.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.757 -1.215 . . . . 10.0 111.327 -178.406 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' THR . 0.4 OUTLIER 66.19 27.78 10.25 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 -177.728 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.51 -17.23 42.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -49.98 -18.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.186 . . . . 10.0 110.796 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.836 ' N ' HD22 ' A' ' 165' ' ' LEU . 1.5 tttt -71.97 -31.44 66.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.681 -1.262 . . . . 10.0 109.658 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -69.38 -45.1 70.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 10.0 109.582 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.019 HG22 ' HB ' ' A' ' 155' ' ' VAL . 31.1 t -53.31 -18.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.661 0.743 . . . . 10.0 110.2 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 m-85 -84.3 -40.52 17.87 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 10.0 111.902 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.62 ' O ' HD22 ' A' ' 174' ' ' LEU . 22.8 t70 -65.69 -52.19 53.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.89 -1.131 . . . . 10.0 112.268 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.748 ' OE2' HD12 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -63.92 -25.53 68.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.773 -1.204 . . . . 10.0 109.972 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -66.87 -32.07 73.09 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.264 -0.897 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 49.0 mm -62.74 -50.27 80.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.413 -0.804 . . . . 10.0 109.696 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.854 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -72.63 -34.07 67.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.56 -0.712 . . . . 10.0 111.073 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.662 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -85.24 -2.35 57.95 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.154 -0.966 . . . . 10.0 110.202 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -87.12 -22.31 25.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.052 -1.03 . . . . 10.0 110.129 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -100.22 -20.38 15.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 10.0 108.793 179.272 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 118.09 -0.957 . . . . 10.0 110.426 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' ' 49' ' ' GLU . 46.4 m -128.4 156.65 42.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.297 -1.119 . . . . 10.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -81.66 97.66 8.01 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.151 -0.968 . . . . 10.0 108.582 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.055 . . . . 10.0 111.024 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.722 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -72.24 -154.47 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.722 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 38.2 Cg_endo -65.74 73.87 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-N 119.062 0.701 . . . . 10.0 110.523 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.53 ' HB2' HG22 ' A' ' 46' ' ' ILE . 3.3 tp10 -53.32 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.591 -0.693 . . . . 10.0 110.073 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.692 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -79.56 -50.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.7 -1.25 . . . . 10.0 112.25 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.658 ' N ' HG12 ' B' ' 8' ' ' ILE . 61.0 m -88.82 146.72 24.81 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.808 -1.182 . . . . 10.0 110.994 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.44 HD23 ' O ' ' B' ' 8' ' ' ILE . 0.7 OUTLIER -170.8 98.05 0.43 Allowed Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.359 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 45' ' ' MET . 51.4 Cg_endo -86.16 97.56 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.229 1.647 . . . . 10.0 109.073 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.1 p -68.37 160.61 29.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.07 -1.019 . . . . 10.0 111.894 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.537 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.2 m-20 -124.14 155.86 37.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' VAL . 69.0 m-85 -85.33 156.09 21.05 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.028 0.918 . . . . 10.0 112.672 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 15.9 pt-20 -120.09 154.71 34.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.609 0.719 . . . . 10.0 110.316 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -49.87 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 10.0 111.142 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.67 ' O ' HG23 ' B' ' 18' ' ' ILE . 4.3 t -159.5 144.37 15.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.672 -1.268 . . . . 10.0 110.685 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.67 HG23 ' O ' ' B' ' 17' ' ' THR . 0.8 OUTLIER -160.67 177.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.721 -0.612 . . . . 10.0 109.613 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.2 t-80 -143.07 160.23 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.675 -1.266 . . . . 10.0 111.548 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.791 HG22 ' H ' ' B' ' 22' ' ' PHE . 5.8 p -69.74 148.46 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.192 0.996 . . . . 10.0 112.711 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -127.31 42.68 1.43 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.132 -2.387 . . . . 10.0 107.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -178.94 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.528 -0.983 . . . . 10.0 109.705 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.631 ' O ' HG23 ' B' ' 25' ' ' VAL . 17.3 p-10 -57.95 155.12 11.18 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.85 0.833 . . . . 10.0 112.688 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.21 57.98 0.63 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.781 -0.575 . . . . 10.0 112.37 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' B' ' 22' ' ' PHE . 42.5 t -113.01 -26.83 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.987 -1.071 . . . . 10.0 109.72 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.629 HG22 HG13 ' A' ' 21' ' ' ILE . 3.3 m -107.91 -22.23 12.52 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.611 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -90.49 35.2 3.9 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 106.923 -2.471 . . . . 10.0 106.923 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 28' ' ' PHE . 19.6 mt-10 -149.92 120.41 7.43 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.475 -1.014 . . . . 10.0 110.304 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.667 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 3.8 t80 -124.21 142.71 51.01 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.25 -0.906 . . . . 10.0 108.701 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.5 p -141.06 -46.59 0.39 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.153 -0.967 . . . . 10.0 109.566 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.11 51.02 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.449 -1.86 . . . . 10.0 108.449 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 21.1 mm -73.55 132.64 80.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.835 -0.803 . . . . 10.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 56.3 Cg_endo -80.54 79.88 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.718 1.378 . . . . 10.0 112.243 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' B' ' 33' ' ' PRO . 33.7 tt0 173.61 122.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.005 -1.059 . . . . 10.0 111.126 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.635 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 10.4 pt20 -78.3 -37.73 44.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.706 -0.622 . . . . 10.0 109.658 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.619 ' CG ' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 152.52 33.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.752 0.787 . . . . 10.0 109.066 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -139.97 -21.74 0.87 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.716 -0.615 . . . . 10.0 110.096 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.467 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 10.0 mmm180 -75.26 7.22 3.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.128 . . . . 10.0 109.397 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.884 HD12 ' HG ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -41.28 -25.93 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.33 -0.856 . . . . 10.0 110.207 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.867 ' O ' HD12 ' B' ' 40' ' ' LEU . 2.8 pp -80.44 8.69 7.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.093 -1.004 . . . . 10.0 111.48 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.48 ' O ' ' CG ' ' B' ' 41' ' ' GLN . 3.5 tt0 -171.75 75.03 0.05 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.276 -0.89 . . . . 10.0 109.933 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 44' ' ' ASN . 11.7 t -122.1 160.79 24.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 10.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 61.8 m -66.39 62.88 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.518 -0.739 . . . . 10.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' B' ' 42' ' ' THR . 77.8 m-20 -69.08 -36.04 77.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.029 . . . . 10.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' B' ' 46' ' ' THR . 1.1 pt -100.52 -163.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.268 -0.895 . . . . 10.0 110.591 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.538 ' CB ' ' O ' ' B' ' 45' ' ' ILE . 1.6 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.976 -1.012 . . . . 10.0 109.949 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.555 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 6.4 tmm? . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.14 0.495 . . . . 10.0 109.943 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 75.17 51.09 0.08 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 -178.935 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.86 ' HA ' HG21 ' A' ' 52' ' ' THR . 2.2 m -173.13 75.0 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.467 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -105.3 136.36 39.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.167 -1.583 . . . . 10.0 110.026 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -118.33 114.25 22.67 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.82 105.3 17.3 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.518 -1.363 . . . . 10.0 110.734 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.721 ' HB ' HG21 ' A' ' 75' ' ' THR . 45.7 t -136.3 145.45 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.315 -0.954 . . . . 10.0 110.675 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 17' ' ' THR . 29.6 m -77.96 141.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.657 -0.652 . . . . 10.0 109.278 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.893 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.5 p -161.38 172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.138 -0.976 . . . . 10.0 110.205 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.579 ' N ' HG22 ' A' ' 9' ' ' VAL . . . 149.54 176.22 22.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -49.34 -21.94 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.252 . . . . 10.0 110.373 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 139.28 45.84 0.07 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.556 -1.418 . . . . 10.0 109.556 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.2 -91.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -1.193 . . . . 10.0 110.039 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.893 HG21 ' O ' ' A' ' 9' ' ' VAL . 2.8 t 50.26 -125.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 10.0 111.148 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 96.53 7.47 57.96 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 108.378 -1.889 . . . . 10.0 108.378 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.792 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -57.96 -18.6 24.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.038 -1.272 . . . . 10.0 109.477 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.544 ' CG2' ' HB3' ' A' ' 34' ' ' PRO . 4.9 t -86.48 -24.9 25.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 26.9 p -97.7 -8.22 29.18 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.029 -1.044 . . . . 10.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt -74.6 -38.36 62.62 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -59.29 -37.81 78.62 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 177.204 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.044 HG23 HG21 ' A' ' 25' ' ' THR . 7.2 mm -70.59 -51.38 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 115.032 -0.985 . . . . 10.0 108.651 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.69 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 17.3 p -51.3 -40.41 58.94 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.178 -0.952 . . . . 10.0 109.546 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.618 ' CE1' ' O ' ' A' ' 160' ' ' LEU . 10.7 t80 -79.89 -32.71 40.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.9 -1.125 . . . . 10.0 110.862 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' LEU . 33.9 p -97.04 -9.63 27.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 10.0 112.789 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' THR . . . . . 1.044 HG21 HG23 ' A' ' 21' ' ' ILE . 81.1 p -102.18 -88.07 0.39 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.133 -1.604 . . . . 10.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.72 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.2 p30 -123.55 -33.21 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 116.997 -1.881 . . . . 10.0 113.029 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 152.94 -141.84 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 CA-C-N 119.052 0.842 . . . . 10.0 111.638 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.768 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 0.2 OUTLIER -146.94 88.93 5.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-O 122.191 0.996 . . . . 10.0 110.505 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' B' ' 28' ' ' GLU . 44.4 Cg_endo -89.93 -61.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.113 1.875 . . . . 10.0 111.259 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.682 ' HA ' HG21 ' B' ' 30' ' ' THR . 1.1 m -168.2 46.69 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.348 -1.47 . . . . 10.0 114.179 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.625 ' HG2' ' CB ' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -170.05 -175.96 2.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.188 -1.57 . . . . 10.0 110.365 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 1.4 m-85 -108.11 136.77 47.23 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.512 0.673 . . . . 10.0 110.05 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.899 HG12 ' O ' ' B' ' 25' ' ' VAL 0.339 25.6 m -128.24 64.04 65.26 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.304 -0.872 . . . . 10.0 110.916 -177.995 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 36' ' ' VAL . 64.9 Cg_endo -91.78 174.2 2.36 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.787 1.414 . . . . 10.0 109.974 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p -63.03 96.28 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.577 -2.009 . . . . 10.0 105.577 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 HG23 ' A' ' 58' ' ' THR . 3.2 t -79.36 -96.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.485 -0.759 . . . . 10.0 111.2 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' B' ' 18' ' ' ILE . 3.5 t80 -62.78 112.26 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 119.635 -1.915 . . . . 10.0 108.148 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 55' ' ' LEU . 3.0 t0 -150.79 111.27 4.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 10.0 111.488 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.553 ' HA ' ' CE1' ' A' ' 56' ' ' PHE . 7.8 m-20 -120.65 97.93 5.79 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 12.2 t80 -132.37 125.48 30.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.399 -0.813 . . . . 10.0 110.972 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' C ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.38 96.38 2.98 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.466 -2.05 . . . . 10.0 105.466 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 43' ' ' THR . 2.2 t -149.76 -177.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.895 -1.122 . . . . 10.0 111.864 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.61 ' H ' HG12 ' A' ' 42' ' ' VAL . 18.6 m -163.16 176.78 9.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.457 -0.571 . . . . 10.0 109.457 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.83 HG12 ' CD1' ' A' ' 46' ' ' ILE . 98.5 t -145.49 134.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.921 -1.112 . . . . 10.0 108.871 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.636 ' HB3' HD13 ' B' ' 10' ' ' LEU . 58.0 mtp -85.31 128.23 34.62 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 117.362 -1.735 . . . . 10.0 107.698 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -124.84 94.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.751 -1.218 . . . . 10.0 108.97 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 62.73 19.88 61.19 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.51 34.32 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.392 -1.483 . . . . 10.0 109.392 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' ILE . 4.6 tt0 -112.64 95.91 34.6 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.391 -1.064 . . . . 10.0 110.84 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.7 138.64 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.867 1.456 . . . . 10.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 4.7 t80 -110.75 110.87 21.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 10.0 109.56 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 3' ' ' THR . 89.4 m -68.49 128.33 36.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.217 -0.927 . . . . 10.0 111.749 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 52' ' ' THR . 13.3 mt -134.59 138.67 44.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.249 -0.907 . . . . 10.0 109.864 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -170.43 126.52 1.35 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.853 HD11 ' OD1' ' A' ' 38' ' ' ASP . 3.0 pp -144.45 160.28 41.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 10.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 17.7 m-85 -158.5 146.72 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 10.0 109.053 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 10.7 t0 -153.89 175.75 12.97 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.945 -1.097 . . . . 10.0 110.938 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' THR . . . . . 1.027 HG23 HG13 ' A' ' 36' ' ' VAL . 1.8 t -45.89 166.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.646 -0.659 . . . . 10.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -100.5 89.76 4.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.458 -0.776 . . . . 10.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -62.33 -57.33 17.24 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 106.704 -2.558 . . . . 10.0 106.704 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.578 ' HG2' ' CA ' ' B' ' 21' ' ' GLY . 17.8 mt-30 -62.52 -21.48 65.56 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.658 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 51.02 66.97 1.02 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.669 0.747 . . . . 10.0 111.33 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 37' ' ' PHE . 13.1 p-10 -119.18 23.59 11.24 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.654 -0.654 . . . . 10.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 1.2 p90 -177.4 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 10.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 51.39 21.02 1.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.064 . . . . 10.0 111.271 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 9.6 mmt180 -56.61 -30.27 63.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.697 -1.252 . . . . 10.0 108.971 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.607 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 4.6 mm? -79.03 7.69 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.68 -0.638 . . . . 10.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.686 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 9.8 ttp180 -60.35 -22.86 1.03 Allowed Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.118 -0.989 . . . . 10.0 112.195 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 44.2 Cg_endo -90.01 22.95 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 N-CA-C 109.263 -1.091 . . . . 10.0 109.263 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? -33.68 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.741 -0.6 . . . . 10.0 111.335 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.568 ' HA ' HD11 ' B' ' 39' ' ' LEU . 58.3 m -37.46 -34.22 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.554 0.693 . . . . 10.0 110.213 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' LEU . 28.4 t80 -84.71 115.93 62.98 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.387 -0.821 . . . . 10.0 109.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.89 150.09 33.99 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.722 1.38 . . . . 10.0 111.395 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.4 56.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 10.0 110.257 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 5' ' ' LYS . 99.3 m -143.5 92.73 2.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.251 -0.906 . . . . 10.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 75' ' ' THR . 11.8 m-20 -31.9 -39.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.98 0.419 . . . . 10.0 111.913 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.4 m -114.26 135.05 55.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.332 1.063 . . . . 10.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . 71.3 m-85 -121.66 149.7 42.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.688 -0.632 . . . . 10.0 110.488 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.4 mm? -119.75 97.98 5.89 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.175 -0.953 . . . . 10.0 108.466 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 p -108.07 144.65 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.012 -1.055 . . . . 10.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 14' ' ' VAL . 42.0 t -144.7 134.94 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.235 -0.916 . . . . 10.0 110.627 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 19.1 p90 -142.08 171.66 13.75 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 85' ' ' VAL . 43.8 t -79.08 150.29 31.87 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.816 -1.178 . . . . 10.0 111.611 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 137' ' ' ILE . 27.3 m -102.54 -14.72 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.498 -0.751 . . . . 10.0 110.681 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.912 ' HB ' HD21 ' A' ' 129' ' ' LEU . 3.5 m -81.81 -41.83 18.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.701 -1.249 . . . . 10.0 108.676 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.7 m -54.31 120.3 25.11 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.382 -0.824 . . . . 10.0 110.28 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 55.7 Cg_endo -82.39 25.09 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.815 1.429 . . . . 10.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 9.0 t -62.64 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.99 -1.069 . . . . 10.0 109.898 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 29.7 t -122.53 65.61 0.95 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 10.0 111.683 -179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 1.8 t80 -64.54 -19.29 65.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.85 -1.156 . . . . 10.0 109.521 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' A' ' 94' ' ' LYS . 8.5 tt0 -69.65 -29.26 66.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.447 -0.783 . . . . 10.0 111.042 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.722 ' OD1' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -83.56 -15.07 50.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.177 . . . . 10.0 111.025 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.722 HG13 ' OD1' ' A' ' 92' ' ' ASN . 29.2 m -94.55 -26.69 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.827 -1.171 . . . . 10.0 108.998 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.809 ' CE ' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.66 -29.22 36.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.431 -0.907 . . . . 10.0 109.167 178.917 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -89.14 -4.77 58.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 10.0 110.603 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -83.97 -50.01 8.42 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.019 -1.051 . . . . 10.0 112.547 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 39.6 m95 -76.9 -24.08 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.055 -1.028 . . . . 10.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 149' ' ' LEU . 62.7 t -67.41 -51.89 30.96 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.646 -1.283 . . . . 10.0 111.606 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -72.85 -8.27 22.07 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.289 1.152 . . . . 10.0 110.416 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -81.38 -31.58 33.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 10.0 112.607 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 108' ' ' THR . 8.0 pt -129.25 -10.17 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.352 -1.468 . . . . 10.0 113.022 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.7 p -72.57 -5.23 35.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.492 -1.38 . . . . 10.0 110.656 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -64.61 -43.13 94.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.045 -1.034 . . . . 10.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -100.67 -27.84 13.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.485 -0.759 . . . . 10.0 109.355 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 102' ' ' THR . 74.3 m -120.49 82.18 32.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 40.1 Cg_endo -65.79 152.4 81.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.842 1.443 . . . . 10.0 110.347 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 6.8 mtmt 60.72 47.3 8.21 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.82 -0.55 . . . . 10.0 111.027 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 101' ' ' ILE . 89.0 m -72.97 133.87 81.54 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 37.0 Cg_endo -62.37 129.13 25.73 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.529 1.278 . . . . 10.0 109.747 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 6.6 t80 -136.96 111.34 8.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.358 -0.839 . . . . 10.0 109.722 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.917 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.4 mm? -90.99 99.86 12.82 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.722 0.772 . . . . 10.0 111.333 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.2 mt -74.29 148.92 41.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -147.15 179.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.822 -1.173 . . . . 10.0 111.391 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.626 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -122.35 133.41 9.24 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.894 -2.082 . . . . 10.0 107.894 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 82' ' ' PHE . 28.9 m -100.12 132.82 45.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.92 -1.341 . . . . 10.0 111.393 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.8 tt0 52.12 61.36 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 10.0 111.03 179.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -79.38 -19.96 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.045 -1.034 . . . . 10.0 109.249 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 119' ' ' LEU . 12.6 p-10 -48.82 61.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.16 0.981 . . . . 10.0 111.22 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 pp 158.56 -24.56 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.722 -1.126 . . . . 10.0 108.462 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 14.5 tpt180 -43.41 -44.31 5.66 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.592 0.71 . . . . 10.0 109.666 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.99 -11.19 7.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 10.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 43.7 t0 -104.83 120.31 50.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 10.0 110.534 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.49 24.43 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 10.0 111.035 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -105.85 -50.46 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.065 -1.022 . . . . 10.0 110.93 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 126' ' ' ILE . 6.0 t -72.09 -30.62 65.28 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.076 -2.194 . . . . 10.0 105.076 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.547 HG23 HD22 ' A' ' 129' ' ' LEU 0.304 0.8 OUTLIER -48.64 -26.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.211 -1.359 . . . . 10.0 107.862 176.309 . . . . . . . . 4 4 . 1 . 004 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -54.32 -36.71 64.04 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.181 0.991 . . . . 10.0 109.676 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -21.95 61.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.518 -0.739 . . . . 10.0 110.878 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HB ' ' A' ' 85' ' ' VAL . 4.0 mp -57.74 -37.79 74.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.292 -0.88 . . . . 10.0 109.627 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.82 82.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.525 -0.734 . . . . 10.0 109.867 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -51.17 -28.55 11.43 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.901 -1.12 . . . . 10.0 108.677 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.598 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 1.3 m120 -90.27 -66.77 0.89 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.228 -0.989 . . . . 10.0 110.553 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.599 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.5 mptp? -140.33 160.5 39.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.8 -0.563 . . . . 10.0 109.548 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.599 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -97.28 1.48 49.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 10.0 111.313 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -120.52 98.53 48.27 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 10.0 111.188 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' PRO . 42.2 Cg_endo -73.95 160.59 42.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.888 1.725 . . . . 10.0 111.255 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.68 136.95 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.954 -1.091 . . . . 10.0 109.997 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.536 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 73.0 p -128.23 167.78 17.72 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.434 -0.791 . . . . 10.0 110.822 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 39.2 Cg_endo -65.37 -12.45 34.94 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.941 1.495 . . . . 10.0 110.907 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 1.5 mt-10 -78.6 -15.61 58.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.094 . . . . 10.0 109.839 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.6 m -94.93 -45.1 7.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.185 -0.947 . . . . 10.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.57 69.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 10.0 110.571 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 2.8 tt0 -50.24 -34.64 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.853 . . . . 10.0 109.74 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -74.84 -47.4 30.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.338 -0.851 . . . . 10.0 110.284 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 1.035 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.1 tp -55.91 -44.7 78.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.02 -1.05 . . . . 10.0 109.409 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -61.74 -50.22 73.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 10.0 109.951 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -18.01 62.47 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.523 -0.871 . . . . 10.0 109.515 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 144' ' ' LYS . 9.7 m-20 -85.96 -57.65 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 10.0 110.856 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.061 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -84.67 4.24 33.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.157 -0.964 . . . . 10.0 110.754 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.84 ' N ' HD13 ' A' ' 149' ' ' LEU . 11.0 mttp 69.49 60.1 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.375 1.084 . . . . 10.0 112.352 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.967 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -96.96 -154.09 0.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.333 -0.849 . . . . 10.0 108.71 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.917 HG11 ' CD1' ' A' ' 111' ' ' LEU . 15.8 t -100.04 -81.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.207 -0.997 . . . . 10.0 108.657 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.641 ' N ' HG12 ' A' ' 152' ' ' VAL . 2.7 tttm -173.73 159.28 3.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.43 -0.908 . . . . 10.0 111.858 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -82.77 105.04 13.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.541 -0.725 . . . . 10.0 109.466 178.304 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.711 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -102.12 -172.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.757 ' HG3' HG21 ' A' ' 117' ' ' ILE . 18.2 tt0 -148.45 137.11 21.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.821 -1.174 . . . . 10.0 109.973 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 165' ' ' LEU . 30.1 p -138.15 116.24 11.73 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.422 -0.911 . . . . 10.0 111.484 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.924 ' O ' HD21 ' A' ' 165' ' ' LEU . 6.2 m -102.6 156.73 17.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.781 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -93.62 -94.0 0.16 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 120.435 -1.416 . . . . 10.0 111.072 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -47.29 -20.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.463 -1.295 . . . . 10.0 109.001 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -93.42 -44.35 8.3 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.077 -1.015 . . . . 10.0 109.533 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm0? 61.59 68.91 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 10.0 110.745 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.89 36.86 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.445 -0.902 . . . . 10.0 111.328 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.78 30.03 0.72 Allowed Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.623 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.924 HD21 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.7 -47.41 73.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.229 -1.159 . . . . 10.0 110.714 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -71.41 -21.28 62.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.315 -0.865 . . . . 10.0 110.526 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -70.78 -39.4 73.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.021 -1.049 . . . . 10.0 111.275 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 155' ' ' VAL . 39.6 t -58.48 -50.79 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.811 -1.181 . . . . 10.0 110.212 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 80.4 t80 -68.27 -36.26 79.12 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.48 -0.762 . . . . 10.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.8 t0 -53.75 -47.56 70.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.867 -1.146 . . . . 10.0 110.478 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.55 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . 11.4 mm-40 -54.82 -40.46 69.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 10.0 109.857 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.445 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.59 -21.35 60.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.139 -0.976 . . . . 10.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.789 ' O ' HD12 ' A' ' 177' ' ' LEU . 37.2 mm -63.25 -40.52 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.254 -0.904 . . . . 10.0 110.038 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -87.17 -15.71 37.52 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.638 -1.289 . . . . 10.0 110.946 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 152' ' ' VAL . . . -98.04 -11.08 23.36 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.977 -1.077 . . . . 10.0 110.596 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.814 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -82.35 -42.82 18.2 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.941 -1.099 . . . . 10.0 109.74 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -96.61 -14.53 22.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.366 -0.834 . . . . 10.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.467 ' OXT' ' O ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.791 -1.099 . . . . 10.0 110.318 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.461 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . 68.6 m -99.74 37.04 1.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.318 -1.107 . . . . 10.0 110.036 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -64.19 103.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 10.0 110.934 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -128.51 178.02 6.59 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.756 0.789 . . . . 10.0 110.724 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.589 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -67.44 -179.99 0.51 Allowed Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.899 -1.889 . . . . 10.0 105.899 177.11 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.589 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 42.8 Cg_endo -69.41 55.28 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 N-CA-C 110.35 -0.673 . . . . 10.0 110.35 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.577 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.8 tp10 15.14 -142.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.693 0.759 . . . . 10.0 112.814 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.772 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -88.25 -110.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.245 -0.909 . . . . 10.0 109.203 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.651 ' H ' HG23 ' B' ' 8' ' ' ILE . 6.1 t -158.12 105.64 1.95 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.081 -1.637 . . . . 10.0 112.031 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -122.91 103.21 37.1 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.97 . . . . 10.0 109.916 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.447 ' HD2' HD23 ' B' ' 10' ' ' LEU . 38.0 Cg_endo -66.91 99.12 0.45 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.373 1.196 . . . . 10.0 109.856 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.5 m -157.15 99.39 1.79 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.39 -0.819 . . . . 10.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 11.6 p-10 -148.63 154.86 40.28 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.818 -1.153 . . . . 10.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 48.1 m-85 -84.64 -165.29 1.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.274 1.035 . . . . 10.0 113.165 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.541 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.3 tp10 -53.38 -167.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.88 0.848 . . . . 10.0 111.891 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -138.03 -166.94 2.06 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 40' ' ' TYR . 9.8 t -119.24 -171.8 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.933 -1.104 . . . . 10.0 112.05 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.725 HD13 ' CD2' ' A' ' 37' ' ' PHE . 1.3 pp -112.4 -177.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -101.08 155.91 17.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.062 . . . . 10.0 111.831 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.7 ' CG2' ' CE2' ' B' ' 22' ' ' PHE . 11.2 m -80.0 152.73 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.483 0.658 . . . . 10.0 111.281 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HG2' ' A' ' 61' ' ' GLN . . . -87.69 133.39 11.77 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.162 -1.575 . . . . 10.0 109.162 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.7 ' CE2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER 179.0 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.88 -1.365 . . . . 10.0 112.914 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.551 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.2 t70 -76.99 116.39 17.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.786 -1.196 . . . . 10.0 107.907 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 46.41 26.11 0.45 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.789 -1.194 . . . . 10.0 107.837 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.899 ' O ' HG12 ' A' ' 33' ' ' VAL 0.262 2.4 t -109.84 -14.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.564 0.697 . . . . 10.0 109.383 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.748 ' O ' HG21 ' A' ' 25' ' ' THR . 1.3 t -83.47 32.88 0.46 Allowed 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.798 -0.564 . . . . 10.0 111.181 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.575 ' CA ' ' OG1' ' A' ' 25' ' ' THR . . . -161.31 69.94 0.23 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.642 -1.783 . . . . 10.0 108.642 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.83 ' N ' HG11 ' A' ' 33' ' ' VAL . 24.9 mt-10 -151.47 131.61 13.52 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.964 0.888 . . . . 10.0 111.43 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.812 ' O ' HG23 ' B' ' 30' ' ' THR . 1.9 t80 -142.7 142.41 31.99 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 29' ' ' PHE . 2.2 p -162.14 -66.13 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 10.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.79 111.5 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.073 -1.611 . . . . 10.0 109.073 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 pt -131.93 158.9 74.22 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.217 . . . . 10.0 110.308 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' B' ' 34' ' ' GLU . 42.2 Cg_endo -70.43 139.99 39.15 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.985 1.519 . . . . 10.0 109.942 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.541 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 3.0 tm-20 56.87 124.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 10.0 110.433 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' B' ' 36' ' ' TRP . 2.3 pm0 -96.31 -30.11 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 10.0 111.244 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.61 ' O ' ' CG ' ' B' ' 36' ' ' TRP . 7.8 t-105 -165.5 27.78 0.05 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.186 0.993 . . . . 10.0 110.099 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.967 ' HB1' HD12 ' B' ' 39' ' ' LEU . . . -158.48 85.27 0.85 Allowed 'General case' 0 C--N 1.287 -2.113 0 O-C-N 121.798 -0.564 . . . . 10.0 109.64 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.541 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 2.4 ttt180 -83.31 41.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.967 HD12 ' HB1' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.01 -39.18 77.68 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.627 0.727 . . . . 10.0 111.238 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.614 HD23 ' H ' ' B' ' 40' ' ' LEU . 0.5 OUTLIER -80.37 19.44 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.645 -0.659 . . . . 10.0 112.293 -177.755 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.441 ' HB2' ' HG3' ' B' ' 38' ' ' ARG . 1.9 mm100 -146.39 -84.79 0.12 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.208 -0.932 . . . . 10.0 110.722 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.427 ' H ' ' HG2' ' B' ' 38' ' ' ARG . 63.1 p -130.7 -178.53 4.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 10.0 109.791 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' B' ' 44' ' ' ASN . 18.7 p -85.35 19.68 2.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.132 -0.98 . . . . 10.0 109.339 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' SER . 6.4 t30 73.81 86.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 10.0 109.903 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -90.86 155.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.15 -0.969 . . . . 10.0 109.988 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 117.851 -1.071 . . . . 10.0 109.679 178.852 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 10.0 110.038 . . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mm100 -74.94 -26.86 59.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.64 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.4 m -46.23 106.16 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.907 -0.495 . . . . 10.0 110.941 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -128.03 119.94 52.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.735 -1.586 . . . . 10.0 111.054 178.115 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.822 ' O ' HG23 ' A' ' 75' ' ' THR . 4.5 mttm -103.8 124.55 49.12 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.895 -1.52 . . . . 10.0 106.895 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.934 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.4 t -89.01 108.0 19.35 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.884 -1.127 . . . . 10.0 110.886 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.776 ' HB ' HG21 ' A' ' 75' ' ' THR . 60.0 t -139.17 163.97 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 10.0 109.476 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG21 ' HB ' ' A' ' 17' ' ' THR . 36.5 t -73.36 157.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.006 -1.059 . . . . 10.0 109.713 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.969 HG13 ' NE2' ' B' ' 35' ' ' GLN . 0.3 OUTLIER -43.58 170.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 10.0 109.984 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -104.94 -29.27 5.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.082 -1.607 . . . . 10.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 9' ' ' VAL . 42.0 m-20 -42.59 -61.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 10.0 110.039 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' B' ' 35' ' ' GLN . . . 92.2 5.8 65.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HD11 ' B' ' 32' ' ' ILE . . . -43.76 -30.93 0.71 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -1.109 . . . . 10.0 110.865 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' B' ' 32' ' ' ILE . 53.1 t -148.92 -69.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.07 -1.019 . . . . 10.0 110.405 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.06 74.32 0.06 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.982 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.4 tttm -65.15 -13.0 57.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -1.056 . . . . 10.0 109.707 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 8' ' ' VAL . 14.3 t -50.27 -29.52 9.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 10.0 110.073 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.614 ' SG ' HD22 ' A' ' 19' ' ' LEU . 27.3 p -78.4 -2.46 38.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.076 -1.015 . . . . 10.0 111.127 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.7 mm? -84.39 -40.22 18.09 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.892 -1.13 . . . . 10.0 109.02 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -38.73 60.54 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.619 -0.832 . . . . 10.0 109.206 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.706 HG21 ' HA2' ' B' ' 27' ' ' GLY . 3.4 mm -80.42 -45.56 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.418 -0.801 . . . . 10.0 110.399 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' B' ' 28' ' ' GLU . 19.7 t -45.84 -50.8 13.85 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.026 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 165' ' ' LEU . 36.6 m-85 -81.49 0.24 38.75 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.847 -1.158 . . . . 10.0 110.43 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.609 ' O ' ' HB ' ' A' ' 25' ' ' THR . 20.1 m -97.93 -54.17 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.404 -1.318 . . . . 10.0 110.779 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 24' ' ' THR . 14.6 t 175.75 -39.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.115 -0.991 . . . . 10.0 112.424 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.671 ' HB2' HG23 ' A' ' 21' ' ' ILE . 65.2 m-20 -85.4 32.39 0.57 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.737 -1.227 . . . . 10.0 111.53 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' C ' ' HD3' ' A' ' 29' ' ' PRO 0.261 8.7 ttpp -45.26 -167.28 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.846 0.831 . . . . 10.0 112.863 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.662 ' CD1' HG21 ' B' ' 30' ' ' THR . 51.1 t80 -107.14 47.48 0.15 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.242 -0.911 . . . . 10.0 111.523 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.561 ' HD3' ' C ' ' A' ' 27' ' ' LYS . 52.9 Cg_endo -73.55 -93.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 122.951 0.974 . . . . 10.0 109.624 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t -167.25 60.17 0.08 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.365 -0.834 . . . . 10.0 109.033 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 24.5 pt-20 -155.81 -173.18 4.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.442 -0.787 . . . . 10.0 109.007 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 8.4 m-85 -111.12 105.43 14.15 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.624 -0.673 . . . . 10.0 110.305 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -126.04 158.73 65.09 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.301 -0.874 . . . . 10.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 49.0 Cg_endo -76.67 92.44 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.656 1.345 . . . . 10.0 110.033 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.917 HG21 ' H ' ' B' ' 25' ' ' VAL . 4.2 t -94.9 154.02 17.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.203 -0.936 . . . . 10.0 110.017 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.885 HG22 HG21 ' B' ' 26' ' ' THR . 16.9 t 77.56 5.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.019 -0.426 . . . . 10.0 110.664 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 73.9 t80 -39.55 161.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.784 0.802 . . . . 10.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 1.051 ' CB ' HD12 ' B' ' 18' ' ' ILE . 3.7 p30 -79.13 -161.08 0.28 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.346 1.07 . . . . 10.0 113.391 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.755 ' O ' HG22 ' B' ' 17' ' ' THR . 1.4 m120 -152.9 -171.52 3.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.58 ' CE2' HG21 ' B' ' 17' ' ' THR . 69.6 m-85 -121.72 152.87 38.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 10.0 111.647 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -131.18 99.51 4.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.302 -0.874 . . . . 10.0 109.715 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 43' ' ' THR . 1.4 p -131.44 -168.9 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 122.104 0.954 . . . . 10.0 111.182 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.743 ' H ' HG22 ' A' ' 42' ' ' VAL . 23.2 m -142.43 151.5 41.85 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.585 0.707 . . . . 10.0 110.005 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -136.08 126.2 41.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.456 -0.778 . . . . 10.0 109.527 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.574 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 30.9 mtt -90.87 96.56 10.7 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.69 -1.204 . . . . 10.0 109.625 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.727 HG22 ' HG3' ' B' ' 7' ' ' GLU . 1.4 mp -72.03 104.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.548 -0.72 . . . . 10.0 110.049 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 43.65 35.06 2.89 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.776 -1.202 . . . . 10.0 110.428 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.52 2.17 30.92 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.879 -1.365 . . . . 10.0 110.802 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' ILE . 79.6 mt-10 -117.45 110.73 40.53 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.741 -1.446 . . . . 10.0 110.297 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.2 Cg_endo -75.13 135.75 19.25 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.566 1.298 . . . . 10.0 110.706 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' HB2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -99.76 122.85 43.36 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 10.0 110.749 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 4' ' ' ILE . 30.2 p -84.6 98.32 10.1 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.05 -1.031 . . . . 10.0 109.439 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -121.48 126.67 49.83 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.662 -1.215 . . . . 10.0 109.672 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 41' ' ' ALA . . . -141.35 100.8 0.27 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.531 -1.828 . . . . 10.0 108.531 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD22 ' CB ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -115.36 117.24 29.88 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.224 -1.162 . . . . 10.0 110.581 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.797 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 20.9 m-85 -134.59 144.4 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.916 ' H ' HD11 ' B' ' 18' ' ' ILE . 22.1 m-20 -105.78 160.76 14.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.475 -1.391 . . . . 10.0 110.008 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CD1' ' B' ' 36' ' ' TRP . 4.3 t -70.42 -177.94 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.06 . . . . 10.0 110.97 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -111.04 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.708 -0.62 . . . . 10.0 109.409 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.587 ' H ' HG11 ' A' ' 36' ' ' VAL . . . -52.02 -34.51 38.88 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 107.781 -2.128 . . . . 10.0 107.781 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.74 HE21 ' HD1' ' B' ' 22' ' ' PHE . 5.9 tt0 -99.94 -19.19 16.72 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 10.0 109.863 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.624 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 65.4 mt-10 58.64 84.98 0.1 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.269 -0.895 . . . . 10.0 110.564 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 61' ' ' GLN . 55.6 m-20 -96.4 -10.39 27.74 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 3.9 p90 -140.3 -35.1 0.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 10.0 109.571 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 2.7 p30 38.11 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 10.0 111.074 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' TYR . 1.7 mmm-85 -58.16 -32.59 68.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.066 -1.021 . . . . 10.0 109.287 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.779 HD12 ' HB3' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -79.93 7.67 8.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -0.759 . . . . 10.0 110.097 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.664 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -52.16 -36.44 32.03 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.335 -0.853 . . . . 10.0 112.74 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 48.9 Cg_endo -77.6 10.49 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 122.62 0.8 . . . . 10.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.885 HD21 HD22 ' B' ' 39' ' ' LEU . 0.3 OUTLIER -45.94 -64.47 0.73 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.935 -1.103 . . . . 10.0 111.954 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 67.4 m 41.06 32.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.899 -1.126 . . . . 10.0 109.969 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 6.7 t80 -171.33 127.8 0.66 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 10.0 110.677 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.96 130.59 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.997 1.525 . . . . 10.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 4.1 mt-30 -138.32 67.35 1.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.232 -0.917 . . . . 10.0 108.943 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.1 m -144.67 92.1 2.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 10.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.1 m-20 -39.13 -30.46 0.05 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.661 -0.65 . . . . 10.0 111.178 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 75' ' ' THR . 1.5 p -112.82 118.22 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.819 -1.176 . . . . 10.0 110.021 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.597 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 23.3 m-85 -119.29 133.92 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.429 -0.794 . . . . 10.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.712 HD22 HD23 ' A' ' 111' ' ' LEU . 1.2 mm? -104.36 97.43 7.37 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.844 HG23 HG21 ' A' ' 9' ' ' VAL . 10.3 p -96.1 147.02 6.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.783 -0.767 . . . . 10.0 110.357 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.726 ' SG ' HG21 ' A' ' 115' ' ' THR . 0.0 OUTLIER -113.9 101.89 9.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.078 0.942 . . . . 10.0 110.882 -178.763 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.765 ' CE1' HG11 ' A' ' 93' ' ' VAL . 35.9 m-85 -92.44 178.32 5.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -0.977 . . . . 10.0 110.003 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.426 ' O ' HG21 ' A' ' 137' ' ' ILE . 52.4 m -108.96 158.2 17.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 10.0 109.262 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.605 ' HA ' HG23 ' A' ' 137' ' ' ILE . 4.1 t -99.18 -19.03 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.16 -0.962 . . . . 10.0 111.188 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.007 HG11 HD23 ' A' ' 129' ' ' LEU . 4.1 t -96.59 -60.16 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.01 -1.056 . . . . 10.0 110.209 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -73.39 114.84 35.36 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.393 -0.817 . . . . 10.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 52.5 Cg_endo -88.59 -3.45 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.076 1.566 . . . . 10.0 110.495 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 133' ' ' LYS . 4.1 p -75.1 21.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.289 -0.882 . . . . 10.0 112.115 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.57 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.5 t -131.4 -31.39 1.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 10.0 109.934 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -72.8 -53.0 12.69 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.095 -1.003 . . . . 10.0 110.678 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 9.3 tp10 -49.79 -17.9 0.41 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.029 -1.044 . . . . 10.0 112.037 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.716 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -91.37 -18.96 23.44 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.497 -1.377 . . . . 10.0 110.822 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.765 HG11 ' CE1' ' A' ' 82' ' ' PHE . 3.6 m -91.06 -18.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 118.39 -1.324 . . . . 10.0 109.306 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.694 ' HD3' HG23 ' A' ' 93' ' ' VAL . 21.2 mmtt -88.65 -20.38 24.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.924 . . . . 10.0 109.138 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -95.99 -0.68 50.31 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.442 178.681 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -91.54 -51.69 5.14 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.773 -1.171 . . . . 10.0 112.578 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.723 ' CH2' HD23 ' A' ' 149' ' ' LEU . 34.3 p-90 -95.37 -26.01 16.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.81 -1.181 . . . . 10.0 111.771 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 56.1 t -53.77 -43.39 96.19 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.705 -1.247 . . . . 10.0 109.777 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 42.1 Cg_endo -75.93 -24.28 11.54 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.292 1.154 . . . . 10.0 110.147 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 6.3 mm-40 -61.27 -13.17 16.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.907 -1.121 . . . . 10.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 24.9 mm 71.68 82.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 10.0 111.311 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -16.66 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -56.46 -47.26 79.55 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.65 -1.241 . . . . 10.0 107.65 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -64.85 -40.35 95.01 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -81.99 -176.6 0.8 Allowed Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.724 -0.61 . . . . 10.0 109.42 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD2' ' SG ' ' A' ' 105' ' ' CYS . 50.5 Cg_endo -77.84 19.72 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.832 1.438 . . . . 10.0 112.856 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 58.35 67.1 0.98 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.377 -1.452 . . . . 10.0 108.929 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 m -45.46 134.89 5.86 Favored Pre-proline 0 N--CA 1.49 1.571 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.915 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 42.6 Cg_endo -69.79 140.75 43.33 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.984 1.518 . . . . 10.0 110.997 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 152' ' ' VAL . 1.3 m-85 -136.95 113.28 9.96 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.704 0.764 . . . . 10.0 110.939 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.825 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.3 mm? -87.98 97.0 10.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.631 HD11 ' HZ ' ' A' ' 90' ' ' PHE . 1.6 tt -79.14 124.07 27.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.038 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.793 HG21 HG11 ' A' ' 168' ' ' VAL . 2.4 t -139.92 164.82 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 10.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -111.61 156.15 15.74 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.119 -1.993 . . . . 10.0 108.119 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.726 HG21 ' SG ' ' A' ' 81' ' ' CYS . 9.6 t -138.01 160.91 38.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.365 . . . . 10.0 111.169 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 115' ' ' THR . 7.2 mt-30 58.98 36.67 24.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.526 -0.734 . . . . 10.0 109.903 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -72.63 -19.52 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.351 -0.843 . . . . 10.0 109.751 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 161' ' ' THR . 7.6 t70 -51.75 58.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 122.156 0.979 . . . . 10.0 112.125 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 3.6 tp 162.27 -23.63 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.526 -1.215 . . . . 10.0 108.131 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.865 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.88 -33.24 23.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.16 -26.56 60.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 10.0 109.901 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.984 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -93.53 132.02 31.11 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.452 -0.78 . . . . 10.0 110.549 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 58.5 Cg_endo -87.0 23.26 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.471 1.447 . . . . 10.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 47.5 t -110.68 -50.62 2.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -0.98 . . . . 10.0 111.016 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.658 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.0 t -70.11 -27.22 64.41 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.984 HD13 ' O ' ' A' ' 122' ' ' ASP 0.306 1.2 mp -51.91 -25.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 10.0 107.361 176.571 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 124' ' ' SER . 25.6 tt0 -58.46 -42.04 86.55 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.282 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -55.92 -41.64 74.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.529 -0.732 . . . . 10.0 110.665 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.007 HD23 HG11 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -75.72 -33.85 60.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 10.0 109.549 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' LYS . . . -52.52 -50.2 63.3 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.326 0.584 . . . . 10.0 110.277 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -28.91 61.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.258 -0.901 . . . . 10.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.4 t30 -71.56 -52.19 19.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.951 . . . . 10.0 109.985 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 3.2 mmtt -134.38 155.75 49.74 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.43 24.09 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.005 . . . . 10.0 111.157 -178.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -148.74 92.95 4.33 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 10.0 109.391 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.72 160.61 48.84 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.183 1.622 . . . . 10.0 110.519 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.605 HG23 ' HA ' ' A' ' 84' ' ' VAL . 4.6 tp -102.07 133.68 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.464 -0.939 . . . . 10.0 108.464 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.9 p -119.67 165.04 18.72 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 121.182 -0.949 . . . . 10.0 110.159 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -64.13 -32.3 63.72 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.935 1.492 . . . . 10.0 110.369 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.529 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 17.3 pt-20 -74.14 -29.82 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 10.0 109.456 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.448 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 81.1 m -80.13 -41.02 26.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.79 . . . . 10.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.21 68.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.471 -0.768 . . . . 10.0 110.54 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 18.9 tt0 -57.11 -42.57 81.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 10.0 109.637 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 14.5 mtmt -68.6 -40.33 80.49 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.161 -0.962 . . . . 10.0 109.494 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.6 tt -56.0 -43.45 77.67 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.029 -1.044 . . . . 10.0 109.671 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -67.45 -51.17 54.73 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 10.0 108.648 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -60.6 -30.37 69.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 10.0 109.624 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 149' ' ' LEU . 32.9 t70 -67.99 -45.06 75.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.307 -0.871 . . . . 10.0 110.301 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.723 HD23 ' CH2' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -92.76 14.78 16.23 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.089 0.947 . . . . 10.0 108.964 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 151' ' ' ALA . 8.9 mttp 56.23 38.28 29.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.786 0.803 . . . . 10.0 110.299 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -60.97 -141.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.198 -0.601 . . . . 10.0 109.563 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.753 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -117.43 -57.7 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.959 -1.088 . . . . 10.0 110.477 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HD2' ' CD ' ' A' ' 171' ' ' GLU . 0.9 OUTLIER -170.89 145.09 2.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.116 -1.434 . . . . 10.0 111.813 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -90.79 119.49 31.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.399 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.947 ' CG2' HG13 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -124.53 -168.88 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.863 -1.148 . . . . 10.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 113' ' ' VAL . 6.0 tt0 -146.82 152.7 39.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.975 . . . . 10.0 110.335 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 31.1 p -160.36 145.18 14.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 10.0 111.394 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.865 ' CB ' HG23 ' A' ' 161' ' ' THR . 18.4 m -149.91 103.79 3.25 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 1.086 ' HB1' ' HG2' ' B' ' 28' ' ' GLU . . . -37.02 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.562 0.696 . . . . 10.0 112.316 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -57.61 -7.9 0.76 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.865 HG23 ' CB ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -134.78 -92.52 0.31 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.069 -1.644 . . . . 10.0 114.669 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.54 ' H ' HG23 ' A' ' 161' ' ' THR . 7.5 mm-40 -11.55 -69.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.817 0.817 . . . . 10.0 112.657 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 11.7 mttt 62.57 30.35 17.06 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.815 0.817 . . . . 10.0 109.44 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.0 -0.94 5.49 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.97 -1.652 . . . . 10.0 108.97 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -65.89 -7.75 18.32 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.279 -1.13 . . . . 10.0 111.847 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.688 ' N ' HD13 ' A' ' 165' ' ' LEU . 11.5 mtmt -56.77 -33.05 66.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.581 -1.324 . . . . 10.0 109.827 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -70.35 -33.71 71.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 10.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.947 HG13 ' CG2' ' A' ' 155' ' ' VAL . 7.3 t -49.22 -35.84 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.752 -1.218 . . . . 10.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 173' ' ' ILE . 6.1 t80 -78.91 -40.93 30.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 10.0 110.734 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 174' ' ' LEU . 14.4 m-20 -54.1 -46.7 72.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.185 -0.947 . . . . 10.0 111.429 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.486 ' OE2' ' CG2' ' A' ' 155' ' ' VAL . 6.9 pt-20 -66.15 -35.01 79.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 10.0 112.158 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -66.86 -17.95 65.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.597 -1.314 . . . . 10.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.657 ' O ' HD12 ' A' ' 177' ' ' LEU . 22.1 mt -66.88 -44.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.366 -0.934 . . . . 10.0 109.119 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -85.09 -17.84 36.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 10.0 111.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.563 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.54 -0.49 51.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.906 -1.122 . . . . 10.0 110.141 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.684 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.95 -49.09 7.29 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.434 -0.791 . . . . 10.0 109.973 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -88.55 -16.58 32.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.552 -0.718 . . . . 10.0 109.598 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 177' ' ' LEU . 2.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.035 -0.984 . . . . 10.0 110.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 109.532 -1.427 . . . . 10.0 109.532 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . 68.7 m -59.66 152.29 22.82 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -1.112 . . . . 10.0 110.328 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 102.05 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.567 -0.708 . . . . 10.0 111.366 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.41 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 8.7 mm-40 -118.68 159.86 22.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -0.835 . . . . 10.0 110.133 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.691 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.55 -150.02 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.691 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 42.6 Cg_endo -70.88 85.72 0.77 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 N-CA-C 109.844 -0.868 . . . . 10.0 109.844 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 46' ' ' ILE . 17.9 mm-40 -53.53 -164.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.648 -0.657 . . . . 10.0 110.826 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 1.5 pp -81.3 -51.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 10.0 112.472 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.7 t -159.09 164.99 34.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.422 -1.424 . . . . 10.0 111.624 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -158.89 106.83 1.59 Allowed Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.577 -0.849 . . . . 10.0 111.951 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 42.6 Cg_endo -69.34 115.07 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.155 1.608 . . . . 10.0 109.607 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.81 178.39 0.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.399 -0.813 . . . . 10.0 111.609 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 43' ' ' THR . 1.7 t0 -135.09 -169.32 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.957 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 5.1 m-85 -99.88 152.71 19.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 10.0 110.435 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -160.7 163.44 32.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.38 -0.825 . . . . 10.0 110.641 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -149.9 167.23 27.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.721 -1.192 . . . . 10.0 112.039 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 39' ' ' ASN 0.257 2.4 p -124.34 162.47 23.72 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.676 -0.64 . . . . 10.0 111.115 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 1.051 HD12 ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -93.31 -167.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.932 -1.105 . . . . 10.0 109.153 177.706 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -112.68 157.48 21.21 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.728 -1.233 . . . . 10.0 111.377 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.1 p -122.73 152.7 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.022 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 61' ' ' GLN . . . -147.33 179.16 24.45 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.211 -1.556 . . . . 10.0 109.211 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.74 ' HD1' HE21 ' A' ' 61' ' ' GLN . 4.4 m-85 62.3 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.298 -1.119 . . . . 10.0 111.417 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 7.0 p-10 -66.71 157.57 32.37 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.578 0.704 . . . . 10.0 111.915 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 24.98 46.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.318 0.58 . . . . 10.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.917 ' H ' HG21 ' A' ' 35' ' ' THR . 1.2 t -104.58 -33.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.885 HG21 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -128.61 17.82 6.34 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.811 0.815 . . . . 10.0 109.411 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 21' ' ' ILE . . . -61.43 -22.3 61.11 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 1.086 ' HG2' ' HB1' ' A' ' 159' ' ' ALA . 3.0 tt0 -153.09 -151.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.633 -0.922 . . . . 10.0 109.041 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -103.78 115.35 30.32 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 120.922 -1.111 . . . . 10.0 110.32 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.662 HG21 ' CD1' ' A' ' 28' ' ' PHE . 34.7 p -130.3 -89.01 0.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 10.0 110.076 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.536 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -80.24 -115.28 0.3 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 13' ' ' ALA . 2.6 tt -173.27 56.14 0.2 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 10.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 44.4 Cg_endo -71.77 155.06 58.85 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.781 1.411 . . . . 10.0 110.883 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.613 ' HG3' ' CG ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -61.19 153.37 26.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.342 -0.849 . . . . 10.0 110.475 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.969 ' NE2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -73.92 -57.37 4.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.349 -0.844 . . . . 10.0 111.234 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.3 t90 174.26 27.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.584 -0.697 . . . . 10.0 109.838 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.965 ' O ' HD23 ' B' ' 40' ' ' LEU . . . 178.22 15.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.266 -0.896 . . . . 10.0 112.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.653 ' HA ' HG21 ' B' ' 42' ' ' THR . 0.0 OUTLIER -62.34 -13.23 26.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 119.974 -1.704 . . . . 10.0 108.109 178.284 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.885 HD22 HD21 ' A' ' 70' ' ' LEU . 5.1 mp -55.45 -9.5 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.639 . . . . 10.0 111.667 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.965 HD23 ' O ' ' B' ' 37' ' ' ALA . 1.9 pp -83.73 22.51 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 10.0 110.093 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' B' ' 40' ' ' LEU . 6.9 mp0 62.92 63.93 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.046 0.927 . . . . 10.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.653 HG21 ' HA ' ' B' ' 38' ' ' ARG . 63.2 p -82.9 -171.26 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.456 0.646 . . . . 10.0 110.864 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 20.4 m -79.59 51.0 1.2 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.36 -0.837 . . . . 10.0 110.248 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.513 ' OD1' ' HD2' ' B' ' 38' ' ' ARG . 74.8 m-20 -46.36 -36.64 6.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 10.0 109.693 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' O ' ' OG1' ' B' ' 46' ' ' THR . 1.9 pt -115.54 168.32 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 10.0 110.02 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.575 HG22 ' O ' ' B' ' 46' ' ' THR . 16.7 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.947 -1.025 . . . . 10.0 110.089 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtm . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.963 0.411 . . . . 10.0 110.05 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' HA ' HD23 ' A' ' 177' ' ' LEU . 98.2 mm-40 -146.21 -33.83 0.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.019 -1.05 . . . . 10.0 109.743 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.511 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 51.8 m -56.54 110.93 0.86 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.324 -0.86 . . . . 10.0 111.01 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.885 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -108.33 128.01 64.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.86 -1.136 . . . . 10.0 110.088 178.018 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.623 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.7 ttmt -112.23 109.54 19.28 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' HB3' HD23 ' A' ' 55' ' ' LEU . 51.7 t -93.94 102.6 14.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.59 -1.319 . . . . 10.0 110.369 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 8' ' ' VAL . 48.8 t -131.78 163.14 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.71 -1.196 . . . . 10.0 110.765 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.858 HG12 ' HG2' ' B' ' 35' ' ' GLN . 1.9 t -78.26 154.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.295 -0.878 . . . . 10.0 109.388 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -160.39 174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.854 -1.154 . . . . 10.0 110.353 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.593 ' O ' ' NE2' ' B' ' 35' ' ' GLN . . . 115.2 173.5 17.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.651 -1.78 . . . . 10.0 108.651 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.13 -29.43 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.712 -1.463 . . . . 10.0 108.894 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 163.7 -81.29 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.721 -1.752 . . . . 10.0 108.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . 39.96 -131.88 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.992 . . . . 10.0 110.937 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.728 ' CG1' HG23 ' A' ' 115' ' ' THR . 6.1 m -110.72 153.89 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 10.0 111.748 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -111.96 110.13 2.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.229 -1.548 . . . . 10.0 109.229 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.13 -20.63 7.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.761 -1.435 . . . . 10.0 110.896 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.499 HG21 ' CG2' ' A' ' 8' ' ' VAL . 11.4 t -73.82 -32.17 63.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.762 -1.212 . . . . 10.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.664 ' HA ' HG23 ' B' ' 26' ' ' THR . 18.3 p -73.68 -15.68 61.23 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.618 -1.301 . . . . 10.0 107.673 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.834 HD13 ' CA ' ' A' ' 159' ' ' ALA . 53.7 mt -95.69 -23.42 17.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -46.85 -43.38 18.58 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.842 0.829 . . . . 10.0 109.046 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.045 HG22 ' HB2' ' A' ' 26' ' ' ASN . 4.6 mm -74.72 -39.88 46.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.546 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 4.6 p -52.02 -49.25 63.75 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 119.435 -0.906 . . . . 10.0 110.254 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 1.241 ' CE2' HD11 ' A' ' 165' ' ' LEU . 4.7 m-85 -62.05 -34.09 75.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.377 -1.452 . . . . 10.0 109.706 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -72.79 -51.99 16.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.562 -0.855 . . . . 10.0 111.048 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.529 HG23 ' ND2' ' A' ' 26' ' ' ASN . 11.8 t -169.49 -20.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.959 -1.896 . . . . 10.0 114.563 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 1.045 ' HB2' HG22 ' A' ' 21' ' ' ILE . 4.8 m-80 -79.29 -8.67 59.22 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.454 -1.404 . . . . 10.0 111.223 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 14.86 -146.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 114.359 1.244 . . . . 10.0 114.359 178.206 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.668 ' CE1' HG22 ' B' ' 30' ' ' THR . 1.8 t80 -100.71 -50.9 0.18 Allowed Pre-proline 0 N--CA 1.507 2.408 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.693 ' HD2' ' HD2' ' A' ' 27' ' ' LYS . 32.6 Cg_endo -54.82 -89.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.835 0 N-CA-C 115.216 1.199 . . . . 10.0 115.216 -176.006 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.89 70.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.523 -1.985 . . . . 10.0 112.63 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.878 ' O ' HG22 ' A' ' 33' ' ' VAL . 41.4 mm-40 -99.82 112.83 25.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.107 -1.071 . . . . 10.0 108.107 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HA ' ' OD1' ' B' ' 23' ' ' ASP . 11.7 m-85 -58.4 62.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.276 0.56 . . . . 10.0 111.218 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 31' ' ' GLU . 9.3 m -117.17 169.77 6.94 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.091 -1.006 . . . . 10.0 109.449 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.69 ' CB ' HG11 ' B' ' 20' ' ' VAL . 49.3 Cg_endo -78.24 137.86 15.51 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.726 1.382 . . . . 10.0 113.551 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.605 ' O ' ' CG2' ' B' ' 20' ' ' VAL . 68.9 p -124.87 158.36 33.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.67 -0.644 . . . . 10.0 109.317 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.677 HG23 ' HB ' ' B' ' 26' ' ' THR . 16.5 t 63.1 -6.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.57 -1.331 . . . . 10.0 111.811 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -67.58 95.29 0.47 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 120.474 -1.391 . . . . 10.0 109.368 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.699 ' HA ' ' CG2' ' B' ' 18' ' ' ILE . 2.3 m-20 -165.78 103.69 0.69 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.308 -1.757 . . . . 10.0 114.278 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.784 ' N ' HG22 ' B' ' 18' ' ' ILE . 53.5 t30 -134.59 97.17 3.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.858 -1.151 . . . . 10.0 108.471 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.747 ' CE1' HG23 ' B' ' 18' ' ' ILE . 2.9 m-30 -118.76 146.58 44.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.669 -0.644 . . . . 10.0 111.063 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.629 ' C ' HG13 ' A' ' 42' ' ' VAL . . . -171.72 98.07 0.18 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.08 -1.013 . . . . 10.0 109.262 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG13 ' C ' ' A' ' 41' ' ' ALA . 30.9 m -156.15 -165.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.988 0.899 . . . . 10.0 112.276 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' TYR . 20.3 m -130.24 155.23 46.63 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.294 0.569 . . . . 10.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' B' ' 12' ' ' SER . 11.6 t -131.2 150.99 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.589 -0.694 . . . . 10.0 109.215 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.637 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 10.6 mtp -110.52 93.14 4.34 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.978 -1.489 . . . . 10.0 107.661 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.731 HG23 ' CG ' ' B' ' 7' ' ' GLU . 1.8 mp -72.57 103.01 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 O-C-N 120.594 -1.316 . . . . 10.0 109.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' B' ' 9' ' ' SER . . . 51.0 30.56 23.26 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.404 -1.379 . . . . 10.0 110.119 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.92 6.12 37.65 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 120.845 -1.385 . . . . 10.0 110.592 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.6 tp10 -110.87 115.1 53.65 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.234 -1.157 . . . . 10.0 109.758 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.7 Cg_endo -71.59 139.0 33.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.947 1.498 . . . . 10.0 110.88 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -114.1 163.04 15.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 10.0 111.9 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.752 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -122.99 104.75 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HA ' HG23 ' A' ' 4' ' ' ILE . 21.2 mt -108.65 147.93 31.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.789 -1.195 . . . . 10.0 110.893 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.44 99.98 0.17 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.044 -1.623 . . . . 10.0 109.044 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -138.34 139.81 39.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -1.177 . . . . 10.0 110.269 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 1.086 ' N ' HD22 ' A' ' 55' ' ' LEU . 18.4 p90 -162.06 139.96 8.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.136 -0.978 . . . . 10.0 110.139 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 m-20 -104.25 170.1 8.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.097 -1.002 . . . . 10.0 110.476 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 5.5 t -43.55 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 10.0 111.927 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -133.29 90.53 2.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.526 -0.733 . . . . 10.0 110.652 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -66.87 71.14 0.18 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 106.885 -2.486 . . . . 10.0 106.885 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER 64.02 28.69 14.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.541 -0.976 . . . . 10.0 109.216 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -58.95 -58.59 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.834 -1.166 . . . . 10.0 109.768 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.8 OUTLIER 175.09 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.256 -0.903 . . . . 10.0 110.147 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.607 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -151.7 -34.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 10.0 109.917 -179.25 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.8 t0 79.05 20.99 0.7 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.365 0.602 . . . . 10.0 109.616 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -58.73 -19.11 37.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 178.576 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' C ' HD22 ' A' ' 70' ' ' LEU . 1.1 pp -55.23 -16.32 3.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 1.1 ttm180 -99.68 -52.98 0.19 Allowed Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 45.7 Cg_endo -70.54 -16.51 34.28 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 120.466 0.778 . . . . 10.0 112.625 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.925 HD21 HD11 ' B' ' 39' ' ' LEU . 0.9 OUTLIER -54.84 -10.91 0.52 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.678 -1.264 . . . . 10.0 111.949 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.832 ' OG ' HD12 ' B' ' 39' ' ' LEU . 1.0 OUTLIER -45.83 -31.78 2.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.953 -1.092 . . . . 10.0 110.449 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 134.44 34.42 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 10.0 111.27 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.602 ' O ' ' HB2' ' A' ' 74' ' ' GLN . 43.3 Cg_endo -80.27 159.2 23.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.899 1.473 . . . . 10.0 110.588 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.602 ' HB2' ' O ' ' A' ' 73' ' ' PRO . 0.1 OUTLIER 163.91 78.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.29 0.567 . . . . 10.0 109.586 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 77' ' ' VAL . 89.1 m -146.83 99.59 3.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.312 -0.867 . . . . 10.0 109.962 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 75' ' ' THR . 81.5 m-20 -38.86 -30.59 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.487 -0.758 . . . . 10.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 75' ' ' THR . 0.5 OUTLIER -119.02 120.37 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 10.0 109.337 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 67.0 m-85 -108.19 129.48 55.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.909 -1.12 . . . . 10.0 111.906 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.98 HD22 HD23 ' A' ' 111' ' ' LEU . 2.0 mm? -104.05 97.05 7.09 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -107.24 145.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.101 -0.999 . . . . 10.0 110.495 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 39.4 t -141.43 126.17 18.01 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.157 -0.964 . . . . 10.0 111.192 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CA ' ' OG1' ' A' ' 115' ' ' THR . 1.8 p90 -135.01 168.26 19.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.441 -0.787 . . . . 10.0 110.654 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.6 t -77.3 161.06 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 10.0 109.74 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -110.74 14.98 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 10.0 111.118 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 129' ' ' LEU . 3.0 m -125.48 -17.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.69 -1.257 . . . . 10.0 111.716 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.887 ' CA ' HD23 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -60.66 -159.7 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.992 -1.067 . . . . 10.0 110.096 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.3 Cg_endo -71.9 178.31 6.01 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 122.804 0.897 . . . . 10.0 110.099 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.84 66.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.246 -0.909 . . . . 10.0 110.087 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' PRO . 66.1 m -89.96 -15.28 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.691 . . . . 10.0 110.537 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.587 ' CZ ' ' HE3' ' A' ' 94' ' ' LYS . 6.1 t80 -86.24 -50.23 7.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 10.0 110.188 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -65.65 -30.59 71.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.545 -0.722 . . . . 10.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.9 OUTLIER -79.29 -14.22 59.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.821 -1.174 . . . . 10.0 109.58 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.653 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 2.7 t -83.84 -21.81 8.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.612 -1.305 . . . . 10.0 107.914 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.587 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -72.12 -37.87 69.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 178.583 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 1.4 pt-20 -69.49 -10.53 58.45 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.943 -0.703 . . . . 10.0 109.263 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -87.34 -52.37 5.42 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.316 -0.954 . . . . 10.0 112.582 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 98' ' ' VAL . 54.9 p-90 -93.91 -15.93 24.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.752 -1.217 . . . . 10.0 112.444 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 58.8 t -66.9 -50.78 41.47 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.745 -1.222 . . . . 10.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.0 Cg_endo -71.58 -20.64 26.7 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.21 1.111 . . . . 10.0 109.761 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 5.7 mm-40 -57.14 -35.97 70.14 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.344 -0.943 . . . . 10.0 109.264 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 99' ' ' PRO . 10.2 mt 55.15 118.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.379 -0.825 . . . . 10.0 110.881 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 105' ' ' CYS . 4.2 p -48.66 -24.91 1.52 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.001 -1.062 . . . . 10.0 109.07 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.469 ' HB2' HG22 ' A' ' 101' ' ' ILE . 62.5 m-70 -76.2 -33.13 59.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.528 -0.732 . . . . 10.0 109.843 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 1.4 t-80 -105.91 -16.71 14.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 10.0 110.847 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 102' ' ' THR . 1.1 m -166.4 175.51 2.21 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.041 . . . . 10.0 110.085 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 105' ' ' CYS . 43.0 Cg_endo -70.72 86.72 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.641 1.337 . . . . 10.0 111.747 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.635 ' HB3' ' N ' ' A' ' 102' ' ' THR . 8.5 tttp -102.58 4.88 38.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 10.0 109.589 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 109' ' ' PRO . 90.8 m -43.02 147.48 0.67 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 10.0 110.309 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 108' ' ' THR . 34.3 Cg_endo -58.22 160.67 15.57 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.019 1.813 . . . . 10.0 112.81 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.587 ' O ' HG13 ' A' ' 152' ' ' VAL . 1.7 p90 -151.01 144.53 24.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.2 1.0 . . . . 10.0 109.417 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 HD22 ' A' ' 79' ' ' LEU . 1.2 mm? -77.88 99.68 6.07 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.841 0.829 . . . . 10.0 109.745 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 75.5 mt -62.9 146.87 51.88 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 80' ' ' VAL . 3.0 t -148.39 173.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.46 -1.4 . . . . 10.0 111.929 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -109.66 138.43 14.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.842 -1.703 . . . . 10.0 108.842 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.728 HG23 ' CG1' ' A' ' 14' ' ' VAL . 97.1 m -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.003 -1.292 . . . . 10.0 110.626 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.8 tp60 41.9 59.8 2.43 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.432 -0.793 . . . . 10.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.03 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.54 -42.05 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.998 -1.482 . . . . 10.0 106.998 179.196 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 4.8 p30 -51.91 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.284 1.04 . . . . 10.0 110.385 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 162.34 -28.07 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.47 -41.43 20.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.592 0.711 . . . . 10.0 109.62 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 77.5 m-20 -67.57 -10.14 49.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.401 -0.812 . . . . 10.0 109.99 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 126' ' ' ILE . 14.8 t0 -82.3 117.15 67.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.824 . . . . 10.0 109.301 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.62 23.77 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.154 1.607 . . . . 10.0 110.97 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 37.2 t -107.84 -49.35 3.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.167 -0.958 . . . . 10.0 109.932 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 119' ' ' LEU . 14.4 t -75.06 -31.25 61.23 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 122' ' ' ASP 0.295 1.2 mp -56.02 -23.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 176.751 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.4 tt0 -47.99 -42.25 27.36 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.382 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -71.13 -49.55 42.95 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.48 -0.763 . . . . 10.0 110.547 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 85' ' ' VAL . 4.9 mp -67.3 -43.68 81.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.67 0.748 . . . . 10.0 110.691 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.46 77.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 10.0 110.594 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -52.23 -21.3 3.27 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.214 -0.929 . . . . 10.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.464 ' C ' ' HD3' ' A' ' 133' ' ' LYS . 22.0 t-20 -85.9 -68.12 0.76 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.381 -0.825 . . . . 10.0 111.242 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.464 ' HD3' ' C ' ' A' ' 132' ' ' ASN . 0.4 OUTLIER -124.59 129.4 50.51 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.532 -0.73 . . . . 10.0 110.6 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.499 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 1.1 mp0 -84.25 9.05 13.9 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.357 -0.839 . . . . 10.0 109.172 179.547 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -118.6 94.03 46.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.415 -0.803 . . . . 10.0 110.368 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 162.35 28.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.586 1.524 . . . . 10.0 110.182 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.975 HG23 HG12 ' A' ' 84' ' ' VAL . 2.4 tp -103.98 146.61 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.004 -1.06 . . . . 10.0 110.34 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.4 p -132.69 171.12 9.7 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 10.0 110.102 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.646 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . 40.0 Cg_endo -71.69 -22.55 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.551 1.29 . . . . 10.0 111.445 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -55.15 21.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.085 . . . . 10.0 109.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -65.4 -39.85 92.7 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.372 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.47 -30.01 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.009 -1.057 . . . . 10.0 111.144 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.38 -49.3 67.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.183 -0.948 . . . . 10.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 148' ' ' ASP . 7.2 ttmt -62.91 -44.01 97.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.347 -0.941 . . . . 10.0 109.078 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.827 ' HG ' HD22 ' A' ' 149' ' ' LEU . 7.0 tt -59.32 -33.51 71.21 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.486 -0.758 . . . . 10.0 109.157 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 1.011 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -67.34 -50.02 61.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.69 0.757 . . . . 10.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -84.34 -10.12 57.87 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.35 -0.94 . . . . 10.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 144' ' ' LYS . 37.6 t0 -93.77 -37.55 11.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.599 -1.313 . . . . 10.0 110.795 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.827 HD22 ' HG ' ' A' ' 145' ' ' LEU . 1.4 mp -101.07 24.75 8.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 10.0 109.735 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.9 mtpt 61.95 39.21 13.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.561 -0.745 . . . . 10.0 112.017 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 1.011 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -95.26 -156.05 0.5 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.71 -66.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.473 -1.392 . . . . 10.0 110.259 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.576 ' N ' HG22 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -172.68 174.8 3.59 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.679 -1.608 . . . . 10.0 112.003 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 139' ' ' PRO . 41.5 p90 -104.34 133.6 48.97 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -137.71 -169.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.307 -0.871 . . . . 10.0 109.781 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 164' ' ' GLY . 78.4 mm-40 -144.13 162.86 35.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.016 -1.053 . . . . 10.0 110.138 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 163' ' ' LYS . 15.5 p -164.89 133.82 3.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.282 -0.886 . . . . 10.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.582 ' H ' HD23 ' A' ' 165' ' ' LEU . 32.6 t -120.78 173.38 7.25 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.834 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -86.67 -78.76 0.28 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 120.899 -1.126 . . . . 10.0 111.789 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.8 pp -91.49 -4.25 55.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.434 -1.416 . . . . 10.0 111.108 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.1 m -96.1 -32.41 12.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.087 -1.008 . . . . 10.0 111.466 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.54 ' HA ' ' HG ' ' A' ' 165' ' ' LEU . 3.9 mt-30 75.92 67.84 0.07 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.236 -0.915 . . . . 10.0 109.772 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.565 ' HG2' HG12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -102.9 102.73 12.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.831 -1.147 . . . . 10.0 109.719 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.971 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 78.14 10.51 86.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.36 -1.896 . . . . 10.0 108.36 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.241 HD11 ' CE2' ' A' ' 23' ' ' TYR 0.254 0.2 OUTLIER -54.34 -51.84 63.46 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.995 0.902 . . . . 10.0 110.78 -179.658 . . . . . . . . 4 4 . 1 . 006 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -80.91 -10.56 59.7 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.809 -0.557 . . . . 10.0 111.101 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.535 ' HB3' HG12 ' A' ' 155' ' ' VAL . 1.9 t-20 -85.31 -31.57 22.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.193 -0.942 . . . . 10.0 110.342 -179.368 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 164' ' ' GLY . 2.8 t -71.92 -25.82 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.02 -1.05 . . . . 10.0 108.219 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.556 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -76.2 -49.68 16.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.314 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 26.2 m-20 -63.03 -49.88 72.88 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.282 -0.886 . . . . 10.0 112.269 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.89 -40.79 94.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.896 -1.128 . . . . 10.0 111.25 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -60.54 -22.5 63.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.98 -1.075 . . . . 10.0 109.925 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.595 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.2 mm -61.13 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.219 -0.926 . . . . 10.0 109.864 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.34 -45.85 65.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.255 -0.903 . . . . 10.0 110.557 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.2 4.42 23.53 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.351 -0.843 . . . . 10.0 110.532 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -84.47 -39.37 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 10.0 110.666 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -101.83 -14.76 17.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 10.0 110.409 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.877 -1.059 . . . . 10.0 110.68 -179.626 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.411 . . . . 10.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.533 ' O ' ' N ' ' B' ' 4' ' ' GLU . 54.3 m -98.81 33.5 2.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.244 -1.151 . . . . 10.0 110.646 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 174' ' ' LEU . 1.3 ttmt -50.15 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 10.0 110.597 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 2' ' ' SER . 31.9 mm-40 -134.74 167.61 20.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.186 -0.946 . . . . 10.0 110.664 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.671 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.03 -153.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.158 -1.052 . . . . 10.0 108.158 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.671 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.3 Cg_endo -69.87 84.22 0.68 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 N-CA-C 109.463 -1.014 . . . . 10.0 109.463 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.731 ' CG ' HG23 ' A' ' 46' ' ' ILE . 1.3 tp10 -44.43 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.79 0.805 . . . . 10.0 111.115 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 1.069 HD12 ' N ' ' B' ' 9' ' ' SER . 1.6 pp -91.56 -23.39 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 122.566 1.174 . . . . 10.0 107.939 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 9' ' ' SER . . . . . 1.069 ' N ' HD12 ' B' ' 8' ' ' ILE . 43.3 m -57.24 -166.64 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.68 -1.145 . . . . 10.0 112.205 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.637 ' HB3' ' O ' ' A' ' 45' ' ' MET . 0.2 OUTLIER -37.48 117.23 0.82 Allowed Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.478 1.288 . . . . 10.0 114.478 -176.434 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.541 ' HD2' HD13 ' B' ' 10' ' ' LEU . 49.7 Cg_endo -93.95 111.31 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.488 1.459 . . . . 10.0 109.266 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -86.51 -168.01 2.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.799 -1.188 . . . . 10.0 110.054 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 147.03 0.97 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.499 -0.75 . . . . 10.0 110.009 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.621 ' O ' HG11 ' A' ' 42' ' ' VAL . 80.2 m-85 -90.88 163.16 14.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 10.0 110.14 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.658 ' HB3' ' CG ' ' A' ' 40' ' ' TYR . 2.3 mp0 -50.59 179.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.991 0.901 . . . . 10.0 112.322 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -81.3 -167.42 1.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.764 0.792 . . . . 10.0 112.719 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.3 m -85.46 152.81 22.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.688 -0.633 . . . . 10.0 109.843 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.784 HG22 ' N ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -123.83 129.09 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 10.0 109.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 17.2 t60 -141.93 151.04 42.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.639 -1.288 . . . . 10.0 112.728 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.69 HG11 ' CB ' ' A' ' 34' ' ' PRO . 1.7 p -120.9 154.96 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.331 0.586 . . . . 10.0 111.181 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' B' ' 22' ' ' PHE . . . -124.31 56.64 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 106.93 -2.468 . . . . 10.0 106.93 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.047 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 172.06 101.43 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.534 -0.98 . . . . 10.0 109.529 -177.756 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.625 ' O ' HG23 ' B' ' 25' ' ' VAL . 9.8 t0 -61.77 139.94 58.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.114 -0.991 . . . . 10.0 111.165 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' THR . . . 33.79 61.83 0.46 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.558 -0.714 . . . . 10.0 111.336 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 1.047 HG21 ' CD1' ' B' ' 22' ' ' PHE . 19.4 t -113.13 -27.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.163 -0.961 . . . . 10.0 110.818 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.677 ' HB ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -121.19 -12.25 8.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 10.0 111.181 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 26' ' ' ASN . . . -72.7 -29.91 64.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.239 -1.944 . . . . 10.0 108.239 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 13.2 mt-10 -83.44 97.63 9.08 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.925 0.869 . . . . 10.0 109.781 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.816 ' CB ' HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -110.64 144.52 39.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 120.07 -0.652 . . . . 10.0 109.404 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.668 HG22 ' CE1' ' A' ' 28' ' ' PHE . 7.2 p -148.14 -39.25 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.203 -0.936 . . . . 10.0 110.39 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.51 -154.56 11.43 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 120.046 -1.073 . . . . 10.0 110.773 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.07 76.21 6.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.782 -0.834 . . . . 10.0 111.621 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.652 ' CG ' ' CE1' ' B' ' 29' ' ' PHE . 43.9 Cg_endo -74.24 171.32 18.25 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.838 1.441 . . . . 10.0 109.199 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.541 ' OE2' ' HA ' ' B' ' 39' ' ' LEU . 6.2 tt0 -62.38 171.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 10.0 111.642 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.858 ' HG2' HG12 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -94.25 16.55 14.62 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.758 -0.589 . . . . 10.0 110.786 -179.807 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.862 ' C ' HD12 ' A' ' 70' ' ' LEU . 53.4 m0 58.85 52.99 6.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 10.0 111.616 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -177.83 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.358 -0.839 . . . . 10.0 111.593 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.504 ' O ' HD23 ' B' ' 40' ' ' LEU . 1.2 mpt_? -46.41 -36.36 6.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.964 -1.085 . . . . 10.0 110.792 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.925 HD11 HD21 ' A' ' 70' ' ' LEU . 11.7 mt 43.03 20.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.025 0.75 . . . . 10.0 113.025 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.504 HD23 ' O ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -122.37 10.03 9.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.513 -1.367 . . . . 10.0 110.75 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.504 ' OE1' ' HA ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER 70.23 -13.27 0.45 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.744 -0.598 . . . . 10.0 112.092 178.834 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.484 HG22 ' N ' ' B' ' 43' ' ' SER . 92.7 m -132.98 167.31 20.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.705 -1.247 . . . . 10.0 110.101 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.484 ' N ' HG22 ' B' ' 42' ' ' THR . 7.5 t -88.27 41.33 1.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 10.0 110.547 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.503 ' H ' HD11 ' B' ' 40' ' ' LEU . 32.8 t-20 -91.79 115.48 28.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 10.0 110.537 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.449 HD12 ' H ' ' B' ' 45' ' ' ILE . 3.3 mp -99.39 -36.44 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 10.0 109.867 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 45' ' ' ILE . 5.3 m . . . . . 0 C--N 1.304 -1.412 0 CA-C-O 118.099 -0.953 . . . . 10.0 110.419 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.206 0.527 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -143.91 -14.51 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.224 -0.922 . . . . 10.0 110.542 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 57.0 m -71.91 112.43 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.302 -0.874 . . . . 10.0 111.758 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.048 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -106.26 121.63 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 118.854 -1.138 . . . . 10.0 108.974 177.214 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.3 mmtm -94.0 113.78 25.83 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.791 -1.189 . . . . 10.0 107.791 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.431 ' C ' HG23 ' A' ' 7' ' ' VAL . 95.3 m -99.69 105.08 16.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.223 -0.923 . . . . 10.0 109.231 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.724 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 39.7 t -143.02 146.8 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.94 -1.104 . . . . 10.0 111.084 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.617 HG22 ' OG1' ' A' ' 17' ' ' THR . 21.8 t -59.77 141.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 10.0 109.961 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 80' ' ' VAL . 25.7 m -72.73 -169.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 10.0 110.925 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' B' ' 37' ' ' ALA . . . -129.67 11.06 6.03 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -49.96 -46.71 52.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.303 -1.116 . . . . 10.0 109.15 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 134.32 -12.41 4.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 81' ' ' CYS . . . -69.99 172.37 7.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.478 -1.013 . . . . 10.0 109.347 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 19' ' ' LEU . 2.5 p -58.63 161.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.995 -1.066 . . . . 10.0 109.237 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.546 ' N ' ' HG3' ' B' ' 35' ' ' GLN . . . -71.7 112.25 4.02 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.336 . . . . 10.0 109.761 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.921 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -49.75 -29.3 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.035 -1.274 . . . . 10.0 108.593 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 8' ' ' VAL . 94.6 m -59.84 -33.02 71.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.503 -0.748 . . . . 10.0 109.371 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 1.9 t -81.77 -13.86 57.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.601 -0.84 . . . . 10.0 109.899 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 159' ' ' ALA . 4.4 mt -92.58 -31.19 15.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 10.0 109.486 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.13 -31.41 72.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 10.0 107.683 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.84 HG21 HG23 ' B' ' 26' ' ' THR 0.26 9.3 mm -72.19 -45.86 60.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.33 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 21' ' ' ILE . 20.1 p -48.85 -26.1 2.24 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.905 -1.118 . . . . 10.0 108.611 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 1.183 ' CE2' HD12 ' A' ' 165' ' ' LEU . 2.8 m-85 -86.3 -26.02 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 10.0 108.596 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 21' ' ' ILE . 56.2 m -89.91 -31.15 17.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.667 . . . . 10.0 111.651 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.725 ' HB ' HG11 ' A' ' 33' ' ' VAL . 1.5 p -92.29 -81.32 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.613 -1.304 . . . . 10.0 109.687 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 8.9 m-80 -148.62 -30.19 0.28 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.931 -0.708 . . . . 10.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 6.4 pttt 145.96 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 CA-C-O 121.146 0.498 . . . . 10.0 109.815 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.887 ' CZ ' HG22 ' B' ' 30' ' ' THR . 0.1 OUTLIER -121.03 -62.2 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 113.076 0.769 . . . . 10.0 113.076 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.61 ' HD2' ' H ' ' A' ' 28' ' ' PHE . 42.6 Cg_endo -67.98 0.05 4.89 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 122.859 0.926 . . . . 10.0 113.356 -177.452 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 3.0 t -162.26 58.75 0.23 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.362 -1.461 . . . . 10.0 111.48 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -141.55 88.44 2.14 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.152 -0.967 . . . . 10.0 110.183 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.66 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 56.1 m-85 -80.07 56.81 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 10.0 109.61 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.725 HG11 ' HB ' ' A' ' 25' ' ' THR . 10.1 m -95.98 125.31 48.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.598 -0.688 . . . . 10.0 110.313 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.483 ' C ' HG21 ' B' ' 20' ' ' VAL . 46.7 Cg_endo -71.89 94.48 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.85 1.447 . . . . 10.0 110.633 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' THR . . . . . 1.045 ' CB ' HG21 ' B' ' 26' ' ' THR . 0.0 OUTLIER -154.58 161.59 41.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 10.0 111.427 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.869 HG12 ' N ' ' A' ' 37' ' ' PHE . 1.6 t 158.28 -78.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.869 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.9 t80 -61.3 140.22 58.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 10.0 110.96 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HA ' HG13 ' B' ' 18' ' ' ILE . 35.6 t0 -164.56 85.73 0.44 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 39' ' ' ASN . 4.0 p-10 -104.96 103.46 13.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 10.0 111.421 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' B' ' 16' ' ' HIS . 0.2 OUTLIER -170.24 -168.4 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 10.0 110.076 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.574 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -141.04 165.22 28.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.045 -1.035 . . . . 10.0 110.358 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HA ' ' B' ' 14' ' ' PHE . 60.2 t -155.57 171.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 10.0 110.972 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.4 m -140.17 146.24 38.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.816 -0.552 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.696 ' CG1' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -105.34 170.64 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.007 -1.058 . . . . 10.0 109.443 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 8.4 mtt -144.0 121.71 11.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.447 -0.783 . . . . 10.0 109.93 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 ' CG1' ' A' ' 44' ' ' VAL . 1.4 mp -138.0 130.62 40.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.357 -0.84 . . . . 10.0 109.535 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 46.72 23.27 1.37 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.34 -1.504 . . . . 10.0 109.34 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.61 2.34 67.57 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.061 -1.258 . . . . 10.0 110.214 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 4.3 mm-40 -94.3 111.58 54.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.049 -1.265 . . . . 10.0 111.163 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 45.2 Cg_endo -70.11 152.35 67.47 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.87 1.458 . . . . 10.0 109.906 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.789 ' O ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -116.06 163.55 15.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.072 -1.017 . . . . 10.0 110.876 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.647 ' O ' HG22 ' A' ' 4' ' ' ILE 0.256 39.0 m -124.21 112.51 17.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.78 -0.575 . . . . 10.0 109.795 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.4 pp -146.59 179.94 7.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.9 -1.125 . . . . 10.0 111.445 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.826 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -169.26 133.38 2.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 55' ' ' LEU . 1.8 tm? -124.59 123.97 41.21 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.062 -1.257 . . . . 10.0 110.338 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 55' ' ' LEU . 58.9 m-85 -133.51 112.95 11.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 10.0 111.001 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.1 t0 -92.24 134.78 34.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 10.0 109.658 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.77 ' O ' HG23 ' A' ' 58' ' ' THR . 12.4 t -84.22 98.24 9.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 10.0 111.982 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . . . 164.7 62.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.358 -0.839 . . . . 10.0 109.89 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 37' ' ' PHE . . . -40.41 -30.07 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.347 -1.501 . . . . 10.0 109.347 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 1.9 pt20 -170.82 23.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -1.124 . . . . 10.0 111.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 8.2 mt-10 -150.63 -93.71 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.881 -1.137 . . . . 10.0 110.606 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p30 169.74 47.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.689 -1.257 . . . . 10.0 111.073 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.582 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 55.5 p90 -162.12 -44.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.861 -1.15 . . . . 10.0 111.237 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 1.8 t0 77.06 113.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.32 -0.863 . . . . 10.0 111.901 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -21.88 12.82 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.622 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 18.1 mt -84.26 5.9 24.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.469 -0.769 . . . . 10.0 109.01 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.982 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.8 ptt180 -52.32 -32.48 9.13 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 113.709 1.003 . . . . 10.0 113.709 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.624 ' HD3' ' CG ' ' A' ' 68' ' ' ARG . 53.4 Cg_endo -74.66 76.58 3.21 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 CA-C-N 120.038 1.049 . . . . 10.0 110.325 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -101.0 -29.98 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.87 -1.144 . . . . 10.0 111.184 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 43.9 24.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 10.0 110.667 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -164.3 98.59 0.91 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.915 -1.115 . . . . 10.0 111.678 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 48.4 Cg_endo -69.76 167.66 23.81 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.925 1.487 . . . . 10.0 111.134 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 67.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.537 -0.727 . . . . 10.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.82 HG23 ' CB ' ' A' ' 5' ' ' LYS . 52.6 m -145.42 97.85 3.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.398 -0.814 . . . . 10.0 109.493 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 64.5 m-20 -33.7 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.169 0.509 . . . . 10.0 111.36 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 75' ' ' THR . 0.4 OUTLIER -122.26 120.25 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.085 -1.01 . . . . 10.0 110.423 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 39.3 m-85 -116.48 140.61 49.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.616 -0.677 . . . . 10.0 109.735 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.921 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.1 mm? -113.96 98.96 7.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.932 -1.105 . . . . 10.0 108.819 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HA ' HG21 ' A' ' 9' ' ' VAL . 12.9 p -106.31 148.05 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.553 -0.717 . . . . 10.0 110.893 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 41.2 t -134.59 125.15 26.63 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.863 . . . . 10.0 110.805 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 13.6 p90 -136.66 157.72 46.11 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.242 -0.983 . . . . 10.0 110.345 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.424 ' OG ' HG22 ' A' ' 85' ' ' VAL . 44.0 t -83.4 137.69 33.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 10.0 112.133 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 HG13 ' A' ' 85' ' ' VAL . 18.7 m -90.53 2.32 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.666 -0.646 . . . . 10.0 109.859 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.647 HG13 HG23 ' A' ' 84' ' ' VAL . 35.0 m -119.21 48.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 10.0 109.187 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . 21.1 p -133.36 176.69 2.71 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 42.3 Cg_endo -70.52 158.8 54.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.306 1.161 . . . . 10.0 110.733 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 87' ' ' PRO . 3.6 m -31.3 87.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.477 0.656 . . . . 10.0 111.899 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' PRO . 31.0 t -117.14 -54.2 2.42 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 10.0 109.832 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.612 ' CE1' ' HE2' ' A' ' 94' ' ' LYS . 8.8 t80 -49.41 -38.49 29.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.105 . . . . 10.0 109.303 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 34.7 tt0 -60.84 -35.4 76.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 10.0 109.719 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.543 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.1 OUTLIER -69.96 -15.43 63.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.362 -0.836 . . . . 10.0 109.527 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.534 ' O ' ' NE1' ' A' ' 97' ' ' TRP . 62.1 t -87.76 -16.0 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.209 -0.932 . . . . 10.0 109.405 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE3' HD13 ' A' ' 145' ' ' LEU . 2.6 mmtt -85.8 -29.54 23.71 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.7 pt-20 -94.4 5.97 50.16 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.481 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HE3' HD22 ' B' ' 40' ' ' LEU . 8.3 tmtt? -95.92 -51.83 4.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 10.0 112.317 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.914 ' CH2' HD23 ' A' ' 149' ' ' LEU . 49.6 p-90 -104.06 -25.5 12.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.748 -1.22 . . . . 10.0 111.694 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.0 t -64.87 -41.91 59.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.838 -1.164 . . . . 10.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.7 Cg_endo -82.65 -23.32 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.431 1.227 . . . . 10.0 110.635 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.5 mm-40 -93.87 7.48 44.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.031 . . . . 10.0 110.363 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 37.0 mm 59.32 103.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 10.0 111.023 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.768 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.6 m -44.7 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.428 -0.952 . . . . 10.0 108.428 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.768 ' N ' HG22 ' A' ' 102' ' ' THR . 21.3 m-70 -113.23 -6.38 13.61 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.497 -0.752 . . . . 10.0 109.295 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.578 ' O ' ' CB ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER 157.07 16.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 -178.267 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 5.5 t 83.04 34.65 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.853 -0.53 . . . . 10.0 110.026 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.8 Cg_endo -80.85 -18.27 9.15 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 O-C-N 123.177 1.093 . . . . 10.0 109.603 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 64.0 54.22 1.74 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.596 0.713 . . . . 10.0 110.558 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.527 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 13.5 t -52.29 157.8 2.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.505 -0.747 . . . . 10.0 109.552 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.527 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 42.4 Cg_endo -70.5 140.0 38.91 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.294 1.154 . . . . 10.0 110.404 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -135.61 112.41 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.297 -0.877 . . . . 10.0 109.662 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.986 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 3.0 mm? -77.08 97.63 4.77 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.106 -0.996 . . . . 10.0 109.242 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 11.2 mt -69.91 141.01 53.19 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.926 ' CG2' HG11 ' A' ' 168' ' ' VAL . 47.0 t -140.94 168.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.805 -1.184 . . . . 10.0 112.509 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -107.52 159.23 14.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.285 -1.926 . . . . 10.0 108.285 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' C ' ' A' ' 82' ' ' PHE . 85.5 m -115.55 120.41 39.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.399 . . . . 10.0 111.341 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.32 55.57 5.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.582 -0.699 . . . . 10.0 111.375 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -55.74 -22.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.084 . . . . 10.0 108.714 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 21.3 t70 -52.0 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.453 1.12 . . . . 10.0 110.708 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.723 ' N ' ' O ' ' A' ' 117' ' ' ILE . 16.0 tp 159.71 -24.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.447 -1.252 . . . . 10.0 108.381 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -49.12 -42.77 40.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.748 -0.595 . . . . 10.0 109.6 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m-20 -53.92 -20.2 5.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.021 -1.049 . . . . 10.0 109.234 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.8 t0 -82.53 118.0 70.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.688 . . . . 10.0 110.537 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 48.4 Cg_endo -90.58 23.0 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.661 1.574 . . . . 10.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 p -101.36 -49.41 4.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 10.0 110.149 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.714 HG21 HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.89 -26.83 43.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.201 -2.148 . . . . 10.0 105.201 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.815 ' HA ' HD22 ' A' ' 129' ' ' LEU 0.281 1.1 mp -56.66 -26.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 176.858 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -49.38 -35.07 17.74 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.636 -0.711 . . . . 10.0 111.128 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -61.81 -38.31 87.64 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.188 -0.945 . . . . 10.0 110.744 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -59.03 -32.9 70.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 10.0 110.086 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -56.23 -45.01 80.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 10.0 109.833 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -55.94 -16.89 5.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.337 -0.852 . . . . 10.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.99 -18.3 5.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.922 -1.111 . . . . 10.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -165.57 110.54 0.87 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.014 -1.054 . . . . 10.0 109.998 -179.301 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.52 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -71.91 -24.62 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 10.0 110.511 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -98.12 104.83 24.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 10.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 44.1 Cg_endo -71.54 154.47 60.11 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.793 1.417 . . . . 10.0 110.379 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.5 tp -94.08 135.38 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 10.0 109.013 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 16.2 p -124.01 168.81 11.8 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.325 -0.859 . . . . 10.0 109.589 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -66.3 -15.27 47.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.527 1.278 . . . . 10.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.66 -37.81 22.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 10.0 110.426 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.6 m -79.33 -32.66 43.4 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.538 -0.726 . . . . 10.0 110.821 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.27 -44.86 74.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 10.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -64.52 -27.76 69.19 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.27 -0.972 . . . . 10.0 109.453 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 147' ' ' ARG . 2.0 mmtp -67.53 -43.89 79.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.11 -0.994 . . . . 10.0 108.639 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.877 HD13 ' HE3' ' A' ' 94' ' ' LYS . 4.3 tt -63.05 -46.22 88.53 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -52.22 -43.12 64.1 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.816 0.817 . . . . 10.0 109.179 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 3.8 ttp85 -55.6 -28.74 56.89 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.524 0.678 . . . . 10.0 109.463 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.489 ' C ' HD12 ' A' ' 149' ' ' LEU . 22.9 t70 -78.17 -43.95 27.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.623 -0.673 . . . . 10.0 110.776 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.914 HD23 ' CH2' ' A' ' 97' ' ' TRP . 5.7 mp -88.06 9.83 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 10.0 108.88 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 10.2 mttt 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.895 0.855 . . . . 10.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.805 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -59.9 -151.34 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.197 -0.668 . . . . 10.0 109.197 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.913 ' CG1' HD13 ' A' ' 111' ' ' LEU . 1.4 p -116.86 -64.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.594 -1.316 . . . . 10.0 110.747 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.603 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -173.9 140.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.453 -1.404 . . . . 10.0 111.863 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 29.0 t80 -84.78 108.06 17.27 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.388 -0.925 . . . . 10.0 109.889 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.957 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -103.61 -169.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.752 . . . . 10.0 110.174 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' HA3' ' A' ' 164' ' ' GLY . 0.5 OUTLIER -127.74 160.29 32.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.958 . . . . 10.0 110.14 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.925 ' SG ' HD23 ' A' ' 165' ' ' LEU 0.251 1.6 t -166.02 135.87 3.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 10.0 110.238 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.556 ' OG ' ' CG ' ' A' ' 163' ' ' LYS . 34.2 m -131.17 83.88 2.14 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.078 -1.453 . . . . 10.0 107.078 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 1.052 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -29.26 -53.2 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.691 -1.141 . . . . 10.0 113.132 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.8 tp -71.06 -53.75 13.6 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.693 -1.254 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.4 p -84.74 -89.54 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.911 -1.118 . . . . 10.0 111.169 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.605 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 2.4 pt20 159.28 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 10.0 109.364 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.556 ' CG ' ' OG ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -105.33 69.19 0.83 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.026 -1.069 . . . . 10.0 110.591 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 76.98 0.93 71.24 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.993 -1.643 . . . . 10.0 108.993 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.183 HD12 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -50.12 -44.41 52.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.42 -1.047 . . . . 10.0 109.608 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.879 ' N ' HD13 ' A' ' 165' ' ' LEU . 14.8 tttm -70.69 -25.64 63.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.156 -0.965 . . . . 10.0 109.367 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 19.3 m120 -75.45 -33.89 60.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 10.0 111.641 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.957 HG22 ' HB ' ' A' ' 155' ' ' VAL . 10.7 t -57.96 -49.75 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.786 -1.197 . . . . 10.0 110.056 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.26 -40.0 88.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.659 -0.651 . . . . 10.0 110.43 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.6 t0 -60.12 -46.41 89.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 10.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.5 -42.63 99.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 10.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.986 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.28 -24.52 43.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 10.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.639 ' O ' HD11 ' A' ' 177' ' ' LEU . 77.4 mt -63.92 -47.03 92.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.115 -0.99 . . . . 10.0 109.595 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.802 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.07 -41.45 70.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 10.0 111.087 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -80.71 -2.72 48.0 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.198 -0.938 . . . . 10.0 110.899 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.048 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.67 -22.5 24.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.045 -1.035 . . . . 10.0 110.821 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -90.06 -22.19 21.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.077 -1.015 . . . . 10.0 110.138 -179.324 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.025 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.254 -1.538 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -124.23 140.44 52.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.174 -1.192 . . . . 10.0 110.475 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.747 ' HE2' HD12 ' A' ' 174' ' ' LEU . 10.1 tptt -84.26 103.15 13.21 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.204 -0.935 . . . . 10.0 108.511 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -82.66 152.61 25.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.238 -0.914 . . . . 10.0 110.692 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.632 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.76 -48.14 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.77 -0.581 . . . . 10.0 110.555 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.2 Cg_endo -91.32 24.06 0.58 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.977 -1.201 . . . . 10.0 108.977 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.628 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 2.0 pm0 -39.55 166.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.544 0.688 . . . . 10.0 111.659 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.85 -88.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 10.0 111.192 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.5 p -82.37 171.19 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 10.0 111.96 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.909 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.96 96.8 0.48 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 10.0 111.818 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.49 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 46.9 Cg_endo -76.1 133.61 15.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.418 1.22 . . . . 10.0 109.117 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 56.4 p -93.16 117.95 30.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 10.0 111.105 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.09 136.45 54.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.523 -0.736 . . . . 10.0 109.303 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.794 ' HA ' HG13 ' A' ' 42' ' ' VAL . 11.4 p90 -139.98 166.53 24.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.939 -1.101 . . . . 10.0 110.635 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.6 tt0 -164.19 110.88 1.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.087 -1.008 . . . . 10.0 110.78 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 40' ' ' TYR . 6.4 p-80 -165.76 137.54 3.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 10.0 110.17 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.508 ' C ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -150.59 98.48 2.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 10.0 110.636 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.729 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -155.55 -170.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.4 p-80 -141.81 153.75 44.73 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 117.6 -1.64 . . . . 10.0 112.605 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.985 HG21 ' CA ' ' A' ' 35' ' ' THR . 3.5 m -103.39 152.34 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.461 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -124.09 73.77 0.4 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.742 -1.218 . . . . 10.0 110.313 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.858 ' CD2' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 167.4 97.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.385 -1.067 . . . . 10.0 109.189 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.777 ' O ' HG23 ' B' ' 25' ' ' VAL . 21.1 m-20 -61.33 154.48 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.438 -0.789 . . . . 10.0 111.815 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 32' ' ' TYR . . . 39.76 38.11 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.638 . . . . 10.0 111.065 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.858 HG21 ' CD2' ' B' ' 22' ' ' PHE . 37.1 t -111.39 -23.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 10.0 108.821 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 26' ' ' THR . . . . . 1.045 HG21 ' CB ' ' A' ' 35' ' ' THR . 10.0 t -88.97 -10.61 47.04 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.36 0.6 . . . . 10.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.63 -0.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.517 -1.433 . . . . 10.0 109.517 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' B' ' 28' ' ' GLU . 6.8 pt-20 -104.51 122.11 44.86 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.969 -1.312 . . . . 10.0 110.733 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.3 OUTLIER -121.59 118.61 29.66 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.736 -0.839 . . . . 10.0 108.736 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.887 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 23.0 p -122.19 -4.99 8.93 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.986 -0.685 . . . . 10.0 109.589 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.89 39.09 0.78 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.167 -1.573 . . . . 10.0 109.167 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' B' ' 33' ' ' PRO . 28.4 mm -69.0 142.15 92.94 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.329 -1.1 . . . . 10.0 110.435 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' B' ' 32' ' ' ILE . 45.0 Cg_endo -68.9 177.61 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.293 1.681 . . . . 10.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' B' ' 37' ' ' ALA . 5.4 tm-20 -23.09 138.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.437 0.637 . . . . 10.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.546 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 7.6 mm100 -100.81 -71.72 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.67 0.989 . . . . 10.0 113.67 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.724 ' CZ3' HG11 ' A' ' 7' ' ' VAL . 16.5 t90 -108.69 30.36 6.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.357 -0.839 . . . . 10.0 112.611 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.904 ' HB1' HD12 ' B' ' 39' ' ' LEU . . . -178.18 89.3 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 118.986 -1.086 . . . . 10.0 111.383 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.505 ' HA ' ' HG3' ' B' ' 34' ' ' GLU . 5.3 ttp180 -82.87 43.3 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.904 HD12 ' HB1' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -50.75 -49.88 56.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.892 -178.541 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.502 HD22 ' HE3' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -107.68 13.29 26.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.197 -0.939 . . . . 10.0 110.284 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.457 ' CB ' ' HG2' ' B' ' 38' ' ' ARG . 2.6 mt-30 -120.89 10.72 10.93 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.805 -0.559 . . . . 10.0 110.134 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.763 HG23 ' H ' ' B' ' 44' ' ' ASN . 14.5 t -83.36 173.86 11.19 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.134 -0.979 . . . . 10.0 109.503 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.76 18.39 0.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 10.0 111.139 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.763 ' H ' HG23 ' B' ' 42' ' ' THR . 5.4 m120 -129.2 137.76 51.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.898 -1.126 . . . . 10.0 110.689 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -39.98 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 10.0 111.271 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 118.039 -0.982 . . . . 10.0 110.33 -178.737 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.283 0.563 . . . . 10.0 109.703 . . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.507 ' HG2' ' N ' ' A' ' 3' ' ' THR . 0.7 OUTLIER -177.9 -160.74 0.05 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 10.0 110.749 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 3' ' ' THR . 85.0 m 41.25 58.29 2.64 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.36 -0.837 . . . . 10.0 111.019 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -143.16 150.52 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 117.28 -1.768 . . . . 10.0 113.804 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.629 ' N ' HG13 ' A' ' 4' ' ' ILE . 27.9 mtmt -131.32 126.1 34.45 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.279 -0.888 . . . . 10.0 109.601 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' C ' HG23 ' A' ' 7' ' ' VAL . 10.0 t -85.36 129.98 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.133 -0.979 . . . . 10.0 109.336 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 6' ' ' CYS . 4.1 t -146.97 175.97 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.919 -1.113 . . . . 10.0 110.421 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG21 HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER -108.93 146.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.537 -1.352 . . . . 10.0 111.178 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.27 -168.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.211 -0.93 . . . . 10.0 110.389 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.753 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 114.02 134.9 5.96 Favored Glycine 0 C--N 1.29 -1.994 0 N-CA-C 109.251 -1.54 . . . . 10.0 109.251 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.24 -14.8 19.72 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.507 -0.996 . . . . 10.0 110.054 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.49 -108.17 0.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.941 -1.664 . . . . 10.0 108.941 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.54 -130.3 0.08 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.03 -1.277 . . . . 10.0 110.933 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' C ' ' HG3' ' B' ' 35' ' ' GLN . 17.8 m -110.4 148.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.186 . . . . 10.0 110.618 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -51.58 137.95 29.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.6 -28.27 11.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.671 -1.488 . . . . 10.0 110.72 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.536 HG21 HG21 ' A' ' 8' ' ' VAL . 77.1 p -88.88 -37.44 15.31 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.492 -0.755 . . . . 10.0 110.336 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 19' ' ' LEU . 21.8 p -85.35 -13.46 49.47 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.925 -1.109 . . . . 10.0 109.745 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' B' ' 29' ' ' PHE . 4.4 mm? -81.9 -42.89 18.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.36 -1.463 . . . . 10.0 109.048 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 165' ' ' LEU . 5.6 tt -46.85 -37.74 9.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.632 -1.248 . . . . 10.0 107.632 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.868 HG21 HG23 ' B' ' 26' ' ' THR 0.256 5.6 mm -67.86 -46.99 81.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.779 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 p -48.3 -31.52 6.11 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.596 -0.842 . . . . 10.0 109.843 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.699 ' CD2' HD11 ' A' ' 165' ' ' LEU . 3.4 m-85 -93.77 -18.86 21.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.785 -1.197 . . . . 10.0 109.399 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 93.5 m -94.4 -22.5 18.26 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 10.0 112.604 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -109.16 -77.84 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.033 -1.667 . . . . 10.0 110.891 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 80.4 m-20 -152.19 -23.68 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.144 -1.423 . . . . 10.0 113.025 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 49.5 pttt 167.68 -158.7 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 O-C-N 120.855 -1.153 . . . . 10.0 112.481 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 2.7 p90 -120.5 -15.74 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 115.055 1.502 . . . . 10.0 115.055 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 42.6 Cg_endo -70.31 -63.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 CA-C-N 120.041 1.05 . . . . 10.0 113.335 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -165.5 73.48 0.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.567 -1.333 . . . . 10.0 109.701 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' OE1' ' N ' ' A' ' 26' ' ' ASN . 2.5 pt-20 -108.65 164.71 12.12 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.953 0.882 . . . . 10.0 110.927 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -82.06 99.16 9.01 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.025 0.917 . . . . 10.0 109.03 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.878 ' CG2' HG22 ' B' ' 26' ' ' THR 0.286 6.6 m -112.5 169.99 5.76 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.935 -177.44 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 42.0 Cg_endo -63.48 -150.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 124.097 1.577 . . . . 10.0 109.25 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.429 ' HB ' HG12 ' B' ' 20' ' ' VAL . 34.6 p -109.14 134.01 52.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.312 -1.492 . . . . 10.0 113.358 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.643 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 44.3 t -57.07 -74.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.777 -0.577 . . . . 10.0 109.752 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.68 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 19.8 t80 -45.05 123.43 3.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.712 ' HA ' HD11 ' B' ' 18' ' ' ILE . 12.1 t0 -149.73 86.59 1.46 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.381 -1.328 . . . . 10.0 111.479 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 16' ' ' HIS . 19.1 t-20 -97.82 99.98 11.33 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.721 -1.215 . . . . 10.0 107.721 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 2.3 m-85 -122.69 121.44 36.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.661 . . . . 10.0 109.63 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' B' ' 14' ' ' PHE . . . -112.48 116.12 29.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 10.0 110.253 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 43' ' ' THR . 40.1 t -132.86 173.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.897 -1.127 . . . . 10.0 110.244 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 51' ' ' TYR . 67.6 m -155.03 151.27 28.23 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.767 -0.773 . . . . 10.0 110.216 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -144.83 128.67 12.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.491 -0.883 . . . . 10.0 111.357 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.571 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -86.8 97.57 10.7 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.336 -0.946 . . . . 10.0 109.417 178.628 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 51' ' ' TYR . 2.9 mp -78.96 114.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.073 -1.017 . . . . 10.0 108.27 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 55.69 19.76 21.84 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 118.654 -1.736 . . . . 10.0 109.189 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 109.93 -8.13 31.5 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.349 -1.089 . . . . 10.0 110.645 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' C ' ' HA ' ' A' ' 45' ' ' MET . 30.1 mm-40 -96.43 105.33 21.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.28 . . . . 10.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 44.3 Cg_endo -71.19 130.71 18.0 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.495 1.463 . . . . 10.0 110.387 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.572 ' CE1' HD13 ' A' ' 46' ' ' ILE . 3.8 m-30 -98.18 118.31 34.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.838 -1.163 . . . . 10.0 111.616 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.7 p -92.28 99.23 12.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.077 -1.014 . . . . 10.0 108.568 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.03 147.33 44.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.039 -1.038 . . . . 10.0 110.94 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -129.62 109.52 0.96 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.04 -1.624 . . . . 10.0 109.04 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.807 ' C ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -98.28 127.45 44.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -1.204 . . . . 10.0 110.543 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.745 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.5 t80 -137.92 122.12 18.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.947 . . . . 10.0 111.283 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -107.8 164.73 12.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.902 -1.124 . . . . 10.0 109.719 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' B' ' 36' ' ' TRP . 99.6 m -47.44 164.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.798 -1.189 . . . . 10.0 111.001 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' A' ' 62' ' ' GLU . . . -104.74 91.68 3.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.73 -0.606 . . . . 10.0 109.961 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.574 ' HA3' HG23 ' B' ' 20' ' ' VAL . . . -48.01 -41.47 21.76 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.843 -2.503 . . . . 10.0 106.843 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 20.3 pt20 -71.87 -31.93 66.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 5.6 mt-10 56.42 81.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.813 0.816 . . . . 10.0 111.681 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.537 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 97.9 m-20 -126.38 3.92 6.98 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.32 0.581 . . . . 10.0 109.513 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 171.46 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 10.0 110.911 -178.915 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 5.4 p-10 -113.83 15.61 18.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.828 -1.17 . . . . 10.0 110.808 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.7 ptt-85 -77.83 -33.99 52.09 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.091 -1.006 . . . . 10.0 110.136 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.551 ' CA ' HD21 ' A' ' 70' ' ' LEU . 4.9 mt -111.41 5.27 19.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.909 -1.12 . . . . 10.0 111.726 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -97.07 -54.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.474 -1.391 . . . . 10.0 113.296 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.749 ' HG2' HD13 ' A' ' 70' ' ' LEU . 42.8 Cg_endo -71.46 -62.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.233 1.123 . . . . 10.0 111.335 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.957 ' N ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -50.62 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.383 -0.823 . . . . 10.0 111.855 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.627 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 17.4 p -31.37 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.416 0.626 . . . . 10.0 110.371 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 p90 48.13 138.62 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.3 0 N-CA-C 113.383 0.883 . . . . 10.0 113.383 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.97 167.28 27.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.65 1.567 . . . . 10.0 111.205 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -83.39 32.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.19 -0.944 . . . . 10.0 110.588 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 27.7 m -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 4.6 p-10 160.78 118.69 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.972 HG11 ' HA ' ' A' ' 176' ' ' ALA . 16.0 m -64.47 157.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.944 -1.872 . . . . 10.0 105.944 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 72' ' ' TYR . 43.9 m-85 -121.86 155.63 35.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.085 -1.634 . . . . 10.0 114.451 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 HG12 ' A' ' 168' ' ' VAL . 2.3 mm? -118.71 97.68 5.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 10' ' ' GLY . 14.3 p -110.03 154.97 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.119 -0.988 . . . . 10.0 109.708 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.519 ' CB ' ' OG1' ' A' ' 115' ' ' THR . 4.7 m -123.3 109.33 13.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.946 -1.096 . . . . 10.0 111.663 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CE1' HG21 ' A' ' 93' ' ' VAL . 93.8 m-85 -87.89 168.7 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 10.0 109.918 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.2 m -75.91 157.59 33.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.988 -1.07 . . . . 10.0 108.417 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 85' ' ' VAL . 3.5 p -81.91 -23.1 9.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.745 -1.222 . . . . 10.0 111.09 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -129.86 -88.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.847 -1.158 . . . . 10.0 108.808 178.251 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.603 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 44.52 -171.72 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.497 -0.752 . . . . 10.0 109.675 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 53.3 Cg_endo -73.34 162.84 39.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.421 1.222 . . . . 10.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -63.03 78.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.117 . . . . 10.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 29.1 t -106.36 -45.83 4.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.848 . . . . 10.0 110.791 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 112' ' ' LEU . 62.5 t80 -49.14 -19.4 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.156 -0.965 . . . . 10.0 110.193 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 7.3 mm-40 -78.79 -19.75 51.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.333 -0.855 . . . . 10.0 111.634 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.75 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -93.68 -14.6 26.19 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.388 -1.445 . . . . 10.0 109.38 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.75 HG13 ' ND2' ' A' ' 92' ' ' ASN . 31.5 m -85.58 -30.87 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.215 -0.994 . . . . 10.0 108.435 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.892 ' CE ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.16 -25.68 59.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.118 -0.989 . . . . 10.0 109.801 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.58 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -96.23 3.21 53.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 10.0 111.109 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.26 -50.33 3.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.571 -1.331 . . . . 10.0 111.06 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.64 -40.22 13.48 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.92 -1.112 . . . . 10.0 113.251 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 ' HG ' ' A' ' 149' ' ' LEU . 55.9 t -70.78 -51.62 11.35 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.33 -1.481 . . . . 10.0 112.806 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 95' ' ' GLU . 40.1 Cg_endo -64.71 -21.1 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.311 1.164 . . . . 10.0 109.365 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.783 ' HG2' HG22 ' A' ' 101' ' ' ILE . 64.6 tt0 -51.39 -57.0 10.12 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.127 -0.983 . . . . 10.0 109.999 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 149.67 119.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 109.743 -0.465 . . . . 10.0 109.743 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 108' ' ' THR . 25.3 m -92.36 -83.97 0.29 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 17.7 m80 -107.73 -11.47 15.41 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 103' ' ' HIS . 4.5 p80 173.11 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.565 -1.272 . . . . 10.0 107.565 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 96.9 m -130.98 164.98 38.38 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HB2' HG12 ' A' ' 98' ' ' VAL . 38.8 Cg_endo -67.88 92.04 0.37 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 123.608 1.32 . . . . 10.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 1.6 tttt -139.31 9.45 2.49 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.441 -0.787 . . . . 10.0 109.982 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.454 ' N ' ' OG1' ' A' ' 102' ' ' THR . 23.6 m -46.21 139.95 5.47 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.679 -1.263 . . . . 10.0 109.843 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.891 ' CG ' HG12 ' A' ' 77' ' ' VAL . 51.2 Cg_endo -70.76 117.65 5.26 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.003 1.528 . . . . 10.0 108.352 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.439 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -126.59 110.23 12.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.289 -0.882 . . . . 10.0 111.711 -177.954 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.033 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.2 mm? -85.6 98.08 10.45 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.526 -1.287 . . . . 10.0 107.526 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 90' ' ' PHE . 70.1 mt -84.13 127.87 34.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.042 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.814 HG11 ' HB3' ' A' ' 157' ' ' CYS . 19.2 t -133.5 165.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.857 . . . . 10.0 110.131 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -116.28 112.25 2.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -92.89 160.86 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.375 -1.073 . . . . 10.0 111.358 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 59.93 43.72 14.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.497 -0.752 . . . . 10.0 110.481 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -74.32 -18.97 17.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 179.054 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 117' ' ' ILE . 13.2 m-20 -53.46 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 122.7 1.238 . . . . 10.0 110.499 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 120' ' ' ARG . 1.8 pp 166.44 -27.68 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 114.138 -1.392 . . . . 10.0 107.596 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.739 ' N ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.12 -41.75 12.81 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.726 0.774 . . . . 10.0 109.07 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.88 -23.31 63.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.549 0.69 . . . . 10.0 110.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.485 ' O ' HD13 ' A' ' 126' ' ' ILE . 27.0 t70 -93.04 119.63 67.56 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 10.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.92 21.83 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 124.277 1.672 . . . . 10.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.475 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 32.2 t -107.19 -45.0 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 10.0 110.169 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 t -71.63 -30.26 65.57 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.8 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.315 0.9 OUTLIER -50.87 -26.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.188 -1.369 . . . . 10.0 108.315 177.18 . . . . . . . . 4 4 . 1 . 008 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -54.8 -40.45 69.5 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.509 0.671 . . . . 10.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -81.86 -36.03 28.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.462 -0.773 . . . . 10.0 109.904 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.847 ' HA ' HD22 ' A' ' 132' ' ' ASN . 8.5 mt -59.41 -45.29 91.92 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.778 -1.201 . . . . 10.0 108.586 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -49.01 -39.27 26.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 10.0 110.357 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -53.95 -19.09 4.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.571 -0.706 . . . . 10.0 111.13 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.847 HD22 ' HA ' ' A' ' 129' ' ' LEU . 8.4 p30 -118.36 -2.15 11.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.311 -1.356 . . . . 10.0 111.964 -178.189 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.531 ' HG2' ' O ' ' A' ' 86' ' ' SER . 0.0 OUTLIER -158.15 -25.51 0.08 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.148 -0.97 . . . . 10.0 111.043 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 9.0 pm0 40.79 19.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.753 -0.592 . . . . 10.0 111.595 -179.145 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' LYS . 1.2 ptmt -153.77 95.1 2.87 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.776 -1.203 . . . . 10.0 110.036 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.939 ' HB3' HG12 ' A' ' 85' ' ' VAL . 44.4 Cg_endo -71.07 156.84 59.13 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 O-C-N 124.055 1.555 . . . . 10.0 110.357 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' A' ' 142' ' ' ALA . 2.0 mm -93.7 122.35 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 10.0 109.779 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.1 p -118.95 173.36 3.48 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.515 -0.74 . . . . 10.0 109.219 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.568 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.8 Cg_endo -63.37 -10.17 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.803 0.896 . . . . 10.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -94.12 -44.96 7.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 10.0 109.836 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -48.78 45.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 10.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 137' ' ' ILE . . . -62.47 -40.38 96.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 10.0 111.297 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 27.0 tt0 -61.18 -39.85 91.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.126 . . . . 10.0 109.526 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -60.61 -49.55 77.07 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.665 -1.214 . . . . 10.0 108.416 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.892 HD11 ' CE ' ' A' ' 94' ' ' LYS . 4.3 tt -57.82 -37.79 74.41 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.028 -1.045 . . . . 10.0 109.238 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.702 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -66.57 -35.61 80.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 120.017 -0.673 . . . . 10.0 109.633 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -15.44 60.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.141 -0.975 . . . . 10.0 109.277 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 11.8 t0 -70.3 -10.41 58.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.436 -0.79 . . . . 10.0 110.928 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.75 31.06 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 10.0 111.028 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt 60.03 36.65 21.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.82 0.819 . . . . 10.0 110.314 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -71.19 -176.23 1.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.033 HG11 ' CD1' ' A' ' 111' ' ' LEU . 12.7 t -87.48 -81.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.659 ' N ' HG12 ' A' ' 152' ' ' VAL . 1.6 tttp -173.74 159.38 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.549 -0.72 . . . . 10.0 110.072 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CG ' ' CB ' ' A' ' 142' ' ' ALA . 43.1 t80 -93.98 100.37 12.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.714 -1.241 . . . . 10.0 109.886 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.06 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -95.15 -167.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.51 -0.744 . . . . 10.0 109.328 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -136.05 149.65 48.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.66 -1.275 . . . . 10.0 112.262 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.814 ' HB3' HG11 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -162.9 138.41 6.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.335 -0.853 . . . . 10.0 109.424 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' LEU . 5.0 t -148.13 114.18 5.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 10.0 110.065 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.817 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 3.21 -65.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.739 1.385 . . . . 10.0 114.739 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.9 -38.51 1.12 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.758 -1.214 . . . . 10.0 112.079 -177.428 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.1 p -60.91 -71.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 10.0 111.788 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 158' ' ' SER . 4.4 mm100 -36.6 -69.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.631 -0.668 . . . . 10.0 111.43 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER 66.05 25.27 10.92 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.637 -0.825 . . . . 10.0 110.532 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.82 2.89 9.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.192 -1.963 . . . . 10.0 108.192 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -58.27 -14.76 7.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.666 -0.902 . . . . 10.0 111.944 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.654 ' N ' HD22 ' A' ' 165' ' ' LEU . 9.4 mtmt -63.15 -36.07 82.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.445 -1.409 . . . . 10.0 110.952 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.6 m-20 -63.86 -38.56 91.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 10.0 111.103 -179.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.06 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.8 t -52.8 -34.38 20.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.815 -1.178 . . . . 10.0 110.412 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.89 -24.28 55.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 10.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -74.21 -43.89 55.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.042 -1.063 . . . . 10.0 110.088 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 153' ' ' LYS . 36.4 mt-10 -60.58 -32.94 72.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 10.0 109.995 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.763 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -61.23 -24.78 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.772 -1.205 . . . . 10.0 109.76 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.741 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.8 mm -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.08 -1.013 . . . . 10.0 109.736 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.776 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -76.41 -41.88 46.22 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.004 -1.06 . . . . 10.0 109.986 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.835 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -79.81 -4.2 51.08 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.447 -0.783 . . . . 10.0 109.824 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.972 ' HA ' HG11 ' A' ' 77' ' ' VAL . . . -76.41 -43.17 41.59 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.191 -0.943 . . . . 10.0 108.95 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -108.09 -20.6 13.11 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.56 0.695 . . . . 10.0 109.814 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.184 -0.912 . . . . 10.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 108.517 -1.833 . . . . 10.0 108.517 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' B' ' 4' ' ' GLU . 2.0 m -107.75 55.25 0.65 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.218 -1.166 . . . . 10.0 110.476 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -51.64 105.48 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 10.0 110.457 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' B' ' 2' ' ' SER . 1.5 mt-10 -96.01 156.0 16.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.608 -0.682 . . . . 10.0 110.388 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.61 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -108.6 -50.3 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.159 -0.963 . . . . 10.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 55.6 Cg_endo -95.67 32.3 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 108.298 -1.462 . . . . 10.0 108.298 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.5 pp20? -38.57 158.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.912 -0.493 . . . . 10.0 109.676 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.677 HG13 ' HA2' ' A' ' 47' ' ' GLY . 2.1 pp -81.52 -53.33 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.233 . . . . 10.0 112.184 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.559 ' N ' HD12 ' B' ' 8' ' ' ILE . 30.6 t -160.94 173.81 14.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.325 -1.484 . . . . 10.0 111.462 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.666 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.2 pp -164.39 99.2 0.89 Allowed Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.119 -1.032 . . . . 10.0 111.929 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 44.2 Cg_endo -72.65 104.95 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.862 1.453 . . . . 10.0 109.343 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.51 ' HA ' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -53.02 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.956 . . . . 10.0 111.037 -179.29 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -138.31 -168.88 2.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' ALA . 21.6 m-85 -97.13 165.21 12.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.7 -1.25 . . . . 10.0 111.796 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 6.1 pm0 -119.85 171.05 8.69 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.8 -0.562 . . . . 10.0 110.39 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -92.16 -174.97 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.006 -1.059 . . . . 10.0 110.356 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.511 ' C ' HG23 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -147.1 133.47 19.59 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.122 -0.986 . . . . 10.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.835 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -150.07 -177.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.916 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -142.37 154.91 45.04 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.989 -1.069 . . . . 10.0 110.645 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.643 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 2.8 p -91.11 148.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 10.0 110.503 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' A' ' 61' ' ' GLN . . . -99.42 47.94 1.3 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.874 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -177.74 104.62 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.234 -1.156 . . . . 10.0 109.032 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.39 142.0 49.67 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.808 0.813 . . . . 10.0 112.343 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.742 ' HA ' HG22 ' A' ' 33' ' ' VAL . . . 51.57 51.71 16.17 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.746 -0.596 . . . . 10.0 112.38 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.874 HG21 ' HB3' ' B' ' 22' ' ' PHE . 52.1 t -113.32 -39.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.649 -1.282 . . . . 10.0 110.547 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.878 HG22 ' CG2' ' A' ' 33' ' ' VAL . 3.1 t -61.58 -22.78 65.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.137 -0.977 . . . . 10.0 110.18 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.815 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -106.3 31.12 8.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 106.841 -2.504 . . . . 10.0 106.841 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 2.8 mp0 -128.55 114.07 16.26 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.261 1.029 . . . . 10.0 110.663 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.822 ' CG ' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -128.67 140.32 51.81 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.707 0.765 . . . . 10.0 109.955 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -146.29 -69.52 0.26 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.97 1.2 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.631 -1.271 . . . . 10.0 111.289 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.56 ' HB ' ' HD3' ' B' ' 33' ' ' PRO . 2.0 mt -63.29 -55.65 34.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.629 -1.512 . . . . 10.0 111.217 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' B' ' 32' ' ' ILE . 44.1 Cg_endo -70.56 169.38 20.07 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.326 1.172 . . . . 10.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.519 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.4 tp10 -78.63 167.67 20.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.991 -1.068 . . . . 10.0 109.371 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 11.5 mp0 -81.08 19.62 0.88 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.484 -0.76 . . . . 10.0 111.469 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.581 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 4.8 m95 89.9 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 123.074 1.416 . . . . 10.0 107.504 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.695 ' HB1' HD12 ' B' ' 39' ' ' LEU . . . -156.81 81.09 0.94 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.217 -1.356 . . . . 10.0 108.613 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.519 ' CA ' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -82.68 35.32 0.46 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.061 -1.025 . . . . 10.0 108.719 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.695 HD12 ' HB1' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -58.55 -11.85 3.42 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.951 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.552 ' O ' HD12 ' B' ' 40' ' ' LEU . 1.2 pp -71.68 -2.32 16.9 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.783 -1.198 . . . . 10.0 111.926 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.42 ' HG3' HD12 ' B' ' 40' ' ' LEU . 5.6 mt-30 -161.05 -89.21 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.379 -0.825 . . . . 10.0 109.73 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.794 HG23 ' H ' ' B' ' 44' ' ' ASN . 8.8 t -137.8 -170.36 2.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.505 0.669 . . . . 10.0 110.224 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 82.6 p -86.97 6.07 34.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.442 -0.786 . . . . 10.0 111.113 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.794 ' H ' HG23 ' B' ' 42' ' ' THR . 9.7 t-20 -87.73 96.76 10.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.051 -1.03 . . . . 10.0 111.413 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' THR . 22.4 mt -87.32 -65.9 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.95 . . . . 10.0 110.777 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.442 ' C ' ' O ' ' B' ' 45' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.932 -1.032 . . . . 10.0 110.08 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 1.5 mpp? . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.905 0.384 . . . . 10.0 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.622 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.3 mt-30 -139.01 -39.99 0.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 10.0 110.249 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -44.09 101.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.972 . . . . 10.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.891 HD12 ' CB ' ' A' ' 176' ' ' ALA . 2.1 tt -106.47 140.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.658 -1.217 . . . . 10.0 110.302 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 mmtt -112.85 137.05 51.77 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 18.2 t -118.85 108.42 14.8 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.807 -1.183 . . . . 10.0 110.317 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.601 ' N ' HG21 ' A' ' 75' ' ' THR . 9.1 t -137.81 163.62 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 10.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.612 HG22 ' OG1' ' A' ' 17' ' ' THR . 3.1 t -87.02 141.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 10.0 110.548 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 78' ' ' PHE . 46.1 t -136.42 174.69 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.374 -0.829 . . . . 10.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.762 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 125.04 130.6 3.52 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.864 -1.295 . . . . 10.0 109.864 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.82 -27.57 43.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -1.075 . . . . 10.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 140.92 127.61 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.02 -1.232 . . . . 10.0 110.02 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 169.59 -67.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 10.0 109.703 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.966 ' HB ' HG23 ' A' ' 115' ' ' THR . 13.4 t -147.93 107.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 10.0 109.525 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' B' ' 35' ' ' GLN . . . -74.08 99.1 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.882 -1.287 . . . . 10.0 109.882 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -52.64 -36.97 57.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.296 . . . . 10.0 109.709 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 8' ' ' VAL . 53.2 m -52.71 -39.57 62.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.436 -0.79 . . . . 10.0 110.792 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 22' ' ' SER . 14.5 p -81.89 -15.77 52.86 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.673 -1.267 . . . . 10.0 108.988 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.771 HD11 HG13 ' A' ' 14' ' ' VAL . 10.2 mt -84.34 -30.52 25.43 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.906 0.86 . . . . 10.0 109.12 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -54.69 -39.3 67.99 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.788 HG21 HG23 ' B' ' 26' ' ' THR . 3.5 mm -91.27 -42.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 121.666 0.746 . . . . 10.0 109.911 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.576 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 32.9 t -47.6 -40.5 19.52 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.303 -0.959 . . . . 10.0 109.974 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 160' ' ' LEU . 9.4 t80 -100.83 1.46 40.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.238 -1.385 . . . . 10.0 110.625 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 6.3 m -107.21 -19.09 13.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.984 -1.072 . . . . 10.0 111.325 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.612 HG21 ' CG ' ' A' ' 34' ' ' PRO . 11.3 t -112.23 -43.04 3.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.731 -1.23 . . . . 10.0 111.16 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.553 ' N ' HG23 ' A' ' 25' ' ' THR . 0.7 OUTLIER -155.87 -48.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.492 -1.283 . . . . 10.0 112.512 -179.783 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.698 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 168.88 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.217 -0.927 . . . . 10.0 111.892 -178.527 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.623 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 22.4 p90 -114.05 -17.14 0.11 Allowed Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 47.3 Cg_endo -69.04 -112.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.483 0.851 . . . . 10.0 112.217 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 p -166.35 68.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.104 -1.623 . . . . 10.0 111.56 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -121.55 -169.39 1.85 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.404 ' C ' ' O ' ' A' ' 31' ' ' GLU . 5.7 t80 -48.01 100.3 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.65 HG13 ' HA ' ' B' ' 24' ' ' ALA 0.261 12.1 p -149.8 154.25 37.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.661 -0.649 . . . . 10.0 109.682 -177.87 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.634 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 36.8 Cg_endo -60.43 179.96 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.16 1.084 . . . . 10.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.966 ' HB ' HG11 ' B' ' 20' ' ' VAL . 20.3 p -145.35 166.38 25.74 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.117 -0.989 . . . . 10.0 111.693 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' B' ' 25' ' ' VAL . 89.8 t -28.22 -33.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 121.325 0.583 . . . . 10.0 111.321 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -38.94 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 10.0 109.759 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -170.38 91.07 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 119.879 -1.763 . . . . 10.0 113.776 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' HB3' HG13 ' B' ' 18' ' ' ILE . 8.2 t30 -135.88 149.75 49.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 10.0 108.604 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 2.6 m-85 -167.2 113.84 0.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.402 -1.436 . . . . 10.0 111.702 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 15' ' ' GLU . . . -93.69 108.85 20.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.92 -1.141 . . . . 10.0 107.92 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' O ' ' B' ' 14' ' ' PHE . 44.1 t -135.87 171.93 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.184 -1.407 . . . . 10.0 112.31 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 51' ' ' TYR . 54.7 m -147.28 170.6 16.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 51' ' ' TYR . 1.3 p -161.35 129.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.89 -1.131 . . . . 10.0 111.561 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.681 ' CB ' HD22 ' B' ' 10' ' ' LEU . 1.3 mmt -104.95 129.06 53.44 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.826 -1.15 . . . . 10.0 108.131 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.995 HG22 ' HB3' ' B' ' 7' ' ' GLU . 33.6 mt -132.05 99.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.913 -1.117 . . . . 10.0 110.194 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.71 ' CA ' HG22 ' B' ' 8' ' ' ILE . . . 59.76 24.05 59.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.038 -1.625 . . . . 10.0 109.038 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.72 6.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -127.29 95.47 36.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.17 -1.194 . . . . 10.0 110.538 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 51.5 Cg_endo -83.19 132.68 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.236 1.65 . . . . 10.0 112.008 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.852 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.7 m-85 -93.65 150.69 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 10.0 109.29 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.3 m -136.25 100.32 4.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.786 -1.196 . . . . 10.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -149.3 176.35 10.62 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.393 -1.323 . . . . 10.0 112.813 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.82 118.52 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 107.67 -2.172 . . . . 10.0 107.67 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . 2.0 pp -129.78 159.58 36.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.647 -1.502 . . . . 10.0 111.138 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 15.9 p90 -165.69 131.77 2.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 10.0 110.568 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -81.38 176.84 9.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 10.0 110.095 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.518 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 99.1 m -40.2 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 10.0 111.43 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . . . -146.65 63.01 1.2 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 10.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.19 69.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.275 -1.13 . . . . 10.0 110.275 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.528 ' HB2' ' HA3' ' B' ' 21' ' ' GLY . 64.7 tp60 -115.77 -28.79 6.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.065 -1.256 . . . . 10.0 111.23 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 7.3 tp10 -63.53 -50.02 71.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.871 -1.143 . . . . 10.0 110.572 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -142.74 0.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 10.0 111.323 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.2 m-85 65.35 40.26 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.821 -1.178 . . . . 10.0 107.821 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.621 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -78.7 47.72 0.75 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.85 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.932 ' O ' HD23 ' A' ' 70' ' ' LEU . 17.4 mtp180 -82.82 -26.28 31.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.437 -0.789 . . . . 10.0 109.53 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.641 HD21 ' HG2' ' B' ' 41' ' ' GLN . 1.2 mt -111.77 -6.66 14.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 10.0 111.888 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -92.75 -54.9 0.25 Allowed Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 120.376 -1.453 . . . . 10.0 113.19 -177.864 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.625 ' C ' HD13 ' A' ' 70' ' ' LEU . 43.0 Cg_endo -77.61 -5.02 15.17 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.528 1.278 . . . . 10.0 111.987 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.932 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -101.81 -98.8 0.27 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.773 -1.205 . . . . 10.0 110.966 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.773 ' HA ' HD23 ' B' ' 39' ' ' LEU . 40.1 m -36.38 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.744 -0.598 . . . . 10.0 110.467 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 70' ' ' LEU . 15.6 m-85 -103.47 91.92 3.66 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 10.0 109.056 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 71' ' ' SER . 45.4 Cg_endo -70.62 147.43 57.32 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.787 1.414 . . . . 10.0 110.555 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CD ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -169.37 57.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.221 -0.924 . . . . 10.0 110.583 -179.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.655 HG23 ' CB ' ' A' ' 5' ' ' LYS . 18.0 m -145.01 98.05 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.162 -0.961 . . . . 10.0 110.099 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -34.37 -33.21 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 10.0 110.487 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -111.25 120.24 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.313 -0.867 . . . . 10.0 109.644 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.7 m-85 -115.41 140.92 48.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.906 -1.121 . . . . 10.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 111' ' ' LEU . 3.4 mm? -109.39 99.35 8.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 10.0 109.562 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG23 ' HA2' ' A' ' 10' ' ' GLY . 7.1 p -103.82 151.02 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 10.0 110.131 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 115' ' ' THR . 3.2 t -126.71 103.8 7.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 10.0 111.496 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 115' ' ' THR . 67.7 m-85 -89.89 140.05 29.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 10.0 111.056 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -92.52 138.59 31.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.214 -0.929 . . . . 10.0 110.169 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.871 HG11 ' HG3' ' A' ' 120' ' ' ARG . 14.4 m -81.42 -17.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 10.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 84' ' ' VAL . 17.8 m -102.6 38.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.774 0.797 . . . . 10.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 87' ' ' PRO . 47.7 t -110.04 154.34 42.76 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.677 -0.639 . . . . 10.0 109.37 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.535 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 47.9 Cg_endo -68.93 73.62 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.735 1.387 . . . . 10.0 111.099 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 133' ' ' LYS . 43.4 m 39.91 55.04 2.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 10.0 110.429 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.421 ' O ' HG23 ' A' ' 93' ' ' VAL . 62.7 p -91.9 -36.74 13.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 10.0 110.547 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -50.3 -29.96 10.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.09 . . . . 10.0 110.338 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -67.47 -35.7 79.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.901 . . . . 10.0 110.036 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.3 OUTLIER -71.32 -12.81 61.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 10.0 109.39 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t -88.87 -12.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.39 -0.819 . . . . 10.0 109.346 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 6.8 mmtt -89.03 -35.75 16.19 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.0 pt-20 -80.0 -5.05 55.04 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.26 -0.576 . . . . 10.0 110.082 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -102.02 -44.89 5.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.935 -1.103 . . . . 10.0 111.763 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.559 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 35.9 m95 -89.59 -29.05 19.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.294 -0.878 . . . . 10.0 112.028 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.929 ' CG2' HD21 ' A' ' 149' ' ' LEU . 62.8 t -62.28 -47.9 88.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.545 -1.347 . . . . 10.0 110.596 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.765 ' O ' HD12 ' A' ' 101' ' ' ILE . 48.9 Cg_endo -74.68 -15.56 21.53 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 109.115 -1.148 . . . . 10.0 109.115 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 40.9 tt0 -58.97 -29.25 67.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.754 -0.591 . . . . 10.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 99' ' ' PRO . 3.6 mt 57.57 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 10.0 109.603 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.59 ' CG2' ' HG2' ' A' ' 106' ' ' PRO . 3.9 m -43.29 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.345 -0.847 . . . . 10.0 109.08 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.547 ' N ' HG22 ' A' ' 102' ' ' THR . 4.8 m-70 -110.45 -15.9 13.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 162.45 -55.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.592 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 6.9 t -168.06 44.58 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.207 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.4 Cg_endo -81.26 -26.1 3.56 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 N-CA-C 109.083 -1.16 . . . . 10.0 109.083 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.579 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 1.6 pttp 55.66 52.85 10.33 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.342 1.067 . . . . 10.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 10.0 t -45.38 155.17 0.46 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 10.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 38.9 Cg_endo -66.35 148.77 84.81 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.76 1.4 . . . . 10.0 110.486 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -139.07 111.9 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 10.0 110.023 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.849 HD13 HG11 ' A' ' 152' ' ' VAL . 1.6 mm? -80.84 98.08 7.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.316 -0.865 . . . . 10.0 109.358 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 56.1 mt -70.22 140.11 52.38 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 111' ' ' LEU . 4.5 t -148.1 168.22 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.809 -1.182 . . . . 10.0 111.679 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.37 150.04 16.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.748 -1.741 . . . . 10.0 108.748 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.966 HG23 ' HB ' ' A' ' 14' ' ' VAL . 24.1 m -103.49 129.94 50.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.353 . . . . 10.0 110.756 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 14' ' ' VAL . 69.4 mt-30 53.27 50.03 18.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 10.0 110.377 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.995 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -65.29 -25.27 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.028 -1.045 . . . . 10.0 110.017 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.8 p-10 -52.06 59.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.267 1.032 . . . . 10.0 110.051 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.796 ' N ' ' O ' ' A' ' 117' ' ' ILE . 9.8 tp 158.64 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.871 ' HG3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.35 -40.11 48.25 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.81 -0.556 . . . . 10.0 109.928 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -28.77 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 10.0 109.993 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.6 m-20 -83.6 130.35 56.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 10.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.3 Cg_endo -86.18 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.664 1.576 . . . . 10.0 110.079 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -98.47 -50.98 4.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 10.0 110.198 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.552 HG21 HD21 ' A' ' 119' ' ' LEU . 6.4 t -75.53 -32.37 60.45 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.014 -2.217 . . . . 10.0 105.014 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 123' ' ' PRO 0.293 1.1 mp -50.69 -28.25 5.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 176.856 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -52.18 -29.89 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.65 0.738 . . . . 10.0 110.471 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 6.4 mmtp -55.75 -36.93 67.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.492 -0.755 . . . . 10.0 111.606 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -57.85 -49.81 75.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.685 -1.26 . . . . 10.0 109.566 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -49.56 -41.23 40.97 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.735 -0.603 . . . . 10.0 111.466 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -21.76 56.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.26 -0.9 . . . . 10.0 110.203 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 12.7 p-10 -128.49 -46.82 1.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 10.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 129' ' ' LEU . 5.2 mmtp -121.74 144.95 48.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.631 -0.668 . . . . 10.0 109.287 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -99.54 6.33 45.85 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.257 -0.902 . . . . 10.0 110.557 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 10.6 mtpt -131.76 94.02 26.34 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 10.0 109.91 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.3 Cg_endo -70.61 160.65 48.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.128 1.593 . . . . 10.0 110.604 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.698 HG22 HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -75.68 133.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.023 . . . . 10.0 108.649 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.2 p -131.19 168.84 15.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.152 -0.968 . . . . 10.0 109.744 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.3 Cg_endo -68.71 -33.11 22.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.758 1.399 . . . . 10.0 109.351 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 15.6 pt-20 -71.18 -23.87 62.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.822 . . . . 10.0 109.181 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 57.4 m -80.03 -40.87 26.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 10.0 109.017 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.472 -0.768 . . . . 10.0 109.31 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' PRO . 37.4 mt-10 -59.63 -42.84 93.61 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.079 -0.648 . . . . 10.0 109.692 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -61.56 -39.79 92.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.373 -0.829 . . . . 10.0 109.434 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.558 HD13 ' HE3' ' A' ' 94' ' ' LYS . 3.8 tp -65.03 -46.45 81.25 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.061 -1.024 . . . . 10.0 108.431 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -57.66 -45.1 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 10.0 110.383 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -26.37 64.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.406 -0.809 . . . . 10.0 109.882 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.495 ' C ' HD12 ' A' ' 149' ' ' LEU . 12.8 m-20 -75.63 -49.95 16.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.324 -0.86 . . . . 10.0 110.574 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.929 HD21 ' CG2' ' A' ' 98' ' ' VAL . 6.5 mp -90.37 1.68 56.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 10.0 108.975 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 6.2 mtmt 65.49 30.31 10.8 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.639 0.733 . . . . 10.0 109.847 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -59.34 -146.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.955 -0.698 . . . . 10.0 109.463 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.849 HG11 HD13 ' A' ' 111' ' ' LEU . 2.7 p -117.51 -57.15 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.368 -1.458 . . . . 10.0 112.047 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.584 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -171.69 151.59 2.93 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 118.148 -1.421 . . . . 10.0 112.291 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.9 p90 -87.54 124.51 33.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 10.0 110.329 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.016 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -126.36 -168.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.355 -0.84 . . . . 10.0 109.879 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 1.9 mt-10 -143.16 144.44 32.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.016 -1.052 . . . . 10.0 110.502 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 168' ' ' VAL . 79.8 m -144.28 129.8 19.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.898 0.856 . . . . 10.0 111.4 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.563 ' N ' HD21 ' A' ' 165' ' ' LEU . 3.9 t -120.74 173.32 7.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.684 ' CB ' HD22 ' A' ' 19' ' ' LEU . . . -93.66 -93.44 0.17 Allowed 'General case' 0 C--N 1.29 -1.99 0 O-C-N 120.984 -1.073 . . . . 10.0 110.438 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.036 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -54.67 -39.19 67.82 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.067 -1.021 . . . . 10.0 109.49 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.54 ' OG1' ' OG ' ' A' ' 158' ' ' SER . 75.0 p -79.39 -35.34 40.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.152 -1.592 . . . . 10.0 110.953 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.583 ' CG ' ' HG ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 58.02 67.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.785 -1.197 . . . . 10.0 109.858 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.591 ' HG2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -87.3 56.8 4.13 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.64 -0.824 . . . . 10.0 111.047 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 125.6 11.41 4.09 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.416 -1.374 . . . . 10.0 111.001 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.583 ' HG ' ' CG ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -54.52 -34.18 61.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.718 -1.46 . . . . 10.0 109.556 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -88.15 -25.01 23.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 10.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -70.91 -38.78 72.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 10.0 111.206 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 155' ' ' VAL . 3.5 t -68.94 -36.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.833 -1.167 . . . . 10.0 109.325 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 173' ' ' ILE . 60.7 t80 -60.11 -37.76 80.97 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.687 -0.633 . . . . 10.0 110.01 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.7 m-20 -67.66 -46.63 71.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -0.943 . . . . 10.0 111.358 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.07 -30.61 69.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 10.0 110.359 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -70.56 -24.47 62.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.062 . . . . 10.0 109.324 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.691 ' O ' HD12 ' A' ' 177' ' ' LEU . 27.8 mm -64.55 -44.74 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.434 -0.791 . . . . 10.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.85 -31.91 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.803 -1.185 . . . . 10.0 110.629 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.462 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . . . -89.01 0.79 56.37 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.472 -0.768 . . . . 10.0 110.838 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.891 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -88.89 -37.23 15.47 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.933 -1.105 . . . . 10.0 110.195 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.95 -13.54 16.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.385 -0.822 . . . . 10.0 109.716 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.42 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -89.96 47.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 10.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.2 100.49 4.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.067 -1.021 . . . . 10.0 110.664 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.469 ' HB2' ' OE1' ' B' ' 7' ' ' GLU . 14.3 mm-40 -101.52 175.67 5.49 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.542 0.687 . . . . 10.0 110.168 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.36 -146.49 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -76.11 13.72 1.23 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 CA-C-N 119.277 0.777 . . . . 10.0 111.815 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.995 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER 36.72 -150.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.229 -0.919 . . . . 10.0 110.166 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.71 HG22 ' CA ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -82.57 -115.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.943 -1.132 . . . . 10.0 107.943 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.648 ' H ' HG23 ' B' ' 8' ' ' ILE . 7.8 t -159.08 110.11 2.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.084 -1.635 . . . . 10.0 111.348 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -116.94 119.96 34.52 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.146 -0.971 . . . . 10.0 108.869 178.382 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.95 100.09 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.67 1.353 . . . . 10.0 112.928 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 m -149.17 126.01 11.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.597 -0.69 . . . . 10.0 109.575 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 43' ' ' THR . 5.9 p-10 -170.89 148.82 2.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.395 -1.441 . . . . 10.0 113.15 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 1.056 ' O ' HG22 ' A' ' 42' ' ' VAL . 5.4 m-85 -129.63 -176.33 3.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.81 149.77 1.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.592 -1.318 . . . . 10.0 112.436 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.9 t60 -171.29 117.34 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.537 -0.727 . . . . 10.0 110.068 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' A' ' 39' ' ' ASN . 9.3 t -128.82 158.46 38.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.868 -1.145 . . . . 10.0 112.261 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.647 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -121.5 -168.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.642 . . . . 10.0 109.265 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.642 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 63.1 m80 -136.25 157.28 47.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 10.0 111.877 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.966 HG11 ' HB ' ' A' ' 35' ' ' THR . 10.2 p -97.63 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.538 -0.726 . . . . 10.0 112.062 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 61' ' ' GLN . . . -108.41 65.48 0.25 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.669 -2.172 . . . . 10.0 107.669 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.741 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER 175.32 114.24 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.433 -1.039 . . . . 10.0 108.673 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.541 ' HA ' HG21 ' A' ' 35' ' ' THR . 32.4 t70 -62.1 152.4 32.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.28 -0.888 . . . . 10.0 112.349 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.65 ' HA ' HG13 ' A' ' 33' ' ' VAL . . . 37.82 71.78 0.14 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.733 -0.604 . . . . 10.0 112.524 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 36' ' ' VAL . 15.4 t -113.15 -46.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.966 -1.084 . . . . 10.0 109.767 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.788 HG23 HG21 ' A' ' 21' ' ' ILE . 1.1 t -82.57 -28.15 31.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.31 0.576 . . . . 10.0 110.51 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 36.35 3.82 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.26 -1.936 . . . . 10.0 108.26 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 36.4 tt0 -142.18 128.95 20.48 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.554 -0.968 . . . . 10.0 110.953 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -140.9 114.54 8.87 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 122.233 1.016 . . . . 10.0 109.284 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' B' ' 31' ' ' GLY . 5.1 p -146.82 -49.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.576 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . 177.83 89.71 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.063 -1.615 . . . . 10.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.614 HG23 ' HD2' ' B' ' 33' ' ' PRO . 83.1 mt -120.0 147.11 43.71 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.195 -1.179 . . . . 10.0 110.445 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.7 Cg_endo -69.45 129.26 17.6 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 10.0 109.767 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' B' ' 38' ' ' ARG . 25.1 tp10 55.92 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 10.0 109.617 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.604 ' O ' ' CE3' ' B' ' 36' ' ' TRP . 72.5 mt-30 -93.08 -27.25 17.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.952 -1.092 . . . . 10.0 112.521 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.693 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER 162.61 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.104 -1.073 . . . . 10.0 108.104 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 70' ' ' LEU . . . -175.19 75.64 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' B' ' 40' ' ' LEU . 3.9 mtm180 -79.17 50.24 1.04 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.295 -1.372 . . . . 10.0 107.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 71' ' ' SER . 1.2 mp -38.42 -30.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.105 0.955 . . . . 10.0 108.766 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 42' ' ' THR . 0.9 OUTLIER -80.74 34.05 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.169 178.744 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.641 ' HG2' HD21 ' A' ' 67' ' ' LEU . 44.8 tp60 -33.94 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.395 0.617 . . . . 10.0 110.382 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.9 HG22 ' OD1' ' B' ' 44' ' ' ASN . 20.7 m -110.16 72.17 0.78 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.575 -2.009 . . . . 10.0 105.575 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -44.74 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.517 0.675 . . . . 10.0 111.971 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.9 ' OD1' HG22 ' B' ' 42' ' ' THR . 3.5 m120 -98.09 141.51 30.94 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.657 -0.652 . . . . 10.0 110.31 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.646 HG22 ' H ' ' B' ' 46' ' ' THR . 21.0 mt 48.0 -178.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 10.0 110.456 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.646 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 118.073 -0.965 . . . . 10.0 109.758 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 1' ' ' MET . 3.3 ptp . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.807 0.813 . . . . 10.0 109.843 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.589 ' NE2' ' O ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -153.86 -35.63 0.1 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.606 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 89.8 m -53.17 94.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.374 -0.829 . . . . 10.0 110.246 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.697 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -109.12 132.27 57.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.524 -1.271 . . . . 10.0 110.062 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' THR . 4.4 mtpp -122.85 104.75 9.47 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.565 ' C ' HG22 ' A' ' 7' ' ' VAL . 29.9 p -108.98 152.85 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.143 -0.973 . . . . 10.0 111.75 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.56 162.53 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.759 -0.588 . . . . 10.0 110.102 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 16.0 m -81.76 137.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 10.0 111.472 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -152.29 169.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.307 -0.871 . . . . 10.0 109.741 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 150.39 88.88 0.07 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.974 -1.251 . . . . 10.0 109.974 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' GLY . 3.8 t0 40.88 25.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -1.072 . . . . 10.0 111.048 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 71.63 36.85 62.04 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.499 -1.44 . . . . 10.0 109.499 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . -108.97 -140.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.532 -0.981 . . . . 10.0 109.657 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.602 HG12 ' CE2' ' B' ' 29' ' ' PHE . 4.7 m -88.27 161.7 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 10.0 109.648 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.517 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -92.2 -174.16 42.09 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.274 -1.13 . . . . 10.0 110.274 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG11 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -110.59 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -1.064 . . . . 10.0 111.001 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 19' ' ' LEU . 73.7 m -50.8 -36.45 37.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.036 -1.04 . . . . 10.0 109.041 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 25.3 p -67.22 4.32 0.97 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.128 0.966 . . . . 10.0 109.718 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 160' ' ' LEU . 3.8 mt -110.46 -38.82 5.11 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.285 -1.509 . . . . 10.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 166' ' ' LYS . 21.1 tp -44.63 -46.2 10.01 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.853 -1.154 . . . . 10.0 111.227 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 1.065 HG22 ' O ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -90.33 -31.14 5.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 117.093 -1.843 . . . . 10.0 109.858 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.805 ' OG ' HD23 ' A' ' 160' ' ' LEU . 21.9 t -47.44 -44.14 24.6 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.346 -0.942 . . . . 10.0 110.311 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.511 ' HB2' ' C ' ' A' ' 159' ' ' ALA . 67.0 t80 -86.42 -0.89 56.94 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.55 -1.344 . . . . 10.0 109.951 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 4.3 m -108.93 -42.87 4.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.851 -1.155 . . . . 10.0 113.984 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 26' ' ' ASN . 60.0 m -117.38 -93.06 0.51 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 119.95 -1.719 . . . . 10.0 111.515 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.841 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.1 OUTLIER -135.81 -21.64 1.47 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.277 -0.889 . . . . 10.0 110.34 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 1.065 ' O ' HG22 ' A' ' 21' ' ' ILE . 14.4 mttt -148.87 -139.32 0.09 Allowed 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.729 -1.952 . . . . 10.0 105.729 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -124.25 18.89 0.08 OUTLIER Pre-proline 0 C--N 1.285 -2.203 0 C-N-CA 116.357 -2.137 . . . . 10.0 115.384 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 46.2 Cg_endo -73.61 -94.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 N-CA-C 109.192 -1.118 . . . . 10.0 109.192 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.588 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . 0.3 OUTLIER -155.48 -12.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.878 -1.139 . . . . 10.0 112.55 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.584 ' C ' HG21 ' A' ' 25' ' ' THR . 6.2 pt-20 -172.47 -170.76 0.74 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.252 -1.388 . . . . 10.0 107.252 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' C ' HG23 ' A' ' 33' ' ' VAL . 75.6 t80 -49.19 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.638 -1.616 . . . . 10.0 106.638 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.802 HG13 ' HD2' ' A' ' 34' ' ' PRO 0.325 60.9 t -152.99 158.92 32.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.721 -0.612 . . . . 10.0 109.666 -175.325 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.802 ' HD2' HG13 ' A' ' 33' ' ' VAL . 39.9 Cg_endo -66.69 171.34 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.155 1.081 . . . . 10.0 110.707 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 28' ' ' PHE . 2.9 m -96.86 146.37 24.99 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.115 -0.991 . . . . 10.0 111.369 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.852 ' CG1' HG11 ' B' ' 20' ' ' VAL . 38.6 t 77.46 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.763 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -33.75 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.141 0.972 . . . . 10.0 110.648 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -170.15 112.22 0.44 Allowed 'General case' 0 C--N 1.289 -2.033 0 O-C-N 119.374 -2.079 . . . . 10.0 112.221 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.594 ' HB3' ' CG1' ' B' ' 18' ' ' ILE . 0.9 OUTLIER -166.4 96.93 0.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.217 -0.927 . . . . 10.0 108.558 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' B' ' 17' ' ' THR . 17.4 p90 -171.77 176.95 3.5 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.354 -0.938 . . . . 10.0 111.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -171.23 98.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.773 HG21 ' O ' ' B' ' 15' ' ' GLU . 16.6 m -157.5 -166.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 10.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 51' ' ' TYR . 24.1 m -105.35 166.83 10.15 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.967 -0.693 . . . . 10.0 111.319 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.58 ' CG1' HD11 ' A' ' 46' ' ' ILE . 2.9 t -127.7 139.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.398 -0.964 . . . . 10.0 108.398 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.738 ' O ' HD23 ' B' ' 10' ' ' LEU . 3.1 mtt -102.57 102.16 12.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.349 -1.34 . . . . 10.0 110.426 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.58 HD11 ' CG1' ' A' ' 44' ' ' VAL . 2.3 mp -110.24 118.59 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.06 . . . . 10.0 110.167 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 54.41 16.96 7.48 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.178 -1.169 . . . . 10.0 110.178 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.03 18.35 34.45 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 68.2 mm-40 -110.59 115.89 53.21 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.39 -1.065 . . . . 10.0 110.315 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.589 ' O ' ' NE2' ' A' ' 2' ' ' GLN . 45.8 Cg_endo -69.24 119.4 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.824 1.434 . . . . 10.0 110.272 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 43' ' ' THR . 3.9 m-30 -97.52 179.93 4.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 10.0 110.72 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 4' ' ' ILE . 5.0 m -146.27 132.66 19.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 10.0 110.039 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -172.27 174.04 4.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.739 -1.225 . . . . 10.0 111.593 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.87 105.4 0.21 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.163 -1.975 . . . . 10.0 108.163 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.942 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -105.52 135.48 46.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.64 -1.506 . . . . 10.0 110.409 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.942 ' N ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -129.03 103.25 6.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 10.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' THR . 51.1 t0 -105.96 121.04 43.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 10.0 109.421 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 13.7 t -39.4 129.39 1.82 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.074 -1.016 . . . . 10.0 111.466 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . . . -72.17 -73.52 0.19 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.811 -0.556 . . . . 10.0 111.515 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.98 7.4 59.29 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.985 -1.646 . . . . 10.0 108.985 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 177.91 -26.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -1.093 . . . . 10.0 110.903 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.999 ' HG2' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -41.87 -71.14 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.858 -1.152 . . . . 10.0 110.383 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 7.2 t70 164.34 -13.77 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.698 -0.626 . . . . 10.0 110.697 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 38.2 p90 -110.86 17.33 20.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.865 -1.147 . . . . 10.0 109.312 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 68' ' ' ARG . 35.1 t70 -49.52 -23.7 1.73 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.434 -0.791 . . . . 10.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -49.92 -36.62 28.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.04 -1.038 . . . . 10.0 109.223 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.6 mt -92.66 11.49 26.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.505 -0.747 . . . . 10.0 110.041 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.658 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -73.37 -22.13 0.48 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.275 -0.891 . . . . 10.0 112.959 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 42.8 Cg_endo -78.21 85.12 1.87 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 CA-C-O 121.944 0.727 . . . . 10.0 110.546 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.578 ' CD1' ' CD1' ' B' ' 39' ' ' LEU . 0.0 OUTLIER -129.27 -47.15 1.2 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.795 0.807 . . . . 10.0 109.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.881 ' CB ' HD23 ' B' ' 40' ' ' LEU . 5.6 m 59.91 12.78 3.26 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.948 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -101.98 110.4 62.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 10.0 112.038 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' C ' ' HG3' ' A' ' 74' ' ' GLN . 48.6 Cg_endo -76.93 148.59 28.2 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.107 1.583 . . . . 10.0 110.7 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.04 67.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 10.0 109.283 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -143.18 87.35 1.96 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.101 -1.0 . . . . 10.0 109.982 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 9.6 m-20 -20.29 -44.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.456 0.91 . . . . 10.0 113.456 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 109' ' ' PRO . 1.1 m -110.5 144.32 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.818 -1.176 . . . . 10.0 111.26 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -156.25 157.41 35.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 10.0 110.977 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.668 ' CD1' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -107.32 98.65 8.25 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 178.423 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 3.9 p -85.07 148.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 10.0 109.95 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB3' HG22 ' A' ' 115' ' ' THR . 41.1 m -117.26 103.16 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.767 -1.173 . . . . 10.0 113.516 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.859 ' C ' HG23 ' A' ' 115' ' ' THR . 43.8 m-85 -99.84 147.69 25.23 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.293 -0.879 . . . . 10.0 109.232 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 46.6 t -90.42 141.1 29.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.513 -1.367 . . . . 10.0 108.95 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG21 ' HG3' ' A' ' 120' ' ' ARG . 2.0 t -80.32 5.58 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.905 . . . . 10.0 110.375 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 1.021 HG23 HD23 ' A' ' 129' ' ' LEU . 33.9 m -143.31 59.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.931 0.872 . . . . 10.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.588 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 2.7 p -125.13 -165.53 0.08 OUTLIER Pre-proline 0 C--N 1.287 -2.125 0 O-C-N 121.376 -0.828 . . . . 10.0 108.773 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.4 Cg_endo -76.18 60.76 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.277 1.146 . . . . 10.0 109.621 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 87' ' ' PRO . 43.6 p 32.86 51.5 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.104 0.478 . . . . 10.0 111.54 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.1 p -77.02 -25.42 52.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 10.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 73.0 t80 -59.22 -40.21 85.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 10.0 111.51 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -70.77 -22.87 62.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.914 -1.116 . . . . 10.0 110.828 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.564 ' OD1' HG13 ' A' ' 93' ' ' VAL . 0.1 OUTLIER -86.13 -20.8 28.12 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.807 -1.183 . . . . 10.0 109.97 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.635 HG22 ' O ' ' A' ' 90' ' ' PHE . 23.1 m -84.23 -29.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.151 -1.02 . . . . 10.0 109.931 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -70.87 -34.03 71.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.072 -1.018 . . . . 10.0 109.6 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 7.2 pt-20 -80.26 -8.22 59.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 10.0 110.971 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 2.1 mmtm -81.73 -52.75 6.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 10.0 111.655 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -73.24 -9.88 59.17 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.982 -1.073 . . . . 10.0 112.202 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 149' ' ' LEU . 77.6 t -76.48 -50.2 2.75 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.621 -1.3 . . . . 10.0 110.828 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.1 Cg_endo -73.42 -25.8 14.96 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.209 1.11 . . . . 10.0 110.647 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -77.07 -23.74 51.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.287 -0.883 . . . . 10.0 110.998 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 49.0 mm 60.15 103.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.026 -1.046 . . . . 10.0 110.329 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.3 m -47.04 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 10.0 108.623 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.667 ' N ' HG22 ' A' ' 102' ' ' THR . 5.5 m170 -112.1 -4.85 14.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.323 -0.861 . . . . 10.0 109.51 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 160.87 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 50.8 t -142.26 137.37 15.61 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 149' ' ' LEU . 44.1 Cg_endo -69.82 80.29 0.91 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.681 1.358 . . . . 10.0 110.68 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' THR . 34.4 mtpt -118.16 -14.44 9.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.469 -0.77 . . . . 10.0 111.181 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 102' ' ' THR . 52.1 m -46.3 136.08 7.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.718 -1.239 . . . . 10.0 109.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.804 ' CG ' HG12 ' A' ' 77' ' ' VAL . 37.5 Cg_endo -64.9 111.9 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 10.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -117.94 103.88 10.37 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.757 0.789 . . . . 10.0 110.209 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.132 HD13 HG11 ' A' ' 152' ' ' VAL . 1.7 mm? -77.41 98.57 5.3 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 90.0 mt -74.03 135.82 43.08 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.693 HG22 HG23 ' A' ' 155' ' ' VAL . 10.8 t -143.28 169.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 10.0 112.552 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.87 153.88 19.54 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.479 -2.248 . . . . 10.0 107.479 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.859 HG23 ' C ' ' A' ' 82' ' ' PHE . 76.3 p -101.04 127.57 47.49 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.497 -1.59 . . . . 10.0 111.057 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.471 ' HG2' ' OD2' ' A' ' 118' ' ' ASP . 0.8 OUTLIER 40.31 55.06 2.82 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.849 -0.74 . . . . 10.0 110.16 178.317 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -40.78 -28.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 C-N-CA 119.467 -0.893 . . . . 10.0 110.16 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.671 ' O ' HD13 ' A' ' 119' ' ' LEU . 2.3 p-10 -52.69 60.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.17 0.986 . . . . 10.0 110.524 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 1.052 ' HG ' HG21 ' A' ' 125' ' ' THR . 0.4 OUTLIER 161.77 -27.95 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HG3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.09 -38.33 11.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.77 17.75 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 10.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.69 ' OD1' HG22 ' A' ' 125' ' ' THR . 6.9 t70 -104.28 110.84 64.81 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 10.0 110.857 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.32 15.46 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.072 1.564 . . . . 10.0 110.779 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 122' ' ' ASP . 47.1 t -109.89 -49.93 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 10.0 109.857 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' THR . . . . . 1.052 HG21 ' HG ' ' A' ' 119' ' ' LEU . 4.7 t -73.67 -24.39 59.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.515 -2.031 . . . . 10.0 105.515 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.738 HD11 HG11 ' A' ' 85' ' ' VAL 0.301 0.6 OUTLIER -59.98 -20.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 176.859 . . . . . . . . 4 4 . 1 . 010 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -48.26 -45.34 34.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.672 -0.642 . . . . 10.0 110.396 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.556 ' C ' HD12 ' A' ' 129' ' ' LEU . 36.5 mmtt -84.96 -13.77 49.65 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.425 -0.797 . . . . 10.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 1.021 HD23 HG23 ' A' ' 85' ' ' VAL . 6.1 mp -95.91 -40.45 9.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.233 -0.917 . . . . 10.0 109.554 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 126' ' ' ILE . . . -57.96 -39.67 78.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.137 -0.977 . . . . 10.0 109.72 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 11.2 pttt -55.66 -20.31 13.59 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.398 -0.814 . . . . 10.0 109.746 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -118.69 9.64 12.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.351 -0.843 . . . . 10.0 109.299 178.723 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' CE ' ' HB3' ' A' ' 136' ' ' PRO . 2.3 tmtt? -141.0 82.99 1.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.102 -0.703 . . . . 10.0 109.102 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.5 mp0 -65.39 -24.44 67.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 10.0 110.409 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 3.2 mmmm -132.79 115.88 14.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 10.0 109.422 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.524 ' HB3' ' CE ' ' A' ' 133' ' ' LYS . 40.1 Cg_endo -67.01 159.4 52.18 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.799 1.421 . . . . 10.0 110.494 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -103.95 134.29 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.289 -0.882 . . . . 10.0 109.564 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.1 p -125.87 164.46 33.01 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 10.0 109.541 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 38.6 Cg_endo -65.64 -13.65 40.86 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.883 1.465 . . . . 10.0 109.823 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.98 -20.86 29.9 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.764 -0.774 . . . . 10.0 110.1 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -96.74 -42.32 8.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 10.0 110.744 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.897 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -73.79 -26.42 60.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 10.0 110.488 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.9 tt0 -61.22 -39.07 88.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 10.0 109.847 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -65.69 -40.1 91.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.895 . . . . 10.0 109.1 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 145' ' ' LEU . 4.1 tt -63.04 -40.7 98.51 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.367 -0.833 . . . . 10.0 109.238 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.465 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -63.58 -44.84 92.91 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.821 0.819 . . . . 10.0 109.088 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -59.91 -25.8 65.42 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.361 -0.536 . . . . 10.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 149' ' ' LEU . 34.8 t0 -70.26 -48.8 55.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.09 -1.006 . . . . 10.0 110.827 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 98' ' ' VAL . 1.5 mp -93.11 24.55 3.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 10.0 108.931 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 151' ' ' ALA . 1.0 OUTLIER 51.91 27.3 4.21 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.741 0.781 . . . . 10.0 109.389 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -57.04 -160.19 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.132 HG11 HD13 ' A' ' 111' ' ' LEU . 7.3 p -108.49 -65.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.677 -1.264 . . . . 10.0 111.761 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.763 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.02 157.74 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.016 -1.678 . . . . 10.0 112.106 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.897 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.1 t80 -107.61 112.61 25.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 10.0 110.107 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -103.36 -168.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.429 -0.794 . . . . 10.0 110.604 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 22.4 tt0 -170.28 98.55 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.221 -0.924 . . . . 10.0 109.749 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.547 ' CB ' ' CA ' ' A' ' 165' ' ' LEU . 73.8 m -153.0 156.35 38.65 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.107 -0.996 . . . . 10.0 111.608 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.686 ' OG ' HG23 ' A' ' 117' ' ' ILE . 3.7 m -140.86 114.75 9.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.835 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . . . -74.09 -87.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.428 -1.42 . . . . 10.0 111.025 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -31.32 -33.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 122.32 1.057 . . . . 10.0 109.383 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -93.94 -70.79 0.69 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.341 -0.845 . . . . 10.0 112.218 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -109.13 -107.71 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.377 -1.452 . . . . 10.0 112.021 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 162' ' ' GLN . 12.2 pttt 174.48 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.425 -0.797 . . . . 10.0 109.521 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.58 49.1 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.145 -1.026 . . . . 10.0 110.75 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -59.39 -2.07 0.28 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.409 -1.054 . . . . 10.0 113.097 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 20' ' ' LEU . 8.9 tttt -59.69 -48.84 80.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.39 -1.444 . . . . 10.0 110.432 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -56.45 -39.75 73.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.437 -0.789 . . . . 10.0 111.755 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.95 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.3 t -53.74 -48.34 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.819 -1.175 . . . . 10.0 111.034 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -78.6 -37.97 41.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.242 -0.911 . . . . 10.0 111.368 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.91 -40.26 92.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.876 -1.14 . . . . 10.0 110.946 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 41.0 mm-40 -62.03 -46.05 90.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 10.0 111.28 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.748 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.36 -24.45 19.54 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.986 . . . . 10.0 110.379 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.671 ' O ' HD12 ' A' ' 177' ' ' LEU . 28.6 mm -63.85 -42.86 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.415 -0.914 . . . . 10.0 109.841 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.846 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -86.17 -17.07 35.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 10.0 111.01 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.75 -1.18 41.13 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.938 -1.101 . . . . 10.0 109.812 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.96 -40.89 13.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 10.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.23 -11.83 18.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 10.0 109.505 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.04 -0.981 . . . . 10.0 110.025 -179.815 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -112.37 131.9 55.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 10.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.509 ' HG2' HD12 ' A' ' 174' ' ' LEU . 4.5 mtpt -88.38 99.96 12.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.137 -0.977 . . . . 10.0 110.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.2 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.74 -0.6 . . . . 10.0 110.001 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.38 -91.15 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.117 -0.989 . . . . 10.0 109.231 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 53.8 Cg_endo -76.57 -10.45 18.71 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 N-CA-C 108.423 -1.414 . . . . 10.0 108.423 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 3.3 pt-20 41.25 -162.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.776 -0.578 . . . . 10.0 110.121 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.559 ' H ' HD12 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -134.77 -67.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.034 -1.041 . . . . 10.0 110.579 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 47.5 t -103.32 132.11 49.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 10.0 111.604 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.961 ' O ' HD13 ' B' ' 10' ' ' LEU . 1.2 tm? -149.36 101.77 3.32 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 120.598 -1.314 . . . . 10.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -91.2 -168.5 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.406 2.071 . . . . 10.0 108.15 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 67.0 m -108.97 173.58 6.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.736 -1.228 . . . . 10.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 43' ' ' THR . 5.3 m-20 -134.33 -165.22 1.62 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.799 0.809 . . . . 10.0 111.657 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.566 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 18.5 m-85 -45.39 -166.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.25 1.024 . . . . 10.0 112.426 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.773 ' O ' HG21 ' A' ' 42' ' ' VAL . 57.1 mt-10 -41.24 154.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.088 -1.008 . . . . 10.0 111.806 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -139.32 -171.1 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 10.0 110.722 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.592 HG22 ' CE1' ' A' ' 40' ' ' TYR . 47.2 p -58.65 156.07 11.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.769 0.795 . . . . 10.0 112.064 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.602 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -128.31 -168.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 74.0 m-70 -109.19 143.89 38.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.503 -1.373 . . . . 10.0 112.277 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.999 HG22 ' HG2' ' A' ' 62' ' ' GLU . 33.3 t -130.82 152.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.695 -0.628 . . . . 10.0 110.838 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -112.02 -175.17 19.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.817 -1.313 . . . . 10.0 109.817 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' B' ' 31' ' ' GLY . 46.0 t80 166.37 116.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.711 -0.876 . . . . 10.0 108.752 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 12.6 t70 -39.41 152.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.105 -0.638 . . . . 10.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 63.11 79.85 0.25 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.735 -1.58 . . . . 10.0 106.735 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.614 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.5 -21.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.882 0.849 . . . . 10.0 110.572 -176.658 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.475 ' C ' ' O ' ' A' ' 26' ' ' ASN . 10.0 t -48.79 -15.96 0.11 Allowed 'General case' 0 C--N 1.286 -2.16 0 O-C-N 120.962 -1.086 . . . . 10.0 112.948 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 26' ' ' ASN . . . 148.22 85.64 0.06 OUTLIER Glycine 0 N--CA 1.504 3.178 0 N-CA-C 109.358 -1.497 . . . . 10.0 109.358 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.579 ' O ' HD22 ' A' ' 160' ' ' LEU . 19.7 pm0 -129.82 -146.4 0.31 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.746 -0.855 . . . . 10.0 109.422 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 14' ' ' VAL . 13.9 p90 -135.35 145.23 47.18 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' C ' ' B' ' 29' ' ' PHE . 1.7 t 30.99 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.082 0.468 . . . . 10.0 110.559 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.58 ' O ' ' CE1' ' B' ' 22' ' ' PHE . . . -153.77 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.694 -1.762 . . . . 10.0 108.694 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.415 HD11 ' OE1' ' B' ' 34' ' ' GLU . 10.7 pt -127.83 145.29 54.48 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.519 -0.989 . . . . 10.0 109.187 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.09 83.22 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.562 1.296 . . . . 10.0 109.925 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' B' ' 38' ' ' ARG . 2.8 tm-20 -160.13 155.6 25.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.568 -0.708 . . . . 10.0 110.315 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.597 ' HG2' ' CG ' ' B' ' 36' ' ' TRP . 2.2 tt0 -91.59 -71.3 0.64 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.027 -1.046 . . . . 10.0 109.7 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.597 ' CG ' ' HG2' ' B' ' 35' ' ' GLN . 0.4 OUTLIER -172.13 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.103 -0.998 . . . . 10.0 112.571 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' SER . . . -130.32 -19.1 3.16 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.478 -0.763 . . . . 10.0 110.468 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 6.6 mtt180 -78.89 6.54 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.404 -1.435 . . . . 10.0 108.108 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.659 ' HB2' ' N ' ' A' ' 71' ' ' SER . 29.7 mt -43.16 -29.96 0.42 Allowed 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.941 -0.475 . . . . 10.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.881 HD23 ' CB ' ' A' ' 71' ' ' SER . 1.1 pp -95.72 14.8 21.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.189 -0.944 . . . . 10.0 110.182 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' B' ' 41' ' ' GLN . 5.5 tt0 -158.78 62.52 0.42 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.462 0.648 . . . . 10.0 109.755 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -91.52 -173.63 3.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.369 -0.832 . . . . 10.0 110.234 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 80.0 p -72.32 9.5 1.0 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.373 -0.829 . . . . 10.0 111.36 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -52.96 -26.06 13.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.574 -1.329 . . . . 10.0 109.84 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pt -108.8 168.86 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.211 -0.931 . . . . 10.0 109.616 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 117.946 -1.026 . . . . 10.0 110.356 -179.936 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' CA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.834 ' HA ' HD23 ' A' ' 177' ' ' LEU . 7.9 mm100 -133.1 0.87 3.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.002 . . . . 10.0 110.532 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.53 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.9 m -64.74 100.62 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 10.0 110.51 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.804 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -114.65 133.73 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.994 -1.082 . . . . 10.0 111.096 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 26.2 mmtt -121.23 100.65 7.17 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.517 -0.92 . . . . 10.0 108.517 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.21 106.58 15.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.04 -1.038 . . . . 10.0 109.75 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.825 ' HB ' HG21 ' A' ' 75' ' ' THR . 71.7 t -133.67 147.56 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 10.0 110.11 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.2 m -91.2 115.72 30.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.424 -0.798 . . . . 10.0 110.295 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.7 -166.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.277 -0.889 . . . . 10.0 110.045 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 1.04 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 126.43 -144.83 15.36 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 10.0 109.81 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.88 -37.84 20.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -1.223 . . . . 10.0 109.897 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 133.8 31.88 0.38 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' HG22 ' B' ' 32' ' ' ILE . . . -61.27 -133.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.991 -1.3 . . . . 10.0 109.066 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.75 HG22 ' CG2' ' B' ' 32' ' ' ILE . 5.0 t -128.93 -24.79 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.546 -1.347 . . . . 10.0 111.144 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 8' ' ' VAL . . . 157.0 128.94 1.09 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.351 -1.404 . . . . 10.0 110.062 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.973 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -57.77 -24.53 57.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.205 -1.173 . . . . 10.0 110.154 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 35' ' ' THR . 24.8 m -59.37 -32.73 70.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 10.0 110.847 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.708 ' SG ' HD22 ' A' ' 19' ' ' LEU . 16.6 p -61.0 -29.03 69.46 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.138 -0.976 . . . . 10.0 110.388 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.708 HD22 ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -80.51 -30.31 37.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.941 -1.1 . . . . 10.0 110.718 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 24' ' ' THR . 12.8 tp -49.2 -30.65 7.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.101 -0.999 . . . . 10.0 110.122 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 26' ' ' THR . 3.8 mm -106.74 -44.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 10.0 109.7 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 39.6 t -49.7 -40.07 39.12 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.364 -0.934 . . . . 10.0 109.303 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.681 ' CE2' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -82.09 -28.93 32.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.07 . . . . 10.0 109.311 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 25.2 m -65.58 -50.22 65.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 10.0 110.7 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' N ' ' A' ' 26' ' ' ASN . 14.7 t -175.24 -37.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.2 -1.4 . . . . 10.0 112.693 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.759 ' ND2' HG11 ' A' ' 33' ' ' VAL . 23.3 m120 -70.75 -9.79 58.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.156 -0.965 . . . . 10.0 111.985 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.636 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 0.8 OUTLIER 33.75 -150.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 10.0 110.661 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HE1' HD22 ' A' ' 160' ' ' LEU . 12.6 p90 -131.31 59.41 45.49 Favored Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.167 -0.958 . . . . 10.0 111.437 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.837 ' HD2' HG21 ' B' ' 26' ' ' THR . 55.7 Cg_endo -96.02 -89.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.672 1.581 . . . . 10.0 110.618 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 m -167.26 67.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.063 -1.023 . . . . 10.0 110.92 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.59 ' HG3' ' CG2' ' A' ' 33' ' ' VAL . 12.4 pt-20 -134.72 -172.66 3.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' C ' HG22 ' A' ' 33' ' ' VAL . 53.6 m-85 -109.98 110.24 21.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.056 -1.028 . . . . 10.0 112.167 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG11 ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -155.36 105.78 2.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 178.55 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.483 ' C ' HG21 ' B' ' 20' ' ' VAL . 50.0 Cg_endo -72.5 112.78 3.55 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.841 1.694 . . . . 10.0 114.67 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.8 m -157.96 94.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.503 -0.748 . . . . 10.0 109.222 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 35' ' ' THR . 54.9 t -163.62 -96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.334 -0.854 . . . . 10.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 36' ' ' VAL . 6.8 t80 -57.22 141.11 47.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 10.0 111.122 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.615 ' HA ' HD11 ' B' ' 18' ' ' ILE . 4.8 t70 -164.31 101.37 0.84 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.252 -0.905 . . . . 10.0 110.376 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.642 ' CB ' HG21 ' B' ' 18' ' ' ILE . 11.4 t-20 -104.86 118.26 36.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.237 -1.54 . . . . 10.0 109.279 179.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.64 ' CE2' ' HG3' ' B' ' 15' ' ' GLU . 6.5 m-85 -146.72 113.53 6.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.068 -1.02 . . . . 10.0 111.107 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' B' ' 15' ' ' GLU . . . -118.41 115.29 24.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.72 -1.238 . . . . 10.0 109.976 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.94 -168.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 10.0 111.462 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.714 ' H ' HG22 ' A' ' 42' ' ' VAL . 20.2 m -163.71 145.16 9.15 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.493 0.663 . . . . 10.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 HD23 ' B' ' 10' ' ' LEU . 0.9 OUTLIER -137.73 123.75 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.381 -0.824 . . . . 10.0 109.771 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 7.3 mtm -92.06 98.19 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.869 -1.133 . . . . 10.0 109.406 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.9 mp -86.36 120.93 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.593 -0.692 . . . . 10.0 109.874 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 44.6 26.38 1.05 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 110.02 -24.88 17.79 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.012 -1.287 . . . . 10.0 111.307 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.46 110.98 30.82 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 120.714 -1.462 . . . . 10.0 110.545 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.3 Cg_endo -73.64 141.06 30.42 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.044 1.549 . . . . 10.0 111.042 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 53' ' ' LEU . 1.6 t80 -91.9 122.33 34.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.358 -0.839 . . . . 10.0 109.524 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.733 ' O ' HG22 ' A' ' 4' ' ' ILE 0.258 56.3 m -107.54 99.69 9.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.8 . . . . 10.0 109.772 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 54' ' ' GLY . 1.8 pp -144.23 168.63 19.59 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.341 -1.344 . . . . 10.0 112.33 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.738 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.4 126.9 1.32 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.87 -2.092 . . . . 10.0 107.87 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -124.55 142.32 51.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.82 -1.4 . . . . 10.0 110.354 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -139.82 104.91 5.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 10.0 110.837 -178.644 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 79.4 m-20 -80.97 -179.66 7.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.172 -0.955 . . . . 10.0 110.497 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 14' ' ' VAL . 14.0 t -85.33 -175.97 5.93 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.549 1.166 . . . . 10.0 113.361 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -142.0 -70.83 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 61' ' ' GLN . . . 40.54 24.09 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.117 -1.193 . . . . 10.0 110.117 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.566 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 1.4 mm-40 -171.47 -35.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.214 -1.168 . . . . 10.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 2.0 mt-10 -54.6 -80.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 117.813 -1.555 . . . . 10.0 108.861 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER 172.1 27.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 10.0 111.595 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.16 -52.43 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.672 -1.267 . . . . 10.0 110.807 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 24.0 t0 42.0 32.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.472 -0.767 . . . . 10.0 109.361 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.19 1.91 29.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.469 -0.769 . . . . 10.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.607 ' O ' HD22 ' A' ' 70' ' ' LEU . 2.4 mp -103.72 -14.46 16.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.413 -0.804 . . . . 10.0 110.03 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 3.9 ttt180 -82.26 -27.38 0.43 Allowed Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.7 Cg_endo -81.78 5.6 6.2 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.859 0.926 . . . . 10.0 111.072 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.898 HD11 ' CB ' ' B' ' 37' ' ' ALA . 2.0 pt? -49.34 -40.46 35.45 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.399 -0.813 . . . . 10.0 112.97 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 34.3 m 49.38 21.03 0.51 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.67 -1.269 . . . . 10.0 110.841 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 71' ' ' SER . 13.2 m-85 -143.92 130.61 10.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.925 -1.109 . . . . 10.0 110.366 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 50.8 Cg_endo -72.88 150.07 48.7 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.832 1.438 . . . . 10.0 111.276 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -177.48 47.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.047 0.927 . . . . 10.0 109.708 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' HB ' ' A' ' 7' ' ' VAL . 57.5 m -140.25 89.74 2.31 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.149 -0.97 . . . . 10.0 110.228 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -42.58 -30.72 0.38 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.53 -0.731 . . . . 10.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 75' ' ' THR . 13.6 m -123.19 124.84 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.78 -1.2 . . . . 10.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 1.7 m-85 -116.5 154.57 30.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.421 -0.799 . . . . 10.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.979 HD22 HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -111.0 97.95 7.19 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.843 -1.169 . . . . 10.0 107.843 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.04 HG23 ' HA2' ' A' ' 10' ' ' GLY . 8.2 p -103.39 125.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.159 -0.963 . . . . 10.0 111.033 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.464 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 4.2 m -127.38 125.96 41.63 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.299 -0.875 . . . . 10.0 109.084 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -135.91 178.85 6.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 10.0 110.245 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 t -81.03 149.5 29.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 10.0 112.059 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HE ' ' A' ' 120' ' ' ARG . 6.1 t -100.48 -2.01 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.704 -0.623 . . . . 10.0 110.125 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.9 m -132.97 53.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.75 0.786 . . . . 10.0 109.842 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 19.4 p -121.29 158.39 53.38 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 121.513 -0.742 . . . . 10.0 110.5 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 120.64 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.557 . . . . 10.0 111.647 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m 44.41 64.77 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 10.0 111.612 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -124.22 -43.34 2.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.677 -1.264 . . . . 10.0 110.918 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 1.102 ' CE1' HD11 ' A' ' 137' ' ' ILE . 6.4 t80 -56.12 -50.21 71.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.828 -1.17 . . . . 10.0 110.694 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.96 -15.33 12.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.955 -1.091 . . . . 10.0 111.823 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.804 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -86.9 -20.21 27.74 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.698 -1.251 . . . . 10.0 111.079 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 94' ' ' LYS . 19.3 m -90.18 -14.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.552 -1.343 . . . . 10.0 108.896 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 93' ' ' VAL . 25.9 mmtt -88.14 -33.41 18.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.15 0.976 . . . . 10.0 108.842 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 10.6 pt-20 -78.76 -5.82 54.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.105 -0.702 . . . . 10.0 109.105 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -84.24 -50.23 8.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 10.0 112.27 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 20.7 m95 -80.99 -23.8 38.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.014 -1.054 . . . . 10.0 113.376 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.786 HG22 HD21 ' A' ' 149' ' ' LEU . 4.4 t -69.23 -50.54 20.16 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.048 -1.658 . . . . 10.0 110.676 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.7 Cg_endo -72.84 -6.23 18.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.139 1.073 . . . . 10.0 109.564 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 101' ' ' ILE . 0.5 OUTLIER -68.98 -32.96 72.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 10.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 100' ' ' GLU . 2.7 pt 36.0 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.481 0.658 . . . . 10.0 111.318 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -47.11 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 109.416 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.686 ' H ' HG23 ' A' ' 102' ' ' THR . 30.4 m80 -106.74 -4.63 19.19 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.432 -0.793 . . . . 10.0 109.395 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -175.8 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 10.0 109.948 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.894 ' O ' HG22 ' A' ' 102' ' ' THR . 20.0 p -134.77 167.46 22.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 10.0 110.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 54.4 Cg_endo -81.01 72.38 6.55 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.773 1.407 . . . . 10.0 111.411 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -112.84 -10.11 13.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 10.0 112.029 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -52.92 125.39 39.65 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 120.687 -1.258 . . . . 10.0 110.432 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 77' ' ' VAL . 54.5 Cg_endo -73.72 153.12 48.43 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.052 1.553 . . . . 10.0 111.952 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.531 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 21.8 p90 -165.02 156.57 15.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.231 -1.025 . . . . 10.0 108.231 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.979 HD23 HD22 ' A' ' 79' ' ' LEU . 1.9 mm? -102.9 103.32 13.46 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 122.104 0.954 . . . . 10.0 111.007 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 155' ' ' VAL . 88.2 mt -66.33 138.57 57.7 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.179 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.611 ' CG2' HG11 ' A' ' 168' ' ' VAL . 1.4 t -150.42 171.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.792 -1.192 . . . . 10.0 111.776 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -133.25 122.11 3.04 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.486 -1.846 . . . . 10.0 108.486 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 31.0 p -100.55 170.96 8.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.165 -1.197 . . . . 10.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.9 mt-30 50.22 33.95 8.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.473 -0.767 . . . . 10.0 109.392 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.979 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -69.05 -21.88 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 10.0 109.688 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.649 ' CG ' HG21 ' A' ' 161' ' ' THR . 17.3 t70 -51.45 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.958 0.885 . . . . 10.0 110.282 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.769 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.2 tp 160.33 -30.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.017 -1.105 . . . . 10.0 108.017 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HE ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.46 -37.5 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.57 0.7 . . . . 10.0 109.876 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 64.2 t0 -55.74 -24.83 37.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 10.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD13 ' A' ' 126' ' ' ILE . 9.0 t0 -90.22 109.4 33.09 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.24 -0.913 . . . . 10.0 111.249 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 51.5 Cg_endo -76.92 24.12 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.592 1.528 . . . . 10.0 112.142 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 m -100.97 -47.05 4.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.748 -1.22 . . . . 10.0 109.728 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.436 ' O ' HD22 ' A' ' 129' ' ' LEU . 3.4 t -71.94 -26.34 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.035 -2.209 . . . . 10.0 105.035 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 122' ' ' ASP 0.301 1.1 mp -50.69 -26.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.15 -38.84 54.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.521 0.677 . . . . 10.0 110.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.534 ' N ' ' CD ' ' A' ' 128' ' ' LYS . 13.0 mptt -75.22 -44.6 45.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.469 -0.769 . . . . 10.0 110.679 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -60.16 -49.1 78.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.854 0.835 . . . . 10.0 108.971 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . -52.97 -40.92 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.469 0.652 . . . . 10.0 109.582 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -25.21 11.77 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.946 -1.097 . . . . 10.0 110.009 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -88.59 -48.65 7.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 10.0 112.177 -178.96 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -126.98 0.84 6.58 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.484 -0.76 . . . . 10.0 110.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER 45.52 23.32 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 10.0 111.494 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -154.19 101.06 2.45 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.033 -1.042 . . . . 10.0 111.781 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.9 Cg_endo -74.03 160.12 43.43 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.124 1.592 . . . . 10.0 109.919 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 1.102 HD11 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -81.77 128.19 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.529 -1.357 . . . . 10.0 109.077 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.5 p -125.37 170.89 8.41 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.475 -0.765 . . . . 10.0 110.404 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.5 Cg_endo -68.21 -7.27 19.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.786 1.414 . . . . 10.0 110.519 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -92.58 -38.54 11.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 10.0 110.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.436 ' CG2' ' CZ ' ' A' ' 90' ' ' PHE . 84.3 m -74.68 -44.68 48.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.635 -0.665 . . . . 10.0 111.593 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 154' ' ' TYR . . . -77.67 -38.54 47.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 111.581 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 143' ' ' GLU . 5.4 tm-20 -62.97 -27.04 69.13 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.792 -1.193 . . . . 10.0 108.94 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -49.59 10.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 10.0 109.93 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 94' ' ' LYS . 5.1 tt -56.2 -41.82 76.19 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.237 -0.914 . . . . 10.0 110.022 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.34 73.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 10.0 108.89 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -60.23 -29.07 68.51 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.823 -0.751 . . . . 10.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.03 -47.49 51.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 10.0 110.499 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.786 HD21 HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -90.05 16.33 8.56 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.075 0.94 . . . . 10.0 108.966 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 27.12 1.99 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.798 0.809 . . . . 10.0 109.525 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.68 -148.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.137 -0.625 . . . . 10.0 109.877 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 ' CD1' ' A' ' 111' ' ' LEU . 19.1 t -98.51 -75.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.231 -0.987 . . . . 10.0 109.963 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -173.56 -177.18 1.4 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.739 -1.184 . . . . 10.0 111.637 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -110.69 116.54 31.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.709 -0.619 . . . . 10.0 110.358 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.994 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -122.77 -168.98 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.954 -1.091 . . . . 10.0 110.169 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.422 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 1.1 pt-20 -161.97 143.49 11.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 10.0 111.403 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 162' ' ' GLN . 28.4 p -159.19 177.28 11.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.472 -0.767 . . . . 10.0 111.301 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 162' ' ' GLN . 47.1 t -144.91 170.58 15.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 10.0 109.725 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.644 ' CB ' HD12 ' A' ' 19' ' ' LEU . . . -89.59 -48.77 7.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 10.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.549 HD22 ' HE1' ' A' ' 28' ' ' PHE . 2.0 pp -118.61 -0.7 11.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 10.0 112.176 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.649 HG21 ' CG ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -120.13 -80.07 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.429 -1.42 . . . . 10.0 111.968 -178.811 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 5.7 tp60 -40.73 -63.75 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.991 -1.068 . . . . 10.0 112.071 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 25.2 mttt 70.14 51.01 0.41 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.932 0.872 . . . . 10.0 109.295 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.84 24.37 2.59 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.316 -1.514 . . . . 10.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -78.78 1.43 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -1.224 . . . . 10.0 110.767 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.422 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -79.39 -39.47 32.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.851 -1.156 . . . . 10.0 109.596 178.809 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.35 -40.77 97.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.173 -0.954 . . . . 10.0 110.682 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 155' ' ' VAL . 4.3 t -59.23 -28.21 38.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.185 -0.947 . . . . 10.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 169' ' ' PHE . 4.4 t80 -84.04 -21.34 31.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.488 -0.757 . . . . 10.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -74.31 -49.45 22.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.091 -1.005 . . . . 10.0 111.135 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.52 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.1 mm-40 -58.22 -37.22 74.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 10.0 110.578 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -55.61 -32.71 63.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.158 -0.964 . . . . 10.0 110.045 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.708 ' O ' HD12 ' A' ' 177' ' ' LEU . 66.9 mt -60.8 -44.3 97.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.153 -0.967 . . . . 10.0 110.132 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -70.57 -30.59 67.34 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.732 -1.23 . . . . 10.0 111.567 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -86.37 -17.78 33.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 10.0 111.234 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.804 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -65.72 -30.97 71.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 10.0 109.318 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -110.35 -11.68 14.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 10.0 110.188 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.959 -1.019 . . . . 10.0 110.439 -179.866 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 108.809 -1.716 . . . . 10.0 108.809 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -130.14 136.92 49.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.488 -1.007 . . . . 10.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' B' ' 3' ' ' LYS . 5.7 tptt -99.38 103.31 15.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.01 -1.057 . . . . 10.0 108.388 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.515 ' HB3' ' OE2' ' B' ' 7' ' ' GLU . 6.1 mm-40 -104.28 161.03 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.306 -0.871 . . . . 10.0 110.769 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.659 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.07 -153.26 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.564 -1.272 . . . . 10.0 107.564 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 40.3 Cg_endo -69.85 90.88 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 109.91 -0.842 . . . . 10.0 109.91 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 39.1 mm-40 -56.6 -152.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.893 -0.505 . . . . 10.0 110.691 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.892 HD12 ' N ' ' B' ' 9' ' ' SER . 2.7 pp -79.64 -51.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.756 -1.215 . . . . 10.0 111.406 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.892 ' N ' HD12 ' B' ' 8' ' ' ILE . 32.2 t -155.3 171.5 19.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.594 -1.316 . . . . 10.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.953 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.25 133.33 3.28 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 118.857 -1.137 . . . . 10.0 113.023 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 46.3 Cg_endo -86.4 177.16 4.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 N-CA-C 108.459 -1.4 . . . . 10.0 108.459 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -133.48 148.75 51.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.633 -1.292 . . . . 10.0 111.655 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -104.55 -179.65 4.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.64 -0.662 . . . . 10.0 109.471 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.6 m-85 -91.81 164.4 13.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.987 -1.07 . . . . 10.0 111.113 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.64 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 1.5 pm0 -127.85 177.25 6.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.2 0.524 . . . . 10.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.617 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 7.5 m-70 -95.6 166.23 11.94 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.487 -0.758 . . . . 10.0 111.901 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.555 ' C ' HG23 ' B' ' 18' ' ' ILE . 42.5 m -128.91 146.23 51.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.422 -0.799 . . . . 10.0 110.669 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.755 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -159.42 -171.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 10.0 110.481 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 64.6 m80 -140.02 156.73 46.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.552 -0.718 . . . . 10.0 109.73 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 37' ' ' PHE . 14.0 m -105.98 143.72 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 10.0 112.658 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -147.85 132.62 4.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.894 ' O ' HG22 ' B' ' 25' ' ' VAL . 0.4 OUTLIER 173.46 114.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.175 -1.191 . . . . 10.0 109.416 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' B' ' 22' ' ' PHE . 83.3 m-20 -39.46 132.74 1.49 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.78 . . . . 10.0 109.121 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.63 70.04 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.289 -1.004 . . . . 10.0 108.289 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.894 HG22 ' O ' ' B' ' 22' ' ' PHE . 2.0 t -88.16 -17.98 8.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 122.543 1.163 . . . . 10.0 108.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.837 HG21 ' HD2' ' A' ' 29' ' ' PRO 0.287 7.2 t -48.72 -19.05 0.32 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.713 -1.131 . . . . 10.0 111.175 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -154.51 -33.9 0.03 OUTLIER Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.513 -1.835 . . . . 10.0 108.513 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . 0.1 OUTLIER 52.45 23.96 2.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.769 -0.842 . . . . 10.0 111.394 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.608 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 51.6 t80 -112.35 115.6 28.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 122.093 0.949 . . . . 10.0 109.937 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.529 HG23 ' O ' ' B' ' 29' ' ' PHE . 33.5 p -156.51 -70.14 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.509 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.46 118.1 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.033 -1.227 . . . . 10.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.75 ' CG2' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -150.95 160.9 31.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -1.158 . . . . 10.0 109.51 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 34' ' ' GLU . 55.8 Cg_endo -76.85 136.91 17.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.906 1.477 . . . . 10.0 111.126 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.584 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 2.6 tt0 55.04 146.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.671 0.748 . . . . 10.0 110.736 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.549 ' HG2' ' N ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -85.85 -63.46 1.32 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.923 -1.111 . . . . 10.0 111.399 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.692 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 65.7 t90 -143.48 21.1 1.87 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.341 -0.85 . . . . 10.0 108.892 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.962 ' CB ' HD21 ' B' ' 39' ' ' LEU . . . 167.1 132.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.026 -1.101 . . . . 10.0 108.026 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.635 ' HG3' ' HB2' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -96.77 43.74 1.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.563 1.173 . . . . 10.0 109.63 -178.298 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.962 HD21 ' CB ' ' B' ' 37' ' ' ALA . 0.1 OUTLIER -61.39 -51.17 69.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.326 -0.852 . . . . 10.0 112.964 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.58 18.15 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.635 ' HB2' ' HG3' ' B' ' 38' ' ' ARG . 3.9 mm-40 -119.22 -85.01 0.66 Allowed 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.811 -1.18 . . . . 10.0 110.486 178.892 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 66.9 p -136.04 54.4 1.9 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.593 ' HB3' ' HA ' ' B' ' 39' ' ' LEU . 81.9 p -74.63 -1.3 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.458 ' OD1' ' C ' ' B' ' 44' ' ' ASN . 42.7 p30 -161.23 168.72 23.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.166 -0.614 . . . . 10.0 109.999 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.15 -49.19 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 10.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 46' ' ' THR . . . . . 0.434 HG23 ' ND2' ' B' ' 44' ' ' ASN . 3.0 t . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.958 -1.02 . . . . 10.0 110.261 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.15 0.5 . . . . 10.0 110.056 . . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.622 ' OE1' HD22 ' A' ' 177' ' ' LEU . 4.4 mt-30 -136.71 2.62 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.29 -0.881 . . . . 10.0 110.03 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 3.0 m -60.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.364 -0.835 . . . . 10.0 109.555 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -108.97 132.32 57.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.705 -1.198 . . . . 10.0 110.425 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -121.07 97.56 5.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.313 -0.867 . . . . 10.0 110.522 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -79.67 111.49 16.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 10.0 111.003 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HG21 ' A' ' 75' ' ' THR . 56.1 t -131.06 172.47 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 10.0 108.962 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.591 ' CG1' ' HB3' ' B' ' 35' ' ' GLN . 46.5 t -92.04 130.83 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.753 -1.217 . . . . 10.0 111.729 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.771 ' CG1' HG12 ' A' ' 80' ' ' VAL . 74.4 t -145.34 179.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.647 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 122.35 170.53 13.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.79 -1.324 . . . . 10.0 109.79 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -50.75 -39.51 52.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.151 . . . . 10.0 109.859 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.653 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 151.14 159.05 8.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.547 -1.421 . . . . 10.0 109.547 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.742 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 179.82 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -1.097 . . . . 10.0 108.852 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.808 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.7 t 149.22 89.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . 42.68 92.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.365 -1.494 . . . . 10.0 109.365 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -49.47 -34.62 17.33 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.918 -1.342 . . . . 10.0 109.296 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.2 m -49.84 -25.22 2.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.738 -1.226 . . . . 10.0 108.724 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 26' ' ' THR . 13.7 p -63.73 -18.26 63.85 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.233 -0.987 . . . . 10.0 108.706 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.2 mm? -69.36 -33.31 72.88 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.15 -0.969 . . . . 10.0 108.863 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -48.61 -37.75 19.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 10.0 108.829 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.643 HG21 ' HA3' ' B' ' 27' ' ' GLY . 1.5 mm -64.3 -43.6 97.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.68 0.752 . . . . 10.0 110.012 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' A' ' 27' ' ' LYS . 40.3 t -47.89 -44.26 29.43 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.335 -0.946 . . . . 10.0 109.738 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CZ ' ' CD1' ' A' ' 165' ' ' LEU . 6.9 m-85 -90.98 -3.81 56.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.573 -0.705 . . . . 10.0 109.676 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 14.4 m -112.41 -33.46 6.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.855 . . . . 10.0 112.403 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.798 HG21 ' CD ' ' A' ' 34' ' ' PRO . 17.3 m -136.58 -82.51 0.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.187 -1.57 . . . . 10.0 113.064 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 25' ' ' THR . 2.3 m120 -153.89 51.42 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.626 -1.296 . . . . 10.0 113.724 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 30.81 -131.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.619 -0.675 . . . . 10.0 112.676 177.609 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.635 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 11.0 p90 -111.83 81.28 3.39 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-O 121.216 0.531 . . . . 10.0 110.765 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 52.8 Cg_endo -90.61 -169.53 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.717 1.611 . . . . 10.0 110.777 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.28 43.37 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 10.0 110.319 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.39 -176.93 5.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.99 133.07 44.15 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.107 -0.995 . . . . 10.0 111.162 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.582 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -134.71 -177.3 0.68 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.798 ' CD ' HG21 ' A' ' 25' ' ' THR . 36.7 Cg_endo -59.28 -176.89 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.061 1.032 . . . . 10.0 109.421 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.673 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 1.3 p -117.26 167.31 11.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.043 -1.036 . . . . 10.0 111.567 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HB ' ' CG1' ' B' ' 20' ' ' VAL 0.273 74.1 t -55.77 -8.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 112.46 0.541 . . . . 10.0 112.46 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -32.69 87.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.43 1.11 . . . . 10.0 113.46 -177.45 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' VAL . 11.4 m-20 -157.53 104.74 2.01 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 120.718 -1.239 . . . . 10.0 111.368 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' B' ' 18' ' ' ILE . 0.6 OUTLIER -170.42 102.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 10.0 108.651 178.969 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.826 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -153.66 175.22 13.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.669 -1.212 . . . . 10.0 112.177 -178.529 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.944 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -165.71 148.37 7.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.829 -0.748 . . . . 10.0 110.791 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 1.013 HG11 ' O ' ' B' ' 14' ' ' PHE . 0.2 OUTLIER -171.52 -165.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.41 -0.806 . . . . 10.0 111.105 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 51' ' ' TYR . 74.9 m -137.38 146.05 44.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 10.0 110.217 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -103.6 176.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.244 -0.91 . . . . 10.0 109.467 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.583 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 39.5 mtp -154.37 126.18 7.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 10.0 110.472 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 mp -139.06 123.43 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 10.0 109.196 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.93 22.41 6.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.49 6.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.0 mt-10 -120.81 99.56 47.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.293 -1.122 . . . . 10.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 43.6 Cg_endo -71.6 136.31 27.99 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.632 1.333 . . . . 10.0 110.319 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -99.88 157.02 16.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.102 -0.999 . . . . 10.0 110.347 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 4' ' ' ILE . 40.1 m -126.95 106.62 9.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 10.0 111.973 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -148.37 166.71 27.24 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.438 -1.414 . . . . 10.0 111.293 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.16 134.99 3.2 Favored Glycine 0 C--N 1.288 -2.092 0 N-CA-C 108.629 -1.789 . . . . 10.0 108.629 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.826 HD11 ' CE1' ' A' ' 40' ' ' TYR . 4.6 pp -153.19 167.45 29.24 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.112 -1.228 . . . . 10.0 110.308 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.494 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 22.4 p90 -170.29 131.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 10.0 110.908 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 5.1 p-10 -99.09 176.83 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 10.0 110.252 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.409 HG22 ' N ' ' A' ' 59' ' ' ALA . 21.5 m -40.75 162.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.167 0.984 . . . . 10.0 112.638 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.987 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -134.39 68.93 1.47 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.512 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.613 ' HA3' ' CD2' ' B' ' 22' ' ' PHE . . . -43.61 -82.23 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 107.904 -2.078 . . . . 10.0 107.904 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.273 -1.134 . . . . 10.0 107.951 177.121 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.987 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.5 pt-20 41.99 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.406 1.098 . . . . 10.0 111.034 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.5 -12.73 57.6 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 1.2 p90 -133.83 -27.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.851 -0.531 . . . . 10.0 109.693 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 68' ' ' ARG . 5.3 t70 43.12 35.98 0.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 10.0 110.496 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.8 -7.83 59.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.986 -1.071 . . . . 10.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.71 HD12 ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -111.63 4.14 18.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 10.0 110.358 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.733 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.7 mmt180 -53.61 -40.53 81.25 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.214 -0.929 . . . . 10.0 111.868 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 52.5 Cg_endo -83.72 78.71 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.414 1.218 . . . . 10.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -105.61 -105.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 10.0 110.488 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 47.07 35.7 3.66 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -148.26 114.92 3.91 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 120.154 -0.618 . . . . 10.0 110.948 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' GLN . 53.9 Cg_endo -75.52 -151.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.925 1.487 . . . . 10.0 110.004 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 76.64 79.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.79 . . . . 10.0 111.275 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.5 m -139.09 96.67 3.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 71.0 m-20 -23.14 -41.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.856 -0.611 . . . . 10.0 112.37 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.71 HG21 HG12 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -142.13 130.09 21.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.894 -1.129 . . . . 10.0 110.838 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.84 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.7 p90 -148.25 170.19 18.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.055 -1.028 . . . . 10.0 110.596 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.968 HD13 HG12 ' A' ' 168' ' ' VAL . 4.1 mt -112.34 102.53 10.67 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.86 . . . . 10.0 110.067 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.771 HG12 ' CG1' ' A' ' 9' ' ' VAL . 1.7 m -98.79 127.52 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.676 -0.861 . . . . 10.0 108.676 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 115' ' ' THR . 0.5 OUTLIER -105.66 100.44 10.0 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.638 -1.288 . . . . 10.0 112.048 -178.322 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' A' ' 80' ' ' VAL . 57.6 m-85 -86.86 176.1 7.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.247 -0.908 . . . . 10.0 109.908 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 47.9 t -100.72 142.67 31.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -0.845 . . . . 10.0 108.878 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG22 ' HG2' ' A' ' 120' ' ' ARG . 34.0 m -56.16 -16.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.041 -1.037 . . . . 10.0 110.675 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.657 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -112.66 -88.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.868 -1.145 . . . . 10.0 109.293 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 34.25 75.27 0.47 Allowed Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.942 -0.474 . . . . 10.0 110.612 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 43.6 Cg_endo -69.79 162.12 43.3 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.978 1.515 . . . . 10.0 110.62 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 133' ' ' LYS . 15.8 m 47.42 39.37 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.783 . . . . 10.0 111.402 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -135.06 -68.6 0.52 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.91 -1.119 . . . . 10.0 110.38 -179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 p90 -57.18 -16.67 8.53 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.322 -0.861 . . . . 10.0 110.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 90' ' ' PHE . 18.1 mt-10 -78.59 -24.54 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 10.0 110.208 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.618 ' OD1' HG13 ' A' ' 93' ' ' VAL . 0.8 OUTLIER -80.95 -14.76 57.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 10.0 110.311 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.875 HG23 ' HD3' ' A' ' 94' ' ' LYS . 16.6 m -87.93 -22.74 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 118.288 -1.365 . . . . 10.0 108.486 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.968 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.43 -27.73 63.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -89.39 -1.27 57.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.746 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 13.3 mmtm -102.46 -53.16 2.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.948 -1.101 . . . . 10.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.453 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 41.7 m95 -90.32 -38.37 13.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.704 -1.247 . . . . 10.0 112.547 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.7 t -64.22 -51.06 64.51 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.541 -1.349 . . . . 10.0 111.29 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 42.0 Cg_endo -67.58 -16.05 46.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.055 1.029 . . . . 10.0 109.556 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ILE . 5.0 tm-20 -55.54 -51.39 67.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.347 -0.846 . . . . 10.0 109.957 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CB ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 163.32 1.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.522 -0.736 . . . . 10.0 112.114 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.97 HG22 ' CB ' ' A' ' 107' ' ' LYS . 46.9 p -60.1 -26.84 66.53 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.279 -1.513 . . . . 10.0 111.314 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -10.06 18.54 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.376 -0.828 . . . . 10.0 111.418 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -120.0 -3.42 10.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.718 -1.238 . . . . 10.0 110.926 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.514 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 24.9 p -161.17 166.57 14.93 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.902 -1.124 . . . . 10.0 110.65 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 38.1 Cg_endo -65.36 110.39 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.741 1.39 . . . . 10.0 109.304 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.97 ' CB ' HG22 ' A' ' 102' ' ' THR 0.261 0.0 OUTLIER -92.35 -95.46 0.14 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.89 0.852 . . . . 10.0 111.06 -178.052 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' ASP . 1.1 m -167.26 120.36 0.78 Allowed Pre-proline 0 C--N 1.29 -1.992 0 C-N-CA 120.064 -0.655 . . . . 10.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 42.1 Cg_endo -68.62 149.91 74.24 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.938 1.494 . . . . 10.0 111.052 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.623 ' CE1' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -129.7 119.78 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 10.0 108.89 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -75.05 97.24 3.37 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.572 ' C ' HG23 ' A' ' 113' ' ' VAL . 51.1 mt -63.81 144.47 57.02 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.81 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 65.4 t -154.66 157.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 10.0 111.619 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.1 154.39 19.87 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.78 -1.728 . . . . 10.0 108.78 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.709 HG22 ' SG ' ' A' ' 81' ' ' CYS . 45.9 p -120.79 136.74 54.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.877 -1.366 . . . . 10.0 110.518 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' THR . 2.0 tt0 39.75 50.86 2.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.944 0.878 . . . . 10.0 108.718 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.011 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.29 -32.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.173 -177.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -52.35 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.999 0.904 . . . . 10.0 111.064 -177.244 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.763 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.9 tp 153.03 -33.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.849 -1.167 . . . . 10.0 107.849 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.6 tpp180 -53.86 -27.83 32.4 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 19.3 t0 -72.23 -5.76 38.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 10.0 110.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.684 ' O ' HD13 ' A' ' 126' ' ' ILE . 17.0 m-20 -79.82 157.91 73.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 10.0 110.668 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.5 Cg_endo -83.0 23.04 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.935 1.756 . . . . 10.0 111.507 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.8 p -105.8 -46.97 4.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.043 -1.035 . . . . 10.0 109.324 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 120' ' ' ARG . 8.2 t -69.98 -27.65 64.89 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.684 HD13 ' O ' ' A' ' 122' ' ' ASP 0.307 0.7 OUTLIER -49.26 -27.53 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.144 -1.389 . . . . 10.0 107.427 177.1 . . . . . . . . 4 4 . 1 . 012 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.03 -37.44 61.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.049 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -82.52 -50.75 8.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 10.0 111.426 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -67.92 -20.72 65.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.631 -1.293 . . . . 10.0 109.261 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -62.07 -40.87 97.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.491 -0.756 . . . . 10.0 109.968 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -62.46 -18.19 61.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 10.0 109.678 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 12.3 t-20 -97.99 -72.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 10.0 110.281 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 1.2 mptp? -149.55 144.35 26.19 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.347 -0.846 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.466 ' O ' ' HD3' ' A' ' 136' ' ' PRO . 1.0 OUTLIER -86.02 21.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 10.0 110.404 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -112.21 93.92 24.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.124 -0.985 . . . . 10.0 110.633 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.657 ' HB3' HG12 ' A' ' 85' ' ' VAL . 46.1 Cg_endo -83.17 156.67 14.91 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.158 1.609 . . . . 10.0 110.841 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -89.25 114.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -0.944 . . . . 10.0 109.057 179.109 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.6 p -114.72 169.25 6.86 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.386 -0.821 . . . . 10.0 109.631 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 36.7 Cg_endo -61.84 -19.39 65.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.43 1.226 . . . . 10.0 110.523 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.59 -41.93 44.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 10.0 108.749 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.5 m -83.35 -41.18 18.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.664 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -52.24 -41.8 63.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.6 -0.687 . . . . 10.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.27 -49.6 76.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.429 -0.795 . . . . 10.0 109.259 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' ASP . 22.9 mttm -60.53 -39.93 89.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.487 -0.931 . . . . 10.0 108.487 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.968 HD21 ' HE2' ' A' ' 94' ' ' LYS . 10.4 tt -58.67 -39.51 80.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.592 -0.693 . . . . 10.0 109.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.691 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -69.76 -48.08 60.6 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.627 -0.829 . . . . 10.0 108.85 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.42 -23.71 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.729 0.776 . . . . 10.0 108.98 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 144' ' ' LYS . 38.2 t70 -54.6 -27.49 39.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.594 -0.691 . . . . 10.0 111.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.979 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.26 38.1 0.79 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.914 -1.116 . . . . 10.0 112.402 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 18.0 mtpt 64.49 38.08 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.317 -0.864 . . . . 10.0 112.197 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.691 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -72.97 -158.39 0.05 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 111' ' ' LEU . 2.1 p -114.9 -62.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.323 -1.486 . . . . 10.0 111.358 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.59 ' H ' HG13 ' A' ' 152' ' ' VAL . 6.9 tttt -173.04 156.48 3.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.385 -1.447 . . . . 10.0 112.714 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.664 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 78.9 t80 -101.32 105.73 16.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 10.0 109.521 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 168' ' ' VAL . 1.3 t -96.81 -167.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 10.0 110.854 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.648 ' H ' HG12 ' A' ' 155' ' ' VAL . 46.1 mt-10 -132.37 139.53 48.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.477 -0.764 . . . . 10.0 110.463 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 2.7 t -166.96 133.0 2.23 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.337 1.065 . . . . 10.0 110.969 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.7 ' C ' ' HB3' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -150.98 80.03 1.32 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.446 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -21.11 -43.48 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.49 0.922 . . . . 10.0 113.49 -177.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.0 tp -76.56 -59.26 2.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.366 -1.458 . . . . 10.0 110.069 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -115.3 39.08 3.03 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 123.179 1.466 . . . . 10.0 108.611 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.7 ' HB3' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -59.38 -106.96 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 113.604 -1.634 . . . . 10.0 111.798 -177.649 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 6.6 mttt 71.69 63.02 0.14 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.665 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.31 -21.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.554 -1.308 . . . . 10.0 111.05 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.851 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -62.59 -8.24 6.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.401 -1.647 . . . . 10.0 110.912 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.558 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.0 ptmt -65.2 -31.57 72.8 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.962 -1.086 . . . . 10.0 109.537 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.58 -27.7 60.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.454 -0.779 . . . . 10.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 79' ' ' LEU . 11.9 t -53.32 -48.17 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 10.0 109.676 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 t80 -73.55 -30.51 63.1 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.866 -0.521 . . . . 10.0 111.259 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.502 ' O ' HD22 ' A' ' 174' ' ' LEU . 6.1 m-20 -69.37 -46.17 67.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 10.0 111.781 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 -25.32 59.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.209 . . . . 10.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.196 -0.94 . . . . 10.0 109.491 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.633 ' O ' HD11 ' A' ' 177' ' ' LEU . 26.3 mm -63.24 -48.03 89.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.299 -0.96 . . . . 10.0 109.305 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -73.44 -42.97 61.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 10.0 110.784 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 109' ' ' PRO . . . -76.23 -2.08 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 10.0 111.065 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.82 -30.63 20.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.985 -1.072 . . . . 10.0 110.659 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.633 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -85.77 -17.19 36.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -0.855 . . . . 10.0 109.163 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 118.07 -0.967 . . . . 10.0 110.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.464 -1.454 . . . . 10.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -89.43 56.34 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -1.142 . . . . 10.0 110.602 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -77.38 98.21 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 10.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -91.3 155.22 18.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.824 . . . . 10.0 110.192 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.702 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.35 -152.09 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.702 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.7 Cg_endo -69.95 87.35 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 N-CA-C 110.279 -0.701 . . . . 10.0 110.279 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 22.6 mm-40 -50.92 -175.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 10.0 110.155 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 9' ' ' SER . 1.7 pp -79.77 -44.43 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.016 -1.053 . . . . 10.0 111.271 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.649 ' HB2' HD12 ' B' ' 8' ' ' ILE . 7.5 t -126.25 163.66 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.659 -1.276 . . . . 10.0 110.828 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.935 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.37 96.79 0.51 Allowed Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.764 -1.174 . . . . 10.0 113.367 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.583 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 40.2 Cg_endo -81.91 157.71 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 N-CA-C 108.007 -1.574 . . . . 10.0 108.007 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -149.02 125.24 10.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.14 -1.6 . . . . 10.0 112.2 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 43' ' ' THR . 10.0 m-20 -80.35 156.97 26.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.152 -1.055 . . . . 10.0 108.152 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 1.013 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.0 m-85 -110.34 142.63 41.74 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.411 -1.431 . . . . 10.0 111.301 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -58.93 143.28 48.45 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.361 0.601 . . . . 10.0 112.335 -177.777 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.661 ' C ' ' HB3' ' A' ' 40' ' ' TYR . 8.1 t60 -88.58 97.6 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.521 -0.737 . . . . 10.0 109.798 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.42 ' N ' ' HB3' ' A' ' 40' ' ' TYR . 4.2 m -83.85 155.35 22.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.874 0.845 . . . . 10.0 112.934 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.71 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.9 pp -125.98 -167.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.596 ' HA ' ' CB ' ' A' ' 37' ' ' PHE . 22.2 m-70 -123.14 143.87 49.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 10.0 110.605 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.684 ' CG1' ' HA ' ' A' ' 59' ' ' ALA . 41.2 t -135.41 155.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.446 -0.784 . . . . 10.0 110.413 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -122.67 151.76 16.87 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.0 -1.095 . . . . 10.0 112.737 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.628 ' HB3' ' CB ' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 159.33 112.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' B' ' 24' ' ' ALA . 8.3 m-20 -44.66 143.32 1.41 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.465 -0.772 . . . . 10.0 111.653 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 19.82 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 120.968 0.413 . . . . 10.0 111.762 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.628 ' CB ' ' HB3' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -112.59 -41.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.438 -0.789 . . . . 10.0 109.322 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.2 t -53.58 -18.3 2.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.62 -0.675 . . . . 10.0 109.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.643 ' HA3' HG21 ' A' ' 21' ' ' ILE . . . -128.09 25.51 4.89 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 107.78 -2.128 . . . . 10.0 107.78 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.581 ' OE1' HG22 ' B' ' 25' ' ' VAL . 23.9 tt0 -92.93 110.25 21.71 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.854 -1.38 . . . . 10.0 111.995 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 159' ' ' ALA . 45.7 t80 -140.75 111.06 6.69 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.515 -1.22 . . . . 10.0 109.297 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 47.6 p -116.67 -79.61 0.59 Allowed 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.465 -0.939 . . . . 10.0 108.465 178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.454 ' O ' HG13 ' B' ' 32' ' ' ILE . . . 139.16 97.18 0.37 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.721 -1.228 . . . . 10.0 110.971 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.582 HG22 ' CD ' ' B' ' 33' ' ' PRO . 0.1 OUTLIER 178.51 -51.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.111 -1.229 . . . . 10.0 110.284 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' B' ' 32' ' ' ILE . 49.3 Cg_endo -92.44 154.31 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.712 1.375 . . . . 10.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.63 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -49.19 174.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 10.0 108.762 178.889 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.653 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 23.7 mt-30 -88.42 -73.78 0.48 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.457 -1.402 . . . . 10.0 111.946 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -122.61 19.26 10.37 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.311 1.053 . . . . 10.0 108.792 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.931 ' O ' HD23 ' B' ' 39' ' ' LEU . . . -112.75 52.34 0.79 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.522 ' CG ' ' HB2' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -75.6 42.95 0.23 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.199 1.0 . . . . 10.0 108.794 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.931 HD23 ' O ' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -51.83 -29.39 19.23 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.565 -0.743 . . . . 10.0 111.151 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' B' ' 39' ' ' LEU . 1.2 pp -114.72 13.68 17.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 10.0 109.957 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.522 ' HB2' ' CG ' ' B' ' 38' ' ' ARG . 28.3 mt-30 -131.73 35.09 3.82 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.788 -0.57 . . . . 10.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 43' ' ' SER . 44.9 m -102.35 168.39 9.36 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.101 -0.999 . . . . 10.0 110.259 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.477 ' N ' HG22 ' B' ' 42' ' ' THR . 96.6 p -61.6 -7.96 3.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 10.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -123.82 100.84 6.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.806 -1.184 . . . . 10.0 110.025 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.45 160.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 10.0 109.746 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.298 -1.653 0 C-N-CA 119.139 -1.024 . . . . 10.0 110.322 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.157 0.503 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.667 ' HA ' HD23 ' A' ' 177' ' ' LEU . 96.5 mm-40 -146.61 -38.53 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.332 -0.855 . . . . 10.0 109.607 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -47.28 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 10.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -111.07 130.46 64.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.286 -0.966 . . . . 10.0 108.892 177.101 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER -113.19 98.57 7.21 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.412 -0.915 . . . . 10.0 109.598 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.1 t -84.88 101.31 12.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.283 -0.885 . . . . 10.0 109.072 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.71 ' HB ' HG21 ' A' ' 75' ' ' THR . 48.4 t -121.84 142.46 38.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.135 -1.026 . . . . 10.0 110.739 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.731 HG23 ' HA3' ' A' ' 15' ' ' GLY . 2.4 p -63.29 125.86 20.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.671 -0.643 . . . . 10.0 109.994 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -141.64 168.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.148 -0.97 . . . . 10.0 109.672 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.791 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 169.97 158.19 13.47 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.7 -1.36 . . . . 10.0 109.7 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -50.03 -22.62 1.67 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.404 -1.056 . . . . 10.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.0 35.4 0.08 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.599 -1.4 . . . . 10.0 109.599 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 32' ' ' ILE . . . -125.55 -155.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -1.103 . . . . 10.0 109.661 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' ' 29' ' ' PHE . 20.1 t -69.71 108.79 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 10.0 109.471 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.731 ' HA3' HG23 ' A' ' 8' ' ' VAL . . . -52.55 164.51 1.64 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.888 -1.285 . . . . 10.0 109.888 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -87.68 5.89 37.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -1.086 . . . . 10.0 110.267 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.579 HG23 ' N ' ' A' ' 18' ' ' CYS . 14.1 t -75.08 -43.06 55.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.167 -0.958 . . . . 10.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' B' ' 26' ' ' THR . 30.8 p -74.72 -9.23 58.37 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.375 -1.33 . . . . 10.0 108.429 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 159' ' ' ALA . 3.9 mm? -76.8 -36.2 57.11 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.385 -0.822 . . . . 10.0 109.631 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -37.79 49.82 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.197 -1.038 . . . . 10.0 108.197 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.522 ' CG2' ' HA3' ' B' ' 27' ' ' GLY . 1.4 mm -91.61 -51.76 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.685 0.755 . . . . 10.0 109.912 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.686 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 68.4 m -49.52 -45.59 47.45 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.51 -0.876 . . . . 10.0 109.808 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CB ' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.58 -32.47 73.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 10.0 109.726 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 m -75.77 -51.85 11.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 10.0 112.073 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' N ' ' A' ' 26' ' ' ASN . 15.3 t -153.67 -46.15 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.54 -1.664 . . . . 10.0 113.82 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.634 ' N ' HG23 ' A' ' 25' ' ' THR . 30.5 m120 -67.98 -23.67 65.06 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.907 -1.12 . . . . 10.0 111.596 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.686 ' N ' ' HA ' ' A' ' 22' ' ' SER . 2.6 pttt 24.37 -148.59 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.287 1.042 . . . . 10.0 113.249 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.615 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 15.0 t80 -53.39 149.77 13.63 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.085 -1.01 . . . . 10.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 36.5 Cg_endo -60.42 100.3 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 O-C-N 123.527 1.278 . . . . 10.0 112.49 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 t -168.09 28.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.695 -0.628 . . . . 10.0 109.632 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 13.0 pt-20 -171.24 -174.33 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.849 0.833 . . . . 10.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 11.1 m-85 -72.91 154.49 40.54 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG23 ' HD2' ' A' ' 34' ' ' PRO . 1.8 p -176.91 153.04 1.07 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.516 -1.365 . . . . 10.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.769 ' HD2' HG23 ' A' ' 33' ' ' VAL . 37.7 Cg_endo -61.79 -175.28 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 124.069 1.563 . . . . 10.0 110.55 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 82.5 p -126.03 163.11 23.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.177 0.989 . . . . 10.0 112.68 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.824 ' N ' HG11 ' B' ' 20' ' ' VAL . 73.2 t -50.64 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.002 ' N ' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -51.64 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.757 -1.214 . . . . 10.0 110.213 -175.597 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' VAL . 57.0 t0 -133.66 85.64 2.22 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.663 -0.698 . . . . 10.0 110.564 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' B' ' 17' ' ' THR . 48.5 t30 -84.4 99.65 10.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.916 -1.115 . . . . 10.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.97 120.71 41.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 10.0 109.652 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' OE1' ' B' ' 15' ' ' GLU . . . -124.0 137.13 54.64 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.693 -1.203 . . . . 10.0 111.023 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 43' ' ' THR . 55.8 t -157.94 170.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.012 . . . . 10.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' THR . . . . . 1.069 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.1 m -149.82 146.55 27.21 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.95 133.17 10.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 120.912 -1.118 . . . . 10.0 112.133 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.577 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 27.0 mtp -92.4 99.82 12.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 10.0 109.794 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 5.7 mt -88.16 130.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 10.0 110.636 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' B' ' 8' ' ' ILE . . . 43.78 25.77 0.65 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.267 -1.533 . . . . 10.0 109.267 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 96.87 21.66 20.36 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.225 -1.15 . . . . 10.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' C ' ' HA ' ' A' ' 45' ' ' MET . 27.9 mt-10 -126.34 105.43 24.64 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.972 -1.31 . . . . 10.0 110.526 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 41.4 Cg_endo -67.26 131.45 25.05 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 124.028 1.541 . . . . 10.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 1.069 ' O ' HG23 ' A' ' 43' ' ' THR . 1.5 t80 -88.53 152.26 21.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 10.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.84 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.7 m -130.38 98.72 4.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.706 . . . . 10.0 109.267 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 54' ' ' GLY . 2.3 pp -152.33 173.6 14.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.12 -1.432 . . . . 10.0 112.259 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.5 134.38 2.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.151 -1.98 . . . . 10.0 108.151 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 55' ' ' LEU . 4.0 pp -130.32 152.43 49.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.683 -1.481 . . . . 10.0 110.712 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.524 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 16.8 p90 -169.81 150.45 3.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 10.0 110.432 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 63.6 m-20 -93.04 172.96 7.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.222 -0.923 . . . . 10.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -64.28 -169.03 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.117 0.961 . . . . 10.0 112.078 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.981 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -111.34 72.11 0.77 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -39.91 -43.69 2.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.675 -1.37 . . . . 10.0 109.675 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -143.81 13.62 1.7 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.259 -1.142 . . . . 10.0 110.864 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.981 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 mm-40 -53.05 -39.14 63.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.765 -1.209 . . . . 10.0 109.147 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 35.0 m-20 67.21 10.37 7.66 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 62' ' ' GLU . 4.5 m-85 -101.45 -32.57 10.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' CG ' HG23 ' B' ' 42' ' ' THR . 9.7 t70 20.45 49.16 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.226 0.536 . . . . 10.0 111.28 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' TYR . 42.8 mtp180 -83.22 -37.06 24.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.328 -0.858 . . . . 10.0 110.419 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.1 mt -108.13 4.58 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 10.0 110.626 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.719 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -100.27 3.04 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 118.934 -1.107 . . . . 10.0 113.54 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_endo -79.37 52.98 4.51 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 N-CA-C 108.196 -1.502 . . . . 10.0 108.196 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.7 pt? -53.28 -52.9 57.57 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 121.572 -0.705 . . . . 10.0 112.225 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 26.2 t 39.99 27.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.011 . . . . 10.0 109.601 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.47 158.75 0.74 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 10.0 110.017 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.99 107.75 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.696 1.366 . . . . 10.0 109.44 178.485 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.4 tp60 -137.69 36.95 2.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.805 -1.184 . . . . 10.0 110.962 -179.143 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.71 HG21 ' HB ' ' A' ' 7' ' ' VAL . 97.7 m -144.66 91.99 2.24 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.177 -0.952 . . . . 10.0 108.885 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 75' ' ' THR . 10.0 m-20 -24.25 -48.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 5' ' ' LYS . 2.3 m -114.5 133.61 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.983 -1.073 . . . . 10.0 110.986 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -119.77 131.45 55.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 10.0 112.074 -178.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 HD23 ' A' ' 111' ' ' LEU . 2.6 mm? -103.67 98.33 8.22 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.791 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.6 p -114.96 161.45 13.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.356 -0.84 . . . . 10.0 110.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 23.0 p -124.74 101.6 7.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 10.0 111.2 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 115' ' ' THR . 51.9 m-85 -87.26 174.29 8.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 10.0 110.401 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -118.94 130.83 55.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 10.0 109.852 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' HG2' ' A' ' 120' ' ' ARG . 27.8 m -67.14 -10.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.132 -0.98 . . . . 10.0 109.913 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 84' ' ' VAL . 35.3 m -115.8 43.17 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 10.0 109.89 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 36.7 t -105.55 140.06 20.79 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.775 . . . . 10.0 109.784 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 46.9 Cg_endo -71.38 114.46 3.94 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.04 1.547 . . . . 10.0 111.515 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 87' ' ' PRO . 75.3 m 38.9 60.08 1.49 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.426 -0.796 . . . . 10.0 111.458 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.512 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 3.4 t -100.21 -66.16 0.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.086 . . . . 10.0 110.035 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.993 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -48.52 -26.01 1.97 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.344 -0.847 . . . . 10.0 110.301 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.89 -19.43 65.87 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.029 -1.044 . . . . 10.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.654 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.77 -16.24 42.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 10.0 110.067 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 90' ' ' PHE . 18.1 m -88.95 -19.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.821 -1.174 . . . . 10.0 109.005 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.71 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.83 -32.84 57.85 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 178.291 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -85.16 0.38 51.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -111.38 -51.75 2.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.102 -1.039 . . . . 10.0 111.379 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 15.2 m0 -72.97 -30.61 63.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.347 -0.846 . . . . 10.0 111.81 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 149' ' ' LEU . 16.8 t -70.89 -47.89 15.05 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 10.0 111.362 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -70.7 -14.3 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.077 1.041 . . . . 10.0 111.397 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 3.5 mm-40 -67.04 -39.64 86.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.916 -1.115 . . . . 10.0 110.223 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 101' ' ' ILE . 11.3 mt 44.22 85.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.322 -0.951 . . . . 10.0 109.59 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -44.23 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 10.0 110.133 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.525 ' H ' HG23 ' A' ' 102' ' ' THR . 7.1 t60 -103.57 -13.96 16.35 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.192 -0.943 . . . . 10.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.654 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -173.25 -48.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.551 ' O ' ' CG2' ' A' ' 102' ' ' THR . 73.2 m -119.08 164.75 19.56 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.07 112.98 3.52 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.538 1.283 . . . . 10.0 110.282 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -144.18 0.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.885 -1.134 . . . . 10.0 111.728 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 m -47.69 134.89 10.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.681 -1.262 . . . . 10.0 108.819 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.53 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 41.8 Cg_endo -68.38 130.54 21.31 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.561 1.295 . . . . 10.0 109.775 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CE1' ' CZ2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -137.58 113.85 10.09 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.032 0.92 . . . . 10.0 110.931 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.919 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.8 mm? -82.19 100.29 9.76 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.669 HD21 ' C ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -91.3 117.47 29.68 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.889 0.852 . . . . 10.0 110.352 -178.121 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 168' ' ' VAL . 1.6 t -126.3 177.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 10.0 111.618 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.48 159.29 14.6 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 82' ' ' PHE . 87.1 m -113.59 140.77 47.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.302 . . . . 10.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 48.61 36.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 10.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -47.39 -24.82 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.261 -0.976 . . . . 10.0 110.864 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.753 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 3.6 p-10 -52.67 52.33 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 121.397 0.618 . . . . 10.0 112.222 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.76 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 157.34 -53.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -40.07 -30.16 0.09 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.277 -0.874 . . . . 10.0 110.23 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 37.3 t0 -68.02 -19.04 64.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 10.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.975 ' O ' HD13 ' A' ' 126' ' ' ILE . 3.4 m-20 -82.13 148.4 59.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 10.0 110.27 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.3 Cg_endo -86.33 22.74 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.067 1.562 . . . . 10.0 110.226 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 21.0 p -102.95 -50.25 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 10.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.711 HG21 HD12 ' A' ' 119' ' ' LEU . 4.0 t -70.55 -30.44 67.16 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.163 -2.162 . . . . 10.0 105.163 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 122' ' ' ASP 0.298 0.8 OUTLIER -49.54 -30.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.707 -1.59 . . . . 10.0 106.707 176.515 . . . . . . . . 4 4 . 1 . 013 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 124' ' ' SER . 1.5 tp10 -52.84 -38.62 61.63 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.876 0.846 . . . . 10.0 109.971 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -56.5 -39.61 73.57 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.922 -0.487 . . . . 10.0 111.041 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -51.41 -47.75 62.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.938 -1.101 . . . . 10.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.53 59.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.569 -0.707 . . . . 10.0 110.397 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.93 -23.83 0.88 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.232 -0.918 . . . . 10.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 2.1 p-10 -127.95 -25.54 3.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.037 . . . . 10.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -147.79 118.31 7.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.446 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -65.16 -22.36 66.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.61 -0.682 . . . . 10.0 111.855 -178.003 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -108.33 95.24 15.24 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.048 -1.032 . . . . 10.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.747 ' CB ' HD13 ' A' ' 129' ' ' LEU . 43.5 Cg_endo -72.49 157.54 52.67 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.977 1.514 . . . . 10.0 109.763 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 84' ' ' VAL . 5.8 tp -100.49 127.4 53.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 10.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.6 p -125.1 169.83 10.36 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.507 -0.746 . . . . 10.0 109.223 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -63.1 -11.78 26.65 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.637 1.335 . . . . 10.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -83.95 -51.06 7.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 10.0 110.218 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.7 m -68.55 -39.94 80.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 10.0 110.514 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -51.16 -27.39 8.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 10.0 110.039 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.38 -49.95 61.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 10.0 109.732 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.5 72.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.196 -0.94 . . . . 10.0 108.976 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.55 ' CG ' ' HE2' ' A' ' 94' ' ' LYS . 2.5 tt -64.08 -49.72 71.17 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.398 -0.813 . . . . 10.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -61.71 -41.0 97.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -57.85 -24.45 57.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.014 -0.674 . . . . 10.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.526 ' C ' HD12 ' A' ' 149' ' ' LEU . 51.0 t0 -58.33 -55.19 38.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.34 -0.85 . . . . 10.0 109.428 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 98' ' ' VAL . 6.7 mp -96.55 9.23 42.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.007 -1.109 . . . . 10.0 108.007 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.9 mttp 61.86 35.99 16.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.044 0.926 . . . . 10.0 109.62 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -58.12 -154.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.476 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.919 HG11 ' CD1' ' A' ' 111' ' ' LEU . 4.3 t -89.08 -76.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.945 -1.097 . . . . 10.0 110.627 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.669 ' C ' HD21 ' A' ' 112' ' ' LEU . 2.1 tppt? -174.88 159.83 2.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.281 -1.368 . . . . 10.0 112.125 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 18.0 p90 -84.26 112.57 20.41 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.658 0.742 . . . . 10.0 109.98 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.009 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -115.71 -169.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 10.0 110.637 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.08 144.49 21.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 10.0 109.928 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.66 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 24.0 p -149.42 148.93 30.04 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.023 0.916 . . . . 10.0 111.738 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.533 ' HB3' ' H ' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -149.13 96.06 2.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -35.73 -56.41 0.68 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.618 -0.676 . . . . 10.0 112.071 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.496 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.3 pp -99.98 -11.02 20.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.667 -1.271 . . . . 10.0 113.796 -177.538 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.562 HG21 ' CB ' ' A' ' 118' ' ' ASP . 30.0 m -98.79 -90.19 0.3 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 119.93 -1.731 . . . . 10.0 111.613 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 43.7 mt-30 -52.61 -68.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.731 -1.231 . . . . 10.0 110.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 24.8 mtmm 74.07 57.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.597 0.713 . . . . 10.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 26.77 0.24 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.643 -1.783 . . . . 10.0 108.643 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.807 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.42 4.85 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -1.037 . . . . 10.0 111.758 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.464 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -52.81 -22.59 5.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 10.0 109.543 178.77 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 71.5 m-20 -69.13 -38.49 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 10.0 110.049 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.009 HG22 ' HB ' ' A' ' 155' ' ' VAL . 17.2 t -49.71 -40.11 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 10.0 109.179 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -79.98 -26.07 40.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 10.0 110.329 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.693 ' HA ' HD12 ' A' ' 173' ' ' ILE . 21.8 m-20 -58.65 -45.72 88.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.008 . . . . 10.0 110.148 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.53 ' HB3' HG13 ' A' ' 152' ' ' VAL . 5.6 mm-40 -74.68 -26.0 59.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.032 . . . . 10.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -67.11 -31.72 72.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 10.0 109.586 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.737 HG23 ' OH ' ' A' ' 51' ' ' TYR . 46.3 mt -59.15 -46.99 91.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.462 -0.774 . . . . 10.0 109.977 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -70.13 -35.5 74.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.203 -0.936 . . . . 10.0 110.686 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 109' ' ' PRO . . . -88.56 -3.39 58.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.39 -0.819 . . . . 10.0 109.866 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.736 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -77.94 -33.76 51.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 10.0 110.049 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -98.08 -24.05 15.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 10.0 109.182 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.022 -0.989 . . . . 10.0 110.208 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 10.0 109.723 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 15.5 m 54.24 49.82 17.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -1.147 . . . . 10.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 105.01 2.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 10.0 109.749 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' B' ' 2' ' ' SER . 15.8 mm-40 -100.81 162.85 12.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.522 -0.736 . . . . 10.0 110.404 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.696 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -69.42 -147.84 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.4 Cg_endo -69.66 87.5 0.54 Allowed 'Trans proline' 0 N--CA 1.481 0.766 0 CA-C-N 119.549 0.874 . . . . 10.0 110.327 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.577 ' CD ' HG22 ' A' ' 46' ' ' ILE . 2.8 mp0 -54.11 -164.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.666 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -80.41 -71.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.421 -1.424 . . . . 10.0 109.923 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -149.32 -175.2 4.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.375 -1.33 . . . . 10.0 112.2 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.943 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.35 138.3 4.97 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 119.223 -0.991 . . . . 10.0 112.846 -178.503 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 50.3 Cg_endo -81.01 153.83 19.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 108.243 -1.484 . . . . 10.0 108.243 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -129.64 151.23 50.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.399 -1.438 . . . . 10.0 111.689 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 42' ' ' VAL . 19.4 m-20 -108.06 170.26 8.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.667 -0.864 . . . . 10.0 108.667 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.11 148.46 48.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.674 -1.266 . . . . 10.0 111.37 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.727 ' OE1' ' HB3' ' A' ' 41' ' ' ALA . 3.8 tm-20 -148.0 -179.93 7.27 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -136.98 -175.3 3.99 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 117.267 -1.773 . . . . 10.0 113.511 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 39' ' ' ASN . 15.1 t -121.62 -169.7 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.863 0.84 . . . . 10.0 112.41 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.906 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.3 OUTLIER -122.28 -168.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.739 -0.6 . . . . 10.0 109.691 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 17.2 p80 -100.24 155.66 17.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.656 -1.277 . . . . 10.0 113.41 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 1.002 HG22 ' N ' ' A' ' 37' ' ' PHE 0.255 40.7 t -109.91 155.45 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.22 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.21 54.34 0.59 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.99 -1.644 . . . . 10.0 108.99 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 177.19 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.263 . . . . 10.0 109.874 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 25' ' ' VAL . 74.4 m-20 -71.42 152.77 42.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.532 -0.73 . . . . 10.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.625 ' CB ' HG11 ' A' ' 33' ' ' VAL . . . 50.06 38.01 15.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.597 -0.689 . . . . 10.0 111.431 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' B' ' 22' ' ' PHE . 54.8 t -111.0 -22.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.829 -1.175 . . . . 10.0 107.829 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.6 t -88.18 -26.56 22.34 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.466 0.651 . . . . 10.0 109.902 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -116.42 39.84 2.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.231 -1.948 . . . . 10.0 108.231 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.587 ' HG3' ' N ' ' A' ' 29' ' ' PRO . 9.9 mp0 -140.03 122.26 15.89 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.883 0.849 . . . . 10.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 8.0 t80 -116.87 128.11 54.93 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 ' CE2' ' A' ' 28' ' ' PHE . 47.1 p -141.13 -44.9 0.38 Allowed 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.649 -0.657 . . . . 10.0 110.45 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.421 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 130.44 76.7 0.16 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.995 -1.242 . . . . 10.0 109.995 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.6 HD11 ' HG2' ' B' ' 35' ' ' GLN . 26.5 pt -110.05 160.89 26.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.282 -1.128 . . . . 10.0 109.318 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.572 ' O ' ' C ' ' B' ' 34' ' ' GLU . 47.9 Cg_endo -73.85 175.16 11.16 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.706 1.371 . . . . 10.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.572 ' C ' ' O ' ' B' ' 33' ' ' PRO . 2.3 tm-20 -1.0 114.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 121.203 0.525 . . . . 10.0 112.373 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.6 ' HG2' HD11 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -97.45 -71.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.041 -1.037 . . . . 10.0 111.89 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.05 -12.5 19.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.122 0.963 . . . . 10.0 111.247 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -90.81 60.64 4.51 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.566 ' HG3' ' CB ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -81.75 43.37 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 10.0 108.9 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 71' ' ' SER . 2.3 mp -49.62 -44.65 47.48 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.995 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.17 18.03 10.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 10.0 110.687 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.566 ' CB ' ' HG3' ' B' ' 38' ' ' ARG . 17.1 mm-40 -123.94 39.65 3.91 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.774 -0.579 . . . . 10.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.616 HG23 ' CG ' ' A' ' 65' ' ' ASP . 21.9 m -99.15 165.44 11.71 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.92 -1.113 . . . . 10.0 110.855 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.412 ' O ' ' C ' ' B' ' 44' ' ' ASN . 52.7 m -62.64 -7.15 4.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 10.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' B' ' 43' ' ' SER . 0.2 OUTLIER 43.09 59.09 3.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.081 -1.012 . . . . 10.0 110.168 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.0 -40.71 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.907 . . . . 10.0 110.665 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 117.932 -1.032 . . . . 10.0 110.514 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.091 0.472 . . . . 10.0 110.225 . . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.58 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.4 mt-30 -130.92 -3.48 4.04 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.104 -0.997 . . . . 10.0 109.9 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.583 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 23.7 m -68.39 106.18 2.42 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 10.0 110.878 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.041 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -109.22 123.75 65.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.057 -1.057 . . . . 10.0 109.397 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.4 mmmt -107.71 130.75 54.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 55' ' ' LEU . 60.8 m -109.87 116.62 31.98 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.124 -1.03 . . . . 10.0 110.056 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.574 HG21 ' OG1' ' A' ' 75' ' ' THR . 25.5 t -126.79 166.19 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.688 . . . . 10.0 109.986 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -101.52 125.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 10.0 110.257 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 10' ' ' GLY . 12.0 t -132.73 -171.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 10.0 109.534 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.74 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 109.26 171.48 20.71 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.411 -1.476 . . . . 10.0 109.411 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 82' ' ' PHE . 1.4 m-20 -45.32 -37.17 4.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 10.0 109.684 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' B' ' 35' ' ' GLN . . . 150.25 143.28 3.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 33' ' ' PRO . . . -157.32 -130.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -1.125 . . . . 10.0 110.205 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.578 HG21 ' H ' ' B' ' 30' ' ' THR . 60.5 t -119.78 -44.51 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.957 -1.089 . . . . 10.0 110.974 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -176.65 -177.69 45.82 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.899 -1.28 . . . . 10.0 109.899 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.744 ' HB2' HG22 ' A' ' 8' ' ' VAL . 6.0 ttpm? -97.79 -50.49 4.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.18 . . . . 10.0 110.386 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.8 p -72.15 -18.31 61.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 10.0 110.026 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' B' ' 28' ' ' GLU . 28.3 p -63.92 -17.2 63.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 10.0 110.79 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' CA ' ' HZ2' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -93.09 -38.59 11.53 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.001 -1.062 . . . . 10.0 110.759 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 50.4 tp -55.19 -38.34 68.24 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.673 -1.211 . . . . 10.0 108.541 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.674 ' HA ' ' HB ' ' A' ' 24' ' ' THR 0.273 6.3 tp -80.98 -30.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.697 0.76 . . . . 10.0 110.039 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 38.4 m -46.93 -54.54 9.83 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.793 -1.163 . . . . 10.0 108.724 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.694 ' CG ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.62 3.75 51.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.481 -1.688 . . . . 10.0 111.035 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 24' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 25' ' ' THR . 19.2 m -77.1 -52.54 9.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.481 -1.288 . . . . 10.0 107.821 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 24' ' ' THR . 0.6 OUTLIER -179.59 -71.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.695 -1.202 . . . . 10.0 113.745 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.763 ' H ' HG23 ' A' ' 25' ' ' THR . 26.1 m-20 -85.78 48.59 1.62 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.806 -1.184 . . . . 10.0 112.076 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' HG23 ' B' ' 26' ' ' THR . 3.2 pttt -44.92 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.222 1.01 . . . . 10.0 111.872 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 39.3 t80 -90.08 19.92 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 114.819 1.414 . . . . 10.0 114.819 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.641 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 55.4 Cg_endo -80.77 -118.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.038 0 N-CA-C 109.563 -0.976 . . . . 10.0 109.563 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.462 ' OG ' ' C ' ' A' ' 29' ' ' PRO . 1.2 m -167.81 68.91 0.08 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.151 -1.593 . . . . 10.0 111.033 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 26' ' ' ASN . 2.9 pt-20 -141.87 -171.04 3.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.884 -1.135 . . . . 10.0 110.033 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 33' ' ' VAL . 6.0 t80 -70.2 121.75 18.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.592 0.71 . . . . 10.0 112.004 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.816 HG12 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.19 -168.28 0.19 Allowed Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.476 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.816 ' CD ' HG12 ' A' ' 33' ' ' VAL . 41.6 Cg_endo -72.05 -178.52 3.25 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 122.611 0.795 . . . . 10.0 111.046 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 22.5 p -129.85 162.46 28.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 10.0 111.921 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' CA ' ' A' ' 60' ' ' GLY . 71.6 t -58.66 -90.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 10.0 110.213 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.611 ' N ' HG12 ' B' ' 20' ' ' VAL . 1.7 t80 -47.26 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 10.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' ' CE2' ' A' ' 40' ' ' TYR . 9.4 t0 -141.02 84.2 1.92 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.408 -0.807 . . . . 10.0 109.666 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.823 ' CB ' HD11 ' B' ' 18' ' ' ILE . 9.6 t-20 -79.32 99.26 7.03 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.786 -1.196 . . . . 10.0 109.928 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' B' ' 16' ' ' HIS . 21.1 m-85 -91.93 121.16 33.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.416 -0.802 . . . . 10.0 109.832 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -145.83 96.72 2.85 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.52 -0.872 . . . . 10.0 111.293 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 43' ' ' THR . 82.4 t -162.64 -165.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.816 ' H ' HG12 ' A' ' 42' ' ' VAL . 40.1 m -126.43 165.67 18.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.588 -1.945 . . . . 10.0 112.139 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -123.59 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.565 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 0.5 OUTLIER -101.18 107.31 18.68 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.981 -1.074 . . . . 10.0 109.998 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' B' ' 10' ' ' LEU . 3.7 mp -121.7 130.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 10.0 110.376 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 50.87 25.01 8.88 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.0 13.76 71.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 10.0 109.561 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -116.18 123.52 30.76 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.344 -1.092 . . . . 10.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.08 141.45 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.52 . . . . 10.0 110.709 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 m-30 -109.97 116.32 31.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.317 -0.864 . . . . 10.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 58.1 m -85.35 106.91 17.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 10.0 109.923 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 4.3 mt -121.58 153.38 38.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 10.0 111.063 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.51 99.4 0.16 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 6' ' ' CYS . 3.3 pp -138.07 167.75 21.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -1.221 . . . . 10.0 110.644 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.541 ' N ' HD12 ' A' ' 55' ' ' LEU . 27.1 p90 -169.11 130.03 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.834 . . . . 10.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 11.0 t0 -82.05 160.95 23.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.92 -1.112 . . . . 10.0 109.045 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.713 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 8.9 m -128.52 159.79 34.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.744 -1.222 . . . . 10.0 111.481 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 75.04 28.79 1.02 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.973 0.892 . . . . 10.0 109.143 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.684 ' CA ' HG11 ' A' ' 36' ' ' VAL . . . -80.88 -75.08 1.1 Allowed Glycine 0 C--N 1.297 -1.588 0 N-CA-C 106.972 -2.451 . . . . 10.0 106.972 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HA ' ' N ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER -89.14 20.5 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -1.082 . . . . 10.0 110.098 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' O ' ' CZ ' ' A' ' 64' ' ' TYR . 60.3 mm-40 -104.22 -48.91 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 10.0 110.421 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 31.8 t0 66.12 47.9 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 10.0 109.448 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER 157.16 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.423 0.63 . . . . 10.0 109.553 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 2.3 p30 36.92 53.54 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 10.0 111.763 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -52.93 -29.13 26.83 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.623 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.5 mp -82.32 10.9 6.12 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.251 0.548 . . . . 10.0 109.755 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.782 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -63.07 -18.06 0.44 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -84.04 80.42 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 CA-C-N 120.043 1.051 . . . . 10.0 110.206 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -90.73 -28.36 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.75 . . . . 10.0 110.366 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 30.7 t 42.75 25.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 10.0 110.615 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 16.2 m-85 -120.22 93.06 47.83 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.018 -1.051 . . . . 10.0 110.488 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.89 73.35 6.06 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 10.0 111.168 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -114.74 65.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 10.0 109.924 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.626 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 48.1 m -143.84 96.18 2.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.569 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.4 t70 -33.32 -31.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 120.83 0.348 . . . . 10.0 111.417 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.979 HG11 ' HB2' ' A' ' 176' ' ' ALA . 3.1 m -122.69 123.5 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.205 -0.934 . . . . 10.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.652 ' CD1' HG21 ' A' ' 9' ' ' VAL . 21.3 m-85 -109.56 143.15 39.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.3 -0.875 . . . . 10.0 109.89 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 168' ' ' VAL . 1.1 mm? -108.35 97.99 7.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.108 . . . . 10.0 110.414 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.586 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 2.1 m -105.45 131.55 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 10.0 108.658 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 113' ' ' VAL . 41.3 t -136.98 124.45 22.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.795 -1.19 . . . . 10.0 110.963 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 8.1 p90 -149.55 179.63 7.83 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.458 -0.897 . . . . 10.0 111.35 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 m -75.21 163.14 27.83 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.244 -0.91 . . . . 10.0 111.148 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.637 ' O ' HG22 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -127.83 9.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 10.0 112.5 -178.091 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -80.49 -72.56 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.127 -1.608 . . . . 10.0 107.751 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 85' ' ' VAL . 60.8 m -76.8 135.26 67.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.665 -1.272 . . . . 10.0 108.496 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 42.1 Cg_endo -72.37 -23.92 20.03 Favored 'Trans proline' 0 C--N 1.297 -2.139 0 O-C-N 123.662 1.348 . . . . 10.0 110.144 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 89' ' ' SER . 66.7 m 41.26 38.96 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 88' ' ' SER . 15.3 m 64.13 40.36 6.99 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.377 0.608 . . . . 10.0 110.243 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' ' HE2' ' A' ' 94' ' ' LYS . 7.1 t80 -48.59 -26.34 2.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 10.0 108.761 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.5 tt0 -56.85 -27.43 60.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 10.0 109.072 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.12 -22.07 61.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.88 0.848 . . . . 10.0 109.396 179.169 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.833 HG13 ' CZ2' ' A' ' 97' ' ' TRP . 6.8 t -82.85 -8.43 11.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.261 -0.899 . . . . 10.0 109.356 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HE2' ' CE2' ' A' ' 90' ' ' PHE . 4.0 mmtp -86.63 -32.44 20.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 8.0 pt-20 -84.08 3.13 36.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.846 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -103.37 -50.29 3.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.964 -1.094 . . . . 10.0 111.843 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.833 ' CZ2' HG13 ' A' ' 93' ' ' VAL . 5.6 m0 -86.52 -49.06 7.84 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.98 -1.075 . . . . 10.0 112.022 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.564 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 18.2 t -54.21 -50.39 84.89 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.861 -1.149 . . . . 10.0 111.575 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 43.2 Cg_endo -70.54 -15.92 34.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.089 1.047 . . . . 10.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -54.2 -30.25 49.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 10.0 109.119 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 104' ' ' HIS . 4.6 mt 60.24 114.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.493 -0.883 . . . . 10.0 110.223 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -49.83 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 109.632 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.656 ' H ' HG23 ' A' ' 102' ' ' THR . 6.0 p-80 -109.49 6.97 24.58 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.367 -0.833 . . . . 10.0 109.546 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.79 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.1 OUTLIER 169.59 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 10.0 109.575 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.901 ' O ' HG22 ' A' ' 102' ' ' THR . 75.8 m -119.66 155.71 54.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.51 -0.744 . . . . 10.0 110.205 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 55.2 Cg_endo -76.6 73.41 5.22 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.149 1.605 . . . . 10.0 111.64 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 18.5 ttpt -126.9 -2.02 6.56 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.698 -1.251 . . . . 10.0 109.826 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 102' ' ' THR . 96.3 m -46.22 129.24 7.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.118 -0.989 . . . . 10.0 109.721 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 47.0 Cg_endo -71.75 149.22 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.81 1.426 . . . . 10.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 97' ' ' TRP . 43.6 m-85 -132.99 119.58 20.27 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.081 -1.048 . . . . 10.0 111.772 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.889 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.5 mm? -88.79 93.38 9.56 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.235 -1.395 . . . . 10.0 107.235 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 2.2 mt -70.99 147.2 48.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.469 -0.769 . . . . 10.0 109.617 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 168' ' ' VAL . 1.8 t -146.51 178.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.952 . . . . 10.0 111.32 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -126.3 116.35 2.53 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.814 -1.715 . . . . 10.0 108.814 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.832 HG22 ' HG3' ' A' ' 116' ' ' GLN . 64.4 m -81.79 123.72 29.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.067 -1.254 . . . . 10.0 109.723 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.6 mt-30 47.1 69.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -93.83 -45.41 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.969 -0.692 . . . . 10.0 111.41 -177.592 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 35.8 t70 -51.43 56.16 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 121.921 0.867 . . . . 10.0 112.86 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 2.5 tp 152.95 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' ILE . 17.6 tpp180 -58.66 -17.72 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' CG2' ' A' ' 84' ' ' VAL . 14.6 m-20 -111.54 19.51 18.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.84 -0.537 . . . . 10.0 110.548 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.847 ' OD1' HG22 ' A' ' 125' ' ' THR . 21.2 p-10 -80.63 145.41 58.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.025 -1.047 . . . . 10.0 108.994 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.57 24.19 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.382 1.727 . . . . 10.0 112.469 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -110.23 -48.13 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.56 -1.337 . . . . 10.0 110.288 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.847 HG22 ' OD1' ' A' ' 122' ' ' ASP . 9.3 t -86.49 -24.68 25.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.09 -1.818 . . . . 10.0 106.09 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 120' ' ' ARG 0.278 1.1 mp -62.68 -21.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 176.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -47.84 -46.68 31.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.625 0.726 . . . . 10.0 109.636 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 -41.33 12.5 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.509 -0.744 . . . . 10.0 111.192 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 125' ' ' THR . 4.6 mt -57.09 -41.58 79.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 10.0 110.999 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.994 -1.067 . . . . 10.0 109.214 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -71.2 -8.51 54.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 10.0 110.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.547 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 57.9 t-20 -65.82 -33.62 76.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 10.0 110.496 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.616 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mptt -117.67 -68.03 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 143.53 -17.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 123.377 0.671 . . . . 10.0 110.023 177.793 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -136.48 94.9 13.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.978 -1.077 . . . . 10.0 110.844 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.8 Cg_endo -71.05 161.5 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.028 1.541 . . . . 10.0 110.657 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' VAL . 7.1 tp -102.76 134.97 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 10.0 109.232 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.7 p -120.2 172.23 4.84 Favored Pre-proline 0 C--N 1.295 -1.777 0 O-C-N 121.238 -0.914 . . . . 10.0 109.062 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.65 -17.41 52.69 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.276 1.146 . . . . 10.0 109.703 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 mt-10 -79.7 -42.78 23.95 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.81 . . . . 10.0 109.945 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 m -73.9 -43.5 58.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.359 -0.838 . . . . 10.0 109.889 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -57.75 -50.38 73.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 10.0 110.752 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 3.0 pp20? -65.92 -30.41 70.99 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.209 -0.997 . . . . 10.0 108.966 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -71.22 -35.82 71.64 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -60.73 -45.8 92.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.036 -1.098 . . . . 10.0 108.036 178.155 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.911 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.66 -50.17 74.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.887 0.851 . . . . 10.0 109.114 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 147' ' ' ARG . 4.7 ttm180 -65.55 -17.75 64.81 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.48 0.657 . . . . 10.0 109.729 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -67.92 -18.74 64.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.824 . . . . 10.0 110.97 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -152.03 38.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.9 -1.125 . . . . 10.0 111.326 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 8.9 mttp 62.08 53.43 2.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.005 0.907 . . . . 10.0 112.105 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.911 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -105.36 173.15 6.43 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.895 -0.779 . . . . 10.0 108.895 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.862 HG21 HD11 ' A' ' 111' ' ' LEU . 2.9 t -71.23 -87.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.005 -1.06 . . . . 10.0 110.821 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.832 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.12 168.75 4.05 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.088 -1.007 . . . . 10.0 111.006 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.636 ' OH ' HG11 ' A' ' 84' ' ' VAL . 77.6 t80 -81.04 119.0 22.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 10.0 110.581 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.758 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.7 OUTLIER -118.83 -169.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.141 -0.974 . . . . 10.0 110.463 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 86.7 mt-10 -146.36 138.54 25.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.661 -1.274 . . . . 10.0 111.874 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 30.1 t -141.2 130.56 23.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.131 0.967 . . . . 10.0 111.373 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 162' ' ' GLN . 18.9 m -148.35 81.15 1.47 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.997 0.903 . . . . 10.0 109.387 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.652 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . . . -52.98 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.995 . . . . 10.0 111.062 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 161' ' ' THR 0.262 0.4 OUTLIER -48.05 -50.7 27.1 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.961 -1.087 . . . . 10.0 110.288 -179.825 . . . . . . . . 4 4 . 1 . 014 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.896 ' N ' HD13 ' A' ' 160' ' ' LEU . 1.1 m -76.8 -70.52 0.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.227 0.825 . . . . 10.0 113.227 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.656 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 2.7 mm-40 -123.85 -91.16 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.0 -1.688 . . . . 10.0 112.238 -178.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.771 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 1.3 mmtt 124.36 -154.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.788 1.235 . . . . 10.0 108.531 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.615 ' N ' HD13 ' A' ' 165' ' ' LEU . . . 96.11 14.06 46.89 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.535 -2.626 . . . . 10.0 106.535 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.908 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -84.34 5.23 27.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.964 -0.618 . . . . 10.0 111.478 -178.832 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.526 ' N ' HD22 ' A' ' 165' ' ' LEU . 13.8 mttt -50.47 -27.57 6.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 10.0 108.613 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' HB3' HG11 ' A' ' 155' ' ' VAL . 25.9 t-20 -65.12 -43.95 90.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.526 -0.734 . . . . 10.0 109.813 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.831 HG12 ' CD1' ' A' ' 79' ' ' LEU . 93.9 t -50.54 -29.39 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 10.0 109.165 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 14.8 m-85 -96.78 -22.14 17.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.74 -0.6 . . . . 10.0 109.958 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.1 t0 -67.54 -51.29 52.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 10.0 111.067 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.407 ' HA ' HD23 ' A' ' 174' ' ' LEU . 4.8 mt-10 -72.34 -40.5 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 10.0 111.097 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.889 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.8 -31.77 59.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.988 -1.07 . . . . 10.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.667 ' O ' HD11 ' A' ' 177' ' ' LEU . 30.1 mt -58.48 -44.16 88.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.995 -1.065 . . . . 10.0 109.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -76.69 -48.59 18.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 10.0 112.182 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.3 -10.27 22.93 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.354 -0.841 . . . . 10.0 110.865 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.041 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -79.0 -41.41 29.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 10.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.667 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -77.3 -19.91 55.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.402 -0.811 . . . . 10.0 109.164 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 117.982 -1.009 . . . . 10.0 110.341 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.495 -1.442 . . . . 10.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -106.19 138.01 43.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -1.145 . . . . 10.0 110.567 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.44 102.56 9.32 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.42 -0.8 . . . . 10.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -101.56 140.39 35.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.687 -0.633 . . . . 10.0 110.926 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.634 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -98.77 -49.02 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 10.0 110.213 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 51.9 Cg_endo -83.62 -18.15 5.83 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.086 -1.159 . . . . 10.0 109.086 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.761 ' OE2' HD23 ' B' ' 10' ' ' LEU . 0.5 OUTLIER 32.93 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.521 0.677 . . . . 10.0 111.71 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -141.96 -61.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.071 -1.018 . . . . 10.0 110.117 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 t -134.44 132.09 38.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 10.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.761 HD23 ' OE2' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -132.33 99.62 15.9 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.546 -0.721 . . . . 10.0 111.176 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 41.6 Cg_endo -72.54 117.06 4.95 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.604 1.318 . . . . 10.0 108.761 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -47.82 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 10.0 111.202 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -151.96 -166.66 2.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.857 -0.527 . . . . 10.0 109.717 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.745 ' C ' HG11 ' A' ' 42' ' ' VAL . 24.0 m-85 -109.49 -170.05 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.99 1.108 . . . . 10.0 113.99 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.652 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -160.85 -169.69 2.48 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 53.8 t60 -136.07 146.93 47.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.022 -1.049 . . . . 10.0 110.837 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.644 ' C ' HD13 ' B' ' 18' ' ' ILE . 2.8 t -150.27 143.33 24.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.173 -1.579 . . . . 10.0 112.203 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.823 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -110.99 -167.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 68.3 t60 -107.38 153.4 22.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.775 -1.203 . . . . 10.0 112.275 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.66 HG11 ' N ' ' A' ' 36' ' ' VAL . 1.6 m -124.98 153.1 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.729 0.776 . . . . 10.0 111.405 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 60' ' ' GLY . . . -134.62 98.43 0.31 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.32 -1.912 . . . . 10.0 108.32 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.725 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.1 t80 -179.34 117.46 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.014 -1.286 . . . . 10.0 109.314 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 22' ' ' PHE . 16.0 t0 -38.95 156.3 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.643 0.735 . . . . 10.0 111.133 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.01 46.73 10.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.667 -0.646 . . . . 10.0 110.512 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 22' ' ' PHE . 64.9 t -78.54 -17.59 13.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 27' ' ' LYS 0.256 5.7 t -50.06 -29.87 9.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.874 -1.057 . . . . 10.0 111.747 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -134.99 4.44 4.23 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.16 -1.976 . . . . 10.0 108.16 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 0.5 OUTLIER 54.08 19.99 2.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.416 -1.05 . . . . 10.0 110.664 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.709 ' C ' HG22 ' B' ' 30' ' ' THR . 4.2 t80 -113.15 133.08 55.21 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.762 -0.586 . . . . 10.0 109.973 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.709 HG22 ' C ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER 161.97 135.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.238 0.542 . . . . 10.0 110.95 179.524 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 -179.61 50.98 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.051 -1.219 . . . . 10.0 110.051 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 1.1 pp -143.17 36.1 0.21 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.26 -1.141 . . . . 10.0 112.055 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 46.2 Cg_endo -73.2 171.64 17.19 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.172 1.091 . . . . 10.0 109.437 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' PRO . 41.8 tp10 -48.96 167.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.699 -1.25 . . . . 10.0 108.788 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.606 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 2.1 mp0 -82.13 20.08 1.08 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.39 -0.819 . . . . 10.0 110.853 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.679 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.5 m95 87.84 49.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 36' ' ' TRP . . . 168.56 99.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.455 -0.942 . . . . 10.0 108.455 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HD2' ' HD3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -88.16 44.14 1.18 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.294 -1.743 . . . . 10.0 106.294 177.863 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.825 ' HG ' HD23 ' B' ' 40' ' ' LEU . 0.9 OUTLIER -55.39 -21.11 14.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.726 -177.747 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.825 HD23 ' HG ' ' B' ' 39' ' ' LEU . 0.7 OUTLIER -121.2 10.32 10.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.805 -1.184 . . . . 10.0 111.177 -179.33 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.35 -81.75 0.48 Allowed 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.638 -0.664 . . . . 10.0 109.401 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.487 ' O ' ' N ' ' B' ' 44' ' ' ASN . 83.8 m -128.4 122.04 30.47 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -67.72 50.78 0.06 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.162 -0.961 . . . . 10.0 110.371 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' B' ' 42' ' ' THR . 56.3 t-20 -64.81 130.25 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 10.0 109.965 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -114.54 161.61 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.043 . . . . 10.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.297 -1.692 0 CA-C-O 117.896 -1.05 . . . . 10.0 110.111 178.76 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 2.5 ttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.478 0.656 . . . . 10.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.563 ' O ' HG22 ' A' ' 4' ' ' ILE . 7.6 mm-40 -149.51 -83.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.734 ' N ' HG21 ' A' ' 52' ' ' THR . 4.3 m -38.87 91.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.584 -0.697 . . . . 10.0 110.171 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.823 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 1.6 tt -135.59 138.76 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.088 -1.008 . . . . 10.0 110.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.615 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.35 122.84 28.64 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.132 0.968 . . . . 10.0 111.313 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.739 ' HA ' HG13 ' A' ' 77' ' ' VAL . 40.4 t -71.34 126.1 28.73 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.746 0.784 . . . . 10.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 8' ' ' VAL . 4.3 t -140.43 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.667 . . . . 10.0 109.212 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.716 ' H ' HG12 ' A' ' 7' ' ' VAL . 71.5 t -93.87 143.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.05 -1.031 . . . . 10.0 109.82 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -132.74 -166.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.505 -0.747 . . . . 10.0 110.397 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.698 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 89.49 -158.92 27.95 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.567 -1.413 . . . . 10.0 109.567 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.59 -10.19 57.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.986 -1.302 . . . . 10.0 109.4 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.525 ' HA2' ' HG3' ' B' ' 35' ' ' GLN . . . 112.07 89.68 1.87 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . -166.15 50.03 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.211 -1.17 . . . . 10.0 110.265 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.618 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER 68.32 157.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.058 -1.026 . . . . 10.0 109.411 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.685 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -122.87 -153.32 8.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.756 -1.738 . . . . 10.0 108.756 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 1.016 ' HA ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.01 0.36 21.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.523 -0.986 . . . . 10.0 110.873 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 -50.63 18.23 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.315 -0.866 . . . . 10.0 111.493 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' SG ' HD22 ' A' ' 19' ' ' LEU . 31.9 p -61.88 -17.89 58.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.778 -1.201 . . . . 10.0 109.443 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.21 -28.15 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.371 -0.831 . . . . 10.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -49.57 -41.39 41.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.604 -1.31 . . . . 10.0 109.331 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.724 ' HB ' ' HA2' ' B' ' 27' ' ' GLY . 1.2 mm -84.59 -39.97 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.369 1.08 . . . . 10.0 109.09 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 19' ' ' LEU . 16.1 t -46.73 -49.21 19.95 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.359 -0.837 . . . . 10.0 110.546 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.939 ' CZ ' HD12 ' A' ' 165' ' ' LEU . 29.8 m-85 -79.94 -14.28 58.72 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.002 -1.061 . . . . 10.0 110.316 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 m -100.04 -31.63 11.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 10.0 112.849 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.419 ' OG1' HG23 ' A' ' 21' ' ' ILE . 82.8 p -110.74 -90.2 0.48 Allowed 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.051 -1.656 . . . . 10.0 112.118 -177.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.586 ' C ' ' HG3' ' A' ' 27' ' ' LYS . 47.7 t-20 -159.85 20.96 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.51 -0.744 . . . . 10.0 111.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.602 ' O ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER 26.86 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.431 0.901 . . . . 10.0 113.431 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CD2' HG22 ' B' ' 30' ' ' THR . 1.0 OUTLIER -53.24 95.24 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.951 -0.468 . . . . 10.0 110.244 -178.066 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' CD ' ' O ' ' A' ' 27' ' ' LYS . 55.4 Cg_endo -103.92 -160.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.695 1.596 . . . . 10.0 110.179 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -112.65 33.04 5.21 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -142.36 -171.29 3.37 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.935 0.874 . . . . 10.0 109.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.25 73.7 0.94 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.336 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 1.4 m -60.91 -168.44 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.274 -1.01 . . . . 10.0 108.274 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.66 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 36.8 Cg_endo -66.06 158.19 55.66 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-O 122.044 0.768 . . . . 10.0 112.11 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.956 HG23 ' HB2' ' A' ' 37' ' ' PHE . 5.1 t -89.39 165.3 14.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.644 0.735 . . . . 10.0 112.18 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 58' ' ' THR . 1.6 t -54.42 -14.18 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.559 -0.713 . . . . 10.0 111.058 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 1.121 ' CD1' HG22 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -35.69 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.511 -0.743 . . . . 10.0 109.989 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.613 ' C ' ' HA ' ' B' ' 18' ' ' ILE . 68.5 m-20 -137.79 131.96 31.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.913 2.19 . . . . 10.0 116.913 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.805 ' HB3' HD13 ' B' ' 18' ' ' ILE 0.26 35.1 p-10 -104.9 107.37 18.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.007 -0.997 . . . . 10.0 111.101 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 39' ' ' ASN . 23.8 m-85 -155.21 108.84 2.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 119.368 -2.082 . . . . 10.0 113.101 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -171.65 99.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.423 -1.325 . . . . 10.0 107.423 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -156.11 -168.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.899 -1.125 . . . . 10.0 111.436 -177.558 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.942 HG23 ' C ' ' A' ' 51' ' ' TYR . 27.0 m -151.68 115.55 4.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.648 -0.821 . . . . 10.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -79.76 152.05 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.556 . . . . 10.0 110.047 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.6 ' O ' ' O ' ' B' ' 10' ' ' LEU . 33.6 mtm -127.43 92.89 3.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.339 -1.344 . . . . 10.0 108.125 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 38.3 mt -95.6 141.13 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 120.909 0.385 . . . . 10.0 110.249 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.792 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 40.97 26.96 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 86.24 33.33 14.64 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.161 -1.199 . . . . 10.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' CG ' ' B' ' 4' ' ' GLU . 52.7 mm-40 -127.46 102.52 23.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.085 -1.244 . . . . 10.0 110.723 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 48.0 Cg_endo -74.92 124.2 8.48 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.874 1.46 . . . . 10.0 110.303 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.942 ' C ' HG23 ' A' ' 43' ' ' THR . 6.3 m-30 -99.83 110.99 23.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.683 -1.261 . . . . 10.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.734 HG21 ' N ' ' A' ' 3' ' ' THR . 1.4 m -71.69 117.04 12.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.636 -0.665 . . . . 10.0 110.546 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' HG ' ' C ' ' A' ' 52' ' ' THR . 5.2 mt -137.71 160.72 38.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.884 -1.135 . . . . 10.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 5' ' ' LYS . . . -170.92 110.87 0.38 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.959 -1.256 . . . . 10.0 109.959 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 ' CB ' ' A' ' 40' ' ' TYR . 2.2 pp -138.57 152.53 48.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.97 -1.312 . . . . 10.0 111.924 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 20.6 p90 -160.27 140.65 11.67 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.307 -0.86 . . . . 10.0 108.766 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.676 ' HB2' HG13 ' A' ' 36' ' ' VAL . 1.7 m-20 -92.8 154.37 18.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.804 -1.185 . . . . 10.0 111.468 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 36' ' ' VAL . 1.6 t -60.55 133.77 56.42 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 10.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HA ' ' CA ' ' B' ' 21' ' ' GLY . . . -87.12 79.1 8.74 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.677 -0.64 . . . . 10.0 111.439 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.572 ' N ' ' HA2' ' B' ' 21' ' ' GLY . . . -42.94 -50.07 6.14 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.559 -2.617 . . . . 10.0 106.559 177.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 3.5 mm-40 -62.99 -44.18 96.73 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 4.5 mt-10 65.41 84.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.121 0.962 . . . . 10.0 111.366 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.709 ' OD2' HG11 ' B' ' 20' ' ' VAL . 21.5 m-20 -95.52 -8.86 34.01 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.811 0.815 . . . . 10.0 108.858 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.4 p90 -139.65 10.32 2.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.664 -0.865 . . . . 10.0 108.664 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.1 p-10 -30.62 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.26 0.552 . . . . 10.0 112.101 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -48.46 -26.88 2.33 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.829 -1.169 . . . . 10.0 109.451 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 mp -97.02 6.68 48.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.432 -0.792 . . . . 10.0 110.273 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 1.048 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -72.69 -24.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.103 -0.998 . . . . 10.0 112.891 -179.362 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 38.0 Cg_endo -70.91 71.42 2.1 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 109.275 -1.086 . . . . 10.0 109.275 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 1.048 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -69.93 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.793 -0.567 . . . . 10.0 111.519 -178.984 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.815 ' HA ' HD22 ' B' ' 39' ' ' LEU . 0.5 OUTLIER 54.67 35.21 23.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.805 -1.185 . . . . 10.0 108.482 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 4.9 m-85 -118.1 -53.48 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.629 -0.669 . . . . 10.0 111.222 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.615 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 55.7 Cg_endo -85.92 76.8 2.7 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 122.978 0.988 . . . . 10.0 111.296 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.16 0.32 52.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.904 -1.122 . . . . 10.0 110.443 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 75' ' ' THR . 2.7 m -140.1 84.21 1.96 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.287 -0.883 . . . . 10.0 110.048 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 4' ' ' ILE . 1.9 m-20 -140.52 -97.62 0.15 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.704 -0.622 . . . . 10.0 109.424 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.739 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -140.78 118.53 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 10.0 108.743 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 21.4 m-85 -114.85 125.51 53.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.018 . . . . 10.0 111.443 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.603 HD22 HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -111.47 99.76 8.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 178.647 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 112' ' ' LEU . 1.7 p -82.64 133.79 28.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.618 -0.676 . . . . 10.0 110.457 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.452 ' C ' ' OG1' ' A' ' 115' ' ' THR . 11.3 t -124.27 101.21 7.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.176 -0.953 . . . . 10.0 109.161 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.8 p90 -133.53 162.24 32.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.662 -1.215 . . . . 10.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB3' HG22 ' A' ' 85' ' ' VAL . 63.6 m -75.76 158.64 31.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.648 -0.658 . . . . 10.0 110.328 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 -11.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.472 -0.767 . . . . 10.0 109.403 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 129' ' ' LEU . 33.9 m -68.62 -1.93 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.776 . . . . 10.0 109.701 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.2 m -128.08 82.86 67.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.201 -0.937 . . . . 10.0 109.871 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 44.2 Cg_endo -63.81 -19.26 66.71 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.35 1.711 . . . . 10.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.507 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 67.9 m -89.04 22.36 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 10.0 109.122 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 46.9 t -124.75 -56.23 1.59 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.779 -0.576 . . . . 10.0 109.881 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.531 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.4 p90 -53.38 -39.95 64.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.631 -1.293 . . . . 10.0 109.469 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 17.8 pt-20 -67.55 -26.5 66.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.555 -0.715 . . . . 10.0 109.55 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.661 ' OD1' HG23 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -77.13 -14.3 59.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.224 -0.922 . . . . 10.0 108.667 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.661 HG23 ' OD1' ' A' ' 92' ' ' ASN . 32.9 t -88.5 -16.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.787 0.803 . . . . 10.0 109.601 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 145' ' ' LEU . 1.1 mmtt -86.22 -33.48 20.73 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 5.4 pt-20 -77.02 -9.04 58.44 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.163 -0.615 . . . . 10.0 109.421 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -90.3 -52.4 4.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.844 -1.16 . . . . 10.0 111.976 -178.453 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -93.09 -31.83 14.68 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.563 -1.336 . . . . 10.0 112.487 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 95.0 t -54.32 -46.75 98.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.572 -1.33 . . . . 10.0 110.863 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.4 Cg_endo -73.9 -23.41 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.323 1.17 . . . . 10.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 29.1 mm-40 -63.46 -16.36 60.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 10.0 110.772 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 104' ' ' HIS . 9.6 mm 56.62 104.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.141 -0.975 . . . . 10.0 110.058 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.565 ' HB ' ' CG ' ' A' ' 106' ' ' PRO . 5.9 m -44.08 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 4.8 t-160 -112.89 -15.43 12.9 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.524 -0.735 . . . . 10.0 110.23 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.603 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER 165.91 -49.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.875 -1.528 . . . . 10.0 106.875 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.585 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 19.5 t 179.26 58.92 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 CA-C-N 115.206 -0.906 . . . . 10.0 108.924 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.632 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 52.2 Cg_endo -89.62 -62.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.002 1.527 . . . . 10.0 110.191 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 108.2 51.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 124.972 1.309 . . . . 10.0 110.905 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.487 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 31.2 m -45.88 144.29 2.88 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.892 -1.13 . . . . 10.0 109.319 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 43.7 Cg_endo -69.6 144.49 55.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.763 1.402 . . . . 10.0 110.776 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.448 ' C ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -133.66 113.02 11.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.399 -0.813 . . . . 10.0 111.641 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 152' ' ' VAL . 2.6 mm? -83.09 97.41 8.77 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 177.934 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -77.02 145.68 37.84 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.413 -0.804 . . . . 10.0 110.447 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.0 t -152.97 176.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.147 -0.97 . . . . 10.0 111.83 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -112.32 159.82 13.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.42 -1.872 . . . . 10.0 108.42 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.696 HG22 ' HG2' ' A' ' 116' ' ' GLN . 81.8 m -127.03 150.75 49.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.675 -1.485 . . . . 10.0 111.457 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.696 ' HG2' HG22 ' A' ' 115' ' ' THR . 4.2 pt20 33.6 57.35 0.54 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.376 0.607 . . . . 10.0 110.97 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.964 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -80.13 -25.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 10.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.862 ' HB2' HG21 ' A' ' 161' ' ' THR . 15.7 t0 -52.48 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.566 1.174 . . . . 10.0 110.708 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.741 ' N ' ' O ' ' A' ' 117' ' ' ILE . 4.6 tp 167.42 -30.24 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.035 -1.439 . . . . 10.0 107.634 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 ttp180 -46.5 -38.56 9.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -55.07 -25.53 31.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 10.0 109.503 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 119' ' ' LEU . 6.8 m-20 -92.63 150.6 40.03 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 10.0 111.526 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.525 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 56.2 Cg_endo -80.79 17.15 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.578 1.831 . . . . 10.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.9 p -96.68 -50.75 4.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.984 -1.072 . . . . 10.0 110.188 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.469 ' O ' ' CD ' ' A' ' 128' ' ' LYS . 15.3 t -71.74 -28.11 63.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.832 -2.284 . . . . 10.0 104.832 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.304 0.4 OUTLIER -49.67 -27.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 176.794 . . . . . . . . 4 4 . 1 . 015 nuclear build full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -50.12 -32.07 14.99 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.495 0.664 . . . . 10.0 109.998 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 125' ' ' THR . 0.3 OUTLIER -65.64 -32.19 73.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.334 -0.854 . . . . 10.0 110.391 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -54.71 -38.69 67.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.109 -0.994 . . . . 10.0 109.373 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.443 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -54.15 -51.28 64.78 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.551 -0.86 . . . . 10.0 109.512 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -71.74 -13.28 61.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.014 . . . . 10.0 108.398 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 17.1 m120 -126.93 46.39 2.51 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.771 -0.581 . . . . 10.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 68.08 135.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 10.0 110.322 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.443 ' OE1' ' HA ' ' A' ' 130' ' ' ALA . 1.2 mp0 -80.74 3.71 21.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 10.0 110.686 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 27.2 mmtp -101.53 99.49 11.59 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 10.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.66 161.74 44.74 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.862 1.454 . . . . 10.0 112.155 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 137' ' ' ILE . 2.2 tp -84.71 143.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 10.0 109.011 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 43.6 p -134.4 171.26 9.34 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 10.0 110.312 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.1 Cg_endo -65.98 -30.55 47.99 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.556 1.293 . . . . 10.0 110.473 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -67.54 -38.13 83.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 10.0 109.01 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 m -88.79 -38.96 14.24 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.518 0.675 . . . . 10.0 109.484 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -69.05 -36.17 77.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.692 -0.63 . . . . 10.0 110.343 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 5.2 tt0 -65.31 -37.56 87.49 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.351 -0.843 . . . . 10.0 109.403 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 42.3 tttp -66.79 -36.04 81.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 10.0 108.806 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 94' ' ' LYS . 2.9 tp -62.56 -48.97 77.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -63.47 -49.35 73.95 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.564 -0.854 . . . . 10.0 109.435 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -27.1 68.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.281 0.562 . . . . 10.0 109.567 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 149' ' ' LEU . 1.9 m-20 -74.68 -47.45 31.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 10.0 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 3.2 mp -88.73 12.07 15.92 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.892 0.853 . . . . 10.0 109.445 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 19.2 mtmt 59.69 33.11 21.81 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.816 0.817 . . . . 10.0 110.216 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.493 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -61.58 -152.85 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.145 -0.622 . . . . 10.0 110.117 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -117.97 -51.52 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.035 -1.041 . . . . 10.0 111.471 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -172.52 143.62 1.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.613 -1.235 . . . . 10.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 53.8 p90 -90.32 121.64 32.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 10.0 109.623 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -127.14 -169.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 10.0 110.771 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -145.69 148.21 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 10.0 110.033 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.57 ' SG ' HG11 ' A' ' 113' ' ' VAL . 27.6 p -156.52 154.11 29.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.326 -0.859 . . . . 10.0 109.171 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.928 ' HB3' HG23 ' A' ' 161' ' ' THR . 1.3 t -149.61 88.47 1.56 Allowed 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.066 -1.054 . . . . 10.0 109.933 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.744 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -42.84 -79.86 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.519 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -31.3 -39.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.216 1.008 . . . . 10.0 109.351 -178.742 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.928 HG23 ' HB3' ' A' ' 158' ' ' SER . 0.0 OUTLIER -111.2 -97.91 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.021 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 158.75 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.833 . . . . 10.0 109.754 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 157' ' ' CYS . 21.8 tptt -105.47 43.59 1.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.851 -1.155 . . . . 10.0 110.221 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.44 40.84 87.17 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.741 -1.344 . . . . 10.0 109.741 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.939 HD12 ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -61.71 -12.27 15.77 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.237 -1.155 . . . . 10.0 110.785 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.581 ' N ' HD13 ' A' ' 165' ' ' LEU . 2.5 mttp -53.24 -29.67 33.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.889 -1.132 . . . . 10.0 109.834 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -70.86 -29.79 66.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 10.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 155' ' ' VAL . 2.3 t -66.86 -19.37 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 10.0 110.035 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 25.4 t80 -96.55 -45.3 6.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.212 -0.93 . . . . 10.0 112.094 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.22 -49.14 61.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.985 -1.072 . . . . 10.0 110.82 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.78 -39.73 76.46 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.087 -1.008 . . . . 10.0 110.137 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -54.85 -27.24 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.765 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 34.8 mm -67.14 -45.93 85.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.959 -1.088 . . . . 10.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.831 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -80.49 -27.63 37.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.945 -1.097 . . . . 10.0 109.954 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -85.43 -1.66 57.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.763 . . . . 10.0 109.418 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -83.11 -42.43 17.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.329 -0.857 . . . . 10.0 110.497 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -87.73 -19.12 28.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.494 -0.754 . . . . 10.0 109.826 -178.555 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 175' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 120.858 -1.151 . . . . 10.0 109.998 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.661 -1.376 . . . . 10.0 109.661 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.3 m -119.55 157.59 28.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -1.159 . . . . 10.0 110.748 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.08 100.66 13.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.376 -0.828 . . . . 10.0 110.022 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 49' ' ' GLU . 53.4 mm-40 -81.28 157.99 24.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.876 . . . . 10.0 110.669 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.708 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -118.09 -52.32 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.481 -0.762 . . . . 10.0 110.129 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.7 Cg_endo -89.59 21.37 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.26 1.137 . . . . 10.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 46' ' ' ILE . 4.0 pt-20 -55.39 168.44 0.37 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.956 . . . . 10.0 110.353 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.837 HG23 ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -80.27 -148.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 10.0 108.649 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.837 ' N ' HG23 ' B' ' 8' ' ' ILE . 66.6 m -121.55 98.6 6.04 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.262 -0.899 . . . . 10.0 108.864 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.793 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -132.8 98.06 16.51 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.334 -0.854 . . . . 10.0 111.093 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.513 ' HA ' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_endo -90.31 111.39 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.704 1.371 . . . . 10.0 110.25 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 43' ' ' THR . 14.0 m -142.27 102.81 4.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 10.0 111.151 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.557 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 7.5 p-10 -170.84 132.09 0.87 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.486 -0.759 . . . . 10.0 110.488 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.49 100.02 2.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 10.0 112.389 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 42' ' ' VAL . 27.2 tt0 -173.01 123.65 0.42 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.592 -0.693 . . . . 10.0 109.217 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.615 ' C ' ' HB2' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -163.72 151.13 12.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.538 -1.352 . . . . 10.0 111.639 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.573 ' N ' ' HB2' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -136.48 104.3 5.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.083 -1.011 . . . . 10.0 110.584 179.163 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 1.121 HG22 ' CD1' ' A' ' 37' ' ' PHE . 31.7 mm -50.84 106.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.998 -1.064 . . . . 10.0 112.769 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.706 ' C ' ' HA ' ' A' ' 37' ' ' PHE . 55.4 m170 -102.75 116.45 32.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.019 . . . . 10.0 111.096 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.743 ' HA ' ' N ' ' A' ' 37' ' ' PHE . 3.1 p -87.55 149.09 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.219 -0.926 . . . . 10.0 113.461 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' A' ' 59' ' ' ALA . . . -143.47 -65.65 0.02 OUTLIER Glycine 0 CA--C 1.538 1.491 0 C-N-CA 119.791 -1.195 . . . . 10.0 112.137 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.798 ' HB3' HG21 ' B' ' 25' ' ' VAL . 5.6 t80 -177.32 126.94 0.15 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 120.674 -1.486 . . . . 10.0 109.227 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 33' ' ' VAL . 9.4 m-20 -38.47 148.27 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.853 0.835 . . . . 10.0 111.471 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' OE2' ' B' ' 28' ' ' GLU . . . 52.87 31.35 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.37 0.507 . . . . 10.0 112.37 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.798 HG21 ' HB3' ' B' ' 22' ' ' PHE . 9.8 t -109.63 -31.56 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 5.4 t -94.21 -0.61 55.04 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.593 0.711 . . . . 10.0 109.145 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.724 ' HA2' ' HB ' ' A' ' 21' ' ' ILE . . . -114.28 2.9 23.78 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.738 -1.22 . . . . 10.0 110.159 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.64 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 1.7 pm0 -178.12 -158.69 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.982 -1.305 . . . . 10.0 110.602 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.59 ' HB2' HG11 ' A' ' 14' ' ' VAL . 1.2 t80 -131.39 135.29 47.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.72 0.772 . . . . 10.0 109.508 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.664 HG22 ' CD2' ' A' ' 28' ' ' PHE . 15.0 p -151.01 -64.32 0.19 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.461 -0.774 . . . . 10.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.528 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -70.86 171.13 45.62 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.116 -1.193 . . . . 10.0 110.116 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 15.8 mm -125.72 47.79 2.45 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.904 . . . . 10.0 110.198 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 45.7 Cg_endo -71.01 171.97 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.977 1.514 . . . . 10.0 110.385 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' B' ' 35' ' ' GLN . 1.8 tp10 -50.57 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 10.0 109.73 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -81.62 19.11 1.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.195 -0.94 . . . . 10.0 109.45 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.65 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 37.1 m0 71.1 39.38 0.98 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -172.34 74.06 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 113.386 -1.734 . . . . 10.0 106.887 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' B' ' 41' ' ' GLN . 6.7 mtm180 -72.82 55.17 0.38 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.238 -1.393 . . . . 10.0 107.238 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 71' ' ' SER . 11.9 mt -51.42 -36.44 43.71 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.49 -1.232 . . . . 10.0 111.749 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.406 ' O ' HD12 ' B' ' 40' ' ' LEU . 1.5 pp -123.35 12.49 9.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.605 -1.309 . . . . 10.0 111.846 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' B' ' 41' ' ' GLN . 1.8 mm100 -91.82 -34.19 14.66 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.235 -0.916 . . . . 10.0 110.433 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.784 ' O ' HG23 ' B' ' 42' ' ' THR . 3.7 t -135.49 51.64 2.06 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.33 1.062 . . . . 10.0 108.254 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.7 m -136.89 -34.93 0.72 Allowed 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -125.46 153.72 43.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.995 -0.682 . . . . 10.0 110.366 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -50.03 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 10.0 110.482 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.047 -0.977 . . . . 10.0 110.159 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.178 0.513 . . . . 10.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.631 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.9 OUTLIER -164.72 25.36 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.163 -0.961 . . . . 10.0 109.453 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.571 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 30.2 m -89.47 127.01 35.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.581 -0.699 . . . . 10.0 110.303 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.39 136.2 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.281 -0.968 . . . . 10.0 110.266 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.6 mtpt -124.53 98.95 5.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 10.0 109.595 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.37 99.83 9.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.895 -1.128 . . . . 10.0 110.764 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 75' ' ' THR . 61.7 t -134.29 144.48 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 10.0 109.442 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.779 HG11 ' HB3' ' B' ' 35' ' ' GLN . 94.4 t -59.67 166.04 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 10.0 110.925 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.937 ' C ' ' HB3' ' B' ' 37' ' ' ALA . 3.4 t -112.39 -174.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.426 -0.797 . . . . 10.0 109.348 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.711 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -63.39 -144.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.014 -1.089 . . . . 10.0 110.417 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.632 ' OD2' HG23 ' A' ' 80' ' ' VAL . 5.9 m-20 62.24 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.416 -1.049 . . . . 10.0 109.951 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 112.14 54.16 0.49 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.029 -1.228 . . . . 10.0 110.029 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -175.94 68.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -1.22 . . . . 10.0 110.559 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 14' ' ' VAL . 10.9 p -179.1 58.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 10.0 109.715 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -103.95 88.28 0.61 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.832 -1.307 . . . . 10.0 109.832 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.647 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.13 -31.56 63.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.795 -1.415 . . . . 10.0 110.7 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HB ' ' OD2' ' A' ' 57' ' ' ASP . 11.3 m -62.47 -41.32 98.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 10.0 111.481 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 26' ' ' THR . 17.8 m -95.07 -15.47 23.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.748 -1.22 . . . . 10.0 110.449 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.903 HD11 ' CB ' ' B' ' 29' ' ' PHE . 4.6 mm? -93.02 -34.79 13.57 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.145 -0.972 . . . . 10.0 109.808 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.58 -37.18 77.82 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.647 -1.983 . . . . 10.0 105.647 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 26' ' ' THR 0.266 0.4 OUTLIER -63.41 -50.19 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.328 -1.36 . . . . 10.0 107.328 176.34 . . . . . . . . 4 4 . 1 . 016 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.713 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 23.8 m -49.05 -49.72 39.99 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.869 ' CD2' HD11 ' A' ' 165' ' ' LEU . 33.9 m-85 -72.96 -29.34 63.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.959 -1.088 . . . . 10.0 110.442 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -65.32 -50.37 65.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 10.0 109.396 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 26' ' ' ASN . 10.2 t -169.6 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.253 -0.979 . . . . 10.0 111.095 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.709 ' CB ' HG11 ' A' ' 33' ' ' VAL . 0.2 OUTLIER -61.15 -20.46 62.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 10.0 111.473 -179.398 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.713 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 26.13 -134.02 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.873 -0.517 . . . . 10.0 111.994 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' B' ' 30' ' ' THR . 6.1 t80 -129.53 45.59 1.82 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.02 -1.05 . . . . 10.0 112.924 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 59.6 Cg_endo -97.11 -119.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.179 0 N-CA-C 108.777 -1.278 . . . . 10.0 108.777 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.87 69.79 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.678 -1.264 . . . . 10.0 109.504 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.966 ' O ' ' HB2' ' B' ' 24' ' ' ALA . 18.0 pt-20 -138.56 -173.73 3.63 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 120.937 -1.102 . . . . 10.0 110.648 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' HG22 ' A' ' 33' ' ' VAL . 12.5 t80 -71.65 135.8 47.04 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.991 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.709 HG11 ' CB ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -157.52 -171.42 0.28 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.241 -0.912 . . . . 10.0 109.119 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.691 ' HG2' HG21 ' B' ' 26' ' ' THR . 40.1 Cg_endo -65.33 -148.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 122.859 0.926 . . . . 10.0 111.699 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.436 ' C ' ' HB ' ' B' ' 26' ' ' THR . 46.7 p -128.0 162.68 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.696 -1.253 . . . . 10.0 113.47 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.998 HG12 ' HB2' ' A' ' 59' ' ' ALA 0.256 6.9 t -70.6 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-N 115.296 -0.865 . . . . 10.0 110.311 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.733 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -33.45 129.42 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.572 0.701 . . . . 10.0 110.957 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 10.0 t70 -138.96 83.45 1.95 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' B' ' 18' ' ' ILE . 7.4 t-20 -88.42 98.45 11.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -0.932 . . . . 10.0 110.511 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.679 ' HA ' ' H ' ' B' ' 16' ' ' HIS . 19.6 m-85 -127.69 116.03 19.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.222 -0.923 . . . . 10.0 109.453 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.948 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -133.69 100.34 4.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.05 -1.031 . . . . 10.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 41' ' ' ALA . 3.1 t -167.33 -166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 51' ' ' TYR . 52.0 m -137.15 161.65 35.56 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 119.452 -2.03 . . . . 10.0 113.636 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.812 HG22 ' HB2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -105.25 -176.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.765 -0.585 . . . . 10.0 110.59 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.607 ' O ' ' O ' ' B' ' 10' ' ' LEU . 27.5 mtp -139.74 96.56 3.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.937 -1.105 . . . . 10.0 108.836 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 11.6 mt -102.43 131.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.783 -0.573 . . . . 10.0 111.146 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 8' ' ' ILE . . . 38.2 27.81 0.04 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.346 -1.102 . . . . 10.0 110.346 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 98.97 -16.85 58.96 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.958 -1.319 . . . . 10.0 110.652 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -101.74 108.59 56.61 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.283 . . . . 10.0 110.153 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 42.8 Cg_endo -73.63 156.58 49.17 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.063 1.559 . . . . 10.0 111.668 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.812 ' HB2' HG22 ' A' ' 44' ' ' VAL . 1.9 m-85 -105.95 113.96 27.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.034 . . . . 10.0 112.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.869 ' O ' HG22 ' A' ' 4' ' ' ILE 0.271 98.2 m -75.82 110.07 9.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 10.0 109.459 178.385 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.7 pp -149.32 173.25 13.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 10.0 112.857 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.54 118.02 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.688 -2.165 . . . . 10.0 107.688 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.6 pp -129.25 149.55 51.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.728 -1.454 . . . . 10.0 111.332 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.514 ' CD2' ' C ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -172.16 129.38 0.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 10.0 110.088 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD2' ' HB ' ' A' ' 17' ' ' THR . 1.3 m-20 -102.62 158.3 16.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.059 -1.026 . . . . 10.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 13.9 t -43.55 147.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.011 . . . . 10.0 109.68 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . 177.57 -72.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.783 . . . . 10.0 112.144 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 45.38 52.62 8.59 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.154 -1.979 . . . . 10.0 108.154 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 20' ' ' VAL . 16.4 mm-40 60.77 40.56 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.679 -0.895 . . . . 10.0 109.869 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.643 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.3 OUTLIER 174.24 -70.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 10.0 111.092 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 169.14 44.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.897 -1.127 . . . . 10.0 110.314 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -148.94 -49.93 0.15 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.84 . . . . 10.0 109.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 69.45 80.86 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.681 0.753 . . . . 10.0 109.825 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 26.6 ttp180 -52.32 -26.81 13.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.642 -0.661 . . . . 10.0 110.371 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -86.03 -0.62 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 10.0 110.276 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.744 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -110.85 13.24 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 -178.455 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -60.99 126.64 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 N-CA-C 108.613 -1.341 . . . . 10.0 108.613 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.2 OUTLIER -113.62 -77.38 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 10.0 111.874 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.606 ' HA ' ' CA ' ' B' ' 40' ' ' LEU . 19.5 m 61.31 34.39 18.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.148 -0.97 . . . . 10.0 108.482 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.09 131.44 6.44 Favored Pre-proline 0 N--CA 1.487 1.399 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.673 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.31 79.85 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.719 1.378 . . . . 10.0 110.03 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -131.06 60.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 10.0 110.242 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 ' HB ' ' A' ' 7' ' ' VAL . 9.9 m -144.47 96.91 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.143 -0.973 . . . . 10.0 109.435 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 108' ' ' THR . 84.8 m-20 -38.52 -27.86 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.947 -0.47 . . . . 10.0 111.198 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.797 HG11 ' HB2' ' A' ' 176' ' ' ALA . 17.7 m -130.38 116.73 37.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.717 -1.239 . . . . 10.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-85 -109.2 130.87 55.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.477 -0.764 . . . . 10.0 108.997 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.906 HD12 ' CE1' ' A' ' 169' ' ' PHE . 2.5 mm? -103.21 96.94 7.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.091 . . . . 10.0 109.08 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.632 HG23 ' OD2' ' A' ' 11' ' ' ASP . 14.8 p -108.8 143.7 18.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.662 -0.649 . . . . 10.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.458 ' C ' ' OG1' ' A' ' 115' ' ' THR . 53.7 t -133.75 129.71 37.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.259 -0.976 . . . . 10.0 110.569 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 24.2 p90 -137.15 178.0 7.43 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.387 -0.82 . . . . 10.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.7 p -76.68 162.54 27.64 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.126 -0.984 . . . . 10.0 111.556 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.963 HG23 HG13 ' A' ' 85' ' ' VAL . 28.4 m -112.96 -1.5 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 121.325 -0.86 . . . . 10.0 111.69 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.963 HG13 HG23 ' A' ' 84' ' ' VAL . 14.5 m -128.88 38.05 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.849 -1.157 . . . . 10.0 111.468 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.556 ' N ' HD23 ' A' ' 129' ' ' LEU . 59.8 m -95.97 149.23 35.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.057 -1.027 . . . . 10.0 108.964 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 41.0 Cg_endo -67.49 113.04 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.632 1.333 . . . . 10.0 110.382 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.5 m 54.5 64.13 1.92 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 10.0 109.987 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 86' ' ' SER . 22.1 p -116.55 -60.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 10.0 110.949 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 9.4 t80 -59.96 -38.87 83.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.011 -1.055 . . . . 10.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.48 -17.63 64.9 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.844 -1.16 . . . . 10.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.589 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -77.62 -21.62 52.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 10.0 110.353 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG13 ' ND2' ' A' ' 92' ' ' ASN . 2.2 m -89.72 -5.09 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.591 -1.243 . . . . 10.0 109.414 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 90' ' ' PHE . 12.9 mmtt -94.49 -32.72 13.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.137 -0.977 . . . . 10.0 108.391 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 3.6 pt-20 -77.64 -10.85 59.74 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.021 -0.672 . . . . 10.0 109.221 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -112.35 -50.53 2.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 10.0 111.852 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.492 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 60.6 m95 -69.39 -47.11 65.21 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.564 -0.71 . . . . 10.0 112.256 -178.008 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 98.9 t -55.93 -49.28 93.92 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.49 -1.381 . . . . 10.0 110.331 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.4 Cg_endo -72.86 -12.92 26.55 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.257 1.135 . . . . 10.0 110.643 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -68.69 -36.68 78.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 10.0 110.601 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 104' ' ' HIS . 78.6 mt 55.11 85.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.206 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.9 m -39.37 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.681 0.753 . . . . 10.0 110.114 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.691 ' N ' HG22 ' A' ' 102' ' ' THR . 6.0 m170 -109.87 -2.98 16.91 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.5 -0.75 . . . . 10.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.706 ' HA ' HG23 ' A' ' 101' ' ' ILE . 66.2 t60 80.37 16.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.622 0.725 . . . . 10.0 109.494 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.603 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.8 OUTLIER -150.76 -65.81 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.808 -0.757 . . . . 10.0 111.44 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 41.6 Cg_endo -68.81 -31.3 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.51 1.268 . . . . 10.0 111.892 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 42.31 63.12 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.367 1.079 . . . . 10.0 108.485 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 76' ' ' ASP . 8.7 t -44.91 141.46 3.03 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.674 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 43.1 Cg_endo -69.99 163.39 38.65 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.286 1.677 . . . . 10.0 112.068 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.5 m-85 -127.13 114.69 18.04 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.698 -0.626 . . . . 10.0 109.701 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.027 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -73.95 92.59 2.12 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 15.8 mt -69.33 139.33 54.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.732 -0.605 . . . . 10.0 109.372 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -144.98 -179.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.965 -1.085 . . . . 10.0 111.41 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -118.49 125.14 6.3 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.681 HG22 ' HG2' ' A' ' 116' ' ' GLN . 52.9 m -92.42 140.83 29.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.971 -1.311 . . . . 10.0 111.36 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 115' ' ' THR . 6.9 mm100 40.14 57.44 2.4 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.196 -0.602 . . . . 10.0 109.754 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.008 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -76.87 -29.21 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.29 -0.964 . . . . 10.0 110.103 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.839 ' O ' HD23 ' A' ' 119' ' ' LEU . 44.2 t0 -51.73 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.459 0.647 . . . . 10.0 111.85 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER 147.33 -30.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 CA-C-N 114.858 -1.064 . . . . 10.0 108.572 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.694 ' HG3' HG22 ' A' ' 85' ' ' VAL . 15.2 tpp180 -55.51 -31.35 61.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.778 -0.577 . . . . 10.0 110.315 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -86.88 4.93 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 10.0 111.044 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.825 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -82.29 165.74 40.86 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 10.0 110.403 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 54.9 Cg_endo -79.2 23.38 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.074 1.565 . . . . 10.0 111.086 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 t -108.45 -50.14 3.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.92 -1.112 . . . . 10.0 110.278 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.66 HG21 ' HA ' ' A' ' 120' ' ' ARG . 14.5 t -79.06 -28.09 43.14 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.779 -1.934 . . . . 10.0 105.779 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 122' ' ' ASP 0.289 1.4 mp -59.82 -22.59 24.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 20.1 tt0 -48.89 -33.66 11.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.49 0.662 . . . . 10.0 109.864 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.36 -49.05 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.661 -0.649 . . . . 10.0 110.775 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.836 HD23 ' C ' ' A' ' 85' ' ' VAL . 1.3 tm? -49.87 -50.48 45.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 10.0 110.963 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -55.82 -49.94 71.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.201 -0.937 . . . . 10.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 17.9 mttt -60.01 -22.49 62.67 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.612 -0.68 . . . . 10.0 110.027 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' CB ' ' HB3' ' A' ' 87' ' ' PRO . 23.0 t-20 -99.68 -62.46 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.934 -1.104 . . . . 10.0 111.337 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -109.69 -0.36 18.59 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.365 -0.835 . . . . 10.0 111.494 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 130' ' ' ALA . 1.0 OUTLIER 64.13 -44.52 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.707 . . . . 10.0 112.334 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.531 ' HD2' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -113.99 128.71 25.49 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 120.94 -1.1 . . . . 10.0 111.087 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.1 161.65 44.07 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.877 1.462 . . . . 10.0 110.527 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 84' ' ' VAL . 4.1 tp -95.36 133.19 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.921 -1.112 . . . . 10.0 109.506 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.6 p -123.8 179.17 1.12 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 10.0 109.399 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 44.2 Cg_endo -73.52 -26.64 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.228 1.12 . . . . 10.0 110.421 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -66.87 -47.9 70.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 10.0 110.413 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.1 m -74.65 -39.75 61.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.504 -0.747 . . . . 10.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.51 -35.67 77.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 10.0 110.663 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -51.41 -39.74 57.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.351 -0.843 . . . . 10.0 109.955 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -49.21 78.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.333 -0.854 . . . . 10.0 110.422 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.532 ' CD2' HD22 ' A' ' 149' ' ' LEU . 7.7 tt -58.61 -33.17 69.71 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.013 -1.055 . . . . 10.0 109.644 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.836 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -71.32 -48.18 52.03 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.889 0.852 . . . . 10.0 109.471 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -63.46 -26.92 68.95 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.303 -0.559 . . . . 10.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB3' HD13 ' A' ' 149' ' ' LEU . 20.4 t0 -79.61 -40.25 29.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 10.0 110.659 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.3 mp -91.47 20.83 4.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 10.0 109.125 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' HD2' ' A' ' 107' ' ' LYS . 4.8 mtpt 57.03 20.6 5.57 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.935 0.874 . . . . 10.0 109.41 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -69.36 -174.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.027 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.2 p -91.59 -72.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.826 -1.172 . . . . 10.0 111.578 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.915 ' H ' HG13 ' A' ' 152' ' ' VAL . 5.4 tttt -173.86 173.46 3.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.217 -1.552 . . . . 10.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.934 ' OH ' HG12 ' A' ' 84' ' ' VAL . 18.6 t80 -112.26 104.44 12.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 10.0 109.448 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.835 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -109.17 -168.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 10.0 110.405 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 155' ' ' VAL . 67.3 mt-10 -152.51 135.57 15.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.784 -1.198 . . . . 10.0 111.164 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.505 ' SG ' HG11 ' A' ' 113' ' ' VAL . 28.1 p -152.4 172.74 16.03 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.722 0.773 . . . . 10.0 109.563 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.584 ' HB3' ' CB ' ' A' ' 162' ' ' GLN . 34.0 t -140.9 175.17 9.83 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -73.22 -54.62 7.98 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.409 -0.807 . . . . 10.0 111.97 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 1.131 HD13 ' N ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -129.23 -22.54 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.736 -1.227 . . . . 10.0 113.39 -178.017 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 161' ' ' THR . . . . . 1.131 ' N ' HD13 ' A' ' 160' ' ' LEU . 10.0 t -90.47 -51.87 5.19 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.312 -1.492 . . . . 10.0 113.637 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.602 ' N ' HG23 ' A' ' 161' ' ' THR . 6.7 tp60 -59.76 -63.21 1.38 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.308 -1.495 . . . . 10.0 111.696 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 28.4 ttpt 79.47 34.67 0.18 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.513 0.673 . . . . 10.0 109.383 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -118.19 20.64 10.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.886 -1.686 . . . . 10.0 108.886 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.869 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -78.04 4.96 10.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -1.091 . . . . 10.0 110.652 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -93.78 -44.15 8.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.037 -1.039 . . . . 10.0 110.085 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.44 -31.44 72.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 10.0 110.142 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.835 HG22 ' HB ' ' A' ' 155' ' ' VAL . 14.5 t -65.09 -49.23 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.27 -0.894 . . . . 10.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE1' HD12 ' A' ' 79' ' ' LEU . 9.0 m-85 -76.82 -23.65 52.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.389 -0.82 . . . . 10.0 111.302 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.37 -50.3 60.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.896 -1.127 . . . . 10.0 111.766 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 153' ' ' LYS . 20.0 pt-20 -61.23 -24.59 66.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 10.0 109.825 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.654 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -67.53 -26.54 66.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.244 -0.982 . . . . 10.0 109.045 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.538 ' O ' HD11 ' A' ' 177' ' ' LEU . 34.2 mm -60.18 -45.54 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 10.0 110.179 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.855 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -74.36 -38.14 63.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 10.0 109.642 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -78.56 -6.59 55.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.489 -0.757 . . . . 10.0 109.712 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.797 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.76 -38.15 47.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 10.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.631 ' HB3' ' HA ' ' A' ' 2' ' ' GLN . 0.4 OUTLIER -76.51 -34.79 58.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 10.0 110.286 -178.676 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.893 -1.051 . . . . 10.0 110.159 179.884 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 108.977 -1.649 . . . . 10.0 108.977 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.506 ' O ' ' N ' ' B' ' 4' ' ' GLU . 13.8 m -111.3 44.9 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -1.112 . . . . 10.0 111.211 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 10.0 109.305 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' B' ' 6' ' ' PRO . 2.2 mm-40 -92.16 144.48 25.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.856 -1.152 . . . . 10.0 110.116 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.32 -41.74 14.36 Favored Pre-proline 0 C--N 1.292 -1.909 0 O-C-N 121.724 -0.61 . . . . 10.0 110.645 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 43.3 Cg_endo -89.39 57.78 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.746 1.393 . . . . 10.0 112.418 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.451 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -97.78 160.72 14.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.69 -1.256 . . . . 10.0 108.327 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.53 ' CG1' ' HA2' ' A' ' 47' ' ' GLY . 5.8 pt -80.39 -117.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.879 -1.138 . . . . 10.0 109.376 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -147.58 104.05 3.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.69 -1.256 . . . . 10.0 109.628 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 45' ' ' MET . 14.2 tp -143.65 97.13 5.52 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 118.957 -1.097 . . . . 10.0 112.092 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -101.37 98.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.166 1.911 . . . . 10.0 108.685 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.4 m -148.5 99.59 3.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.248 -1.532 . . . . 10.0 112.895 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.768 ' HB3' ' CA ' ' A' ' 44' ' ' VAL . 5.0 p-10 -143.17 153.44 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.984 0.897 . . . . 10.0 112.153 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.742 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 53.6 m-85 -110.37 -172.25 2.0 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.694 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -174.88 -170.5 0.47 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 10.0 110.562 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.679 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -104.52 168.98 8.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.784 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 6.7 t -151.5 146.22 25.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.583 -1.323 . . . . 10.0 111.805 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 37' ' ' PHE . 1.6 pp -149.18 179.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.358 -0.979 . . . . 10.0 108.358 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -134.5 159.27 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 10.0 112.496 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 36' ' ' VAL . 54.2 t -104.74 153.34 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.564 0.697 . . . . 10.0 112.394 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.5 63.95 0.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.661 -1.776 . . . . 10.0 108.661 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.83 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -170.57 100.74 0.25 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.452 -1.028 . . . . 10.0 109.371 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 25' ' ' VAL . 11.9 t70 -53.09 150.07 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.822 0.82 . . . . 10.0 111.968 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 31' ' ' GLU . . . 39.21 51.31 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.865 -0.522 . . . . 10.0 112.254 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.904 HG12 ' CG2' ' A' ' 36' ' ' VAL . 38.9 t -111.77 -25.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.784 -1.198 . . . . 10.0 108.487 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.691 HG21 ' HG2' ' A' ' 34' ' ' PRO . 11.3 t -70.64 -20.66 62.71 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.29 53.45 0.74 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 106.902 -2.479 . . . . 10.0 106.902 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.25 58.02 1.69 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.681 -0.893 . . . . 10.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 19' ' ' LEU . 20.4 t80 -85.78 133.17 34.0 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-O 122.059 0.933 . . . . 10.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 19.2 p -146.9 -178.83 6.4 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.08 81.13 0.04 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.59 -1.804 . . . . 10.0 108.59 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.7 HG23 ' HD2' ' B' ' 33' ' ' PRO . 90.2 mt -111.67 145.5 32.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.366 -1.079 . . . . 10.0 111.474 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.0 Cg_endo -69.91 178.59 4.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.933 1.755 . . . . 10.0 110.462 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' B' ' 38' ' ' ARG . 34.3 tt0 -8.0 131.07 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.518 0.932 . . . . 10.0 113.518 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.779 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -83.4 -70.52 0.56 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.641 0.734 . . . . 10.0 109.862 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.694 ' O ' HD12 ' B' ' 39' ' ' LEU . 0.2 OUTLIER -172.99 24.64 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.912 -0.715 . . . . 10.0 111.58 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.937 ' HB3' ' C ' ' A' ' 9' ' ' VAL . . . -127.36 -28.62 2.79 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.495 -0.753 . . . . 10.0 109.552 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.532 ' HB3' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -56.88 -14.8 3.8 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 177.621 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.694 HD12 ' O ' ' B' ' 36' ' ' TRP . 23.7 mt -40.03 -25.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.897 -0.502 . . . . 10.0 110.982 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.606 ' CA ' ' HA ' ' A' ' 71' ' ' SER . 2.2 pp -93.1 11.76 26.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.014 . . . . 10.0 111.295 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 38' ' ' ARG . 3.0 mt-30 -137.71 -92.05 0.22 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.568 -0.707 . . . . 10.0 109.146 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.458 ' OG1' ' NH1' ' B' ' 38' ' ' ARG . 60.9 p -135.82 169.97 16.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.377 -0.827 . . . . 10.0 109.682 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.49 ' HA ' ' OE1' ' B' ' 34' ' ' GLU . 88.2 p -86.57 18.88 3.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -0.977 . . . . 10.0 110.538 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -157.99 166.9 31.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.019 -1.051 . . . . 10.0 110.595 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 45' ' ' ILE . . . . . 0.488 HD12 ' H ' ' B' ' 45' ' ' ILE . 2.9 mp -87.02 -52.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 10.0 109.631 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 10.0 110.524 -179.874 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.11 0.481 . . . . 10.0 109.91 . . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.904 ' O ' HG21 ' A' ' 52' ' ' THR . 0.1 OUTLIER 68.7 79.17 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.891 0.853 . . . . 10.0 109.278 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 3' ' ' THR . 1.2 m -175.95 78.56 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.984 HD13 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -115.24 121.51 67.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.764 -1.21 . . . . 10.0 110.615 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 1.082 ' O ' HG23 ' A' ' 75' ' ' THR . 62.0 mttt -128.93 112.66 14.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 55' ' ' LEU . 26.4 p -94.67 141.29 28.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.058 -1.057 . . . . 10.0 110.444 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 9' ' ' VAL . 57.9 t -144.72 152.26 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.565 -0.709 . . . . 10.0 109.224 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.846 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 35.0 m -65.84 102.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.204 -0.935 . . . . 10.0 111.309 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 78' ' ' PHE . 21.3 t -109.53 177.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.213 -0.93 . . . . 10.0 109.143 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.777 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 151.74 166.99 14.51 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.502 -1.332 . . . . 10.0 110.062 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -47.79 -27.63 2.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.304 -1.116 . . . . 10.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 140.83 43.72 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.699 -1.36 . . . . 10.0 109.699 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.8 -114.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.343 -1.092 . . . . 10.0 109.687 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.825 HG21 ' H ' ' B' ' 30' ' ' THR . 80.0 t -113.89 -92.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.736 -1.227 . . . . 10.0 110.657 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.529 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 170.14 144.65 4.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.927 -1.269 . . . . 10.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.14 -23.17 61.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.977 . . . . 10.0 111.77 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.698 HG21 ' OD2' ' A' ' 57' ' ' ASP . 16.6 m -62.66 -50.27 71.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.938 -1.101 . . . . 10.0 112.03 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.58 ' HB3' ' CB ' ' A' ' 35' ' ' THR . 31.3 p -78.59 8.77 4.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.46 -1.4 . . . . 10.0 110.3 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -88.0 -28.01 21.69 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.553 -1.342 . . . . 10.0 107.622 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -69.65 -34.19 73.65 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.82 HG13 HG23 ' B' ' 26' ' ' THR . 6.7 mm -75.25 -48.18 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' LYS . 26.9 t -54.29 -43.08 70.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.622 ' CG ' ' HB2' ' A' ' 162' ' ' GLN . 74.8 t80 -77.78 -0.94 29.0 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.743 -1.223 . . . . 10.0 109.442 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 22.2 m -112.09 -49.1 2.99 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.85 -84.66 0.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.011 -1.681 . . . . 10.0 114.032 -176.611 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.951 ' HB3' HG11 ' A' ' 33' ' ' VAL . 2.8 m-20 -67.32 -33.49 75.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 10.0 112.033 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER 59.96 -144.71 0.52 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.048 -1.061 . . . . 10.0 110.082 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 2.4 t80 -142.54 57.25 6.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.058 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 51.3 Cg_endo -82.8 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.767 1.404 . . . . 10.0 110.306 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 44.05 3.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.14 -0.975 . . . . 10.0 110.435 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.648 ' HG3' HG12 ' A' ' 33' ' ' VAL . 7.0 pt-20 -155.63 142.44 18.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 10.0 109.214 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -86.08 104.32 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.49 -0.757 . . . . 10.0 110.735 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.951 HG11 ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -129.03 68.58 80.05 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-O 122.42 1.105 . . . . 10.0 108.194 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' B' ' 25' ' ' VAL . 50.5 Cg_endo -76.44 162.93 32.87 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.13 1.887 . . . . 10.0 112.145 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.655 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 3.7 t -57.01 160.48 3.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.288 -0.882 . . . . 10.0 110.29 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 t -148.45 -114.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.836 -1.165 . . . . 10.0 110.554 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.751 ' C ' HG12 ' B' ' 20' ' ' VAL . 4.4 t80 -102.26 105.87 16.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.831 -1.168 . . . . 10.0 111.928 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -128.0 93.08 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.311 -0.868 . . . . 10.0 109.433 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 36.0 t-20 -91.27 98.75 11.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.405 -1.318 . . . . 10.0 110.399 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CB ' HD12 ' A' ' 55' ' ' LEU . 16.5 t80 -107.36 126.92 53.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -153.88 112.88 3.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.807 -1.183 . . . . 10.0 110.454 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 43' ' ' THR . 22.2 t -131.12 172.39 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.779 -0.768 . . . . 10.0 109.724 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.541 ' N ' HG12 ' A' ' 42' ' ' VAL . 63.8 m -135.66 148.97 49.15 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.31 -0.956 . . . . 10.0 110.388 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.635 HG13 HD12 ' A' ' 46' ' ' ILE . 1.1 t -118.88 174.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 3.8 mtt -149.96 120.67 7.54 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.546 -0.862 . . . . 10.0 109.956 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HG13 ' A' ' 44' ' ' VAL . 1.4 mp -134.64 126.75 48.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.305 -0.998 . . . . 10.0 108.305 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 48.08 31.09 8.0 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.271 -1.532 . . . . 10.0 109.271 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.19 31.52 31.18 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.099 -1.236 . . . . 10.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.55 ' OE1' ' NE2' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -119.68 115.77 33.54 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.846 -1.384 . . . . 10.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 52.7 Cg_endo -76.91 141.54 21.44 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.859 1.452 . . . . 10.0 111.193 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.93 ' OH ' HG23 ' A' ' 173' ' ' ILE . 0.5 OUTLIER -103.45 112.56 25.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 10.0 110.305 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 2' ' ' GLN . 27.5 p -78.05 100.28 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 10.0 110.186 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 22.3 mt -117.58 140.32 49.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.666 -1.271 . . . . 10.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.54 130.23 2.28 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.219 -1.552 . . . . 10.0 109.219 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -137.99 132.29 32.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 10.0 108.863 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.974 ' N ' HD22 ' A' ' 55' ' ' LEU . 50.8 p90 -157.26 148.98 22.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 10.0 112.4 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.698 ' OD2' HG21 ' A' ' 17' ' ' THR . 23.7 m-20 -124.05 -169.37 1.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.835 -0.54 . . . . 10.0 110.455 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -45.85 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.25 1.024 . . . . 10.0 112.532 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -157.24 42.17 0.33 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.723 -1.236 . . . . 10.0 109.851 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -47.63 -27.45 4.48 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.422 -2.271 . . . . 10.0 107.422 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.61 ' CG ' ' HA3' ' B' ' 21' ' ' GLY . 2.4 tp60 -73.34 -55.85 5.85 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.855 -0.791 . . . . 10.0 109.259 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.846 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 5.3 mm-40 -59.88 -40.71 89.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.086 -1.046 . . . . 10.0 110.131 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 7.5 t70 75.61 38.85 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.008 0.908 . . . . 10.0 108.588 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -151.96 5.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.943 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.691 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 19.1 t70 -115.17 25.56 10.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.692 -1.255 . . . . 10.0 111.131 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.944 ' O ' HD11 ' A' ' 70' ' ' LEU . 60.3 mtm180 -83.94 -25.44 30.11 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.096 -1.002 . . . . 10.0 109.364 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.986 ' C ' HD21 ' A' ' 70' ' ' LEU . 20.8 mt -111.41 10.34 21.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.558 -0.714 . . . . 10.0 110.35 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.583 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -102.17 -41.91 0.21 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 114.038 1.125 . . . . 10.0 114.038 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 41.4 Cg_endo -69.4 -42.71 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.842 0.917 . . . . 10.0 111.727 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.986 HD21 ' C ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -48.85 -19.84 0.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.21 -0.931 . . . . 10.0 109.695 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 14.2 m -126.83 51.33 1.87 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.538 -0.726 . . . . 10.0 110.059 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.701 ' CE1' HD21 ' B' ' 39' ' ' LEU . 0.0 OUTLIER -109.68 75.66 0.83 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.215 -0.928 . . . . 10.0 111.987 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 52.2 Cg_endo -77.31 -0.88 11.04 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.957 1.503 . . . . 10.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -81.56 49.69 1.36 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.954 -1.091 . . . . 10.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 75' ' ' THR . . . . . 1.082 HG23 ' O ' ' A' ' 5' ' ' LYS . 82.3 m -142.0 84.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.443 -0.785 . . . . 10.0 110.296 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 5.2 m-20 -55.09 -22.63 17.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 10.0 109.979 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 4' ' ' ILE . 2.5 m -118.65 116.75 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 9' ' ' VAL . 87.4 m-85 -107.03 144.47 33.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 10.0 110.137 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.714 HD11 HG12 ' A' ' 168' ' ' VAL . 1.9 mm? -103.46 97.81 7.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.994 . . . . 10.0 108.866 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG23 ' HA2' ' A' ' 10' ' ' GLY . 4.7 p -98.78 130.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.581 -0.699 . . . . 10.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 28.2 p -133.61 115.09 14.25 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.126 -0.984 . . . . 10.0 110.731 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 80' ' ' VAL . 94.6 m-85 -97.21 157.77 15.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.584 -0.697 . . . . 10.0 110.967 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' THR . 57.1 m -85.13 157.06 20.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.427 -0.796 . . . . 10.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 84' ' ' VAL . 30.4 m -60.71 -10.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.403 -0.81 . . . . 10.0 110.769 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 HD22 ' A' ' 129' ' ' LEU . 8.6 m -134.54 -53.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 10.0 110.116 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 44.9 -172.82 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.029 -1.044 . . . . 10.0 111.987 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 53.7 Cg_endo -82.6 41.17 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.194 1.628 . . . . 10.0 111.468 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 133' ' ' LYS . 3.5 m 39.78 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 10.0 110.795 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.422 ' O ' ' OG ' ' A' ' 89' ' ' SER . 3.4 t -175.63 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.839 -1.163 . . . . 10.0 111.649 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.745 ' CE2' HD13 ' A' ' 145' ' ' LEU . 27.2 t80 -90.66 -23.94 20.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.794 -1.191 . . . . 10.0 109.466 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -22.75 28.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.179 -0.951 . . . . 10.0 108.855 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.423 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.5 OUTLIER -83.37 -13.98 53.78 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.258 -0.977 . . . . 10.0 110.151 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' HD3' ' A' ' 94' ' ' LYS . 1.6 m -87.72 -16.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 118.162 -1.415 . . . . 10.0 109.28 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.922 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -81.66 -41.54 21.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 10.0 109.271 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -76.85 -4.62 44.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.993 -0.683 . . . . 10.0 109.172 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -111.72 -47.51 3.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.05 -1.031 . . . . 10.0 111.688 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 8.0 m0 -77.24 -49.09 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 10.0 112.318 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 149' ' ' LEU . 4.6 t -65.67 -46.59 67.46 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.687 -1.258 . . . . 10.0 112.814 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 39.1 Cg_endo -69.09 -12.79 35.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 N-CA-C 109.338 -1.062 . . . . 10.0 109.338 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.629 ' C ' HG22 ' A' ' 101' ' ' ILE . 1.9 mt-10 -89.36 -58.95 2.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 10.0 109.569 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 ' C ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER 161.18 80.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 10.0 108.798 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.857 HG21 ' HB ' ' A' ' 108' ' ' THR . 2.5 m -48.1 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 10.0 109.744 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.708 ' N ' HG22 ' A' ' 102' ' ' THR . 46.0 t-80 -105.38 -22.45 13.03 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' CE1' ' HG ' ' A' ' 105' ' ' CYS . 5.5 p80 178.31 -33.49 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.49 ' HG ' ' CE1' ' A' ' 104' ' ' HIS . 4.8 p -144.66 160.04 48.9 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HB3' HG12 ' A' ' 98' ' ' VAL . 43.8 Cg_endo -72.4 84.56 1.16 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.645 1.339 . . . . 10.0 109.743 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 176.02 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.405 -0.809 . . . . 10.0 111.363 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.857 ' HB ' HG21 ' A' ' 102' ' ' THR . 99.8 m -51.66 150.98 6.35 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 10.0 110.31 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 108' ' ' THR . 37.6 Cg_endo -63.59 110.21 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.865 1.455 . . . . 10.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.13 100.24 8.94 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.27 0.557 . . . . 10.0 109.631 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.927 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 1.6 mm? -78.37 97.92 5.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 146' ' ' ALA . 64.5 mt -78.23 154.48 31.0 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.793 -0.567 . . . . 10.0 109.836 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 114' ' ' GLY . 6.3 t -156.53 175.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.96 -1.087 . . . . 10.0 111.31 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -124.3 96.79 0.53 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 116' ' ' GLN . 1.3 m -95.16 170.97 9.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -1.086 . . . . 10.0 110.947 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.535 ' N ' ' CG2' ' A' ' 115' ' ' THR . 36.6 tp60 57.94 38.12 26.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.48 -0.762 . . . . 10.0 110.831 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.042 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -95.35 -36.67 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 178.239 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.7 p-10 -52.13 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.554 1.169 . . . . 10.0 110.352 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.752 ' N ' ' O ' ' A' ' 117' ' ' ILE . 13.0 tp 159.25 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.187 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -45.72 -42.48 11.84 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 178.711 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' ARG . 3.8 m-20 -45.94 -25.73 0.59 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.433 -0.907 . . . . 10.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.569 ' HB3' HD12 ' A' ' 119' ' ' LEU . 62.7 t0 -94.84 123.17 58.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.668 -0.645 . . . . 10.0 110.759 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.9 Cg_endo -80.76 24.73 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.607 1.538 . . . . 10.0 110.536 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 73.1 m -96.52 -50.46 4.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 10.0 110.366 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.615 ' HB ' HD21 ' A' ' 119' ' ' LEU . 1.6 t -72.8 -33.58 66.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.906 -2.257 . . . . 10.0 104.906 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.667 HD11 ' HD2' ' A' ' 120' ' ' ARG 0.301 0.9 OUTLIER -49.43 -30.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.267 -1.382 . . . . 10.0 107.267 176.573 . . . . . . . . 4 4 . 1 . 017 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -51.65 -43.88 62.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.594 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -75.09 -32.25 61.4 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.538 -0.726 . . . . 10.0 110.054 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.782 HD22 HG23 ' A' ' 85' ' ' VAL . 4.3 mt -77.11 -36.95 55.15 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.272 -0.893 . . . . 10.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.25 -49.42 53.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 10.0 110.267 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -26.51 4.97 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.212 -0.93 . . . . 10.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.637 HD22 ' HA ' ' A' ' 129' ' ' LEU . 19.8 p30 -121.79 7.69 9.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.378 -0.929 . . . . 10.0 111.56 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.93 82.69 2.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.802 -1.186 . . . . 10.0 109.838 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -72.49 -17.95 61.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.847 -1.158 . . . . 10.0 109.424 179.546 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 113.44 4.41 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.484 ' HB3' ' HE3' ' A' ' 133' ' ' LYS . 40.5 Cg_endo -68.89 157.12 63.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.907 1.477 . . . . 10.0 110.529 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -103.27 132.03 50.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.358 -0.839 . . . . 10.0 109.738 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.9 p -122.89 167.72 13.8 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.299 -0.876 . . . . 10.0 110.046 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -66.79 -24.82 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 10.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.43 -35.46 77.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 10.0 109.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.6 m -84.81 -31.28 23.95 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.255 0.55 . . . . 10.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.44 -34.14 65.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 10.0 111.53 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -56.16 -43.5 78.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.927 -1.108 . . . . 10.0 109.369 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -63.9 -41.02 97.8 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.495 -0.882 . . . . 10.0 108.681 179.338 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.919 HD11 ' HG3' ' A' ' 94' ' ' LYS . 3.1 tt -59.87 -50.72 72.68 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.56 -0.712 . . . . 10.0 109.34 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.43 -41.38 80.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.156 -0.965 . . . . 10.0 108.632 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -79.49 -0.15 32.01 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.531 -0.731 . . . . 10.0 109.388 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 15.8 t0 -86.51 -10.53 53.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.582 -0.699 . . . . 10.0 110.476 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.988 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.28 32.11 0.47 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 10.0 111.673 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.3 mttt 62.24 41.2 10.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 10.0 111.649 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -80.31 -163.38 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.739 -0.601 . . . . 10.0 109.538 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.752 HG22 ' CB ' ' A' ' 175' ' ' ALA . 40.3 t -98.04 -79.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.991 . . . . 10.0 109.969 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 6.3 tptp -172.57 165.22 5.57 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.759 -0.776 . . . . 10.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 40.5 p90 -96.33 124.44 40.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.777 . . . . 10.0 109.751 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.884 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -111.86 -169.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.174 -0.954 . . . . 10.0 110.237 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 31.4 mt-10 -130.15 135.18 47.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.147 -0.971 . . . . 10.0 109.789 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.663 ' SG ' HD22 ' A' ' 165' ' ' LEU . 6.5 t -150.9 124.76 9.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.962 -1.086 . . . . 10.0 111.205 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 165' ' ' LEU . 30.0 m -128.39 154.61 45.82 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 177.697 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 19' ' ' LEU . . . -99.65 -45.85 5.63 Favored 'General case' 0 C--N 1.283 -2.301 0 O-C-N 120.469 -1.395 . . . . 10.0 108.305 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 160' ' ' LEU 0.294 2.7 tm? -61.58 -51.29 69.16 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.751 0.786 . . . . 10.0 109.215 177.799 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 28.6 m -102.94 -18.79 14.87 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 113.204 0.816 . . . . 10.0 113.204 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 23' ' ' TYR . 6.3 tt0 61.01 75.31 0.42 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.367 -1.458 . . . . 10.0 109.203 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 4.6 tptt -95.08 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.921 -0.711 . . . . 10.0 111.767 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 119.58 31.56 1.34 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.4 -1.381 . . . . 10.0 110.796 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.99 -43.2 73.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.965 -1.314 . . . . 10.0 110.512 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.22 -35.78 58.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 10.0 110.825 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.625 ' C ' HG11 ' A' ' 155' ' ' VAL . 5.2 m120 -60.83 -32.54 71.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.267 -0.896 . . . . 10.0 111.585 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' A' ' 155' ' ' VAL . 34.6 t -64.41 -46.75 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.83 -1.169 . . . . 10.0 110.492 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 12.8 t80 -70.35 -28.03 64.81 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.493 -0.754 . . . . 10.0 111.753 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 19.3 t70 -57.51 -50.02 74.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.771 -1.206 . . . . 10.0 111.992 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.788 ' OE1' HG22 ' A' ' 155' ' ' VAL . 12.7 pt-20 -68.58 -23.9 64.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.903 -1.123 . . . . 10.0 110.814 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.927 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -70.77 -21.16 62.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.016 -1.052 . . . . 10.0 109.05 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.93 HG23 ' OH ' ' A' ' 51' ' ' TYR . 9.8 mm -67.32 -43.34 88.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 10.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -73.13 -42.35 62.97 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.029 -1.044 . . . . 10.0 111.645 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -82.56 -2.58 54.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.323 -0.861 . . . . 10.0 109.944 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -78.47 -43.13 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.302 -0.874 . . . . 10.0 109.704 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.832 HD21 ' HE1' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -107.05 -23.34 12.35 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.746 0.784 . . . . 10.0 110.307 -178.598 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.988 -1.006 . . . . 10.0 110.354 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 1' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.396 -1.481 . . . . 10.0 109.396 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 1.0 OUTLIER 73.23 137.54 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -1.007 . . . . 10.0 111.173 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -98.33 87.1 3.79 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.174 -0.954 . . . . 10.0 109.374 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 49' ' ' GLU . 41.3 mt-10 -119.38 171.3 8.42 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.747 0.784 . . . . 10.0 110.569 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.57 -161.55 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 178.38 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 40.5 Cg_endo -66.89 80.57 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.305 -1.075 . . . . 10.0 109.305 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.494 ' CB ' ' CG2' ' A' ' 46' ' ' ILE . 10.9 pm0 -45.98 175.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.447 0.641 . . . . 10.0 110.666 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.89 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -135.19 -39.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 10.0 110.621 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.1 t -123.0 151.41 41.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 10.0 110.985 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -167.44 97.83 0.63 Allowed Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 120.716 -1.24 . . . . 10.0 112.801 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 45' ' ' MET . 45.2 Cg_endo -73.91 145.51 36.1 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.668 1.351 . . . . 10.0 109.085 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -97.16 154.91 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.936 -1.103 . . . . 10.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -151.91 136.56 17.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 10.0 109.623 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.56 143.22 50.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 10.0 110.515 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 42.9 tp10 -146.7 147.21 30.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 10.0 109.896 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 19' ' ' HIS . 2.3 t60 -143.17 129.17 19.59 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 10.0 109.93 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -96.06 -167.94 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 10.0 110.468 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.633 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -55.59 179.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 10.0 111.736 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 16' ' ' HIS . 13.2 m80 -122.62 162.65 21.48 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.622 0.725 . . . . 10.0 111.528 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 37' ' ' PHE . 6.4 m -64.49 152.64 8.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.61 ' HA3' ' CG ' ' A' ' 61' ' ' GLN . . . -73.96 151.7 44.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.689 -1.364 . . . . 10.0 109.689 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.062 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 67.61 97.86 0.06 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.415 -1.05 . . . . 10.0 109.326 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 70.8 m-20 -53.76 143.23 21.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 10.0 110.658 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 59.32 31.03 20.84 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.433 -0.792 . . . . 10.0 111.954 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 1.062 HG21 ' CG ' ' B' ' 22' ' ' PHE . 21.4 t -113.7 -17.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.917 -1.114 . . . . 10.0 109.997 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.82 HG23 HG13 ' A' ' 21' ' ' ILE . 10.3 t -83.48 31.73 0.46 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.674 -0.641 . . . . 10.0 110.958 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.789 ' HA3' HG22 ' A' ' 21' ' ' ILE . . . -113.07 -91.64 1.95 Allowed Glycine 0 N--CA 1.488 2.111 0 O-C-N 120.85 -1.156 . . . . 10.0 110.225 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.778 ' HB2' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -1.14 124.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.859 1.314 . . . . 10.0 113.986 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.643 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -120.79 142.79 49.25 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.484 -1.235 . . . . 10.0 109.239 178.383 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 14' ' ' VAL . 68.7 p -152.33 -137.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 10.0 110.314 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.92 45.77 1.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' B' ' 33' ' ' PRO . 50.4 mm -68.29 144.21 96.44 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.256 -1.144 . . . . 10.0 109.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' B' ' 32' ' ' ILE . 41.0 Cg_endo -70.79 141.51 41.21 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.954 1.502 . . . . 10.0 111.699 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 9.6 tp10 53.58 163.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.012 0.911 . . . . 10.0 112.058 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 4.5 mm100 -89.91 19.4 4.86 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.58 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.846 ' CZ3' HG21 ' A' ' 8' ' ' VAL . 3.8 m-90 87.33 26.86 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-O 122.549 1.166 . . . . 10.0 108.071 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.589 ' CA ' ' HA ' ' A' ' 70' ' ' LEU . . . -160.99 85.87 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.138 -1.431 . . . . 10.0 107.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HG2' ' CB ' ' B' ' 41' ' ' GLN . 3.2 ttm180 -82.91 53.25 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.721 1.248 . . . . 10.0 108.537 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.701 HD21 ' CE1' ' A' ' 72' ' ' TYR . 1.1 mp -44.16 -50.09 8.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.483 -1.235 . . . . 10.0 111.369 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' B' ' 39' ' ' LEU . 0.5 OUTLIER -122.97 14.99 9.95 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.449 -0.901 . . . . 10.0 111.78 -178.319 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.494 ' CB ' ' HG2' ' B' ' 38' ' ' ARG . 9.3 mt-30 -115.21 34.51 4.83 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.566 -0.709 . . . . 10.0 110.257 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 33.0 p -77.09 -178.05 4.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.163 -0.961 . . . . 10.0 109.885 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -83.53 26.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 10.0 110.478 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -85.31 115.92 23.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.041 . . . . 10.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -179.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 10.0 111.875 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.149 179.295 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.562 ' HA ' ' CA ' ' A' ' 177' ' ' LEU . 15.2 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.306 0.574 . . . . 10.0 110.6 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -144.23 -86.11 0.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.202 -0.936 . . . . 10.0 109.275 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 3' ' ' THR . 3.5 m -41.26 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.943 -0.473 . . . . 10.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.983 HG22 ' O ' ' A' ' 52' ' ' THR . 1.9 tt -136.01 154.02 33.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 118.231 -1.388 . . . . 10.0 113.321 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.747 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -135.23 109.66 8.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.816 0.817 . . . . 10.0 110.716 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.674 ' C ' HG22 ' A' ' 7' ' ' VAL . 30.1 m -67.98 142.64 55.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.931 -1.106 . . . . 10.0 109.882 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.674 HG22 ' C ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -167.49 -169.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.846 -1.159 . . . . 10.0 111.004 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.0 t -105.47 164.49 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.548 -0.72 . . . . 10.0 110.279 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 1.029 HG11 ' HB ' ' A' ' 80' ' ' VAL . 27.7 m -79.99 -168.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.913 -1.117 . . . . 10.0 111.718 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' B' ' 39' ' ' LEU . . . -148.27 17.17 1.33 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.54 -34.92 78.07 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.073 -1.251 . . . . 10.0 108.995 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 141.25 -151.73 22.79 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.985 -1.246 . . . . 10.0 109.985 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 57.73 160.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -1.094 . . . . 10.0 111.4 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.623 HG22 ' SG ' ' A' ' 18' ' ' CYS . 12.4 p -52.57 152.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.445 -0.784 . . . . 10.0 109.981 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -65.24 161.32 41.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -88.68 -32.34 18.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 10.0 109.316 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.5 p -67.66 -26.15 66.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.506 -0.746 . . . . 10.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG22 ' A' ' 14' ' ' VAL . 24.8 p -75.12 -0.1 18.02 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.821 -1.175 . . . . 10.0 110.073 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.905 HD13 ' CA ' ' A' ' 159' ' ' ALA . 6.3 mt -104.19 -21.46 13.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 10.0 109.866 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.51 -35.81 81.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.745 0.784 . . . . 10.0 110.136 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.72 HG22 ' CA ' ' B' ' 27' ' ' GLY . 1.6 mm -97.87 -45.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.858 0.837 . . . . 10.0 109.404 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.627 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 15.9 t -49.33 -46.92 47.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.386 -0.926 . . . . 10.0 109.757 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -67.68 -45.68 74.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.354 -1.466 . . . . 10.0 110.628 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 5.5 p -58.73 -51.19 71.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.647 -1.283 . . . . 10.0 110.442 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -153.65 -59.93 0.13 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 118.001 -1.48 . . . . 10.0 114.218 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.679 ' HB3' HG21 ' A' ' 33' ' ' VAL . 20.3 m-20 -49.45 -26.07 3.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.846 -1.159 . . . . 10.0 111.562 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.4 OUTLIER 29.54 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 112.753 0.649 . . . . 10.0 112.753 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -126.19 65.36 56.96 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.164 . . . . 10.0 111.216 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.567 ' HD3' ' HG3' ' A' ' 27' ' ' LYS . 58.3 Cg_endo -95.39 -93.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.212 1.275 . . . . 10.0 109.691 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 29' ' ' PRO . 4.4 m -167.49 59.29 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.346 -0.846 . . . . 10.0 110.488 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -149.02 178.75 8.42 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.858 -1.152 . . . . 10.0 108.936 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 16.9 m-85 -121.99 131.94 54.27 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.511 -0.743 . . . . 10.0 110.979 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.915 HG23 ' CG2' ' A' ' 35' ' ' THR . 4.1 m -132.59 168.89 15.61 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.498 -0.751 . . . . 10.0 109.537 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 46.7 Cg_endo -71.92 95.78 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.826 1.435 . . . . 10.0 109.106 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.915 ' CG2' HG23 ' A' ' 33' ' ' VAL . 32.7 p -131.99 163.83 27.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 10.0 111.482 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG13 HG23 ' A' ' 58' ' ' THR . 27.8 t 80.01 3.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.356 0.598 . . . . 10.0 109.572 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 45.4 t80 -41.27 124.6 2.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.811 ' CB ' ' HB ' ' B' ' 18' ' ' ILE . 5.5 m-20 -64.46 -153.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.769 -1.172 . . . . 10.0 111.504 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.798 ' CB ' HD11 ' A' ' 55' ' ' LEU . 2.5 t-20 -154.09 -163.11 1.55 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.137 -0.977 . . . . 10.0 111.79 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' B' ' 16' ' ' HIS . 41.3 p90 -131.97 -174.49 3.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.775 0.798 . . . . 10.0 110.974 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.8 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -156.67 139.02 14.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -164.75 -176.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.145 . . . . 10.0 110.701 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 51' ' ' TYR . 58.6 m -121.5 144.34 48.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.981 -0.688 . . . . 10.0 109.983 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -111.37 164.32 7.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.314 -0.866 . . . . 10.0 108.844 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 0.4 OUTLIER -150.55 103.91 3.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.364 -0.976 . . . . 10.0 108.364 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.892 HG23 ' HB3' ' B' ' 10' ' ' LEU . 4.2 mt -125.02 130.1 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.062 -1.024 . . . . 10.0 110.904 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 40.24 27.17 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 95.85 30.4 7.99 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.701 -1.238 . . . . 10.0 110.097 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.492 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -120.98 94.97 49.04 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 120.898 -1.354 . . . . 10.0 110.447 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.4 Cg_endo -75.57 144.52 28.54 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.094 1.576 . . . . 10.0 111.134 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' THR . 1.7 m-85 -126.66 122.62 35.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.466 -0.771 . . . . 10.0 109.092 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.983 ' O ' HG22 ' A' ' 4' ' ' ILE 0.265 93.5 m -108.43 97.41 7.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 10.0 109.836 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -153.37 174.93 13.7 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.634 -1.626 . . . . 10.0 111.895 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.644 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . -172.55 136.54 3.81 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 108.589 -1.804 . . . . 10.0 108.589 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -131.71 135.27 46.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.895 -1.356 . . . . 10.0 109.659 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 55' ' ' LEU . 62.3 m-85 -133.76 158.95 42.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' THR . 28.7 t0 -124.17 171.17 10.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.887 -1.133 . . . . 10.0 109.787 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.827 HG23 HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.87 -176.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.122 -1.031 . . . . 10.0 110.647 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 62' ' ' GLU . . . -144.56 75.12 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.864 -1.147 . . . . 10.0 110.517 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -15.41 59.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.305 -1.518 . . . . 10.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' N ' ' HA3' ' B' ' 21' ' ' GLY . 26.1 mt-30 -144.53 -16.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.119 -1.224 . . . . 10.0 111.643 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.734 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 1.8 tt0 -62.52 -48.71 78.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.479 -1.388 . . . . 10.0 109.285 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 4.3 t0 -134.21 1.28 3.2 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.706 -0.621 . . . . 10.0 109.559 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 17.4 m-85 66.64 37.65 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 t0 -137.43 72.83 1.42 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.026 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 9.6 ptt180 -85.03 -30.61 24.0 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.623 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD11 ' A' ' 70' ' ' LEU . 20.6 mt -86.86 -25.58 24.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 10.0 111.29 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.696 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 mtm-85 -109.85 12.68 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.729 -1.232 . . . . 10.0 114.242 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.3 Cg_endo -73.59 0.96 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 110.189 -0.735 . . . . 10.0 110.189 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -102.46 -113.94 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.426 -0.796 . . . . 10.0 110.819 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.785 ' N ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER 42.43 44.11 3.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 10.0 110.662 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -160.16 174.37 4.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 10.0 110.753 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.743 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 36.6 Cg_endo -62.11 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.112 1.059 . . . . 10.0 110.862 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.607 ' HG3' ' CD ' ' A' ' 5' ' ' LYS . 15.1 mp0 54.21 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.35 -1.469 . . . . 10.0 108.311 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 75' ' ' THR . 1.3 m -139.58 86.63 2.12 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.358 -0.839 . . . . 10.0 112.404 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.854 ' OD2' HG22 ' A' ' 77' ' ' VAL . 1.6 t70 -110.48 -72.72 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 1.056 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 24.8 m -141.92 112.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.792 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.986 ' HB3' HG12 ' A' ' 9' ' ' VAL . 84.0 m-85 -88.65 127.3 35.57 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.711 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' HA ' ' A' ' 169' ' ' PHE . 4.0 mm? -100.76 97.93 8.51 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.215 -0.928 . . . . 10.0 109.662 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 1.029 ' HB ' HG11 ' A' ' 9' ' ' VAL . 7.5 p -106.65 150.55 9.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.961 -0.695 . . . . 10.0 109.947 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.6 m -133.13 118.86 19.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.924 -1.11 . . . . 10.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.536 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 31.4 p90 -127.03 166.66 17.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.457 -0.777 . . . . 10.0 110.431 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -78.93 158.51 28.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.63 -1.293 . . . . 10.0 111.852 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.506 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 28.4 m -114.39 2.9 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.607 -0.683 . . . . 10.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.853 ' HA ' HD21 ' A' ' 129' ' ' LEU . 19.2 m -105.58 39.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 10.0 109.761 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 73.0 m -114.94 172.13 3.88 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 40.2 Cg_endo -68.71 81.1 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.048 1.026 . . . . 10.0 110.771 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 37.76 39.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.206 0.527 . . . . 10.0 110.844 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.8 m -62.0 -38.26 87.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.047 -1.033 . . . . 10.0 110.81 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 16.3 p90 -48.46 -38.15 19.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 10.0 111.071 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 9.6 tt0 -59.22 -37.93 78.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.345 -0.847 . . . . 10.0 110.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.833 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -68.62 -18.32 64.28 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.223 -0.923 . . . . 10.0 109.771 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.833 HG23 ' ND2' ' A' ' 92' ' ' ASN . 64.6 t -89.62 -7.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 10.0 109.449 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.983 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -93.29 -25.58 17.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 8.3 pt-20 -94.78 2.67 55.52 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.403 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -110.08 -49.03 3.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.989 -1.069 . . . . 10.0 111.79 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.57 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 24.5 m95 -89.9 -33.21 16.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.751 -1.218 . . . . 10.0 111.643 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 96.3 t -71.7 -49.96 10.52 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.658 -1.276 . . . . 10.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -70.57 -10.49 28.02 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.178 1.094 . . . . 10.0 109.764 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 22.4 tt0 -64.06 -48.58 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 10.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 106' ' ' PRO . 20.9 tt -176.43 -29.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.053 -1.029 . . . . 10.0 110.395 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 106' ' ' PRO . 58.3 p -61.76 -11.95 14.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.272 -0.892 . . . . 10.0 109.977 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -55.62 -35.21 65.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.337 -0.852 . . . . 10.0 110.59 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -152.1 10.18 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.965 -1.094 . . . . 10.0 111.937 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' CYS . . . . . 0.67 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 1.7 m -113.12 -81.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.452 -1.405 . . . . 10.0 111.103 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 102' ' ' THR . 55.2 Cg_endo -74.84 -22.99 14.61 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 122.557 0.767 . . . . 10.0 112.029 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 106' ' ' PRO . 6.0 tttt 45.8 42.93 9.38 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.729 -1.232 . . . . 10.0 109.85 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.564 HG23 HG23 ' A' ' 75' ' ' THR . 18.5 m -67.1 139.37 95.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.433 -0.792 . . . . 10.0 110.573 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 48.8 Cg_endo -71.94 125.14 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.091 1.574 . . . . 10.0 110.067 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -100.06 99.79 10.57 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.548 -0.72 . . . . 10.0 110.224 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.7 mm? -75.67 96.89 3.67 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.665 -1.235 . . . . 10.0 107.665 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 154' ' ' TYR . 96.0 mt -80.02 113.44 18.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.643 -0.708 . . . . 10.0 110.114 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 114' ' ' GLY . 1.6 t -120.01 -175.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.087 -1.008 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -147.09 101.56 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 4.8 t -99.73 178.09 4.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.246 . . . . 10.0 110.955 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 115' ' ' THR . 31.2 mt-30 58.88 30.09 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 10.0 109.17 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 0.978 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -80.17 -13.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.951 -0.7 . . . . 10.0 110.581 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.658 ' CB ' HG21 ' A' ' 161' ' ' THR . 5.5 p-10 -51.59 58.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 122.493 1.139 . . . . 10.0 111.544 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER 165.72 -28.54 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.82 -29.54 11.97 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.729 -0.607 . . . . 10.0 109.367 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.28 -26.76 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 10.0 109.709 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' O ' HD13 ' A' ' 126' ' ' ILE . 22.2 m-20 -93.3 123.57 60.22 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.568 -0.708 . . . . 10.0 109.939 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.0 Cg_endo -78.15 24.35 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.89 1.468 . . . . 10.0 111.41 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 15.6 m -98.09 -50.55 4.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.967 -1.083 . . . . 10.0 110.39 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -29.73 64.24 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.306 1.1 mp -51.82 -26.51 7.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.109 -1.405 . . . . 10.0 107.365 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 124' ' ' SER . 28.9 tt0 -50.6 -29.35 10.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.926 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.463 ' O ' ' ND2' ' A' ' 132' ' ' ASN . 10.3 mmtp -61.39 -29.08 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.709 . . . . 10.0 111.345 -179.53 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.853 HD21 ' HA ' ' A' ' 85' ' ' VAL . 9.2 mp -65.12 -42.92 93.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.804 -1.185 . . . . 10.0 109.835 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.66 -30.4 65.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.762 -0.586 . . . . 10.0 110.662 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 8.5 mmtp -64.85 -15.06 61.36 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.473 ' HB2' ' HD2' ' A' ' 133' ' ' LYS . 1.5 p30 -127.64 -41.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 10.0 110.739 179.267 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -149.66 136.46 19.45 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.401 -0.812 . . . . 10.0 110.213 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.455 ' N ' ' OE1' ' A' ' 134' ' ' GLN . 0.9 OUTLIER -82.15 -10.11 59.29 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.362 0.601 . . . . 10.0 110.315 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.8 OUTLIER -110.72 98.47 37.74 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 10.0 111.764 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.832 ' HB3' HD23 ' A' ' 129' ' ' LEU . 45.1 Cg_endo -71.56 161.79 44.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.372 1.722 . . . . 10.0 109.904 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 137' ' ' ILE . 1.5 tp -77.84 116.67 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.626 -1.296 . . . . 10.0 109.682 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 42.9 p -121.8 172.19 5.34 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -67.66 -16.56 46.87 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.25 1.132 . . . . 10.0 111.331 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -79.62 -24.78 41.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 10.0 109.263 178.897 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 141' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.3 m -97.21 -35.0 10.9 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.662 0.744 . . . . 10.0 109.341 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -72.3 -39.9 67.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.778 -0.576 . . . . 10.0 110.904 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 25.7 mt-10 -62.23 -50.22 72.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.569 -0.852 . . . . 10.0 109.597 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -61.24 -42.18 98.17 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.983 HD11 ' HG3' ' A' ' 94' ' ' LYS . 4.8 tt -58.8 -45.68 89.35 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.33 -0.856 . . . . 10.0 109.399 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.541 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.33 -48.7 80.6 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.522 0.677 . . . . 10.0 109.629 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 10.3 mtm-85 -71.13 -14.36 62.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.231 -0.918 . . . . 10.0 109.314 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 9.4 t0 -69.3 -13.33 62.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 10.0 111.115 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.998 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.51 26.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.025 -1.047 . . . . 10.0 110.155 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER 64.45 36.27 8.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.684 0.754 . . . . 10.0 110.637 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -69.4 -155.59 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -118.77 -62.29 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.781 -1.199 . . . . 10.0 111.112 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttmt -171.99 154.73 3.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.521 -1.362 . . . . 10.0 112.041 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 54.3 t80 -106.8 101.4 10.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 10.0 108.981 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.949 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -107.42 -170.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.469 -0.769 . . . . 10.0 110.139 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -152.56 133.39 14.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.08 -1.013 . . . . 10.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.607 ' SG ' HG11 ' A' ' 113' ' ' VAL . 26.9 p -153.63 157.75 40.11 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.557 -0.905 . . . . 10.0 108.557 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.578 ' HB2' ' H ' ' A' ' 162' ' ' GLN . 54.0 m -138.68 164.32 29.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.185 -1.042 . . . . 10.0 108.185 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.905 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -62.06 -59.26 5.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.631 -1.293 . . . . 10.0 112.33 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.58 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 2.6 pp -121.16 4.7 10.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.454 -1.404 . . . . 10.0 112.898 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -104.07 -47.34 4.2 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.333 -1.479 . . . . 10.0 113.544 -178.021 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.578 ' H ' ' HB2' ' A' ' 158' ' ' SER . 10.7 mm100 -91.51 -44.38 9.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.444 -1.41 . . . . 10.0 112.026 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 15.4 ttpt 63.95 28.73 14.5 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.205 1.002 . . . . 10.0 109.325 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -109.45 15.86 32.18 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.088 -1.605 . . . . 10.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -69.51 -3.17 13.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.541 -0.976 . . . . 10.0 110.471 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -89.65 -25.32 21.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 10.0 109.946 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -34.92 23.39 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.092 -1.005 . . . . 10.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.949 HG22 ' HB ' ' A' ' 155' ' ' VAL . 16.2 t -59.62 -38.77 77.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 10.0 110.692 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.56 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 t80 -80.17 -44.05 20.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 10.0 111.796 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.696 ' O ' HD22 ' A' ' 174' ' ' LEU . 29.7 t70 -52.51 -44.08 65.47 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.528 -1.358 . . . . 10.0 110.688 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.598 ' HA ' HD23 ' A' ' 174' ' ' LEU . 14.5 mt-10 -60.62 -41.82 95.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.237 -0.914 . . . . 10.0 111.466 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.931 ' HB1' ' HB ' ' A' ' 77' ' ' VAL . . . -56.14 -33.21 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 10.0 111.092 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 177' ' ' LEU . 20.8 mm -61.01 -44.68 98.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 118.316 -1.354 . . . . 10.0 108.423 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.84 -21.04 62.48 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.375 -0.828 . . . . 10.0 109.839 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.95 -7.5 36.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.397 -0.814 . . . . 10.0 111.005 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.056 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -85.97 -33.65 21.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.017 . . . . 10.0 111.343 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -100.31 -10.65 21.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.767 -1.208 . . . . 10.0 109.418 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.191 . . . . 10.0 109.138 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 10.0 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 2' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 56.9 m -80.39 36.82 0.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.09 -1.241 . . . . 10.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 174' ' ' LEU . 9.4 mtpp -61.0 100.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 10.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' B' ' 2' ' ' SER . 9.2 mm-40 -108.43 161.97 14.54 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.588 0.709 . . . . 10.0 111.262 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.681 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.48 -143.17 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.202 -1.036 . . . . 10.0 108.202 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.681 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 43.9 Cg_endo -74.27 7.31 2.62 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 CA-C-N 119.448 0.839 . . . . 10.0 110.626 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.829 ' CB ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER 41.81 -149.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 10.0 110.517 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.561 HG23 ' H ' ' B' ' 9' ' ' SER . 0.0 OUTLIER -100.48 -99.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.46 -0.775 . . . . 10.0 109.951 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.561 ' H ' HG23 ' B' ' 8' ' ' ILE . 31.1 m -78.12 151.96 33.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.592 -1.317 . . . . 10.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.892 ' HB3' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -164.89 98.81 0.84 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.459 -1.401 . . . . 10.0 112.348 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 45' ' ' MET . 45.0 Cg_endo -75.72 124.18 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.771 1.406 . . . . 10.0 108.893 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.8 m -93.14 166.37 12.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.44 174.99 10.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.465 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.1 p90 -149.23 150.04 31.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.724 -1.235 . . . . 10.0 111.62 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -170.85 117.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.67 -0.644 . . . . 10.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 16' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 p-80 -162.83 156.42 20.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.624 -1.297 . . . . 10.0 111.737 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.928 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -166.95 96.25 0.51 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.297 -0.877 . . . . 10.0 110.226 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.928 HG23 ' O ' ' B' ' 17' ' ' THR . 0.6 OUTLIER -172.9 167.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.605 . . . . 10.0 109.466 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.42 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 50.0 t60 -145.75 159.6 42.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.211 -1.556 . . . . 10.0 114.551 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 35' ' ' THR . 4.8 p -69.08 146.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.648 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -146.48 155.84 26.71 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.364 -1.894 . . . . 10.0 108.364 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 1.06 ' HB3' HG21 ' B' ' 25' ' ' VAL . 8.1 m-30 58.81 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.213 -1.169 . . . . 10.0 110.359 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.498 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.1 m-20 -60.65 157.55 14.33 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.634 0.73 . . . . 10.0 111.764 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' HA ' ' A' ' 32' ' ' TYR . . . 43.89 43.89 5.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.69 -0.631 . . . . 10.0 111.331 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 1.06 HG21 ' HB3' ' B' ' 22' ' ' PHE . 6.7 t -111.7 -35.1 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 119.356 -0.938 . . . . 10.0 108.663 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -101.93 7.44 41.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 177.584 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.72 ' CA ' HG22 ' A' ' 21' ' ' ILE . . . -125.14 24.87 5.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.881 -2.088 . . . . 10.0 107.881 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 11.3 tt0 -158.66 132.59 7.71 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.768 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -110.04 118.92 37.69 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.238 1.018 . . . . 10.0 110.7 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -143.07 162.31 35.87 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.575 -0.739 . . . . 10.0 109.664 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.43 -165.9 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.205 -1.158 . . . . 10.0 110.205 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.461 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 24.2 pt -143.01 52.87 2.35 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.372 -1.075 . . . . 10.0 110.458 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 55.5 Cg_endo -74.72 163.14 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.83 1.437 . . . . 10.0 111.05 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.914 ' OE1' HD21 ' B' ' 40' ' ' LEU . 3.6 tp10 -43.7 155.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.963 . . . . 10.0 109.97 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 14' ' ' VAL . 4.1 mm-40 -67.83 -66.76 0.52 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.238 -0.985 . . . . 10.0 111.141 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.625 ' CD2' ' O ' ' B' ' 36' ' ' TRP . 9.4 t90 -161.96 21.05 0.11 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 122.51 1.148 . . . . 10.0 108.114 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.753 ' O ' HD23 ' B' ' 39' ' ' LEU . . . -155.95 93.92 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.081 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' B' ' 42' ' ' THR . 0.0 OUTLIER -88.78 45.13 1.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.466 -1.309 . . . . 10.0 107.466 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.753 HD23 ' O ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -51.13 -20.79 1.63 Allowed 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.832 -1.076 . . . . 10.0 111.727 -178.095 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.914 HD21 ' OE1' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -79.22 9.38 4.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.745 -1.222 . . . . 10.0 110.502 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' B' ' 40' ' ' LEU . 0.0 OUTLIER 73.63 -20.92 0.28 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.992 -0.442 . . . . 10.0 111.707 179.126 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.628 ' O ' HD11 ' B' ' 40' ' ' LEU . 26.9 p -134.33 178.01 7.31 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.213 . . . . 10.0 109.87 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 88.3 p -93.06 15.57 14.83 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.422 -0.798 . . . . 10.0 109.018 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.665 ' O ' HD13 ' B' ' 40' ' ' LEU . 27.2 t-20 -85.09 115.9 23.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 10.0 110.724 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.94 -45.24 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 10.0 109.5 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.942 -1.028 . . . . 10.0 110.031 -179.769 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.085 0.469 . . . . 10.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 4' ' ' ILE . 2.8 mm100 -78.72 -48.54 14.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.236 -0.915 . . . . 10.0 108.776 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.59 ' HA ' HG22 ' A' ' 52' ' ' THR . 1.4 m -40.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.976 -0.75 . . . . 10.0 108.976 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 1.011 HD13 ' HB1' ' A' ' 176' ' ' ALA . 1.2 tt -134.55 149.06 29.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.001 -1.079 . . . . 10.0 111.935 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HG3' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -126.95 119.38 26.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.823 ' HA ' HG13 ' A' ' 77' ' ' VAL . 7.5 m -89.32 135.31 33.65 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.732 0.777 . . . . 10.0 109.479 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' B' ' 36' ' ' TRP . 11.0 t -144.31 158.5 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.46 -0.775 . . . . 10.0 109.972 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 30.5 m -63.83 136.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.44 -0.787 . . . . 10.0 111.235 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.88 HG11 ' HB3' ' A' ' 78' ' ' PHE . 7.6 t -145.27 -173.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.558 -0.714 . . . . 10.0 109.242 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.712 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 126.93 -129.05 6.42 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.942 -1.263 . . . . 10.0 109.942 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.98 22.95 14.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.435 -1.038 . . . . 10.0 109.224 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' B' ' 33' ' ' PRO . . . 100.82 90.07 2.07 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.644 -1.782 . . . . 10.0 108.644 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' B' ' 35' ' ' GLN . . . -141.18 96.16 2.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 10.0 110.659 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 35' ' ' GLN . 0.6 OUTLIER -82.91 133.59 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.918 -1.114 . . . . 10.0 109.684 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 19' ' ' LEU . . . 98.75 2.42 57.35 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.914 -1.136 . . . . 10.0 110.356 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.2 tttt -51.0 -47.73 61.52 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.024 -1.28 . . . . 10.0 111.013 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 22.7 m -62.06 -30.94 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.283 -1.511 . . . . 10.0 109.645 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' B' ' 26' ' ' THR . 14.9 m -70.18 -11.8 61.15 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.742 -1.224 . . . . 10.0 108.916 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' B' ' 29' ' ' PHE . 4.3 mm? -70.26 -30.67 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -49.29 -40.36 34.45 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.841 -1.541 . . . . 10.0 106.841 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.7 mm -67.54 -36.5 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 122.349 1.071 . . . . 10.0 108.948 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.578 ' HA ' ' CA ' ' A' ' 27' ' ' LYS . 3.5 p -60.05 -42.29 94.16 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.883 -0.727 . . . . 10.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 165' ' ' LEU . 31.7 m-85 -71.52 -7.45 47.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.824 -1.172 . . . . 10.0 108.768 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 66.5 p -107.65 -44.31 4.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.531 -0.867 . . . . 10.0 110.143 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.78 HG23 ' H ' ' A' ' 26' ' ' ASN . 1.9 t -166.2 -65.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 116.798 -1.961 . . . . 10.0 115.361 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.794 ' CG ' HG21 ' A' ' 33' ' ' VAL . 15.9 t-20 -79.0 45.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.018 -1.676 . . . . 10.0 113.181 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.739 ' C ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -56.04 -126.71 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.577 -0.702 . . . . 10.0 111.392 179.022 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.619 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 3.8 t80 -106.91 55.11 0.19 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.739 ' HD3' ' C ' ' A' ' 27' ' ' LYS . 60.9 Cg_endo -95.87 -104.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 120.827 1.018 . . . . 10.0 110.042 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -168.87 67.34 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.711 -1.243 . . . . 10.0 111.564 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HG3' ' ND2' ' A' ' 26' ' ' ASN . 22.0 pt-20 -147.45 -173.81 4.36 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.808 -1.183 . . . . 10.0 108.294 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' C ' HG13 ' A' ' 33' ' ' VAL . 87.0 m-85 -123.64 138.4 54.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.851 -1.156 . . . . 10.0 111.705 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG21 ' CG ' ' A' ' 26' ' ' ASN 0.263 12.3 m -149.1 133.19 8.77 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' THR . 50.3 Cg_endo -73.67 89.18 0.99 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.05 1.027 . . . . 10.0 110.567 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.615 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -158.34 101.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 179.167 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 35' ' ' THR . 91.2 t -156.88 -97.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.636 -1.29 . . . . 10.0 111.995 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.604 ' N ' HG12 ' A' ' 36' ' ' VAL . 1.7 t80 -70.86 126.94 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 10.0 110.522 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.604 ' HB3' ' CG ' ' A' ' 56' ' ' PHE . 3.2 t70 -160.89 -177.82 6.4 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.055 -1.028 . . . . 10.0 110.103 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.776 ' HB3' HG21 ' B' ' 18' ' ' ILE . 50.4 t30 -167.63 102.65 0.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 10.0 109.125 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.675 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 7.3 t80 -92.76 141.73 28.12 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.989 -1.07 . . . . 10.0 110.577 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -159.58 98.16 1.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 10.0 109.38 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -144.79 -174.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 10.0 110.622 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 51' ' ' TYR . 6.8 m -142.07 146.66 35.69 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' B' ' 12' ' ' SER . 18.1 t -120.91 136.86 56.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.652 ' HB3' HD23 ' B' ' 10' ' ' LEU . 10.3 mtt -89.36 109.45 20.36 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 117.736 -1.586 . . . . 10.0 109.181 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.25 109.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.185 -1.572 . . . . 10.0 109.544 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 50.02 28.09 11.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.07 -28.0 17.09 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 111.15 16.15 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.246 . . . . 10.0 110.475 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 56.0 Cg_endo -73.04 134.64 21.73 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.159 1.61 . . . . 10.0 109.561 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.4 t80 -89.34 139.97 29.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.752 -1.218 . . . . 10.0 109.549 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' HG22 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -122.06 97.88 5.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 10.0 110.343 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.8 pp -148.85 171.36 16.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.733 -1.229 . . . . 10.0 111.621 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -173.28 120.85 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.377 -1.889 . . . . 10.0 108.377 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.849 HD12 ' C ' ' A' ' 55' ' ' LEU . 1.5 pp -157.58 144.69 18.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.408 -1.643 . . . . 10.0 112.845 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' CG ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -174.66 172.34 3.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.251 -0.905 . . . . 10.0 110.384 175.093 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -90.82 157.33 17.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 10.0 110.187 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.5 m -129.29 135.74 49.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.028 . . . . 10.0 111.662 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . . . 55.85 -152.44 0.37 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.39 -0.819 . . . . 10.0 110.934 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HG21 ' B' ' 25' ' ' VAL . . . 96.09 -7.84 67.22 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.236 -1.946 . . . . 10.0 108.236 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.586 ' CG ' ' HB2' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -152.84 -41.76 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.509 -0.994 . . . . 10.0 110.444 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 8.7 mm-40 -73.1 -43.25 62.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.502 -1.279 . . . . 10.0 109.386 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 2.1 t70 73.46 52.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.668 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -165.24 0.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.195 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 6.1 p30 -22.53 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.493 0.663 . . . . 10.0 112.487 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -54.29 -34.16 60.26 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 178.483 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.614 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 83.7 mt -76.43 6.24 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.442 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.756 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -57.82 -31.29 9.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.826 -1.171 . . . . 10.0 113.651 -179.012 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.614 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 52.0 Cg_endo -72.47 81.11 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 CA-C-N 119.36 0.807 . . . . 10.0 110.037 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.772 HD11 ' CB ' ' B' ' 37' ' ' ALA . 0.7 OUTLIER -108.72 -34.14 6.78 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.751 -1.218 . . . . 10.0 110.913 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.657 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 77.16 -17.3 0.57 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 10.0 110.808 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.663 ' N ' HD12 ' A' ' 70' ' ' LEU . 79.2 t80 104.29 115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.838 0 C-N-CA 123.682 0.793 . . . . 10.0 111.181 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 43.9 Cg_endo -71.58 164.7 34.86 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.89 1.469 . . . . 10.0 109.307 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 1.1 mt-30 -139.35 7.01 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.821 -1.174 . . . . 10.0 111.11 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -141.78 84.89 1.91 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.852 -1.155 . . . . 10.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.645 ' O ' HD11 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -174.15 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.516 -0.74 . . . . 10.0 109.015 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -163.91 143.19 2.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.19 -0.944 . . . . 10.0 108.801 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.88 ' HB3' HG11 ' A' ' 9' ' ' VAL . 14.0 m-85 -131.72 119.56 21.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.899 -1.126 . . . . 10.0 111.942 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 111' ' ' LEU . 1.1 mm? -90.58 97.85 11.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 10.0 109.043 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 10' ' ' GLY . 11.0 m -99.38 150.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 10.0 110.35 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.6 p -123.66 108.41 12.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 10.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 97.9 m-85 -91.96 139.54 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.207 -0.933 . . . . 10.0 111.058 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.5 p -77.98 163.64 25.78 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 137' ' ' ILE . 1.9 m -119.43 -14.64 8.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 10.0 110.321 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 120' ' ' ARG . 32.7 m -115.11 44.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.798 0.809 . . . . 10.0 109.868 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.638 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -133.83 -159.13 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 41.6 Cg_endo -73.26 142.85 34.44 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 122.715 0.85 . . . . 10.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 m -65.29 77.15 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.007 -1.077 . . . . 10.0 109.695 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' PRO . 80.1 p -105.05 -15.71 15.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 10.0 111.642 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.5 p90 -49.79 -39.73 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.258 . . . . 10.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 1.5 tt0 -62.21 -34.17 75.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 10.0 110.269 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.551 ' HA ' ' CG ' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.11 -14.01 61.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.063 -1.023 . . . . 10.0 109.682 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.508 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 21.2 t -87.95 -18.03 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 10.0 109.444 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.857 ' HG3' HD11 ' A' ' 145' ' ' LEU . 3.7 mmtt -85.42 -35.53 21.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -82.74 -1.03 50.32 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.162 0.506 . . . . 10.0 109.847 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -111.24 -50.01 2.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.832 -1.167 . . . . 10.0 112.052 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 50.1 m95 -84.77 -49.36 8.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 10.0 112.339 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 23.2 t -52.79 -46.48 96.58 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.657 -1.277 . . . . 10.0 109.951 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.0 Cg_endo -71.75 -16.3 29.88 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.392 1.206 . . . . 10.0 109.779 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 43.5 tt0 -63.36 -16.55 60.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 10.0 109.72 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt 69.02 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.472 0.653 . . . . 10.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.723 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.1 m -52.39 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.868 . . . . 10.0 108.916 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' HIS . . . . . 0.723 ' N ' HG22 ' A' ' 102' ' ' THR . 10.9 p-80 -110.54 -4.2 15.61 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 10.0 108.174 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 104' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.1 OUTLIER 162.58 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 35.6 t -138.15 131.49 16.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 42.7 Cg_endo -69.84 67.67 1.77 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.757 1.399 . . . . 10.0 111.256 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 -11.04 15.08 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.057 -1.027 . . . . 10.0 110.659 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.9 t -49.21 147.3 5.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.653 -1.279 . . . . 10.0 109.715 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.62 130.42 26.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.852 1.448 . . . . 10.0 110.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.8 102.21 10.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.44 -0.787 . . . . 10.0 109.667 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 152' ' ' VAL . 2.6 mm? -78.62 95.41 5.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.817 -1.153 . . . . 10.0 108.026 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 145' ' ' LEU . 12.5 mt -72.31 137.91 47.0 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 22.8 t -148.43 158.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.787 -1.196 . . . . 10.0 111.594 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.433 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -96.56 148.21 18.92 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.765 -1.734 . . . . 10.0 108.765 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 81' ' ' CYS . 30.5 m -111.35 126.71 55.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.167 -1.196 . . . . 10.0 110.638 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 44.17 62.18 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.438 -0.789 . . . . 10.0 110.412 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.021 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.89 -29.24 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.206 -0.997 . . . . 10.0 109.542 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -52.47 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.427 1.108 . . . . 10.0 110.175 -177.58 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER 166.73 -26.66 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.219 -1.355 . . . . 10.0 107.827 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.76 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -51.14 -33.21 25.73 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.307 0.575 . . . . 10.0 109.731 178.631 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ASP . . . . . 0.458 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 75.7 m-20 -73.77 -11.46 60.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.027 . . . . 10.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.868 ' O ' HD13 ' A' ' 126' ' ' ILE . 38.0 t0 -86.4 115.86 63.73 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 10.0 110.162 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.47 21.65 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.734 1.386 . . . . 10.0 111.447 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 38.7 t -105.59 -51.24 3.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 10.0 109.993 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.52 HG21 HD12 ' A' ' 119' ' ' LEU . 14.3 t -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.967 -2.235 . . . . 10.0 104.967 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 122' ' ' ASP 0.296 1.3 mp -54.47 -23.56 11.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.227 -1.351 . . . . 10.0 107.79 176.474 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -49.21 -41.73 37.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.583 0.706 . . . . 10.0 110.172 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 1.8 mmmm -92.44 -41.32 10.37 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.603 -0.686 . . . . 10.0 109.994 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 85' ' ' VAL . 6.0 mp -65.83 -32.75 74.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.761 . . . . 10.0 109.403 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -59.88 -51.51 69.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 10.0 109.869 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -64.62 -25.33 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.196 -1.002 . . . . 10.0 108.903 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.418 ' OD1' ' N ' ' A' ' 87' ' ' PRO . 23.3 t-20 -69.38 -8.64 48.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 10.0 110.583 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -167.67 115.3 0.75 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 10.0 108.557 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -64.51 -19.9 65.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 10.0 111.904 -178.262 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 4.8 mptt -137.67 106.34 8.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.747 -1.221 . . . . 10.0 110.284 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 41.9 Cg_endo -66.74 160.45 46.45 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.487 . . . . 10.0 109.654 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 84' ' ' VAL . 3.4 tp -86.86 138.35 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.782 -1.199 . . . . 10.0 109.704 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 55.8 p -131.43 166.33 28.79 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.463 -0.773 . . . . 10.0 109.813 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 42.4 Cg_endo -67.8 -11.5 32.31 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.737 1.388 . . . . 10.0 110.965 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 75.2 mt-10 -75.16 -44.3 47.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.946 -1.096 . . . . 10.0 109.405 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -77.72 -36.55 50.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.662 0.744 . . . . 10.0 109.388 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 145' ' ' LEU . . . -64.93 -49.94 68.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 10.0 111.476 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.3 -46.94 62.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.009 -1.057 . . . . 10.0 109.578 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 140' ' ' GLU . 3.2 mtpm? -70.68 -30.05 66.53 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.542 -0.863 . . . . 10.0 109.439 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -69.53 -38.95 77.73 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.332 -0.855 . . . . 10.0 109.693 178.87 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -65.71 -49.67 67.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 10.0 108.263 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -24.07 67.53 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.852 -0.739 . . . . 10.0 109.166 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 21.1 t70 -59.97 -30.93 69.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 10.0 111.177 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 1.029 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -132.87 29.9 4.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.888 -1.132 . . . . 10.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 31.9 mttt 67.45 36.08 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 10.0 112.176 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -69.68 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.221 -0.991 . . . . 10.0 108.929 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 111' ' ' LEU . 2.4 p -114.57 -58.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.596 -1.315 . . . . 10.0 112.014 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.618 ' H ' HG13 ' A' ' 152' ' ' VAL . 2.8 ttmm -172.3 148.72 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.367 -1.458 . . . . 10.0 111.675 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 83.9 t80 -86.0 121.7 29.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 10.0 110.466 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 0.995 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -130.03 -174.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.868 -1.145 . . . . 10.0 110.169 179.4 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 48.8 mt-10 -148.09 149.23 31.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.862 -1.149 . . . . 10.0 112.195 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.0 p -148.22 156.09 42.14 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.905 0.859 . . . . 10.0 110.894 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 163' ' ' LYS . 1.7 t -139.38 89.8 2.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.627 0.727 . . . . 10.0 109.495 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.787 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -12.05 -58.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.554 0.946 . . . . 10.0 113.554 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -106.99 -43.12 4.72 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.056 -1.028 . . . . 10.0 112.84 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.647 HG21 ' CB ' ' A' ' 118' ' ' ASP . 6.3 p -65.25 -23.58 67.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.264 -1.523 . . . . 10.0 109.577 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' OE1' ' A' ' 162' ' ' GLN . 0.3 OUTLIER 71.19 77.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.457 -0.777 . . . . 10.0 110.946 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 158' ' ' SER . 12.6 mmmt -80.86 23.43 0.55 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.529 -0.868 . . . . 10.0 111.865 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.27 45.41 11.43 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.101 -1.2 . . . . 10.0 110.101 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -74.96 -3.37 31.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.339 -1.095 . . . . 10.0 112.774 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 166' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.7 ttmt -53.62 -38.99 64.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.57 -1.331 . . . . 10.0 110.223 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -75.6 -26.1 57.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 10.0 111.684 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 155' ' ' VAL . 87.7 t -52.88 -51.49 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 10.0 111.353 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CZ ' ' OD1' ' A' ' 170' ' ' ASP . 2.3 p90 -85.16 -32.23 22.83 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.699 -0.801 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.58 ' OD1' ' CZ ' ' A' ' 169' ' ' PHE . 1.0 OUTLIER -56.45 -41.54 76.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.993 -1.067 . . . . 10.0 110.972 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.611 ' HA ' HD21 ' A' ' 174' ' ' LEU . 9.0 pt-20 -69.8 -30.64 68.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.991 -1.068 . . . . 10.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.832 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -71.49 -4.61 27.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.012 -1.055 . . . . 10.0 109.457 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 169' ' ' PHE . 44.9 mm -82.52 -46.0 19.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.549 -0.861 . . . . 10.0 108.967 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -83.63 -30.97 26.48 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.738 -1.185 . . . . 10.0 108.679 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -77.03 -0.28 23.95 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.393 -0.817 . . . . 10.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 1.011 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -90.04 -39.25 13.04 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.378 -0.826 . . . . 10.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -89.74 -19.94 24.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 10.0 109.393 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.283 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 55.43 33.28 20.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -1.012 . . . . 10.0 110.767 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.76 89.39 5.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.099 -1.001 . . . . 10.0 110.274 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.515 ' C ' ' HD2' ' B' ' 6' ' ' PRO . 3.1 mt-10 -92.81 118.83 31.52 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.209 -0.932 . . . . 10.0 110.245 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.716 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -71.72 -21.38 0.5 Allowed Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 121.38 -0.825 . . . . 10.0 111.903 178.516 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 44.3 Cg_endo -88.06 -9.77 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 O-C-N 122.597 0.788 . . . . 10.0 111.044 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.483 ' OE1' ' HB2' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -53.57 171.27 0.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 118.47 -1.292 . . . . 10.0 109.713 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.709 HG23 ' N ' ' B' ' 9' ' ' SER . 0.4 OUTLIER -78.16 -169.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.011 -1.477 . . . . 10.0 107.011 177.909 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.709 ' N ' HG23 ' B' ' 8' ' ' ILE . 33.3 t -129.02 98.9 5.08 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 118.994 -1.082 . . . . 10.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 45' ' ' MET . 41.1 tp -92.5 99.89 3.27 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 118.558 -1.257 . . . . 10.0 108.994 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' B' ' 9' ' ' SER . 37.8 Cg_endo -61.29 99.43 0.16 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.194 1.102 . . . . 10.0 110.795 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 12' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 4.9 m -152.36 99.83 2.53 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.327 -0.858 . . . . 10.0 111.422 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 13' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -169.17 121.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.62 -0.675 . . . . 10.0 110.353 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 14' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -159.42 102.93 1.58 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.005 -1.059 . . . . 10.0 110.558 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.69 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.64 106.5 0.22 Allowed 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.273 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -166.82 123.24 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 10.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.507 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -161.97 111.28 1.51 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.92 . . . . 10.0 110.183 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.776 HG21 ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -153.43 -173.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.044 -1.035 . . . . 10.0 110.296 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 64.2 m80 -115.35 142.8 46.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.082 -1.011 . . . . 10.0 110.569 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 1.1 p -142.88 149.11 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.485 -0.76 . . . . 10.0 111.346 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -87.95 -124.67 2.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.254 -1.938 . . . . 10.0 108.254 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER 173.54 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -1.152 . . . . 10.0 111.363 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 61' ' ' GLN . 9.4 t70 -144.05 159.41 42.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.683 -0.635 . . . . 10.0 109.537 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.626 ' HB1' ' HG3' ' B' ' 28' ' ' GLU . . . -61.03 -5.54 1.46 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.905 -1.122 . . . . 10.0 109.913 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.548 ' HA ' ' HB2' ' B' ' 28' ' ' GLU 0.276 0.5 OUTLIER -49.67 -34.98 9.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.883 1.325 . . . . 10.0 107.566 178.878 . . . . . . . . 4 4 . 1 . 019 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.644 ' HA ' ' HB3' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -52.63 -32.59 42.59 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.111 -1.404 . . . . 10.0 111.064 -179.133 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 27' ' ' LYS . . . -123.79 -7.92 6.48 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.655 -1.778 . . . . 10.0 108.655 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.626 ' HG3' ' HB1' ' B' ' 24' ' ' ALA . 18.3 mt-10 -83.74 39.94 0.71 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.68 -0.894 . . . . 10.0 110.453 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.992 ' HB2' HD21 ' A' ' 19' ' ' LEU . 46.3 t80 -76.07 94.97 3.53 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.756 -1.202 . . . . 10.0 107.756 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.605 HG21 ' CE1' ' A' ' 28' ' ' PHE . 34.3 p -112.89 -19.22 12.04 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.19 -0.914 . . . . 10.0 110.491 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.62 -167.53 14.68 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.129 -1.588 . . . . 10.0 109.129 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.632 HD13 ' N ' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -133.59 69.47 76.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.239 -1.153 . . . . 10.0 110.811 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.4 Cg_endo -74.22 156.57 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.088 1.572 . . . . 10.0 108.464 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -35.21 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.268 -0.895 . . . . 10.0 111.003 -178.522 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.502 ' HA ' ' C ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -73.26 -71.22 0.32 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.496 0.665 . . . . 10.0 112.039 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 7' ' ' VAL . 41.1 t90 -157.26 34.65 0.28 Allowed 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.772 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -157.8 83.69 0.88 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -81.19 51.13 1.54 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.58 HD12 ' O ' ' B' ' 37' ' ' ALA . 1.2 mp -39.13 -29.49 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.86 0.838 . . . . 10.0 109.197 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 42' ' ' THR . 0.8 OUTLIER -87.39 32.45 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.791 -0.568 . . . . 10.0 109.716 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' B' ' 38' ' ' ARG . 15.7 tp60 -33.39 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.468 0.651 . . . . 10.0 110.133 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.793 ' O ' ' N ' ' B' ' 44' ' ' ASN . 69.1 p -120.26 65.18 0.83 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' B' ' 40' ' ' LEU . 10.4 t -41.28 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.744 0.783 . . . . 10.0 112.282 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.793 ' N ' ' O ' ' B' ' 42' ' ' THR . 0.8 OUTLIER 52.53 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.603 0.716 . . . . 10.0 110.947 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.3 -29.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.446 -0.784 . . . . 10.0 108.927 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 117.949 -1.024 . . . . 10.0 110.169 -179.461 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.2 ptm . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.401 0.62 . . . . 10.0 110.149 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' LEU . 3.6 mt-30 -74.92 -33.66 62.02 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.849 HG23 HD13 ' A' ' 53' ' ' LEU . 1.2 m -40.79 118.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 4' ' ' ILE . . . . . 0.955 HG13 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -104.16 127.27 58.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.16 -1.816 . . . . 10.0 110.77 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mttp -121.42 97.78 5.67 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' HG11 ' A' ' 77' ' ' VAL . 19.6 m -118.19 120.43 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.848 -1.141 . . . . 10.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' VAL . . . . . 0.661 ' N ' HG21 ' A' ' 75' ' ' THR . 47.1 t -127.55 144.6 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.488 -0.93 . . . . 10.0 108.488 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.867 HG21 ' OG1' ' A' ' 17' ' ' THR . 33.6 m -62.73 116.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.287 -0.883 . . . . 10.0 110.709 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 10' ' ' GLY . 77.2 t -115.72 177.69 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.182 -0.949 . . . . 10.0 109.136 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 167.78 172.64 35.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' HA ' HD21 ' B' ' 40' ' ' LEU . 8.3 p-10 -96.23 18.49 13.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.118 -1.225 . . . . 10.0 109.731 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLY . . . . . 0.54 ' CA ' ' OE1' ' B' ' 34' ' ' GLU . . . 74.61 51.74 7.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 -54.41 2.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.529 -0.983 . . . . 10.0 110.785 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' B' ' 29' ' ' PHE . 6.3 m -136.26 -7.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 10.0 111.586 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' B' ' 32' ' ' ILE . . . 81.64 81.63 0.86 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 3.8 tptt -63.04 -27.24 69.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.54 -0.977 . . . . 10.0 112.008 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.867 ' OG1' HG21 ' A' ' 8' ' ' VAL . 93.9 m -55.15 -51.85 65.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.399 -1.438 . . . . 10.0 110.188 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . 0.666 ' CB ' ' HA ' ' B' ' 26' ' ' THR . 31.0 p -74.81 0.23 16.14 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.44 -0.904 . . . . 10.0 109.985 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' LEU . . . . . 0.992 HD13 ' CB ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -88.16 -36.07 17.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.003 -1.061 . . . . 10.0 109.097 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 16' ' ' LYS . 4.3 mm? -51.68 -38.55 55.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ILE . . . . . 0.627 HG22 ' HA2' ' B' ' 27' ' ' GLY . 0.5 OUTLIER -76.67 -51.34 19.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.641 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' SER . . . . . 0.728 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 49.3 m -46.27 -40.85 12.22 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 119.077 -1.049 . . . . 10.0 108.846 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' TYR . . . . . 1.021 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -64.22 -23.28 67.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.187 -0.946 . . . . 10.0 109.461 177.774 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 24' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' ILE . 63.2 m -105.04 -29.97 10.07 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.686 0.755 . . . . 10.0 109.889 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' THR . . . . . 0.839 HG22 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.73 64.5 1.51 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.73 -1.581 . . . . 10.0 106.73 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 22' ' ' SER . 43.2 p30 -33.96 49.75 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.583 1.553 . . . . 10.0 114.406 -177.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.802 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -67.22 109.12 2.96 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.381 -0.824 . . . . 10.0 110.749 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PHE . . . . . 0.594 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 43.4 t80 -176.12 -56.52 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.237 -0.914 . . . . 10.0 110.406 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 41.2 Cg_endo -69.69 -67.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.126 1.066 . . . . 10.0 110.58 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 p -166.29 58.67 0.1 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.271 -0.893 . . . . 10.0 109.714 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 59.0 mm-40 -127.45 114.77 17.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -0.964 . . . . 10.0 110.271 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' C ' ' HD3' ' A' ' 34' ' ' PRO . 5.9 t80 -73.39 59.98 0.61 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.725 -0.609 . . . . 10.0 110.358 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.839 ' HB ' HG22 ' A' ' 25' ' ' THR . 20.3 m -119.99 76.11 22.01 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.172 -0.955 . . . . 10.0 110.912 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' O ' HG23 ' A' ' 35' ' ' THR . 44.2 Cg_endo -87.7 132.84 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.809 1.673 . . . . 10.0 110.99 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' THR . . . . . 0.609 ' OG1' HD12 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -157.02 102.64 1.99 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.729 -1.232 . . . . 10.0 111.9 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' B' ' 20' ' ' VAL . 78.6 t -95.29 10.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.654 -1.279 . . . . 10.0 109.017 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' B' ' 18' ' ' ILE . 1.3 m-30 -33.91 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.087 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASP . . . . . 0.927 ' HB2' ' HA ' ' B' ' 18' ' ' ILE . 1.5 m-20 -85.81 -149.02 0.13 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.903 -1.519 . . . . 10.0 108.594 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ASN . . . . . 0.749 ' CG ' HD11 ' A' ' 55' ' ' LEU . 1.3 t-20 -133.7 -163.62 1.38 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -128.05 163.27 24.94 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.605 -1.31 . . . . 10.0 112.194 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . . . -153.65 153.72 32.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -172.34 -168.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 120.528 -1.357 . . . . 10.0 111.625 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 43' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 42' ' ' VAL . 92.3 m -132.39 153.31 50.92 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.503 -0.771 . . . . 10.0 109.887 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -142.07 -171.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.039 . . . . 10.0 110.395 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 45' ' ' MET . . . . . 0.575 ' HB2' ' HG2' ' B' ' 11' ' ' PRO . 85.6 mtp -142.65 138.45 30.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.647 . . . . 10.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . 0.714 HD12 HG13 ' A' ' 44' ' ' VAL . 1.1 mp -146.91 115.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.222 -0.924 . . . . 10.0 109.714 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 41.01 27.58 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.656 -1.259 . . . . 10.0 109.98 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.37 -16.18 49.22 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.189 -1.183 . . . . 10.0 111.412 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' OE2' ' HB2' ' B' ' 4' ' ' GLU . 1.7 mp0 -98.69 105.04 28.0 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.553 -1.557 . . . . 10.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 52.2 Cg_endo -82.91 151.74 14.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.894 1.471 . . . . 10.0 112.269 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.624 ' CG ' HG12 ' A' ' 44' ' ' VAL . 2.8 m-30 -81.52 174.07 11.79 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.919 ' O ' HG22 ' A' ' 4' ' ' ILE . 16.2 m -152.73 124.1 7.67 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.611 -1.306 . . . . 10.0 112.249 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER 64.65 -169.21 0.2 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.93 0.871 . . . . 10.0 113.282 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 41' ' ' ALA . . . -169.72 -167.17 29.86 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.054 -1.618 . . . . 10.0 109.054 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.749 HD11 ' CG ' ' A' ' 39' ' ' ASN . 1.6 pp -111.22 156.57 21.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -1.116 . . . . 10.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' LEU . 56.9 m-85 -132.88 166.03 23.26 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.346 -0.613 . . . . 10.0 109.346 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 8.1 t70 -104.57 179.69 4.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.772 -1.205 . . . . 10.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' ASP . 12.0 t -45.26 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.469 1.128 . . . . 10.0 112.425 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -132.94 63.35 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 10.0 109.114 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . -49.42 -39.94 30.04 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.646 -2.582 . . . . 10.0 106.646 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . 0.553 ' CG ' ' HB2' ' A' ' 63' ' ' ASP . 2.7 tp60 -63.92 -35.62 81.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.7 mt-10 55.63 32.76 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.939 0.876 . . . . 10.0 109.819 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 5.6 t70 -90.08 -5.68 56.29 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.527 -0.916 . . . . 10.0 108.527 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -139.23 -38.33 0.49 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.13 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.2 p30 38.9 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.187 -0.605 . . . . 10.0 109.998 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -58.17 -36.87 73.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.745 -1.222 . . . . 10.0 109.173 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.671 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 5.1 mt -91.77 13.86 17.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.331 0.586 . . . . 10.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -81.47 -13.12 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 114.341 1.238 . . . . 10.0 114.341 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -69.71 67.76 1.7 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 109.031 -1.18 . . . . 10.0 109.031 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' B' ' 37' ' ' ALA . 4.9 mt -50.46 -71.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.559 0.695 . . . . 10.0 111.665 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' B' ' 39' ' ' LEU . 21.7 p -35.31 -29.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.958 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -98.29 105.83 31.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.415 -0.803 . . . . 10.0 108.859 178.67 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 43.4 Cg_endo -77.83 113.93 3.55 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.859 1.452 . . . . 10.0 110.721 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLN . . . . . 0.47 ' NE2' ' HB3' ' A' ' 72' ' ' TYR . 4.9 mt-30 -133.77 60.61 1.7 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.477 -0.764 . . . . 10.0 110.288 -179.664 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.8 m -144.25 97.33 3.03 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.934 -1.104 . . . . 10.0 109.545 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 76' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' THR . 14.5 t70 -28.83 -38.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.662 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 77' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -121.09 136.96 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.269 -0.894 . . . . 10.0 109.706 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 41.8 m-85 -115.7 144.67 43.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LEU . . . . . 0.923 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -114.01 102.34 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 10.0 109.129 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 4.4 p -96.8 151.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.982 . . . . 10.0 108.812 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' CYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 19.8 t -134.8 100.37 4.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.847 -1.158 . . . . 10.0 112.496 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 47.8 m-85 -88.45 156.18 19.26 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.316 -0.865 . . . . 10.0 109.884 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 18.8 m -85.01 147.12 26.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.843 -1.161 . . . . 10.0 109.282 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 115' ' ' THR . 43.7 t -47.62 -60.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.077 -1.014 . . . . 10.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 129' ' ' LEU . 3.8 t -78.75 -62.52 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . 0.618 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER 44.8 179.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.847 0 CA-C-O 121.58 0.705 . . . . 10.0 112.375 178.218 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 52.2 Cg_endo -78.72 145.99 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.462 1.77 . . . . 10.0 109.985 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 88' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 135' ' ' LYS . 95.2 p -68.38 67.81 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 10.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' SER . . . . . 0.427 ' O ' HG23 ' A' ' 93' ' ' VAL . 0.3 OUTLIER -136.69 13.37 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 10.0 111.666 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 82' ' ' PHE . 16.9 t80 -71.33 -34.15 70.29 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.619 -1.301 . . . . 10.0 110.64 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 4.5 mt-10 -74.69 -29.89 61.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.026 -1.046 . . . . 10.0 110.982 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' ASN . . . . . 0.491 ' C ' ' HG2' ' A' ' 95' ' ' GLU . 0.6 OUTLIER -86.89 -9.69 55.12 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.741 -1.183 . . . . 10.0 109.496 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . 0.544 HG13 ' CD2' ' A' ' 97' ' ' TRP . 14.4 t -90.35 -36.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.996 -1.065 . . . . 10.0 109.102 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' LYS . . . . . 0.817 ' HE2' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.26 -25.39 62.45 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 10.0 110.095 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 12.9 pt-20 -78.52 -25.06 45.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 10.0 111.616 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 25.2 mttp -110.93 -50.65 2.93 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.892 -1.13 . . . . 10.0 111.998 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 97' ' ' TRP . . . . . 0.865 ' CH2' HD13 ' B' ' 40' ' ' LEU . 23.1 m0 -64.42 -17.19 63.55 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.297 -0.877 . . . . 10.0 112.405 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' VAL . . . . . 0.871 HG11 ' CD2' ' A' ' 149' ' ' LEU . 53.8 t -82.91 -50.7 0.72 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.772 -1.205 . . . . 10.0 112.033 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.8 Cg_endo -68.58 -6.47 17.83 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.119 1.063 . . . . 10.0 111.209 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 mm-40 -90.48 -32.0 16.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.876 -1.14 . . . . 10.0 110.464 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ILE . . . . . 0.744 ' O ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -91.96 -29.14 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.038 -1.039 . . . . 10.0 110.239 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 98' ' ' VAL . 69.9 p -62.26 -12.18 19.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 10.0 109.915 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -57.56 -40.68 79.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.558 -0.714 . . . . 10.0 110.639 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.96 -33.76 39.29 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 10.0 110.803 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.3 t -136.29 128.49 17.37 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 10.0 110.092 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.29 126.5 13.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.117 1.588 . . . . 10.0 111.851 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER 55.84 52.07 11.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.37 -0.831 . . . . 10.0 111.119 178.707 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 108' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 22.4 m -63.31 145.17 97.24 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 10.0 109.61 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 41.1 Cg_endo -68.37 157.63 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.642 1.338 . . . . 10.0 109.365 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' PHE . . . . . 0.59 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -159.95 121.97 3.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.94 -1.1 . . . . 10.0 111.237 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -92.29 102.51 15.01 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.149 0.975 . . . . 10.0 110.682 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 112' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 71.2 mt -75.56 135.24 40.58 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.817 -0.809 . . . . 10.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' VAL . . . . . 0.684 ' CG2' HG11 ' A' ' 168' ' ' VAL . 19.4 t -133.75 169.96 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.654 -1.279 . . . . 10.0 112.694 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -140.35 107.11 0.52 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.583 -2.207 . . . . 10.0 107.583 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 t -106.75 -179.51 3.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.267 . . . . 10.0 111.708 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 116' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 83' ' ' SER . 16.9 mt-30 61.56 48.16 5.98 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.798 -0.564 . . . . 10.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ILE . . . . . 1.068 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -107.37 -50.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.167 -0.958 . . . . 10.0 110.118 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ASP . . . . . 0.982 ' CB ' HG21 ' A' ' 161' ' ' THR . 11.6 t0 -52.7 61.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.191 0.996 . . . . 10.0 109.947 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 119' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER 152.57 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.339 -1.3 . . . . 10.0 108.41 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -46.73 -37.4 8.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 10.0 109.135 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.0 -21.99 9.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.42 -0.8 . . . . 10.0 109.542 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 123' ' ' PRO . 22.9 t0 -84.28 131.77 49.63 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 10.0 110.889 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.534 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.7 Cg_endo -78.22 24.66 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.925 1.487 . . . . 10.0 111.265 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' SER . . . . . 0.482 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 37.1 m -102.76 -46.96 4.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.002 -1.061 . . . . 10.0 109.843 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' THR . . . . . 0.597 HG21 HD12 ' A' ' 119' ' ' LEU . 6.8 t -78.41 -27.42 46.65 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.493 -2.039 . . . . 10.0 105.493 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.29 1.1 mp -57.06 -25.26 22.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 177.072 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 127' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 5.4 tm-20 -50.24 -50.18 50.65 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.747 0.784 . . . . 10.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -65.06 -44.77 87.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.691 -0.63 . . . . 10.0 111.062 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 85' ' ' VAL . 5.6 mt -59.92 -35.51 75.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.235 -0.916 . . . . 10.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 130' ' ' ALA . . . . . 0.66 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -49.62 -42.24 44.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.606 -0.684 . . . . 10.0 110.294 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -19.9 42.17 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.46 -0.775 . . . . 10.0 110.498 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ASN . . . . . 0.527 ' OD1' ' HA ' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -123.07 43.89 2.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.953 -1.092 . . . . 10.0 112.348 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.1 mptm? 67.72 150.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 10.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -116.77 66.24 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 10.0 111.387 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 88' ' ' SER . 5.0 mmmt -104.83 94.68 7.8 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.112 -0.992 . . . . 10.0 108.958 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 43.7 Cg_endo -71.22 161.43 45.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.075 1.566 . . . . 10.0 110.681 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 137' ' ' ILE . 3.9 tp -120.13 121.41 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.215 -0.928 . . . . 10.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.4 p -108.46 164.29 15.06 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.22 -0.925 . . . . 10.0 109.206 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 38.3 Cg_endo -67.51 -29.16 37.61 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.589 1.31 . . . . 10.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.78 -34.12 72.6 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.5 m -93.38 -33.51 13.84 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.746 0.784 . . . . 10.0 109.054 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -75.38 -38.56 59.93 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.601 -0.687 . . . . 10.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.0 mt-10 -59.54 -49.23 78.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.258 -0.901 . . . . 10.0 109.836 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -45.26 93.42 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 10.0 109.156 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' HE2' ' A' ' 94' ' ' LYS . 2.8 tt -60.05 -49.37 77.93 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.228 -1.026 . . . . 10.0 108.228 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -55.25 -38.71 68.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 10.0 109.128 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 1.6 mtp-105 -72.23 -4.85 31.89 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.603 -0.686 . . . . 10.0 109.873 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.15 -52.04 7.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 10.0 110.278 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' LEU . . . . . 0.871 ' CD2' HG11 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -89.94 4.86 48.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 10.0 109.309 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 150' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 1.8 mttp 73.16 31.17 1.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 151' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -55.89 -159.82 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.952 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' VAL . . . . . 0.593 HG11 HD13 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -119.08 -54.74 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 118.941 -1.103 . . . . 10.0 111.516 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -171.53 147.14 2.32 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.934 -1.506 . . . . 10.0 112.621 -179.512 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 154' ' ' TYR . . . . . 0.555 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 43.2 t80 -97.64 100.05 11.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.735 -0.603 . . . . 10.0 109.45 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 155' ' ' VAL . . . . . 1.007 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.9 t -101.39 -170.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 10.0 110.367 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 155' ' ' VAL . 12.8 pt-20 -148.22 168.2 23.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 10.0 110.184 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 157' ' ' CYS . . . . . 0.594 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.3 p -176.99 164.8 2.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.157 -0.965 . . . . 10.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' SER . . . . . 0.628 ' CB ' HG23 ' A' ' 161' ' ' THR . 60.2 m -146.27 128.23 15.49 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.605 -0.685 . . . . 10.0 109.939 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ALA . . . . . 0.992 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -63.86 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.621 -0.674 . . . . 10.0 111.597 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' B' ' 29' ' ' PHE . 0.4 OUTLIER -28.06 -52.95 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.57 1.176 . . . . 10.0 109.481 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 161' ' ' THR . . . . . 0.982 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -95.74 -102.28 0.16 Allowed 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.731 -1.122 . . . . 10.0 110.43 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 162' ' ' GLN . . . . . 0.626 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 159.27 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 -178.989 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 163' ' ' LYS . . . . . 0.552 ' HD2' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -97.35 27.37 4.25 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.566 -1.254 . . . . 10.0 112.545 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 164' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 157' ' ' CYS . . . 135.95 14.96 0.95 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 118.708 -1.711 . . . . 10.0 111.99 177.945 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 165' ' ' LEU . . . . . 1.021 HD22 ' CB ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -49.36 -53.44 22.34 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.177 -1.778 . . . . 10.0 109.833 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -67.14 -29.49 69.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.463 0.649 . . . . 10.0 109.588 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ASN . . . . . 0.589 ' C ' HG11 ' A' ' 155' ' ' VAL . 14.3 m-20 -62.3 -32.11 72.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 10.0 111.4 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.5 t -70.88 -49.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.448 -1.408 . . . . 10.0 109.171 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' O ' HG13 ' A' ' 173' ' ' ILE . 92.4 t80 -59.31 -22.92 61.97 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.762 -0.586 . . . . 10.0 110.452 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 167' ' ' ASN . 80.8 m-20 -59.17 -50.93 72.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 10.0 110.416 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 51.2 mp0 -65.88 -31.52 72.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.036 -1.04 . . . . 10.0 108.883 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 172' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -63.63 -24.19 67.69 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.814 -0.554 . . . . 10.0 109.625 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 177' ' ' LEU . 72.1 mt -63.61 -43.71 98.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.091 -1.044 . . . . 10.0 108.542 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' LEU . . . . . 0.799 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.75 -42.33 67.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.188 -0.945 . . . . 10.0 110.179 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.1 -0.12 30.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.526 -0.733 . . . . 10.0 109.985 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 176' ' ' ALA . . . . . 0.955 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -83.33 -44.57 14.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.898 . . . . 10.0 109.851 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -98.85 -17.56 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.822 . . . . 10.0 109.302 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 118.003 -0.998 . . . . 10.0 110.028 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -126.54 150.2 48.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -1.131 . . . . 10.0 110.196 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -117.96 88.41 2.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.365 -0.835 . . . . 10.0 109.272 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 4' ' ' GLU . . . . . 0.442 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 2.8 mm-40 -87.36 178.18 6.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.84 0.828 . . . . 10.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 5' ' ' ARG . . . . . 0.632 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.12 -149.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 6' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -72.14 0.37 7.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 CA-C-N 119.325 0.795 . . . . 10.0 110.589 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 7' ' ' GLU . . . . . 0.486 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.8 mm-40 46.21 -165.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 10.0 110.427 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 8' ' ' ILE . . . . . 0.663 HD12 ' OG ' ' B' ' 9' ' ' SER . 1.4 pp -80.35 -45.01 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 10.0 111.661 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 9' ' ' SER . . . . . 0.663 ' OG ' HD12 ' B' ' 8' ' ' ILE . 67.4 m -122.08 151.32 41.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.221 . . . . 10.0 112.137 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 10' ' ' LEU . . . . . 0.875 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -170.84 97.53 0.43 Allowed Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.363 -0.836 . . . . 10.0 113.153 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 11' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -77.35 156.08 32.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 N-CA-C 107.877 -1.624 . . . . 10.0 107.877 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -117.68 163.49 16.39 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.587 -1.321 . . . . 10.0 111.966 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.32 176.46 10.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.073 -1.084 . . . . 10.0 108.073 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -170.63 144.61 2.38 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.784 -1.198 . . . . 10.0 110.792 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 59.8 tt0 -141.02 137.48 32.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -121.77 129.44 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.036 -1.04 . . . . 10.0 112.103 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 17' ' ' THR . . . . . 0.647 ' C ' HD12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -141.54 98.22 3.31 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.223 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 18' ' ' ILE . . . . . 0.927 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.4 mp -106.45 140.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 19' ' ' HIS . . . . . 0.585 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 61.7 m-70 -132.89 123.59 26.29 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.353 -0.842 . . . . 10.0 110.94 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 20' ' ' VAL . . . . . 0.71 HG23 ' HB ' ' A' ' 36' ' ' VAL . 1.4 p -140.37 130.18 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 10.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -145.56 10.87 1.71 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.846 -1.302 . . . . 10.0 109.846 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 22' ' ' PHE . . . . . 0.769 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -143.93 85.26 1.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.334 -1.098 . . . . 10.0 109.794 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 23' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 10.7 t70 -56.97 151.88 14.01 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.565 0.698 . . . . 10.0 111.416 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 24' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 69.98 19.84 6.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.557 -0.714 . . . . 10.0 111.099 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 25' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' B' ' 22' ' ' PHE . 25.3 t -110.47 -39.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.057 -1.027 . . . . 10.0 110.281 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CB ' ' A' ' 18' ' ' CYS . 6.5 m -94.95 -10.04 32.23 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.314 -0.866 . . . . 10.0 112.605 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 27' ' ' GLY . . . . . 0.627 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -111.59 -15.89 9.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.629 -1.788 . . . . 10.0 108.629 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -86.3 108.44 18.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.638 1.209 . . . . 10.0 110.683 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 29' ' ' PHE . . . . . 0.94 ' CE2' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -117.8 113.65 22.11 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.31 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' CE1' ' A' ' 28' ' ' PHE . 42.3 p -154.78 -61.94 0.12 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.483 -0.78 . . . . 10.0 109.78 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 31' ' ' GLY . . . . . 0.468 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -165.52 66.62 0.21 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.611 -1.796 . . . . 10.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 32' ' ' ILE . . . . . 0.572 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 11.2 pt -102.77 168.26 9.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.349 -1.089 . . . . 10.0 110.947 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 33' ' ' PRO . . . . . 0.572 ' HD2' ' HB ' ' B' ' 32' ' ' ILE . 38.6 Cg_endo -65.42 178.12 2.27 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.004 1.528 . . . . 10.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 34' ' ' GLU . . . . . 0.54 ' OE1' ' CA ' ' A' ' 12' ' ' GLY . 6.6 tp10 -36.56 160.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.744 0.783 . . . . 10.0 111.89 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -72.63 -70.68 0.33 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.583 -0.698 . . . . 10.0 112.768 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 36' ' ' TRP . . . . . 0.653 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.27 22.44 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 10.0 110.101 -179.003 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 37' ' ' ALA . . . . . 0.667 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . 178.96 99.7 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.817 0.818 . . . . 10.0 110.026 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 38' ' ' ARG . . . . . 0.556 ' CG ' ' HB3' ' B' ' 41' ' ' GLN . 1.8 ttt180 -84.16 45.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.902 -1.518 . . . . 10.0 106.902 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 39' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -50.63 -39.0 49.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.981 -1.009 . . . . 10.0 112.081 -177.466 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 40' ' ' LEU . . . . . 0.865 HD13 ' CH2' ' A' ' 97' ' ' TRP . 1.8 pp -105.56 16.9 24.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 10.0 111.174 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 41' ' ' GLN . . . . . 0.556 ' HB3' ' CG ' ' B' ' 38' ' ' ARG . 2.3 mt-30 -142.4 26.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.425 -0.797 . . . . 10.0 110.545 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 42' ' ' THR . . . . . 0.601 HG23 ' H ' ' B' ' 44' ' ' ASN . 11.4 t -121.81 -171.06 2.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 10.0 110.158 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -93.19 33.67 1.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.012 . . . . 10.0 110.76 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 44' ' ' ASN . . . . . 0.601 ' H ' HG23 ' B' ' 42' ' ' THR . 64.3 t30 -51.81 -64.45 0.81 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 10.0 110.385 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 82.2 mt -109.98 -70.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 10.0 109.972 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.558 0 CA-C-O 118.099 -0.953 . . . . 10.0 110.267 -179.763 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.431 0.634 . . . . 10.0 110.088 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 30.1 mm100 -129.57 -24.32 2.77 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.552 -0.717 . . . . 10.0 109.997 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 95.1 m -57.84 115.93 3.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 10.0 111.289 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.588 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -122.85 132.77 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.592 -0.843 . . . . 10.0 109.898 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.888 ' HB3' HG22 ' A' ' 75' ' ' THR . 46.4 mmtt -123.2 101.65 7.5 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.4 t -113.24 145.17 41.47 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.885 0.85 . . . . 10.0 112.801 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -151.59 -176.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HD1' ' B' ' 36' ' ' TRP . 22.7 m -91.59 108.55 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 10.0 109.877 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 10' ' ' GLY . 2.1 t -113.47 -170.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.977 -1.077 . . . . 10.0 110.19 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 137.62 -144.77 16.26 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.73 20.22 16.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 10.0 109.637 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.19 75.87 0.99 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.034 -1.626 . . . . 10.0 109.034 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.63 -174.59 3.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.427 -1.043 . . . . 10.0 109.766 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.534 ' HB ' ' CD2' ' B' ' 29' ' ' PHE . 40.6 t -67.13 161.77 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 10.0 110.647 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -53.02 111.97 1.98 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.427 -1.869 . . . . 10.0 108.427 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -48.61 -28.0 3.18 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.179 -1.189 . . . . 10.0 110.428 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.489 HG23 HD12 ' A' ' 20' ' ' LEU . 26.1 m -66.01 -30.62 71.2 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.15 -0.969 . . . . 10.0 111.072 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 16.3 p -63.2 -9.89 13.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.175 . . . . 10.0 109.733 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' B' ' 29' ' ' PHE . 5.3 mt -94.81 -34.08 12.62 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.424 -0.797 . . . . 10.0 110.184 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.489 HD12 HG23 ' A' ' 17' ' ' THR . 79.4 mt -46.49 -30.46 2.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 26' ' ' ASN 0.251 1.7 mm -85.76 -47.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.749 0.785 . . . . 10.0 109.552 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 21' ' ' ILE . 57.1 m -48.26 -38.34 18.4 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.887 -1.125 . . . . 10.0 108.115 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.778 ' CG ' HD11 ' A' ' 165' ' ' LEU . 20.2 m-85 -68.06 -31.0 70.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 25' ' ' THR . 95.9 m -76.83 -51.87 10.52 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.847 -0.533 . . . . 10.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 24' ' ' THR . 2.9 t -178.99 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 115.875 1.805 . . . . 10.0 115.875 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.699 ' OD1' HG23 ' A' ' 21' ' ' ILE . 15.4 m120 -67.47 -8.32 32.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.088 -1.632 . . . . 10.0 113.085 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.593 ' O ' ' O ' ' B' ' 27' ' ' GLY . 26.4 pttt 33.59 -131.6 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 121.195 -0.941 . . . . 10.0 111.262 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.644 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.7 p90 . . . . . 0 N--CA 1.507 2.381 0 O-C-N 120.5 -1.375 . . . . 10.0 112.815 -179.658 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' B' ' 19' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 CA-C-O 123.266 1.507 . . . . 10.0 114.945 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.978 ' CG2' HG11 ' B' ' 25' ' ' VAL 0.279 2.5 t -45.99 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 116.226 1.936 . . . . 10.0 116.226 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.855 ' N ' HG12 ' A' ' 36' ' ' VAL . 4.6 t80 -32.29 154.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.944 0.878 . . . . 10.0 111.603 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -168.03 83.0 0.18 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.565 ' HB3' HD13 ' B' ' 18' ' ' ILE . 50.8 t30 -113.66 109.11 18.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.159 -0.963 . . . . 10.0 110.017 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.718 ' CD2' ' HA ' ' B' ' 16' ' ' HIS . 3.6 t80 -128.43 128.35 44.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.694 -0.629 . . . . 10.0 110.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -141.58 94.68 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.878 HG13 ' HB2' ' B' ' 14' ' ' PHE 0.296 51.6 t -163.94 178.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.394 0.616 . . . . 10.0 110.227 -176.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 18.9 m -125.24 126.47 45.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.522 -0.736 . . . . 10.0 109.502 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.939 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -73.76 165.71 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 10.0 110.024 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.548 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 51.5 mtt -137.69 104.79 5.41 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.199 -1.0 . . . . 10.0 109.531 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' B' ' 7' ' ' GLU . 38.7 mt -123.75 128.79 74.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.751 -0.593 . . . . 10.0 109.734 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 52.18 21.39 8.13 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 8.61 67.87 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.155 -1.203 . . . . 10.0 110.302 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.47 112.56 65.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.836 -1.39 . . . . 10.0 110.976 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 44.1 Cg_endo -74.4 139.35 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.951 1.501 . . . . 10.0 110.251 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.939 ' HB2' HG12 ' A' ' 44' ' ' VAL . 3.6 t80 -117.49 121.37 40.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -0.95 . . . . 10.0 109.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -74.82 119.82 19.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.625 -1.297 . . . . 10.0 110.151 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 13.3 mt -123.11 149.31 44.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.915 . . . . 10.0 110.592 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 5' ' ' LYS . . . -170.89 110.47 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.752 -1.213 . . . . 10.0 110.332 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -150.41 168.43 24.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -1.211 . . . . 10.0 110.076 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 67' ' ' LEU . 32.9 p90 -166.36 140.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.882 -1.136 . . . . 10.0 111.218 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 3.8 t70 -119.72 159.99 23.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.394 -0.816 . . . . 10.0 110.444 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -56.31 -168.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.841 0.829 . . . . 10.0 112.131 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.735 ' HB2' ' CD1' ' A' ' 64' ' ' TYR . . . 53.5 70.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.637 -0.664 . . . . 10.0 110.865 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 66' ' ' ARG . . . -75.33 -9.04 84.3 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.326 -1.91 . . . . 10.0 108.326 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.602 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.8 tt0 -156.45 24.51 0.35 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.422 -1.046 . . . . 10.0 110.22 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 4.4 tt0 79.3 -7.63 1.71 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.494 -0.754 . . . . 10.0 109.963 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 1.1 m-20 -94.28 -11.47 30.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 10.0 108.759 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.735 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 46.7 m-85 62.65 26.67 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.142 -1.059 . . . . 10.0 108.142 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 30.5 t0 -114.88 -36.49 4.45 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.111 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 6.3 mmt85 -56.4 -26.18 52.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.905 -1.122 . . . . 10.0 108.934 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.67 HD11 ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.81 10.88 36.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.827 -0.546 . . . . 10.0 109.751 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.666 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -82.79 -20.37 0.28 Allowed Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 113.356 0.873 . . . . 10.0 113.356 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 45.9 Cg_endo -75.33 2.07 7.2 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 N-CA-C 110.37 -0.665 . . . . 10.0 110.37 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.638 ' N ' HD23 ' A' ' 70' ' ' LEU . 0.5 OUTLIER -52.78 -64.47 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.199 -0.938 . . . . 10.0 112.184 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.497 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 24.8 t 41.98 27.08 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.367 -1.458 . . . . 10.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 71' ' ' SER . 2.1 t80 -179.84 120.6 0.22 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 10.0 110.744 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.28 118.33 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.838 1.441 . . . . 10.0 110.225 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.71 66.74 1.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.964 -1.085 . . . . 10.0 110.584 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -145.33 99.99 3.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.16 -0.963 . . . . 10.0 109.703 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.66 ' CA ' HG21 ' A' ' 108' ' ' THR . 21.6 m-20 -24.63 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.953 0.724 . . . . 10.0 112.953 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.542 HG11 ' CB ' ' A' ' 176' ' ' ALA . 1.0 OUTLIER -94.03 118.0 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.964 -1.085 . . . . 10.0 110.781 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.504 ' CB ' HG21 ' A' ' 9' ' ' VAL . 97.3 m-85 -111.33 127.6 55.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 10.0 111.203 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 111' ' ' LEU . 1.9 mm? -95.44 97.69 9.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 10.0 108.342 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' HB ' ' A' ' 9' ' ' VAL . 1.6 m -106.41 148.18 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.397 -0.814 . . . . 10.0 109.822 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 7.2 t -138.17 122.37 18.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.855 -1.153 . . . . 10.0 110.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.542 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 43.0 p90 -124.46 172.95 8.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.239 -0.913 . . . . 10.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.851 ' OG ' HG22 ' A' ' 85' ' ' VAL . 47.3 t -105.24 148.81 26.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.7 -1.25 . . . . 10.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 19.4 m -86.79 19.02 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.478 -0.764 . . . . 10.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.851 HG22 ' OG ' ' A' ' 83' ' ' SER . 35.3 m -128.0 48.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.39 -0.819 . . . . 10.0 110.513 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.53 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 49.6 m -123.2 166.18 19.27 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.287 -0.883 . . . . 10.0 110.358 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . 48.2 Cg_endo -72.44 105.9 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.965 1.508 . . . . 10.0 111.056 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 39.46 42.9 0.93 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.304 -0.873 . . . . 10.0 110.836 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 86' ' ' SER . 65.6 m -79.15 -49.51 12.47 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.022 . . . . 10.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.652 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 34.9 t80 -57.53 -30.38 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.336 -0.853 . . . . 10.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 57.4 mm-40 -70.47 -15.09 62.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.051 -1.031 . . . . 10.0 110.504 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.697 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.63 -21.46 30.28 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.18 -1.008 . . . . 10.0 111.38 -178.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.697 HG13 ' ND2' ' A' ' 92' ' ' ASN . 4.2 m -87.68 -16.38 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 117.765 -1.574 . . . . 10.0 108.544 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.816 ' HE2' HD22 ' A' ' 145' ' ' LEU . 1.2 mmtp -68.68 -37.45 79.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 4.4 pt-20 -95.51 8.29 43.73 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.306 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -111.18 -52.09 2.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.58 -1.248 . . . . 10.0 112.595 -178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 19.7 m95 -95.59 -18.79 20.29 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.502 -0.749 . . . . 10.0 111.527 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.1 t -85.45 -46.85 0.61 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 120.97 -1.081 . . . . 10.0 111.5 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 51.4 Cg_endo -74.85 -24.15 13.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 108.759 -1.285 . . . . 10.0 108.759 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.526 ' C ' HG12 ' A' ' 101' ' ' ILE . 8.6 tt0 -87.59 -22.53 24.72 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.526 HG12 ' C ' ' A' ' 100' ' ' GLU . 4.2 mm 60.55 125.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.825 HG21 ' OG1' ' A' ' 108' ' ' THR . 1.2 m -40.84 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.04 -1.037 . . . . 10.0 109.761 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.7 ' N ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -108.32 10.74 27.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.222 -0.924 . . . . 10.0 109.778 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 17.5 m80 82.52 14.08 0.47 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.902 0.382 . . . . 10.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.537 ' HB3' ' CD ' ' A' ' 106' ' ' PRO . 1.6 t -170.65 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 118.814 -1.154 . . . . 10.0 112.029 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 105' ' ' CYS . 37.7 Cg_endo -63.77 -21.74 69.51 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.338 1.178 . . . . 10.0 111.532 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 106' ' ' PRO . 2.0 mttt 47.49 51.13 14.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.733 -1.229 . . . . 10.0 108.843 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.825 ' OG1' HG21 ' A' ' 102' ' ' THR . 1.4 m -45.65 150.48 0.93 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 108' ' ' THR . 39.6 Cg_endo -63.66 149.92 89.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.746 1.393 . . . . 10.0 112.748 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -131.73 109.5 10.21 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.068 HD13 HG11 ' A' ' 152' ' ' VAL . 1.9 mm? -77.2 95.4 4.29 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.028 -1.069 . . . . 10.0 109.388 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.42 ' C ' ' CG2' ' A' ' 113' ' ' VAL . 19.1 mt -75.62 142.02 42.73 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.154 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -148.32 -177.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.596 -1.315 . . . . 10.0 112.332 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -125.4 120.61 3.95 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.752 -1.739 . . . . 10.0 108.752 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 23.4 p -78.32 139.2 38.85 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.829 -1.395 . . . . 10.0 110.952 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 115' ' ' THR . 56.7 mt-30 34.41 57.38 0.67 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.204 0.526 . . . . 10.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -79.75 -27.72 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 10.0 110.592 -178.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.813 ' OD2' HG21 ' A' ' 161' ' ' THR . 25.1 t0 -51.88 61.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.835 0.826 . . . . 10.0 111.966 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.706 ' N ' ' O ' ' A' ' 117' ' ' ILE . 20.1 tp 152.79 -39.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.705 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 1.2 mpt_? -46.04 -25.66 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.855 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 4.1 p30 -84.69 -0.13 52.4 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.306 -0.872 . . . . 10.0 111.145 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.831 ' O ' HD13 ' A' ' 126' ' ' ILE . 5.8 p-10 -83.32 160.14 60.35 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.88 -1.138 . . . . 10.0 109.944 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.83 22.73 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.55 1.289 . . . . 10.0 111.769 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.479 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 4.2 m -109.68 -47.6 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.976 -1.078 . . . . 10.0 109.79 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.809 HG22 ' OD1' ' A' ' 122' ' ' ASP . 6.6 t -78.44 -27.14 46.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.828 -1.915 . . . . 10.0 105.828 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 122' ' ' ASP 0.283 1.0 OUTLIER -53.19 -28.82 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.391 -1.337 . . . . 10.0 107.391 177.02 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -52.99 -40.41 63.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.578 0.704 . . . . 10.0 111.308 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -60.4 -34.13 73.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.472 -0.767 . . . . 10.0 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.79 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -61.89 -39.16 90.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.831 -1.168 . . . . 10.0 109.659 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -52.83 -44.56 66.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.568 -0.708 . . . . 10.0 111.232 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -54.66 -18.12 4.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.149 -0.97 . . . . 10.0 110.376 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -126.9 -53.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.735 -1.228 . . . . 10.0 110.279 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -137.03 116.01 12.36 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.596 -0.69 . . . . 10.0 110.518 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.577 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -74.97 -3.02 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.697 -0.627 . . . . 10.0 110.5 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 93.97 6.55 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.579 -0.701 . . . . 10.0 109.277 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 49.3 Cg_endo -73.75 161.71 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.898 1.473 . . . . 10.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.53 HG12 ' CG ' ' A' ' 90' ' ' PHE . 1.5 tp -100.83 134.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.266 -0.896 . . . . 10.0 109.505 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.513 ' H ' HD12 ' A' ' 137' ' ' ILE . 20.1 p -120.04 165.56 17.59 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.352 -0.843 . . . . 10.0 109.807 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.71 -35.13 29.41 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.829 1.436 . . . . 10.0 111.063 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.09 -15.81 63.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.113 -0.992 . . . . 10.0 110.999 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.3 m -98.36 -36.54 9.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -64.57 -29.12 70.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.802 . . . . 10.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.81 -41.47 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.019 -1.05 . . . . 10.0 109.314 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -56.16 -36.96 68.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 10.0 109.465 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.816 HD22 ' HE2' ' A' ' 94' ' ' LYS . 4.2 tp -62.06 -49.55 75.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.116 -0.99 . . . . 10.0 108.902 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.11 -44.44 94.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.036 . . . . 10.0 109.406 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -78.04 -7.96 57.58 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.525 -0.734 . . . . 10.0 110.297 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.9 t70 -98.6 -37.88 9.36 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.388 1.09 . . . . 10.0 109.235 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.033 HD22 ' O ' ' A' ' 149' ' ' LEU 0.26 0.0 OUTLIER -103.07 -1.15 29.64 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.513 -178.658 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 24.4 mttm 67.78 54.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 10.0 111.359 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -86.24 -150.36 0.15 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.068 HG11 HD13 ' A' ' 111' ' ' LEU . 9.9 p -116.54 -51.56 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.567 -1.333 . . . . 10.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.893 ' HD3' HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -172.42 142.31 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.603 -1.31 . . . . 10.0 111.238 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 142' ' ' ALA . 46.6 t80 -94.26 110.15 21.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 10.0 109.069 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.893 HG13 ' HD3' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -116.19 -168.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.973 -1.08 . . . . 10.0 112.087 -178.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -153.27 147.04 25.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 10.0 110.781 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 25.6 p -148.07 152.51 37.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 10.0 111.275 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' ' OG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -135.14 86.23 2.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.192 -1.41 . . . . 10.0 107.192 178.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.643 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . . . -24.37 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.7 tp -94.12 -55.05 3.34 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.403 -1.436 . . . . 10.0 112.196 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.813 HG21 ' OD2' ' A' ' 118' ' ' ASP . 24.5 p -64.68 -26.68 68.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.96 -1.087 . . . . 10.0 111.008 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.536 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.8 mt-30 79.26 77.05 0.05 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.528 -0.732 . . . . 10.0 112.024 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.523 ' HD2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -78.35 47.99 0.73 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 10.0 110.006 178.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 163' ' ' LYS . . . 43.49 41.68 5.46 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.706 -1.358 . . . . 10.0 109.706 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.778 HD11 ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.11 2.51 3.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 10.0 112.704 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 165' ' ' LEU . 26.9 tttp -58.47 -23.64 58.28 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.782 -1.199 . . . . 10.0 108.694 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -76.86 -17.61 58.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.692 -0.63 . . . . 10.0 111.038 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.825 HG22 ' HB ' ' A' ' 155' ' ' VAL . 42.8 t -67.9 -41.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.822 -1.174 . . . . 10.0 108.775 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -86.55 -47.57 9.12 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.599 0.714 . . . . 10.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.867 ' HA ' HD12 ' A' ' 173' ' ' ILE . 22.1 t0 -51.88 -35.14 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.336 -0.852 . . . . 10.0 111.789 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.6 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.3 mm-40 -90.02 -11.28 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.058 . . . . 10.0 110.771 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.831 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -91.74 -15.27 28.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.038 -1.097 . . . . 10.0 108.038 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 170' ' ' ASP . 53.9 mt -73.63 -49.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.097 -0.641 . . . . 10.0 109.322 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 171' ' ' GLU . 2.1 pt? -76.35 -19.12 58.5 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 118.813 -1.155 . . . . 10.0 111.113 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.41 -14.78 34.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 10.0 110.085 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.542 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -70.25 -44.87 67.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 10.0 109.653 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.7 OUTLIER -74.64 -29.09 61.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.744 0.783 . . . . 10.0 109.055 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -129.81 151.77 50.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 10.0 110.601 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.44 92.49 4.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 10.0 110.065 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.02 165.94 12.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.499 -0.75 . . . . 10.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.664 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.62 -149.76 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.664 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -73.23 96.18 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 N-CA-C 109.772 -0.896 . . . . 10.0 109.772 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.751 ' HB2' HG22 ' A' ' 46' ' ' ILE . 19.6 mm-40 -49.56 -169.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.605 0.717 . . . . 10.0 110.249 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.706 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -77.64 -42.47 29.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.756 -1.215 . . . . 10.0 111.949 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.66 ' N ' HG12 ' B' ' 8' ' ' ILE . 20.7 t -134.78 172.67 12.65 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.06 -1.025 . . . . 10.0 111.348 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.644 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.5 pp -167.25 98.02 0.64 Allowed Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.293 -0.963 . . . . 10.0 111.805 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 38.4 Cg_endo -69.19 134.69 29.85 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 N-CA-C 108.001 -1.577 . . . . 10.0 108.001 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' B' ' 11' ' ' PRO . 0.9 OUTLIER -53.13 -169.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.689 -1.257 . . . . 10.0 111.388 -178.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.69 ' OD1' HG11 ' A' ' 42' ' ' VAL . 6.0 p30 -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.992 0.901 . . . . 10.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.878 ' HB2' HG13 ' A' ' 42' ' ' VAL . 49.9 m-85 -54.92 -165.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.8 0.81 . . . . 10.0 111.547 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.682 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.5 tt0 -43.59 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.718 ' HA ' ' CD2' ' A' ' 40' ' ' TYR . 14.2 p80 -146.58 -169.41 3.27 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.569 0.699 . . . . 10.0 111.871 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -79.85 163.17 24.59 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.972 0.891 . . . . 10.0 112.423 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.785 ' N ' HD12 ' B' ' 18' ' ' ILE . 3.3 mp -126.19 175.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.798 -0.816 . . . . 10.0 108.798 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.549 ' CB ' ' OG1' ' A' ' 35' ' ' THR . 79.3 m-70 -141.59 115.55 9.24 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.491 -1.38 . . . . 10.0 112.094 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.612 ' H ' ' N ' ' A' ' 37' ' ' PHE . 18.4 t -144.96 103.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 114.055 1.132 . . . . 10.0 114.055 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.684 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . -150.69 -72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.614 -0.995 . . . . 10.0 110.614 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.827 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.1 t80 175.86 134.02 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.66 -1.607 . . . . 10.0 106.66 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 89.0 m-20 -39.0 131.37 1.41 Allowed 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 122.043 0.925 . . . . 10.0 111.252 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.586 ' HB1' ' OE2' ' B' ' 28' ' ' GLU . . . 69.47 46.41 0.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.865 -0.522 . . . . 10.0 111.383 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.978 HG11 ' CG2' ' A' ' 36' ' ' VAL . 25.4 t -111.0 -57.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.919 -1.113 . . . . 10.0 109.181 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 38.6 m -51.85 -24.84 6.72 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.176 0.988 . . . . 10.0 109.228 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.667 ' HA3' ' HB2' ' A' ' 26' ' ' ASN . . . -115.63 46.25 1.19 Allowed Glycine 0 N--CA 1.482 1.757 0 N-CA-C 107.727 -2.149 . . . . 10.0 107.727 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.586 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 2.2 mt-10 -162.58 123.54 2.51 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.643 0.735 . . . . 10.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.751 ' HB2' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -122.24 129.26 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 178.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' GLY . 16.6 p -143.85 174.16 11.07 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.587 -0.696 . . . . 10.0 111.032 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' THR . . . 35.78 -152.65 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.448 -1.061 . . . . 10.0 110.448 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.425 ' O ' HG23 ' B' ' 32' ' ' ILE . 0.5 OUTLIER -150.81 70.45 8.69 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.99 . . . . 10.0 109.473 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.522 ' HB2' ' CH2' ' B' ' 36' ' ' TRP . 51.0 Cg_endo -73.61 177.85 7.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.573 1.828 . . . . 10.0 111.92 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' CZ3' ' B' ' 36' ' ' TRP . 24.3 tt0 -57.83 159.45 5.4 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 10.0 111.006 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 21.2 pt20 -83.51 11.82 6.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.719 -0.613 . . . . 10.0 111.376 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.753 ' HD1' HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER 70.18 36.53 1.85 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.768 0.794 . . . . 10.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . . . . . . . . . . . -168.57 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.66 -0.65 . . . . 10.0 110.904 179.461 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CG ' ' OE1' ' B' ' 35' ' ' GLN . 2.2 mmt180 . . . . . 0 N--CA 1.493 1.675 0 O-C-N 120.676 -1.265 . . . . 10.0 110.131 179.397 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.066 0.46 . . . . 10.0 110.122 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.714 ' HB3' HD23 ' A' ' 177' ' ' LEU . 1.8 mt-30 -95.75 -17.94 20.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -43.2 99.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.631 -0.668 . . . . 10.0 110.54 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.071 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -116.45 121.03 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 10.0 110.595 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.957 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -93.47 131.27 38.84 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.805 ' HB3' HD23 ' A' ' 55' ' ' LEU . 94.4 m -110.36 103.79 12.48 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.743 -1.223 . . . . 10.0 110.39 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 56' ' ' PHE . 46.1 t -142.82 162.8 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.229 -0.988 . . . . 10.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -80.46 152.14 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.157 -1.017 . . . . 10.0 109.432 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 10' ' ' GLY . 3.3 t -83.13 -170.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.255 -0.903 . . . . 10.0 110.193 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -95.58 42.16 2.36 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.776 -1.202 . . . . 10.0 111.218 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 80' ' ' VAL . 2.5 t0 -82.16 -31.35 30.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.707 -1.467 . . . . 10.0 109.006 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.551 ' HA2' ' C ' ' B' ' 34' ' ' GLU . . . 61.48 51.53 57.18 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.236 -1.546 . . . . 10.0 109.236 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB1' ' NE2' ' A' ' 116' ' ' GLN . . . -160.32 -77.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 10.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.883 HG13 ' HG ' ' A' ' 19' ' ' LEU . 89.5 t -112.17 117.94 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 10.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CZ2' ' B' ' 36' ' ' TRP . . . -98.95 143.79 16.82 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.784 -1.326 . . . . 10.0 109.784 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -65.4 -21.42 66.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 10.0 112.283 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -99.52 -36.14 9.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.389 -1.444 . . . . 10.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' B' ' 28' ' ' GLU . 26.2 p -73.71 -29.91 62.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.024 -1.047 . . . . 10.0 109.798 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.883 ' HG ' HG13 ' A' ' 14' ' ' VAL . 3.7 mm? -86.78 -18.02 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.868 -1.145 . . . . 10.0 110.49 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.52 -41.4 76.69 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.038 0.923 . . . . 10.0 108.878 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' B' ' 28' ' ' GLU . 7.3 mm -69.04 -39.78 80.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.71 0.767 . . . . 10.0 110.205 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -47.16 -45.93 23.15 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.585 -0.846 . . . . 10.0 109.814 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.648 ' CZ ' ' O ' ' A' ' 159' ' ' ALA . 4.9 m-85 -93.58 3.76 55.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.651 -1.281 . . . . 10.0 110.184 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 2.9 m -110.94 -21.25 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.816 -1.177 . . . . 10.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.43 ' O ' ' CG ' ' A' ' 26' ' ' ASN . 0.6 OUTLIER -88.07 -76.25 0.39 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.456 -1.403 . . . . 10.0 108.647 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 19.1 m120 -156.17 -33.66 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.563 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.575 ' HD2' ' HB2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER 175.03 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.188 0.518 . . . . 10.0 109.95 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER . . . . . 0 C--N 1.297 -1.683 0 O-C-N 121.183 -0.948 . . . . 10.0 112.26 -178.89 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 5.8 t . . . . . 0 N--CA 1.494 1.768 0 CA-C-O 121.352 0.596 . . . . 10.0 110.865 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 62' ' ' GLU . 65.3 t 61.57 5.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.747 -0.595 . . . . 10.0 111.101 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.641 ' O ' ' O ' ' A' ' 38' ' ' ASP . 1.7 t80 -42.29 100.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.476 -0.765 . . . . 10.0 109.829 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.767 ' H ' ' H ' ' B' ' 19' ' ' HIS . 0.5 OUTLIER -47.19 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.884 0.85 . . . . 10.0 111.648 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.796 ' HB3' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -156.55 -167.61 2.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.932 -1.73 . . . . 10.0 111.417 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.632 ' CE1' HD13 ' B' ' 18' ' ' ILE . 7.8 m-30 -112.96 153.48 27.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.411 -0.805 . . . . 10.0 112.852 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.627 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . . . -135.64 119.69 17.57 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' B' ' 15' ' ' GLU . 0.5 OUTLIER -171.81 176.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.368 -1.458 . . . . 10.0 111.709 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' TYR . 66.1 m -129.49 130.92 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.773 -0.58 . . . . 10.0 110.21 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 46' ' ' ILE . 13.2 t -105.17 150.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 10.0 109.42 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.716 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 94.7 mtp -117.65 95.62 5.02 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.798 -1.556 . . . . 10.0 106.798 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.75 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 3.2 mp -102.8 130.46 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.136 0.493 . . . . 10.0 111.513 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 40.1 27.69 0.14 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.837 -1.173 . . . . 10.0 110.745 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.76 18.18 45.41 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.011 -1.288 . . . . 10.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.0 mm-40 -114.87 98.98 51.35 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.294 . . . . 10.0 109.87 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 53.3 Cg_endo -77.89 118.34 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.972 1.511 . . . . 10.0 110.94 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.926 ' O ' HG23 ' A' ' 43' ' ' THR . 2.7 m-85 -89.05 117.6 28.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.992 -1.068 . . . . 10.0 109.385 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -100.56 104.19 15.53 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.065 -1.022 . . . . 10.0 111.029 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -158.08 178.44 10.2 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.444 -1.302 . . . . 10.0 111.381 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.851 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.32 111.46 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.965 -1.654 . . . . 10.0 108.965 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 6' ' ' CYS . 1.8 tm? -130.47 132.8 45.85 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.846 -1.385 . . . . 10.0 110.781 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.766 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 p90 -152.57 155.31 37.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 10.0 109.789 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 15.8 t0 -99.15 179.8 4.49 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.631 -1.293 . . . . 10.0 110.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.7 m -104.81 117.3 33.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 10.0 111.137 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . . . -65.7 91.2 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 10.0 110.256 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.528 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -68.92 63.07 0.5 Allowed Glycine 0 N--CA 1.485 1.908 0 N-CA-C 107.816 -2.114 . . . . 10.0 107.816 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ALA . 22.0 tt0 75.03 21.03 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.985 -0.715 . . . . 10.0 110.569 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 36' ' ' VAL . 9.0 mm-40 -50.07 -46.08 53.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.338 -1.345 . . . . 10.0 109.68 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER 162.37 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.163 -0.961 . . . . 10.0 110.923 178.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -178.06 44.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.916 -1.115 . . . . 10.0 109.3 -179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 13.9 p-10 -81.4 38.5 0.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.306 -0.871 . . . . 10.0 110.169 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -49.91 -28.06 6.13 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.272 -0.892 . . . . 10.0 109.111 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 67' ' ' LEU . 3.1 mp -81.67 11.12 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 10.0 109.361 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.635 ' C ' HD23 ' A' ' 70' ' ' LEU . 4.5 ptt85 -60.19 -24.76 1.63 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.852 . . . . 10.0 112.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 47.9 Cg_endo -89.92 86.57 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 109.523 -0.991 . . . . 10.0 109.523 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.1 OUTLIER -117.64 -78.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.965 . . . . 10.0 111.831 -178.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.5 m 62.03 39.62 13.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 10.0 109.365 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 76.79 41.94 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 10.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.43 113.44 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.135 1.598 . . . . 10.0 110.385 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -163.62 89.59 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 10.0 110.184 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 5' ' ' LYS . 23.0 m -145.89 98.64 3.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.104 -0.997 . . . . 10.0 109.173 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 19.9 t70 -25.77 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.046 0.45 . . . . 10.0 112.15 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -107.68 126.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.947 -1.096 . . . . 10.0 109.897 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.4 m-85 -130.33 139.41 50.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 10.0 110.921 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.708 ' CD1' HG13 ' A' ' 168' ' ' VAL . 1.9 mm? -113.6 98.54 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 11' ' ' ASP . 9.3 p -97.37 137.47 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 10.0 110.846 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 115' ' ' THR . 65.3 m -121.47 112.15 18.16 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.263 -0.898 . . . . 10.0 110.609 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CZ ' ' HD1' ' A' ' 90' ' ' PHE . 35.1 p90 -129.24 160.37 33.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.214 -0.928 . . . . 10.0 110.538 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 116' ' ' GLN . 51.0 m -79.16 162.54 25.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.34 -0.85 . . . . 10.0 111.277 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 137' ' ' ILE . 30.7 m -102.15 23.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.672 -0.643 . . . . 10.0 110.349 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.74 ' CG2' HD23 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -142.02 28.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.201 -0.937 . . . . 10.0 109.875 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.586 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -85.93 -173.84 0.46 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.03 . . . . 10.0 110.294 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 50.4 Cg_endo -75.2 72.09 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.889 1.468 . . . . 10.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 m 46.87 40.64 9.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.351 -0.843 . . . . 10.0 110.189 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.602 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 11.8 p -76.46 -25.68 54.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 10.0 110.689 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 74.1 t80 -75.1 -18.7 60.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.475 -0.765 . . . . 10.0 112.617 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.79 -17.34 36.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.458 -1.401 . . . . 10.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.674 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -88.84 -14.9 35.85 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.051 -1.03 . . . . 10.0 109.673 179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 1.086 HG23 ' HD3' ' A' ' 94' ' ' LYS . 12.8 m -84.76 -20.8 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 118.863 -1.135 . . . . 10.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 1.086 ' HD3' HG23 ' A' ' 93' ' ' VAL . 20.8 mmtt -80.08 -30.54 39.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.919 0.866 . . . . 10.0 109.544 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -96.88 9.44 41.87 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.65 -0.82 . . . . 10.0 109.415 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.8 -51.43 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.094 -1.042 . . . . 10.0 111.044 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 35.5 m95 -90.53 -40.52 11.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.187 -0.946 . . . . 10.0 112.376 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 92.0 t -53.0 -47.75 94.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.581 -1.324 . . . . 10.0 111.135 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.3 Cg_endo -75.14 -17.26 19.39 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.215 1.113 . . . . 10.0 110.644 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -69.52 -23.95 63.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.097 -1.002 . . . . 10.0 111.551 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 18.0 mt 54.75 99.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.564 -1.335 . . . . 10.0 109.776 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.58 HG21 ' HG2' ' A' ' 106' ' ' PRO . 21.0 m -46.89 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 10.0 109.6 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 37.6 t60 -110.46 -6.73 14.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.269 -0.894 . . . . 10.0 108.752 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 154.79 -49.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.61 ' H ' ' HD3' ' A' ' 106' ' ' PRO . 0.6 OUTLIER -176.14 46.19 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.716 -0.675 . . . . 10.0 110.746 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' H ' ' A' ' 105' ' ' CYS . 57.0 Cg_endo -78.94 -29.47 3.33 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.288 1.152 . . . . 10.0 109.539 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 71.1 57.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.53 0.681 . . . . 10.0 110.511 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.574 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 2.9 m -46.55 149.6 1.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 10.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 38.4 Cg_endo -63.56 114.22 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.683 1.359 . . . . 10.0 110.762 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 2.2 t80 -115.11 107.6 15.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.458 -0.776 . . . . 10.0 109.173 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.0 ' CD1' HG11 ' A' ' 152' ' ' VAL . 2.0 mm? -96.32 103.69 15.61 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.59 0.71 . . . . 10.0 109.61 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 83.7 mt -85.88 143.29 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.663 -0.648 . . . . 10.0 111.029 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.6 t -141.86 170.53 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.992 -1.068 . . . . 10.0 111.482 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -134.93 98.13 0.3 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 106.934 -2.467 . . . . 10.0 106.934 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.712 HG22 ' SG ' ' A' ' 157' ' ' CYS . 27.1 p -114.55 -171.12 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 10.0 111.501 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.758 ' NE2' ' HB1' ' A' ' 13' ' ' ALA . 78.3 mt-30 56.55 18.44 3.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.53 -0.731 . . . . 10.0 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.007 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -82.94 -22.01 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.934 -0.706 . . . . 10.0 109.297 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 7.7 p-10 -51.52 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 122.051 0.929 . . . . 10.0 111.057 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.744 ' N ' ' O ' ' A' ' 117' ' ' ILE . 17.3 tp 157.85 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.681 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.03 -43.01 14.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.0 p-10 -50.29 -23.49 2.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.507 0.67 . . . . 10.0 109.682 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 76.9 m-20 -87.59 138.08 31.87 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.993 -0.683 . . . . 10.0 110.201 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.4 Cg_endo -80.09 23.37 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.174 1.618 . . . . 10.0 110.865 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 t -102.52 -50.65 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.882 -1.136 . . . . 10.0 110.285 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.624 ' HB ' HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.57 -26.45 45.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.295 1.1 mp -61.24 -23.22 29.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.555 -1.202 . . . . 10.0 107.801 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -49.09 -41.06 34.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.586 0.708 . . . . 10.0 110.501 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -89.26 -30.59 18.38 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.608 0.718 . . . . 10.0 110.397 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.8 mp -74.73 -49.85 19.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 10.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.498 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -61.74 -42.68 99.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.599 -0.688 . . . . 10.0 110.394 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -53.69 -20.07 4.92 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.007 -1.077 . . . . 10.0 108.997 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -85.16 -44.09 13.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 10.0 109.648 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 133.95 19.79 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.538 0.685 . . . . 10.0 109.926 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.524 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -83.23 -4.16 58.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 10.0 110.269 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -119.18 103.04 48.02 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 10.0 111.54 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.1 Cg_endo -69.92 162.4 42.3 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.033 1.544 . . . . 10.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.591 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -99.55 138.28 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 10.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.8 p -126.07 170.21 10.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 10.0 109.737 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 43.3 Cg_endo -68.63 -15.02 40.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.531 1.279 . . . . 10.0 110.46 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.38 -42.04 54.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 10.0 109.762 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -75.52 -40.95 56.31 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.732 -0.605 . . . . 10.0 110.553 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.89 -44.94 65.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 10.0 111.269 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.8 -43.93 48.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 10.0 109.619 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 67.4 tttt -66.42 -40.32 89.48 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.508 -0.745 . . . . 10.0 109.294 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 148' ' ' ASP . 2.1 tt -63.66 -48.26 77.94 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.559 -0.856 . . . . 10.0 109.42 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.645 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.42 -42.12 86.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 10.0 108.93 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -80.66 1.86 28.26 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.679 -0.808 . . . . 10.0 108.991 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.607 ' HB3' HD13 ' A' ' 149' ' ' LEU . 14.4 t70 -79.21 -31.82 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.48 -0.763 . . . . 10.0 112.214 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.921 HD13 ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -135.65 -8.17 2.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.032 -1.668 . . . . 10.0 113.088 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.676 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 6.2 pttt 125.93 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.899 0.88 . . . . 10.0 111.703 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.645 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -116.83 -177.44 3.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.882 -1.136 . . . . 10.0 109.65 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.0 HG11 ' CD1' ' A' ' 111' ' ' LEU . 1.1 t -90.16 -78.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.766 -1.208 . . . . 10.0 109.531 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.833 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -171.93 164.53 6.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.023 -1.048 . . . . 10.0 111.093 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 57.8 t80 -104.76 101.1 10.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.411 -0.806 . . . . 10.0 109.562 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' A' ' 168' ' ' VAL . 38.2 t -87.76 169.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 10.0 109.137 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' N ' HG12 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -134.64 121.67 21.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.929 -1.107 . . . . 10.0 109.737 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG22 ' A' ' 115' ' ' THR . 25.6 p -141.23 169.99 16.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.051 -1.031 . . . . 10.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.583 ' N ' ' HB2' ' A' ' 162' ' ' GLN . 1.1 t -143.76 118.6 9.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.691 -0.631 . . . . 10.0 109.576 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.893 ' HB1' ' CZ ' ' B' ' 29' ' ' PHE . . . -12.25 -54.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.569 0.951 . . . . 10.0 113.569 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.5 pp -131.9 -3.82 3.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.471 -1.393 . . . . 10.0 111.788 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 158' ' ' SER . 59.5 m -98.05 -90.17 0.28 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.664 -1.273 . . . . 10.0 111.995 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB2' ' N ' ' A' ' 158' ' ' SER . 1.7 mm-40 -38.3 -39.44 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.945 . . . . 10.0 111.98 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.62 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 18.4 ttpt 49.5 26.29 1.65 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.056 -1.058 . . . . 10.0 108.938 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -94.62 -8.3 59.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.008 -1.637 . . . . 10.0 109.008 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -49.81 -9.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.414 -1.051 . . . . 10.0 112.306 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.775 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.17 -46.19 65.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.352 -1.468 . . . . 10.0 111.061 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 167' ' ' ASN . 1.4 m-80 -59.39 -27.97 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 10.0 108.298 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' A' ' 155' ' ' VAL . 0.5 OUTLIER -51.48 -50.68 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.576 0.703 . . . . 10.0 110.897 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.584 ' N ' HG12 ' A' ' 168' ' ' VAL . 18.4 t80 -87.14 -25.74 23.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.499 -0.751 . . . . 10.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.0 t70 -50.39 -49.55 54.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 10.0 109.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.0 mp0 -67.12 -45.02 78.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 10.0 110.257 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.954 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -50.95 -21.21 1.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 10.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 177' ' ' LEU . 24.4 mm -70.07 -43.86 78.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 10.0 110.338 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.899 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.42 -23.82 34.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.577 -1.327 . . . . 10.0 111.068 -178.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.46 -11.55 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 10.0 111.322 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.071 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -80.42 -45.92 16.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.229 . . . . 10.0 109.991 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 173' ' ' ILE . 1.1 mp -89.99 -19.62 24.24 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.96 0.886 . . . . 10.0 108.917 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 10.0 110.337 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.473 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.576 -1.41 . . . . 10.0 109.576 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -75.89 145.08 40.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 10.0 109.99 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.543 ' CD ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -98.85 93.36 6.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.056 -1.028 . . . . 10.0 110.614 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.421 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 30.2 mm-40 -129.75 159.64 35.88 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.439 0.638 . . . . 10.0 110.49 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.26 -158.18 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 106.834 -1.543 . . . . 10.0 106.834 177.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -67.41 112.47 2.59 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 N-CA-C 109.236 -1.101 . . . . 10.0 109.236 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' HG22 ' A' ' 46' ' ' ILE . 12.1 tp10 -55.29 -128.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.605 0.717 . . . . 10.0 110.717 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -78.97 -101.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.892 -1.13 . . . . 10.0 109.682 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.666 ' H ' HG23 ' B' ' 8' ' ' ILE . 25.3 t -142.91 112.2 6.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.341 -1.475 . . . . 10.0 111.895 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -171.04 97.54 0.42 Allowed Pre-proline 0 N--CA 1.489 1.517 0 CA-C-O 121.632 0.73 . . . . 10.0 109.605 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.69 99.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.074 1.849 . . . . 10.0 111.214 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.4 m -136.62 98.41 3.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.691 -1.255 . . . . 10.0 109.748 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -167.4 138.79 3.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.63 -1.228 . . . . 10.0 112.364 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.579 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 58.3 m-85 -115.71 107.31 14.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.695 . . . . 10.0 110.305 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.655 ' HB3' HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -88.81 174.19 8.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.782 1.277 . . . . 10.0 113.242 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -90.0 -165.75 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.552 -1.204 . . . . 10.0 112.317 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -119.41 146.12 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.669 -0.645 . . . . 10.0 109.816 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.632 HD13 ' CE1' ' A' ' 40' ' ' TYR . 1.3 mp -76.77 173.06 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 10.0 112.463 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.767 ' H ' ' H ' ' A' ' 38' ' ' ASP . 27.4 m170 -141.95 117.28 10.16 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.436 0.902 . . . . 10.0 113.436 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.519 ' HB ' ' HD1' ' A' ' 37' ' ' PHE . 2.8 p -144.93 143.58 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.237 -0.914 . . . . 10.0 110.562 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 62' ' ' GLU . . . -148.12 30.69 1.33 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.668 -1.253 . . . . 10.0 110.178 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.699 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -171.69 91.26 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.021 -1.282 . . . . 10.0 110.392 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' B' ' 24' ' ' ALA . 4.1 m-20 -67.39 151.78 46.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.852 -1.155 . . . . 10.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.464 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.71 54.92 0.69 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.671 -0.643 . . . . 10.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.699 HG21 ' CD1' ' B' ' 22' ' ' PHE . 0.9 OUTLIER -113.61 -36.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.239 -0.984 . . . . 10.0 108.687 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.832 HG23 ' N ' ' B' ' 29' ' ' PHE 0.262 0.5 OUTLIER -149.62 11.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.125 -1.03 . . . . 10.0 112.946 -178.148 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 59.09 30.56 67.17 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.719 -2.952 . . . . 10.0 105.719 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.602 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER 59.34 16.68 5.23 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.692 0.758 . . . . 10.0 109.328 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.893 ' CZ ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -143.26 147.82 35.41 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.211 0.529 . . . . 10.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.794 HG22 ' OG1' ' B' ' 26' ' ' THR . 19.0 p -134.81 -178.55 5.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.163 . . . . 10.0 110.213 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.19 -28.73 9.56 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.013 -1.089 . . . . 10.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.723 HG22 ' O ' ' B' ' 32' ' ' ILE . 31.4 mm -132.97 50.76 5.99 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.605 -1.527 . . . . 10.0 111.56 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.551 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 55.8 Cg_endo -75.5 150.58 36.28 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.615 1.324 . . . . 10.0 110.651 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.551 ' C ' ' HA2' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -75.12 -169.75 1.0 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.998 -1.064 . . . . 10.0 109.226 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 1.2 mp0 -76.43 20.4 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.19 -0.944 . . . . 10.0 110.779 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.639 ' CD2' HG11 ' A' ' 8' ' ' VAL . 8.5 m-90 65.7 20.71 11.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.802 -1.555 . . . . 10.0 106.802 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.862 ' HA ' HD11 ' A' ' 70' ' ' LEU . . . -155.02 83.06 1.08 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.482 ' HD2' ' OE2' ' B' ' 34' ' ' GLU . 22.2 tpt180 . . . . . 0 N--CA 1.489 1.509 0 CA-C-O 122.751 1.262 . . . . 10.0 107.988 -179.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.602 ' CG ' HD22 ' A' ' 177' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.705 0.288 . . . . 10.0 110.41 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -179.19 152.78 0.56 Allowed 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.166 -0.959 . . . . 10.0 110.002 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 52' ' ' THR . 85.1 m 61.42 48.43 5.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 113.707 1.003 . . . . 10.0 113.707 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -112.66 128.86 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.159 -1.588 . . . . 10.0 110.942 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 1.041 ' CB ' HG23 ' A' ' 75' ' ' THR . 4.1 mmtm -118.11 147.53 43.2 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.3 t -119.26 106.05 11.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.837 -1.165 . . . . 10.0 109.993 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 8' ' ' VAL . 4.0 t -128.41 170.88 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.769 -1.207 . . . . 10.0 110.966 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 16' ' ' LYS . 8.5 t -85.25 129.92 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.469 -0.769 . . . . 10.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 10' ' ' GLY . 40.6 t -132.46 176.55 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.972 -1.08 . . . . 10.0 111.567 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 131.95 -173.27 20.7 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.067 -1.613 . . . . 10.0 109.067 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 11' ' ' ASP . 2.3 p30 -84.67 15.43 3.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.432 . . . . 10.0 109.559 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.635 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 89.27 52.8 2.63 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.588 -1.805 . . . . 10.0 108.588 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -133.13 105.2 6.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.721 -0.87 . . . . 10.0 109.19 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 4.5 t 66.71 119.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -0.806 . . . . 10.0 109.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.503 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -90.13 115.07 4.5 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.912 -1.675 . . . . 10.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.54 -19.98 2.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.65 -1.5 . . . . 10.0 111.482 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.681 HG21 ' CG ' ' A' ' 57' ' ' ASP . 88.9 m -82.1 -41.8 20.03 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.721 -1.237 . . . . 10.0 111.809 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HA ' HG23 ' B' ' 26' ' ' THR . 23.7 p -79.73 1.79 25.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.809 -1.182 . . . . 10.0 109.909 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 159' ' ' ALA . 3.2 mm? -109.11 -41.31 4.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.843 -1.161 . . . . 10.0 109.52 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.804 HD12 HD21 ' A' ' 165' ' ' LEU . 1.5 tp -48.14 -34.07 9.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.629 HG13 HG22 ' B' ' 26' ' ' THR . 2.5 mm -73.83 -41.7 53.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.409 -0.959 . . . . 10.0 108.409 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 23.0 t -48.55 -41.76 31.36 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.445 -0.902 . . . . 10.0 110.117 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -97.26 -0.63 46.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.556 -1.34 . . . . 10.0 109.405 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 17.5 m -109.99 -19.01 13.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.012 . . . . 10.0 112.58 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 37.8 m -116.76 -72.34 0.69 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.231 -1.543 . . . . 10.0 111.544 -178.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 34.1 m-20 -147.73 -33.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.311 -1.356 . . . . 10.0 112.773 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 165.83 -138.8 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 O-C-N 121.331 -0.856 . . . . 10.0 111.606 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.601 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.0 OUTLIER . . . . . 0 N--CA 1.497 1.912 0 O-C-N 121.131 -0.981 . . . . 10.0 113.457 -177.731 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG23 ' B' ' 20' ' ' VAL . 22.3 p . . . . . 0 N--CA 1.5 2.036 0 N-CA-C 113.24 0.83 . . . . 10.0 113.24 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 58' ' ' THR . 58.1 t 62.99 -43.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.72 -0.613 . . . . 10.0 111.358 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.724 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 7.8 p90 -36.38 100.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.161 0.981 . . . . 10.0 110.374 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.952 ' HB3' HD11 ' A' ' 55' ' ' LEU . 1.5 m-20 -167.71 102.92 0.49 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 117.297 -1.761 . . . . 10.0 112.489 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.623 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 61.4 t30 -147.8 98.78 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.069 -1.019 . . . . 10.0 108.361 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 75.6 m-85 -139.73 147.05 40.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.86 -1.136 . . . . 10.0 112.65 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' B' ' 16' ' ' HIS . . . -140.85 98.55 3.42 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.835 HG23 ' O ' ' B' ' 14' ' ' PHE . 7.5 p -135.23 -173.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -0.854 . . . . 10.0 110.269 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 42' ' ' VAL . 94.1 m -136.72 167.29 21.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.48 152.24 37.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.215 -1.031 . . . . 10.0 108.215 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.737 ' C ' HD12 ' A' ' 46' ' ' ILE . 7.1 mtm -144.67 131.15 19.82 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.001 -0.68 . . . . 10.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.737 HD12 ' C ' ' A' ' 45' ' ' MET . 1.4 mp -147.94 114.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.204 -0.935 . . . . 10.0 110.693 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 67.51 6.5 42.14 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.934 -1.267 . . . . 10.0 109.934 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.54 24.06 6.31 Favored Glycine 0 N--CA 1.489 2.179 0 O-C-N 121.064 -1.257 . . . . 10.0 110.008 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 13.7 pt-20 -118.67 111.33 37.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.33 . . . . 10.0 109.723 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.49 146.94 57.03 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.87 1.458 . . . . 10.0 111.542 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 44' ' ' VAL . 2.8 m-85 -136.71 107.12 6.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.348 -0.845 . . . . 10.0 111.122 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.818 HG21 ' H ' ' A' ' 3' ' ' THR . 47.3 m -83.64 153.04 24.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.164 -0.96 . . . . 10.0 109.169 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 53' ' ' LEU . 1.4 pp -167.26 166.34 14.81 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.716 -1.24 . . . . 10.0 110.765 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.61 131.92 2.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.405 -1.478 . . . . 10.0 109.405 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.041 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.63 124.03 49.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -1.034 . . . . 10.0 109.403 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.913 ' N ' HD22 ' A' ' 55' ' ' LEU . 5.1 m-85 -135.96 104.51 5.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.11 -0.994 . . . . 10.0 110.259 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.681 ' CG ' HG21 ' A' ' 17' ' ' THR . 23.5 t0 -105.34 146.36 29.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.141 -0.975 . . . . 10.0 110.231 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.735 ' O ' HG13 ' A' ' 36' ' ' VAL . 66.5 m -45.72 131.15 9.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.345 -0.847 . . . . 10.0 109.283 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -101.26 89.75 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.607 -0.683 . . . . 10.0 111.305 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . -53.41 -23.78 20.49 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.558 -2.217 . . . . 10.0 107.558 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' B' ' 21' ' ' GLY . 29.1 tt0 178.02 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 122.004 -0.704 . . . . 10.0 109.516 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 64' ' ' TYR . 9.6 tm-20 -53.62 -51.95 61.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.129 -0.982 . . . . 10.0 110.687 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER 177.05 -17.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.275 -0.891 . . . . 10.0 110.988 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.54 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 19.9 p90 -119.74 16.53 12.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.004 -1.06 . . . . 10.0 109.395 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 38.0 t0 -37.42 -30.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.729 -0.607 . . . . 10.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.517 ' HG3' HD23 ' A' ' 67' ' ' LEU . 12.6 ptp180 -51.03 -22.22 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 10.0 110.004 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.544 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.9 mm? -106.95 11.41 29.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 10.0 109.048 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 10.6 ttp-105 -54.48 -37.98 60.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.775 -0.578 . . . . 10.0 111.641 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 39.8 Cg_endo -68.06 59.19 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 109.953 -0.826 . . . . 10.0 109.953 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.605 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.3 OUTLIER -92.72 -57.34 2.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.61 -0.681 . . . . 10.0 109.986 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.584 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 1.5 t 58.44 53.24 6.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.245 -0.909 . . . . 10.0 109.628 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.638 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 1.2 p90 -149.11 113.72 3.6 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 118.564 -1.254 . . . . 10.0 112.542 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.23 94.65 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.509 1.473 . . . . 10.0 109.971 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.98 76.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.791 -1.193 . . . . 10.0 110.791 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 1.041 HG23 ' CB ' ' A' ' 5' ' ' LYS . 54.1 m -144.83 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.179 -0.951 . . . . 10.0 109.626 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 75' ' ' THR . 2.3 m-20 -18.95 -53.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.449 0.642 . . . . 10.0 111.843 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -88.84 123.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.442 -0.903 . . . . 10.0 109.352 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.497 ' CD2' HG21 ' A' ' 9' ' ' VAL . 93.8 m-85 -116.01 139.96 49.74 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.403 -0.81 . . . . 10.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 168' ' ' VAL . 1.6 mm? -108.15 98.17 7.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.621 HG23 ' HA2' ' A' ' 10' ' ' GLY . 9.2 p -92.84 122.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.619 -0.832 . . . . 10.0 110.708 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.82 104.3 11.19 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.564 -0.71 . . . . 10.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.499 ' C ' HG22 ' A' ' 115' ' ' THR . 13.0 p90 -136.57 179.82 6.14 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.221 -0.925 . . . . 10.0 109.239 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.433 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 90.2 p -75.28 161.5 29.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.861 -1.149 . . . . 10.0 111.333 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' OH ' ' A' ' 154' ' ' TYR . 6.6 m -78.78 -9.87 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.616 . . . . 10.0 111.134 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.929 HG11 HD23 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -115.17 -82.29 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.99 -1.069 . . . . 10.0 108.116 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.5 t 66.38 147.66 0.11 Allowed Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 120.407 -1.433 . . . . 10.0 111.79 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 134' ' ' GLN . 49.9 Cg_endo -76.76 167.78 24.73 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 124.384 1.728 . . . . 10.0 112.247 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 1.0 OUTLIER 71.77 15.35 5.87 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.985 178.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.498 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.5 t 61.64 102.01 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.023 -1.048 . . . . 10.0 110.474 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -46.76 -31.77 3.2 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.395 -0.922 . . . . 10.0 109.046 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 73.9 tt0 -53.55 -29.39 36.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 10.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.796 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -82.17 -11.82 58.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 10.0 109.535 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.796 HG23 ' ND2' ' A' ' 92' ' ' ASN . 89.1 t -89.63 -36.04 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.181 -0.949 . . . . 10.0 109.391 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.67 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.14 -17.75 62.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.458 -0.897 . . . . 10.0 109.285 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.84 -4.82 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.111 -0.993 . . . . 10.0 110.804 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -78.37 -41.63 32.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 10.0 110.469 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.501 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 24.2 m95 -80.52 -27.84 37.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.428 -0.795 . . . . 10.0 110.195 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.716 HG22 HD22 ' A' ' 149' ' ' LEU . 93.9 t -52.83 -50.77 79.47 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.159 -0.963 . . . . 10.0 110.861 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.5 Cg_endo -68.35 -17.95 44.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.277 1.146 . . . . 10.0 109.731 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.553 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -58.02 -29.57 65.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 10.0 110.142 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 7.0 mt 63.01 106.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.301 -0.874 . . . . 10.0 111.417 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -49.17 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.363 -0.977 . . . . 10.0 108.363 178.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.699 ' H ' HG23 ' A' ' 102' ' ' THR . 40.4 m170 -105.19 -7.62 18.9 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.162 -0.961 . . . . 10.0 110.181 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 1.7 m-70 174.68 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 10.0 109.764 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.832 ' O ' HG22 ' A' ' 102' ' ' THR . 81.3 m -119.2 144.91 37.16 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.058 . . . . 10.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.05 91.67 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 123.679 1.358 . . . . 10.0 110.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.561 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -153.36 18.31 0.55 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.201 -0.937 . . . . 10.0 109.591 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -56.25 131.58 75.4 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.254 -0.904 . . . . 10.0 109.634 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 135.69 25.7 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.557 1.293 . . . . 10.0 109.637 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.505 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -132.48 106.01 7.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.288 -0.882 . . . . 10.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 152' ' ' VAL . 3.1 mm? -74.91 95.61 2.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.972 -1.862 . . . . 10.0 105.972 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 46.2 mt -70.08 139.07 52.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.558 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.9 t -149.6 167.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.141 . . . . 10.0 111.454 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.463 ' O ' ' CG2' ' A' ' 117' ' ' ILE . . . -124.52 107.27 1.0 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.956 -2.057 . . . . 10.0 107.956 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.499 HG22 ' C ' ' A' ' 82' ' ' PHE . 3.5 t -93.88 155.62 17.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -1.189 . . . . 10.0 110.543 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 48.73 48.65 19.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.832 . . . . 10.0 109.894 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.988 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -82.62 -13.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 10.0 110.662 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 51.3 p30 -52.01 51.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 112.3 0.481 . . . . 10.0 112.3 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.738 ' N ' ' O ' ' A' ' 117' ' ' ILE . 12.3 tp 152.47 -34.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' A' ' 84' ' ' VAL . 10.9 tpp180 -55.54 -33.87 64.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.504 0.669 . . . . 10.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.15 -14.43 60.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 10.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.738 ' O ' HD13 ' A' ' 126' ' ' ILE . 70.9 m-20 -82.7 142.12 45.33 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.233 -0.917 . . . . 10.0 110.837 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.5 Cg_endo -75.44 22.99 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.12 1.59 . . . . 10.0 111.558 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -103.07 -50.57 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.757 -1.214 . . . . 10.0 109.967 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 t -74.26 -28.16 61.09 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.411 -2.07 . . . . 10.0 105.411 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 122' ' ' ASP 0.29 0.6 OUTLIER -51.1 -30.88 10.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 176.888 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.3 -47.82 46.72 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.885 0.85 . . . . 10.0 110.235 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -37.29 62.58 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.466 0.651 . . . . 10.0 110.005 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.929 HD23 HG11 ' A' ' 85' ' ' VAL . 3.4 mp -55.64 -27.1 47.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.114 0.959 . . . . 10.0 109.942 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.25 -28.39 57.1 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.405 -1.434 . . . . 10.0 109.022 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -69.94 -17.31 63.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.015 -0.674 . . . . 10.0 109.982 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.597 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -129.25 34.28 4.42 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.204 -1.398 . . . . 10.0 112.589 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 55.91 63.94 1.88 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.135 -0.978 . . . . 10.0 110.225 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.834 ' O ' HG12 ' A' ' 85' ' ' VAL . 2.5 mt-30 -128.86 80.99 2.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 140.13 39.44 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.78 . . . . 10.0 109.901 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.48 ' N ' HG13 ' A' ' 85' ' ' VAL . 42.6 Cg_endo -66.53 161.65 40.31 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.203 1.633 . . . . 10.0 111.741 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.574 HG12 ' CE2' ' A' ' 90' ' ' PHE . 3.5 tp -126.64 139.92 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 10.0 109.479 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -118.78 165.42 16.84 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.323 -0.86 . . . . 10.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.9 Cg_endo -65.67 -21.57 58.72 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.8 1.421 . . . . 10.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -70.54 -47.66 59.29 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.283 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -77.9 -42.15 34.24 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.916 -0.714 . . . . 10.0 110.292 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.88 90.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.912 -1.118 . . . . 10.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 139' ' ' PRO . 20.4 mm-40 -52.95 -48.19 67.55 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.483 -0.887 . . . . 10.0 110.132 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -62.18 -34.63 76.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.175 -0.953 . . . . 10.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 8.8 tp -66.46 -50.08 64.52 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.905 -1.122 . . . . 10.0 108.222 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.965 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.09 -41.62 88.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.284 -0.885 . . . . 10.0 109.95 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 147' ' ' ARG . 40.3 mmm-85 -78.61 -7.29 57.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.344 -0.847 . . . . 10.0 110.18 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 2.5 m-20 -76.88 -48.66 17.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.028 -1.045 . . . . 10.0 110.806 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.798 HD12 ' H ' ' A' ' 149' ' ' LEU . 2.2 mp -102.09 9.84 39.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 10.0 109.819 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 5.6 mtpt 81.51 23.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.028 0.918 . . . . 10.0 110.512 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.26 -176.34 0.21 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 111' ' ' LEU . 2.5 p -84.99 -77.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.773 -1.204 . . . . 10.0 111.83 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.877 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -173.66 -179.04 1.72 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.437 -1.414 . . . . 10.0 110.889 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.713 ' OH ' HG12 ' A' ' 84' ' ' VAL . 68.1 t80 -108.7 120.86 43.7 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 10.0 109.778 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -124.51 -169.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.226 -0.922 . . . . 10.0 109.349 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -157.2 144.42 18.62 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.291 -1.364 . . . . 10.0 112.679 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 27.4 p -157.49 162.43 38.89 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.448 0.642 . . . . 10.0 110.133 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.6 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 18.9 p -133.14 172.84 12.12 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 108.49 -0.93 . . . . 10.0 108.49 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.737 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -54.96 -64.85 0.7 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.894 0.702 . . . . 10.0 112.894 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.0 pp -132.91 -3.83 3.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.66 -1.275 . . . . 10.0 112.13 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.539 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.4 m -96.33 -53.56 3.57 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.65 -1.282 . . . . 10.0 113.167 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.565 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -63.25 -53.03 59.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.757 -1.215 . . . . 10.0 111.327 -178.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' THR . 0.4 OUTLIER 66.19 27.78 10.25 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 -177.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.51 -17.23 42.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -49.98 -18.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.186 . . . . 10.0 110.796 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.836 ' N ' HD22 ' A' ' 165' ' ' LEU . 1.5 tttt -71.97 -31.44 66.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.681 -1.262 . . . . 10.0 109.658 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -69.38 -45.1 70.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 10.0 109.582 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.019 HG22 ' HB ' ' A' ' 155' ' ' VAL . 31.1 t -53.31 -18.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.661 0.743 . . . . 10.0 110.2 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 m-85 -84.3 -40.52 17.87 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 10.0 111.902 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.62 ' O ' HD22 ' A' ' 174' ' ' LEU . 22.8 t70 -65.69 -52.19 53.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.89 -1.131 . . . . 10.0 112.268 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.748 ' OE2' HD12 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -63.92 -25.53 68.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.773 -1.204 . . . . 10.0 109.972 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -66.87 -32.07 73.09 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.264 -0.897 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 49.0 mm -62.74 -50.27 80.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.413 -0.804 . . . . 10.0 109.696 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.854 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -72.63 -34.07 67.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.56 -0.712 . . . . 10.0 111.073 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.662 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -85.24 -2.35 57.95 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.154 -0.966 . . . . 10.0 110.202 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -87.12 -22.31 25.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.052 -1.03 . . . . 10.0 110.129 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -100.22 -20.38 15.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 10.0 108.793 179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 118.09 -0.957 . . . . 10.0 110.426 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' ' 49' ' ' GLU . 46.4 m -128.4 156.65 42.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.297 -1.119 . . . . 10.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -81.66 97.66 8.01 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.151 -0.968 . . . . 10.0 108.582 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.055 . . . . 10.0 111.024 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.722 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -72.24 -154.47 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.722 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 38.2 Cg_endo -65.74 73.87 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-N 119.062 0.701 . . . . 10.0 110.523 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.53 ' HB2' HG22 ' A' ' 46' ' ' ILE . 3.3 tp10 -53.32 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.591 -0.693 . . . . 10.0 110.073 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.692 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -79.56 -50.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.7 -1.25 . . . . 10.0 112.25 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.658 ' N ' HG12 ' B' ' 8' ' ' ILE . 61.0 m -88.82 146.72 24.81 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.808 -1.182 . . . . 10.0 110.994 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.44 HD23 ' O ' ' B' ' 8' ' ' ILE . 0.7 OUTLIER -170.8 98.05 0.43 Allowed Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.359 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 45' ' ' MET . 51.4 Cg_endo -86.16 97.56 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.229 1.647 . . . . 10.0 109.073 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.1 p -68.37 160.61 29.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.07 -1.019 . . . . 10.0 111.894 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.537 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.2 m-20 -124.14 155.86 37.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' VAL . 69.0 m-85 -85.33 156.09 21.05 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.028 0.918 . . . . 10.0 112.672 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 15.9 pt-20 -120.09 154.71 34.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.609 0.719 . . . . 10.0 110.316 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -49.87 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 10.0 111.142 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.67 ' O ' HG23 ' B' ' 18' ' ' ILE . 4.3 t -159.5 144.37 15.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.672 -1.268 . . . . 10.0 110.685 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.67 HG23 ' O ' ' B' ' 17' ' ' THR . 0.8 OUTLIER -160.67 177.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.721 -0.612 . . . . 10.0 109.613 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.2 t-80 -143.07 160.23 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.675 -1.266 . . . . 10.0 111.548 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.791 HG22 ' H ' ' B' ' 22' ' ' PHE . 5.8 p -69.74 148.46 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.192 0.996 . . . . 10.0 112.711 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -127.31 42.68 1.43 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.132 -2.387 . . . . 10.0 107.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -178.94 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.528 -0.983 . . . . 10.0 109.705 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.631 ' O ' HG23 ' B' ' 25' ' ' VAL . 17.3 p-10 -57.95 155.12 11.18 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.85 0.833 . . . . 10.0 112.688 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.21 57.98 0.63 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.781 -0.575 . . . . 10.0 112.37 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' B' ' 22' ' ' PHE . 42.5 t -113.01 -26.83 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.987 -1.071 . . . . 10.0 109.72 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.629 HG22 HG13 ' A' ' 21' ' ' ILE . 3.3 m -107.91 -22.23 12.52 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.611 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -90.49 35.2 3.9 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 106.923 -2.471 . . . . 10.0 106.923 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 28' ' ' PHE . 19.6 mt-10 -149.92 120.41 7.43 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.475 -1.014 . . . . 10.0 110.304 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.667 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 3.8 t80 -124.21 142.71 51.01 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.25 -0.906 . . . . 10.0 108.701 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.5 p -141.06 -46.59 0.39 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.153 -0.967 . . . . 10.0 109.566 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.11 51.02 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.449 -1.86 . . . . 10.0 108.449 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 21.1 mm -73.55 132.64 80.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.835 -0.803 . . . . 10.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 56.3 Cg_endo -80.54 79.88 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.718 1.378 . . . . 10.0 112.243 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' B' ' 33' ' ' PRO . 33.7 tt0 173.61 122.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.005 -1.059 . . . . 10.0 111.126 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.635 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 10.4 pt20 -78.3 -37.73 44.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.706 -0.622 . . . . 10.0 109.658 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.619 ' CG ' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 152.52 33.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.752 0.787 . . . . 10.0 109.066 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -139.97 -21.74 0.87 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.716 -0.615 . . . . 10.0 110.096 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.467 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 10.0 mmm180 . . . . . 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.128 . . . . 10.0 109.397 178.659 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.555 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 6.4 tmm? . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.14 0.495 . . . . 10.0 109.943 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 75.17 51.09 0.08 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 -178.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.86 ' HA ' HG21 ' A' ' 52' ' ' THR . 2.2 m -173.13 75.0 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.467 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -105.3 136.36 39.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.167 -1.583 . . . . 10.0 110.026 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -118.33 114.25 22.67 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.82 105.3 17.3 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.518 -1.363 . . . . 10.0 110.734 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.721 ' HB ' HG21 ' A' ' 75' ' ' THR . 45.7 t -136.3 145.45 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.315 -0.954 . . . . 10.0 110.675 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 17' ' ' THR . 29.6 m -77.96 141.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.657 -0.652 . . . . 10.0 109.278 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.893 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.5 p -161.38 172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.138 -0.976 . . . . 10.0 110.205 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.579 ' N ' HG22 ' A' ' 9' ' ' VAL . . . 149.54 176.22 22.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -49.34 -21.94 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.252 . . . . 10.0 110.373 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 139.28 45.84 0.07 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.556 -1.418 . . . . 10.0 109.556 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.2 -91.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -1.193 . . . . 10.0 110.039 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.893 HG21 ' O ' ' A' ' 9' ' ' VAL . 2.8 t 50.26 -125.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 10.0 111.148 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 96.53 7.47 57.96 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 108.378 -1.889 . . . . 10.0 108.378 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.792 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -57.96 -18.6 24.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.038 -1.272 . . . . 10.0 109.477 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.479 HG21 HG11 ' A' ' 8' ' ' VAL . 4.9 t -86.48 -24.9 25.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.439 ' SG ' ' O ' ' A' ' 15' ' ' GLY . 26.9 p -97.7 -8.22 29.18 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.029 -1.044 . . . . 10.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt -74.6 -38.36 62.62 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -59.29 -37.81 78.62 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 177.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.044 HG23 HG21 ' A' ' 25' ' ' THR . 7.2 mm -70.59 -51.38 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 115.032 -0.985 . . . . 10.0 108.651 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.69 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 17.3 p -51.3 -40.41 58.94 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.178 -0.952 . . . . 10.0 109.546 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.618 ' CE1' ' O ' ' A' ' 160' ' ' LEU . 10.7 t80 -79.89 -32.71 40.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.9 -1.125 . . . . 10.0 110.862 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' LEU . 33.9 p -97.04 -9.63 27.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 10.0 112.789 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 1.044 HG21 HG23 ' A' ' 21' ' ' ILE . 81.1 p -102.18 -88.07 0.39 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.133 -1.604 . . . . 10.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.72 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.2 p30 -123.55 -33.21 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 116.997 -1.881 . . . . 10.0 113.029 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 152.94 -141.84 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 CA-C-N 119.052 0.842 . . . . 10.0 111.638 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.768 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 0.2 OUTLIER . . . . . 0 N--CA 1.492 1.634 0 CA-C-O 122.191 0.996 . . . . 10.0 110.505 179.503 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p . . . . . 0 N--CA 1.484 1.232 0 N-CA-C 105.577 -2.009 . . . . 10.0 105.577 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 HG23 ' A' ' 58' ' ' THR . 3.2 t -79.36 -96.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.485 -0.759 . . . . 10.0 111.2 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' B' ' 18' ' ' ILE . 3.5 t80 -62.78 112.26 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 119.635 -1.915 . . . . 10.0 108.148 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 55' ' ' LEU . 3.0 t0 -150.79 111.27 4.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 10.0 111.488 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.553 ' HA ' ' CE1' ' A' ' 56' ' ' PHE . 7.8 m-20 -120.65 97.93 5.79 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 12.2 t80 -132.37 125.48 30.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.399 -0.813 . . . . 10.0 110.972 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.531 ' C ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.38 96.38 2.98 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.466 -2.05 . . . . 10.0 105.466 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 43' ' ' THR . 2.2 t -149.76 -177.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.895 -1.122 . . . . 10.0 111.864 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.61 ' H ' HG12 ' A' ' 42' ' ' VAL . 18.6 m -163.16 176.78 9.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.457 -0.571 . . . . 10.0 109.457 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.83 HG12 ' CD1' ' A' ' 46' ' ' ILE . 98.5 t -145.49 134.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.921 -1.112 . . . . 10.0 108.871 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.636 ' HB3' HD13 ' B' ' 10' ' ' LEU . 58.0 mtp -85.31 128.23 34.62 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 117.362 -1.735 . . . . 10.0 107.698 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -124.84 94.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.751 -1.218 . . . . 10.0 108.97 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 62.73 19.88 61.19 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.51 34.32 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.392 -1.483 . . . . 10.0 109.392 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' ILE . 4.6 tt0 -112.64 95.91 34.6 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.391 -1.064 . . . . 10.0 110.84 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.7 138.64 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.867 1.456 . . . . 10.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 4.7 t80 -110.75 110.87 21.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 10.0 109.56 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 3' ' ' THR . 89.4 m -68.49 128.33 36.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.217 -0.927 . . . . 10.0 111.749 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 52' ' ' THR . 13.3 mt -134.59 138.67 44.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.249 -0.907 . . . . 10.0 109.864 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -170.43 126.52 1.35 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.853 HD11 ' OD1' ' A' ' 38' ' ' ASP . 3.0 pp -144.45 160.28 41.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 10.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 17.7 m-85 -158.5 146.72 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 10.0 109.053 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 10.7 t0 -153.89 175.75 12.97 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.945 -1.097 . . . . 10.0 110.938 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 1.027 HG23 HG13 ' A' ' 36' ' ' VAL . 1.8 t -45.89 166.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.646 -0.659 . . . . 10.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -100.5 89.76 4.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.458 -0.776 . . . . 10.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -62.33 -57.33 17.24 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 106.704 -2.558 . . . . 10.0 106.704 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.578 ' HG2' ' CA ' ' B' ' 21' ' ' GLY . 17.8 mt-30 -62.52 -21.48 65.56 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.658 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 51.02 66.97 1.02 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.669 0.747 . . . . 10.0 111.33 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 37' ' ' PHE . 13.1 p-10 -119.18 23.59 11.24 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.654 -0.654 . . . . 10.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 1.2 p90 -177.4 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 10.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 51.39 21.02 1.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.064 . . . . 10.0 111.271 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 9.6 mmt180 -56.61 -30.27 63.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.697 -1.252 . . . . 10.0 108.971 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.607 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 4.6 mm? -79.03 7.69 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.68 -0.638 . . . . 10.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.686 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 9.8 ttp180 -60.35 -22.86 1.03 Allowed Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.118 -0.989 . . . . 10.0 112.195 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 44.2 Cg_endo -90.01 22.95 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 N-CA-C 109.263 -1.091 . . . . 10.0 109.263 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? -33.68 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.741 -0.6 . . . . 10.0 111.335 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.537 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 58.3 m -37.46 -34.22 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.554 0.693 . . . . 10.0 110.213 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' LEU . 28.4 t80 -84.71 115.93 62.98 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.387 -0.821 . . . . 10.0 109.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.89 150.09 33.99 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.722 1.38 . . . . 10.0 111.395 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.4 56.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 10.0 110.257 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 5' ' ' LYS . 99.3 m -143.5 92.73 2.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.251 -0.906 . . . . 10.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 75' ' ' THR . 11.8 m-20 -31.9 -39.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.98 0.419 . . . . 10.0 111.913 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.4 m -114.26 135.05 55.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.332 1.063 . . . . 10.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . 71.3 m-85 -121.66 149.7 42.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.688 -0.632 . . . . 10.0 110.488 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.4 mm? -119.75 97.98 5.89 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.175 -0.953 . . . . 10.0 108.466 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 p -108.07 144.65 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.012 -1.055 . . . . 10.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 14' ' ' VAL . 42.0 t -144.7 134.94 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.235 -0.916 . . . . 10.0 110.627 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 19.1 p90 -142.08 171.66 13.75 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 85' ' ' VAL . 43.8 t -79.08 150.29 31.87 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.816 -1.178 . . . . 10.0 111.611 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 137' ' ' ILE . 27.3 m -102.54 -14.72 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.498 -0.751 . . . . 10.0 110.681 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.912 ' HB ' HD21 ' A' ' 129' ' ' LEU . 3.5 m -81.81 -41.83 18.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.701 -1.249 . . . . 10.0 108.676 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.7 m -54.31 120.3 25.11 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.382 -0.824 . . . . 10.0 110.28 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 55.7 Cg_endo -82.39 25.09 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.815 1.429 . . . . 10.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 9.0 t -62.64 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.99 -1.069 . . . . 10.0 109.898 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 29.7 t -122.53 65.61 0.95 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 10.0 111.683 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 1.8 t80 -64.54 -19.29 65.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.85 -1.156 . . . . 10.0 109.521 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' A' ' 94' ' ' LYS . 8.5 tt0 -69.65 -29.26 66.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.447 -0.783 . . . . 10.0 111.042 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.857 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -83.56 -15.07 50.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.177 . . . . 10.0 111.025 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.857 HG13 ' ND2' ' A' ' 92' ' ' ASN . 29.2 m -94.55 -26.69 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.827 -1.171 . . . . 10.0 108.998 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.809 ' CE ' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.66 -29.22 36.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.431 -0.907 . . . . 10.0 109.167 178.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -89.14 -4.77 58.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 10.0 110.603 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -83.97 -50.01 8.42 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.019 -1.051 . . . . 10.0 112.547 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 39.6 m95 -76.9 -24.08 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.055 -1.028 . . . . 10.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 149' ' ' LEU . 62.7 t -67.41 -51.89 30.96 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.646 -1.283 . . . . 10.0 111.606 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -72.85 -8.27 22.07 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.289 1.152 . . . . 10.0 110.416 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -81.38 -31.58 33.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 10.0 112.607 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 108' ' ' THR . 8.0 pt -129.25 -10.17 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.352 -1.468 . . . . 10.0 113.022 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.7 p -72.57 -5.23 35.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.492 -1.38 . . . . 10.0 110.656 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -64.61 -43.13 94.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.045 -1.034 . . . . 10.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -100.67 -27.84 13.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.485 -0.759 . . . . 10.0 109.355 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 102' ' ' THR . 74.3 m -120.49 82.18 32.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 40.1 Cg_endo -65.79 152.4 81.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.842 1.443 . . . . 10.0 110.347 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 6.8 mtmt 60.72 47.3 8.21 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.82 -0.55 . . . . 10.0 111.027 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 101' ' ' ILE . 89.0 m -72.97 133.87 81.54 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 37.0 Cg_endo -62.37 129.13 25.73 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.529 1.278 . . . . 10.0 109.747 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 6.6 t80 -136.96 111.34 8.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.358 -0.839 . . . . 10.0 109.722 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.917 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.4 mm? -90.99 99.86 12.82 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.722 0.772 . . . . 10.0 111.333 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.2 mt -74.29 148.92 41.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -147.15 179.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.822 -1.173 . . . . 10.0 111.391 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.626 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -122.35 133.41 9.24 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.894 -2.082 . . . . 10.0 107.894 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 82' ' ' PHE . 28.9 m -100.12 132.82 45.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.92 -1.341 . . . . 10.0 111.393 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 52.12 61.36 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 10.0 111.03 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -79.38 -19.96 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.045 -1.034 . . . . 10.0 109.249 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 119' ' ' LEU . 12.6 p-10 -48.82 61.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.16 0.981 . . . . 10.0 111.22 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 pp 158.56 -24.56 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.722 -1.126 . . . . 10.0 108.462 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 14.5 tpt180 -43.41 -44.31 5.66 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.592 0.71 . . . . 10.0 109.666 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.99 -11.19 7.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 10.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 43.7 t0 -104.83 120.31 50.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 10.0 110.534 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.49 24.43 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 10.0 111.035 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -105.85 -50.46 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.065 -1.022 . . . . 10.0 110.93 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 126' ' ' ILE . 6.0 t -72.09 -30.62 65.28 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.076 -2.194 . . . . 10.0 105.076 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.547 HG23 HD22 ' A' ' 129' ' ' LEU 0.304 0.8 OUTLIER -48.64 -26.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.211 -1.359 . . . . 10.0 107.862 176.309 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -54.32 -36.71 64.04 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.181 0.991 . . . . 10.0 109.676 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -21.95 61.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.518 -0.739 . . . . 10.0 110.878 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HB ' ' A' ' 85' ' ' VAL . 4.0 mp -57.74 -37.79 74.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.292 -0.88 . . . . 10.0 109.627 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.82 82.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.525 -0.734 . . . . 10.0 109.867 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -51.17 -28.55 11.43 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.901 -1.12 . . . . 10.0 108.677 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.598 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 1.3 m120 -90.27 -66.77 0.89 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.228 -0.989 . . . . 10.0 110.553 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.599 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.5 mptp? -140.33 160.5 39.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.8 -0.563 . . . . 10.0 109.548 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.599 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -97.28 1.48 49.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 10.0 111.313 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -120.52 98.53 48.27 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 10.0 111.188 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' PRO . 42.2 Cg_endo -73.95 160.59 42.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.888 1.725 . . . . 10.0 111.255 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.68 136.95 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.954 -1.091 . . . . 10.0 109.997 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.536 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 73.0 p -128.23 167.78 17.72 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.434 -0.791 . . . . 10.0 110.822 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 39.2 Cg_endo -65.37 -12.45 34.94 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.941 1.495 . . . . 10.0 110.907 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.435 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 1.5 mt-10 -78.6 -15.61 58.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.094 . . . . 10.0 109.839 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.6 m -94.93 -45.1 7.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.185 -0.947 . . . . 10.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.57 69.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 10.0 110.571 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 2.8 tt0 -50.24 -34.64 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.853 . . . . 10.0 109.74 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -74.84 -47.4 30.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.338 -0.851 . . . . 10.0 110.284 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 1.035 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.1 tp -55.91 -44.7 78.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.02 -1.05 . . . . 10.0 109.409 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -61.74 -50.22 73.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 10.0 109.951 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -18.01 62.47 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.523 -0.871 . . . . 10.0 109.515 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 144' ' ' LYS . 9.7 m-20 -85.96 -57.65 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 10.0 110.856 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.061 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -84.67 4.24 33.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.157 -0.964 . . . . 10.0 110.754 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.84 ' N ' HD13 ' A' ' 149' ' ' LEU . 11.0 mttp 69.49 60.1 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.375 1.084 . . . . 10.0 112.352 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.967 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -96.96 -154.09 0.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.333 -0.849 . . . . 10.0 108.71 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.917 HG11 ' CD1' ' A' ' 111' ' ' LEU . 15.8 t -100.04 -81.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.207 -0.997 . . . . 10.0 108.657 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.641 ' N ' HG12 ' A' ' 152' ' ' VAL . 2.7 tttm -173.73 159.28 3.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.43 -0.908 . . . . 10.0 111.858 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -82.77 105.04 13.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.541 -0.725 . . . . 10.0 109.466 178.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.711 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -102.12 -172.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.757 ' HG3' HG21 ' A' ' 117' ' ' ILE . 18.2 tt0 -148.45 137.11 21.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.821 -1.174 . . . . 10.0 109.973 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 165' ' ' LEU . 30.1 p -138.15 116.24 11.73 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.422 -0.911 . . . . 10.0 111.484 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.924 ' O ' HD21 ' A' ' 165' ' ' LEU . 6.2 m -102.6 156.73 17.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.781 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -93.62 -94.0 0.16 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 120.435 -1.416 . . . . 10.0 111.072 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -47.29 -20.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.463 -1.295 . . . . 10.0 109.001 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -93.42 -44.35 8.3 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.077 -1.015 . . . . 10.0 109.533 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm0? 61.59 68.91 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 10.0 110.745 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.89 36.86 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.445 -0.902 . . . . 10.0 111.328 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.78 30.03 0.72 Allowed Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.623 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.924 HD21 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.7 -47.41 73.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.229 -1.159 . . . . 10.0 110.714 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -71.41 -21.28 62.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.315 -0.865 . . . . 10.0 110.526 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -70.78 -39.4 73.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.021 -1.049 . . . . 10.0 111.275 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 155' ' ' VAL . 39.6 t -58.48 -50.79 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.811 -1.181 . . . . 10.0 110.212 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 80.4 t80 -68.27 -36.26 79.12 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.48 -0.762 . . . . 10.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.8 t0 -53.75 -47.56 70.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.867 -1.146 . . . . 10.0 110.478 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.55 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . 11.4 mm-40 -54.82 -40.46 69.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 10.0 109.857 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.445 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.59 -21.35 60.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.139 -0.976 . . . . 10.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.789 ' O ' HD12 ' A' ' 177' ' ' LEU . 37.2 mm -63.25 -40.52 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.254 -0.904 . . . . 10.0 110.038 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -87.17 -15.71 37.52 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.638 -1.289 . . . . 10.0 110.946 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 152' ' ' VAL . . . -98.04 -11.08 23.36 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.977 -1.077 . . . . 10.0 110.596 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.814 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -82.35 -42.82 18.2 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.941 -1.099 . . . . 10.0 109.74 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -96.61 -14.53 22.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.366 -0.834 . . . . 10.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.467 ' OXT' ' O ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.791 -1.099 . . . . 10.0 110.318 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.461 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . 68.6 m -99.74 37.04 1.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.318 -1.107 . . . . 10.0 110.036 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -64.19 103.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 10.0 110.934 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -128.51 178.02 6.59 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.756 0.789 . . . . 10.0 110.724 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.589 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -67.44 -179.99 0.51 Allowed Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.899 -1.889 . . . . 10.0 105.899 177.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.589 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 42.8 Cg_endo -69.41 55.28 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 N-CA-C 110.35 -0.673 . . . . 10.0 110.35 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.577 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.8 tp10 15.14 -142.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.693 0.759 . . . . 10.0 112.814 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.772 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -88.25 -110.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.245 -0.909 . . . . 10.0 109.203 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.651 ' H ' HG23 ' B' ' 8' ' ' ILE . 6.1 t -158.12 105.64 1.95 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.081 -1.637 . . . . 10.0 112.031 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -122.91 103.21 37.1 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.97 . . . . 10.0 109.916 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.447 ' HD2' HD23 ' B' ' 10' ' ' LEU . 38.0 Cg_endo -66.91 99.12 0.45 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.373 1.196 . . . . 10.0 109.856 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.5 m -157.15 99.39 1.79 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.39 -0.819 . . . . 10.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 11.6 p-10 -148.63 154.86 40.28 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.818 -1.153 . . . . 10.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 48.1 m-85 -84.64 -165.29 1.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.274 1.035 . . . . 10.0 113.165 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.541 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.3 tp10 -53.38 -167.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.88 0.848 . . . . 10.0 111.891 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -138.03 -166.94 2.06 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 40' ' ' TYR . 9.8 t -119.24 -171.8 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.933 -1.104 . . . . 10.0 112.05 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.725 HD13 ' CD2' ' A' ' 37' ' ' PHE . 1.3 pp -112.4 -177.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -101.08 155.91 17.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.062 . . . . 10.0 111.831 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.7 ' CG2' ' CE2' ' B' ' 22' ' ' PHE . 11.2 m -80.0 152.73 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.483 0.658 . . . . 10.0 111.281 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HG2' ' A' ' 61' ' ' GLN . . . -87.69 133.39 11.77 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.162 -1.575 . . . . 10.0 109.162 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.7 ' CE2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER 179.0 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.88 -1.365 . . . . 10.0 112.914 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.551 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.2 t70 -76.99 116.39 17.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.786 -1.196 . . . . 10.0 107.907 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 46.41 26.11 0.45 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.789 -1.194 . . . . 10.0 107.837 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.551 HG23 ' O ' ' B' ' 23' ' ' ASP 0.262 2.4 t -109.84 -14.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.564 0.697 . . . . 10.0 109.383 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.748 ' O ' HG21 ' A' ' 25' ' ' THR . 1.3 t -83.47 32.88 0.46 Allowed 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.798 -0.564 . . . . 10.0 111.181 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.575 ' CA ' ' OG1' ' A' ' 25' ' ' THR . . . -161.31 69.94 0.23 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.642 -1.783 . . . . 10.0 108.642 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.768 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 24.9 mt-10 -151.47 131.61 13.52 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.964 0.888 . . . . 10.0 111.43 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.812 ' O ' HG23 ' B' ' 30' ' ' THR . 1.9 t80 -142.7 142.41 31.99 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 29' ' ' PHE . 2.2 p -162.14 -66.13 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 10.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.79 111.5 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.073 -1.611 . . . . 10.0 109.073 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 pt -131.93 158.9 74.22 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.217 . . . . 10.0 110.308 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' B' ' 34' ' ' GLU . 42.2 Cg_endo -70.43 139.99 39.15 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.985 1.519 . . . . 10.0 109.942 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.541 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 3.0 tm-20 56.87 124.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 10.0 110.433 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' B' ' 36' ' ' TRP . 2.3 pm0 -96.31 -30.11 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 10.0 111.244 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.61 ' O ' ' CG ' ' B' ' 36' ' ' TRP . 7.8 t-105 -165.5 27.78 0.05 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.186 0.993 . . . . 10.0 110.099 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.519 ' C ' ' HG3' ' B' ' 34' ' ' GLU . . . -158.48 85.27 0.85 Allowed 'General case' 0 C--N 1.287 -2.113 0 O-C-N 121.798 -0.564 . . . . 10.0 109.64 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.541 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 2.4 ttt180 . . . . . 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 179.154 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 10.0 110.038 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mm100 -74.94 -26.86 59.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.64 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.4 m -46.23 106.16 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.907 -0.495 . . . . 10.0 110.941 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -128.03 119.94 52.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.735 -1.586 . . . . 10.0 111.054 178.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.822 ' O ' HG23 ' A' ' 75' ' ' THR . 4.5 mttm -103.8 124.55 49.12 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.895 -1.52 . . . . 10.0 106.895 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.934 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.4 t -89.01 108.0 19.35 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.884 -1.127 . . . . 10.0 110.886 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.776 ' HB ' HG21 ' A' ' 75' ' ' THR . 60.0 t -139.17 163.97 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 10.0 109.476 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.511 HG21 ' HB ' ' A' ' 17' ' ' THR . 36.5 t -73.36 157.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.006 -1.059 . . . . 10.0 109.713 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.969 HG13 ' NE2' ' B' ' 35' ' ' GLN . 0.3 OUTLIER -43.58 170.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 10.0 109.984 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -104.94 -29.27 5.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.082 -1.607 . . . . 10.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 9' ' ' VAL . 42.0 m-20 -42.59 -61.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 10.0 110.039 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' B' ' 35' ' ' GLN . . . 92.2 5.8 65.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HD11 ' B' ' 32' ' ' ILE . . . -43.76 -30.93 0.71 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -1.109 . . . . 10.0 110.865 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' B' ' 32' ' ' ILE . 53.1 t -148.92 -69.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.07 -1.019 . . . . 10.0 110.405 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.06 74.32 0.06 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.982 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.4 tttm -65.15 -13.0 57.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -1.056 . . . . 10.0 109.707 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 8' ' ' VAL . 14.3 t -50.27 -29.52 9.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 10.0 110.073 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.614 ' SG ' HD22 ' A' ' 19' ' ' LEU . 27.3 p -78.4 -2.46 38.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.076 -1.015 . . . . 10.0 111.127 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.7 mm? -84.39 -40.22 18.09 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.892 -1.13 . . . . 10.0 109.02 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -38.73 60.54 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.619 -0.832 . . . . 10.0 109.206 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.706 HG21 ' HA2' ' B' ' 27' ' ' GLY . 3.4 mm -80.42 -45.56 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.418 -0.801 . . . . 10.0 110.399 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' B' ' 28' ' ' GLU . 19.7 t -45.84 -50.8 13.85 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.026 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 165' ' ' LEU . 36.6 m-85 -81.49 0.24 38.75 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.847 -1.158 . . . . 10.0 110.43 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.609 ' O ' ' HB ' ' A' ' 25' ' ' THR . 20.1 m -97.93 -54.17 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.404 -1.318 . . . . 10.0 110.779 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 24' ' ' THR . 14.6 t 175.75 -39.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.115 -0.991 . . . . 10.0 112.424 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.671 ' HB2' HG23 ' A' ' 21' ' ' ILE . 65.2 m-20 -85.4 32.39 0.57 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.737 -1.227 . . . . 10.0 111.53 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.537 ' O ' ' O ' ' A' ' 26' ' ' ASN 0.261 8.7 ttpp -45.26 -167.28 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.846 0.831 . . . . 10.0 112.863 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.662 ' CD1' HG21 ' B' ' 30' ' ' THR . 51.1 t80 . . . . . 0 N--CA 1.493 1.723 0 O-C-N 121.242 -0.911 . . . . 10.0 111.523 -179.41 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.917 HG21 ' H ' ' B' ' 25' ' ' VAL . 4.2 t . . . . . 0 N--CA 1.498 1.926 0 N-CA-C 110.017 -0.364 . . . . 10.0 110.017 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.885 HG22 HG21 ' B' ' 26' ' ' THR . 16.9 t 77.56 5.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.019 -0.426 . . . . 10.0 110.664 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 73.9 t80 -39.55 161.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.784 0.802 . . . . 10.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 1.051 ' CB ' HD12 ' B' ' 18' ' ' ILE . 3.7 p30 -79.13 -161.08 0.28 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.346 1.07 . . . . 10.0 113.391 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.755 ' O ' HG22 ' B' ' 17' ' ' THR . 1.4 m120 -152.9 -171.52 3.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.58 ' CE2' HG21 ' B' ' 17' ' ' THR . 69.6 m-85 -121.72 152.87 38.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 10.0 111.647 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -131.18 99.51 4.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.302 -0.874 . . . . 10.0 109.715 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 43' ' ' THR . 1.4 p -131.44 -168.9 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 122.104 0.954 . . . . 10.0 111.182 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.743 ' H ' HG22 ' A' ' 42' ' ' VAL . 23.2 m -142.43 151.5 41.85 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.585 0.707 . . . . 10.0 110.005 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -136.08 126.2 41.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.456 -0.778 . . . . 10.0 109.527 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.574 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 30.9 mtt -90.87 96.56 10.7 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.69 -1.204 . . . . 10.0 109.625 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.727 HG22 ' HG3' ' B' ' 7' ' ' GLU . 1.4 mp -72.03 104.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.548 -0.72 . . . . 10.0 110.049 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 43.65 35.06 2.89 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.776 -1.202 . . . . 10.0 110.428 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.52 2.17 30.92 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.879 -1.365 . . . . 10.0 110.802 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' ILE . 79.6 mt-10 -117.45 110.73 40.53 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.741 -1.446 . . . . 10.0 110.297 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.2 Cg_endo -75.13 135.75 19.25 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.566 1.298 . . . . 10.0 110.706 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.655 ' HB2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -99.76 122.85 43.36 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 10.0 110.749 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 4' ' ' ILE . 30.2 p -84.6 98.32 10.1 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.05 -1.031 . . . . 10.0 109.439 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -121.48 126.67 49.83 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.662 -1.215 . . . . 10.0 109.672 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 41' ' ' ALA . . . -141.35 100.8 0.27 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.531 -1.828 . . . . 10.0 108.531 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.934 HD22 ' CB ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -115.36 117.24 29.88 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.224 -1.162 . . . . 10.0 110.581 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.797 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 20.9 m-85 -134.59 144.4 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.916 ' H ' HD11 ' B' ' 18' ' ' ILE . 22.1 m-20 -105.78 160.76 14.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.475 -1.391 . . . . 10.0 110.008 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CD1' ' B' ' 36' ' ' TRP . 4.3 t -70.42 -177.94 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.06 . . . . 10.0 110.97 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -111.04 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.708 -0.62 . . . . 10.0 109.409 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.587 ' H ' HG11 ' A' ' 36' ' ' VAL . . . -52.02 -34.51 38.88 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 107.781 -2.128 . . . . 10.0 107.781 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.536 ' CB ' ' HA3' ' B' ' 21' ' ' GLY . 20.4 tt0 -99.94 -19.19 16.72 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 10.0 109.863 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.624 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 65.4 mt-10 58.64 84.98 0.1 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.269 -0.895 . . . . 10.0 110.564 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 61' ' ' GLN . 55.6 m-20 -96.4 -10.39 27.74 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 3.9 p90 -140.3 -35.1 0.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 10.0 109.571 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 2.7 p30 38.11 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 10.0 111.074 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' TYR . 1.7 mmm-85 -58.16 -32.59 68.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.066 -1.021 . . . . 10.0 109.287 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.779 HD12 ' HB3' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -79.93 7.67 8.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -0.759 . . . . 10.0 110.097 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.664 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -52.16 -36.44 32.03 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.335 -0.853 . . . . 10.0 112.74 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 48.9 Cg_endo -77.6 10.49 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 122.62 0.8 . . . . 10.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.779 ' HB3' HD12 ' A' ' 67' ' ' LEU . 0.3 OUTLIER -45.94 -64.47 0.73 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.935 -1.103 . . . . 10.0 111.954 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 67.4 m 41.06 32.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.899 -1.126 . . . . 10.0 109.969 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 6.7 t80 -171.33 127.8 0.66 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 10.0 110.677 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.96 130.59 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.997 1.525 . . . . 10.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 4.1 mt-30 -138.32 67.35 1.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.232 -0.917 . . . . 10.0 108.943 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.1 m -144.67 92.1 2.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 10.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.1 m-20 -39.13 -30.46 0.05 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.661 -0.65 . . . . 10.0 111.178 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 75' ' ' THR . 1.5 p -112.82 118.22 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.819 -1.176 . . . . 10.0 110.021 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.597 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 23.3 m-85 -119.29 133.92 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.429 -0.794 . . . . 10.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.712 HD22 HD23 ' A' ' 111' ' ' LEU . 1.2 mm? -104.36 97.43 7.37 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.844 HG23 HG21 ' A' ' 9' ' ' VAL . 10.3 p -96.1 147.02 6.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.783 -0.767 . . . . 10.0 110.357 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.726 ' SG ' HG21 ' A' ' 115' ' ' THR . 0.0 OUTLIER -113.9 101.89 9.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.078 0.942 . . . . 10.0 110.882 -178.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.765 ' CE1' HG11 ' A' ' 93' ' ' VAL . 35.9 m-85 -92.44 178.32 5.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -0.977 . . . . 10.0 110.003 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.426 ' O ' HG21 ' A' ' 137' ' ' ILE . 52.4 m -108.96 158.2 17.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 10.0 109.262 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.605 ' HA ' HG23 ' A' ' 137' ' ' ILE . 4.1 t -99.18 -19.03 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.16 -0.962 . . . . 10.0 111.188 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.007 HG11 HD23 ' A' ' 129' ' ' LEU . 4.1 t -96.59 -60.16 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.01 -1.056 . . . . 10.0 110.209 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -73.39 114.84 35.36 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.393 -0.817 . . . . 10.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 52.5 Cg_endo -88.59 -3.45 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.076 1.566 . . . . 10.0 110.495 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 133' ' ' LYS . 4.1 p -75.1 21.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.289 -0.882 . . . . 10.0 112.115 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.57 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.5 t -131.4 -31.39 1.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 10.0 109.934 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -72.8 -53.0 12.69 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.095 -1.003 . . . . 10.0 110.678 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 9.3 tp10 -49.79 -17.9 0.41 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.029 -1.044 . . . . 10.0 112.037 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.716 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -91.37 -18.96 23.44 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.497 -1.377 . . . . 10.0 110.822 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.765 HG11 ' CE1' ' A' ' 82' ' ' PHE . 3.6 m -91.06 -18.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 118.39 -1.324 . . . . 10.0 109.306 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.694 ' HD3' HG23 ' A' ' 93' ' ' VAL . 21.2 mmtt -88.65 -20.38 24.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.924 . . . . 10.0 109.138 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -95.99 -0.68 50.31 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.442 178.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -91.54 -51.69 5.14 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.773 -1.171 . . . . 10.0 112.578 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.723 ' CH2' HD23 ' A' ' 149' ' ' LEU . 34.3 p-90 -95.37 -26.01 16.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.81 -1.181 . . . . 10.0 111.771 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 56.1 t -53.77 -43.39 96.19 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.705 -1.247 . . . . 10.0 109.777 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 42.1 Cg_endo -75.93 -24.28 11.54 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.292 1.154 . . . . 10.0 110.147 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 6.3 mm-40 -61.27 -13.17 16.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.907 -1.121 . . . . 10.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 24.9 mm 71.68 82.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 10.0 111.311 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -16.66 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -56.46 -47.26 79.55 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.65 -1.241 . . . . 10.0 107.65 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -64.85 -40.35 95.01 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -81.99 -176.6 0.8 Allowed Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.724 -0.61 . . . . 10.0 109.42 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD2' ' SG ' ' A' ' 105' ' ' CYS . 50.5 Cg_endo -77.84 19.72 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.832 1.438 . . . . 10.0 112.856 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 58.35 67.1 0.98 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.377 -1.452 . . . . 10.0 108.929 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 m -45.46 134.89 5.86 Favored Pre-proline 0 N--CA 1.49 1.571 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.915 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 42.6 Cg_endo -69.79 140.75 43.33 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.984 1.518 . . . . 10.0 110.997 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 152' ' ' VAL . 1.3 m-85 -136.95 113.28 9.96 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.704 0.764 . . . . 10.0 110.939 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.825 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.3 mm? -87.98 97.0 10.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.631 HD11 ' HZ ' ' A' ' 90' ' ' PHE . 1.6 tt -79.14 124.07 27.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.038 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.793 HG21 HG11 ' A' ' 168' ' ' VAL . 2.4 t -139.92 164.82 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 10.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -111.61 156.15 15.74 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.119 -1.993 . . . . 10.0 108.119 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.726 HG21 ' SG ' ' A' ' 81' ' ' CYS . 9.6 t -138.01 160.91 38.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.365 . . . . 10.0 111.169 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 115' ' ' THR . 7.2 mt-30 58.98 36.67 24.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.526 -0.734 . . . . 10.0 109.903 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -72.63 -19.52 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.351 -0.843 . . . . 10.0 109.751 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 161' ' ' THR . 7.6 t70 -51.75 58.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 122.156 0.979 . . . . 10.0 112.125 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 3.6 tp 162.27 -23.63 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.526 -1.215 . . . . 10.0 108.131 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.865 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.88 -33.24 23.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.16 -26.56 60.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 10.0 109.901 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.984 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -93.53 132.02 31.11 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.452 -0.78 . . . . 10.0 110.549 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 58.5 Cg_endo -87.0 23.26 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.471 1.447 . . . . 10.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 47.5 t -110.68 -50.62 2.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -0.98 . . . . 10.0 111.016 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.658 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.0 t -70.11 -27.22 64.41 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.984 HD13 ' O ' ' A' ' 122' ' ' ASP 0.306 1.2 mp -51.91 -25.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 10.0 107.361 176.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 124' ' ' SER . 25.6 tt0 -58.46 -42.04 86.55 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.282 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -55.92 -41.64 74.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.529 -0.732 . . . . 10.0 110.665 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.007 HD23 HG11 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -75.72 -33.85 60.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 10.0 109.549 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' LYS . . . -52.52 -50.2 63.3 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.326 0.584 . . . . 10.0 110.277 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -28.91 61.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.258 -0.901 . . . . 10.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.4 t30 -71.56 -52.19 19.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.951 . . . . 10.0 109.985 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.594 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 3.2 mmtt -134.38 155.75 49.74 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.549 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -105.43 24.09 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.005 . . . . 10.0 111.157 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -148.74 92.95 4.33 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 10.0 109.391 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.72 160.61 48.84 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.183 1.622 . . . . 10.0 110.519 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.605 HG23 ' HA ' ' A' ' 84' ' ' VAL . 4.6 tp -102.07 133.68 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.464 -0.939 . . . . 10.0 108.464 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.9 p -119.67 165.04 18.72 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 121.182 -0.949 . . . . 10.0 110.159 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -64.13 -32.3 63.72 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.935 1.492 . . . . 10.0 110.369 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.529 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 17.3 pt-20 -74.14 -29.82 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 10.0 109.456 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.441 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 81.1 m -80.13 -41.02 26.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.79 . . . . 10.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.21 68.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.471 -0.768 . . . . 10.0 110.54 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 18.9 tt0 -57.11 -42.57 81.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 10.0 109.637 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 14.5 mtmt -68.6 -40.33 80.49 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.161 -0.962 . . . . 10.0 109.494 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.6 tt -56.0 -43.45 77.67 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.029 -1.044 . . . . 10.0 109.671 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -67.45 -51.17 54.73 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 10.0 108.648 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -60.6 -30.37 69.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 10.0 109.624 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 149' ' ' LEU . 32.9 t70 -67.99 -45.06 75.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.307 -0.871 . . . . 10.0 110.301 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.723 HD23 ' CH2' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -92.76 14.78 16.23 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.089 0.947 . . . . 10.0 108.964 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 151' ' ' ALA . 8.9 mttp 56.23 38.28 29.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.786 0.803 . . . . 10.0 110.299 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -60.97 -141.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.198 -0.601 . . . . 10.0 109.563 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.753 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -117.43 -57.7 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.959 -1.088 . . . . 10.0 110.477 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HD2' ' CD ' ' A' ' 171' ' ' GLU . 0.9 OUTLIER -170.89 145.09 2.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.116 -1.434 . . . . 10.0 111.813 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -90.79 119.49 31.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.947 ' CG2' HG13 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -124.53 -168.88 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.863 -1.148 . . . . 10.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 113' ' ' VAL . 6.0 tt0 -146.82 152.7 39.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.975 . . . . 10.0 110.335 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 31.1 p -160.36 145.18 14.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 10.0 111.394 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.865 ' CB ' HG23 ' A' ' 161' ' ' THR . 18.4 m -149.91 103.79 3.25 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 1.086 ' HB1' ' HG2' ' B' ' 28' ' ' GLU . . . -37.02 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.562 0.696 . . . . 10.0 112.316 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -57.61 -7.9 0.76 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.865 HG23 ' CB ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -134.78 -92.52 0.31 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.069 -1.644 . . . . 10.0 114.669 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.54 ' H ' HG23 ' A' ' 161' ' ' THR . 7.5 mm-40 -11.55 -69.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.817 0.817 . . . . 10.0 112.657 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 11.7 mttt 62.57 30.35 17.06 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.815 0.817 . . . . 10.0 109.44 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.0 -0.94 5.49 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.97 -1.652 . . . . 10.0 108.97 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -65.89 -7.75 18.32 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.279 -1.13 . . . . 10.0 111.847 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.688 ' N ' HD13 ' A' ' 165' ' ' LEU . 11.5 mtmt -56.77 -33.05 66.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.581 -1.324 . . . . 10.0 109.827 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -70.35 -33.71 71.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 10.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.947 HG13 ' CG2' ' A' ' 155' ' ' VAL . 7.3 t -49.22 -35.84 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.752 -1.218 . . . . 10.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 173' ' ' ILE . 6.1 t80 -78.91 -40.93 30.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 10.0 110.734 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 174' ' ' LEU . 14.4 m-20 -54.1 -46.7 72.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.185 -0.947 . . . . 10.0 111.429 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.486 ' OE2' ' CG2' ' A' ' 155' ' ' VAL . 6.9 pt-20 -66.15 -35.01 79.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 10.0 112.158 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -66.86 -17.95 65.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.597 -1.314 . . . . 10.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.657 ' O ' HD12 ' A' ' 177' ' ' LEU . 22.1 mt -66.88 -44.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.366 -0.934 . . . . 10.0 109.119 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -85.09 -17.84 36.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 10.0 111.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.563 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.54 -0.49 51.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.906 -1.122 . . . . 10.0 110.141 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.684 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.95 -49.09 7.29 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.434 -0.791 . . . . 10.0 109.973 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -88.55 -16.58 32.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.552 -0.718 . . . . 10.0 109.598 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 177' ' ' LEU . 2.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.035 -0.984 . . . . 10.0 110.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 109.532 -1.427 . . . . 10.0 109.532 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . 68.7 m -59.66 152.29 22.82 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -1.112 . . . . 10.0 110.328 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 102.05 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.567 -0.708 . . . . 10.0 111.366 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.41 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 8.7 mm-40 -118.68 159.86 22.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -0.835 . . . . 10.0 110.133 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.691 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.55 -150.02 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.691 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 42.6 Cg_endo -70.88 85.72 0.77 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 N-CA-C 109.844 -0.868 . . . . 10.0 109.844 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 46' ' ' ILE . 17.9 mm-40 -53.53 -164.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.648 -0.657 . . . . 10.0 110.826 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 1.5 pp -81.3 -51.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 10.0 112.472 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.7 t -159.09 164.99 34.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.422 -1.424 . . . . 10.0 111.624 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -158.89 106.83 1.59 Allowed Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.577 -0.849 . . . . 10.0 111.951 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 42.6 Cg_endo -69.34 115.07 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.155 1.608 . . . . 10.0 109.607 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.81 178.39 0.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.399 -0.813 . . . . 10.0 111.609 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 43' ' ' THR . 1.7 t0 -135.09 -169.32 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.957 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 5.1 m-85 -99.88 152.71 19.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 10.0 110.435 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -160.7 163.44 32.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.38 -0.825 . . . . 10.0 110.641 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -149.9 167.23 27.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.721 -1.192 . . . . 10.0 112.039 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 39' ' ' ASN 0.257 2.4 p -124.34 162.47 23.72 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.676 -0.64 . . . . 10.0 111.115 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 1.051 HD12 ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -93.31 -167.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.932 -1.105 . . . . 10.0 109.153 177.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -112.68 157.48 21.21 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.728 -1.233 . . . . 10.0 111.377 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.1 p -122.73 152.7 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.022 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 61' ' ' GLN . . . -147.33 179.16 24.45 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.211 -1.556 . . . . 10.0 109.211 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 4.4 m-85 62.3 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.298 -1.119 . . . . 10.0 111.417 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.469 ' O ' ' C ' ' B' ' 24' ' ' ALA . 7.0 p-10 -66.71 157.57 32.37 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.578 0.704 . . . . 10.0 111.915 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 24.98 46.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.318 0.58 . . . . 10.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.917 ' H ' HG21 ' A' ' 35' ' ' THR . 1.2 t -104.58 -33.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.885 HG21 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -128.61 17.82 6.34 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.811 0.815 . . . . 10.0 109.411 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 21' ' ' ILE . . . -61.43 -22.3 61.11 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 1.086 ' HG2' ' HB1' ' A' ' 159' ' ' ALA . 3.0 tt0 -153.09 -151.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.633 -0.922 . . . . 10.0 109.041 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -103.78 115.35 30.32 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 120.922 -1.111 . . . . 10.0 110.32 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.662 HG21 ' CD1' ' A' ' 28' ' ' PHE . 34.7 p -130.3 -89.01 0.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 10.0 110.076 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.536 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -80.24 -115.28 0.3 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 13' ' ' ALA . 2.6 tt -173.27 56.14 0.2 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 10.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 44.4 Cg_endo -71.77 155.06 58.85 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.781 1.411 . . . . 10.0 110.883 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.613 ' HG3' ' CG ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -61.19 153.37 26.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.342 -0.849 . . . . 10.0 110.475 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.969 ' NE2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -73.92 -57.37 4.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.349 -0.844 . . . . 10.0 111.234 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.3 t90 174.26 27.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.584 -0.697 . . . . 10.0 109.838 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.585 ' HA ' ' CD1' ' A' ' 70' ' ' LEU . . . 178.22 15.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.266 -0.896 . . . . 10.0 112.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.613 ' CG ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.652 0 O-C-N 119.974 -1.704 . . . . 10.0 108.109 178.284 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtm . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.963 0.411 . . . . 10.0 110.05 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.55 ' HA ' HD23 ' A' ' 177' ' ' LEU . 28.9 mm100 -146.21 -33.83 0.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.019 -1.05 . . . . 10.0 109.743 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.511 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 51.8 m -56.54 110.93 0.86 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.324 -0.86 . . . . 10.0 111.01 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.885 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -108.33 128.01 64.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.86 -1.136 . . . . 10.0 110.088 178.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.623 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.7 ttmt -112.23 109.54 19.28 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.556 ' HB3' HD23 ' A' ' 55' ' ' LEU . 51.7 t -93.94 102.6 14.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.59 -1.319 . . . . 10.0 110.369 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 8' ' ' VAL . 48.8 t -131.78 163.14 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.71 -1.196 . . . . 10.0 110.765 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.858 HG12 ' HG2' ' B' ' 35' ' ' GLN . 1.9 t -78.26 154.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.295 -0.878 . . . . 10.0 109.388 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -160.39 174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.854 -1.154 . . . . 10.0 110.353 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.578 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 115.2 173.5 17.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.651 -1.78 . . . . 10.0 108.651 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.13 -29.43 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.712 -1.463 . . . . 10.0 108.894 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 163.7 -81.29 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.721 -1.752 . . . . 10.0 108.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . 39.96 -131.88 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.992 . . . . 10.0 110.937 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.728 ' CG1' HG23 ' A' ' 115' ' ' THR . 6.1 m -110.72 153.89 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 10.0 111.748 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -111.96 110.13 2.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.229 -1.548 . . . . 10.0 109.229 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.13 -20.63 7.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.761 -1.435 . . . . 10.0 110.896 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.499 HG21 ' CG2' ' A' ' 8' ' ' VAL . 11.4 t -73.82 -32.17 63.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.762 -1.212 . . . . 10.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.664 ' HA ' HG23 ' B' ' 26' ' ' THR . 18.3 p -73.68 -15.68 61.23 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.618 -1.301 . . . . 10.0 107.673 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.834 HD13 ' CA ' ' A' ' 159' ' ' ALA . 53.7 mt -95.69 -23.42 17.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -46.85 -43.38 18.58 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.842 0.829 . . . . 10.0 109.046 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.045 HG22 ' HB2' ' A' ' 26' ' ' ASN . 4.6 mm -74.72 -39.88 46.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.546 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 4.6 p -52.02 -49.25 63.75 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 119.435 -0.906 . . . . 10.0 110.254 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 1.241 ' CE2' HD11 ' A' ' 165' ' ' LEU . 4.7 m-85 -62.05 -34.09 75.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.377 -1.452 . . . . 10.0 109.706 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -72.79 -51.99 16.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.562 -0.855 . . . . 10.0 111.048 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.529 HG23 ' ND2' ' A' ' 26' ' ' ASN . 11.8 t -169.49 -20.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.959 -1.896 . . . . 10.0 114.563 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 1.045 ' HB2' HG22 ' A' ' 21' ' ' ILE . 4.8 m-80 -79.29 -8.67 59.22 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.454 -1.404 . . . . 10.0 111.223 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.563 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 14.86 -146.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 114.359 1.244 . . . . 10.0 114.359 178.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.668 ' CE1' HG22 ' B' ' 30' ' ' THR . 1.8 t80 . . . . . 0 N--CA 1.507 2.408 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.526 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.605 ' O ' ' CG2' ' B' ' 20' ' ' VAL . 68.9 p . . . . . 0 N--CA 1.501 2.114 0 N-CA-C 109.317 -0.623 . . . . 10.0 109.317 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.677 HG23 ' HB ' ' B' ' 26' ' ' THR . 16.5 t 63.1 -6.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.57 -1.331 . . . . 10.0 111.811 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.706 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -67.58 95.29 0.47 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 120.474 -1.391 . . . . 10.0 109.368 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.699 ' HA ' ' CG2' ' B' ' 18' ' ' ILE . 2.3 m-20 -165.78 103.69 0.69 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.308 -1.757 . . . . 10.0 114.278 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.784 ' N ' HG22 ' B' ' 18' ' ' ILE . 53.5 t30 -134.59 97.17 3.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.858 -1.151 . . . . 10.0 108.471 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.747 ' CE1' HG23 ' B' ' 18' ' ' ILE . 2.9 m-30 -118.76 146.58 44.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.669 -0.644 . . . . 10.0 111.063 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.629 ' C ' HG13 ' A' ' 42' ' ' VAL . . . -171.72 98.07 0.18 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.08 -1.013 . . . . 10.0 109.262 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.629 HG13 ' C ' ' A' ' 41' ' ' ALA . 30.9 m -156.15 -165.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.988 0.899 . . . . 10.0 112.276 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' TYR . 20.3 m -130.24 155.23 46.63 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.294 0.569 . . . . 10.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' B' ' 12' ' ' SER . 11.6 t -131.2 150.99 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.589 -0.694 . . . . 10.0 109.215 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.637 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 10.6 mtp -110.52 93.14 4.34 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.978 -1.489 . . . . 10.0 107.661 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.731 HG23 ' CG ' ' B' ' 7' ' ' GLU . 1.8 mp -72.57 103.01 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 O-C-N 120.594 -1.316 . . . . 10.0 109.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' B' ' 9' ' ' SER . . . 51.0 30.56 23.26 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.404 -1.379 . . . . 10.0 110.119 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.92 6.12 37.65 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 120.845 -1.385 . . . . 10.0 110.592 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.6 tp10 -110.87 115.1 53.65 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.234 -1.157 . . . . 10.0 109.758 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.7 Cg_endo -71.59 139.0 33.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.947 1.498 . . . . 10.0 110.88 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -114.1 163.04 15.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 10.0 111.9 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.752 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -122.99 104.75 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HA ' HG23 ' A' ' 4' ' ' ILE . 21.2 mt -108.65 147.93 31.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.789 -1.195 . . . . 10.0 110.893 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.44 99.98 0.17 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.044 -1.623 . . . . 10.0 109.044 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -138.34 139.81 39.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -1.177 . . . . 10.0 110.269 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 1.086 ' N ' HD22 ' A' ' 55' ' ' LEU . 18.4 p90 -162.06 139.96 8.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.136 -0.978 . . . . 10.0 110.139 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 m-20 -104.25 170.1 8.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.097 -1.002 . . . . 10.0 110.476 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 5.5 t -43.55 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 10.0 111.927 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -133.29 90.53 2.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.526 -0.733 . . . . 10.0 110.652 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -66.87 71.14 0.18 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 106.885 -2.486 . . . . 10.0 106.885 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER 64.02 28.69 14.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.541 -0.976 . . . . 10.0 109.216 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -58.95 -58.59 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.834 -1.166 . . . . 10.0 109.768 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.8 OUTLIER 175.09 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.256 -0.903 . . . . 10.0 110.147 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.607 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -151.7 -34.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 10.0 109.917 -179.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.8 t0 79.05 20.99 0.7 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.365 0.602 . . . . 10.0 109.616 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.475 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -58.73 -19.11 37.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 178.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' C ' HD22 ' A' ' 70' ' ' LEU . 1.1 pp -55.23 -16.32 3.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 1.1 ttm180 -99.68 -52.98 0.19 Allowed Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 45.7 Cg_endo -70.54 -16.51 34.28 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 120.466 0.778 . . . . 10.0 112.625 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.862 HD12 ' C ' ' B' ' 36' ' ' TRP . 0.9 OUTLIER -54.84 -10.91 0.52 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.678 -1.264 . . . . 10.0 111.949 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.614 ' HA ' ' O ' ' B' ' 37' ' ' ALA . 1.0 OUTLIER -45.83 -31.78 2.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.953 -1.092 . . . . 10.0 110.449 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 134.44 34.42 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 10.0 111.27 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.616 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 43.3 Cg_endo -80.27 159.2 23.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.899 1.473 . . . . 10.0 110.588 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 163.91 78.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.29 0.567 . . . . 10.0 109.586 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 77' ' ' VAL . 89.1 m -146.83 99.59 3.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.312 -0.867 . . . . 10.0 109.962 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 75' ' ' THR . 81.5 m-20 -38.86 -30.59 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.487 -0.758 . . . . 10.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 75' ' ' THR . 0.5 OUTLIER -119.02 120.37 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 10.0 109.337 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 67.0 m-85 -108.19 129.48 55.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.909 -1.12 . . . . 10.0 111.906 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.98 HD22 HD23 ' A' ' 111' ' ' LEU . 2.0 mm? -104.05 97.05 7.09 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -107.24 145.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.101 -0.999 . . . . 10.0 110.495 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 39.4 t -141.43 126.17 18.01 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.157 -0.964 . . . . 10.0 111.192 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CA ' ' OG1' ' A' ' 115' ' ' THR . 1.8 p90 -135.01 168.26 19.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.441 -0.787 . . . . 10.0 110.654 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.6 t -77.3 161.06 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 10.0 109.74 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -110.74 14.98 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 10.0 111.118 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 129' ' ' LEU . 3.0 m -125.48 -17.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.69 -1.257 . . . . 10.0 111.716 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.887 ' CA ' HD23 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -60.66 -159.7 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.992 -1.067 . . . . 10.0 110.096 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.3 Cg_endo -71.9 178.31 6.01 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 122.804 0.897 . . . . 10.0 110.099 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.84 66.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.246 -0.909 . . . . 10.0 110.087 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' PRO . 66.1 m -89.96 -15.28 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.691 . . . . 10.0 110.537 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.587 ' CZ ' ' HE3' ' A' ' 94' ' ' LYS . 6.1 t80 -86.24 -50.23 7.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 10.0 110.188 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -65.65 -30.59 71.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.545 -0.722 . . . . 10.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -79.29 -14.22 59.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.821 -1.174 . . . . 10.0 109.58 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.653 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 2.7 t -83.84 -21.81 8.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.612 -1.305 . . . . 10.0 107.914 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.587 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -72.12 -37.87 69.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 178.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 1.4 pt-20 -69.49 -10.53 58.45 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.943 -0.703 . . . . 10.0 109.263 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -87.34 -52.37 5.42 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.316 -0.954 . . . . 10.0 112.582 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 98' ' ' VAL . 54.9 p-90 -93.91 -15.93 24.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.752 -1.217 . . . . 10.0 112.444 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 58.8 t -66.9 -50.78 41.47 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.745 -1.222 . . . . 10.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.0 Cg_endo -71.58 -20.64 26.7 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.21 1.111 . . . . 10.0 109.761 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 5.7 mm-40 -57.14 -35.97 70.14 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.344 -0.943 . . . . 10.0 109.264 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 99' ' ' PRO . 10.2 mt 55.15 118.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.379 -0.825 . . . . 10.0 110.881 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 105' ' ' CYS . 4.2 p -48.66 -24.91 1.52 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.001 -1.062 . . . . 10.0 109.07 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.469 ' HB2' HG22 ' A' ' 101' ' ' ILE . 62.5 m-70 -76.2 -33.13 59.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.528 -0.732 . . . . 10.0 109.843 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 1.4 t-80 -105.91 -16.71 14.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 10.0 110.847 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 102' ' ' THR . 1.1 m -166.4 175.51 2.21 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.041 . . . . 10.0 110.085 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 105' ' ' CYS . 43.0 Cg_endo -70.72 86.72 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.641 1.337 . . . . 10.0 111.747 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.635 ' HB3' ' N ' ' A' ' 102' ' ' THR . 8.5 tttp -102.58 4.88 38.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 10.0 109.589 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 109' ' ' PRO . 90.8 m -43.02 147.48 0.67 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 10.0 110.309 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 108' ' ' THR . 34.3 Cg_endo -58.22 160.67 15.57 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.019 1.813 . . . . 10.0 112.81 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.587 ' O ' HG13 ' A' ' 152' ' ' VAL . 1.7 p90 -151.01 144.53 24.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.2 1.0 . . . . 10.0 109.417 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 HD22 ' A' ' 79' ' ' LEU . 1.2 mm? -77.88 99.68 6.07 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.841 0.829 . . . . 10.0 109.745 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 75.5 mt -62.9 146.87 51.88 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 80' ' ' VAL . 3.0 t -148.39 173.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.46 -1.4 . . . . 10.0 111.929 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -109.66 138.43 14.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.842 -1.703 . . . . 10.0 108.842 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.728 HG23 ' CG1' ' A' ' 14' ' ' VAL . 97.1 m -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.003 -1.292 . . . . 10.0 110.626 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.8 tp60 41.9 59.8 2.43 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.432 -0.793 . . . . 10.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.03 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.54 -42.05 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.998 -1.482 . . . . 10.0 106.998 179.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 4.8 p30 -51.91 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.284 1.04 . . . . 10.0 110.385 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 162.34 -28.07 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.47 -41.43 20.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.592 0.711 . . . . 10.0 109.62 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 77.5 m-20 -67.57 -10.14 49.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.401 -0.812 . . . . 10.0 109.99 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 126' ' ' ILE . 14.8 t0 -82.3 117.15 67.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.824 . . . . 10.0 109.301 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.62 23.77 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.154 1.607 . . . . 10.0 110.97 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 37.2 t -107.84 -49.35 3.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.167 -0.958 . . . . 10.0 109.932 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 119' ' ' LEU . 14.4 t -75.06 -31.25 61.23 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 122' ' ' ASP 0.295 1.2 mp -56.02 -23.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 176.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.4 tt0 -47.99 -42.25 27.36 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.382 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -71.13 -49.55 42.95 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.48 -0.763 . . . . 10.0 110.547 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 85' ' ' VAL . 4.9 mp -67.3 -43.68 81.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.67 0.748 . . . . 10.0 110.691 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.46 77.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 10.0 110.594 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -52.23 -21.3 3.27 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.214 -0.929 . . . . 10.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 3.1 t30 -85.9 -68.12 0.76 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.381 -0.825 . . . . 10.0 111.242 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.502 ' HD3' ' ND2' ' A' ' 132' ' ' ASN . 0.4 OUTLIER -124.59 129.4 50.51 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.532 -0.73 . . . . 10.0 110.6 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.648 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.6 OUTLIER -84.25 9.05 13.9 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.357 -0.839 . . . . 10.0 109.172 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -118.6 94.03 46.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.415 -0.803 . . . . 10.0 110.368 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 162.35 28.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.586 1.524 . . . . 10.0 110.182 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.975 HG23 HG12 ' A' ' 84' ' ' VAL . 2.4 tp -103.98 146.61 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.004 -1.06 . . . . 10.0 110.34 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.4 p -132.69 171.12 9.7 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 10.0 110.102 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.646 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . 40.0 Cg_endo -71.69 -22.55 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.551 1.29 . . . . 10.0 111.445 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -55.15 21.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.085 . . . . 10.0 109.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -65.4 -39.85 92.7 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.372 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.47 -30.01 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.009 -1.057 . . . . 10.0 111.144 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.38 -49.3 67.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.183 -0.948 . . . . 10.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 148' ' ' ASP . 7.2 ttmt -62.91 -44.01 97.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.347 -0.941 . . . . 10.0 109.078 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.827 ' HG ' HD22 ' A' ' 149' ' ' LEU . 7.0 tt -59.32 -33.51 71.21 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.486 -0.758 . . . . 10.0 109.157 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 1.011 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -67.34 -50.02 61.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.69 0.757 . . . . 10.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -84.34 -10.12 57.87 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.35 -0.94 . . . . 10.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 144' ' ' LYS . 37.6 t0 -93.77 -37.55 11.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.599 -1.313 . . . . 10.0 110.795 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.827 HD22 ' HG ' ' A' ' 145' ' ' LEU . 1.4 mp -101.07 24.75 8.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 10.0 109.735 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.9 mtpt 61.95 39.21 13.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.561 -0.745 . . . . 10.0 112.017 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 1.011 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -95.26 -156.05 0.5 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.71 -66.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.473 -1.392 . . . . 10.0 110.259 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.576 ' N ' HG22 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -172.68 174.8 3.59 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.679 -1.608 . . . . 10.0 112.003 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 139' ' ' PRO . 41.5 p90 -104.34 133.6 48.97 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -137.71 -169.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.307 -0.871 . . . . 10.0 109.781 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 164' ' ' GLY . 78.4 mm-40 -144.13 162.86 35.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.016 -1.053 . . . . 10.0 110.138 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 163' ' ' LYS . 15.5 p -164.89 133.82 3.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.282 -0.886 . . . . 10.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.582 ' H ' HD23 ' A' ' 165' ' ' LEU . 32.6 t -120.78 173.38 7.25 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.834 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -86.67 -78.76 0.28 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 120.899 -1.126 . . . . 10.0 111.789 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.8 pp -91.49 -4.25 55.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.434 -1.416 . . . . 10.0 111.108 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.1 m -96.1 -32.41 12.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.087 -1.008 . . . . 10.0 111.466 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.54 ' HA ' ' HG ' ' A' ' 165' ' ' LEU . 3.9 mt-30 75.92 67.84 0.07 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.236 -0.915 . . . . 10.0 109.772 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.565 ' HG2' HG12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -102.9 102.73 12.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.831 -1.147 . . . . 10.0 109.719 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.971 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 78.14 10.51 86.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.36 -1.896 . . . . 10.0 108.36 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.241 HD11 ' CE2' ' A' ' 23' ' ' TYR 0.254 0.2 OUTLIER -54.34 -51.84 63.46 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.995 0.902 . . . . 10.0 110.78 -179.658 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -80.91 -10.56 59.7 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.809 -0.557 . . . . 10.0 111.101 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.535 ' HB3' HG12 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -85.31 -31.57 22.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.193 -0.942 . . . . 10.0 110.342 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 164' ' ' GLY . 2.8 t -71.92 -25.82 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.02 -1.05 . . . . 10.0 108.219 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.556 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -76.2 -49.68 16.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.314 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 26.2 m-20 -63.03 -49.88 72.88 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.282 -0.886 . . . . 10.0 112.269 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.89 -40.79 94.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.896 -1.128 . . . . 10.0 111.25 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -60.54 -22.5 63.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.98 -1.075 . . . . 10.0 109.925 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.595 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.2 mm -61.13 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.219 -0.926 . . . . 10.0 109.864 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.34 -45.85 65.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.255 -0.903 . . . . 10.0 110.557 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.2 4.42 23.53 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.351 -0.843 . . . . 10.0 110.532 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -84.47 -39.37 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 10.0 110.666 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -101.83 -14.76 17.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 10.0 110.409 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.877 -1.059 . . . . 10.0 110.68 -179.626 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.411 . . . . 10.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.533 ' O ' ' N ' ' B' ' 4' ' ' GLU . 54.3 m -98.81 33.5 2.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.244 -1.151 . . . . 10.0 110.646 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 174' ' ' LEU . 1.3 ttmt -50.15 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 10.0 110.597 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 2' ' ' SER . 31.9 mm-40 -134.74 167.61 20.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.186 -0.946 . . . . 10.0 110.664 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.671 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.03 -153.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.158 -1.052 . . . . 10.0 108.158 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.671 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.3 Cg_endo -69.87 84.22 0.68 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 N-CA-C 109.463 -1.014 . . . . 10.0 109.463 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.731 ' CG ' HG23 ' A' ' 46' ' ' ILE . 1.3 tp10 -44.43 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.79 0.805 . . . . 10.0 111.115 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 1.069 HD12 ' N ' ' B' ' 9' ' ' SER . 1.6 pp -91.56 -23.39 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 122.566 1.174 . . . . 10.0 107.939 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 1.069 ' N ' HD12 ' B' ' 8' ' ' ILE . 43.3 m -57.24 -166.64 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.68 -1.145 . . . . 10.0 112.205 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.637 ' HB3' ' O ' ' A' ' 45' ' ' MET . 0.2 OUTLIER -37.48 117.23 0.82 Allowed Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.478 1.288 . . . . 10.0 114.478 -176.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.541 ' HD2' HD13 ' B' ' 10' ' ' LEU . 49.7 Cg_endo -93.95 111.31 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.488 1.459 . . . . 10.0 109.266 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -86.51 -168.01 2.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.799 -1.188 . . . . 10.0 110.054 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 147.03 0.97 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.499 -0.75 . . . . 10.0 110.009 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.621 ' O ' HG11 ' A' ' 42' ' ' VAL . 80.2 m-85 -90.88 163.16 14.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 10.0 110.14 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.658 ' HB3' ' CG ' ' A' ' 40' ' ' TYR . 2.3 mp0 -50.59 179.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.991 0.901 . . . . 10.0 112.322 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -81.3 -167.42 1.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.764 0.792 . . . . 10.0 112.719 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.3 m -85.46 152.81 22.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.688 -0.633 . . . . 10.0 109.843 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.784 HG22 ' N ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -123.83 129.09 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 10.0 109.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 17.2 t60 -141.93 151.04 42.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.639 -1.288 . . . . 10.0 112.728 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.68 ' HA ' ' HG3' ' A' ' 62' ' ' GLU . 1.7 p -120.9 154.96 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.331 0.586 . . . . 10.0 111.181 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' B' ' 22' ' ' PHE . . . -124.31 56.64 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 106.93 -2.468 . . . . 10.0 106.93 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.047 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 172.06 101.43 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.534 -0.98 . . . . 10.0 109.529 -177.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.625 ' O ' HG23 ' B' ' 25' ' ' VAL . 9.8 t0 -61.77 139.94 58.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.114 -0.991 . . . . 10.0 111.165 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' THR . . . 33.79 61.83 0.46 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.558 -0.714 . . . . 10.0 111.336 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 1.047 HG21 ' CD1' ' B' ' 22' ' ' PHE . 19.4 t -113.13 -27.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.163 -0.961 . . . . 10.0 110.818 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.677 ' HB ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -121.19 -12.25 8.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 10.0 111.181 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 26' ' ' ASN . . . -72.7 -29.91 64.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.239 -1.944 . . . . 10.0 108.239 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 13.2 mt-10 -83.44 97.63 9.08 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.925 0.869 . . . . 10.0 109.781 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.816 ' CB ' HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -110.64 144.52 39.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 120.07 -0.652 . . . . 10.0 109.404 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.668 HG22 ' CE1' ' A' ' 28' ' ' PHE . 7.2 p -148.14 -39.25 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.203 -0.936 . . . . 10.0 110.39 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.51 -154.56 11.43 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 120.046 -1.073 . . . . 10.0 110.773 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.07 76.21 6.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.782 -0.834 . . . . 10.0 111.621 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.652 ' CG ' ' CE1' ' B' ' 29' ' ' PHE . 43.9 Cg_endo -74.24 171.32 18.25 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.838 1.441 . . . . 10.0 109.199 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . . . . . . . . . 6.2 tt0 -62.38 171.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 10.0 111.642 -178.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.858 ' HG2' HG12 ' A' ' 8' ' ' VAL . 3.9 mt-30 -94.25 16.55 14.62 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.758 -0.589 . . . . 10.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.862 ' C ' HD12 ' A' ' 70' ' ' LEU . 53.4 m0 58.85 52.99 6.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 10.0 111.616 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -177.83 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.358 -0.839 . . . . 10.0 111.593 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.432 ' NH1' ' HB3' ' A' ' 73' ' ' PRO . 1.2 mpt_? . . . . . 0 N--CA 1.499 1.998 0 O-C-N 120.964 -1.085 . . . . 10.0 110.792 -179.271 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.206 0.527 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -143.91 -14.51 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.224 -0.922 . . . . 10.0 110.542 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 57.0 m -71.91 112.43 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.302 -0.874 . . . . 10.0 111.758 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.048 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -106.26 121.63 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 118.854 -1.138 . . . . 10.0 108.974 177.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.3 mmtm -94.0 113.78 25.83 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.791 -1.189 . . . . 10.0 107.791 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.431 ' C ' HG23 ' A' ' 7' ' ' VAL . 95.3 m -99.69 105.08 16.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.223 -0.923 . . . . 10.0 109.231 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.724 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 39.7 t -143.02 146.8 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.94 -1.104 . . . . 10.0 111.084 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.617 HG22 ' OG1' ' A' ' 17' ' ' THR . 21.8 t -59.77 141.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 10.0 109.961 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 80' ' ' VAL . 25.7 m -72.73 -169.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 10.0 110.925 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' B' ' 37' ' ' ALA . . . -129.67 11.06 6.03 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -49.96 -46.71 52.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.303 -1.116 . . . . 10.0 109.15 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 134.32 -12.41 4.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 81' ' ' CYS . . . -69.99 172.37 7.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.478 -1.013 . . . . 10.0 109.347 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 19' ' ' LEU . 2.5 p -58.63 161.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.995 -1.066 . . . . 10.0 109.237 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.546 ' N ' ' HG3' ' B' ' 35' ' ' GLN . . . -71.7 112.25 4.02 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.336 . . . . 10.0 109.761 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.921 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -49.75 -29.3 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.035 -1.274 . . . . 10.0 108.593 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 8' ' ' VAL . 94.6 m -59.84 -33.02 71.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.503 -0.748 . . . . 10.0 109.371 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 1.9 t -81.77 -13.86 57.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.601 -0.84 . . . . 10.0 109.899 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 159' ' ' ALA . 4.4 mt -92.58 -31.19 15.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 10.0 109.486 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.13 -31.41 72.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 10.0 107.683 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.84 HG21 HG23 ' B' ' 26' ' ' THR 0.26 9.3 mm -72.19 -45.86 60.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.33 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 21' ' ' ILE . 20.1 p -48.85 -26.1 2.24 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.905 -1.118 . . . . 10.0 108.611 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 1.183 ' CE2' HD12 ' A' ' 165' ' ' LEU . 2.8 m-85 -86.3 -26.02 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 10.0 108.596 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 21' ' ' ILE . 56.2 m -89.91 -31.15 17.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.667 . . . . 10.0 111.651 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . . . . . . . . . 1.5 p -92.29 -81.32 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.613 -1.304 . . . . 10.0 109.687 -179.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 8.9 m-80 -148.62 -30.19 0.28 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.931 -0.708 . . . . 10.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 6.4 pttt 145.96 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 CA-C-O 121.146 0.498 . . . . 10.0 109.815 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.887 ' CZ ' HG22 ' B' ' 30' ' ' THR . 0.1 OUTLIER . . . . . 0 N--CA 1.496 1.841 0 N-CA-C 113.076 0.769 . . . . 10.0 113.076 -178.248 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 1.045 ' CB ' HG21 ' B' ' 26' ' ' THR . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.607 0 CA-C-O 120.995 0.426 . . . . 10.0 111.427 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.869 HG12 ' N ' ' A' ' 37' ' ' PHE . 1.6 t 158.28 -78.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.869 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.9 t80 -61.3 140.22 58.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 10.0 110.96 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HA ' HG13 ' B' ' 18' ' ' ILE . 35.6 t0 -164.56 85.73 0.44 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 39' ' ' ASN . 4.0 p-10 -104.96 103.46 13.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 10.0 111.421 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' B' ' 16' ' ' HIS . 0.2 OUTLIER -170.24 -168.4 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 10.0 110.076 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.574 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -141.04 165.22 28.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.045 -1.035 . . . . 10.0 110.358 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HA ' ' B' ' 14' ' ' PHE . 60.2 t -155.57 171.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 10.0 110.972 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.4 m -140.17 146.24 38.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.816 -0.552 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.696 ' CG1' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -105.34 170.64 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.007 -1.058 . . . . 10.0 109.443 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 8.4 mtt -144.0 121.71 11.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.447 -0.783 . . . . 10.0 109.93 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 ' CG1' ' A' ' 44' ' ' VAL . 1.4 mp -138.0 130.62 40.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.357 -0.84 . . . . 10.0 109.535 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 46.72 23.27 1.37 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.34 -1.504 . . . . 10.0 109.34 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.61 2.34 67.57 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.061 -1.258 . . . . 10.0 110.214 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 4.3 mm-40 -94.3 111.58 54.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.049 -1.265 . . . . 10.0 111.163 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 45.2 Cg_endo -70.11 152.35 67.47 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.87 1.458 . . . . 10.0 109.906 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.789 ' O ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -116.06 163.55 15.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.072 -1.017 . . . . 10.0 110.876 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.647 ' O ' HG22 ' A' ' 4' ' ' ILE 0.256 39.0 m -124.21 112.51 17.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.78 -0.575 . . . . 10.0 109.795 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.4 pp -146.59 179.94 7.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.9 -1.125 . . . . 10.0 111.445 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.826 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -169.26 133.38 2.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 55' ' ' LEU . 1.8 tm? -124.59 123.97 41.21 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.062 -1.257 . . . . 10.0 110.338 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 55' ' ' LEU . 58.9 m-85 -133.51 112.95 11.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 10.0 111.001 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.1 t0 -92.24 134.78 34.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 10.0 109.658 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.77 ' O ' HG23 ' A' ' 58' ' ' THR . 12.4 t -84.22 98.24 9.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 10.0 111.982 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . . . 164.7 62.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.358 -0.839 . . . . 10.0 109.89 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 37' ' ' PHE . . . -40.41 -30.07 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.347 -1.501 . . . . 10.0 109.347 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 1.9 pt20 -170.82 23.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -1.124 . . . . 10.0 111.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 8.2 mt-10 -150.63 -93.71 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.881 -1.137 . . . . 10.0 110.606 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p30 169.74 47.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.689 -1.257 . . . . 10.0 111.073 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.582 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 55.5 p90 -162.12 -44.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.861 -1.15 . . . . 10.0 111.237 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 1.8 t0 77.06 113.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.32 -0.863 . . . . 10.0 111.901 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -21.88 12.82 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.622 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 18.1 mt -84.26 5.9 24.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.469 -0.769 . . . . 10.0 109.01 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.982 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.8 ptt180 -52.32 -32.48 9.13 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 113.709 1.003 . . . . 10.0 113.709 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.624 ' HD3' ' CG ' ' A' ' 68' ' ' ARG . 53.4 Cg_endo -74.66 76.58 3.21 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 CA-C-N 120.038 1.049 . . . . 10.0 110.325 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -101.0 -29.98 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.87 -1.144 . . . . 10.0 111.184 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 43.9 24.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 10.0 110.667 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -164.3 98.59 0.91 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.915 -1.115 . . . . 10.0 111.678 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 48.4 Cg_endo -69.76 167.66 23.81 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.925 1.487 . . . . 10.0 111.134 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 67.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.537 -0.727 . . . . 10.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.82 HG23 ' CB ' ' A' ' 5' ' ' LYS . 52.6 m -145.42 97.85 3.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.398 -0.814 . . . . 10.0 109.493 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 64.5 m-20 -33.7 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.169 0.509 . . . . 10.0 111.36 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 75' ' ' THR . 0.4 OUTLIER -122.26 120.25 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.085 -1.01 . . . . 10.0 110.423 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 39.3 m-85 -116.48 140.61 49.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.616 -0.677 . . . . 10.0 109.735 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.921 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.1 mm? -113.96 98.96 7.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.932 -1.105 . . . . 10.0 108.819 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HA ' HG21 ' A' ' 9' ' ' VAL . 12.9 p -106.31 148.05 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.553 -0.717 . . . . 10.0 110.893 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 41.2 t -134.59 125.15 26.63 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.863 . . . . 10.0 110.805 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 13.6 p90 -136.66 157.72 46.11 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.242 -0.983 . . . . 10.0 110.345 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.424 ' OG ' HG22 ' A' ' 85' ' ' VAL . 44.0 t -83.4 137.69 33.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 10.0 112.133 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 HG13 ' A' ' 85' ' ' VAL . 18.7 m -90.53 2.32 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.666 -0.646 . . . . 10.0 109.859 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.647 HG13 HG23 ' A' ' 84' ' ' VAL . 35.0 m -119.21 48.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 10.0 109.187 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . 21.1 p -133.36 176.69 2.71 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 42.3 Cg_endo -70.52 158.8 54.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.306 1.161 . . . . 10.0 110.733 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 87' ' ' PRO . 3.6 m -31.3 87.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.477 0.656 . . . . 10.0 111.899 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' PRO . 31.0 t -117.14 -54.2 2.42 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 10.0 109.832 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.612 ' CE1' ' HE2' ' A' ' 94' ' ' LYS . 8.8 t80 -49.41 -38.49 29.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.105 . . . . 10.0 109.303 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 34.7 tt0 -60.84 -35.4 76.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 10.0 109.719 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.649 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -69.96 -15.43 63.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.362 -0.836 . . . . 10.0 109.527 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.649 HG23 ' ND2' ' A' ' 92' ' ' ASN . 62.1 t -87.76 -16.0 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.209 -0.932 . . . . 10.0 109.405 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE3' HD13 ' A' ' 145' ' ' LEU . 2.6 mmtt -85.8 -29.54 23.71 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.7 pt-20 -94.4 5.97 50.16 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.481 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.3 tmtt? -95.92 -51.83 4.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 10.0 112.317 -178.691 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.914 ' CH2' HD23 ' A' ' 149' ' ' LEU . 49.6 p-90 -104.06 -25.5 12.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.748 -1.22 . . . . 10.0 111.694 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.0 t -64.87 -41.91 59.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.838 -1.164 . . . . 10.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.7 Cg_endo -82.65 -23.32 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.431 1.227 . . . . 10.0 110.635 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.5 mm-40 -93.87 7.48 44.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.031 . . . . 10.0 110.363 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 37.0 mm 59.32 103.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 10.0 111.023 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.768 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.6 m -44.7 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.428 -0.952 . . . . 10.0 108.428 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.768 ' N ' HG22 ' A' ' 102' ' ' THR . 21.3 m-70 -113.23 -6.38 13.61 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.497 -0.752 . . . . 10.0 109.295 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.578 ' O ' ' CB ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER 157.07 16.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 -178.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 5.5 t 83.04 34.65 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.853 -0.53 . . . . 10.0 110.026 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.8 Cg_endo -80.85 -18.27 9.15 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 O-C-N 123.177 1.093 . . . . 10.0 109.603 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 64.0 54.22 1.74 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.596 0.713 . . . . 10.0 110.558 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.527 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 13.5 t -52.29 157.8 2.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.505 -0.747 . . . . 10.0 109.552 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.527 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 42.4 Cg_endo -70.5 140.0 38.91 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.294 1.154 . . . . 10.0 110.404 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.513 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -135.61 112.41 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.297 -0.877 . . . . 10.0 109.662 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.986 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 3.0 mm? -77.08 97.63 4.77 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.106 -0.996 . . . . 10.0 109.242 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 11.2 mt -69.91 141.01 53.19 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.926 ' CG2' HG11 ' A' ' 168' ' ' VAL . 47.0 t -140.94 168.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.805 -1.184 . . . . 10.0 112.509 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -107.52 159.23 14.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.285 -1.926 . . . . 10.0 108.285 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' C ' ' A' ' 82' ' ' PHE . 85.5 m -115.55 120.41 39.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.399 . . . . 10.0 111.341 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.32 55.57 5.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.582 -0.699 . . . . 10.0 111.375 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -55.74 -22.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.084 . . . . 10.0 108.714 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 21.3 t70 -52.0 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.453 1.12 . . . . 10.0 110.708 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.723 ' N ' ' O ' ' A' ' 117' ' ' ILE . 16.0 tp 159.71 -24.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.447 -1.252 . . . . 10.0 108.381 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -49.12 -42.77 40.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.748 -0.595 . . . . 10.0 109.6 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.421 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m-20 -53.92 -20.2 5.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.021 -1.049 . . . . 10.0 109.234 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.8 t0 -82.53 118.0 70.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.688 . . . . 10.0 110.537 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 48.4 Cg_endo -90.58 23.0 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.661 1.574 . . . . 10.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 p -101.36 -49.41 4.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 10.0 110.149 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.714 HG21 HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.89 -26.83 43.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.201 -2.148 . . . . 10.0 105.201 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.815 ' HA ' HD22 ' A' ' 129' ' ' LEU 0.281 1.1 mp -56.66 -26.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 176.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -49.38 -35.07 17.74 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.636 -0.711 . . . . 10.0 111.128 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -61.81 -38.31 87.64 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.188 -0.945 . . . . 10.0 110.744 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -59.03 -32.9 70.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 10.0 110.086 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -56.23 -45.01 80.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 10.0 109.833 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -55.94 -16.89 5.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.337 -0.852 . . . . 10.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.99 -18.3 5.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.922 -1.111 . . . . 10.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -165.57 110.54 0.87 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.014 -1.054 . . . . 10.0 109.998 -179.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.52 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -71.91 -24.62 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 10.0 110.511 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -98.12 104.83 24.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 10.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 44.1 Cg_endo -71.54 154.47 60.11 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.793 1.417 . . . . 10.0 110.379 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.5 tp -94.08 135.38 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 10.0 109.013 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 16.2 p -124.01 168.81 11.8 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.325 -0.859 . . . . 10.0 109.589 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -66.3 -15.27 47.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.527 1.278 . . . . 10.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.66 -37.81 22.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 10.0 110.426 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.6 m -79.33 -32.66 43.4 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.538 -0.726 . . . . 10.0 110.821 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.27 -44.86 74.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 10.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -64.52 -27.76 69.19 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.27 -0.972 . . . . 10.0 109.453 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 147' ' ' ARG . 2.0 mmtp -67.53 -43.89 79.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.11 -0.994 . . . . 10.0 108.639 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.877 HD13 ' HE3' ' A' ' 94' ' ' LYS . 4.3 tt -63.05 -46.22 88.53 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -52.22 -43.12 64.1 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.816 0.817 . . . . 10.0 109.179 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 3.8 ttp85 -55.6 -28.74 56.89 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.524 0.678 . . . . 10.0 109.463 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.489 ' C ' HD12 ' A' ' 149' ' ' LEU . 22.9 t70 -78.17 -43.95 27.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.623 -0.673 . . . . 10.0 110.776 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.914 HD23 ' CH2' ' A' ' 97' ' ' TRP . 5.7 mp -88.06 9.83 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 10.0 108.88 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 10.2 mttt 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.895 0.855 . . . . 10.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.805 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -59.9 -151.34 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.197 -0.668 . . . . 10.0 109.197 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.913 ' CG1' HD13 ' A' ' 111' ' ' LEU . 1.4 p -116.86 -64.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.594 -1.316 . . . . 10.0 110.747 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.603 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -173.9 140.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.453 -1.404 . . . . 10.0 111.863 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 29.0 t80 -84.78 108.06 17.27 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.388 -0.925 . . . . 10.0 109.889 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.957 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -103.61 -169.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.752 . . . . 10.0 110.174 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' HA3' ' A' ' 164' ' ' GLY . 0.5 OUTLIER -127.74 160.29 32.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.958 . . . . 10.0 110.14 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.925 ' SG ' HD23 ' A' ' 165' ' ' LEU 0.251 1.6 t -166.02 135.87 3.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 10.0 110.238 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.556 ' OG ' ' CG ' ' A' ' 163' ' ' LYS . 34.2 m -131.17 83.88 2.14 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.078 -1.453 . . . . 10.0 107.078 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 1.052 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -29.26 -53.2 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.691 -1.141 . . . . 10.0 113.132 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.8 tp -71.06 -53.75 13.6 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.693 -1.254 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.4 p -84.74 -89.54 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.911 -1.118 . . . . 10.0 111.169 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.605 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 2.4 pt20 159.28 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 10.0 109.364 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.556 ' CG ' ' OG ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -105.33 69.19 0.83 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.026 -1.069 . . . . 10.0 110.591 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 76.98 0.93 71.24 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.993 -1.643 . . . . 10.0 108.993 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.183 HD12 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -50.12 -44.41 52.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.42 -1.047 . . . . 10.0 109.608 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.879 ' N ' HD13 ' A' ' 165' ' ' LEU . 14.8 tttm -70.69 -25.64 63.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.156 -0.965 . . . . 10.0 109.367 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 19.3 m120 -75.45 -33.89 60.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 10.0 111.641 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.957 HG22 ' HB ' ' A' ' 155' ' ' VAL . 10.7 t -57.96 -49.75 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.786 -1.197 . . . . 10.0 110.056 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.26 -40.0 88.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.659 -0.651 . . . . 10.0 110.43 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.6 t0 -60.12 -46.41 89.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 10.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.5 -42.63 99.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 10.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.986 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.28 -24.52 43.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 10.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.639 ' O ' HD11 ' A' ' 177' ' ' LEU . 77.4 mt -63.92 -47.03 92.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.115 -0.99 . . . . 10.0 109.595 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.802 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.07 -41.45 70.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 10.0 111.087 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -80.71 -2.72 48.0 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.198 -0.938 . . . . 10.0 110.899 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.048 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.67 -22.5 24.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.045 -1.035 . . . . 10.0 110.821 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -90.06 -22.19 21.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.077 -1.015 . . . . 10.0 110.138 -179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.025 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.254 -1.538 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -124.23 140.44 52.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.174 -1.192 . . . . 10.0 110.475 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.747 ' HE2' HD12 ' A' ' 174' ' ' LEU . 10.1 tptt -84.26 103.15 13.21 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.204 -0.935 . . . . 10.0 108.511 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -82.66 152.61 25.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.238 -0.914 . . . . 10.0 110.692 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.632 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.76 -48.14 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.77 -0.581 . . . . 10.0 110.555 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.2 Cg_endo -91.32 24.06 0.58 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.977 -1.201 . . . . 10.0 108.977 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.628 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 2.0 pm0 -39.55 166.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.544 0.688 . . . . 10.0 111.659 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.85 -88.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 10.0 111.192 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.5 p -82.37 171.19 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 10.0 111.96 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.909 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.96 96.8 0.48 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 10.0 111.818 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.49 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 46.9 Cg_endo -76.1 133.61 15.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.418 1.22 . . . . 10.0 109.117 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 56.4 p -93.16 117.95 30.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 10.0 111.105 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.09 136.45 54.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.523 -0.736 . . . . 10.0 109.303 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.794 ' HA ' HG13 ' A' ' 42' ' ' VAL . 11.4 p90 -139.98 166.53 24.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.939 -1.101 . . . . 10.0 110.635 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.6 tt0 -164.19 110.88 1.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.087 -1.008 . . . . 10.0 110.78 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 p80 -165.76 137.54 3.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 10.0 110.17 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.508 ' C ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -150.59 98.48 2.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 10.0 110.636 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.729 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -155.55 -170.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.4 p-80 -141.81 153.75 44.73 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 117.6 -1.64 . . . . 10.0 112.605 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.985 HG21 ' CA ' ' A' ' 35' ' ' THR . 3.5 m -103.39 152.34 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.461 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -124.09 73.77 0.4 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.742 -1.218 . . . . 10.0 110.313 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.858 ' CD2' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 167.4 97.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.385 -1.067 . . . . 10.0 109.189 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.777 ' O ' HG23 ' B' ' 25' ' ' VAL . 21.1 m-20 -61.33 154.48 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.438 -0.789 . . . . 10.0 111.815 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.476 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 39.76 38.11 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.638 . . . . 10.0 111.065 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.858 HG21 ' CD2' ' B' ' 22' ' ' PHE . 37.1 t -111.39 -23.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 10.0 108.821 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 1.045 HG21 ' CB ' ' A' ' 35' ' ' THR . 10.0 t -88.97 -10.61 47.04 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.36 0.6 . . . . 10.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.63 -0.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.517 -1.433 . . . . 10.0 109.517 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' B' ' 28' ' ' GLU . 6.8 pt-20 -104.51 122.11 44.86 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.969 -1.312 . . . . 10.0 110.733 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.3 OUTLIER -121.59 118.61 29.66 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.736 -0.839 . . . . 10.0 108.736 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.887 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 23.0 p -122.19 -4.99 8.93 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.986 -0.685 . . . . 10.0 109.589 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.89 39.09 0.78 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.167 -1.573 . . . . 10.0 109.167 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' B' ' 33' ' ' PRO . 28.4 mm -69.0 142.15 92.94 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.329 -1.1 . . . . 10.0 110.435 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' B' ' 32' ' ' ILE . 45.0 Cg_endo -68.9 177.61 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.293 1.681 . . . . 10.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' B' ' 37' ' ' ALA . 5.4 tm-20 -23.09 138.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.437 0.637 . . . . 10.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.546 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 7.6 mm100 -100.81 -71.72 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.67 0.989 . . . . 10.0 113.67 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.724 ' CZ3' HG11 ' A' ' 7' ' ' VAL . 16.5 t90 -108.69 30.36 6.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.357 -0.839 . . . . 10.0 112.611 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.746 ' HA ' HD21 ' A' ' 70' ' ' LEU . . . -178.18 89.3 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 118.986 -1.086 . . . . 10.0 111.383 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.505 ' HA ' ' HG3' ' B' ' 34' ' ' GLU . 5.3 ttp180 . . . . . 0 N--CA 1.488 1.459 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.283 0.563 . . . . 10.0 109.703 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -177.9 -160.74 0.05 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 10.0 110.749 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 3' ' ' THR . 85.0 m 41.25 58.29 2.64 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.36 -0.837 . . . . 10.0 111.019 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -143.16 150.52 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 117.28 -1.768 . . . . 10.0 113.804 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.629 ' N ' HG13 ' A' ' 4' ' ' ILE . 27.9 mtmt -131.32 126.1 34.45 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.279 -0.888 . . . . 10.0 109.601 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.465 ' C ' HG23 ' A' ' 7' ' ' VAL . 10.0 t -85.36 129.98 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.133 -0.979 . . . . 10.0 109.336 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 6' ' ' CYS . 4.1 t -146.97 175.97 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.919 -1.113 . . . . 10.0 110.421 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.536 HG21 HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER -108.93 146.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.537 -1.352 . . . . 10.0 111.178 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.27 -168.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.211 -0.93 . . . . 10.0 110.389 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.753 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 114.02 134.9 5.96 Favored Glycine 0 C--N 1.29 -1.994 0 N-CA-C 109.251 -1.54 . . . . 10.0 109.251 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.24 -14.8 19.72 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.507 -0.996 . . . . 10.0 110.054 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.49 -108.17 0.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.941 -1.664 . . . . 10.0 108.941 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.54 -130.3 0.08 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.03 -1.277 . . . . 10.0 110.933 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.556 ' C ' ' HG3' ' B' ' 35' ' ' GLN . 17.8 m -110.4 148.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.186 . . . . 10.0 110.618 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -51.58 137.95 29.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.6 -28.27 11.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.671 -1.488 . . . . 10.0 110.72 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.536 HG21 HG21 ' A' ' 8' ' ' VAL . 77.1 p -88.88 -37.44 15.31 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.492 -0.755 . . . . 10.0 110.336 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 19' ' ' LEU . 21.8 p -85.35 -13.46 49.47 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.925 -1.109 . . . . 10.0 109.745 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' B' ' 29' ' ' PHE . 4.4 mm? -81.9 -42.89 18.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.36 -1.463 . . . . 10.0 109.048 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 165' ' ' LEU . 5.6 tt -46.85 -37.74 9.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.632 -1.248 . . . . 10.0 107.632 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.868 HG21 HG23 ' B' ' 26' ' ' THR 0.256 5.6 mm -67.86 -46.99 81.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.779 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 p -48.3 -31.52 6.11 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.596 -0.842 . . . . 10.0 109.843 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.699 ' CD2' HD11 ' A' ' 165' ' ' LEU . 3.4 m-85 -93.77 -18.86 21.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.785 -1.197 . . . . 10.0 109.399 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 93.5 m -94.4 -22.5 18.26 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 10.0 112.604 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -109.16 -77.84 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.033 -1.667 . . . . 10.0 110.891 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 80.4 m-20 -152.19 -23.68 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.144 -1.423 . . . . 10.0 113.025 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 49.5 pttt 167.68 -158.7 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 O-C-N 120.855 -1.153 . . . . 10.0 112.481 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 2.7 p90 . . . . . 0 N--CA 1.498 1.943 0 N-CA-C 115.055 1.502 . . . . 10.0 115.055 -178.203 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.429 ' HB ' HG12 ' B' ' 20' ' ' VAL . 34.6 p . . . . . 0 N--CA 1.499 2.004 0 N-CA-C 113.358 0.873 . . . . 10.0 113.358 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.643 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 44.3 t -57.07 -74.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.777 -0.577 . . . . 10.0 109.752 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.68 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 19.8 t80 -45.05 123.43 3.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.712 ' HA ' HD11 ' B' ' 18' ' ' ILE . 12.1 t0 -149.73 86.59 1.46 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.381 -1.328 . . . . 10.0 111.479 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 16' ' ' HIS . 19.1 t-20 -97.82 99.98 11.33 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.721 -1.215 . . . . 10.0 107.721 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 2.3 m-85 -122.69 121.44 36.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.661 . . . . 10.0 109.63 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' B' ' 14' ' ' PHE . . . -112.48 116.12 29.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 10.0 110.253 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 43' ' ' THR . 40.1 t -132.86 173.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.897 -1.127 . . . . 10.0 110.244 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 51' ' ' TYR . 67.6 m -155.03 151.27 28.23 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.767 -0.773 . . . . 10.0 110.216 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -144.83 128.67 12.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.491 -0.883 . . . . 10.0 111.357 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.571 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -86.8 97.57 10.7 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.336 -0.946 . . . . 10.0 109.417 178.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 51' ' ' TYR . 2.9 mp -78.96 114.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.073 -1.017 . . . . 10.0 108.27 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 55.69 19.76 21.84 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 118.654 -1.736 . . . . 10.0 109.189 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 109.93 -8.13 31.5 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.349 -1.089 . . . . 10.0 110.645 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.543 ' C ' ' HA ' ' A' ' 45' ' ' MET . 30.1 mm-40 -96.43 105.33 21.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.28 . . . . 10.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 44.3 Cg_endo -71.19 130.71 18.0 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.495 1.463 . . . . 10.0 110.387 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.572 ' CE1' HD13 ' A' ' 46' ' ' ILE . 3.8 m-30 -98.18 118.31 34.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.838 -1.163 . . . . 10.0 111.616 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.7 p -92.28 99.23 12.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.077 -1.014 . . . . 10.0 108.568 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.03 147.33 44.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.039 -1.038 . . . . 10.0 110.94 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -129.62 109.52 0.96 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.04 -1.624 . . . . 10.0 109.04 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.807 ' C ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -98.28 127.45 44.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -1.204 . . . . 10.0 110.543 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.745 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.5 t80 -137.92 122.12 18.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.947 . . . . 10.0 111.283 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -107.8 164.73 12.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.902 -1.124 . . . . 10.0 109.719 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' B' ' 36' ' ' TRP . 99.6 m -47.44 164.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.798 -1.189 . . . . 10.0 111.001 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' A' ' 62' ' ' GLU . . . -104.74 91.68 3.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.73 -0.606 . . . . 10.0 109.961 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.574 ' HA3' HG23 ' B' ' 20' ' ' VAL . . . -48.01 -41.47 21.76 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.843 -2.503 . . . . 10.0 106.843 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 20.3 pt20 -71.87 -31.93 66.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 5.6 mt-10 56.42 81.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.813 0.816 . . . . 10.0 111.681 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.537 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 97.9 m-20 -126.38 3.92 6.98 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.32 0.581 . . . . 10.0 109.513 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 171.46 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 10.0 110.911 -178.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 5.4 p-10 -113.83 15.61 18.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.828 -1.17 . . . . 10.0 110.808 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.7 ptt-85 -77.83 -33.99 52.09 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.091 -1.006 . . . . 10.0 110.136 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.551 ' CA ' HD21 ' A' ' 70' ' ' LEU . 4.9 mt -111.41 5.27 19.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.909 -1.12 . . . . 10.0 111.726 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -97.07 -54.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.474 -1.391 . . . . 10.0 113.296 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.749 ' HG2' HD13 ' A' ' 70' ' ' LEU . 42.8 Cg_endo -71.46 -62.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.233 1.123 . . . . 10.0 111.335 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.957 ' N ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -50.62 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.383 -0.823 . . . . 10.0 111.855 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.627 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 17.4 p -31.37 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.416 0.626 . . . . 10.0 110.371 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 p90 48.13 138.62 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.3 0 N-CA-C 113.383 0.883 . . . . 10.0 113.383 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.97 167.28 27.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.65 1.567 . . . . 10.0 111.205 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -83.39 32.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.19 -0.944 . . . . 10.0 110.588 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 27.7 m -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 4.6 p-10 160.78 118.69 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.972 HG11 ' HA ' ' A' ' 176' ' ' ALA . 16.0 m -64.47 157.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.944 -1.872 . . . . 10.0 105.944 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 72' ' ' TYR . 43.9 m-85 -121.86 155.63 35.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.085 -1.634 . . . . 10.0 114.451 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 HG12 ' A' ' 168' ' ' VAL . 2.3 mm? -118.71 97.68 5.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 10' ' ' GLY . 14.3 p -110.03 154.97 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.119 -0.988 . . . . 10.0 109.708 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.519 ' CB ' ' OG1' ' A' ' 115' ' ' THR . 4.7 m -123.3 109.33 13.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.946 -1.096 . . . . 10.0 111.663 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CE1' HG21 ' A' ' 93' ' ' VAL . 93.8 m-85 -87.89 168.7 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 10.0 109.918 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.2 m -75.91 157.59 33.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.988 -1.07 . . . . 10.0 108.417 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 85' ' ' VAL . 3.5 p -81.91 -23.1 9.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.745 -1.222 . . . . 10.0 111.09 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -129.86 -88.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.847 -1.158 . . . . 10.0 108.808 178.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.603 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 44.52 -171.72 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.497 -0.752 . . . . 10.0 109.675 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 53.3 Cg_endo -73.34 162.84 39.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.421 1.222 . . . . 10.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -63.03 78.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.117 . . . . 10.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 29.1 t -106.36 -45.83 4.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.848 . . . . 10.0 110.791 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 112' ' ' LEU . 62.5 t80 -49.14 -19.4 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.156 -0.965 . . . . 10.0 110.193 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 7.3 mm-40 -78.79 -19.75 51.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.333 -0.855 . . . . 10.0 111.634 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.75 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -93.68 -14.6 26.19 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.388 -1.445 . . . . 10.0 109.38 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.75 HG13 ' ND2' ' A' ' 92' ' ' ASN . 31.5 m -85.58 -30.87 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.215 -0.994 . . . . 10.0 108.435 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.892 ' CE ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.16 -25.68 59.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.118 -0.989 . . . . 10.0 109.801 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.58 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -96.23 3.21 53.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 10.0 111.109 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.26 -50.33 3.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.571 -1.331 . . . . 10.0 111.06 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.64 -40.22 13.48 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.92 -1.112 . . . . 10.0 113.251 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 ' HG ' ' A' ' 149' ' ' LEU . 55.9 t -70.78 -51.62 11.35 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.33 -1.481 . . . . 10.0 112.806 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 95' ' ' GLU . 40.1 Cg_endo -64.71 -21.1 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.311 1.164 . . . . 10.0 109.365 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.783 ' HG2' HG22 ' A' ' 101' ' ' ILE . 64.6 tt0 -51.39 -57.0 10.12 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.127 -0.983 . . . . 10.0 109.999 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 149.67 119.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 109.743 -0.465 . . . . 10.0 109.743 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 108' ' ' THR . 25.3 m -92.36 -83.97 0.29 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 36.7 m-70 -107.73 -11.47 15.41 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 103' ' ' HIS . 4.5 p80 173.11 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.565 -1.272 . . . . 10.0 107.565 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 96.9 m -130.98 164.98 38.38 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HB2' HG12 ' A' ' 98' ' ' VAL . 38.8 Cg_endo -67.88 92.04 0.37 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 123.608 1.32 . . . . 10.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 1.6 tttt -139.31 9.45 2.49 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.441 -0.787 . . . . 10.0 109.982 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.454 ' N ' ' OG1' ' A' ' 102' ' ' THR . 23.6 m -46.21 139.95 5.47 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.679 -1.263 . . . . 10.0 109.843 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.891 ' CG ' HG12 ' A' ' 77' ' ' VAL . 51.2 Cg_endo -70.76 117.65 5.26 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.003 1.528 . . . . 10.0 108.352 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.439 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -126.59 110.23 12.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.289 -0.882 . . . . 10.0 111.711 -177.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.033 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.2 mm? -85.6 98.08 10.45 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.526 -1.287 . . . . 10.0 107.526 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 90' ' ' PHE . 70.1 mt -84.13 127.87 34.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.042 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.814 HG11 ' HB3' ' A' ' 157' ' ' CYS . 19.2 t -133.5 165.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.857 . . . . 10.0 110.131 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -116.28 112.25 2.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -92.89 160.86 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.375 -1.073 . . . . 10.0 111.358 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 59.93 43.72 14.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.497 -0.752 . . . . 10.0 110.481 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -74.32 -18.97 17.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 179.054 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 117' ' ' ILE . 13.2 m-20 -53.46 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 122.7 1.238 . . . . 10.0 110.499 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 120' ' ' ARG . 1.8 pp 166.44 -27.68 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 114.138 -1.392 . . . . 10.0 107.596 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.739 ' N ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.12 -41.75 12.81 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.726 0.774 . . . . 10.0 109.07 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.88 -23.31 63.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.549 0.69 . . . . 10.0 110.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.485 ' O ' HD13 ' A' ' 126' ' ' ILE . 27.0 t70 -93.04 119.63 67.56 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 10.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.92 21.83 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 124.277 1.672 . . . . 10.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.475 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 32.2 t -107.19 -45.0 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 10.0 110.169 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 t -71.63 -30.26 65.57 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.8 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.315 0.9 OUTLIER -50.87 -26.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.188 -1.369 . . . . 10.0 108.315 177.18 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -54.8 -40.45 69.5 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.509 0.671 . . . . 10.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -81.86 -36.03 28.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.462 -0.773 . . . . 10.0 109.904 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 126' ' ' ILE . 8.5 mt -59.41 -45.29 91.92 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.778 -1.201 . . . . 10.0 108.586 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -49.01 -39.27 26.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 10.0 110.357 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -53.95 -19.09 4.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.571 -0.706 . . . . 10.0 111.13 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.573 ' ND2' ' HG2' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -118.36 -2.15 11.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.311 -1.356 . . . . 10.0 111.964 -178.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.573 ' HG2' ' ND2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -158.15 -25.51 0.08 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.148 -0.97 . . . . 10.0 111.043 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 40.79 19.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.753 -0.592 . . . . 10.0 111.595 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' LYS . 1.2 ptmt -153.77 95.1 2.87 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.776 -1.203 . . . . 10.0 110.036 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.939 ' HB3' HG12 ' A' ' 85' ' ' VAL . 44.4 Cg_endo -71.07 156.84 59.13 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 O-C-N 124.055 1.555 . . . . 10.0 110.357 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' A' ' 142' ' ' ALA . 2.0 mm -93.7 122.35 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 10.0 109.779 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.1 p -118.95 173.36 3.48 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.515 -0.74 . . . . 10.0 109.219 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.568 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.8 Cg_endo -63.37 -10.17 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.803 0.896 . . . . 10.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -94.12 -44.96 7.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 10.0 109.836 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -48.78 45.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 10.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 137' ' ' ILE . . . -62.47 -40.38 96.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 10.0 111.297 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 27.0 tt0 -61.18 -39.85 91.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.126 . . . . 10.0 109.526 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -60.61 -49.55 77.07 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.665 -1.214 . . . . 10.0 108.416 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.892 HD11 ' CE ' ' A' ' 94' ' ' LYS . 4.3 tt -57.82 -37.79 74.41 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.028 -1.045 . . . . 10.0 109.238 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.702 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -66.57 -35.61 80.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 120.017 -0.673 . . . . 10.0 109.633 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -15.44 60.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.141 -0.975 . . . . 10.0 109.277 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 11.8 t0 -70.3 -10.41 58.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.436 -0.79 . . . . 10.0 110.928 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.75 31.06 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 10.0 111.028 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt 60.03 36.65 21.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.82 0.819 . . . . 10.0 110.314 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -71.19 -176.23 1.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.033 HG11 ' CD1' ' A' ' 111' ' ' LEU . 12.7 t -87.48 -81.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.659 ' N ' HG12 ' A' ' 152' ' ' VAL . 1.6 tttp -173.74 159.38 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.549 -0.72 . . . . 10.0 110.072 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CG ' ' CB ' ' A' ' 142' ' ' ALA . 43.1 t80 -93.98 100.37 12.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.714 -1.241 . . . . 10.0 109.886 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.06 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -95.15 -167.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.51 -0.744 . . . . 10.0 109.328 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -136.05 149.65 48.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.66 -1.275 . . . . 10.0 112.262 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.814 ' HB3' HG11 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -162.9 138.41 6.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.335 -0.853 . . . . 10.0 109.424 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' LEU . 5.0 t -148.13 114.18 5.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 10.0 110.065 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.817 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 3.21 -65.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.739 1.385 . . . . 10.0 114.739 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.9 -38.51 1.12 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.758 -1.214 . . . . 10.0 112.079 -177.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.1 p -60.91 -71.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 10.0 111.788 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 158' ' ' SER . 4.4 mm100 -36.6 -69.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.631 -0.668 . . . . 10.0 111.43 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER 66.05 25.27 10.92 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.637 -0.825 . . . . 10.0 110.532 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.82 2.89 9.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.192 -1.963 . . . . 10.0 108.192 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -58.27 -14.76 7.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.666 -0.902 . . . . 10.0 111.944 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.654 ' N ' HD22 ' A' ' 165' ' ' LEU . 9.4 mtmt -63.15 -36.07 82.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.445 -1.409 . . . . 10.0 110.952 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' HD22 ' A' ' 167' ' ' ASN . 0.9 OUTLIER -63.86 -38.56 91.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 10.0 111.103 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.06 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.8 t -52.8 -34.38 20.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.815 -1.178 . . . . 10.0 110.412 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.89 -24.28 55.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 10.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -74.21 -43.89 55.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.042 -1.063 . . . . 10.0 110.088 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 153' ' ' LYS . 36.4 mt-10 -60.58 -32.94 72.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 10.0 109.995 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.763 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -61.23 -24.78 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.772 -1.205 . . . . 10.0 109.76 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.741 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.8 mm -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.08 -1.013 . . . . 10.0 109.736 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.776 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -76.41 -41.88 46.22 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.004 -1.06 . . . . 10.0 109.986 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.835 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -79.81 -4.2 51.08 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.447 -0.783 . . . . 10.0 109.824 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.972 ' HA ' HG11 ' A' ' 77' ' ' VAL . . . -76.41 -43.17 41.59 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.191 -0.943 . . . . 10.0 108.95 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -108.09 -20.6 13.11 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.56 0.695 . . . . 10.0 109.814 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.184 -0.912 . . . . 10.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 108.517 -1.833 . . . . 10.0 108.517 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' B' ' 4' ' ' GLU . 2.0 m -107.75 55.25 0.65 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.218 -1.166 . . . . 10.0 110.476 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -51.64 105.48 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 10.0 110.457 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' B' ' 2' ' ' SER . 1.5 mt-10 -96.01 156.0 16.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.608 -0.682 . . . . 10.0 110.388 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.61 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -108.6 -50.3 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.159 -0.963 . . . . 10.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 55.6 Cg_endo -95.67 32.3 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 108.298 -1.462 . . . . 10.0 108.298 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.5 pp20? -38.57 158.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.912 -0.493 . . . . 10.0 109.676 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.677 HG13 ' HA2' ' A' ' 47' ' ' GLY . 2.1 pp -81.52 -53.33 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.233 . . . . 10.0 112.184 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.559 ' N ' HD12 ' B' ' 8' ' ' ILE . 30.6 t -160.94 173.81 14.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.325 -1.484 . . . . 10.0 111.462 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.666 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.2 pp -164.39 99.2 0.89 Allowed Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.119 -1.032 . . . . 10.0 111.929 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 44.2 Cg_endo -72.65 104.95 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.862 1.453 . . . . 10.0 109.343 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.51 ' HA ' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -53.02 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.956 . . . . 10.0 111.037 -179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -138.31 -168.88 2.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' ALA . 21.6 m-85 -97.13 165.21 12.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.7 -1.25 . . . . 10.0 111.796 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 6.1 pm0 -119.85 171.05 8.69 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.8 -0.562 . . . . 10.0 110.39 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -92.16 -174.97 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.006 -1.059 . . . . 10.0 110.356 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.511 ' C ' HG23 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -147.1 133.47 19.59 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.122 -0.986 . . . . 10.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.835 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -150.07 -177.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.916 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -142.37 154.91 45.04 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.989 -1.069 . . . . 10.0 110.645 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.643 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 2.8 p -91.11 148.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 10.0 110.503 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' A' ' 61' ' ' GLN . . . -99.42 47.94 1.3 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.874 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -177.74 104.62 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.234 -1.156 . . . . 10.0 109.032 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.39 142.0 49.67 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.808 0.813 . . . . 10.0 112.343 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.451 ' O ' ' HG2' ' B' ' 28' ' ' GLU . . . 51.57 51.71 16.17 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.746 -0.596 . . . . 10.0 112.38 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.874 HG21 ' HB3' ' B' ' 22' ' ' PHE . 52.1 t -113.32 -39.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.649 -1.282 . . . . 10.0 110.547 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.868 HG23 HG21 ' A' ' 21' ' ' ILE . 3.1 t -61.58 -22.78 65.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.137 -0.977 . . . . 10.0 110.18 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.592 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -106.3 31.12 8.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 106.841 -2.504 . . . . 10.0 106.841 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 2.8 mp0 -128.55 114.07 16.26 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.261 1.029 . . . . 10.0 110.663 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.822 ' CG ' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -128.67 140.32 51.81 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.707 0.765 . . . . 10.0 109.955 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -146.29 -69.52 0.26 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.97 1.2 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.631 -1.271 . . . . 10.0 111.289 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.56 ' HB ' ' HD3' ' B' ' 33' ' ' PRO . 2.0 mt -63.29 -55.65 34.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.629 -1.512 . . . . 10.0 111.217 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' B' ' 32' ' ' ILE . 44.1 Cg_endo -70.56 169.38 20.07 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.326 1.172 . . . . 10.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.519 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.4 tp10 -78.63 167.67 20.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.991 -1.068 . . . . 10.0 109.371 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 11.5 mp0 -81.08 19.62 0.88 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.484 -0.76 . . . . 10.0 111.469 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.581 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 4.8 m95 89.9 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 123.074 1.416 . . . . 10.0 107.504 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.662 ' HA ' ' HB3' ' A' ' 70' ' ' LEU . . . -156.81 81.09 0.94 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.217 -1.356 . . . . 10.0 108.613 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.519 ' CA ' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.496 1.846 0 O-C-N 121.061 -1.025 . . . . 10.0 108.719 178.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 1.5 mpp? . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.905 0.384 . . . . 10.0 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.622 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.3 mt-30 -139.01 -39.99 0.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 10.0 110.249 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -44.09 101.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.972 . . . . 10.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.891 HD12 ' CB ' ' A' ' 176' ' ' ALA . 2.1 tt -106.47 140.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.658 -1.217 . . . . 10.0 110.302 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 mmtt -112.85 137.05 51.77 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 18.2 t -118.85 108.42 14.8 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.807 -1.183 . . . . 10.0 110.317 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.601 ' N ' HG21 ' A' ' 75' ' ' THR . 9.1 t -137.81 163.62 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 10.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.612 HG22 ' OG1' ' A' ' 17' ' ' THR . 3.1 t -87.02 141.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 10.0 110.548 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 78' ' ' PHE . 46.1 t -136.42 174.69 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.374 -0.829 . . . . 10.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.762 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 125.04 130.6 3.52 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.864 -1.295 . . . . 10.0 109.864 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.82 -27.57 43.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -1.075 . . . . 10.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 140.92 127.61 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.02 -1.232 . . . . 10.0 110.02 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 169.59 -67.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 10.0 109.703 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.966 ' HB ' HG23 ' A' ' 115' ' ' THR . 13.4 t -147.93 107.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 10.0 109.525 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' B' ' 35' ' ' GLN . . . -74.08 99.1 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.882 -1.287 . . . . 10.0 109.882 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -52.64 -36.97 57.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.296 . . . . 10.0 109.709 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 8' ' ' VAL . 53.2 m -52.71 -39.57 62.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.436 -0.79 . . . . 10.0 110.792 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 22' ' ' SER . 14.5 p -81.89 -15.77 52.86 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.673 -1.267 . . . . 10.0 108.988 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.771 HD11 HG13 ' A' ' 14' ' ' VAL . 10.2 mt -84.34 -30.52 25.43 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.906 0.86 . . . . 10.0 109.12 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -54.69 -39.3 67.99 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.788 HG21 HG23 ' B' ' 26' ' ' THR . 3.5 mm -91.27 -42.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 121.666 0.746 . . . . 10.0 109.911 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.576 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 32.9 t -47.6 -40.5 19.52 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.303 -0.959 . . . . 10.0 109.974 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 160' ' ' LEU . 9.4 t80 -100.83 1.46 40.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.238 -1.385 . . . . 10.0 110.625 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 6.3 m -107.21 -19.09 13.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.984 -1.072 . . . . 10.0 111.325 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.607 HG22 ' O ' ' A' ' 21' ' ' ILE . 11.3 t -112.23 -43.04 3.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.731 -1.23 . . . . 10.0 111.16 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.553 ' N ' HG23 ' A' ' 25' ' ' THR . 7.3 m-20 -155.87 -48.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.492 -1.283 . . . . 10.0 112.512 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.698 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 168.88 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.217 -0.927 . . . . 10.0 111.892 -178.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 22.4 p90 . . . . . 0 N--CA 1.498 1.931 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.966 ' HB ' HG11 ' B' ' 20' ' ' VAL . 20.3 p . . . . . 0 N--CA 1.489 1.487 0 CA-C-O 121.0 0.429 . . . . 10.0 111.693 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' B' ' 25' ' ' VAL . 89.8 t -28.22 -33.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 121.325 0.583 . . . . 10.0 111.321 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -38.94 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 10.0 109.759 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -170.38 91.07 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 119.879 -1.763 . . . . 10.0 113.776 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.581 ' HB3' HG13 ' B' ' 18' ' ' ILE . 8.2 t30 -135.88 149.75 49.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 10.0 108.604 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 2.6 m-85 -167.2 113.84 0.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.402 -1.436 . . . . 10.0 111.702 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 15' ' ' GLU . . . -93.69 108.85 20.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.92 -1.141 . . . . 10.0 107.92 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' O ' ' B' ' 14' ' ' PHE . 44.1 t -135.87 171.93 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.184 -1.407 . . . . 10.0 112.31 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 51' ' ' TYR . 54.7 m -147.28 170.6 16.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 51' ' ' TYR . 1.3 p -161.35 129.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.89 -1.131 . . . . 10.0 111.561 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.681 ' CB ' HD22 ' B' ' 10' ' ' LEU . 1.3 mmt -104.95 129.06 53.44 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.826 -1.15 . . . . 10.0 108.131 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.995 HG22 ' HB3' ' B' ' 7' ' ' GLU . 33.6 mt -132.05 99.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.913 -1.117 . . . . 10.0 110.194 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.71 ' CA ' HG22 ' B' ' 8' ' ' ILE . . . 59.76 24.05 59.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.038 -1.625 . . . . 10.0 109.038 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.72 6.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -127.29 95.47 36.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.17 -1.194 . . . . 10.0 110.538 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 51.5 Cg_endo -83.19 132.68 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.236 1.65 . . . . 10.0 112.008 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.852 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.7 m-85 -93.65 150.69 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 10.0 109.29 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.3 m -136.25 100.32 4.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.786 -1.196 . . . . 10.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -149.3 176.35 10.62 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.393 -1.323 . . . . 10.0 112.813 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.82 118.52 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 107.67 -2.172 . . . . 10.0 107.67 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . 2.0 pp -129.78 159.58 36.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.647 -1.502 . . . . 10.0 111.138 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 15.9 p90 -165.69 131.77 2.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 10.0 110.568 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -81.38 176.84 9.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 10.0 110.095 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.518 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 99.1 m -40.2 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 10.0 111.43 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . . . -146.65 63.01 1.2 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 10.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.19 69.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.275 -1.13 . . . . 10.0 110.275 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.528 ' HB2' ' HA3' ' B' ' 21' ' ' GLY . 64.7 tp60 -115.77 -28.79 6.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.065 -1.256 . . . . 10.0 111.23 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 7.3 tp10 -63.53 -50.02 71.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.871 -1.143 . . . . 10.0 110.572 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -142.74 0.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 10.0 111.323 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.2 m-85 65.35 40.26 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.821 -1.178 . . . . 10.0 107.821 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.621 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -78.7 47.72 0.75 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.85 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.932 ' O ' HD23 ' A' ' 70' ' ' LEU . 17.4 mtp180 -82.82 -26.28 31.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.437 -0.789 . . . . 10.0 109.53 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 1.2 mt -111.77 -6.66 14.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 10.0 111.888 -178.798 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -92.75 -54.9 0.25 Allowed Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 120.376 -1.453 . . . . 10.0 113.19 -177.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.625 ' C ' HD13 ' A' ' 70' ' ' LEU . 43.0 Cg_endo -77.61 -5.02 15.17 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.528 1.278 . . . . 10.0 111.987 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.932 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -101.81 -98.8 0.27 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.773 -1.205 . . . . 10.0 110.966 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.535 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 40.1 m -36.38 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.744 -0.598 . . . . 10.0 110.467 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 70' ' ' LEU . 15.6 m-85 -103.47 91.92 3.66 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 10.0 109.056 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 71' ' ' SER . 45.4 Cg_endo -70.62 147.43 57.32 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.787 1.414 . . . . 10.0 110.555 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CD ' ' A' ' 74' ' ' GLN . 3.2 pp0? -169.37 57.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.221 -0.924 . . . . 10.0 110.583 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.655 HG23 ' CB ' ' A' ' 5' ' ' LYS . 18.0 m -145.01 98.05 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.162 -0.961 . . . . 10.0 110.099 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -34.37 -33.21 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 10.0 110.487 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -111.25 120.24 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.313 -0.867 . . . . 10.0 109.644 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.7 m-85 -115.41 140.92 48.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.906 -1.121 . . . . 10.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 111' ' ' LEU . 3.4 mm? -109.39 99.35 8.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 10.0 109.562 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.762 HG23 ' HA2' ' A' ' 10' ' ' GLY . 7.1 p -103.82 151.02 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 10.0 110.131 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 115' ' ' THR . 3.2 t -126.71 103.8 7.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 10.0 111.496 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 115' ' ' THR . 67.7 m-85 -89.89 140.05 29.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 10.0 111.056 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -92.52 138.59 31.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.214 -0.929 . . . . 10.0 110.169 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.871 HG11 ' HG3' ' A' ' 120' ' ' ARG . 14.4 m -81.42 -17.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 10.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 84' ' ' VAL . 17.8 m -102.6 38.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.774 0.797 . . . . 10.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 87' ' ' PRO . 47.7 t -110.04 154.34 42.76 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.677 -0.639 . . . . 10.0 109.37 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.535 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 47.9 Cg_endo -68.93 73.62 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.735 1.387 . . . . 10.0 111.099 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 133' ' ' LYS . 43.4 m 39.91 55.04 2.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 10.0 110.429 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.442 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 62.7 p -91.9 -36.74 13.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 10.0 110.547 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -50.3 -29.96 10.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.09 . . . . 10.0 110.338 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -67.47 -35.7 79.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.901 . . . . 10.0 110.036 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.32 -12.81 61.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 10.0 109.39 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t -88.87 -12.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.39 -0.819 . . . . 10.0 109.346 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 6.8 mmtt -89.03 -35.75 16.19 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.0 pt-20 -80.0 -5.05 55.04 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.26 -0.576 . . . . 10.0 110.082 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -102.02 -44.89 5.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.935 -1.103 . . . . 10.0 111.763 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.559 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 35.9 m95 -89.59 -29.05 19.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.294 -0.878 . . . . 10.0 112.028 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.929 ' CG2' HD21 ' A' ' 149' ' ' LEU . 62.8 t -62.28 -47.9 88.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.545 -1.347 . . . . 10.0 110.596 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.765 ' O ' HD12 ' A' ' 101' ' ' ILE . 48.9 Cg_endo -74.68 -15.56 21.53 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 109.115 -1.148 . . . . 10.0 109.115 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 40.9 tt0 -58.97 -29.25 67.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.754 -0.591 . . . . 10.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 99' ' ' PRO . 3.6 mt 57.57 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 10.0 109.603 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.59 ' CG2' ' HG2' ' A' ' 106' ' ' PRO . 3.9 m -43.29 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.345 -0.847 . . . . 10.0 109.08 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.547 ' N ' HG22 ' A' ' 102' ' ' THR . 4.8 m-70 -110.45 -15.9 13.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 162.45 -55.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.592 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 6.9 t -168.06 44.58 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.207 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.4 Cg_endo -81.26 -26.1 3.56 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 N-CA-C 109.083 -1.16 . . . . 10.0 109.083 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.579 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 1.6 pttp 55.66 52.85 10.33 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.342 1.067 . . . . 10.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 10.0 t -45.38 155.17 0.46 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 10.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 38.9 Cg_endo -66.35 148.77 84.81 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.76 1.4 . . . . 10.0 110.486 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -139.07 111.9 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 10.0 110.023 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.849 HD13 HG11 ' A' ' 152' ' ' VAL . 1.6 mm? -80.84 98.08 7.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.316 -0.865 . . . . 10.0 109.358 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 56.1 mt -70.22 140.11 52.38 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 111' ' ' LEU . 4.5 t -148.1 168.22 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.809 -1.182 . . . . 10.0 111.679 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.37 150.04 16.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.748 -1.741 . . . . 10.0 108.748 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.966 HG23 ' HB ' ' A' ' 14' ' ' VAL . 24.1 m -103.49 129.94 50.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.353 . . . . 10.0 110.756 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 14' ' ' VAL . 69.4 mt-30 53.27 50.03 18.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 10.0 110.377 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.995 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -65.29 -25.27 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.028 -1.045 . . . . 10.0 110.017 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.8 p-10 -52.06 59.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.267 1.032 . . . . 10.0 110.051 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.796 ' N ' ' O ' ' A' ' 117' ' ' ILE . 9.8 tp 158.64 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.871 ' HG3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.35 -40.11 48.25 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.81 -0.556 . . . . 10.0 109.928 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -28.77 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 10.0 109.993 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.6 m-20 -83.6 130.35 56.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 10.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.3 Cg_endo -86.18 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.664 1.576 . . . . 10.0 110.079 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -98.47 -50.98 4.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 10.0 110.198 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.552 HG21 HD21 ' A' ' 119' ' ' LEU . 6.4 t -75.53 -32.37 60.45 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.014 -2.217 . . . . 10.0 105.014 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 123' ' ' PRO 0.293 1.1 mp -50.69 -28.25 5.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 176.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -52.18 -29.89 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.65 0.738 . . . . 10.0 110.471 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 6.4 mmtp -55.75 -36.93 67.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.492 -0.755 . . . . 10.0 111.606 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -57.85 -49.81 75.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.685 -1.26 . . . . 10.0 109.566 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -49.56 -41.23 40.97 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.735 -0.603 . . . . 10.0 111.466 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -21.76 56.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.26 -0.9 . . . . 10.0 110.203 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 12.7 p-10 -128.49 -46.82 1.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 10.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 129' ' ' LEU . 5.2 mmtp -121.74 144.95 48.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.631 -0.668 . . . . 10.0 109.287 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -99.54 6.33 45.85 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.257 -0.902 . . . . 10.0 110.557 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 10.6 mtpt -131.76 94.02 26.34 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 10.0 109.91 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.3 Cg_endo -70.61 160.65 48.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.128 1.593 . . . . 10.0 110.604 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.698 HG22 HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -75.68 133.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.023 . . . . 10.0 108.649 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.2 p -131.19 168.84 15.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.152 -0.968 . . . . 10.0 109.744 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.3 Cg_endo -68.71 -33.11 22.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.758 1.399 . . . . 10.0 109.351 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 15.6 pt-20 -71.18 -23.87 62.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.822 . . . . 10.0 109.181 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 57.4 m -80.03 -40.87 26.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 10.0 109.017 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.472 -0.768 . . . . 10.0 109.31 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' PRO . 37.4 mt-10 -59.63 -42.84 93.61 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.079 -0.648 . . . . 10.0 109.692 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -61.56 -39.79 92.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.373 -0.829 . . . . 10.0 109.434 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.558 HD13 ' HE3' ' A' ' 94' ' ' LYS . 3.8 tp -65.03 -46.45 81.25 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.061 -1.024 . . . . 10.0 108.431 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -57.66 -45.1 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 10.0 110.383 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -26.37 64.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.406 -0.809 . . . . 10.0 109.882 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.495 ' C ' HD12 ' A' ' 149' ' ' LEU . 12.8 m-20 -75.63 -49.95 16.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.324 -0.86 . . . . 10.0 110.574 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.929 HD21 ' CG2' ' A' ' 98' ' ' VAL . 6.5 mp -90.37 1.68 56.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 10.0 108.975 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 6.2 mtmt 65.49 30.31 10.8 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.639 0.733 . . . . 10.0 109.847 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -59.34 -146.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.955 -0.698 . . . . 10.0 109.463 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.849 HG11 HD13 ' A' ' 111' ' ' LEU . 2.7 p -117.51 -57.15 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.368 -1.458 . . . . 10.0 112.047 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.584 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -171.69 151.59 2.93 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 118.148 -1.421 . . . . 10.0 112.291 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.9 p90 -87.54 124.51 33.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 10.0 110.329 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.016 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -126.36 -168.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.355 -0.84 . . . . 10.0 109.879 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.4 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 1.9 mt-10 -143.16 144.44 32.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.016 -1.052 . . . . 10.0 110.502 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 168' ' ' VAL . 79.8 m -144.28 129.8 19.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.898 0.856 . . . . 10.0 111.4 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.563 ' N ' HD21 ' A' ' 165' ' ' LEU . 3.9 t -120.74 173.32 7.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.684 ' CB ' HD22 ' A' ' 19' ' ' LEU . . . -93.66 -93.44 0.17 Allowed 'General case' 0 C--N 1.29 -1.99 0 O-C-N 120.984 -1.073 . . . . 10.0 110.438 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.036 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -54.67 -39.19 67.82 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.067 -1.021 . . . . 10.0 109.49 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.54 ' OG1' ' OG ' ' A' ' 158' ' ' SER . 75.0 p -79.39 -35.34 40.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.152 -1.592 . . . . 10.0 110.953 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.583 ' CG ' ' HG ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 58.02 67.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.785 -1.197 . . . . 10.0 109.858 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.591 ' HG2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -87.3 56.8 4.13 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.64 -0.824 . . . . 10.0 111.047 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 125.6 11.41 4.09 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.416 -1.374 . . . . 10.0 111.001 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.583 ' HG ' ' CG ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -54.52 -34.18 61.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.718 -1.46 . . . . 10.0 109.556 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -88.15 -25.01 23.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 10.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -70.91 -38.78 72.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 10.0 111.206 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 155' ' ' VAL . 3.5 t -68.94 -36.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.833 -1.167 . . . . 10.0 109.325 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 173' ' ' ILE . 60.7 t80 -60.11 -37.76 80.97 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.687 -0.633 . . . . 10.0 110.01 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.7 m-20 -67.66 -46.63 71.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -0.943 . . . . 10.0 111.358 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.07 -30.61 69.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 10.0 110.359 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -70.56 -24.47 62.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.062 . . . . 10.0 109.324 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.691 ' O ' HD12 ' A' ' 177' ' ' LEU . 27.8 mm -64.55 -44.74 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.434 -0.791 . . . . 10.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.85 -31.91 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.803 -1.185 . . . . 10.0 110.629 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.462 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . . . -89.01 0.79 56.37 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.472 -0.768 . . . . 10.0 110.838 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.891 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -88.89 -37.23 15.47 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.933 -1.105 . . . . 10.0 110.195 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.95 -13.54 16.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.385 -0.822 . . . . 10.0 109.716 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.42 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -89.96 47.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 10.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.2 100.49 4.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.067 -1.021 . . . . 10.0 110.664 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.469 ' HB2' ' OE1' ' B' ' 7' ' ' GLU . 14.3 mm-40 -101.52 175.67 5.49 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.542 0.687 . . . . 10.0 110.168 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.36 -146.49 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -76.11 13.72 1.23 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 CA-C-N 119.277 0.777 . . . . 10.0 111.815 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.995 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER 36.72 -150.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.229 -0.919 . . . . 10.0 110.166 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.71 HG22 ' CA ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -82.57 -115.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.943 -1.132 . . . . 10.0 107.943 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.648 ' H ' HG23 ' B' ' 8' ' ' ILE . 7.8 t -159.08 110.11 2.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.084 -1.635 . . . . 10.0 111.348 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -116.94 119.96 34.52 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.146 -0.971 . . . . 10.0 108.869 178.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.95 100.09 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.67 1.353 . . . . 10.0 112.928 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 m -149.17 126.01 11.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.597 -0.69 . . . . 10.0 109.575 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 43' ' ' THR . 5.9 p-10 -170.89 148.82 2.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.395 -1.441 . . . . 10.0 113.15 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 1.056 ' O ' HG22 ' A' ' 42' ' ' VAL . 5.4 m-85 -129.63 -176.33 3.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.81 149.77 1.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.592 -1.318 . . . . 10.0 112.436 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.9 t60 -171.29 117.34 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.537 -0.727 . . . . 10.0 110.068 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' A' ' 39' ' ' ASN . 9.3 t -128.82 158.46 38.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.868 -1.145 . . . . 10.0 112.261 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.647 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -121.5 -168.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.642 . . . . 10.0 109.265 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.642 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 63.1 m80 -136.25 157.28 47.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 10.0 111.877 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.966 HG11 ' HB ' ' A' ' 35' ' ' THR . 10.2 p -97.63 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.538 -0.726 . . . . 10.0 112.062 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 61' ' ' GLN . . . -108.41 65.48 0.25 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.669 -2.172 . . . . 10.0 107.669 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.741 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER 175.32 114.24 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.433 -1.039 . . . . 10.0 108.673 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.541 ' HA ' HG21 ' A' ' 35' ' ' THR . 32.4 t70 -62.1 152.4 32.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.28 -0.888 . . . . 10.0 112.349 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.612 ' N ' HG22 ' A' ' 35' ' ' THR . . . 37.82 71.78 0.14 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.733 -0.604 . . . . 10.0 112.524 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 36' ' ' VAL . 15.4 t -113.15 -46.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.966 -1.084 . . . . 10.0 109.767 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.788 HG23 HG21 ' A' ' 21' ' ' ILE . 1.1 t -82.57 -28.15 31.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.31 0.576 . . . . 10.0 110.51 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 36.35 3.82 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.26 -1.936 . . . . 10.0 108.26 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 36.4 tt0 -142.18 128.95 20.48 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.554 -0.968 . . . . 10.0 110.953 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -140.9 114.54 8.87 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 122.233 1.016 . . . . 10.0 109.284 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' B' ' 31' ' ' GLY . 5.1 p -146.82 -49.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.576 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . 177.83 89.71 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.063 -1.615 . . . . 10.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.614 HG23 ' HD2' ' B' ' 33' ' ' PRO . 83.1 mt -120.0 147.11 43.71 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.195 -1.179 . . . . 10.0 110.445 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.7 Cg_endo -69.45 129.26 17.6 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 10.0 109.767 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' B' ' 38' ' ' ARG . 25.1 tp10 55.92 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 10.0 109.617 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.604 ' O ' ' CE3' ' B' ' 36' ' ' TRP . 72.5 mt-30 -93.08 -27.25 17.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.952 -1.092 . . . . 10.0 112.521 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.693 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER 162.61 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.104 -1.073 . . . . 10.0 108.104 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 70' ' ' LEU . . . -175.19 75.64 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.501 ' N ' ' HG2' ' B' ' 34' ' ' GLU . 3.9 mtm180 . . . . . 0 C--N 1.293 -1.876 0 N-CA-C 107.295 -1.372 . . . . 10.0 107.295 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 1' ' ' MET . 3.3 ptp . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.807 0.813 . . . . 10.0 109.843 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HA ' HD23 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -153.86 -35.63 0.1 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.606 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 89.8 m -53.17 94.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.374 -0.829 . . . . 10.0 110.246 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.697 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -109.12 132.27 57.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.524 -1.271 . . . . 10.0 110.062 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' THR . 4.4 mtpp -122.85 104.75 9.47 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.565 ' C ' HG22 ' A' ' 7' ' ' VAL . 29.9 p -108.98 152.85 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.143 -0.973 . . . . 10.0 111.75 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.56 162.53 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.759 -0.588 . . . . 10.0 110.102 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 16.0 m -81.76 137.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 10.0 111.472 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -152.29 169.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.307 -0.871 . . . . 10.0 109.741 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.535 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 150.39 88.88 0.07 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.974 -1.251 . . . . 10.0 109.974 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' GLY . 3.8 t0 40.88 25.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -1.072 . . . . 10.0 111.048 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 71.63 36.85 62.04 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.499 -1.44 . . . . 10.0 109.499 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . -108.97 -140.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.532 -0.981 . . . . 10.0 109.657 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.602 HG12 ' CE2' ' B' ' 29' ' ' PHE . 4.7 m -88.27 161.7 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 10.0 109.648 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.517 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -92.2 -174.16 42.09 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.274 -1.13 . . . . 10.0 110.274 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG11 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -110.59 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -1.064 . . . . 10.0 111.001 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 19' ' ' LEU . 73.7 m -50.8 -36.45 37.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.036 -1.04 . . . . 10.0 109.041 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 25.3 p -67.22 4.32 0.97 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.128 0.966 . . . . 10.0 109.718 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 160' ' ' LEU . 3.8 mt -110.46 -38.82 5.11 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.285 -1.509 . . . . 10.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 166' ' ' LYS . 21.1 tp -44.63 -46.2 10.01 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.853 -1.154 . . . . 10.0 111.227 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 1.065 HG22 ' O ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -90.33 -31.14 5.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 117.093 -1.843 . . . . 10.0 109.858 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.805 ' OG ' HD23 ' A' ' 160' ' ' LEU . 21.9 t -47.44 -44.14 24.6 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.346 -0.942 . . . . 10.0 110.311 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.511 ' HB2' ' C ' ' A' ' 159' ' ' ALA . 67.0 t80 -86.42 -0.89 56.94 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.55 -1.344 . . . . 10.0 109.951 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 4.3 m -108.93 -42.87 4.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.851 -1.155 . . . . 10.0 113.984 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 26' ' ' ASN . 60.0 m -117.38 -93.06 0.51 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 119.95 -1.719 . . . . 10.0 111.515 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.841 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.1 OUTLIER -135.81 -21.64 1.47 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.277 -0.889 . . . . 10.0 110.34 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 1.065 ' O ' HG22 ' A' ' 21' ' ' ILE . 14.4 mttt -148.87 -139.32 0.09 Allowed 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.729 -1.952 . . . . 10.0 105.729 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER . . . . . 0 C--N 1.285 -2.203 0 C-N-CA 116.357 -2.137 . . . . 10.0 115.384 179.022 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 28' ' ' PHE . 2.9 m . . . . . 0 N--CA 1.499 2.009 0 CA-C-O 120.93 0.395 . . . . 10.0 111.369 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.852 ' CG1' HG11 ' B' ' 20' ' ' VAL . 38.6 t 77.46 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.763 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -33.75 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.141 0.972 . . . . 10.0 110.648 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -170.15 112.22 0.44 Allowed 'General case' 0 C--N 1.289 -2.033 0 O-C-N 119.374 -2.079 . . . . 10.0 112.221 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.594 ' HB3' ' CG1' ' B' ' 18' ' ' ILE . 0.9 OUTLIER -166.4 96.93 0.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.217 -0.927 . . . . 10.0 108.558 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' B' ' 17' ' ' THR . 17.4 p90 -171.77 176.95 3.5 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.354 -0.938 . . . . 10.0 111.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -171.23 98.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.773 HG21 ' O ' ' B' ' 15' ' ' GLU . 16.6 m -157.5 -166.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 10.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 51' ' ' TYR . 24.1 m -105.35 166.83 10.15 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.967 -0.693 . . . . 10.0 111.319 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.58 ' CG1' HD11 ' A' ' 46' ' ' ILE . 2.9 t -127.7 139.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.398 -0.964 . . . . 10.0 108.398 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.738 ' O ' HD23 ' B' ' 10' ' ' LEU . 3.1 mtt -102.57 102.16 12.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.349 -1.34 . . . . 10.0 110.426 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.58 HD11 ' CG1' ' A' ' 44' ' ' VAL . 2.3 mp -110.24 118.59 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.06 . . . . 10.0 110.167 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 54.41 16.96 7.48 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.178 -1.169 . . . . 10.0 110.178 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.03 18.35 34.45 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 68.2 mm-40 -110.59 115.89 53.21 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.39 -1.065 . . . . 10.0 110.315 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 45.8 Cg_endo -69.24 119.4 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.824 1.434 . . . . 10.0 110.272 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 43' ' ' THR . 3.9 m-30 -97.52 179.93 4.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 10.0 110.72 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 4' ' ' ILE . 5.0 m -146.27 132.66 19.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 10.0 110.039 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -172.27 174.04 4.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.739 -1.225 . . . . 10.0 111.593 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.87 105.4 0.21 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.163 -1.975 . . . . 10.0 108.163 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.942 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -105.52 135.48 46.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.64 -1.506 . . . . 10.0 110.409 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.942 ' N ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -129.03 103.25 6.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 10.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' THR . 51.1 t0 -105.96 121.04 43.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 10.0 109.421 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 13.7 t -39.4 129.39 1.82 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.074 -1.016 . . . . 10.0 111.466 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . . . -72.17 -73.52 0.19 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.811 -0.556 . . . . 10.0 111.515 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.98 7.4 59.29 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.985 -1.646 . . . . 10.0 108.985 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 177.91 -26.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -1.093 . . . . 10.0 110.903 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.999 ' HG2' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -41.87 -71.14 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.858 -1.152 . . . . 10.0 110.383 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 7.2 t70 164.34 -13.77 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.698 -0.626 . . . . 10.0 110.697 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 38.2 p90 -110.86 17.33 20.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.865 -1.147 . . . . 10.0 109.312 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 68' ' ' ARG . 35.1 t70 -49.52 -23.7 1.73 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.434 -0.791 . . . . 10.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -49.92 -36.62 28.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.04 -1.038 . . . . 10.0 109.223 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.6 mt -92.66 11.49 26.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.505 -0.747 . . . . 10.0 110.041 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.658 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -73.37 -22.13 0.48 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.275 -0.891 . . . . 10.0 112.959 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 42.8 Cg_endo -78.21 85.12 1.87 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 CA-C-O 121.944 0.727 . . . . 10.0 110.546 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.568 ' CD2' ' O ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -129.27 -47.15 1.2 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.795 0.807 . . . . 10.0 109.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.544 ' CB ' ' O ' ' B' ' 37' ' ' ALA . 5.6 m 59.91 12.78 3.26 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.948 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -101.98 110.4 62.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 10.0 112.038 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.422 ' C ' ' HG3' ' A' ' 74' ' ' GLN . 48.6 Cg_endo -76.93 148.59 28.2 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.107 1.583 . . . . 10.0 110.7 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.04 67.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 10.0 109.283 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -143.18 87.35 1.96 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.101 -1.0 . . . . 10.0 109.982 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 9.6 m-20 -20.29 -44.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.456 0.91 . . . . 10.0 113.456 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 109' ' ' PRO . 1.1 m -110.5 144.32 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.818 -1.176 . . . . 10.0 111.26 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -156.25 157.41 35.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 10.0 110.977 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.668 ' CD1' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -107.32 98.65 8.25 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 178.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 3.9 p -85.07 148.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 10.0 109.95 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB3' HG22 ' A' ' 115' ' ' THR . 41.1 m -117.26 103.16 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.767 -1.173 . . . . 10.0 113.516 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.859 ' C ' HG23 ' A' ' 115' ' ' THR . 43.8 m-85 -99.84 147.69 25.23 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.293 -0.879 . . . . 10.0 109.232 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 46.6 t -90.42 141.1 29.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.513 -1.367 . . . . 10.0 108.95 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.557 HG21 ' HG3' ' A' ' 120' ' ' ARG . 2.0 t -80.32 5.58 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.905 . . . . 10.0 110.375 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 1.021 HG23 HD23 ' A' ' 129' ' ' LEU . 33.9 m -143.31 59.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.931 0.872 . . . . 10.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.588 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 2.7 p -125.13 -165.53 0.08 OUTLIER Pre-proline 0 C--N 1.287 -2.125 0 O-C-N 121.376 -0.828 . . . . 10.0 108.773 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.4 Cg_endo -76.18 60.76 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.277 1.146 . . . . 10.0 109.621 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 87' ' ' PRO . 43.6 p 32.86 51.5 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.104 0.478 . . . . 10.0 111.54 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.1 p -77.02 -25.42 52.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 10.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 73.0 t80 -59.22 -40.21 85.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 10.0 111.51 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -70.77 -22.87 62.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.914 -1.116 . . . . 10.0 110.828 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.714 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -86.13 -20.8 28.12 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.807 -1.183 . . . . 10.0 109.97 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.714 HG13 ' ND2' ' A' ' 92' ' ' ASN . 23.1 m -84.23 -29.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.151 -1.02 . . . . 10.0 109.931 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -70.87 -34.03 71.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.072 -1.018 . . . . 10.0 109.6 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.57 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 7.2 pt-20 -80.26 -8.22 59.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 10.0 110.971 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 2.1 mmtm -81.73 -52.75 6.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 10.0 111.655 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -73.24 -9.88 59.17 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.982 -1.073 . . . . 10.0 112.202 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 149' ' ' LEU . 77.6 t -76.48 -50.2 2.75 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.621 -1.3 . . . . 10.0 110.828 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.1 Cg_endo -73.42 -25.8 14.96 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.209 1.11 . . . . 10.0 110.647 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -77.07 -23.74 51.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.287 -0.883 . . . . 10.0 110.998 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 49.0 mm 60.15 103.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.026 -1.046 . . . . 10.0 110.329 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.3 m -47.04 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 10.0 108.623 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.667 ' N ' HG22 ' A' ' 102' ' ' THR . 5.5 m170 -112.1 -4.85 14.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.323 -0.861 . . . . 10.0 109.51 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 160.87 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 50.8 t -142.26 137.37 15.61 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 149' ' ' LEU . 44.1 Cg_endo -69.82 80.29 0.91 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.681 1.358 . . . . 10.0 110.68 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' THR . 34.4 mtpt -118.16 -14.44 9.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.469 -0.77 . . . . 10.0 111.181 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 102' ' ' THR . 52.1 m -46.3 136.08 7.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.718 -1.239 . . . . 10.0 109.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.804 ' CG ' HG12 ' A' ' 77' ' ' VAL . 37.5 Cg_endo -64.9 111.9 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 10.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -117.94 103.88 10.37 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.757 0.789 . . . . 10.0 110.209 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.132 HD13 HG11 ' A' ' 152' ' ' VAL . 1.7 mm? -77.41 98.57 5.3 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 90.0 mt -74.03 135.82 43.08 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.693 HG22 HG23 ' A' ' 155' ' ' VAL . 10.8 t -143.28 169.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 10.0 112.552 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.87 153.88 19.54 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.479 -2.248 . . . . 10.0 107.479 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.859 HG23 ' C ' ' A' ' 82' ' ' PHE . 76.3 p -101.04 127.57 47.49 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.497 -1.59 . . . . 10.0 111.057 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.471 ' HG2' ' OD2' ' A' ' 118' ' ' ASP . 0.8 OUTLIER 40.31 55.06 2.82 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.849 -0.74 . . . . 10.0 110.16 178.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -40.78 -28.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 C-N-CA 119.467 -0.893 . . . . 10.0 110.16 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.671 ' O ' HD13 ' A' ' 119' ' ' LEU . 2.3 p-10 -52.69 60.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.17 0.986 . . . . 10.0 110.524 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 1.052 ' HG ' HG21 ' A' ' 125' ' ' THR . 0.4 OUTLIER 161.77 -27.95 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HG3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.09 -38.33 11.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.77 17.75 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 10.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.69 ' OD1' HG22 ' A' ' 125' ' ' THR . 6.9 t70 -104.28 110.84 64.81 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 10.0 110.857 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.32 15.46 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.072 1.564 . . . . 10.0 110.779 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 122' ' ' ASP . 47.1 t -109.89 -49.93 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 10.0 109.857 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 1.052 HG21 ' HG ' ' A' ' 119' ' ' LEU . 4.7 t -73.67 -24.39 59.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.515 -2.031 . . . . 10.0 105.515 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.738 HD11 HG11 ' A' ' 85' ' ' VAL 0.301 0.6 OUTLIER -59.98 -20.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 176.859 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -48.26 -45.34 34.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.672 -0.642 . . . . 10.0 110.396 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.556 ' C ' HD12 ' A' ' 129' ' ' LEU . 36.5 mmtt -84.96 -13.77 49.65 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.425 -0.797 . . . . 10.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 1.021 HD23 HG23 ' A' ' 85' ' ' VAL . 6.1 mp -95.91 -40.45 9.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.233 -0.917 . . . . 10.0 109.554 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 126' ' ' ILE . . . -57.96 -39.67 78.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.137 -0.977 . . . . 10.0 109.72 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 11.2 pttt -55.66 -20.31 13.59 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.398 -0.814 . . . . 10.0 109.746 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -118.69 9.64 12.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.351 -0.843 . . . . 10.0 109.299 178.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.524 ' CE ' ' HB3' ' A' ' 136' ' ' PRO . 2.3 tmtt? -141.0 82.99 1.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.102 -0.703 . . . . 10.0 109.102 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.486 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 1.3 mp0 -65.39 -24.44 67.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 3.2 mmmm -132.79 115.88 14.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 10.0 109.422 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.524 ' HB3' ' CE ' ' A' ' 133' ' ' LYS . 40.1 Cg_endo -67.01 159.4 52.18 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.799 1.421 . . . . 10.0 110.494 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -103.95 134.29 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.289 -0.882 . . . . 10.0 109.564 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.1 p -125.87 164.46 33.01 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 10.0 109.541 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 38.6 Cg_endo -65.64 -13.65 40.86 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.883 1.465 . . . . 10.0 109.823 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.98 -20.86 29.9 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.764 -0.774 . . . . 10.0 110.1 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -96.74 -42.32 8.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 10.0 110.744 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.897 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -73.79 -26.42 60.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 10.0 110.488 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.9 tt0 -61.22 -39.07 88.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 10.0 109.847 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -65.69 -40.1 91.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.895 . . . . 10.0 109.1 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 145' ' ' LEU . 4.1 tt -63.04 -40.7 98.51 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.367 -0.833 . . . . 10.0 109.238 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.465 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -63.58 -44.84 92.91 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.821 0.819 . . . . 10.0 109.088 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -59.91 -25.8 65.42 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.361 -0.536 . . . . 10.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 149' ' ' LEU . 34.8 t0 -70.26 -48.8 55.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.09 -1.006 . . . . 10.0 110.827 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 98' ' ' VAL . 1.5 mp -93.11 24.55 3.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 10.0 108.931 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 151' ' ' ALA . 1.0 OUTLIER 51.91 27.3 4.21 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.741 0.781 . . . . 10.0 109.389 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -57.04 -160.19 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.132 HG11 HD13 ' A' ' 111' ' ' LEU . 7.3 p -108.49 -65.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.677 -1.264 . . . . 10.0 111.761 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.763 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.02 157.74 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.016 -1.678 . . . . 10.0 112.106 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.897 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.1 t80 -107.61 112.61 25.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 10.0 110.107 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -103.36 -168.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.429 -0.794 . . . . 10.0 110.604 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 22.4 tt0 -170.28 98.55 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.221 -0.924 . . . . 10.0 109.749 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.547 ' CB ' ' CA ' ' A' ' 165' ' ' LEU . 73.8 m -153.0 156.35 38.65 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.107 -0.996 . . . . 10.0 111.608 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.686 ' OG ' HG23 ' A' ' 117' ' ' ILE . 3.7 m -140.86 114.75 9.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.835 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . . . -74.09 -87.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.428 -1.42 . . . . 10.0 111.025 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -31.32 -33.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 122.32 1.057 . . . . 10.0 109.383 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -93.94 -70.79 0.69 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.341 -0.845 . . . . 10.0 112.218 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -109.13 -107.71 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.377 -1.452 . . . . 10.0 112.021 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 162' ' ' GLN . 12.2 pttt 174.48 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.425 -0.797 . . . . 10.0 109.521 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.58 49.1 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.145 -1.026 . . . . 10.0 110.75 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -59.39 -2.07 0.28 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.409 -1.054 . . . . 10.0 113.097 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 20' ' ' LEU . 8.9 tttt -59.69 -48.84 80.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.39 -1.444 . . . . 10.0 110.432 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -56.45 -39.75 73.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.437 -0.789 . . . . 10.0 111.755 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.95 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.3 t -53.74 -48.34 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.819 -1.175 . . . . 10.0 111.034 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -78.6 -37.97 41.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.242 -0.911 . . . . 10.0 111.368 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.91 -40.26 92.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.876 -1.14 . . . . 10.0 110.946 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 41.0 mm-40 -62.03 -46.05 90.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 10.0 111.28 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.748 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.36 -24.45 19.54 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.986 . . . . 10.0 110.379 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.671 ' O ' HD12 ' A' ' 177' ' ' LEU . 28.6 mm -63.85 -42.86 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.415 -0.914 . . . . 10.0 109.841 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.846 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -86.17 -17.07 35.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 10.0 111.01 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.75 -1.18 41.13 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.938 -1.101 . . . . 10.0 109.812 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.96 -40.89 13.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 10.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.23 -11.83 18.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 10.0 109.505 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.04 -0.981 . . . . 10.0 110.025 -179.815 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -112.37 131.9 55.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 10.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.509 ' HG2' HD12 ' A' ' 174' ' ' LEU . 4.5 mtpt -88.38 99.96 12.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.137 -0.977 . . . . 10.0 110.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.2 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.74 -0.6 . . . . 10.0 110.001 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.38 -91.15 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.117 -0.989 . . . . 10.0 109.231 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 53.8 Cg_endo -76.57 -10.45 18.71 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 N-CA-C 108.423 -1.414 . . . . 10.0 108.423 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 3.3 pt-20 41.25 -162.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.776 -0.578 . . . . 10.0 110.121 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.559 ' H ' HD12 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -134.77 -67.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.034 -1.041 . . . . 10.0 110.579 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 47.5 t -103.32 132.11 49.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 10.0 111.604 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.961 ' O ' HD13 ' B' ' 10' ' ' LEU . 1.2 tm? -149.36 101.77 3.32 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 120.598 -1.314 . . . . 10.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -91.2 -168.5 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.406 2.071 . . . . 10.0 108.15 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 67.0 m -108.97 173.58 6.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.736 -1.228 . . . . 10.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 43' ' ' THR . 5.3 m-20 -134.33 -165.22 1.62 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.799 0.809 . . . . 10.0 111.657 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.566 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 18.5 m-85 -45.39 -166.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.25 1.024 . . . . 10.0 112.426 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.773 ' O ' HG21 ' A' ' 42' ' ' VAL . 57.1 mt-10 -41.24 154.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.088 -1.008 . . . . 10.0 111.806 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -139.32 -171.1 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 10.0 110.722 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.592 HG22 ' CE1' ' A' ' 40' ' ' TYR . 47.2 p -58.65 156.07 11.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.769 0.795 . . . . 10.0 112.064 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.602 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -128.31 -168.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 74.0 m-70 -109.19 143.89 38.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.503 -1.373 . . . . 10.0 112.277 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.999 HG22 ' HG2' ' A' ' 62' ' ' GLU . 33.3 t -130.82 152.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.695 -0.628 . . . . 10.0 110.838 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -112.02 -175.17 19.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.817 -1.313 . . . . 10.0 109.817 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' B' ' 31' ' ' GLY . 46.0 t80 166.37 116.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.711 -0.876 . . . . 10.0 108.752 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 12.6 t70 -39.41 152.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.105 -0.638 . . . . 10.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 63.11 79.85 0.25 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.735 -1.58 . . . . 10.0 106.735 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.614 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.5 -21.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.882 0.849 . . . . 10.0 110.572 -176.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.475 ' C ' ' O ' ' A' ' 26' ' ' ASN . 10.0 t -48.79 -15.96 0.11 Allowed 'General case' 0 C--N 1.286 -2.16 0 O-C-N 120.962 -1.086 . . . . 10.0 112.948 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 26' ' ' ASN . . . 148.22 85.64 0.06 OUTLIER Glycine 0 N--CA 1.504 3.178 0 N-CA-C 109.358 -1.497 . . . . 10.0 109.358 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.579 ' O ' HD22 ' A' ' 160' ' ' LEU . 19.7 pm0 -129.82 -146.4 0.31 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.746 -0.855 . . . . 10.0 109.422 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 14' ' ' VAL . 13.9 p90 -135.35 145.23 47.18 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' C ' ' B' ' 29' ' ' PHE . 1.7 t 30.99 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.082 0.468 . . . . 10.0 110.559 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.58 ' O ' ' CE1' ' B' ' 22' ' ' PHE . . . -153.77 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.694 -1.762 . . . . 10.0 108.694 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.415 HD11 ' OE1' ' B' ' 34' ' ' GLU . 10.7 pt -127.83 145.29 54.48 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.519 -0.989 . . . . 10.0 109.187 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.09 83.22 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.562 1.296 . . . . 10.0 109.925 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' B' ' 38' ' ' ARG . 2.8 tm-20 -160.13 155.6 25.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.568 -0.708 . . . . 10.0 110.315 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.597 ' HG2' ' CG ' ' B' ' 36' ' ' TRP . 2.2 tt0 -91.59 -71.3 0.64 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.027 -1.046 . . . . 10.0 109.7 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.597 ' CG ' ' HG2' ' B' ' 35' ' ' GLN . 0.4 OUTLIER -172.13 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.103 -0.998 . . . . 10.0 112.571 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' SER . . . -130.32 -19.1 3.16 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.478 -0.763 . . . . 10.0 110.468 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 6.6 mtt180 . . . . . 0 N--CA 1.488 1.456 0 O-C-N 120.404 -1.435 . . . . 10.0 108.108 177.259 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' CA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.834 ' HA ' HD23 ' A' ' 177' ' ' LEU . 7.9 mm100 -133.1 0.87 3.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.002 . . . . 10.0 110.532 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.53 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.9 m -64.74 100.62 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 10.0 110.51 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.804 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -114.65 133.73 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.994 -1.082 . . . . 10.0 111.096 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 26.2 mmtt -121.23 100.65 7.17 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.517 -0.92 . . . . 10.0 108.517 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.21 106.58 15.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.04 -1.038 . . . . 10.0 109.75 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.825 ' HB ' HG21 ' A' ' 75' ' ' THR . 71.7 t -133.67 147.56 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 10.0 110.11 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.2 m -91.2 115.72 30.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.424 -0.798 . . . . 10.0 110.295 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.7 -166.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.277 -0.889 . . . . 10.0 110.045 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 1.04 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 126.43 -144.83 15.36 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 10.0 109.81 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.88 -37.84 20.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -1.223 . . . . 10.0 109.897 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 133.8 31.88 0.38 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' HG22 ' B' ' 32' ' ' ILE . . . -61.27 -133.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.991 -1.3 . . . . 10.0 109.066 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.75 HG22 ' CG2' ' B' ' 32' ' ' ILE . 5.0 t -128.93 -24.79 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.546 -1.347 . . . . 10.0 111.144 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 8' ' ' VAL . . . 157.0 128.94 1.09 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.351 -1.404 . . . . 10.0 110.062 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.973 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -57.77 -24.53 57.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.205 -1.173 . . . . 10.0 110.154 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 35' ' ' THR . 24.8 m -59.37 -32.73 70.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 10.0 110.847 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.708 ' SG ' HD22 ' A' ' 19' ' ' LEU . 16.6 p -61.0 -29.03 69.46 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.138 -0.976 . . . . 10.0 110.388 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.708 HD22 ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -80.51 -30.31 37.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.941 -1.1 . . . . 10.0 110.718 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 24' ' ' THR . 12.8 tp -49.2 -30.65 7.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.101 -0.999 . . . . 10.0 110.122 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 26' ' ' THR . 3.8 mm -106.74 -44.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 10.0 109.7 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 39.6 t -49.7 -40.07 39.12 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.364 -0.934 . . . . 10.0 109.303 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.681 ' CE2' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -82.09 -28.93 32.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.07 . . . . 10.0 109.311 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 25.2 m -65.58 -50.22 65.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 10.0 110.7 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' N ' ' A' ' 26' ' ' ASN . 14.7 t -175.24 -37.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.2 -1.4 . . . . 10.0 112.693 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.584 ' O ' ' HG2' ' A' ' 27' ' ' LYS . 23.3 m120 -70.75 -9.79 58.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.156 -0.965 . . . . 10.0 111.985 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.636 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 0.8 OUTLIER 33.75 -150.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 10.0 110.661 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HE1' HD22 ' A' ' 160' ' ' LEU . 12.6 p90 . . . . . 0 C--N 1.298 -1.658 0 O-C-N 121.167 -0.958 . . . . 10.0 111.437 -178.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.8 m . . . . . 0 N--CA 1.491 1.579 0 N-CA-C 109.222 -0.658 . . . . 10.0 109.222 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 35' ' ' THR . 54.9 t -163.62 -96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.334 -0.854 . . . . 10.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 36' ' ' VAL . 6.8 t80 -57.22 141.11 47.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 10.0 111.122 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.615 ' HA ' HD11 ' B' ' 18' ' ' ILE . 4.8 t70 -164.31 101.37 0.84 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.252 -0.905 . . . . 10.0 110.376 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.642 ' CB ' HG21 ' B' ' 18' ' ' ILE . 0.4 OUTLIER -104.86 118.26 36.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.237 -1.54 . . . . 10.0 109.279 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.64 ' CE2' ' HG3' ' B' ' 15' ' ' GLU . 6.5 m-85 -146.72 113.53 6.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.068 -1.02 . . . . 10.0 111.107 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' B' ' 15' ' ' GLU . . . -118.41 115.29 24.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.72 -1.238 . . . . 10.0 109.976 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.94 -168.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 10.0 111.462 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.714 ' H ' HG22 ' A' ' 42' ' ' VAL . 20.2 m -163.71 145.16 9.15 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.493 0.663 . . . . 10.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 HD23 ' B' ' 10' ' ' LEU . 0.9 OUTLIER -137.73 123.75 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.381 -0.824 . . . . 10.0 109.771 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 7.3 mtm -92.06 98.19 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.869 -1.133 . . . . 10.0 109.406 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.9 mp -86.36 120.93 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.593 -0.692 . . . . 10.0 109.874 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 44.6 26.38 1.05 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 110.02 -24.88 17.79 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.012 -1.287 . . . . 10.0 111.307 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.46 110.98 30.82 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 120.714 -1.462 . . . . 10.0 110.545 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.3 Cg_endo -73.64 141.06 30.42 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.044 1.549 . . . . 10.0 111.042 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 53' ' ' LEU . 1.6 t80 -91.9 122.33 34.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.358 -0.839 . . . . 10.0 109.524 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.733 ' O ' HG22 ' A' ' 4' ' ' ILE 0.258 56.3 m -107.54 99.69 9.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.8 . . . . 10.0 109.772 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 54' ' ' GLY . 1.8 pp -144.23 168.63 19.59 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.341 -1.344 . . . . 10.0 112.33 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.738 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.4 126.9 1.32 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.87 -2.092 . . . . 10.0 107.87 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -124.55 142.32 51.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.82 -1.4 . . . . 10.0 110.354 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -139.82 104.91 5.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 10.0 110.837 -178.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 79.4 m-20 -80.97 -179.66 7.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.172 -0.955 . . . . 10.0 110.497 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 14' ' ' VAL . 14.0 t -85.33 -175.97 5.93 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.549 1.166 . . . . 10.0 113.361 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -142.0 -70.83 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 61' ' ' GLN . . . 40.54 24.09 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.117 -1.193 . . . . 10.0 110.117 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.566 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 1.4 mm-40 -171.47 -35.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.214 -1.168 . . . . 10.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 2.0 mt-10 -54.6 -80.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 117.813 -1.555 . . . . 10.0 108.861 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER 172.1 27.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 10.0 111.595 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.16 -52.43 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.672 -1.267 . . . . 10.0 110.807 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 24.0 t0 42.0 32.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.472 -0.767 . . . . 10.0 109.361 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.19 1.91 29.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.469 -0.769 . . . . 10.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.607 ' O ' HD22 ' A' ' 70' ' ' LEU . 2.4 mp -103.72 -14.46 16.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.413 -0.804 . . . . 10.0 110.03 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 3.9 ttt180 -82.26 -27.38 0.43 Allowed Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.7 Cg_endo -81.78 5.6 6.2 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.859 0.926 . . . . 10.0 111.072 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.898 HD11 ' CB ' ' B' ' 37' ' ' ALA . 2.0 pt? -49.34 -40.46 35.45 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.399 -0.813 . . . . 10.0 112.97 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 34.3 m 49.38 21.03 0.51 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.67 -1.269 . . . . 10.0 110.841 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 71' ' ' SER . 13.2 m-85 -143.92 130.61 10.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.925 -1.109 . . . . 10.0 110.366 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 50.8 Cg_endo -72.88 150.07 48.7 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.832 1.438 . . . . 10.0 111.276 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -177.48 47.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.047 0.927 . . . . 10.0 109.708 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' HB ' ' A' ' 7' ' ' VAL . 57.5 m -140.25 89.74 2.31 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.149 -0.97 . . . . 10.0 110.228 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -42.58 -30.72 0.38 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.53 -0.731 . . . . 10.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 75' ' ' THR . 13.6 m -123.19 124.84 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.78 -1.2 . . . . 10.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 1.7 m-85 -116.5 154.57 30.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.421 -0.799 . . . . 10.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.979 HD22 HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -111.0 97.95 7.19 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.843 -1.169 . . . . 10.0 107.843 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.04 HG23 ' HA2' ' A' ' 10' ' ' GLY . 8.2 p -103.39 125.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.159 -0.963 . . . . 10.0 111.033 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.464 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 4.2 m -127.38 125.96 41.63 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.299 -0.875 . . . . 10.0 109.084 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -135.91 178.85 6.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 10.0 110.245 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 t -81.03 149.5 29.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 10.0 112.059 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HE ' ' A' ' 120' ' ' ARG . 6.1 t -100.48 -2.01 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.704 -0.623 . . . . 10.0 110.125 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.9 m -132.97 53.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.75 0.786 . . . . 10.0 109.842 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 19.4 p -121.29 158.39 53.38 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 121.513 -0.742 . . . . 10.0 110.5 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 120.64 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.557 . . . . 10.0 111.647 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m 44.41 64.77 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 10.0 111.612 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -124.22 -43.34 2.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.677 -1.264 . . . . 10.0 110.918 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 1.102 ' CE1' HD11 ' A' ' 137' ' ' ILE . 6.4 t80 -56.12 -50.21 71.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.828 -1.17 . . . . 10.0 110.694 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.96 -15.33 12.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.955 -1.091 . . . . 10.0 111.823 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.804 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -86.9 -20.21 27.74 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.698 -1.251 . . . . 10.0 111.079 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 94' ' ' LYS . 19.3 m -90.18 -14.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.552 -1.343 . . . . 10.0 108.896 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 93' ' ' VAL . 25.9 mmtt -88.14 -33.41 18.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.15 0.976 . . . . 10.0 108.842 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 10.6 pt-20 -78.76 -5.82 54.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.105 -0.702 . . . . 10.0 109.105 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -84.24 -50.23 8.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 10.0 112.27 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 20.7 m95 -80.99 -23.8 38.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.014 -1.054 . . . . 10.0 113.376 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.786 HG22 HD21 ' A' ' 149' ' ' LEU . 4.4 t -69.23 -50.54 20.16 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.048 -1.658 . . . . 10.0 110.676 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.7 Cg_endo -72.84 -6.23 18.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.139 1.073 . . . . 10.0 109.564 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 101' ' ' ILE . 0.5 OUTLIER -68.98 -32.96 72.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 10.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 100' ' ' GLU . 2.7 pt 36.0 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.481 0.658 . . . . 10.0 111.318 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -47.11 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 109.416 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.686 ' H ' HG23 ' A' ' 102' ' ' THR . 30.4 m80 -106.74 -4.63 19.19 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.432 -0.793 . . . . 10.0 109.395 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -175.8 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 10.0 109.948 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.894 ' O ' HG22 ' A' ' 102' ' ' THR . 20.0 p -134.77 167.46 22.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 10.0 110.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 54.4 Cg_endo -81.01 72.38 6.55 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.773 1.407 . . . . 10.0 111.411 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -112.84 -10.11 13.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 10.0 112.029 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -52.92 125.39 39.65 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 120.687 -1.258 . . . . 10.0 110.432 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 77' ' ' VAL . 54.5 Cg_endo -73.72 153.12 48.43 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.052 1.553 . . . . 10.0 111.952 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.531 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 21.8 p90 -165.02 156.57 15.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.231 -1.025 . . . . 10.0 108.231 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.979 HD23 HD22 ' A' ' 79' ' ' LEU . 1.9 mm? -102.9 103.32 13.46 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 122.104 0.954 . . . . 10.0 111.007 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 155' ' ' VAL . 88.2 mt -66.33 138.57 57.7 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.179 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.611 ' CG2' HG11 ' A' ' 168' ' ' VAL . 1.4 t -150.42 171.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.792 -1.192 . . . . 10.0 111.776 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -133.25 122.11 3.04 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.486 -1.846 . . . . 10.0 108.486 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 31.0 p -100.55 170.96 8.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.165 -1.197 . . . . 10.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.22 33.95 8.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.473 -0.767 . . . . 10.0 109.392 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.979 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -69.05 -21.88 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 10.0 109.688 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.649 ' CG ' HG21 ' A' ' 161' ' ' THR . 17.3 t70 -51.45 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.958 0.885 . . . . 10.0 110.282 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.769 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.2 tp 160.33 -30.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.017 -1.105 . . . . 10.0 108.017 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HE ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.46 -37.5 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.57 0.7 . . . . 10.0 109.876 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 64.2 t0 -55.74 -24.83 37.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 10.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD13 ' A' ' 126' ' ' ILE . 9.0 t0 -90.22 109.4 33.09 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.24 -0.913 . . . . 10.0 111.249 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 51.5 Cg_endo -76.92 24.12 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.592 1.528 . . . . 10.0 112.142 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 m -100.97 -47.05 4.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.748 -1.22 . . . . 10.0 109.728 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.436 ' O ' HD22 ' A' ' 129' ' ' LEU . 3.4 t -71.94 -26.34 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.035 -2.209 . . . . 10.0 105.035 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 122' ' ' ASP 0.301 1.1 mp -50.69 -26.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.15 -38.84 54.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.521 0.677 . . . . 10.0 110.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.534 ' N ' ' CD ' ' A' ' 128' ' ' LYS . 13.0 mptt -75.22 -44.6 45.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.469 -0.769 . . . . 10.0 110.679 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -60.16 -49.1 78.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.854 0.835 . . . . 10.0 108.971 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . -52.97 -40.92 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.469 0.652 . . . . 10.0 109.582 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -25.21 11.77 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.946 -1.097 . . . . 10.0 110.009 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -88.59 -48.65 7.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 10.0 112.177 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -126.98 0.84 6.58 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.484 -0.76 . . . . 10.0 110.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER 45.52 23.32 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 10.0 111.494 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -154.19 101.06 2.45 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.033 -1.042 . . . . 10.0 111.781 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.9 Cg_endo -74.03 160.12 43.43 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.124 1.592 . . . . 10.0 109.919 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 1.102 HD11 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -81.77 128.19 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.529 -1.357 . . . . 10.0 109.077 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.5 p -125.37 170.89 8.41 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.475 -0.765 . . . . 10.0 110.404 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.5 Cg_endo -68.21 -7.27 19.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.786 1.414 . . . . 10.0 110.519 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -92.58 -38.54 11.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 10.0 110.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.436 ' CG2' ' CZ ' ' A' ' 90' ' ' PHE . 84.3 m -74.68 -44.68 48.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.635 -0.665 . . . . 10.0 111.593 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 154' ' ' TYR . . . -77.67 -38.54 47.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 111.581 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 143' ' ' GLU . 5.4 tm-20 -62.97 -27.04 69.13 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.792 -1.193 . . . . 10.0 108.94 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -49.59 10.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 10.0 109.93 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 94' ' ' LYS . 5.1 tt -56.2 -41.82 76.19 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.237 -0.914 . . . . 10.0 110.022 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.34 73.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 10.0 108.89 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -60.23 -29.07 68.51 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.823 -0.751 . . . . 10.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.03 -47.49 51.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 10.0 110.499 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.786 HD21 HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -90.05 16.33 8.56 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.075 0.94 . . . . 10.0 108.966 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 27.12 1.99 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.798 0.809 . . . . 10.0 109.525 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.68 -148.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.137 -0.625 . . . . 10.0 109.877 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 ' CD1' ' A' ' 111' ' ' LEU . 19.1 t -98.51 -75.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.231 -0.987 . . . . 10.0 109.963 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -173.56 -177.18 1.4 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.739 -1.184 . . . . 10.0 111.637 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -110.69 116.54 31.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.709 -0.619 . . . . 10.0 110.358 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.994 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -122.77 -168.98 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.954 -1.091 . . . . 10.0 110.169 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.422 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 1.1 pt-20 -161.97 143.49 11.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 10.0 111.403 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 162' ' ' GLN . 28.4 p -159.19 177.28 11.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.472 -0.767 . . . . 10.0 111.301 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 162' ' ' GLN . 47.1 t -144.91 170.58 15.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 10.0 109.725 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.644 ' CB ' HD12 ' A' ' 19' ' ' LEU . . . -89.59 -48.77 7.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 10.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.549 HD22 ' HE1' ' A' ' 28' ' ' PHE . 2.0 pp -118.61 -0.7 11.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 10.0 112.176 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.649 HG21 ' CG ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -120.13 -80.07 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.429 -1.42 . . . . 10.0 111.968 -178.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 5.7 tp60 -40.73 -63.75 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.991 -1.068 . . . . 10.0 112.071 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 25.2 mttt 70.14 51.01 0.41 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.932 0.872 . . . . 10.0 109.295 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.84 24.37 2.59 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.316 -1.514 . . . . 10.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -78.78 1.43 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -1.224 . . . . 10.0 110.767 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.422 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -79.39 -39.47 32.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.851 -1.156 . . . . 10.0 109.596 178.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.35 -40.77 97.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.173 -0.954 . . . . 10.0 110.682 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 155' ' ' VAL . 4.3 t -59.23 -28.21 38.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.185 -0.947 . . . . 10.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 169' ' ' PHE . 4.4 t80 -84.04 -21.34 31.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.488 -0.757 . . . . 10.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -74.31 -49.45 22.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.091 -1.005 . . . . 10.0 111.135 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.52 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.1 mm-40 -58.22 -37.22 74.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 10.0 110.578 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -55.61 -32.71 63.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.158 -0.964 . . . . 10.0 110.045 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.708 ' O ' HD12 ' A' ' 177' ' ' LEU . 66.9 mt -60.8 -44.3 97.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.153 -0.967 . . . . 10.0 110.132 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -70.57 -30.59 67.34 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.732 -1.23 . . . . 10.0 111.567 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -86.37 -17.78 33.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 10.0 111.234 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.804 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -65.72 -30.97 71.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 10.0 109.318 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -110.35 -11.68 14.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 10.0 110.188 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.959 -1.019 . . . . 10.0 110.439 -179.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 108.809 -1.716 . . . . 10.0 108.809 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -130.14 136.92 49.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.488 -1.007 . . . . 10.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' B' ' 3' ' ' LYS . 5.7 tptt -99.38 103.31 15.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.01 -1.057 . . . . 10.0 108.388 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.515 ' HB3' ' OE2' ' B' ' 7' ' ' GLU . 6.1 mm-40 -104.28 161.03 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.306 -0.871 . . . . 10.0 110.769 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.659 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.07 -153.26 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.564 -1.272 . . . . 10.0 107.564 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 40.3 Cg_endo -69.85 90.88 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 109.91 -0.842 . . . . 10.0 109.91 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 39.1 mm-40 -56.6 -152.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.893 -0.505 . . . . 10.0 110.691 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.892 HD12 ' N ' ' B' ' 9' ' ' SER . 2.7 pp -79.64 -51.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.756 -1.215 . . . . 10.0 111.406 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.892 ' N ' HD12 ' B' ' 8' ' ' ILE . 32.2 t -155.3 171.5 19.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.594 -1.316 . . . . 10.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.953 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.25 133.33 3.28 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 118.857 -1.137 . . . . 10.0 113.023 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 46.3 Cg_endo -86.4 177.16 4.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 N-CA-C 108.459 -1.4 . . . . 10.0 108.459 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -133.48 148.75 51.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.633 -1.292 . . . . 10.0 111.655 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -104.55 -179.65 4.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.64 -0.662 . . . . 10.0 109.471 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.6 m-85 -91.81 164.4 13.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.987 -1.07 . . . . 10.0 111.113 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.64 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 1.5 pm0 -127.85 177.25 6.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.2 0.524 . . . . 10.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.617 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 7.5 m-70 -95.6 166.23 11.94 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.487 -0.758 . . . . 10.0 111.901 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.555 ' C ' HG23 ' B' ' 18' ' ' ILE . 42.5 m -128.91 146.23 51.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.422 -0.799 . . . . 10.0 110.669 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.755 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -159.42 -171.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 10.0 110.481 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 64.6 m80 -140.02 156.73 46.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.552 -0.718 . . . . 10.0 109.73 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 37' ' ' PHE . 14.0 m -105.98 143.72 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 10.0 112.658 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -147.85 132.62 4.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.894 ' O ' HG22 ' B' ' 25' ' ' VAL . 0.4 OUTLIER 173.46 114.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.175 -1.191 . . . . 10.0 109.416 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' B' ' 22' ' ' PHE . 83.3 m-20 -39.46 132.74 1.49 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.78 . . . . 10.0 109.121 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.63 70.04 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.289 -1.004 . . . . 10.0 108.289 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.894 HG22 ' O ' ' B' ' 22' ' ' PHE . 2.0 t -88.16 -17.98 8.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 122.543 1.163 . . . . 10.0 108.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.583 ' O ' HG22 ' A' ' 21' ' ' ILE 0.287 7.2 t -48.72 -19.05 0.32 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.713 -1.131 . . . . 10.0 111.175 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -154.51 -33.9 0.03 OUTLIER Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.513 -1.835 . . . . 10.0 108.513 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . 0.1 OUTLIER 52.45 23.96 2.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.769 -0.842 . . . . 10.0 111.394 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.608 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 51.6 t80 -112.35 115.6 28.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 122.093 0.949 . . . . 10.0 109.937 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.529 HG23 ' O ' ' B' ' 29' ' ' PHE . 33.5 p -156.51 -70.14 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.509 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.46 118.1 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.033 -1.227 . . . . 10.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.75 ' CG2' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -150.95 160.9 31.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -1.158 . . . . 10.0 109.51 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 34' ' ' GLU . 55.8 Cg_endo -76.85 136.91 17.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.906 1.477 . . . . 10.0 111.126 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.584 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 2.6 tt0 55.04 146.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.671 0.748 . . . . 10.0 110.736 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.549 ' HG2' ' N ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -85.85 -63.46 1.32 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.923 -1.111 . . . . 10.0 111.399 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.692 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 65.7 t90 -143.48 21.1 1.87 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.341 -0.85 . . . . 10.0 108.892 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.898 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . 167.1 132.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.026 -1.101 . . . . 10.0 108.026 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.584 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.512 0 CA-C-O 122.563 1.173 . . . . 10.0 109.63 -178.298 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.15 0.5 . . . . 10.0 110.056 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.767 ' NE2' HD22 ' A' ' 177' ' ' LEU . 1.7 mt-30 -136.71 2.62 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.29 -0.881 . . . . 10.0 110.03 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 3.0 m -60.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.364 -0.835 . . . . 10.0 109.555 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -108.97 132.32 57.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.705 -1.198 . . . . 10.0 110.425 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -121.07 97.56 5.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.313 -0.867 . . . . 10.0 110.522 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -79.67 111.49 16.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 10.0 111.003 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HG21 ' A' ' 75' ' ' THR . 56.1 t -131.06 172.47 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 10.0 108.962 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.591 ' CG1' ' HB3' ' B' ' 35' ' ' GLN . 46.5 t -92.04 130.83 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.753 -1.217 . . . . 10.0 111.729 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.771 ' CG1' HG12 ' A' ' 80' ' ' VAL . 74.4 t -145.34 179.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.647 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 122.35 170.53 13.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.79 -1.324 . . . . 10.0 109.79 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -50.75 -39.51 52.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.151 . . . . 10.0 109.859 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.653 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 151.14 159.05 8.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.547 -1.421 . . . . 10.0 109.547 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.742 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 179.82 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -1.097 . . . . 10.0 108.852 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.808 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.7 t 149.22 89.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . 42.68 92.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.365 -1.494 . . . . 10.0 109.365 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -49.47 -34.62 17.33 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.918 -1.342 . . . . 10.0 109.296 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.2 m -49.84 -25.22 2.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.738 -1.226 . . . . 10.0 108.724 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 26' ' ' THR . 13.7 p -63.73 -18.26 63.85 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.233 -0.987 . . . . 10.0 108.706 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.2 mm? -69.36 -33.31 72.88 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.15 -0.969 . . . . 10.0 108.863 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -48.61 -37.75 19.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 10.0 108.829 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.643 HG21 ' HA3' ' B' ' 27' ' ' GLY . 1.5 mm -64.3 -43.6 97.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.68 0.752 . . . . 10.0 110.012 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' A' ' 27' ' ' LYS . 40.3 t -47.89 -44.26 29.43 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.335 -0.946 . . . . 10.0 109.738 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CZ ' ' CD1' ' A' ' 165' ' ' LEU . 6.9 m-85 -90.98 -3.81 56.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.573 -0.705 . . . . 10.0 109.676 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 14.4 m -112.41 -33.46 6.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.855 . . . . 10.0 112.403 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.569 HG22 ' N ' ' A' ' 26' ' ' ASN . 17.3 m -136.58 -82.51 0.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.187 -1.57 . . . . 10.0 113.064 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 25' ' ' THR . 2.3 m120 -153.89 51.42 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.626 -1.296 . . . . 10.0 113.724 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.585 ' HG2' ' N ' ' A' ' 28' ' ' PHE . 0.0 OUTLIER 30.81 -131.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.619 -0.675 . . . . 10.0 112.676 177.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.635 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 11.0 p90 . . . . . 0 N--CA 1.493 1.716 0 CA-C-O 121.216 0.531 . . . . 10.0 110.765 -178.64 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.673 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 1.3 p . . . . . 0 N--CA 1.493 1.712 0 CA-C-O 121.806 0.812 . . . . 10.0 111.567 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HB ' ' CG1' ' B' ' 20' ' ' VAL 0.273 74.1 t -55.77 -8.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 112.46 0.541 . . . . 10.0 112.46 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -32.69 87.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.43 1.11 . . . . 10.0 113.46 -177.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' VAL . 11.4 m-20 -157.53 104.74 2.01 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 120.718 -1.239 . . . . 10.0 111.368 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' B' ' 18' ' ' ILE . 0.6 OUTLIER -170.42 102.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 10.0 108.651 178.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.826 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -153.66 175.22 13.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.669 -1.212 . . . . 10.0 112.177 -178.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.944 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -165.71 148.37 7.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.829 -0.748 . . . . 10.0 110.791 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 1.013 HG11 ' O ' ' B' ' 14' ' ' PHE . 0.2 OUTLIER -171.52 -165.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.41 -0.806 . . . . 10.0 111.105 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 51' ' ' TYR . 74.9 m -137.38 146.05 44.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 10.0 110.217 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -103.6 176.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.244 -0.91 . . . . 10.0 109.467 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.583 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 39.5 mtp -154.37 126.18 7.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 10.0 110.472 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 mp -139.06 123.43 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 10.0 109.196 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.93 22.41 6.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.49 6.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.0 mt-10 -120.81 99.56 47.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.293 -1.122 . . . . 10.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 43.6 Cg_endo -71.6 136.31 27.99 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.632 1.333 . . . . 10.0 110.319 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -99.88 157.02 16.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.102 -0.999 . . . . 10.0 110.347 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 4' ' ' ILE . 40.1 m -126.95 106.62 9.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 10.0 111.973 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -148.37 166.71 27.24 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.438 -1.414 . . . . 10.0 111.293 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.16 134.99 3.2 Favored Glycine 0 C--N 1.288 -2.092 0 N-CA-C 108.629 -1.789 . . . . 10.0 108.629 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.826 HD11 ' CE1' ' A' ' 40' ' ' TYR . 4.6 pp -153.19 167.45 29.24 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.112 -1.228 . . . . 10.0 110.308 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.494 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 22.4 p90 -170.29 131.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 10.0 110.908 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 5.1 p-10 -99.09 176.83 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 10.0 110.252 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.409 HG22 ' N ' ' A' ' 59' ' ' ALA . 21.5 m -40.75 162.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.167 0.984 . . . . 10.0 112.638 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.987 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -134.39 68.93 1.47 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.512 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.613 ' HA3' ' CD2' ' B' ' 22' ' ' PHE . . . -43.61 -82.23 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 107.904 -2.078 . . . . 10.0 107.904 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.273 -1.134 . . . . 10.0 107.951 177.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.987 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.5 pt-20 41.99 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.406 1.098 . . . . 10.0 111.034 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.5 -12.73 57.6 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 1.2 p90 -133.83 -27.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.851 -0.531 . . . . 10.0 109.693 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 68' ' ' ARG . 5.3 t70 43.12 35.98 0.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 10.0 110.496 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.8 -7.83 59.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.986 -1.071 . . . . 10.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.71 HD12 ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -111.63 4.14 18.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 10.0 110.358 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.733 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.7 mmt180 -53.61 -40.53 81.25 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.214 -0.929 . . . . 10.0 111.868 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 52.5 Cg_endo -83.72 78.71 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.414 1.218 . . . . 10.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -105.61 -105.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 10.0 110.488 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 47.07 35.7 3.66 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -148.26 114.92 3.91 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 120.154 -0.618 . . . . 10.0 110.948 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' GLN . 53.9 Cg_endo -75.52 -151.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.925 1.487 . . . . 10.0 110.004 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 76.64 79.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.79 . . . . 10.0 111.275 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.5 m -139.09 96.67 3.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 71.0 m-20 -23.14 -41.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.856 -0.611 . . . . 10.0 112.37 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.71 HG21 HG12 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -142.13 130.09 21.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.894 -1.129 . . . . 10.0 110.838 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.84 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.7 p90 -148.25 170.19 18.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.055 -1.028 . . . . 10.0 110.596 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.968 HD13 HG12 ' A' ' 168' ' ' VAL . 4.1 mt -112.34 102.53 10.67 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.86 . . . . 10.0 110.067 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.771 HG12 ' CG1' ' A' ' 9' ' ' VAL . 1.7 m -98.79 127.52 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.676 -0.861 . . . . 10.0 108.676 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 115' ' ' THR . 0.5 OUTLIER -105.66 100.44 10.0 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.638 -1.288 . . . . 10.0 112.048 -178.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' A' ' 80' ' ' VAL . 57.6 m-85 -86.86 176.1 7.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.247 -0.908 . . . . 10.0 109.908 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 47.9 t -100.72 142.67 31.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -0.845 . . . . 10.0 108.878 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.74 HG22 ' HG2' ' A' ' 120' ' ' ARG . 34.0 m -56.16 -16.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.041 -1.037 . . . . 10.0 110.675 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.657 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -112.66 -88.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.868 -1.145 . . . . 10.0 109.293 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 34.25 75.27 0.47 Allowed Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.942 -0.474 . . . . 10.0 110.612 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 43.6 Cg_endo -69.79 162.12 43.3 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.978 1.515 . . . . 10.0 110.62 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 133' ' ' LYS . 15.8 m 47.42 39.37 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.783 . . . . 10.0 111.402 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.544 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -135.06 -68.6 0.52 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.91 -1.119 . . . . 10.0 110.38 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 p90 -57.18 -16.67 8.53 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.322 -0.861 . . . . 10.0 110.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 90' ' ' PHE . 18.1 mt-10 -78.59 -24.54 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 10.0 110.208 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.758 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.95 -14.76 57.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 10.0 110.311 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.875 HG23 ' HD3' ' A' ' 94' ' ' LYS . 16.6 m -87.93 -22.74 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 118.288 -1.365 . . . . 10.0 108.486 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.968 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.43 -27.73 63.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -89.39 -1.27 57.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 13.3 mmtm -102.46 -53.16 2.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.948 -1.101 . . . . 10.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.453 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 41.7 m95 -90.32 -38.37 13.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.704 -1.247 . . . . 10.0 112.547 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.7 t -64.22 -51.06 64.51 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.541 -1.349 . . . . 10.0 111.29 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 42.0 Cg_endo -67.58 -16.05 46.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.055 1.029 . . . . 10.0 109.556 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ILE . 5.0 tm-20 -55.54 -51.39 67.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.347 -0.846 . . . . 10.0 109.957 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CB ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 163.32 1.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.522 -0.736 . . . . 10.0 112.114 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.97 HG22 ' CB ' ' A' ' 107' ' ' LYS . 46.9 p -60.1 -26.84 66.53 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.279 -1.513 . . . . 10.0 111.314 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -10.06 18.54 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.376 -0.828 . . . . 10.0 111.418 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -120.0 -3.42 10.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.718 -1.238 . . . . 10.0 110.926 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.514 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 24.9 p -161.17 166.57 14.93 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.902 -1.124 . . . . 10.0 110.65 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 38.1 Cg_endo -65.36 110.39 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.741 1.39 . . . . 10.0 109.304 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.97 ' CB ' HG22 ' A' ' 102' ' ' THR 0.261 0.0 OUTLIER -92.35 -95.46 0.14 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.89 0.852 . . . . 10.0 111.06 -178.052 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' ASP . 1.1 m -167.26 120.36 0.78 Allowed Pre-proline 0 C--N 1.29 -1.992 0 C-N-CA 120.064 -0.655 . . . . 10.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 42.1 Cg_endo -68.62 149.91 74.24 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.938 1.494 . . . . 10.0 111.052 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.623 ' CE1' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -129.7 119.78 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 10.0 108.89 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -75.05 97.24 3.37 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.572 ' C ' HG23 ' A' ' 113' ' ' VAL . 51.1 mt -63.81 144.47 57.02 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.81 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 65.4 t -154.66 157.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 10.0 111.619 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.1 154.39 19.87 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.78 -1.728 . . . . 10.0 108.78 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.709 HG22 ' SG ' ' A' ' 81' ' ' CYS . 45.9 p -120.79 136.74 54.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.877 -1.366 . . . . 10.0 110.518 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.0 OUTLIER 39.75 50.86 2.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.944 0.878 . . . . 10.0 108.718 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.011 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.29 -32.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.173 -177.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -52.35 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.999 0.904 . . . . 10.0 111.064 -177.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.763 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.9 tp 153.03 -33.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.849 -1.167 . . . . 10.0 107.849 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.6 tpp180 -53.86 -27.83 32.4 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 19.3 t0 -72.23 -5.76 38.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 10.0 110.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.684 ' O ' HD13 ' A' ' 126' ' ' ILE . 17.0 m-20 -79.82 157.91 73.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 10.0 110.668 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.5 Cg_endo -83.0 23.04 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.935 1.756 . . . . 10.0 111.507 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.8 p -105.8 -46.97 4.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.043 -1.035 . . . . 10.0 109.324 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 120' ' ' ARG . 8.2 t -69.98 -27.65 64.89 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.684 HD13 ' O ' ' A' ' 122' ' ' ASP 0.307 0.7 OUTLIER -49.26 -27.53 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.144 -1.389 . . . . 10.0 107.427 177.1 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.03 -37.44 61.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.049 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -82.52 -50.75 8.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 10.0 111.426 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -67.92 -20.72 65.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.631 -1.293 . . . . 10.0 109.261 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -62.07 -40.87 97.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.491 -0.756 . . . . 10.0 109.968 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -62.46 -18.19 61.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 10.0 109.678 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 12.3 t-20 -97.99 -72.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 10.0 110.281 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 1.2 mptp? -149.55 144.35 26.19 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.347 -0.846 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.617 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -86.02 21.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 10.0 110.404 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -112.21 93.92 24.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.124 -0.985 . . . . 10.0 110.633 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.657 ' HB3' HG12 ' A' ' 85' ' ' VAL . 46.1 Cg_endo -83.17 156.67 14.91 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.158 1.609 . . . . 10.0 110.841 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -89.25 114.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -0.944 . . . . 10.0 109.057 179.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.6 p -114.72 169.25 6.86 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.386 -0.821 . . . . 10.0 109.631 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 36.7 Cg_endo -61.84 -19.39 65.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.43 1.226 . . . . 10.0 110.523 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.59 -41.93 44.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 10.0 108.749 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.5 m -83.35 -41.18 18.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.664 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -52.24 -41.8 63.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.6 -0.687 . . . . 10.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.27 -49.6 76.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.429 -0.795 . . . . 10.0 109.259 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' ASP . 22.9 mttm -60.53 -39.93 89.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.487 -0.931 . . . . 10.0 108.487 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.968 HD21 ' HE2' ' A' ' 94' ' ' LYS . 10.4 tt -58.67 -39.51 80.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.592 -0.693 . . . . 10.0 109.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.691 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -69.76 -48.08 60.6 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.627 -0.829 . . . . 10.0 108.85 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.42 -23.71 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.729 0.776 . . . . 10.0 108.98 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 144' ' ' LYS . 38.2 t70 -54.6 -27.49 39.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.594 -0.691 . . . . 10.0 111.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.979 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.26 38.1 0.79 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.914 -1.116 . . . . 10.0 112.402 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 18.0 mtpt 64.49 38.08 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.317 -0.864 . . . . 10.0 112.197 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.691 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -72.97 -158.39 0.05 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 111' ' ' LEU . 2.1 p -114.9 -62.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.323 -1.486 . . . . 10.0 111.358 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.59 ' H ' HG13 ' A' ' 152' ' ' VAL . 6.9 tttt -173.04 156.48 3.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.385 -1.447 . . . . 10.0 112.714 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.664 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 78.9 t80 -101.32 105.73 16.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 10.0 109.521 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 168' ' ' VAL . 1.3 t -96.81 -167.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 10.0 110.854 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.648 ' H ' HG12 ' A' ' 155' ' ' VAL . 46.1 mt-10 -132.37 139.53 48.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.477 -0.764 . . . . 10.0 110.463 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 2.7 t -166.96 133.0 2.23 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.337 1.065 . . . . 10.0 110.969 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.7 ' C ' ' HB3' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -150.98 80.03 1.32 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -21.11 -43.48 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.49 0.922 . . . . 10.0 113.49 -177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.0 tp -76.56 -59.26 2.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.366 -1.458 . . . . 10.0 110.069 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -115.3 39.08 3.03 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 123.179 1.466 . . . . 10.0 108.611 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.7 ' HB3' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -59.38 -106.96 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 113.604 -1.634 . . . . 10.0 111.798 -177.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 6.6 mttt 71.69 63.02 0.14 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.665 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.31 -21.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.554 -1.308 . . . . 10.0 111.05 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.851 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -62.59 -8.24 6.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.401 -1.647 . . . . 10.0 110.912 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.558 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.0 ptmt -65.2 -31.57 72.8 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.962 -1.086 . . . . 10.0 109.537 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.58 -27.7 60.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.454 -0.779 . . . . 10.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 79' ' ' LEU . 11.9 t -53.32 -48.17 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 10.0 109.676 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 t80 -73.55 -30.51 63.1 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.866 -0.521 . . . . 10.0 111.259 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.502 ' O ' HD22 ' A' ' 174' ' ' LEU . 6.1 m-20 -69.37 -46.17 67.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 10.0 111.781 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 -25.32 59.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.209 . . . . 10.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.196 -0.94 . . . . 10.0 109.491 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.633 ' O ' HD11 ' A' ' 177' ' ' LEU . 26.3 mm -63.24 -48.03 89.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.299 -0.96 . . . . 10.0 109.305 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -73.44 -42.97 61.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 10.0 110.784 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 109' ' ' PRO . . . -76.23 -2.08 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 10.0 111.065 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.82 -30.63 20.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.985 -1.072 . . . . 10.0 110.659 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.767 HD22 ' NE2' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -85.77 -17.19 36.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -0.855 . . . . 10.0 109.163 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 118.07 -0.967 . . . . 10.0 110.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.464 -1.454 . . . . 10.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -89.43 56.34 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -1.142 . . . . 10.0 110.602 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -77.38 98.21 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 10.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -91.3 155.22 18.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.824 . . . . 10.0 110.192 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.702 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.35 -152.09 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.702 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.7 Cg_endo -69.95 87.35 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 N-CA-C 110.279 -0.701 . . . . 10.0 110.279 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 22.6 mm-40 -50.92 -175.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 10.0 110.155 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 9' ' ' SER . 1.7 pp -79.77 -44.43 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.016 -1.053 . . . . 10.0 111.271 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.649 ' HB2' HD12 ' B' ' 8' ' ' ILE . 7.5 t -126.25 163.66 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.659 -1.276 . . . . 10.0 110.828 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.935 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.37 96.79 0.51 Allowed Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.764 -1.174 . . . . 10.0 113.367 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.583 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 40.2 Cg_endo -81.91 157.71 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 N-CA-C 108.007 -1.574 . . . . 10.0 108.007 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -149.02 125.24 10.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.14 -1.6 . . . . 10.0 112.2 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 43' ' ' THR . 10.0 m-20 -80.35 156.97 26.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.152 -1.055 . . . . 10.0 108.152 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 1.013 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.0 m-85 -110.34 142.63 41.74 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.411 -1.431 . . . . 10.0 111.301 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -58.93 143.28 48.45 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.361 0.601 . . . . 10.0 112.335 -177.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.661 ' C ' ' HB3' ' A' ' 40' ' ' TYR . 8.1 t60 -88.58 97.6 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.521 -0.737 . . . . 10.0 109.798 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.42 ' N ' ' HB3' ' A' ' 40' ' ' TYR . 4.2 m -83.85 155.35 22.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.874 0.845 . . . . 10.0 112.934 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.71 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.9 pp -125.98 -167.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.596 ' HA ' ' CB ' ' A' ' 37' ' ' PHE . 22.2 m-70 -123.14 143.87 49.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 10.0 110.605 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.684 ' CG1' ' HA ' ' A' ' 59' ' ' ALA . 41.2 t -135.41 155.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.446 -0.784 . . . . 10.0 110.413 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -122.67 151.76 16.87 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.0 -1.095 . . . . 10.0 112.737 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.628 ' HB3' ' CB ' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 159.33 112.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' B' ' 24' ' ' ALA . 8.3 m-20 -44.66 143.32 1.41 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.465 -0.772 . . . . 10.0 111.653 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 19.82 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 120.968 0.413 . . . . 10.0 111.762 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.628 ' CB ' ' HB3' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -112.59 -41.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.438 -0.789 . . . . 10.0 109.322 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.2 t -53.58 -18.3 2.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.62 -0.675 . . . . 10.0 109.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.643 ' HA3' HG21 ' A' ' 21' ' ' ILE . . . -128.09 25.51 4.89 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 107.78 -2.128 . . . . 10.0 107.78 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.581 ' OE1' HG22 ' B' ' 25' ' ' VAL . 23.9 tt0 -92.93 110.25 21.71 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.854 -1.38 . . . . 10.0 111.995 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 159' ' ' ALA . 45.7 t80 -140.75 111.06 6.69 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.515 -1.22 . . . . 10.0 109.297 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.466 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 47.6 p -116.67 -79.61 0.59 Allowed 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.465 -0.939 . . . . 10.0 108.465 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.454 ' O ' HG13 ' B' ' 32' ' ' ILE . . . 139.16 97.18 0.37 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.721 -1.228 . . . . 10.0 110.971 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.582 HG22 ' CD ' ' B' ' 33' ' ' PRO . 0.1 OUTLIER 178.51 -51.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.111 -1.229 . . . . 10.0 110.284 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' B' ' 32' ' ' ILE . 49.3 Cg_endo -92.44 154.31 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.712 1.375 . . . . 10.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.63 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -49.19 174.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 10.0 108.762 178.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.653 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 23.7 mt-30 -88.42 -73.78 0.48 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.457 -1.402 . . . . 10.0 111.946 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -122.61 19.26 10.37 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.311 1.053 . . . . 10.0 108.792 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.558 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -112.75 52.34 0.79 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.46 ' NE ' ' OE2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 C--N 1.299 -1.604 0 CA-C-O 122.199 1.0 . . . . 10.0 108.794 179.742 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.157 0.503 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.667 ' HA ' HD23 ' A' ' 177' ' ' LEU . 24.9 mm100 -146.61 -38.53 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.332 -0.855 . . . . 10.0 109.607 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -47.28 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 10.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -111.07 130.46 64.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.286 -0.966 . . . . 10.0 108.892 177.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER -113.19 98.57 7.21 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.412 -0.915 . . . . 10.0 109.598 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.1 t -84.88 101.31 12.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.283 -0.885 . . . . 10.0 109.072 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.71 ' HB ' HG21 ' A' ' 75' ' ' THR . 48.4 t -121.84 142.46 38.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.135 -1.026 . . . . 10.0 110.739 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.731 HG23 ' HA3' ' A' ' 15' ' ' GLY . 2.4 p -63.29 125.86 20.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.671 -0.643 . . . . 10.0 109.994 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -141.64 168.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.148 -0.97 . . . . 10.0 109.672 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.791 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 169.97 158.19 13.47 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.7 -1.36 . . . . 10.0 109.7 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -50.03 -22.62 1.67 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.404 -1.056 . . . . 10.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.0 35.4 0.08 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.599 -1.4 . . . . 10.0 109.599 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 32' ' ' ILE . . . -125.55 -155.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -1.103 . . . . 10.0 109.661 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' ' 29' ' ' PHE . 20.1 t -69.71 108.79 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 10.0 109.471 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.731 ' HA3' HG23 ' A' ' 8' ' ' VAL . . . -52.55 164.51 1.64 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.888 -1.285 . . . . 10.0 109.888 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -87.68 5.89 37.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -1.086 . . . . 10.0 110.267 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.579 HG23 ' N ' ' A' ' 18' ' ' CYS . 14.1 t -75.08 -43.06 55.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.167 -0.958 . . . . 10.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' B' ' 26' ' ' THR . 30.8 p -74.72 -9.23 58.37 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.375 -1.33 . . . . 10.0 108.429 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 159' ' ' ALA . 3.9 mm? -76.8 -36.2 57.11 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.385 -0.822 . . . . 10.0 109.631 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -37.79 49.82 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.197 -1.038 . . . . 10.0 108.197 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.522 ' CG2' ' HA3' ' B' ' 27' ' ' GLY . 1.4 mm -91.61 -51.76 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.685 0.755 . . . . 10.0 109.912 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.686 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 68.4 m -49.52 -45.59 47.45 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.51 -0.876 . . . . 10.0 109.808 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CB ' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.58 -32.47 73.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 10.0 109.726 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 m -75.77 -51.85 11.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 10.0 112.073 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' N ' ' A' ' 26' ' ' ASN . 15.3 t -153.67 -46.15 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.54 -1.664 . . . . 10.0 113.82 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.634 ' N ' HG23 ' A' ' 25' ' ' THR . 30.5 m120 -67.98 -23.67 65.06 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.907 -1.12 . . . . 10.0 111.596 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.686 ' N ' ' HA ' ' A' ' 22' ' ' SER . 2.6 pttt 24.37 -148.59 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.287 1.042 . . . . 10.0 113.249 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.508 ' CE2' HG22 ' B' ' 30' ' ' THR . 15.0 t80 . . . . . 0 C--N 1.299 -1.612 0 O-C-N 121.085 -1.01 . . . . 10.0 109.504 179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 82.5 p . . . . . 0 N--CA 1.491 1.591 0 CA-C-O 122.177 0.989 . . . . 10.0 112.68 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.824 ' N ' HG11 ' B' ' 20' ' ' VAL . 73.2 t -50.64 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.002 ' N ' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -51.64 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.757 -1.214 . . . . 10.0 110.213 -175.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' VAL . 57.0 t0 -133.66 85.64 2.22 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.663 -0.698 . . . . 10.0 110.564 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' B' ' 17' ' ' THR . 2.0 t-20 -84.4 99.65 10.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.916 -1.115 . . . . 10.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.97 120.71 41.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 10.0 109.652 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' OE1' ' B' ' 15' ' ' GLU . . . -124.0 137.13 54.64 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.693 -1.203 . . . . 10.0 111.023 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 43' ' ' THR . 55.8 t -157.94 170.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.012 . . . . 10.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 1.069 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.1 m -149.82 146.55 27.21 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.95 133.17 10.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 120.912 -1.118 . . . . 10.0 112.133 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.577 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 27.0 mtp -92.4 99.82 12.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 10.0 109.794 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 5.7 mt -88.16 130.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 10.0 110.636 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' B' ' 8' ' ' ILE . . . 43.78 25.77 0.65 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.267 -1.533 . . . . 10.0 109.267 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 96.87 21.66 20.36 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.225 -1.15 . . . . 10.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.54 ' C ' ' HA ' ' A' ' 45' ' ' MET . 27.9 mt-10 -126.34 105.43 24.64 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.972 -1.31 . . . . 10.0 110.526 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 41.4 Cg_endo -67.26 131.45 25.05 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 124.028 1.541 . . . . 10.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 1.069 ' O ' HG23 ' A' ' 43' ' ' THR . 1.5 t80 -88.53 152.26 21.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 10.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.84 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.7 m -130.38 98.72 4.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.706 . . . . 10.0 109.267 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 54' ' ' GLY . 2.3 pp -152.33 173.6 14.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.12 -1.432 . . . . 10.0 112.259 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.5 134.38 2.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.151 -1.98 . . . . 10.0 108.151 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 55' ' ' LEU . 4.0 pp -130.32 152.43 49.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.683 -1.481 . . . . 10.0 110.712 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.524 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 16.8 p90 -169.81 150.45 3.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 10.0 110.432 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 63.6 m-20 -93.04 172.96 7.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.222 -0.923 . . . . 10.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -64.28 -169.03 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.117 0.961 . . . . 10.0 112.078 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.981 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -111.34 72.11 0.77 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -39.91 -43.69 2.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.675 -1.37 . . . . 10.0 109.675 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -143.81 13.62 1.7 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.259 -1.142 . . . . 10.0 110.864 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.981 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 mm-40 -53.05 -39.14 63.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.765 -1.209 . . . . 10.0 109.147 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 35.0 m-20 67.21 10.37 7.66 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 62' ' ' GLU . 4.5 m-85 -101.45 -32.57 10.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.53 ' C ' ' O ' ' A' ' 64' ' ' TYR . 9.7 t70 20.45 49.16 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.226 0.536 . . . . 10.0 111.28 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' TYR . 42.8 mtp180 -83.22 -37.06 24.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.328 -0.858 . . . . 10.0 110.419 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.509 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.1 mt -108.13 4.58 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 10.0 110.626 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.719 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -100.27 3.04 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 118.934 -1.107 . . . . 10.0 113.54 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_endo -79.37 52.98 4.51 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 N-CA-C 108.196 -1.502 . . . . 10.0 108.196 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.7 pt? -53.28 -52.9 57.57 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 121.572 -0.705 . . . . 10.0 112.225 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 26.2 t 39.99 27.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.011 . . . . 10.0 109.601 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.47 158.75 0.74 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 10.0 110.017 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 47.1 Cg_endo -72.99 107.75 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.696 1.366 . . . . 10.0 109.44 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -137.69 36.95 2.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.805 -1.184 . . . . 10.0 110.962 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.71 HG21 ' HB ' ' A' ' 7' ' ' VAL . 97.7 m -144.66 91.99 2.24 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.177 -0.952 . . . . 10.0 108.885 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 75' ' ' THR . 10.0 m-20 -24.25 -48.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 5' ' ' LYS . 2.3 m -114.5 133.61 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.983 -1.073 . . . . 10.0 110.986 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -119.77 131.45 55.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 10.0 112.074 -178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 HD23 ' A' ' 111' ' ' LEU . 2.6 mm? -103.67 98.33 8.22 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.791 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.6 p -114.96 161.45 13.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.356 -0.84 . . . . 10.0 110.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 23.0 p -124.74 101.6 7.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 10.0 111.2 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 115' ' ' THR . 51.9 m-85 -87.26 174.29 8.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 10.0 110.401 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -118.94 130.83 55.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 10.0 109.852 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' HG2' ' A' ' 120' ' ' ARG . 27.8 m -67.14 -10.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.132 -0.98 . . . . 10.0 109.913 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 84' ' ' VAL . 35.3 m -115.8 43.17 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 10.0 109.89 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 36.7 t -105.55 140.06 20.79 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.775 . . . . 10.0 109.784 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 46.9 Cg_endo -71.38 114.46 3.94 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.04 1.547 . . . . 10.0 111.515 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 87' ' ' PRO . 75.3 m 38.9 60.08 1.49 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.426 -0.796 . . . . 10.0 111.458 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.512 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 3.4 t -100.21 -66.16 0.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.086 . . . . 10.0 110.035 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.993 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -48.52 -26.01 1.97 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.344 -0.847 . . . . 10.0 110.301 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.89 -19.43 65.87 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.029 -1.044 . . . . 10.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.654 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.77 -16.24 42.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 10.0 110.067 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 90' ' ' PHE . 18.1 m -88.95 -19.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.821 -1.174 . . . . 10.0 109.005 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.71 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.83 -32.84 57.85 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 178.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -85.16 0.38 51.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -111.38 -51.75 2.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.102 -1.039 . . . . 10.0 111.379 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 15.2 m0 -72.97 -30.61 63.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.347 -0.846 . . . . 10.0 111.81 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 149' ' ' LEU . 16.8 t -70.89 -47.89 15.05 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 10.0 111.362 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -70.7 -14.3 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.077 1.041 . . . . 10.0 111.397 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 3.5 mm-40 -67.04 -39.64 86.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.916 -1.115 . . . . 10.0 110.223 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 101' ' ' ILE . 11.3 mt 44.22 85.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.322 -0.951 . . . . 10.0 109.59 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -44.23 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 10.0 110.133 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.525 ' H ' HG23 ' A' ' 102' ' ' THR . 7.1 t60 -103.57 -13.96 16.35 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.192 -0.943 . . . . 10.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.654 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -173.25 -48.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.551 ' O ' ' CG2' ' A' ' 102' ' ' THR . 73.2 m -119.08 164.75 19.56 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.07 112.98 3.52 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.538 1.283 . . . . 10.0 110.282 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -144.18 0.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.885 -1.134 . . . . 10.0 111.728 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 m -47.69 134.89 10.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.681 -1.262 . . . . 10.0 108.819 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.53 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 41.8 Cg_endo -68.38 130.54 21.31 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.561 1.295 . . . . 10.0 109.775 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CE1' ' CZ2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -137.58 113.85 10.09 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.032 0.92 . . . . 10.0 110.931 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.919 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.8 mm? -82.19 100.29 9.76 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.669 HD21 ' C ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -91.3 117.47 29.68 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.889 0.852 . . . . 10.0 110.352 -178.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 168' ' ' VAL . 1.6 t -126.3 177.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 10.0 111.618 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.48 159.29 14.6 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 82' ' ' PHE . 87.1 m -113.59 140.77 47.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.302 . . . . 10.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 48.61 36.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 10.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -47.39 -24.82 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.261 -0.976 . . . . 10.0 110.864 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.753 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 3.6 p-10 -52.67 52.33 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 121.397 0.618 . . . . 10.0 112.222 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.76 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 157.34 -53.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -40.07 -30.16 0.09 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.277 -0.874 . . . . 10.0 110.23 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 37.3 t0 -68.02 -19.04 64.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 10.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.975 ' O ' HD13 ' A' ' 126' ' ' ILE . 3.4 m-20 -82.13 148.4 59.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 10.0 110.27 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.3 Cg_endo -86.33 22.74 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.067 1.562 . . . . 10.0 110.226 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 21.0 p -102.95 -50.25 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 10.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.711 HG21 HD12 ' A' ' 119' ' ' LEU . 4.0 t -70.55 -30.44 67.16 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.163 -2.162 . . . . 10.0 105.163 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 122' ' ' ASP 0.298 0.8 OUTLIER -49.54 -30.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.707 -1.59 . . . . 10.0 106.707 176.515 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 124' ' ' SER . 1.5 tp10 -52.84 -38.62 61.63 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.876 0.846 . . . . 10.0 109.971 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -56.5 -39.61 73.57 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.922 -0.487 . . . . 10.0 111.041 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -51.41 -47.75 62.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.938 -1.101 . . . . 10.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.53 59.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.569 -0.707 . . . . 10.0 110.397 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.93 -23.83 0.88 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.232 -0.918 . . . . 10.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 2.1 p-10 -127.95 -25.54 3.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.037 . . . . 10.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -147.79 118.31 7.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.597 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -65.16 -22.36 66.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.61 -0.682 . . . . 10.0 111.855 -178.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -108.33 95.24 15.24 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.048 -1.032 . . . . 10.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.747 ' CB ' HD13 ' A' ' 129' ' ' LEU . 43.5 Cg_endo -72.49 157.54 52.67 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.977 1.514 . . . . 10.0 109.763 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 84' ' ' VAL . 5.8 tp -100.49 127.4 53.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 10.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.6 p -125.1 169.83 10.36 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.507 -0.746 . . . . 10.0 109.223 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -63.1 -11.78 26.65 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.637 1.335 . . . . 10.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -83.95 -51.06 7.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 10.0 110.218 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.7 m -68.55 -39.94 80.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 10.0 110.514 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -51.16 -27.39 8.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 10.0 110.039 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.38 -49.95 61.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 10.0 109.732 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.5 72.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.196 -0.94 . . . . 10.0 108.976 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.55 ' CG ' ' HE2' ' A' ' 94' ' ' LYS . 2.5 tt -64.08 -49.72 71.17 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.398 -0.813 . . . . 10.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -61.71 -41.0 97.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -57.85 -24.45 57.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.014 -0.674 . . . . 10.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.526 ' C ' HD12 ' A' ' 149' ' ' LEU . 51.0 t0 -58.33 -55.19 38.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.34 -0.85 . . . . 10.0 109.428 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 98' ' ' VAL . 6.7 mp -96.55 9.23 42.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.007 -1.109 . . . . 10.0 108.007 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.9 mttp 61.86 35.99 16.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.044 0.926 . . . . 10.0 109.62 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -58.12 -154.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.476 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.919 HG11 ' CD1' ' A' ' 111' ' ' LEU . 4.3 t -89.08 -76.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.945 -1.097 . . . . 10.0 110.627 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.669 ' C ' HD21 ' A' ' 112' ' ' LEU . 2.1 tppt? -174.88 159.83 2.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.281 -1.368 . . . . 10.0 112.125 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 18.0 p90 -84.26 112.57 20.41 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.658 0.742 . . . . 10.0 109.98 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.009 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -115.71 -169.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 10.0 110.637 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.08 144.49 21.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 10.0 109.928 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.66 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 24.0 p -149.42 148.93 30.04 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.023 0.916 . . . . 10.0 111.738 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.533 ' HB3' ' H ' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -149.13 96.06 2.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -35.73 -56.41 0.68 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.618 -0.676 . . . . 10.0 112.071 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.496 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.3 pp -99.98 -11.02 20.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.667 -1.271 . . . . 10.0 113.796 -177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.562 HG21 ' CB ' ' A' ' 118' ' ' ASP . 30.0 m -98.79 -90.19 0.3 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 119.93 -1.731 . . . . 10.0 111.613 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 9.9 mt-30 -52.61 -68.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.731 -1.231 . . . . 10.0 110.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 24.8 mtmm 74.07 57.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.597 0.713 . . . . 10.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 26.77 0.24 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.643 -1.783 . . . . 10.0 108.643 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.807 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.42 4.85 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -1.037 . . . . 10.0 111.758 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.464 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -52.81 -22.59 5.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 10.0 109.543 178.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 20.2 m120 -69.13 -38.49 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 10.0 110.049 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.009 HG22 ' HB ' ' A' ' 155' ' ' VAL . 17.2 t -49.71 -40.11 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 10.0 109.179 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -79.98 -26.07 40.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 10.0 110.329 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.693 ' HA ' HD12 ' A' ' 173' ' ' ILE . 21.8 m-20 -58.65 -45.72 88.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.008 . . . . 10.0 110.148 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.53 ' HB3' HG13 ' A' ' 152' ' ' VAL . 5.6 mm-40 -74.68 -26.0 59.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.032 . . . . 10.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -67.11 -31.72 72.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 10.0 109.586 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.737 HG23 ' OH ' ' A' ' 51' ' ' TYR . 46.3 mt -59.15 -46.99 91.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.462 -0.774 . . . . 10.0 109.977 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -70.13 -35.5 74.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.203 -0.936 . . . . 10.0 110.686 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 109' ' ' PRO . . . -88.56 -3.39 58.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.39 -0.819 . . . . 10.0 109.866 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.736 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -77.94 -33.76 51.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 10.0 110.049 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -98.08 -24.05 15.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 10.0 109.182 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.022 -0.989 . . . . 10.0 110.208 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 10.0 109.723 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 15.5 m 54.24 49.82 17.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -1.147 . . . . 10.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 105.01 2.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 10.0 109.749 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' B' ' 2' ' ' SER . 15.8 mm-40 -100.81 162.85 12.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.522 -0.736 . . . . 10.0 110.404 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.696 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -69.42 -147.84 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.4 Cg_endo -69.66 87.5 0.54 Allowed 'Trans proline' 0 N--CA 1.481 0.766 0 CA-C-N 119.549 0.874 . . . . 10.0 110.327 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.577 ' CD ' HG22 ' A' ' 46' ' ' ILE . 2.8 mp0 -54.11 -164.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.666 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -80.41 -71.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.421 -1.424 . . . . 10.0 109.923 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -149.32 -175.2 4.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.375 -1.33 . . . . 10.0 112.2 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.943 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.35 138.3 4.97 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 119.223 -0.991 . . . . 10.0 112.846 -178.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 50.3 Cg_endo -81.01 153.83 19.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 108.243 -1.484 . . . . 10.0 108.243 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -129.64 151.23 50.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.399 -1.438 . . . . 10.0 111.689 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 42' ' ' VAL . 19.4 m-20 -108.06 170.26 8.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.667 -0.864 . . . . 10.0 108.667 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.11 148.46 48.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.674 -1.266 . . . . 10.0 111.37 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.727 ' OE1' ' HB3' ' A' ' 41' ' ' ALA . 3.8 tm-20 -148.0 -179.93 7.27 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -136.98 -175.3 3.99 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 117.267 -1.773 . . . . 10.0 113.511 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 39' ' ' ASN . 15.1 t -121.62 -169.7 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.863 0.84 . . . . 10.0 112.41 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.906 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.3 OUTLIER -122.28 -168.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.739 -0.6 . . . . 10.0 109.691 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 17.2 p80 -100.24 155.66 17.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.656 -1.277 . . . . 10.0 113.41 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 1.002 HG22 ' N ' ' A' ' 37' ' ' PHE 0.255 40.7 t -109.91 155.45 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.22 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.21 54.34 0.59 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.99 -1.644 . . . . 10.0 108.99 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 177.19 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.263 . . . . 10.0 109.874 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 25' ' ' VAL . 74.4 m-20 -71.42 152.77 42.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.532 -0.73 . . . . 10.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.501 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 50.06 38.01 15.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.597 -0.689 . . . . 10.0 111.431 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' B' ' 22' ' ' PHE . 54.8 t -111.0 -22.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.829 -1.175 . . . . 10.0 107.829 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.6 t -88.18 -26.56 22.34 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.466 0.651 . . . . 10.0 109.902 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -116.42 39.84 2.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.231 -1.948 . . . . 10.0 108.231 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.565 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 9.9 mp0 -140.03 122.26 15.89 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.883 0.849 . . . . 10.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 8.0 t80 -116.87 128.11 54.93 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 ' CE2' ' A' ' 28' ' ' PHE . 47.1 p -141.13 -44.9 0.38 Allowed 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.649 -0.657 . . . . 10.0 110.45 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.421 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 130.44 76.7 0.16 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.995 -1.242 . . . . 10.0 109.995 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.6 HD11 ' HG2' ' B' ' 35' ' ' GLN . 26.5 pt -110.05 160.89 26.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.282 -1.128 . . . . 10.0 109.318 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.572 ' O ' ' C ' ' B' ' 34' ' ' GLU . 47.9 Cg_endo -73.85 175.16 11.16 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.706 1.371 . . . . 10.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.572 ' C ' ' O ' ' B' ' 33' ' ' PRO . 2.3 tm-20 -1.0 114.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 121.203 0.525 . . . . 10.0 112.373 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.6 ' HG2' HD11 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -97.45 -71.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.041 -1.037 . . . . 10.0 111.89 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.05 -12.5 19.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.122 0.963 . . . . 10.0 111.247 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -90.81 60.64 4.51 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 10.0 108.9 179.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.091 0.472 . . . . 10.0 110.225 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.58 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.4 mt-30 -130.92 -3.48 4.04 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.104 -0.997 . . . . 10.0 109.9 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.583 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 23.7 m -68.39 106.18 2.42 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 10.0 110.878 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.041 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -109.22 123.75 65.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.057 -1.057 . . . . 10.0 109.397 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.4 mmmt -107.71 130.75 54.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 55' ' ' LEU . 60.8 m -109.87 116.62 31.98 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.124 -1.03 . . . . 10.0 110.056 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.574 HG21 ' OG1' ' A' ' 75' ' ' THR . 25.5 t -126.79 166.19 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.688 . . . . 10.0 109.986 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -101.52 125.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 10.0 110.257 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 10' ' ' GLY . 12.0 t -132.73 -171.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 10.0 109.534 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.74 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 109.26 171.48 20.71 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.411 -1.476 . . . . 10.0 109.411 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 82' ' ' PHE . 1.4 m-20 -45.32 -37.17 4.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 10.0 109.684 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' B' ' 35' ' ' GLN . . . 150.25 143.28 3.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 33' ' ' PRO . . . -157.32 -130.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -1.125 . . . . 10.0 110.205 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.578 HG21 ' H ' ' B' ' 30' ' ' THR . 60.5 t -119.78 -44.51 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.957 -1.089 . . . . 10.0 110.974 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -176.65 -177.69 45.82 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.899 -1.28 . . . . 10.0 109.899 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.744 ' HB2' HG22 ' A' ' 8' ' ' VAL . 6.0 ttpm? -97.79 -50.49 4.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.18 . . . . 10.0 110.386 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.8 p -72.15 -18.31 61.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 10.0 110.026 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' B' ' 28' ' ' GLU . 28.3 p -63.92 -17.2 63.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 10.0 110.79 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.548 ' CA ' ' HZ2' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -93.09 -38.59 11.53 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.001 -1.062 . . . . 10.0 110.759 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 50.4 tp -55.19 -38.34 68.24 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.673 -1.211 . . . . 10.0 108.541 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.674 ' HA ' ' HB ' ' A' ' 24' ' ' THR 0.273 6.3 tp -80.98 -30.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.697 0.76 . . . . 10.0 110.039 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 38.4 m -46.93 -54.54 9.83 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.793 -1.163 . . . . 10.0 108.724 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.694 ' CG ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.62 3.75 51.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.481 -1.688 . . . . 10.0 111.035 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 25' ' ' THR . 19.2 m -77.1 -52.54 9.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.481 -1.288 . . . . 10.0 107.821 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 24' ' ' THR . 0.6 OUTLIER -179.59 -71.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.695 -1.202 . . . . 10.0 113.745 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.763 ' H ' HG23 ' A' ' 25' ' ' THR . 26.1 m-20 -85.78 48.59 1.62 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.806 -1.184 . . . . 10.0 112.076 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' HG23 ' B' ' 26' ' ' THR . 3.2 pttt -44.92 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.222 1.01 . . . . 10.0 111.872 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 39.3 t80 . . . . . 0 C--N 1.289 -2.027 0 N-CA-C 114.819 1.414 . . . . 10.0 114.819 -178.106 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 22.5 p . . . . . 0 N--CA 1.497 1.876 0 CA-C-O 121.35 0.595 . . . . 10.0 111.921 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' CA ' ' A' ' 60' ' ' GLY . 71.6 t -58.66 -90.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 10.0 110.213 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.611 ' N ' HG12 ' B' ' 20' ' ' VAL . 1.7 t80 -47.26 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 10.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' ' CE2' ' A' ' 40' ' ' TYR . 9.4 t0 -141.02 84.2 1.92 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.408 -0.807 . . . . 10.0 109.666 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.823 ' CB ' HD11 ' B' ' 18' ' ' ILE . 9.6 t-20 -79.32 99.26 7.03 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.786 -1.196 . . . . 10.0 109.928 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' B' ' 16' ' ' HIS . 21.1 m-85 -91.93 121.16 33.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.416 -0.802 . . . . 10.0 109.832 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -145.83 96.72 2.85 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.52 -0.872 . . . . 10.0 111.293 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 43' ' ' THR . 82.4 t -162.64 -165.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.816 ' H ' HG12 ' A' ' 42' ' ' VAL . 40.1 m -126.43 165.67 18.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.588 -1.945 . . . . 10.0 112.139 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -123.59 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.565 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 0.5 OUTLIER -101.18 107.31 18.68 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.981 -1.074 . . . . 10.0 109.998 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' B' ' 10' ' ' LEU . 3.7 mp -121.7 130.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 10.0 110.376 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 50.87 25.01 8.88 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.0 13.76 71.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 10.0 109.561 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -116.18 123.52 30.76 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.344 -1.092 . . . . 10.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.08 141.45 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.52 . . . . 10.0 110.709 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 m-30 -109.97 116.32 31.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.317 -0.864 . . . . 10.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 58.1 m -85.35 106.91 17.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 10.0 109.923 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 4.3 mt -121.58 153.38 38.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 10.0 111.063 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.51 99.4 0.16 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 6' ' ' CYS . 3.3 pp -138.07 167.75 21.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -1.221 . . . . 10.0 110.644 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.541 ' N ' HD12 ' A' ' 55' ' ' LEU . 27.1 p90 -169.11 130.03 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.834 . . . . 10.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 11.0 t0 -82.05 160.95 23.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.92 -1.112 . . . . 10.0 109.045 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.713 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 8.9 m -128.52 159.79 34.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.744 -1.222 . . . . 10.0 111.481 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 75.04 28.79 1.02 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.973 0.892 . . . . 10.0 109.143 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.684 ' CA ' HG11 ' A' ' 36' ' ' VAL . . . -80.88 -75.08 1.1 Allowed Glycine 0 C--N 1.297 -1.588 0 N-CA-C 106.972 -2.451 . . . . 10.0 106.972 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HA ' ' N ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER -89.14 20.5 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -1.082 . . . . 10.0 110.098 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.613 ' O ' ' CZ ' ' A' ' 64' ' ' TYR . 60.3 mm-40 -104.22 -48.91 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 10.0 110.421 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 31.8 t0 66.12 47.9 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 10.0 109.448 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.613 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER 157.16 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.423 0.63 . . . . 10.0 109.553 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 2.3 p30 36.92 53.54 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 10.0 111.763 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -52.93 -29.13 26.83 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.623 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.5 mp -82.32 10.9 6.12 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.251 0.548 . . . . 10.0 109.755 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.782 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -63.07 -18.06 0.44 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -84.04 80.42 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 CA-C-N 120.043 1.051 . . . . 10.0 110.206 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -90.73 -28.36 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.75 . . . . 10.0 110.366 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 30.7 t 42.75 25.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 10.0 110.615 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 16.2 m-85 -120.22 93.06 47.83 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.018 -1.051 . . . . 10.0 110.488 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.89 73.35 6.06 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 10.0 111.168 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.74 65.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 10.0 109.924 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.626 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 48.1 m -143.84 96.18 2.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.569 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.4 t70 -33.32 -31.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 120.83 0.348 . . . . 10.0 111.417 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.979 HG11 ' HB2' ' A' ' 176' ' ' ALA . 3.1 m -122.69 123.5 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.205 -0.934 . . . . 10.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.652 ' CD1' HG21 ' A' ' 9' ' ' VAL . 21.3 m-85 -109.56 143.15 39.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.3 -0.875 . . . . 10.0 109.89 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 168' ' ' VAL . 1.1 mm? -108.35 97.99 7.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.108 . . . . 10.0 110.414 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.586 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 2.1 m -105.45 131.55 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 10.0 108.658 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 113' ' ' VAL . 41.3 t -136.98 124.45 22.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.795 -1.19 . . . . 10.0 110.963 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 8.1 p90 -149.55 179.63 7.83 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.458 -0.897 . . . . 10.0 111.35 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 m -75.21 163.14 27.83 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.244 -0.91 . . . . 10.0 111.148 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.637 ' O ' HG22 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -127.83 9.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 10.0 112.5 -178.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -80.49 -72.56 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.127 -1.608 . . . . 10.0 107.751 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 85' ' ' VAL . 60.8 m -76.8 135.26 67.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.665 -1.272 . . . . 10.0 108.496 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 42.1 Cg_endo -72.37 -23.92 20.03 Favored 'Trans proline' 0 C--N 1.297 -2.139 0 O-C-N 123.662 1.348 . . . . 10.0 110.144 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 89' ' ' SER . 66.7 m 41.26 38.96 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 88' ' ' SER . 15.3 m 64.13 40.36 6.99 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.377 0.608 . . . . 10.0 110.243 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' ' HE2' ' A' ' 94' ' ' LYS . 7.1 t80 -48.59 -26.34 2.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 10.0 108.761 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.5 tt0 -56.85 -27.43 60.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 10.0 109.072 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.12 -22.07 61.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.88 0.848 . . . . 10.0 109.396 179.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.833 HG13 ' CZ2' ' A' ' 97' ' ' TRP . 6.8 t -82.85 -8.43 11.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.261 -0.899 . . . . 10.0 109.356 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HE2' ' CE2' ' A' ' 90' ' ' PHE . 4.0 mmtp -86.63 -32.44 20.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 8.0 pt-20 -84.08 3.13 36.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.846 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -103.37 -50.29 3.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.964 -1.094 . . . . 10.0 111.843 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.833 ' CZ2' HG13 ' A' ' 93' ' ' VAL . 5.6 m0 -86.52 -49.06 7.84 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.98 -1.075 . . . . 10.0 112.022 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.564 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 18.2 t -54.21 -50.39 84.89 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.861 -1.149 . . . . 10.0 111.575 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 43.2 Cg_endo -70.54 -15.92 34.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.089 1.047 . . . . 10.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -54.2 -30.25 49.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 10.0 109.119 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 104' ' ' HIS . 4.6 mt 60.24 114.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.493 -0.883 . . . . 10.0 110.223 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -49.83 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 109.632 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.656 ' H ' HG23 ' A' ' 102' ' ' THR . 7.3 p80 -109.49 6.97 24.58 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.367 -0.833 . . . . 10.0 109.546 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.79 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.3 OUTLIER 169.59 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 10.0 109.575 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.901 ' O ' HG22 ' A' ' 102' ' ' THR . 75.8 m -119.66 155.71 54.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.51 -0.744 . . . . 10.0 110.205 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 55.2 Cg_endo -76.6 73.41 5.22 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.149 1.605 . . . . 10.0 111.64 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 18.5 ttpt -126.9 -2.02 6.56 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.698 -1.251 . . . . 10.0 109.826 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 102' ' ' THR . 96.3 m -46.22 129.24 7.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.118 -0.989 . . . . 10.0 109.721 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 47.0 Cg_endo -71.75 149.22 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.81 1.426 . . . . 10.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 97' ' ' TRP . 43.6 m-85 -132.99 119.58 20.27 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.081 -1.048 . . . . 10.0 111.772 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.889 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.5 mm? -88.79 93.38 9.56 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.235 -1.395 . . . . 10.0 107.235 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 2.2 mt -70.99 147.2 48.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.469 -0.769 . . . . 10.0 109.617 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 168' ' ' VAL . 1.8 t -146.51 178.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.952 . . . . 10.0 111.32 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -126.3 116.35 2.53 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.814 -1.715 . . . . 10.0 108.814 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.832 HG22 ' HG3' ' A' ' 116' ' ' GLN . 64.4 m -81.79 123.72 29.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.067 -1.254 . . . . 10.0 109.723 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.6 mt-30 47.1 69.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -93.83 -45.41 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.969 -0.692 . . . . 10.0 111.41 -177.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 35.8 t70 -51.43 56.16 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 121.921 0.867 . . . . 10.0 112.86 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 2.5 tp 152.95 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' ILE . 17.6 tpp180 -58.66 -17.72 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' CG2' ' A' ' 84' ' ' VAL . 14.6 m-20 -111.54 19.51 18.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.84 -0.537 . . . . 10.0 110.548 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.847 ' OD1' HG22 ' A' ' 125' ' ' THR . 21.2 p-10 -80.63 145.41 58.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.025 -1.047 . . . . 10.0 108.994 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.57 24.19 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.382 1.727 . . . . 10.0 112.469 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -110.23 -48.13 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.56 -1.337 . . . . 10.0 110.288 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.847 HG22 ' OD1' ' A' ' 122' ' ' ASP . 9.3 t -86.49 -24.68 25.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.09 -1.818 . . . . 10.0 106.09 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 120' ' ' ARG 0.278 1.1 mp -62.68 -21.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 176.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -47.84 -46.68 31.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.625 0.726 . . . . 10.0 109.636 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 -41.33 12.5 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.509 -0.744 . . . . 10.0 111.192 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 125' ' ' THR . 4.6 mt -57.09 -41.58 79.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 10.0 110.999 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.994 -1.067 . . . . 10.0 109.214 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -71.2 -8.51 54.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 10.0 110.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.547 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 57.9 t-20 -65.82 -33.62 76.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 10.0 110.496 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.616 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mptt -117.67 -68.03 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 143.53 -17.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 123.377 0.671 . . . . 10.0 110.023 177.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -136.48 94.9 13.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.978 -1.077 . . . . 10.0 110.844 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.8 Cg_endo -71.05 161.5 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.028 1.541 . . . . 10.0 110.657 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' VAL . 7.1 tp -102.76 134.97 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 10.0 109.232 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.7 p -120.2 172.23 4.84 Favored Pre-proline 0 C--N 1.295 -1.777 0 O-C-N 121.238 -0.914 . . . . 10.0 109.062 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.65 -17.41 52.69 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.276 1.146 . . . . 10.0 109.703 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 mt-10 -79.7 -42.78 23.95 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.81 . . . . 10.0 109.945 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 m -73.9 -43.5 58.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.359 -0.838 . . . . 10.0 109.889 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -57.75 -50.38 73.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 10.0 110.752 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 3.0 pp20? -65.92 -30.41 70.99 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.209 -0.997 . . . . 10.0 108.966 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -71.22 -35.82 71.64 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -60.73 -45.8 92.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.036 -1.098 . . . . 10.0 108.036 178.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.911 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.66 -50.17 74.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.887 0.851 . . . . 10.0 109.114 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 147' ' ' ARG . 4.7 ttm180 -65.55 -17.75 64.81 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.48 0.657 . . . . 10.0 109.729 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -67.92 -18.74 64.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.824 . . . . 10.0 110.97 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -152.03 38.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.9 -1.125 . . . . 10.0 111.326 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 8.9 mttp 62.08 53.43 2.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.005 0.907 . . . . 10.0 112.105 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.911 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -105.36 173.15 6.43 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.895 -0.779 . . . . 10.0 108.895 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.862 HG21 HD11 ' A' ' 111' ' ' LEU . 2.9 t -71.23 -87.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.005 -1.06 . . . . 10.0 110.821 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.832 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.12 168.75 4.05 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.088 -1.007 . . . . 10.0 111.006 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.636 ' OH ' HG11 ' A' ' 84' ' ' VAL . 77.6 t80 -81.04 119.0 22.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 10.0 110.581 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.758 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.7 OUTLIER -118.83 -169.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.141 -0.974 . . . . 10.0 110.463 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 86.7 mt-10 -146.36 138.54 25.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.661 -1.274 . . . . 10.0 111.874 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 30.1 t -141.2 130.56 23.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.131 0.967 . . . . 10.0 111.373 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 162' ' ' GLN . 18.9 m -148.35 81.15 1.47 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.997 0.903 . . . . 10.0 109.387 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.652 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . . . -52.98 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.995 . . . . 10.0 111.062 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 161' ' ' THR 0.262 0.4 OUTLIER -48.05 -50.7 27.1 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.961 -1.087 . . . . 10.0 110.288 -179.825 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.896 ' N ' HD13 ' A' ' 160' ' ' LEU . 1.1 m -76.8 -70.52 0.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.227 0.825 . . . . 10.0 113.227 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.656 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -123.85 -91.16 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.0 -1.688 . . . . 10.0 112.238 -178.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.771 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 1.3 mmtt 124.36 -154.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.788 1.235 . . . . 10.0 108.531 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.615 ' N ' HD13 ' A' ' 165' ' ' LEU . . . 96.11 14.06 46.89 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.535 -2.626 . . . . 10.0 106.535 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.908 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -84.34 5.23 27.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.964 -0.618 . . . . 10.0 111.478 -178.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.526 ' N ' HD22 ' A' ' 165' ' ' LEU . 13.8 mttt -50.47 -27.57 6.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 10.0 108.613 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.597 ' HB3' HG11 ' A' ' 155' ' ' VAL . 25.9 t-20 -65.12 -43.95 90.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.526 -0.734 . . . . 10.0 109.813 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.831 HG12 ' CD1' ' A' ' 79' ' ' LEU . 93.9 t -50.54 -29.39 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 10.0 109.165 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 14.8 m-85 -96.78 -22.14 17.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.74 -0.6 . . . . 10.0 109.958 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.1 t0 -67.54 -51.29 52.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 10.0 111.067 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.407 ' HA ' HD23 ' A' ' 174' ' ' LEU . 4.8 mt-10 -72.34 -40.5 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 10.0 111.097 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.889 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.8 -31.77 59.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.988 -1.07 . . . . 10.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.667 ' O ' HD11 ' A' ' 177' ' ' LEU . 30.1 mt -58.48 -44.16 88.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.995 -1.065 . . . . 10.0 109.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -76.69 -48.59 18.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 10.0 112.182 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.3 -10.27 22.93 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.354 -0.841 . . . . 10.0 110.865 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.041 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -79.0 -41.41 29.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 10.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.667 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -77.3 -19.91 55.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.402 -0.811 . . . . 10.0 109.164 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 117.982 -1.009 . . . . 10.0 110.341 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.495 -1.442 . . . . 10.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -106.19 138.01 43.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -1.145 . . . . 10.0 110.567 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.44 102.56 9.32 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.42 -0.8 . . . . 10.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -101.56 140.39 35.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.687 -0.633 . . . . 10.0 110.926 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.634 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -98.77 -49.02 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 10.0 110.213 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 51.9 Cg_endo -83.62 -18.15 5.83 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.086 -1.159 . . . . 10.0 109.086 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.761 ' OE2' HD23 ' B' ' 10' ' ' LEU . 0.5 OUTLIER 32.93 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.521 0.677 . . . . 10.0 111.71 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -141.96 -61.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.071 -1.018 . . . . 10.0 110.117 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 t -134.44 132.09 38.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 10.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.761 HD23 ' OE2' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -132.33 99.62 15.9 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.546 -0.721 . . . . 10.0 111.176 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 41.6 Cg_endo -72.54 117.06 4.95 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.604 1.318 . . . . 10.0 108.761 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -47.82 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 10.0 111.202 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -151.96 -166.66 2.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.857 -0.527 . . . . 10.0 109.717 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.745 ' C ' HG11 ' A' ' 42' ' ' VAL . 24.0 m-85 -109.49 -170.05 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.99 1.108 . . . . 10.0 113.99 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.652 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -160.85 -169.69 2.48 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 53.8 t60 -136.07 146.93 47.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.022 -1.049 . . . . 10.0 110.837 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.644 ' C ' HD13 ' B' ' 18' ' ' ILE . 2.8 t -150.27 143.33 24.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.173 -1.579 . . . . 10.0 112.203 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.823 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -110.99 -167.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 68.3 t60 -107.38 153.4 22.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.775 -1.203 . . . . 10.0 112.275 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.66 HG11 ' N ' ' A' ' 36' ' ' VAL . 1.6 m -124.98 153.1 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.729 0.776 . . . . 10.0 111.405 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 60' ' ' GLY . . . -134.62 98.43 0.31 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.32 -1.912 . . . . 10.0 108.32 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.725 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.1 t80 -179.34 117.46 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.014 -1.286 . . . . 10.0 109.314 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 22' ' ' PHE . 16.0 t0 -38.95 156.3 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.643 0.735 . . . . 10.0 111.133 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.01 46.73 10.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.667 -0.646 . . . . 10.0 110.512 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 22' ' ' PHE . 64.9 t -78.54 -17.59 13.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 27' ' ' LYS 0.256 5.7 t -50.06 -29.87 9.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.874 -1.057 . . . . 10.0 111.747 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -134.99 4.44 4.23 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.16 -1.976 . . . . 10.0 108.16 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 0.5 OUTLIER 54.08 19.99 2.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.416 -1.05 . . . . 10.0 110.664 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.709 ' C ' HG22 ' B' ' 30' ' ' THR . 4.2 t80 -113.15 133.08 55.21 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.762 -0.586 . . . . 10.0 109.973 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.709 HG22 ' C ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER 161.97 135.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.238 0.542 . . . . 10.0 110.95 179.524 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 -179.61 50.98 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.051 -1.219 . . . . 10.0 110.051 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 1.1 pp -143.17 36.1 0.21 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.26 -1.141 . . . . 10.0 112.055 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 46.2 Cg_endo -73.2 171.64 17.19 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.172 1.091 . . . . 10.0 109.437 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' PRO . 41.8 tp10 -48.96 167.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.699 -1.25 . . . . 10.0 108.788 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.606 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 2.1 mp0 -82.13 20.08 1.08 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.39 -0.819 . . . . 10.0 110.853 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.679 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.5 m95 87.84 49.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 36' ' ' TRP . . . 168.56 99.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.455 -0.942 . . . . 10.0 108.455 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HD2' ' HD3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER . . . . . 0 C--N 1.291 -1.971 0 N-CA-C 106.294 -1.743 . . . . 10.0 106.294 177.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 2.5 ttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.478 0.656 . . . . 10.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.563 ' O ' HG22 ' A' ' 4' ' ' ILE . 7.6 mm-40 -149.51 -83.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.734 ' N ' HG21 ' A' ' 52' ' ' THR . 4.3 m -38.87 91.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.584 -0.697 . . . . 10.0 110.171 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.823 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 1.6 tt -135.59 138.76 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.088 -1.008 . . . . 10.0 110.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.615 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.35 122.84 28.64 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.132 0.968 . . . . 10.0 111.313 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.739 ' HA ' HG13 ' A' ' 77' ' ' VAL . 40.4 t -71.34 126.1 28.73 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.746 0.784 . . . . 10.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 8' ' ' VAL . 4.3 t -140.43 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.667 . . . . 10.0 109.212 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.716 ' H ' HG12 ' A' ' 7' ' ' VAL . 71.5 t -93.87 143.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.05 -1.031 . . . . 10.0 109.82 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -132.74 -166.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.505 -0.747 . . . . 10.0 110.397 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.698 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 89.49 -158.92 27.95 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.567 -1.413 . . . . 10.0 109.567 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.59 -10.19 57.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.986 -1.302 . . . . 10.0 109.4 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.525 ' HA2' ' HG3' ' B' ' 35' ' ' GLN . . . 112.07 89.68 1.87 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . -166.15 50.03 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.211 -1.17 . . . . 10.0 110.265 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.618 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER 68.32 157.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.058 -1.026 . . . . 10.0 109.411 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.685 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -122.87 -153.32 8.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.756 -1.738 . . . . 10.0 108.756 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 1.016 ' HA ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.01 0.36 21.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.523 -0.986 . . . . 10.0 110.873 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 -50.63 18.23 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.315 -0.866 . . . . 10.0 111.493 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.585 ' SG ' HD22 ' A' ' 19' ' ' LEU . 31.9 p -61.88 -17.89 58.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.778 -1.201 . . . . 10.0 109.443 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.21 -28.15 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.371 -0.831 . . . . 10.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -49.57 -41.39 41.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.604 -1.31 . . . . 10.0 109.331 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.724 ' HB ' ' HA2' ' B' ' 27' ' ' GLY . 1.2 mm -84.59 -39.97 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.369 1.08 . . . . 10.0 109.09 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 19' ' ' LEU . 16.1 t -46.73 -49.21 19.95 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.359 -0.837 . . . . 10.0 110.546 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.939 ' CZ ' HD12 ' A' ' 165' ' ' LEU . 29.8 m-85 -79.94 -14.28 58.72 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.002 -1.061 . . . . 10.0 110.316 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 m -100.04 -31.63 11.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 10.0 112.849 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.419 ' OG1' HG23 ' A' ' 21' ' ' ILE . 82.8 p -110.74 -90.2 0.48 Allowed 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.051 -1.656 . . . . 10.0 112.118 -177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.586 ' C ' ' HG3' ' A' ' 27' ' ' LYS . 47.7 t-20 -159.85 20.96 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.51 -0.744 . . . . 10.0 111.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.59 ' HD2' ' N ' ' A' ' 28' ' ' PHE . 0.1 OUTLIER 26.86 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.431 0.901 . . . . 10.0 113.431 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CD2' HG22 ' B' ' 30' ' ' THR . 1.0 OUTLIER . . . . . 0 N--CA 1.502 2.141 0 O-C-N 121.951 -0.468 . . . . 10.0 110.244 -178.066 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.956 HG23 ' HB2' ' A' ' 37' ' ' PHE . 5.1 t . . . . . 0 N--CA 1.492 1.673 0 CA-C-O 121.644 0.735 . . . . 10.0 112.18 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 58' ' ' THR . 1.6 t -54.42 -14.18 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.559 -0.713 . . . . 10.0 111.058 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 1.121 ' CD1' HG22 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -35.69 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.511 -0.743 . . . . 10.0 109.989 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.613 ' C ' ' HA ' ' B' ' 18' ' ' ILE . 68.5 m-20 -137.79 131.96 31.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.913 2.19 . . . . 10.0 116.913 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.805 ' HB3' HD13 ' B' ' 18' ' ' ILE 0.26 35.1 p-10 -104.9 107.37 18.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.007 -0.997 . . . . 10.0 111.101 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 39' ' ' ASN . 23.8 m-85 -155.21 108.84 2.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 119.368 -2.082 . . . . 10.0 113.101 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -171.65 99.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.423 -1.325 . . . . 10.0 107.423 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -156.11 -168.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.899 -1.125 . . . . 10.0 111.436 -177.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.942 HG23 ' C ' ' A' ' 51' ' ' TYR . 27.0 m -151.68 115.55 4.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.648 -0.821 . . . . 10.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -79.76 152.05 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.556 . . . . 10.0 110.047 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.6 ' O ' ' O ' ' B' ' 10' ' ' LEU . 33.6 mtm -127.43 92.89 3.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.339 -1.344 . . . . 10.0 108.125 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 38.3 mt -95.6 141.13 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 120.909 0.385 . . . . 10.0 110.249 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.792 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 40.97 26.96 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 86.24 33.33 14.64 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.161 -1.199 . . . . 10.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' CG ' ' B' ' 4' ' ' GLU . 52.7 mm-40 -127.46 102.52 23.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.085 -1.244 . . . . 10.0 110.723 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 48.0 Cg_endo -74.92 124.2 8.48 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.874 1.46 . . . . 10.0 110.303 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.942 ' C ' HG23 ' A' ' 43' ' ' THR . 6.3 m-30 -99.83 110.99 23.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.683 -1.261 . . . . 10.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.734 HG21 ' N ' ' A' ' 3' ' ' THR . 1.4 m -71.69 117.04 12.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.636 -0.665 . . . . 10.0 110.546 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.471 ' HG ' ' C ' ' A' ' 52' ' ' THR . 5.2 mt -137.71 160.72 38.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.884 -1.135 . . . . 10.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 5' ' ' LYS . . . -170.92 110.87 0.38 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.959 -1.256 . . . . 10.0 109.959 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 ' CB ' ' A' ' 40' ' ' TYR . 2.2 pp -138.57 152.53 48.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.97 -1.312 . . . . 10.0 111.924 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 20.6 p90 -160.27 140.65 11.67 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.307 -0.86 . . . . 10.0 108.766 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.676 ' HB2' HG13 ' A' ' 36' ' ' VAL . 1.7 m-20 -92.8 154.37 18.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.804 -1.185 . . . . 10.0 111.468 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 36' ' ' VAL . 1.6 t -60.55 133.77 56.42 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 10.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HA ' ' CA ' ' B' ' 21' ' ' GLY . . . -87.12 79.1 8.74 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.677 -0.64 . . . . 10.0 111.439 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.572 ' N ' ' HA2' ' B' ' 21' ' ' GLY . . . -42.94 -50.07 6.14 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.559 -2.617 . . . . 10.0 106.559 177.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 3.5 mm-40 -62.99 -44.18 96.73 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 4.5 mt-10 65.41 84.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.121 0.962 . . . . 10.0 111.366 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.709 ' OD2' HG11 ' B' ' 20' ' ' VAL . 21.5 m-20 -95.52 -8.86 34.01 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.811 0.815 . . . . 10.0 108.858 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.4 p90 -139.65 10.32 2.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.664 -0.865 . . . . 10.0 108.664 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.1 p-10 -30.62 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.26 0.552 . . . . 10.0 112.101 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -48.46 -26.88 2.33 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.829 -1.169 . . . . 10.0 109.451 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 mp -97.02 6.68 48.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.432 -0.792 . . . . 10.0 110.273 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 1.048 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -72.69 -24.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.103 -0.998 . . . . 10.0 112.891 -179.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 38.0 Cg_endo -70.91 71.42 2.1 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 109.275 -1.086 . . . . 10.0 109.275 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 1.048 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -69.93 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.793 -0.567 . . . . 10.0 111.519 -178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.456 ' H ' ' CG ' ' A' ' 70' ' ' LEU . 0.5 OUTLIER 54.67 35.21 23.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.805 -1.185 . . . . 10.0 108.482 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 4.9 m-85 -118.1 -53.48 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.629 -0.669 . . . . 10.0 111.222 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.615 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 55.7 Cg_endo -85.92 76.8 2.7 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 122.978 0.988 . . . . 10.0 111.296 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.16 0.32 52.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.904 -1.122 . . . . 10.0 110.443 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 75' ' ' THR . 2.7 m -140.1 84.21 1.96 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.287 -0.883 . . . . 10.0 110.048 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 4' ' ' ILE . 1.9 m-20 -140.52 -97.62 0.15 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.704 -0.622 . . . . 10.0 109.424 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.739 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -140.78 118.53 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 10.0 108.743 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 21.4 m-85 -114.85 125.51 53.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.018 . . . . 10.0 111.443 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.603 HD22 HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -111.47 99.76 8.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 178.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 112' ' ' LEU . 1.7 p -82.64 133.79 28.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.618 -0.676 . . . . 10.0 110.457 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.452 ' C ' ' OG1' ' A' ' 115' ' ' THR . 11.3 t -124.27 101.21 7.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.176 -0.953 . . . . 10.0 109.161 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.8 p90 -133.53 162.24 32.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.662 -1.215 . . . . 10.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB3' HG22 ' A' ' 85' ' ' VAL . 63.6 m -75.76 158.64 31.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.648 -0.658 . . . . 10.0 110.328 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 -11.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.472 -0.767 . . . . 10.0 109.403 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 129' ' ' LEU . 33.9 m -68.62 -1.93 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.776 . . . . 10.0 109.701 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.2 m -128.08 82.86 67.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.201 -0.937 . . . . 10.0 109.871 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 44.2 Cg_endo -63.81 -19.26 66.71 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.35 1.711 . . . . 10.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.507 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 67.9 m -89.04 22.36 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 10.0 109.122 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.547 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 46.9 t -124.75 -56.23 1.59 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.779 -0.576 . . . . 10.0 109.881 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.531 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.4 p90 -53.38 -39.95 64.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.631 -1.293 . . . . 10.0 109.469 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 17.8 pt-20 -67.55 -26.5 66.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.555 -0.715 . . . . 10.0 109.55 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.811 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -77.13 -14.3 59.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.224 -0.922 . . . . 10.0 108.667 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.811 HG23 ' ND2' ' A' ' 92' ' ' ASN . 32.9 t -88.5 -16.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.787 0.803 . . . . 10.0 109.601 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 145' ' ' LEU . 1.1 mmtt -86.22 -33.48 20.73 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 5.4 pt-20 -77.02 -9.04 58.44 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.163 -0.615 . . . . 10.0 109.421 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -90.3 -52.4 4.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.844 -1.16 . . . . 10.0 111.976 -178.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -93.09 -31.83 14.68 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.563 -1.336 . . . . 10.0 112.487 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 95.0 t -54.32 -46.75 98.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.572 -1.33 . . . . 10.0 110.863 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.4 Cg_endo -73.9 -23.41 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.323 1.17 . . . . 10.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 29.1 mm-40 -63.46 -16.36 60.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 10.0 110.772 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 104' ' ' HIS . 9.6 mm 56.62 104.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.141 -0.975 . . . . 10.0 110.058 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.565 ' HB ' ' CG ' ' A' ' 106' ' ' PRO . 5.9 m -44.08 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 4.8 t-160 -112.89 -15.43 12.9 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.524 -0.735 . . . . 10.0 110.23 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.603 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER 165.91 -49.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.875 -1.528 . . . . 10.0 106.875 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.585 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 19.5 t 179.26 58.92 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 CA-C-N 115.206 -0.906 . . . . 10.0 108.924 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.632 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 52.2 Cg_endo -89.62 -62.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.002 1.527 . . . . 10.0 110.191 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 108.2 51.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 124.972 1.309 . . . . 10.0 110.905 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.487 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 31.2 m -45.88 144.29 2.88 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.892 -1.13 . . . . 10.0 109.319 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 43.7 Cg_endo -69.6 144.49 55.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.763 1.402 . . . . 10.0 110.776 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.448 ' C ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -133.66 113.02 11.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.399 -0.813 . . . . 10.0 111.641 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 152' ' ' VAL . 2.6 mm? -83.09 97.41 8.77 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -77.02 145.68 37.84 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.413 -0.804 . . . . 10.0 110.447 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.0 t -152.97 176.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.147 -0.97 . . . . 10.0 111.83 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -112.32 159.82 13.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.42 -1.872 . . . . 10.0 108.42 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.696 HG22 ' HG2' ' A' ' 116' ' ' GLN . 81.8 m -127.03 150.75 49.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.675 -1.485 . . . . 10.0 111.457 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.696 ' HG2' HG22 ' A' ' 115' ' ' THR . 4.2 pt20 33.6 57.35 0.54 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.376 0.607 . . . . 10.0 110.97 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.964 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -80.13 -25.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 10.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.862 ' HB2' HG21 ' A' ' 161' ' ' THR . 15.7 t0 -52.48 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.566 1.174 . . . . 10.0 110.708 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.741 ' N ' ' O ' ' A' ' 117' ' ' ILE . 4.6 tp 167.42 -30.24 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.035 -1.439 . . . . 10.0 107.634 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 ttp180 -46.5 -38.56 9.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -55.07 -25.53 31.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 10.0 109.503 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 119' ' ' LEU . 6.8 m-20 -92.63 150.6 40.03 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 10.0 111.526 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.525 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 56.2 Cg_endo -80.79 17.15 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.578 1.831 . . . . 10.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.9 p -96.68 -50.75 4.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.984 -1.072 . . . . 10.0 110.188 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.469 ' O ' ' CD ' ' A' ' 128' ' ' LYS . 15.3 t -71.74 -28.11 63.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.832 -2.284 . . . . 10.0 104.832 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.304 0.4 OUTLIER -49.67 -27.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 176.794 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -50.12 -32.07 14.99 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.495 0.664 . . . . 10.0 109.998 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 125' ' ' THR . 0.3 OUTLIER -65.64 -32.19 73.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.334 -0.854 . . . . 10.0 110.391 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -54.71 -38.69 67.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.109 -0.994 . . . . 10.0 109.373 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.595 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -54.15 -51.28 64.78 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.551 -0.86 . . . . 10.0 109.512 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -71.74 -13.28 61.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.014 . . . . 10.0 108.398 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 17.1 m120 -126.93 46.39 2.51 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.771 -0.581 . . . . 10.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 68.08 135.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 10.0 110.322 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.595 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.74 3.71 21.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 10.0 110.686 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 27.2 mmtp -101.53 99.49 11.59 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 10.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.66 161.74 44.74 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.862 1.454 . . . . 10.0 112.155 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 137' ' ' ILE . 2.2 tp -84.71 143.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 10.0 109.011 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 43.6 p -134.4 171.26 9.34 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 10.0 110.312 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.1 Cg_endo -65.98 -30.55 47.99 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.556 1.293 . . . . 10.0 110.473 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -67.54 -38.13 83.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 10.0 109.01 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 m -88.79 -38.96 14.24 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.518 0.675 . . . . 10.0 109.484 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -69.05 -36.17 77.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.692 -0.63 . . . . 10.0 110.343 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 5.2 tt0 -65.31 -37.56 87.49 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.351 -0.843 . . . . 10.0 109.403 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 42.3 tttp -66.79 -36.04 81.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 10.0 108.806 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 94' ' ' LYS . 2.9 tp -62.56 -48.97 77.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -63.47 -49.35 73.95 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.564 -0.854 . . . . 10.0 109.435 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -27.1 68.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.281 0.562 . . . . 10.0 109.567 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 149' ' ' LEU . 1.9 m-20 -74.68 -47.45 31.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 10.0 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 3.2 mp -88.73 12.07 15.92 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.892 0.853 . . . . 10.0 109.445 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 19.2 mtmt 59.69 33.11 21.81 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.816 0.817 . . . . 10.0 110.216 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.493 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -61.58 -152.85 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.145 -0.622 . . . . 10.0 110.117 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -117.97 -51.52 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.035 -1.041 . . . . 10.0 111.471 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -172.52 143.62 1.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.613 -1.235 . . . . 10.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 53.8 p90 -90.32 121.64 32.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 10.0 109.623 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -127.14 -169.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 10.0 110.771 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -145.69 148.21 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 10.0 110.033 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.57 ' SG ' HG11 ' A' ' 113' ' ' VAL . 27.6 p -156.52 154.11 29.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.326 -0.859 . . . . 10.0 109.171 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.928 ' HB3' HG23 ' A' ' 161' ' ' THR . 1.3 t -149.61 88.47 1.56 Allowed 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.066 -1.054 . . . . 10.0 109.933 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.744 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -42.84 -79.86 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.519 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -31.3 -39.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.216 1.008 . . . . 10.0 109.351 -178.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.928 HG23 ' HB3' ' A' ' 158' ' ' SER . 0.0 OUTLIER -111.2 -97.91 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.021 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 158.75 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.833 . . . . 10.0 109.754 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 157' ' ' CYS . 21.8 tptt -105.47 43.59 1.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.851 -1.155 . . . . 10.0 110.221 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.44 40.84 87.17 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.741 -1.344 . . . . 10.0 109.741 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.939 HD12 ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -61.71 -12.27 15.77 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.237 -1.155 . . . . 10.0 110.785 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.581 ' N ' HD13 ' A' ' 165' ' ' LEU . 2.5 mttp -53.24 -29.67 33.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.889 -1.132 . . . . 10.0 109.834 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -70.86 -29.79 66.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 10.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 155' ' ' VAL . 2.3 t -66.86 -19.37 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 10.0 110.035 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 25.4 t80 -96.55 -45.3 6.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.212 -0.93 . . . . 10.0 112.094 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.22 -49.14 61.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.985 -1.072 . . . . 10.0 110.82 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.78 -39.73 76.46 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.087 -1.008 . . . . 10.0 110.137 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -54.85 -27.24 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.765 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 34.8 mm -67.14 -45.93 85.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.959 -1.088 . . . . 10.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.831 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -80.49 -27.63 37.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.945 -1.097 . . . . 10.0 109.954 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -85.43 -1.66 57.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.763 . . . . 10.0 109.418 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -83.11 -42.43 17.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.329 -0.857 . . . . 10.0 110.497 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -87.73 -19.12 28.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.494 -0.754 . . . . 10.0 109.826 -178.555 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 175' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 120.858 -1.151 . . . . 10.0 109.998 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.661 -1.376 . . . . 10.0 109.661 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.3 m -119.55 157.59 28.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -1.159 . . . . 10.0 110.748 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.08 100.66 13.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.376 -0.828 . . . . 10.0 110.022 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 49' ' ' GLU . 53.4 mm-40 -81.28 157.99 24.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.876 . . . . 10.0 110.669 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.708 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -118.09 -52.32 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.481 -0.762 . . . . 10.0 110.129 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.7 Cg_endo -89.59 21.37 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.26 1.137 . . . . 10.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 46' ' ' ILE . 4.0 pt-20 -55.39 168.44 0.37 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.956 . . . . 10.0 110.353 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.837 HG23 ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -80.27 -148.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 10.0 108.649 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.837 ' N ' HG23 ' B' ' 8' ' ' ILE . 66.6 m -121.55 98.6 6.04 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.262 -0.899 . . . . 10.0 108.864 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.793 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -132.8 98.06 16.51 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.334 -0.854 . . . . 10.0 111.093 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.513 ' HA ' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_endo -90.31 111.39 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.704 1.371 . . . . 10.0 110.25 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 43' ' ' THR . 14.0 m -142.27 102.81 4.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 10.0 111.151 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.557 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 7.5 p-10 -170.84 132.09 0.87 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.486 -0.759 . . . . 10.0 110.488 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.49 100.02 2.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 10.0 112.389 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 42' ' ' VAL . 27.2 tt0 -173.01 123.65 0.42 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.592 -0.693 . . . . 10.0 109.217 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.615 ' C ' ' HB2' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -163.72 151.13 12.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.538 -1.352 . . . . 10.0 111.639 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.573 ' N ' ' HB2' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -136.48 104.3 5.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.083 -1.011 . . . . 10.0 110.584 179.163 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 1.121 HG22 ' CD1' ' A' ' 37' ' ' PHE . 31.7 mm -50.84 106.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.998 -1.064 . . . . 10.0 112.769 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.706 ' C ' ' HA ' ' A' ' 37' ' ' PHE . 55.4 m170 -102.75 116.45 32.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.019 . . . . 10.0 111.096 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.743 ' HA ' ' N ' ' A' ' 37' ' ' PHE . 3.1 p -87.55 149.09 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.219 -0.926 . . . . 10.0 113.461 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' A' ' 59' ' ' ALA . . . -143.47 -65.65 0.02 OUTLIER Glycine 0 CA--C 1.538 1.491 0 C-N-CA 119.791 -1.195 . . . . 10.0 112.137 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.798 ' HB3' HG21 ' B' ' 25' ' ' VAL . 5.6 t80 -177.32 126.94 0.15 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 120.674 -1.486 . . . . 10.0 109.227 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.42 ' C ' ' O ' ' B' ' 22' ' ' PHE . 9.4 m-20 -38.47 148.27 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.853 0.835 . . . . 10.0 111.471 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' OE2' ' B' ' 28' ' ' GLU . . . 52.87 31.35 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.37 0.507 . . . . 10.0 112.37 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.798 HG21 ' HB3' ' B' ' 22' ' ' PHE . 9.8 t -109.63 -31.56 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 5.4 t -94.21 -0.61 55.04 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.593 0.711 . . . . 10.0 109.145 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.724 ' HA2' ' HB ' ' A' ' 21' ' ' ILE . . . -114.28 2.9 23.78 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.738 -1.22 . . . . 10.0 110.159 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.64 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 1.7 pm0 -178.12 -158.69 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.982 -1.305 . . . . 10.0 110.602 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.59 ' HB2' HG11 ' A' ' 14' ' ' VAL . 1.2 t80 -131.39 135.29 47.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.72 0.772 . . . . 10.0 109.508 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.664 HG22 ' CD2' ' A' ' 28' ' ' PHE . 15.0 p -151.01 -64.32 0.19 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.461 -0.774 . . . . 10.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.528 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -70.86 171.13 45.62 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.116 -1.193 . . . . 10.0 110.116 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 15.8 mm -125.72 47.79 2.45 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.904 . . . . 10.0 110.198 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 45.7 Cg_endo -71.01 171.97 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.977 1.514 . . . . 10.0 110.385 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' B' ' 35' ' ' GLN . 1.8 tp10 -50.57 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 10.0 109.73 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -81.62 19.11 1.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.195 -0.94 . . . . 10.0 109.45 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.65 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 37.1 m0 71.1 39.38 0.98 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -172.34 74.06 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 113.386 -1.734 . . . . 10.0 106.887 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.411 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 6.7 mtm180 . . . . . 0 C--N 1.302 -1.489 0 N-CA-C 107.238 -1.393 . . . . 10.0 107.238 179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.178 0.513 . . . . 10.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.702 HE21 HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -164.72 25.36 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.163 -0.961 . . . . 10.0 109.453 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.571 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 30.2 m -89.47 127.01 35.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.581 -0.699 . . . . 10.0 110.303 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.39 136.2 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.281 -0.968 . . . . 10.0 110.266 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.6 mtpt -124.53 98.95 5.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 10.0 109.595 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.37 99.83 9.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.895 -1.128 . . . . 10.0 110.764 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 75' ' ' THR . 61.7 t -134.29 144.48 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 10.0 109.442 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.779 HG11 ' HB3' ' B' ' 35' ' ' GLN . 94.4 t -59.67 166.04 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 10.0 110.925 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.937 ' C ' ' HB3' ' B' ' 37' ' ' ALA . 3.4 t -112.39 -174.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.426 -0.797 . . . . 10.0 109.348 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.711 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -63.39 -144.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.014 -1.089 . . . . 10.0 110.417 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . 0.632 ' OD2' HG23 ' A' ' 80' ' ' VAL . 5.9 m-20 62.24 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.416 -1.049 . . . . 10.0 109.951 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 112.14 54.16 0.49 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.029 -1.228 . . . . 10.0 110.029 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -175.94 68.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -1.22 . . . . 10.0 110.559 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 14' ' ' VAL . 10.9 p -179.1 58.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 10.0 109.715 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -103.95 88.28 0.61 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.832 -1.307 . . . . 10.0 109.832 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.647 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.13 -31.56 63.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.795 -1.415 . . . . 10.0 110.7 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.428 ' HB ' ' OD2' ' A' ' 57' ' ' ASP . 11.3 m -62.47 -41.32 98.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 10.0 111.481 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 26' ' ' THR . 17.8 m -95.07 -15.47 23.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.748 -1.22 . . . . 10.0 110.449 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.903 HD11 ' CB ' ' B' ' 29' ' ' PHE . 4.6 mm? -93.02 -34.79 13.57 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.145 -0.972 . . . . 10.0 109.808 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.58 -37.18 77.82 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.647 -1.983 . . . . 10.0 105.647 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 26' ' ' THR 0.266 0.4 OUTLIER -63.41 -50.19 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.328 -1.36 . . . . 10.0 107.328 176.34 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.713 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 23.8 m -49.05 -49.72 39.99 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.869 ' CD2' HD11 ' A' ' 165' ' ' LEU . 33.9 m-85 -72.96 -29.34 63.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.959 -1.088 . . . . 10.0 110.442 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -65.32 -50.37 65.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 10.0 109.396 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 26' ' ' ASN . 10.2 t -169.6 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.253 -0.979 . . . . 10.0 111.095 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.536 ' HB3' ' CG2' ' A' ' 21' ' ' ILE . 35.8 t-20 -61.15 -20.46 62.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 10.0 111.473 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.713 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 26.13 -134.02 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.873 -0.517 . . . . 10.0 111.994 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' B' ' 30' ' ' THR . 6.1 t80 . . . . . 0 N--CA 1.496 1.842 0 O-C-N 121.02 -1.05 . . . . 10.0 112.924 -178.537 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.436 ' C ' ' HB ' ' B' ' 26' ' ' THR . 46.7 p . . . . . 0 N--CA 1.495 1.809 0 CA-C-O 122.38 1.086 . . . . 10.0 113.47 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.998 HG12 ' HB2' ' A' ' 59' ' ' ALA 0.256 6.9 t -70.6 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-N 115.296 -0.865 . . . . 10.0 110.311 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.733 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -33.45 129.42 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.572 0.701 . . . . 10.0 110.957 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 10.0 t70 -138.96 83.45 1.95 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' B' ' 18' ' ' ILE . 7.4 t-20 -88.42 98.45 11.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -0.932 . . . . 10.0 110.511 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.679 ' HA ' ' H ' ' B' ' 16' ' ' HIS . 19.6 m-85 -127.69 116.03 19.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.222 -0.923 . . . . 10.0 109.453 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.948 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -133.69 100.34 4.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.05 -1.031 . . . . 10.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 41' ' ' ALA . 3.1 t -167.33 -166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 51' ' ' TYR . 52.0 m -137.15 161.65 35.56 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 119.452 -2.03 . . . . 10.0 113.636 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.812 HG22 ' HB2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -105.25 -176.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.765 -0.585 . . . . 10.0 110.59 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.607 ' O ' ' O ' ' B' ' 10' ' ' LEU . 27.5 mtp -139.74 96.56 3.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.937 -1.105 . . . . 10.0 108.836 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 11.6 mt -102.43 131.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.783 -0.573 . . . . 10.0 111.146 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 8' ' ' ILE . . . 38.2 27.81 0.04 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.346 -1.102 . . . . 10.0 110.346 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 98.97 -16.85 58.96 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.958 -1.319 . . . . 10.0 110.652 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -101.74 108.59 56.61 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.283 . . . . 10.0 110.153 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 42.8 Cg_endo -73.63 156.58 49.17 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.063 1.559 . . . . 10.0 111.668 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.812 ' HB2' HG22 ' A' ' 44' ' ' VAL . 1.9 m-85 -105.95 113.96 27.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.034 . . . . 10.0 112.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.869 ' O ' HG22 ' A' ' 4' ' ' ILE 0.271 98.2 m -75.82 110.07 9.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 10.0 109.459 178.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.7 pp -149.32 173.25 13.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 10.0 112.857 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.432 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.54 118.02 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.688 -2.165 . . . . 10.0 107.688 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.6 pp -129.25 149.55 51.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.728 -1.454 . . . . 10.0 111.332 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.514 ' CD2' ' C ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -172.16 129.38 0.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 10.0 110.088 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD2' ' HB ' ' A' ' 17' ' ' THR . 1.3 m-20 -102.62 158.3 16.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.059 -1.026 . . . . 10.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 13.9 t -43.55 147.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.011 . . . . 10.0 109.68 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . 177.57 -72.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.783 . . . . 10.0 112.144 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 45.38 52.62 8.59 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.154 -1.979 . . . . 10.0 108.154 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 20' ' ' VAL . 16.4 mm-40 60.77 40.56 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.679 -0.895 . . . . 10.0 109.869 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.643 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.3 OUTLIER 174.24 -70.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 10.0 111.092 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 169.14 44.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.897 -1.127 . . . . 10.0 110.314 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -148.94 -49.93 0.15 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.84 . . . . 10.0 109.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 69.45 80.86 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.681 0.753 . . . . 10.0 109.825 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 26.6 ttp180 -52.32 -26.81 13.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.642 -0.661 . . . . 10.0 110.371 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.547 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -86.03 -0.62 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 10.0 110.276 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.744 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -110.85 13.24 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 -178.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -60.99 126.64 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 N-CA-C 108.613 -1.341 . . . . 10.0 108.613 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.2 OUTLIER -113.62 -77.38 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 10.0 111.874 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.511 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 19.5 m 61.31 34.39 18.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.148 -0.97 . . . . 10.0 108.482 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.09 131.44 6.44 Favored Pre-proline 0 N--CA 1.487 1.399 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.673 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.31 79.85 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.719 1.378 . . . . 10.0 110.03 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -131.06 60.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 10.0 110.242 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 ' HB ' ' A' ' 7' ' ' VAL . 9.9 m -144.47 96.91 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.143 -0.973 . . . . 10.0 109.435 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 108' ' ' THR . 84.8 m-20 -38.52 -27.86 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.947 -0.47 . . . . 10.0 111.198 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.797 HG11 ' HB2' ' A' ' 176' ' ' ALA . 17.7 m -130.38 116.73 37.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.717 -1.239 . . . . 10.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-85 -109.2 130.87 55.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.477 -0.764 . . . . 10.0 108.997 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.906 HD12 ' CE1' ' A' ' 169' ' ' PHE . 2.5 mm? -103.21 96.94 7.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.091 . . . . 10.0 109.08 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.632 HG23 ' OD2' ' A' ' 11' ' ' ASP . 14.8 p -108.8 143.7 18.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.662 -0.649 . . . . 10.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.458 ' C ' ' OG1' ' A' ' 115' ' ' THR . 53.7 t -133.75 129.71 37.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.259 -0.976 . . . . 10.0 110.569 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 24.2 p90 -137.15 178.0 7.43 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.387 -0.82 . . . . 10.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.7 p -76.68 162.54 27.64 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.126 -0.984 . . . . 10.0 111.556 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.963 HG23 HG13 ' A' ' 85' ' ' VAL . 28.4 m -112.96 -1.5 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 121.325 -0.86 . . . . 10.0 111.69 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.963 HG13 HG23 ' A' ' 84' ' ' VAL . 14.5 m -128.88 38.05 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.849 -1.157 . . . . 10.0 111.468 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.556 ' N ' HD23 ' A' ' 129' ' ' LEU . 59.8 m -95.97 149.23 35.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.057 -1.027 . . . . 10.0 108.964 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 41.0 Cg_endo -67.49 113.04 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.632 1.333 . . . . 10.0 110.382 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.5 m 54.5 64.13 1.92 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 10.0 109.987 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 86' ' ' SER . 22.1 p -116.55 -60.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 10.0 110.949 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 9.4 t80 -59.96 -38.87 83.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.011 -1.055 . . . . 10.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.48 -17.63 64.9 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.844 -1.16 . . . . 10.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.589 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -77.62 -21.62 52.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 10.0 110.353 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.589 HG13 ' ND2' ' A' ' 92' ' ' ASN . 2.2 m -89.72 -5.09 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.591 -1.243 . . . . 10.0 109.414 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 90' ' ' PHE . 12.9 mmtt -94.49 -32.72 13.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.137 -0.977 . . . . 10.0 108.391 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 3.6 pt-20 -77.64 -10.85 59.74 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.021 -0.672 . . . . 10.0 109.221 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -112.35 -50.53 2.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 10.0 111.852 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.492 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 60.6 m95 -69.39 -47.11 65.21 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.564 -0.71 . . . . 10.0 112.256 -178.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 98.9 t -55.93 -49.28 93.92 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.49 -1.381 . . . . 10.0 110.331 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.4 Cg_endo -72.86 -12.92 26.55 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.257 1.135 . . . . 10.0 110.643 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.49 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -68.69 -36.68 78.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 10.0 110.601 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 104' ' ' HIS . 78.6 mt 55.11 85.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.206 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.9 m -39.37 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.681 0.753 . . . . 10.0 110.114 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.691 ' N ' HG22 ' A' ' 102' ' ' THR . 6.0 m170 -109.87 -2.98 16.91 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.5 -0.75 . . . . 10.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.706 ' HA ' HG23 ' A' ' 101' ' ' ILE . 66.2 t60 80.37 16.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.622 0.725 . . . . 10.0 109.494 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.603 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.8 OUTLIER -150.76 -65.81 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.808 -0.757 . . . . 10.0 111.44 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 41.6 Cg_endo -68.81 -31.3 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.51 1.268 . . . . 10.0 111.892 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 42.31 63.12 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.367 1.079 . . . . 10.0 108.485 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 76' ' ' ASP . 8.7 t -44.91 141.46 3.03 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.674 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 43.1 Cg_endo -69.99 163.39 38.65 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.286 1.677 . . . . 10.0 112.068 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.5 m-85 -127.13 114.69 18.04 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.698 -0.626 . . . . 10.0 109.701 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.027 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -73.95 92.59 2.12 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 15.8 mt -69.33 139.33 54.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.732 -0.605 . . . . 10.0 109.372 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -144.98 -179.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.965 -1.085 . . . . 10.0 111.41 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -118.49 125.14 6.3 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.681 HG22 ' HG2' ' A' ' 116' ' ' GLN . 52.9 m -92.42 140.83 29.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.971 -1.311 . . . . 10.0 111.36 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 115' ' ' THR . 6.9 mm100 40.14 57.44 2.4 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.196 -0.602 . . . . 10.0 109.754 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.008 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -76.87 -29.21 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.29 -0.964 . . . . 10.0 110.103 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.839 ' O ' HD23 ' A' ' 119' ' ' LEU . 44.2 t0 -51.73 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.459 0.647 . . . . 10.0 111.85 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER 147.33 -30.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 CA-C-N 114.858 -1.064 . . . . 10.0 108.572 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.694 ' HG3' HG22 ' A' ' 85' ' ' VAL . 15.2 tpp180 -55.51 -31.35 61.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.778 -0.577 . . . . 10.0 110.315 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -86.88 4.93 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 10.0 111.044 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.825 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -82.29 165.74 40.86 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 10.0 110.403 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 54.9 Cg_endo -79.2 23.38 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.074 1.565 . . . . 10.0 111.086 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 t -108.45 -50.14 3.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.92 -1.112 . . . . 10.0 110.278 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.66 HG21 ' HA ' ' A' ' 120' ' ' ARG . 14.5 t -79.06 -28.09 43.14 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.779 -1.934 . . . . 10.0 105.779 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 122' ' ' ASP 0.289 1.4 mp -59.82 -22.59 24.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 20.1 tt0 -48.89 -33.66 11.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.49 0.662 . . . . 10.0 109.864 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.36 -49.05 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.661 -0.649 . . . . 10.0 110.775 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.836 HD23 ' C ' ' A' ' 85' ' ' VAL . 1.3 tm? -49.87 -50.48 45.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 10.0 110.963 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -55.82 -49.94 71.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.201 -0.937 . . . . 10.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 17.9 mttt -60.01 -22.49 62.67 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.612 -0.68 . . . . 10.0 110.027 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.492 ' CB ' ' HB3' ' A' ' 87' ' ' PRO . 23.0 t-20 -99.68 -62.46 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.934 -1.104 . . . . 10.0 111.337 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -109.69 -0.36 18.59 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.365 -0.835 . . . . 10.0 111.494 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER 64.13 -44.52 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.707 . . . . 10.0 112.334 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.531 ' HD2' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -113.99 128.71 25.49 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 120.94 -1.1 . . . . 10.0 111.087 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.1 161.65 44.07 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.877 1.462 . . . . 10.0 110.527 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 84' ' ' VAL . 4.1 tp -95.36 133.19 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.921 -1.112 . . . . 10.0 109.506 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.6 p -123.8 179.17 1.12 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 10.0 109.399 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 44.2 Cg_endo -73.52 -26.64 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.228 1.12 . . . . 10.0 110.421 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -66.87 -47.9 70.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 10.0 110.413 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.1 m -74.65 -39.75 61.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.504 -0.747 . . . . 10.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.51 -35.67 77.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 10.0 110.663 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -51.41 -39.74 57.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.351 -0.843 . . . . 10.0 109.955 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -49.21 78.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.333 -0.854 . . . . 10.0 110.422 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.532 ' CD2' HD22 ' A' ' 149' ' ' LEU . 7.7 tt -58.61 -33.17 69.71 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.013 -1.055 . . . . 10.0 109.644 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.836 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -71.32 -48.18 52.03 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.889 0.852 . . . . 10.0 109.471 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -63.46 -26.92 68.95 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.303 -0.559 . . . . 10.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB3' HD13 ' A' ' 149' ' ' LEU . 20.4 t0 -79.61 -40.25 29.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 10.0 110.659 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.3 mp -91.47 20.83 4.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 10.0 109.125 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' HD2' ' A' ' 107' ' ' LYS . 4.8 mtpt 57.03 20.6 5.57 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.935 0.874 . . . . 10.0 109.41 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -69.36 -174.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.027 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.2 p -91.59 -72.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.826 -1.172 . . . . 10.0 111.578 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.915 ' H ' HG13 ' A' ' 152' ' ' VAL . 5.4 tttt -173.86 173.46 3.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.217 -1.552 . . . . 10.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.934 ' OH ' HG12 ' A' ' 84' ' ' VAL . 18.6 t80 -112.26 104.44 12.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 10.0 109.448 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.835 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -109.17 -168.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 10.0 110.405 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 155' ' ' VAL . 67.3 mt-10 -152.51 135.57 15.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.784 -1.198 . . . . 10.0 111.164 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.505 ' SG ' HG11 ' A' ' 113' ' ' VAL . 28.1 p -152.4 172.74 16.03 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.722 0.773 . . . . 10.0 109.563 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.584 ' HB3' ' CB ' ' A' ' 162' ' ' GLN . 34.0 t -140.9 175.17 9.83 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -73.22 -54.62 7.98 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.409 -0.807 . . . . 10.0 111.97 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 1.131 HD13 ' N ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -129.23 -22.54 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.736 -1.227 . . . . 10.0 113.39 -178.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 1.131 ' N ' HD13 ' A' ' 160' ' ' LEU . 10.0 t -90.47 -51.87 5.19 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.312 -1.492 . . . . 10.0 113.637 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.602 ' N ' HG23 ' A' ' 161' ' ' THR . 6.7 tp60 -59.76 -63.21 1.38 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.308 -1.495 . . . . 10.0 111.696 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 28.4 ttpt 79.47 34.67 0.18 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.513 0.673 . . . . 10.0 109.383 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -118.19 20.64 10.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.886 -1.686 . . . . 10.0 108.886 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.869 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -78.04 4.96 10.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -1.091 . . . . 10.0 110.652 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -93.78 -44.15 8.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.037 -1.039 . . . . 10.0 110.085 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.44 -31.44 72.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 10.0 110.142 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.835 HG22 ' HB ' ' A' ' 155' ' ' VAL . 14.5 t -65.09 -49.23 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.27 -0.894 . . . . 10.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE1' HD12 ' A' ' 79' ' ' LEU . 9.0 m-85 -76.82 -23.65 52.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.389 -0.82 . . . . 10.0 111.302 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.37 -50.3 60.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.896 -1.127 . . . . 10.0 111.766 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 153' ' ' LYS . 20.0 pt-20 -61.23 -24.59 66.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 10.0 109.825 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.654 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -67.53 -26.54 66.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.244 -0.982 . . . . 10.0 109.045 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.538 ' O ' HD11 ' A' ' 177' ' ' LEU . 34.2 mm -60.18 -45.54 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 10.0 110.179 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.855 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -74.36 -38.14 63.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 10.0 109.642 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -78.56 -6.59 55.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.489 -0.757 . . . . 10.0 109.712 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.797 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.76 -38.15 47.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 10.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.702 HD23 HE21 ' A' ' 2' ' ' GLN . 0.4 OUTLIER -76.51 -34.79 58.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 10.0 110.286 -178.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.893 -1.051 . . . . 10.0 110.159 179.884 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 108.977 -1.649 . . . . 10.0 108.977 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.506 ' O ' ' N ' ' B' ' 4' ' ' GLU . 13.8 m -111.3 44.9 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -1.112 . . . . 10.0 111.211 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 10.0 109.305 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' B' ' 6' ' ' PRO . 2.2 mm-40 -92.16 144.48 25.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.856 -1.152 . . . . 10.0 110.116 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.32 -41.74 14.36 Favored Pre-proline 0 C--N 1.292 -1.909 0 O-C-N 121.724 -0.61 . . . . 10.0 110.645 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 43.3 Cg_endo -89.39 57.78 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.746 1.393 . . . . 10.0 112.418 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.451 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -97.78 160.72 14.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.69 -1.256 . . . . 10.0 108.327 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.53 ' CG1' ' HA2' ' A' ' 47' ' ' GLY . 5.8 pt -80.39 -117.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.879 -1.138 . . . . 10.0 109.376 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -147.58 104.05 3.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.69 -1.256 . . . . 10.0 109.628 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 45' ' ' MET . 14.2 tp -143.65 97.13 5.52 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 118.957 -1.097 . . . . 10.0 112.092 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -101.37 98.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.166 1.911 . . . . 10.0 108.685 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.4 m -148.5 99.59 3.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.248 -1.532 . . . . 10.0 112.895 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.768 ' HB3' ' CA ' ' A' ' 44' ' ' VAL . 5.0 p-10 -143.17 153.44 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.984 0.897 . . . . 10.0 112.153 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.742 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 53.6 m-85 -110.37 -172.25 2.0 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.694 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -174.88 -170.5 0.47 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 10.0 110.562 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.679 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 22.8 m170 -104.52 168.98 8.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 6.7 t -151.5 146.22 25.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.583 -1.323 . . . . 10.0 111.805 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 37' ' ' PHE . 1.6 pp -149.18 179.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.358 -0.979 . . . . 10.0 108.358 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -134.5 159.27 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 10.0 112.496 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 36' ' ' VAL . 54.2 t -104.74 153.34 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.564 0.697 . . . . 10.0 112.394 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.5 63.95 0.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.661 -1.776 . . . . 10.0 108.661 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.83 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -170.57 100.74 0.25 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.452 -1.028 . . . . 10.0 109.371 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 25' ' ' VAL . 11.9 t70 -53.09 150.07 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.822 0.82 . . . . 10.0 111.968 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 39.21 51.31 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.865 -0.522 . . . . 10.0 112.254 179.394 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.904 HG12 ' CG2' ' A' ' 36' ' ' VAL . 38.9 t -111.77 -25.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.784 -1.198 . . . . 10.0 108.487 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.628 HG23 HG21 ' A' ' 21' ' ' ILE . 11.3 t -70.64 -20.66 62.71 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.29 53.45 0.74 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 106.902 -2.479 . . . . 10.0 106.902 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.25 58.02 1.69 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.681 -0.893 . . . . 10.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 19' ' ' LEU . 20.4 t80 -85.78 133.17 34.0 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-O 122.059 0.933 . . . . 10.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 19.2 p -146.9 -178.83 6.4 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.08 81.13 0.04 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.59 -1.804 . . . . 10.0 108.59 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.7 HG23 ' HD2' ' B' ' 33' ' ' PRO . 90.2 mt -111.67 145.5 32.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.366 -1.079 . . . . 10.0 111.474 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.0 Cg_endo -69.91 178.59 4.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.933 1.755 . . . . 10.0 110.462 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' B' ' 38' ' ' ARG . 34.3 tt0 -8.0 131.07 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.518 0.932 . . . . 10.0 113.518 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.779 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -83.4 -70.52 0.56 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.641 0.734 . . . . 10.0 109.862 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.615 ' CG ' ' HB ' ' A' ' 58' ' ' THR . 0.2 OUTLIER -172.99 24.64 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.912 -0.715 . . . . 10.0 111.58 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.937 ' HB3' ' C ' ' A' ' 9' ' ' VAL . . . -127.36 -28.62 2.79 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.495 -0.753 . . . . 10.0 109.552 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.532 ' HB3' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.328 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 177.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.11 0.481 . . . . 10.0 109.91 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.904 ' O ' HG21 ' A' ' 52' ' ' THR . 0.0 OUTLIER 68.7 79.17 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.891 0.853 . . . . 10.0 109.278 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 3' ' ' THR . 1.2 m -175.95 78.56 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.984 HD13 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -115.24 121.51 67.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.764 -1.21 . . . . 10.0 110.615 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 1.082 ' O ' HG23 ' A' ' 75' ' ' THR . 62.0 mttt -128.93 112.66 14.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 55' ' ' LEU . 26.4 p -94.67 141.29 28.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.058 -1.057 . . . . 10.0 110.444 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 9' ' ' VAL . 57.9 t -144.72 152.26 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.565 -0.709 . . . . 10.0 109.224 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.846 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 35.0 m -65.84 102.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.204 -0.935 . . . . 10.0 111.309 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 78' ' ' PHE . 21.3 t -109.53 177.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.213 -0.93 . . . . 10.0 109.143 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.777 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 151.74 166.99 14.51 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.502 -1.332 . . . . 10.0 110.062 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -47.79 -27.63 2.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.304 -1.116 . . . . 10.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 140.83 43.72 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.699 -1.36 . . . . 10.0 109.699 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.8 -114.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.343 -1.092 . . . . 10.0 109.687 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.825 HG21 ' H ' ' B' ' 30' ' ' THR . 80.0 t -113.89 -92.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.736 -1.227 . . . . 10.0 110.657 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.529 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 170.14 144.65 4.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.927 -1.269 . . . . 10.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.14 -23.17 61.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.977 . . . . 10.0 111.77 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.698 HG21 ' OD2' ' A' ' 57' ' ' ASP . 16.6 m -62.66 -50.27 71.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.938 -1.101 . . . . 10.0 112.03 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.58 ' HB3' ' CB ' ' A' ' 35' ' ' THR . 31.3 p -78.59 8.77 4.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.46 -1.4 . . . . 10.0 110.3 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -88.0 -28.01 21.69 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.553 -1.342 . . . . 10.0 107.622 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -69.65 -34.19 73.65 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.82 HG13 HG23 ' B' ' 26' ' ' THR . 6.7 mm -75.25 -48.18 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' LYS . 26.9 t -54.29 -43.08 70.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.622 ' CG ' ' HB2' ' A' ' 162' ' ' GLN . 74.8 t80 -77.78 -0.94 29.0 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.743 -1.223 . . . . 10.0 109.442 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 22.2 m -112.09 -49.1 2.99 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.85 -84.66 0.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.011 -1.681 . . . . 10.0 114.032 -176.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.676 ' H ' HG23 ' A' ' 25' ' ' THR . 2.8 m-20 -67.32 -33.49 75.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 10.0 112.033 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER 59.96 -144.71 0.52 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.048 -1.061 . . . . 10.0 110.082 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.525 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.4 t80 . . . . . 0 N--CA 1.491 1.579 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.058 179.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.655 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 3.7 t . . . . . 0 N--CA 1.496 1.826 0 CA-C-O 120.853 0.359 . . . . 10.0 110.29 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 t -148.45 -114.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.836 -1.165 . . . . 10.0 110.554 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.751 ' C ' HG12 ' B' ' 20' ' ' VAL . 4.4 t80 -102.26 105.87 16.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.831 -1.168 . . . . 10.0 111.928 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -128.0 93.08 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.311 -0.868 . . . . 10.0 109.433 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 36.0 t-20 -91.27 98.75 11.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.405 -1.318 . . . . 10.0 110.399 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CB ' HD12 ' A' ' 55' ' ' LEU . 16.5 t80 -107.36 126.92 53.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -153.88 112.88 3.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.807 -1.183 . . . . 10.0 110.454 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 43' ' ' THR . 22.2 t -131.12 172.39 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.779 -0.768 . . . . 10.0 109.724 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.541 ' N ' HG12 ' A' ' 42' ' ' VAL . 63.8 m -135.66 148.97 49.15 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.31 -0.956 . . . . 10.0 110.388 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.635 HG13 HD12 ' A' ' 46' ' ' ILE . 1.1 t -118.88 174.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 3.8 mtt -149.96 120.67 7.54 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.546 -0.862 . . . . 10.0 109.956 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HG13 ' A' ' 44' ' ' VAL . 1.4 mp -134.64 126.75 48.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.305 -0.998 . . . . 10.0 108.305 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 48.08 31.09 8.0 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.271 -1.532 . . . . 10.0 109.271 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.19 31.52 31.18 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.099 -1.236 . . . . 10.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -119.68 115.77 33.54 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.846 -1.384 . . . . 10.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 52.7 Cg_endo -76.91 141.54 21.44 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.859 1.452 . . . . 10.0 111.193 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.93 ' OH ' HG23 ' A' ' 173' ' ' ILE . 0.5 OUTLIER -103.45 112.56 25.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 10.0 110.305 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 2' ' ' GLN . 27.5 p -78.05 100.28 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 10.0 110.186 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 22.3 mt -117.58 140.32 49.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.666 -1.271 . . . . 10.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.54 130.23 2.28 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.219 -1.552 . . . . 10.0 109.219 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -137.99 132.29 32.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 10.0 108.863 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.974 ' N ' HD22 ' A' ' 55' ' ' LEU . 50.8 p90 -157.26 148.98 22.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 10.0 112.4 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.698 ' OD2' HG21 ' A' ' 17' ' ' THR . 23.7 m-20 -124.05 -169.37 1.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.835 -0.54 . . . . 10.0 110.455 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -45.85 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.25 1.024 . . . . 10.0 112.532 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -157.24 42.17 0.33 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.723 -1.236 . . . . 10.0 109.851 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -47.63 -27.45 4.48 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.422 -2.271 . . . . 10.0 107.422 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.61 ' CG ' ' HA3' ' B' ' 21' ' ' GLY . 2.4 tp60 -73.34 -55.85 5.85 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.855 -0.791 . . . . 10.0 109.259 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.846 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 5.3 mm-40 -59.88 -40.71 89.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.086 -1.046 . . . . 10.0 110.131 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 7.5 t70 75.61 38.85 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.008 0.908 . . . . 10.0 108.588 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -151.96 5.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.943 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.691 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 19.1 t70 -115.17 25.56 10.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.692 -1.255 . . . . 10.0 111.131 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.944 ' O ' HD11 ' A' ' 70' ' ' LEU . 60.3 mtm180 -83.94 -25.44 30.11 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.096 -1.002 . . . . 10.0 109.364 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.986 ' C ' HD21 ' A' ' 70' ' ' LEU . 20.8 mt -111.41 10.34 21.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.558 -0.714 . . . . 10.0 110.35 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.583 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -102.17 -41.91 0.21 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 114.038 1.125 . . . . 10.0 114.038 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 41.4 Cg_endo -69.4 -42.71 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.842 0.917 . . . . 10.0 111.727 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.986 HD21 ' C ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -48.85 -19.84 0.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.21 -0.931 . . . . 10.0 109.695 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 14.2 m -126.83 51.33 1.87 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.538 -0.726 . . . . 10.0 110.059 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.578 ' O ' ' CD1' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -109.68 75.66 0.83 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.215 -0.928 . . . . 10.0 111.987 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 52.2 Cg_endo -77.31 -0.88 11.04 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.957 1.503 . . . . 10.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -81.56 49.69 1.36 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.954 -1.091 . . . . 10.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 1.082 HG23 ' O ' ' A' ' 5' ' ' LYS . 82.3 m -142.0 84.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.443 -0.785 . . . . 10.0 110.296 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 5.2 m-20 -55.09 -22.63 17.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 10.0 109.979 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 4' ' ' ILE . 2.5 m -118.65 116.75 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 9' ' ' VAL . 87.4 m-85 -107.03 144.47 33.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 10.0 110.137 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.714 HD11 HG12 ' A' ' 168' ' ' VAL . 1.9 mm? -103.46 97.81 7.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.994 . . . . 10.0 108.866 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.777 HG23 ' HA2' ' A' ' 10' ' ' GLY . 4.7 p -98.78 130.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.581 -0.699 . . . . 10.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 28.2 p -133.61 115.09 14.25 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.126 -0.984 . . . . 10.0 110.731 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 80' ' ' VAL . 94.6 m-85 -97.21 157.77 15.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.584 -0.697 . . . . 10.0 110.967 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' THR . 57.1 m -85.13 157.06 20.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.427 -0.796 . . . . 10.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 84' ' ' VAL . 30.4 m -60.71 -10.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.403 -0.81 . . . . 10.0 110.769 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 HD22 ' A' ' 129' ' ' LEU . 8.6 m -134.54 -53.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 10.0 110.116 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 44.9 -172.82 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.029 -1.044 . . . . 10.0 111.987 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 53.7 Cg_endo -82.6 41.17 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.194 1.628 . . . . 10.0 111.468 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 133' ' ' LYS . 3.5 m 39.78 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 10.0 110.795 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.537 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 3.4 t -175.63 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.839 -1.163 . . . . 10.0 111.649 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.745 ' CE2' HD13 ' A' ' 145' ' ' LEU . 27.2 t80 -90.66 -23.94 20.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.794 -1.191 . . . . 10.0 109.466 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -22.75 28.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.179 -0.951 . . . . 10.0 108.855 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -83.37 -13.98 53.78 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.258 -0.977 . . . . 10.0 110.151 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' HD3' ' A' ' 94' ' ' LYS . 1.6 m -87.72 -16.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 118.162 -1.415 . . . . 10.0 109.28 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.922 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -81.66 -41.54 21.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 10.0 109.271 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -76.85 -4.62 44.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.993 -0.683 . . . . 10.0 109.172 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -111.72 -47.51 3.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.05 -1.031 . . . . 10.0 111.688 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 8.0 m0 -77.24 -49.09 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 10.0 112.318 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 149' ' ' LEU . 4.6 t -65.67 -46.59 67.46 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.687 -1.258 . . . . 10.0 112.814 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 39.1 Cg_endo -69.09 -12.79 35.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 N-CA-C 109.338 -1.062 . . . . 10.0 109.338 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.629 ' C ' HG22 ' A' ' 101' ' ' ILE . 1.9 mt-10 -89.36 -58.95 2.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 10.0 109.569 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 ' C ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER 161.18 80.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 10.0 108.798 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.857 HG21 ' HB ' ' A' ' 108' ' ' THR . 2.5 m -48.1 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 10.0 109.744 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.708 ' N ' HG22 ' A' ' 102' ' ' THR . 46.0 t-80 -105.38 -22.45 13.03 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.49 ' CE1' ' HG ' ' A' ' 105' ' ' CYS . 5.5 p80 178.31 -33.49 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.49 ' HG ' ' CE1' ' A' ' 104' ' ' HIS . 4.8 p -144.66 160.04 48.9 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HB3' HG12 ' A' ' 98' ' ' VAL . 43.8 Cg_endo -72.4 84.56 1.16 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.645 1.339 . . . . 10.0 109.743 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 176.02 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.405 -0.809 . . . . 10.0 111.363 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.857 ' HB ' HG21 ' A' ' 102' ' ' THR . 99.8 m -51.66 150.98 6.35 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 10.0 110.31 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 108' ' ' THR . 37.6 Cg_endo -63.59 110.21 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.865 1.455 . . . . 10.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.13 100.24 8.94 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.27 0.557 . . . . 10.0 109.631 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.927 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 1.6 mm? -78.37 97.92 5.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 146' ' ' ALA . 64.5 mt -78.23 154.48 31.0 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.793 -0.567 . . . . 10.0 109.836 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 114' ' ' GLY . 6.3 t -156.53 175.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.96 -1.087 . . . . 10.0 111.31 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.577 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -124.3 96.79 0.53 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 116' ' ' GLN . 1.3 m -95.16 170.97 9.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -1.086 . . . . 10.0 110.947 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.535 ' N ' ' CG2' ' A' ' 115' ' ' THR . 36.6 tp60 57.94 38.12 26.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.48 -0.762 . . . . 10.0 110.831 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.042 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -95.35 -36.67 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 178.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.7 p-10 -52.13 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.554 1.169 . . . . 10.0 110.352 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.752 ' N ' ' O ' ' A' ' 117' ' ' ILE . 13.0 tp 159.25 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.187 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -45.72 -42.48 11.84 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' ARG . 3.8 m-20 -45.94 -25.73 0.59 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.433 -0.907 . . . . 10.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.569 ' HB3' HD12 ' A' ' 119' ' ' LEU . 62.7 t0 -94.84 123.17 58.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.668 -0.645 . . . . 10.0 110.759 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.9 Cg_endo -80.76 24.73 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.607 1.538 . . . . 10.0 110.536 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 73.1 m -96.52 -50.46 4.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 10.0 110.366 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.615 ' HB ' HD21 ' A' ' 119' ' ' LEU . 1.6 t -72.8 -33.58 66.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.906 -2.257 . . . . 10.0 104.906 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.667 HD11 ' HD2' ' A' ' 120' ' ' ARG 0.301 0.9 OUTLIER -49.43 -30.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.267 -1.382 . . . . 10.0 107.267 176.573 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -51.65 -43.88 62.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.594 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -75.09 -32.25 61.4 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.538 -0.726 . . . . 10.0 110.054 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.782 HD22 HG23 ' A' ' 85' ' ' VAL . 4.3 mt -77.11 -36.95 55.15 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.272 -0.893 . . . . 10.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.25 -49.42 53.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 10.0 110.267 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -26.51 4.97 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.212 -0.93 . . . . 10.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.79 7.69 9.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.378 -0.929 . . . . 10.0 111.56 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.93 82.69 2.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.802 -1.186 . . . . 10.0 109.838 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.49 -17.95 61.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.847 -1.158 . . . . 10.0 109.424 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 113.44 4.41 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.484 ' HB3' ' HE3' ' A' ' 133' ' ' LYS . 40.5 Cg_endo -68.89 157.12 63.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.907 1.477 . . . . 10.0 110.529 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -103.27 132.03 50.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.358 -0.839 . . . . 10.0 109.738 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.9 p -122.89 167.72 13.8 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.299 -0.876 . . . . 10.0 110.046 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -66.79 -24.82 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 10.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.43 -35.46 77.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 10.0 109.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.6 m -84.81 -31.28 23.95 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.255 0.55 . . . . 10.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.44 -34.14 65.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 10.0 111.53 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -56.16 -43.5 78.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.927 -1.108 . . . . 10.0 109.369 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -63.9 -41.02 97.8 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.495 -0.882 . . . . 10.0 108.681 179.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.919 HD11 ' HG3' ' A' ' 94' ' ' LYS . 3.1 tt -59.87 -50.72 72.68 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.56 -0.712 . . . . 10.0 109.34 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.43 -41.38 80.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.156 -0.965 . . . . 10.0 108.632 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -79.49 -0.15 32.01 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.531 -0.731 . . . . 10.0 109.388 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 15.8 t0 -86.51 -10.53 53.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.582 -0.699 . . . . 10.0 110.476 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.988 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.28 32.11 0.47 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 10.0 111.673 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.3 mttt 62.24 41.2 10.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 10.0 111.649 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -80.31 -163.38 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.739 -0.601 . . . . 10.0 109.538 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.752 HG22 ' CB ' ' A' ' 175' ' ' ALA . 40.3 t -98.04 -79.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.991 . . . . 10.0 109.969 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 6.3 tptp -172.57 165.22 5.57 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.759 -0.776 . . . . 10.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 40.5 p90 -96.33 124.44 40.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.777 . . . . 10.0 109.751 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.884 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -111.86 -169.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.174 -0.954 . . . . 10.0 110.237 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 31.4 mt-10 -130.15 135.18 47.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.147 -0.971 . . . . 10.0 109.789 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.663 ' SG ' HD22 ' A' ' 165' ' ' LEU . 6.5 t -150.9 124.76 9.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.962 -1.086 . . . . 10.0 111.205 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 165' ' ' LEU . 30.0 m -128.39 154.61 45.82 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 177.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 19' ' ' LEU . . . -99.65 -45.85 5.63 Favored 'General case' 0 C--N 1.283 -2.301 0 O-C-N 120.469 -1.395 . . . . 10.0 108.305 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 160' ' ' LEU 0.294 2.7 tm? -61.58 -51.29 69.16 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.751 0.786 . . . . 10.0 109.215 177.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 28.6 m -102.94 -18.79 14.87 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 113.204 0.816 . . . . 10.0 113.204 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 23' ' ' TYR . 1.7 tt0 61.01 75.31 0.42 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.367 -1.458 . . . . 10.0 109.203 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 4.6 tptt -95.08 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.921 -0.711 . . . . 10.0 111.767 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 119.58 31.56 1.34 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.4 -1.381 . . . . 10.0 110.796 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.99 -43.2 73.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.965 -1.314 . . . . 10.0 110.512 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.22 -35.78 58.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 10.0 110.825 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.625 ' C ' HG11 ' A' ' 155' ' ' VAL . 5.2 m120 -60.83 -32.54 71.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.267 -0.896 . . . . 10.0 111.585 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' A' ' 155' ' ' VAL . 34.6 t -64.41 -46.75 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.83 -1.169 . . . . 10.0 110.492 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 12.8 t80 -70.35 -28.03 64.81 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.493 -0.754 . . . . 10.0 111.753 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 19.3 t70 -57.51 -50.02 74.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.771 -1.206 . . . . 10.0 111.992 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.788 ' OE1' HG22 ' A' ' 155' ' ' VAL . 12.7 pt-20 -68.58 -23.9 64.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.903 -1.123 . . . . 10.0 110.814 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.927 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -70.77 -21.16 62.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.016 -1.052 . . . . 10.0 109.05 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.93 HG23 ' OH ' ' A' ' 51' ' ' TYR . 9.8 mm -67.32 -43.34 88.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 10.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -73.13 -42.35 62.97 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.029 -1.044 . . . . 10.0 111.645 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -82.56 -2.58 54.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.323 -0.861 . . . . 10.0 109.944 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -78.47 -43.13 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.302 -0.874 . . . . 10.0 109.704 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.832 HD21 ' HE1' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -107.05 -23.34 12.35 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.746 0.784 . . . . 10.0 110.307 -178.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.988 -1.006 . . . . 10.0 110.354 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.396 -1.481 . . . . 10.0 109.396 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 1.0 OUTLIER 73.23 137.54 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -1.007 . . . . 10.0 111.173 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -98.33 87.1 3.79 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.174 -0.954 . . . . 10.0 109.374 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 49' ' ' GLU . 41.3 mt-10 -119.38 171.3 8.42 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.747 0.784 . . . . 10.0 110.569 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.57 -161.55 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 178.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 40.5 Cg_endo -66.89 80.57 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.305 -1.075 . . . . 10.0 109.305 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.494 ' CB ' ' CG2' ' A' ' 46' ' ' ILE . 10.9 pm0 -45.98 175.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.447 0.641 . . . . 10.0 110.666 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.89 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -135.19 -39.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 10.0 110.621 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.1 t -123.0 151.41 41.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 10.0 110.985 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -167.44 97.83 0.63 Allowed Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 120.716 -1.24 . . . . 10.0 112.801 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 45' ' ' MET . 45.2 Cg_endo -73.91 145.51 36.1 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.668 1.351 . . . . 10.0 109.085 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -97.16 154.91 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.936 -1.103 . . . . 10.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -151.91 136.56 17.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 10.0 109.623 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.56 143.22 50.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 10.0 110.515 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 42.9 tp10 -146.7 147.21 30.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 10.0 109.896 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 19' ' ' HIS . 2.3 t60 -143.17 129.17 19.59 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 10.0 109.93 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -96.06 -167.94 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 10.0 110.468 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.633 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -55.59 179.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 10.0 111.736 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 16' ' ' HIS . 13.2 m80 -122.62 162.65 21.48 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.622 0.725 . . . . 10.0 111.528 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 37' ' ' PHE . 6.4 m -64.49 152.64 8.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.61 ' HA3' ' CG ' ' A' ' 61' ' ' GLN . . . -73.96 151.7 44.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.689 -1.364 . . . . 10.0 109.689 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.062 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 67.61 97.86 0.06 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.415 -1.05 . . . . 10.0 109.326 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 70.8 m-20 -53.76 143.23 21.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 10.0 110.658 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 59.32 31.03 20.84 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.433 -0.792 . . . . 10.0 111.954 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 1.062 HG21 ' CG ' ' B' ' 22' ' ' PHE . 21.4 t -113.7 -17.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.917 -1.114 . . . . 10.0 109.997 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.82 HG23 HG13 ' A' ' 21' ' ' ILE . 10.3 t -83.48 31.73 0.46 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.674 -0.641 . . . . 10.0 110.958 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.789 ' HA3' HG22 ' A' ' 21' ' ' ILE . . . -113.07 -91.64 1.95 Allowed Glycine 0 N--CA 1.488 2.111 0 O-C-N 120.85 -1.156 . . . . 10.0 110.225 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.52 ' OE2' ' CD1' ' A' ' 28' ' ' PHE . 0.0 OUTLIER -1.14 124.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.859 1.314 . . . . 10.0 113.986 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.643 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -120.79 142.79 49.25 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.484 -1.235 . . . . 10.0 109.239 178.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 14' ' ' VAL . 68.7 p -152.33 -137.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 10.0 110.314 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.92 45.77 1.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' B' ' 33' ' ' PRO . 50.4 mm -68.29 144.21 96.44 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.256 -1.144 . . . . 10.0 109.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' B' ' 32' ' ' ILE . 41.0 Cg_endo -70.79 141.51 41.21 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.954 1.502 . . . . 10.0 111.699 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 9.6 tp10 53.58 163.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.012 0.911 . . . . 10.0 112.058 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 4.5 mm100 -89.91 19.4 4.86 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.58 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.846 ' CZ3' HG21 ' A' ' 8' ' ' VAL . 3.8 m-90 87.33 26.86 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-O 122.549 1.166 . . . . 10.0 108.071 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.589 ' CA ' ' HA ' ' A' ' 70' ' ' LEU . . . -160.99 85.87 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.138 -1.431 . . . . 10.0 107.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.462 ' HA ' ' OE2' ' B' ' 34' ' ' GLU . 3.2 ttm180 . . . . . 0 N--CA 1.489 1.525 0 CA-C-O 122.721 1.248 . . . . 10.0 108.537 -179.335 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.562 ' HA ' ' CA ' ' A' ' 177' ' ' LEU . 15.2 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.306 0.574 . . . . 10.0 110.6 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -144.23 -86.11 0.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.202 -0.936 . . . . 10.0 109.275 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 3' ' ' THR . 3.5 m -41.26 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.943 -0.473 . . . . 10.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.983 HG22 ' O ' ' A' ' 52' ' ' THR . 1.9 tt -136.01 154.02 33.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 118.231 -1.388 . . . . 10.0 113.321 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.747 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -135.23 109.66 8.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.816 0.817 . . . . 10.0 110.716 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.674 ' C ' HG22 ' A' ' 7' ' ' VAL . 30.1 m -67.98 142.64 55.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.931 -1.106 . . . . 10.0 109.882 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.674 HG22 ' C ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -167.49 -169.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.846 -1.159 . . . . 10.0 111.004 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.0 t -105.47 164.49 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.548 -0.72 . . . . 10.0 110.279 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 1.029 HG11 ' HB ' ' A' ' 80' ' ' VAL . 27.7 m -79.99 -168.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.913 -1.117 . . . . 10.0 111.718 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.494 ' CA ' ' HB3' ' B' ' 37' ' ' ALA . . . -148.27 17.17 1.33 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.54 -34.92 78.07 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.073 -1.251 . . . . 10.0 108.995 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 141.25 -151.73 22.79 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.985 -1.246 . . . . 10.0 109.985 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 57.73 160.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -1.094 . . . . 10.0 111.4 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.623 HG22 ' SG ' ' A' ' 18' ' ' CYS . 12.4 p -52.57 152.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.445 -0.784 . . . . 10.0 109.981 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -65.24 161.32 41.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.482 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -88.68 -32.34 18.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 10.0 109.316 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.5 p -67.66 -26.15 66.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.506 -0.746 . . . . 10.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG22 ' A' ' 14' ' ' VAL . 24.8 p -75.12 -0.1 18.02 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.821 -1.175 . . . . 10.0 110.073 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.905 HD13 ' CA ' ' A' ' 159' ' ' ALA . 6.3 mt -104.19 -21.46 13.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 10.0 109.866 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.51 -35.81 81.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.745 0.784 . . . . 10.0 110.136 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.72 HG22 ' CA ' ' B' ' 27' ' ' GLY . 1.6 mm -97.87 -45.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.858 0.837 . . . . 10.0 109.404 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.627 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 15.9 t -49.33 -46.92 47.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.386 -0.926 . . . . 10.0 109.757 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -67.68 -45.68 74.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.354 -1.466 . . . . 10.0 110.628 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 5.5 p -58.73 -51.19 71.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.647 -1.283 . . . . 10.0 110.442 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -153.65 -59.93 0.13 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 118.001 -1.48 . . . . 10.0 114.218 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.632 ' H ' HG23 ' A' ' 25' ' ' THR . 20.3 m-20 -49.45 -26.07 3.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.846 -1.159 . . . . 10.0 111.562 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.4 OUTLIER 29.54 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 112.753 0.649 . . . . 10.0 112.753 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.682 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER . . . . . 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.164 . . . . 10.0 111.216 -178.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.827 ' O ' HG23 ' B' ' 20' ' ' VAL . 32.7 p . . . . . 0 N--CA 1.494 1.767 0 CA-C-O 121.252 0.549 . . . . 10.0 111.482 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.827 HG13 HG23 ' A' ' 58' ' ' THR . 27.8 t 80.01 3.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.356 0.598 . . . . 10.0 109.572 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.606 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 45.4 t80 -41.27 124.6 2.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.811 ' CB ' ' HB ' ' B' ' 18' ' ' ILE . 5.5 m-20 -64.46 -153.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.769 -1.172 . . . . 10.0 111.504 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.798 ' CB ' HD11 ' A' ' 55' ' ' LEU . 2.5 t-20 -154.09 -163.11 1.55 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.137 -0.977 . . . . 10.0 111.79 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' B' ' 16' ' ' HIS . 41.3 p90 -131.97 -174.49 3.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.775 0.798 . . . . 10.0 110.974 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.8 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -156.67 139.02 14.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -164.75 -176.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.145 . . . . 10.0 110.701 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 51' ' ' TYR . 58.6 m -121.5 144.34 48.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.981 -0.688 . . . . 10.0 109.983 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -111.37 164.32 7.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.314 -0.866 . . . . 10.0 108.844 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 0.4 OUTLIER -150.55 103.91 3.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.364 -0.976 . . . . 10.0 108.364 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.892 HG23 ' HB3' ' B' ' 10' ' ' LEU . 4.2 mt -125.02 130.1 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.062 -1.024 . . . . 10.0 110.904 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 40.24 27.17 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 95.85 30.4 7.99 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.701 -1.238 . . . . 10.0 110.097 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.492 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -120.98 94.97 49.04 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 120.898 -1.354 . . . . 10.0 110.447 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.4 Cg_endo -75.57 144.52 28.54 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.094 1.576 . . . . 10.0 111.134 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' THR . 1.7 m-85 -126.66 122.62 35.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.466 -0.771 . . . . 10.0 109.092 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.983 ' O ' HG22 ' A' ' 4' ' ' ILE 0.265 93.5 m -108.43 97.41 7.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 10.0 109.836 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -153.37 174.93 13.7 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.634 -1.626 . . . . 10.0 111.895 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.644 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . -172.55 136.54 3.81 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 108.589 -1.804 . . . . 10.0 108.589 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.798 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -131.71 135.27 46.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.895 -1.356 . . . . 10.0 109.659 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 55' ' ' LEU . 62.3 m-85 -133.76 158.95 42.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' THR . 28.7 t0 -124.17 171.17 10.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.887 -1.133 . . . . 10.0 109.787 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.827 HG23 HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.87 -176.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.122 -1.031 . . . . 10.0 110.647 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 62' ' ' GLU . . . -144.56 75.12 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.864 -1.147 . . . . 10.0 110.517 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -15.41 59.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.305 -1.518 . . . . 10.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.475 ' N ' ' HA3' ' B' ' 21' ' ' GLY . 26.1 mt-30 -144.53 -16.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.119 -1.224 . . . . 10.0 111.643 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.734 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 1.8 tt0 -62.52 -48.71 78.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.479 -1.388 . . . . 10.0 109.285 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 4.3 t0 -134.21 1.28 3.2 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.706 -0.621 . . . . 10.0 109.559 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 17.4 m-85 66.64 37.65 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 t0 -137.43 72.83 1.42 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.026 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 9.6 ptt180 -85.03 -30.61 24.0 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.623 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD11 ' A' ' 70' ' ' LEU . 20.6 mt -86.86 -25.58 24.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 10.0 111.29 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.696 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 mtm-85 -109.85 12.68 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.729 -1.232 . . . . 10.0 114.242 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.3 Cg_endo -73.59 0.96 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 110.189 -0.735 . . . . 10.0 110.189 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -102.46 -113.94 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.426 -0.796 . . . . 10.0 110.819 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.785 ' N ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER 42.43 44.11 3.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 10.0 110.662 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -160.16 174.37 4.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 10.0 110.753 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.743 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 36.6 Cg_endo -62.11 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.112 1.059 . . . . 10.0 110.862 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.607 ' HG3' ' CD ' ' A' ' 5' ' ' LYS . 1.3 mp0 54.21 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.35 -1.469 . . . . 10.0 108.311 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 75' ' ' THR . 1.3 m -139.58 86.63 2.12 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.358 -0.839 . . . . 10.0 112.404 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.854 ' OD2' HG22 ' A' ' 77' ' ' VAL . 1.6 t70 -110.48 -72.72 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 1.056 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 24.8 m -141.92 112.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.792 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.986 ' HB3' HG12 ' A' ' 9' ' ' VAL . 84.0 m-85 -88.65 127.3 35.57 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.711 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' HA ' ' A' ' 169' ' ' PHE . 4.0 mm? -100.76 97.93 8.51 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.215 -0.928 . . . . 10.0 109.662 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 1.029 ' HB ' HG11 ' A' ' 9' ' ' VAL . 7.5 p -106.65 150.55 9.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.961 -0.695 . . . . 10.0 109.947 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.6 m -133.13 118.86 19.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.924 -1.11 . . . . 10.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.536 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 31.4 p90 -127.03 166.66 17.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.457 -0.777 . . . . 10.0 110.431 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -78.93 158.51 28.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.63 -1.293 . . . . 10.0 111.852 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.506 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 28.4 m -114.39 2.9 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.607 -0.683 . . . . 10.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.853 ' HA ' HD21 ' A' ' 129' ' ' LEU . 19.2 m -105.58 39.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 10.0 109.761 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 73.0 m -114.94 172.13 3.88 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 40.2 Cg_endo -68.71 81.1 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.048 1.026 . . . . 10.0 110.771 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 37.76 39.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.206 0.527 . . . . 10.0 110.844 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.8 m -62.0 -38.26 87.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.047 -1.033 . . . . 10.0 110.81 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 16.3 p90 -48.46 -38.15 19.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 10.0 111.071 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 9.6 tt0 -59.22 -37.93 78.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.345 -0.847 . . . . 10.0 110.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.833 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -68.62 -18.32 64.28 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.223 -0.923 . . . . 10.0 109.771 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.833 HG23 ' ND2' ' A' ' 92' ' ' ASN . 64.6 t -89.62 -7.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 10.0 109.449 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.983 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -93.29 -25.58 17.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 8.3 pt-20 -94.78 2.67 55.52 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.403 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -110.08 -49.03 3.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.989 -1.069 . . . . 10.0 111.79 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.57 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 24.5 m95 -89.9 -33.21 16.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.751 -1.218 . . . . 10.0 111.643 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 96.3 t -71.7 -49.96 10.52 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.658 -1.276 . . . . 10.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -70.57 -10.49 28.02 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.178 1.094 . . . . 10.0 109.764 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 22.4 tt0 -64.06 -48.58 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 10.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 106' ' ' PRO . 20.9 tt -176.43 -29.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.053 -1.029 . . . . 10.0 110.395 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 106' ' ' PRO . 58.3 p -61.76 -11.95 14.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.272 -0.892 . . . . 10.0 109.977 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -55.62 -35.21 65.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.337 -0.852 . . . . 10.0 110.59 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -152.1 10.18 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.965 -1.094 . . . . 10.0 111.937 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . 0.67 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 1.7 m -113.12 -81.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.452 -1.405 . . . . 10.0 111.103 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 102' ' ' THR . 55.2 Cg_endo -74.84 -22.99 14.61 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 122.557 0.767 . . . . 10.0 112.029 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 106' ' ' PRO . 6.0 tttt 45.8 42.93 9.38 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.729 -1.232 . . . . 10.0 109.85 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.564 HG23 HG23 ' A' ' 75' ' ' THR . 18.5 m -67.1 139.37 95.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.433 -0.792 . . . . 10.0 110.573 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.545 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 48.8 Cg_endo -71.94 125.14 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.091 1.574 . . . . 10.0 110.067 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.579 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -100.06 99.79 10.57 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.548 -0.72 . . . . 10.0 110.224 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.7 mm? -75.67 96.89 3.67 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.665 -1.235 . . . . 10.0 107.665 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 154' ' ' TYR . 96.0 mt -80.02 113.44 18.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.643 -0.708 . . . . 10.0 110.114 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 114' ' ' GLY . 1.6 t -120.01 -175.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.087 -1.008 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -147.09 101.56 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 4.8 t -99.73 178.09 4.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.246 . . . . 10.0 110.955 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 115' ' ' THR . 31.2 mt-30 58.88 30.09 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 10.0 109.17 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 0.978 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -80.17 -13.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.951 -0.7 . . . . 10.0 110.581 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.658 ' CB ' HG21 ' A' ' 161' ' ' THR . 5.5 p-10 -51.59 58.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 122.493 1.139 . . . . 10.0 111.544 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER 165.72 -28.54 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.82 -29.54 11.97 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.729 -0.607 . . . . 10.0 109.367 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.28 -26.76 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 10.0 109.709 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.476 ' O ' HD13 ' A' ' 126' ' ' ILE . 22.2 m-20 -93.3 123.57 60.22 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.568 -0.708 . . . . 10.0 109.939 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.0 Cg_endo -78.15 24.35 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.89 1.468 . . . . 10.0 111.41 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 15.6 m -98.09 -50.55 4.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.967 -1.083 . . . . 10.0 110.39 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -29.73 64.24 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.306 1.1 mp -51.82 -26.51 7.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.109 -1.405 . . . . 10.0 107.365 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 124' ' ' SER . 28.9 tt0 -50.6 -29.35 10.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.926 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -61.39 -29.08 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.709 . . . . 10.0 111.345 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.853 HD21 ' HA ' ' A' ' 85' ' ' VAL . 9.2 mp -65.12 -42.92 93.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.804 -1.185 . . . . 10.0 109.835 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.66 -30.4 65.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.762 -0.586 . . . . 10.0 110.662 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 8.5 mmtp -64.85 -15.06 61.36 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -127.64 -41.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 10.0 110.739 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -149.66 136.46 19.45 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.401 -0.812 . . . . 10.0 110.213 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -82.15 -10.11 59.29 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.362 0.601 . . . . 10.0 110.315 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.8 OUTLIER -110.72 98.47 37.74 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 10.0 111.764 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.832 ' HB3' HD23 ' A' ' 129' ' ' LEU . 45.1 Cg_endo -71.56 161.79 44.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.372 1.722 . . . . 10.0 109.904 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 137' ' ' ILE . 1.5 tp -77.84 116.67 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.626 -1.296 . . . . 10.0 109.682 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 42.9 p -121.8 172.19 5.34 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -67.66 -16.56 46.87 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.25 1.132 . . . . 10.0 111.331 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -79.62 -24.78 41.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 10.0 109.263 178.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.3 m -97.21 -35.0 10.9 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.662 0.744 . . . . 10.0 109.341 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -72.3 -39.9 67.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.778 -0.576 . . . . 10.0 110.904 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 25.7 mt-10 -62.23 -50.22 72.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.569 -0.852 . . . . 10.0 109.597 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -61.24 -42.18 98.17 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.983 HD11 ' HG3' ' A' ' 94' ' ' LYS . 4.8 tt -58.8 -45.68 89.35 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.33 -0.856 . . . . 10.0 109.399 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.541 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.33 -48.7 80.6 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.522 0.677 . . . . 10.0 109.629 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 10.3 mtm-85 -71.13 -14.36 62.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.231 -0.918 . . . . 10.0 109.314 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 9.4 t0 -69.3 -13.33 62.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 10.0 111.115 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.998 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.51 26.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.025 -1.047 . . . . 10.0 110.155 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER 64.45 36.27 8.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.684 0.754 . . . . 10.0 110.637 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -69.4 -155.59 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -118.77 -62.29 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.781 -1.199 . . . . 10.0 111.112 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttmt -171.99 154.73 3.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.521 -1.362 . . . . 10.0 112.041 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 54.3 t80 -106.8 101.4 10.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 10.0 108.981 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.949 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -107.42 -170.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.469 -0.769 . . . . 10.0 110.139 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -152.56 133.39 14.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.08 -1.013 . . . . 10.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.607 ' SG ' HG11 ' A' ' 113' ' ' VAL . 26.9 p -153.63 157.75 40.11 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.557 -0.905 . . . . 10.0 108.557 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.578 ' HB2' ' H ' ' A' ' 162' ' ' GLN . 54.0 m -138.68 164.32 29.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.185 -1.042 . . . . 10.0 108.185 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.905 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -62.06 -59.26 5.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.631 -1.293 . . . . 10.0 112.33 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.58 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 2.6 pp -121.16 4.7 10.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.454 -1.404 . . . . 10.0 112.898 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -104.07 -47.34 4.2 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.333 -1.479 . . . . 10.0 113.544 -178.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.578 ' H ' ' HB2' ' A' ' 158' ' ' SER . 10.7 mm100 -91.51 -44.38 9.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.444 -1.41 . . . . 10.0 112.026 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 15.4 ttpt 63.95 28.73 14.5 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.205 1.002 . . . . 10.0 109.325 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -109.45 15.86 32.18 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.088 -1.605 . . . . 10.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -69.51 -3.17 13.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.541 -0.976 . . . . 10.0 110.471 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -89.65 -25.32 21.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 10.0 109.946 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -34.92 23.39 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.092 -1.005 . . . . 10.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.949 HG22 ' HB ' ' A' ' 155' ' ' VAL . 16.2 t -59.62 -38.77 77.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 10.0 110.692 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.56 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 t80 -80.17 -44.05 20.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 10.0 111.796 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.696 ' O ' HD22 ' A' ' 174' ' ' LEU . 29.7 t70 -52.51 -44.08 65.47 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.528 -1.358 . . . . 10.0 110.688 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.598 ' HA ' HD23 ' A' ' 174' ' ' LEU . 14.5 mt-10 -60.62 -41.82 95.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.237 -0.914 . . . . 10.0 111.466 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.931 ' HB1' ' HB ' ' A' ' 77' ' ' VAL . . . -56.14 -33.21 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 10.0 111.092 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 177' ' ' LEU . 20.8 mm -61.01 -44.68 98.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 118.316 -1.354 . . . . 10.0 108.423 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.84 -21.04 62.48 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.375 -0.828 . . . . 10.0 109.839 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.95 -7.5 36.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.397 -0.814 . . . . 10.0 111.005 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.056 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -85.97 -33.65 21.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.017 . . . . 10.0 111.343 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -100.31 -10.65 21.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.767 -1.208 . . . . 10.0 109.418 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.191 . . . . 10.0 109.138 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 10.0 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 56.9 m -80.39 36.82 0.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.09 -1.241 . . . . 10.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 174' ' ' LEU . 9.4 mtpp -61.0 100.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 10.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' B' ' 2' ' ' SER . 9.2 mm-40 -108.43 161.97 14.54 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.588 0.709 . . . . 10.0 111.262 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.681 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.48 -143.17 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.202 -1.036 . . . . 10.0 108.202 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.681 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 43.9 Cg_endo -74.27 7.31 2.62 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 CA-C-N 119.448 0.839 . . . . 10.0 110.626 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.829 ' CB ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER 41.81 -149.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 10.0 110.517 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.561 HG23 ' H ' ' B' ' 9' ' ' SER . 0.0 OUTLIER -100.48 -99.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.46 -0.775 . . . . 10.0 109.951 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.561 ' H ' HG23 ' B' ' 8' ' ' ILE . 31.1 m -78.12 151.96 33.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.592 -1.317 . . . . 10.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.892 ' HB3' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -164.89 98.81 0.84 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.459 -1.401 . . . . 10.0 112.348 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 45' ' ' MET . 45.0 Cg_endo -75.72 124.18 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.771 1.406 . . . . 10.0 108.893 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.8 m -93.14 166.37 12.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.44 174.99 10.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.465 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.1 p90 -149.23 150.04 31.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.724 -1.235 . . . . 10.0 111.62 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -170.85 117.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.67 -0.644 . . . . 10.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 p-80 -162.83 156.42 20.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.624 -1.297 . . . . 10.0 111.737 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.928 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -166.95 96.25 0.51 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.297 -0.877 . . . . 10.0 110.226 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.928 HG23 ' O ' ' B' ' 17' ' ' THR . 0.6 OUTLIER -172.9 167.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.605 . . . . 10.0 109.466 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.42 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 50.0 t60 -145.75 159.6 42.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.211 -1.556 . . . . 10.0 114.551 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 35' ' ' THR . 4.8 p -69.08 146.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.648 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -146.48 155.84 26.71 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.364 -1.894 . . . . 10.0 108.364 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 1.06 ' HB3' HG21 ' B' ' 25' ' ' VAL . 8.1 m-30 58.81 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.213 -1.169 . . . . 10.0 110.359 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.498 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.1 m-20 -60.65 157.55 14.33 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.634 0.73 . . . . 10.0 111.764 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . . . . . . . . . . . 43.89 43.89 5.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.69 -0.631 . . . . 10.0 111.331 178.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 1.06 HG21 ' HB3' ' B' ' 22' ' ' PHE . 6.7 t -111.7 -35.1 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 119.356 -0.938 . . . . 10.0 108.663 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -101.93 7.44 41.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 177.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.72 ' CA ' HG22 ' A' ' 21' ' ' ILE . . . -125.14 24.87 5.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.881 -2.088 . . . . 10.0 107.881 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 11.3 tt0 -158.66 132.59 7.71 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.768 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -110.04 118.92 37.69 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.238 1.018 . . . . 10.0 110.7 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -143.07 162.31 35.87 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.575 -0.739 . . . . 10.0 109.664 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.43 -165.9 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.205 -1.158 . . . . 10.0 110.205 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.461 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 24.2 pt -143.01 52.87 2.35 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.372 -1.075 . . . . 10.0 110.458 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 55.5 Cg_endo -74.72 163.14 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.83 1.437 . . . . 10.0 111.05 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.489 ' OE2' ' O ' ' A' ' 10' ' ' GLY . 3.6 tp10 -43.7 155.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.963 . . . . 10.0 109.97 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 14' ' ' VAL . 4.1 mm-40 -67.83 -66.76 0.52 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.238 -0.985 . . . . 10.0 111.141 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.625 ' CD2' ' O ' ' B' ' 36' ' ' TRP . 9.4 t90 -161.96 21.05 0.11 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 122.51 1.148 . . . . 10.0 108.114 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.568 ' HA ' ' CG ' ' A' ' 70' ' ' LEU . . . -155.95 93.92 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.081 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.411 ' HA ' ' CD ' ' B' ' 34' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.37 0 N-CA-C 107.466 -1.309 . . . . 10.0 107.466 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.085 0.469 . . . . 10.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 4' ' ' ILE . 2.8 mm100 -78.72 -48.54 14.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.236 -0.915 . . . . 10.0 108.776 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.59 ' HA ' HG22 ' A' ' 52' ' ' THR . 1.4 m -40.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.976 -0.75 . . . . 10.0 108.976 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 1.011 HD13 ' HB1' ' A' ' 176' ' ' ALA . 1.2 tt -134.55 149.06 29.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.001 -1.079 . . . . 10.0 111.935 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HG3' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -126.95 119.38 26.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.823 ' HA ' HG13 ' A' ' 77' ' ' VAL . 7.5 m -89.32 135.31 33.65 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.732 0.777 . . . . 10.0 109.479 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' B' ' 36' ' ' TRP . 11.0 t -144.31 158.5 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.46 -0.775 . . . . 10.0 109.972 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 30.5 m -63.83 136.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.44 -0.787 . . . . 10.0 111.235 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.88 HG11 ' HB3' ' A' ' 78' ' ' PHE . 7.6 t -145.27 -173.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.558 -0.714 . . . . 10.0 109.242 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.712 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 126.93 -129.05 6.42 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.942 -1.263 . . . . 10.0 109.942 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.98 22.95 14.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.435 -1.038 . . . . 10.0 109.224 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' B' ' 33' ' ' PRO . . . 100.82 90.07 2.07 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.644 -1.782 . . . . 10.0 108.644 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' B' ' 35' ' ' GLN . . . -141.18 96.16 2.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 10.0 110.659 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 35' ' ' GLN . 0.6 OUTLIER -82.91 133.59 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.918 -1.114 . . . . 10.0 109.684 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 19' ' ' LEU . . . 98.75 2.42 57.35 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.914 -1.136 . . . . 10.0 110.356 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.2 tttt -51.0 -47.73 61.52 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.024 -1.28 . . . . 10.0 111.013 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 22.7 m -62.06 -30.94 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.283 -1.511 . . . . 10.0 109.645 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' B' ' 26' ' ' THR . 14.9 m -70.18 -11.8 61.15 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.742 -1.224 . . . . 10.0 108.916 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' B' ' 29' ' ' PHE . 4.3 mm? -70.26 -30.67 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -49.29 -40.36 34.45 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.841 -1.541 . . . . 10.0 106.841 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.7 mm -67.54 -36.5 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 122.349 1.071 . . . . 10.0 108.948 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.578 ' HA ' ' CA ' ' A' ' 27' ' ' LYS . 3.5 p -60.05 -42.29 94.16 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.883 -0.727 . . . . 10.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 165' ' ' LEU . 31.7 m-85 -71.52 -7.45 47.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.824 -1.172 . . . . 10.0 108.768 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 66.5 p -107.65 -44.31 4.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.531 -0.867 . . . . 10.0 110.143 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.78 HG23 ' H ' ' A' ' 26' ' ' ASN . 1.9 t -166.2 -65.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 116.798 -1.961 . . . . 10.0 115.361 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.78 ' H ' HG23 ' A' ' 25' ' ' THR . 15.9 t-20 -79.0 45.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.018 -1.676 . . . . 10.0 113.181 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.606 ' HA ' ' HA3' ' B' ' 27' ' ' GLY . 0.0 OUTLIER -56.04 -126.71 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.577 -0.702 . . . . 10.0 111.392 179.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.619 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 3.8 t80 . . . . . 0 N--CA 1.5 2.045 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 -177.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.615 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.71 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 35' ' ' THR . 91.2 t -156.88 -97.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.636 -1.29 . . . . 10.0 111.995 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.604 ' N ' HG12 ' A' ' 36' ' ' VAL . 1.7 t80 -70.86 126.94 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 10.0 110.522 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.604 ' HB3' ' CG ' ' A' ' 56' ' ' PHE . 3.2 t70 -160.89 -177.82 6.4 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.055 -1.028 . . . . 10.0 110.103 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.776 ' HB3' HG21 ' B' ' 18' ' ' ILE . 1.2 t-20 -167.63 102.65 0.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 10.0 109.125 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.675 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 7.3 t80 -92.76 141.73 28.12 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.989 -1.07 . . . . 10.0 110.577 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -159.58 98.16 1.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 10.0 109.38 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -144.79 -174.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 10.0 110.622 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 51' ' ' TYR . 6.8 m -142.07 146.66 35.69 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' B' ' 12' ' ' SER . 18.1 t -120.91 136.86 56.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.652 ' HB3' HD23 ' B' ' 10' ' ' LEU . 10.3 mtt -89.36 109.45 20.36 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 117.736 -1.586 . . . . 10.0 109.181 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.25 109.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.185 -1.572 . . . . 10.0 109.544 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 50.02 28.09 11.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.07 -28.0 17.09 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 111.15 16.15 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.246 . . . . 10.0 110.475 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 56.0 Cg_endo -73.04 134.64 21.73 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.159 1.61 . . . . 10.0 109.561 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.4 t80 -89.34 139.97 29.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.752 -1.218 . . . . 10.0 109.549 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' HG22 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -122.06 97.88 5.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 10.0 110.343 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.8 pp -148.85 171.36 16.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.733 -1.229 . . . . 10.0 111.621 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -173.28 120.85 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.377 -1.889 . . . . 10.0 108.377 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.849 HD12 ' C ' ' A' ' 55' ' ' LEU . 1.5 pp -157.58 144.69 18.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.408 -1.643 . . . . 10.0 112.845 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.604 ' CG ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -174.66 172.34 3.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.251 -0.905 . . . . 10.0 110.384 175.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -90.82 157.33 17.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 10.0 110.187 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.5 m -129.29 135.74 49.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.028 . . . . 10.0 111.662 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . . . 55.85 -152.44 0.37 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.39 -0.819 . . . . 10.0 110.934 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HG21 ' B' ' 25' ' ' VAL . . . 96.09 -7.84 67.22 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.236 -1.946 . . . . 10.0 108.236 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.586 ' CG ' ' HB2' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -152.84 -41.76 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.509 -0.994 . . . . 10.0 110.444 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 8.7 mm-40 -73.1 -43.25 62.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.502 -1.279 . . . . 10.0 109.386 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 2.1 t70 73.46 52.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.668 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -165.24 0.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.195 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 6.1 p30 -22.53 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.493 0.663 . . . . 10.0 112.487 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.477 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -54.29 -34.16 60.26 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 178.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.614 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 83.7 mt -76.43 6.24 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.442 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.756 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -57.82 -31.29 9.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.826 -1.171 . . . . 10.0 113.651 -179.012 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.614 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 52.0 Cg_endo -72.47 81.11 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 CA-C-N 119.36 0.807 . . . . 10.0 110.037 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.772 HD11 ' CB ' ' B' ' 37' ' ' ALA . 0.7 OUTLIER -108.72 -34.14 6.78 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.751 -1.218 . . . . 10.0 110.913 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.657 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 77.16 -17.3 0.57 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 10.0 110.808 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.663 ' N ' HD12 ' A' ' 70' ' ' LEU . 79.2 t80 104.29 115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.838 0 C-N-CA 123.682 0.793 . . . . 10.0 111.181 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 43.9 Cg_endo -71.58 164.7 34.86 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.89 1.469 . . . . 10.0 109.307 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 1.1 mt-30 -139.35 7.01 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.821 -1.174 . . . . 10.0 111.11 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -141.78 84.89 1.91 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.852 -1.155 . . . . 10.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.645 ' O ' HD11 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -174.15 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.516 -0.74 . . . . 10.0 109.015 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -163.91 143.19 2.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.19 -0.944 . . . . 10.0 108.801 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.88 ' HB3' HG11 ' A' ' 9' ' ' VAL . 14.0 m-85 -131.72 119.56 21.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.899 -1.126 . . . . 10.0 111.942 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 111' ' ' LEU . 1.1 mm? -90.58 97.85 11.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 10.0 109.043 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 10' ' ' GLY . 11.0 m -99.38 150.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 10.0 110.35 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.6 p -123.66 108.41 12.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 10.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 97.9 m-85 -91.96 139.54 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.207 -0.933 . . . . 10.0 111.058 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.5 p -77.98 163.64 25.78 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 137' ' ' ILE . 1.9 m -119.43 -14.64 8.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 10.0 110.321 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 120' ' ' ARG . 32.7 m -115.11 44.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.798 0.809 . . . . 10.0 109.868 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.638 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -133.83 -159.13 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 41.6 Cg_endo -73.26 142.85 34.44 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 122.715 0.85 . . . . 10.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 m -65.29 77.15 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.007 -1.077 . . . . 10.0 109.695 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' PRO . 80.1 p -105.05 -15.71 15.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 10.0 111.642 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.5 p90 -49.79 -39.73 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.258 . . . . 10.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 1.5 tt0 -62.21 -34.17 75.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 10.0 110.269 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.594 HD22 HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.11 -14.01 61.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.063 -1.023 . . . . 10.0 109.682 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 92' ' ' ASN . 21.2 t -87.95 -18.03 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 10.0 109.444 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.857 ' HG3' HD11 ' A' ' 145' ' ' LEU . 3.7 mmtt -85.42 -35.53 21.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -82.74 -1.03 50.32 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.162 0.506 . . . . 10.0 109.847 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -111.24 -50.01 2.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.832 -1.167 . . . . 10.0 112.052 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 50.1 m95 -84.77 -49.36 8.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 10.0 112.339 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 23.2 t -52.79 -46.48 96.58 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.657 -1.277 . . . . 10.0 109.951 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.0 Cg_endo -71.75 -16.3 29.88 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.392 1.206 . . . . 10.0 109.779 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 43.5 tt0 -63.36 -16.55 60.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 10.0 109.72 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt 69.02 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.472 0.653 . . . . 10.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.723 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.1 m -52.39 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.868 . . . . 10.0 108.916 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . 0.723 ' N ' HG22 ' A' ' 102' ' ' THR . 10.9 p-80 -110.54 -4.2 15.61 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 10.0 108.174 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.5 OUTLIER 162.58 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 35.6 t -138.15 131.49 16.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 42.7 Cg_endo -69.84 67.67 1.77 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.757 1.399 . . . . 10.0 111.256 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 -11.04 15.08 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.057 -1.027 . . . . 10.0 110.659 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.9 t -49.21 147.3 5.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.653 -1.279 . . . . 10.0 109.715 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.62 130.42 26.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.852 1.448 . . . . 10.0 110.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.8 102.21 10.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.44 -0.787 . . . . 10.0 109.667 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 152' ' ' VAL . 2.6 mm? -78.62 95.41 5.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.817 -1.153 . . . . 10.0 108.026 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 145' ' ' LEU . 12.5 mt -72.31 137.91 47.0 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 22.8 t -148.43 158.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.787 -1.196 . . . . 10.0 111.594 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.433 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -96.56 148.21 18.92 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.765 -1.734 . . . . 10.0 108.765 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 81' ' ' CYS . 30.5 m -111.35 126.71 55.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.167 -1.196 . . . . 10.0 110.638 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 44.17 62.18 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.438 -0.789 . . . . 10.0 110.412 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.021 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.89 -29.24 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.206 -0.997 . . . . 10.0 109.542 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -52.47 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.427 1.108 . . . . 10.0 110.175 -177.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER 166.73 -26.66 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.219 -1.355 . . . . 10.0 107.827 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.76 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -51.14 -33.21 25.73 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.307 0.575 . . . . 10.0 109.731 178.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . 0.458 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 75.7 m-20 -73.77 -11.46 60.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.027 . . . . 10.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.868 ' O ' HD13 ' A' ' 126' ' ' ILE . 38.0 t0 -86.4 115.86 63.73 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 10.0 110.162 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.47 21.65 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.734 1.386 . . . . 10.0 111.447 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 38.7 t -105.59 -51.24 3.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 10.0 109.993 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.52 HG21 HD12 ' A' ' 119' ' ' LEU . 14.3 t -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.967 -2.235 . . . . 10.0 104.967 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 122' ' ' ASP 0.296 1.3 mp -54.47 -23.56 11.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.227 -1.351 . . . . 10.0 107.79 176.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -49.21 -41.73 37.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.583 0.706 . . . . 10.0 110.172 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 1.8 mmmm -92.44 -41.32 10.37 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.603 -0.686 . . . . 10.0 109.994 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 85' ' ' VAL . 6.0 mp -65.83 -32.75 74.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.761 . . . . 10.0 109.403 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -59.88 -51.51 69.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 10.0 109.869 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -64.62 -25.33 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.196 -1.002 . . . . 10.0 108.903 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.57 ' ND2' ' N ' ' A' ' 87' ' ' PRO . 2.2 t30 -69.38 -8.64 48.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 10.0 110.583 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -167.67 115.3 0.75 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 10.0 108.557 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.511 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -64.51 -19.9 65.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 10.0 111.904 -178.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 4.8 mptt -137.67 106.34 8.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.747 -1.221 . . . . 10.0 110.284 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 41.9 Cg_endo -66.74 160.45 46.45 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.487 . . . . 10.0 109.654 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 84' ' ' VAL . 3.4 tp -86.86 138.35 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.782 -1.199 . . . . 10.0 109.704 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 55.8 p -131.43 166.33 28.79 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.463 -0.773 . . . . 10.0 109.813 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 42.4 Cg_endo -67.8 -11.5 32.31 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.737 1.388 . . . . 10.0 110.965 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 75.2 mt-10 -75.16 -44.3 47.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.946 -1.096 . . . . 10.0 109.405 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -77.72 -36.55 50.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.662 0.744 . . . . 10.0 109.388 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 145' ' ' LEU . . . -64.93 -49.94 68.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 10.0 111.476 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.3 -46.94 62.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.009 -1.057 . . . . 10.0 109.578 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 140' ' ' GLU . 3.2 mtpm? -70.68 -30.05 66.53 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.542 -0.863 . . . . 10.0 109.439 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -69.53 -38.95 77.73 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.332 -0.855 . . . . 10.0 109.693 178.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -65.71 -49.67 67.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 10.0 108.263 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -24.07 67.53 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.852 -0.739 . . . . 10.0 109.166 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 21.1 t70 -59.97 -30.93 69.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 10.0 111.177 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 1.029 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -132.87 29.9 4.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.888 -1.132 . . . . 10.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 31.9 mttt 67.45 36.08 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 10.0 112.176 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -69.68 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.221 -0.991 . . . . 10.0 108.929 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 111' ' ' LEU . 2.4 p -114.57 -58.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.596 -1.315 . . . . 10.0 112.014 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.618 ' H ' HG13 ' A' ' 152' ' ' VAL . 2.8 ttmm -172.3 148.72 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.367 -1.458 . . . . 10.0 111.675 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 83.9 t80 -86.0 121.7 29.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 10.0 110.466 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 0.995 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -130.03 -174.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.868 -1.145 . . . . 10.0 110.169 179.4 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 48.8 mt-10 -148.09 149.23 31.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.862 -1.149 . . . . 10.0 112.195 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.0 p -148.22 156.09 42.14 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.905 0.859 . . . . 10.0 110.894 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 163' ' ' LYS . 1.7 t -139.38 89.8 2.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.627 0.727 . . . . 10.0 109.495 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.787 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -12.05 -58.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.554 0.946 . . . . 10.0 113.554 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -106.99 -43.12 4.72 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.056 -1.028 . . . . 10.0 112.84 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.647 HG21 ' CB ' ' A' ' 118' ' ' ASP . 6.3 p -65.25 -23.58 67.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.264 -1.523 . . . . 10.0 109.577 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' OE1' ' A' ' 162' ' ' GLN . 0.3 OUTLIER 71.19 77.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.457 -0.777 . . . . 10.0 110.946 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 158' ' ' SER . 12.6 mmmt -80.86 23.43 0.55 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.529 -0.868 . . . . 10.0 111.865 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.27 45.41 11.43 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.101 -1.2 . . . . 10.0 110.101 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -74.96 -3.37 31.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.339 -1.095 . . . . 10.0 112.774 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.7 ttmt -53.62 -38.99 64.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.57 -1.331 . . . . 10.0 110.223 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -75.6 -26.1 57.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 10.0 111.684 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 155' ' ' VAL . 87.7 t -52.88 -51.49 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 10.0 111.353 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CZ ' ' OD1' ' A' ' 170' ' ' ASP . 2.3 p90 -85.16 -32.23 22.83 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.699 -0.801 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.58 ' OD1' ' CZ ' ' A' ' 169' ' ' PHE . 1.0 OUTLIER -56.45 -41.54 76.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.993 -1.067 . . . . 10.0 110.972 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.611 ' HA ' HD21 ' A' ' 174' ' ' LEU . 9.0 pt-20 -69.8 -30.64 68.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.991 -1.068 . . . . 10.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.832 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -71.49 -4.61 27.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.012 -1.055 . . . . 10.0 109.457 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 169' ' ' PHE . 44.9 mm -82.52 -46.0 19.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.549 -0.861 . . . . 10.0 108.967 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -83.63 -30.97 26.48 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.738 -1.185 . . . . 10.0 108.679 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -77.03 -0.28 23.95 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.393 -0.817 . . . . 10.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 1.011 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -90.04 -39.25 13.04 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.378 -0.826 . . . . 10.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -89.74 -19.94 24.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 10.0 109.393 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.283 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 55.43 33.28 20.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -1.012 . . . . 10.0 110.767 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.76 89.39 5.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.099 -1.001 . . . . 10.0 110.274 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.515 ' C ' ' HD2' ' B' ' 6' ' ' PRO . 3.1 mt-10 -92.81 118.83 31.52 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.209 -0.932 . . . . 10.0 110.245 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.716 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -71.72 -21.38 0.5 Allowed Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 121.38 -0.825 . . . . 10.0 111.903 178.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 44.3 Cg_endo -88.06 -9.77 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 O-C-N 122.597 0.788 . . . . 10.0 111.044 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.483 ' OE1' ' HB2' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -53.57 171.27 0.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 118.47 -1.292 . . . . 10.0 109.713 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.709 HG23 ' N ' ' B' ' 9' ' ' SER . 0.4 OUTLIER -78.16 -169.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.011 -1.477 . . . . 10.0 107.011 177.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.709 ' N ' HG23 ' B' ' 8' ' ' ILE . 33.3 t -129.02 98.9 5.08 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 118.994 -1.082 . . . . 10.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 45' ' ' MET . 41.1 tp -92.5 99.89 3.27 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 118.558 -1.257 . . . . 10.0 108.994 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' B' ' 9' ' ' SER . 37.8 Cg_endo -61.29 99.43 0.16 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.194 1.102 . . . . 10.0 110.795 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 4.9 m -152.36 99.83 2.53 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.327 -0.858 . . . . 10.0 111.422 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -169.17 121.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.62 -0.675 . . . . 10.0 110.353 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -159.42 102.93 1.58 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.005 -1.059 . . . . 10.0 110.558 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.69 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.64 106.5 0.22 Allowed 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.273 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -166.82 123.24 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 10.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.507 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -161.97 111.28 1.51 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.92 . . . . 10.0 110.183 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.776 HG21 ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -153.43 -173.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.044 -1.035 . . . . 10.0 110.296 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 64.2 m80 -115.35 142.8 46.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.082 -1.011 . . . . 10.0 110.569 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 1.1 p -142.88 149.11 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.485 -0.76 . . . . 10.0 111.346 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -87.95 -124.67 2.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.254 -1.938 . . . . 10.0 108.254 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER 173.54 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -1.152 . . . . 10.0 111.363 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 61' ' ' GLN . 9.4 t70 -144.05 159.41 42.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.683 -0.635 . . . . 10.0 109.537 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.626 ' HB1' ' HG3' ' B' ' 28' ' ' GLU . . . -61.03 -5.54 1.46 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.905 -1.122 . . . . 10.0 109.913 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.548 ' HA ' ' HB2' ' B' ' 28' ' ' GLU 0.276 0.5 OUTLIER -49.67 -34.98 9.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.883 1.325 . . . . 10.0 107.566 178.878 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.644 ' HA ' ' HB3' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -52.63 -32.59 42.59 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.111 -1.404 . . . . 10.0 111.064 -179.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 27' ' ' LYS . . . -123.79 -7.92 6.48 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.655 -1.778 . . . . 10.0 108.655 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.626 ' HG3' ' HB1' ' B' ' 24' ' ' ALA . 18.3 mt-10 -83.74 39.94 0.71 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.68 -0.894 . . . . 10.0 110.453 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.992 ' HB2' HD21 ' A' ' 19' ' ' LEU . 46.3 t80 -76.07 94.97 3.53 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.756 -1.202 . . . . 10.0 107.756 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.605 HG21 ' CE1' ' A' ' 28' ' ' PHE . 34.3 p -112.89 -19.22 12.04 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.19 -0.914 . . . . 10.0 110.491 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.62 -167.53 14.68 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.129 -1.588 . . . . 10.0 109.129 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.632 HD13 ' N ' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -133.59 69.47 76.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.239 -1.153 . . . . 10.0 110.811 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.4 Cg_endo -74.22 156.57 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.088 1.572 . . . . 10.0 108.464 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -35.21 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.268 -0.895 . . . . 10.0 111.003 -178.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -73.26 -71.22 0.32 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.496 0.665 . . . . 10.0 112.039 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 7' ' ' VAL . 41.1 t90 -157.26 34.65 0.28 Allowed 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.772 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -157.8 83.69 0.88 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.543 ' HD3' ' HB2' ' A' ' 68' ' ' ARG . 0.0 OUTLIER . . . . . 0 C--N 1.301 -1.523 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 179.612 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.2 ptm . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.401 0.62 . . . . 10.0 110.149 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -74.92 -33.66 62.02 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.849 HG23 HD13 ' A' ' 53' ' ' LEU . 1.2 m -40.79 118.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' ILE . . . . . 0.955 HG13 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -104.16 127.27 58.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.16 -1.816 . . . . 10.0 110.77 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mttp -121.42 97.78 5.67 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' HG11 ' A' ' 77' ' ' VAL . 19.6 m -118.19 120.43 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.848 -1.141 . . . . 10.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' VAL . . . . . 0.661 ' N ' HG21 ' A' ' 75' ' ' THR . 47.1 t -127.55 144.6 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.488 -0.93 . . . . 10.0 108.488 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' VAL . . . . . 0.867 HG21 ' OG1' ' A' ' 17' ' ' THR . 33.6 m -62.73 116.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.287 -0.883 . . . . 10.0 110.709 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 10' ' ' GLY . 77.2 t -115.72 177.69 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.182 -0.949 . . . . 10.0 109.136 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 167.78 172.64 35.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 8.3 p-10 -96.23 18.49 13.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.118 -1.225 . . . . 10.0 109.731 179.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLY . . . . . 0.54 ' CA ' ' OE1' ' B' ' 34' ' ' GLU . . . 74.61 51.74 7.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 -54.41 2.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.529 -0.983 . . . . 10.0 110.785 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' B' ' 29' ' ' PHE . 6.3 m -136.26 -7.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 10.0 111.586 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' B' ' 32' ' ' ILE . . . 81.64 81.63 0.86 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 3.8 tptt -63.04 -27.24 69.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.54 -0.977 . . . . 10.0 112.008 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.867 ' OG1' HG21 ' A' ' 8' ' ' VAL . 93.9 m -55.15 -51.85 65.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.399 -1.438 . . . . 10.0 110.188 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . 0.666 ' CB ' ' HA ' ' B' ' 26' ' ' THR . 31.0 p -74.81 0.23 16.14 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.44 -0.904 . . . . 10.0 109.985 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' LEU . . . . . 0.992 HD13 ' CB ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -88.16 -36.07 17.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.003 -1.061 . . . . 10.0 109.097 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 16' ' ' LYS . 4.3 mm? -51.68 -38.55 55.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ILE . . . . . 0.627 HG22 ' HA2' ' B' ' 27' ' ' GLY . 0.5 OUTLIER -76.67 -51.34 19.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.641 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' SER . . . . . 0.728 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 49.3 m -46.27 -40.85 12.22 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 119.077 -1.049 . . . . 10.0 108.846 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' TYR . . . . . 1.021 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -64.22 -23.28 67.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.187 -0.946 . . . . 10.0 109.461 177.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' ILE . 63.2 m -105.04 -29.97 10.07 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.686 0.755 . . . . 10.0 109.889 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' THR . . . . . 0.802 ' O ' ' N ' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -137.73 64.5 1.51 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.73 -1.581 . . . . 10.0 106.73 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -33.96 49.75 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.583 1.553 . . . . 10.0 114.406 -177.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.802 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -67.22 109.12 2.96 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.381 -0.824 . . . . 10.0 110.749 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' PHE . . . . . 0.583 ' CE1' HG22 ' B' ' 30' ' ' THR . 43.4 t80 . . . . . 0 N--CA 1.495 1.807 0 O-C-N 121.237 -0.914 . . . . 10.0 110.406 177.992 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' THR . . . . . 0.609 ' OG1' HD12 ' A' ' 21' ' ' ILE . 0.3 OUTLIER . . . . . 0 N--CA 1.496 1.835 0 CA-C-O 120.823 0.345 . . . . 10.0 111.9 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' B' ' 20' ' ' VAL . 78.6 t -95.29 10.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.654 -1.279 . . . . 10.0 109.017 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' B' ' 18' ' ' ILE . 1.3 m-30 -33.91 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.087 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASP . . . . . 0.927 ' HB2' ' HA ' ' B' ' 18' ' ' ILE . 1.5 m-20 -85.81 -149.02 0.13 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.903 -1.519 . . . . 10.0 108.594 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ASN . . . . . 0.749 ' CG ' HD11 ' A' ' 55' ' ' LEU . 1.3 t-20 -133.7 -163.62 1.38 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -128.05 163.27 24.94 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.605 -1.31 . . . . 10.0 112.194 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . . . -153.65 153.72 32.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -172.34 -168.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 120.528 -1.357 . . . . 10.0 111.625 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 42' ' ' VAL . 92.3 m -132.39 153.31 50.92 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.503 -0.771 . . . . 10.0 109.887 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -142.07 -171.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.039 . . . . 10.0 110.395 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' MET . . . . . 0.575 ' HB2' ' HG2' ' B' ' 11' ' ' PRO . 85.6 mtp -142.65 138.45 30.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.647 . . . . 10.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . 0.714 HD12 HG13 ' A' ' 44' ' ' VAL . 1.1 mp -146.91 115.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.222 -0.924 . . . . 10.0 109.714 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 41.01 27.58 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.656 -1.259 . . . . 10.0 109.98 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.37 -16.18 49.22 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.189 -1.183 . . . . 10.0 111.412 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' GLU . . . . . 0.442 ' OE2' ' HB2' ' B' ' 4' ' ' GLU . 1.7 mp0 -98.69 105.04 28.0 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.553 -1.557 . . . . 10.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 52.2 Cg_endo -82.91 151.74 14.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.894 1.471 . . . . 10.0 112.269 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.624 ' CG ' HG12 ' A' ' 44' ' ' VAL . 2.8 m-30 -81.52 174.07 11.79 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.919 ' O ' HG22 ' A' ' 4' ' ' ILE . 16.2 m -152.73 124.1 7.67 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.611 -1.306 . . . . 10.0 112.249 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER 64.65 -169.21 0.2 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.93 0.871 . . . . 10.0 113.282 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 41' ' ' ALA . . . -169.72 -167.17 29.86 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.054 -1.618 . . . . 10.0 109.054 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.749 HD11 ' CG ' ' A' ' 39' ' ' ASN . 1.6 pp -111.22 156.57 21.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -1.116 . . . . 10.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PHE . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' LEU . 56.9 m-85 -132.88 166.03 23.26 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.346 -0.613 . . . . 10.0 109.346 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 8.1 t70 -104.57 179.69 4.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.772 -1.205 . . . . 10.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' ASP . 12.0 t -45.26 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.469 1.128 . . . . 10.0 112.425 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -132.94 63.35 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 10.0 109.114 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . -49.42 -39.94 30.04 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.646 -2.582 . . . . 10.0 106.646 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . 0.553 ' CG ' ' HB2' ' A' ' 63' ' ' ASP . 2.7 tp60 -63.92 -35.62 81.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.7 mt-10 55.63 32.76 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.939 0.876 . . . . 10.0 109.819 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 5.6 t70 -90.08 -5.68 56.29 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.527 -0.916 . . . . 10.0 108.527 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -139.23 -38.33 0.49 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.13 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.2 p30 38.9 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.187 -0.605 . . . . 10.0 109.998 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -58.17 -36.87 73.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.745 -1.222 . . . . 10.0 109.173 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.671 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 5.1 mt -91.77 13.86 17.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.331 0.586 . . . . 10.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -81.47 -13.12 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 114.341 1.238 . . . . 10.0 114.341 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -69.71 67.76 1.7 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 109.031 -1.18 . . . . 10.0 109.031 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' B' ' 37' ' ' ALA . 4.9 mt -50.46 -71.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.559 0.695 . . . . 10.0 111.665 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 21.7 p -35.31 -29.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.958 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -98.29 105.83 31.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.415 -0.803 . . . . 10.0 108.859 178.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 43.4 Cg_endo -77.83 113.93 3.55 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.859 1.452 . . . . 10.0 110.721 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -133.77 60.61 1.7 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.477 -0.764 . . . . 10.0 110.288 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.8 m -144.25 97.33 3.03 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.934 -1.104 . . . . 10.0 109.545 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' THR . 14.5 t70 -28.83 -38.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.662 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -121.09 136.96 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.269 -0.894 . . . . 10.0 109.706 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 41.8 m-85 -115.7 144.67 43.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LEU . . . . . 0.923 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -114.01 102.34 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 10.0 109.129 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 4.4 p -96.8 151.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.982 . . . . 10.0 108.812 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' CYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 19.8 t -134.8 100.37 4.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.847 -1.158 . . . . 10.0 112.496 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 47.8 m-85 -88.45 156.18 19.26 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.316 -0.865 . . . . 10.0 109.884 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 18.8 m -85.01 147.12 26.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.843 -1.161 . . . . 10.0 109.282 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 115' ' ' THR . 43.7 t -47.62 -60.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.077 -1.014 . . . . 10.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 129' ' ' LEU . 3.8 t -78.75 -62.52 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . 0.618 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER 44.8 179.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.847 0 CA-C-O 121.58 0.705 . . . . 10.0 112.375 178.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 52.2 Cg_endo -78.72 145.99 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.462 1.77 . . . . 10.0 109.985 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 135' ' ' LYS . 95.2 p -68.38 67.81 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 10.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.3 OUTLIER -136.69 13.37 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 10.0 111.666 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 82' ' ' PHE . 16.9 t80 -71.33 -34.15 70.29 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.619 -1.301 . . . . 10.0 110.64 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 4.5 mt-10 -74.69 -29.89 61.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.026 -1.046 . . . . 10.0 110.982 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -86.89 -9.69 55.12 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.741 -1.183 . . . . 10.0 109.496 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' VAL . . . . . 0.544 HG13 ' CD2' ' A' ' 97' ' ' TRP . 14.4 t -90.35 -36.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.996 -1.065 . . . . 10.0 109.102 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' LYS . . . . . 0.817 ' HE2' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.26 -25.39 62.45 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 10.0 110.095 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 12.9 pt-20 -78.52 -25.06 45.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 10.0 111.616 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' LYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 25.2 mttp -110.93 -50.65 2.93 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.892 -1.13 . . . . 10.0 111.998 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' TRP . . . . . 0.595 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 23.1 m0 -64.42 -17.19 63.55 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.297 -0.877 . . . . 10.0 112.405 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' VAL . . . . . 0.871 HG11 ' CD2' ' A' ' 149' ' ' LEU . 53.8 t -82.91 -50.7 0.72 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.772 -1.205 . . . . 10.0 112.033 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.8 Cg_endo -68.58 -6.47 17.83 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.119 1.063 . . . . 10.0 111.209 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 mm-40 -90.48 -32.0 16.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.876 -1.14 . . . . 10.0 110.464 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ILE . . . . . 0.744 ' O ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -91.96 -29.14 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.038 -1.039 . . . . 10.0 110.239 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 98' ' ' VAL . 69.9 p -62.26 -12.18 19.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 10.0 109.915 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -57.56 -40.68 79.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.558 -0.714 . . . . 10.0 110.639 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.96 -33.76 39.29 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 10.0 110.803 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.3 t -136.29 128.49 17.37 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 10.0 110.092 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.29 126.5 13.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.117 1.588 . . . . 10.0 111.851 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER 55.84 52.07 11.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.37 -0.831 . . . . 10.0 111.119 178.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 22.4 m -63.31 145.17 97.24 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 10.0 109.61 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 41.1 Cg_endo -68.37 157.63 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.642 1.338 . . . . 10.0 109.365 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' PHE . . . . . 0.59 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -159.95 121.97 3.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.94 -1.1 . . . . 10.0 111.237 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -92.29 102.51 15.01 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.149 0.975 . . . . 10.0 110.682 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 71.2 mt -75.56 135.24 40.58 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.817 -0.809 . . . . 10.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' VAL . . . . . 0.684 ' CG2' HG11 ' A' ' 168' ' ' VAL . 19.4 t -133.75 169.96 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.654 -1.279 . . . . 10.0 112.694 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -140.35 107.11 0.52 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.583 -2.207 . . . . 10.0 107.583 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 t -106.75 -179.51 3.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.267 . . . . 10.0 111.708 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 83' ' ' SER . 16.9 mt-30 61.56 48.16 5.98 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.798 -0.564 . . . . 10.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ILE . . . . . 1.068 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -107.37 -50.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.167 -0.958 . . . . 10.0 110.118 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ASP . . . . . 0.982 ' CB ' HG21 ' A' ' 161' ' ' THR . 11.6 t0 -52.7 61.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.191 0.996 . . . . 10.0 109.947 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER 152.57 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.339 -1.3 . . . . 10.0 108.41 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -46.73 -37.4 8.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 10.0 109.135 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.0 -21.99 9.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.42 -0.8 . . . . 10.0 109.542 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 123' ' ' PRO . 22.9 t0 -84.28 131.77 49.63 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 10.0 110.889 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.534 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.7 Cg_endo -78.22 24.66 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.925 1.487 . . . . 10.0 111.265 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' SER . . . . . 0.482 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 37.1 m -102.76 -46.96 4.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.002 -1.061 . . . . 10.0 109.843 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' THR . . . . . 0.597 HG21 HD12 ' A' ' 119' ' ' LEU . 6.8 t -78.41 -27.42 46.65 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.493 -2.039 . . . . 10.0 105.493 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.29 1.1 mp -57.06 -25.26 22.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 177.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 5.4 tm-20 -50.24 -50.18 50.65 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.747 0.784 . . . . 10.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -65.06 -44.77 87.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.691 -0.63 . . . . 10.0 111.062 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 85' ' ' VAL . 5.6 mt -59.92 -35.51 75.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.235 -0.916 . . . . 10.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' ALA . . . . . 0.66 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -49.62 -42.24 44.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.606 -0.684 . . . . 10.0 110.294 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -19.9 42.17 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.46 -0.775 . . . . 10.0 110.498 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ASN . . . . . 0.527 ' OD1' ' HA ' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -123.07 43.89 2.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.953 -1.092 . . . . 10.0 112.348 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LYS . . . . . 0.523 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.1 mptm? 67.72 150.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 10.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -116.77 66.24 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 10.0 111.387 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 88' ' ' SER . 5.0 mmmt -104.83 94.68 7.8 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.112 -0.992 . . . . 10.0 108.958 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 43.7 Cg_endo -71.22 161.43 45.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.075 1.566 . . . . 10.0 110.681 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 137' ' ' ILE . 3.9 tp -120.13 121.41 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.215 -0.928 . . . . 10.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.4 p -108.46 164.29 15.06 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.22 -0.925 . . . . 10.0 109.206 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 38.3 Cg_endo -67.51 -29.16 37.61 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.589 1.31 . . . . 10.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.78 -34.12 72.6 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.5 m -93.38 -33.51 13.84 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.746 0.784 . . . . 10.0 109.054 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -75.38 -38.56 59.93 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.601 -0.687 . . . . 10.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.0 mt-10 -59.54 -49.23 78.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.258 -0.901 . . . . 10.0 109.836 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -45.26 93.42 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 10.0 109.156 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' HE2' ' A' ' 94' ' ' LYS . 2.8 tt -60.05 -49.37 77.93 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.228 -1.026 . . . . 10.0 108.228 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -55.25 -38.71 68.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 10.0 109.128 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 1.6 mtp-105 -72.23 -4.85 31.89 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.603 -0.686 . . . . 10.0 109.873 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.15 -52.04 7.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 10.0 110.278 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' LEU . . . . . 0.871 ' CD2' HG11 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -89.94 4.86 48.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 10.0 109.309 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 1.8 mttp 73.16 31.17 1.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -55.89 -159.82 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.952 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' VAL . . . . . 0.593 HG11 HD13 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -119.08 -54.74 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 118.941 -1.103 . . . . 10.0 111.516 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -171.53 147.14 2.32 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.934 -1.506 . . . . 10.0 112.621 -179.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 154' ' ' TYR . . . . . 0.555 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 43.2 t80 -97.64 100.05 11.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.735 -0.603 . . . . 10.0 109.45 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 155' ' ' VAL . . . . . 1.007 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.9 t -101.39 -170.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 10.0 110.367 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 156' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 155' ' ' VAL . 12.8 pt-20 -148.22 168.2 23.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 10.0 110.184 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' CYS . . . . . 0.594 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.3 p -176.99 164.8 2.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.157 -0.965 . . . . 10.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' SER . . . . . 0.628 ' CB ' HG23 ' A' ' 161' ' ' THR . 60.2 m -146.27 128.23 15.49 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.605 -0.685 . . . . 10.0 109.939 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ALA . . . . . 0.992 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -63.86 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.621 -0.674 . . . . 10.0 111.597 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' B' ' 29' ' ' PHE . 0.4 OUTLIER -28.06 -52.95 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.57 1.176 . . . . 10.0 109.481 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' THR . . . . . 0.982 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -95.74 -102.28 0.16 Allowed 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.731 -1.122 . . . . 10.0 110.43 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' GLN . . . . . 0.626 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 159.27 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 -178.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' LYS . . . . . 0.552 ' HD2' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -97.35 27.37 4.25 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.566 -1.254 . . . . 10.0 112.545 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 157' ' ' CYS . . . 135.95 14.96 0.95 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 118.708 -1.711 . . . . 10.0 111.99 177.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' LEU . . . . . 1.021 HD22 ' CB ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -49.36 -53.44 22.34 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.177 -1.778 . . . . 10.0 109.833 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -67.14 -29.49 69.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.463 0.649 . . . . 10.0 109.588 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ASN . . . . . 0.589 ' C ' HG11 ' A' ' 155' ' ' VAL . 1.3 m120 -62.3 -32.11 72.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 10.0 111.4 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.5 t -70.88 -49.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.448 -1.408 . . . . 10.0 109.171 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' PHE . . . . . 0.432 ' O ' HG13 ' A' ' 173' ' ' ILE . 92.4 t80 -59.31 -22.92 61.97 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.762 -0.586 . . . . 10.0 110.452 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 167' ' ' ASN . 80.8 m-20 -59.17 -50.93 72.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 10.0 110.416 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 51.2 mp0 -65.88 -31.52 72.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.036 -1.04 . . . . 10.0 108.883 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -63.63 -24.19 67.69 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.814 -0.554 . . . . 10.0 109.625 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 177' ' ' LEU . 72.1 mt -63.61 -43.71 98.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.091 -1.044 . . . . 10.0 108.542 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' LEU . . . . . 0.799 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.75 -42.33 67.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.188 -0.945 . . . . 10.0 110.179 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.1 -0.12 30.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.526 -0.733 . . . . 10.0 109.985 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' ALA . . . . . 0.955 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -83.33 -44.57 14.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.898 . . . . 10.0 109.851 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -98.85 -17.56 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.822 . . . . 10.0 109.302 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 118.003 -0.998 . . . . 10.0 110.028 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -126.54 150.2 48.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -1.131 . . . . 10.0 110.196 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -117.96 88.41 2.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.365 -0.835 . . . . 10.0 109.272 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 4' ' ' GLU . . . . . 0.442 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 2.8 mm-40 -87.36 178.18 6.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.84 0.828 . . . . 10.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 5' ' ' ARG . . . . . 0.632 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.12 -149.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 6' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -72.14 0.37 7.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 CA-C-N 119.325 0.795 . . . . 10.0 110.589 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 7' ' ' GLU . . . . . 0.486 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.8 mm-40 46.21 -165.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 10.0 110.427 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 8' ' ' ILE . . . . . 0.663 HD12 ' OG ' ' B' ' 9' ' ' SER . 1.4 pp -80.35 -45.01 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 10.0 111.661 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 9' ' ' SER . . . . . 0.663 ' OG ' HD12 ' B' ' 8' ' ' ILE . 67.4 m -122.08 151.32 41.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.221 . . . . 10.0 112.137 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 10' ' ' LEU . . . . . 0.875 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -170.84 97.53 0.43 Allowed Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.363 -0.836 . . . . 10.0 113.153 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 11' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -77.35 156.08 32.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 N-CA-C 107.877 -1.624 . . . . 10.0 107.877 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -117.68 163.49 16.39 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.587 -1.321 . . . . 10.0 111.966 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.32 176.46 10.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.073 -1.084 . . . . 10.0 108.073 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -170.63 144.61 2.38 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.784 -1.198 . . . . 10.0 110.792 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 59.8 tt0 -141.02 137.48 32.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -121.77 129.44 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.036 -1.04 . . . . 10.0 112.103 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 17' ' ' THR . . . . . 0.647 ' C ' HD12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -141.54 98.22 3.31 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 18' ' ' ILE . . . . . 0.927 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.4 mp -106.45 140.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 19' ' ' HIS . . . . . 0.585 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 33.8 m170 -132.89 123.59 26.29 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.353 -0.842 . . . . 10.0 110.94 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 20' ' ' VAL . . . . . 0.71 HG23 ' HB ' ' A' ' 36' ' ' VAL . 1.4 p -140.37 130.18 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 10.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -145.56 10.87 1.71 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.846 -1.302 . . . . 10.0 109.846 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 22' ' ' PHE . . . . . 0.769 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -143.93 85.26 1.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.334 -1.098 . . . . 10.0 109.794 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 23' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 10.7 t70 -56.97 151.88 14.01 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.565 0.698 . . . . 10.0 111.416 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 24' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 69.98 19.84 6.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.557 -0.714 . . . . 10.0 111.099 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 25' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' B' ' 22' ' ' PHE . 25.3 t -110.47 -39.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.057 -1.027 . . . . 10.0 110.281 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CB ' ' A' ' 18' ' ' CYS . 6.5 m -94.95 -10.04 32.23 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.314 -0.866 . . . . 10.0 112.605 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 27' ' ' GLY . . . . . 0.627 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -111.59 -15.89 9.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.629 -1.788 . . . . 10.0 108.629 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -86.3 108.44 18.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.638 1.209 . . . . 10.0 110.683 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 29' ' ' PHE . . . . . 0.94 ' CE2' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -117.8 113.65 22.11 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.31 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' CE1' ' A' ' 28' ' ' PHE . 42.3 p -154.78 -61.94 0.12 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.483 -0.78 . . . . 10.0 109.78 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 31' ' ' GLY . . . . . 0.468 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -165.52 66.62 0.21 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.611 -1.796 . . . . 10.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 32' ' ' ILE . . . . . 0.572 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 11.2 pt -102.77 168.26 9.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.349 -1.089 . . . . 10.0 110.947 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 33' ' ' PRO . . . . . 0.572 ' HD2' ' HB ' ' B' ' 32' ' ' ILE . 38.6 Cg_endo -65.42 178.12 2.27 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.004 1.528 . . . . 10.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 34' ' ' GLU . . . . . 0.54 ' OE1' ' CA ' ' A' ' 12' ' ' GLY . 6.6 tp10 -36.56 160.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.744 0.783 . . . . 10.0 111.89 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -72.63 -70.68 0.33 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.583 -0.698 . . . . 10.0 112.768 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 36' ' ' TRP . . . . . 0.653 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.27 22.44 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 10.0 110.101 -179.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' B' B ' 37' ' ' ALA . . . . . 0.667 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . 178.96 99.7 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.817 0.818 . . . . 10.0 110.026 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 38' ' ' ARG . . . . . 0.468 ' HA ' ' HG2' ' B' ' 34' ' ' GLU . 1.8 ttt180 . . . . . 0 C--N 1.297 -1.708 0 N-CA-C 106.902 -1.518 . . . . 10.0 106.902 178.071 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.446 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.547 0 CA-C-O 121.431 0.634 . . . . 10.0 110.088 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.537 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 30.1 mm100 -129.57 -24.32 2.77 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.552 -0.717 . . . . 10.0 109.997 179.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.567 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 95.1 m -57.84 115.93 3.14 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.243 -0.91 . . . . 10.0 111.289 -179.603 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.588 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -122.85 132.77 70.7 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 C-N-CA 119.592 -0.843 . . . . 10.0 109.898 178.538 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.888 ' HB3' HG22 ' A' ' 75' ' ' THR . 46.4 mmtt -123.2 101.65 7.5 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.503 -0.925 . . . . 10.0 108.503 179.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 47.4 t -113.24 145.17 41.47 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.885 0.85 . . . . 10.0 112.801 -177.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.809 HG22 HG21 ' A' ' 75' ' ' THR . 0.2 OUTLIER -151.59 -176.0 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 N-CA-C 108.65 -0.871 . . . . 10.0 108.65 178.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.753 HG21 ' HD1' ' B' ' 36' ' ' TRP . 22.7 m -91.59 108.55 20.11 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 O-C-N 121.224 -0.922 . . . . 10.0 109.877 179.394 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.616 HG12 ' H ' ' A' ' 10' ' ' GLY . 2.1 t -113.47 -170.71 0.45 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 O-C-N 120.977 -1.077 . . . . 10.0 110.19 -179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.616 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 137.62 -144.77 16.26 Favored Glycine 0 N--CA 1.492 2.402 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -113.73 20.22 16.06 Favored 'General case' 0 N--CA 1.491 1.582 0 O-C-N 121.226 -1.161 . . . . 10.0 109.637 179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 106.19 75.87 0.99 Allowed Glycine 0 N--CA 1.486 2.016 0 N-CA-C 109.034 -1.626 . . . . 10.0 109.034 -179.481 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -137.63 -174.59 3.81 Favored 'General case' 0 C--N 1.303 -1.45 0 O-C-N 121.427 -1.043 . . . . 10.0 109.766 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.534 ' HB ' ' CD2' ' B' ' 29' ' ' PHE . 40.6 t -67.13 161.77 3.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.114 -0.991 . . . . 10.0 110.647 -179.832 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.473 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -53.02 111.97 1.98 Allowed Glycine 0 N--CA 1.487 2.098 0 N-CA-C 108.427 -1.869 . . . . 10.0 108.427 178.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 11.1 tppt? -48.61 -28.0 3.18 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.179 -1.189 . . . . 10.0 110.428 -178.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.489 HG23 HD12 ' A' ' 20' ' ' LEU . 26.1 m -66.01 -30.62 71.2 Favored 'General case' 0 C--N 1.299 -1.603 0 O-C-N 121.15 -0.969 . . . . 10.0 111.072 -179.809 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 16.3 p -63.2 -9.89 13.08 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 120.819 -1.175 . . . . 10.0 109.733 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.751 HD21 ' HB2' ' B' ' 29' ' ' PHE . 5.3 mt -94.81 -34.08 12.62 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.424 -0.797 . . . . 10.0 110.184 -179.396 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.489 HD12 HG23 ' A' ' 17' ' ' THR . 79.4 mt -46.49 -30.46 2.21 Favored 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 108.311 -0.996 . . . . 10.0 108.311 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.699 HG23 ' OD1' ' A' ' 26' ' ' ASN 0.251 1.7 mm -85.76 -47.57 16.57 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.798 0 CA-C-O 121.749 0.785 . . . . 10.0 109.552 178.421 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.421 ' C ' ' O ' ' A' ' 21' ' ' ILE . 57.1 m -48.26 -38.34 18.4 Favored 'General case' 0 C--N 1.288 -2.067 0 C-N-CA 118.887 -1.125 . . . . 10.0 108.115 -179.568 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.778 ' CG ' HD11 ' A' ' 165' ' ' LEU . 20.2 m-85 -68.06 -31.0 70.35 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 107.797 -1.186 . . . . 10.0 107.797 177.192 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 25' ' ' THR . 95.9 m -76.83 -51.87 10.52 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.847 -0.533 . . . . 10.0 110.475 179.709 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.651 HG22 HG22 ' A' ' 24' ' ' THR . 2.9 t -178.99 -34.97 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.383 0 N-CA-C 115.875 1.805 . . . . 10.0 115.875 179.745 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.717 ' OD1' HG23 ' A' ' 33' ' ' VAL . 15.4 m120 -67.47 -8.32 32.48 Favored 'General case' 0 N--CA 1.5 2.051 0 O-C-N 120.088 -1.632 . . . . 10.0 113.085 -176.473 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.644 ' HG3' ' HD3' ' A' ' 29' ' ' PRO . 26.4 pttt 33.59 -131.6 0.05 OUTLIER 'General case' 0 N--CA 1.516 2.845 0 O-C-N 121.195 -0.941 . . . . 10.0 111.262 179.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.644 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 2.7 p90 -145.33 50.65 1.14 Allowed Pre-proline 0 N--CA 1.507 2.381 0 O-C-N 120.5 -1.375 . . . . 10.0 112.815 -179.658 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.644 ' HD3' ' HG3' ' A' ' 27' ' ' LYS . 46.4 Cg_endo -103.53 -86.64 0.0 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.775 1.65 . . . . 10.0 110.396 -179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 84.2 p -166.98 36.63 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.387 -0.821 . . . . 10.0 110.149 -179.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.798 ' O ' ' HB2' ' B' ' 24' ' ' ALA . 0.0 OUTLIER -78.61 -169.65 1.8 Allowed 'General case' 0 C--N 1.301 -1.53 0 CA-C-O 122.571 1.176 . . . . 10.0 111.853 -179.176 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.478 ' O ' ' OE1' ' A' ' 31' ' ' GLU . 5.8 t80 -109.33 120.07 41.38 Favored 'General case' 0 C--N 1.294 -1.815 0 CA-C-N 114.825 -1.079 . . . . 10.0 109.006 178.411 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.827 HG22 ' HD2' ' A' ' 34' ' ' PRO 0.286 2.4 p -145.42 161.59 40.68 Favored Pre-proline 0 N--CA 1.502 2.127 0 O-C-N 121.191 -0.943 . . . . 10.0 109.688 -177.926 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.827 ' HD2' HG22 ' A' ' 33' ' ' VAL . 33.5 Cg_endo -55.65 168.76 1.47 Allowed 'Trans proline' 0 N--CA 1.491 1.356 0 O-C-N 122.935 0.966 . . . . 10.0 110.63 179.027 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.549 ' OG1' ' CB ' ' B' ' 19' ' ' HIS . 0.3 OUTLIER -92.96 165.23 12.97 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 123.266 1.507 . . . . 10.0 114.945 -176.373 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.978 ' CG2' HG11 ' B' ' 25' ' ' VAL 0.279 2.5 t -45.99 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.243 0 N-CA-C 116.226 1.936 . . . . 10.0 116.226 -177.933 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.855 ' N ' HG12 ' A' ' 36' ' ' VAL . 4.6 t80 -32.29 154.52 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.73 0 CA-C-O 121.944 0.878 . . . . 10.0 111.603 -175.488 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.573 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -168.03 83.0 0.18 Allowed 'General case' 0 C--N 1.298 -1.66 0 N-CA-C 108.008 -1.108 . . . . 10.0 108.008 -179.443 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.565 ' HB3' HD13 ' B' ' 18' ' ' ILE . 50.8 t30 -113.66 109.11 18.07 Favored 'General case' 0 C--N 1.303 -1.447 0 O-C-N 121.159 -0.963 . . . . 10.0 110.017 -179.101 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.718 ' CD2' ' HA ' ' B' ' 16' ' ' HIS . 3.6 t80 -128.43 128.35 44.27 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.694 -0.629 . . . . 10.0 110.128 -179.498 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.743 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -141.58 94.68 2.71 Favored 'General case' 0 N--CA 1.492 1.632 0 N-CA-C 107.495 -1.298 . . . . 10.0 107.495 177.851 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.878 HG13 ' HB2' ' B' ' 14' ' ' PHE 0.296 51.6 t -163.94 178.77 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.552 0 CA-C-O 121.394 0.616 . . . . 10.0 110.227 -176.845 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.595 ' HA ' ' O ' ' A' ' 51' ' ' TYR . 18.9 m -125.24 126.47 45.22 Favored 'General case' 0 C--N 1.301 -1.537 0 O-C-N 121.522 -0.736 . . . . 10.0 109.502 177.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.939 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -73.76 165.71 2.99 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 121.153 -0.967 . . . . 10.0 110.024 179.914 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.548 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 51.5 mtt -137.69 104.79 5.41 Favored 'General case' 0 C--N 1.297 -1.687 0 C-N-CA 119.199 -1.0 . . . . 10.0 109.531 178.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.751 HG22 ' HB2' ' B' ' 7' ' ' GLU . 38.7 mt -123.75 128.79 74.55 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.622 0 O-C-N 121.751 -0.593 . . . . 10.0 109.734 -179.126 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.584 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 52.18 21.39 8.13 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 109.633 -1.387 . . . . 10.0 109.633 -179.857 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 89.47 8.61 67.87 Favored Glycine 0 N--CA 1.49 2.286 0 O-C-N 121.155 -1.203 . . . . 10.0 110.302 179.437 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -103.47 112.56 65.73 Favored Pre-proline 0 N--CA 1.49 1.543 0 O-C-N 120.836 -1.39 . . . . 10.0 110.976 -179.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.525 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 44.1 Cg_endo -74.4 139.35 25.86 Favored 'Trans proline' 0 C--N 1.305 -1.717 0 O-C-N 123.951 1.501 . . . . 10.0 110.251 179.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.939 ' HB2' HG12 ' A' ' 44' ' ' VAL . 3.6 t80 -117.49 121.37 40.83 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.179 -0.95 . . . . 10.0 109.963 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.58 ' O ' HG22 ' A' ' 4' ' ' ILE . 1.1 m -74.82 119.82 19.52 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 120.625 -1.297 . . . . 10.0 110.151 179.84 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.472 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 13.3 mt -123.11 149.31 44.66 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 121.235 -0.915 . . . . 10.0 110.592 -179.765 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.473 ' O ' ' HA ' ' A' ' 5' ' ' LYS . . . -170.89 110.47 0.36 Allowed Glycine 0 N--CA 1.496 2.664 0 C-N-CA 119.752 -1.213 . . . . 10.0 110.332 179.475 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.5 pp -150.41 168.43 24.17 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.141 -1.211 . . . . 10.0 110.076 179.484 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.67 ' CD2' HD11 ' A' ' 67' ' ' LEU . 32.9 p90 -166.36 140.83 4.32 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.882 -1.136 . . . . 10.0 111.218 178.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.417 ' O ' ' HG ' ' A' ' 67' ' ' LEU . 3.8 t70 -119.72 159.99 23.42 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.394 -0.816 . . . . 10.0 110.444 -179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.57 ' HA ' ' CB ' ' A' ' 67' ' ' LEU . 0.2 OUTLIER -56.31 -168.8 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.797 0 CA-C-O 121.841 0.829 . . . . 10.0 112.131 -179.223 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.735 ' HB2' ' CD1' ' A' ' 64' ' ' TYR . . . 53.5 70.55 0.58 Allowed 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.637 -0.664 . . . . 10.0 110.865 -179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.479 ' HA3' ' HB2' ' A' ' 66' ' ' ARG . . . -75.33 -9.04 84.3 Favored Glycine 0 N--CA 1.485 1.93 0 N-CA-C 108.326 -1.91 . . . . 10.0 108.326 178.465 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.602 ' O ' ' CB ' ' A' ' 62' ' ' GLU . 1.8 tt0 -156.45 24.51 0.35 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 121.422 -1.046 . . . . 10.0 110.22 179.708 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.602 ' CB ' ' O ' ' A' ' 61' ' ' GLN . 4.4 tt0 79.3 -7.63 1.71 Allowed 'General case' 0 N--CA 1.502 2.153 0 O-C-N 121.494 -0.754 . . . . 10.0 109.963 -179.685 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.483 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 1.1 m-20 -94.28 -11.47 30.09 Favored 'General case' 0 C--N 1.304 -1.391 0 O-C-N 121.281 -0.887 . . . . 10.0 108.759 178.602 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.735 ' CD1' ' HB2' ' A' ' 59' ' ' ALA . 46.7 m-85 62.65 26.67 15.78 Favored 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 108.142 -1.059 . . . . 10.0 108.142 -179.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.421 ' O ' ' HB3' ' A' ' 68' ' ' ARG . 30.5 t0 -114.88 -36.49 4.45 Favored 'General case' 0 C--N 1.298 -1.671 0 C-N-CA 119.925 -0.71 . . . . 10.0 111.111 -178.448 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.479 ' HB2' ' HA3' ' A' ' 60' ' ' GLY . 6.3 mmt85 -56.4 -26.18 52.41 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.905 -1.122 . . . . 10.0 108.934 179.338 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.67 HD11 ' CD2' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -103.81 10.88 36.32 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.827 -0.546 . . . . 10.0 109.751 179.8 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.666 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -82.79 -20.37 0.28 Allowed Pre-proline 0 N--CA 1.495 1.78 0 N-CA-C 113.356 0.873 . . . . 10.0 113.356 -179.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.666 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 45.9 Cg_endo -75.33 2.07 7.2 Favored 'Trans proline' 0 N--CA 1.484 0.968 0 N-CA-C 110.37 -0.665 . . . . 10.0 110.37 -179.466 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.002 HD11 HD13 ' B' ' 39' ' ' LEU . 0.5 OUTLIER -52.78 -64.47 0.81 Allowed 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.199 -0.938 . . . . 10.0 112.184 -179.209 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.552 ' HA ' ' N ' ' B' ' 40' ' ' LEU . 24.8 t 41.98 27.08 0.06 Allowed 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.367 -1.458 . . . . 10.0 110.249 179.29 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.444 ' HB2' ' O ' ' A' ' 71' ' ' SER . 2.1 t80 -179.84 120.6 0.22 Allowed Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.248 -0.908 . . . . 10.0 110.744 -179.44 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -80.28 118.33 3.61 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 O-C-N 123.838 1.441 . . . . 10.0 110.225 179.064 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -128.71 66.74 1.4 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.964 -1.085 . . . . 10.0 110.584 -179.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.888 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -145.33 99.99 3.39 Favored 'General case' 0 C--N 1.307 -1.277 0 O-C-N 121.16 -0.963 . . . . 10.0 109.703 179.825 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.66 ' CA ' HG21 ' A' ' 108' ' ' THR . 21.6 m-20 -24.63 -53.51 0.04 OUTLIER 'General case' 0 N--CA 1.499 2.019 0 N-CA-C 112.953 0.724 . . . . 10.0 112.953 -178.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.542 HG11 ' CB ' ' A' ' 176' ' ' ALA . 1.0 OUTLIER -94.03 118.0 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.929 0 O-C-N 120.964 -1.085 . . . . 10.0 110.781 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.504 ' CB ' HG21 ' A' ' 9' ' ' VAL . 97.3 m-85 -111.33 127.6 55.69 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.43 -0.794 . . . . 10.0 111.203 -179.438 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.783 HD22 HD23 ' A' ' 111' ' ' LEU . 1.9 mm? -95.44 97.69 9.99 Favored 'General case' 0 N--CA 1.487 1.419 0 O-C-N 120.924 -1.11 . . . . 10.0 108.342 178.058 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.571 HG12 ' HB ' ' A' ' 9' ' ' VAL . 1.6 m -106.41 148.18 11.07 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.397 -0.814 . . . . 10.0 109.822 -178.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.491 ' SG ' ' CG2' ' A' ' 115' ' ' THR . 7.2 t -138.17 122.37 18.09 Favored 'General case' 0 C--N 1.303 -1.448 0 O-C-N 120.855 -1.153 . . . . 10.0 110.353 179.883 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.542 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 43.0 p90 -124.46 172.95 8.77 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.239 -0.913 . . . . 10.0 109.523 178.599 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.851 ' OG ' HG22 ' A' ' 85' ' ' VAL . 47.3 t -105.24 148.81 26.56 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.7 -1.25 . . . . 10.0 111.058 -178.678 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.49 ' HA ' ' CG2' ' A' ' 137' ' ' ILE . 19.4 m -86.79 19.02 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.478 -0.764 . . . . 10.0 110.225 179.965 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.851 HG22 ' OG ' ' A' ' 83' ' ' SER . 35.3 m -128.0 48.41 0.49 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 O-C-N 121.39 -0.819 . . . . 10.0 110.513 -179.357 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.53 ' HB3' ' OG ' ' A' ' 89' ' ' SER . 49.6 m -123.2 166.18 19.27 Favored Pre-proline 0 C--N 1.294 -1.807 0 O-C-N 121.287 -0.883 . . . . 10.0 110.358 -179.376 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HB3' ' ND2' ' A' ' 132' ' ' ASN . 48.2 Cg_endo -72.44 105.9 1.97 Allowed 'Trans proline' 0 C--N 1.305 -1.727 0 O-C-N 123.965 1.508 . . . . 10.0 111.056 -179.155 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.419 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER 39.46 42.9 0.93 Allowed 'General case' 0 N--CA 1.497 1.908 0 O-C-N 121.304 -0.873 . . . . 10.0 110.836 179.303 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.53 ' OG ' ' HB3' ' A' ' 86' ' ' SER . 65.6 m -79.15 -49.51 12.47 Favored 'General case' 0 C--N 1.303 -1.415 0 O-C-N 121.065 -1.022 . . . . 10.0 110.446 -179.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.652 ' CD2' ' HE3' ' A' ' 94' ' ' LYS . 34.9 t80 -57.53 -30.38 65.13 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.336 -0.853 . . . . 10.0 110.299 -179.929 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.469 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 57.4 mm-40 -70.47 -15.09 62.77 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.051 -1.031 . . . . 10.0 110.504 179.422 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.697 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.63 -21.46 30.28 Favored 'General case' 0 N--CA 1.488 1.432 0 C-N-CA 119.18 -1.008 . . . . 10.0 111.38 -178.796 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.697 HG13 ' ND2' ' A' ' 92' ' ' ASN . 4.2 m -87.68 -16.38 9.09 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 C-N-CA 117.765 -1.574 . . . . 10.0 108.544 179.536 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.816 ' HE2' HD22 ' A' ' 145' ' ' LEU . 1.2 mmtp -68.68 -37.45 79.58 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 107.58 -1.267 . . . . 10.0 107.58 177.45 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 4.4 pt-20 -95.51 8.29 43.73 Favored 'General case' 0 C--N 1.296 -1.738 0 CA-C-N 115.582 -0.736 . . . . 10.0 110.306 -179.795 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.564 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -111.18 -52.09 2.81 Favored 'General case' 0 N--CA 1.49 1.559 0 C-N-CA 118.58 -1.248 . . . . 10.0 112.595 -178.951 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.564 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 19.7 m95 -95.59 -18.79 20.29 Favored 'General case' 0 C--N 1.294 -1.806 0 O-C-N 121.502 -0.749 . . . . 10.0 111.527 -177.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.799 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.1 t -85.45 -46.85 0.61 Allowed Pre-proline 0 C--N 1.296 -1.73 0 O-C-N 120.97 -1.081 . . . . 10.0 111.5 -179.029 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.558 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 51.4 Cg_endo -74.85 -24.15 13.45 Favored 'Trans proline' 0 C--N 1.314 -1.26 0 N-CA-C 108.759 -1.285 . . . . 10.0 108.759 -179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.526 ' C ' HG12 ' A' ' 101' ' ' ILE . 8.6 tt0 -87.59 -22.53 24.72 Favored 'General case' 0 N--CA 1.488 1.469 0 CA-C-N 116.163 -0.471 . . . . 10.0 110.488 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.526 HG12 ' C ' ' A' ' 100' ' ' GLU . 4.2 mm 60.55 125.16 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 N-CA-C 108.6 -0.889 . . . . 10.0 108.6 -178.651 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.825 HG21 ' OG1' ' A' ' 108' ' ' THR . 1.2 m -40.84 -78.22 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.867 0 O-C-N 121.04 -1.037 . . . . 10.0 109.761 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.7 ' N ' HG22 ' A' ' 102' ' ' THR . 0.1 OUTLIER -108.32 10.74 27.57 Favored 'General case' 0 C--N 1.296 -1.746 0 O-C-N 121.222 -0.924 . . . . 10.0 109.778 178.731 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.566 ' HB2' ' O ' ' A' ' 103' ' ' HIS . 17.5 m80 82.52 14.08 0.47 Allowed 'General case' 0 N--CA 1.5 2.064 0 CA-C-O 120.902 0.382 . . . . 10.0 110.776 179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.537 ' HB3' ' CD ' ' A' ' 106' ' ' PRO . 1.6 t -170.65 -60.81 0.0 OUTLIER Pre-proline 0 N--CA 1.486 1.337 0 C-N-CA 118.814 -1.154 . . . . 10.0 112.029 -179.217 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.537 ' CD ' ' HB3' ' A' ' 105' ' ' CYS . 37.7 Cg_endo -63.77 -21.74 69.51 Favored 'Trans proline' 0 C--N 1.306 -1.66 0 O-C-N 123.338 1.178 . . . . 10.0 111.532 -178.358 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.42 ' C ' ' O ' ' A' ' 106' ' ' PRO . 2.0 mttt 47.49 51.13 14.09 Favored 'General case' 0 C--N 1.303 -1.428 0 O-C-N 120.733 -1.229 . . . . 10.0 108.843 -179.624 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.825 ' OG1' HG21 ' A' ' 102' ' ' THR . 1.4 m -45.65 150.48 0.93 Allowed Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 109.402 -0.592 . . . . 10.0 109.402 179.943 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.729 ' HD2' HG22 ' A' ' 108' ' ' THR . 39.6 Cg_endo -63.66 149.92 89.71 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 O-C-N 123.746 1.393 . . . . 10.0 112.748 -178.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.696 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -131.73 109.5 10.21 Favored 'General case' 0 N--CA 1.488 1.432 0 N-CA-C 109.013 -0.736 . . . . 10.0 109.013 179.121 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.068 HD13 HG11 ' A' ' 152' ' ' VAL . 1.9 mm? -77.2 95.4 4.29 Favored 'General case' 0 C--N 1.291 -1.969 0 C-N-CA 119.028 -1.069 . . . . 10.0 109.388 -179.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.42 ' C ' ' CG2' ' A' ' 113' ' ' VAL . 19.1 mt -75.62 142.02 42.73 Favored 'General case' 0 N--CA 1.491 1.612 0 CA-C-N 115.616 -0.72 . . . . 10.0 109.154 179.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.7 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -148.32 -177.48 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.157 0 O-C-N 120.596 -1.315 . . . . 10.0 112.332 -179.013 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.7 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -125.4 120.61 3.95 Favored Glycine 0 N--CA 1.493 2.462 0 N-CA-C 108.752 -1.739 . . . . 10.0 108.752 178.663 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.491 ' CG2' ' SG ' ' A' ' 81' ' ' CYS . 23.4 p -78.32 139.2 38.85 Favored 'General case' 0 N--CA 1.502 2.174 0 O-C-N 120.829 -1.395 . . . . 10.0 110.952 -179.386 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.487 ' C ' ' O ' ' A' ' 115' ' ' THR . 56.7 mt-30 34.41 57.38 0.67 Allowed 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 121.204 0.526 . . . . 10.0 110.085 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -79.75 -27.72 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.317 -0.864 . . . . 10.0 110.592 -178.822 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.813 ' OD2' HG21 ' A' ' 161' ' ' THR . 25.1 t0 -51.88 61.6 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.12 0 CA-C-O 121.835 0.826 . . . . 10.0 111.966 -176.065 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.706 ' N ' ' O ' ' A' ' 117' ' ' ILE . 20.1 tp 152.79 -39.95 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 N-CA-C 107.282 -1.377 . . . . 10.0 107.282 179.846 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.705 ' HB2' ' HA ' ' A' ' 117' ' ' ILE . 1.2 mpt_? -46.04 -25.66 0.6 Allowed 'General case' 0 C--N 1.298 -1.641 0 CA-C-N 115.327 -0.851 . . . . 10.0 109.855 178.387 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.43 ' OD1' ' C ' ' A' ' 121' ' ' ASP . 4.1 p30 -84.69 -0.13 52.4 Favored 'General case' 0 N--CA 1.487 1.381 0 O-C-N 121.306 -0.872 . . . . 10.0 111.145 -179.313 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.831 ' O ' HD13 ' A' ' 126' ' ' ILE . 5.8 p-10 -83.32 160.14 60.35 Favored Pre-proline 0 N--CA 1.499 2.003 0 O-C-N 120.88 -1.138 . . . . 10.0 109.944 179.738 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 51.3 Cg_endo -84.83 22.73 0.91 Allowed 'Trans proline' 0 C--N 1.315 -1.229 0 O-C-N 123.55 1.289 . . . . 10.0 111.769 -179.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.479 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 4.2 m -109.68 -47.6 3.34 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.976 -1.078 . . . . 10.0 109.79 179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.809 HG22 ' OD1' ' A' ' 122' ' ' ASP . 6.6 t -78.44 -27.14 46.43 Favored 'General case' 0 C--N 1.296 -1.719 0 N-CA-C 105.828 -1.915 . . . . 10.0 105.828 177.298 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.831 HD13 ' O ' ' A' ' 122' ' ' ASP 0.283 1.0 OUTLIER -53.19 -28.82 15.18 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 N-CA-C 107.391 -1.337 . . . . 10.0 107.391 177.02 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 17.0 tp10 -52.99 -40.41 63.77 Favored 'General case' 0 N--CA 1.492 1.671 0 CA-C-O 121.578 0.704 . . . . 10.0 111.308 179.487 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 17.5 mmtm -60.4 -34.13 73.48 Favored 'General case' 0 N--CA 1.499 2.02 0 O-C-N 121.472 -0.767 . . . . 10.0 112.028 -178.57 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.79 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -61.89 -39.16 90.99 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 120.831 -1.168 . . . . 10.0 109.659 -179.685 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.504 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -52.83 -44.56 66.81 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.568 -0.708 . . . . 10.0 111.232 -179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 2.5 mtpm? -54.66 -18.12 4.19 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 121.149 -0.97 . . . . 10.0 110.376 -179.109 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.56 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 8.1 t30 -126.9 -53.61 1.42 Allowed 'General case' 0 N--CA 1.487 1.383 0 O-C-N 120.735 -1.228 . . . . 10.0 110.279 179.041 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.464 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -137.03 116.01 12.36 Favored 'General case' 0 C--N 1.296 -1.743 0 O-C-N 121.596 -0.69 . . . . 10.0 110.518 -179.931 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.577 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.4 OUTLIER -74.97 -3.02 29.78 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.697 -0.627 . . . . 10.0 110.5 -179.761 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -104.49 93.97 6.55 Favored Pre-proline 0 C--N 1.304 -1.37 0 O-C-N 121.579 -0.701 . . . . 10.0 109.277 179.018 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 49.3 Cg_endo -73.75 161.71 41.12 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.898 1.473 . . . . 10.0 110.333 -179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.53 HG12 ' CG ' ' A' ' 90' ' ' PHE . 1.5 tp -100.83 134.93 39.24 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.464 0 O-C-N 121.266 -0.896 . . . . 10.0 109.505 179.477 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.513 ' H ' HD12 ' A' ' 137' ' ' ILE . 20.1 p -120.04 165.56 17.59 Favored Pre-proline 0 C--N 1.296 -1.754 0 O-C-N 121.352 -0.843 . . . . 10.0 109.807 -179.227 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.494 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.71 -35.13 29.41 Favored 'Trans proline' 0 C--N 1.303 -1.842 0 O-C-N 123.829 1.436 . . . . 10.0 111.063 -179.079 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -70.09 -15.81 63.04 Favored 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.113 -0.992 . . . . 10.0 110.999 -179.447 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 6.3 m -98.36 -36.54 9.95 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.315 -0.866 . . . . 10.0 110.184 -179.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.611 ' CB ' ' CE2' ' A' ' 154' ' ' TYR . . . -64.57 -29.12 70.14 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.416 -0.802 . . . . 10.0 110.305 -179.993 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -53.81 -41.47 67.37 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.019 -1.05 . . . . 10.0 109.314 179.527 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.49 ' O ' ' CB ' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -56.16 -36.96 68.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.557 -0.714 . . . . 10.0 109.465 179.022 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.816 HD22 ' HE2' ' A' ' 94' ' ' LYS . 4.2 tp -62.06 -49.55 75.53 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.116 -0.99 . . . . 10.0 108.902 178.803 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.426 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.11 -44.44 94.87 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.042 -1.036 . . . . 10.0 109.406 179.276 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 28.2 ttp85 -78.04 -7.96 57.58 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.525 -0.734 . . . . 10.0 110.297 179.43 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.49 ' CB ' ' O ' ' A' ' 144' ' ' LYS . 4.9 t70 -98.6 -37.88 9.36 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 122.388 1.09 . . . . 10.0 109.235 179.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.033 HD22 ' O ' ' A' ' 149' ' ' LEU 0.26 0.0 OUTLIER -103.07 -1.15 29.64 Favored 'General case' 0 C--N 1.293 -1.891 0 CA-C-N 115.309 -0.86 . . . . 10.0 109.513 -178.658 . . . . . . . . 4 4 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.548 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 24.4 mttm 67.78 54.69 0.63 Allowed 'General case' 0 N--CA 1.491 1.611 0 O-C-N 121.168 -0.958 . . . . 10.0 111.359 178.229 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.553 ' HB2' ' CD1' ' A' ' 149' ' ' LEU . . . -86.24 -150.36 0.15 Allowed 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 109.061 -0.718 . . . . 10.0 109.061 178.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.068 HG11 HD13 ' A' ' 111' ' ' LEU . 9.9 p -116.54 -51.56 4.55 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.477 0 O-C-N 120.567 -1.333 . . . . 10.0 110.533 179.878 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.893 ' HD3' HG13 ' A' ' 155' ' ' VAL . 0.1 OUTLIER -172.42 142.31 1.28 Allowed 'General case' 0 N--CA 1.495 1.782 0 O-C-N 120.603 -1.31 . . . . 10.0 111.238 179.44 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.611 ' CE2' ' CB ' ' A' ' 142' ' ' ALA . 46.6 t80 -94.26 110.15 21.92 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 121.15 -0.969 . . . . 10.0 109.069 178.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.893 HG13 ' HD3' ' A' ' 153' ' ' LYS . 0.8 OUTLIER -116.19 -168.4 0.42 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.93 0 O-C-N 120.973 -1.08 . . . . 10.0 112.087 -178.595 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 19.1 mt-10 -153.27 147.04 25.21 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.279 -0.888 . . . . 10.0 110.781 -179.719 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.59 ' HB3' ' HB2' ' A' ' 165' ' ' LEU . 25.6 p -148.07 152.51 37.51 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.174 -0.954 . . . . 10.0 111.275 179.219 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.552 ' HB3' ' OG1' ' A' ' 161' ' ' THR . 0.5 OUTLIER -135.14 86.23 2.23 Favored 'General case' 0 C--N 1.299 -1.614 0 N-CA-C 107.192 -1.41 . . . . 10.0 107.192 178.66 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.643 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . . . -24.37 -49.67 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.91 0 N-CA-C 113.802 1.038 . . . . 10.0 113.802 -177.096 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.701 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.7 tp -94.12 -55.05 3.34 Favored 'General case' 0 C--N 1.301 -1.533 0 O-C-N 120.403 -1.436 . . . . 10.0 112.196 -178.367 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.813 HG21 ' OD2' ' A' ' 118' ' ' ASP . 24.5 p -64.68 -26.68 68.49 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.96 -1.087 . . . . 10.0 111.008 -177.9 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.536 ' CB ' ' O ' ' A' ' 161' ' ' THR . 3.8 mt-30 79.26 77.05 0.05 Allowed 'General case' 0 N--CA 1.502 2.146 0 O-C-N 121.528 -0.732 . . . . 10.0 112.024 177.871 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.523 ' HD2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -78.35 47.99 0.73 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.208 -0.932 . . . . 10.0 110.006 178.319 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.412 ' C ' ' O ' ' A' ' 163' ' ' LYS . . . 43.49 41.68 5.46 Favored Glycine 0 N--CA 1.494 2.53 0 N-CA-C 109.706 -1.358 . . . . 10.0 109.706 -179.892 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.778 HD11 ' CG ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -70.11 2.51 3.56 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.451 -1.029 . . . . 10.0 112.704 -179.088 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.624 ' N ' HD13 ' A' ' 165' ' ' LEU . 26.9 tttp -58.47 -23.64 58.28 Favored 'General case' 0 C--N 1.298 -1.667 0 O-C-N 120.782 -1.199 . . . . 10.0 108.694 178.644 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 30.1 m120 -76.86 -17.61 58.87 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.692 -0.63 . . . . 10.0 111.038 -179.917 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.825 HG22 ' HB ' ' A' ' 155' ' ' VAL . 42.8 t -67.9 -41.22 84.64 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 120.822 -1.174 . . . . 10.0 108.775 179.087 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 14.8 t80 -86.55 -47.57 9.12 Favored 'General case' 0 C--N 1.297 -1.686 0 CA-C-O 121.599 0.714 . . . . 10.0 110.236 179.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.867 ' HA ' HD12 ' A' ' 173' ' ' ILE . 22.1 t0 -51.88 -35.14 44.05 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.336 -0.852 . . . . 10.0 111.789 -179.306 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.6 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.3 mm-40 -90.02 -11.28 41.97 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.008 -1.058 . . . . 10.0 110.771 -178.81 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.831 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -91.74 -15.27 28.61 Favored 'General case' 0 C--N 1.296 -1.756 0 N-CA-C 108.038 -1.097 . . . . 10.0 108.038 178.114 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.867 HD12 ' HA ' ' A' ' 170' ' ' ASP . 53.9 mt -73.63 -49.38 36.09 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.249 0 C-N-CA 120.097 -0.641 . . . . 10.0 109.322 179.152 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.6 ' CD2' ' HA ' ' A' ' 171' ' ' GLU . 2.1 pt? -76.35 -19.12 58.5 Favored 'General case' 0 C--N 1.313 -1.004 0 C-N-CA 118.813 -1.155 . . . . 10.0 111.113 -179.659 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -89.41 -14.78 34.71 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.121 -0.987 . . . . 10.0 110.085 179.482 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.542 ' CB ' HG11 ' A' ' 77' ' ' VAL . . . -70.25 -44.87 67.59 Favored 'General case' 0 N--CA 1.494 1.752 0 O-C-N 121.204 -0.935 . . . . 10.0 109.653 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.567 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.7 OUTLIER -74.64 -29.09 61.14 Favored 'General case' 0 N--CA 1.491 1.611 0 CA-C-O 121.744 0.783 . . . . 10.0 109.055 179.629 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.458 ' C ' ' O ' ' A' ' 177' ' ' LEU . 0.5 OUTLIER . . . . . 0 N--CA 1.495 1.796 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.603 179.934 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.32 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 68.3 m -129.81 151.77 50.03 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.094 -1.239 . . . . 10.0 110.601 -179.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -109.44 92.49 4.07 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.17 -0.956 . . . . 10.0 110.065 179.673 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -114.02 165.94 12.12 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.499 -0.75 . . . . 10.0 110.869 -179.823 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.664 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.62 -149.76 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.543 0 N-CA-C 107.867 -1.16 . . . . 10.0 107.867 178.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.664 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -73.23 96.18 0.87 Allowed 'Trans proline' 0 C--N 1.32 -0.934 0 N-CA-C 109.772 -0.896 . . . . 10.0 109.772 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.751 ' HB2' HG22 ' A' ' 46' ' ' ILE . 19.6 mm-40 -49.56 -169.7 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.843 0 CA-C-O 121.605 0.717 . . . . 10.0 110.249 -179.56 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.706 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.3 OUTLIER -77.64 -42.47 29.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.546 0 O-C-N 120.756 -1.215 . . . . 10.0 111.949 -178.996 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.66 ' N ' HG12 ' B' ' 8' ' ' ILE . 20.7 t -134.78 172.67 12.65 Favored 'General case' 0 C--N 1.292 -1.903 0 O-C-N 121.06 -1.025 . . . . 10.0 111.348 -178.905 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.644 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.5 pp -167.25 98.02 0.64 Allowed Pre-proline 0 C--N 1.307 -1.28 0 C-N-CA 119.293 -0.963 . . . . 10.0 111.805 179.768 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.548 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 38.4 Cg_endo -69.19 134.69 29.85 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 N-CA-C 108.001 -1.577 . . . . 10.0 108.001 177.03 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.465 ' O ' ' O ' ' B' ' 11' ' ' PRO . 0.9 OUTLIER -53.13 -169.46 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.689 -1.257 . . . . 10.0 111.388 -178.465 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.69 ' OD1' HG11 ' A' ' 42' ' ' VAL . 6.0 p30 -137.6 -172.71 3.3 Favored 'General case' 0 C--N 1.303 -1.44 0 CA-C-O 121.992 0.901 . . . . 10.0 111.263 -179.284 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.878 ' HB2' HG13 ' A' ' 42' ' ' VAL . 49.9 m-85 -54.92 -165.04 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.675 0 CA-C-O 121.8 0.81 . . . . 10.0 111.547 -179.559 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.682 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.5 tt0 -43.59 -175.81 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.863 0 N-CA-C 113.369 0.877 . . . . 10.0 113.369 -178.759 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.718 ' HA ' ' CD2' ' A' ' 40' ' ' TYR . 14.2 p80 -146.58 -169.41 3.27 Favored 'General case' 0 N--CA 1.492 1.655 0 CA-C-O 121.569 0.699 . . . . 10.0 111.871 -179.767 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.417 ' HA ' ' O ' ' A' ' 39' ' ' ASN . 1.0 OUTLIER -79.85 163.17 24.59 Favored 'General case' 0 N--CA 1.497 1.912 0 CA-C-O 121.972 0.891 . . . . 10.0 112.423 -178.431 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.785 ' N ' HD12 ' B' ' 18' ' ' ILE . 3.3 mp -126.19 175.62 8.01 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 N-CA-C 108.798 -0.816 . . . . 10.0 108.798 -179.881 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.549 ' CB ' ' OG1' ' A' ' 35' ' ' THR . 79.3 m-70 -141.59 115.55 9.24 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 120.491 -1.38 . . . . 10.0 112.094 179.836 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.612 ' H ' ' N ' ' A' ' 37' ' ' PHE . 18.4 t -144.96 103.63 0.68 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.155 0 N-CA-C 114.055 1.132 . . . . 10.0 114.055 179.138 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.684 ' HA3' ' CG2' ' A' ' 36' ' ' VAL . . . -150.69 -72.86 0.01 OUTLIER Glycine 0 N--CA 1.49 2.283 0 N-CA-C 110.614 -0.995 . . . . 10.0 110.614 178.514 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.827 ' O ' HG23 ' B' ' 25' ' ' VAL . 69.1 t80 175.86 134.02 0.05 OUTLIER 'General case' 0 C--N 1.308 -1.209 0 N-CA-C 106.66 -1.607 . . . . 10.0 106.66 -179.426 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 89.0 m-20 -39.0 131.37 1.41 Allowed 'General case' 0 C--N 1.277 -2.556 0 CA-C-O 122.043 0.925 . . . . 10.0 111.252 -178.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.798 ' HB2' ' O ' ' A' ' 31' ' ' GLU . . . 69.47 46.41 0.75 Allowed 'General case' 0 N--CA 1.497 1.886 0 O-C-N 121.865 -0.522 . . . . 10.0 111.383 -179.456 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.978 HG11 ' CG2' ' A' ' 36' ' ' VAL . 25.4 t -111.0 -57.09 4.15 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.394 0 O-C-N 120.919 -1.113 . . . . 10.0 109.181 177.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.628 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 38.6 m -51.85 -24.84 6.72 Favored 'General case' 0 C--N 1.31 -1.11 0 CA-C-O 122.176 0.988 . . . . 10.0 109.228 179.107 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.676 ' H ' HG11 ' A' ' 33' ' ' VAL . . . -115.63 46.25 1.19 Allowed Glycine 0 N--CA 1.482 1.757 0 N-CA-C 107.727 -2.149 . . . . 10.0 107.727 179.128 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.586 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 2.2 mt-10 -162.58 123.54 2.51 Favored 'General case' 0 N--CA 1.485 1.297 0 CA-C-O 121.643 0.735 . . . . 10.0 110.152 -179.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.751 ' HB2' HD21 ' A' ' 19' ' ' LEU . 1.0 OUTLIER -122.24 129.26 52.06 Favored 'General case' 0 C--N 1.296 -1.723 0 N-CA-C 108.506 -0.924 . . . . 10.0 108.506 178.643 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.446 ' O ' ' C ' ' B' ' 31' ' ' GLY . 16.6 p -143.85 174.16 11.07 Favored 'General case' 0 C--N 1.293 -1.884 0 O-C-N 121.587 -0.696 . . . . 10.0 111.032 -179.294 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.446 ' C ' ' O ' ' B' ' 30' ' ' THR . . . 35.78 -152.65 0.01 OUTLIER Glycine 0 N--CA 1.493 2.448 0 N-CA-C 110.448 -1.061 . . . . 10.0 110.448 179.391 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.425 ' O ' HG23 ' B' ' 32' ' ' ILE . 0.5 OUTLIER -150.81 70.45 8.69 Favored Pre-proline 0 N--CA 1.489 1.49 0 O-C-N 121.517 -0.99 . . . . 10.0 109.473 -179.801 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.522 ' HB2' ' CH2' ' B' ' 36' ' ' TRP . 51.0 Cg_endo -73.61 177.85 7.48 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 124.573 1.828 . . . . 10.0 111.92 -179.186 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.461 ' HB3' ' CZ3' ' B' ' 36' ' ' TRP . 24.3 tt0 -57.83 159.45 5.4 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.794 0.807 . . . . 10.0 111.006 -179.751 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.59 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 21.2 pt20 -83.51 11.82 6.51 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.719 -0.613 . . . . 10.0 111.376 -179.356 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.753 ' HD1' HG21 ' A' ' 8' ' ' VAL . 0.8 OUTLIER 70.18 36.53 1.85 Allowed 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 121.768 0.794 . . . . 10.0 110.996 -179.853 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.602 ' O ' HD23 ' B' ' 40' ' ' LEU . . . -168.57 -27.27 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.66 -0.65 . . . . 10.0 110.904 179.461 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.524 ' CG ' ' OE1' ' B' ' 35' ' ' GLN . 2.2 mmt180 -60.4 -8.53 2.73 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 120.676 -1.265 . . . . 10.0 110.131 179.397 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 1.002 HD13 HD11 ' A' ' 70' ' ' LEU . 2.5 mp -50.3 -13.99 0.15 Allowed 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.11 -0.994 . . . . 10.0 111.696 179.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.602 HD23 ' O ' ' B' ' 37' ' ' ALA . 0.9 OUTLIER -65.58 -8.76 21.66 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.648 -1.283 . . . . 10.0 110.771 179.581 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -169.68 47.53 0.03 OUTLIER 'General case' 0 C--N 1.286 -2.16 0 CA-C-O 121.598 0.713 . . . . 10.0 109.495 179.62 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 3.7 t -104.91 -168.72 1.51 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.618 -0.676 . . . . 10.0 110.177 -179.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 17.7 m -85.49 54.37 3.09 Favored 'General case' 0 N--CA 1.493 1.682 0 O-C-N 121.172 -0.955 . . . . 10.0 110.099 179.895 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 19.7 p30 -62.02 174.04 0.96 Allowed 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.225 -0.922 . . . . 10.0 110.291 -179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.448 ' O ' ' O ' ' B' ' 46' ' ' THR . 48.1 mt -88.26 -65.92 0.9 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.412 -0.805 . . . . 10.0 110.904 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.448 ' O ' ' O ' ' B' ' 45' ' ' ILE . 50.1 m . . . . . 0 C--N 1.301 -1.532 0 CA-C-O 118.016 -0.992 . . . . 10.0 110.126 -179.486 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.606 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.54 0 CA-C-O 121.066 0.46 . . . . 10.0 110.122 . . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.714 ' HB3' HD23 ' A' ' 177' ' ' LEU . 1.8 mt-30 -95.75 -17.94 20.83 Favored 'General case' 0 C--N 1.305 -1.36 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 179.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.532 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -43.2 99.77 0.02 OUTLIER 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.631 -0.668 . . . . 10.0 110.54 -179.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.071 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -116.45 121.03 66.7 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.733 0 C-N-CA 118.996 -1.082 . . . . 10.0 110.595 178.831 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.957 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.4 OUTLIER -93.47 131.27 38.84 Favored 'General case' 0 C--N 1.291 -1.977 0 N-CA-C 107.094 -1.447 . . . . 10.0 107.094 177.016 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.805 ' HB3' HD23 ' A' ' 55' ' ' LEU . 94.4 m -110.36 103.79 12.48 Favored 'General case' 0 C--N 1.296 -1.748 0 O-C-N 120.743 -1.223 . . . . 10.0 110.39 -178.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.622 HG22 ' HE1' ' A' ' 56' ' ' PHE . 46.1 t -142.82 162.8 17.67 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.531 0 C-N-CA 119.229 -0.988 . . . . 10.0 110.031 179.913 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.639 HG11 ' CD2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -80.46 152.14 4.51 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.76 0 C-N-CA 119.157 -1.017 . . . . 10.0 109.432 -179.861 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.766 HG12 ' H ' ' A' ' 10' ' ' GLY . 3.3 t -83.13 -170.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.255 -0.903 . . . . 10.0 110.193 -179.141 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.766 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -95.58 42.16 2.36 Favored Glycine 0 N--CA 1.488 2.167 0 C-N-CA 119.776 -1.202 . . . . 10.0 111.218 -178.558 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.605 ' OD2' HG22 ' A' ' 80' ' ' VAL . 2.5 t0 -82.16 -31.35 30.53 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.707 -1.467 . . . . 10.0 109.006 178.916 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.551 ' HA2' ' C ' ' B' ' 34' ' ' GLU . . . 61.48 51.53 57.18 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.236 -1.546 . . . . 10.0 109.236 179.876 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.758 ' HB1' ' NE2' ' A' ' 116' ' ' GLN . . . -160.32 -77.98 0.06 Allowed 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.34 -1.094 . . . . 10.0 110.315 -179.774 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.883 HG13 ' HG ' ' A' ' 19' ' ' LEU . 89.5 t -112.17 117.94 56.47 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 O-C-N 121.043 -1.036 . . . . 10.0 110.433 -179.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.451 ' N ' ' CZ2' ' B' ' 36' ' ' TRP . . . -98.95 143.79 16.82 Favored Glycine 0 N--CA 1.493 2.468 0 N-CA-C 109.784 -1.326 . . . . 10.0 109.784 -179.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 7.2 pttt -65.4 -21.42 66.67 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.417 -1.049 . . . . 10.0 112.283 -179.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 2.6 m -99.52 -36.14 9.64 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 120.389 -1.444 . . . . 10.0 110.932 -179.311 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.57 ' HB2' ' O ' ' B' ' 28' ' ' GLU . 26.2 p -73.71 -29.91 62.54 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.024 -1.047 . . . . 10.0 109.798 179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.883 ' HG ' HG13 ' A' ' 14' ' ' VAL . 3.7 mm? -86.78 -18.02 32.09 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 120.868 -1.145 . . . . 10.0 110.49 179.019 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 47.6 tp -56.52 -41.4 76.69 Favored 'General case' 0 N--CA 1.491 1.6 0 CA-C-O 122.038 0.923 . . . . 10.0 108.878 179.133 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.602 ' HB ' ' HB3' ' B' ' 28' ' ' GLU . 7.3 mm -69.04 -39.78 80.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 CA-C-O 121.71 0.767 . . . . 10.0 110.205 178.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 28.6 t -47.16 -45.93 23.15 Favored 'General case' 0 C--N 1.289 -2.04 0 C-N-CA 119.585 -0.846 . . . . 10.0 109.814 -178.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.648 ' CZ ' ' O ' ' A' ' 159' ' ' ALA . 4.9 m-85 -93.58 3.76 55.01 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.651 -1.281 . . . . 10.0 110.184 178.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.556 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 2.9 m -110.94 -21.25 12.11 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.816 -1.177 . . . . 10.0 111.652 -177.945 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.865 ' HB ' HG11 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -88.07 -76.25 0.39 Allowed 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.456 -1.403 . . . . 10.0 108.647 179.037 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.575 ' HB2' ' HD2' ' A' ' 27' ' ' LYS . 19.1 m120 -156.17 -33.66 0.09 Allowed 'General case' 0 C--N 1.292 -1.895 0 CA-C-N 115.982 -0.554 . . . . 10.0 109.563 179.25 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.578 ' HD3' ' O ' ' A' ' 30' ' ' SER . 0.0 OUTLIER 175.03 -130.34 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 CA-C-O 121.188 0.518 . . . . 10.0 109.95 179.723 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' C ' ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -139.68 -62.63 0.02 OUTLIER Pre-proline 0 C--N 1.297 -1.683 0 O-C-N 121.183 -0.948 . . . . 10.0 112.26 -178.89 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.546 ' HD2' ' H ' ' A' ' 28' ' ' PHE . 50.3 Cg_endo -74.58 0.4 8.72 Favored 'Trans proline' 0 C--N 1.313 -1.328 0 O-C-N 123.101 1.053 . . . . 10.0 113.02 -177.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.578 ' O ' ' HD3' ' A' ' 27' ' ' LYS . 25.4 m -161.17 51.41 0.25 Allowed 'General case' 0 N--CA 1.498 1.975 0 O-C-N 120.321 -1.487 . . . . 10.0 111.507 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.579 ' O ' ' N ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -115.45 103.51 10.84 Favored 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.072 -1.018 . . . . 10.0 110.84 -179.908 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 1.047 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 2.1 t80 -63.59 59.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.55 -0.718 . . . . 10.0 110.322 179.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.865 HG11 ' HB ' ' A' ' 25' ' ' THR . 3.7 m -127.23 167.43 17.89 Favored Pre-proline 0 C--N 1.306 -1.296 0 O-C-N 121.375 -0.828 . . . . 10.0 109.912 -179.499 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 40.9 Cg_endo -70.16 146.1 56.73 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 O-C-N 123.709 1.373 . . . . 10.0 109.57 179.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.563 ' CG2' ' O ' ' B' ' 22' ' ' PHE . 5.8 t -118.81 156.26 29.72 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 120.841 -1.162 . . . . 10.0 110.865 -179.239 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.714 HG11 ' CG ' ' A' ' 62' ' ' GLU . 65.3 t 61.57 5.18 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.896 0 O-C-N 121.747 -0.595 . . . . 10.0 111.101 -179.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.641 ' O ' ' O ' ' A' ' 38' ' ' ASP . 1.7 t80 -42.29 100.02 0.02 OUTLIER 'General case' 0 C--N 1.297 -1.676 0 O-C-N 121.476 -0.765 . . . . 10.0 109.829 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.767 ' H ' ' H ' ' B' ' 19' ' ' HIS . 0.5 OUTLIER -47.19 -151.5 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.909 0 CA-C-O 121.884 0.85 . . . . 10.0 111.648 -179.638 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.796 ' HB3' HD13 ' A' ' 55' ' ' LEU . 0.5 OUTLIER -156.55 -167.61 2.45 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 119.932 -1.73 . . . . 10.0 111.417 -179.277 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.632 ' CE1' HD13 ' B' ' 18' ' ' ILE . 7.8 m-30 -112.96 153.48 27.96 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.411 -0.805 . . . . 10.0 112.852 -177.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.627 ' HA ' ' HA2' ' A' ' 54' ' ' GLY . . . -135.64 119.69 17.57 Favored 'General case' 0 N--CA 1.49 1.568 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 177.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.655 HG11 ' HB3' ' B' ' 15' ' ' GLU . 0.5 OUTLIER -171.81 176.67 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.484 1.251 0 O-C-N 120.368 -1.458 . . . . 10.0 111.709 -176.773 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.926 HG23 ' O ' ' A' ' 51' ' ' TYR . 66.1 m -129.49 130.92 46.45 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.773 -0.58 . . . . 10.0 110.21 178.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.727 ' CG1' HD11 ' A' ' 46' ' ' ILE . 13.2 t -105.17 150.03 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.268 -0.895 . . . . 10.0 109.42 179.17 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.716 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 94.7 mtp -117.65 95.62 5.02 Favored 'General case' 0 C--O 1.204 -1.321 0 N-CA-C 106.798 -1.556 . . . . 10.0 106.798 178.4 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.75 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 3.2 mp -102.8 130.46 52.82 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.525 0 CA-C-O 121.136 0.493 . . . . 10.0 111.513 -177.402 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.803 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 40.1 27.69 0.14 Allowed Glycine 0 N--CA 1.496 2.636 0 C-N-CA 119.837 -1.173 . . . . 10.0 110.745 179.293 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.46 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 91.76 18.18 45.41 Favored Glycine 0 N--CA 1.494 2.535 0 O-C-N 121.011 -1.288 . . . . 10.0 110.363 179.481 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.516 ' N ' ' O ' ' A' ' 46' ' ' ILE . 4.0 mm-40 -114.87 98.98 51.35 Favored Pre-proline 0 N--CA 1.489 1.486 0 O-C-N 121.0 -1.294 . . . . 10.0 109.87 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.418 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 53.3 Cg_endo -77.89 118.34 4.43 Favored 'Trans proline' 0 C--N 1.303 -1.85 0 O-C-N 123.972 1.511 . . . . 10.0 110.94 -179.286 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.926 ' O ' HG23 ' A' ' 43' ' ' THR . 2.7 m-85 -89.05 117.6 28.17 Favored 'General case' 0 N--CA 1.489 1.504 0 O-C-N 120.992 -1.068 . . . . 10.0 109.385 178.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.597 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -100.56 104.19 15.53 Favored 'General case' 0 C--N 1.298 -1.634 0 O-C-N 121.065 -1.022 . . . . 10.0 111.029 -178.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.851 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -158.08 178.44 10.2 Favored 'General case' 0 N--CA 1.485 1.301 0 C-N-CA 118.444 -1.302 . . . . 10.0 111.381 178.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.851 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.32 111.46 0.41 Allowed Glycine 0 N--CA 1.491 2.352 0 N-CA-C 108.965 -1.654 . . . . 10.0 108.965 -179.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.805 HD23 ' HB3' ' A' ' 6' ' ' CYS . 1.8 tm? -130.47 132.8 45.85 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 120.846 -1.385 . . . . 10.0 110.781 -179.119 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.766 ' N ' HD22 ' A' ' 55' ' ' LEU . 2.7 p90 -152.57 155.31 37.15 Favored 'General case' 0 N--CA 1.497 1.882 0 O-C-N 121.527 -0.733 . . . . 10.0 109.789 179.784 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.601 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 15.8 t0 -99.15 179.8 4.49 Favored 'General case' 0 N--CA 1.498 1.944 0 O-C-N 120.631 -1.293 . . . . 10.0 110.584 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 87.7 m -104.81 117.3 33.71 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.249 -0.907 . . . . 10.0 111.137 -179.452 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.61 ' HA ' ' HG2' ' A' ' 62' ' ' GLU . . . -65.7 91.2 0.13 Allowed 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.295 -0.878 . . . . 10.0 110.256 179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.944 ' HA2' HD12 ' B' ' 45' ' ' ILE . . . -68.92 63.07 0.5 Allowed Glycine 0 N--CA 1.485 1.908 0 N-CA-C 107.816 -2.114 . . . . 10.0 107.816 178.737 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' N ' ' O ' ' A' ' 59' ' ' ALA . 22.0 tt0 75.03 21.03 2.04 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.985 -0.715 . . . . 10.0 110.569 -178.911 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.714 ' CG ' HG11 ' A' ' 36' ' ' VAL . 9.0 mm-40 -50.07 -46.08 53.04 Favored 'General case' 0 N--CA 1.488 1.43 0 C-N-CA 118.338 -1.345 . . . . 10.0 109.68 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.545 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.1 OUTLIER 162.37 17.46 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 O-C-N 121.163 -0.961 . . . . 10.0 110.923 178.839 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.617 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.1 OUTLIER -178.06 44.63 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.916 -1.115 . . . . 10.0 109.3 -179.351 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 68' ' ' ARG . 13.9 p-10 -81.4 38.5 0.49 Allowed 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.306 -0.871 . . . . 10.0 110.169 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 63.3 mtt180 -49.91 -28.06 6.13 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.272 -0.892 . . . . 10.0 109.111 179.157 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.746 HD12 ' H ' ' A' ' 67' ' ' LEU . 3.1 mp -81.67 11.12 5.05 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.545 -0.722 . . . . 10.0 109.361 178.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.635 ' C ' HD23 ' A' ' 70' ' ' LEU . 4.5 ptt85 -60.19 -24.76 1.63 Allowed Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 121.338 -0.852 . . . . 10.0 112.844 -179.513 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.635 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 47.9 Cg_endo -89.92 86.57 0.4 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 109.523 -0.991 . . . . 10.0 109.523 179.741 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.862 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.1 OUTLIER -117.64 -78.72 0.58 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.157 -0.965 . . . . 10.0 111.831 -178.617 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.476 ' HB2' ' O ' ' A' ' 70' ' ' LEU . 7.5 m 62.03 39.62 13.04 Favored 'General case' 0 C--N 1.301 -1.524 0 O-C-N 121.17 -0.956 . . . . 10.0 109.365 -178.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -137.49 76.79 41.94 Favored Pre-proline 0 N--CA 1.492 1.67 0 O-C-N 121.332 -0.855 . . . . 10.0 110.215 -179.576 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -70.43 113.44 3.48 Favored 'Trans proline' 0 C--N 1.303 -1.819 0 O-C-N 124.135 1.598 . . . . 10.0 110.385 -179.948 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -163.62 89.59 0.6 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.081 -1.012 . . . . 10.0 110.184 179.974 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.764 HG23 ' CB ' ' A' ' 5' ' ' LYS . 23.0 m -145.89 98.64 3.14 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.104 -0.997 . . . . 10.0 109.173 179.062 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 19.9 t70 -25.77 -40.0 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.115 0 CA-C-O 121.046 0.45 . . . . 10.0 112.15 -179.182 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.957 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.9 OUTLIER -107.68 126.89 64.03 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.801 0 O-C-N 120.947 -1.096 . . . . 10.0 109.897 179.606 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.651 ' HB3' HG22 ' A' ' 9' ' ' VAL . 1.4 m-85 -130.33 139.41 50.7 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 121.148 -0.97 . . . . 10.0 110.921 -178.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.708 ' CD1' HG13 ' A' ' 168' ' ' VAL . 1.9 mm? -113.6 98.54 7.12 Favored 'General case' 0 N--CA 1.492 1.651 0 N-CA-C 108.659 -0.867 . . . . 10.0 108.659 178.662 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.605 HG22 ' OD2' ' A' ' 11' ' ' ASP . 9.3 p -97.37 137.47 24.91 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.535 0 O-C-N 121.161 -0.962 . . . . 10.0 110.846 -178.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.628 ' HB3' HG21 ' A' ' 115' ' ' THR . 65.3 m -121.47 112.15 18.16 Favored 'General case' 0 N--CA 1.487 1.38 0 O-C-N 121.263 -0.898 . . . . 10.0 110.609 -179.684 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.438 ' CZ ' ' HD1' ' A' ' 90' ' ' PHE . 35.1 p90 -129.24 160.37 33.18 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.214 -0.928 . . . . 10.0 110.538 179.695 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.43 ' OG ' ' HB2' ' A' ' 116' ' ' GLN . 51.0 m -79.16 162.54 25.71 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 121.34 -0.85 . . . . 10.0 111.277 -178.883 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.507 HG12 HG22 ' A' ' 137' ' ' ILE . 30.7 m -102.15 23.11 1.76 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.294 0 O-C-N 121.672 -0.643 . . . . 10.0 110.349 -179.831 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.74 ' CG2' HD23 ' A' ' 129' ' ' LEU . 0.6 OUTLIER -142.02 28.14 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 O-C-N 121.201 -0.937 . . . . 10.0 109.875 -179.584 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.586 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.6 OUTLIER -85.93 -173.84 0.46 Allowed Pre-proline 0 C--N 1.299 -1.615 0 O-C-N 121.051 -1.03 . . . . 10.0 110.294 -179.662 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.586 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 50.4 Cg_endo -75.2 72.09 4.9 Favored 'Trans proline' 0 C--N 1.307 -1.638 0 O-C-N 123.889 1.468 . . . . 10.0 110.679 -179.841 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 13.0 m 46.87 40.64 9.41 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.351 -0.843 . . . . 10.0 110.189 179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.602 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 11.8 p -76.46 -25.68 54.6 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.383 -0.823 . . . . 10.0 110.689 -179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.67 ' CZ ' ' CE ' ' A' ' 94' ' ' LYS . 74.1 t80 -75.1 -18.7 60.21 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 121.475 -0.765 . . . . 10.0 112.617 -178.264 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 19.9 mt-10 -85.79 -17.34 36.05 Favored 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.458 -1.401 . . . . 10.0 110.825 -179.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.674 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -88.84 -14.9 35.85 Favored 'General case' 0 C--N 1.299 -1.609 0 O-C-N 121.051 -1.03 . . . . 10.0 109.673 179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 1.086 HG23 ' HD3' ' A' ' 94' ' ' LYS . 12.8 m -84.76 -20.8 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.427 0 C-N-CA 118.863 -1.135 . . . . 10.0 109.401 179.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 1.086 ' HD3' HG23 ' A' ' 93' ' ' VAL . 20.8 mmtt -80.08 -30.54 39.28 Favored 'General case' 0 N--CA 1.492 1.646 0 CA-C-O 121.919 0.866 . . . . 10.0 109.544 -179.919 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -96.88 9.44 41.87 Favored 'General case' 0 C--N 1.292 -1.912 0 C-N-CA 119.65 -0.82 . . . . 10.0 109.415 178.965 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -98.8 -51.43 3.89 Favored 'General case' 0 N--CA 1.491 1.615 0 C-N-CA 119.094 -1.042 . . . . 10.0 111.044 179.686 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.536 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 35.5 m95 -90.53 -40.52 11.92 Favored 'General case' 0 N--CA 1.498 1.929 0 O-C-N 121.187 -0.946 . . . . 10.0 112.376 -178.676 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 92.0 t -53.0 -47.75 94.48 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 120.581 -1.324 . . . . 10.0 111.135 -178.623 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.3 Cg_endo -75.14 -17.26 19.39 Favored 'Trans proline' 0 C--N 1.309 -1.501 0 O-C-N 123.215 1.113 . . . . 10.0 110.644 179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.536 ' CG ' ' O ' ' A' ' 97' ' ' TRP . 0.0 OUTLIER -69.52 -23.95 63.67 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.097 -1.002 . . . . 10.0 111.551 -178.706 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.518 ' N ' ' HG3' ' A' ' 100' ' ' GLU . 18.0 mt 54.75 99.74 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 120.564 -1.335 . . . . 10.0 109.776 -179.483 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.58 HG21 ' HG2' ' A' ' 106' ' ' PRO . 21.0 m -46.89 -85.66 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.502 -0.749 . . . . 10.0 109.6 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.587 ' O ' ' CG ' ' A' ' 104' ' ' HIS . 37.6 t60 -110.46 -6.73 14.86 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.269 -0.894 . . . . 10.0 108.752 178.07 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.587 ' CG ' ' O ' ' A' ' 103' ' ' HIS . 0.3 OUTLIER 154.79 -49.21 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 N-CA-C 106.269 -1.752 . . . . 10.0 106.269 -179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.61 ' H ' ' HD3' ' A' ' 106' ' ' PRO . 0.6 OUTLIER -176.14 46.19 0.04 OUTLIER Pre-proline 0 C--N 1.304 -1.4 0 CA-C-N 115.716 -0.675 . . . . 10.0 110.746 178.292 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.61 ' HD3' ' H ' ' A' ' 105' ' ' CYS . 57.0 Cg_endo -78.94 -29.47 3.33 Favored 'Trans proline' 0 C--N 1.317 -1.12 0 O-C-N 123.288 1.152 . . . . 10.0 109.539 179.285 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 71.1 57.1 0.2 Allowed 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.53 0.681 . . . . 10.0 110.511 -179.356 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.574 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 2.9 m -46.55 149.6 1.38 Allowed Pre-proline 0 N--CA 1.49 1.572 0 O-C-N 121.527 -0.733 . . . . 10.0 109.756 179.367 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.574 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 38.4 Cg_endo -63.56 114.22 2.45 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 O-C-N 123.683 1.359 . . . . 10.0 110.762 179.673 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.503 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 2.2 t80 -115.11 107.6 15.55 Favored 'General case' 0 N--CA 1.486 1.328 0 O-C-N 121.458 -0.776 . . . . 10.0 109.173 179.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.0 ' CD1' HG11 ' A' ' 152' ' ' VAL . 2.0 mm? -96.32 103.69 15.61 Favored 'General case' 0 C--N 1.297 -1.712 0 CA-C-O 121.59 0.71 . . . . 10.0 109.61 -179.472 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.515 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 83.7 mt -85.88 143.29 28.31 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.663 -0.648 . . . . 10.0 111.029 -179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.513 ' HA ' ' O ' ' A' ' 155' ' ' VAL . 2.6 t -141.86 170.53 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 O-C-N 120.992 -1.068 . . . . 10.0 111.482 179.626 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -134.93 98.13 0.3 Allowed Glycine 0 N--CA 1.489 2.168 0 N-CA-C 106.934 -2.467 . . . . 10.0 106.934 177.895 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.712 HG22 ' SG ' ' A' ' 157' ' ' CYS . 27.1 p -114.55 -171.12 1.86 Allowed 'General case' 0 N--CA 1.492 1.666 0 O-C-N 121.191 -1.182 . . . . 10.0 111.501 -177.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.758 ' NE2' ' HB1' ' A' ' 13' ' ' ALA . 78.3 mt-30 56.55 18.44 3.58 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.53 -0.731 . . . . 10.0 109.107 -179.188 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.007 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -82.94 -22.01 8.92 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 C-N-CA 119.934 -0.706 . . . . 10.0 109.297 179.402 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.559 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 7.7 p-10 -51.52 58.4 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.368 0 CA-C-O 122.051 0.929 . . . . 10.0 111.057 -177.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.744 ' N ' ' O ' ' A' ' 117' ' ' ILE . 17.3 tp 157.85 -29.04 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.282 0 N-CA-C 107.547 -1.279 . . . . 10.0 107.547 -179.559 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.681 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -46.03 -43.01 14.05 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 108.663 -0.866 . . . . 10.0 108.663 178.767 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.432 ' OD1' ' N ' ' A' ' 121' ' ' ASP . 18.0 p-10 -50.29 -23.49 2.33 Favored 'General case' 0 C--N 1.302 -1.493 0 CA-C-O 121.507 0.67 . . . . 10.0 109.682 179.273 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.43 ' HB2' ' O ' ' A' ' 119' ' ' LEU . 76.9 m-20 -87.59 138.08 31.87 Favored Pre-proline 0 C--N 1.301 -1.531 0 C-N-CA 119.993 -0.683 . . . . 10.0 110.201 -179.938 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.424 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.4 Cg_endo -80.09 23.37 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.706 0 O-C-N 124.174 1.618 . . . . 10.0 110.865 179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 19.5 t -102.52 -50.65 3.52 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.882 -1.136 . . . . 10.0 110.285 -179.363 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.624 ' HB ' HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.57 -26.45 45.57 Favored 'General case' 0 C--N 1.295 -1.783 0 N-CA-C 105.535 -2.024 . . . . 10.0 105.535 177.186 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.681 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.295 1.1 mp -61.24 -23.22 29.55 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.545 0 CA-C-N 114.555 -1.202 . . . . 10.0 107.801 176.68 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 35.1 tt0 -49.09 -41.06 34.4 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.586 0.708 . . . . 10.0 110.501 179.831 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.511 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.5 OUTLIER -89.26 -30.59 18.38 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.608 0.718 . . . . 10.0 110.397 -179.7 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.74 HD23 ' CG2' ' A' ' 85' ' ' VAL . 4.8 mp -74.73 -49.85 19.56 Favored 'General case' 0 N--CA 1.496 1.859 0 O-C-N 121.595 -0.691 . . . . 10.0 111.141 -179.631 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.498 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -61.74 -42.68 99.29 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.599 -0.688 . . . . 10.0 110.394 -179.012 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.511 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -53.69 -20.07 4.92 Favored 'General case' 0 C--N 1.303 -1.415 0 C-N-CA 119.007 -1.077 . . . . 10.0 108.997 179.595 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.528 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -85.16 -44.09 13.26 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.205 -0.934 . . . . 10.0 109.648 179.259 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 133.95 19.79 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.538 0.685 . . . . 10.0 109.926 179.479 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.524 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -83.23 -4.16 58.14 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.308 -0.87 . . . . 10.0 110.269 179.9 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.438 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -119.18 103.04 48.02 Favored Pre-proline 0 N--CA 1.491 1.616 0 O-C-N 121.266 -0.896 . . . . 10.0 111.54 -179.139 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.438 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.1 Cg_endo -69.92 162.4 42.3 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.033 1.544 . . . . 10.0 109.952 178.88 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.591 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.3 OUTLIER -99.55 138.28 24.43 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.59 0 O-C-N 121.088 -1.007 . . . . 10.0 109.434 -179.988 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.547 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.8 p -126.07 170.21 10.05 Favored Pre-proline 0 N--CA 1.489 1.513 0 O-C-N 121.351 -0.843 . . . . 10.0 109.737 -179.234 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.547 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 43.3 Cg_endo -68.63 -15.02 40.72 Favored 'Trans proline' 0 C--N 1.308 -1.605 0 O-C-N 123.531 1.279 . . . . 10.0 110.46 -179.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -75.38 -42.04 54.88 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.216 -0.928 . . . . 10.0 109.762 179.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 1.9 m -75.52 -40.95 56.31 Favored 'General case' 0 C--N 1.297 -1.696 0 O-C-N 121.732 -0.605 . . . . 10.0 110.553 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -70.89 -44.94 65.24 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.297 -0.877 . . . . 10.0 111.269 -179.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -49.8 -43.93 48.79 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.113 -0.992 . . . . 10.0 109.619 -179.571 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.465 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 67.4 tttt -66.42 -40.32 89.48 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.508 -0.745 . . . . 10.0 109.294 179.287 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.493 ' O ' ' HB3' ' A' ' 148' ' ' ASP . 2.1 tt -63.66 -48.26 77.94 Favored 'General case' 0 C--N 1.306 -1.324 0 C-N-CA 119.559 -0.856 . . . . 10.0 109.42 179.289 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.645 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -58.42 -42.12 86.52 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.025 -1.047 . . . . 10.0 108.93 179.152 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 mmt180 -80.66 1.86 28.26 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.679 -0.808 . . . . 10.0 108.991 178.409 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.607 ' HB3' HD13 ' A' ' 149' ' ' LEU . 14.4 t70 -79.21 -31.82 43.84 Favored 'General case' 0 N--CA 1.486 1.338 0 O-C-N 121.48 -0.763 . . . . 10.0 112.214 -178.81 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.921 HD13 ' N ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -135.65 -8.17 2.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.032 -1.668 . . . . 10.0 113.088 -179.243 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.676 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 6.2 pttt 125.93 63.82 0.0 OUTLIER 'General case' 0 N--CA 1.519 3.013 0 C-N-CA 123.899 0.88 . . . . 10.0 111.703 178.8 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.645 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -116.83 -177.44 3.19 Favored 'General case' 0 N--CA 1.494 1.771 0 O-C-N 120.882 -1.136 . . . . 10.0 109.65 179.009 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.0 HG11 ' CD1' ' A' ' 111' ' ' LEU . 1.1 t -90.16 -78.15 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.737 0 O-C-N 120.766 -1.208 . . . . 10.0 109.531 179.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.833 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -171.93 164.53 6.34 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 121.023 -1.048 . . . . 10.0 111.093 -179.891 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.515 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 57.8 t80 -104.76 101.1 10.73 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.411 -0.806 . . . . 10.0 109.562 178.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.866 ' HB ' HG23 ' A' ' 168' ' ' VAL . 38.2 t -87.76 169.55 1.39 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.541 0 O-C-N 121.245 -0.91 . . . . 10.0 109.137 179.588 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' N ' HG12 ' A' ' 155' ' ' VAL . 1.0 OUTLIER -134.64 121.67 21.19 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 120.929 -1.107 . . . . 10.0 109.737 179.989 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.712 ' SG ' HG22 ' A' ' 115' ' ' THR . 25.6 p -141.23 169.99 16.57 Favored 'General case' 0 C--N 1.302 -1.484 0 O-C-N 121.051 -1.031 . . . . 10.0 110.569 -179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.583 ' N ' ' HB2' ' A' ' 162' ' ' GLN . 1.1 t -143.76 118.6 9.92 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.691 -0.631 . . . . 10.0 109.576 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.893 ' HB1' ' CZ ' ' B' ' 29' ' ' PHE . . . -12.25 -54.47 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.747 0 N-CA-C 113.569 0.951 . . . . 10.0 113.569 -179.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.803 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.5 pp -131.9 -3.82 3.61 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.471 -1.393 . . . . 10.0 111.788 -179.735 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.579 ' HB ' ' HB3' ' A' ' 158' ' ' SER . 59.5 m -98.05 -90.17 0.28 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.664 -1.273 . . . . 10.0 111.995 -178.349 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.583 ' HB2' ' N ' ' A' ' 158' ' ' SER . 1.7 mm-40 -38.3 -39.44 0.43 Allowed 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.187 -0.945 . . . . 10.0 111.98 -178.595 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.62 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 18.4 ttpt 49.5 26.29 1.65 Allowed 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.056 -1.058 . . . . 10.0 108.938 -178.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.404 ' O ' ' N ' ' A' ' 166' ' ' LYS . . . -94.62 -8.3 59.66 Favored Glycine 0 N--CA 1.49 2.286 0 N-CA-C 109.008 -1.637 . . . . 10.0 109.008 179.482 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.785 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -49.81 -9.89 0.04 OUTLIER 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.414 -1.051 . . . . 10.0 112.306 -179.804 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.775 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -70.17 -46.19 65.18 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.352 -1.468 . . . . 10.0 111.061 -179.885 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.412 HD22 ' N ' ' A' ' 167' ' ' ASN . 1.4 m-80 -59.39 -27.97 66.47 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 120.876 -1.14 . . . . 10.0 108.298 179.345 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.866 HG23 ' HB ' ' A' ' 155' ' ' VAL . 0.5 OUTLIER -51.48 -50.68 28.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-O 121.576 0.703 . . . . 10.0 110.897 179.971 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.584 ' N ' HG12 ' A' ' 168' ' ' VAL . 18.4 t80 -87.14 -25.74 23.95 Favored 'General case' 0 C--N 1.295 -1.788 0 O-C-N 121.499 -0.751 . . . . 10.0 110.943 -179.309 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.488 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.0 t70 -50.39 -49.55 54.1 Favored 'General case' 0 N--CA 1.493 1.681 0 O-C-N 120.985 -1.072 . . . . 10.0 109.84 -179.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.453 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 3.0 mp0 -67.12 -45.02 78.44 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.227 -0.92 . . . . 10.0 110.257 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.954 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -50.95 -21.21 1.63 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.256 -0.902 . . . . 10.0 109.9 179.666 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.727 ' O ' HD12 ' A' ' 177' ' ' LEU . 24.4 mm -70.07 -43.86 78.73 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 C-N-CA 119.611 -0.836 . . . . 10.0 110.338 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.899 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -82.42 -23.82 34.66 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.577 -1.327 . . . . 10.0 111.068 -178.99 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -87.46 -11.55 48.71 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.943 -1.098 . . . . 10.0 111.322 -179.166 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.071 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -80.42 -45.92 16.84 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.734 -1.229 . . . . 10.0 109.991 179.646 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.727 HD12 ' O ' ' A' ' 173' ' ' ILE . 1.1 mp -89.99 -19.62 24.24 Favored 'General case' 0 N--CA 1.494 1.737 0 CA-C-O 121.96 0.886 . . . . 10.0 108.917 179.385 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 30.5 mt-10 . . . . . 0 N--CA 1.49 1.562 0 CA-C-O 117.842 -1.075 . . . . 10.0 110.337 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.473 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.275 0 N-CA-C 109.576 -1.41 . . . . 10.0 109.576 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 49.6 m -75.89 145.08 40.77 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.267 -1.137 . . . . 10.0 109.99 -179.895 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.543 ' CD ' HD12 ' A' ' 174' ' ' LEU . 0.0 OUTLIER -98.85 93.36 6.01 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.056 -1.028 . . . . 10.0 110.614 179.912 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.421 ' O ' ' OH ' ' A' ' 51' ' ' TYR . 30.2 mm-40 -129.75 159.64 35.88 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 121.439 0.638 . . . . 10.0 110.49 179.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.694 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.26 -158.18 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 N-CA-C 106.834 -1.543 . . . . 10.0 106.834 177.697 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.694 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -67.41 112.47 2.59 Favored 'Trans proline' 0 C--N 1.312 -1.354 0 N-CA-C 109.236 -1.101 . . . . 10.0 109.236 179.512 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' HG22 ' A' ' 46' ' ' ILE . 12.1 tp10 -55.29 -128.97 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.605 0.717 . . . . 10.0 110.717 -178.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.803 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -78.97 -101.0 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.892 -1.13 . . . . 10.0 109.682 -179.835 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.666 ' H ' HG23 ' B' ' 8' ' ' ILE . 25.3 t -142.91 112.2 6.68 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 120.341 -1.475 . . . . 10.0 111.895 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.75 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.0 OUTLIER -171.04 97.54 0.42 Allowed Pre-proline 0 N--CA 1.489 1.517 0 CA-C-O 121.632 0.73 . . . . 10.0 109.605 178.82 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -96.69 99.41 0.08 OUTLIER 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 122.074 1.849 . . . . 10.0 111.214 -179.972 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.648 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.4 m -136.62 98.41 3.79 Favored 'General case' 0 N--CA 1.493 1.691 0 O-C-N 120.691 -1.255 . . . . 10.0 109.748 178.417 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.614 ' HB2' HG22 ' A' ' 42' ' ' VAL . 0.1 OUTLIER -167.4 138.79 3.1 Favored 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.63 -1.228 . . . . 10.0 112.364 -178.944 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.579 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 58.3 m-85 -115.71 107.31 14.92 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.589 -0.695 . . . . 10.0 110.305 178.425 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.655 ' HB3' HG11 ' A' ' 42' ' ' VAL . 0.2 OUTLIER -88.81 174.19 8.12 Favored 'General case' 0 N--CA 1.489 1.493 0 CA-C-O 122.782 1.277 . . . . 10.0 113.242 -178.276 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.2 OUTLIER -90.0 -165.75 1.42 Allowed 'General case' 0 N--CA 1.492 1.639 0 CA-C-N 114.552 -1.204 . . . . 10.0 112.317 -178.938 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . . . . . . . . . 23.1 m -119.41 146.12 45.64 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.669 -0.645 . . . . 10.0 109.816 -179.421 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.632 HD13 ' CE1' ' A' ' 40' ' ' TYR . 1.3 mp -76.77 173.06 1.02 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.715 0 O-C-N 120.977 -1.077 . . . . 10.0 112.463 -178.781 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.767 ' H ' ' H ' ' A' ' 38' ' ' ASP . 27.4 m170 -141.95 117.28 10.16 Favored 'General case' 0 N--CA 1.492 1.662 0 N-CA-C 113.436 0.902 . . . . 10.0 113.436 -179.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.519 ' HB ' ' HD1' ' A' ' 37' ' ' PHE . 2.8 p -144.93 143.58 22.38 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.025 0 O-C-N 121.237 -0.914 . . . . 10.0 110.562 177.777 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.551 ' HA3' ' O ' ' A' ' 62' ' ' GLU . . . -148.12 30.69 1.33 Allowed Glycine 0 N--CA 1.492 2.378 0 C-N-CA 119.668 -1.253 . . . . 10.0 110.178 179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.699 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -171.69 91.26 0.13 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.021 -1.282 . . . . 10.0 110.392 -179.542 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.464 ' O ' ' C ' ' B' ' 24' ' ' ALA . 4.1 m-20 -67.39 151.78 46.83 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 120.852 -1.155 . . . . 10.0 110.621 -179.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 1.047 ' HB2' ' HA ' ' A' ' 32' ' ' TYR . . . 34.71 54.92 0.69 Allowed 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.671 -0.643 . . . . 10.0 110.892 179.94 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.699 HG21 ' CD1' ' B' ' 22' ' ' PHE . 0.9 OUTLIER -113.61 -36.59 2.44 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.809 0 C-N-CA 119.239 -0.984 . . . . 10.0 108.687 179.816 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.832 HG23 ' N ' ' B' ' 29' ' ' PHE 0.262 0.5 OUTLIER -149.62 11.41 0.77 Allowed 'General case' 0 C--N 1.304 -1.394 0 C-N-CA 119.125 -1.03 . . . . 10.0 112.946 -178.148 . . . . . . . . 4 4 . 1 . 002 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.501 ' O ' ' HB3' ' B' ' 28' ' ' GLU . . . 59.09 30.56 67.17 Favored Glycine 0 N--CA 1.493 2.489 0 N-CA-C 105.719 -2.952 . . . . 10.0 105.719 -178.218 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.602 ' HB3' ' HB ' ' A' ' 21' ' ' ILE . 1.0 OUTLIER 59.34 16.68 5.23 Favored 'General case' 0 C--N 1.308 -1.234 0 CA-C-O 121.692 0.758 . . . . 10.0 109.328 -178.923 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.893 ' CZ ' ' HB1' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -143.26 147.82 35.41 Favored 'General case' 0 C--N 1.297 -1.704 0 CA-C-O 121.211 0.529 . . . . 10.0 109.912 179.775 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.794 HG22 ' OG1' ' B' ' 26' ' ' THR . 19.0 p -134.81 -178.55 5.13 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 120.839 -1.163 . . . . 10.0 110.213 179.731 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -95.19 -28.73 9.56 Favored Glycine 0 N--CA 1.491 2.301 0 C-N-CA 120.013 -1.089 . . . . 10.0 111.261 -179.02 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.723 HG22 ' O ' ' B' ' 32' ' ' ILE . 31.4 mm -132.97 50.76 5.99 Favored Pre-proline 0 N--CA 1.498 1.948 0 O-C-N 120.605 -1.527 . . . . 10.0 111.56 -178.908 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.551 ' HG2' ' O ' ' A' ' 13' ' ' ALA . 55.8 Cg_endo -75.5 150.58 36.28 Favored 'Trans proline' 0 C--N 1.303 -1.843 0 O-C-N 123.615 1.324 . . . . 10.0 110.651 178.943 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.551 ' C ' ' HA2' ' A' ' 12' ' ' GLY . 0.8 OUTLIER -75.12 -169.75 1.0 Allowed 'General case' 0 N--CA 1.496 1.847 0 O-C-N 120.998 -1.064 . . . . 10.0 109.226 178.818 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.545 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 1.2 mp0 -76.43 20.4 0.22 Allowed 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.19 -0.944 . . . . 10.0 110.779 179.808 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.639 ' CD2' HG11 ' A' ' 8' ' ' VAL . 8.5 m-90 65.7 20.71 11.56 Favored 'General case' 0 C--N 1.304 -1.408 0 N-CA-C 106.802 -1.555 . . . . 10.0 106.802 -176.848 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.862 ' HA ' HD11 ' A' ' 70' ' ' LEU . . . -155.02 83.06 1.08 Allowed 'General case' 0 C--N 1.297 -1.698 0 N-CA-C 106.353 -1.721 . . . . 10.0 106.353 179.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.507 ' CG ' ' O ' ' B' ' 42' ' ' THR . 22.2 tpt180 -70.27 55.63 0.15 Allowed 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 122.751 1.262 . . . . 10.0 107.988 -179.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.808 HD23 ' HB1' ' B' ' 37' ' ' ALA . 2.8 pp -91.55 -21.46 20.85 Favored 'General case' 0 C--N 1.281 -2.391 0 CA-C-N 114.553 -1.203 . . . . 10.0 111.219 -178.395 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.719 ' O ' HD12 ' B' ' 40' ' ' LEU . 3.8 pp -77.84 5.18 10.1 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.998 -1.064 . . . . 10.0 111.771 -178.611 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.685 ' HG3' HG23 ' B' ' 42' ' ' THR . 0.3 OUTLIER -154.35 -85.79 0.06 Allowed 'General case' 0 C--N 1.293 -1.877 0 O-C-N 121.124 -0.985 . . . . 10.0 111.3 179.838 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.685 HG23 ' HG3' ' B' ' 41' ' ' GLN . 72.6 p -129.87 171.9 12.25 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.158 -0.964 . . . . 10.0 110.924 -179.232 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.452 ' O ' ' HB2' ' A' ' 68' ' ' ARG . 53.0 m -79.07 7.51 7.29 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.494 -0.754 . . . . 10.0 110.26 179.663 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.444 ' ND2' ' O ' ' B' ' 44' ' ' ASN . 0.9 OUTLIER -117.36 134.44 54.82 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.083 -1.01 . . . . 10.0 110.945 -179.613 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.944 HD12 ' HA2' ' A' ' 60' ' ' GLY . 7.0 mt -97.5 176.28 0.74 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.583 0 O-C-N 121.606 -0.684 . . . . 10.0 109.31 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.474 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.1 OUTLIER . . . . . 0 C--N 1.3 -1.58 0 C-N-CA 119.15 -1.02 . . . . 10.0 110.291 179.284 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.602 ' CG ' HD22 ' A' ' 177' ' ' LEU . 0.8 OUTLIER . . . . . 0 N--CA 1.495 1.822 0 CA-C-O 120.705 0.288 . . . . 10.0 110.41 . . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.613 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -179.19 152.78 0.56 Allowed 'General case' 0 C--N 1.308 -1.212 0 O-C-N 121.166 -0.959 . . . . 10.0 110.002 179.385 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.818 ' H ' HG21 ' A' ' 52' ' ' THR . 85.1 m 61.42 48.43 5.97 Favored 'General case' 0 C--N 1.299 -1.611 0 N-CA-C 113.707 1.003 . . . . 10.0 113.707 178.504 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.012 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.1 OUTLIER -112.66 128.86 69.12 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.055 0 O-C-N 120.159 -1.588 . . . . 10.0 110.942 177.864 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 1.041 ' CB ' HG23 ' A' ' 75' ' ' THR . 4.1 mmtm -118.11 147.53 43.2 Favored 'General case' 0 C--N 1.296 -1.747 0 N-CA-C 107.753 -1.203 . . . . 10.0 107.753 176.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.3 t -119.26 106.05 11.94 Favored 'General case' 0 N--CA 1.498 1.928 0 O-C-N 120.837 -1.165 . . . . 10.0 109.993 179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' CG1' ' N ' ' A' ' 8' ' ' VAL . 4.0 t -128.41 170.88 17.33 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.959 0 O-C-N 120.769 -1.207 . . . . 10.0 110.966 -179.673 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.616 HG22 ' HE2' ' A' ' 16' ' ' LYS . 8.5 t -85.25 129.92 37.04 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.97 0 O-C-N 121.469 -0.769 . . . . 10.0 110.438 -179.723 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.587 HG12 ' N ' ' A' ' 10' ' ' GLY . 40.6 t -132.46 176.55 8.78 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.782 0 O-C-N 120.972 -1.08 . . . . 10.0 111.567 -179.318 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.621 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 131.95 -173.27 20.7 Favored Glycine 0 N--CA 1.499 2.892 0 N-CA-C 109.067 -1.613 . . . . 10.0 109.067 -179.914 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.408 ' OD1' ' C ' ' A' ' 11' ' ' ASP . 2.3 p30 -84.67 15.43 3.84 Favored 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.765 -1.432 . . . . 10.0 109.559 179.069 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.635 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 89.27 52.8 2.63 Favored Glycine 0 N--CA 1.487 2.086 0 N-CA-C 108.588 -1.805 . . . . 10.0 108.588 -179.417 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.505 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -133.13 105.2 6.89 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.721 -0.87 . . . . 10.0 109.19 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.505 ' HB ' ' O ' ' A' ' 13' ' ' ALA . 4.5 t 66.71 119.36 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.578 0 O-C-N 121.41 -0.806 . . . . 10.0 109.949 -179.186 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.503 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -90.13 115.07 4.5 Favored Glycine 0 N--CA 1.492 2.396 0 N-CA-C 108.912 -1.675 . . . . 10.0 108.912 179.649 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.616 ' HE2' HG22 ' A' ' 8' ' ' VAL . 0.0 OUTLIER -52.54 -19.98 2.65 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 120.65 -1.5 . . . . 10.0 111.482 -179.043 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.681 HG21 ' CG ' ' A' ' 57' ' ' ASP . 88.9 m -82.1 -41.8 20.03 Favored 'General case' 0 N--CA 1.503 2.207 0 O-C-N 120.721 -1.237 . . . . 10.0 111.809 -179.574 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.614 ' HA ' HG23 ' B' ' 26' ' ' THR . 23.7 p -79.73 1.79 25.24 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 120.809 -1.182 . . . . 10.0 109.909 -179.372 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.678 HD12 ' O ' ' A' ' 159' ' ' ALA . 3.2 mm? -109.11 -41.31 4.73 Favored 'General case' 0 C--N 1.303 -1.424 0 O-C-N 120.843 -1.161 . . . . 10.0 109.52 178.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.804 HD12 HD21 ' A' ' 165' ' ' LEU . 1.5 tp -48.14 -34.07 9.32 Favored 'General case' 0 N--CA 1.495 1.81 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 178.74 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.629 HG13 HG22 ' B' ' 26' ' ' THR . 2.5 mm -73.83 -41.7 53.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.665 0 N-CA-C 108.409 -0.959 . . . . 10.0 108.409 177.563 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.491 ' HA ' ' O ' ' A' ' 27' ' ' LYS . 23.0 t -48.55 -41.76 31.36 Favored 'General case' 0 C--N 1.295 -1.778 0 C-N-CA 119.445 -0.902 . . . . 10.0 110.117 -179.662 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.737 ' CE2' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -97.26 -0.63 46.32 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.556 -1.34 . . . . 10.0 109.405 178.21 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.548 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 17.5 m -109.99 -19.01 13.24 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.082 -1.012 . . . . 10.0 112.58 -177.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 1.002 HG21 HG21 ' A' ' 33' ' ' VAL . 37.8 m -116.76 -72.34 0.69 Allowed 'General case' 0 C--N 1.305 -1.35 0 O-C-N 120.231 -1.543 . . . . 10.0 111.544 -178.695 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.609 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 34.1 m-20 -147.73 -33.41 0.26 Allowed 'General case' 0 C--N 1.304 -1.386 0 C-N-CA 118.311 -1.356 . . . . 10.0 112.773 -179.13 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 165.83 -138.8 0.0 OUTLIER 'General case' 0 N--CA 1.513 2.68 0 O-C-N 121.331 -0.856 . . . . 10.0 111.606 179.544 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.648 ' H ' ' CD ' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -137.62 -45.14 0.02 OUTLIER Pre-proline 0 N--CA 1.497 1.912 0 O-C-N 121.131 -0.981 . . . . 10.0 113.457 -177.731 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.648 ' CD ' ' H ' ' A' ' 28' ' ' PHE . 42.7 Cg_endo -91.17 4.21 4.24 Favored 'Trans proline' 0 C--N 1.302 -1.9 0 N-CA-C 114.739 1.015 . . . . 10.0 114.739 -176.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.401 ' HB2' ' O ' ' A' ' 29' ' ' PRO . 9.1 t -172.38 71.95 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.915 0 O-C-N 119.605 -1.935 . . . . 10.0 112.312 179.483 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.587 ' HG3' ' CG1' ' A' ' 33' ' ' VAL . 13.2 pt-20 -148.93 126.2 11.47 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 120.835 -1.166 . . . . 10.0 111.135 179.093 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.45 ' C ' HG12 ' A' ' 33' ' ' VAL . 33.9 t80 -89.08 116.27 27.23 Favored 'General case' 0 N--CA 1.495 1.798 0 O-C-N 121.372 -0.83 . . . . 10.0 108.82 178.717 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 1.002 HG21 HG21 ' A' ' 25' ' ' THR . 0.1 OUTLIER -162.01 160.33 21.82 Favored Pre-proline 0 C--N 1.302 -1.467 0 O-C-N 121.342 -0.849 . . . . 10.0 110.133 -177.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.778 ' HD2' HG23 ' A' ' 33' ' ' VAL . 36.9 Cg_endo -61.28 131.89 38.63 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 O-C-N 123.758 1.399 . . . . 10.0 109.09 178.406 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.545 ' O ' HG23 ' B' ' 20' ' ' VAL . 22.3 p -137.99 154.63 49.33 Favored 'General case' 0 N--CA 1.5 2.036 0 O-C-N 120.604 -1.31 . . . . 10.0 113.24 -177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.735 HG13 ' O ' ' A' ' 58' ' ' THR . 58.1 t 62.99 -43.57 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.504 2.258 0 O-C-N 121.72 -0.613 . . . . 10.0 111.358 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.724 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 7.8 p90 -36.38 100.98 0.02 OUTLIER 'General case' 0 C--N 1.306 -1.297 0 CA-C-O 122.161 0.981 . . . . 10.0 110.374 -179.986 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.952 ' HB3' HD11 ' A' ' 55' ' ' LEU . 1.5 m-20 -167.71 102.92 0.49 Allowed 'General case' 0 C--N 1.286 -2.17 0 C-N-CA 117.297 -1.761 . . . . 10.0 112.489 179.832 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.623 ' OD1' ' CE1' ' A' ' 56' ' ' PHE . 61.4 t30 -147.8 98.78 3.01 Favored 'General case' 0 C--N 1.298 -1.668 0 O-C-N 121.069 -1.019 . . . . 10.0 108.361 177.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.642 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 75.6 m-85 -139.73 147.05 40.34 Favored 'General case' 0 N--CA 1.489 1.511 0 C-N-CA 118.86 -1.136 . . . . 10.0 112.65 -178.258 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.429 ' H ' ' H ' ' B' ' 16' ' ' HIS . . . -140.85 98.55 3.42 Favored 'General case' 0 C--N 1.302 -1.493 0 N-CA-C 108.264 -1.013 . . . . 10.0 108.264 177.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.835 HG23 ' O ' ' B' ' 14' ' ' PHE . 7.5 p -135.23 -173.07 0.91 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 121.333 -0.854 . . . . 10.0 110.269 -178.611 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.784 ' H ' HG22 ' A' ' 42' ' ' VAL . 94.1 m -136.72 167.29 21.72 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 109.251 -0.648 . . . . 10.0 109.251 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.718 HG13 ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -130.48 152.24 37.17 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.669 0 N-CA-C 108.215 -1.031 . . . . 10.0 108.215 178.12 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.737 ' C ' HD12 ' A' ' 46' ' ' ILE . 7.1 mtm -144.67 131.15 19.82 Favored 'General case' 0 C--N 1.289 -2.055 0 C-N-CA 120.001 -0.68 . . . . 10.0 109.37 -179.585 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.737 HD12 ' C ' ' A' ' 45' ' ' MET . 1.4 mp -147.94 114.97 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.299 -1.604 0 O-C-N 121.204 -0.935 . . . . 10.0 110.693 -179.215 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.559 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 67.51 6.5 42.14 Favored Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.934 -1.267 . . . . 10.0 109.934 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 108.54 24.06 6.31 Favored Glycine 0 N--CA 1.489 2.179 0 O-C-N 121.064 -1.257 . . . . 10.0 110.008 179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 49' ' ' GLU . 13.7 pt-20 -118.67 111.33 37.82 Favored Pre-proline 0 N--CA 1.49 1.545 0 O-C-N 120.939 -1.33 . . . . 10.0 109.723 179.457 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 48.5 Cg_endo -70.49 146.94 57.03 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 O-C-N 123.87 1.458 . . . . 10.0 111.542 -178.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.65 ' CD2' HG12 ' A' ' 44' ' ' VAL . 2.8 m-85 -136.71 107.12 6.45 Favored 'General case' 0 N--CA 1.487 1.413 0 O-C-N 121.348 -0.845 . . . . 10.0 111.122 179.355 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.818 HG21 ' H ' ' A' ' 3' ' ' THR . 47.3 m -83.64 153.04 24.47 Favored 'General case' 0 C--N 1.302 -1.496 0 O-C-N 121.164 -0.96 . . . . 10.0 109.169 178.565 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.805 HD12 ' C ' ' A' ' 53' ' ' LEU . 1.4 pp -167.26 166.34 14.81 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 120.716 -1.24 . . . . 10.0 110.765 179.441 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.61 131.92 2.35 Favored Glycine 0 N--CA 1.489 2.184 0 N-CA-C 109.405 -1.478 . . . . 10.0 109.405 -179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.041 ' O ' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -115.63 124.03 49.89 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.443 -1.034 . . . . 10.0 109.403 -179.738 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.913 ' N ' HD22 ' A' ' 55' ' ' LEU . 5.1 m-85 -135.96 104.51 5.73 Favored 'General case' 0 N--CA 1.497 1.912 0 O-C-N 121.11 -0.994 . . . . 10.0 110.259 -179.855 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.681 ' CG ' HG21 ' A' ' 17' ' ' THR . 23.5 t0 -105.34 146.36 29.51 Favored 'General case' 0 C--N 1.297 -1.683 0 O-C-N 121.141 -0.975 . . . . 10.0 110.231 179.289 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.735 ' O ' HG13 ' A' ' 36' ' ' VAL . 66.5 m -45.72 131.15 9.2 Favored 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.345 -0.847 . . . . 10.0 109.283 179.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.54 ' HB2' ' CZ ' ' A' ' 64' ' ' TYR . . . -101.26 89.75 3.88 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.607 -0.683 . . . . 10.0 111.305 -178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.465 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . -53.41 -23.78 20.49 Favored Glycine 0 N--CA 1.486 2.024 0 N-CA-C 107.558 -2.217 . . . . 10.0 107.558 178.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.512 ' HB3' ' O ' ' B' ' 21' ' ' GLY . 29.1 tt0 178.02 31.32 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.762 0 O-C-N 122.004 -0.704 . . . . 10.0 109.516 179.134 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.491 ' OE1' ' CD2' ' A' ' 64' ' ' TYR . 9.6 tm-20 -53.62 -51.95 61.44 Favored 'General case' 0 N--CA 1.499 1.978 0 O-C-N 121.129 -0.982 . . . . 10.0 110.687 -179.821 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.404 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 0.9 OUTLIER 177.05 -17.31 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 121.275 -0.891 . . . . 10.0 110.988 179.774 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.54 ' CZ ' ' HB2' ' A' ' 59' ' ' ALA . 19.9 p90 -119.74 16.53 12.73 Favored 'General case' 0 N--CA 1.492 1.669 0 O-C-N 121.004 -1.06 . . . . 10.0 109.395 179.208 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.503 ' OD1' ' HB2' ' A' ' 68' ' ' ARG . 38.0 t0 -37.42 -30.21 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.729 -0.607 . . . . 10.0 111.232 -179.664 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.517 ' HG3' HD23 ' A' ' 67' ' ' LEU . 12.6 ptp180 -51.03 -22.22 2.22 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.22 -0.925 . . . . 10.0 110.004 179.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.544 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.9 mm? -106.95 11.41 29.89 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.3 -0.875 . . . . 10.0 109.048 179.223 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.641 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 10.6 ttp-105 -54.48 -37.98 60.61 Favored Pre-proline 0 N--CA 1.491 1.575 0 O-C-N 121.775 -0.578 . . . . 10.0 111.641 179.447 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.641 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 39.8 Cg_endo -68.06 59.19 0.93 Allowed 'Trans proline' 0 C--N 1.315 -1.23 0 N-CA-C 109.953 -0.826 . . . . 10.0 109.953 178.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.884 ' HG ' HD12 ' B' ' 39' ' ' LEU . 0.3 OUTLIER -92.72 -57.34 2.69 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.61 -0.681 . . . . 10.0 109.986 179.646 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.769 ' OG ' HD23 ' B' ' 40' ' ' LEU . 1.5 t 58.44 53.24 6.41 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.245 -0.909 . . . . 10.0 109.628 179.0 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.638 ' O ' ' CG ' ' A' ' 72' ' ' TYR . 1.2 p90 -149.11 113.72 3.6 Favored Pre-proline 0 N--CA 1.488 1.472 0 C-N-CA 118.564 -1.254 . . . . 10.0 112.542 -177.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_endo -84.23 94.65 0.73 Allowed 'Trans proline' 0 C--N 1.308 -1.566 0 C-N-CA 121.509 1.473 . . . . 10.0 109.971 178.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -129.98 76.09 1.7 Allowed 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.791 -1.193 . . . . 10.0 110.791 -179.454 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 1.041 HG23 ' CB ' ' A' ' 5' ' ' LYS . 54.1 m -144.83 97.87 3.09 Favored 'General case' 0 C--N 1.299 -1.629 0 O-C-N 121.179 -0.951 . . . . 10.0 109.626 178.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.549 ' C ' ' O ' ' A' ' 75' ' ' THR . 2.3 m-20 -18.95 -53.14 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.212 0 CA-C-O 121.449 0.642 . . . . 10.0 111.843 -179.475 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.678 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -88.84 123.23 41.02 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.442 -0.903 . . . . 10.0 109.352 179.709 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.497 ' CD2' HG21 ' A' ' 9' ' ' VAL . 93.8 m-85 -116.01 139.96 49.74 Favored 'General case' 0 C--N 1.298 -1.67 0 O-C-N 121.403 -0.81 . . . . 10.0 109.897 179.719 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.616 HD11 HG12 ' A' ' 168' ' ' VAL . 1.6 mm? -108.15 98.17 7.76 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 107.778 -1.193 . . . . 10.0 107.778 178.698 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.621 HG23 ' HA2' ' A' ' 10' ' ' GLY . 9.2 p -92.84 122.8 44.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.673 0 C-N-CA 119.619 -0.832 . . . . 10.0 110.708 -178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . . . . . . . . . 84.0 m -116.82 104.3 11.19 Favored 'General case' 0 C--N 1.305 -1.349 0 O-C-N 121.564 -0.71 . . . . 10.0 110.629 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.499 ' C ' HG22 ' A' ' 115' ' ' THR . 13.0 p90 -136.57 179.82 6.14 Favored 'General case' 0 C--N 1.3 -1.546 0 O-C-N 121.221 -0.925 . . . . 10.0 109.239 179.183 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.433 ' O ' ' CD2' ' A' ' 82' ' ' PHE . 90.2 p -75.28 161.5 29.26 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.861 -1.149 . . . . 10.0 111.333 -177.932 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.713 HG12 ' OH ' ' A' ' 154' ' ' TYR . 6.6 m -78.78 -9.87 12.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.741 0 CA-C-O 121.395 0.616 . . . . 10.0 111.134 -179.413 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.929 HG11 HD23 ' A' ' 129' ' ' LEU . 0.2 OUTLIER -115.17 -82.29 0.27 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.721 0 O-C-N 120.99 -1.069 . . . . 10.0 108.116 -179.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.499 ' CB ' ' O ' ' A' ' 85' ' ' VAL . 1.5 t 66.38 147.66 0.11 Allowed Pre-proline 0 N--CA 1.497 1.921 0 O-C-N 120.407 -1.433 . . . . 10.0 111.79 177.193 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.655 ' HA ' ' HG3' ' A' ' 134' ' ' GLN . 49.9 Cg_endo -76.76 167.78 24.73 Favored 'Trans proline' 0 C--N 1.308 -1.558 0 O-C-N 124.384 1.728 . . . . 10.0 112.247 -179.557 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.463 ' CB ' ' O ' ' A' ' 87' ' ' PRO . 1.0 OUTLIER 71.77 15.35 5.87 Favored 'General case' 0 N--CA 1.491 1.622 0 CA-C-N 115.952 -0.567 . . . . 10.0 111.985 178.855 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.498 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.5 t 61.64 102.01 0.03 OUTLIER 'General case' 0 C--N 1.296 -1.744 0 O-C-N 121.023 -1.048 . . . . 10.0 110.474 178.777 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.597 ' CE1' ' HB3' ' A' ' 94' ' ' LYS . 0.2 OUTLIER -46.76 -31.77 3.2 Favored 'General case' 0 C--N 1.295 -1.781 0 C-N-CA 119.395 -0.922 . . . . 10.0 109.046 179.75 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 73.9 tt0 -53.55 -29.39 36.79 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.181 -0.949 . . . . 10.0 110.679 179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.796 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -82.17 -11.82 58.5 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.827 -1.171 . . . . 10.0 109.535 179.46 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.796 HG23 ' ND2' ' A' ' 92' ' ' ASN . 89.1 t -89.63 -36.04 8.19 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.404 0 O-C-N 121.181 -0.949 . . . . 10.0 109.391 179.428 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.67 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -71.14 -17.75 62.54 Favored 'General case' 0 C--N 1.299 -1.6 0 C-N-CA 119.458 -0.897 . . . . 10.0 109.285 179.029 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.665 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.0 OUTLIER -97.84 -4.82 35.96 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.111 -0.993 . . . . 10.0 110.804 -179.932 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 8.7 tptt -78.37 -41.63 32.76 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.832 -1.168 . . . . 10.0 110.469 179.692 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.501 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 24.2 m95 -80.52 -27.84 37.54 Favored 'General case' 0 C--N 1.297 -1.677 0 O-C-N 121.428 -0.795 . . . . 10.0 110.195 -179.099 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.716 HG22 HD22 ' A' ' 149' ' ' LEU . 93.9 t -52.83 -50.77 79.47 Favored Pre-proline 0 C--N 1.3 -1.546 0 O-C-N 121.159 -0.963 . . . . 10.0 110.861 179.755 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.603 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.5 Cg_endo -68.35 -17.95 44.29 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.277 1.146 . . . . 10.0 109.731 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.553 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -58.02 -29.57 65.42 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.474 -0.766 . . . . 10.0 110.142 -179.953 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.553 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 7.0 mt 63.01 106.38 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 1.976 0 O-C-N 121.301 -0.874 . . . . 10.0 111.417 179.499 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.832 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.1 OUTLIER -49.17 -91.12 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.318 0 N-CA-C 108.363 -0.977 . . . . 10.0 108.363 178.653 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.699 ' H ' HG23 ' A' ' 102' ' ' THR . 40.4 m170 -105.19 -7.62 18.9 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 121.162 -0.961 . . . . 10.0 110.181 178.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.606 ' CD2' ' O ' ' A' ' 103' ' ' HIS . 1.7 m-70 174.68 -33.48 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.212 -0.93 . . . . 10.0 109.764 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.832 ' O ' HG22 ' A' ' 102' ' ' THR . 81.3 m -119.2 144.91 37.16 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 121.008 -1.058 . . . . 10.0 109.892 179.168 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -69.05 91.67 0.44 Allowed 'Trans proline' 0 C--N 1.299 -2.051 0 O-C-N 123.679 1.358 . . . . 10.0 110.49 -179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.561 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -153.36 18.31 0.55 Allowed 'General case' 0 N--CA 1.486 1.337 0 O-C-N 121.201 -0.937 . . . . 10.0 109.591 -179.602 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 9.4 m -56.25 131.58 75.4 Favored Pre-proline 0 C--N 1.302 -1.479 0 O-C-N 121.254 -0.904 . . . . 10.0 109.634 179.398 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -72.06 135.69 25.7 Favored 'Trans proline' 0 C--N 1.303 -1.864 0 O-C-N 123.557 1.293 . . . . 10.0 109.637 179.405 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.505 ' O ' ' CG1' ' A' ' 152' ' ' VAL . 1.3 m-85 -132.48 106.01 7.59 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.288 -0.882 . . . . 10.0 110.438 -179.774 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.078 HD13 HG11 ' A' ' 152' ' ' VAL . 3.1 mm? -74.91 95.61 2.99 Favored 'General case' 0 C--N 1.297 -1.682 0 N-CA-C 105.972 -1.862 . . . . 10.0 105.972 177.605 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.58 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 46.2 mt -70.08 139.07 52.52 Favored 'General case' 0 C--N 1.294 -1.823 0 N-CA-C 109.182 -0.673 . . . . 10.0 109.182 -178.628 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.558 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.9 t -149.6 167.34 2.92 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.64 0 O-C-N 120.875 -1.141 . . . . 10.0 111.454 -178.324 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.463 ' O ' ' CG2' ' A' ' 117' ' ' ILE . . . -124.52 107.27 1.0 Allowed Glycine 0 N--CA 1.486 1.982 0 N-CA-C 107.956 -2.057 . . . . 10.0 107.956 178.754 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.499 HG22 ' C ' ' A' ' 82' ' ' PHE . 3.5 t -93.88 155.62 17.08 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.179 -1.189 . . . . 10.0 110.543 -178.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 8.4 mm100 48.73 48.65 19.82 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.368 -0.832 . . . . 10.0 109.894 -179.867 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.988 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.5 OUTLIER -82.62 -13.02 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 O-C-N 121.232 -0.917 . . . . 10.0 110.662 -179.581 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.622 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 51.3 p30 -52.01 51.46 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.409 0 N-CA-C 112.3 0.481 . . . . 10.0 112.3 -176.278 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.738 ' N ' ' O ' ' A' ' 117' ' ' ILE . 12.3 tp 152.47 -34.28 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.332 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 -179.907 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.683 ' HG2' HG22 ' A' ' 84' ' ' VAL . 10.9 tpp180 -55.54 -33.87 64.19 Favored 'General case' 0 C--N 1.302 -1.488 0 CA-C-O 121.504 0.669 . . . . 10.0 109.997 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -74.15 -14.43 60.96 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.396 -0.815 . . . . 10.0 110.447 -179.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.738 ' O ' HD13 ' A' ' 126' ' ' ILE . 70.9 m-20 -82.7 142.12 45.33 Favored Pre-proline 0 C--N 1.302 -1.481 0 O-C-N 121.233 -0.917 . . . . 10.0 110.837 -179.503 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.5 Cg_endo -75.44 22.99 0.43 Allowed 'Trans proline' 0 C--N 1.305 -1.712 0 O-C-N 124.12 1.59 . . . . 10.0 111.558 179.269 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 70.7 m -103.07 -50.57 3.46 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 120.757 -1.214 . . . . 10.0 109.967 179.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 11.5 t -74.26 -28.16 61.09 Favored 'General case' 0 C--N 1.294 -1.833 0 N-CA-C 105.411 -2.07 . . . . 10.0 105.411 177.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.738 HD13 ' O ' ' A' ' 122' ' ' ASP 0.29 0.6 OUTLIER -51.1 -30.88 10.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.508 0 N-CA-C 107.184 -1.413 . . . . 10.0 107.184 176.888 . . . . . . . . 4 4 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -49.3 -47.82 46.72 Favored 'General case' 0 N--CA 1.489 1.496 0 CA-C-O 121.885 0.85 . . . . 10.0 110.235 179.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -74.73 -37.29 62.58 Favored 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.466 0.651 . . . . 10.0 110.005 -179.864 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.929 HD23 HG11 ' A' ' 85' ' ' VAL . 3.4 mp -55.64 -27.1 47.87 Favored 'General case' 0 C--N 1.301 -1.519 0 CA-C-O 122.114 0.959 . . . . 10.0 109.942 179.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -76.25 -28.39 57.1 Favored 'General case' 0 C--N 1.299 -1.59 0 O-C-N 120.405 -1.434 . . . . 10.0 109.022 179.752 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 4.1 mtpp -69.94 -17.31 63.31 Favored 'General case' 0 C--N 1.298 -1.655 0 C-N-CA 120.015 -0.674 . . . . 10.0 109.982 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.597 ' CB ' ' NE2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -129.25 34.28 4.42 Favored 'General case' 0 N--CA 1.5 2.049 0 C-N-CA 118.204 -1.398 . . . . 10.0 112.589 179.702 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.433 ' HB2' ' O ' ' A' ' 132' ' ' ASN . 0.8 OUTLIER 55.91 63.94 1.88 Allowed 'General case' 0 C--N 1.297 -1.711 0 O-C-N 121.135 -0.978 . . . . 10.0 110.225 179.125 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.834 ' O ' HG12 ' A' ' 85' ' ' VAL . 2.5 mt-30 -128.86 80.99 2.0 Favored 'General case' 0 C--N 1.302 -1.477 0 N-CA-C 108.537 -0.912 . . . . 10.0 108.537 179.294 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.2 140.13 39.44 Favored Pre-proline 0 N--CA 1.492 1.668 0 O-C-N 121.453 -0.78 . . . . 10.0 109.901 -179.782 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.48 ' N ' HG13 ' A' ' 85' ' ' VAL . 42.6 Cg_endo -66.53 161.65 40.31 Favored 'Trans proline' 0 C--N 1.306 -1.663 0 O-C-N 124.203 1.633 . . . . 10.0 111.741 -179.228 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.574 HG12 ' CE2' ' A' ' 90' ' ' PHE . 3.5 tp -126.64 139.92 50.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.594 -0.691 . . . . 10.0 109.479 -179.839 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.5 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.3 p -118.78 165.42 16.84 Favored Pre-proline 0 C--N 1.301 -1.529 0 O-C-N 121.323 -0.86 . . . . 10.0 109.609 -179.844 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.5 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 37.9 Cg_endo -65.67 -21.57 58.72 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 O-C-N 123.8 1.421 . . . . 10.0 110.236 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 18.4 tt0 -70.54 -47.66 59.29 Favored 'General case' 0 C--N 1.301 -1.515 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.283 179.395 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 93.6 m -77.9 -42.15 34.24 Favored 'General case' 0 C--N 1.297 -1.676 0 C-N-CA 119.916 -0.714 . . . . 10.0 110.292 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -62.78 -45.88 90.58 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.912 -1.118 . . . . 10.0 110.527 -179.969 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.434 ' CG ' ' O ' ' A' ' 139' ' ' PRO . 20.4 mm-40 -52.95 -48.19 67.55 Favored 'General case' 0 C--N 1.3 -1.58 0 C-N-CA 119.483 -0.887 . . . . 10.0 110.132 -179.486 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 54.1 mmtt -62.18 -34.63 76.79 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.175 -0.953 . . . . 10.0 109.705 179.798 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 8.8 tp -66.46 -50.08 64.52 Favored 'General case' 0 N--CA 1.485 1.308 0 O-C-N 120.905 -1.122 . . . . 10.0 108.222 178.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.965 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.09 -41.62 88.49 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.284 -0.885 . . . . 10.0 109.95 179.459 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.418 ' HA ' ' HD2' ' A' ' 147' ' ' ARG . 40.3 mmm-85 -78.61 -7.29 57.46 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.344 -0.847 . . . . 10.0 110.18 179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 145' ' ' LEU . 2.5 m-20 -76.88 -48.66 17.68 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.028 -1.045 . . . . 10.0 110.806 -179.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.798 HD12 ' H ' ' A' ' 149' ' ' LEU . 2.2 mp -102.09 9.84 39.97 Favored 'General case' 0 N--CA 1.496 1.845 0 O-C-N 121.088 -1.007 . . . . 10.0 109.819 -179.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.557 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 5.6 mtpt 81.51 23.13 0.29 Allowed 'General case' 0 N--CA 1.494 1.746 0 CA-C-O 122.028 0.918 . . . . 10.0 110.512 179.519 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.965 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -64.26 -176.34 0.21 Allowed 'General case' 0 C--N 1.295 -1.764 0 N-CA-C 108.873 -0.788 . . . . 10.0 108.873 178.031 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.078 HG11 HD13 ' A' ' 111' ' ' LEU . 2.5 p -84.99 -77.74 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 120.773 -1.204 . . . . 10.0 111.83 -179.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.877 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -173.66 -179.04 1.72 Allowed 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.437 -1.414 . . . . 10.0 110.889 -179.223 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.713 ' OH ' HG12 ' A' ' 84' ' ' VAL . 68.1 t80 -108.7 120.86 43.7 Favored 'General case' 0 C--N 1.301 -1.529 0 O-C-N 121.622 -0.674 . . . . 10.0 109.778 178.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.019 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -124.51 -169.72 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.518 0 O-C-N 121.226 -0.922 . . . . 10.0 109.349 -179.895 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 15.6 tt0 -157.2 144.42 18.62 Favored 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.291 -1.364 . . . . 10.0 112.679 -179.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.587 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 27.4 p -157.49 162.43 38.89 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 121.448 0.642 . . . . 10.0 110.133 179.082 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.6 ' O ' ' OH ' ' A' ' 23' ' ' TYR . 18.9 p -133.14 172.84 12.12 Favored 'General case' 0 C--O 1.197 -1.699 0 N-CA-C 108.49 -0.93 . . . . 10.0 108.49 179.264 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.737 ' O ' ' CE2' ' A' ' 23' ' ' TYR . . . -54.96 -64.85 0.7 Allowed 'General case' 0 N--CA 1.497 1.882 0 N-CA-C 112.894 0.702 . . . . 10.0 112.894 -178.617 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.616 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.0 pp -132.91 -3.83 3.19 Favored 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.66 -1.275 . . . . 10.0 112.13 -178.471 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.539 ' O ' ' HG3' ' A' ' 163' ' ' LYS . 19.4 m -96.33 -53.56 3.57 Favored 'General case' 0 N--CA 1.501 2.104 0 O-C-N 120.65 -1.282 . . . . 10.0 113.167 -177.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.565 ' HB2' ' CB ' ' A' ' 158' ' ' SER . 0.4 OUTLIER -63.25 -53.03 59.43 Favored 'General case' 0 N--CA 1.498 1.971 0 O-C-N 120.757 -1.215 . . . . 10.0 111.327 -178.406 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.539 ' HG3' ' O ' ' A' ' 161' ' ' THR . 0.4 OUTLIER 66.19 27.78 10.25 Favored 'General case' 0 C--N 1.293 -1.863 0 N-CA-C 107.727 -1.212 . . . . 10.0 107.727 -177.728 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -93.51 -17.23 42.97 Favored Glycine 0 N--CA 1.489 2.215 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 -178.669 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.836 HD22 ' N ' ' A' ' 166' ' ' LYS . 0.0 OUTLIER -49.98 -18.43 0.53 Allowed 'General case' 0 C--N 1.303 -1.436 0 O-C-N 121.185 -1.186 . . . . 10.0 110.796 179.937 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.836 ' N ' HD22 ' A' ' 165' ' ' LEU . 1.5 tttt -71.97 -31.44 66.29 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.681 -1.262 . . . . 10.0 109.658 179.012 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -69.38 -45.1 70.11 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.82 -1.175 . . . . 10.0 109.582 179.274 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.019 HG22 ' HB ' ' A' ' 155' ' ' VAL . 31.1 t -53.31 -18.05 1.53 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 CA-C-O 121.661 0.743 . . . . 10.0 110.2 179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.511 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 m-85 -84.3 -40.52 17.87 Favored 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.337 -0.852 . . . . 10.0 111.902 -178.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.62 ' O ' HD22 ' A' ' 174' ' ' LEU . 22.8 t70 -65.69 -52.19 53.49 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 120.89 -1.131 . . . . 10.0 112.268 -177.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.748 ' OE2' HD12 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -63.92 -25.53 68.19 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 120.773 -1.204 . . . . 10.0 109.972 -179.604 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.597 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -66.87 -32.07 73.09 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.264 -0.897 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.521 ' O ' ' CD1' ' A' ' 177' ' ' LEU . 49.0 mm -62.74 -50.27 80.4 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 O-C-N 121.413 -0.804 . . . . 10.0 109.696 179.396 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.854 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -72.63 -34.07 67.06 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.56 -0.712 . . . . 10.0 111.073 -179.25 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.662 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -85.24 -2.35 57.95 Favored 'General case' 0 C--N 1.298 -1.641 0 O-C-N 121.154 -0.966 . . . . 10.0 110.202 -179.533 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.012 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -87.12 -22.31 25.45 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.052 -1.03 . . . . 10.0 110.129 179.921 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.602 HD22 ' CG ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -100.22 -20.38 15.95 Favored 'General case' 0 N--CA 1.494 1.768 0 O-C-N 121.206 -0.934 . . . . 10.0 108.793 179.272 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 . . . . . 0 C--N 1.306 -1.319 0 CA-C-O 118.09 -0.957 . . . . 10.0 110.426 -179.746 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.5 -1.44 . . . . 10.0 109.5 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.467 ' O ' ' OE1' ' A' ' 49' ' ' GLU . 46.4 m -128.4 156.65 42.82 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 121.297 -1.119 . . . . 10.0 109.59 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.0 mtmp? -81.66 97.66 8.01 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.151 -0.968 . . . . 10.0 108.582 179.11 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -112.43 156.88 21.8 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.013 -1.055 . . . . 10.0 111.024 -178.728 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.722 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -72.24 -154.47 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.585 0 N-CA-C 107.591 -1.263 . . . . 10.0 107.591 179.344 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.722 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 38.2 Cg_endo -65.74 73.87 0.31 Allowed 'Trans proline' 0 C--N 1.313 -1.312 0 CA-C-N 119.062 0.701 . . . . 10.0 110.523 -179.305 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.53 ' HB2' HG22 ' A' ' 46' ' ' ILE . 3.3 tp10 -53.32 -176.03 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.091 0 O-C-N 121.591 -0.693 . . . . 10.0 110.073 179.97 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.692 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -79.56 -50.73 17.6 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 120.7 -1.25 . . . . 10.0 112.25 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.658 ' N ' HG12 ' B' ' 8' ' ' ILE . 61.0 m -88.82 146.72 24.81 Favored 'General case' 0 C--N 1.295 -1.765 0 O-C-N 120.808 -1.182 . . . . 10.0 110.994 -179.203 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.44 HD23 ' O ' ' B' ' 8' ' ' ILE . 0.7 OUTLIER -170.8 98.05 0.43 Allowed Pre-proline 0 C--N 1.3 -1.574 0 C-N-CA 119.11 -1.036 . . . . 10.0 111.359 179.812 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.519 ' HD2' ' CB ' ' A' ' 45' ' ' MET . 51.4 Cg_endo -86.16 97.56 0.55 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 124.229 1.647 . . . . 10.0 109.073 178.363 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 20.1 p -68.37 160.61 29.2 Favored 'General case' 0 N--CA 1.497 1.884 0 O-C-N 121.07 -1.019 . . . . 10.0 111.894 -178.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.537 ' O ' HG21 ' A' ' 42' ' ' VAL . 1.2 m-20 -124.14 155.86 37.72 Favored 'General case' 0 C--N 1.303 -1.434 0 N-CA-C 109.223 -0.658 . . . . 10.0 109.223 178.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.835 ' O ' HG23 ' A' ' 42' ' ' VAL . 69.0 m-85 -85.33 156.09 21.05 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-O 122.028 0.918 . . . . 10.0 112.672 -178.314 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.635 ' HB2' ' HB3' ' A' ' 40' ' ' TYR . 15.9 pt-20 -120.09 154.71 34.28 Favored 'General case' 0 N--CA 1.484 1.227 0 CA-C-O 121.609 0.719 . . . . 10.0 110.316 -179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.642 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -49.87 -168.18 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.773 -0.58 . . . . 10.0 111.142 -179.968 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.67 ' O ' HG23 ' B' ' 18' ' ' ILE . 4.3 t -159.5 144.37 15.42 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 120.672 -1.268 . . . . 10.0 110.685 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.67 HG23 ' O ' ' B' ' 17' ' ' THR . 0.8 OUTLIER -160.67 177.51 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.823 0 O-C-N 121.721 -0.612 . . . . 10.0 109.613 179.467 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.587 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 51.2 t-80 -143.07 160.23 40.77 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.675 -1.266 . . . . 10.0 111.548 179.683 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.791 HG22 ' H ' ' B' ' 22' ' ' PHE . 5.8 p -69.74 148.46 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.061 0 CA-C-O 122.192 0.996 . . . . 10.0 112.711 -177.529 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.512 ' O ' ' HB3' ' A' ' 61' ' ' GLN . . . -127.31 42.68 1.43 Allowed Glycine 0 N--CA 1.49 2.242 0 N-CA-C 107.132 -2.387 . . . . 10.0 107.132 177.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.818 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.2 OUTLIER -178.94 103.85 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.379 0 O-C-N 121.528 -0.983 . . . . 10.0 109.705 -178.572 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.631 ' O ' HG23 ' B' ' 25' ' ' VAL . 17.3 p-10 -57.95 155.12 11.18 Favored 'General case' 0 N--CA 1.501 2.086 0 CA-C-O 121.85 0.833 . . . . 10.0 112.688 -179.04 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.418 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 34.21 57.98 0.63 Allowed 'General case' 0 N--CA 1.5 2.041 0 O-C-N 121.781 -0.575 . . . . 10.0 112.37 178.647 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.818 HG21 ' CG ' ' B' ' 22' ' ' PHE . 42.5 t -113.01 -26.83 2.9 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.652 0 O-C-N 120.987 -1.071 . . . . 10.0 109.72 178.551 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.629 HG22 HG13 ' A' ' 21' ' ' ILE . 3.3 m -107.91 -22.23 12.52 Favored 'General case' 0 C--N 1.307 -1.249 0 N-CA-C 108.927 -0.768 . . . . 10.0 108.927 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.611 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -90.49 35.2 3.9 Favored Glycine 0 N--CA 1.494 2.532 0 N-CA-C 106.923 -2.471 . . . . 10.0 106.923 177.55 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.517 ' HG2' ' O ' ' A' ' 28' ' ' PHE . 19.6 mt-10 -149.92 120.41 7.43 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.475 -1.014 . . . . 10.0 110.304 -178.979 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.667 ' CD2' ' HB1' ' A' ' 159' ' ' ALA . 3.8 t80 -124.21 142.71 51.01 Favored 'General case' 0 C--N 1.29 -1.992 0 O-C-N 121.25 -0.906 . . . . 10.0 108.701 177.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 30.5 p -141.06 -46.59 0.39 Allowed 'General case' 0 C--N 1.289 -2.064 0 O-C-N 121.153 -0.967 . . . . 10.0 109.566 179.481 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 147.11 51.02 0.02 OUTLIER Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.449 -1.86 . . . . 10.0 108.449 -179.682 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 21.1 mm -73.55 132.64 80.96 Favored Pre-proline 0 N--CA 1.489 1.501 0 O-C-N 121.835 -0.803 . . . . 10.0 110.02 -179.95 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.56 ' O ' ' HB2' ' B' ' 34' ' ' GLU . 56.3 Cg_endo -80.54 79.88 3.2 Favored 'Trans proline' 0 C--N 1.308 -1.555 0 O-C-N 123.718 1.378 . . . . 10.0 112.243 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.56 ' HB2' ' O ' ' B' ' 33' ' ' PRO . 33.7 tt0 173.61 122.78 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.963 0 O-C-N 121.005 -1.059 . . . . 10.0 111.126 177.604 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.635 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 10.4 pt20 -78.3 -37.73 44.07 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.706 -0.622 . . . . 10.0 109.658 -179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.619 ' CG ' ' O ' ' B' ' 35' ' ' GLN . 0.0 OUTLIER 152.52 33.57 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.189 0 CA-C-O 121.752 0.787 . . . . 10.0 109.066 -179.793 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.457 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -139.97 -21.74 0.87 Allowed 'General case' 0 C--N 1.295 -1.773 0 O-C-N 121.716 -0.615 . . . . 10.0 110.096 -179.474 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.467 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 10.0 mmm180 -75.26 7.22 3.6 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.895 -1.128 . . . . 10.0 109.397 178.659 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.884 HD12 ' HG ' ' A' ' 70' ' ' LEU . 0.4 OUTLIER -41.28 -25.93 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.347 0 O-C-N 121.33 -0.856 . . . . 10.0 110.207 179.573 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.867 ' O ' HD12 ' B' ' 40' ' ' LEU . 2.8 pp -80.44 8.69 7.12 Favored 'General case' 0 N--CA 1.498 1.942 0 O-C-N 121.093 -1.004 . . . . 10.0 111.48 -179.498 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.48 ' O ' ' CG ' ' B' ' 41' ' ' GLN . 3.5 tt0 -171.75 75.03 0.05 Allowed 'General case' 0 C--N 1.289 -2.054 0 O-C-N 121.276 -0.89 . . . . 10.0 109.933 179.866 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.436 ' O ' ' N ' ' B' ' 44' ' ' ASN . 11.7 t -122.1 160.79 24.31 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.385 -0.822 . . . . 10.0 110.946 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 61.8 m -66.39 62.88 0.04 OUTLIER 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.518 -0.739 . . . . 10.0 110.964 -179.558 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.436 ' N ' ' O ' ' B' ' 42' ' ' THR . 77.8 m-20 -69.08 -36.04 77.17 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.053 -1.029 . . . . 10.0 110.17 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.538 ' O ' ' CB ' ' B' ' 46' ' ' THR . 1.1 pt -100.52 -163.4 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.378 0 O-C-N 121.268 -0.895 . . . . 10.0 110.591 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.538 ' CB ' ' O ' ' B' ' 45' ' ' ILE . 1.6 m . . . . . 0 N--CA 1.489 1.507 0 CA-C-O 117.976 -1.012 . . . . 10.0 109.949 -179.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.555 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 6.4 tmm? . . . . . 0 N--CA 1.494 1.739 0 CA-C-O 121.14 0.495 . . . . 10.0 109.943 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.555 ' HB2' ' O ' ' A' ' 1' ' ' MET . 0.0 OUTLIER 75.17 51.09 0.08 Allowed 'General case' 0 C--N 1.307 -1.278 0 N-CA-C 107.701 -1.222 . . . . 10.0 107.701 -178.935 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.86 ' HA ' HG21 ' A' ' 52' ' ' THR . 2.2 m -173.13 75.0 0.04 OUTLIER 'General case' 0 N--CA 1.485 1.321 0 CA-C-N 115.73 -0.668 . . . . 10.0 110.467 -178.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.814 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -105.3 136.36 39.57 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 120.167 -1.583 . . . . 10.0 110.026 178.623 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' O ' HG22 ' A' ' 77' ' ' VAL . 0.0 OUTLIER -118.33 114.25 22.67 Favored 'General case' 0 C--N 1.296 -1.746 0 N-CA-C 106.939 -1.504 . . . . 10.0 106.939 177.665 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 63.2 m -95.82 105.3 17.3 Favored 'General case' 0 C--N 1.298 -1.651 0 O-C-N 120.518 -1.363 . . . . 10.0 110.734 -178.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.721 ' HB ' HG21 ' A' ' 75' ' ' THR . 45.7 t -136.3 145.45 30.69 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.6 0 C-N-CA 119.315 -0.954 . . . . 10.0 110.675 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 17' ' ' THR . 29.6 m -77.96 141.46 15.48 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.657 -0.652 . . . . 10.0 109.278 179.519 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.893 ' O ' HG21 ' A' ' 14' ' ' VAL . 1.5 p -161.38 172.83 0.3 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 121.138 -0.976 . . . . 10.0 110.205 -178.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.579 ' N ' HG22 ' A' ' 9' ' ' VAL . . . 149.54 176.22 22.54 Favored Glycine 0 N--CA 1.492 2.405 0 N-CA-C 109.333 -1.507 . . . . 10.0 109.333 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.7 p-10 -49.34 -21.94 0.98 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.072 -1.252 . . . . 10.0 110.373 -179.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.437 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 139.28 45.84 0.07 OUTLIER Glycine 0 N--CA 1.494 2.514 0 N-CA-C 109.556 -1.418 . . . . 10.0 109.556 179.793 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -159.2 -91.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.171 -1.193 . . . . 10.0 110.039 179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.893 HG21 ' O ' ' A' ' 9' ' ' VAL . 2.8 t 50.26 -125.88 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 O-C-N 121.441 -0.787 . . . . 10.0 111.148 179.28 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.543 ' O ' ' HG ' ' A' ' 19' ' ' LEU . . . 96.53 7.47 57.96 Favored Glycine 0 N--CA 1.485 1.912 0 N-CA-C 108.378 -1.889 . . . . 10.0 108.378 -178.42 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.792 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.2 OUTLIER -57.96 -18.6 24.63 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.038 -1.272 . . . . 10.0 109.477 -179.776 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.544 ' CG2' ' HB3' ' A' ' 34' ' ' PRO . 4.9 t -86.48 -24.9 25.42 Favored 'General case' 0 C--N 1.302 -1.487 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 178.571 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.562 ' HB2' ' H ' ' A' ' 33' ' ' VAL . 26.9 p -97.7 -8.22 29.18 Favored 'General case' 0 C--N 1.308 -1.237 0 O-C-N 121.029 -1.044 . . . . 10.0 109.515 179.622 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.781 HD13 ' HB2' ' A' ' 159' ' ' ALA . 1.4 mt -74.6 -38.36 62.62 Favored 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 107.204 -1.406 . . . . 10.0 107.204 177.608 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.862 ' N ' HD12 ' A' ' 165' ' ' LEU . 0.9 OUTLIER -59.29 -37.81 78.62 Favored 'General case' 0 N--CA 1.49 1.552 0 N-CA-C 106.746 -1.576 . . . . 10.0 106.746 177.204 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.044 HG23 HG21 ' A' ' 25' ' ' THR . 7.2 mm -70.59 -51.38 37.62 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.654 0 CA-C-N 115.032 -0.985 . . . . 10.0 108.651 178.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.69 ' OG ' ' HB1' ' A' ' 159' ' ' ALA . 17.3 p -51.3 -40.41 58.94 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.178 -0.952 . . . . 10.0 109.546 179.595 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.618 ' CE1' ' O ' ' A' ' 160' ' ' LEU . 10.7 t80 -79.89 -32.71 40.28 Favored 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.9 -1.125 . . . . 10.0 110.862 179.67 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.733 HG23 ' O ' ' A' ' 20' ' ' LEU . 33.9 p -97.04 -9.63 27.73 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.011 -1.056 . . . . 10.0 112.789 -177.981 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 1.044 HG21 HG23 ' A' ' 21' ' ' ILE . 81.1 p -102.18 -88.07 0.39 Allowed 'General case' 0 C--N 1.311 -1.087 0 O-C-N 120.133 -1.604 . . . . 10.0 109.389 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.72 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 1.2 p30 -123.55 -33.21 3.25 Favored 'General case' 0 N--CA 1.491 1.599 0 C-N-CA 116.997 -1.881 . . . . 10.0 113.029 179.437 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.72 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER 152.94 -141.84 0.0 OUTLIER 'General case' 0 N--CA 1.529 3.494 0 CA-C-N 119.052 0.842 . . . . 10.0 111.638 179.653 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.768 ' HA ' ' HA ' ' B' ' 28' ' ' GLU . 0.2 OUTLIER -146.94 88.93 5.77 Favored Pre-proline 0 N--CA 1.492 1.634 0 CA-C-O 122.191 0.996 . . . . 10.0 110.505 179.503 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' B' ' 28' ' ' GLU . 44.4 Cg_endo -89.93 -61.23 0.01 OUTLIER 'Trans proline' 0 C--N 1.311 -1.407 0 C-N-CA 122.113 1.875 . . . . 10.0 111.259 -179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.682 ' HA ' HG21 ' B' ' 30' ' ' THR . 1.1 m -168.2 46.69 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.94 0 O-C-N 120.348 -1.47 . . . . 10.0 114.179 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.625 ' HG2' ' CB ' ' B' ' 28' ' ' GLU . 0.5 OUTLIER -170.05 -175.96 2.16 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 120.188 -1.57 . . . . 10.0 110.365 177.863 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.575 ' N ' ' HG3' ' A' ' 31' ' ' GLU . 1.4 m-85 -108.11 136.77 47.23 Favored 'General case' 0 N--CA 1.493 1.693 0 CA-C-O 121.512 0.673 . . . . 10.0 110.05 179.016 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.899 HG12 ' O ' ' B' ' 25' ' ' VAL 0.339 25.6 m -128.24 64.04 65.26 Favored Pre-proline 0 C--N 1.301 -1.526 0 O-C-N 121.304 -0.872 . . . . 10.0 110.916 -177.995 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.765 ' O ' HG23 ' A' ' 36' ' ' VAL . 64.9 Cg_endo -91.78 174.2 2.36 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 O-C-N 123.787 1.414 . . . . 10.0 109.974 179.616 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . . . . . . . . . 30.3 p -63.03 96.28 0.09 Allowed 'General case' 0 C--N 1.305 -1.353 0 N-CA-C 105.577 -2.009 . . . . 10.0 105.577 176.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 1.027 HG13 HG23 ' A' ' 58' ' ' THR . 3.2 t -79.36 -96.16 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.516 0 O-C-N 121.485 -0.759 . . . . 10.0 111.2 -176.635 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.725 ' CD2' HD13 ' B' ' 18' ' ' ILE . 3.5 t80 -62.78 112.26 2.46 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 119.635 -1.915 . . . . 10.0 108.148 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.853 ' OD1' HD11 ' A' ' 55' ' ' LEU . 3.0 t0 -150.79 111.27 4.21 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.079 -1.013 . . . . 10.0 111.488 -177.893 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.553 ' HA ' ' CE1' ' A' ' 56' ' ' PHE . 7.8 m-20 -120.65 97.93 5.79 Favored 'General case' 0 C--N 1.301 -1.525 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.752 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.525 ' HB2' ' HB ' ' B' ' 17' ' ' THR . 12.2 t80 -132.37 125.48 30.95 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.399 -0.813 . . . . 10.0 110.972 -178.107 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.531 ' C ' ' CG2' ' A' ' 42' ' ' VAL . . . -141.38 96.38 2.98 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.466 -2.05 . . . . 10.0 105.466 177.591 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.61 HG12 ' H ' ' A' ' 43' ' ' THR . 2.2 t -149.76 -177.08 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.487 0 C-N-CA 118.895 -1.122 . . . . 10.0 111.864 -175.583 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.61 ' H ' HG12 ' A' ' 42' ' ' VAL . 18.6 m -163.16 176.78 9.66 Favored 'General case' 0 N--CA 1.493 1.677 0 N-CA-C 109.457 -0.571 . . . . 10.0 109.457 -179.108 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.83 HG12 ' CD1' ' A' ' 46' ' ' ILE . 98.5 t -145.49 134.3 17.19 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.481 0 O-C-N 120.921 -1.112 . . . . 10.0 108.871 178.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.636 ' HB3' HD13 ' B' ' 10' ' ' LEU . 58.0 mtp -85.31 128.23 34.62 Favored 'General case' 0 C--N 1.29 -2.017 0 C-N-CA 117.362 -1.735 . . . . 10.0 107.698 178.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.83 ' CD1' HG12 ' A' ' 44' ' ' VAL . 0.9 OUTLIER -124.84 94.45 2.78 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.616 0 O-C-N 120.751 -1.218 . . . . 10.0 108.97 -178.667 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.772 ' HA3' HG22 ' B' ' 8' ' ' ILE . . . 62.73 19.88 61.19 Favored Glycine 0 C--N 1.284 -2.337 0 N-CA-C 109.596 -1.402 . . . . 10.0 109.596 -179.395 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 107.88 2.51 34.32 Favored Glycine 0 N--CA 1.487 2.072 0 N-CA-C 109.392 -1.483 . . . . 10.0 109.392 -179.773 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.505 ' O ' HG12 ' A' ' 46' ' ' ILE . 4.6 tt0 -112.64 95.91 34.6 Favored Pre-proline 0 N--CA 1.487 1.384 0 O-C-N 121.391 -1.064 . . . . 10.0 110.84 -179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.7 138.64 35.27 Favored 'Trans proline' 0 C--N 1.304 -1.785 0 O-C-N 123.867 1.456 . . . . 10.0 110.968 178.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.502 ' O ' HG23 ' A' ' 43' ' ' THR . 4.7 t80 -110.75 110.87 21.7 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.07 -1.019 . . . . 10.0 109.56 179.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.86 HG21 ' HA ' ' A' ' 3' ' ' THR . 89.4 m -68.49 128.33 36.21 Favored 'General case' 0 N--CA 1.496 1.874 0 O-C-N 121.217 -0.927 . . . . 10.0 111.749 -178.639 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.433 ' HG ' ' C ' ' A' ' 52' ' ' THR . 13.3 mt -134.59 138.67 44.75 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.249 -0.907 . . . . 10.0 109.864 179.223 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.467 ' HA2' ' O ' ' A' ' 40' ' ' TYR . . . -170.43 126.52 1.35 Allowed Glycine 0 N--CA 1.491 2.346 0 N-CA-C 109.536 -1.426 . . . . 10.0 109.536 179.822 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.853 HD11 ' OD1' ' A' ' 38' ' ' ASP . 3.0 pp -144.45 160.28 41.35 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.211 -1.17 . . . . 10.0 110.341 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.553 ' CE1' ' HA ' ' A' ' 39' ' ' ASN . 17.7 m-85 -158.5 146.72 18.45 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.501 -0.749 . . . . 10.0 109.053 179.069 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.563 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 10.7 t0 -153.89 175.75 12.97 Favored 'General case' 0 C--N 1.299 -1.599 0 O-C-N 120.945 -1.097 . . . . 10.0 110.938 -179.248 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 1.027 HG23 HG13 ' A' ' 36' ' ' VAL . 1.8 t -45.89 166.15 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.646 -0.659 . . . . 10.0 111.208 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.658 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -100.5 89.76 4.05 Favored 'General case' 0 N--CA 1.499 1.977 0 O-C-N 121.458 -0.776 . . . . 10.0 111.836 -178.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.612 ' N ' HG12 ' A' ' 36' ' ' VAL . . . -62.33 -57.33 17.24 Favored Glycine 0 N--CA 1.486 1.98 0 N-CA-C 106.704 -2.558 . . . . 10.0 106.704 177.472 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.578 ' HG2' ' CA ' ' B' ' 21' ' ' GLY . 17.8 mt-30 -62.52 -21.48 65.56 Favored 'General case' 0 C--N 1.306 -1.295 0 N-CA-C 107.946 -1.131 . . . . 10.0 107.946 177.368 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.658 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 51.02 66.97 1.02 Allowed 'General case' 0 N--CA 1.496 1.866 0 CA-C-O 121.669 0.747 . . . . 10.0 111.33 178.615 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' OD2' ' CZ ' ' A' ' 37' ' ' PHE . 13.1 p-10 -119.18 23.59 11.24 Favored 'General case' 0 C--N 1.285 -2.219 0 O-C-N 121.654 -0.654 . . . . 10.0 110.316 179.414 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.688 ' CE1' ' CE1' ' A' ' 37' ' ' PHE . 1.2 p90 -177.4 -33.54 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.684 0 O-C-N 121.252 -0.905 . . . . 10.0 110.517 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 51.39 21.02 1.09 Allowed 'General case' 0 N--CA 1.489 1.497 0 O-C-N 120.997 -1.064 . . . . 10.0 111.271 178.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.508 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 9.6 mmt180 -56.61 -30.27 63.06 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 120.697 -1.252 . . . . 10.0 108.971 179.344 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.607 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 4.6 mm? -79.03 7.69 6.92 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.68 -0.638 . . . . 10.0 110.889 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.686 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 9.8 ttp180 -60.35 -22.86 1.03 Allowed Pre-proline 0 N--CA 1.498 1.942 0 O-C-N 121.118 -0.989 . . . . 10.0 112.195 179.062 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.642 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 44.2 Cg_endo -90.01 22.95 0.72 Allowed 'Trans proline' 0 C--N 1.32 -0.947 0 N-CA-C 109.263 -1.091 . . . . 10.0 109.263 178.661 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.854 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.4 pt? -33.68 -36.57 0.03 OUTLIER 'General case' 0 N--CA 1.484 1.252 0 O-C-N 121.741 -0.6 . . . . 10.0 111.335 179.424 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.568 ' HA ' HD11 ' B' ' 39' ' ' LEU . 58.3 m -37.46 -34.22 0.09 Allowed 'General case' 0 N--CA 1.494 1.735 0 CA-C-O 121.554 0.693 . . . . 10.0 110.213 179.265 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.417 ' N ' ' O ' ' A' ' 70' ' ' LEU . 28.4 t80 -84.71 115.93 62.98 Favored Pre-proline 0 N--CA 1.496 1.834 0 O-C-N 121.387 -0.821 . . . . 10.0 109.796 179.847 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -75.89 150.09 33.99 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 O-C-N 123.722 1.38 . . . . 10.0 111.395 -179.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.561 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.4 56.74 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.506 -0.746 . . . . 10.0 110.257 -179.795 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.775 HG23 ' HB3' ' A' ' 5' ' ' LYS . 99.3 m -143.5 92.73 2.39 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.251 -0.906 . . . . 10.0 110.003 179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' C ' ' O ' ' A' ' 75' ' ' THR . 11.8 m-20 -31.9 -39.25 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 CA-C-O 120.98 0.419 . . . . 10.0 111.913 -179.712 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.82 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.4 m -114.26 135.05 55.24 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-O 122.332 1.063 . . . . 10.0 110.56 -179.857 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.786 ' HB3' HG11 ' A' ' 9' ' ' VAL . 71.3 m-85 -121.66 149.7 42.82 Favored 'General case' 0 C--N 1.3 -1.544 0 O-C-N 121.688 -0.632 . . . . 10.0 110.488 -178.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.792 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.4 mm? -119.75 97.98 5.89 Favored 'General case' 0 C--N 1.299 -1.597 0 O-C-N 121.175 -0.953 . . . . 10.0 108.466 178.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.501 ' O ' HG23 ' A' ' 113' ' ' VAL . 2.6 p -108.07 144.65 16.35 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.561 0 O-C-N 121.012 -1.055 . . . . 10.0 109.931 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.603 ' H ' HG22 ' A' ' 14' ' ' VAL . 42.0 t -144.7 134.94 24.22 Favored 'General case' 0 C--N 1.307 -1.267 0 O-C-N 121.235 -0.916 . . . . 10.0 110.627 -179.077 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.59 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 19.1 p90 -142.08 171.66 13.75 Favored 'General case' 0 C--N 1.296 -1.759 0 N-CA-C 108.959 -0.756 . . . . 10.0 108.959 179.039 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.401 ' OG ' HG22 ' A' ' 85' ' ' VAL . 43.8 t -79.08 150.29 31.87 Favored 'General case' 0 N--CA 1.497 1.918 0 O-C-N 120.816 -1.178 . . . . 10.0 111.611 -178.762 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.575 ' HA ' HG23 ' A' ' 137' ' ' ILE . 27.3 m -102.54 -14.72 8.14 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.513 0 O-C-N 121.498 -0.751 . . . . 10.0 110.681 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.912 ' HB ' HD21 ' A' ' 129' ' ' LEU . 3.5 m -81.81 -41.83 18.75 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 120.701 -1.249 . . . . 10.0 108.676 179.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.465 ' N ' ' CG2' ' A' ' 85' ' ' VAL . 14.7 m -54.31 120.3 25.11 Favored Pre-proline 0 N--CA 1.488 1.464 0 O-C-N 121.382 -0.824 . . . . 10.0 110.28 179.057 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.53 ' CG ' ' O ' ' A' ' 133' ' ' LYS . 55.7 Cg_endo -82.39 25.09 0.68 Allowed 'Trans proline' 0 C--N 1.302 -1.903 0 O-C-N 123.815 1.429 . . . . 10.0 111.263 179.284 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HA ' ' HE3' ' A' ' 133' ' ' LYS . 9.0 t -62.64 -136.69 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.247 0 O-C-N 120.99 -1.069 . . . . 10.0 109.898 179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 29.7 t -122.53 65.61 0.95 Allowed 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.418 -0.801 . . . . 10.0 111.683 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.59 ' CD1' ' CZ ' ' A' ' 82' ' ' PHE . 1.8 t80 -64.54 -19.29 65.53 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.85 -1.156 . . . . 10.0 109.521 178.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.524 ' HG3' ' HE2' ' A' ' 94' ' ' LYS . 8.5 tt0 -69.65 -29.26 66.69 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.447 -0.783 . . . . 10.0 111.042 -179.103 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.857 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -83.56 -15.07 50.61 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.817 -1.177 . . . . 10.0 111.025 -179.522 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.857 HG13 ' ND2' ' A' ' 92' ' ' ASN . 29.2 m -94.55 -26.69 4.4 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.827 -1.171 . . . . 10.0 108.998 179.003 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.809 ' CE ' HD13 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -80.66 -29.22 36.67 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 119.431 -0.907 . . . . 10.0 109.167 178.917 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.506 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -89.14 -4.77 58.17 Favored 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.33 -0.856 . . . . 10.0 110.603 179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -83.97 -50.01 8.42 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.019 -1.051 . . . . 10.0 112.547 -178.389 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.474 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 39.6 m95 -76.9 -24.08 52.53 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.055 -1.028 . . . . 10.0 112.26 -177.78 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.738 HG13 HD23 ' A' ' 149' ' ' LEU . 62.7 t -67.41 -51.89 30.96 Favored Pre-proline 0 N--CA 1.492 1.655 0 O-C-N 120.646 -1.283 . . . . 10.0 111.606 -178.455 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.619 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 51.0 Cg_endo -72.85 -8.27 22.07 Favored 'Trans proline' 0 C--N 1.31 -1.455 0 O-C-N 123.289 1.152 . . . . 10.0 110.416 -179.906 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . . . . . . . . . 1.9 tt0 -81.38 -31.58 33.22 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.399 -0.813 . . . . 10.0 112.607 -178.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.409 HD12 HG21 ' A' ' 108' ' ' THR . 8.0 pt -129.25 -10.17 2.93 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 120.352 -1.468 . . . . 10.0 113.022 -178.17 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 98' ' ' VAL . 81.7 p -72.57 -5.23 35.74 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 120.492 -1.38 . . . . 10.0 110.656 -179.281 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 10.4 t-80 -64.61 -43.13 94.74 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.045 -1.034 . . . . 10.0 110.149 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 52.5 m80 -100.67 -27.84 13.16 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.485 -0.759 . . . . 10.0 109.355 179.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.47 ' O ' ' HA ' ' A' ' 102' ' ' THR . 74.3 m -120.49 82.18 32.35 Favored Pre-proline 0 N--CA 1.488 1.475 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.127 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.483 ' O ' ' HB2' ' A' ' 107' ' ' LYS . 40.1 Cg_endo -65.79 152.4 81.67 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 O-C-N 123.842 1.443 . . . . 10.0 110.347 -179.494 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.483 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 6.8 mtmt 60.72 47.3 8.21 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.82 -0.55 . . . . 10.0 111.027 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.409 HG21 HD12 ' A' ' 101' ' ' ILE . 89.0 m -72.97 133.87 81.54 Favored Pre-proline 0 C--N 1.303 -1.444 0 N-CA-C 108.471 -0.937 . . . . 10.0 108.471 178.416 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.585 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 37.0 Cg_endo -62.37 129.13 25.73 Favored 'Trans proline' 0 C--N 1.302 -1.893 0 O-C-N 123.529 1.278 . . . . 10.0 109.747 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.489 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 6.6 t80 -136.96 111.34 8.51 Favored 'General case' 0 C--N 1.301 -1.513 0 O-C-N 121.358 -0.839 . . . . 10.0 109.722 -179.221 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.917 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.4 mm? -90.99 99.86 12.82 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-O 121.722 0.772 . . . . 10.0 111.333 -179.025 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.563 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 96.2 mt -74.29 148.92 41.0 Favored 'General case' 0 C--N 1.292 -1.924 0 N-CA-C 108.775 -0.824 . . . . 10.0 108.775 178.445 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.626 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.7 t -147.15 179.5 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.88 0 O-C-N 120.822 -1.173 . . . . 10.0 111.391 -179.166 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.626 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -122.35 133.41 9.24 Favored Glycine 0 N--CA 1.488 2.162 0 N-CA-C 107.894 -2.082 . . . . 10.0 107.894 178.514 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.5 ' N ' ' O ' ' A' ' 82' ' ' PHE . 28.9 m -100.12 132.82 45.26 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 120.92 -1.341 . . . . 10.0 111.393 -178.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER 52.12 61.36 3.25 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 121.485 -0.759 . . . . 10.0 111.03 179.269 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.971 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -79.38 -19.96 12.59 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.045 -1.034 . . . . 10.0 109.249 179.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.55 ' O ' ' HB3' ' A' ' 119' ' ' LEU . 12.6 p-10 -48.82 61.45 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 CA-C-O 122.16 0.981 . . . . 10.0 111.22 -177.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 pp 158.56 -24.56 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.107 0 CA-C-N 114.722 -1.126 . . . . 10.0 108.462 -179.728 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 14.5 tpt180 -43.41 -44.31 5.66 Favored 'General case' 0 N--CA 1.49 1.568 0 CA-C-O 121.592 0.71 . . . . 10.0 109.666 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 42.9 m-20 -60.99 -11.19 7.29 Favored 'General case' 0 N--CA 1.489 1.503 0 O-C-N 121.689 -0.632 . . . . 10.0 110.522 -179.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.449 ' O ' HD13 ' A' ' 126' ' ' ILE . 43.7 t0 -104.83 120.31 50.55 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.303 -0.873 . . . . 10.0 110.534 -179.594 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -82.49 24.43 0.73 Allowed 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.53 1.487 . . . . 10.0 111.035 -179.693 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 30.8 t -105.85 -50.46 3.18 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.065 -1.022 . . . . 10.0 110.93 -178.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.496 HG22 HD13 ' A' ' 126' ' ' ILE . 6.0 t -72.09 -30.62 65.28 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 105.076 -2.194 . . . . 10.0 105.076 177.466 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.547 HG23 HD22 ' A' ' 129' ' ' LEU 0.304 0.8 OUTLIER -48.64 -26.58 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.662 0 CA-C-N 114.211 -1.359 . . . . 10.0 107.862 176.309 . . . . . . . . 4 4 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 29.2 tt0 -54.32 -36.71 64.04 Favored 'General case' 0 N--CA 1.488 1.43 0 CA-C-O 122.181 0.991 . . . . 10.0 109.676 179.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -60.0 -21.95 61.95 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 121.518 -0.739 . . . . 10.0 110.878 -179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.912 HD21 ' HB ' ' A' ' 85' ' ' VAL . 4.0 mp -57.74 -37.79 74.2 Favored 'General case' 0 C--N 1.299 -1.626 0 O-C-N 121.292 -0.88 . . . . 10.0 109.627 -179.366 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -62.17 -47.82 82.8 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 121.525 -0.734 . . . . 10.0 109.867 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 13.2 ttmt -51.17 -28.55 11.43 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 118.901 -1.12 . . . . 10.0 108.677 179.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.598 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 1.3 m120 -90.27 -66.77 0.89 Allowed 'General case' 0 N--CA 1.485 1.286 0 C-N-CA 119.228 -0.989 . . . . 10.0 110.553 -179.886 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.599 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.5 mptp? -140.33 160.5 39.83 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.8 -0.563 . . . . 10.0 109.548 -179.649 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.599 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -97.28 1.48 49.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.15 -0.969 . . . . 10.0 111.313 -178.189 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.526 ' O ' ' HA ' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -120.52 98.53 48.27 Favored Pre-proline 0 N--CA 1.494 1.736 0 O-C-N 120.807 -1.183 . . . . 10.0 111.188 -179.484 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.482 ' HA ' ' HA ' ' A' ' 87' ' ' PRO . 42.2 Cg_endo -73.95 160.59 42.87 Favored 'Trans proline' 0 N--CA 1.493 1.483 0 C-N-CA 121.888 1.725 . . . . 10.0 111.255 -179.724 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.575 HG23 ' HA ' ' A' ' 84' ' ' VAL . 0.5 OUTLIER -114.68 136.95 49.68 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.842 0 O-C-N 120.954 -1.091 . . . . 10.0 109.997 -179.992 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.536 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 73.0 p -128.23 167.78 17.72 Favored Pre-proline 0 N--CA 1.496 1.87 0 O-C-N 121.434 -0.791 . . . . 10.0 110.822 -179.071 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 39.2 Cg_endo -65.37 -12.45 34.94 Favored 'Trans proline' 0 C--N 1.311 -1.437 0 O-C-N 123.941 1.495 . . . . 10.0 110.907 179.515 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.435 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 1.5 mt-10 -78.6 -15.61 58.34 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 120.95 -1.094 . . . . 10.0 109.839 179.612 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 20.6 m -94.93 -45.1 7.42 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.185 -0.947 . . . . 10.0 110.305 179.823 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -71.69 -40.57 69.46 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.372 -0.83 . . . . 10.0 110.571 -179.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 2.8 tt0 -50.24 -34.64 23.79 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.334 -0.853 . . . . 10.0 109.74 -179.967 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.435 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 0.2 OUTLIER -74.84 -47.4 30.61 Favored 'General case' 0 N--CA 1.487 1.416 0 O-C-N 121.338 -0.851 . . . . 10.0 110.284 179.632 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 1.035 ' O ' HD12 ' A' ' 149' ' ' LEU . 1.1 tp -55.91 -44.7 78.51 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.02 -1.05 . . . . 10.0 109.409 179.004 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.578 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -61.74 -50.22 73.26 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.551 -0.718 . . . . 10.0 109.951 179.828 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -71.23 -18.01 62.47 Favored 'General case' 0 C--N 1.297 -1.688 0 C-N-CA 119.523 -0.871 . . . . 10.0 109.515 179.139 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' N ' ' O ' ' A' ' 144' ' ' LYS . 9.7 m-20 -85.96 -57.65 2.95 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.381 -0.824 . . . . 10.0 110.856 -179.768 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.061 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -84.67 4.24 33.4 Favored 'General case' 0 N--CA 1.496 1.868 0 O-C-N 121.157 -0.964 . . . . 10.0 110.754 -179.391 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.84 ' N ' HD13 ' A' ' 149' ' ' LEU . 11.0 mttp 69.49 60.1 0.3 Allowed 'General case' 0 N--CA 1.492 1.631 0 CA-C-O 122.375 1.084 . . . . 10.0 112.352 177.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.967 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -96.96 -154.09 0.44 Allowed 'General case' 0 N--CA 1.496 1.857 0 CA-C-N 115.333 -0.849 . . . . 10.0 108.71 177.693 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.917 HG11 ' CD1' ' A' ' 111' ' ' LEU . 15.8 t -100.04 -81.83 0.25 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 C-N-CA 119.207 -0.997 . . . . 10.0 108.657 178.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.641 ' N ' HG12 ' A' ' 152' ' ' VAL . 2.7 tttm -173.73 159.28 3.46 Favored 'General case' 0 C--N 1.297 -1.715 0 C-N-CA 119.43 -0.908 . . . . 10.0 111.858 179.695 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.598 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 0.2 OUTLIER -82.77 105.04 13.46 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.541 -0.725 . . . . 10.0 109.466 178.304 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.711 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -102.12 -172.25 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.523 0 N-CA-C 108.146 -1.057 . . . . 10.0 108.146 179.056 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.757 ' HG3' HG21 ' A' ' 117' ' ' ILE . 18.2 tt0 -148.45 137.11 21.5 Favored 'General case' 0 C--N 1.298 -1.639 0 O-C-N 120.821 -1.174 . . . . 10.0 109.973 179.737 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.833 ' HB2' HD22 ' A' ' 165' ' ' LEU . 30.1 p -138.15 116.24 11.73 Favored 'General case' 0 C--N 1.302 -1.474 0 C-N-CA 119.422 -0.911 . . . . 10.0 111.484 -179.57 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.924 ' O ' HD21 ' A' ' 165' ' ' LEU . 6.2 m -102.6 156.73 17.42 Favored 'General case' 0 C--N 1.301 -1.511 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 177.355 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.781 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -93.62 -94.0 0.16 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 120.435 -1.416 . . . . 10.0 111.072 -178.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.66 HD22 ' CD1' ' A' ' 28' ' ' PHE . 0.2 OUTLIER -47.29 -20.52 0.2 Allowed 'General case' 0 N--CA 1.49 1.526 0 C-N-CA 118.463 -1.295 . . . . 10.0 109.001 179.525 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.524 ' O ' ' HB3' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -93.42 -44.35 8.3 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.077 -1.015 . . . . 10.0 109.533 179.191 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.611 ' HB2' ' CD2' ' A' ' 23' ' ' TYR . 1.4 tm0? 61.59 68.91 0.68 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.279 -0.888 . . . . 10.0 110.745 178.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -97.89 36.86 1.48 Allowed 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 119.445 -0.902 . . . . 10.0 111.328 -179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 128.78 30.03 0.72 Allowed Glycine 0 N--CA 1.494 2.505 0 C-N-CA 119.631 -1.271 . . . . 10.0 110.623 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.924 HD21 ' O ' ' A' ' 158' ' ' SER . 0.2 OUTLIER -54.7 -47.41 73.74 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.229 -1.159 . . . . 10.0 110.714 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 3.6 tppt? -71.41 -21.28 62.01 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.315 -0.865 . . . . 10.0 110.526 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -70.78 -39.4 73.21 Favored 'General case' 0 N--CA 1.494 1.756 0 O-C-N 121.021 -1.049 . . . . 10.0 111.275 -179.264 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.711 HG22 ' HB ' ' A' ' 155' ' ' VAL . 39.6 t -58.48 -50.79 77.61 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.474 0 O-C-N 120.811 -1.181 . . . . 10.0 110.212 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.513 ' HB2' ' NZ ' ' A' ' 16' ' ' LYS . 80.4 t80 -68.27 -36.26 79.12 Favored 'General case' 0 C--N 1.297 -1.698 0 O-C-N 121.48 -0.762 . . . . 10.0 110.864 179.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.513 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 21.8 t0 -53.75 -47.56 70.55 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.867 -1.146 . . . . 10.0 110.478 -179.706 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.55 ' HB3' ' CG1' ' A' ' 152' ' ' VAL . 11.4 mm-40 -54.82 -40.46 69.58 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.011 -1.055 . . . . 10.0 109.857 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.445 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -59.59 -21.35 60.25 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.139 -0.976 . . . . 10.0 109.123 179.297 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.789 ' O ' HD12 ' A' ' 177' ' ' LEU . 37.2 mm -63.25 -40.52 89.36 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.254 -0.904 . . . . 10.0 110.038 179.486 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.79 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -87.17 -15.71 37.52 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 120.638 -1.289 . . . . 10.0 110.946 -179.122 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.799 ' HB2' HG22 ' A' ' 152' ' ' VAL . . . -98.04 -11.08 23.36 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.977 -1.077 . . . . 10.0 110.596 -179.76 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.814 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -82.35 -42.82 18.2 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.941 -1.099 . . . . 10.0 109.74 179.764 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.789 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -96.61 -14.53 22.11 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.366 -0.834 . . . . 10.0 109.523 179.953 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.467 ' OXT' ' O ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.68 0 CA-C-O 117.791 -1.099 . . . . 10.0 110.318 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.306 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.461 ' HB3' ' OE2' ' A' ' 49' ' ' GLU . 68.6 m -99.74 37.04 1.67 Allowed 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.318 -1.107 . . . . 10.0 110.036 179.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 11.5 mtpt -64.19 103.71 0.65 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.215 -0.928 . . . . 10.0 110.934 -179.304 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 55.8 mm-40 -128.51 178.02 6.59 Favored 'General case' 0 N--CA 1.488 1.463 0 CA-C-O 121.756 0.789 . . . . 10.0 110.724 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.589 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -67.44 -179.99 0.51 Allowed Pre-proline 0 C--N 1.297 -1.712 0 N-CA-C 105.899 -1.889 . . . . 10.0 105.899 177.11 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.589 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 42.8 Cg_endo -69.41 55.28 1.12 Allowed 'Trans proline' 0 C--N 1.302 -1.908 0 N-CA-C 110.35 -0.673 . . . . 10.0 110.35 -179.464 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.577 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.8 tp10 15.14 -142.47 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 121.693 0.759 . . . . 10.0 112.814 179.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.772 HG22 ' HA3' ' A' ' 47' ' ' GLY . 0.2 OUTLIER -88.25 -110.19 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 121.245 -0.909 . . . . 10.0 109.203 179.789 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.651 ' H ' HG23 ' B' ' 8' ' ' ILE . 6.1 t -158.12 105.64 1.95 Allowed 'General case' 0 N--CA 1.493 1.725 0 O-C-N 120.081 -1.637 . . . . 10.0 112.031 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.636 HD13 ' HB3' ' A' ' 45' ' ' MET . 0.6 OUTLIER -122.91 103.21 37.1 Favored Pre-proline 0 N--CA 1.49 1.567 0 O-C-N 121.147 -0.97 . . . . 10.0 109.916 178.358 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.447 ' HD2' HD23 ' B' ' 10' ' ' LEU . 38.0 Cg_endo -66.91 99.12 0.45 Allowed 'Trans proline' 0 C--N 1.303 -1.846 0 O-C-N 123.373 1.196 . . . . 10.0 109.856 179.636 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.614 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 14.5 m -157.15 99.39 1.79 Allowed 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.39 -0.819 . . . . 10.0 110.499 179.892 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.554 ' CB ' ' O ' ' A' ' 43' ' ' THR . 11.6 p-10 -148.63 154.86 40.28 Favored 'General case' 0 C--N 1.292 -1.914 0 C-N-CA 118.818 -1.153 . . . . 10.0 111.782 179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.58 ' HB2' ' HA ' ' A' ' 42' ' ' VAL . 48.1 m-85 -84.64 -165.29 1.14 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.274 1.035 . . . . 10.0 113.165 -178.725 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.541 ' O ' ' CG2' ' A' ' 42' ' ' VAL . 2.3 tp10 -53.38 -167.92 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 121.88 0.848 . . . . 10.0 111.891 -178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 25.6 p-80 -138.03 -166.94 2.06 Favored 'General case' 0 C--N 1.301 -1.518 0 N-CA-C 109.046 -0.724 . . . . 10.0 109.046 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.525 ' HB ' ' HB2' ' A' ' 40' ' ' TYR . 9.8 t -119.24 -171.8 2.18 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.933 -1.104 . . . . 10.0 112.05 -178.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.725 HD13 ' CD2' ' A' ' 37' ' ' PHE . 1.3 pp -112.4 -177.13 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.854 0 N-CA-C 109.067 -0.716 . . . . 10.0 109.067 179.017 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 6.0 m-70 -101.08 155.91 17.72 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 121.0 -1.062 . . . . 10.0 111.831 -179.253 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.7 ' CG2' ' CE2' ' B' ' 22' ' ' PHE . 11.2 m -80.0 152.73 4.58 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.446 0 CA-C-O 121.483 0.658 . . . . 10.0 111.281 -179.419 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' CA ' ' HG2' ' A' ' 61' ' ' GLN . . . -87.69 133.39 11.77 Favored Glycine 0 N--CA 1.489 2.222 0 N-CA-C 109.162 -1.575 . . . . 10.0 109.162 179.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.7 ' CE2' ' CG2' ' B' ' 20' ' ' VAL . 0.0 OUTLIER 179.0 93.28 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.75 0 O-C-N 120.88 -1.365 . . . . 10.0 112.914 -179.959 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.551 ' O ' HG23 ' B' ' 25' ' ' VAL . 15.2 t70 -76.99 116.39 17.61 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.786 -1.196 . . . . 10.0 107.907 177.151 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.417 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 46.41 26.11 0.45 Allowed 'General case' 0 N--CA 1.498 1.97 0 O-C-N 120.789 -1.194 . . . . 10.0 107.837 -177.205 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.899 ' O ' HG12 ' A' ' 33' ' ' VAL 0.262 2.4 t -109.84 -14.06 10.5 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.698 0 CA-C-O 121.564 0.697 . . . . 10.0 109.383 -178.811 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.748 ' O ' HG21 ' A' ' 25' ' ' THR . 1.3 t -83.47 32.88 0.46 Allowed 'General case' 0 C--N 1.29 -1.999 0 O-C-N 121.798 -0.564 . . . . 10.0 111.181 -178.351 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.575 ' CA ' ' OG1' ' A' ' 25' ' ' THR . . . -161.31 69.94 0.23 Allowed Glycine 0 N--CA 1.496 2.676 0 N-CA-C 108.642 -1.783 . . . . 10.0 108.642 179.394 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.83 ' N ' HG11 ' A' ' 33' ' ' VAL . 24.9 mt-10 -151.47 131.61 13.52 Favored 'General case' 0 C--N 1.292 -1.93 0 CA-C-O 121.964 0.888 . . . . 10.0 111.43 -178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.812 ' O ' HG23 ' B' ' 30' ' ' THR . 1.9 t80 -142.7 142.41 31.99 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 108.766 -0.828 . . . . 10.0 108.766 178.184 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.812 HG23 ' O ' ' B' ' 29' ' ' PHE . 2.2 p -162.14 -66.13 0.05 Allowed 'General case' 0 N--CA 1.489 1.512 0 O-C-N 121.252 -0.905 . . . . 10.0 110.859 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 148.79 111.5 0.6 Allowed Glycine 0 N--CA 1.491 2.31 0 N-CA-C 109.073 -1.611 . . . . 10.0 109.073 -179.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 10.5 pt -131.93 158.9 74.22 Favored Pre-proline 0 N--CA 1.493 1.697 0 O-C-N 121.132 -1.217 . . . . 10.0 110.308 -179.718 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.512 ' O ' ' O ' ' B' ' 34' ' ' GLU . 42.2 Cg_endo -70.43 139.99 39.15 Favored 'Trans proline' 0 C--N 1.303 -1.817 0 O-C-N 123.985 1.519 . . . . 10.0 109.942 178.845 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.541 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 3.0 tm-20 56.87 124.12 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.511 -0.743 . . . . 10.0 110.433 -179.572 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.502 ' HG2' ' N ' ' B' ' 36' ' ' TRP . 2.3 pm0 -96.31 -30.11 13.61 Favored 'General case' 0 C--N 1.303 -1.436 0 O-C-N 120.558 -1.339 . . . . 10.0 111.244 -179.448 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.61 ' O ' ' CG ' ' B' ' 36' ' ' TRP . 7.8 t-105 -165.5 27.78 0.05 Allowed 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.186 0.993 . . . . 10.0 110.099 179.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.967 ' HB1' HD12 ' B' ' 39' ' ' LEU . . . -158.48 85.27 0.85 Allowed 'General case' 0 C--N 1.287 -2.113 0 O-C-N 121.798 -0.564 . . . . 10.0 109.64 179.789 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.541 ' CA ' ' HG3' ' B' ' 34' ' ' GLU . 2.4 ttt180 -83.31 41.08 0.75 Allowed 'General case' 0 N--CA 1.49 1.541 0 N-CA-C 108.051 -1.092 . . . . 10.0 108.051 179.154 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.967 HD12 ' HB1' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -58.01 -39.18 77.68 Favored 'General case' 0 N--CA 1.491 1.624 0 CA-C-O 121.627 0.727 . . . . 10.0 111.238 -179.02 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.614 HD23 ' H ' ' B' ' 40' ' ' LEU . 0.5 OUTLIER -80.37 19.44 0.77 Allowed 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.645 -0.659 . . . . 10.0 112.293 -177.755 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.441 ' HB2' ' HG3' ' B' ' 38' ' ' ARG . 1.9 mm100 -146.39 -84.79 0.12 Allowed 'General case' 0 C--N 1.29 -1.991 0 O-C-N 121.208 -0.932 . . . . 10.0 110.722 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.427 ' H ' ' HG2' ' B' ' 38' ' ' ARG . 63.1 p -130.7 -178.53 4.83 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.3 -0.875 . . . . 10.0 109.791 -179.938 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.527 ' O ' ' CB ' ' B' ' 44' ' ' ASN . 18.7 p -85.35 19.68 2.23 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.132 -0.98 . . . . 10.0 109.339 178.735 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.527 ' CB ' ' O ' ' B' ' 43' ' ' SER . 6.4 t30 73.81 86.31 0.1 Allowed 'General case' 0 N--CA 1.491 1.619 0 O-C-N 121.372 -0.83 . . . . 10.0 109.903 -179.432 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 7.6 mt -90.86 155.79 3.05 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.15 -0.969 . . . . 10.0 109.988 -179.849 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 57.5 p . . . . . 0 C--N 1.299 -1.601 0 CA-C-O 117.851 -1.071 . . . . 10.0 109.679 178.852 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.477 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 0.6 OUTLIER . . . . . 0 N--CA 1.492 1.633 0 CA-C-O 121.635 0.731 . . . . 10.0 110.038 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.568 ' NE2' ' HB3' ' A' ' 177' ' ' LEU . 3.2 mm100 -74.94 -26.86 59.92 Favored 'General case' 0 C--N 1.3 -1.582 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.64 ' HA ' ' CB ' ' A' ' 52' ' ' THR . 1.4 m -46.23 106.16 0.08 Allowed 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.907 -0.495 . . . . 10.0 110.941 179.075 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.684 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -128.03 119.94 52.42 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.466 0 C-N-CA 117.735 -1.586 . . . . 10.0 111.054 178.115 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.822 ' O ' HG23 ' A' ' 75' ' ' THR . 4.5 mttm -103.8 124.55 49.12 Favored 'General case' 0 C--N 1.291 -1.943 0 N-CA-C 106.895 -1.52 . . . . 10.0 106.895 176.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.934 ' CB ' HD22 ' A' ' 55' ' ' LEU . 2.4 t -89.01 108.0 19.35 Favored 'General case' 0 C--N 1.3 -1.569 0 C-N-CA 118.884 -1.127 . . . . 10.0 110.886 -178.123 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.776 ' HB ' HG21 ' A' ' 75' ' ' THR . 60.0 t -139.17 163.97 25.71 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 119.792 -0.763 . . . . 10.0 109.476 178.903 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.511 HG21 ' HB ' ' A' ' 17' ' ' THR . 36.5 t -73.36 157.58 6.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.562 0 O-C-N 121.006 -1.059 . . . . 10.0 109.713 179.652 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.969 HG13 ' NE2' ' B' ' 35' ' ' GLN . 0.3 OUTLIER -43.58 170.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.557 0 O-C-N 121.383 -0.823 . . . . 10.0 109.984 -179.859 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.569 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . -104.94 -29.27 5.29 Favored Glycine 0 N--CA 1.485 1.901 0 N-CA-C 109.082 -1.607 . . . . 10.0 109.082 179.389 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.446 ' N ' HG22 ' A' ' 9' ' ' VAL . 42.0 m-20 -42.59 -61.14 1.3 Allowed 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.444 -1.033 . . . . 10.0 110.039 -179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.487 ' N ' ' OE1' ' B' ' 35' ' ' GLN . . . 92.2 5.8 65.37 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.567 ' O ' HD11 ' B' ' 32' ' ' ILE . . . -43.76 -30.93 0.71 Allowed 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.314 -1.109 . . . . 10.0 110.865 -179.826 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.498 ' HA ' HG13 ' B' ' 32' ' ' ILE . 53.1 t -148.92 -69.85 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.759 0 O-C-N 121.07 -1.019 . . . . 10.0 110.405 -179.673 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 137.06 74.32 0.06 OUTLIER Glycine 0 N--CA 1.488 2.149 0 N-CA-C 109.048 -1.621 . . . . 10.0 109.048 -179.6 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.982 ' HA ' HD23 ' A' ' 19' ' ' LEU . 4.4 tttm -65.15 -13.0 57.06 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.405 -1.056 . . . . 10.0 109.707 -179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.511 ' HB ' HG21 ' A' ' 8' ' ' VAL . 14.3 t -50.27 -29.52 9.83 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.309 -0.869 . . . . 10.0 110.073 -179.935 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.614 ' SG ' HD22 ' A' ' 19' ' ' LEU . 27.3 p -78.4 -2.46 38.44 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.076 -1.015 . . . . 10.0 111.127 -179.145 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.996 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.7 mm? -84.39 -40.22 18.09 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.892 -1.13 . . . . 10.0 109.02 178.776 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -52.57 -38.73 60.54 Favored 'General case' 0 C--N 1.294 -1.805 0 C-N-CA 119.619 -0.832 . . . . 10.0 109.206 178.772 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.706 HG21 ' HA2' ' B' ' 27' ' ' GLY . 3.4 mm -80.42 -45.56 21.93 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.94 0 O-C-N 121.418 -0.801 . . . . 10.0 110.399 179.333 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.524 ' OG ' ' HG3' ' B' ' 28' ' ' GLU . 19.7 t -45.84 -50.8 13.85 Favored 'General case' 0 C--N 1.293 -1.854 0 C-N-CA 119.641 -0.824 . . . . 10.0 110.026 -178.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 1.053 ' CD2' HD11 ' A' ' 165' ' ' LEU . 36.6 m-85 -81.49 0.24 38.75 Favored 'General case' 0 C--N 1.296 -1.722 0 O-C-N 120.847 -1.158 . . . . 10.0 110.43 179.977 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.609 ' O ' ' HB ' ' A' ' 25' ' ' THR . 20.1 m -97.93 -54.17 3.17 Favored 'General case' 0 N--CA 1.49 1.539 0 C-N-CA 118.404 -1.318 . . . . 10.0 110.779 179.28 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.609 ' HB ' ' O ' ' A' ' 24' ' ' THR . 14.6 t 175.75 -39.04 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.04 0 O-C-N 121.115 -0.991 . . . . 10.0 112.424 179.533 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.671 ' HB2' HG23 ' A' ' 21' ' ' ILE . 65.2 m-20 -85.4 32.39 0.57 Allowed 'General case' 0 N--CA 1.5 2.032 0 O-C-N 120.737 -1.227 . . . . 10.0 111.53 -178.048 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.561 ' C ' ' HD3' ' A' ' 29' ' ' PRO 0.261 8.7 ttpp -45.26 -167.28 0.0 OUTLIER 'General case' 0 C--N 1.304 -1.403 0 CA-C-O 121.846 0.831 . . . . 10.0 112.863 179.521 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.662 ' CD1' HG21 ' B' ' 30' ' ' THR . 51.1 t80 -107.14 47.48 0.15 Allowed Pre-proline 0 N--CA 1.493 1.723 0 O-C-N 121.242 -0.911 . . . . 10.0 111.523 -179.41 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.561 ' HD3' ' C ' ' A' ' 27' ' ' LYS . 52.9 Cg_endo -73.55 -93.59 0.01 OUTLIER 'Trans proline' 0 C--N 1.314 -1.266 0 O-C-N 122.951 0.974 . . . . 10.0 109.624 179.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.4 t -167.25 60.17 0.08 Allowed 'General case' 0 C--N 1.303 -1.42 0 O-C-N 121.365 -0.834 . . . . 10.0 109.033 179.54 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.415 ' HG2' ' HG2' ' A' ' 29' ' ' PRO . 24.5 pt-20 -155.81 -173.18 4.41 Favored 'General case' 0 C--N 1.305 -1.332 0 O-C-N 121.442 -0.787 . . . . 10.0 109.007 -179.227 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.469 ' CD1' ' N ' ' A' ' 32' ' ' TYR . 8.4 m-85 -111.12 105.43 14.15 Favored 'General case' 0 C--N 1.291 -1.95 0 O-C-N 121.624 -0.673 . . . . 10.0 110.305 -179.85 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.535 ' HB ' ' OD1' ' A' ' 26' ' ' ASN . 3.7 m -126.04 158.73 65.09 Favored Pre-proline 0 C--N 1.304 -1.371 0 O-C-N 121.301 -0.874 . . . . 10.0 109.7 -179.881 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.538 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 49.0 Cg_endo -76.67 92.44 1.09 Allowed 'Trans proline' 0 C--N 1.307 -1.657 0 O-C-N 123.656 1.345 . . . . 10.0 110.033 179.525 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.917 HG21 ' H ' ' B' ' 25' ' ' VAL . 4.2 t -94.9 154.02 17.42 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.203 -0.936 . . . . 10.0 110.017 -179.743 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.885 HG22 HG21 ' B' ' 26' ' ' THR . 16.9 t 77.56 5.56 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.898 0 O-C-N 122.019 -0.426 . . . . 10.0 110.664 179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.616 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 73.9 t80 -39.55 161.75 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.784 0.802 . . . . 10.0 110.492 -179.432 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 1.051 ' CB ' HD12 ' B' ' 18' ' ' ILE . 3.7 p30 -79.13 -161.08 0.28 Allowed 'General case' 0 C--N 1.292 -1.906 0 CA-C-O 122.346 1.07 . . . . 10.0 113.391 -178.113 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.755 ' O ' HG22 ' B' ' 17' ' ' THR . 1.4 m120 -152.9 -171.52 3.96 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 -179.833 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.58 ' CE2' HG21 ' B' ' 17' ' ' THR . 69.6 m-85 -121.72 152.87 38.93 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 120.599 -1.313 . . . . 10.0 111.647 -178.791 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.797 ' HB2' ' CE1' ' A' ' 56' ' ' PHE . . . -131.18 99.51 4.89 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.302 -0.874 . . . . 10.0 109.715 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.743 HG22 ' H ' ' A' ' 43' ' ' THR . 1.4 p -131.44 -168.9 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.297 0 CA-C-O 122.104 0.954 . . . . 10.0 111.182 -178.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.743 ' H ' HG22 ' A' ' 42' ' ' VAL . 23.2 m -142.43 151.5 41.85 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.585 0.707 . . . . 10.0 110.005 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.655 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -136.08 126.2 41.09 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.469 0 O-C-N 121.456 -0.778 . . . . 10.0 109.527 -179.239 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.574 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 30.9 mtt -90.87 96.56 10.7 Favored 'General case' 0 C--N 1.302 -1.477 0 C-N-CA 118.69 -1.204 . . . . 10.0 109.625 179.465 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.727 HG22 ' HG3' ' B' ' 7' ' ' GLU . 1.4 mp -72.03 104.95 1.86 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.637 0 O-C-N 121.548 -0.72 . . . . 10.0 110.049 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.47 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 43.65 35.06 2.89 Favored Glycine 0 N--CA 1.492 2.399 0 C-N-CA 119.776 -1.202 . . . . 10.0 110.428 179.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 109.52 2.17 30.92 Favored Glycine 0 N--CA 1.495 2.598 0 O-C-N 120.879 -1.365 . . . . 10.0 110.802 179.265 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.575 ' O ' ' N ' ' A' ' 46' ' ' ILE . 79.6 mt-10 -117.45 110.73 40.53 Favored Pre-proline 0 N--CA 1.49 1.563 0 O-C-N 120.741 -1.446 . . . . 10.0 110.297 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.435 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.2 Cg_endo -75.13 135.75 19.25 Favored 'Trans proline' 0 C--N 1.304 -1.811 0 O-C-N 123.566 1.298 . . . . 10.0 110.706 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.655 ' HB2' HG23 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -99.76 122.85 43.36 Favored 'General case' 0 C--N 1.304 -1.401 0 O-C-N 121.097 -1.002 . . . . 10.0 110.749 179.819 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.678 ' O ' HG23 ' A' ' 4' ' ' ILE . 30.2 p -84.6 98.32 10.1 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.05 -1.031 . . . . 10.0 109.439 179.017 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mt -121.48 126.67 49.83 Favored 'General case' 0 C--N 1.301 -1.51 0 C-N-CA 118.662 -1.215 . . . . 10.0 109.672 179.571 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.498 ' HA2' ' CB ' ' A' ' 41' ' ' ALA . . . -141.35 100.8 0.27 Allowed Glycine 0 N--CA 1.488 2.126 0 N-CA-C 108.531 -1.828 . . . . 10.0 108.531 179.716 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.934 HD22 ' CB ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -115.36 117.24 29.88 Favored 'General case' 0 C--N 1.302 -1.471 0 O-C-N 121.224 -1.162 . . . . 10.0 110.581 -178.641 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.797 ' CE1' ' HB2' ' A' ' 41' ' ' ALA . 20.9 m-85 -134.59 144.4 47.89 Favored 'General case' 0 N--CA 1.497 1.908 0 N-CA-C 108.865 -0.791 . . . . 10.0 108.865 178.52 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.916 ' H ' HD11 ' B' ' 18' ' ' ILE . 22.1 m-20 -105.78 160.76 14.98 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 120.475 -1.391 . . . . 10.0 110.008 178.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.565 ' OG1' ' CD1' ' B' ' 36' ' ' TRP . 4.3 t -70.42 -177.94 1.61 Allowed 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.003 -1.06 . . . . 10.0 110.97 -179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.624 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -111.04 90.94 3.47 Favored 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.708 -0.62 . . . . 10.0 109.409 179.116 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.587 ' H ' HG11 ' A' ' 36' ' ' VAL . . . -52.02 -34.51 38.88 Favored Glycine 0 N--CA 1.485 1.911 0 N-CA-C 107.781 -2.128 . . . . 10.0 107.781 179.654 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.536 ' CB ' ' HA3' ' B' ' 21' ' ' GLY . 20.4 tt0 -99.94 -19.19 16.72 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 121.841 -0.799 . . . . 10.0 109.863 179.011 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.624 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 65.4 mt-10 58.64 84.98 0.1 Allowed 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.269 -0.895 . . . . 10.0 110.564 -179.707 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.443 ' OD1' ' HG2' ' A' ' 61' ' ' GLN . 55.6 m-20 -96.4 -10.39 27.74 Favored 'General case' 0 C--N 1.289 -2.056 0 N-CA-C 108.968 -0.753 . . . . 10.0 108.968 178.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.602 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 3.9 p90 -140.3 -35.1 0.51 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.534 -0.729 . . . . 10.0 109.571 179.273 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.457 ' CG ' ' O ' ' A' ' 64' ' ' TYR . 2.7 p30 38.11 27.36 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.638 -0.664 . . . . 10.0 111.074 179.258 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.497 ' N ' ' O ' ' A' ' 64' ' ' TYR . 1.7 mmm-85 -58.16 -32.59 68.35 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.066 -1.021 . . . . 10.0 109.287 179.434 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.779 HD12 ' HB3' ' A' ' 70' ' ' LEU . 0.1 OUTLIER -79.93 7.67 8.45 Favored 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.486 -0.759 . . . . 10.0 110.097 179.695 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.664 ' O ' ' CD2' ' A' ' 70' ' ' LEU . 0.3 OUTLIER -52.16 -36.44 32.03 Favored Pre-proline 0 N--CA 1.505 2.28 0 O-C-N 121.335 -0.853 . . . . 10.0 112.74 179.947 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.607 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 48.9 Cg_endo -77.6 10.49 2.51 Favored 'Trans proline' 0 C--N 1.306 -1.666 0 O-C-N 122.62 0.8 . . . . 10.0 110.225 179.466 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.885 HD21 HD22 ' B' ' 39' ' ' LEU . 0.3 OUTLIER -45.94 -64.47 0.73 Allowed 'General case' 0 N--CA 1.481 1.107 0 O-C-N 120.935 -1.103 . . . . 10.0 111.954 -179.27 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.474 ' H ' ' HG ' ' A' ' 70' ' ' LEU . 67.4 m 41.06 32.49 0.18 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.899 -1.126 . . . . 10.0 109.969 179.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 6.7 t80 -171.33 127.8 0.66 Allowed Pre-proline 0 N--CA 1.492 1.664 0 O-C-N 121.167 -0.958 . . . . 10.0 110.677 -178.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.3 Cg_endo -80.96 130.59 7.53 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 O-C-N 123.997 1.525 . . . . 10.0 111.128 179.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.535 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 4.1 mt-30 -138.32 67.35 1.41 Allowed 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.232 -0.917 . . . . 10.0 108.943 178.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.822 HG23 ' O ' ' A' ' 5' ' ' LYS . 95.1 m -144.67 92.1 2.25 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.289 -0.882 . . . . 10.0 109.547 -179.668 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.492 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.1 m-20 -39.13 -30.46 0.05 Allowed 'General case' 0 C--N 1.294 -1.832 0 O-C-N 121.661 -0.65 . . . . 10.0 111.178 -178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.626 ' O ' HG22 ' A' ' 75' ' ' THR . 1.5 p -112.82 118.22 57.36 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.855 0 O-C-N 120.819 -1.176 . . . . 10.0 110.021 178.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.597 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 23.3 m-85 -119.29 133.92 55.49 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.429 -0.794 . . . . 10.0 110.427 179.884 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.712 HD22 HD23 ' A' ' 111' ' ' LEU . 1.2 mm? -104.36 97.43 7.37 Favored 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 107.533 -1.284 . . . . 10.0 107.533 177.781 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.844 HG23 HG21 ' A' ' 9' ' ' VAL . 10.3 p -96.1 147.02 6.38 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.67 0 C-N-CA 119.783 -0.767 . . . . 10.0 110.357 -178.817 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.726 ' SG ' HG21 ' A' ' 115' ' ' THR . 0.0 OUTLIER -113.9 101.89 9.69 Favored 'General case' 0 C--N 1.298 -1.655 0 CA-C-O 122.078 0.942 . . . . 10.0 110.882 -178.763 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.765 ' CE1' HG11 ' A' ' 93' ' ' VAL . 35.9 m-85 -92.44 178.32 5.86 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 121.137 -0.977 . . . . 10.0 110.003 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.426 ' O ' HG21 ' A' ' 137' ' ' ILE . 52.4 m -108.96 158.2 17.93 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.364 -0.835 . . . . 10.0 109.262 179.112 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.605 ' HA ' HG23 ' A' ' 137' ' ' ILE . 4.1 t -99.18 -19.03 6.06 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 O-C-N 121.16 -0.962 . . . . 10.0 111.188 -178.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.007 HG11 HD23 ' A' ' 129' ' ' LEU . 4.1 t -96.59 -60.16 2.8 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.01 -1.056 . . . . 10.0 110.209 -179.778 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 48.1 t -73.39 114.84 35.36 Favored Pre-proline 0 C--N 1.301 -1.506 0 O-C-N 121.393 -0.817 . . . . 10.0 109.958 179.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.594 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 52.5 Cg_endo -88.59 -3.45 6.58 Favored 'Trans proline' 0 C--N 1.305 -1.743 0 O-C-N 124.076 1.566 . . . . 10.0 110.495 -179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.48 ' HB3' ' HG3' ' A' ' 133' ' ' LYS . 4.1 p -75.1 21.42 0.12 Allowed 'General case' 0 N--CA 1.495 1.807 0 O-C-N 121.289 -0.882 . . . . 10.0 112.115 -179.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.57 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 19.5 t -131.4 -31.39 1.62 Allowed 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.876 -1.14 . . . . 10.0 109.934 179.22 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.631 ' HZ ' HD11 ' A' ' 112' ' ' LEU . 0.3 OUTLIER -72.8 -53.0 12.69 Favored 'General case' 0 C--N 1.298 -1.642 0 O-C-N 121.095 -1.003 . . . . 10.0 110.678 -179.501 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.42 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 9.3 tp10 -49.79 -17.9 0.41 Allowed 'General case' 0 C--N 1.299 -1.627 0 O-C-N 121.029 -1.044 . . . . 10.0 112.037 -178.702 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.716 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.5 OUTLIER -91.37 -18.96 23.44 Favored 'General case' 0 C--N 1.3 -1.555 0 O-C-N 120.497 -1.377 . . . . 10.0 110.822 -179.913 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.765 HG11 ' CE1' ' A' ' 82' ' ' PHE . 3.6 m -91.06 -18.25 7.51 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.539 0 C-N-CA 118.39 -1.324 . . . . 10.0 109.306 179.046 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.694 ' HD3' HG23 ' A' ' 93' ' ' VAL . 21.2 mmtt -88.65 -20.38 24.98 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.221 -0.924 . . . . 10.0 109.138 179.55 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.608 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.8 OUTLIER -95.99 -0.68 50.31 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.442 178.681 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.1 ttmt -91.54 -51.69 5.14 Favored 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.773 -1.171 . . . . 10.0 112.578 -178.715 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.723 ' CH2' HD23 ' A' ' 149' ' ' LEU . 34.3 p-90 -95.37 -26.01 16.06 Favored 'General case' 0 N--CA 1.499 2.01 0 O-C-N 120.81 -1.181 . . . . 10.0 111.771 -178.813 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.601 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 56.1 t -53.77 -43.39 96.19 Favored Pre-proline 0 C--N 1.299 -1.597 0 O-C-N 120.705 -1.247 . . . . 10.0 109.777 179.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.601 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 42.1 Cg_endo -75.93 -24.28 11.54 Favored 'Trans proline' 0 C--N 1.312 -1.388 0 O-C-N 123.292 1.154 . . . . 10.0 110.147 179.058 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.56 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 6.3 mm-40 -61.27 -13.17 16.76 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 120.907 -1.121 . . . . 10.0 110.379 179.424 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.56 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 24.9 mm 71.68 82.82 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.068 0 O-C-N 121.399 -0.813 . . . . 10.0 111.311 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -85.13 -16.66 39.75 Favored 'General case' 0 N--CA 1.489 1.489 0 N-CA-C 108.221 -1.029 . . . . 10.0 108.221 177.999 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 6.6 t60 -56.46 -47.26 79.55 Favored 'General case' 0 C--N 1.307 -1.281 0 N-CA-C 107.65 -1.241 . . . . 10.0 107.65 178.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 9.6 t-80 -64.85 -40.35 95.01 Favored 'General case' 0 C--N 1.299 -1.62 0 N-CA-C 108.651 -0.87 . . . . 10.0 108.651 178.132 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.489 ' SG ' ' HD2' ' A' ' 106' ' ' PRO . 0.0 OUTLIER -81.99 -176.6 0.8 Allowed Pre-proline 0 N--CA 1.488 1.444 0 O-C-N 121.724 -0.61 . . . . 10.0 109.42 179.383 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.489 ' HD2' ' SG ' ' A' ' 105' ' ' CYS . 50.5 Cg_endo -77.84 19.72 0.76 Allowed 'Trans proline' 0 C--N 1.305 -1.731 0 O-C-N 123.832 1.438 . . . . 10.0 112.856 -178.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.488 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 58.35 67.1 0.98 Allowed 'General case' 0 N--CA 1.485 1.286 0 O-C-N 120.377 -1.452 . . . . 10.0 108.929 179.927 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 21.0 m -45.46 134.89 5.86 Favored Pre-proline 0 N--CA 1.49 1.571 0 CA-C-N 115.714 -0.675 . . . . 10.0 110.915 -179.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.492 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 42.6 Cg_endo -69.79 140.75 43.33 Favored 'Trans proline' 0 C--N 1.312 -1.36 0 O-C-N 123.984 1.518 . . . . 10.0 110.997 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.671 ' H ' HG12 ' A' ' 152' ' ' VAL . 1.3 m-85 -136.95 113.28 9.96 Favored 'General case' 0 N--CA 1.488 1.431 0 CA-C-O 121.704 0.764 . . . . 10.0 110.939 -179.634 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.825 ' N ' HD22 ' A' ' 111' ' ' LEU . 2.3 mm? -87.98 97.0 10.71 Favored 'General case' 0 C--N 1.294 -1.805 0 N-CA-C 107.379 -1.341 . . . . 10.0 107.379 177.865 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.631 HD11 ' HZ ' ' A' ' 90' ' ' PHE . 1.6 tt -79.14 124.07 27.97 Favored 'General case' 0 C--N 1.293 -1.851 0 CA-C-N 115.858 -0.61 . . . . 10.0 110.038 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.793 HG21 HG11 ' A' ' 168' ' ' VAL . 2.4 t -139.92 164.82 22.74 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.836 0 O-C-N 120.945 -1.097 . . . . 10.0 111.487 -178.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.481 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -111.61 156.15 15.74 Favored Glycine 0 N--CA 1.488 2.104 0 N-CA-C 108.119 -1.993 . . . . 10.0 108.119 178.303 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.726 HG21 ' SG ' ' A' ' 81' ' ' CYS . 9.6 t -138.01 160.91 38.08 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.88 -1.365 . . . . 10.0 111.169 -179.321 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.497 ' HB2' ' O ' ' A' ' 115' ' ' THR . 7.2 mt-30 58.98 36.67 24.55 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.526 -0.734 . . . . 10.0 109.903 -179.857 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -72.63 -19.52 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.643 0 O-C-N 121.351 -0.843 . . . . 10.0 109.751 -179.828 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.629 ' HB2' HG21 ' A' ' 161' ' ' THR . 7.6 t70 -51.75 58.5 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.32 0 CA-C-O 122.156 0.979 . . . . 10.0 112.125 -176.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 3.6 tp 162.27 -23.63 0.0 OUTLIER 'General case' 0 C--N 1.286 -2.184 0 CA-C-N 114.526 -1.215 . . . . 10.0 108.131 178.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.865 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.88 -33.24 23.21 Favored 'General case' 0 C--N 1.306 -1.304 0 N-CA-C 109.009 -0.738 . . . . 10.0 109.009 179.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -57.16 -26.56 60.78 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.291 -0.881 . . . . 10.0 109.901 179.57 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.984 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.0 OUTLIER -93.53 132.02 31.11 Favored Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.452 -0.78 . . . . 10.0 110.549 -179.863 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.403 ' HD3' ' HA ' ' A' ' 122' ' ' ASP . 58.5 Cg_endo -87.0 23.26 0.84 Allowed 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 121.471 1.447 . . . . 10.0 110.256 179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.417 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 47.5 t -110.68 -50.62 2.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 121.133 -0.98 . . . . 10.0 111.016 -178.555 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.658 HG21 ' HG ' ' A' ' 119' ' ' LEU . 10.0 t -70.11 -27.22 64.41 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 105.457 -2.053 . . . . 10.0 105.457 177.739 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.984 HD13 ' O ' ' A' ' 122' ' ' ASP 0.306 1.2 mp -51.91 -25.38 6.03 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.618 0 N-CA-C 107.361 -1.348 . . . . 10.0 107.361 176.571 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.417 ' CB ' ' O ' ' A' ' 124' ' ' SER . 25.6 tt0 -58.46 -42.04 86.55 Favored 'General case' 0 N--CA 1.491 1.593 0 CA-C-N 115.744 -0.662 . . . . 10.0 111.282 179.498 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 14.2 mmtm -55.92 -41.64 74.9 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 121.529 -0.732 . . . . 10.0 110.665 -179.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.007 HD23 HG11 ' A' ' 85' ' ' VAL . 0.8 OUTLIER -75.72 -33.85 60.31 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.242 -0.911 . . . . 10.0 109.549 179.374 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.454 ' O ' ' O ' ' A' ' 133' ' ' LYS . . . -52.52 -50.2 63.3 Favored 'General case' 0 C--N 1.299 -1.612 0 CA-C-O 121.326 0.584 . . . . 10.0 110.277 -179.661 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -56.71 -28.91 61.81 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.258 -0.901 . . . . 10.0 109.452 179.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.504 ' O ' ' HD3' ' A' ' 133' ' ' LYS . 50.4 t30 -71.56 -52.19 19.48 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.179 -0.951 . . . . 10.0 109.985 179.769 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.594 ' CB ' ' HG2' ' A' ' 87' ' ' PRO . 3.2 mmtt -134.38 155.75 49.74 Favored 'General case' 0 C--N 1.297 -1.692 0 N-CA-C 108.7 -0.852 . . . . 10.0 108.7 179.774 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.549 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -105.43 24.09 12.71 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.093 -1.005 . . . . 10.0 111.157 -178.733 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.566 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -148.74 92.95 4.33 Favored Pre-proline 0 N--CA 1.489 1.481 0 O-C-N 121.2 -0.937 . . . . 10.0 109.391 178.326 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 42.2 Cg_endo -68.72 160.61 48.84 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 124.183 1.622 . . . . 10.0 110.519 -179.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.605 HG23 ' HA ' ' A' ' 84' ' ' VAL . 4.6 tp -102.07 133.68 44.92 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.368 0 N-CA-C 108.464 -0.939 . . . . 10.0 108.464 179.719 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.499 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.9 p -119.67 165.04 18.72 Favored Pre-proline 0 C--N 1.296 -1.733 0 O-C-N 121.182 -0.949 . . . . 10.0 110.159 -178.456 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HB3' ' OH ' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -64.13 -32.3 63.72 Favored 'Trans proline' 0 C--N 1.306 -1.658 0 O-C-N 123.935 1.492 . . . . 10.0 110.369 -179.416 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.529 ' O ' ' CE ' ' A' ' 144' ' ' LYS . 17.3 pt-20 -74.14 -29.82 61.99 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.06 -1.025 . . . . 10.0 109.456 179.163 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.448 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 81.1 m -80.13 -41.02 26.26 Favored 'General case' 0 N--CA 1.493 1.687 0 O-C-N 121.437 -0.79 . . . . 10.0 110.247 179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -72.53 -38.21 68.11 Favored 'General case' 0 N--CA 1.49 1.574 0 O-C-N 121.471 -0.768 . . . . 10.0 110.54 -179.368 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.477 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 18.9 tt0 -57.11 -42.57 81.08 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 121.541 -0.724 . . . . 10.0 109.637 179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.529 ' CE ' ' O ' ' A' ' 140' ' ' GLU . 14.5 mtmt -68.6 -40.33 80.49 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 121.161 -0.962 . . . . 10.0 109.494 179.398 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . . . . . . . . . 6.6 tt -56.0 -43.45 77.67 Favored 'General case' 0 C--N 1.308 -1.221 0 O-C-N 121.029 -1.044 . . . . 10.0 109.671 179.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.458 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -67.45 -51.17 54.73 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 121.191 -0.943 . . . . 10.0 108.648 178.916 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 21.1 tpp85 -60.6 -30.37 69.79 Favored 'General case' 0 C--N 1.3 -1.585 0 C-N-CA 120.026 -0.67 . . . . 10.0 109.624 178.535 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.47 ' HB3' HD13 ' A' ' 149' ' ' LEU . 32.9 t70 -67.99 -45.06 75.16 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.307 -0.871 . . . . 10.0 110.301 -179.177 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.723 HD23 ' CH2' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -92.76 14.78 16.23 Favored 'General case' 0 N--CA 1.493 1.723 0 CA-C-O 122.089 0.947 . . . . 10.0 108.964 179.178 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.457 ' O ' ' O ' ' A' ' 151' ' ' ALA . 8.9 mttp 56.23 38.28 29.66 Favored 'General case' 0 C--N 1.299 -1.62 0 CA-C-O 121.786 0.803 . . . . 10.0 110.299 179.04 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.458 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -60.97 -141.22 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.826 0 C-N-CA 120.198 -0.601 . . . . 10.0 109.563 179.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.753 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -117.43 -57.7 3.54 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 120.959 -1.088 . . . . 10.0 110.477 179.065 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.468 ' HD2' ' CD ' ' A' ' 171' ' ' GLU . 0.9 OUTLIER -170.89 145.09 2.31 Favored 'General case' 0 N--CA 1.491 1.588 0 C-N-CA 118.116 -1.434 . . . . 10.0 111.813 179.778 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.598 ' HB2' HD22 ' A' ' 112' ' ' LEU . 0.0 OUTLIER -90.79 119.49 31.05 Favored 'General case' 0 C--N 1.303 -1.445 0 N-CA-C 108.621 -0.881 . . . . 10.0 108.621 178.399 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.947 ' CG2' HG13 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -124.53 -168.88 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.845 0 O-C-N 120.863 -1.148 . . . . 10.0 110.203 179.97 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.402 ' N ' HG13 ' A' ' 113' ' ' VAL . 6.0 tt0 -146.82 152.7 39.17 Favored 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.141 -0.975 . . . . 10.0 110.335 -179.431 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.562 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 31.1 p -160.36 145.18 14.56 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.157 -0.964 . . . . 10.0 111.394 -179.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.865 ' CB ' HG23 ' A' ' 161' ' ' THR . 18.4 m -149.91 103.79 3.25 Favored 'General case' 0 C--N 1.294 -1.806 0 N-CA-C 107.455 -1.313 . . . . 10.0 107.455 178.18 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 1.086 ' HB1' ' HG2' ' B' ' 28' ' ' GLU . . . -37.02 -81.2 0.01 OUTLIER 'General case' 0 C--N 1.293 -1.869 0 CA-C-O 121.562 0.696 . . . . 10.0 112.316 -177.532 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.517 HD23 ' H ' ' A' ' 160' ' ' LEU . 0.3 OUTLIER -57.61 -7.9 0.76 Allowed 'General case' 0 C--N 1.293 -1.858 0 N-CA-C 113.76 1.022 . . . . 10.0 113.76 -177.846 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.865 HG23 ' CB ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -134.78 -92.52 0.31 Allowed 'General case' 0 N--CA 1.509 2.503 0 O-C-N 120.069 -1.644 . . . . 10.0 114.669 -178.465 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.54 ' H ' HG23 ' A' ' 161' ' ' THR . 7.5 mm-40 -11.55 -69.17 0.01 OUTLIER 'General case' 0 N--CA 1.506 2.37 0 CA-C-O 121.817 0.817 . . . . 10.0 112.657 -176.852 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.619 ' HA ' ' CE1' ' A' ' 23' ' ' TYR . 11.7 mttt 62.57 30.35 17.06 Favored 'General case' 0 C--N 1.285 -2.219 0 CA-C-O 121.815 0.817 . . . . 10.0 109.44 -178.841 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -130.0 -0.94 5.49 Favored Glycine 0 N--CA 1.488 2.153 0 N-CA-C 108.97 -1.652 . . . . 10.0 108.97 179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.053 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -65.89 -7.75 18.32 Favored 'General case' 0 N--CA 1.487 1.386 0 O-C-N 121.279 -1.13 . . . . 10.0 111.847 -179.656 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.688 ' N ' HD13 ' A' ' 165' ' ' LEU . 11.5 mtmt -56.77 -33.05 66.23 Favored 'General case' 0 N--CA 1.492 1.638 0 O-C-N 120.581 -1.324 . . . . 10.0 109.827 179.895 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 -70.35 -33.71 71.77 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.309 -0.869 . . . . 10.0 110.9 179.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.947 HG13 ' CG2' ' A' ' 155' ' ' VAL . 7.3 t -49.22 -35.84 8.51 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.791 0 O-C-N 120.752 -1.218 . . . . 10.0 109.639 -179.878 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.4 ' O ' HG13 ' A' ' 173' ' ' ILE . 6.1 t80 -78.91 -40.93 30.87 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.284 -0.885 . . . . 10.0 110.734 -179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.403 ' O ' HD22 ' A' ' 174' ' ' LEU . 14.4 m-20 -54.1 -46.7 72.15 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.185 -0.947 . . . . 10.0 111.429 -179.121 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.486 ' OE2' ' CG2' ' A' ' 155' ' ' VAL . 6.9 pt-20 -66.15 -35.01 79.35 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.21 -0.931 . . . . 10.0 112.158 -178.256 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.641 ' HB2' ' CG ' ' A' ' 111' ' ' LEU . . . -66.86 -17.95 65.14 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.597 -1.314 . . . . 10.0 109.881 -179.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.657 ' O ' HD12 ' A' ' 177' ' ' LEU . 22.1 mt -66.88 -44.4 88.92 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 C-N-CA 119.366 -0.934 . . . . 10.0 109.119 179.079 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.797 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -85.09 -17.84 36.12 Favored 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.266 -0.896 . . . . 10.0 111.068 -179.704 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.563 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.54 -0.49 51.99 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.906 -1.122 . . . . 10.0 110.141 179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.684 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.95 -49.09 7.29 Favored 'General case' 0 C--N 1.301 -1.512 0 O-C-N 121.434 -0.791 . . . . 10.0 109.973 179.588 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.657 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.9 OUTLIER -88.55 -16.58 32.23 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.552 -0.718 . . . . 10.0 109.598 -179.767 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.439 ' C ' ' O ' ' A' ' 177' ' ' LEU . 2.7 mt-10 . . . . . 0 N--CA 1.494 1.731 0 CA-C-O 118.035 -0.984 . . . . 10.0 110.081 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.467 ' N ' ' CD1' ' A' ' 51' ' ' TYR . . . . . . . . 0 N--CA 1.487 2.091 0 N-CA-C 109.532 -1.427 . . . . 10.0 109.532 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.439 ' HB2' ' CD ' ' A' ' 49' ' ' GLU . 68.7 m -59.66 152.29 22.82 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.31 -1.112 . . . . 10.0 110.328 179.777 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.82 102.05 13.35 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.567 -0.708 . . . . 10.0 111.366 -178.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.41 ' HG3' ' OE1' ' A' ' 49' ' ' GLU . 8.7 mm-40 -118.68 159.86 22.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.363 -0.835 . . . . 10.0 110.133 179.002 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.691 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.55 -150.02 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.76 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 179.456 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.691 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 42.6 Cg_endo -70.88 85.72 0.77 Allowed 'Trans proline' 0 C--N 1.32 -0.946 0 N-CA-C 109.844 -0.868 . . . . 10.0 109.844 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.727 ' HG3' HG22 ' A' ' 46' ' ' ILE . 17.9 mm-40 -53.53 -164.68 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.648 -0.657 . . . . 10.0 110.826 -179.282 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.427 HG13 ' HA2' ' A' ' 47' ' ' GLY . 1.5 pp -81.3 -51.97 14.63 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.473 0 O-C-N 121.26 -0.9 . . . . 10.0 112.472 -178.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 43.7 t -159.09 164.99 34.86 Favored 'General case' 0 N--CA 1.496 1.866 0 O-C-N 120.422 -1.424 . . . . 10.0 111.624 -179.502 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.574 ' CB ' ' O ' ' A' ' 45' ' ' MET . 0.7 OUTLIER -158.89 106.83 1.59 Allowed Pre-proline 0 N--CA 1.483 1.225 0 C-N-CA 119.577 -0.849 . . . . 10.0 111.951 -179.477 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 42.6 Cg_endo -69.34 115.07 3.85 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 124.155 1.608 . . . . 10.0 109.607 178.174 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 68.0 m -58.81 178.39 0.12 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.399 -0.813 . . . . 10.0 111.609 -178.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.428 ' HB2' ' O ' ' A' ' 43' ' ' THR . 1.7 t0 -135.09 -169.32 2.34 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.334 -0.854 . . . . 10.0 110.957 -179.251 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.533 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 5.1 m-85 -99.88 152.71 19.84 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.285 -0.884 . . . . 10.0 110.435 -179.459 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.619 ' HB3' ' CB ' ' A' ' 42' ' ' VAL . 0.0 OUTLIER -160.7 163.44 32.41 Favored 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.38 -0.825 . . . . 10.0 110.641 -179.151 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 5.3 t-160 -149.9 167.23 27.21 Favored 'General case' 0 N--CA 1.492 1.64 0 C-N-CA 118.721 -1.192 . . . . 10.0 112.039 179.402 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.755 HG22 ' O ' ' A' ' 39' ' ' ASN 0.257 2.4 p -124.34 162.47 23.72 Favored 'General case' 0 C--N 1.309 -1.192 0 O-C-N 121.676 -0.64 . . . . 10.0 111.115 -177.563 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 1.051 HD12 ' CB ' ' A' ' 38' ' ' ASP . 0.9 OUTLIER -93.31 -167.2 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.932 -1.105 . . . . 10.0 109.153 177.706 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 90.1 m-70 -112.68 157.48 21.21 Favored 'General case' 0 N--CA 1.497 1.925 0 O-C-N 120.728 -1.233 . . . . 10.0 111.377 -179.336 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.619 ' CG2' ' O ' ' A' ' 35' ' ' THR . 1.1 p -122.73 152.7 27.32 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.922 0 CA-C-N 115.803 -0.635 . . . . 10.0 111.022 -178.369 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.536 ' HA3' ' CB ' ' A' ' 61' ' ' GLN . . . -147.33 179.16 24.45 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.211 -1.556 . . . . 10.0 109.211 178.648 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.504 ' HB2' ' O ' ' B' ' 21' ' ' GLY . 4.4 m-85 62.3 96.76 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.298 -1.119 . . . . 10.0 111.417 179.606 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.503 ' HA ' ' O ' ' A' ' 33' ' ' VAL . 7.0 p-10 -66.71 157.57 32.37 Favored 'General case' 0 N--CA 1.493 1.709 0 CA-C-O 121.578 0.704 . . . . 10.0 111.915 -179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.469 ' C ' ' O ' ' B' ' 23' ' ' ASP . . . 24.98 46.5 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.213 0 CA-C-O 121.318 0.58 . . . . 10.0 112.452 179.499 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.917 ' H ' HG21 ' A' ' 35' ' ' THR . 1.2 t -104.58 -33.61 3.03 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.906 0 N-CA-C 107.255 -1.387 . . . . 10.0 107.255 178.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.885 HG21 HG22 ' A' ' 36' ' ' VAL . 0.7 OUTLIER -128.61 17.82 6.34 Favored 'General case' 0 C--N 1.298 -1.638 0 CA-C-O 121.811 0.815 . . . . 10.0 109.411 179.61 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.706 ' HA2' HG21 ' A' ' 21' ' ' ILE . . . -61.43 -22.3 61.11 Favored Glycine 0 N--CA 1.494 2.542 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 179.686 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 1.086 ' HG2' ' HB1' ' A' ' 159' ' ' ALA . 3.0 tt0 -153.09 -151.87 0.4 Allowed 'General case' 0 C--N 1.297 -1.701 0 O-C-N 121.633 -0.922 . . . . 10.0 109.041 -179.414 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.532 ' C ' ' CD1' ' B' ' 29' ' ' PHE . 0.1 OUTLIER -103.78 115.35 30.32 Favored 'General case' 0 C--N 1.286 -2.166 0 O-C-N 120.922 -1.111 . . . . 10.0 110.32 -179.775 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.662 HG21 ' CD1' ' A' ' 28' ' ' PHE . 34.7 p -130.3 -89.01 0.49 Allowed 'General case' 0 C--N 1.291 -1.953 0 CA-C-N 115.342 -0.844 . . . . 10.0 110.076 -179.43 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.536 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -80.24 -115.28 0.3 Allowed Glycine 0 N--CA 1.493 2.486 0 N-CA-C 109.056 -1.618 . . . . 10.0 109.056 179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.567 HD11 ' O ' ' A' ' 13' ' ' ALA . 2.6 tt -173.27 56.14 0.2 Allowed Pre-proline 0 N--CA 1.494 1.741 0 O-C-N 120.955 -1.321 . . . . 10.0 111.13 179.639 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.417 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 44.4 Cg_endo -71.77 155.06 58.85 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.781 1.411 . . . . 10.0 110.883 179.448 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.613 ' HG3' ' CG ' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -61.19 153.37 26.2 Favored 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.342 -0.849 . . . . 10.0 110.475 179.598 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.969 ' NE2' HG13 ' A' ' 9' ' ' VAL . 0.5 OUTLIER -73.92 -57.37 4.02 Favored 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.349 -0.844 . . . . 10.0 111.234 179.984 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.566 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.3 t90 174.26 27.5 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.584 -0.697 . . . . 10.0 109.838 179.752 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.965 ' O ' HD23 ' B' ' 40' ' ' LEU . . . 178.22 15.07 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.866 0 O-C-N 121.266 -0.896 . . . . 10.0 112.996 -179.245 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.653 ' HA ' HG21 ' B' ' 42' ' ' THR . 0.0 OUTLIER -62.34 -13.23 26.73 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 119.974 -1.704 . . . . 10.0 108.109 178.284 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.885 HD22 HD21 ' A' ' 70' ' ' LEU . 5.1 mp -55.45 -9.5 0.48 Allowed 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.678 -0.639 . . . . 10.0 111.667 179.167 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.965 HD23 ' O ' ' B' ' 37' ' ' ALA . 1.9 pp -83.73 22.51 1.1 Allowed 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.878 -1.139 . . . . 10.0 110.093 179.249 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.531 ' HB2' ' O ' ' B' ' 40' ' ' LEU . 6.9 mp0 62.92 63.93 0.91 Allowed 'General case' 0 N--CA 1.49 1.533 0 CA-C-O 122.046 0.927 . . . . 10.0 110.048 -179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.653 HG21 ' HA ' ' B' ' 38' ' ' ARG . 63.2 p -82.9 -171.26 3.45 Favored 'General case' 0 N--CA 1.49 1.541 0 CA-C-O 121.456 0.646 . . . . 10.0 110.864 -179.638 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 20.4 m -79.59 51.0 1.2 Allowed 'General case' 0 C--N 1.302 -1.466 0 O-C-N 121.36 -0.837 . . . . 10.0 110.248 -179.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.513 ' OD1' ' HD2' ' B' ' 38' ' ' ARG . 74.8 m-20 -46.36 -36.64 6.58 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.149 -0.969 . . . . 10.0 109.693 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.471 ' O ' ' OG1' ' B' ' 46' ' ' THR . 1.9 pt -115.54 168.32 7.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 121.348 -0.845 . . . . 10.0 110.02 179.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.575 HG22 ' O ' ' B' ' 46' ' ' THR . 16.7 m . . . . . 0 N--CA 1.491 1.585 0 CA-C-O 117.947 -1.025 . . . . 10.0 110.089 179.33 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 6.9 mtm . . . . . 0 N--CA 1.496 1.862 0 CA-C-O 120.963 0.411 . . . . 10.0 110.05 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.55 ' HA ' HD23 ' A' ' 177' ' ' LEU . 28.9 mm100 -146.21 -33.83 0.31 Allowed 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.019 -1.05 . . . . 10.0 109.743 178.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.511 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 51.8 m -56.54 110.93 0.86 Allowed 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.324 -0.86 . . . . 10.0 111.01 -179.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.885 HD12 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -108.33 128.01 64.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.525 0 C-N-CA 118.86 -1.136 . . . . 10.0 110.088 178.018 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.623 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.7 ttmt -112.23 109.54 19.28 Favored 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.429 -1.323 . . . . 10.0 107.429 177.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.556 ' HB3' HD23 ' A' ' 55' ' ' LEU . 51.7 t -93.94 102.6 14.7 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.59 -1.319 . . . . 10.0 110.369 -178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.418 HG12 ' N ' ' A' ' 8' ' ' VAL . 48.8 t -131.78 163.14 38.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.506 0 C-N-CA 118.71 -1.196 . . . . 10.0 110.765 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.858 HG12 ' HG2' ' B' ' 35' ' ' GLN . 1.9 t -78.26 154.36 5.11 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.792 0 O-C-N 121.295 -0.878 . . . . 10.0 109.388 179.372 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.578 ' CG2' ' N ' ' A' ' 10' ' ' GLY . 0.2 OUTLIER -160.39 174.71 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.804 0 O-C-N 120.854 -1.154 . . . . 10.0 110.353 -179.38 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.578 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 115.2 173.5 17.7 Favored Glycine 0 N--CA 1.49 2.268 0 N-CA-C 108.651 -1.78 . . . . 10.0 108.651 -179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -61.13 -29.43 69.77 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.712 -1.463 . . . . 10.0 108.894 179.476 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' O ' ' C ' ' A' ' 13' ' ' ALA . . . 163.7 -81.29 0.12 Allowed Glycine 0 N--CA 1.489 2.204 0 N-CA-C 108.721 -1.752 . . . . 10.0 108.721 -179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.427 ' C ' ' O ' ' A' ' 12' ' ' GLY . . . 39.96 -131.88 0.28 Allowed 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.513 -0.992 . . . . 10.0 110.937 179.309 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.728 ' CG1' HG23 ' A' ' 115' ' ' THR . 6.1 m -110.72 153.89 12.42 Favored 'Isoleucine or valine' 0 N--CA 1.499 1.978 0 O-C-N 121.121 -0.987 . . . . 10.0 111.748 -178.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.499 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -111.96 110.13 2.59 Favored Glycine 0 N--CA 1.494 2.5 0 N-CA-C 109.229 -1.548 . . . . 10.0 109.229 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.455 ' HG3' ' N ' ' A' ' 17' ' ' THR . 0.0 OUTLIER -54.13 -20.63 7.0 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.761 -1.435 . . . . 10.0 110.896 -179.448 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.499 HG21 ' CG2' ' A' ' 8' ' ' VAL . 11.4 t -73.82 -32.17 63.59 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 120.762 -1.212 . . . . 10.0 110.287 -179.919 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.664 ' HA ' HG23 ' B' ' 26' ' ' THR . 18.3 p -73.68 -15.68 61.23 Favored 'General case' 0 N--CA 1.483 1.198 0 O-C-N 120.618 -1.301 . . . . 10.0 107.673 178.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.834 HD13 ' CA ' ' A' ' 159' ' ' ALA . 53.7 mt -95.69 -23.42 17.01 Favored 'General case' 0 C--N 1.307 -1.25 0 N-CA-C 107.942 -1.133 . . . . 10.0 107.942 178.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.555 ' HA ' ' CD2' ' A' ' 23' ' ' TYR . 0.6 OUTLIER -46.85 -43.38 18.58 Favored 'General case' 0 N--CA 1.502 2.162 0 CA-C-O 121.842 0.829 . . . . 10.0 109.046 -179.55 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.045 HG22 ' HB2' ' A' ' 26' ' ' ASN . 4.6 mm -74.72 -39.88 46.62 Favored 'Isoleucine or valine' 0 C--N 1.287 -2.119 0 N-CA-C 107.976 -1.12 . . . . 10.0 107.976 177.36 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.546 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 4.6 p -52.02 -49.25 63.75 Favored 'General case' 0 C--N 1.285 -2.201 0 C-N-CA 119.435 -0.906 . . . . 10.0 110.254 179.426 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 1.241 ' CE2' HD11 ' A' ' 165' ' ' LEU . 4.7 m-85 -62.05 -34.09 75.6 Favored 'General case' 0 N--CA 1.495 1.776 0 O-C-N 120.377 -1.452 . . . . 10.0 109.706 179.477 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.609 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 0.6 OUTLIER -72.79 -51.99 16.77 Favored 'General case' 0 N--CA 1.488 1.444 0 C-N-CA 119.562 -0.855 . . . . 10.0 111.048 -178.49 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.529 HG23 ' ND2' ' A' ' 26' ' ' ASN . 11.8 t -169.49 -20.98 0.02 OUTLIER 'General case' 0 N--CA 1.508 2.468 0 C-N-CA 116.959 -1.896 . . . . 10.0 114.563 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 1.045 ' HB2' HG22 ' A' ' 21' ' ' ILE . 4.8 m-80 -79.29 -8.67 59.22 Favored 'General case' 0 N--CA 1.498 1.958 0 O-C-N 120.454 -1.404 . . . . 10.0 111.223 -178.443 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.693 ' HD2' ' HD2' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 14.86 -146.13 0.0 OUTLIER 'General case' 0 N--CA 1.51 2.547 0 N-CA-C 114.359 1.244 . . . . 10.0 114.359 178.206 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.668 ' CE1' HG22 ' B' ' 30' ' ' THR . 1.8 t80 -100.71 -50.9 0.18 Allowed Pre-proline 0 N--CA 1.507 2.408 0 N-CA-C 116.057 1.873 . . . . 10.0 116.057 -175.526 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.693 ' HD2' ' HD2' ' A' ' 27' ' ' LYS . 32.6 Cg_endo -54.82 -89.91 0.0 OUTLIER 'Trans proline' 0 N--CA 1.499 1.835 0 N-CA-C 115.216 1.199 . . . . 10.0 115.216 -176.006 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -167.89 70.46 0.09 Allowed 'General case' 0 N--CA 1.499 1.987 0 O-C-N 119.523 -1.985 . . . . 10.0 112.63 -177.671 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.878 ' O ' HG22 ' A' ' 33' ' ' VAL . 41.4 mm-40 -99.82 112.83 25.07 Favored 'General case' 0 C--N 1.294 -1.822 0 N-CA-C 108.107 -1.071 . . . . 10.0 108.107 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.51 ' HA ' ' OD1' ' B' ' 23' ' ' ASP . 11.7 m-85 -58.4 62.72 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 CA-C-O 121.276 0.56 . . . . 10.0 111.218 -179.184 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.878 HG22 ' O ' ' A' ' 31' ' ' GLU . 9.3 m -117.17 169.77 6.94 Favored Pre-proline 0 C--N 1.304 -1.373 0 O-C-N 121.091 -1.006 . . . . 10.0 109.449 179.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.69 ' CB ' HG11 ' B' ' 20' ' ' VAL . 49.3 Cg_endo -78.24 137.86 15.51 Favored 'Trans proline' 0 C--N 1.306 -1.7 0 O-C-N 123.726 1.382 . . . . 10.0 113.551 -177.662 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.605 ' O ' ' CG2' ' B' ' 20' ' ' VAL . 68.9 p -124.87 158.36 33.66 Favored 'General case' 0 N--CA 1.501 2.114 0 O-C-N 121.67 -0.644 . . . . 10.0 109.317 178.108 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.677 HG23 ' HB ' ' B' ' 26' ' ' THR . 16.5 t 63.1 -6.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.502 2.136 0 O-C-N 120.57 -1.331 . . . . 10.0 111.811 -179.761 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.706 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.4 OUTLIER -67.58 95.29 0.47 Allowed 'General case' 0 C--N 1.309 -1.176 0 O-C-N 120.474 -1.391 . . . . 10.0 109.368 -179.248 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.699 ' HA ' ' CG2' ' B' ' 18' ' ' ILE . 2.3 m-20 -165.78 103.69 0.69 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 117.308 -1.757 . . . . 10.0 114.278 -179.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.784 ' N ' HG22 ' B' ' 18' ' ' ILE . 53.5 t30 -134.59 97.17 3.73 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.858 -1.151 . . . . 10.0 108.471 176.131 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.747 ' CE1' HG23 ' B' ' 18' ' ' ILE . 2.9 m-30 -118.76 146.58 44.67 Favored 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.669 -0.644 . . . . 10.0 111.063 -178.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.629 ' C ' HG13 ' A' ' 42' ' ' VAL . . . -171.72 98.07 0.18 Allowed 'General case' 0 C--N 1.302 -1.476 0 O-C-N 121.08 -1.013 . . . . 10.0 109.262 178.217 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.629 HG13 ' C ' ' A' ' 41' ' ' ALA . 30.9 m -156.15 -165.59 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.874 0 CA-C-O 121.988 0.899 . . . . 10.0 112.276 -178.323 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.615 HG23 ' O ' ' A' ' 51' ' ' TYR . 20.3 m -130.24 155.23 46.63 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.294 0.569 . . . . 10.0 111.319 -179.175 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.551 ' HA ' ' CB ' ' B' ' 12' ' ' SER . 11.6 t -131.2 150.99 35.03 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.493 0 O-C-N 121.589 -0.694 . . . . 10.0 109.215 179.093 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.637 ' O ' ' HB3' ' B' ' 10' ' ' LEU . 10.6 mtp -110.52 93.14 4.34 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.978 -1.489 . . . . 10.0 107.661 177.693 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.731 HG23 ' CG ' ' B' ' 7' ' ' GLU . 1.8 mp -72.57 103.01 1.52 Allowed 'Isoleucine or valine' 0 C--N 1.289 -2.065 0 O-C-N 120.594 -1.316 . . . . 10.0 109.015 -179.15 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.649 ' CA ' ' HB3' ' B' ' 9' ' ' SER . . . 51.0 30.56 23.26 Favored Glycine 0 N--CA 1.495 2.58 0 C-N-CA 119.404 -1.379 . . . . 10.0 110.119 -178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 105.92 6.12 37.65 Favored Glycine 0 N--CA 1.496 2.637 0 O-C-N 120.845 -1.385 . . . . 10.0 110.592 179.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.527 ' O ' ' HA ' ' A' ' 45' ' ' MET . 11.6 tp10 -110.87 115.1 53.65 Favored Pre-proline 0 N--CA 1.492 1.654 0 O-C-N 121.234 -1.157 . . . . 10.0 109.758 179.728 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.506 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.7 Cg_endo -71.59 139.0 33.32 Favored 'Trans proline' 0 C--N 1.311 -1.398 0 O-C-N 123.947 1.498 . . . . 10.0 110.88 -178.847 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.615 ' O ' HG23 ' A' ' 43' ' ' THR . 0.1 OUTLIER -114.1 163.04 15.72 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.133 -0.979 . . . . 10.0 111.9 -179.894 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.752 ' O ' HG22 ' A' ' 4' ' ' ILE . 3.1 m -122.99 104.75 9.43 Favored 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 178.865 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.431 ' HA ' HG23 ' A' ' 4' ' ' ILE . 21.2 mt -108.65 147.93 31.16 Favored 'General case' 0 N--CA 1.494 1.743 0 O-C-N 120.789 -1.195 . . . . 10.0 110.893 -179.308 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -163.44 99.98 0.17 Allowed Glycine 0 N--CA 1.491 2.34 0 N-CA-C 109.044 -1.623 . . . . 10.0 109.044 179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 1.086 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -138.34 139.81 39.2 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.199 -1.177 . . . . 10.0 110.269 -179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 1.086 ' N ' HD22 ' A' ' 55' ' ' LEU . 18.4 p90 -162.06 139.96 8.8 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 121.136 -0.978 . . . . 10.0 110.139 179.353 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.49 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 m-20 -104.25 170.1 8.1 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 121.097 -1.002 . . . . 10.0 110.476 -179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.501 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 5.5 t -43.55 175.38 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 CA-C-O 121.942 0.877 . . . . 10.0 111.927 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.559 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -133.29 90.53 2.74 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.526 -0.733 . . . . 10.0 110.652 -179.419 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.476 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -66.87 71.14 0.18 Allowed Glycine 0 N--CA 1.486 2.027 0 N-CA-C 106.885 -2.486 . . . . 10.0 106.885 178.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' A' ' 59' ' ' ALA . 0.1 OUTLIER 64.02 28.69 14.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.541 -0.976 . . . . 10.0 109.216 -177.877 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.68 ' HG3' ' HA ' ' B' ' 20' ' ' VAL . 0.3 OUTLIER -58.95 -58.59 7.99 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 120.834 -1.166 . . . . 10.0 109.768 179.726 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.607 ' O ' ' CD1' ' A' ' 64' ' ' TYR . 0.8 OUTLIER 175.09 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.256 -0.903 . . . . 10.0 110.147 179.556 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.607 ' CD1' ' O ' ' A' ' 63' ' ' ASP . 0.1 OUTLIER -151.7 -34.45 0.14 Allowed 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.29 -0.881 . . . . 10.0 109.917 -179.25 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.552 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 12.8 t0 79.05 20.99 0.7 Allowed 'General case' 0 N--CA 1.49 1.527 0 CA-C-O 121.365 0.602 . . . . 10.0 109.616 -179.424 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.475 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -58.73 -19.11 37.21 Favored 'General case' 0 C--N 1.304 -1.387 0 N-CA-C 108.059 -1.089 . . . . 10.0 108.059 178.576 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' C ' HD22 ' A' ' 70' ' ' LEU . 1.1 pp -55.23 -16.32 3.15 Favored 'General case' 0 C--N 1.307 -1.264 0 N-CA-C 108.846 -0.798 . . . . 10.0 108.846 177.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.555 ' HB3' ' HD3' ' A' ' 69' ' ' PRO . 1.1 ttm180 -99.68 -52.98 0.19 Allowed Pre-proline 0 N--CA 1.496 1.853 0 N-CA-C 113.84 1.052 . . . . 10.0 113.84 -178.815 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.555 ' HD3' ' HB3' ' A' ' 68' ' ' ARG . 45.7 Cg_endo -70.54 -16.51 34.28 Favored 'Trans proline' 0 N--CA 1.499 1.842 0 C-N-CA 120.466 0.778 . . . . 10.0 112.625 -178.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.925 HD21 HD11 ' B' ' 39' ' ' LEU . 0.9 OUTLIER -54.84 -10.91 0.52 Allowed 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.678 -1.264 . . . . 10.0 111.949 -179.687 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.832 ' OG ' HD12 ' B' ' 39' ' ' LEU . 1.0 OUTLIER -45.83 -31.78 2.27 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.953 -1.092 . . . . 10.0 110.449 179.773 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -88.42 134.44 34.42 Favored Pre-proline 0 N--CA 1.498 1.932 0 O-C-N 121.397 -0.814 . . . . 10.0 111.27 -178.785 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.616 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 43.3 Cg_endo -80.27 159.2 23.17 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.899 1.473 . . . . 10.0 110.588 178.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.616 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 163.91 78.56 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.354 0 CA-C-O 121.29 0.567 . . . . 10.0 109.586 179.741 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.705 HG22 ' O ' ' A' ' 77' ' ' VAL . 89.1 m -146.83 99.59 3.21 Favored 'General case' 0 C--N 1.306 -1.32 0 O-C-N 121.312 -0.867 . . . . 10.0 109.962 179.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.46 ' C ' ' O ' ' A' ' 75' ' ' THR . 81.5 m-20 -38.86 -30.59 0.05 OUTLIER 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.487 -0.758 . . . . 10.0 110.817 -179.963 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.705 ' O ' HG22 ' A' ' 75' ' ' THR . 0.5 OUTLIER -119.02 120.37 63.75 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.085 0 O-C-N 121.441 -0.787 . . . . 10.0 109.337 179.736 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.586 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 67.0 m-85 -108.19 129.48 55.18 Favored 'General case' 0 N--CA 1.491 1.611 0 O-C-N 120.909 -1.12 . . . . 10.0 111.906 -178.711 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.98 HD22 HD23 ' A' ' 111' ' ' LEU . 2.0 mm? -104.05 97.05 7.09 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 108.759 -0.83 . . . . 10.0 108.759 179.082 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.585 ' O ' HG23 ' A' ' 113' ' ' VAL . 8.2 p -107.24 145.8 14.24 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 O-C-N 121.101 -0.999 . . . . 10.0 110.495 -179.342 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.478 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 39.4 t -141.43 126.17 18.01 Favored 'General case' 0 C--N 1.303 -1.417 0 O-C-N 121.157 -0.964 . . . . 10.0 111.192 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CA ' ' OG1' ' A' ' 115' ' ' THR . 1.8 p90 -135.01 168.26 19.44 Favored 'General case' 0 N--CA 1.499 1.995 0 O-C-N 121.441 -0.787 . . . . 10.0 110.654 179.115 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 13.6 t -77.3 161.06 28.39 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.338 -0.851 . . . . 10.0 109.74 179.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.975 HG12 HG23 ' A' ' 137' ' ' ILE . 0.1 OUTLIER -110.74 14.98 8.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.083 -1.011 . . . . 10.0 111.118 -179.27 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.896 HG23 HD22 ' A' ' 129' ' ' LEU . 3.0 m -125.48 -17.23 3.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.827 0 O-C-N 120.69 -1.257 . . . . 10.0 111.716 -179.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.887 ' CA ' HD23 ' A' ' 129' ' ' LEU . 0.9 OUTLIER -60.66 -159.7 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.769 0 O-C-N 120.992 -1.067 . . . . 10.0 110.096 -179.77 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.661 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.3 Cg_endo -71.9 178.31 6.01 Favored 'Trans proline' 0 N--CA 1.487 1.092 0 O-C-N 122.804 0.897 . . . . 10.0 110.099 -178.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -63.84 66.68 0.02 OUTLIER 'General case' 0 N--CA 1.493 1.709 0 O-C-N 121.246 -0.909 . . . . 10.0 110.087 -179.449 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.549 ' N ' ' O ' ' A' ' 87' ' ' PRO . 66.1 m -89.96 -15.28 32.3 Favored 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.595 -0.691 . . . . 10.0 110.537 -179.853 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.587 ' CZ ' ' HE3' ' A' ' 94' ' ' LYS . 6.1 t80 -86.24 -50.23 7.12 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.325 -0.859 . . . . 10.0 110.188 -179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.2 tt0 -65.65 -30.59 71.32 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 121.545 -0.722 . . . . 10.0 110.643 -179.786 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.523 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -79.29 -14.22 59.16 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 120.821 -1.174 . . . . 10.0 109.58 179.684 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.653 ' O ' ' CD1' ' A' ' 97' ' ' TRP . 2.7 t -83.84 -21.81 8.45 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.387 0 O-C-N 120.612 -1.305 . . . . 10.0 107.914 177.695 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.587 ' HE3' ' CZ ' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -72.12 -37.87 69.39 Favored 'General case' 0 N--CA 1.49 1.557 0 N-CA-C 108.712 -0.847 . . . . 10.0 108.712 178.583 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.523 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 1.4 pt-20 -69.49 -10.53 58.45 Favored 'General case' 0 C--N 1.299 -1.616 0 C-N-CA 119.943 -0.703 . . . . 10.0 109.263 179.304 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.618 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 0.8 OUTLIER -87.34 -52.37 5.42 Favored 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 119.316 -0.954 . . . . 10.0 112.582 -178.68 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.712 ' CZ3' HG22 ' A' ' 98' ' ' VAL . 54.9 p-90 -93.91 -15.93 24.5 Favored 'General case' 0 N--CA 1.498 1.941 0 O-C-N 120.752 -1.217 . . . . 10.0 112.444 -178.028 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.712 HG22 ' CZ3' ' A' ' 97' ' ' TRP . 58.8 t -66.9 -50.78 41.47 Favored Pre-proline 0 N--CA 1.494 1.743 0 O-C-N 120.745 -1.222 . . . . 10.0 110.992 -179.447 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.553 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.0 Cg_endo -71.58 -20.64 26.7 Favored 'Trans proline' 0 C--N 1.314 -1.237 0 O-C-N 123.21 1.111 . . . . 10.0 109.761 179.773 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.618 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 5.7 mm-40 -57.14 -35.97 70.14 Favored 'General case' 0 C--N 1.301 -1.533 0 C-N-CA 119.344 -0.943 . . . . 10.0 109.264 178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.538 HG13 ' O ' ' A' ' 99' ' ' PRO . 10.2 mt 55.15 118.09 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.958 0 O-C-N 121.379 -0.825 . . . . 10.0 110.881 178.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.64 ' HA ' ' O ' ' A' ' 105' ' ' CYS . 4.2 p -48.66 -24.91 1.52 Allowed 'General case' 0 N--CA 1.496 1.827 0 O-C-N 121.001 -1.062 . . . . 10.0 109.07 -179.512 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.469 ' HB2' HG22 ' A' ' 101' ' ' ILE . 62.5 m-70 -76.2 -33.13 59.28 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.528 -0.732 . . . . 10.0 109.843 179.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.472 ' HB3' ' O ' ' A' ' 100' ' ' GLU . 1.4 t-80 -105.91 -16.71 14.57 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.375 -0.828 . . . . 10.0 110.847 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.64 ' O ' ' HA ' ' A' ' 102' ' ' THR . 1.1 m -166.4 175.51 2.21 Favored Pre-proline 0 N--CA 1.495 1.783 0 O-C-N 121.034 -1.041 . . . . 10.0 110.085 179.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.488 ' HD2' ' HB3' ' A' ' 105' ' ' CYS . 43.0 Cg_endo -70.72 86.72 0.7 Allowed 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.641 1.337 . . . . 10.0 111.747 -179.467 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.635 ' HB3' ' N ' ' A' ' 102' ' ' THR . 8.5 tttp -102.58 4.88 38.9 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.381 -0.825 . . . . 10.0 109.589 179.411 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.654 HG23 ' HD2' ' A' ' 109' ' ' PRO . 90.8 m -43.02 147.48 0.67 Allowed Pre-proline 0 N--CA 1.49 1.534 0 O-C-N 121.551 -0.718 . . . . 10.0 110.309 -179.435 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.654 ' HD2' HG23 ' A' ' 108' ' ' THR . 34.3 Cg_endo -58.22 160.67 15.57 Favored 'Trans proline' 0 C--N 1.309 -1.531 0 C-N-CA 122.019 1.813 . . . . 10.0 112.81 -178.448 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.587 ' O ' HG13 ' A' ' 152' ' ' VAL . 1.7 p90 -151.01 144.53 24.95 Favored 'General case' 0 C--N 1.304 -1.371 0 CA-C-O 122.2 1.0 . . . . 10.0 109.417 -178.534 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.98 HD23 HD22 ' A' ' 79' ' ' LEU . 1.2 mm? -77.88 99.68 6.07 Favored 'General case' 0 C--N 1.293 -1.888 0 CA-C-O 121.841 0.829 . . . . 10.0 109.745 -179.68 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.518 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 75.5 mt -62.9 146.87 51.88 Favored 'General case' 0 C--N 1.298 -1.671 0 N-CA-C 109.128 -0.693 . . . . 10.0 109.128 179.747 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.585 HG23 ' O ' ' A' ' 80' ' ' VAL . 3.0 t -148.39 173.91 1.66 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.115 0 O-C-N 120.46 -1.4 . . . . 10.0 111.929 -179.519 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.543 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -109.66 138.43 14.81 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 108.842 -1.703 . . . . 10.0 108.842 178.916 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.728 HG23 ' CG1' ' A' ' 14' ' ' VAL . 97.1 m -91.88 130.18 37.7 Favored 'General case' 0 N--CA 1.49 1.54 0 O-C-N 121.003 -1.292 . . . . 10.0 110.626 -179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.408 ' C ' ' O ' ' A' ' 115' ' ' THR . 3.8 tp60 41.9 59.8 2.43 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.432 -0.793 . . . . 10.0 110.099 -179.901 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.03 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -61.54 -42.05 92.5 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.755 0 N-CA-C 106.998 -1.482 . . . . 10.0 106.998 179.196 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.534 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 4.8 p30 -51.91 60.04 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.113 0 CA-C-O 122.284 1.04 . . . . 10.0 110.385 -177.748 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.77 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 162.34 -28.07 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.224 0 N-CA-C 107.703 -1.221 . . . . 10.0 107.703 -179.046 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.561 ' HG3' HG23 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.47 -41.43 20.58 Favored 'General case' 0 N--CA 1.487 1.406 0 CA-C-O 121.592 0.711 . . . . 10.0 109.62 178.845 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.541 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 77.5 m-20 -67.57 -10.14 49.11 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.401 -0.812 . . . . 10.0 109.99 -179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.703 ' O ' HD13 ' A' ' 126' ' ' ILE . 14.8 t0 -82.3 117.15 67.38 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.381 -0.824 . . . . 10.0 109.301 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -82.62 23.77 0.78 Allowed 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 124.154 1.607 . . . . 10.0 110.97 -179.245 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.474 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 37.2 t -107.84 -49.35 3.24 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.167 -0.958 . . . . 10.0 109.932 -179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.528 HG21 HD21 ' A' ' 119' ' ' LEU . 14.4 t -75.06 -31.25 61.23 Favored 'General case' 0 C--N 1.296 -1.722 0 N-CA-C 105.42 -2.067 . . . . 10.0 105.42 177.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.703 HD13 ' O ' ' A' ' 122' ' ' ASP 0.295 1.2 mp -56.02 -23.67 16.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.547 0 N-CA-C 107.64 -1.244 . . . . 10.0 107.64 176.751 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.474 ' HB2' ' O ' ' A' ' 124' ' ' SER . 12.4 tt0 -47.99 -42.25 27.36 Favored 'General case' 0 C--N 1.303 -1.45 0 CA-C-N 115.598 -0.728 . . . . 10.0 110.382 -179.405 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 2.1 mmtm -71.13 -49.55 42.95 Favored 'General case' 0 C--N 1.294 -1.819 0 O-C-N 121.48 -0.763 . . . . 10.0 110.547 179.668 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.896 HD22 HG23 ' A' ' 85' ' ' VAL . 4.9 mp -67.3 -43.68 81.11 Favored 'General case' 0 N--CA 1.491 1.604 0 CA-C-O 121.67 0.748 . . . . 10.0 110.691 -179.537 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -56.22 -42.46 77.27 Favored 'General case' 0 N--CA 1.489 1.508 0 O-C-N 121.429 -0.794 . . . . 10.0 110.594 -179.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.0 tptm -52.23 -21.3 3.27 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.214 -0.929 . . . . 10.0 109.69 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.605 ' ND2' ' HB3' ' A' ' 87' ' ' PRO . 3.1 t30 -85.9 -68.12 0.76 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 121.381 -0.825 . . . . 10.0 111.242 -178.969 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.502 ' HD3' ' ND2' ' A' ' 132' ' ' ASN . 0.4 OUTLIER -124.59 129.4 50.51 Favored 'General case' 0 C--N 1.296 -1.733 0 O-C-N 121.532 -0.73 . . . . 10.0 110.6 -179.05 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.648 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.6 OUTLIER -84.25 9.05 13.9 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.357 -0.839 . . . . 10.0 109.172 179.547 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 22.2 mmtm -118.6 94.03 46.82 Favored Pre-proline 0 N--CA 1.487 1.393 0 O-C-N 121.415 -0.803 . . . . 10.0 110.368 -179.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -78.38 162.35 28.09 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.586 1.524 . . . . 10.0 110.182 179.599 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.975 HG23 HG12 ' A' ' 84' ' ' VAL . 2.4 tp -103.98 146.61 11.25 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.004 -1.06 . . . . 10.0 110.34 179.542 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.546 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 30.4 p -132.69 171.12 9.7 Favored Pre-proline 0 N--CA 1.495 1.785 0 O-C-N 121.216 -0.928 . . . . 10.0 110.102 -179.107 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.646 ' HB2' ' CE1' ' A' ' 154' ' ' TYR . 40.0 Cg_endo -71.69 -22.55 23.89 Favored 'Trans proline' 0 C--N 1.312 -1.377 0 O-C-N 123.551 1.29 . . . . 10.0 111.445 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -64.65 -55.15 21.97 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.965 -1.085 . . . . 10.0 109.803 179.515 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 23.8 m -65.4 -39.85 92.7 Favored 'General case' 0 C--N 1.297 -1.691 0 CA-C-N 116.191 -0.459 . . . . 10.0 111.372 -179.445 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -66.47 -30.01 70.26 Favored 'General case' 0 N--CA 1.494 1.772 0 O-C-N 121.009 -1.057 . . . . 10.0 111.144 -179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 5.6 tm-20 -53.38 -49.3 67.51 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.183 -0.948 . . . . 10.0 110.063 -179.96 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.479 ' O ' ' N ' ' A' ' 148' ' ' ASP . 7.2 ttmt -62.91 -44.01 97.24 Favored 'General case' 0 C--N 1.3 -1.578 0 C-N-CA 119.347 -0.941 . . . . 10.0 109.078 179.043 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.827 ' HG ' HD22 ' A' ' 149' ' ' LEU . 7.0 tt -59.32 -33.51 71.21 Favored 'General case' 0 C--N 1.307 -1.261 0 O-C-N 121.486 -0.758 . . . . 10.0 109.157 179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 1.011 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -67.34 -50.02 61.69 Favored 'General case' 0 C--N 1.304 -1.399 0 CA-C-O 121.69 0.757 . . . . 10.0 109.578 179.705 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.8 mmm-85 -84.34 -10.12 57.87 Favored 'General case' 0 C--N 1.298 -1.667 0 C-N-CA 119.35 -0.94 . . . . 10.0 110.824 179.597 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.479 ' N ' ' O ' ' A' ' 144' ' ' LYS . 37.6 t0 -93.77 -37.55 11.72 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.599 -1.313 . . . . 10.0 110.795 179.792 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.827 HD22 ' HG ' ' A' ' 145' ' ' LEU . 1.4 mp -101.07 24.75 8.93 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.978 -1.076 . . . . 10.0 109.735 -179.945 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.455 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 11.9 mtpt 61.95 39.21 13.73 Favored 'General case' 0 C--N 1.288 -2.091 0 CA-C-N 115.561 -0.745 . . . . 10.0 112.017 177.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 1.011 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -95.26 -156.05 0.5 Allowed 'General case' 0 C--N 1.29 -2.014 0 N-CA-C 108.261 -1.015 . . . . 10.0 108.261 177.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.865 HG21 ' CD1' ' A' ' 111' ' ' LEU . 0.1 OUTLIER -116.71 -66.65 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.424 0 O-C-N 120.473 -1.392 . . . . 10.0 110.259 179.326 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.576 ' N ' HG22 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -172.68 174.8 3.59 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 117.679 -1.608 . . . . 10.0 112.003 -179.317 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.646 ' CE1' ' HB2' ' A' ' 139' ' ' PRO . 41.5 p90 -104.34 133.6 48.97 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.569 -0.9 . . . . 10.0 108.569 178.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.667 HG11 ' HA ' ' A' ' 168' ' ' VAL . 0.0 OUTLIER -137.71 -169.08 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.294 -1.81 0 O-C-N 121.307 -0.871 . . . . 10.0 109.781 -179.534 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.475 ' HB2' ' HA3' ' A' ' 164' ' ' GLY . 78.4 mm-40 -144.13 162.86 35.22 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.016 -1.053 . . . . 10.0 110.138 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.561 ' N ' ' O ' ' A' ' 163' ' ' LYS . 15.5 p -164.89 133.82 3.49 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.282 -0.886 . . . . 10.0 109.668 179.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.582 ' H ' HD23 ' A' ' 165' ' ' LEU . 32.6 t -120.78 173.38 7.25 Favored 'General case' 0 C--N 1.296 -1.725 0 N-CA-C 107.913 -1.143 . . . . 10.0 107.913 179.031 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.834 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -86.67 -78.76 0.28 Allowed 'General case' 0 C--N 1.289 -2.047 0 O-C-N 120.899 -1.126 . . . . 10.0 111.789 -178.328 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.736 ' C ' HD12 ' A' ' 160' ' ' LEU . 3.8 pp -91.49 -4.25 55.71 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.434 -1.416 . . . . 10.0 111.108 -178.831 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.531 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 87.1 m -96.1 -32.41 12.54 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.087 -1.008 . . . . 10.0 111.466 -179.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.54 ' HA ' ' HG ' ' A' ' 165' ' ' LEU . 3.9 mt-30 75.92 67.84 0.07 Allowed 'General case' 0 N--CA 1.5 2.058 0 O-C-N 121.236 -0.915 . . . . 10.0 109.772 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.565 ' HG2' HG12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -102.9 102.73 12.83 Favored 'General case' 0 C--N 1.296 -1.742 0 C-N-CA 118.831 -1.147 . . . . 10.0 109.719 179.683 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.971 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 78.14 10.51 86.16 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 108.36 -1.896 . . . . 10.0 108.36 -178.686 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.241 HD11 ' CE2' ' A' ' 23' ' ' TYR 0.254 0.2 OUTLIER -54.34 -51.84 63.46 Favored 'General case' 0 C--N 1.303 -1.431 0 CA-C-O 121.995 0.902 . . . . 10.0 110.78 -179.658 . . . . . . . . 4 4 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 8.2 mttt -80.91 -10.56 59.7 Favored 'General case' 0 C--N 1.293 -1.861 0 O-C-N 121.809 -0.557 . . . . 10.0 111.101 -179.184 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.535 ' HB3' HG12 ' A' ' 155' ' ' VAL . 0.6 OUTLIER -85.31 -31.57 22.97 Favored 'General case' 0 C--N 1.301 -1.519 0 O-C-N 121.193 -0.942 . . . . 10.0 110.342 -179.368 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.971 HG23 ' O ' ' A' ' 164' ' ' GLY . 2.8 t -71.92 -25.82 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.02 -1.05 . . . . 10.0 108.219 179.001 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.556 ' O ' HG12 ' A' ' 173' ' ' ILE . 0.4 OUTLIER -76.2 -49.68 16.55 Favored 'General case' 0 C--N 1.301 -1.536 0 CA-C-N 115.595 -0.729 . . . . 10.0 111.314 -179.646 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.451 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 26.2 m-20 -63.03 -49.88 72.88 Favored 'General case' 0 N--CA 1.499 1.982 0 O-C-N 121.282 -0.886 . . . . 10.0 112.269 -178.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 24.2 mm-40 -60.89 -40.79 94.4 Favored 'General case' 0 N--CA 1.495 1.785 0 O-C-N 120.896 -1.128 . . . . 10.0 111.25 -179.007 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.841 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -60.54 -22.5 63.7 Favored 'General case' 0 C--N 1.3 -1.56 0 O-C-N 120.98 -1.075 . . . . 10.0 109.925 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.595 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.2 mm -61.13 -45.93 97.63 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.395 0 O-C-N 121.219 -0.926 . . . . 10.0 109.864 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.792 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.34 -45.85 65.32 Favored 'General case' 0 C--N 1.304 -1.395 0 O-C-N 121.255 -0.903 . . . . 10.0 110.557 -179.598 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -82.2 4.42 23.53 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.351 -0.843 . . . . 10.0 110.532 -179.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.885 ' HB1' HD12 ' A' ' 4' ' ' ILE . . . -84.47 -39.37 18.99 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.108 -0.995 . . . . 10.0 110.666 -179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.595 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -101.83 -14.76 17.15 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.279 -0.888 . . . . 10.0 110.409 -178.348 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 13.5 tm-20 . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 117.877 -1.059 . . . . 10.0 110.68 -179.626 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.317 0 N-CA-C 109.571 -1.411 . . . . 10.0 109.571 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.533 ' O ' ' N ' ' B' ' 4' ' ' GLU . 54.3 m -98.81 33.5 2.3 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 121.244 -1.151 . . . . 10.0 110.646 -179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.482 ' HD3' ' O ' ' A' ' 174' ' ' LEU . 1.3 ttmt -50.15 88.09 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.776 0 O-C-N 121.222 -0.924 . . . . 10.0 110.597 -179.373 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.533 ' N ' ' O ' ' B' ' 2' ' ' SER . 31.9 mm-40 -134.74 167.61 20.54 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.186 -0.946 . . . . 10.0 110.664 179.751 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.671 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.03 -153.75 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 108.158 -1.052 . . . . 10.0 108.158 179.112 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.671 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.3 Cg_endo -69.87 84.22 0.68 Allowed 'Trans proline' 0 C--N 1.322 -0.848 0 N-CA-C 109.463 -1.014 . . . . 10.0 109.463 -179.811 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.731 ' CG ' HG23 ' A' ' 46' ' ' ILE . 1.3 tp10 -44.43 169.14 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.553 0 CA-C-O 121.79 0.805 . . . . 10.0 111.115 -179.265 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 1.069 HD12 ' N ' ' B' ' 9' ' ' SER . 1.6 pp -91.56 -23.39 5.83 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 CA-C-O 122.566 1.174 . . . . 10.0 107.939 177.41 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 1.069 ' N ' HD12 ' B' ' 8' ' ' ILE . 43.3 m -57.24 -166.64 0.0 OUTLIER 'General case' 0 C--N 1.29 -1.999 0 CA-C-N 114.68 -1.145 . . . . 10.0 112.205 -178.089 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.637 ' HB3' ' O ' ' A' ' 45' ' ' MET . 0.2 OUTLIER -37.48 117.23 0.82 Allowed Pre-proline 0 N--CA 1.493 1.719 0 N-CA-C 114.478 1.288 . . . . 10.0 114.478 -176.434 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.541 ' HD2' HD13 ' B' ' 10' ' ' LEU . 49.7 Cg_endo -93.95 111.31 0.19 Allowed 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.488 1.459 . . . . 10.0 109.266 177.257 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.551 ' CB ' ' HA ' ' A' ' 44' ' ' VAL . 0.3 OUTLIER -86.51 -168.01 2.08 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 120.799 -1.188 . . . . 10.0 110.054 -179.778 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -45.68 147.03 0.97 Allowed 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.499 -0.75 . . . . 10.0 110.009 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.621 ' O ' HG11 ' A' ' 42' ' ' VAL . 80.2 m-85 -90.88 163.16 14.5 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.395 -0.816 . . . . 10.0 110.14 -179.851 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.658 ' HB3' ' CG ' ' A' ' 40' ' ' TYR . 2.3 mp0 -50.59 179.67 0.01 OUTLIER 'General case' 0 N--CA 1.499 2.015 0 CA-C-O 121.991 0.901 . . . . 10.0 112.322 -178.418 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.618 ' O ' ' CE1' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -81.3 -167.42 1.45 Allowed 'General case' 0 N--CA 1.495 1.798 0 CA-C-O 121.764 0.792 . . . . 10.0 112.719 -178.237 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.421 ' O ' ' HB3' ' A' ' 39' ' ' ASN . 1.3 m -85.46 152.81 22.92 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 121.688 -0.633 . . . . 10.0 109.843 179.701 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.784 HG22 ' N ' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -123.83 129.09 74.54 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.77 0 O-C-N 121.18 -0.95 . . . . 10.0 109.883 -179.963 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.558 ' O ' ' HA ' ' A' ' 37' ' ' PHE . 17.2 t60 -141.93 151.04 42.23 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 120.639 -1.288 . . . . 10.0 112.728 -179.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.69 HG11 ' CB ' ' A' ' 34' ' ' PRO . 1.7 p -120.9 154.96 24.46 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 CA-C-O 121.331 0.586 . . . . 10.0 111.181 -179.779 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.428 ' O ' ' CB ' ' B' ' 22' ' ' PHE . . . -124.31 56.64 0.68 Allowed Glycine 0 N--CA 1.492 2.371 0 N-CA-C 106.93 -2.468 . . . . 10.0 106.93 177.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.047 ' CD1' HG21 ' B' ' 25' ' ' VAL . 0.0 OUTLIER 172.06 101.43 0.01 OUTLIER 'General case' 0 N--CA 1.485 1.319 0 O-C-N 121.534 -0.98 . . . . 10.0 109.529 -177.756 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.625 ' O ' HG23 ' B' ' 25' ' ' VAL . 9.8 t0 -61.77 139.94 58.28 Favored 'General case' 0 N--CA 1.496 1.857 0 O-C-N 121.114 -0.991 . . . . 10.0 111.165 -179.554 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.455 ' HA ' ' CG2' ' A' ' 35' ' ' THR . . . 33.79 61.83 0.46 Allowed 'General case' 0 N--CA 1.497 1.888 0 O-C-N 121.558 -0.714 . . . . 10.0 111.336 179.567 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 1.047 HG21 ' CD1' ' B' ' 22' ' ' PHE . 19.4 t -113.13 -27.26 2.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.582 0 O-C-N 121.163 -0.961 . . . . 10.0 110.818 -179.909 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.677 ' HB ' HG23 ' A' ' 36' ' ' VAL . 0.6 OUTLIER -121.19 -12.25 8.7 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.234 -0.916 . . . . 10.0 111.181 -179.027 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.581 ' HA3' ' CB ' ' A' ' 26' ' ' ASN . . . -72.7 -29.91 64.76 Favored Glycine 0 N--CA 1.495 2.603 0 N-CA-C 108.239 -1.944 . . . . 10.0 108.239 -179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.566 ' HA ' ' HA ' ' A' ' 28' ' ' PHE . 13.2 mt-10 -83.44 97.63 9.08 Favored 'General case' 0 C--N 1.299 -1.595 0 CA-C-O 121.925 0.869 . . . . 10.0 109.781 179.623 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.816 ' CB ' HD21 ' A' ' 19' ' ' LEU . 0.8 OUTLIER -110.64 144.52 39.42 Favored 'General case' 0 C--N 1.282 -2.359 0 C-N-CA 120.07 -0.652 . . . . 10.0 109.404 179.743 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.668 HG22 ' CE1' ' A' ' 28' ' ' PHE . 7.2 p -148.14 -39.25 0.18 Allowed 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.203 -0.936 . . . . 10.0 110.39 -178.646 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -113.51 -154.56 11.43 Favored Glycine 0 N--CA 1.487 2.093 0 C-N-CA 120.046 -1.073 . . . . 10.0 110.773 -178.686 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . . . . . . . . . 2.2 pt -116.07 76.21 6.32 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.782 -0.834 . . . . 10.0 111.621 -178.658 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.652 ' CG ' ' CE1' ' B' ' 29' ' ' PHE . 43.9 Cg_endo -74.24 171.32 18.25 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.838 1.441 . . . . 10.0 109.199 178.571 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.541 ' OE2' ' HA ' ' B' ' 39' ' ' LEU . 6.2 tt0 -62.38 171.21 1.99 Allowed 'General case' 0 N--CA 1.492 1.64 0 O-C-N 121.133 -0.979 . . . . 10.0 111.642 -178.591 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.858 ' HG2' HG12 ' A' ' 8' ' ' VAL . 3.9 mt-30 -94.25 16.55 14.62 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.758 -0.589 . . . . 10.0 110.786 -179.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.862 ' C ' HD12 ' A' ' 70' ' ' LEU . 53.4 m0 58.85 52.99 6.05 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.431 -0.793 . . . . 10.0 111.616 179.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.614 ' O ' ' HA ' ' A' ' 71' ' ' SER . . . -177.83 -70.76 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.052 0 O-C-N 121.358 -0.839 . . . . 10.0 111.593 179.396 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.504 ' O ' HD23 ' B' ' 40' ' ' LEU . 1.2 mpt_? -46.41 -36.36 6.43 Favored 'General case' 0 N--CA 1.499 1.998 0 O-C-N 120.964 -1.085 . . . . 10.0 110.792 -179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.925 HD11 HD21 ' A' ' 70' ' ' LEU . 11.7 mt 43.03 20.35 0.02 OUTLIER 'General case' 0 C--N 1.302 -1.457 0 N-CA-C 113.025 0.75 . . . . 10.0 113.025 179.331 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.504 HD23 ' O ' ' B' ' 38' ' ' ARG . 0.7 OUTLIER -122.37 10.03 9.82 Favored 'General case' 0 N--CA 1.497 1.91 0 O-C-N 120.513 -1.367 . . . . 10.0 110.75 179.082 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.504 ' OE1' ' HA ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER 70.23 -13.27 0.45 Allowed 'General case' 0 N--CA 1.502 2.149 0 O-C-N 121.744 -0.598 . . . . 10.0 112.092 178.834 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.484 HG22 ' N ' ' B' ' 43' ' ' SER . 92.7 m -132.98 167.31 20.51 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 120.705 -1.247 . . . . 10.0 110.101 -179.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.484 ' N ' HG22 ' B' ' 42' ' ' THR . 7.5 t -88.27 41.33 1.0 Allowed 'General case' 0 N--CA 1.488 1.474 0 O-C-N 121.097 -1.002 . . . . 10.0 110.547 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.503 ' H ' HD11 ' B' ' 40' ' ' LEU . 32.8 t-20 -91.79 115.48 28.09 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.03 -1.044 . . . . 10.0 110.537 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.449 HD12 ' H ' ' B' ' 45' ' ' ILE . 3.3 mp -99.39 -36.44 5.38 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.564 0 O-C-N 121.489 -0.757 . . . . 10.0 109.867 179.82 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.413 ' C ' ' O ' ' B' ' 45' ' ' ILE . 5.3 m . . . . . 0 C--N 1.304 -1.412 0 CA-C-O 118.099 -0.953 . . . . 10.0 110.419 -179.475 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 mmt . . . . . 0 N--CA 1.493 1.72 0 CA-C-O 121.206 0.527 . . . . 10.0 110.128 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.493 ' O ' ' HB ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -143.91 -14.51 0.63 Allowed 'General case' 0 C--N 1.306 -1.313 0 O-C-N 121.224 -0.922 . . . . 10.0 110.542 -179.216 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.58 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 57.0 m -71.91 112.43 8.0 Favored 'General case' 0 N--CA 1.485 1.287 0 O-C-N 121.302 -0.874 . . . . 10.0 111.758 -178.837 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.048 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -106.26 121.63 59.01 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.523 0 C-N-CA 118.854 -1.138 . . . . 10.0 108.974 177.214 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.82 ' CB ' HG23 ' A' ' 75' ' ' THR . 2.3 mmtm -94.0 113.78 25.83 Favored 'General case' 0 C--N 1.291 -1.951 0 N-CA-C 107.791 -1.189 . . . . 10.0 107.791 178.279 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.431 ' C ' HG23 ' A' ' 7' ' ' VAL . 95.3 m -99.69 105.08 16.87 Favored 'General case' 0 C--N 1.3 -1.554 0 O-C-N 121.223 -0.923 . . . . 10.0 109.231 -179.423 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.724 HG11 ' CZ3' ' B' ' 36' ' ' TRP . 39.7 t -143.02 146.8 21.25 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 C-N-CA 118.94 -1.104 . . . . 10.0 111.084 -179.078 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.617 HG22 ' OG1' ' A' ' 17' ' ' THR . 21.8 t -59.77 141.36 16.6 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.566 0 O-C-N 121.375 -0.828 . . . . 10.0 109.961 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.592 HG21 ' HA ' ' A' ' 80' ' ' VAL . 25.7 m -72.73 -169.84 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 121.348 -0.845 . . . . 10.0 110.925 -179.717 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.4 ' HA3' ' HB3' ' B' ' 37' ' ' ALA . . . -129.67 11.06 6.03 Favored Glycine 0 N--CA 1.487 2.047 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.689 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 18.5 t0 -49.96 -46.71 52.61 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.303 -1.116 . . . . 10.0 109.15 179.428 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.401 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 134.32 -12.41 4.65 Favored Glycine 0 N--CA 1.486 2.031 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.538 ' CB ' ' O ' ' A' ' 81' ' ' CYS . . . -69.99 172.37 7.96 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 121.478 -1.013 . . . . 10.0 109.347 179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.647 ' CG1' HD11 ' A' ' 19' ' ' LEU . 2.5 p -58.63 161.15 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.499 0 O-C-N 120.995 -1.066 . . . . 10.0 109.237 179.556 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.546 ' N ' ' HG3' ' B' ' 35' ' ' GLN . . . -71.7 112.25 4.02 Favored Glycine 0 N--CA 1.488 2.142 0 N-CA-C 109.761 -1.336 . . . . 10.0 109.761 -179.729 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.921 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.1 OUTLIER -49.75 -29.3 7.41 Favored 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.035 -1.274 . . . . 10.0 108.593 179.339 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.617 ' OG1' HG22 ' A' ' 8' ' ' VAL . 94.6 m -59.84 -33.02 71.22 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.503 -0.748 . . . . 10.0 109.371 179.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.628 ' HA ' ' O ' ' B' ' 26' ' ' THR . 1.9 t -81.77 -13.86 57.19 Favored 'General case' 0 C--N 1.307 -1.245 0 C-N-CA 119.601 -0.84 . . . . 10.0 109.899 179.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.052 HD13 ' HB2' ' A' ' 159' ' ' ALA . 4.4 mt -92.58 -31.19 15.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.119 -0.988 . . . . 10.0 109.486 179.586 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.4 tp -66.13 -31.41 72.25 Favored 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 107.683 -1.228 . . . . 10.0 107.683 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.84 HG21 HG23 ' B' ' 26' ' ' THR 0.26 9.3 mm -72.19 -45.86 60.29 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.667 0 CA-C-N 115.072 -0.967 . . . . 10.0 110.33 179.145 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.41 ' C ' ' O ' ' A' ' 21' ' ' ILE . 20.1 p -48.85 -26.1 2.24 Favored 'General case' 0 C--N 1.295 -1.771 0 C-N-CA 118.905 -1.118 . . . . 10.0 108.611 -179.655 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 1.183 ' CE2' HD12 ' A' ' 165' ' ' LEU . 2.8 m-85 -86.3 -26.02 25.15 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.185 -0.947 . . . . 10.0 108.596 177.578 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.521 ' N ' ' O ' ' A' ' 21' ' ' ILE . 56.2 m -89.91 -31.15 17.42 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 121.632 -0.667 . . . . 10.0 111.651 -178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.725 ' HB ' HG11 ' A' ' 33' ' ' VAL . 1.5 p -92.29 -81.32 0.34 Allowed 'General case' 0 N--CA 1.487 1.405 0 O-C-N 120.613 -1.304 . . . . 10.0 109.687 -179.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.639 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 8.9 m-80 -148.62 -30.19 0.28 Allowed 'General case' 0 C--N 1.295 -1.783 0 C-N-CA 119.931 -0.708 . . . . 10.0 110.771 179.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.639 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 6.4 pttt 145.96 -140.51 0.0 OUTLIER 'General case' 0 N--CA 1.511 2.589 0 CA-C-O 121.146 0.498 . . . . 10.0 109.815 -179.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.887 ' CZ ' HG22 ' B' ' 30' ' ' THR . 0.1 OUTLIER -121.03 -62.2 0.03 OUTLIER Pre-proline 0 N--CA 1.496 1.841 0 N-CA-C 113.076 0.769 . . . . 10.0 113.076 -178.248 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.61 ' HD2' ' H ' ' A' ' 28' ' ' PHE . 42.6 Cg_endo -67.98 0.05 4.89 Favored 'Trans proline' 0 N--CA 1.492 1.391 0 O-C-N 122.859 0.926 . . . . 10.0 113.356 -177.452 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.534 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 3.0 t -162.26 58.75 0.23 Allowed 'General case' 0 N--CA 1.497 1.897 0 O-C-N 120.362 -1.461 . . . . 10.0 111.48 -179.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.453 ' HG2' ' O ' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -141.55 88.44 2.14 Favored 'General case' 0 C--N 1.301 -1.517 0 O-C-N 121.152 -0.967 . . . . 10.0 110.183 179.201 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.66 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 56.1 m-85 -80.07 56.81 2.5 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.098 -1.001 . . . . 10.0 109.61 179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.725 HG11 ' HB ' ' A' ' 25' ' ' THR . 10.1 m -95.98 125.31 48.97 Favored Pre-proline 0 C--N 1.305 -1.356 0 O-C-N 121.598 -0.688 . . . . 10.0 110.313 -179.463 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.483 ' C ' HG21 ' B' ' 20' ' ' VAL . 46.7 Cg_endo -71.89 94.48 0.71 Allowed 'Trans proline' 0 C--N 1.306 -1.677 0 O-C-N 123.85 1.447 . . . . 10.0 110.633 -179.736 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 1.045 ' CB ' HG21 ' B' ' 26' ' ' THR . 0.0 OUTLIER -154.58 161.59 41.54 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.034 -1.041 . . . . 10.0 111.427 -179.818 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.869 HG12 ' N ' ' A' ' 37' ' ' PHE . 1.6 t 158.28 -78.7 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.509 2.507 0 N-CA-C 108.995 -0.743 . . . . 10.0 108.995 179.22 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.869 ' N ' HG12 ' A' ' 36' ' ' VAL . 29.9 t80 -61.3 140.22 58.02 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.397 -0.814 . . . . 10.0 110.96 -179.409 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.591 ' HA ' HG13 ' B' ' 18' ' ' ILE . 35.6 t0 -164.56 85.73 0.44 Allowed 'General case' 0 C--N 1.298 -1.672 0 N-CA-C 108.408 -0.96 . . . . 10.0 108.408 179.038 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.522 ' ND2' ' O ' ' A' ' 39' ' ' ASN . 4.0 p-10 -104.96 103.46 13.03 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.785 -1.197 . . . . 10.0 111.421 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.593 ' CG ' ' HA ' ' B' ' 16' ' ' HIS . 0.2 OUTLIER -170.24 -168.4 0.72 Allowed 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.219 -0.925 . . . . 10.0 110.076 179.419 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.574 ' C ' HG23 ' A' ' 42' ' ' VAL . . . -141.04 165.22 28.15 Favored 'General case' 0 N--CA 1.493 1.689 0 O-C-N 121.045 -1.035 . . . . 10.0 110.358 -179.366 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.794 HG13 ' HA ' ' B' ' 14' ' ' PHE . 60.2 t -155.57 171.64 0.61 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.574 0 O-C-N 121.136 -0.977 . . . . 10.0 110.972 -179.921 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.789 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.4 m -140.17 146.24 38.51 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.816 -0.552 . . . . 10.0 109.855 179.092 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.696 ' CG1' HD12 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -105.34 170.64 2.03 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.419 0 O-C-N 121.007 -1.058 . . . . 10.0 109.443 179.305 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.498 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 8.4 mtt -144.0 121.71 11.88 Favored 'General case' 0 C--N 1.299 -1.595 0 O-C-N 121.447 -0.783 . . . . 10.0 109.93 179.693 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.696 HD12 ' CG1' ' A' ' 44' ' ' VAL . 1.4 mp -138.0 130.62 40.64 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.524 0 O-C-N 121.357 -0.84 . . . . 10.0 109.535 -179.81 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.423 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 46.72 23.27 1.37 Allowed Glycine 0 N--CA 1.49 2.284 0 N-CA-C 109.34 -1.504 . . . . 10.0 109.34 -179.468 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 92.61 2.34 67.57 Favored Glycine 0 N--CA 1.494 2.533 0 O-C-N 121.061 -1.258 . . . . 10.0 110.214 179.63 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.422 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 4.3 mm-40 -94.3 111.58 54.1 Favored Pre-proline 0 N--CA 1.492 1.666 0 O-C-N 121.049 -1.265 . . . . 10.0 111.163 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.428 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 45.2 Cg_endo -70.11 152.35 67.47 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 123.87 1.458 . . . . 10.0 109.906 178.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.789 ' O ' HG23 ' A' ' 43' ' ' THR . 0.4 OUTLIER -116.06 163.55 15.77 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.072 -1.017 . . . . 10.0 110.876 -179.763 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.647 ' O ' HG22 ' A' ' 4' ' ' ILE 0.256 39.0 m -124.21 112.51 17.13 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 121.78 -0.575 . . . . 10.0 109.795 -179.716 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.826 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.4 pp -146.59 179.94 7.2 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 120.9 -1.125 . . . . 10.0 111.445 -179.598 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.826 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -169.26 133.38 2.83 Favored Glycine 0 N--CA 1.492 2.412 0 N-CA-C 108.925 -1.67 . . . . 10.0 108.925 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.767 ' C ' HD13 ' A' ' 55' ' ' LEU . 1.8 tm? -124.59 123.97 41.21 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 121.062 -1.257 . . . . 10.0 110.338 -179.343 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.581 ' N ' HD22 ' A' ' 55' ' ' LEU . 58.9 m-85 -133.51 112.95 11.94 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.236 -0.915 . . . . 10.0 111.001 -179.738 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 42.1 t0 -92.24 134.78 34.56 Favored 'General case' 0 N--CA 1.493 1.72 0 O-C-N 121.057 -1.027 . . . . 10.0 109.658 179.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.77 ' O ' HG23 ' A' ' 58' ' ' THR . 12.4 t -84.22 98.24 9.84 Favored 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.3 -0.875 . . . . 10.0 111.982 -178.725 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.866 ' HB3' ' CG1' ' A' ' 36' ' ' VAL . . . 164.7 62.5 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.358 -0.839 . . . . 10.0 109.89 178.854 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.555 ' HA2' ' CG ' ' A' ' 37' ' ' PHE . . . -40.41 -30.07 0.28 Allowed Glycine 0 N--CA 1.491 2.326 0 N-CA-C 109.347 -1.501 . . . . 10.0 109.347 -179.955 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.518 ' HA ' ' HA3' ' B' ' 21' ' ' GLY . 1.9 pt20 -170.82 23.45 0.02 OUTLIER 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.29 -1.124 . . . . 10.0 111.063 179.327 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.495 ' O ' ' HB3' ' A' ' 63' ' ' ASP . 8.2 mt-10 -150.63 -93.71 0.06 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 120.881 -1.137 . . . . 10.0 110.606 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.527 ' N ' ' OD1' ' A' ' 63' ' ' ASP . 4.5 p30 169.74 47.59 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 O-C-N 120.689 -1.257 . . . . 10.0 111.073 179.867 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.582 ' O ' ' CB ' ' A' ' 65' ' ' ASP . 55.5 p90 -162.12 -44.54 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.689 0 O-C-N 120.861 -1.15 . . . . 10.0 111.237 179.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.582 ' CB ' ' O ' ' A' ' 64' ' ' TYR . 1.8 t0 77.06 113.61 0.07 Allowed 'General case' 0 N--CA 1.505 2.28 0 O-C-N 121.32 -0.863 . . . . 10.0 111.901 179.601 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.86 -21.88 12.82 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 108.505 -0.924 . . . . 10.0 108.505 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.622 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 18.1 mt -84.26 5.9 24.86 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.469 -0.769 . . . . 10.0 109.01 178.319 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.982 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.8 ptt180 -52.32 -32.48 9.13 Favored Pre-proline 0 N--CA 1.494 1.74 0 N-CA-C 113.709 1.003 . . . . 10.0 113.709 -179.235 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.624 ' HD3' ' CG ' ' A' ' 68' ' ' ARG . 53.4 Cg_endo -74.66 76.58 3.21 Favored 'Trans proline' 0 N--CA 1.489 1.239 0 CA-C-N 120.038 1.049 . . . . 10.0 110.325 179.815 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.982 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -101.0 -29.98 11.88 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 120.87 -1.144 . . . . 10.0 111.184 -179.358 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.485 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 43.9 24.61 0.08 Allowed 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.317 -0.864 . . . . 10.0 110.667 -179.633 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.416 ' H ' HD12 ' A' ' 70' ' ' LEU . 0.6 OUTLIER -164.3 98.59 0.91 Allowed Pre-proline 0 N--CA 1.497 1.92 0 O-C-N 120.915 -1.115 . . . . 10.0 111.678 -179.869 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.412 ' HB2' ' CZ ' ' A' ' 78' ' ' PHE . 48.4 Cg_endo -69.76 167.66 23.81 Favored 'Trans proline' 0 C--N 1.308 -1.578 0 O-C-N 123.925 1.487 . . . . 10.0 111.134 178.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -169.64 67.62 0.06 Allowed 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.537 -0.727 . . . . 10.0 109.499 179.703 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.82 HG23 ' CB ' ' A' ' 5' ' ' LYS . 52.6 m -145.42 97.85 3.05 Favored 'General case' 0 C--N 1.305 -1.351 0 O-C-N 121.398 -0.814 . . . . 10.0 109.493 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.496 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 64.5 m-20 -33.7 -31.44 0.01 OUTLIER 'General case' 0 N--CA 1.497 1.921 0 CA-C-O 121.169 0.509 . . . . 10.0 111.36 -179.677 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.623 ' O ' HG22 ' A' ' 75' ' ' THR . 0.4 OUTLIER -122.26 120.25 60.67 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.085 -1.01 . . . . 10.0 110.423 -179.653 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.631 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 39.3 m-85 -116.48 140.61 49.18 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.616 -0.677 . . . . 10.0 109.735 179.55 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.921 HD12 ' HD3' ' A' ' 16' ' ' LYS . 1.1 mm? -113.96 98.96 7.31 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.932 -1.105 . . . . 10.0 108.819 179.259 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.592 ' HA ' HG21 ' A' ' 9' ' ' VAL . 12.9 p -106.31 148.05 11.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.553 -0.717 . . . . 10.0 110.893 -178.645 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.568 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 41.2 t -134.59 125.15 26.63 Favored 'General case' 0 C--N 1.306 -1.321 0 O-C-N 121.318 -0.863 . . . . 10.0 110.805 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.544 ' CZ ' ' CD1' ' A' ' 90' ' ' PHE . 13.6 p90 -136.66 157.72 46.11 Favored 'General case' 0 N--CA 1.494 1.728 0 C-N-CA 119.242 -0.983 . . . . 10.0 110.345 178.807 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.424 ' OG ' HG22 ' A' ' 85' ' ' VAL . 44.0 t -83.4 137.69 33.82 Favored 'General case' 0 N--CA 1.495 1.822 0 O-C-N 121.38 -0.825 . . . . 10.0 112.133 -177.372 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.647 HG23 HG13 ' A' ' 85' ' ' VAL . 18.7 m -90.53 2.32 7.45 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.378 0 O-C-N 121.666 -0.646 . . . . 10.0 109.859 179.261 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.647 HG13 HG23 ' A' ' 84' ' ' VAL . 35.0 m -119.21 48.36 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.389 -0.819 . . . . 10.0 109.187 -179.768 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.56 ' HB2' ' HD2' ' A' ' 87' ' ' PRO . 21.1 p -133.36 176.69 2.71 Favored Pre-proline 0 C--N 1.299 -1.623 0 N-CA-C 108.867 -0.79 . . . . 10.0 108.867 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.56 ' HD2' ' HB2' ' A' ' 86' ' ' SER . 42.3 Cg_endo -70.52 158.8 54.9 Favored 'Trans proline' 0 C--N 1.309 -1.527 0 O-C-N 123.306 1.161 . . . . 10.0 110.733 -179.658 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.459 ' C ' ' O ' ' A' ' 87' ' ' PRO . 3.6 m -31.3 87.64 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.842 0 CA-C-O 121.477 0.656 . . . . 10.0 111.899 -179.245 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.544 ' N ' ' O ' ' A' ' 87' ' ' PRO . 31.0 t -117.14 -54.2 2.42 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.444 -0.785 . . . . 10.0 109.832 178.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.612 ' CE1' ' HE2' ' A' ' 94' ' ' LYS . 8.8 t80 -49.41 -38.49 29.25 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.932 -1.105 . . . . 10.0 109.303 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.428 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 34.7 tt0 -60.84 -35.4 76.45 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 121.231 -0.918 . . . . 10.0 109.719 179.222 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.649 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -69.96 -15.43 63.04 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.362 -0.836 . . . . 10.0 109.527 -179.83 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.649 HG23 ' ND2' ' A' ' 92' ' ' ASN . 62.1 t -87.76 -16.0 9.21 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 O-C-N 121.209 -0.932 . . . . 10.0 109.405 179.244 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.877 ' HE3' HD13 ' A' ' 145' ' ' LEU . 2.6 mmtt -85.8 -29.54 23.71 Favored 'General case' 0 C--N 1.3 -1.581 0 N-CA-C 108.071 -1.085 . . . . 10.0 108.071 179.384 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.543 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.7 pt-20 -94.4 5.97 50.16 Favored 'General case' 0 C--N 1.296 -1.749 0 CA-C-N 115.74 -0.664 . . . . 10.0 109.481 179.305 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.502 ' HE3' HD22 ' B' ' 40' ' ' LEU . 8.3 tmtt? -95.92 -51.83 4.31 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.135 -0.978 . . . . 10.0 112.317 -178.691 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.914 ' CH2' HD23 ' A' ' 149' ' ' LEU . 49.6 p-90 -104.06 -25.5 12.95 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.748 -1.22 . . . . 10.0 111.694 -179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.593 ' N ' ' CD ' ' A' ' 99' ' ' PRO . 48.0 t -64.87 -41.91 59.07 Favored Pre-proline 0 N--CA 1.491 1.597 0 O-C-N 120.838 -1.164 . . . . 10.0 110.478 179.568 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' CD ' ' N ' ' A' ' 98' ' ' VAL . 47.7 Cg_endo -82.65 -23.32 4.05 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.431 1.227 . . . . 10.0 110.635 -179.751 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.459 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 1.5 mm-40 -93.87 7.48 44.79 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.051 -1.031 . . . . 10.0 110.363 179.767 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.459 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 37.0 mm 59.32 103.54 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 121.297 -0.877 . . . . 10.0 111.023 179.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.768 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.6 m -44.7 -86.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.403 0 N-CA-C 108.428 -0.952 . . . . 10.0 108.428 178.878 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.768 ' N ' HG22 ' A' ' 102' ' ' THR . 21.3 m-70 -113.23 -6.38 13.61 Favored 'General case' 0 C--N 1.296 -1.753 0 O-C-N 121.497 -0.752 . . . . 10.0 109.295 177.762 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.578 ' O ' ' CB ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER 157.07 16.15 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.257 0 N-CA-C 109.4 -0.593 . . . . 10.0 109.4 -178.267 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.67 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 5.5 t 83.04 34.65 0.02 OUTLIER Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.853 -0.53 . . . . 10.0 110.026 -176.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.67 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.8 Cg_endo -80.85 -18.27 9.15 Favored 'Trans proline' 0 N--CA 1.484 0.934 0 O-C-N 123.177 1.093 . . . . 10.0 109.603 179.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.564 ' HB2' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 64.0 54.22 1.74 Allowed 'General case' 0 N--CA 1.487 1.421 0 CA-C-O 121.596 0.713 . . . . 10.0 110.558 -179.207 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.527 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 13.5 t -52.29 157.8 2.19 Favored Pre-proline 0 N--CA 1.494 1.74 0 O-C-N 121.505 -0.747 . . . . 10.0 109.552 179.331 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.527 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 42.4 Cg_endo -70.5 140.0 38.91 Favored 'Trans proline' 0 C--N 1.311 -1.422 0 O-C-N 123.294 1.154 . . . . 10.0 110.404 179.848 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.513 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -135.61 112.41 10.17 Favored 'General case' 0 N--CA 1.487 1.378 0 O-C-N 121.297 -0.877 . . . . 10.0 109.662 -179.849 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.986 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 3.0 mm? -77.08 97.63 4.77 Favored 'General case' 0 C--N 1.299 -1.614 0 O-C-N 121.106 -0.996 . . . . 10.0 109.242 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.633 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 11.2 mt -69.91 141.01 53.19 Favored 'General case' 0 C--N 1.292 -1.908 0 CA-C-N 115.999 -0.546 . . . . 10.0 109.529 179.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.926 ' CG2' HG11 ' A' ' 168' ' ' VAL . 47.0 t -140.94 168.63 16.07 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.805 -1.184 . . . . 10.0 112.509 -178.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.569 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -107.52 159.23 14.61 Favored Glycine 0 N--CA 1.492 2.428 0 N-CA-C 108.285 -1.926 . . . . 10.0 108.285 178.438 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.435 ' OG1' ' C ' ' A' ' 82' ' ' PHE . 85.5 m -115.55 120.41 39.36 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 120.822 -1.399 . . . . 10.0 111.341 -179.166 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 44.32 55.57 5.49 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.582 -0.699 . . . . 10.0 111.375 178.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -55.74 -22.26 12.29 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.786 0 O-C-N 120.966 -1.084 . . . . 10.0 108.714 179.16 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.539 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 21.3 t70 -52.0 61.92 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 122.453 1.12 . . . . 10.0 110.708 -177.147 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.723 ' N ' ' O ' ' A' ' 117' ' ' ILE . 16.0 tp 159.71 -24.19 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.269 0 CA-C-N 114.447 -1.252 . . . . 10.0 108.381 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.532 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -49.12 -42.77 40.37 Favored 'General case' 0 C--N 1.305 -1.363 0 O-C-N 121.748 -0.595 . . . . 10.0 109.6 179.024 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.421 ' N ' ' HD2' ' A' ' 120' ' ' ARG . 1.2 m-20 -53.92 -20.2 5.71 Favored 'General case' 0 N--CA 1.489 1.506 0 O-C-N 121.021 -1.049 . . . . 10.0 109.234 179.012 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.784 ' O ' HD13 ' A' ' 126' ' ' ILE . 51.8 t0 -82.53 118.0 70.37 Favored Pre-proline 0 N--CA 1.492 1.63 0 O-C-N 121.6 -0.688 . . . . 10.0 110.537 179.904 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.524 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 48.4 Cg_endo -90.58 23.0 0.69 Allowed 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 121.661 1.574 . . . . 10.0 110.214 179.668 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.1 p -101.36 -49.41 4.06 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.19 -0.944 . . . . 10.0 110.149 -179.33 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.714 HG21 HD21 ' A' ' 119' ' ' LEU . 6.1 t -78.89 -26.83 43.87 Favored 'General case' 0 C--N 1.295 -1.799 0 N-CA-C 105.201 -2.148 . . . . 10.0 105.201 176.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.815 ' HA ' HD22 ' A' ' 129' ' ' LEU 0.281 1.1 mp -56.66 -26.85 24.35 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.434 0 N-CA-C 107.221 -1.4 . . . . 10.0 107.221 176.858 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 53.2 tt0 -49.38 -35.07 17.74 Favored 'General case' 0 N--CA 1.488 1.458 0 CA-C-N 115.636 -0.711 . . . . 10.0 111.128 -179.588 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 23.1 mmmt -61.81 -38.31 87.64 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 121.188 -0.945 . . . . 10.0 110.744 -179.636 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 126' ' ' ILE . 0.0 OUTLIER -59.03 -32.9 70.15 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.147 -0.97 . . . . 10.0 110.086 -179.979 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.488 ' O ' ' NE2' ' A' ' 134' ' ' GLN . . . -56.23 -45.01 80.13 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.026 -1.046 . . . . 10.0 109.833 179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 1.5 mttp -55.94 -16.89 5.37 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.337 -0.852 . . . . 10.0 110.386 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -124.99 -18.3 5.54 Favored 'General case' 0 N--CA 1.489 1.521 0 O-C-N 120.922 -1.111 . . . . 10.0 111.223 -179.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.497 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER -165.57 110.54 0.87 Allowed 'General case' 0 C--N 1.303 -1.419 0 O-C-N 121.014 -1.054 . . . . 10.0 109.998 -179.301 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.52 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.7 OUTLIER -71.91 -24.62 61.68 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.422 -0.799 . . . . 10.0 110.511 179.645 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 18.1 mtpp -98.12 104.83 24.62 Favored Pre-proline 0 N--CA 1.489 1.517 0 O-C-N 121.426 -0.796 . . . . 10.0 110.347 -179.937 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 44.1 Cg_endo -71.54 154.47 60.11 Favored 'Trans proline' 0 C--N 1.304 -1.781 0 O-C-N 123.793 1.417 . . . . 10.0 110.379 179.641 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.554 ' CG2' ' HA ' ' A' ' 84' ' ' VAL . 3.5 tp -94.08 135.38 28.64 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.485 0 O-C-N 121.143 -0.973 . . . . 10.0 109.013 179.266 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.522 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 16.2 p -124.01 168.81 11.8 Favored Pre-proline 0 C--N 1.298 -1.649 0 O-C-N 121.325 -0.859 . . . . 10.0 109.589 -178.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.522 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -66.3 -15.27 47.57 Favored 'Trans proline' 0 C--N 1.306 -1.692 0 O-C-N 123.527 1.278 . . . . 10.0 110.65 -179.28 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 31.5 mt-10 -83.66 -37.81 22.33 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 121.187 -0.946 . . . . 10.0 110.426 179.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 36.6 m -79.33 -32.66 43.4 Favored 'General case' 0 C--N 1.298 -1.662 0 O-C-N 121.538 -0.726 . . . . 10.0 110.821 -179.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.61 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.27 -44.86 74.64 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.242 -0.911 . . . . 10.0 111.283 -179.107 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.468 ' HG3' ' N ' ' A' ' 144' ' ' LYS . 0.0 OUTLIER -64.52 -27.76 69.19 Favored 'General case' 0 C--N 1.297 -1.702 0 C-N-CA 119.27 -0.972 . . . . 10.0 109.453 -179.877 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.472 ' O ' ' HB3' ' A' ' 147' ' ' ARG . 2.0 mmtp -67.53 -43.89 79.71 Favored 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.11 -0.994 . . . . 10.0 108.639 178.51 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.877 HD13 ' HE3' ' A' ' 94' ' ' LYS . 4.3 tt -63.05 -46.22 88.53 Favored 'General case' 0 C--N 1.306 -1.305 0 N-CA-C 107.9 -1.148 . . . . 10.0 107.9 178.263 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.805 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -52.22 -43.12 64.1 Favored 'General case' 0 N--CA 1.487 1.404 0 CA-C-O 121.816 0.817 . . . . 10.0 109.179 178.549 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.472 ' HB3' ' O ' ' A' ' 144' ' ' LYS . 3.8 ttp85 -55.6 -28.74 56.89 Favored 'General case' 0 C--N 1.3 -1.575 0 CA-C-O 121.524 0.678 . . . . 10.0 109.463 179.062 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.489 ' C ' HD12 ' A' ' 149' ' ' LEU . 22.9 t70 -78.17 -43.95 27.25 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.623 -0.673 . . . . 10.0 110.776 -179.621 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.914 HD23 ' CH2' ' A' ' 97' ' ' TRP . 5.7 mp -88.06 9.83 21.2 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.203 -0.936 . . . . 10.0 108.88 179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.53 ' HB2' ' HB3' ' A' ' 107' ' ' LYS . 10.2 mttt 60.24 28.14 17.71 Favored 'General case' 0 C--N 1.3 -1.549 0 CA-C-O 121.895 0.855 . . . . 10.0 109.928 179.418 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.805 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -59.9 -151.34 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.77 0 N-CA-C 109.197 -0.668 . . . . 10.0 109.197 179.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.913 ' CG1' HD13 ' A' ' 111' ' ' LEU . 1.4 p -116.86 -64.9 1.65 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.354 0 O-C-N 120.594 -1.316 . . . . 10.0 110.747 179.446 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.603 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.8 OUTLIER -173.9 140.87 0.76 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.453 -1.404 . . . . 10.0 111.863 179.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.633 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 29.0 t80 -84.78 108.06 17.27 Favored 'General case' 0 N--CA 1.49 1.571 0 C-N-CA 119.388 -0.925 . . . . 10.0 109.889 178.27 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.957 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.6 OUTLIER -103.61 -169.32 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.498 -0.752 . . . . 10.0 110.174 -179.669 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.553 ' HG2' ' HA3' ' A' ' 164' ' ' GLY . 0.5 OUTLIER -127.74 160.29 32.17 Favored 'General case' 0 N--CA 1.489 1.52 0 O-C-N 121.166 -0.958 . . . . 10.0 110.14 179.976 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.925 ' SG ' HD23 ' A' ' 165' ' ' LEU 0.251 1.6 t -166.02 135.87 3.36 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.322 -0.861 . . . . 10.0 110.238 -178.446 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.556 ' OG ' ' CG ' ' A' ' 163' ' ' LYS . 34.2 m -131.17 83.88 2.14 Favored 'General case' 0 C--N 1.296 -1.758 0 N-CA-C 107.078 -1.453 . . . . 10.0 107.078 176.735 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 1.052 ' HB2' HD13 ' A' ' 19' ' ' LEU . . . -29.26 -53.2 0.12 Allowed 'General case' 0 C--N 1.293 -1.865 0 CA-C-N 114.691 -1.141 . . . . 10.0 113.132 -178.31 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.689 ' O ' HD12 ' A' ' 160' ' ' LEU . 1.8 tp -71.06 -53.75 13.6 Favored 'General case' 0 C--N 1.305 -1.358 0 O-C-N 120.693 -1.254 . . . . 10.0 111.257 -178.653 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.558 ' O ' ' CB ' ' A' ' 162' ' ' GLN . 12.4 p -84.74 -89.54 0.1 Allowed 'General case' 0 N--CA 1.487 1.411 0 O-C-N 120.911 -1.118 . . . . 10.0 111.169 -179.077 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.605 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 2.4 pt20 159.28 76.71 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.599 -0.688 . . . . 10.0 109.364 -179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.556 ' CG ' ' OG ' ' A' ' 158' ' ' SER . 0.1 OUTLIER -105.33 69.19 0.83 Allowed 'General case' 0 C--N 1.298 -1.662 0 C-N-CA 119.026 -1.069 . . . . 10.0 110.591 -179.783 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.584 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 76.98 0.93 71.24 Favored Glycine 0 N--CA 1.487 2.092 0 N-CA-C 108.993 -1.643 . . . . 10.0 108.993 -179.855 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.183 HD12 ' CE2' ' A' ' 23' ' ' TYR . 0.1 OUTLIER -50.12 -44.41 52.27 Favored 'General case' 0 C--N 1.302 -1.47 0 O-C-N 121.42 -1.047 . . . . 10.0 109.608 179.538 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.879 ' N ' HD13 ' A' ' 165' ' ' LEU . 14.8 tttm -70.69 -25.64 63.06 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.156 -0.965 . . . . 10.0 109.367 178.467 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.433 ' HB2' ' O ' ' A' ' 164' ' ' GLY . 19.3 m120 -75.45 -33.89 60.92 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.674 -0.641 . . . . 10.0 111.641 -179.05 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.957 HG22 ' HB ' ' A' ' 155' ' ' VAL . 10.7 t -57.96 -49.75 80.21 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 O-C-N 120.786 -1.197 . . . . 10.0 110.056 -179.395 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 7.9 t80 -60.26 -40.0 88.78 Favored 'General case' 0 C--N 1.296 -1.723 0 O-C-N 121.659 -0.651 . . . . 10.0 110.43 -179.717 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.535 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.6 t0 -60.12 -46.41 89.72 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.255 -0.903 . . . . 10.0 110.713 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 4.1 mm-40 -61.5 -42.63 99.09 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.947 -1.096 . . . . 10.0 109.909 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.986 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -56.28 -24.52 43.62 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 121.344 -0.847 . . . . 10.0 110.048 179.77 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.639 ' O ' HD11 ' A' ' 177' ' ' LEU . 77.4 mt -63.92 -47.03 92.44 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.488 0 O-C-N 121.115 -0.99 . . . . 10.0 109.595 179.776 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.802 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.07 -41.45 70.68 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.401 -0.812 . . . . 10.0 111.087 -179.535 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -80.71 -2.72 48.0 Favored 'General case' 0 C--N 1.298 -1.648 0 O-C-N 121.198 -0.938 . . . . 10.0 110.899 -179.325 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.048 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -87.67 -22.5 24.64 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.045 -1.035 . . . . 10.0 110.821 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.639 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -90.06 -22.19 21.95 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.077 -1.015 . . . . 10.0 110.138 -179.324 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 2.2 mt-10 . . . . . 0 N--CA 1.492 1.66 0 CA-C-O 117.938 -1.029 . . . . 10.0 110.025 179.95 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.258 0 N-CA-C 109.254 -1.538 . . . . 10.0 109.254 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 67.0 m -124.23 140.44 52.96 Favored 'General case' 0 N--CA 1.489 1.478 0 O-C-N 121.174 -1.192 . . . . 10.0 110.475 -179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.747 ' HE2' HD12 ' A' ' 174' ' ' LEU . 10.1 tptt -84.26 103.15 13.21 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.204 -0.935 . . . . 10.0 108.511 179.083 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 19.4 mt-10 -82.66 152.61 25.78 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.238 -0.914 . . . . 10.0 110.692 -179.196 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.632 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.76 -48.14 0.08 OUTLIER Pre-proline 0 C--N 1.302 -1.476 0 O-C-N 121.77 -0.581 . . . . 10.0 110.555 -179.286 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.632 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.2 Cg_endo -91.32 24.06 0.58 Allowed 'Trans proline' 0 C--N 1.317 -1.129 0 N-CA-C 108.977 -1.201 . . . . 10.0 108.977 179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.628 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 2.0 pm0 -39.55 166.1 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.528 0 CA-C-O 121.544 0.688 . . . . 10.0 111.659 -178.017 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -112.85 -88.49 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.492 0 O-C-N 121.381 -0.824 . . . . 10.0 111.192 179.885 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.423 ' O ' ' N ' ' A' ' 47' ' ' GLY . 86.5 p -82.37 171.19 14.47 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.041 -1.037 . . . . 10.0 111.96 -178.612 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.909 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.96 96.8 0.48 Allowed Pre-proline 0 N--CA 1.487 1.405 0 O-C-N 121.448 -0.783 . . . . 10.0 111.818 -179.981 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.49 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 46.9 Cg_endo -76.1 133.61 15.16 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.418 1.22 . . . . 10.0 109.117 178.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 56.4 p -93.16 117.95 30.66 Favored 'General case' 0 N--CA 1.491 1.613 0 O-C-N 120.958 -1.089 . . . . 10.0 111.105 -179.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 51.2 m-20 -120.09 136.45 54.58 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.523 -0.736 . . . . 10.0 109.303 179.062 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.794 ' HA ' HG13 ' A' ' 42' ' ' VAL . 11.4 p90 -139.98 166.53 24.39 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 120.939 -1.101 . . . . 10.0 110.635 -179.949 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.414 ' H ' HG22 ' A' ' 42' ' ' VAL . 2.6 tt0 -164.19 110.88 1.07 Allowed 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.087 -1.008 . . . . 10.0 110.78 -179.313 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.593 ' HA ' ' CG ' ' A' ' 40' ' ' TYR . 1.1 p80 -165.76 137.54 3.94 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.174 -0.954 . . . . 10.0 110.17 179.374 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.508 ' C ' ' CG2' ' B' ' 18' ' ' ILE . 0.0 OUTLIER -150.59 98.48 2.64 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.167 -0.958 . . . . 10.0 110.636 -179.908 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.729 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.1 OUTLIER -155.55 -170.98 0.08 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 178.853 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.496 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 18.4 p-80 -141.81 153.75 44.73 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 117.6 -1.64 . . . . 10.0 112.605 179.134 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.985 HG21 ' CA ' ' A' ' 35' ' ' THR . 3.5 m -103.39 152.34 6.11 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 CA-C-N 115.639 -0.709 . . . . 10.0 110.461 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.518 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -124.09 73.77 0.4 Allowed Glycine 0 N--CA 1.494 2.537 0 C-N-CA 119.742 -1.218 . . . . 10.0 110.313 -179.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.858 ' CD2' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 167.4 97.54 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.385 -1.067 . . . . 10.0 109.189 179.469 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.777 ' O ' HG23 ' B' ' 25' ' ' VAL . 21.1 m-20 -61.33 154.48 23.81 Favored 'General case' 0 N--CA 1.495 1.779 0 O-C-N 121.438 -0.789 . . . . 10.0 111.815 -178.938 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.66 ' HB2' ' HA ' ' A' ' 32' ' ' TYR . . . 39.76 38.11 0.41 Allowed 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.679 -0.638 . . . . 10.0 111.065 179.337 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.858 HG21 ' CD2' ' B' ' 22' ' ' PHE . 37.1 t -111.39 -23.25 4.53 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.726 0 O-C-N 120.894 -1.129 . . . . 10.0 108.821 179.334 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 1.045 HG21 ' CB ' ' A' ' 35' ' ' THR . 10.0 t -88.97 -10.61 47.04 Favored 'General case' 0 C--N 1.298 -1.651 0 CA-C-O 121.36 0.6 . . . . 10.0 110.167 179.599 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.53 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.63 -0.37 9.26 Favored Glycine 0 N--CA 1.488 2.151 0 N-CA-C 109.517 -1.433 . . . . 10.0 109.517 -179.742 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.58 ' O ' ' HG3' ' B' ' 28' ' ' GLU . 6.8 pt-20 -104.51 122.11 44.86 Favored 'General case' 0 C--N 1.304 -1.413 0 O-C-N 120.969 -1.312 . . . . 10.0 110.733 -179.527 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.587 ' CD1' ' O ' ' B' ' 29' ' ' PHE . 0.3 OUTLIER -121.59 118.61 29.66 Favored 'General case' 0 C--N 1.287 -2.111 0 N-CA-C 108.736 -0.839 . . . . 10.0 108.736 178.715 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.887 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 23.0 p -122.19 -4.99 8.93 Favored 'General case' 0 C--N 1.29 -1.995 0 C-N-CA 119.986 -0.685 . . . . 10.0 109.589 -179.67 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 117.89 39.09 0.78 Allowed Glycine 0 N--CA 1.489 2.212 0 N-CA-C 109.167 -1.573 . . . . 10.0 109.167 -179.661 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.532 HG23 ' HD2' ' B' ' 33' ' ' PRO . 28.4 mm -69.0 142.15 92.94 Favored Pre-proline 0 N--CA 1.491 1.618 0 O-C-N 121.329 -1.1 . . . . 10.0 110.435 -179.782 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.532 ' HD2' HG23 ' B' ' 32' ' ' ILE . 45.0 Cg_endo -68.9 177.61 4.82 Favored 'Trans proline' 0 C--N 1.304 -1.814 0 O-C-N 124.293 1.681 . . . . 10.0 111.136 179.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.621 ' HG3' ' O ' ' B' ' 37' ' ' ALA . 5.4 tm-20 -23.09 138.15 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.142 0 CA-C-O 121.437 0.637 . . . . 10.0 112.525 -179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.546 ' HG3' ' N ' ' A' ' 15' ' ' GLY . 7.6 mm100 -100.81 -71.72 0.7 Allowed 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 113.67 0.989 . . . . 10.0 113.67 -178.803 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.724 ' CZ3' HG11 ' A' ' 7' ' ' VAL . 16.5 t90 -108.69 30.36 6.57 Favored 'General case' 0 N--CA 1.502 2.139 0 O-C-N 121.357 -0.839 . . . . 10.0 112.611 -176.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.904 ' HB1' HD12 ' B' ' 39' ' ' LEU . . . -178.18 89.3 0.02 OUTLIER 'General case' 0 C--N 1.285 -2.219 0 C-N-CA 118.986 -1.086 . . . . 10.0 111.383 179.858 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.505 ' HA ' ' HG3' ' B' ' 34' ' ' GLU . 5.3 ttp180 -82.87 43.3 0.84 Allowed 'General case' 0 N--CA 1.488 1.459 0 N-CA-C 107.839 -1.171 . . . . 10.0 107.839 177.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.904 HD12 ' HB1' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -50.75 -49.88 56.93 Favored 'General case' 0 C--N 1.3 -1.546 0 CA-C-N 115.637 -0.711 . . . . 10.0 110.892 -178.541 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.502 HD22 ' HE3' ' A' ' 96' ' ' LYS . 0.4 OUTLIER -107.68 13.29 26.71 Favored 'General case' 0 N--CA 1.494 1.766 0 O-C-N 121.197 -0.939 . . . . 10.0 110.284 -179.837 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.457 ' CB ' ' HG2' ' B' ' 38' ' ' ARG . 2.6 mt-30 -120.89 10.72 10.93 Favored 'General case' 0 C--N 1.292 -1.928 0 O-C-N 121.805 -0.559 . . . . 10.0 110.134 179.748 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.763 HG23 ' H ' ' B' ' 44' ' ' ASN . 14.5 t -83.36 173.86 11.19 Favored 'General case' 0 C--N 1.306 -1.302 0 O-C-N 121.134 -0.979 . . . . 10.0 109.503 179.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -80.76 18.39 0.99 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.181 -0.949 . . . . 10.0 111.139 -179.294 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.763 ' H ' HG23 ' B' ' 42' ' ' THR . 5.4 m120 -129.2 137.76 51.32 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.898 -1.126 . . . . 10.0 110.689 179.894 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -60.59 -39.98 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.462 0 O-C-N 121.363 -0.836 . . . . 10.0 111.271 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 2.8 m . . . . . 0 C--N 1.302 -1.493 0 CA-C-O 118.039 -0.982 . . . . 10.0 110.33 -178.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.542 ' HA ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.494 1.745 0 CA-C-O 121.283 0.563 . . . . 10.0 109.703 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.579 ' NE2' ' N ' ' A' ' 2' ' ' GLN . 0.0 OUTLIER -177.9 -160.74 0.05 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.341 -0.85 . . . . 10.0 110.749 -178.859 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.602 HG22 ' O ' ' A' ' 3' ' ' THR . 85.0 m 41.25 58.29 2.64 Favored 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.36 -0.837 . . . . 10.0 111.019 178.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.706 HG23 ' O ' ' A' ' 52' ' ' THR . 0.3 OUTLIER -143.16 150.52 17.63 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.858 0 C-N-CA 117.28 -1.768 . . . . 10.0 113.804 -179.574 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.629 ' N ' HG13 ' A' ' 4' ' ' ILE . 27.9 mtmt -131.32 126.1 34.45 Favored 'General case' 0 N--CA 1.487 1.382 0 O-C-N 121.279 -0.888 . . . . 10.0 109.601 178.447 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.465 ' C ' HG23 ' A' ' 7' ' ' VAL . 10.0 t -85.36 129.98 34.69 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.133 -0.979 . . . . 10.0 109.336 179.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.465 HG23 ' C ' ' A' ' 6' ' ' CYS . 4.1 t -146.97 175.97 1.55 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 120.919 -1.113 . . . . 10.0 110.421 -179.13 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.536 HG21 HG21 ' A' ' 17' ' ' THR . 0.0 OUTLIER -108.93 146.69 14.23 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.956 0 O-C-N 120.537 -1.352 . . . . 10.0 111.178 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.753 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.27 -168.7 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.332 0 O-C-N 121.211 -0.93 . . . . 10.0 110.389 179.513 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.753 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 114.02 134.9 5.96 Favored Glycine 0 C--N 1.29 -1.994 0 N-CA-C 109.251 -1.54 . . . . 10.0 109.251 179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -60.24 -14.8 19.72 Favored 'General case' 0 C--N 1.299 -1.589 0 O-C-N 121.507 -0.996 . . . . 10.0 110.054 179.814 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 163.49 -108.17 0.33 Allowed Glycine 0 N--CA 1.495 2.616 0 N-CA-C 108.941 -1.664 . . . . 10.0 108.941 -179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 69.54 -130.3 0.08 Allowed 'General case' 0 N--CA 1.499 2.0 0 O-C-N 121.03 -1.277 . . . . 10.0 110.933 179.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.556 ' C ' ' HG3' ' B' ' 35' ' ' GLN . 17.8 m -110.4 148.96 13.52 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.972 0 O-C-N 120.803 -1.186 . . . . 10.0 110.618 -179.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.705 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -51.58 137.95 29.73 Favored Glycine 0 N--CA 1.49 2.26 0 N-CA-C 108.445 -1.862 . . . . 10.0 108.445 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.503 ' HB2' ' CG1' ' A' ' 8' ' ' VAL . 0.1 OUTLIER -103.6 -28.27 11.82 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.671 -1.488 . . . . 10.0 110.72 -179.632 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.536 HG21 HG21 ' A' ' 8' ' ' VAL . 77.1 p -88.88 -37.44 15.31 Favored 'General case' 0 N--CA 1.487 1.424 0 O-C-N 121.492 -0.755 . . . . 10.0 110.336 -180.0 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.553 ' SG ' HD22 ' A' ' 19' ' ' LEU . 21.8 p -85.35 -13.46 49.47 Favored 'General case' 0 C--N 1.307 -1.278 0 O-C-N 120.925 -1.109 . . . . 10.0 109.745 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.822 HD11 ' CG ' ' B' ' 29' ' ' PHE . 4.4 mm? -81.9 -42.89 18.89 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 120.36 -1.463 . . . . 10.0 109.048 177.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.548 ' HA ' HD21 ' A' ' 165' ' ' LEU . 5.6 tt -46.85 -37.74 9.23 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 107.632 -1.248 . . . . 10.0 107.632 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.868 HG21 HG23 ' B' ' 26' ' ' THR 0.256 5.6 mm -67.86 -46.99 81.13 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.791 0 CA-C-N 115.16 -0.927 . . . . 10.0 109.779 178.264 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . . . . . . . . . 47.5 p -48.3 -31.52 6.11 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.596 -0.842 . . . . 10.0 109.843 -179.279 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.699 ' CD2' HD11 ' A' ' 165' ' ' LEU . 3.4 m-85 -93.77 -18.86 21.61 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.785 -1.197 . . . . 10.0 109.399 178.351 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.477 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 93.5 m -94.4 -22.5 18.26 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.257 -0.902 . . . . 10.0 112.604 -177.61 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.657 HG22 ' O ' ' A' ' 21' ' ' ILE . 0.1 OUTLIER -109.16 -77.84 0.59 Allowed 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.033 -1.667 . . . . 10.0 110.891 -179.555 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.628 ' O ' ' HB3' ' A' ' 27' ' ' LYS . 80.4 m-20 -152.19 -23.68 0.18 Allowed 'General case' 0 N--CA 1.492 1.626 0 C-N-CA 118.144 -1.423 . . . . 10.0 113.025 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.628 ' HB3' ' O ' ' A' ' 26' ' ' ASN . 49.5 pttt 167.68 -158.7 0.01 OUTLIER 'General case' 0 N--CA 1.513 2.709 0 O-C-N 120.855 -1.153 . . . . 10.0 112.481 179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.618 ' O ' ' HA ' ' B' ' 28' ' ' GLU . 2.7 p90 -120.5 -15.74 0.08 OUTLIER Pre-proline 0 N--CA 1.498 1.943 0 N-CA-C 115.055 1.502 . . . . 10.0 115.055 -178.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.592 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 42.6 Cg_endo -70.31 -63.68 0.04 OUTLIER 'Trans proline' 0 N--CA 1.497 1.731 0 CA-C-N 120.041 1.05 . . . . 10.0 113.335 -178.697 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 26.8 m -165.5 73.48 0.19 Allowed 'General case' 0 N--CA 1.502 2.14 0 O-C-N 120.567 -1.333 . . . . 10.0 109.701 -179.603 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.572 ' OE1' ' N ' ' A' ' 26' ' ' ASN . 2.5 pt-20 -108.65 164.71 12.12 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.953 0.882 . . . . 10.0 110.927 -179.336 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 6.6 t80 -82.06 99.16 9.01 Favored 'General case' 0 N--CA 1.499 2.009 0 CA-C-O 122.025 0.917 . . . . 10.0 109.03 179.244 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.878 ' CG2' HG22 ' B' ' 26' ' ' THR 0.286 6.6 m -112.5 169.99 5.76 Favored Pre-proline 0 C--N 1.294 -1.808 0 CA-C-N 115.803 -0.635 . . . . 10.0 110.935 -177.44 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.537 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 42.0 Cg_endo -63.48 -150.4 0.02 OUTLIER 'Trans proline' 0 C--N 1.311 -1.431 0 O-C-N 124.097 1.577 . . . . 10.0 109.25 179.033 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.429 ' HB ' HG12 ' B' ' 20' ' ' VAL . 34.6 p -109.14 134.01 52.26 Favored 'General case' 0 N--CA 1.499 2.004 0 O-C-N 120.312 -1.492 . . . . 10.0 113.358 -178.089 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.643 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 44.3 t -57.07 -74.81 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.005 0 O-C-N 121.777 -0.577 . . . . 10.0 109.752 178.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.68 ' CE2' ' HB ' ' B' ' 18' ' ' ILE . 19.8 t80 -45.05 123.43 3.88 Favored 'General case' 0 N--CA 1.491 1.613 0 N-CA-C 108.252 -1.018 . . . . 10.0 108.252 179.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.712 ' HA ' HD11 ' B' ' 18' ' ' ILE . 12.1 t0 -149.73 86.59 1.46 Allowed 'General case' 0 C--N 1.297 -1.709 0 C-N-CA 118.381 -1.328 . . . . 10.0 111.479 -178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.477 ' O ' ' CB ' ' B' ' 16' ' ' HIS . 19.1 t-20 -97.82 99.98 11.33 Favored 'General case' 0 C--N 1.305 -1.347 0 N-CA-C 107.721 -1.215 . . . . 10.0 107.721 178.052 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.556 ' HA ' ' HB2' ' B' ' 16' ' ' HIS . 2.3 m-85 -122.69 121.44 36.38 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.642 -0.661 . . . . 10.0 109.63 -179.045 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.441 ' O ' ' O ' ' B' ' 14' ' ' PHE . . . -112.48 116.12 29.76 Favored 'General case' 0 C--N 1.301 -1.52 0 O-C-N 121.14 -0.975 . . . . 10.0 110.253 -179.925 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.533 HG12 ' N ' ' A' ' 43' ' ' THR . 40.1 t -132.86 173.98 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.902 0 O-C-N 120.897 -1.127 . . . . 10.0 110.244 179.617 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.553 HG23 ' O ' ' A' ' 51' ' ' TYR . 67.6 m -155.03 151.27 28.23 Favored 'General case' 0 N--CA 1.498 1.955 0 C-N-CA 119.767 -0.773 . . . . 10.0 110.216 179.453 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.511 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.1 OUTLIER -144.83 128.67 12.34 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.498 0 C-N-CA 119.491 -0.883 . . . . 10.0 111.357 -179.911 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.571 ' O ' ' CB ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -86.8 97.57 10.7 Favored 'General case' 0 C--N 1.301 -1.535 0 C-N-CA 119.336 -0.946 . . . . 10.0 109.417 178.628 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.572 HD13 ' CE1' ' A' ' 51' ' ' TYR . 2.9 mp -78.96 114.92 20.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.42 0 O-C-N 121.073 -1.017 . . . . 10.0 108.27 179.659 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.677 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 55.69 19.76 21.84 Favored Glycine 0 N--CA 1.481 1.641 0 C-N-CA 118.654 -1.736 . . . . 10.0 109.189 -179.097 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.413 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 109.93 -8.13 31.5 Favored Glycine 0 N--CA 1.492 2.402 0 O-C-N 121.349 -1.089 . . . . 10.0 110.645 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.543 ' C ' ' HA ' ' A' ' 45' ' ' MET . 30.1 mm-40 -96.43 105.33 21.89 Favored Pre-proline 0 N--CA 1.491 1.623 0 O-C-N 121.024 -1.28 . . . . 10.0 110.332 179.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 44.3 Cg_endo -71.19 130.71 18.0 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.495 1.463 . . . . 10.0 110.387 -179.685 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.572 ' CE1' HD13 ' A' ' 46' ' ' ILE . 3.8 m-30 -98.18 118.31 34.53 Favored 'General case' 0 N--CA 1.486 1.371 0 O-C-N 120.838 -1.163 . . . . 10.0 111.616 -179.58 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.706 ' O ' HG23 ' A' ' 4' ' ' ILE . 1.7 p -92.28 99.23 12.05 Favored 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.077 -1.014 . . . . 10.0 108.568 178.897 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.9 mt -119.03 147.33 44.23 Favored 'General case' 0 N--CA 1.499 2.002 0 O-C-N 121.039 -1.038 . . . . 10.0 110.94 -179.401 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 5' ' ' LYS . . . -129.62 109.52 0.96 Allowed Glycine 0 N--CA 1.493 2.475 0 N-CA-C 109.04 -1.624 . . . . 10.0 109.04 179.278 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.807 ' C ' HD13 ' A' ' 55' ' ' LEU . 0.9 OUTLIER -98.28 127.45 44.22 Favored 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.152 -1.204 . . . . 10.0 110.543 -179.76 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.745 ' N ' HD22 ' A' ' 55' ' ' LEU . 11.5 t80 -137.92 122.12 18.07 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.186 -0.947 . . . . 10.0 111.283 -179.881 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.521 ' OD1' ' N ' ' A' ' 57' ' ' ASP . 0.9 OUTLIER -107.8 164.73 12.0 Favored 'General case' 0 N--CA 1.5 2.067 0 O-C-N 120.902 -1.124 . . . . 10.0 109.719 178.891 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.549 ' OG1' ' CG ' ' B' ' 36' ' ' TRP . 99.6 m -47.44 164.63 0.04 OUTLIER 'General case' 0 N--CA 1.498 1.938 0 O-C-N 120.798 -1.189 . . . . 10.0 111.001 -179.702 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.542 ' O ' ' CG ' ' A' ' 62' ' ' GLU . . . -104.74 91.68 3.95 Favored 'General case' 0 N--CA 1.49 1.565 0 O-C-N 121.73 -0.606 . . . . 10.0 109.961 179.794 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.574 ' HA3' HG23 ' B' ' 20' ' ' VAL . . . -48.01 -41.47 21.76 Favored Glycine 0 N--CA 1.492 2.38 0 N-CA-C 106.843 -2.503 . . . . 10.0 106.843 178.134 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.482 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 20.3 pt20 -71.87 -31.93 66.96 Favored 'General case' 0 N--CA 1.485 1.282 0 N-CA-C 108.143 -1.058 . . . . 10.0 108.143 177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.542 ' CG ' ' O ' ' A' ' 59' ' ' ALA . 5.6 mt-10 56.42 81.83 0.12 Allowed 'General case' 0 N--CA 1.49 1.557 0 CA-C-O 121.813 0.816 . . . . 10.0 111.681 178.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.537 ' C ' ' CG ' ' A' ' 64' ' ' TYR . 97.9 m-20 -126.38 3.92 6.98 Favored 'General case' 0 C--N 1.292 -1.92 0 CA-C-O 121.32 0.581 . . . . 10.0 109.513 178.457 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.646 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 0.0 OUTLIER 171.46 28.63 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.889 0 O-C-N 121.407 -0.808 . . . . 10.0 110.911 -178.915 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.486 ' O ' ' CD ' ' A' ' 69' ' ' PRO . 5.4 p-10 -113.83 15.61 18.59 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.828 -1.17 . . . . 10.0 110.808 -179.396 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.592 ' O ' HD11 ' A' ' 70' ' ' LEU . 11.7 ptt-85 -77.83 -33.99 52.09 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.091 -1.006 . . . . 10.0 110.136 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.551 ' CA ' HD21 ' A' ' 70' ' ' LEU . 4.9 mt -111.41 5.27 19.55 Favored 'General case' 0 N--CA 1.496 1.865 0 O-C-N 120.909 -1.12 . . . . 10.0 111.726 179.874 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.521 ' H ' ' HD2' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -97.07 -54.34 0.21 Allowed Pre-proline 0 N--CA 1.5 2.044 0 O-C-N 120.474 -1.391 . . . . 10.0 113.296 -178.538 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.749 ' HG2' HD13 ' A' ' 70' ' ' LEU . 42.8 Cg_endo -71.46 -62.6 0.04 OUTLIER 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.233 1.123 . . . . 10.0 111.335 -178.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.957 ' N ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -50.62 -96.31 0.0 OUTLIER 'General case' 0 C--N 1.299 -1.598 0 O-C-N 121.383 -0.823 . . . . 10.0 111.855 -179.967 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.627 ' O ' ' CD2' ' A' ' 72' ' ' TYR . 17.4 p -31.37 -36.16 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.416 0.626 . . . . 10.0 110.371 -179.411 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.66 ' CD1' ' CZ ' ' A' ' 78' ' ' PHE . 3.5 p90 48.13 138.62 0.0 OUTLIER Pre-proline 0 N--CA 1.505 2.3 0 N-CA-C 113.383 0.883 . . . . 10.0 113.383 179.298 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 49.4 Cg_endo -73.97 167.28 27.6 Favored 'Trans proline' 0 N--CA 1.494 1.503 0 C-N-CA 121.65 1.567 . . . . 10.0 111.205 -179.302 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 2.9 mt-30 -83.39 32.22 0.45 Allowed 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.19 -0.944 . . . . 10.0 110.588 179.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.547 ' O ' ' CB ' ' A' ' 76' ' ' ASP . 27.7 m -144.03 90.79 2.15 Favored 'General case' 0 N--CA 1.486 1.371 0 N-CA-C 107.856 -1.164 . . . . 10.0 107.856 178.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.599 ' N ' ' OD1' ' A' ' 76' ' ' ASP . 4.6 p-10 160.78 118.69 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.567 0 N-CA-C 109.015 -0.735 . . . . 10.0 109.015 -178.466 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.972 HG11 ' HA ' ' A' ' 176' ' ' ALA . 16.0 m -64.47 157.05 5.11 Favored 'Isoleucine or valine' 0 C--N 1.29 -2.001 0 N-CA-C 105.944 -1.872 . . . . 10.0 105.944 178.783 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.66 ' CZ ' ' CD1' ' A' ' 72' ' ' TYR . 43.9 m-85 -121.86 155.63 35.0 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 120.085 -1.634 . . . . 10.0 114.451 -174.764 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.777 HD11 HG12 ' A' ' 168' ' ' VAL . 2.3 mm? -118.71 97.68 5.85 Favored 'General case' 0 N--CA 1.49 1.533 0 N-CA-C 108.556 -0.905 . . . . 10.0 108.556 177.301 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.496 HG23 ' HA2' ' A' ' 10' ' ' GLY . 14.3 p -110.03 154.97 11.4 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.67 0 O-C-N 121.119 -0.988 . . . . 10.0 109.708 -179.579 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.519 ' CB ' ' OG1' ' A' ' 115' ' ' THR . 4.7 m -123.3 109.33 13.8 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 120.946 -1.096 . . . . 10.0 111.663 -178.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.408 ' CE1' HG21 ' A' ' 93' ' ' VAL . 93.8 m-85 -87.89 168.7 12.67 Favored 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.333 -0.854 . . . . 10.0 109.918 178.642 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 59.2 m -75.91 157.59 33.04 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 120.988 -1.07 . . . . 10.0 108.417 178.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.784 HG13 HG22 ' A' ' 85' ' ' VAL . 3.5 p -81.91 -23.1 9.76 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.745 -1.222 . . . . 10.0 111.09 -178.079 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.939 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -129.86 -88.33 0.09 OUTLIER 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 O-C-N 120.847 -1.158 . . . . 10.0 108.808 178.251 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.603 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 44.52 -171.72 0.0 OUTLIER Pre-proline 0 N--CA 1.492 1.673 0 O-C-N 121.497 -0.752 . . . . 10.0 109.675 178.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.603 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 53.3 Cg_endo -73.34 162.84 39.36 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.421 1.222 . . . . 10.0 109.933 179.475 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 16.2 m -63.03 78.4 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.536 0 O-C-N 120.913 -1.117 . . . . 10.0 109.491 179.875 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.543 ' HA ' ' OD1' ' A' ' 92' ' ' ASN . 29.1 t -106.36 -45.83 4.18 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.344 -0.848 . . . . 10.0 110.791 -178.743 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.848 ' HE1' HD22 ' A' ' 112' ' ' LEU . 62.5 t80 -49.14 -19.4 0.44 Allowed 'General case' 0 N--CA 1.489 1.477 0 O-C-N 121.156 -0.965 . . . . 10.0 110.193 179.413 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.401 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 7.3 mm-40 -78.79 -19.75 51.45 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.333 -0.855 . . . . 10.0 111.634 -179.378 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.75 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.6 OUTLIER -93.68 -14.6 26.19 Favored 'General case' 0 C--N 1.302 -1.458 0 O-C-N 120.388 -1.445 . . . . 10.0 109.38 179.621 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.75 HG13 ' ND2' ' A' ' 92' ' ' ASN . 31.5 m -85.58 -30.87 6.53 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.529 0 C-N-CA 119.215 -0.994 . . . . 10.0 108.435 179.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.892 ' CE ' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -74.16 -25.68 59.86 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.118 -0.989 . . . . 10.0 109.801 178.47 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.58 ' HA ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -96.23 3.21 53.28 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.164 -0.96 . . . . 10.0 111.109 -179.9 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -102.26 -50.33 3.65 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.571 -1.331 . . . . 10.0 111.06 -179.808 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 27.2 m95 -88.64 -40.22 13.48 Favored 'General case' 0 C--N 1.296 -1.751 0 O-C-N 120.92 -1.112 . . . . 10.0 113.251 -178.148 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.685 HG11 ' HG ' ' A' ' 149' ' ' LEU . 55.9 t -70.78 -51.62 11.35 Favored Pre-proline 0 N--CA 1.493 1.692 0 O-C-N 120.33 -1.481 . . . . 10.0 112.806 -177.721 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.58 ' HG3' ' HA ' ' A' ' 95' ' ' GLU . 40.1 Cg_endo -64.71 -21.1 65.34 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 123.311 1.164 . . . . 10.0 109.365 -179.311 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.783 ' HG2' HG22 ' A' ' 101' ' ' ILE . 64.6 tt0 -51.39 -57.0 10.12 Favored 'General case' 0 N--CA 1.485 1.282 0 O-C-N 121.127 -0.983 . . . . 10.0 109.999 179.203 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.783 HG22 ' HG2' ' A' ' 100' ' ' GLU . 0.0 OUTLIER 149.67 119.82 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.514 2.766 0 N-CA-C 109.743 -0.465 . . . . 10.0 109.743 179.788 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.454 ' OG1' ' N ' ' A' ' 108' ' ' THR . 25.3 m -92.36 -83.97 0.29 Allowed 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.712 -1.218 . . . . 10.0 107.712 178.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.51 ' O ' ' HB3' ' A' ' 104' ' ' HIS . 36.7 m-70 -107.73 -11.47 15.41 Favored 'General case' 0 C--N 1.29 -2.002 0 N-CA-C 107.805 -1.183 . . . . 10.0 107.805 176.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.51 ' HB3' ' O ' ' A' ' 103' ' ' HIS . 4.5 p80 173.11 -30.92 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.313 0 N-CA-C 107.565 -1.272 . . . . 10.0 107.565 179.797 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.432 ' HB3' ' HD2' ' A' ' 106' ' ' PRO . 96.9 m -130.98 164.98 38.38 Favored Pre-proline 0 C--N 1.304 -1.373 0 N-CA-C 109.005 -0.739 . . . . 10.0 109.005 178.818 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.614 ' HB2' HG12 ' A' ' 98' ' ' VAL . 38.8 Cg_endo -67.88 92.04 0.37 Allowed 'Trans proline' 0 C--N 1.299 -2.072 0 O-C-N 123.608 1.32 . . . . 10.0 110.98 -179.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.551 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 1.6 tttt -139.31 9.45 2.49 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.441 -0.787 . . . . 10.0 109.982 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.454 ' N ' ' OG1' ' A' ' 102' ' ' THR . 23.6 m -46.21 139.95 5.47 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.679 -1.263 . . . . 10.0 109.843 -179.539 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.891 ' CG ' HG12 ' A' ' 77' ' ' VAL . 51.2 Cg_endo -70.76 117.65 5.26 Favored 'Trans proline' 0 C--N 1.301 -1.927 0 O-C-N 124.003 1.528 . . . . 10.0 108.352 179.147 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.439 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 0.1 OUTLIER -126.59 110.23 12.99 Favored 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.289 -0.882 . . . . 10.0 111.711 -177.954 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.033 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.2 mm? -85.6 98.08 10.45 Favored 'General case' 0 C--N 1.297 -1.715 0 N-CA-C 107.526 -1.287 . . . . 10.0 107.526 177.481 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.848 HD22 ' HE1' ' A' ' 90' ' ' PHE . 70.1 mt -84.13 127.87 34.2 Favored 'General case' 0 C--N 1.298 -1.664 0 CA-C-N 115.86 -0.609 . . . . 10.0 111.042 -177.894 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.814 HG11 ' HB3' ' A' ' 157' ' ' CYS . 19.2 t -133.5 165.86 30.86 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.681 0 O-C-N 121.33 -0.857 . . . . 10.0 110.131 179.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.474 ' N ' HG12 ' A' ' 113' ' ' VAL . . . -116.28 112.25 2.55 Favored Glycine 0 N--CA 1.49 2.276 0 N-CA-C 109.248 -1.541 . . . . 10.0 109.248 178.996 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.519 ' OG1' ' CB ' ' A' ' 81' ' ' CYS . 0.2 OUTLIER -92.89 160.86 14.72 Favored 'General case' 0 N--CA 1.497 1.899 0 O-C-N 121.375 -1.073 . . . . 10.0 111.358 -179.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 3.7 tt0 59.93 43.72 14.45 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.497 -0.752 . . . . 10.0 110.481 178.416 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.004 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -74.32 -18.97 17.02 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.724 0 N-CA-C 108.48 -0.933 . . . . 10.0 108.48 179.054 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.661 ' N ' HD12 ' A' ' 117' ' ' ILE . 13.2 m-20 -53.46 61.58 0.0 OUTLIER 'General case' 0 N--CA 1.507 2.38 0 CA-C-O 122.7 1.238 . . . . 10.0 110.499 -177.439 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.739 HD12 ' N ' ' A' ' 120' ' ' ARG . 1.8 pp 166.44 -27.68 0.0 OUTLIER 'General case' 0 C--N 1.276 -2.588 0 CA-C-N 114.138 -1.392 . . . . 10.0 107.596 -178.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.739 ' N ' HD12 ' A' ' 119' ' ' LEU . 1.0 OUTLIER -46.12 -41.75 12.81 Favored 'General case' 0 C--N 1.301 -1.517 0 CA-C-O 121.726 0.774 . . . . 10.0 109.07 178.156 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 88.8 m-20 -59.88 -23.31 63.33 Favored 'General case' 0 C--N 1.303 -1.446 0 CA-C-O 121.549 0.69 . . . . 10.0 110.473 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.485 ' O ' HD13 ' A' ' 126' ' ' ILE . 27.0 t70 -93.04 119.63 67.56 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 121.388 -0.82 . . . . 10.0 111.607 -178.616 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 57.6 Cg_endo -90.92 21.83 0.79 Allowed 'Trans proline' 0 C--N 1.31 -1.494 0 O-C-N 124.277 1.672 . . . . 10.0 109.063 179.043 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.475 ' HB3' ' OD2' ' A' ' 122' ' ' ASP . 32.2 t -107.19 -45.0 4.22 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.239 -0.913 . . . . 10.0 110.169 -178.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 7.1 t -71.63 -30.26 65.57 Favored 'General case' 0 N--CA 1.493 1.715 0 N-CA-C 104.944 -2.243 . . . . 10.0 104.944 176.271 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.8 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.315 0.9 OUTLIER -50.87 -26.16 3.99 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.873 0 CA-C-N 114.188 -1.369 . . . . 10.0 108.315 177.18 . . . . . . . . 4 4 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 5.9 tt0 -54.8 -40.45 69.5 Favored 'General case' 0 N--CA 1.492 1.643 0 CA-C-O 121.509 0.671 . . . . 10.0 111.034 -179.491 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.48 ' O ' ' HB2' ' A' ' 131' ' ' LYS . 0.0 OUTLIER -81.86 -36.03 28.68 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.462 -0.773 . . . . 10.0 109.904 179.982 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.8 HD12 ' HA ' ' A' ' 126' ' ' ILE . 8.5 mt -59.41 -45.29 91.92 Favored 'General case' 0 N--CA 1.486 1.366 0 O-C-N 120.778 -1.201 . . . . 10.0 108.586 178.461 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.475 ' HA ' ' H ' ' A' ' 134' ' ' GLN . . . -49.01 -39.27 26.23 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.418 -0.801 . . . . 10.0 110.357 179.514 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.48 ' HB2' ' O ' ' A' ' 128' ' ' LYS . 0.9 OUTLIER -53.95 -19.09 4.12 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.571 -0.706 . . . . 10.0 111.13 -179.245 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.573 ' ND2' ' HG2' ' A' ' 133' ' ' LYS . 0.6 OUTLIER -118.36 -2.15 11.15 Favored 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 118.311 -1.356 . . . . 10.0 111.964 -178.189 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.573 ' HG2' ' ND2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -158.15 -25.51 0.08 Allowed 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.148 -0.97 . . . . 10.0 111.043 -179.728 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.518 ' HG2' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 40.79 19.71 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.753 -0.592 . . . . 10.0 111.595 -179.145 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.521 ' N ' ' O ' ' A' ' 133' ' ' LYS . 1.2 ptmt -153.77 95.1 2.87 Favored Pre-proline 0 N--CA 1.488 1.435 0 O-C-N 120.776 -1.203 . . . . 10.0 110.036 178.828 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.939 ' HB3' HG12 ' A' ' 85' ' ' VAL . 44.4 Cg_endo -71.07 156.84 59.13 Favored 'Trans proline' 0 C--N 1.297 -2.181 0 O-C-N 124.055 1.555 . . . . 10.0 110.357 179.317 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.612 HG23 ' HB2' ' A' ' 142' ' ' ALA . 2.0 mm -93.7 122.35 45.11 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.856 0 O-C-N 121.051 -1.031 . . . . 10.0 109.779 179.128 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.568 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.1 p -118.95 173.36 3.48 Favored Pre-proline 0 N--CA 1.494 1.768 0 O-C-N 121.515 -0.74 . . . . 10.0 109.219 -179.136 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.568 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.8 Cg_endo -63.37 -10.17 20.43 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 122.803 0.896 . . . . 10.0 110.528 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 27.0 tt0 -94.12 -44.96 7.76 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.184 -0.948 . . . . 10.0 109.836 178.566 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.67 -48.78 45.25 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 121.399 -0.813 . . . . 10.0 109.524 179.588 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 137' ' ' ILE . . . -62.47 -40.38 96.48 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.425 -0.797 . . . . 10.0 111.297 -179.88 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.422 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 27.0 tt0 -61.18 -39.85 91.71 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.899 -1.126 . . . . 10.0 109.526 179.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 31.6 mttm -60.61 -49.55 77.07 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 118.665 -1.214 . . . . 10.0 108.416 178.872 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.892 HD11 ' CE ' ' A' ' 94' ' ' LYS . 4.3 tt -57.82 -37.79 74.41 Favored 'General case' 0 C--N 1.312 -1.058 0 O-C-N 121.028 -1.045 . . . . 10.0 109.238 179.061 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.702 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -66.57 -35.61 80.64 Favored 'General case' 0 N--CA 1.488 1.431 0 C-N-CA 120.017 -0.673 . . . . 10.0 109.633 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.63 -15.44 60.82 Favored 'General case' 0 C--N 1.3 -1.583 0 O-C-N 121.141 -0.975 . . . . 10.0 109.277 179.166 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.462 ' O ' ' OD1' ' A' ' 148' ' ' ASP . 11.8 t0 -70.3 -10.41 58.88 Favored 'General case' 0 N--CA 1.499 2.024 0 O-C-N 121.436 -0.79 . . . . 10.0 110.928 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.75 31.06 0.46 Allowed 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.129 -0.982 . . . . 10.0 111.028 -179.056 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 3.4 mtpt 60.03 36.65 21.41 Favored 'General case' 0 N--CA 1.487 1.391 0 CA-C-O 121.82 0.819 . . . . 10.0 110.314 177.998 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.702 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -71.19 -176.23 1.39 Allowed 'General case' 0 C--N 1.294 -1.832 0 N-CA-C 108.519 -0.919 . . . . 10.0 108.519 178.763 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.033 HG11 ' CD1' ' A' ' 111' ' ' LEU . 12.7 t -87.48 -81.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.298 -1.633 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.811 179.826 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.659 ' N ' HG12 ' A' ' 152' ' ' VAL . 1.6 tttp -173.74 159.38 3.48 Favored 'General case' 0 C--N 1.296 -1.727 0 O-C-N 121.549 -0.72 . . . . 10.0 110.072 -179.628 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.431 ' CG ' ' CB ' ' A' ' 142' ' ' ALA . 43.1 t80 -93.98 100.37 12.52 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 120.714 -1.241 . . . . 10.0 109.886 178.675 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.06 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -95.15 -167.01 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.498 1.96 0 O-C-N 121.51 -0.744 . . . . 10.0 109.328 -179.903 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 79.3 mt-10 -136.05 149.65 48.85 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 120.66 -1.275 . . . . 10.0 112.262 -178.519 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.814 ' HB3' HG11 ' A' ' 113' ' ' VAL . 0.7 OUTLIER -162.9 138.41 6.9 Favored 'General case' 0 N--CA 1.498 1.97 0 O-C-N 121.335 -0.853 . . . . 10.0 109.424 178.882 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 160' ' ' LEU . 5.0 t -148.13 114.18 5.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.3 -0.875 . . . . 10.0 110.065 179.293 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.817 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . 3.21 -65.47 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.631 0 N-CA-C 114.739 1.385 . . . . 10.0 114.739 179.682 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.955 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.1 OUTLIER -131.9 -38.51 1.12 Allowed 'General case' 0 C--N 1.294 -1.82 0 O-C-N 120.758 -1.214 . . . . 10.0 112.079 -177.428 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.45 ' O ' ' C ' ' A' ' 162' ' ' GLN . 70.1 p -60.91 -71.74 0.13 Allowed 'General case' 0 N--CA 1.489 1.482 0 O-C-N 121.188 -0.945 . . . . 10.0 111.788 -177.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.526 ' H ' ' HB3' ' A' ' 158' ' ' SER . 4.4 mm100 -36.6 -69.07 0.12 Allowed 'General case' 0 N--CA 1.489 1.519 0 O-C-N 121.631 -0.668 . . . . 10.0 111.43 -178.175 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.602 ' HA ' ' CD1' ' A' ' 23' ' ' TYR . 0.6 OUTLIER 66.05 25.27 10.92 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 119.637 -0.825 . . . . 10.0 110.532 -179.823 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -123.82 2.89 9.29 Favored Glycine 0 N--CA 1.492 2.377 0 N-CA-C 108.192 -1.963 . . . . 10.0 108.192 178.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.839 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -58.27 -14.76 7.95 Favored 'General case' 0 N--CA 1.491 1.606 0 O-C-N 121.666 -0.902 . . . . 10.0 111.944 -179.791 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.654 ' N ' HD22 ' A' ' 165' ' ' LEU . 9.4 mtmt -63.15 -36.07 82.38 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 120.445 -1.409 . . . . 10.0 110.952 -179.534 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.421 ' N ' HD22 ' A' ' 167' ' ' ASN . 0.9 OUTLIER -63.86 -38.56 91.56 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.324 -0.86 . . . . 10.0 111.103 -179.243 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.06 HG22 ' HB ' ' A' ' 155' ' ' VAL . 5.8 t -52.8 -34.38 20.02 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 O-C-N 120.815 -1.178 . . . . 10.0 110.412 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 41.2 m-85 -75.89 -24.28 55.63 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.129 -0.982 . . . . 10.0 111.004 179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.426 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -74.21 -43.89 55.38 Favored 'General case' 0 N--CA 1.491 1.619 0 C-N-CA 119.042 -1.063 . . . . 10.0 110.088 -179.972 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.473 ' OE2' ' HD2' ' A' ' 153' ' ' LYS . 36.4 mt-10 -60.58 -32.94 72.02 Favored 'General case' 0 N--CA 1.489 1.523 0 O-C-N 120.892 -1.13 . . . . 10.0 109.995 179.568 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.763 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -61.23 -24.78 66.61 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 120.772 -1.205 . . . . 10.0 109.76 179.467 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.741 ' O ' HD12 ' A' ' 177' ' ' LEU . 18.8 mm -62.46 -42.31 95.22 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.088 0 O-C-N 121.08 -1.013 . . . . 10.0 109.736 179.346 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.776 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -76.41 -41.88 46.22 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.004 -1.06 . . . . 10.0 109.986 -179.901 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.835 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -79.81 -4.2 51.08 Favored 'General case' 0 C--N 1.303 -1.44 0 O-C-N 121.447 -0.783 . . . . 10.0 109.824 179.795 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.972 ' HA ' HG11 ' A' ' 77' ' ' VAL . . . -76.41 -43.17 41.59 Favored 'General case' 0 C--N 1.305 -1.331 0 O-C-N 121.191 -0.943 . . . . 10.0 108.95 179.094 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.741 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.5 OUTLIER -108.09 -20.6 13.11 Favored 'General case' 0 C--N 1.299 -1.625 0 CA-C-O 121.56 0.695 . . . . 10.0 109.814 -179.119 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.493 1.721 0 CA-C-O 118.184 -0.912 . . . . 10.0 110.336 179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 2.099 0 N-CA-C 108.517 -1.833 . . . . 10.0 108.517 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.52 ' O ' ' HG3' ' B' ' 4' ' ' GLU . 2.0 m -107.75 55.25 0.65 Allowed 'General case' 0 C--N 1.299 -1.622 0 O-C-N 121.218 -1.166 . . . . 10.0 110.476 -179.182 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 13.1 mtpt -51.64 105.48 0.11 Allowed 'General case' 0 N--CA 1.493 1.68 0 O-C-N 121.086 -1.009 . . . . 10.0 110.457 -179.852 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.52 ' HG3' ' O ' ' B' ' 2' ' ' SER . 1.5 mt-10 -96.01 156.0 16.52 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.608 -0.682 . . . . 10.0 110.388 179.986 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.61 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.1 OUTLIER -108.6 -50.3 0.08 OUTLIER Pre-proline 0 N--CA 1.486 1.37 0 O-C-N 121.159 -0.963 . . . . 10.0 110.897 179.881 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.61 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 55.6 Cg_endo -95.67 32.3 0.17 Allowed 'Trans proline' 0 C--N 1.317 -1.122 0 N-CA-C 108.298 -1.462 . . . . 10.0 108.298 179.538 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.487 ' O ' ' O ' ' B' ' 6' ' ' PRO . 1.5 pp20? -38.57 158.72 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.406 0 O-C-N 121.912 -0.493 . . . . 10.0 109.676 -178.57 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.677 HG13 ' HA2' ' A' ' 47' ' ' GLY . 2.1 pp -81.52 -53.33 12.38 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.435 0 O-C-N 120.728 -1.233 . . . . 10.0 112.184 -178.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.559 ' N ' HD12 ' B' ' 8' ' ' ILE . 30.6 t -160.94 173.81 14.73 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.325 -1.484 . . . . 10.0 111.462 179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.666 ' O ' HD12 ' B' ' 10' ' ' LEU . 1.2 pp -164.39 99.2 0.89 Allowed Pre-proline 0 C--N 1.303 -1.456 0 C-N-CA 119.119 -1.032 . . . . 10.0 111.929 -178.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.479 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 44.2 Cg_endo -72.65 104.95 1.82 Allowed 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 123.862 1.453 . . . . 10.0 109.343 178.077 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.51 ' HA ' HG13 ' A' ' 44' ' ' VAL . 0.3 OUTLIER -53.02 -169.35 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.17 -0.956 . . . . 10.0 111.037 -179.29 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 17.7 t0 -138.31 -168.88 2.46 Favored 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.393 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.441 ' O ' ' O ' ' A' ' 41' ' ' ALA . 21.6 m-85 -97.13 165.21 12.17 Favored 'General case' 0 N--CA 1.492 1.626 0 O-C-N 120.7 -1.25 . . . . 10.0 111.796 -179.169 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.472 ' HB3' ' CG2' ' A' ' 42' ' ' VAL . 6.1 pm0 -119.85 171.05 8.69 Favored 'General case' 0 C--N 1.307 -1.276 0 O-C-N 121.8 -0.562 . . . . 10.0 110.39 -179.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.556 ' HB2' ' HA ' ' A' ' 40' ' ' TYR . 0.1 OUTLIER -92.16 -174.97 3.92 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.006 -1.059 . . . . 10.0 110.356 179.688 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.511 ' C ' HG23 ' B' ' 18' ' ' ILE . 0.1 OUTLIER -147.1 133.47 19.59 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 121.122 -0.986 . . . . 10.0 109.904 -179.237 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.835 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -150.07 -177.97 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 C-N-CA 119.541 -0.863 . . . . 10.0 109.916 -179.31 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 18.0 m80 -142.37 154.91 45.04 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 120.989 -1.069 . . . . 10.0 110.645 179.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.643 ' CG2' ' HB ' ' A' ' 36' ' ' VAL . 2.8 p -91.11 148.97 4.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.778 0 O-C-N 121.268 -0.895 . . . . 10.0 110.503 179.753 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.433 ' H ' ' N ' ' A' ' 61' ' ' GLN . . . -99.42 47.94 1.3 Allowed Glycine 0 N--CA 1.49 2.278 0 N-CA-C 109.11 -1.596 . . . . 10.0 109.11 179.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.874 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -177.74 104.62 0.05 OUTLIER 'General case' 0 N--CA 1.486 1.366 0 O-C-N 121.234 -1.156 . . . . 10.0 109.032 -179.585 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -58.39 142.0 49.67 Favored 'General case' 0 N--CA 1.504 2.239 0 CA-C-O 121.808 0.813 . . . . 10.0 112.343 -178.327 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.742 ' HA ' HG22 ' A' ' 33' ' ' VAL . . . 51.57 51.71 16.17 Favored 'General case' 0 N--CA 1.504 2.272 0 O-C-N 121.746 -0.596 . . . . 10.0 112.38 179.349 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.874 HG21 ' HB3' ' B' ' 22' ' ' PHE . 52.1 t -113.32 -39.28 3.08 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.473 0 O-C-N 120.649 -1.282 . . . . 10.0 110.547 179.434 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.878 HG22 ' CG2' ' A' ' 33' ' ' VAL . 3.1 t -61.58 -22.78 65.5 Favored 'General case' 0 N--CA 1.498 1.956 0 O-C-N 121.137 -0.977 . . . . 10.0 110.18 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.815 ' HA3' HG11 ' A' ' 33' ' ' VAL . . . -106.3 31.12 8.63 Favored Glycine 0 N--CA 1.49 2.264 0 N-CA-C 106.841 -2.504 . . . . 10.0 106.841 177.821 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.618 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 2.8 mp0 -128.55 114.07 16.26 Favored 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.261 1.029 . . . . 10.0 110.663 -178.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.822 ' CG ' HD11 ' A' ' 19' ' ' LEU . 15.6 t80 -128.67 140.32 51.81 Favored 'General case' 0 C--N 1.286 -2.174 0 CA-C-O 121.707 0.765 . . . . 10.0 109.955 179.849 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 61.6 p -146.29 -69.52 0.26 Allowed 'General case' 0 C--N 1.293 -1.886 0 N-CA-C 108.882 -0.784 . . . . 10.0 108.882 179.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 149.25 -19.97 1.2 Allowed Glycine 0 N--CA 1.492 2.391 0 C-N-CA 119.631 -1.271 . . . . 10.0 111.289 178.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.56 ' HB ' ' HD3' ' B' ' 33' ' ' PRO . 2.0 mt -63.29 -55.65 34.24 Favored Pre-proline 0 N--CA 1.495 1.786 0 O-C-N 120.629 -1.512 . . . . 10.0 111.217 -179.242 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.56 ' HD3' ' HB ' ' B' ' 32' ' ' ILE . 44.1 Cg_endo -70.56 169.38 20.07 Favored 'Trans proline' 0 C--N 1.305 -1.738 0 O-C-N 123.326 1.172 . . . . 10.0 109.413 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.519 ' HG2' ' CA ' ' B' ' 38' ' ' ARG . 25.4 tp10 -78.63 167.67 20.89 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 120.991 -1.068 . . . . 10.0 109.371 179.772 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.581 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 11.5 mp0 -81.08 19.62 0.88 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.484 -0.76 . . . . 10.0 111.469 -179.251 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.581 ' CB ' ' O ' ' B' ' 35' ' ' GLN . 4.8 m95 89.9 26.35 0.02 OUTLIER 'General case' 0 N--CA 1.504 2.234 0 CA-C-O 123.074 1.416 . . . . 10.0 107.504 -178.037 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.695 ' HB1' HD12 ' B' ' 39' ' ' LEU . . . -156.81 81.09 0.94 Allowed 'General case' 0 C--N 1.296 -1.76 0 CA-C-N 114.217 -1.356 . . . . 10.0 108.613 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.519 ' CA ' ' HG2' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -82.68 35.32 0.46 Allowed 'General case' 0 N--CA 1.496 1.846 0 O-C-N 121.061 -1.025 . . . . 10.0 108.719 178.941 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.695 HD12 ' HB1' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -58.55 -11.85 3.42 Favored 'General case' 0 C--N 1.293 -1.876 0 CA-C-N 115.698 -0.683 . . . . 10.0 110.951 -179.378 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.552 ' O ' HD12 ' B' ' 40' ' ' LEU . 1.2 pp -71.68 -2.32 16.9 Favored 'General case' 0 N--CA 1.5 2.033 0 O-C-N 120.783 -1.198 . . . . 10.0 111.926 -178.801 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.42 ' HG3' HD12 ' B' ' 40' ' ' LEU . 5.6 mt-30 -161.05 -89.21 0.03 OUTLIER 'General case' 0 C--N 1.289 -2.048 0 O-C-N 121.379 -0.825 . . . . 10.0 109.73 179.737 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.794 HG23 ' H ' ' B' ' 44' ' ' ASN . 8.8 t -137.8 -170.36 2.75 Favored 'General case' 0 C--N 1.305 -1.332 0 CA-C-O 121.505 0.669 . . . . 10.0 110.224 179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.55 ' HB2' ' HB2' ' A' ' 66' ' ' ARG . 82.6 p -86.97 6.07 34.03 Favored 'General case' 0 C--N 1.303 -1.414 0 O-C-N 121.442 -0.786 . . . . 10.0 111.113 -179.755 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.794 ' H ' HG23 ' B' ' 42' ' ' THR . 9.7 t-20 -87.73 96.76 10.56 Favored 'General case' 0 N--CA 1.498 1.951 0 O-C-N 121.051 -1.03 . . . . 10.0 111.413 -178.93 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.442 ' O ' ' C ' ' B' ' 46' ' ' THR . 22.4 mt -87.32 -65.9 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.49 0 O-C-N 121.179 -0.95 . . . . 10.0 110.777 179.362 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.442 ' C ' ' O ' ' B' ' 45' ' ' ILE . 0.1 OUTLIER . . . . . 0 N--CA 1.491 1.602 0 CA-C-O 117.932 -1.032 . . . . 10.0 110.08 -178.675 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.478 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 1.5 mpp? . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 120.905 0.384 . . . . 10.0 110.219 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.622 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.3 mt-30 -139.01 -39.99 0.48 Allowed 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.09 -1.006 . . . . 10.0 110.249 179.79 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.582 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 1.4 m -44.09 101.35 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.59 0 O-C-N 121.144 -0.972 . . . . 10.0 110.778 179.732 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.891 HD12 ' CB ' ' A' ' 176' ' ' ALA . 2.1 tt -106.47 140.44 24.58 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.596 0 C-N-CA 118.658 -1.217 . . . . 10.0 110.302 178.136 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.909 ' O ' HG22 ' A' ' 77' ' ' VAL . 2.7 mmtt -112.85 137.05 51.77 Favored 'General case' 0 C--N 1.292 -1.905 0 N-CA-C 107.624 -1.25 . . . . 10.0 107.624 177.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' CB ' ' A' ' 55' ' ' LEU . 18.2 t -118.85 108.42 14.8 Favored 'General case' 0 C--N 1.297 -1.687 0 O-C-N 120.807 -1.183 . . . . 10.0 110.317 -179.43 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.601 ' N ' HG21 ' A' ' 75' ' ' THR . 9.1 t -137.81 163.62 29.87 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.73 0 O-C-N 121.234 -0.916 . . . . 10.0 110.353 -179.942 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.612 HG22 ' OG1' ' A' ' 17' ' ' THR . 3.1 t -87.02 141.72 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 O-C-N 121.361 -0.837 . . . . 10.0 110.548 -179.629 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' A' ' 78' ' ' PHE . 46.1 t -136.42 174.69 11.79 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.374 0 O-C-N 121.374 -0.829 . . . . 10.0 110.049 179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.762 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 125.04 130.6 3.52 Favored Glycine 0 N--CA 1.491 2.325 0 N-CA-C 109.864 -1.295 . . . . 10.0 109.864 179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -54.82 -27.57 43.0 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.372 -1.075 . . . . 10.0 110.19 179.561 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.707 ' O ' ' HB2' ' A' ' 13' ' ' ALA . . . 140.92 127.61 2.34 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.02 -1.232 . . . . 10.0 110.02 179.856 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.707 ' HB2' ' O ' ' A' ' 12' ' ' GLY . . . 169.59 -67.03 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.636 0 O-C-N 121.27 -1.135 . . . . 10.0 109.703 179.753 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.966 ' HB ' HG23 ' A' ' 115' ' ' THR . 13.4 t -147.93 107.85 0.58 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.612 0 O-C-N 121.393 -0.817 . . . . 10.0 109.525 179.368 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.415 ' HA2' ' HB3' ' B' ' 35' ' ' GLN . . . -74.08 99.1 1.03 Allowed Glycine 0 N--CA 1.49 2.294 0 N-CA-C 109.882 -1.287 . . . . 10.0 109.882 -179.538 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.504 ' HG3' ' SG ' ' A' ' 157' ' ' CYS . 0.0 OUTLIER -52.64 -36.97 57.69 Favored 'General case' 0 N--CA 1.49 1.544 0 O-C-N 120.996 -1.296 . . . . 10.0 109.709 179.615 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.612 ' OG1' HG22 ' A' ' 8' ' ' VAL . 53.2 m -52.71 -39.57 62.15 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.436 -0.79 . . . . 10.0 110.792 -179.765 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.517 ' O ' ' HB2' ' A' ' 22' ' ' SER . 14.5 p -81.89 -15.77 52.86 Favored 'General case' 0 N--CA 1.484 1.237 0 O-C-N 120.673 -1.267 . . . . 10.0 108.988 179.584 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.771 HD11 HG13 ' A' ' 14' ' ' VAL . 10.2 mt -84.34 -30.52 25.43 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 121.906 0.86 . . . . 10.0 109.12 179.163 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.501 ' O ' ' HB ' ' A' ' 24' ' ' THR . 0.6 OUTLIER -54.69 -39.3 67.99 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.209 -1.034 . . . . 10.0 108.209 178.167 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.788 HG21 HG23 ' B' ' 26' ' ' THR . 3.5 mm -91.27 -42.1 13.59 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.699 0 CA-C-O 121.666 0.746 . . . . 10.0 109.911 179.253 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.576 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 32.9 t -47.6 -40.5 19.52 Favored 'General case' 0 C--N 1.295 -1.779 0 C-N-CA 119.303 -0.959 . . . . 10.0 109.974 -178.581 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.639 ' CD1' ' O ' ' A' ' 160' ' ' LEU . 9.4 t80 -100.83 1.46 40.13 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 118.238 -1.385 . . . . 10.0 110.625 178.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.501 ' HB ' ' O ' ' A' ' 20' ' ' LEU . 6.3 m -107.21 -19.09 13.71 Favored 'General case' 0 N--CA 1.49 1.569 0 O-C-N 120.984 -1.072 . . . . 10.0 111.325 -179.488 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.612 HG21 ' CG ' ' A' ' 34' ' ' PRO . 11.3 t -112.23 -43.04 3.6 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.731 -1.23 . . . . 10.0 111.16 -179.191 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.553 ' N ' HG23 ' A' ' 25' ' ' THR . 7.3 m-20 -155.87 -48.61 0.08 Allowed 'General case' 0 N--CA 1.487 1.421 0 C-N-CA 118.492 -1.283 . . . . 10.0 112.512 -179.783 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.698 ' C ' ' HD3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER 168.88 -154.81 0.01 OUTLIER 'General case' 0 N--CA 1.505 2.317 0 O-C-N 121.217 -0.927 . . . . 10.0 111.892 -178.527 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.623 ' N ' ' CD ' ' A' ' 29' ' ' PRO . 22.4 p90 -114.05 -17.14 0.11 Allowed Pre-proline 0 N--CA 1.498 1.931 0 N-CA-C 114.223 1.194 . . . . 10.0 114.223 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.623 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 47.3 Cg_endo -69.04 -112.64 0.0 OUTLIER 'Trans proline' 0 N--CA 1.494 1.53 0 CA-C-N 119.483 0.851 . . . . 10.0 112.217 -178.276 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 68.5 p -166.35 68.36 0.11 Allowed 'General case' 0 N--CA 1.495 1.791 0 O-C-N 120.104 -1.623 . . . . 10.0 111.56 -178.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.577 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -121.55 -169.39 1.85 Allowed 'General case' 0 C--N 1.3 -1.573 0 N-CA-C 107.959 -1.126 . . . . 10.0 107.959 178.638 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.477 ' O ' ' ND2' ' A' ' 26' ' ' ASN . 5.7 t80 -48.01 100.3 0.02 OUTLIER 'General case' 0 C--N 1.292 -1.904 0 N-CA-C 108.31 -0.996 . . . . 10.0 108.31 179.47 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.65 HG13 ' HA ' ' B' ' 24' ' ' ALA 0.261 12.1 p -149.8 154.25 37.22 Favored Pre-proline 0 N--CA 1.492 1.641 0 O-C-N 121.661 -0.649 . . . . 10.0 109.682 -177.87 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.634 ' HD2' ' CG2' ' A' ' 33' ' ' VAL . 36.8 Cg_endo -60.43 179.96 0.3 Allowed 'Trans proline' 0 C--N 1.312 -1.387 0 O-C-N 123.16 1.084 . . . . 10.0 110.223 179.23 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.966 ' HB ' HG11 ' B' ' 20' ' ' VAL . 20.3 p -145.35 166.38 25.74 Favored 'General case' 0 C--N 1.299 -1.601 0 O-C-N 121.117 -0.989 . . . . 10.0 111.693 -177.646 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.771 HG23 ' HB ' ' B' ' 25' ' ' VAL . 89.8 t -28.22 -33.65 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.329 0 CA-C-O 121.325 0.583 . . . . 10.0 111.321 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.679 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.0 OUTLIER -38.94 96.63 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.451 -0.781 . . . . 10.0 109.759 179.354 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.472 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.2 OUTLIER -170.38 91.07 0.17 Allowed 'General case' 0 N--CA 1.488 1.445 0 O-C-N 119.879 -1.763 . . . . 10.0 113.776 -179.804 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.581 ' HB3' HG13 ' B' ' 18' ' ' ILE . 8.2 t30 -135.88 149.75 49.11 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.058 -1.026 . . . . 10.0 108.604 176.913 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.56 ' CD2' ' O ' ' A' ' 39' ' ' ASN . 2.6 m-85 -167.2 113.84 0.77 Allowed 'General case' 0 C--N 1.302 -1.485 0 O-C-N 120.402 -1.436 . . . . 10.0 111.702 -179.601 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' O ' ' N ' ' B' ' 15' ' ' GLU . . . -93.69 108.85 20.53 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 107.92 -1.141 . . . . 10.0 107.92 178.234 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.056 HG22 ' O ' ' B' ' 14' ' ' PHE . 44.1 t -135.87 171.93 16.39 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.536 0 C-N-CA 118.184 -1.407 . . . . 10.0 112.31 -178.038 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.669 HG23 ' O ' ' A' ' 51' ' ' TYR . 54.7 m -147.28 170.6 16.95 Favored 'General case' 0 C--N 1.298 -1.647 0 N-CA-C 108.631 -0.877 . . . . 10.0 108.631 -179.714 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.852 HG12 ' HB2' ' A' ' 51' ' ' TYR . 1.3 p -161.35 129.18 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.297 -1.7 0 O-C-N 120.89 -1.131 . . . . 10.0 111.561 179.455 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.681 ' CB ' HD22 ' B' ' 10' ' ' LEU . 1.3 mmt -104.95 129.06 53.44 Favored 'General case' 0 C--N 1.287 -2.14 0 C-N-CA 118.826 -1.15 . . . . 10.0 108.131 178.17 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.995 HG22 ' HB3' ' B' ' 7' ' ' GLU . 33.6 mt -132.05 99.3 3.58 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 120.913 -1.117 . . . . 10.0 110.194 -179.024 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.71 ' CA ' HG22 ' B' ' 8' ' ' ILE . . . 59.76 24.05 59.57 Favored Glycine 0 N--CA 1.49 2.261 0 N-CA-C 109.038 -1.625 . . . . 10.0 109.038 -179.532 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 104.02 27.72 6.15 Favored Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.448 -1.461 . . . . 10.0 109.448 -179.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 43.1 mm-40 -127.29 95.47 36.08 Favored Pre-proline 0 N--CA 1.491 1.594 0 O-C-N 121.17 -1.194 . . . . 10.0 110.538 -179.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.546 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 51.5 Cg_endo -83.19 132.68 6.18 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.236 1.65 . . . . 10.0 112.008 -179.557 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.852 ' HB2' HG12 ' A' ' 44' ' ' VAL . 2.7 m-85 -93.65 150.69 20.21 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.15 -0.969 . . . . 10.0 109.29 177.578 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.855 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.3 m -136.25 100.32 4.36 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 120.786 -1.196 . . . . 10.0 110.222 -179.925 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.776 HD12 ' N ' ' A' ' 54' ' ' GLY . 3.0 pp -149.3 176.35 10.62 Favored 'General case' 0 N--CA 1.495 1.792 0 C-N-CA 118.393 -1.323 . . . . 10.0 112.813 -179.657 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.776 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -170.82 118.52 0.75 Allowed Glycine 0 N--CA 1.492 2.38 0 N-CA-C 107.67 -2.172 . . . . 10.0 107.67 179.536 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.555 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . 2.0 pp -129.78 159.58 36.1 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.647 -1.502 . . . . 10.0 111.138 -178.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.551 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 15.9 p90 -165.69 131.77 2.61 Favored 'General case' 0 N--CA 1.493 1.721 0 O-C-N 121.274 -0.891 . . . . 10.0 110.568 179.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.506 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 1.0 OUTLIER -81.38 176.84 9.38 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.245 -0.91 . . . . 10.0 110.095 179.418 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.518 ' O ' ' CG1' ' A' ' 36' ' ' VAL . 99.1 m -40.2 164.42 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.795 0 CA-C-O 121.734 0.778 . . . . 10.0 111.43 -179.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.56 ' HB3' ' HB2' ' A' ' 65' ' ' ASP . . . -146.65 63.01 1.2 Allowed 'General case' 0 N--CA 1.498 1.965 0 O-C-N 121.602 -0.686 . . . . 10.0 109.609 -179.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -61.76 -28.19 69.62 Favored Glycine 0 N--CA 1.49 2.291 0 N-CA-C 110.275 -1.13 . . . . 10.0 110.275 -179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.528 ' HB2' ' HA3' ' B' ' 21' ' ' GLY . 64.7 tp60 -115.77 -28.79 6.61 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.065 -1.256 . . . . 10.0 111.23 -179.396 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.546 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 7.3 tp10 -63.53 -50.02 71.2 Favored 'General case' 0 N--CA 1.492 1.674 0 O-C-N 120.871 -1.143 . . . . 10.0 110.572 -179.233 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.523 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 0.4 OUTLIER -142.74 0.92 1.28 Allowed 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.074 -1.016 . . . . 10.0 111.323 179.858 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.523 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 42.2 m-85 65.35 40.26 4.87 Favored 'General case' 0 N--CA 1.491 1.582 0 N-CA-C 107.821 -1.178 . . . . 10.0 107.821 -179.549 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.621 ' O ' HD21 ' A' ' 70' ' ' LEU . 0.2 OUTLIER -78.7 47.72 0.75 Allowed 'General case' 0 C--N 1.299 -1.621 0 CA-C-N 115.142 -0.936 . . . . 10.0 110.85 -178.833 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.932 ' O ' HD23 ' A' ' 70' ' ' LEU . 17.4 mtp180 -82.82 -26.28 31.87 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.437 -0.789 . . . . 10.0 109.53 178.974 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.641 HD21 ' HG2' ' B' ' 41' ' ' GLN . 1.2 mt -111.77 -6.66 14.28 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.556 -0.715 . . . . 10.0 111.888 -178.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.537 ' CB ' ' HD3' ' A' ' 69' ' ' PRO . 0.1 OUTLIER -92.75 -54.9 0.25 Allowed Pre-proline 0 N--CA 1.498 1.974 0 O-C-N 120.376 -1.453 . . . . 10.0 113.19 -177.864 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.625 ' C ' HD13 ' A' ' 70' ' ' LEU . 43.0 Cg_endo -77.61 -5.02 15.17 Favored 'Trans proline' 0 C--N 1.301 -1.934 0 O-C-N 123.528 1.278 . . . . 10.0 111.987 -179.264 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.932 HD23 ' O ' ' A' ' 66' ' ' ARG . 0.5 OUTLIER -101.81 -98.8 0.27 Allowed 'General case' 0 N--CA 1.486 1.372 0 O-C-N 120.773 -1.205 . . . . 10.0 110.966 -179.313 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.773 ' HA ' HD23 ' B' ' 39' ' ' LEU . 40.1 m -36.38 -29.94 0.02 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.744 -0.598 . . . . 10.0 110.467 -179.48 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.525 ' N ' ' O ' ' A' ' 70' ' ' LEU . 15.6 m-85 -103.47 91.92 3.66 Favored Pre-proline 0 N--CA 1.49 1.553 0 O-C-N 121.512 -0.743 . . . . 10.0 109.056 178.845 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.535 ' HD3' ' O ' ' A' ' 71' ' ' SER . 45.4 Cg_endo -70.62 147.43 57.32 Favored 'Trans proline' 0 C--N 1.309 -1.552 0 O-C-N 123.787 1.414 . . . . 10.0 110.555 -179.156 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CD ' ' A' ' 74' ' ' GLN . 3.2 pp0? -169.37 57.26 0.05 OUTLIER 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.221 -0.924 . . . . 10.0 110.583 -179.382 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.655 HG23 ' CB ' ' A' ' 5' ' ' LYS . 18.0 m -145.01 98.05 3.11 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.162 -0.961 . . . . 10.0 110.099 179.25 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.476 ' C ' ' O ' ' A' ' 75' ' ' THR . 0.9 OUTLIER -34.37 -33.21 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.859 0 CA-C-O 121.384 0.611 . . . . 10.0 110.487 179.969 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.909 HG22 ' O ' ' A' ' 5' ' ' LYS . 0.7 OUTLIER -111.25 120.24 61.43 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.313 -0.867 . . . . 10.0 109.644 179.602 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' A' ' 9' ' ' VAL . 47.7 m-85 -115.41 140.92 48.7 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 120.906 -1.121 . . . . 10.0 111.28 -178.724 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.54 HD22 HD23 ' A' ' 111' ' ' LEU . 3.4 mm? -109.39 99.35 8.6 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.277 -0.889 . . . . 10.0 109.562 178.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.762 HG23 ' HA2' ' A' ' 10' ' ' GLY . 7.1 p -103.82 151.02 6.75 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.319 -0.863 . . . . 10.0 110.131 -179.828 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.474 ' O ' ' OG1' ' A' ' 115' ' ' THR . 3.2 t -126.71 103.8 7.74 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.174 -0.954 . . . . 10.0 111.496 -179.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.531 ' O ' ' N ' ' A' ' 115' ' ' THR . 67.7 m-85 -89.89 140.05 29.99 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.303 -0.873 . . . . 10.0 111.056 179.554 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 9.2 t -92.52 138.59 31.38 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.214 -0.929 . . . . 10.0 110.169 179.545 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.871 HG11 ' HG3' ' A' ' 120' ' ' ARG . 14.4 m -81.42 -17.08 12.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.481 0 O-C-N 121.015 -1.053 . . . . 10.0 110.699 -179.792 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.67 HG13 HG23 ' A' ' 84' ' ' VAL . 17.8 m -102.6 38.94 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.714 0 CA-C-O 121.774 0.797 . . . . 10.0 109.666 -179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.488 ' OG ' ' HD2' ' A' ' 87' ' ' PRO . 47.7 t -110.04 154.34 42.76 Favored Pre-proline 0 N--CA 1.493 1.683 0 O-C-N 121.677 -0.639 . . . . 10.0 109.37 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.535 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 47.9 Cg_endo -68.93 73.62 0.98 Allowed 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.735 1.387 . . . . 10.0 111.099 -179.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.456 ' OG ' ' HG3' ' A' ' 133' ' ' LYS . 43.4 m 39.91 55.04 2.6 Favored 'General case' 0 N--CA 1.493 1.677 0 O-C-N 121.478 -0.764 . . . . 10.0 110.429 179.609 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.442 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 62.7 p -91.9 -36.74 13.3 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.229 -0.919 . . . . 10.0 110.547 -179.865 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.9 p90 -50.3 -29.96 10.92 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.955 -1.09 . . . . 10.0 110.338 -179.563 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.494 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 0.5 OUTLIER -67.47 -35.7 79.69 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.259 -0.901 . . . . 10.0 110.036 179.905 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.494 ' HA ' ' HG2' ' A' ' 95' ' ' GLU . 0.0 OUTLIER -71.32 -12.81 61.64 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.104 -0.998 . . . . 10.0 109.39 179.789 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.462 ' HB ' ' HD3' ' A' ' 94' ' ' LYS . 3.1 t -88.87 -12.2 10.15 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.568 0 O-C-N 121.39 -0.819 . . . . 10.0 109.346 179.097 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.581 ' N ' ' CD ' ' A' ' 94' ' ' LYS . 6.8 mmtt -89.03 -35.75 16.19 Favored 'General case' 0 C--N 1.3 -1.55 0 N-CA-C 108.232 -1.025 . . . . 10.0 108.232 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.494 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 5.0 pt-20 -80.0 -5.05 55.04 Favored 'General case' 0 C--N 1.3 -1.544 0 C-N-CA 120.26 -0.576 . . . . 10.0 110.082 179.027 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 12.2 mmtp -102.02 -44.89 5.34 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.935 -1.103 . . . . 10.0 111.763 -178.964 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.559 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 35.9 m95 -89.59 -29.05 19.13 Favored 'General case' 0 N--CA 1.497 1.898 0 O-C-N 121.294 -0.878 . . . . 10.0 112.028 -178.759 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.929 ' CG2' HD21 ' A' ' 149' ' ' LEU . 62.8 t -62.28 -47.9 88.66 Favored Pre-proline 0 N--CA 1.489 1.514 0 O-C-N 120.545 -1.347 . . . . 10.0 110.596 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.765 ' O ' HD12 ' A' ' 101' ' ' ILE . 48.9 Cg_endo -74.68 -15.56 21.53 Favored 'Trans proline' 0 C--N 1.309 -1.516 0 N-CA-C 109.115 -1.148 . . . . 10.0 109.115 178.74 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.522 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 40.9 tt0 -58.97 -29.25 67.05 Favored 'General case' 0 N--CA 1.49 1.539 0 O-C-N 121.754 -0.591 . . . . 10.0 110.886 -179.884 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.765 HD12 ' O ' ' A' ' 99' ' ' PRO . 3.6 mt 57.57 94.21 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.722 0 O-C-N 121.115 -0.991 . . . . 10.0 109.603 -179.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.59 ' CG2' ' HG2' ' A' ' 106' ' ' PRO . 3.9 m -43.29 -81.8 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.345 -0.847 . . . . 10.0 109.08 179.756 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.547 ' N ' HG22 ' A' ' 102' ' ' THR . 4.8 m-70 -110.45 -15.9 13.81 Favored 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 108.388 -0.967 . . . . 10.0 108.388 177.403 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.505 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 162.45 -55.2 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.478 0 N-CA-C 106.164 -1.791 . . . . 10.0 106.164 -179.39 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.592 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 6.9 t -168.06 44.58 0.08 OUTLIER Pre-proline 0 C--N 1.301 -1.519 0 CA-C-N 115.581 -0.736 . . . . 10.0 110.207 178.179 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.592 ' HD3' ' N ' ' A' ' 105' ' ' CYS . 56.4 Cg_endo -81.26 -26.1 3.56 Favored 'Trans proline' 0 N--CA 1.484 0.918 0 N-CA-C 109.083 -1.16 . . . . 10.0 109.083 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.579 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 1.6 pttp 55.66 52.85 10.33 Favored 'General case' 0 N--CA 1.497 1.883 0 CA-C-O 122.342 1.067 . . . . 10.0 110.776 -179.421 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.498 ' OG1' ' HD2' ' A' ' 109' ' ' PRO . 10.0 t -45.38 155.17 0.46 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.513 -0.742 . . . . 10.0 109.934 179.103 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.498 ' HD2' ' OG1' ' A' ' 108' ' ' THR . 38.9 Cg_endo -66.35 148.77 84.81 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.76 1.4 . . . . 10.0 110.486 -179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.467 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.2 OUTLIER -139.07 111.9 7.82 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.333 -0.855 . . . . 10.0 110.023 -179.462 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.849 HD13 HG11 ' A' ' 152' ' ' VAL . 1.6 mm? -80.84 98.08 7.67 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.316 -0.865 . . . . 10.0 109.358 179.574 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.606 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 56.1 mt -70.22 140.11 52.38 Favored 'General case' 0 C--N 1.294 -1.841 0 N-CA-C 108.988 -0.745 . . . . 10.0 108.988 179.462 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.491 HG23 ' O ' ' A' ' 111' ' ' LEU . 4.5 t -148.1 168.22 4.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 O-C-N 120.809 -1.182 . . . . 10.0 111.679 -179.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.483 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.37 150.04 16.75 Favored Glycine 0 N--CA 1.491 2.31 0 N-CA-C 108.748 -1.741 . . . . 10.0 108.748 178.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.966 HG23 ' HB ' ' A' ' 14' ' ' VAL . 24.1 m -103.49 129.94 50.76 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.9 -1.353 . . . . 10.0 110.756 -179.442 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.668 ' HG3' HG21 ' A' ' 14' ' ' VAL . 69.4 mt-30 53.27 50.03 18.52 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.395 -0.816 . . . . 10.0 110.377 179.518 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.995 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -65.29 -25.27 36.81 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.692 0 O-C-N 121.028 -1.045 . . . . 10.0 110.017 -179.598 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.564 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.8 p-10 -52.06 59.82 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.196 0 CA-C-O 122.267 1.032 . . . . 10.0 110.051 -177.761 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.796 ' N ' ' O ' ' A' ' 117' ' ' ILE . 9.8 tp 158.64 -26.51 0.0 OUTLIER 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 108.164 -1.05 . . . . 10.0 108.164 -178.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.871 ' HG3' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -50.35 -40.11 48.25 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.81 -0.556 . . . . 10.0 109.928 179.589 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -52.97 -28.77 25.32 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.927 . . . . 10.0 109.993 179.543 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.487 ' O ' HD13 ' A' ' 126' ' ' ILE . 1.6 m-20 -83.6 130.35 56.27 Favored Pre-proline 0 N--CA 1.492 1.671 0 O-C-N 121.385 -0.822 . . . . 10.0 110.834 -179.717 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.536 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.3 Cg_endo -86.18 24.49 0.75 Allowed 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.664 1.576 . . . . 10.0 110.079 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 35.8 t -98.47 -50.98 4.1 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.273 -0.892 . . . . 10.0 110.198 -179.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.552 HG21 HD21 ' A' ' 119' ' ' LEU . 6.4 t -75.53 -32.37 60.45 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.014 -2.217 . . . . 10.0 105.014 176.983 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.536 ' HB ' ' HA ' ' A' ' 123' ' ' PRO 0.293 1.1 mp -50.69 -28.25 5.71 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.675 0 N-CA-C 107.08 -1.452 . . . . 10.0 107.08 176.856 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.8 tt0 -52.18 -29.89 24.41 Favored 'General case' 0 N--CA 1.489 1.515 0 CA-C-O 121.65 0.738 . . . . 10.0 110.471 178.902 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.457 ' O ' ' OD1' ' A' ' 132' ' ' ASN . 6.4 mmtp -55.75 -36.93 67.84 Favored 'General case' 0 C--N 1.297 -1.679 0 O-C-N 121.492 -0.755 . . . . 10.0 111.606 -178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.583 ' O ' ' N ' ' A' ' 133' ' ' LYS . 0.2 OUTLIER -57.85 -49.81 75.42 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.685 -1.26 . . . . 10.0 109.566 179.752 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.479 ' HA ' ' OE1' ' A' ' 134' ' ' GLN . . . -49.56 -41.23 40.97 Favored 'General case' 0 C--N 1.296 -1.721 0 O-C-N 121.735 -0.603 . . . . 10.0 111.466 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.78 -21.76 56.63 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.26 -0.9 . . . . 10.0 110.203 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.535 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 12.7 p-10 -128.49 -46.82 1.31 Allowed 'General case' 0 N--CA 1.494 1.736 0 O-C-N 121.153 -0.967 . . . . 10.0 111.13 -179.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.583 ' N ' ' O ' ' A' ' 129' ' ' LEU . 5.2 mmtp -121.74 144.95 48.5 Favored 'General case' 0 C--N 1.298 -1.636 0 O-C-N 121.631 -0.668 . . . . 10.0 109.287 179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.55 ' NE2' ' C ' ' A' ' 133' ' ' LYS . 0.1 OUTLIER -99.54 6.33 45.85 Favored 'General case' 0 C--N 1.297 -1.713 0 O-C-N 121.257 -0.902 . . . . 10.0 110.557 -179.103 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.429 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 10.6 mtpt -131.76 94.02 26.34 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 121.292 -0.88 . . . . 10.0 109.91 179.301 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.429 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.3 Cg_endo -70.61 160.65 48.75 Favored 'Trans proline' 0 C--N 1.306 -1.689 0 O-C-N 124.128 1.593 . . . . 10.0 110.604 -179.967 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.698 HG22 HG12 ' A' ' 84' ' ' VAL . 0.2 OUTLIER -75.68 133.57 31.01 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.062 -1.023 . . . . 10.0 108.649 178.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.52 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 24.2 p -131.19 168.84 15.55 Favored Pre-proline 0 C--N 1.296 -1.745 0 O-C-N 121.152 -0.968 . . . . 10.0 109.744 -178.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.52 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.3 Cg_endo -68.71 -33.11 22.1 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.758 1.399 . . . . 10.0 109.351 179.332 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.505 ' HG2' ' OG1' ' A' ' 138' ' ' THR . 15.6 pt-20 -71.18 -23.87 62.13 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.384 -0.822 . . . . 10.0 109.181 178.741 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.44 ' HG1' ' HG1' ' A' ' 138' ' ' THR . 57.4 m -80.03 -40.87 26.87 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.354 -0.841 . . . . 10.0 109.017 178.509 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -60.93 -40.86 94.82 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.472 -0.768 . . . . 10.0 109.31 179.021 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.445 ' HG3' ' O ' ' A' ' 139' ' ' PRO . 37.4 mt-10 -59.63 -42.84 93.61 Favored 'General case' 0 C--N 1.299 -1.588 0 C-N-CA 120.079 -0.648 . . . . 10.0 109.692 179.572 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 10.7 mttp -61.56 -39.79 92.39 Favored 'General case' 0 N--CA 1.489 1.497 0 O-C-N 121.373 -0.829 . . . . 10.0 109.434 179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.558 HD13 ' HE3' ' A' ' 94' ' ' LYS . 3.8 tp -65.03 -46.45 81.25 Favored 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.061 -1.024 . . . . 10.0 108.431 178.196 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.593 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -57.66 -45.1 85.99 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.374 -0.829 . . . . 10.0 110.383 179.85 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -69.45 -26.37 64.56 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 121.406 -0.809 . . . . 10.0 109.882 179.608 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.495 ' C ' HD12 ' A' ' 149' ' ' LEU . 12.8 m-20 -75.63 -49.95 16.91 Favored 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.324 -0.86 . . . . 10.0 110.574 -179.71 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.929 HD21 ' CG2' ' A' ' 98' ' ' VAL . 6.5 mp -90.37 1.68 56.34 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.262 -0.899 . . . . 10.0 108.975 179.587 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.514 ' HB2' ' HD3' ' A' ' 107' ' ' LYS . 6.2 mtmt 65.49 30.31 10.8 Favored 'General case' 0 C--N 1.301 -1.54 0 CA-C-O 121.639 0.733 . . . . 10.0 109.847 179.664 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.593 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -59.34 -146.66 0.0 OUTLIER 'General case' 0 C--N 1.297 -1.708 0 C-N-CA 119.955 -0.698 . . . . 10.0 109.463 179.644 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.849 HG11 HD13 ' A' ' 111' ' ' LEU . 2.7 p -117.51 -57.15 3.68 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.408 0 O-C-N 120.368 -1.458 . . . . 10.0 112.047 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.584 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -171.69 151.59 2.93 Favored 'General case' 0 N--CA 1.496 1.826 0 C-N-CA 118.148 -1.421 . . . . 10.0 112.291 -179.332 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.606 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 5.9 p90 -87.54 124.51 33.55 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.493 -0.754 . . . . 10.0 110.329 178.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.016 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -126.36 -168.33 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.785 0 O-C-N 121.355 -0.84 . . . . 10.0 109.879 179.921 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.4 ' O ' ' HA3' ' A' ' 164' ' ' GLY . 1.9 mt-10 -143.16 144.44 32.2 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.016 -1.052 . . . . 10.0 110.502 -179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.912 ' SG ' HG21 ' A' ' 168' ' ' VAL . 79.8 m -144.28 129.8 19.01 Favored 'General case' 0 N--CA 1.492 1.666 0 CA-C-O 121.898 0.856 . . . . 10.0 111.4 -179.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.563 ' N ' HD21 ' A' ' 165' ' ' LEU . 3.9 t -120.74 173.32 7.28 Favored 'General case' 0 C--N 1.294 -1.82 0 N-CA-C 107.605 -1.258 . . . . 10.0 107.605 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.684 ' CB ' HD22 ' A' ' 19' ' ' LEU . . . -93.66 -93.44 0.17 Allowed 'General case' 0 C--N 1.29 -1.99 0 O-C-N 120.984 -1.073 . . . . 10.0 110.438 -178.667 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.036 ' O ' HD12 ' A' ' 160' ' ' LEU . 0.2 OUTLIER -54.67 -39.19 67.82 Favored 'General case' 0 C--N 1.297 -1.705 0 O-C-N 121.067 -1.021 . . . . 10.0 109.49 179.713 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.54 ' OG1' ' OG ' ' A' ' 158' ' ' SER . 75.0 p -79.39 -35.34 40.9 Favored 'General case' 0 C--N 1.3 -1.562 0 O-C-N 120.152 -1.592 . . . . 10.0 110.953 179.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.583 ' CG ' ' HG ' ' A' ' 165' ' ' LEU . 0.3 OUTLIER 58.02 67.57 0.94 Allowed 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.785 -1.197 . . . . 10.0 109.858 179.711 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.591 ' HG2' HD11 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -87.3 56.8 4.13 Favored 'General case' 0 C--N 1.297 -1.71 0 C-N-CA 119.64 -0.824 . . . . 10.0 111.047 -179.578 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.621 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 125.6 11.41 4.09 Favored Glycine 0 N--CA 1.491 2.305 0 C-N-CA 119.416 -1.374 . . . . 10.0 111.001 178.747 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.583 ' HG ' ' CG ' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -54.52 -34.18 61.27 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 120.718 -1.46 . . . . 10.0 109.556 179.832 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 28.6 mtpt -88.15 -25.01 23.19 Favored 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.308 -0.87 . . . . 10.0 110.722 -179.824 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 4.6 m-80 -70.91 -38.78 72.97 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.276 -0.89 . . . . 10.0 111.206 -179.027 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.016 HG22 ' HB ' ' A' ' 155' ' ' VAL . 3.5 t -68.94 -36.51 74.36 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 O-C-N 120.833 -1.167 . . . . 10.0 109.325 179.88 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.535 ' O ' HG12 ' A' ' 173' ' ' ILE . 60.7 t80 -60.11 -37.76 80.97 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.687 -0.633 . . . . 10.0 110.01 178.996 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.553 ' O ' HD22 ' A' ' 174' ' ' LEU . 10.7 m-20 -67.66 -46.63 71.86 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 121.19 -0.943 . . . . 10.0 111.358 -179.669 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 73.6 mm-40 -60.07 -30.61 69.34 Favored 'General case' 0 N--CA 1.493 1.724 0 O-C-N 120.914 -1.116 . . . . 10.0 110.359 -179.576 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.762 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -70.56 -24.47 62.79 Favored 'General case' 0 N--CA 1.489 1.494 0 O-C-N 121.002 -1.062 . . . . 10.0 109.324 178.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.691 ' O ' HD12 ' A' ' 177' ' ' LEU . 27.8 mm -64.55 -44.74 96.85 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.413 0 O-C-N 121.434 -0.791 . . . . 10.0 110.057 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.826 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -79.85 -31.91 40.49 Favored 'General case' 0 N--CA 1.486 1.359 0 O-C-N 120.803 -1.185 . . . . 10.0 110.629 -179.637 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.462 ' HB2' ' CG2' ' A' ' 152' ' ' VAL . . . -89.01 0.79 56.37 Favored 'General case' 0 C--N 1.298 -1.643 0 O-C-N 121.472 -0.768 . . . . 10.0 110.838 -179.548 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.891 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -88.89 -37.23 15.47 Favored 'General case' 0 C--N 1.306 -1.326 0 O-C-N 120.933 -1.105 . . . . 10.0 110.195 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.691 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.95 -13.54 16.87 Favored 'General case' 0 N--CA 1.497 1.896 0 O-C-N 121.385 -0.822 . . . . 10.0 109.716 -179.668 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.497 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.2 OUTLIER . . . . . 0 N--CA 1.495 1.775 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.42 -179.556 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.354 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 19.5 m -89.96 47.01 1.4 Allowed 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.282 -1.128 . . . . 10.0 110.273 -179.87 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.2 100.49 4.32 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.067 -1.021 . . . . 10.0 110.664 -179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.469 ' HB2' ' OE1' ' B' ' 7' ' ' GLU . 14.3 mm-40 -101.52 175.67 5.49 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.542 0.687 . . . . 10.0 110.168 179.606 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.36 -146.49 0.0 OUTLIER Pre-proline 0 C--N 1.298 -1.643 0 N-CA-C 108.303 -0.999 . . . . 10.0 108.303 179.937 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 44.9 Cg_endo -76.11 13.72 1.23 Allowed 'Trans proline' 0 C--N 1.319 -1.018 0 CA-C-N 119.277 0.777 . . . . 10.0 111.815 -178.896 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.995 ' HB3' HG22 ' A' ' 46' ' ' ILE . 0.7 OUTLIER 36.72 -150.92 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 O-C-N 121.229 -0.919 . . . . 10.0 110.166 179.516 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.71 HG22 ' CA ' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -82.57 -115.89 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.303 -1.448 0 N-CA-C 107.943 -1.132 . . . . 10.0 107.943 177.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.648 ' H ' HG23 ' B' ' 8' ' ' ILE . 7.8 t -159.08 110.11 2.06 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 120.084 -1.635 . . . . 10.0 111.348 179.178 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.681 HD22 ' CB ' ' A' ' 45' ' ' MET . 1.0 OUTLIER -116.94 119.96 34.52 Favored Pre-proline 0 N--CA 1.486 1.357 0 O-C-N 121.146 -0.971 . . . . 10.0 108.869 178.382 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 43.4 Cg_endo -68.95 100.09 0.7 Allowed 'Trans proline' 0 C--N 1.306 -1.695 0 O-C-N 123.67 1.353 . . . . 10.0 112.928 -177.738 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.56 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.2 m -149.17 126.01 11.17 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.597 -0.69 . . . . 10.0 109.575 177.466 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.411 ' HA ' ' O ' ' A' ' 43' ' ' THR . 5.9 p-10 -170.89 148.82 2.91 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.395 -1.441 . . . . 10.0 113.15 -179.389 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 1.056 ' O ' HG22 ' A' ' 42' ' ' VAL . 5.4 m-85 -129.63 -176.33 3.87 Favored 'General case' 0 N--CA 1.492 1.646 0 N-CA-C 108.313 -0.995 . . . . 10.0 108.313 178.042 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.512 ' N ' ' O ' ' A' ' 41' ' ' ALA . 0.0 OUTLIER -173.81 149.77 1.6 Allowed 'General case' 0 N--CA 1.496 1.844 0 O-C-N 120.592 -1.318 . . . . 10.0 112.436 -179.78 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.54 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 2.9 t60 -171.29 117.34 0.44 Allowed 'General case' 0 N--CA 1.498 1.938 0 O-C-N 121.537 -0.727 . . . . 10.0 110.068 178.313 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.561 ' HA ' ' HB3' ' A' ' 39' ' ' ASN . 9.3 t -128.82 158.46 38.63 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.868 -1.145 . . . . 10.0 112.261 -178.62 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.647 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -121.5 -168.58 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 N-CA-C 109.265 -0.642 . . . . 10.0 109.265 178.875 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.642 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 63.1 m80 -136.25 157.28 47.2 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.66 -1.275 . . . . 10.0 111.877 -179.366 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.966 HG11 ' HB ' ' A' ' 35' ' ' THR . 10.2 p -97.63 153.45 3.91 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 O-C-N 121.538 -0.726 . . . . 10.0 112.062 -179.165 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HB2' ' A' ' 61' ' ' GLN . . . -108.41 65.48 0.25 Allowed Glycine 0 N--CA 1.488 2.113 0 N-CA-C 107.669 -2.172 . . . . 10.0 107.669 177.612 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.741 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER 175.32 114.24 0.02 OUTLIER 'General case' 0 C--N 1.308 -1.215 0 O-C-N 121.433 -1.039 . . . . 10.0 108.673 -178.978 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.541 ' HA ' HG21 ' A' ' 35' ' ' THR . 32.4 t70 -62.1 152.4 32.93 Favored 'General case' 0 N--CA 1.498 1.953 0 O-C-N 121.28 -0.888 . . . . 10.0 112.349 -178.224 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.65 ' HA ' HG13 ' A' ' 33' ' ' VAL . . . 37.82 71.78 0.14 Allowed 'General case' 0 N--CA 1.502 2.134 0 O-C-N 121.733 -0.604 . . . . 10.0 112.524 179.214 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.771 ' HB ' HG23 ' A' ' 36' ' ' VAL . 15.4 t -113.15 -46.24 5.19 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.534 0 O-C-N 120.966 -1.084 . . . . 10.0 109.767 178.478 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.788 HG23 HG21 ' A' ' 21' ' ' ILE . 1.1 t -82.57 -28.15 31.12 Favored 'General case' 0 C--N 1.303 -1.42 0 CA-C-O 121.31 0.576 . . . . 10.0 110.51 -179.207 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . . . . . . . . . . . -94.72 36.35 3.82 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 108.26 -1.936 . . . . 10.0 108.26 179.255 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.511 ' HA ' ' O ' ' A' ' 28' ' ' PHE . 36.4 tt0 -142.18 128.95 20.48 Favored 'General case' 0 C--N 1.302 -1.497 0 O-C-N 121.554 -0.968 . . . . 10.0 110.953 -179.467 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.709 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.1 OUTLIER -140.9 114.54 8.87 Favored 'General case' 0 C--N 1.284 -2.274 0 CA-C-O 122.233 1.016 . . . . 10.0 109.284 178.391 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.417 ' OG1' ' N ' ' B' ' 31' ' ' GLY . 5.1 p -146.82 -49.22 0.19 Allowed 'General case' 0 C--N 1.293 -1.87 0 CA-C-N 115.572 -0.74 . . . . 10.0 109.576 -179.697 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.417 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . 177.83 89.71 0.08 OUTLIER Glycine 0 N--CA 1.494 2.509 0 N-CA-C 109.063 -1.615 . . . . 10.0 109.063 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.614 HG23 ' HD2' ' B' ' 33' ' ' PRO . 83.1 mt -120.0 147.11 43.71 Favored Pre-proline 0 N--CA 1.496 1.826 0 O-C-N 121.195 -1.179 . . . . 10.0 110.445 -179.385 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.614 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.7 Cg_endo -69.45 129.26 17.6 Favored 'Trans proline' 0 C--N 1.309 -1.54 0 O-C-N 123.754 1.397 . . . . 10.0 109.767 179.559 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.501 ' HG2' ' N ' ' B' ' 38' ' ' ARG . 25.1 tp10 55.92 159.56 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.364 -0.835 . . . . 10.0 109.617 -178.727 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.604 ' O ' ' CE3' ' B' ' 36' ' ' TRP . 72.5 mt-30 -93.08 -27.25 17.07 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.952 -1.092 . . . . 10.0 112.521 -178.193 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.693 ' O ' HD12 ' A' ' 70' ' ' LEU . 0.0 OUTLIER 162.61 38.28 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.169 0 N-CA-C 108.104 -1.073 . . . . 10.0 108.104 -178.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.76 ' HA ' HD12 ' A' ' 70' ' ' LEU . . . -175.19 75.64 0.03 OUTLIER 'General case' 0 C--N 1.29 -2.001 0 N-CA-C 106.591 -1.633 . . . . 10.0 106.591 -178.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.505 ' O ' ' N ' ' B' ' 40' ' ' LEU . 3.9 mtm180 -79.17 50.24 1.04 Allowed 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 107.295 -1.372 . . . . 10.0 107.295 -179.969 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.773 HD23 ' HA ' ' A' ' 71' ' ' SER . 1.2 mp -38.42 -30.09 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.708 0 CA-C-O 122.105 0.955 . . . . 10.0 108.766 -179.329 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.565 ' O ' ' N ' ' B' ' 42' ' ' THR . 0.9 OUTLIER -80.74 34.05 0.33 Allowed 'General case' 0 N--CA 1.489 1.492 0 CA-C-N 115.735 -0.666 . . . . 10.0 110.169 178.744 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.641 ' HG2' HD21 ' A' ' 67' ' ' LEU . 6.2 tp-100 -33.94 -30.25 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.771 0 CA-C-O 121.395 0.617 . . . . 10.0 110.382 -179.419 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 1.058 HG22 ' ND2' ' B' ' 44' ' ' ASN . 20.7 m -110.16 72.17 0.78 Allowed 'General case' 0 C--N 1.3 -1.545 0 N-CA-C 105.575 -2.009 . . . . 10.0 105.575 177.354 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.4 p -44.74 64.34 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.959 0 CA-C-O 121.517 0.675 . . . . 10.0 111.971 -177.159 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 1.058 ' ND2' HG22 ' B' ' 42' ' ' THR . 2.1 m-80 -98.09 141.51 30.94 Favored 'General case' 0 C--N 1.295 -1.777 0 O-C-N 121.657 -0.652 . . . . 10.0 110.31 179.831 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.646 HG22 ' H ' ' B' ' 46' ' ' THR . 21.0 mt 48.0 -178.63 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.49 1.537 0 O-C-N 121.41 -0.806 . . . . 10.0 110.456 179.133 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.646 ' H ' HG22 ' B' ' 45' ' ' ILE . 0.2 OUTLIER . . . . . 0 C--N 1.302 -1.498 0 CA-C-O 118.073 -0.965 . . . . 10.0 109.758 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.406 ' O ' ' HG3' ' A' ' 1' ' ' MET . 3.3 ptp . . . . . 0 N--CA 1.494 1.727 0 CA-C-O 121.807 0.813 . . . . 10.0 109.843 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.479 ' HA ' HD23 ' A' ' 177' ' ' LEU . 0.6 OUTLIER -153.86 -35.63 0.1 Allowed 'General case' 0 C--N 1.301 -1.509 0 N-CA-C 108.911 -0.774 . . . . 10.0 108.911 179.548 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.606 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 89.8 m -53.17 94.28 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.419 0 O-C-N 121.374 -0.829 . . . . 10.0 110.246 179.589 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.697 ' C ' HD13 ' A' ' 4' ' ' ILE . 0.0 OUTLIER -109.12 132.27 57.65 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.681 0 C-N-CA 118.524 -1.271 . . . . 10.0 110.062 178.753 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.855 ' HB3' HG22 ' A' ' 75' ' ' THR . 4.4 mtpp -122.85 104.75 9.47 Favored 'General case' 0 C--N 1.289 -2.062 0 N-CA-C 107.045 -1.465 . . . . 10.0 107.045 178.525 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.565 ' C ' HG22 ' A' ' 7' ' ' VAL . 29.9 p -108.98 152.85 24.4 Favored 'General case' 0 C--N 1.3 -1.577 0 O-C-N 121.143 -0.973 . . . . 10.0 111.75 -177.493 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.621 HG22 HG21 ' A' ' 75' ' ' THR . 0.0 OUTLIER -167.56 162.53 0.63 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.759 -0.588 . . . . 10.0 110.102 178.963 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.517 ' HB ' ' HA3' ' A' ' 15' ' ' GLY . 16.0 m -81.76 137.16 21.67 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.682 0 O-C-N 121.511 -0.743 . . . . 10.0 111.472 -179.159 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.694 HG11 ' HB2' ' A' ' 78' ' ' PHE . 0.2 OUTLIER -152.29 169.78 1.2 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.307 -0.871 . . . . 10.0 109.741 179.076 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.535 ' N ' ' CG2' ' A' ' 9' ' ' VAL . . . 150.39 88.88 0.07 OUTLIER Glycine 0 N--CA 1.488 2.161 0 N-CA-C 109.974 -1.251 . . . . 10.0 109.974 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.423 ' C ' ' O ' ' A' ' 10' ' ' GLY . 3.8 t0 40.88 25.92 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.726 0 O-C-N 121.378 -1.072 . . . . 10.0 111.048 179.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.597 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 71.63 36.85 62.04 Favored Glycine 0 N--CA 1.494 2.534 0 N-CA-C 109.499 -1.44 . . . . 10.0 109.499 179.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.421 ' N ' ' O ' ' A' ' 10' ' ' GLY . . . -108.97 -140.06 0.38 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.532 -0.981 . . . . 10.0 109.657 179.743 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.602 HG12 ' CE2' ' B' ' 29' ' ' PHE . 4.7 m -88.27 161.7 2.72 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 O-C-N 121.184 -0.948 . . . . 10.0 109.648 179.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.517 ' HA3' ' HB ' ' A' ' 8' ' ' VAL . . . -92.2 -174.16 42.09 Favored Glycine 0 N--CA 1.495 2.58 0 N-CA-C 110.274 -1.13 . . . . 10.0 110.274 -179.413 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.644 ' HD3' HG11 ' A' ' 113' ' ' VAL . 0.1 OUTLIER -110.59 -51.1 2.9 Favored 'General case' 0 N--CA 1.491 1.598 0 O-C-N 121.391 -1.064 . . . . 10.0 111.001 -179.757 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.432 ' C ' ' H ' ' A' ' 19' ' ' LEU . 73.7 m -50.8 -36.45 37.21 Favored 'General case' 0 N--CA 1.497 1.887 0 O-C-N 121.036 -1.04 . . . . 10.0 109.041 179.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.786 ' HA ' ' HB2' ' A' ' 28' ' ' PHE . 25.3 p -67.22 4.32 0.97 Allowed 'General case' 0 C--N 1.307 -1.274 0 CA-C-O 122.128 0.966 . . . . 10.0 109.718 178.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.841 HD22 HD21 ' A' ' 160' ' ' LEU . 3.8 mt -110.46 -38.82 5.11 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 120.285 -1.509 . . . . 10.0 110.854 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.598 HD13 ' HA ' ' A' ' 166' ' ' LYS . 21.1 tp -44.63 -46.2 10.01 Favored 'General case' 0 C--N 1.281 -2.411 0 O-C-N 120.853 -1.154 . . . . 10.0 111.227 -178.58 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 1.065 HG22 ' O ' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -90.33 -31.14 5.08 Favored 'Isoleucine or valine' 0 C--N 1.284 -2.266 0 C-N-CA 117.093 -1.843 . . . . 10.0 109.858 179.372 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.805 ' OG ' HD23 ' A' ' 160' ' ' LEU . 21.9 t -47.44 -44.14 24.6 Favored 'General case' 0 C--N 1.282 -2.358 0 C-N-CA 119.346 -0.942 . . . . 10.0 110.311 -179.567 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.511 ' HB2' ' C ' ' A' ' 159' ' ' ALA . 67.0 t80 -86.42 -0.89 56.94 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 120.55 -1.344 . . . . 10.0 109.951 178.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.572 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 4.3 m -108.93 -42.87 4.34 Favored 'General case' 0 N--CA 1.499 2.019 0 O-C-N 120.851 -1.155 . . . . 10.0 113.984 -178.298 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.841 HG22 ' OD1' ' A' ' 26' ' ' ASN . 60.0 m -117.38 -93.06 0.51 Allowed 'General case' 0 N--CA 1.485 1.289 0 O-C-N 119.95 -1.719 . . . . 10.0 111.515 -177.196 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.841 ' OD1' HG22 ' A' ' 25' ' ' THR . 0.1 OUTLIER -135.81 -21.64 1.47 Allowed 'General case' 0 N--CA 1.503 2.214 0 O-C-N 121.277 -0.889 . . . . 10.0 110.34 -179.677 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 1.065 ' O ' HG22 ' A' ' 21' ' ' ILE . 14.4 mttt -148.87 -139.32 0.09 Allowed 'General case' 0 C--O 1.195 -1.764 0 N-CA-C 105.729 -1.952 . . . . 10.0 105.729 177.173 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.786 ' HB2' ' HA ' ' A' ' 18' ' ' CYS . 0.1 OUTLIER -124.25 18.89 0.08 OUTLIER Pre-proline 0 C--N 1.285 -2.203 0 C-N-CA 116.357 -2.137 . . . . 10.0 115.384 179.022 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' CD ' ' N ' ' A' ' 28' ' ' PHE . 46.2 Cg_endo -73.61 -94.73 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.459 0 N-CA-C 109.192 -1.118 . . . . 10.0 109.192 176.451 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.588 ' HA ' ' CD1' ' A' ' 21' ' ' ILE . 0.3 OUTLIER -155.48 -12.29 0.11 Allowed 'General case' 0 N--CA 1.503 2.178 0 O-C-N 120.878 -1.139 . . . . 10.0 112.55 179.12 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.584 ' C ' HG21 ' A' ' 25' ' ' THR . 6.2 pt-20 -172.47 -170.76 0.74 Allowed 'General case' 0 C--N 1.287 -2.145 0 N-CA-C 107.252 -1.388 . . . . 10.0 107.252 -179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.481 ' C ' HG23 ' A' ' 33' ' ' VAL . 75.6 t80 -49.19 98.16 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.806 0 N-CA-C 106.638 -1.616 . . . . 10.0 106.638 178.522 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.802 HG13 ' HD2' ' A' ' 34' ' ' PRO 0.325 60.9 t -152.99 158.92 32.81 Favored Pre-proline 0 C--N 1.3 -1.564 0 O-C-N 121.721 -0.612 . . . . 10.0 109.666 -175.325 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.802 ' HD2' HG13 ' A' ' 33' ' ' VAL . 39.9 Cg_endo -66.69 171.34 11.01 Favored 'Trans proline' 0 N--CA 1.491 1.367 0 O-C-N 123.155 1.081 . . . . 10.0 110.707 178.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.662 ' CG2' ' CZ ' ' A' ' 28' ' ' PHE . 2.9 m -96.86 146.37 24.99 Favored 'General case' 0 N--CA 1.499 2.009 0 O-C-N 121.115 -0.991 . . . . 10.0 111.369 -178.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.852 ' CG1' HG11 ' B' ' 20' ' ' VAL . 38.6 t 77.46 -15.68 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.058 0 N-CA-C 112.128 0.418 . . . . 10.0 112.128 178.359 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.763 ' O ' ' CG ' ' A' ' 37' ' ' PHE . 0.3 OUTLIER -33.75 87.4 0.0 OUTLIER 'General case' 0 N--CA 1.499 1.998 0 CA-C-O 122.141 0.972 . . . . 10.0 110.648 179.276 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.6 ' N ' ' O ' ' A' ' 36' ' ' VAL . 0.4 OUTLIER -170.15 112.22 0.44 Allowed 'General case' 0 C--N 1.289 -2.033 0 O-C-N 119.374 -2.079 . . . . 10.0 112.221 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.594 ' HB3' ' CG1' ' B' ' 18' ' ' ILE . 0.9 OUTLIER -166.4 96.93 0.58 Allowed 'General case' 0 C--N 1.3 -1.558 0 O-C-N 121.217 -0.927 . . . . 10.0 108.558 178.016 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.592 ' CE1' HG22 ' B' ' 17' ' ' THR . 17.4 p90 -171.77 176.95 3.5 Favored 'General case' 0 N--CA 1.487 1.393 0 C-N-CA 119.354 -0.938 . . . . 10.0 111.271 -179.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.57 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -171.23 98.34 0.2 Allowed 'General case' 0 N--CA 1.49 1.551 0 N-CA-C 109.193 -0.669 . . . . 10.0 109.193 179.534 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.773 HG21 ' O ' ' B' ' 15' ' ' GLU . 16.6 m -157.5 -166.12 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.492 1.648 0 O-C-N 121.189 -0.945 . . . . 10.0 110.712 -179.484 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.684 HG23 ' O ' ' A' ' 51' ' ' TYR . 24.1 m -105.35 166.83 10.15 Favored 'General case' 0 N--CA 1.495 1.8 0 C-N-CA 119.967 -0.693 . . . . 10.0 111.319 -178.713 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.58 ' CG1' HD11 ' A' ' 46' ' ' ILE . 2.9 t -127.7 139.18 52.62 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.447 0 N-CA-C 108.398 -0.964 . . . . 10.0 108.398 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.738 ' O ' HD23 ' B' ' 10' ' ' LEU . 3.1 mtt -102.57 102.16 12.37 Favored 'General case' 0 N--CA 1.492 1.668 0 C-N-CA 118.349 -1.34 . . . . 10.0 110.426 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.58 HD11 ' CG1' ' A' ' 44' ' ' VAL . 2.3 mp -110.24 118.59 57.38 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 O-C-N 121.003 -1.06 . . . . 10.0 110.167 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.589 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 54.41 16.96 7.48 Favored Glycine 0 N--CA 1.493 2.493 0 N-CA-C 110.178 -1.169 . . . . 10.0 110.178 179.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 95.03 18.35 34.45 Favored Glycine 0 N--CA 1.497 2.704 0 N-CA-C 109.381 -1.488 . . . . 10.0 109.381 -179.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.401 ' HA ' ' HD2' ' A' ' 50' ' ' PRO . 68.2 mm-40 -110.59 115.89 53.21 Favored Pre-proline 0 C--N 1.303 -1.452 0 O-C-N 121.39 -1.065 . . . . 10.0 110.315 -179.818 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.451 ' O ' ' OE1' ' A' ' 2' ' ' GLN . 45.8 Cg_endo -69.24 119.4 6.38 Favored 'Trans proline' 0 C--N 1.306 -1.686 0 O-C-N 123.824 1.434 . . . . 10.0 110.272 179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.684 ' O ' HG23 ' A' ' 43' ' ' THR . 3.9 m-30 -97.52 179.93 4.69 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.034 -1.041 . . . . 10.0 110.72 -179.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.691 ' O ' HG22 ' A' ' 4' ' ' ILE . 5.0 m -146.27 132.66 19.62 Favored 'General case' 0 N--CA 1.492 1.641 0 O-C-N 121.232 -0.917 . . . . 10.0 110.039 -179.834 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.674 ' O ' HD12 ' A' ' 53' ' ' LEU . 1.3 pp -172.27 174.04 4.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 120.739 -1.225 . . . . 10.0 111.593 178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -173.87 105.4 0.21 Allowed Glycine 0 N--CA 1.487 2.097 0 N-CA-C 108.163 -1.975 . . . . 10.0 108.163 -179.998 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.942 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.9 OUTLIER -105.52 135.48 46.84 Favored 'General case' 0 N--CA 1.488 1.441 0 O-C-N 120.64 -1.506 . . . . 10.0 110.409 -179.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.942 ' N ' HD22 ' A' ' 55' ' ' LEU . 16.1 m-85 -129.03 103.25 6.89 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.313 -0.867 . . . . 10.0 110.649 -179.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' O ' ' C ' ' A' ' 58' ' ' THR . 51.1 t0 -105.96 121.04 43.28 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 121.255 -0.903 . . . . 10.0 109.421 179.356 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.487 ' O ' HG23 ' A' ' 58' ' ' THR . 13.7 t -39.4 129.39 1.82 Allowed 'General case' 0 N--CA 1.493 1.718 0 O-C-N 121.074 -1.016 . . . . 10.0 111.466 -179.153 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.548 ' HB2' ' CE1' ' A' ' 64' ' ' TYR . . . -72.17 -73.52 0.19 Allowed 'General case' 0 N--CA 1.502 2.172 0 O-C-N 121.811 -0.556 . . . . 10.0 111.515 -179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . 69.98 7.4 59.29 Favored Glycine 0 N--CA 1.49 2.271 0 N-CA-C 108.985 -1.646 . . . . 10.0 108.985 -178.832 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.432 ' O ' ' C ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER 177.91 -26.02 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.595 0 O-C-N 121.342 -1.093 . . . . 10.0 110.903 179.635 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.999 ' HG2' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -41.87 -71.14 0.09 Allowed 'General case' 0 N--CA 1.498 1.942 0 O-C-N 120.858 -1.152 . . . . 10.0 110.383 -179.492 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.568 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 7.2 t70 164.34 -13.77 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.087 0 O-C-N 121.698 -0.626 . . . . 10.0 110.697 179.68 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.548 ' CE1' ' HB2' ' A' ' 59' ' ' ALA . 38.2 p90 -110.86 17.33 20.65 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 120.865 -1.147 . . . . 10.0 109.312 179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.525 ' HA ' ' HB3' ' A' ' 68' ' ' ARG . 35.1 t70 -49.52 -23.7 1.73 Allowed 'General case' 0 C--N 1.302 -1.489 0 O-C-N 121.434 -0.791 . . . . 10.0 109.503 179.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 5.4 ttt-85 -49.92 -36.62 28.26 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 121.04 -1.038 . . . . 10.0 109.223 178.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.6 mt -92.66 11.49 26.5 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 121.505 -0.747 . . . . 10.0 110.041 179.621 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.658 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -73.37 -22.13 0.48 Allowed Pre-proline 0 N--CA 1.496 1.852 0 O-C-N 121.275 -0.891 . . . . 10.0 112.959 -179.435 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.658 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 42.8 Cg_endo -78.21 85.12 1.87 Allowed 'Trans proline' 0 C--N 1.322 -0.834 0 CA-C-O 121.944 0.727 . . . . 10.0 110.546 -179.398 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.578 ' CD1' ' CD1' ' B' ' 39' ' ' LEU . 0.0 OUTLIER -129.27 -47.15 1.2 Allowed 'General case' 0 N--CA 1.497 1.887 0 CA-C-O 121.795 0.807 . . . . 10.0 109.091 179.883 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.881 ' CB ' HD23 ' B' ' 40' ' ' LEU . 5.6 m 59.91 12.78 3.26 Favored 'General case' 0 C--N 1.297 -1.697 0 CA-C-N 115.941 -0.572 . . . . 10.0 110.948 178.81 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 3.4 m-85 -101.98 110.4 62.21 Favored Pre-proline 0 N--CA 1.494 1.75 0 O-C-N 121.079 -1.013 . . . . 10.0 112.038 -178.81 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.422 ' C ' ' HG3' ' A' ' 74' ' ' GLN . 48.6 Cg_endo -76.93 148.59 28.2 Favored 'Trans proline' 0 C--N 1.308 -1.566 0 O-C-N 124.107 1.583 . . . . 10.0 110.7 178.811 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.559 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -175.04 67.48 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.414 0 O-C-N 121.303 -0.873 . . . . 10.0 109.283 179.571 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.855 HG22 ' HB3' ' A' ' 5' ' ' LYS . 0.0 OUTLIER -143.18 87.35 1.96 Allowed 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.101 -1.0 . . . . 10.0 109.982 -179.161 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.489 ' C ' ' O ' ' A' ' 75' ' ' THR . 9.6 m-20 -20.29 -44.6 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.153 0 N-CA-C 113.456 0.91 . . . . 10.0 113.456 -178.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.804 HG12 ' CG ' ' A' ' 109' ' ' PRO . 1.1 m -110.5 144.32 18.76 Favored 'Isoleucine or valine' 0 N--CA 1.499 2.016 0 O-C-N 120.818 -1.176 . . . . 10.0 111.26 -179.02 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.694 ' HB2' HG11 ' A' ' 9' ' ' VAL . 0.0 OUTLIER -156.25 157.41 35.76 Favored 'General case' 0 N--CA 1.498 1.939 0 O-C-N 121.118 -0.989 . . . . 10.0 110.977 179.568 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.668 ' CD1' HG12 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -107.32 98.65 8.25 Favored 'General case' 0 N--CA 1.491 1.58 0 N-CA-C 108.231 -1.026 . . . . 10.0 108.231 178.423 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.58 ' CG1' ' CE2' ' A' ' 82' ' ' PHE . 3.9 p -85.07 148.31 4.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.604 0 O-C-N 121.394 -0.816 . . . . 10.0 109.95 -179.429 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.65 ' HB3' HG22 ' A' ' 115' ' ' THR . 41.1 m -117.26 103.16 9.9 Favored 'General case' 0 N--CA 1.493 1.694 0 C-N-CA 118.767 -1.173 . . . . 10.0 113.516 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.859 ' C ' HG23 ' A' ' 115' ' ' THR . 43.8 m-85 -99.84 147.69 25.23 Favored 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.293 -0.879 . . . . 10.0 109.232 177.063 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.471 ' HA ' ' OG1' ' A' ' 115' ' ' THR . 46.6 t -90.42 141.1 29.08 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.513 -1.367 . . . . 10.0 108.95 178.28 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.557 HG21 ' HG3' ' A' ' 120' ' ' ARG . 2.0 t -80.32 5.58 1.42 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.251 -0.905 . . . . 10.0 110.375 -179.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 1.021 HG23 HD23 ' A' ' 129' ' ' LEU . 33.9 m -143.31 59.04 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.301 -1.538 0 CA-C-O 121.931 0.872 . . . . 10.0 109.82 -179.297 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.588 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 2.7 p -125.13 -165.53 0.08 OUTLIER Pre-proline 0 C--N 1.287 -2.125 0 O-C-N 121.376 -0.828 . . . . 10.0 108.773 -179.848 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.588 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 43.4 Cg_endo -76.18 60.76 6.38 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.277 1.146 . . . . 10.0 109.621 179.512 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.452 ' C ' ' O ' ' A' ' 87' ' ' PRO . 43.6 p 32.86 51.5 0.26 Allowed 'General case' 0 N--CA 1.498 1.936 0 CA-C-O 121.104 0.478 . . . . 10.0 111.54 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 60.1 p -77.02 -25.42 52.58 Favored 'General case' 0 N--CA 1.492 1.633 0 O-C-N 121.156 -0.965 . . . . 10.0 110.807 179.714 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.635 ' O ' HG22 ' A' ' 93' ' ' VAL . 73.0 t80 -59.22 -40.21 85.14 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.17 -0.956 . . . . 10.0 111.51 -178.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.514 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 0.0 OUTLIER -70.77 -22.87 62.34 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.914 -1.116 . . . . 10.0 110.828 -179.346 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.714 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -86.13 -20.8 28.12 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 120.807 -1.183 . . . . 10.0 109.97 179.888 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.714 HG13 ' ND2' ' A' ' 92' ' ' ASN . 23.1 m -84.23 -29.49 7.2 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.503 0 C-N-CA 119.151 -1.02 . . . . 10.0 109.931 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.578 ' O ' HG23 ' A' ' 98' ' ' VAL . 0.0 OUTLIER -70.87 -34.03 71.2 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.072 -1.018 . . . . 10.0 109.6 179.229 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.57 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 7.2 pt-20 -80.26 -8.22 59.36 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.334 -0.853 . . . . 10.0 110.971 -179.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.577 ' O ' ' HG3' ' A' ' 100' ' ' GLU . 2.1 mmtm -81.73 -52.75 6.83 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 120.847 -1.158 . . . . 10.0 111.655 -179.293 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 71.2 m95 -73.24 -9.88 59.17 Favored 'General case' 0 C--N 1.294 -1.829 0 O-C-N 120.982 -1.073 . . . . 10.0 112.202 -178.636 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.911 HG22 HD21 ' A' ' 149' ' ' LEU . 77.6 t -76.48 -50.2 2.75 Favored Pre-proline 0 N--CA 1.492 1.626 0 O-C-N 120.621 -1.3 . . . . 10.0 110.828 -179.502 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.602 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 49.1 Cg_endo -73.42 -25.8 14.96 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 O-C-N 123.209 1.11 . . . . 10.0 110.647 179.431 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.577 ' HG3' ' O ' ' A' ' 96' ' ' LYS . 2.0 mt-10 -77.07 -23.74 51.96 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.287 -0.883 . . . . 10.0 110.998 -179.528 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.505 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 49.0 mm 60.15 103.69 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.766 0 O-C-N 121.026 -1.046 . . . . 10.0 110.329 -179.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.667 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.3 m -47.04 -85.28 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.193 -0.942 . . . . 10.0 108.623 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.667 ' N ' HG22 ' A' ' 102' ' ' THR . 5.5 m170 -112.1 -4.85 14.33 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.323 -0.861 . . . . 10.0 109.51 177.961 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.521 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.0 OUTLIER 160.87 -34.55 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.793 0 N-CA-C 107.401 -1.333 . . . . 10.0 107.401 -179.563 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 50.8 t -142.26 137.37 15.61 Favored Pre-proline 0 C--N 1.302 -1.457 0 N-CA-C 108.387 -0.968 . . . . 10.0 108.387 178.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' A' ' 149' ' ' LEU . 44.1 Cg_endo -69.82 80.29 0.91 Allowed 'Trans proline' 0 C--N 1.301 -1.926 0 O-C-N 123.681 1.358 . . . . 10.0 110.68 -178.841 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.419 ' O ' ' C ' ' A' ' 108' ' ' THR . 34.4 mtpt -118.16 -14.44 9.89 Favored 'General case' 0 N--CA 1.489 1.48 0 O-C-N 121.469 -0.77 . . . . 10.0 111.181 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.493 ' OG1' HG21 ' A' ' 102' ' ' THR . 52.1 m -46.3 136.08 7.06 Favored Pre-proline 0 N--CA 1.492 1.643 0 O-C-N 120.718 -1.239 . . . . 10.0 109.884 179.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.804 ' CG ' HG12 ' A' ' 77' ' ' VAL . 37.5 Cg_endo -64.9 111.9 1.86 Allowed 'Trans proline' 0 C--N 1.305 -1.726 0 O-C-N 123.989 1.521 . . . . 10.0 110.211 179.755 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.553 ' O ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -117.94 103.88 10.37 Favored 'General case' 0 C--N 1.302 -1.473 0 CA-C-O 121.757 0.789 . . . . 10.0 110.209 -179.705 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.132 HD13 HG11 ' A' ' 152' ' ' VAL . 1.7 mm? -77.41 98.57 5.3 Favored 'General case' 0 C--N 1.298 -1.651 0 N-CA-C 108.515 -0.92 . . . . 10.0 108.515 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.557 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 90.0 mt -74.03 135.82 43.08 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.384 -0.969 . . . . 10.0 108.384 -179.908 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.693 HG22 HG23 ' A' ' 155' ' ' VAL . 10.8 t -143.28 169.73 11.23 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 120.886 -1.134 . . . . 10.0 112.552 -177.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.527 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.87 153.88 19.54 Favored Glycine 0 N--CA 1.486 1.968 0 N-CA-C 107.479 -2.248 . . . . 10.0 107.479 177.826 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.859 HG23 ' C ' ' A' ' 82' ' ' PHE . 76.3 p -101.04 127.57 47.49 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 120.497 -1.59 . . . . 10.0 111.057 -179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.471 ' HG2' ' OD2' ' A' ' 118' ' ' ASP . 0.8 OUTLIER 40.31 55.06 2.82 Favored 'General case' 0 N--CA 1.488 1.443 0 C-N-CA 119.849 -0.74 . . . . 10.0 110.16 178.317 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.998 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -40.78 -28.05 0.11 Allowed 'Isoleucine or valine' 0 N--CA 1.504 2.233 0 C-N-CA 119.467 -0.893 . . . . 10.0 110.16 -178.866 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.671 ' O ' HD13 ' A' ' 119' ' ' LEU . 2.3 p-10 -52.69 60.08 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.21 0 CA-C-O 122.17 0.986 . . . . 10.0 110.524 -177.586 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 1.052 ' HG ' HG21 ' A' ' 125' ' ' THR . 0.4 OUTLIER 161.77 -27.95 0.0 OUTLIER 'General case' 0 C--N 1.283 -2.296 0 N-CA-C 107.546 -1.279 . . . . 10.0 107.546 -178.994 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.557 ' HG3' HG21 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.09 -38.33 11.17 Favored 'General case' 0 C--N 1.304 -1.378 0 N-CA-C 108.733 -0.84 . . . . 10.0 108.733 178.316 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 2.8 p30 -89.77 17.75 6.28 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.438 -0.789 . . . . 10.0 110.326 179.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.69 ' OD1' HG22 ' A' ' 125' ' ' THR . 6.9 t70 -104.28 110.84 64.81 Favored Pre-proline 0 N--CA 1.494 1.754 0 O-C-N 121.328 -0.857 . . . . 10.0 110.857 -179.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.7 Cg_endo -80.32 15.46 1.73 Allowed 'Trans proline' 0 C--N 1.31 -1.453 0 O-C-N 124.072 1.564 . . . . 10.0 110.779 179.219 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.414 ' HB3' ' OD1' ' A' ' 122' ' ' ASP . 47.1 t -109.89 -49.93 3.03 Favored 'General case' 0 N--CA 1.49 1.543 0 O-C-N 121.138 -0.976 . . . . 10.0 109.857 -179.617 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 1.052 HG21 ' HG ' ' A' ' 119' ' ' LEU . 4.7 t -73.67 -24.39 59.96 Favored 'General case' 0 C--N 1.295 -1.794 0 N-CA-C 105.515 -2.031 . . . . 10.0 105.515 177.083 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.738 HD11 HG11 ' A' ' 85' ' ' VAL 0.301 0.6 OUTLIER -59.98 -20.64 20.1 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.49 0 N-CA-C 107.524 -1.287 . . . . 10.0 107.524 176.859 . . . . . . . . 4 4 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 43.2 tt0 -48.26 -45.34 34.43 Favored 'General case' 0 C--N 1.302 -1.468 0 O-C-N 121.672 -0.642 . . . . 10.0 110.396 -179.521 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.556 ' C ' HD12 ' A' ' 129' ' ' LEU . 36.5 mmtt -84.96 -13.77 49.65 Favored 'General case' 0 C--N 1.295 -1.763 0 O-C-N 121.425 -0.797 . . . . 10.0 110.36 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 1.021 HD23 HG23 ' A' ' 85' ' ' VAL . 6.1 mp -95.91 -40.45 9.29 Favored 'General case' 0 N--CA 1.496 1.837 0 O-C-N 121.233 -0.917 . . . . 10.0 109.554 179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.506 ' HB2' HG23 ' A' ' 126' ' ' ILE . . . -57.96 -39.67 78.69 Favored 'General case' 0 N--CA 1.491 1.603 0 O-C-N 121.137 -0.977 . . . . 10.0 109.72 179.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.483 ' HG2' ' O ' ' A' ' 128' ' ' LYS . 11.2 pttt -55.66 -20.31 13.59 Favored 'General case' 0 N--CA 1.486 1.354 0 O-C-N 121.398 -0.814 . . . . 10.0 109.746 179.821 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.533 ' ND2' ' O ' ' A' ' 129' ' ' LEU . 0.7 OUTLIER -118.69 9.64 12.21 Favored 'General case' 0 N--CA 1.487 1.396 0 O-C-N 121.351 -0.843 . . . . 10.0 109.299 178.723 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.524 ' CE ' ' HB3' ' A' ' 136' ' ' PRO . 2.3 tmtt? -141.0 82.99 1.86 Allowed 'General case' 0 C--N 1.305 -1.365 0 N-CA-C 109.102 -0.703 . . . . 10.0 109.102 -179.575 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.486 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 1.3 mp0 -65.39 -24.44 67.22 Favored 'General case' 0 N--CA 1.493 1.715 0 O-C-N 121.131 -0.98 . . . . 10.0 110.409 -179.813 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.434 ' HA ' ' HD2' ' A' ' 135' ' ' LYS . 3.2 mmmm -132.79 115.88 14.58 Favored Pre-proline 0 N--CA 1.49 1.561 0 O-C-N 121.406 -0.809 . . . . 10.0 109.422 179.248 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.524 ' HB3' ' CE ' ' A' ' 133' ' ' LYS . 40.1 Cg_endo -67.01 159.4 52.18 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.799 1.421 . . . . 10.0 110.494 -179.827 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.528 ' O ' ' CG1' ' A' ' 84' ' ' VAL . 0.3 OUTLIER -103.95 134.29 45.62 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.386 0 O-C-N 121.289 -0.882 . . . . 10.0 109.564 -179.863 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.472 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 33.1 p -125.87 164.46 33.01 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.367 -0.833 . . . . 10.0 109.541 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.475 ' O ' ' HB2' ' A' ' 143' ' ' GLU . 38.6 Cg_endo -65.64 -13.65 40.86 Favored 'Trans proline' 0 C--N 1.303 -1.838 0 O-C-N 123.883 1.465 . . . . 10.0 109.823 -179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.5 mt-10 -84.98 -20.86 29.9 Favored 'General case' 0 N--CA 1.487 1.375 0 C-N-CA 119.764 -0.774 . . . . 10.0 110.1 179.16 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 2.0 m -96.74 -42.32 8.06 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.306 -0.871 . . . . 10.0 110.744 -179.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.897 ' HB3' ' CD2' ' A' ' 154' ' ' TYR . . . -73.79 -26.42 60.62 Favored 'General case' 0 N--CA 1.491 1.625 0 O-C-N 121.06 -1.025 . . . . 10.0 110.488 -179.722 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.475 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.9 tt0 -61.22 -39.07 88.88 Favored 'General case' 0 N--CA 1.492 1.647 0 O-C-N 121.135 -0.978 . . . . 10.0 109.847 179.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 3.8 mmpt? -65.69 -40.1 91.95 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.269 -0.895 . . . . 10.0 109.1 179.241 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.697 ' O ' HD23 ' A' ' 145' ' ' LEU . 4.1 tt -63.04 -40.7 98.51 Favored 'General case' 0 C--N 1.306 -1.301 0 O-C-N 121.367 -0.833 . . . . 10.0 109.238 179.098 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.465 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -63.58 -44.84 92.91 Favored 'General case' 0 N--CA 1.49 1.566 0 CA-C-O 121.821 0.819 . . . . 10.0 109.088 179.154 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.1 tpt180 -59.91 -25.8 65.42 Favored 'General case' 0 C--N 1.297 -1.717 0 C-N-CA 120.361 -0.536 . . . . 10.0 110.306 179.729 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.415 ' HB3' HD13 ' A' ' 149' ' ' LEU . 34.8 t0 -70.26 -48.8 55.23 Favored 'General case' 0 N--CA 1.495 1.796 0 O-C-N 121.09 -1.006 . . . . 10.0 110.827 -179.347 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.911 HD21 HG22 ' A' ' 98' ' ' VAL . 1.5 mp -93.11 24.55 3.71 Favored 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.059 -1.026 . . . . 10.0 108.931 179.325 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.474 ' O ' ' O ' ' A' ' 151' ' ' ALA . 1.0 OUTLIER 51.91 27.3 4.21 Favored 'General case' 0 C--N 1.294 -1.819 0 CA-C-O 121.741 0.781 . . . . 10.0 109.389 179.818 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.474 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -57.04 -160.19 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 N-CA-C 109.167 -0.679 . . . . 10.0 109.167 179.346 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.132 HG11 HD13 ' A' ' 111' ' ' LEU . 7.3 p -108.49 -65.71 1.42 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.407 0 O-C-N 120.677 -1.264 . . . . 10.0 111.761 -179.639 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.763 ' H ' HG13 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.02 157.74 2.98 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.016 -1.678 . . . . 10.0 112.106 179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.897 ' CD2' ' HB3' ' A' ' 142' ' ' ALA . 4.1 t80 -107.61 112.61 25.41 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 121.198 -0.939 . . . . 10.0 110.107 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.95 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -103.36 -168.05 0.21 Allowed 'Isoleucine or valine' 0 N--CA 1.503 2.175 0 O-C-N 121.429 -0.794 . . . . 10.0 110.604 179.517 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.447 ' O ' ' SG ' ' A' ' 157' ' ' CYS . 22.4 tt0 -170.28 98.55 0.27 Allowed 'General case' 0 N--CA 1.501 2.1 0 O-C-N 121.221 -0.924 . . . . 10.0 109.749 -179.828 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.547 ' CB ' ' CA ' ' A' ' 165' ' ' LEU . 73.8 m -153.0 156.35 38.65 Favored 'General case' 0 N--CA 1.502 2.13 0 O-C-N 121.107 -0.996 . . . . 10.0 111.608 -178.904 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.686 ' OG ' HG23 ' A' ' 117' ' ' ILE . 3.7 m -140.86 114.75 9.04 Favored 'General case' 0 C--N 1.299 -1.604 0 N-CA-C 108.116 -1.068 . . . . 10.0 108.116 178.867 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.835 ' CB ' ' HB3' ' A' ' 19' ' ' LEU . . . -74.09 -87.15 0.03 OUTLIER 'General case' 0 N--CA 1.496 1.849 0 O-C-N 120.428 -1.42 . . . . 10.0 111.025 -178.506 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.841 HD21 HD22 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -31.32 -33.67 0.01 OUTLIER 'General case' 0 N--CA 1.51 2.543 0 CA-C-O 122.32 1.057 . . . . 10.0 109.383 -179.586 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.621 ' N ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -93.94 -70.79 0.69 Allowed 'General case' 0 C--N 1.301 -1.506 0 CA-C-N 115.341 -0.845 . . . . 10.0 112.218 -178.906 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.582 ' N ' ' O ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -109.13 -107.71 0.34 Allowed 'General case' 0 N--CA 1.487 1.418 0 O-C-N 120.377 -1.452 . . . . 10.0 112.021 -178.721 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.541 ' HB3' ' O ' ' A' ' 162' ' ' GLN . 12.2 pttt 174.48 -169.36 0.04 OUTLIER 'General case' 0 N--CA 1.497 1.917 0 O-C-N 121.425 -0.797 . . . . 10.0 109.521 -178.62 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 82.25 -11.58 49.1 Favored Glycine 0 N--CA 1.498 2.806 0 C-N-CA 120.145 -1.026 . . . . 10.0 110.75 178.357 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.716 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -59.39 -2.07 0.28 Allowed 'General case' 0 N--CA 1.496 1.831 0 O-C-N 121.409 -1.054 . . . . 10.0 113.097 -179.289 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.598 ' HA ' HD13 ' A' ' 20' ' ' LEU . 8.9 tttt -59.69 -48.84 80.08 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.39 -1.444 . . . . 10.0 110.432 179.212 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 16.9 t-20 -56.45 -39.75 73.66 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.437 -0.789 . . . . 10.0 111.755 -179.216 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.95 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.3 t -53.74 -48.34 61.06 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.489 0 O-C-N 120.819 -1.175 . . . . 10.0 111.034 -179.13 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -78.6 -37.97 41.13 Favored 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.242 -0.911 . . . . 10.0 111.368 -179.508 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 16.5 m-20 -60.91 -40.26 92.44 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 120.876 -1.14 . . . . 10.0 110.946 -179.054 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.511 ' HG3' ' HE3' ' A' ' 153' ' ' LYS . 41.0 mm-40 -62.03 -46.05 90.88 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.192 -0.943 . . . . 10.0 111.28 -179.091 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.748 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.36 -24.45 19.54 Favored 'General case' 0 C--N 1.301 -1.539 0 O-C-N 121.123 -0.986 . . . . 10.0 110.379 -179.375 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.671 ' O ' HD12 ' A' ' 177' ' ' LEU . 28.6 mm -63.85 -42.86 97.25 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.446 0 C-N-CA 119.415 -0.914 . . . . 10.0 109.841 -179.982 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.846 ' N ' HD13 ' A' ' 174' ' ' LEU . 0.1 OUTLIER -86.17 -17.07 35.87 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.045 -1.034 . . . . 10.0 111.01 -179.116 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.512 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -98.75 -1.18 41.13 Favored 'General case' 0 C--N 1.302 -1.461 0 O-C-N 120.938 -1.101 . . . . 10.0 109.812 179.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.516 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.96 -40.89 13.54 Favored 'General case' 0 N--CA 1.487 1.377 0 O-C-N 121.264 -0.897 . . . . 10.0 110.36 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.671 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -102.23 -11.83 18.45 Favored 'General case' 0 N--CA 1.496 1.85 0 O-C-N 121.362 -0.836 . . . . 10.0 109.505 -179.514 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 4.3 mm-40 . . . . . 0 N--CA 1.489 1.501 0 CA-C-O 118.04 -0.981 . . . . 10.0 110.025 -179.815 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.468 ' HA3' ' HG2' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.49 2.237 0 N-CA-C 109.418 -1.473 . . . . 10.0 109.418 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 50.2 m -112.37 131.9 55.29 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.172 -1.193 . . . . 10.0 109.886 179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.509 ' HG2' HD12 ' A' ' 174' ' ' LEU . 4.5 mtpt -88.38 99.96 12.66 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.137 -0.977 . . . . 10.0 110.115 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 47.6 mm-40 -95.2 158.72 15.34 Favored 'General case' 0 N--CA 1.487 1.406 0 O-C-N 121.74 -0.6 . . . . 10.0 110.001 -179.681 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.687 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -109.38 -91.15 0.0 OUTLIER Pre-proline 0 C--N 1.305 -1.331 0 O-C-N 121.117 -0.989 . . . . 10.0 109.231 179.322 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.687 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 53.8 Cg_endo -76.57 -10.45 18.71 Favored 'Trans proline' 0 C--N 1.322 -0.827 0 N-CA-C 108.423 -1.414 . . . . 10.0 108.423 178.105 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.516 ' CG ' ' O ' ' B' ' 6' ' ' PRO . 3.3 pt-20 41.25 -162.71 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.408 0 O-C-N 121.776 -0.578 . . . . 10.0 110.121 -179.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.559 ' H ' HD12 ' B' ' 8' ' ' ILE . 0.1 OUTLIER -134.77 -67.35 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 121.034 -1.041 . . . . 10.0 110.579 -179.737 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 47' ' ' GLY . 47.5 t -103.32 132.11 49.84 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.401 -0.812 . . . . 10.0 111.604 -178.207 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.961 ' O ' HD13 ' B' ' 10' ' ' LEU . 1.2 tm? -149.36 101.77 3.32 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 120.598 -1.314 . . . . 10.0 112.158 -179.649 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.59 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -91.2 -168.5 0.26 Allowed 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 122.406 2.071 . . . . 10.0 108.15 177.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 67.0 m -108.97 173.58 6.25 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.736 -1.228 . . . . 10.0 111.25 179.867 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.596 ' CB ' ' O ' ' A' ' 43' ' ' THR . 5.3 m-20 -134.33 -165.22 1.62 Allowed 'General case' 0 N--CA 1.487 1.399 0 CA-C-O 121.799 0.809 . . . . 10.0 111.657 -178.397 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.566 ' CB ' ' CG1' ' A' ' 42' ' ' VAL . 18.5 m-85 -45.39 -166.77 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.48 0 CA-C-O 122.25 1.024 . . . . 10.0 112.426 -179.587 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.773 ' O ' HG21 ' A' ' 42' ' ' VAL . 57.1 mt-10 -41.24 154.6 0.04 OUTLIER 'General case' 0 N--CA 1.5 2.05 0 O-C-N 121.088 -1.008 . . . . 10.0 111.806 -178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.523 ' O ' ' HB3' ' A' ' 40' ' ' TYR . 0.4 OUTLIER -139.32 -171.1 3.04 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.097 -1.002 . . . . 10.0 110.722 -179.85 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.592 HG22 ' CE1' ' A' ' 40' ' ' TYR . 47.2 p -58.65 156.07 11.5 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.769 0.795 . . . . 10.0 112.064 -179.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.602 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.3 pp -128.31 -168.57 0.57 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 N-CA-C 108.609 -0.886 . . . . 10.0 108.609 178.628 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.639 ' HA ' ' HB2' ' A' ' 37' ' ' PHE . 74.0 m-70 -109.19 143.89 38.0 Favored 'General case' 0 N--CA 1.495 1.816 0 O-C-N 120.503 -1.373 . . . . 10.0 112.277 -178.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.999 HG22 ' HG2' ' A' ' 62' ' ' GLU . 33.3 t -130.82 152.28 37.29 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.054 0 O-C-N 121.695 -0.628 . . . . 10.0 110.838 179.363 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.578 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -112.02 -175.17 19.79 Favored Glycine 0 N--CA 1.491 2.308 0 N-CA-C 109.817 -1.313 . . . . 10.0 109.817 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.58 ' CE1' ' O ' ' B' ' 31' ' ' GLY . 46.0 t80 166.37 116.75 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.711 -0.876 . . . . 10.0 108.752 179.754 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.647 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 12.6 t70 -39.41 152.73 0.03 OUTLIER 'General case' 0 N--CA 1.498 1.974 0 C-N-CA 120.105 -0.638 . . . . 10.0 109.508 -179.701 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.647 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 63.11 79.85 0.25 Allowed 'General case' 0 N--CA 1.486 1.368 0 N-CA-C 106.735 -1.58 . . . . 10.0 106.735 -177.214 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.614 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 0.2 OUTLIER -110.5 -21.09 5.83 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.775 0 CA-C-O 121.882 0.849 . . . . 10.0 110.572 -176.658 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.475 ' C ' ' O ' ' A' ' 26' ' ' ASN . 10.0 t -48.79 -15.96 0.11 Allowed 'General case' 0 C--N 1.286 -2.16 0 O-C-N 120.962 -1.086 . . . . 10.0 112.948 -178.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.594 ' HA2' ' O ' ' A' ' 26' ' ' ASN . . . 148.22 85.64 0.06 OUTLIER Glycine 0 N--CA 1.504 3.178 0 N-CA-C 109.358 -1.497 . . . . 10.0 109.358 179.842 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.579 ' O ' HD22 ' A' ' 160' ' ' LEU . 19.7 pm0 -129.82 -146.4 0.31 Allowed 'General case' 0 C--N 1.301 -1.542 0 O-C-N 121.746 -0.855 . . . . 10.0 109.422 179.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.602 ' CE2' HG12 ' A' ' 14' ' ' VAL . 13.9 p90 -135.35 145.23 47.18 Favored 'General case' 0 C--N 1.293 -1.876 0 N-CA-C 108.484 -0.932 . . . . 10.0 108.484 179.883 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' C ' ' B' ' 29' ' ' PHE . 1.7 t 30.99 -129.76 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.082 0.468 . . . . 10.0 110.559 -179.905 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.58 ' O ' ' CE1' ' B' ' 22' ' ' PHE . . . -153.77 -41.63 0.02 OUTLIER Glycine 0 N--CA 1.489 2.215 0 N-CA-C 108.694 -1.762 . . . . 10.0 108.694 179.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.415 HD11 ' OE1' ' B' ' 34' ' ' GLU . 10.7 pt -127.83 145.29 54.48 Favored Pre-proline 0 C--N 1.301 -1.535 0 O-C-N 121.519 -0.989 . . . . 10.0 109.187 179.274 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . . . . . . . . . 43.0 Cg_endo -70.09 83.22 0.77 Allowed 'Trans proline' 0 C--N 1.308 -1.556 0 O-C-N 123.562 1.296 . . . . 10.0 109.925 -178.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.588 ' HG3' ' HB2' ' B' ' 38' ' ' ARG . 2.8 tm-20 -160.13 155.6 25.39 Favored 'General case' 0 C--N 1.302 -1.495 0 O-C-N 121.568 -0.708 . . . . 10.0 110.315 -178.831 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.597 ' HG2' ' CG ' ' B' ' 36' ' ' TRP . 2.2 tt0 -91.59 -71.3 0.64 Allowed 'General case' 0 C--N 1.306 -1.284 0 O-C-N 121.027 -1.046 . . . . 10.0 109.7 -179.658 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.597 ' CG ' ' HG2' ' B' ' 35' ' ' GLN . 0.4 OUTLIER -172.13 13.85 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.111 0 O-C-N 121.103 -0.998 . . . . 10.0 112.571 179.081 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.544 ' O ' ' CB ' ' A' ' 71' ' ' SER . . . -130.32 -19.1 3.16 Favored 'General case' 0 C--N 1.284 -2.256 0 O-C-N 121.478 -0.763 . . . . 10.0 110.468 179.381 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.588 ' HB2' ' HG3' ' B' ' 34' ' ' GLU . 6.6 mtt180 -78.89 6.54 8.93 Favored 'General case' 0 N--CA 1.488 1.456 0 O-C-N 120.404 -1.435 . . . . 10.0 108.108 177.259 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.659 ' HB2' ' N ' ' A' ' 71' ' ' SER . 29.7 mt -43.16 -29.96 0.42 Allowed 'General case' 0 N--CA 1.482 1.163 0 O-C-N 121.941 -0.475 . . . . 10.0 111.01 179.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.881 HD23 ' CB ' ' A' ' 71' ' ' SER . 1.1 pp -95.72 14.8 21.96 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.189 -0.944 . . . . 10.0 110.182 -179.75 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.513 ' O ' ' CG ' ' B' ' 41' ' ' GLN . 5.5 tt0 -158.78 62.52 0.42 Allowed 'General case' 0 C--N 1.292 -1.921 0 CA-C-O 121.462 0.648 . . . . 10.0 109.755 -179.597 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 17.4 p -91.52 -173.63 3.63 Favored 'General case' 0 C--N 1.301 -1.503 0 O-C-N 121.369 -0.832 . . . . 10.0 110.234 -179.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 80.0 p -72.32 9.5 1.0 Allowed 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.373 -0.829 . . . . 10.0 111.36 179.962 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 55.5 m-20 -52.96 -26.06 13.96 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 120.574 -1.329 . . . . 10.0 109.84 179.639 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.7 pt -108.8 168.86 3.47 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.476 0 O-C-N 121.211 -0.931 . . . . 10.0 109.616 179.148 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.4 m . . . . . 0 C--N 1.3 -1.563 0 CA-C-O 117.946 -1.026 . . . . 10.0 110.356 -179.936 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.542 ' O ' ' CA ' ' A' ' 177' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.494 1.727 0 N-CA-C 109.865 -0.42 . . . . 10.0 109.865 . . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.834 ' HA ' HD23 ' A' ' 177' ' ' LEU . 7.9 mm100 -133.1 0.87 3.48 Favored 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.098 -1.002 . . . . 10.0 110.532 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.53 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 17.9 m -64.74 100.62 0.41 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.133 -0.979 . . . . 10.0 110.51 -179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.804 ' HB ' ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -114.65 133.73 59.85 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.545 0 C-N-CA 118.994 -1.082 . . . . 10.0 111.096 179.413 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.624 ' CB ' ' HA ' ' A' ' 75' ' ' THR . 26.2 mmtt -121.23 100.65 7.17 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 108.517 -0.92 . . . . 10.0 108.517 178.75 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 51.1 t -83.21 106.58 15.11 Favored 'General case' 0 C--N 1.3 -1.564 0 O-C-N 121.04 -1.038 . . . . 10.0 109.75 -179.562 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.825 ' HB ' HG21 ' A' ' 75' ' ' THR . 71.7 t -133.67 147.56 30.81 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.544 0 O-C-N 121.208 -0.932 . . . . 10.0 110.11 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.7 ' O ' HG23 ' A' ' 8' ' ' VAL . 14.2 m -91.2 115.72 30.93 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.569 0 O-C-N 121.424 -0.798 . . . . 10.0 110.295 -179.898 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.601 HG22 ' H ' ' A' ' 10' ' ' GLY . 0.5 OUTLIER -139.7 -166.83 0.38 Allowed 'Isoleucine or valine' 0 C--N 1.304 -1.374 0 O-C-N 121.277 -0.889 . . . . 10.0 110.045 179.779 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 1.04 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 126.43 -144.83 15.36 Favored Glycine 0 N--CA 1.493 2.449 0 N-CA-C 109.81 -1.316 . . . . 10.0 109.81 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 23.2 t70 -48.88 -37.84 20.83 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.121 -1.223 . . . . 10.0 109.897 -179.808 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.492 ' O ' ' O ' ' A' ' 13' ' ' ALA . . . 133.8 31.88 0.38 Allowed Glycine 0 N--CA 1.483 1.806 0 N-CA-C 109.948 -1.261 . . . . 10.0 109.948 179.806 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.549 ' O ' HG22 ' B' ' 32' ' ' ILE . . . -61.27 -133.75 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.67 0 O-C-N 120.991 -1.3 . . . . 10.0 109.066 179.439 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.75 HG22 ' CG2' ' B' ' 32' ' ' ILE . 5.0 t -128.93 -24.79 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.859 0 O-C-N 120.546 -1.347 . . . . 10.0 111.144 -179.799 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.572 ' HA2' HG21 ' A' ' 8' ' ' VAL . . . 157.0 128.94 1.09 Allowed Glycine 0 N--CA 1.493 2.442 0 C-N-CA 119.351 -1.404 . . . . 10.0 110.062 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.973 ' HD3' HD12 ' A' ' 79' ' ' LEU . 0.3 OUTLIER -57.77 -24.53 57.56 Favored 'General case' 0 N--CA 1.493 1.683 0 O-C-N 121.205 -1.173 . . . . 10.0 110.154 -179.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.691 HG22 HG22 ' A' ' 35' ' ' THR . 24.8 m -59.37 -32.73 70.4 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.307 -0.871 . . . . 10.0 110.847 -179.755 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.708 ' SG ' HD22 ' A' ' 19' ' ' LEU . 16.6 p -61.0 -29.03 69.46 Favored 'General case' 0 C--N 1.307 -1.262 0 O-C-N 121.138 -0.976 . . . . 10.0 110.388 -179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.708 HD22 ' SG ' ' A' ' 18' ' ' CYS . 0.3 OUTLIER -80.51 -30.31 37.26 Favored 'General case' 0 N--CA 1.487 1.39 0 O-C-N 120.941 -1.1 . . . . 10.0 110.718 179.706 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.457 ' O ' ' OG1' ' A' ' 24' ' ' THR . 12.8 tp -49.2 -30.65 7.26 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.101 -0.999 . . . . 10.0 110.122 -179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.583 HG22 ' O ' ' B' ' 26' ' ' THR . 3.8 mm -106.74 -44.68 7.59 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.367 -0.833 . . . . 10.0 109.7 179.441 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.578 ' HB3' ' HA ' ' A' ' 19' ' ' LEU . 39.6 t -49.7 -40.07 39.12 Favored 'General case' 0 C--N 1.292 -1.918 0 C-N-CA 119.364 -0.934 . . . . 10.0 109.303 179.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.681 ' CE2' HD21 ' A' ' 165' ' ' LEU . 0.1 OUTLIER -82.09 -28.93 32.05 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 120.987 -1.07 . . . . 10.0 109.311 179.068 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.476 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 25.2 m -65.58 -50.22 65.91 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.236 -0.915 . . . . 10.0 110.7 -179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.509 HG23 ' N ' ' A' ' 26' ' ' ASN . 14.7 t -175.24 -37.89 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.143 0 C-N-CA 118.2 -1.4 . . . . 10.0 112.693 179.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.759 ' ND2' HG11 ' A' ' 33' ' ' VAL . 23.3 m120 -70.75 -9.79 58.09 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.156 -0.965 . . . . 10.0 111.985 -177.62 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.636 ' O ' ' HA3' ' B' ' 27' ' ' GLY . 0.8 OUTLIER 33.75 -150.99 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.267 -0.896 . . . . 10.0 110.661 -179.417 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.549 ' HE1' HD22 ' A' ' 160' ' ' LEU . 12.6 p90 -131.31 59.41 45.49 Favored Pre-proline 0 C--N 1.298 -1.658 0 O-C-N 121.167 -0.958 . . . . 10.0 111.437 -178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.837 ' HD2' HG21 ' B' ' 26' ' ' THR . 55.7 Cg_endo -96.02 -89.93 0.0 OUTLIER 'Trans proline' 0 C--N 1.32 -0.943 0 C-N-CA 121.672 1.581 . . . . 10.0 110.618 179.839 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 8.8 m -167.26 67.6 0.09 Allowed 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.063 -1.023 . . . . 10.0 110.92 -179.61 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.59 ' HG3' ' CG2' ' A' ' 33' ' ' VAL . 12.4 pt-20 -134.72 -172.66 3.09 Favored 'General case' 0 C--N 1.305 -1.344 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.796 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.492 ' C ' HG22 ' A' ' 33' ' ' VAL . 53.6 m-85 -109.98 110.24 21.1 Favored 'General case' 0 N--CA 1.498 1.931 0 O-C-N 121.056 -1.028 . . . . 10.0 112.167 -178.761 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.759 HG11 ' ND2' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -155.36 105.78 2.22 Favored Pre-proline 0 N--CA 1.498 1.955 0 N-CA-C 108.181 -1.044 . . . . 10.0 108.181 178.55 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.483 ' C ' HG21 ' B' ' 20' ' ' VAL . 50.0 Cg_endo -72.5 112.78 3.55 Favored 'Trans proline' 0 N--CA 1.495 1.584 0 C-N-CA 121.841 1.694 . . . . 10.0 114.67 -176.412 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.719 ' O ' HG23 ' A' ' 36' ' ' VAL . 16.8 m -157.96 94.49 1.33 Allowed 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.503 -0.748 . . . . 10.0 109.222 176.226 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 35' ' ' THR . 54.9 t -163.62 -96.17 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.503 2.214 0 O-C-N 121.334 -0.854 . . . . 10.0 110.331 179.446 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.719 ' N ' HG12 ' A' ' 36' ' ' VAL . 6.8 t80 -57.22 141.11 47.67 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.174 -0.954 . . . . 10.0 111.122 -179.272 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.615 ' HA ' HD11 ' B' ' 18' ' ' ILE . 4.8 t70 -164.31 101.37 0.84 Allowed 'General case' 0 C--N 1.306 -1.319 0 O-C-N 121.252 -0.905 . . . . 10.0 110.376 179.849 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.642 ' CB ' HG21 ' B' ' 18' ' ' ILE . 0.4 OUTLIER -104.86 118.26 36.1 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 120.237 -1.54 . . . . 10.0 109.279 179.522 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.64 ' CE2' ' HG3' ' B' ' 15' ' ' GLU . 6.5 m-85 -146.72 113.53 6.08 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.068 -1.02 . . . . 10.0 111.107 -179.503 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.466 ' O ' ' HA ' ' B' ' 15' ' ' GLU . . . -118.41 115.29 24.34 Favored 'General case' 0 N--CA 1.498 1.933 0 O-C-N 120.72 -1.238 . . . . 10.0 109.976 178.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.714 HG22 ' H ' ' A' ' 43' ' ' THR . 0.9 OUTLIER -135.94 -168.21 0.51 Allowed 'Isoleucine or valine' 0 C--N 1.306 -1.302 0 O-C-N 120.932 -1.105 . . . . 10.0 111.462 -179.05 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.714 ' H ' HG22 ' A' ' 42' ' ' VAL . 20.2 m -163.71 145.16 9.15 Favored 'General case' 0 C--N 1.297 -1.711 0 CA-C-O 121.493 0.663 . . . . 10.0 110.239 179.812 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.897 HG12 HD23 ' B' ' 10' ' ' LEU . 0.9 OUTLIER -137.73 123.75 26.44 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.431 0 O-C-N 121.381 -0.824 . . . . 10.0 109.771 -179.76 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.519 ' HA ' ' HA ' ' A' ' 50' ' ' PRO . 7.3 mtm -92.06 98.19 11.4 Favored 'General case' 0 N--CA 1.492 1.652 0 C-N-CA 118.869 -1.133 . . . . 10.0 109.406 179.047 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.653 HD12 ' N ' ' A' ' 46' ' ' ILE . 1.9 mp -86.36 120.93 36.87 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.474 0 O-C-N 121.593 -0.692 . . . . 10.0 109.874 -179.508 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.6 ' HA3' ' HB3' ' B' ' 7' ' ' GLU . . . 44.6 26.38 1.05 Allowed Glycine 0 N--CA 1.486 1.997 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 -179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.496 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 110.02 -24.88 17.79 Favored Glycine 0 N--CA 1.492 2.409 0 O-C-N 121.012 -1.287 . . . . 10.0 111.307 179.155 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -84.46 110.98 30.82 Favored Pre-proline 0 N--CA 1.497 1.876 0 O-C-N 120.714 -1.462 . . . . 10.0 110.545 -179.756 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.519 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 47.3 Cg_endo -73.64 141.06 30.42 Favored 'Trans proline' 0 C--N 1.312 -1.385 0 O-C-N 124.044 1.549 . . . . 10.0 111.042 -179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.544 ' CD1' HD23 ' A' ' 53' ' ' LEU . 1.6 t80 -91.9 122.33 34.33 Favored 'General case' 0 N--CA 1.489 1.475 0 O-C-N 121.358 -0.839 . . . . 10.0 109.524 179.589 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.733 ' O ' HG22 ' A' ' 4' ' ' ILE 0.258 56.3 m -107.54 99.69 9.17 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 121.421 -0.8 . . . . 10.0 109.772 -179.324 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.738 HD12 ' N ' ' A' ' 54' ' ' GLY . 1.8 pp -144.23 168.63 19.59 Favored 'General case' 0 N--CA 1.488 1.467 0 C-N-CA 118.341 -1.344 . . . . 10.0 112.33 -179.881 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.738 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.4 126.9 1.32 Allowed Glycine 0 N--CA 1.487 2.035 0 N-CA-C 107.87 -2.092 . . . . 10.0 107.87 -179.685 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 2.0 pp -124.55 142.32 51.43 Favored 'General case' 0 C--N 1.3 -1.565 0 O-C-N 120.82 -1.4 . . . . 10.0 110.354 -179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.471 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 1.0 OUTLIER -139.82 104.91 5.0 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.283 -0.886 . . . . 10.0 110.837 -178.644 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.55 ' CB ' ' O ' ' A' ' 36' ' ' VAL . 79.4 m-20 -80.97 -179.66 7.44 Favored 'General case' 0 N--CA 1.494 1.774 0 O-C-N 121.172 -0.955 . . . . 10.0 110.497 179.566 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.573 HG21 HG12 ' A' ' 14' ' ' VAL . 14.0 t -85.33 -175.97 5.93 Favored 'General case' 0 N--CA 1.495 1.803 0 CA-C-O 122.549 1.166 . . . . 10.0 113.361 -177.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.519 ' O ' ' N ' ' A' ' 61' ' ' GLN . . . -142.0 -70.83 0.34 Allowed 'General case' 0 N--CA 1.494 1.769 0 N-CA-C 107.958 -1.127 . . . . 10.0 107.958 -179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.54 ' O ' ' HG2' ' A' ' 61' ' ' GLN . . . 40.54 24.09 0.07 OUTLIER Glycine 0 N--CA 1.49 2.249 0 N-CA-C 110.117 -1.193 . . . . 10.0 110.117 179.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.566 ' HG3' ' HA ' ' B' ' 22' ' ' PHE . 1.4 mm-40 -171.47 -35.24 0.02 OUTLIER 'General case' 0 C--N 1.305 -1.36 0 O-C-N 121.214 -1.168 . . . . 10.0 110.022 179.693 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.594 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 2.0 mt-10 -54.6 -80.22 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.497 0 C-N-CA 117.813 -1.555 . . . . 10.0 108.861 178.732 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.439 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 0.4 OUTLIER 172.1 27.78 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.912 0 O-C-N 120.871 -1.143 . . . . 10.0 111.595 178.912 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.594 ' CZ ' ' HB3' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -144.16 -52.43 0.32 Allowed 'General case' 0 N--CA 1.492 1.66 0 O-C-N 120.672 -1.267 . . . . 10.0 110.807 179.621 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 24.0 t0 42.0 32.98 0.33 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.472 -0.767 . . . . 10.0 109.361 -178.375 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -81.19 1.91 29.99 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.469 -0.769 . . . . 10.0 109.789 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.607 ' O ' HD22 ' A' ' 70' ' ' LEU . 2.4 mp -103.72 -14.46 16.08 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.413 -0.804 . . . . 10.0 110.03 179.765 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.69 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 3.9 ttt180 -82.26 -27.38 0.43 Allowed Pre-proline 0 N--CA 1.502 2.161 0 N-CA-C 113.079 0.77 . . . . 10.0 113.079 -179.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.69 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.7 Cg_endo -81.78 5.6 6.2 Favored 'Trans proline' 0 C--N 1.314 -1.262 0 O-C-N 122.859 0.926 . . . . 10.0 111.072 -179.482 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.898 HD11 ' CB ' ' B' ' 37' ' ' ALA . 2.0 pt? -49.34 -40.46 35.45 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 121.399 -0.813 . . . . 10.0 112.97 -178.748 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.578 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 34.3 m 49.38 21.03 0.51 Allowed 'General case' 0 C--N 1.296 -1.723 0 O-C-N 120.67 -1.269 . . . . 10.0 110.841 -179.992 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.568 ' CD1' ' O ' ' A' ' 71' ' ' SER . 13.2 m-85 -143.92 130.61 10.3 Favored Pre-proline 0 N--CA 1.493 1.721 0 O-C-N 120.925 -1.109 . . . . 10.0 110.366 179.86 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.464 ' O ' ' HB3' ' A' ' 74' ' ' GLN . 50.8 Cg_endo -72.88 150.07 48.7 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 O-C-N 123.832 1.438 . . . . 10.0 111.276 179.554 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.547 ' HG2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -177.48 47.55 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.629 0 CA-C-O 122.047 0.927 . . . . 10.0 109.708 179.217 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.825 HG21 ' HB ' ' A' ' 7' ' ' VAL . 57.5 m -140.25 89.74 2.31 Favored 'General case' 0 C--N 1.304 -1.379 0 O-C-N 121.149 -0.97 . . . . 10.0 110.228 179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . . . . . . . . . 71.0 m-20 -42.58 -30.72 0.38 Allowed 'General case' 0 C--N 1.296 -1.76 0 O-C-N 121.53 -0.731 . . . . 10.0 111.842 -179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.577 ' O ' HG22 ' A' ' 75' ' ' THR . 13.6 m -123.19 124.84 70.94 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.942 0 O-C-N 120.78 -1.2 . . . . 10.0 110.687 179.788 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.595 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 1.7 m-85 -116.5 154.57 30.14 Favored 'General case' 0 N--CA 1.497 1.883 0 O-C-N 121.421 -0.799 . . . . 10.0 111.851 -179.294 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.979 HD22 HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -111.0 97.95 7.19 Favored 'General case' 0 N--CA 1.49 1.56 0 N-CA-C 107.843 -1.169 . . . . 10.0 107.843 177.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.04 HG23 ' HA2' ' A' ' 10' ' ' GLY . 8.2 p -103.39 125.6 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.649 0 O-C-N 121.159 -0.963 . . . . 10.0 111.033 -178.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.464 ' HB3' ' CG2' ' A' ' 115' ' ' THR . 4.2 m -127.38 125.96 41.63 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.299 -0.875 . . . . 10.0 109.084 178.797 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . . . . . . . . . 52.5 p90 -135.91 178.85 6.73 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.11 -0.994 . . . . 10.0 110.245 -179.656 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 31.2 t -81.03 149.5 29.24 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.191 -0.943 . . . . 10.0 112.059 -178.26 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.582 HG11 ' HE ' ' A' ' 120' ' ' ARG . 6.1 t -100.48 -2.01 9.77 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.638 0 O-C-N 121.704 -0.623 . . . . 10.0 110.125 179.766 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.547 ' O ' HG23 ' A' ' 85' ' ' VAL . 22.9 m -132.97 53.93 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.807 0 CA-C-O 121.75 0.786 . . . . 10.0 109.842 -179.857 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.515 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 19.4 p -121.29 158.39 53.38 Favored Pre-proline 0 C--N 1.295 -1.787 0 O-C-N 121.513 -0.742 . . . . 10.0 110.5 -179.845 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -72.05 120.64 6.95 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 O-C-N 124.057 1.557 . . . . 10.0 111.647 -179.539 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 7.2 m 44.41 64.77 1.22 Allowed 'General case' 0 N--CA 1.493 1.705 0 O-C-N 121.258 -0.901 . . . . 10.0 111.612 178.552 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.54 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -124.22 -43.34 2.08 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.677 -1.264 . . . . 10.0 110.918 179.553 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 1.102 ' CE1' HD11 ' A' ' 137' ' ' ILE . 6.4 t80 -56.12 -50.21 71.73 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.828 -1.17 . . . . 10.0 110.694 -179.608 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -58.96 -15.33 12.48 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.955 -1.091 . . . . 10.0 111.823 -179.128 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.804 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -86.9 -20.21 27.74 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 120.698 -1.251 . . . . 10.0 111.079 -179.256 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.842 HG23 ' HD3' ' A' ' 94' ' ' LYS . 19.3 m -90.18 -14.13 9.07 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.562 0 O-C-N 120.552 -1.343 . . . . 10.0 108.896 179.137 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.842 ' HD3' HG23 ' A' ' 93' ' ' VAL . 25.9 mmtt -88.14 -33.41 18.23 Favored 'General case' 0 N--CA 1.489 1.492 0 CA-C-O 122.15 0.976 . . . . 10.0 108.842 178.632 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.538 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 10.6 pt-20 -78.76 -5.82 54.27 Favored 'General case' 0 C--N 1.294 -1.842 0 N-CA-C 109.105 -0.702 . . . . 10.0 109.105 178.599 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 5.1 tptt -84.24 -50.23 8.06 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.342 -0.849 . . . . 10.0 112.27 -178.77 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.568 ' CD1' ' O ' ' A' ' 93' ' ' VAL . 20.7 m95 -80.99 -23.8 38.45 Favored 'General case' 0 N--CA 1.497 1.878 0 O-C-N 121.014 -1.054 . . . . 10.0 113.376 -177.279 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.786 HG22 HD21 ' A' ' 149' ' ' LEU . 4.4 t -69.23 -50.54 20.16 Favored Pre-proline 0 N--CA 1.499 2.007 0 O-C-N 120.048 -1.658 . . . . 10.0 110.676 -178.813 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.578 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.7 Cg_endo -72.84 -6.23 18.64 Favored 'Trans proline' 0 C--N 1.31 -1.483 0 O-C-N 123.139 1.073 . . . . 10.0 109.564 178.41 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.541 ' O ' ' O ' ' A' ' 101' ' ' ILE . 0.5 OUTLIER -68.98 -32.96 72.9 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.749 . . . . 10.0 110.24 179.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.541 ' O ' ' O ' ' A' ' 100' ' ' GLU . 2.7 pt 36.0 103.32 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.338 0 CA-C-O 121.481 0.658 . . . . 10.0 111.318 179.836 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.894 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -47.11 -89.59 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 109.416 179.929 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.686 ' H ' HG23 ' A' ' 102' ' ' THR . 30.4 m80 -106.74 -4.63 19.19 Favored 'General case' 0 C--N 1.296 -1.738 0 O-C-N 121.432 -0.793 . . . . 10.0 109.395 179.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 3.6 t-160 -175.8 -27.36 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.298 -0.876 . . . . 10.0 109.948 -179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.894 ' O ' HG22 ' A' ' 102' ' ' THR . 20.0 p -134.77 167.46 22.71 Favored Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.138 -0.976 . . . . 10.0 110.069 179.459 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.418 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 54.4 Cg_endo -81.01 72.38 6.55 Favored 'Trans proline' 0 C--N 1.305 -1.756 0 O-C-N 123.773 1.407 . . . . 10.0 111.411 -179.468 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 2.0 mtpt -112.84 -10.11 13.6 Favored 'General case' 0 N--CA 1.49 1.551 0 O-C-N 121.156 -0.965 . . . . 10.0 112.029 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 4.0 m -52.92 125.39 39.65 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 120.687 -1.258 . . . . 10.0 110.432 -178.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.546 ' HG2' HG12 ' A' ' 77' ' ' VAL . 54.5 Cg_endo -73.72 153.12 48.43 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 O-C-N 124.052 1.553 . . . . 10.0 111.952 -179.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.531 ' O ' ' HB ' ' A' ' 152' ' ' VAL . 21.8 p90 -165.02 156.57 15.02 Favored 'General case' 0 C--N 1.306 -1.293 0 N-CA-C 108.231 -1.025 . . . . 10.0 108.231 178.062 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.979 HD23 HD22 ' A' ' 79' ' ' LEU . 1.9 mm? -102.9 103.32 13.46 Favored 'General case' 0 C--N 1.288 -2.092 0 CA-C-O 122.104 0.954 . . . . 10.0 111.007 -178.084 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.56 ' O ' HG23 ' A' ' 155' ' ' VAL . 88.2 mt -66.33 138.57 57.7 Favored 'General case' 0 C--N 1.292 -1.9 0 CA-C-N 115.69 -0.686 . . . . 10.0 109.179 179.165 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.611 ' CG2' HG11 ' A' ' 168' ' ' VAL . 1.4 t -150.42 171.54 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.908 0 O-C-N 120.792 -1.192 . . . . 10.0 111.776 -178.861 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.422 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -133.25 122.11 3.04 Favored Glycine 0 N--CA 1.492 2.42 0 N-CA-C 108.486 -1.846 . . . . 10.0 108.486 178.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.464 ' CG2' ' HB3' ' A' ' 81' ' ' CYS . 31.0 p -100.55 170.96 8.03 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 121.165 -1.197 . . . . 10.0 111.056 -179.291 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 9.5 mt-30 50.22 33.95 8.0 Favored 'General case' 0 N--CA 1.488 1.459 0 O-C-N 121.473 -0.767 . . . . 10.0 109.392 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.979 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -69.05 -21.88 25.77 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 C-N-CA 119.382 -0.927 . . . . 10.0 109.688 -179.262 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.649 ' CG ' HG21 ' A' ' 161' ' ' THR . 17.3 t70 -51.45 60.8 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.128 0 CA-C-O 121.958 0.885 . . . . 10.0 110.282 -177.442 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.769 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.2 tp 160.33 -30.45 0.0 OUTLIER 'General case' 0 C--N 1.288 -2.072 0 N-CA-C 108.017 -1.105 . . . . 10.0 108.017 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.582 ' HE ' HG11 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -47.46 -37.5 11.85 Favored 'General case' 0 N--CA 1.487 1.4 0 CA-C-O 121.57 0.7 . . . . 10.0 109.876 179.062 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.506 ' O ' ' HD3' ' A' ' 123' ' ' PRO . 64.2 t0 -55.74 -24.83 37.42 Favored 'General case' 0 N--CA 1.489 1.488 0 O-C-N 121.577 -0.702 . . . . 10.0 110.885 -179.93 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.725 ' O ' HD13 ' A' ' 126' ' ' ILE . 9.0 t0 -90.22 109.4 33.09 Favored Pre-proline 0 N--CA 1.499 1.976 0 O-C-N 121.24 -0.913 . . . . 10.0 111.249 -179.523 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.506 ' HD3' ' O ' ' A' ' 121' ' ' ASP . 51.5 Cg_endo -76.92 24.12 0.49 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 121.592 1.528 . . . . 10.0 112.142 179.017 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 7.4 m -100.97 -47.05 4.9 Favored 'General case' 0 N--CA 1.498 1.935 0 O-C-N 120.748 -1.22 . . . . 10.0 109.728 179.819 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.436 ' O ' HD22 ' A' ' 129' ' ' LEU . 3.4 t -71.94 -26.34 62.25 Favored 'General case' 0 C--N 1.298 -1.668 0 N-CA-C 105.035 -2.209 . . . . 10.0 105.035 176.78 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.725 HD13 ' O ' ' A' ' 122' ' ' ASP 0.301 1.1 mp -50.69 -26.92 4.38 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.459 0 N-CA-C 107.53 -1.285 . . . . 10.0 107.53 176.349 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -51.15 -38.84 54.39 Favored 'General case' 0 N--CA 1.491 1.623 0 CA-C-O 121.521 0.677 . . . . 10.0 110.85 179.564 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.534 ' N ' ' CD ' ' A' ' 128' ' ' LYS . 13.0 mptt -75.22 -44.6 45.35 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.469 -0.769 . . . . 10.0 110.679 -179.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.709 HD23 ' HA ' ' A' ' 126' ' ' ILE . 0.3 OUTLIER -60.16 -49.1 78.98 Favored 'General case' 0 N--CA 1.491 1.607 0 CA-C-O 121.854 0.835 . . . . 10.0 108.971 179.548 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.595 ' O ' ' N ' ' A' ' 134' ' ' GLN . . . -52.97 -40.92 64.09 Favored 'General case' 0 N--CA 1.49 1.538 0 CA-C-O 121.469 0.652 . . . . 10.0 109.582 179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -53.05 -25.21 11.77 Favored 'General case' 0 C--N 1.298 -1.666 0 O-C-N 120.946 -1.097 . . . . 10.0 110.009 179.789 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -88.59 -48.65 7.41 Favored 'General case' 0 N--CA 1.495 1.784 0 O-C-N 121.25 -0.906 . . . . 10.0 112.177 -178.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' CD ' ' O ' ' A' ' 135' ' ' LYS . 0.2 OUTLIER -126.98 0.84 6.58 Favored 'General case' 0 C--N 1.295 -1.783 0 O-C-N 121.484 -0.76 . . . . 10.0 110.806 -178.999 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' O ' ' A' ' 130' ' ' ALA . 0.7 OUTLIER 45.52 23.32 0.13 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.688 -0.633 . . . . 10.0 111.494 178.475 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.523 ' O ' ' CD ' ' A' ' 133' ' ' LYS . 0.4 OUTLIER -154.19 101.06 2.45 Favored Pre-proline 0 C--N 1.302 -1.492 0 O-C-N 121.033 -1.042 . . . . 10.0 111.781 -179.611 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.432 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 48.9 Cg_endo -74.03 160.12 43.43 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 124.124 1.592 . . . . 10.0 109.919 178.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 1.102 HD11 ' CE1' ' A' ' 90' ' ' PHE . 0.2 OUTLIER -81.77 128.19 38.94 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 O-C-N 120.529 -1.357 . . . . 10.0 109.077 179.421 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.562 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 17.5 p -125.37 170.89 8.41 Favored Pre-proline 0 C--N 1.301 -1.525 0 O-C-N 121.475 -0.765 . . . . 10.0 110.404 -178.117 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.562 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.5 Cg_endo -68.21 -7.27 19.49 Favored 'Trans proline' 0 C--N 1.31 -1.475 0 O-C-N 123.786 1.414 . . . . 10.0 110.519 179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 -92.58 -38.54 11.84 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.073 -1.017 . . . . 10.0 110.437 179.735 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.436 ' CG2' ' CZ ' ' A' ' 90' ' ' PHE . 84.3 m -74.68 -44.68 48.96 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.635 -0.665 . . . . 10.0 111.593 -179.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.456 ' HB1' ' HB2' ' A' ' 154' ' ' TYR . . . -77.67 -38.54 47.36 Favored 'General case' 0 N--CA 1.492 1.628 0 O-C-N 121.134 -0.979 . . . . 10.0 111.581 -178.28 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.439 ' O ' ' CD ' ' A' ' 143' ' ' GLU . 5.4 tm-20 -62.97 -27.04 69.13 Favored 'General case' 0 C--N 1.294 -1.83 0 O-C-N 120.792 -1.193 . . . . 10.0 108.94 179.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.76 -49.59 10.95 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.362 -0.836 . . . . 10.0 109.93 179.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.782 HD11 ' HB3' ' A' ' 94' ' ' LYS . 5.1 tt -56.2 -41.82 76.19 Favored 'General case' 0 C--N 1.308 -1.201 0 O-C-N 121.237 -0.914 . . . . 10.0 110.022 179.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . . . . . . . . . . . -63.65 -49.34 73.62 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.143 -0.973 . . . . 10.0 108.89 178.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 17.6 ttt85 -60.23 -29.07 68.51 Favored 'General case' 0 C--N 1.299 -1.613 0 C-N-CA 119.823 -0.751 . . . . 10.0 109.865 179.361 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -72.03 -47.49 51.39 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.389 -0.819 . . . . 10.0 110.499 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.786 HD21 HG22 ' A' ' 98' ' ' VAL . 0.8 OUTLIER -90.05 16.33 8.56 Favored 'General case' 0 N--CA 1.49 1.565 0 CA-C-O 122.075 0.94 . . . . 10.0 108.966 -179.579 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER 49.58 27.12 1.99 Allowed 'General case' 0 C--N 1.3 -1.582 0 CA-C-O 121.798 0.809 . . . . 10.0 109.525 -179.731 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . . . . . . . . . . . -63.68 -148.78 0.0 OUTLIER 'General case' 0 C--N 1.294 -1.847 0 C-N-CA 120.137 -0.625 . . . . 10.0 109.877 179.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.918 HG11 ' CD1' ' A' ' 111' ' ' LEU . 19.1 t -98.51 -75.45 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.492 0 C-N-CA 119.231 -0.987 . . . . 10.0 109.963 179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.3 OUTLIER -173.56 -177.18 1.4 Allowed 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 118.739 -1.184 . . . . 10.0 111.637 -179.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.539 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 0.0 OUTLIER -110.69 116.54 31.49 Favored 'General case' 0 N--CA 1.494 1.742 0 O-C-N 121.709 -0.619 . . . . 10.0 110.358 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.994 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -122.77 -168.98 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.069 0 O-C-N 120.954 -1.091 . . . . 10.0 110.169 179.333 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.422 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 1.1 pt-20 -161.97 143.49 11.0 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 120.831 -1.168 . . . . 10.0 111.403 -179.423 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.569 ' HA ' ' HG2' ' A' ' 162' ' ' GLN . 28.4 p -159.19 177.28 11.23 Favored 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.472 -0.767 . . . . 10.0 111.301 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.606 ' HB2' ' HB2' ' A' ' 162' ' ' GLN . 47.1 t -144.91 170.58 15.86 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.67 -0.644 . . . . 10.0 109.725 179.353 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.644 ' CB ' HD12 ' A' ' 19' ' ' LEU . . . -89.59 -48.77 7.08 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.247 -0.908 . . . . 10.0 110.712 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.549 HD22 ' HE1' ' A' ' 28' ' ' PHE . 2.0 pp -118.61 -0.7 11.29 Favored 'General case' 0 N--CA 1.488 1.467 0 O-C-N 121.135 -0.978 . . . . 10.0 112.176 -178.338 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.649 HG21 ' CG ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -120.13 -80.07 0.61 Allowed 'General case' 0 N--CA 1.496 1.841 0 O-C-N 120.429 -1.42 . . . . 10.0 111.968 -178.811 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.606 ' HB2' ' HB2' ' A' ' 158' ' ' SER . 5.7 tp60 -40.73 -63.75 0.62 Allowed 'General case' 0 N--CA 1.5 2.035 0 O-C-N 120.991 -1.068 . . . . 10.0 112.071 -178.55 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.576 ' HB3' ' CD1' ' A' ' 23' ' ' TYR . 25.2 mttt 70.14 51.01 0.41 Allowed 'General case' 0 N--CA 1.496 1.863 0 CA-C-O 121.932 0.872 . . . . 10.0 109.295 -178.097 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -140.84 24.37 2.59 Favored Glycine 0 N--CA 1.487 2.062 0 N-CA-C 109.316 -1.514 . . . . 10.0 109.316 -179.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.751 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -78.78 1.43 23.24 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.119 -1.224 . . . . 10.0 110.767 179.94 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.422 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.3 OUTLIER -79.39 -39.47 32.41 Favored 'General case' 0 N--CA 1.491 1.618 0 O-C-N 120.851 -1.156 . . . . 10.0 109.596 178.809 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 20.2 t-20 -62.35 -40.77 97.49 Favored 'General case' 0 N--CA 1.497 1.915 0 O-C-N 121.173 -0.954 . . . . 10.0 110.682 179.931 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.994 HG22 ' HB ' ' A' ' 155' ' ' VAL . 4.3 t -59.23 -28.21 38.62 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.526 0 O-C-N 121.185 -0.947 . . . . 10.0 109.599 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.553 ' CD1' ' O ' ' A' ' 169' ' ' PHE . 4.4 t80 -84.04 -21.34 31.63 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.488 -0.757 . . . . 10.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -74.31 -49.45 22.92 Favored 'General case' 0 N--CA 1.497 1.906 0 O-C-N 121.091 -1.005 . . . . 10.0 111.135 -179.49 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.52 ' HA ' HD23 ' A' ' 174' ' ' LEU . 1.1 mm-40 -58.22 -37.22 74.41 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.36 -0.838 . . . . 10.0 110.578 -178.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.499 ' HB2' HD21 ' A' ' 111' ' ' LEU . . . -55.61 -32.71 63.34 Favored 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.158 -0.964 . . . . 10.0 110.045 179.882 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.708 ' O ' HD12 ' A' ' 177' ' ' LEU . 66.9 mt -60.8 -44.3 97.21 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.543 0 O-C-N 121.153 -0.967 . . . . 10.0 110.132 -179.613 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.812 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -70.57 -30.59 67.34 Favored 'General case' 0 C--N 1.297 -1.682 0 O-C-N 120.732 -1.23 . . . . 10.0 111.567 -178.868 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.832 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -86.37 -17.78 33.56 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.299 -0.876 . . . . 10.0 111.234 -179.298 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.804 ' HB1' ' HB ' ' A' ' 4' ' ' ILE . . . -65.72 -30.97 71.72 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.982 -1.074 . . . . 10.0 109.318 179.744 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.834 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -110.35 -11.68 14.5 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 121.3 -0.875 . . . . 10.0 110.188 -179.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 20.6 mt-10 . . . . . 0 N--CA 1.493 1.694 0 CA-C-O 117.959 -1.019 . . . . 10.0 110.439 -179.866 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.269 0 N-CA-C 108.809 -1.716 . . . . 10.0 108.809 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -130.14 136.92 49.82 Favored 'General case' 0 N--CA 1.489 1.502 0 O-C-N 121.488 -1.007 . . . . 10.0 110.479 -179.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.448 ' O ' ' HG3' ' B' ' 3' ' ' LYS . 5.7 tptt -99.38 103.31 15.1 Favored 'General case' 0 C--N 1.306 -1.325 0 O-C-N 121.01 -1.057 . . . . 10.0 108.388 178.752 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.515 ' HB3' ' OE2' ' B' ' 7' ' ' GLU . 6.1 mm-40 -104.28 161.03 14.39 Favored 'General case' 0 C--N 1.3 -1.556 0 O-C-N 121.306 -0.871 . . . . 10.0 110.769 -178.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.659 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -69.07 -153.26 0.0 OUTLIER Pre-proline 0 C--N 1.301 -1.514 0 N-CA-C 107.564 -1.272 . . . . 10.0 107.564 178.789 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.659 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 40.3 Cg_endo -69.85 90.88 0.52 Allowed 'Trans proline' 0 C--N 1.313 -1.296 0 N-CA-C 109.91 -0.842 . . . . 10.0 109.91 -179.852 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.6 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 39.1 mm-40 -56.6 -152.08 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.893 -0.505 . . . . 10.0 110.691 -179.451 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.892 HD12 ' N ' ' B' ' 9' ' ' SER . 2.7 pp -79.64 -51.39 16.52 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.358 0 O-C-N 120.756 -1.215 . . . . 10.0 111.406 -178.941 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.892 ' N ' HD12 ' B' ' 8' ' ' ILE . 32.2 t -155.3 171.5 19.74 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 120.594 -1.316 . . . . 10.0 111.214 179.783 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.953 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.25 133.33 3.28 Favored Pre-proline 0 C--N 1.308 -1.203 0 C-N-CA 118.857 -1.137 . . . . 10.0 113.023 -179.088 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 46.3 Cg_endo -86.4 177.16 4.53 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 N-CA-C 108.459 -1.4 . . . . 10.0 108.459 177.615 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 69.7 m -133.48 148.75 51.74 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 120.633 -1.292 . . . . 10.0 111.655 -179.589 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.497 ' HB2' ' O ' ' A' ' 43' ' ' THR . 0.4 OUTLIER -104.55 -179.65 4.01 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.64 -0.662 . . . . 10.0 109.471 178.85 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.652 ' O ' HG23 ' A' ' 42' ' ' VAL . 21.6 m-85 -91.81 164.4 13.7 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.987 -1.07 . . . . 10.0 111.113 -179.489 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.64 ' HG3' ' CE2' ' A' ' 40' ' ' TYR . 1.5 pm0 -127.85 177.25 6.97 Favored 'General case' 0 C--N 1.301 -1.541 0 CA-C-O 121.2 0.524 . . . . 10.0 110.091 179.816 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.617 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 7.5 m-70 -95.6 166.23 11.94 Favored 'General case' 0 N--CA 1.501 2.097 0 O-C-N 121.487 -0.758 . . . . 10.0 111.901 -178.825 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.555 ' C ' HG23 ' B' ' 18' ' ' ILE . 42.5 m -128.91 146.23 51.01 Favored 'General case' 0 N--CA 1.497 1.897 0 O-C-N 121.422 -0.799 . . . . 10.0 110.669 -179.683 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.755 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.2 OUTLIER -159.42 -171.83 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.826 0 O-C-N 121.501 -0.749 . . . . 10.0 110.481 179.427 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.417 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 64.6 m80 -140.02 156.73 46.48 Favored 'General case' 0 N--CA 1.488 1.428 0 O-C-N 121.552 -0.718 . . . . 10.0 109.73 179.038 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.581 HG12 ' O ' ' A' ' 37' ' ' PHE . 14.0 m -105.98 143.72 16.53 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.448 0 O-C-N 120.861 -1.149 . . . . 10.0 112.658 -177.751 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.513 ' N ' ' OE2' ' A' ' 62' ' ' GLU . . . -147.85 132.62 4.32 Favored Glycine 0 N--CA 1.49 2.275 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.894 ' O ' HG22 ' B' ' 25' ' ' VAL . 0.4 OUTLIER 173.46 114.62 0.02 OUTLIER 'General case' 0 N--CA 1.484 1.255 0 O-C-N 121.175 -1.191 . . . . 10.0 109.416 179.834 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.474 ' C ' ' O ' ' B' ' 22' ' ' PHE . 83.3 m-20 -39.46 132.74 1.49 Allowed 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.451 -0.78 . . . . 10.0 109.121 -179.853 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.472 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.63 70.04 0.65 Allowed 'General case' 0 N--CA 1.496 1.835 0 N-CA-C 108.289 -1.004 . . . . 10.0 108.289 -176.175 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.894 HG22 ' O ' ' B' ' 22' ' ' PHE . 2.0 t -88.16 -17.98 8.3 Favored 'Isoleucine or valine' 0 C--N 1.293 -1.851 0 CA-C-O 122.543 1.163 . . . . 10.0 108.307 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.837 HG21 ' HD2' ' A' ' 29' ' ' PRO 0.287 7.2 t -48.72 -19.05 0.32 Allowed 'General case' 0 C--N 1.293 -1.864 0 CA-C-N 114.713 -1.131 . . . . 10.0 111.175 179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.636 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -154.51 -33.9 0.03 OUTLIER Glycine 0 N--CA 1.498 2.769 0 N-CA-C 108.513 -1.835 . . . . 10.0 108.513 179.079 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.563 ' CB ' ' HB2' ' A' ' 18' ' ' CYS . 0.1 OUTLIER 52.45 23.96 2.76 Favored 'General case' 0 N--CA 1.494 1.731 0 O-C-N 121.769 -0.842 . . . . 10.0 111.394 179.614 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.608 ' CD2' ' CB ' ' A' ' 159' ' ' ALA . 51.6 t80 -112.35 115.6 28.99 Favored 'General case' 0 C--N 1.293 -1.877 0 CA-C-O 122.093 0.949 . . . . 10.0 109.937 178.851 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.529 HG23 ' O ' ' B' ' 29' ' ' PHE . 33.5 p -156.51 -70.14 0.11 Allowed 'General case' 0 N--CA 1.496 1.858 0 CA-C-N 116.018 -0.537 . . . . 10.0 110.509 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 165.46 118.1 0.43 Allowed Glycine 0 N--CA 1.491 2.313 0 N-CA-C 110.033 -1.227 . . . . 10.0 110.033 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.75 ' CG2' HG22 ' A' ' 14' ' ' VAL . 0.0 OUTLIER -150.95 160.9 31.35 Favored Pre-proline 0 N--CA 1.491 1.614 0 O-C-N 121.232 -1.158 . . . . 10.0 109.51 179.404 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.527 ' O ' ' O ' ' B' ' 34' ' ' GLU . 55.8 Cg_endo -76.85 136.91 17.23 Favored 'Trans proline' 0 C--N 1.305 -1.729 0 O-C-N 123.906 1.477 . . . . 10.0 111.126 -178.787 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.584 ' HG3' ' CA ' ' B' ' 38' ' ' ARG . 2.6 tt0 55.04 146.1 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.691 0 CA-C-O 121.671 0.748 . . . . 10.0 110.736 179.354 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.549 ' HG2' ' N ' ' A' ' 13' ' ' ALA . 0.4 OUTLIER -85.85 -63.46 1.32 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 120.923 -1.111 . . . . 10.0 111.399 -179.287 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.692 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 65.7 t90 -143.48 21.1 1.87 Allowed 'General case' 0 C--N 1.291 -1.969 0 O-C-N 121.341 -0.85 . . . . 10.0 108.892 179.762 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.962 ' CB ' HD21 ' B' ' 39' ' ' LEU . . . 167.1 132.47 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.503 0 N-CA-C 108.026 -1.101 . . . . 10.0 108.026 -178.534 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.635 ' HG3' ' HB2' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -96.77 43.74 1.07 Allowed 'General case' 0 C--N 1.301 -1.512 0 CA-C-O 122.563 1.173 . . . . 10.0 109.63 -178.298 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.962 HD21 ' CB ' ' B' ' 37' ' ' ALA . 0.1 OUTLIER -61.39 -51.17 69.89 Favored 'General case' 0 N--CA 1.494 1.77 0 CA-C-N 115.326 -0.852 . . . . 10.0 112.964 -178.432 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -76.58 18.15 0.34 Allowed 'General case' 0 N--CA 1.5 2.033 0 N-CA-C 113.713 1.005 . . . . 10.0 113.713 -176.107 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.635 ' HB2' ' HG3' ' B' ' 38' ' ' ARG . 0.0 OUTLIER -119.22 -85.01 0.66 Allowed 'General case' 0 C--N 1.289 -2.058 0 O-C-N 120.811 -1.18 . . . . 10.0 110.486 178.892 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 66.9 p -136.04 54.4 1.9 Allowed 'General case' 0 C--N 1.306 -1.302 0 N-CA-C 108.254 -1.017 . . . . 10.0 108.254 178.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.593 ' HB3' ' HA ' ' B' ' 39' ' ' LEU . 81.9 p -74.63 -1.3 21.05 Favored 'General case' 0 C--N 1.302 -1.475 0 N-CA-C 106.968 -1.493 . . . . 10.0 106.968 177.488 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.458 ' OD1' ' C ' ' B' ' 44' ' ' ASN . 42.7 p30 -161.23 168.72 23.57 Favored 'General case' 0 N--CA 1.486 1.355 0 C-N-CA 120.166 -0.614 . . . . 10.0 109.999 -179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.9 mp -81.15 -49.19 18.37 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.558 0 O-C-N 121.001 -1.062 . . . . 10.0 109.804 179.667 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . 0.434 HG23 ' ND2' ' B' ' 44' ' ' ASN . 3.0 t . . . . . 0 C--N 1.302 -1.467 0 CA-C-O 117.958 -1.02 . . . . 10.0 110.261 -179.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.507 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.534 0 CA-C-O 121.15 0.5 . . . . 10.0 110.056 . . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.767 ' NE2' HD22 ' A' ' 177' ' ' LEU . 1.7 mt-30 -136.71 2.62 2.67 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.29 -0.881 . . . . 10.0 110.03 -179.729 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.51 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 3.0 m -60.22 95.63 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.36 0 O-C-N 121.364 -0.835 . . . . 10.0 109.555 179.725 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.824 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -108.97 132.32 57.33 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.548 0 C-N-CA 118.705 -1.198 . . . . 10.0 110.425 179.417 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.505 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.3 OUTLIER -121.07 97.56 5.58 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.313 -0.867 . . . . 10.0 110.522 179.641 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.454 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 0.8 OUTLIER -79.67 111.49 16.01 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.295 -0.878 . . . . 10.0 111.003 179.738 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.509 ' HB ' HG21 ' A' ' 75' ' ' THR . 56.1 t -131.06 172.47 16.18 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 121.409 -0.807 . . . . 10.0 108.962 179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.591 ' CG1' ' HB3' ' B' ' 35' ' ' GLN . 46.5 t -92.04 130.83 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.747 0 O-C-N 120.753 -1.217 . . . . 10.0 111.729 -178.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.771 ' CG1' HG12 ' A' ' 80' ' ' VAL . 74.4 t -145.34 179.7 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 N-CA-C 109.0 -0.741 . . . . 10.0 109.0 179.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.647 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 122.35 170.53 13.7 Favored Glycine 0 N--CA 1.495 2.583 0 N-CA-C 109.79 -1.324 . . . . 10.0 109.79 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 98.6 m-20 -50.75 -39.51 52.28 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.244 -1.151 . . . . 10.0 109.859 179.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.653 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 151.14 159.05 8.62 Favored Glycine 0 N--CA 1.489 2.189 0 N-CA-C 109.547 -1.421 . . . . 10.0 109.547 179.644 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.742 ' O ' HG23 ' A' ' 14' ' ' VAL . . . 179.82 -68.16 0.01 OUTLIER 'General case' 0 C--N 1.302 -1.49 0 O-C-N 121.334 -1.097 . . . . 10.0 108.852 -179.722 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.808 ' O ' HG12 ' A' ' 14' ' ' VAL . 1.7 t 149.22 89.2 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.505 2.324 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.772 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.48 ' O ' ' O ' ' A' ' 14' ' ' VAL . . . 42.68 92.59 0.01 OUTLIER Glycine 0 N--CA 1.489 2.19 0 N-CA-C 109.365 -1.494 . . . . 10.0 109.365 -179.819 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.57 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 0.0 OUTLIER -49.47 -34.62 17.33 Favored 'General case' 0 N--CA 1.488 1.448 0 O-C-N 120.918 -1.342 . . . . 10.0 109.296 179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 98.2 m -49.84 -25.22 2.93 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 120.738 -1.226 . . . . 10.0 108.724 178.992 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.586 ' HA ' ' O ' ' B' ' 26' ' ' THR . 13.7 p -63.73 -18.26 63.85 Favored 'General case' 0 C--N 1.308 -1.233 0 C-N-CA 119.233 -0.987 . . . . 10.0 108.706 179.484 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.79 HD11 ' HB2' ' A' ' 159' ' ' ALA . 1.2 mm? -69.36 -33.31 72.88 Favored 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.15 -0.969 . . . . 10.0 108.863 177.586 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 2.2 tp -48.61 -37.75 19.01 Favored 'General case' 0 C--N 1.3 -1.567 0 CA-C-O 121.854 0.835 . . . . 10.0 108.829 179.52 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.643 HG21 ' HA3' ' B' ' 27' ' ' GLY . 1.5 mm -64.3 -43.6 97.19 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.692 0 CA-C-O 121.68 0.752 . . . . 10.0 110.012 178.906 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.536 ' HA ' ' H ' ' A' ' 27' ' ' LYS . 40.3 t -47.89 -44.26 29.43 Favored 'General case' 0 C--N 1.29 -2.008 0 C-N-CA 119.335 -0.946 . . . . 10.0 109.738 -179.456 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.751 ' CZ ' ' CD1' ' A' ' 165' ' ' LEU . 6.9 m-85 -90.98 -3.81 56.98 Favored 'General case' 0 C--N 1.299 -1.6 0 O-C-N 121.573 -0.705 . . . . 10.0 109.676 -179.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.484 ' HB ' ' HA ' ' A' ' 21' ' ' ILE . 14.4 m -112.41 -33.46 6.17 Favored 'General case' 0 N--CA 1.496 1.84 0 O-C-N 121.333 -0.855 . . . . 10.0 112.403 -179.999 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.798 HG21 ' CD ' ' A' ' 34' ' ' PRO . 17.3 m -136.58 -82.51 0.37 Allowed 'General case' 0 N--CA 1.494 1.742 0 O-C-N 120.187 -1.57 . . . . 10.0 113.064 -178.288 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.569 ' N ' HG22 ' A' ' 25' ' ' THR . 2.3 m120 -153.89 51.42 0.68 Allowed 'General case' 0 N--CA 1.499 1.984 0 O-C-N 120.626 -1.296 . . . . 10.0 113.724 -177.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.609 ' O ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER 30.81 -131.93 0.02 OUTLIER 'General case' 0 N--CA 1.5 2.037 0 O-C-N 121.619 -0.675 . . . . 10.0 112.676 177.609 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.635 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 11.0 p90 -111.83 81.28 3.39 Favored Pre-proline 0 N--CA 1.493 1.716 0 CA-C-O 121.216 0.531 . . . . 10.0 110.765 -178.64 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.609 ' HD3' ' O ' ' A' ' 27' ' ' LYS . 52.8 Cg_endo -90.61 -169.53 0.33 Allowed 'Trans proline' 0 C--N 1.315 -1.213 0 C-N-CA 121.717 1.611 . . . . 10.0 110.777 -179.773 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -118.28 43.37 2.48 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 121.24 -0.912 . . . . 10.0 110.319 179.159 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 6.1 pt-20 -145.39 -176.93 5.31 Favored 'General case' 0 C--N 1.303 -1.433 0 N-CA-C 108.063 -1.088 . . . . 10.0 108.063 179.323 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -72.99 133.07 44.15 Favored 'General case' 0 C--N 1.287 -2.126 0 O-C-N 121.107 -0.995 . . . . 10.0 111.162 -179.347 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.582 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -134.71 -177.3 0.68 Allowed Pre-proline 0 N--CA 1.493 1.721 0 N-CA-C 108.234 -1.024 . . . . 10.0 108.234 179.608 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.798 ' CD ' HG21 ' A' ' 25' ' ' THR . 36.7 Cg_endo -59.28 -176.89 0.11 Allowed 'Trans proline' 0 C--N 1.308 -1.593 0 O-C-N 123.061 1.032 . . . . 10.0 109.421 178.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.673 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 1.3 p -117.26 167.31 11.34 Favored 'General case' 0 N--CA 1.493 1.712 0 O-C-N 121.043 -1.036 . . . . 10.0 111.567 -177.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.657 ' HB ' ' CG1' ' B' ' 20' ' ' VAL 0.273 74.1 t -55.77 -8.17 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.501 2.123 0 N-CA-C 112.46 0.541 . . . . 10.0 112.46 -179.98 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.73 ' O ' ' CD1' ' A' ' 37' ' ' PHE . 0.1 OUTLIER -32.69 87.28 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.104 0 CA-C-O 122.43 1.11 . . . . 10.0 113.46 -177.45 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.535 ' N ' ' O ' ' A' ' 36' ' ' VAL . 11.4 m-20 -157.53 104.74 2.01 Favored 'General case' 0 C--N 1.291 -1.936 0 O-C-N 120.718 -1.239 . . . . 10.0 111.368 178.344 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.686 ' HB2' HD11 ' B' ' 18' ' ' ILE . 0.6 OUTLIER -170.42 102.5 0.26 Allowed 'General case' 0 N--CA 1.496 1.865 0 O-C-N 121.225 -0.922 . . . . 10.0 108.651 178.969 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.826 ' CE1' HD11 ' A' ' 55' ' ' LEU . 0.2 OUTLIER -153.66 175.22 13.5 Favored 'General case' 0 C--N 1.304 -1.404 0 C-N-CA 118.669 -1.212 . . . . 10.0 112.177 -178.529 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.944 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -165.71 148.37 7.58 Favored 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 119.829 -0.748 . . . . 10.0 110.791 -179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 1.013 HG11 ' O ' ' B' ' 14' ' ' PHE . 0.2 OUTLIER -171.52 -165.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.506 2.34 0 O-C-N 121.41 -0.806 . . . . 10.0 111.105 -179.92 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.888 HG23 ' O ' ' A' ' 51' ' ' TYR . 74.9 m -137.38 146.05 44.01 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.503 -0.748 . . . . 10.0 110.217 -179.866 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.663 HG12 ' HB2' ' A' ' 51' ' ' TYR . 0.5 OUTLIER -103.6 176.19 0.96 Allowed 'Isoleucine or valine' 0 N--CA 1.499 1.991 0 O-C-N 121.244 -0.91 . . . . 10.0 109.467 179.362 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.583 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 39.5 mtp -154.37 126.18 7.64 Favored 'General case' 0 N--CA 1.488 1.475 0 O-C-N 121.156 -0.965 . . . . 10.0 110.472 179.287 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.562 HG13 ' HB2' ' B' ' 10' ' ' LEU . 2.7 mp -139.06 123.43 20.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.619 0 O-C-N 121.432 -0.792 . . . . 10.0 109.196 179.226 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.499 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 50.93 22.41 6.09 Favored Glycine 0 N--CA 1.49 2.274 0 N-CA-C 109.705 -1.358 . . . . 10.0 109.705 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 94.0 33.49 6.95 Favored Glycine 0 N--CA 1.493 2.481 0 N-CA-C 109.827 -1.309 . . . . 10.0 109.827 179.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.509 ' O ' ' HA ' ' A' ' 45' ' ' MET . 3.0 mt-10 -120.81 99.56 47.06 Favored Pre-proline 0 N--CA 1.491 1.577 0 O-C-N 121.293 -1.122 . . . . 10.0 111.03 -179.557 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.578 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 43.6 Cg_endo -71.6 136.31 27.99 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.632 1.333 . . . . 10.0 110.319 179.355 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.888 ' O ' HG23 ' A' ' 43' ' ' THR . 0.3 OUTLIER -99.88 157.02 16.81 Favored 'General case' 0 N--CA 1.494 1.734 0 O-C-N 121.102 -0.999 . . . . 10.0 110.347 179.947 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.824 ' O ' HG22 ' A' ' 4' ' ' ILE . 40.1 m -126.95 106.62 9.43 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.258 -0.901 . . . . 10.0 111.973 -178.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.885 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -148.37 166.71 27.24 Favored 'General case' 0 C--N 1.309 -1.189 0 O-C-N 120.438 -1.414 . . . . 10.0 111.293 178.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -172.16 134.99 3.2 Favored Glycine 0 C--N 1.288 -2.092 0 N-CA-C 108.629 -1.789 . . . . 10.0 108.629 179.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.826 HD11 ' CE1' ' A' ' 40' ' ' TYR . 4.6 pp -153.19 167.45 29.24 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.112 -1.228 . . . . 10.0 110.308 179.915 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.494 ' HB2' ' OD1' ' A' ' 39' ' ' ASN . 22.4 p90 -170.29 131.0 0.94 Allowed 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.153 -0.967 . . . . 10.0 110.908 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.443 ' OD1' ' C ' ' A' ' 57' ' ' ASP . 5.1 p-10 -99.09 176.83 5.42 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.113 -0.992 . . . . 10.0 110.252 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.409 HG22 ' N ' ' A' ' 59' ' ' ALA . 21.5 m -40.75 162.3 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.032 0 CA-C-O 122.167 0.984 . . . . 10.0 112.638 -179.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.987 ' HB1' ' HA ' ' A' ' 62' ' ' GLU . . . -134.39 68.93 1.47 Allowed 'General case' 0 N--CA 1.497 1.919 0 CA-C-N 115.638 -0.71 . . . . 10.0 109.512 179.398 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.613 ' HA3' ' CD2' ' B' ' 22' ' ' PHE . . . -43.61 -82.23 0.03 OUTLIER Glycine 0 N--CA 1.497 2.759 0 N-CA-C 107.904 -2.078 . . . . 10.0 107.904 179.599 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.554 ' O ' ' CG ' ' A' ' 62' ' ' GLU . 0.0 OUTLIER -54.93 -18.24 4.72 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.273 -1.134 . . . . 10.0 107.951 177.121 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.987 ' HA ' ' HB1' ' A' ' 59' ' ' ALA . 8.5 pt-20 41.99 88.43 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.705 0 CA-C-O 122.406 1.098 . . . . 10.0 111.034 -179.51 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -82.5 -12.73 57.6 Favored 'General case' 0 C--N 1.28 -2.421 0 N-CA-C 107.981 -1.118 . . . . 10.0 107.981 177.878 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.669 ' CD1' ' N ' ' A' ' 64' ' ' TYR . 1.2 p90 -133.83 -27.13 1.5 Allowed 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.851 -0.531 . . . . 10.0 109.693 179.579 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.518 ' OD1' ' CG ' ' A' ' 68' ' ' ARG . 5.3 t70 43.12 35.98 0.89 Allowed 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.101 -0.999 . . . . 10.0 110.496 179.319 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 11.1 mmm180 -83.8 -7.83 59.37 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.986 -1.071 . . . . 10.0 110.321 -179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.71 HD12 ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -111.63 4.14 18.42 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 121.121 -0.987 . . . . 10.0 110.358 179.209 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.733 ' O ' HD23 ' A' ' 70' ' ' LEU . 1.7 mmt180 -53.61 -40.53 81.25 Favored Pre-proline 0 N--CA 1.5 2.071 0 O-C-N 121.214 -0.929 . . . . 10.0 111.868 -179.673 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.589 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 52.5 Cg_endo -83.72 78.71 2.96 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 O-C-N 123.414 1.218 . . . . 10.0 109.542 179.189 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.733 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -105.61 -105.44 0.32 Allowed 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.935 -1.103 . . . . 10.0 110.488 -179.457 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.412 ' C ' ' O ' ' A' ' 70' ' ' LEU . 0.3 OUTLIER 47.07 35.7 3.66 Favored 'General case' 0 C--N 1.305 -1.356 0 N-CA-C 107.926 -1.139 . . . . 10.0 107.926 -178.766 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -148.26 114.92 3.91 Favored Pre-proline 0 N--CA 1.487 1.418 0 C-N-CA 120.154 -0.618 . . . . 10.0 110.948 -178.378 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.54 ' O ' ' CB ' ' A' ' 74' ' ' GLN . 53.9 Cg_endo -75.52 -151.31 0.04 OUTLIER 'Trans proline' 0 C--N 1.307 -1.624 0 O-C-N 123.925 1.487 . . . . 10.0 110.004 179.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.54 ' CB ' ' O ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER 76.64 79.4 0.09 Allowed 'General case' 0 N--CA 1.494 1.763 0 O-C-N 121.435 -0.79 . . . . 10.0 111.275 179.419 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.583 ' O ' ' N ' ' A' ' 77' ' ' VAL . 6.5 m -139.09 96.67 3.15 Favored 'General case' 0 C--N 1.299 -1.593 0 N-CA-C 106.78 -1.563 . . . . 10.0 106.78 177.472 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.664 ' O ' HG23 ' A' ' 108' ' ' THR . 71.0 m-20 -23.14 -41.09 0.01 OUTLIER 'General case' 0 N--CA 1.496 1.872 0 CA-C-N 115.856 -0.611 . . . . 10.0 112.37 -177.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.71 HG21 HG12 ' A' ' 4' ' ' ILE . 0.9 OUTLIER -142.13 130.09 21.03 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.758 0 O-C-N 120.894 -1.129 . . . . 10.0 110.838 179.773 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.84 ' C ' HD23 ' A' ' 79' ' ' LEU . 3.7 p90 -148.25 170.19 18.42 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.055 -1.028 . . . . 10.0 110.596 178.45 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.968 HD13 HG12 ' A' ' 168' ' ' VAL . 4.1 mt -112.34 102.53 10.67 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.323 -0.86 . . . . 10.0 110.067 -179.846 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.771 HG12 ' CG1' ' A' ' 9' ' ' VAL . 1.7 m -98.79 127.52 51.3 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.63 0 N-CA-C 108.676 -0.861 . . . . 10.0 108.676 179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.709 ' SG ' HG22 ' A' ' 115' ' ' THR . 0.5 OUTLIER -105.66 100.44 10.0 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 120.638 -1.288 . . . . 10.0 112.048 -178.322 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.55 ' CE2' ' CG2' ' A' ' 80' ' ' VAL . 57.6 m-85 -86.86 176.1 7.86 Favored 'General case' 0 N--CA 1.495 1.82 0 O-C-N 121.247 -0.908 . . . . 10.0 109.908 178.638 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.459 ' HB3' ' HB2' ' A' ' 86' ' ' SER . 47.9 t -100.72 142.67 31.87 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.348 -0.845 . . . . 10.0 108.878 178.454 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.74 HG22 ' HG2' ' A' ' 120' ' ' ARG . 34.0 m -56.16 -16.95 3.51 Favored 'Isoleucine or valine' 0 C--N 1.305 -1.357 0 O-C-N 121.041 -1.037 . . . . 10.0 110.675 -179.163 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.657 HG12 ' HB3' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -112.66 -88.35 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.551 0 O-C-N 120.868 -1.145 . . . . 10.0 109.293 178.996 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.481 ' C ' ' O ' ' A' ' 85' ' ' VAL . 0.6 OUTLIER 34.25 75.27 0.47 Allowed Pre-proline 0 N--CA 1.499 1.981 0 O-C-N 121.942 -0.474 . . . . 10.0 110.612 179.748 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.454 ' HB2' ' OD1' ' A' ' 132' ' ' ASN . 43.6 Cg_endo -69.79 162.12 43.3 Favored 'Trans proline' 0 C--N 1.303 -1.821 0 O-C-N 123.978 1.515 . . . . 10.0 110.62 -179.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.508 ' OG ' ' HD3' ' A' ' 133' ' ' LYS . 15.8 m 47.42 39.37 9.06 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 121.448 -0.783 . . . . 10.0 111.402 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.544 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 1.0 OUTLIER -135.06 -68.6 0.52 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 120.91 -1.119 . . . . 10.0 110.38 -179.806 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.613 ' O ' HG22 ' A' ' 93' ' ' VAL . 2.0 p90 -57.18 -16.67 8.53 Favored 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.322 -0.861 . . . . 10.0 110.342 -179.523 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.483 ' HG2' ' CZ ' ' A' ' 90' ' ' PHE . 18.1 mt-10 -78.59 -24.54 45.41 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.05 -1.031 . . . . 10.0 110.208 -179.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.758 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -80.95 -14.76 57.67 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.233 -0.917 . . . . 10.0 110.311 -179.906 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.875 HG23 ' HD3' ' A' ' 94' ' ' LYS . 16.6 m -87.93 -22.74 6.69 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.565 0 C-N-CA 118.288 -1.365 . . . . 10.0 108.486 179.227 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.968 ' HE2' HD21 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.43 -27.73 63.49 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 107.718 -1.215 . . . . 10.0 107.718 178.659 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.512 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.5 OUTLIER -89.39 -1.27 57.99 Favored 'General case' 0 C--N 1.295 -1.763 0 N-CA-C 108.392 -0.966 . . . . 10.0 108.392 178.746 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.509 ' HG2' ' O ' ' A' ' 92' ' ' ASN . 13.3 mmtm -102.46 -53.16 2.95 Favored 'General case' 0 N--CA 1.49 1.569 0 C-N-CA 118.948 -1.101 . . . . 10.0 112.374 -179.064 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.453 ' O ' ' HB3' ' A' ' 100' ' ' GLU . 41.7 m95 -90.32 -38.37 13.41 Favored 'General case' 0 N--CA 1.5 2.071 0 O-C-N 120.704 -1.247 . . . . 10.0 112.547 -178.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 149' ' ' LEU . 2.7 t -64.22 -51.06 64.51 Favored Pre-proline 0 N--CA 1.492 1.647 0 O-C-N 120.541 -1.349 . . . . 10.0 111.29 -178.394 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.573 ' HD3' ' O ' ' A' ' 94' ' ' LYS . 42.0 Cg_endo -67.58 -16.05 46.15 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 O-C-N 123.055 1.029 . . . . 10.0 109.556 179.291 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.569 ' O ' ' CB ' ' A' ' 101' ' ' ILE . 5.0 tm-20 -55.54 -51.39 67.22 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 121.347 -0.846 . . . . 10.0 109.957 179.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.569 ' CB ' ' O ' ' A' ' 100' ' ' GLU . 0.3 OUTLIER 163.32 1.58 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.51 2.573 0 O-C-N 121.522 -0.736 . . . . 10.0 112.114 179.539 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.97 HG22 ' CB ' ' A' ' 107' ' ' LYS . 46.9 p -60.1 -26.84 66.53 Favored 'General case' 0 N--CA 1.496 1.86 0 O-C-N 120.279 -1.513 . . . . 10.0 111.314 -178.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -63.87 -10.06 18.54 Favored 'General case' 0 C--N 1.297 -1.7 0 O-C-N 121.376 -0.828 . . . . 10.0 111.418 -178.817 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 36.0 m80 -120.0 -3.42 10.15 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.718 -1.238 . . . . 10.0 110.926 -179.487 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.514 ' HB2' ' HD2' ' A' ' 106' ' ' PRO . 24.9 p -161.17 166.57 14.93 Favored Pre-proline 0 N--CA 1.493 1.685 0 O-C-N 120.902 -1.124 . . . . 10.0 110.65 -179.851 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.514 ' HD2' ' HB2' ' A' ' 105' ' ' CYS . 38.1 Cg_endo -65.36 110.39 1.57 Allowed 'Trans proline' 0 C--N 1.309 -1.551 0 O-C-N 123.741 1.39 . . . . 10.0 109.304 179.003 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.97 ' CB ' HG22 ' A' ' 102' ' ' THR 0.261 0.0 OUTLIER -92.35 -95.46 0.14 Allowed 'General case' 0 C--N 1.298 -1.634 0 CA-C-O 121.89 0.852 . . . . 10.0 111.06 -178.052 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.664 HG23 ' O ' ' A' ' 76' ' ' ASP . 1.1 m -167.26 120.36 0.78 Allowed Pre-proline 0 C--N 1.29 -1.992 0 C-N-CA 120.064 -0.655 . . . . 10.0 109.968 -179.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.5 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 42.1 Cg_endo -68.62 149.91 74.24 Favored 'Trans proline' 0 C--N 1.309 -1.528 0 O-C-N 123.938 1.494 . . . . 10.0 111.052 179.639 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.623 ' CE1' ' HE3' ' A' ' 107' ' ' LYS . 0.0 OUTLIER -129.7 119.78 24.07 Favored 'General case' 0 C--N 1.304 -1.409 0 O-C-N 121.399 -0.813 . . . . 10.0 108.89 -179.962 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.906 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.0 mm? -75.05 97.24 3.37 Favored 'General case' 0 C--N 1.29 -2.007 0 N-CA-C 107.613 -1.254 . . . . 10.0 107.613 178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.572 ' C ' HG23 ' A' ' 113' ' ' VAL . 51.1 mt -63.81 144.47 57.02 Favored 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 116.131 -0.486 . . . . 10.0 109.81 -178.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.585 ' CG1' ' HB3' ' A' ' 157' ' ' CYS . 65.4 t -154.66 157.29 4.4 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.677 0 O-C-N 120.823 -1.173 . . . . 10.0 111.619 -178.613 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.506 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -99.1 154.39 19.87 Favored Glycine 0 N--CA 1.49 2.273 0 N-CA-C 108.78 -1.728 . . . . 10.0 108.78 178.63 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.709 HG22 ' SG ' ' A' ' 81' ' ' CYS . 45.9 p -120.79 136.74 54.82 Favored 'General case' 0 N--CA 1.496 1.864 0 O-C-N 120.877 -1.366 . . . . 10.0 110.518 -179.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.475 ' C ' ' O ' ' A' ' 115' ' ' THR . 0.0 OUTLIER 39.75 50.86 2.34 Favored 'General case' 0 N--CA 1.494 1.727 0 CA-C-O 121.944 0.878 . . . . 10.0 108.718 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.011 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.29 -32.98 9.67 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.589 0 CA-C-N 116.054 -0.521 . . . . 10.0 111.173 -177.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.586 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 0.4 OUTLIER -52.35 59.81 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.145 0 CA-C-O 121.999 0.904 . . . . 10.0 111.064 -177.244 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.763 ' N ' ' O ' ' A' ' 117' ' ' ILE . 7.9 tp 153.03 -33.83 0.01 OUTLIER 'General case' 0 N--CA 1.504 2.24 0 N-CA-C 107.849 -1.167 . . . . 10.0 107.849 -179.279 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.74 ' HG2' HG22 ' A' ' 84' ' ' VAL . 24.6 tpp180 -53.86 -27.83 32.4 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 109.195 -0.668 . . . . 10.0 109.195 179.501 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.45 ' O ' ' OD1' ' A' ' 121' ' ' ASP . 19.3 t0 -72.23 -5.76 38.16 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.364 -0.835 . . . . 10.0 110.102 179.091 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.684 ' O ' HD13 ' A' ' 126' ' ' ILE . 17.0 m-20 -79.82 157.91 73.59 Favored Pre-proline 0 N--CA 1.492 1.646 0 O-C-N 120.978 -1.076 . . . . 10.0 110.668 -179.343 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.43 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 52.5 Cg_endo -83.0 23.04 0.85 Allowed 'Trans proline' 0 C--N 1.307 -1.61 0 C-N-CA 121.935 1.756 . . . . 10.0 111.507 -178.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 95.8 p -105.8 -46.97 4.0 Favored 'General case' 0 N--CA 1.492 1.643 0 O-C-N 121.043 -1.035 . . . . 10.0 109.324 179.523 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 120' ' ' ARG . 8.2 t -69.98 -27.65 64.89 Favored 'General case' 0 C--N 1.294 -1.83 0 N-CA-C 105.193 -2.151 . . . . 10.0 105.193 176.359 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.684 HD13 ' O ' ' A' ' 122' ' ' ASP 0.307 0.7 OUTLIER -49.26 -27.53 2.49 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.487 0 CA-C-N 114.144 -1.389 . . . . 10.0 107.427 177.1 . . . . . . . . 4 4 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -53.03 -37.44 61.55 Favored 'General case' 0 N--CA 1.488 1.459 0 CA-C-N 115.893 -0.594 . . . . 10.0 111.049 179.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.533 ' O ' ' CG ' ' A' ' 131' ' ' LYS . 0.3 OUTLIER -82.52 -50.75 8.49 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.318 -0.864 . . . . 10.0 111.426 -178.381 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.659 HD21 HD12 ' A' ' 126' ' ' ILE . 0.5 OUTLIER -67.92 -20.72 65.12 Favored 'General case' 0 N--CA 1.495 1.808 0 O-C-N 120.631 -1.293 . . . . 10.0 109.261 179.452 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.592 ' HB2' ' O ' ' A' ' 126' ' ' ILE . . . -62.07 -40.87 97.26 Favored 'General case' 0 N--CA 1.49 1.561 0 O-C-N 121.491 -0.756 . . . . 10.0 109.968 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.533 ' CG ' ' O ' ' A' ' 128' ' ' LYS . 0.0 OUTLIER -62.46 -18.19 61.22 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 121.332 -0.855 . . . . 10.0 109.678 179.546 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.467 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 12.3 t-20 -97.99 -72.84 0.63 Allowed 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.325 -0.859 . . . . 10.0 110.281 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.508 ' HD3' ' OG ' ' A' ' 88' ' ' SER . 1.2 mptp? -149.55 144.35 26.19 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 121.347 -0.846 . . . . 10.0 109.954 179.451 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.617 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.3 OUTLIER -86.02 21.65 1.92 Allowed 'General case' 0 C--N 1.302 -1.469 0 O-C-N 121.414 -0.804 . . . . 10.0 110.404 -178.967 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.411 ' CG ' ' HB3' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -112.21 93.92 24.04 Favored Pre-proline 0 N--CA 1.487 1.382 0 O-C-N 121.124 -0.985 . . . . 10.0 110.633 -179.944 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.657 ' HB3' HG12 ' A' ' 85' ' ' VAL . 46.1 Cg_endo -83.17 156.67 14.91 Favored 'Trans proline' 0 C--N 1.304 -1.768 0 O-C-N 124.158 1.609 . . . . 10.0 110.841 179.806 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.549 HG22 ' O ' ' A' ' 137' ' ' ILE . 0.2 OUTLIER -89.25 114.83 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.661 0 O-C-N 121.189 -0.944 . . . . 10.0 109.057 179.109 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.571 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.6 p -114.72 169.25 6.86 Favored Pre-proline 0 C--N 1.302 -1.477 0 O-C-N 121.386 -0.821 . . . . 10.0 109.631 -179.522 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.571 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 36.7 Cg_endo -61.84 -19.39 65.43 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 O-C-N 123.43 1.226 . . . . 10.0 110.523 -179.796 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 35.1 mt-10 -76.59 -41.93 44.44 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.1 -1.0 . . . . 10.0 108.749 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.5 m -83.35 -41.18 18.51 Favored 'General case' 0 N--CA 1.489 1.501 0 N-CA-C 109.081 -0.711 . . . . 10.0 109.081 178.723 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.664 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -52.24 -41.8 63.08 Favored 'General case' 0 N--CA 1.489 1.491 0 O-C-N 121.6 -0.687 . . . . 10.0 110.108 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 21.4 mm-40 -60.27 -49.6 76.95 Favored 'General case' 0 N--CA 1.491 1.605 0 O-C-N 121.429 -0.795 . . . . 10.0 109.259 179.232 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.512 ' O ' ' N ' ' A' ' 148' ' ' ASP . 22.9 mttm -60.53 -39.93 89.65 Favored 'General case' 0 C--N 1.304 -1.392 0 N-CA-C 108.487 -0.931 . . . . 10.0 108.487 178.877 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.968 HD21 ' HE2' ' A' ' 94' ' ' LYS . 10.4 tt -58.67 -39.51 80.88 Favored 'General case' 0 C--N 1.306 -1.295 0 O-C-N 121.592 -0.693 . . . . 10.0 109.246 178.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.691 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -69.76 -48.08 60.6 Favored 'General case' 0 C--N 1.305 -1.369 0 C-N-CA 119.627 -0.829 . . . . 10.0 108.85 179.389 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.9 ttt180 -68.42 -23.71 64.66 Favored 'General case' 0 N--CA 1.491 1.617 0 CA-C-O 121.729 0.776 . . . . 10.0 108.98 178.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.512 ' N ' ' O ' ' A' ' 144' ' ' LYS . 38.2 t70 -54.6 -27.49 39.57 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.594 -0.691 . . . . 10.0 111.3 -179.757 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.979 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.26 38.1 0.79 Allowed 'General case' 0 N--CA 1.496 1.839 0 O-C-N 120.914 -1.116 . . . . 10.0 112.402 -179.631 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.522 ' HB2' ' NZ ' ' A' ' 107' ' ' LYS . 18.0 mtpt 64.49 38.08 7.68 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.317 -0.864 . . . . 10.0 112.197 177.053 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.691 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -72.97 -158.39 0.05 Allowed 'General case' 0 C--N 1.292 -1.909 0 N-CA-C 108.75 -0.833 . . . . 10.0 108.75 178.498 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.906 ' CG1' HD13 ' A' ' 111' ' ' LEU . 2.1 p -114.9 -62.68 2.16 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.351 0 O-C-N 120.323 -1.486 . . . . 10.0 111.358 179.478 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.59 ' H ' HG13 ' A' ' 152' ' ' VAL . 6.9 tttt -173.04 156.48 3.28 Favored 'General case' 0 N--CA 1.496 1.855 0 O-C-N 120.385 -1.447 . . . . 10.0 112.714 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.664 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 78.9 t80 -101.32 105.73 16.83 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.505 -0.747 . . . . 10.0 109.521 178.181 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.692 HG21 ' HA ' ' A' ' 168' ' ' VAL . 1.3 t -96.81 -167.97 0.16 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.305 -0.872 . . . . 10.0 110.854 -179.413 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.648 ' H ' HG12 ' A' ' 155' ' ' VAL . 46.1 mt-10 -132.37 139.53 48.14 Favored 'General case' 0 N--CA 1.497 1.895 0 O-C-N 121.477 -0.764 . . . . 10.0 110.463 -179.553 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.585 ' HB3' ' CG1' ' A' ' 113' ' ' VAL . 2.7 t -166.96 133.0 2.23 Favored 'General case' 0 N--CA 1.496 1.864 0 CA-C-O 122.337 1.065 . . . . 10.0 110.969 -179.591 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.7 ' C ' ' HB3' ' A' ' 162' ' ' GLN . 0.7 OUTLIER -150.98 80.03 1.32 Allowed 'General case' 0 C--N 1.284 -2.242 0 N-CA-C 108.12 -1.067 . . . . 10.0 108.12 176.446 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.79 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -21.11 -43.48 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.265 0 N-CA-C 113.49 0.922 . . . . 10.0 113.49 -177.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.572 ' N ' ' O ' ' A' ' 158' ' ' SER . 3.0 tp -76.56 -59.26 2.85 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 120.366 -1.458 . . . . 10.0 110.069 179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.571 ' HB ' ' CB ' ' A' ' 118' ' ' ASP . 0.2 OUTLIER -115.3 39.08 3.03 Favored 'General case' 0 N--CA 1.499 2.001 0 CA-C-O 123.179 1.466 . . . . 10.0 108.611 178.475 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.7 ' HB3' ' C ' ' A' ' 158' ' ' SER . 0.0 OUTLIER -59.38 -106.96 0.0 OUTLIER 'General case' 0 C--N 1.28 -2.447 0 CA-C-N 113.604 -1.634 . . . . 10.0 111.798 -177.649 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.563 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 6.6 mttt 71.69 63.02 0.14 Allowed 'General case' 0 N--CA 1.497 1.885 0 CA-C-N 115.424 -0.807 . . . . 10.0 109.665 -178.044 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 169.31 -21.19 0.08 OUTLIER Glycine 0 N--CA 1.49 2.252 0 C-N-CA 119.554 -1.308 . . . . 10.0 111.05 -179.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.851 HD22 ' C ' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -62.59 -8.24 6.1 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.401 -1.647 . . . . 10.0 110.912 -179.2 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.558 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.0 ptmt -65.2 -31.57 72.8 Favored 'General case' 0 C--N 1.304 -1.41 0 O-C-N 120.962 -1.086 . . . . 10.0 109.537 179.317 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 12.8 m120 -74.58 -27.7 60.61 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.454 -0.779 . . . . 10.0 110.538 179.775 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.968 HG12 HD13 ' A' ' 79' ' ' LEU . 11.9 t -53.32 -48.17 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 O-C-N 121.182 -0.949 . . . . 10.0 109.676 -179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.555 ' O ' HG12 ' A' ' 173' ' ' ILE . 3.4 t80 -73.55 -30.51 63.1 Favored 'General case' 0 C--N 1.296 -1.734 0 O-C-N 121.866 -0.521 . . . . 10.0 111.259 -179.646 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.502 ' O ' HD22 ' A' ' 174' ' ' LEU . 6.1 m-20 -69.37 -46.17 67.59 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.863 -1.148 . . . . 10.0 111.781 -178.614 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.2 tp10 -74.18 -25.32 59.63 Favored 'General case' 0 N--CA 1.489 1.515 0 O-C-N 120.766 -1.209 . . . . 10.0 110.026 -179.562 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.698 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -68.6 -27.13 65.77 Favored 'General case' 0 C--N 1.3 -1.557 0 O-C-N 121.196 -0.94 . . . . 10.0 109.491 179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.633 ' O ' HD11 ' A' ' 177' ' ' LEU . 26.3 mm -63.24 -48.03 89.44 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.44 0 C-N-CA 119.299 -0.96 . . . . 10.0 109.305 179.58 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.789 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -73.44 -42.97 61.34 Favored 'General case' 0 N--CA 1.489 1.49 0 O-C-N 121.273 -0.892 . . . . 10.0 110.784 -179.857 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.485 ' O ' ' HG3' ' A' ' 109' ' ' PRO . . . -76.23 -2.08 29.6 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 121.517 -0.739 . . . . 10.0 111.065 -179.015 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.698 ' HB2' ' O ' ' A' ' 172' ' ' ALA . . . -87.82 -30.63 20.07 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 120.985 -1.072 . . . . 10.0 110.659 -179.718 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.767 HD22 ' NE2' ' A' ' 2' ' ' GLN . 0.3 OUTLIER -85.77 -17.19 36.5 Favored 'General case' 0 N--CA 1.496 1.841 0 O-C-N 121.332 -0.855 . . . . 10.0 109.163 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.302 -1.483 0 CA-C-O 118.07 -0.967 . . . . 10.0 110.209 -179.98 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.333 0 N-CA-C 109.464 -1.454 . . . . 10.0 109.464 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 31.4 m -89.43 56.34 3.57 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.259 -1.142 . . . . 10.0 110.602 -179.714 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 3.3 mtmt -77.38 98.21 5.17 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 120.9 -1.125 . . . . 10.0 110.336 -179.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 22.6 mm-40 -91.3 155.22 18.69 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 121.382 -0.824 . . . . 10.0 110.192 179.706 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.702 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.35 -152.09 0.0 OUTLIER Pre-proline 0 C--N 1.3 -1.565 0 N-CA-C 107.722 -1.214 . . . . 10.0 107.722 179.231 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.702 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.7 Cg_endo -69.95 87.35 0.58 Allowed 'Trans proline' 0 C--N 1.316 -1.139 0 N-CA-C 110.279 -0.701 . . . . 10.0 110.279 -179.623 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.531 ' HB2' ' CG2' ' A' ' 46' ' ' ILE . 22.6 mm-40 -50.92 -175.77 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.652 -0.655 . . . . 10.0 110.155 -179.893 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.649 HD12 ' HB2' ' B' ' 9' ' ' SER . 1.7 pp -79.77 -44.43 23.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.623 0 O-C-N 121.016 -1.053 . . . . 10.0 111.271 -179.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.649 ' HB2' HD12 ' B' ' 8' ' ' ILE . 7.5 t -126.25 163.66 22.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.659 -1.276 . . . . 10.0 110.828 -179.924 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.935 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -169.37 96.79 0.51 Allowed Pre-proline 0 N--CA 1.484 1.228 0 C-N-CA 118.764 -1.174 . . . . 10.0 113.367 -179.59 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.583 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 40.2 Cg_endo -81.91 157.71 18.22 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 N-CA-C 108.007 -1.574 . . . . 10.0 108.007 176.281 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 70.9 m -149.02 125.24 10.79 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.14 -1.6 . . . . 10.0 112.2 -178.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.439 ' HB2' ' O ' ' A' ' 43' ' ' THR . 10.0 m-20 -80.35 156.97 26.48 Favored 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 108.152 -1.055 . . . . 10.0 108.152 178.067 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 1.013 ' O ' HG11 ' A' ' 42' ' ' VAL . 29.0 m-85 -110.34 142.63 41.74 Favored 'General case' 0 C--N 1.304 -1.405 0 O-C-N 120.411 -1.431 . . . . 10.0 111.301 -179.268 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' ' CD1' ' A' ' 40' ' ' TYR . 0.9 OUTLIER -58.93 143.28 48.45 Favored 'General case' 0 N--CA 1.494 1.725 0 CA-C-O 121.361 0.601 . . . . 10.0 112.335 -177.777 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.661 ' C ' ' HB3' ' A' ' 40' ' ' TYR . 8.1 t60 -88.58 97.6 11.19 Favored 'General case' 0 N--CA 1.483 1.216 0 O-C-N 121.521 -0.737 . . . . 10.0 109.798 178.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.42 ' N ' ' HB3' ' A' ' 40' ' ' TYR . 4.2 m -83.85 155.35 22.98 Favored 'General case' 0 N--CA 1.494 1.759 0 CA-C-O 121.874 0.845 . . . . 10.0 112.934 -177.604 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.71 HD12 ' C ' ' B' ' 18' ' ' ILE . 1.9 pp -125.98 -167.3 0.5 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.542 0 N-CA-C 108.77 -0.826 . . . . 10.0 108.77 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.596 ' HA ' ' CB ' ' A' ' 37' ' ' PHE . 22.2 m-70 -123.14 143.87 49.71 Favored 'General case' 0 C--N 1.3 -1.553 0 O-C-N 121.036 -1.04 . . . . 10.0 110.605 179.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.684 ' CG1' ' HA ' ' A' ' 59' ' ' ALA . 41.2 t -135.41 155.84 37.66 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.446 -0.784 . . . . 10.0 110.413 179.643 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.545 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -122.67 151.76 16.87 Favored Glycine 0 N--CA 1.491 2.315 0 C-N-CA 120.0 -1.095 . . . . 10.0 112.737 -176.635 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.628 ' HB3' ' CB ' ' B' ' 25' ' ' VAL . 0.1 OUTLIER 159.33 112.21 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.845 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 178.675 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.525 ' O ' ' C ' ' B' ' 24' ' ' ALA . 8.3 m-20 -44.66 143.32 1.41 Allowed 'General case' 0 N--CA 1.498 1.954 0 O-C-N 121.465 -0.772 . . . . 10.0 111.653 -178.505 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.537 ' O ' ' HB2' ' B' ' 28' ' ' GLU . . . 19.82 53.48 0.01 OUTLIER 'General case' 0 N--CA 1.507 2.411 0 CA-C-O 120.968 0.413 . . . . 10.0 111.762 179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.628 ' CB ' ' HB3' ' B' ' 22' ' ' PHE . 1.0 OUTLIER -112.59 -41.19 3.85 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.717 0 O-C-N 121.438 -0.789 . . . . 10.0 109.322 -179.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.586 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.2 t -53.58 -18.3 2.79 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.62 -0.675 . . . . 10.0 109.855 179.674 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.643 ' HA3' HG21 ' A' ' 21' ' ' ILE . . . -128.09 25.51 4.89 Favored Glycine 0 N--CA 1.495 2.578 0 N-CA-C 107.78 -2.128 . . . . 10.0 107.78 178.807 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.581 ' OE1' HG22 ' B' ' 25' ' ' VAL . 23.9 tt0 -92.93 110.25 21.71 Favored 'General case' 0 N--CA 1.486 1.343 0 O-C-N 120.854 -1.38 . . . . 10.0 111.995 -178.702 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.617 ' CD1' ' HB3' ' A' ' 159' ' ' ALA . 45.7 t80 -140.75 111.06 6.69 Favored 'General case' 0 C--N 1.273 -2.751 0 CA-C-N 114.515 -1.22 . . . . 10.0 109.297 177.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.466 ' O ' ' NE2' ' A' ' 116' ' ' GLN . 47.6 p -116.67 -79.61 0.59 Allowed 'General case' 0 C--N 1.284 -2.28 0 N-CA-C 108.465 -0.939 . . . . 10.0 108.465 178.937 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.454 ' O ' HG13 ' B' ' 32' ' ' ILE . . . 139.16 97.18 0.37 Allowed Glycine 0 N--CA 1.492 2.405 0 C-N-CA 119.721 -1.228 . . . . 10.0 110.971 178.441 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.582 HG22 ' CD ' ' B' ' 33' ' ' PRO . 0.1 OUTLIER 178.51 -51.58 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.789 0 O-C-N 121.111 -1.229 . . . . 10.0 110.284 178.86 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.582 ' CD ' HG22 ' B' ' 32' ' ' ILE . 49.3 Cg_endo -92.44 154.31 3.01 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.712 1.375 . . . . 10.0 110.409 -179.902 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.63 ' HA ' ' CA ' ' A' ' 12' ' ' GLY . 0.3 OUTLIER -49.19 174.18 0.01 OUTLIER 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.095 -1.003 . . . . 10.0 108.762 178.889 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.653 ' N ' ' HA2' ' A' ' 12' ' ' GLY . 23.7 mt-30 -88.42 -73.78 0.48 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 120.457 -1.402 . . . . 10.0 111.946 -177.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.71 ' CZ2' HD12 ' A' ' 67' ' ' LEU . 0.4 OUTLIER -122.61 19.26 10.37 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 122.311 1.053 . . . . 10.0 108.792 179.331 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.931 ' O ' HD23 ' B' ' 39' ' ' LEU . . . -112.75 52.34 0.79 Allowed 'General case' 0 C--N 1.289 -2.045 0 N-CA-C 108.027 -1.101 . . . . 10.0 108.027 179.733 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.522 ' CG ' ' HB2' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -75.6 42.95 0.23 Allowed 'General case' 0 C--N 1.299 -1.604 0 CA-C-O 122.199 1.0 . . . . 10.0 108.794 179.742 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.931 HD23 ' O ' ' B' ' 37' ' ' ALA . 0.5 OUTLIER -51.83 -29.39 19.23 Favored 'General case' 0 N--CA 1.496 1.84 0 CA-C-N 115.565 -0.743 . . . . 10.0 111.151 -179.039 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.463 HD23 ' CD1' ' B' ' 39' ' ' LEU . 1.2 pp -114.72 13.68 17.36 Favored 'General case' 0 N--CA 1.492 1.642 0 O-C-N 121.124 -0.985 . . . . 10.0 109.957 179.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.522 ' HB2' ' CG ' ' B' ' 38' ' ' ARG . 28.3 mt-30 -131.73 35.09 3.82 Favored 'General case' 0 C--N 1.293 -1.878 0 O-C-N 121.788 -0.57 . . . . 10.0 109.673 179.539 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.477 HG22 ' N ' ' B' ' 43' ' ' SER . 44.9 m -102.35 168.39 9.36 Favored 'General case' 0 C--N 1.308 -1.238 0 O-C-N 121.101 -0.999 . . . . 10.0 110.259 -179.412 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.477 ' N ' HG22 ' B' ' 42' ' ' THR . 96.6 p -61.6 -7.96 3.91 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.325 -0.859 . . . . 10.0 111.044 -179.855 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -123.82 100.84 6.96 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.806 -1.184 . . . . 10.0 110.025 179.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 1.4 mp -61.45 160.24 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 O-C-N 121.306 -0.871 . . . . 10.0 109.746 179.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.298 -1.653 0 C-N-CA 119.139 -1.024 . . . . 10.0 110.322 178.855 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.8 mtt . . . . . 0 N--CA 1.491 1.59 0 CA-C-O 121.157 0.503 . . . . 10.0 110.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.667 ' HA ' HD23 ' A' ' 177' ' ' LEU . 24.9 mm100 -146.61 -38.53 0.22 Allowed 'General case' 0 N--CA 1.487 1.376 0 O-C-N 121.332 -0.855 . . . . 10.0 109.607 179.717 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.559 HG22 ' O ' ' A' ' 3' ' ' THR . 1.8 m -47.28 101.55 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.519 -0.738 . . . . 10.0 111.893 -179.453 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.84 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -111.07 130.46 64.49 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 C-N-CA 119.286 -0.966 . . . . 10.0 108.892 177.101 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.553 ' O ' ' CG2' ' A' ' 75' ' ' THR . 0.2 OUTLIER -113.19 98.57 7.21 Favored 'General case' 0 C--N 1.293 -1.89 0 C-N-CA 119.412 -0.915 . . . . 10.0 109.598 179.474 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 50.1 t -84.88 101.31 12.21 Favored 'General case' 0 C--N 1.301 -1.501 0 O-C-N 121.283 -0.885 . . . . 10.0 109.072 179.36 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.71 ' HB ' HG21 ' A' ' 75' ' ' THR . 48.4 t -121.84 142.46 38.08 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.404 0 C-N-CA 119.135 -1.026 . . . . 10.0 110.739 -179.328 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.731 HG23 ' HA3' ' A' ' 15' ' ' GLY . 2.4 p -63.29 125.86 20.65 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 O-C-N 121.671 -0.643 . . . . 10.0 109.994 179.499 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.635 ' HB ' ' CZ2' ' B' ' 36' ' ' TRP . 0.2 OUTLIER -141.64 168.36 15.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.594 0 O-C-N 121.148 -0.97 . . . . 10.0 109.672 179.706 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.791 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 169.97 158.19 13.47 Favored Glycine 0 N--CA 1.483 1.831 0 N-CA-C 109.7 -1.36 . . . . 10.0 109.7 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 40.5 m-20 -50.03 -22.62 1.67 Allowed 'General case' 0 C--N 1.3 -1.549 0 O-C-N 121.404 -1.056 . . . . 10.0 109.418 179.588 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . . . . . . . . . . . 143.0 35.4 0.08 OUTLIER Glycine 0 N--CA 1.494 2.554 0 N-CA-C 109.599 -1.4 . . . . 10.0 109.599 179.77 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.534 ' HA ' ' O ' ' B' ' 32' ' ' ILE . . . -125.55 -155.72 0.69 Allowed 'General case' 0 N--CA 1.489 1.518 0 O-C-N 121.325 -1.103 . . . . 10.0 109.661 179.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.462 HG11 ' HA ' ' B' ' 29' ' ' PHE . 20.1 t -69.71 108.79 2.15 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.171 -0.956 . . . . 10.0 109.471 179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.731 ' HA3' HG23 ' A' ' 8' ' ' VAL . . . -52.55 164.51 1.64 Allowed Glycine 0 N--CA 1.491 2.335 0 N-CA-C 109.888 -1.285 . . . . 10.0 109.888 -179.438 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 6.5 mtpp -87.68 5.89 37.52 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 121.354 -1.086 . . . . 10.0 110.267 179.604 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.579 HG23 ' N ' ' A' ' 18' ' ' CYS . 14.1 t -75.08 -43.06 55.31 Favored 'General case' 0 C--N 1.303 -1.449 0 O-C-N 121.167 -0.958 . . . . 10.0 109.501 179.627 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.701 ' HA ' ' O ' ' B' ' 26' ' ' THR . 30.8 p -74.72 -9.23 58.37 Favored 'General case' 0 C--N 1.302 -1.466 0 C-N-CA 118.375 -1.33 . . . . 10.0 108.429 179.243 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.954 HD11 ' HB2' ' A' ' 159' ' ' ALA . 3.9 mm? -76.8 -36.2 57.11 Favored 'General case' 0 C--N 1.307 -1.279 0 O-C-N 121.385 -0.822 . . . . 10.0 109.631 178.386 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -51.36 -37.79 49.82 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 108.197 -1.038 . . . . 10.0 108.197 178.411 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.522 ' CG2' ' HA3' ' B' ' 27' ' ' GLY . 1.4 mm -91.61 -51.76 11.14 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.918 0 CA-C-O 121.685 0.755 . . . . 10.0 109.912 178.894 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.686 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 68.4 m -49.52 -45.59 47.45 Favored 'General case' 0 C--N 1.293 -1.889 0 C-N-CA 119.51 -0.876 . . . . 10.0 109.808 -178.73 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.568 ' CB ' HD11 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -67.58 -32.47 73.25 Favored 'General case' 0 C--N 1.302 -1.465 0 O-C-N 121.248 -0.907 . . . . 10.0 109.726 179.517 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 79.7 m -75.77 -51.85 11.73 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 121.116 -0.99 . . . . 10.0 112.073 -178.207 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.634 HG23 ' N ' ' A' ' 26' ' ' ASN . 15.3 t -153.67 -46.15 0.09 Allowed 'General case' 0 N--CA 1.502 2.151 0 C-N-CA 117.54 -1.664 . . . . 10.0 113.82 -179.114 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.634 ' N ' HG23 ' A' ' 25' ' ' THR . 30.5 m120 -67.98 -23.67 65.06 Favored 'General case' 0 C--N 1.297 -1.709 0 O-C-N 120.907 -1.12 . . . . 10.0 111.596 -177.361 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.686 ' N ' ' HA ' ' A' ' 22' ' ' SER . 2.6 pttt 24.37 -148.59 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.223 0 CA-C-O 122.287 1.042 . . . . 10.0 113.249 179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.615 ' CG ' ' HD2' ' A' ' 29' ' ' PRO . 15.0 t80 -53.39 149.77 13.63 Favored Pre-proline 0 C--N 1.299 -1.612 0 O-C-N 121.085 -1.01 . . . . 10.0 109.504 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 28' ' ' PHE . 36.5 Cg_endo -60.42 100.3 0.15 Allowed 'Trans proline' 0 N--CA 1.494 1.528 0 O-C-N 123.527 1.278 . . . . 10.0 112.49 -177.676 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 4.9 t -168.09 28.12 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.695 -0.628 . . . . 10.0 109.632 178.613 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.502 ' HG3' ' O ' ' A' ' 32' ' ' TYR . 13.0 pt-20 -171.24 -174.33 1.44 Allowed 'General case' 0 C--N 1.304 -1.395 0 CA-C-O 121.849 0.833 . . . . 10.0 109.928 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.502 ' O ' ' HG3' ' A' ' 31' ' ' GLU . 11.1 m-85 -72.91 154.49 40.54 Favored 'General case' 0 C--N 1.292 -1.91 0 N-CA-C 108.917 -0.771 . . . . 10.0 108.917 178.654 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.769 HG23 ' HD2' ' A' ' 34' ' ' PRO . 1.8 p -176.91 153.04 1.07 Allowed Pre-proline 0 N--CA 1.489 1.493 0 O-C-N 120.516 -1.365 . . . . 10.0 111.952 -177.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.769 ' HD2' HG23 ' A' ' 33' ' ' VAL . 37.7 Cg_endo -61.79 -175.28 0.16 Allowed 'Trans proline' 0 N--CA 1.493 1.458 0 O-C-N 124.069 1.563 . . . . 10.0 110.55 178.91 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.576 ' HB ' ' HB ' ' B' ' 20' ' ' VAL . 82.5 p -126.03 163.11 23.76 Favored 'General case' 0 N--CA 1.491 1.591 0 CA-C-O 122.177 0.989 . . . . 10.0 112.68 -178.126 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.824 ' N ' HG11 ' B' ' 20' ' ' VAL . 73.2 t -50.64 -77.35 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.508 2.46 0 N-CA-C 115.764 1.765 . . . . 10.0 115.764 -178.168 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.002 ' N ' HG22 ' B' ' 20' ' ' VAL . 0.0 OUTLIER -51.64 93.45 0.01 OUTLIER 'General case' 0 N--CA 1.493 1.721 0 O-C-N 120.757 -1.214 . . . . 10.0 110.213 -175.597 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.527 ' N ' ' O ' ' A' ' 36' ' ' VAL . 57.0 t0 -133.66 85.64 2.22 Favored 'General case' 0 C--N 1.302 -1.467 0 CA-C-N 115.663 -0.698 . . . . 10.0 110.564 -179.09 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.573 ' N ' ' OG1' ' B' ' 17' ' ' THR . 2.0 t-20 -84.4 99.65 10.79 Favored 'General case' 0 N--CA 1.488 1.446 0 O-C-N 120.916 -1.115 . . . . 10.0 110.054 179.546 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.97 120.71 41.63 Favored 'General case' 0 C--N 1.301 -1.53 0 O-C-N 121.067 -1.021 . . . . 10.0 109.652 179.723 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.727 ' HB3' ' OE1' ' B' ' 15' ' ' GLU . . . -124.0 137.13 54.64 Favored 'General case' 0 N--CA 1.495 1.777 0 C-N-CA 118.693 -1.203 . . . . 10.0 111.023 -179.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.609 HG12 ' N ' ' A' ' 43' ' ' THR . 55.8 t -157.94 170.81 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.57 0 O-C-N 121.08 -1.012 . . . . 10.0 110.279 179.236 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 1.069 HG23 ' O ' ' A' ' 51' ' ' TYR . 85.1 m -149.82 146.55 27.21 Favored 'General case' 0 N--CA 1.492 1.659 0 N-CA-C 109.083 -0.71 . . . . 10.0 109.083 179.42 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.891 HG23 ' HB2' ' A' ' 51' ' ' TYR . 0.0 OUTLIER -147.95 133.17 10.98 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.371 0 O-C-N 120.912 -1.118 . . . . 10.0 112.133 -177.95 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.577 ' HB2' ' HD2' ' B' ' 11' ' ' PRO . 27.0 mtp -92.4 99.82 12.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.045 -1.034 . . . . 10.0 109.794 178.605 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.725 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 5.7 mt -88.16 130.94 36.94 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.744 0 O-C-N 121.194 -0.941 . . . . 10.0 110.636 -179.58 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.666 ' HA2' HD12 ' B' ' 8' ' ' ILE . . . 43.78 25.77 0.65 Allowed Glycine 0 N--CA 1.491 2.304 0 N-CA-C 109.267 -1.533 . . . . 10.0 109.267 -179.314 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.439 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 96.87 21.66 20.36 Favored Glycine 0 N--CA 1.491 2.345 0 N-CA-C 110.225 -1.15 . . . . 10.0 110.225 179.812 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.54 ' C ' ' HA ' ' A' ' 45' ' ' MET . 27.9 mt-10 -126.34 105.43 24.64 Favored Pre-proline 0 N--CA 1.492 1.642 0 O-C-N 120.972 -1.31 . . . . 10.0 110.526 179.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.476 ' HA ' ' HA ' ' A' ' 45' ' ' MET . 41.4 Cg_endo -67.26 131.45 25.05 Favored 'Trans proline' 0 N--CA 1.494 1.551 0 O-C-N 124.028 1.541 . . . . 10.0 111.105 -179.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 1.069 ' O ' HG23 ' A' ' 43' ' ' THR . 1.5 t80 -88.53 152.26 21.98 Favored 'General case' 0 N--CA 1.49 1.567 0 O-C-N 121.234 -0.917 . . . . 10.0 110.871 -179.903 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.84 ' O ' HG22 ' A' ' 4' ' ' ILE . 23.7 m -130.38 98.72 4.78 Favored 'General case' 0 N--CA 1.491 1.593 0 O-C-N 121.571 -0.706 . . . . 10.0 109.267 179.367 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.828 HD12 ' N ' ' A' ' 54' ' ' GLY . 2.3 pp -152.33 173.6 14.84 Favored 'General case' 0 N--CA 1.49 1.534 0 C-N-CA 118.12 -1.432 . . . . 10.0 112.259 -179.569 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.828 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.5 134.38 2.97 Favored Glycine 0 N--CA 1.491 2.341 0 N-CA-C 108.151 -1.98 . . . . 10.0 108.151 179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.698 HD12 ' C ' ' A' ' 55' ' ' LEU . 4.0 pp -130.32 152.43 49.74 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.683 -1.481 . . . . 10.0 110.712 -179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.524 ' HB3' ' HA ' ' A' ' 39' ' ' ASN . 16.8 p90 -169.81 150.45 3.94 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.374 -0.829 . . . . 10.0 110.432 179.564 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.505 ' HB2' ' O ' ' A' ' 36' ' ' VAL . 63.6 m-20 -93.04 172.96 7.98 Favored 'General case' 0 N--CA 1.496 1.839 0 O-C-N 121.222 -0.923 . . . . 10.0 111.194 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.671 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.9 OUTLIER -64.28 -169.03 0.03 OUTLIER 'General case' 0 N--CA 1.497 1.878 0 CA-C-O 122.117 0.961 . . . . 10.0 112.078 -179.113 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.981 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -111.34 72.11 0.77 Allowed 'General case' 0 N--CA 1.494 1.755 0 N-CA-C 109.248 -0.649 . . . . 10.0 109.248 179.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -39.91 -43.69 2.52 Favored Glycine 0 N--CA 1.49 2.297 0 N-CA-C 109.675 -1.37 . . . . 10.0 109.675 -179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 9.5 tt0 -143.81 13.62 1.7 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.259 -1.142 . . . . 10.0 110.864 179.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.981 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 13.4 mm-40 -53.05 -39.14 63.02 Favored 'General case' 0 C--N 1.307 -1.245 0 O-C-N 120.765 -1.209 . . . . 10.0 109.147 179.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.549 ' HB2' ' O ' ' A' ' 62' ' ' GLU . 35.0 m-20 67.21 10.37 7.66 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 108.899 -0.778 . . . . 10.0 108.899 -179.381 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.635 ' CE1' ' O ' ' A' ' 62' ' ' GLU . 4.5 m-85 -101.45 -32.57 10.35 Favored 'General case' 0 C--N 1.306 -1.32 0 N-CA-C 107.984 -1.117 . . . . 10.0 107.984 178.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.616 ' CG ' HG23 ' B' ' 42' ' ' THR . 9.7 t70 20.45 49.16 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.155 0 CA-C-O 121.226 0.536 . . . . 10.0 111.28 179.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 64' ' ' TYR . 42.8 mtp180 -83.22 -37.06 24.09 Favored 'General case' 0 C--N 1.303 -1.435 0 O-C-N 121.328 -0.858 . . . . 10.0 110.419 -179.191 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.509 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.1 mt -108.13 4.58 25.06 Favored 'General case' 0 N--CA 1.492 1.625 0 O-C-N 121.246 -0.909 . . . . 10.0 110.626 179.682 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.719 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.2 OUTLIER -100.27 3.04 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.564 0 C-N-CA 118.934 -1.107 . . . . 10.0 113.54 179.985 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.0 Cg_endo -79.37 52.98 4.51 Favored 'Trans proline' 0 C--N 1.315 -1.187 0 N-CA-C 108.196 -1.502 . . . . 10.0 108.196 178.322 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.698 ' N ' HD23 ' A' ' 70' ' ' LEU . 1.7 pt? -53.28 -52.9 57.57 Favored 'General case' 0 C--N 1.312 -1.043 0 O-C-N 121.572 -0.705 . . . . 10.0 112.225 -178.057 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.618 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 26.2 t 39.99 27.96 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.719 0 O-C-N 121.083 -1.011 . . . . 10.0 109.601 -179.428 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.577 ' CG ' ' O ' ' A' ' 71' ' ' SER . 0.3 OUTLIER 179.47 158.75 0.74 Allowed Pre-proline 0 N--CA 1.493 1.686 0 O-C-N 121.473 -0.767 . . . . 10.0 110.017 -178.63 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.525 ' O ' ' NE2' ' A' ' 74' ' ' GLN . 47.1 Cg_endo -72.99 107.75 2.43 Favored 'Trans proline' 0 C--N 1.307 -1.646 0 O-C-N 123.696 1.366 . . . . 10.0 109.44 178.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 73' ' ' PRO . 0.4 OUTLIER -137.69 36.95 2.43 Favored 'General case' 0 N--CA 1.494 1.757 0 O-C-N 120.805 -1.184 . . . . 10.0 110.962 -179.143 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.71 HG21 ' HB ' ' A' ' 7' ' ' VAL . 97.7 m -144.66 91.99 2.24 Favored 'General case' 0 N--CA 1.487 1.405 0 O-C-N 121.177 -0.952 . . . . 10.0 108.885 178.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.511 ' C ' ' O ' ' A' ' 75' ' ' THR . 10.0 m-20 -24.25 -48.06 0.02 OUTLIER 'General case' 0 N--CA 1.498 1.964 0 N-CA-C 113.066 0.765 . . . . 10.0 113.066 -178.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.532 HG22 ' O ' ' A' ' 5' ' ' LYS . 2.3 m -114.5 133.61 60.06 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.894 0 O-C-N 120.983 -1.073 . . . . 10.0 110.986 -178.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' CE1' ' O ' ' A' ' 75' ' ' THR . 87.4 m-85 -119.77 131.45 55.35 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.57 -0.706 . . . . 10.0 112.074 -178.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.607 HD22 HD23 ' A' ' 111' ' ' LEU . 2.6 mm? -103.67 98.33 8.22 Favored 'General case' 0 N--CA 1.486 1.351 0 N-CA-C 107.639 -1.245 . . . . 10.0 107.639 177.039 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.791 HG23 ' HA2' ' A' ' 10' ' ' GLY . 2.6 p -114.96 161.45 13.71 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.651 0 O-C-N 121.356 -0.84 . . . . 10.0 110.632 -178.364 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.404 ' O ' ' SG ' ' A' ' 81' ' ' CYS . 23.0 p -124.74 101.6 7.18 Favored 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.087 -1.008 . . . . 10.0 111.2 -179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.554 ' O ' ' N ' ' A' ' 115' ' ' THR . 51.9 m-85 -87.26 174.29 8.68 Favored 'General case' 0 N--CA 1.492 1.675 0 O-C-N 121.316 -0.865 . . . . 10.0 110.401 179.343 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 15.5 m -118.94 130.83 55.92 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.279 -0.888 . . . . 10.0 109.852 179.534 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.829 HG22 ' HG2' ' A' ' 120' ' ' ARG . 27.8 m -67.14 -10.81 12.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 O-C-N 121.132 -0.98 . . . . 10.0 109.913 179.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.779 HG13 HG23 ' A' ' 84' ' ' VAL . 35.3 m -115.8 43.17 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.762 0 O-C-N 121.417 -0.802 . . . . 10.0 109.89 179.566 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.512 ' OG ' ' HB2' ' A' ' 89' ' ' SER . 36.7 t -105.55 140.06 20.79 Favored Pre-proline 0 N--CA 1.493 1.687 0 O-C-N 121.459 -0.775 . . . . 10.0 109.784 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.44 ' HA ' ' ND2' ' A' ' 132' ' ' ASN . 46.9 Cg_endo -71.38 114.46 3.94 Favored 'Trans proline' 0 C--N 1.303 -1.83 0 O-C-N 124.04 1.547 . . . . 10.0 111.515 -178.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.433 ' C ' ' O ' ' A' ' 87' ' ' PRO . 75.3 m 38.9 60.08 1.49 Allowed 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.426 -0.796 . . . . 10.0 111.458 178.638 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.512 ' HB2' ' OG ' ' A' ' 86' ' ' SER . 3.4 t -100.21 -66.16 0.92 Allowed 'General case' 0 N--CA 1.494 1.752 0 O-C-N 120.962 -1.086 . . . . 10.0 110.035 179.459 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.993 ' O ' HG22 ' A' ' 93' ' ' VAL . 0.2 OUTLIER -48.52 -26.01 1.97 Allowed 'General case' 0 C--N 1.302 -1.483 0 O-C-N 121.344 -0.847 . . . . 10.0 110.301 179.848 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -65.89 -19.43 65.87 Favored 'General case' 0 C--N 1.299 -1.587 0 O-C-N 121.029 -1.044 . . . . 10.0 110.3 -179.913 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.654 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -84.77 -16.24 42.23 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.071 -1.018 . . . . 10.0 110.067 179.464 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.993 HG22 ' O ' ' A' ' 90' ' ' PHE . 18.1 m -88.95 -19.27 7.6 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.508 0 O-C-N 120.821 -1.174 . . . . 10.0 109.005 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.71 ' CD ' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -76.83 -32.84 57.85 Favored 'General case' 0 N--CA 1.494 1.773 0 N-CA-C 107.732 -1.21 . . . . 10.0 107.732 178.291 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.563 ' HG2' ' HA ' ' A' ' 92' ' ' ASN . 0.4 OUTLIER -85.16 0.38 51.93 Favored 'General case' 0 C--N 1.292 -1.932 0 N-CA-C 108.11 -1.07 . . . . 10.0 108.11 177.632 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.546 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.5 OUTLIER -111.38 -51.75 2.84 Favored 'General case' 0 N--CA 1.489 1.504 0 C-N-CA 119.102 -1.039 . . . . 10.0 111.379 179.753 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.6 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 15.2 m0 -72.97 -30.61 63.96 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.347 -0.846 . . . . 10.0 111.81 -178.029 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 1.026 HG22 HD21 ' A' ' 149' ' ' LEU . 16.8 t -70.89 -47.89 15.05 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 120.818 -1.176 . . . . 10.0 111.362 -178.708 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.565 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.7 Cg_endo -70.7 -14.3 33.01 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.077 1.041 . . . . 10.0 111.397 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.546 ' CG ' ' O ' ' A' ' 96' ' ' LYS . 3.5 mm-40 -67.04 -39.64 86.99 Favored 'General case' 0 N--CA 1.493 1.722 0 O-C-N 120.916 -1.115 . . . . 10.0 110.223 179.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.667 HG22 ' O ' ' A' ' 101' ' ' ILE . 11.3 mt 44.22 85.69 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.494 1.751 0 C-N-CA 119.322 -0.951 . . . . 10.0 109.59 -179.697 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.551 ' CG2' ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -44.23 -84.78 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.676 0 O-C-N 121.129 -0.982 . . . . 10.0 110.133 -179.504 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.525 ' H ' HG23 ' A' ' 102' ' ' THR . 7.1 t60 -103.57 -13.96 16.35 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.192 -0.943 . . . . 10.0 110.546 179.891 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.654 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.7 OUTLIER -173.25 -48.12 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.616 0 N-CA-C 108.588 -0.893 . . . . 10.0 108.588 -179.542 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.551 ' O ' ' CG2' ' A' ' 102' ' ' THR . 73.2 m -119.08 164.75 19.56 Favored Pre-proline 0 N--CA 1.488 1.431 0 N-CA-C 108.655 -0.868 . . . . 10.0 108.655 178.774 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -77.07 112.98 3.52 Favored 'Trans proline' 0 C--N 1.3 -1.977 0 O-C-N 123.538 1.283 . . . . 10.0 110.282 -179.658 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -144.18 0.59 1.05 Allowed 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.885 -1.134 . . . . 10.0 111.728 -179.997 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 14.4 m -47.69 134.89 10.63 Favored Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 120.681 -1.262 . . . . 10.0 108.819 179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.53 ' HB3' ' HB1' ' A' ' 175' ' ' ALA . 41.8 Cg_endo -68.38 130.54 21.31 Favored 'Trans proline' 0 C--N 1.305 -1.728 0 O-C-N 123.561 1.295 . . . . 10.0 109.775 -179.808 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.491 ' CE1' ' CZ2' ' A' ' 97' ' ' TRP . 0.2 OUTLIER -137.58 113.85 10.09 Favored 'General case' 0 C--N 1.303 -1.425 0 CA-C-O 122.032 0.92 . . . . 10.0 110.931 -179.47 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.919 ' CD1' HG11 ' A' ' 152' ' ' VAL . 1.8 mm? -82.19 100.29 9.76 Favored 'General case' 0 C--N 1.297 -1.702 0 N-CA-C 107.789 -1.189 . . . . 10.0 107.789 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.669 HD21 ' C ' ' A' ' 153' ' ' LYS . 0.6 OUTLIER -91.3 117.47 29.68 Favored 'General case' 0 C--N 1.293 -1.867 0 CA-C-O 121.889 0.852 . . . . 10.0 110.352 -178.121 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.542 HG21 HG11 ' A' ' 168' ' ' VAL . 1.6 t -126.3 177.31 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.903 0 O-C-N 121.032 -1.043 . . . . 10.0 111.618 -177.561 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.503 ' HA2' ' O ' ' A' ' 82' ' ' PHE . . . -107.48 159.29 14.6 Favored Glycine 0 N--CA 1.492 2.371 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 178.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.554 ' N ' ' O ' ' A' ' 82' ' ' PHE . 87.1 m -113.59 140.77 47.9 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.987 -1.302 . . . . 10.0 110.277 -179.715 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 31.1 mt-30 48.61 36.52 7.74 Favored 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.137 -0.977 . . . . 10.0 109.467 -179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.3 OUTLIER -47.39 -24.82 0.71 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.261 -0.976 . . . . 10.0 110.864 -178.531 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.753 ' O ' ' HB2' ' A' ' 119' ' ' LEU . 3.6 p-10 -52.67 52.33 0.0 OUTLIER 'General case' 0 N--CA 1.515 2.783 0 CA-C-O 121.397 0.618 . . . . 10.0 112.222 -176.639 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.76 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.3 OUTLIER 157.34 -53.22 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.17 0 N-CA-C 106.074 -1.824 . . . . 10.0 106.074 -179.845 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.829 ' HG2' HG22 ' A' ' 84' ' ' VAL . 0.0 OUTLIER -40.07 -30.16 0.09 Allowed 'General case' 0 C--N 1.3 -1.573 0 CA-C-N 115.277 -0.874 . . . . 10.0 110.23 178.124 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 119' ' ' LEU . 37.3 t0 -68.02 -19.04 64.87 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.286 -0.884 . . . . 10.0 110.404 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.975 ' O ' HD13 ' A' ' 126' ' ' ILE . 3.4 m-20 -82.13 148.4 59.97 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.234 -0.916 . . . . 10.0 110.27 179.841 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.463 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.3 Cg_endo -86.33 22.74 0.9 Allowed 'Trans proline' 0 C--N 1.308 -1.601 0 O-C-N 124.067 1.562 . . . . 10.0 110.226 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.502 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 21.0 p -102.95 -50.25 3.56 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.342 -0.848 . . . . 10.0 109.661 -179.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.711 HG21 HD12 ' A' ' 119' ' ' LEU . 4.0 t -70.55 -30.44 67.16 Favored 'General case' 0 C--N 1.297 -1.683 0 N-CA-C 105.163 -2.162 . . . . 10.0 105.163 176.846 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.975 HD13 ' O ' ' A' ' 122' ' ' ASP 0.298 0.8 OUTLIER -49.54 -30.32 4.95 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.494 0 N-CA-C 106.707 -1.59 . . . . 10.0 106.707 176.515 . . . . . . . . 4 4 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.502 ' CB ' ' O ' ' A' ' 124' ' ' SER . 1.5 tp10 -52.84 -38.62 61.63 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 121.876 0.846 . . . . 10.0 109.971 178.743 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 26.1 mmtt -56.5 -39.61 73.57 Favored 'General case' 0 C--N 1.298 -1.646 0 O-C-N 121.922 -0.487 . . . . 10.0 111.041 -179.211 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.806 HD12 ' HA ' ' A' ' 126' ' ' ILE . 3.2 mt -51.41 -47.75 62.85 Favored 'General case' 0 N--CA 1.488 1.464 0 O-C-N 120.938 -1.101 . . . . 10.0 110.043 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.85 -44.53 59.47 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.569 -0.707 . . . . 10.0 110.397 -179.625 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -47.93 -23.83 0.88 Allowed 'General case' 0 C--N 1.301 -1.518 0 O-C-N 121.232 -0.918 . . . . 10.0 109.967 -179.722 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.44 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 2.1 p-10 -127.95 -25.54 3.03 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.04 -1.037 . . . . 10.0 111.194 179.974 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.539 ' HE2' ' HA ' ' A' ' 136' ' ' PRO . 0.0 OUTLIER -147.79 118.31 7.46 Favored 'General case' 0 C--N 1.298 -1.646 0 N-CA-C 108.482 -0.933 . . . . 10.0 108.482 -179.738 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.597 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.0 OUTLIER -65.16 -22.36 66.9 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.61 -0.682 . . . . 10.0 111.855 -178.003 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.538 ' O ' ' CE ' ' A' ' 133' ' ' LYS . 0.8 OUTLIER -108.33 95.24 15.24 Favored Pre-proline 0 C--N 1.299 -1.614 0 O-C-N 121.048 -1.032 . . . . 10.0 110.07 179.761 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.747 ' CB ' HD13 ' A' ' 129' ' ' LEU . 43.5 Cg_endo -72.49 157.54 52.67 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 O-C-N 123.977 1.514 . . . . 10.0 109.763 179.97 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.777 HG23 ' HA ' ' A' ' 84' ' ' VAL . 5.8 tp -100.49 127.4 53.59 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.43 0 O-C-N 121.06 -1.025 . . . . 10.0 109.923 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 22.6 p -125.1 169.83 10.36 Favored Pre-proline 0 C--N 1.301 -1.51 0 O-C-N 121.507 -0.746 . . . . 10.0 109.223 -179.727 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.591 ' O ' ' CD2' ' A' ' 154' ' ' TYR . 37.6 Cg_endo -63.1 -11.78 26.65 Favored 'Trans proline' 0 C--N 1.304 -1.791 0 O-C-N 123.637 1.335 . . . . 10.0 111.321 -179.797 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 14.6 mt-10 -83.95 -51.06 7.45 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.665 -1.272 . . . . 10.0 110.218 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 58.7 m -68.55 -39.94 80.86 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.425 -0.797 . . . . 10.0 110.514 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.516 ' HB1' ' CD1' ' A' ' 112' ' ' LEU . . . -51.16 -27.39 8.56 Favored 'General case' 0 N--CA 1.49 1.562 0 O-C-N 121.168 -0.958 . . . . 10.0 110.039 -179.614 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -67.38 -49.95 61.7 Favored 'General case' 0 N--CA 1.491 1.591 0 O-C-N 121.425 -0.797 . . . . 10.0 109.732 179.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.63 -32.5 72.4 Favored 'General case' 0 C--N 1.304 -1.396 0 O-C-N 121.196 -0.94 . . . . 10.0 108.976 178.758 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.55 ' CG ' ' HE2' ' A' ' 94' ' ' LYS . 2.5 tt -64.08 -49.72 71.17 Favored 'General case' 0 C--N 1.307 -1.272 0 O-C-N 121.398 -0.813 . . . . 10.0 109.193 178.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.582 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -61.71 -41.0 97.02 Favored 'General case' 0 N--CA 1.487 1.387 0 N-CA-C 108.411 -0.959 . . . . 10.0 108.411 178.648 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 2.2 ttp180 -57.85 -24.45 57.56 Favored 'General case' 0 C--N 1.3 -1.563 0 C-N-CA 120.014 -0.674 . . . . 10.0 109.27 178.851 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.526 ' C ' HD12 ' A' ' 149' ' ' LEU . 51.0 t0 -58.33 -55.19 38.26 Favored 'General case' 0 N--CA 1.493 1.707 0 O-C-N 121.34 -0.85 . . . . 10.0 109.428 179.72 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.026 HD21 HG22 ' A' ' 98' ' ' VAL . 6.7 mp -96.55 9.23 42.09 Favored 'General case' 0 N--CA 1.49 1.564 0 N-CA-C 108.007 -1.109 . . . . 10.0 108.007 177.915 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.47 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.9 mttp 61.86 35.99 16.18 Favored 'General case' 0 C--N 1.303 -1.424 0 CA-C-O 122.044 0.926 . . . . 10.0 109.62 179.489 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.582 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -58.12 -154.59 0.0 OUTLIER 'General case' 0 C--N 1.296 -1.747 0 CA-C-N 115.741 -0.663 . . . . 10.0 109.476 179.233 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.919 HG11 ' CD1' ' A' ' 111' ' ' LEU . 4.3 t -89.08 -76.5 0.29 Allowed 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 120.945 -1.097 . . . . 10.0 110.627 -179.827 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.669 ' C ' HD21 ' A' ' 112' ' ' LEU . 2.1 tppt? -174.88 159.83 2.78 Favored 'General case' 0 N--CA 1.495 1.786 0 C-N-CA 118.281 -1.368 . . . . 10.0 112.125 -178.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.608 ' O ' ' CG ' ' A' ' 154' ' ' TYR . 18.0 p90 -84.26 112.57 20.41 Favored 'General case' 0 N--CA 1.49 1.531 0 CA-C-O 121.658 0.742 . . . . 10.0 109.98 178.347 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.009 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -115.71 -169.28 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.223 -0.923 . . . . 10.0 110.637 -179.446 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -155.08 144.49 21.2 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.233 -0.917 . . . . 10.0 109.928 -179.94 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.66 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 24.0 p -149.42 148.93 30.04 Favored 'General case' 0 N--CA 1.491 1.606 0 CA-C-O 122.023 0.916 . . . . 10.0 111.738 -178.539 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.533 ' HB3' ' H ' ' A' ' 162' ' ' GLN . 0.2 OUTLIER -149.13 96.06 2.48 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.523 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.954 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -35.73 -56.41 0.68 Allowed 'General case' 0 C--N 1.297 -1.712 0 O-C-N 121.618 -0.676 . . . . 10.0 112.071 -178.763 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.496 ' C ' HD12 ' A' ' 160' ' ' LEU . 4.3 pp -99.98 -11.02 20.98 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.667 -1.271 . . . . 10.0 113.796 -177.538 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.562 HG21 ' CB ' ' A' ' 118' ' ' ASP . 30.0 m -98.79 -90.19 0.3 Allowed 'General case' 0 N--CA 1.504 2.242 0 O-C-N 119.93 -1.731 . . . . 10.0 111.613 -179.461 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.56 ' O ' ' HB2' ' A' ' 163' ' ' LYS . 9.9 mt-30 -52.61 -68.93 0.13 Allowed 'General case' 0 N--CA 1.491 1.615 0 O-C-N 120.731 -1.231 . . . . 10.0 110.673 -179.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.56 ' HB2' ' O ' ' A' ' 162' ' ' GLN . 24.8 mtmm 74.07 57.42 0.09 Allowed 'General case' 0 N--CA 1.497 1.879 0 CA-C-O 121.597 0.713 . . . . 10.0 110.062 -179.356 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -162.36 26.77 0.24 Allowed Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.643 -1.783 . . . . 10.0 108.643 179.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.807 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -72.42 4.85 3.38 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.438 -1.037 . . . . 10.0 111.758 -179.331 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.464 ' N ' HD22 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -52.81 -22.59 5.55 Favored 'General case' 0 N--CA 1.49 1.534 0 O-C-N 121.103 -0.998 . . . . 10.0 109.543 178.77 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.444 ' O ' ' HB2' ' A' ' 170' ' ' ASP . 20.2 m120 -69.13 -38.49 78.88 Favored 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.324 -0.86 . . . . 10.0 110.049 179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.009 HG22 ' HB ' ' A' ' 155' ' ' VAL . 17.2 t -49.71 -40.11 15.26 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 O-C-N 121.301 -0.874 . . . . 10.0 109.179 179.669 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -79.98 -26.07 40.09 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.771 -0.581 . . . . 10.0 110.329 179.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.693 ' HA ' HD12 ' A' ' 173' ' ' ILE . 21.8 m-20 -58.65 -45.72 88.7 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 121.088 -1.008 . . . . 10.0 110.148 -179.706 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.53 ' HB3' HG13 ' A' ' 152' ' ' VAL . 5.6 mm-40 -74.68 -26.0 59.55 Favored 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.048 -1.032 . . . . 10.0 109.898 179.613 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.603 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -67.11 -31.72 72.38 Favored 'General case' 0 N--CA 1.488 1.437 0 O-C-N 121.262 -0.899 . . . . 10.0 109.586 179.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.737 HG23 ' OH ' ' A' ' 51' ' ' TYR . 46.3 mt -59.15 -46.99 91.65 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.414 0 O-C-N 121.462 -0.774 . . . . 10.0 109.977 179.606 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.832 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.4 OUTLIER -70.13 -35.5 74.12 Favored 'General case' 0 C--N 1.302 -1.491 0 O-C-N 121.203 -0.936 . . . . 10.0 110.686 -179.571 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.53 ' HB1' ' HB3' ' A' ' 109' ' ' PRO . . . -88.56 -3.39 58.82 Favored 'General case' 0 C--N 1.294 -1.847 0 O-C-N 121.39 -0.819 . . . . 10.0 109.866 179.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.736 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -77.94 -33.76 51.47 Favored 'General case' 0 N--CA 1.489 1.522 0 O-C-N 121.169 -0.957 . . . . 10.0 110.049 179.845 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.667 HD23 ' HA ' ' A' ' 2' ' ' GLN . 0.5 OUTLIER -98.08 -24.05 15.49 Favored 'General case' 0 N--CA 1.493 1.692 0 O-C-N 121.212 -0.93 . . . . 10.0 109.182 -179.825 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.638 0 CA-C-O 118.022 -0.989 . . . . 10.0 110.208 179.513 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.4 0 N-CA-C 109.723 -1.351 . . . . 10.0 109.723 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.478 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 15.5 m 54.24 49.82 17.77 Favored 'General case' 0 N--CA 1.494 1.73 0 O-C-N 121.25 -1.147 . . . . 10.0 110.579 179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -69.7 105.01 2.57 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.036 -1.04 . . . . 10.0 109.749 179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.478 ' HG2' ' O ' ' B' ' 2' ' ' SER . 15.8 mm-40 -100.81 162.85 12.62 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.522 -0.736 . . . . 10.0 110.404 -179.277 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.696 ' CB ' ' HD2' ' B' ' 6' ' ' PRO . 0.4 OUTLIER -69.42 -147.84 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.761 0 N-CA-C 108.575 -0.898 . . . . 10.0 108.575 179.882 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.696 ' HD2' ' CB ' ' B' ' 5' ' ' ARG . 41.4 Cg_endo -69.66 87.5 0.54 Allowed 'Trans proline' 0 N--CA 1.481 0.766 0 CA-C-N 119.549 0.874 . . . . 10.0 110.327 -179.368 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.577 ' CD ' HG22 ' A' ' 46' ' ' ILE . 2.8 mp0 -54.11 -164.96 0.0 OUTLIER 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 109.085 -0.709 . . . . 10.0 109.085 179.545 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.666 HD12 ' HA2' ' A' ' 47' ' ' GLY . 0.1 OUTLIER -80.41 -71.84 0.33 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.035 0 O-C-N 120.421 -1.424 . . . . 10.0 109.923 -179.862 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 5.5 t -149.32 -175.2 4.89 Favored 'General case' 0 N--CA 1.489 1.52 0 C-N-CA 118.375 -1.33 . . . . 10.0 112.2 -179.76 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.943 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -163.35 138.3 4.97 Favored Pre-proline 0 N--CA 1.483 1.193 0 C-N-CA 119.223 -0.991 . . . . 10.0 112.846 -178.503 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.577 ' HD2' ' HB2' ' A' ' 45' ' ' MET . 50.3 Cg_endo -81.01 153.83 19.29 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 N-CA-C 108.243 -1.484 . . . . 10.0 108.243 177.75 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 19.1 m -129.64 151.23 50.47 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 120.399 -1.438 . . . . 10.0 111.689 -179.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.461 ' O ' HG13 ' A' ' 42' ' ' VAL . 19.4 m-20 -108.06 170.26 8.11 Favored 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 108.667 -0.864 . . . . 10.0 108.667 178.849 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 91.3 m-85 -125.11 148.46 48.54 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.674 -1.266 . . . . 10.0 111.37 179.703 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.727 ' OE1' ' HB3' ' A' ' 41' ' ' ALA . 3.8 tm-20 -148.0 -179.93 7.27 Favored 'General case' 0 C--N 1.296 -1.717 0 N-CA-C 106.419 -1.697 . . . . 10.0 106.419 178.073 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 17.8 p80 -136.98 -175.3 3.99 Favored 'General case' 0 C--N 1.296 -1.75 0 C-N-CA 117.267 -1.773 . . . . 10.0 113.511 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.573 ' OG1' ' N ' ' A' ' 39' ' ' ASN . 15.1 t -121.62 -169.7 1.91 Allowed 'General case' 0 N--CA 1.489 1.51 0 CA-C-O 121.863 0.84 . . . . 10.0 112.41 -176.832 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.906 HD13 ' H ' ' B' ' 18' ' ' ILE . 0.3 OUTLIER -122.28 -168.96 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.783 0 O-C-N 121.739 -0.6 . . . . 10.0 109.691 179.555 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.521 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 17.2 p80 -100.24 155.66 17.65 Favored 'General case' 0 N--CA 1.498 1.93 0 O-C-N 120.656 -1.277 . . . . 10.0 113.41 -177.598 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 1.002 HG22 ' N ' ' A' ' 37' ' ' PHE 0.255 40.7 t -109.91 155.45 11.11 Favored 'Isoleucine or valine' 0 N--CA 1.503 2.185 0 CA-C-N 115.241 -0.89 . . . . 10.0 111.22 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -116.21 54.34 0.59 Allowed Glycine 0 N--CA 1.49 2.277 0 N-CA-C 108.99 -1.644 . . . . 10.0 108.99 178.723 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.743 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 177.19 105.61 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 O-C-N 121.053 -1.263 . . . . 10.0 109.874 -179.878 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.492 ' O ' HG23 ' B' ' 25' ' ' VAL . 74.4 m-20 -71.42 152.77 42.81 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.532 -0.73 . . . . 10.0 111.309 -179.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.625 ' CB ' HG11 ' A' ' 33' ' ' VAL . . . 50.06 38.01 15.66 Favored 'General case' 0 N--CA 1.498 1.926 0 O-C-N 121.597 -0.689 . . . . 10.0 111.431 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.743 HG21 ' HB3' ' B' ' 22' ' ' PHE . 54.8 t -111.0 -22.5 4.98 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.766 0 N-CA-C 107.829 -1.175 . . . . 10.0 107.829 177.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.701 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 13.6 t -88.18 -26.56 22.34 Favored 'General case' 0 N--CA 1.487 1.419 0 CA-C-O 121.466 0.651 . . . . 10.0 109.902 178.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.595 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -116.42 39.84 2.58 Favored Glycine 0 N--CA 1.488 2.143 0 N-CA-C 108.231 -1.948 . . . . 10.0 108.231 179.71 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.587 ' HG3' ' N ' ' A' ' 29' ' ' PRO . 9.9 mp0 -140.03 122.26 15.89 Favored 'General case' 0 C--N 1.306 -1.301 0 CA-C-O 121.883 0.849 . . . . 10.0 110.942 -179.0 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.623 ' HB3' ' CB ' ' A' ' 159' ' ' ALA . 8.0 t80 -116.87 128.11 54.93 Favored 'General case' 0 C--N 1.291 -1.964 0 N-CA-C 108.893 -0.78 . . . . 10.0 108.893 178.838 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.508 HG22 ' CE2' ' A' ' 28' ' ' PHE . 47.1 p -141.13 -44.9 0.38 Allowed 'General case' 0 C--N 1.295 -1.767 0 O-C-N 121.649 -0.657 . . . . 10.0 110.45 -179.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.421 ' N ' HG21 ' A' ' 14' ' ' VAL . . . 130.44 76.7 0.16 Allowed Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.995 -1.242 . . . . 10.0 109.995 -179.837 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.6 HD11 ' HG2' ' B' ' 35' ' ' GLN . 26.5 pt -110.05 160.89 26.52 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.282 -1.128 . . . . 10.0 109.318 179.399 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.572 ' O ' ' C ' ' B' ' 34' ' ' GLU . 47.9 Cg_endo -73.85 175.16 11.16 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 O-C-N 123.706 1.371 . . . . 10.0 110.803 -179.629 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.572 ' C ' ' O ' ' B' ' 33' ' ' PRO . 2.3 tm-20 -1.0 114.15 0.01 OUTLIER 'General case' 0 N--CA 1.509 2.483 0 CA-C-O 121.203 0.525 . . . . 10.0 112.373 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.6 ' HG2' HD11 ' B' ' 32' ' ' ILE . 0.0 OUTLIER -97.45 -71.68 0.67 Allowed 'General case' 0 N--CA 1.488 1.453 0 O-C-N 121.041 -1.037 . . . . 10.0 111.89 -179.43 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.635 ' CZ2' ' HB ' ' A' ' 9' ' ' VAL . 0.4 OUTLIER -100.05 -12.5 19.65 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-O 122.122 0.963 . . . . 10.0 111.247 -178.892 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.561 ' O ' ' HG3' ' B' ' 34' ' ' GLU . . . -90.81 60.64 4.51 Favored 'General case' 0 C--N 1.282 -2.339 0 N-CA-C 108.275 -1.009 . . . . 10.0 108.275 179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.566 ' HG3' ' CB ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -81.75 43.37 0.76 Allowed 'General case' 0 C--N 1.295 -1.797 0 CA-C-O 122.03 0.919 . . . . 10.0 108.9 179.916 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.596 ' CD2' ' HA ' ' A' ' 71' ' ' SER . 2.3 mp -49.62 -44.65 47.48 Favored 'General case' 0 C--N 1.299 -1.605 0 CA-C-N 115.909 -0.587 . . . . 10.0 110.995 -178.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -122.17 18.03 10.75 Favored 'General case' 0 N--CA 1.495 1.801 0 O-C-N 121.164 -0.96 . . . . 10.0 110.687 -179.475 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.566 ' CB ' ' HG3' ' B' ' 38' ' ' ARG . 17.1 mm-40 -123.94 39.65 3.91 Favored 'General case' 0 C--N 1.292 -1.912 0 O-C-N 121.774 -0.579 . . . . 10.0 110.295 179.531 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.616 HG23 ' CG ' ' A' ' 65' ' ' ASP . 21.9 m -99.15 165.44 11.71 Favored 'General case' 0 N--CA 1.485 1.279 0 O-C-N 120.92 -1.113 . . . . 10.0 110.855 -179.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.412 ' O ' ' C ' ' B' ' 44' ' ' ASN . 52.7 m -62.64 -7.15 4.29 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.603 -0.686 . . . . 10.0 110.643 179.807 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.412 ' C ' ' O ' ' B' ' 43' ' ' SER . 0.2 OUTLIER 43.09 59.09 3.05 Favored 'General case' 0 N--CA 1.492 1.665 0 O-C-N 121.081 -1.012 . . . . 10.0 110.168 -179.48 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 42.5 mt -63.0 -40.71 90.1 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.864 0 O-C-N 121.248 -0.907 . . . . 10.0 110.665 -179.589 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.301 -1.538 0 CA-C-O 117.932 -1.032 . . . . 10.0 110.514 -178.835 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.486 ' O ' ' HB3' ' A' ' 177' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.664 0 CA-C-O 121.091 0.472 . . . . 10.0 110.225 . . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.58 ' HA ' HD23 ' A' ' 177' ' ' LEU . 2.4 mt-30 -130.92 -3.48 4.04 Favored 'General case' 0 N--CA 1.486 1.372 0 O-C-N 121.104 -0.997 . . . . 10.0 109.9 179.52 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.583 ' HA ' ' CG2' ' A' ' 52' ' ' THR . 23.7 m -68.39 106.18 2.42 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.307 -0.871 . . . . 10.0 110.878 -179.824 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.041 HD12 ' CB ' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -109.22 123.75 65.35 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 C-N-CA 119.057 -1.057 . . . . 10.0 109.397 178.048 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.638 ' O ' HG22 ' A' ' 77' ' ' VAL . 7.4 mmmt -107.71 130.75 54.91 Favored 'General case' 0 C--N 1.291 -1.949 0 N-CA-C 107.475 -1.306 . . . . 10.0 107.475 177.894 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.57 ' HB2' ' CB ' ' A' ' 55' ' ' LEU . 60.8 m -109.87 116.62 31.98 Favored 'General case' 0 C--N 1.298 -1.669 0 C-N-CA 119.124 -1.03 . . . . 10.0 110.056 -179.024 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.574 HG21 ' OG1' ' A' ' 75' ' ' THR . 25.5 t -126.79 166.19 23.79 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.498 0 O-C-N 121.6 -0.688 . . . . 10.0 109.986 -179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.744 HG22 ' HB2' ' A' ' 16' ' ' LYS . 0.5 OUTLIER -101.52 125.62 55.53 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.555 0 O-C-N 121.033 -1.042 . . . . 10.0 110.257 -179.75 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.74 HG12 ' H ' ' A' ' 10' ' ' GLY . 12.0 t -132.73 -171.07 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 O-C-N 121.502 -0.749 . . . . 10.0 109.534 -179.54 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.74 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 109.26 171.48 20.71 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.411 -1.476 . . . . 10.0 109.411 -179.665 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.455 ' OD1' ' HB3' ' A' ' 82' ' ' PHE . 1.4 m-20 -45.32 -37.17 4.61 Favored 'General case' 0 N--CA 1.488 1.468 0 O-C-N 121.253 -1.145 . . . . 10.0 109.684 -179.96 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.427 ' HA2' ' OE1' ' B' ' 35' ' ' GLN . . . 150.25 143.28 3.71 Favored Glycine 0 N--CA 1.489 2.192 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.46 ' O ' ' O ' ' B' ' 33' ' ' PRO . . . -157.32 -130.09 0.03 OUTLIER 'General case' 0 N--CA 1.49 1.55 0 O-C-N 121.287 -1.125 . . . . 10.0 110.205 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.578 HG21 ' H ' ' B' ' 30' ' ' THR . 60.5 t -119.78 -44.51 2.61 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.71 0 O-C-N 120.957 -1.089 . . . . 10.0 110.974 -179.536 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.477 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -176.65 -177.69 45.82 Favored Glycine 0 N--CA 1.492 2.397 0 N-CA-C 109.899 -1.28 . . . . 10.0 109.899 -179.663 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.744 ' HB2' HG22 ' A' ' 8' ' ' VAL . 6.0 ttpm? -97.79 -50.49 4.43 Favored 'General case' 0 N--CA 1.491 1.592 0 O-C-N 121.193 -1.18 . . . . 10.0 110.386 -179.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 82.8 p -72.15 -18.31 61.89 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.211 -0.931 . . . . 10.0 110.026 -179.934 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.53 ' HB3' ' HB3' ' B' ' 28' ' ' GLU . 28.3 p -63.92 -17.2 63.0 Favored 'General case' 0 C--N 1.303 -1.455 0 O-C-N 121.255 -0.903 . . . . 10.0 110.79 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.548 ' CA ' ' HZ2' ' A' ' 163' ' ' LYS . 0.1 OUTLIER -93.09 -38.59 11.53 Favored 'General case' 0 C--N 1.31 -1.14 0 O-C-N 121.001 -1.062 . . . . 10.0 110.759 -179.944 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.412 ' O ' ' OG1' ' A' ' 24' ' ' THR . 50.4 tp -55.19 -38.34 68.24 Favored 'General case' 0 C--N 1.294 -1.835 0 C-N-CA 118.673 -1.211 . . . . 10.0 108.541 179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.674 ' HA ' ' HB ' ' A' ' 24' ' ' THR 0.273 6.3 tp -80.98 -30.99 11.89 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.634 0 CA-C-O 121.697 0.76 . . . . 10.0 110.039 179.586 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.612 ' HA ' ' HB3' ' A' ' 27' ' ' LYS . 38.4 m -46.93 -54.54 9.83 Favored 'General case' 0 C--N 1.294 -1.83 0 C-N-CA 118.793 -1.163 . . . . 10.0 108.724 -179.183 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.694 ' CG ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -89.62 3.75 51.62 Favored 'General case' 0 C--N 1.303 -1.424 0 C-N-CA 117.481 -1.688 . . . . 10.0 111.035 178.365 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 25' ' ' THR . 19.2 m -77.1 -52.54 9.12 Favored 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 118.481 -1.288 . . . . 10.0 107.821 177.361 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 1.044 HG22 HG22 ' A' ' 24' ' ' THR . 0.6 OUTLIER -179.59 -71.29 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 118.695 -1.202 . . . . 10.0 113.745 179.037 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.763 ' H ' HG23 ' A' ' 25' ' ' THR . 26.1 m-20 -85.78 48.59 1.62 Allowed 'General case' 0 C--N 1.299 -1.608 0 O-C-N 120.806 -1.184 . . . . 10.0 112.076 -177.138 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.705 ' O ' HG23 ' B' ' 26' ' ' THR . 3.2 pttt -44.92 -110.68 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.013 0 CA-C-O 122.222 1.01 . . . . 10.0 111.872 179.104 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.605 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 39.3 t80 -90.08 19.92 0.03 OUTLIER Pre-proline 0 C--N 1.289 -2.027 0 N-CA-C 114.819 1.414 . . . . 10.0 114.819 -178.106 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.641 ' CD ' ' C ' ' A' ' 27' ' ' LYS . 55.4 Cg_endo -80.77 -118.26 0.01 OUTLIER 'Trans proline' 0 CA--C 1.545 1.038 0 N-CA-C 109.563 -0.976 . . . . 10.0 109.563 178.49 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.462 ' OG ' ' C ' ' A' ' 29' ' ' PRO . 1.2 m -167.81 68.91 0.08 Allowed 'General case' 0 N--CA 1.498 1.964 0 O-C-N 120.151 -1.593 . . . . 10.0 111.033 -179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.507 ' HG2' ' HB3' ' A' ' 26' ' ' ASN . 2.9 pt-20 -141.87 -171.04 3.26 Favored 'General case' 0 C--N 1.305 -1.355 0 O-C-N 120.884 -1.135 . . . . 10.0 110.033 179.57 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.6 ' O ' HG22 ' A' ' 33' ' ' VAL . 6.0 t80 -70.2 121.75 18.17 Favored 'General case' 0 N--CA 1.499 2.023 0 CA-C-O 121.592 0.71 . . . . 10.0 112.004 -178.118 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.816 HG12 ' CD ' ' A' ' 34' ' ' PRO . 0.0 OUTLIER -163.19 -168.28 0.19 Allowed Pre-proline 0 N--CA 1.503 2.181 0 N-CA-C 108.178 -1.045 . . . . 10.0 108.178 179.476 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.816 ' CD ' HG12 ' A' ' 33' ' ' VAL . 41.6 Cg_endo -72.05 -178.52 3.25 Favored 'Trans proline' 0 N--CA 1.487 1.133 0 O-C-N 122.611 0.795 . . . . 10.0 111.046 -179.158 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.617 ' HB ' ' CG2' ' B' ' 20' ' ' VAL . 22.5 p -129.85 162.46 28.48 Favored 'General case' 0 N--CA 1.497 1.876 0 O-C-N 121.082 -1.011 . . . . 10.0 111.921 -177.868 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.684 HG11 ' CA ' ' A' ' 60' ' ' GLY . 71.6 t -58.66 -90.35 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.906 0 O-C-N 121.417 -0.802 . . . . 10.0 110.213 178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.611 ' N ' HG12 ' B' ' 20' ' ' VAL . 1.7 t80 -47.26 93.04 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.554 0 O-C-N 121.386 -0.821 . . . . 10.0 109.405 179.953 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.537 ' CG ' ' CE2' ' A' ' 40' ' ' TYR . 9.4 t0 -141.02 84.2 1.92 Allowed 'General case' 0 C--N 1.298 -1.665 0 O-C-N 121.408 -0.807 . . . . 10.0 109.666 -179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.823 ' CB ' HD11 ' B' ' 18' ' ' ILE . 9.6 t-20 -79.32 99.26 7.03 Favored 'General case' 0 C--N 1.299 -1.588 0 O-C-N 120.786 -1.196 . . . . 10.0 109.928 -179.493 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' O ' ' B' ' 16' ' ' HIS . 21.1 m-85 -91.93 121.16 33.26 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.416 -0.802 . . . . 10.0 109.832 179.518 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.751 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -145.83 96.72 2.85 Favored 'General case' 0 C--N 1.303 -1.434 0 C-N-CA 119.52 -0.872 . . . . 10.0 111.293 -178.788 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.816 HG12 ' H ' ' A' ' 43' ' ' THR . 82.4 t -162.64 -165.36 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.781 0 N-CA-C 106.299 -1.741 . . . . 10.0 106.299 179.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.816 ' H ' HG12 ' A' ' 42' ' ' VAL . 40.1 m -126.43 165.67 18.63 Favored 'General case' 0 N--CA 1.495 1.819 0 O-C-N 119.588 -1.945 . . . . 10.0 112.139 -178.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.589 ' CG2' ' CD1' ' A' ' 53' ' ' LEU . 0.2 OUTLIER -123.59 132.57 71.15 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.475 0 N-CA-C 108.59 -0.893 . . . . 10.0 108.59 178.986 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.565 ' CB ' ' HG2' ' B' ' 11' ' ' PRO . 0.5 OUTLIER -101.18 107.31 18.68 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 120.981 -1.074 . . . . 10.0 109.998 -179.98 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.572 ' HA ' ' CB ' ' B' ' 10' ' ' LEU . 3.7 mp -121.7 130.66 74.4 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.533 0 O-C-N 121.469 -0.769 . . . . 10.0 110.376 -179.568 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.544 ' HA2' HG13 ' B' ' 8' ' ' ILE . . . 50.87 25.01 8.88 Favored Glycine 0 N--CA 1.489 2.227 0 N-CA-C 109.958 -1.257 . . . . 10.0 109.958 179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 85.0 13.76 71.05 Favored Glycine 0 N--CA 1.491 2.33 0 N-CA-C 109.561 -1.416 . . . . 10.0 109.561 179.85 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 11.3 mm-40 -116.18 123.52 30.76 Favored Pre-proline 0 N--CA 1.487 1.422 0 O-C-N 121.344 -1.092 . . . . 10.0 110.192 179.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . . . . . . . . . 47.3 Cg_endo -76.08 141.45 23.65 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 O-C-N 123.987 1.52 . . . . 10.0 110.709 -179.453 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.528 ' HB2' ' HB ' ' A' ' 44' ' ' VAL . 2.0 m-30 -109.97 116.32 31.38 Favored 'General case' 0 N--CA 1.487 1.407 0 O-C-N 121.317 -0.864 . . . . 10.0 110.156 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.583 ' CG2' ' HA ' ' A' ' 3' ' ' THR . 58.1 m -85.35 106.91 17.08 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.273 -0.892 . . . . 10.0 109.923 179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.589 ' CD1' ' CG2' ' A' ' 44' ' ' VAL . 4.3 mt -121.58 153.38 38.12 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.291 -0.881 . . . . 10.0 111.063 -179.578 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -166.51 99.4 0.16 Allowed Glycine 0 N--CA 1.487 2.091 0 N-CA-C 108.492 -1.843 . . . . 10.0 108.492 179.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.57 ' CB ' ' HB2' ' A' ' 6' ' ' CYS . 3.3 pp -138.07 167.75 21.15 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.125 -1.221 . . . . 10.0 110.644 -179.206 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.541 ' N ' HD12 ' A' ' 55' ' ' LEU . 27.1 p90 -169.11 130.03 1.14 Allowed 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.365 -0.834 . . . . 10.0 110.875 179.921 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.485 ' HB3' ' O ' ' A' ' 36' ' ' VAL . 11.0 t0 -82.05 160.95 23.1 Favored 'General case' 0 N--CA 1.493 1.696 0 O-C-N 120.92 -1.112 . . . . 10.0 109.045 178.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.713 ' O ' ' HB3' ' A' ' 59' ' ' ALA . 8.9 m -128.52 159.79 34.38 Favored 'General case' 0 N--CA 1.491 1.575 0 O-C-N 120.744 -1.222 . . . . 10.0 111.481 -179.143 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.713 ' HB3' ' O ' ' A' ' 58' ' ' THR . . . 75.04 28.79 1.02 Allowed 'General case' 0 N--CA 1.492 1.654 0 CA-C-O 121.973 0.892 . . . . 10.0 109.143 -179.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.684 ' CA ' HG11 ' A' ' 36' ' ' VAL . . . -80.88 -75.08 1.1 Allowed Glycine 0 C--N 1.297 -1.588 0 N-CA-C 106.972 -2.451 . . . . 10.0 106.972 177.856 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.459 ' HA ' ' N ' ' B' ' 21' ' ' GLY . 0.0 OUTLIER -89.14 20.5 3.66 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.361 -1.082 . . . . 10.0 110.098 179.778 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.613 ' O ' ' CZ ' ' A' ' 64' ' ' TYR . 60.3 mm-40 -104.22 -48.91 3.73 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.093 -1.004 . . . . 10.0 110.421 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.574 ' O ' ' CB ' ' A' ' 64' ' ' TYR . 31.8 t0 66.12 47.9 1.81 Allowed 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.934 -1.104 . . . . 10.0 109.448 -179.363 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.613 ' CZ ' ' O ' ' A' ' 62' ' ' GLU . 0.3 OUTLIER 157.16 -13.26 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.007 0 CA-C-O 121.423 0.63 . . . . 10.0 109.553 179.185 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.604 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 2.3 p30 36.92 53.54 1.13 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.303 -0.873 . . . . 10.0 111.763 178.724 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . . . . . . . . . 13.9 ttt85 -52.93 -29.13 26.83 Favored 'General case' 0 C--N 1.305 -1.364 0 N-CA-C 107.796 -1.187 . . . . 10.0 107.796 177.918 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.623 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 1.5 mp -82.32 10.9 6.12 Favored 'General case' 0 N--CA 1.486 1.368 0 CA-C-O 121.251 0.548 . . . . 10.0 109.755 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.782 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -63.07 -18.06 0.44 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.998 1.481 . . . . 10.0 114.998 -178.784 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.623 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -84.04 80.42 2.39 Favored 'Trans proline' 0 C--N 1.313 -1.304 0 CA-C-N 120.043 1.051 . . . . 10.0 110.206 -179.35 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.782 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.4 OUTLIER -90.73 -28.36 18.34 Favored 'General case' 0 N--CA 1.49 1.535 0 O-C-N 121.501 -0.75 . . . . 10.0 110.366 -179.508 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.483 ' N ' ' HG ' ' A' ' 70' ' ' LEU . 30.7 t 42.75 25.91 0.06 Allowed 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.304 -0.872 . . . . 10.0 110.615 -179.877 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.49 ' CD2' ' O ' ' A' ' 70' ' ' LEU . 16.2 m-85 -120.22 93.06 47.83 Favored Pre-proline 0 N--CA 1.498 1.937 0 O-C-N 121.018 -1.051 . . . . 10.0 110.488 179.806 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 55.6 Cg_endo -80.89 73.35 6.06 Favored 'Trans proline' 0 C--N 1.304 -1.764 0 O-C-N 123.949 1.499 . . . . 10.0 111.168 -179.818 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -114.74 65.21 0.67 Allowed 'General case' 0 N--CA 1.493 1.686 0 O-C-N 120.99 -1.069 . . . . 10.0 109.924 179.294 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.626 ' HB ' ' CE1' ' A' ' 78' ' ' PHE . 48.1 m -143.84 96.18 2.85 Favored 'General case' 0 C--N 1.301 -1.543 0 N-CA-C 108.579 -0.897 . . . . 10.0 108.579 179.403 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.569 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 7.4 t70 -33.32 -31.72 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.743 0 CA-C-O 120.83 0.348 . . . . 10.0 111.417 -178.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.979 HG11 ' HB2' ' A' ' 176' ' ' ALA . 3.1 m -122.69 123.5 68.47 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.824 0 O-C-N 121.205 -0.934 . . . . 10.0 111.187 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.652 ' CD1' HG21 ' A' ' 9' ' ' VAL . 21.3 m-85 -109.56 143.15 39.64 Favored 'General case' 0 N--CA 1.497 1.911 0 O-C-N 121.3 -0.875 . . . . 10.0 109.89 179.081 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.831 ' CD1' HG12 ' A' ' 168' ' ' VAL . 1.1 mm? -108.35 97.99 7.59 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 120.928 -1.108 . . . . 10.0 110.414 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.586 HG21 ' CZ3' ' A' ' 97' ' ' TRP . 2.1 m -105.45 131.55 54.52 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.728 0 O-C-N 121.245 -0.909 . . . . 10.0 108.658 178.614 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.45 ' CB ' ' HB ' ' A' ' 113' ' ' VAL . 41.3 t -136.98 124.45 22.11 Favored 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.795 -1.19 . . . . 10.0 110.963 -179.108 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.576 ' CZ ' ' CE1' ' A' ' 90' ' ' PHE . 8.1 p90 -149.55 179.63 7.83 Favored 'General case' 0 N--CA 1.499 2.018 0 C-N-CA 119.458 -0.897 . . . . 10.0 111.35 179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 57.4 m -75.21 163.14 27.83 Favored 'General case' 0 N--CA 1.499 2.011 0 O-C-N 121.244 -0.91 . . . . 10.0 111.148 -178.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.637 ' O ' HG22 ' A' ' 137' ' ' ILE . 0.6 OUTLIER -127.83 9.45 3.19 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.606 0 O-C-N 121.183 -0.948 . . . . 10.0 112.5 -178.091 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.651 HG22 ' N ' ' A' ' 86' ' ' SER . 0.1 OUTLIER -80.49 -72.56 0.29 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.904 0 O-C-N 120.127 -1.608 . . . . 10.0 107.751 178.086 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.651 ' N ' HG22 ' A' ' 85' ' ' VAL . 60.8 m -76.8 135.26 67.91 Favored Pre-proline 0 N--CA 1.491 1.593 0 O-C-N 120.665 -1.272 . . . . 10.0 108.496 177.753 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.552 ' HG2' ' CB ' ' A' ' 133' ' ' LYS . 42.1 Cg_endo -72.37 -23.92 20.03 Favored 'Trans proline' 0 C--N 1.297 -2.139 0 O-C-N 123.662 1.348 . . . . 10.0 110.144 -179.712 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.501 ' O ' ' HB2' ' A' ' 89' ' ' SER . 66.7 m 41.26 38.96 0.86 Allowed 'General case' 0 N--CA 1.492 1.634 0 N-CA-C 108.909 -0.775 . . . . 10.0 108.909 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.501 ' HB2' ' O ' ' A' ' 88' ' ' SER . 15.3 m 64.13 40.36 6.99 Favored 'General case' 0 N--CA 1.491 1.581 0 CA-C-O 121.377 0.608 . . . . 10.0 110.243 -179.033 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.598 ' CE2' ' HE2' ' A' ' 94' ' ' LYS . 7.1 t80 -48.59 -26.34 2.17 Favored 'General case' 0 N--CA 1.488 1.451 0 O-C-N 121.176 -0.953 . . . . 10.0 108.761 179.001 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.587 ' HA ' ' HG2' ' A' ' 94' ' ' LYS . 1.5 tt0 -56.85 -27.43 60.27 Favored 'General case' 0 N--CA 1.488 1.431 0 O-C-N 121.37 -0.831 . . . . 10.0 109.072 178.669 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.533 ' O ' ' HG2' ' A' ' 95' ' ' GLU . 0.2 OUTLIER -72.12 -22.07 61.39 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.88 0.848 . . . . 10.0 109.396 179.169 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.833 HG13 ' CZ2' ' A' ' 97' ' ' TRP . 6.8 t -82.85 -8.43 11.3 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.614 0 O-C-N 121.261 -0.899 . . . . 10.0 109.356 179.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.598 ' HE2' ' CE2' ' A' ' 90' ' ' PHE . 4.0 mmtp -86.63 -32.44 20.57 Favored 'General case' 0 N--CA 1.487 1.405 0 N-CA-C 107.298 -1.371 . . . . 10.0 107.298 178.023 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.546 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 8.0 pt-20 -84.08 3.13 36.07 Favored 'General case' 0 C--N 1.303 -1.433 0 CA-C-N 115.446 -0.797 . . . . 10.0 109.846 179.139 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 22.1 tptt -103.37 -50.29 3.5 Favored 'General case' 0 N--CA 1.492 1.663 0 C-N-CA 118.964 -1.094 . . . . 10.0 111.843 -179.315 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.833 ' CZ2' HG13 ' A' ' 93' ' ' VAL . 5.6 m0 -86.52 -49.06 7.84 Favored 'General case' 0 N--CA 1.501 2.089 0 O-C-N 120.98 -1.075 . . . . 10.0 112.022 -178.293 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.564 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 18.2 t -54.21 -50.39 84.89 Favored Pre-proline 0 N--CA 1.494 1.765 0 O-C-N 120.861 -1.149 . . . . 10.0 111.575 -178.189 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.564 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 43.2 Cg_endo -70.54 -15.92 34.21 Favored 'Trans proline' 0 C--N 1.305 -1.721 0 O-C-N 123.089 1.047 . . . . 10.0 109.631 179.431 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.527 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.7 OUTLIER -54.2 -30.25 49.09 Favored 'General case' 0 N--CA 1.488 1.44 0 O-C-N 121.282 -0.886 . . . . 10.0 109.119 179.767 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.79 HG23 ' C ' ' A' ' 104' ' ' HIS . 4.6 mt 60.24 114.07 0.02 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.875 0 C-N-CA 119.493 -0.883 . . . . 10.0 110.223 179.197 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.901 HG22 ' O ' ' A' ' 105' ' ' CYS . 0.0 OUTLIER -49.83 -89.37 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 109.632 -179.981 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.656 ' H ' HG23 ' A' ' 102' ' ' THR . 7.3 p80 -109.49 6.97 24.58 Favored 'General case' 0 C--N 1.297 -1.693 0 O-C-N 121.367 -0.833 . . . . 10.0 109.546 179.015 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.79 ' C ' HG23 ' A' ' 101' ' ' ILE . 0.3 OUTLIER 169.59 -35.75 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.607 0 O-C-N 121.269 -0.894 . . . . 10.0 109.575 -179.95 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.901 ' O ' HG22 ' A' ' 102' ' ' THR . 75.8 m -119.66 155.71 54.35 Favored Pre-proline 0 N--CA 1.492 1.665 0 O-C-N 121.51 -0.744 . . . . 10.0 110.205 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.504 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 55.2 Cg_endo -76.6 73.41 5.22 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.149 1.605 . . . . 10.0 111.64 -179.178 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.477 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 18.5 ttpt -126.9 -2.02 6.56 Favored 'General case' 0 C--N 1.31 -1.137 0 O-C-N 120.698 -1.251 . . . . 10.0 109.826 179.06 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.495 ' OG1' ' HB ' ' A' ' 102' ' ' THR . 96.3 m -46.22 129.24 7.59 Favored Pre-proline 0 N--CA 1.493 1.689 0 O-C-N 121.118 -0.989 . . . . 10.0 109.721 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.569 ' HG2' ' O ' ' A' ' 76' ' ' ASP . 47.0 Cg_endo -71.75 149.22 54.06 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 O-C-N 123.81 1.426 . . . . 10.0 109.328 -179.882 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.616 ' CZ ' ' HB3' ' A' ' 97' ' ' TRP . 43.6 m-85 -132.99 119.58 20.27 Favored 'General case' 0 C--N 1.301 -1.518 0 C-N-CA 119.081 -1.048 . . . . 10.0 111.772 -179.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.889 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.5 mm? -88.79 93.38 9.56 Favored 'General case' 0 C--N 1.288 -2.091 0 N-CA-C 107.235 -1.395 . . . . 10.0 107.235 177.329 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.6 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 2.2 mt -70.99 147.2 48.88 Favored 'General case' 0 C--N 1.297 -1.681 0 O-C-N 121.469 -0.769 . . . . 10.0 109.617 -179.307 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.602 HG13 HG21 ' A' ' 168' ' ' VAL . 1.8 t -146.51 178.51 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.69 0 O-C-N 121.176 -0.952 . . . . 10.0 111.32 -178.726 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.542 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -126.3 116.35 2.53 Favored Glycine 0 N--CA 1.487 2.059 0 N-CA-C 108.814 -1.715 . . . . 10.0 108.814 178.628 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.832 HG22 ' HG3' ' A' ' 116' ' ' GLN . 64.4 m -81.79 123.72 29.02 Favored 'General case' 0 N--CA 1.495 1.815 0 O-C-N 121.067 -1.254 . . . . 10.0 109.723 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.832 ' HG3' HG22 ' A' ' 115' ' ' THR . 3.6 mt-30 47.1 69.04 0.54 Allowed 'General case' 0 N--CA 1.49 1.546 0 N-CA-C 107.706 -1.22 . . . . 10.0 107.706 -179.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.016 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -93.83 -45.41 13.74 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.914 0 C-N-CA 119.969 -0.692 . . . . 10.0 111.41 -177.592 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.59 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 35.8 t70 -51.43 56.16 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.35 0 CA-C-O 121.921 0.867 . . . . 10.0 112.86 -175.097 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.729 ' N ' ' O ' ' A' ' 117' ' ' ILE . 2.5 tp 152.95 -45.58 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.086 0 N-CA-C 107.606 -1.257 . . . . 10.0 107.606 178.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.586 ' O ' HD11 ' A' ' 126' ' ' ILE . 17.6 tpp180 -58.66 -17.72 24.79 Favored 'General case' 0 C--N 1.294 -1.81 0 N-CA-C 108.905 -0.776 . . . . 10.0 108.905 178.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.518 ' OD2' ' CG2' ' A' ' 84' ' ' VAL . 14.6 m-20 -111.54 19.51 18.07 Favored 'General case' 0 C--N 1.305 -1.352 0 O-C-N 121.84 -0.537 . . . . 10.0 110.548 -179.579 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.847 ' OD1' HG22 ' A' ' 125' ' ' THR . 21.2 p-10 -80.63 145.41 58.46 Favored Pre-proline 0 N--CA 1.491 1.579 0 O-C-N 121.025 -1.047 . . . . 10.0 108.994 179.635 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 49.5 Cg_endo -75.57 24.19 0.42 Allowed 'Trans proline' 0 C--N 1.306 -1.669 0 O-C-N 124.382 1.727 . . . . 10.0 112.469 -178.792 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 14.6 t -110.23 -48.13 3.22 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.56 -1.337 . . . . 10.0 110.288 179.643 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.847 HG22 ' OD1' ' A' ' 122' ' ' ASP . 9.3 t -86.49 -24.68 25.49 Favored 'General case' 0 C--N 1.291 -1.947 0 N-CA-C 106.09 -1.818 . . . . 10.0 106.09 177.405 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.586 HD11 ' O ' ' A' ' 120' ' ' ARG 0.278 1.1 mp -62.68 -21.22 27.0 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.39 0 N-CA-C 107.457 -1.312 . . . . 10.0 107.457 176.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -47.84 -46.68 31.29 Favored 'General case' 0 C--N 1.305 -1.36 0 CA-C-O 121.625 0.726 . . . . 10.0 109.636 179.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -88.89 -41.33 12.5 Favored 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.509 -0.744 . . . . 10.0 111.192 179.789 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.719 HD12 ' O ' ' A' ' 125' ' ' THR . 4.6 mt -57.09 -41.58 79.14 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 121.194 -0.941 . . . . 10.0 110.999 -178.683 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -61.22 -42.26 98.3 Favored 'General case' 0 C--N 1.3 -1.561 0 O-C-N 120.994 -1.067 . . . . 10.0 109.214 179.393 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 9.5 mttm -71.2 -8.51 54.02 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.388 -0.82 . . . . 10.0 110.019 179.323 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.547 ' O ' ' HD2' ' A' ' 133' ' ' LYS . 57.9 t-20 -65.82 -33.62 76.26 Favored 'General case' 0 N--CA 1.49 1.575 0 O-C-N 121.106 -0.996 . . . . 10.0 110.496 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.616 ' O ' ' CB ' ' A' ' 134' ' ' GLN . 9.3 mptt -117.67 -68.03 0.95 Allowed 'General case' 0 C--N 1.301 -1.521 0 N-CA-C 108.804 -0.813 . . . . 10.0 108.804 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.616 ' CB ' ' O ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER 143.53 -17.13 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.499 0 C-N-CA 123.377 0.671 . . . . 10.0 110.023 177.793 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.518 ' O ' ' HB3' ' A' ' 87' ' ' PRO . 0.0 OUTLIER -136.48 94.9 13.2 Favored Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 120.978 -1.077 . . . . 10.0 110.844 -179.929 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.402 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 44.8 Cg_endo -71.05 161.5 45.83 Favored 'Trans proline' 0 C--N 1.309 -1.521 0 O-C-N 124.028 1.541 . . . . 10.0 110.657 179.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.637 HG22 ' O ' ' A' ' 84' ' ' VAL . 7.1 tp -102.76 134.97 42.24 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.425 0 O-C-N 120.96 -1.088 . . . . 10.0 109.232 178.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.57 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 29.7 p -120.2 172.23 4.84 Favored Pre-proline 0 C--N 1.295 -1.777 0 O-C-N 121.238 -0.914 . . . . 10.0 109.062 -179.21 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.57 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 40.3 Cg_endo -66.65 -17.41 52.69 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 O-C-N 123.276 1.146 . . . . 10.0 109.703 -179.456 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.453 ' O ' ' HG3' ' A' ' 143' ' ' GLU . 1.6 mt-10 -79.7 -42.78 23.95 Favored 'General case' 0 N--CA 1.486 1.355 0 O-C-N 121.405 -0.81 . . . . 10.0 109.945 179.454 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 19.0 m -73.9 -43.5 58.25 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.359 -0.838 . . . . 10.0 109.889 179.42 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.427 ' HB1' ' CD1' ' A' ' 154' ' ' TYR . . . -57.75 -50.38 73.43 Favored 'General case' 0 N--CA 1.493 1.679 0 O-C-N 121.505 -0.747 . . . . 10.0 110.752 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.453 ' HG3' ' O ' ' A' ' 140' ' ' GLU . 3.0 pp20? -65.92 -30.41 70.99 Favored 'General case' 0 N--CA 1.492 1.662 0 C-N-CA 119.209 -0.997 . . . . 10.0 108.966 179.499 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 40.9 tttp -71.22 -35.82 71.64 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 107.662 -1.236 . . . . 10.0 107.662 177.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.505 ' O ' HD12 ' A' ' 149' ' ' LEU . 0.1 OUTLIER -60.73 -45.8 92.85 Favored 'General case' 0 C--N 1.311 -1.092 0 N-CA-C 108.036 -1.098 . . . . 10.0 108.036 178.155 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.911 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -59.66 -50.17 74.92 Favored 'General case' 0 C--N 1.306 -1.313 0 CA-C-O 121.887 0.851 . . . . 10.0 109.114 179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.457 ' HG2' ' O ' ' A' ' 147' ' ' ARG . 4.7 ttm180 -65.55 -17.75 64.81 Favored 'General case' 0 C--N 1.297 -1.714 0 CA-C-O 121.48 0.657 . . . . 10.0 109.729 179.091 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -67.92 -18.74 64.87 Favored 'General case' 0 N--CA 1.493 1.717 0 O-C-N 121.381 -0.824 . . . . 10.0 110.97 -179.494 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.935 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -152.03 38.33 0.58 Allowed 'General case' 0 N--CA 1.493 1.693 0 O-C-N 120.9 -1.125 . . . . 10.0 111.326 179.882 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.461 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 8.9 mttp 62.08 53.43 2.97 Favored 'General case' 0 N--CA 1.493 1.676 0 CA-C-O 122.005 0.907 . . . . 10.0 112.105 177.305 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.911 ' HB3' ' CA ' ' A' ' 146' ' ' ALA . . . -105.36 173.15 6.43 Favored 'General case' 0 C--N 1.286 -2.155 0 N-CA-C 108.895 -0.779 . . . . 10.0 108.895 178.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.862 HG21 HD11 ' A' ' 111' ' ' LEU . 2.9 t -71.23 -87.05 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.574 0 O-C-N 121.005 -1.06 . . . . 10.0 110.821 -179.244 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.832 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.0 OUTLIER -174.12 168.75 4.05 Favored 'General case' 0 N--CA 1.501 2.083 0 O-C-N 121.088 -1.007 . . . . 10.0 111.006 -179.502 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.636 ' OH ' HG11 ' A' ' 84' ' ' VAL . 77.6 t80 -81.04 119.0 22.98 Favored 'General case' 0 N--CA 1.494 1.738 0 O-C-N 121.146 -0.971 . . . . 10.0 110.581 178.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.758 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.7 OUTLIER -118.83 -169.09 0.48 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.746 0 O-C-N 121.141 -0.974 . . . . 10.0 110.463 179.904 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.504 ' H ' HG12 ' A' ' 155' ' ' VAL . 86.7 mt-10 -146.36 138.54 25.05 Favored 'General case' 0 N--CA 1.497 1.92 0 O-C-N 120.661 -1.274 . . . . 10.0 111.874 -178.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.649 ' HB2' ' HB3' ' A' ' 165' ' ' LEU . 30.1 t -141.2 130.56 23.69 Favored 'General case' 0 N--CA 1.492 1.669 0 CA-C-O 122.131 0.967 . . . . 10.0 111.373 179.569 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.611 ' O ' ' N ' ' A' ' 162' ' ' GLN . 18.9 m -148.35 81.15 1.47 Allowed 'General case' 0 C--N 1.292 -1.932 0 CA-C-O 121.997 0.903 . . . . 10.0 109.387 178.068 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.652 ' CB ' ' HE3' ' A' ' 163' ' ' LYS . . . -52.98 -77.46 0.02 OUTLIER 'General case' 0 N--CA 1.495 1.791 0 O-C-N 121.109 -0.995 . . . . 10.0 111.062 179.839 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.896 HD13 ' N ' ' A' ' 161' ' ' THR 0.262 0.4 OUTLIER -48.05 -50.7 27.1 Favored 'General case' 0 C--N 1.294 -1.822 0 O-C-N 120.961 -1.087 . . . . 10.0 110.288 -179.825 . . . . . . . . 4 4 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.896 ' N ' HD13 ' A' ' 160' ' ' LEU . 1.1 m -76.8 -70.52 0.45 Allowed 'General case' 0 N--CA 1.498 1.941 0 N-CA-C 113.227 0.825 . . . . 10.0 113.227 -178.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.656 ' O ' ' CB ' ' A' ' 163' ' ' LYS . 0.0 OUTLIER -123.85 -91.16 0.55 Allowed 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.0 -1.688 . . . . 10.0 112.238 -178.341 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.771 ' HA ' ' CD1' ' A' ' 165' ' ' LEU . 1.3 mmtt 124.36 -154.28 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.71 0 C-N-CA 124.788 1.235 . . . . 10.0 108.531 -178.559 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.615 ' N ' HD13 ' A' ' 165' ' ' LEU . . . 96.11 14.06 46.89 Favored Glycine 0 N--CA 1.492 2.386 0 N-CA-C 106.535 -2.626 . . . . 10.0 106.535 -177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.908 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -84.34 5.23 27.74 Favored 'General case' 0 C--N 1.302 -1.461 0 CA-C-N 114.964 -0.618 . . . . 10.0 111.478 -178.832 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.526 ' N ' HD22 ' A' ' 165' ' ' LEU . 13.8 mttt -50.47 -27.57 6.77 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.137 -0.977 . . . . 10.0 108.613 179.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.597 ' HB3' HG11 ' A' ' 155' ' ' VAL . 25.9 t-20 -65.12 -43.95 90.32 Favored 'General case' 0 N--CA 1.489 1.505 0 O-C-N 121.526 -0.734 . . . . 10.0 109.813 179.61 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.831 HG12 ' CD1' ' A' ' 79' ' ' LEU . 93.9 t -50.54 -29.39 6.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.502 0 O-C-N 121.301 -0.874 . . . . 10.0 109.165 179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.501 ' CD1' ' N ' ' A' ' 169' ' ' PHE . 14.8 m-85 -96.78 -22.14 17.12 Favored 'General case' 0 C--N 1.299 -1.593 0 O-C-N 121.74 -0.6 . . . . 10.0 109.958 179.395 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.66 ' HA ' HD12 ' A' ' 173' ' ' ILE . 20.1 t0 -67.54 -51.29 52.5 Favored 'General case' 0 N--CA 1.493 1.686 0 O-C-N 121.318 -0.864 . . . . 10.0 111.067 -179.291 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.407 ' HA ' HD23 ' A' ' 174' ' ' LEU . 4.8 mt-10 -72.34 -40.5 67.34 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.093 -1.004 . . . . 10.0 111.097 -179.337 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.889 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -54.8 -31.77 59.41 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 120.988 -1.07 . . . . 10.0 110.242 179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.667 ' O ' HD11 ' A' ' 177' ' ' LEU . 30.1 mt -58.48 -44.16 88.37 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.426 0 O-C-N 120.995 -1.065 . . . . 10.0 109.331 179.535 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.783 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.5 OUTLIER -76.69 -48.59 18.42 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.457 -0.777 . . . . 10.0 112.182 -179.191 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -64.3 -10.27 22.93 Favored 'General case' 0 C--N 1.296 -1.742 0 O-C-N 121.354 -0.841 . . . . 10.0 110.865 -178.665 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.041 ' CB ' HD12 ' A' ' 4' ' ' ILE . . . -79.0 -41.41 29.06 Favored 'General case' 0 N--CA 1.49 1.531 0 O-C-N 121.15 -0.969 . . . . 10.0 110.134 179.928 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.667 HD11 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -77.3 -19.91 55.76 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 121.402 -0.811 . . . . 10.0 109.164 -179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 43.8 mm-40 . . . . . 0 C--N 1.303 -1.443 0 CA-C-O 117.982 -1.009 . . . . 10.0 110.341 -179.971 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.284 0 N-CA-C 109.495 -1.442 . . . . 10.0 109.495 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 29.7 m -106.19 138.01 43.12 Favored 'General case' 0 N--CA 1.489 1.496 0 O-C-N 121.254 -1.145 . . . . 10.0 110.567 -179.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -117.44 102.56 9.32 Favored 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.42 -0.8 . . . . 10.0 109.927 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . . . . . . . . . 79.6 mt-10 -101.56 140.39 35.91 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 121.687 -0.633 . . . . 10.0 110.926 -179.285 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.634 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -98.77 -49.02 0.22 Allowed Pre-proline 0 N--CA 1.489 1.51 0 O-C-N 121.324 -0.86 . . . . 10.0 110.213 179.602 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.634 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 51.9 Cg_endo -83.62 -18.15 5.83 Favored 'Trans proline' 0 C--N 1.317 -1.113 0 N-CA-C 109.086 -1.159 . . . . 10.0 109.086 179.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.761 ' OE2' HD23 ' B' ' 10' ' ' LEU . 0.5 OUTLIER 32.93 -160.73 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.732 0 CA-C-O 121.521 0.677 . . . . 10.0 111.71 179.962 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.544 HG13 ' HA2' ' A' ' 47' ' ' GLY . 0.4 OUTLIER -141.96 -61.8 0.18 Allowed 'Isoleucine or valine' 0 C--N 1.308 -1.21 0 O-C-N 121.071 -1.018 . . . . 10.0 110.117 -179.972 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.539 ' O ' ' N ' ' A' ' 47' ' ' GLY . 8.7 t -134.44 132.09 38.91 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 121.033 -1.042 . . . . 10.0 110.949 -179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.761 HD23 ' OE2' ' B' ' 7' ' ' GLU . 1.0 OUTLIER -132.33 99.62 15.9 Favored Pre-proline 0 C--N 1.303 -1.444 0 O-C-N 121.546 -0.721 . . . . 10.0 111.176 -179.646 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.565 ' HG2' ' CB ' ' A' ' 45' ' ' MET . 41.6 Cg_endo -72.54 117.06 4.95 Favored 'Trans proline' 0 C--N 1.304 -1.789 0 O-C-N 123.604 1.318 . . . . 10.0 108.761 178.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 13.7 m -47.82 172.92 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.221 -0.925 . . . . 10.0 111.202 -178.713 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.597 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.8 OUTLIER -151.96 -166.66 2.56 Favored 'General case' 0 C--N 1.303 -1.451 0 O-C-N 121.857 -0.527 . . . . 10.0 109.717 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.745 ' C ' HG11 ' A' ' 42' ' ' VAL . 24.0 m-85 -109.49 -170.05 1.59 Allowed 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 113.99 1.108 . . . . 10.0 113.99 -177.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.652 ' HA ' ' CG2' ' A' ' 42' ' ' VAL . 0.7 OUTLIER -160.85 -169.69 2.48 Favored 'General case' 0 N--CA 1.498 1.953 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 -179.408 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.581 ' O ' ' CD1' ' A' ' 40' ' ' TYR . 53.8 t60 -136.07 146.93 47.59 Favored 'General case' 0 N--CA 1.494 1.747 0 O-C-N 121.022 -1.049 . . . . 10.0 110.837 179.481 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.644 ' C ' HD13 ' B' ' 18' ' ' ILE . 2.8 t -150.27 143.33 24.86 Favored 'General case' 0 N--CA 1.495 1.781 0 O-C-N 120.173 -1.579 . . . . 10.0 112.203 -179.084 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.823 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -110.99 -167.49 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.5 2.026 0 N-CA-C 109.038 -0.727 . . . . 10.0 109.038 178.395 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.499 ' O ' ' HB3' ' A' ' 37' ' ' PHE . 68.3 t60 -107.38 153.4 22.83 Favored 'General case' 0 N--CA 1.491 1.617 0 O-C-N 120.775 -1.203 . . . . 10.0 112.275 -178.426 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.66 HG11 ' N ' ' A' ' 36' ' ' VAL . 1.6 m -124.98 153.1 31.87 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.396 0 CA-C-O 121.729 0.776 . . . . 10.0 111.405 -178.441 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.555 ' H ' ' C ' ' A' ' 60' ' ' GLY . . . -134.62 98.43 0.31 Allowed Glycine 0 N--CA 1.488 2.117 0 N-CA-C 108.32 -1.912 . . . . 10.0 108.32 178.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.725 ' O ' HG23 ' B' ' 25' ' ' VAL . 1.1 t80 -179.34 117.46 0.06 Allowed 'General case' 0 N--CA 1.485 1.322 0 O-C-N 121.014 -1.286 . . . . 10.0 109.314 -179.371 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.418 ' C ' ' O ' ' B' ' 22' ' ' PHE . 16.0 t0 -38.95 156.3 0.02 OUTLIER 'General case' 0 C--N 1.289 -2.027 0 CA-C-O 121.643 0.735 . . . . 10.0 111.133 -179.201 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.401 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 60.01 46.73 10.54 Favored 'General case' 0 N--CA 1.501 2.079 0 O-C-N 121.667 -0.646 . . . . 10.0 110.512 -178.75 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.725 HG23 ' O ' ' B' ' 22' ' ' PHE . 64.9 t -78.54 -17.59 13.55 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.792 0 N-CA-C 107.151 -1.425 . . . . 10.0 107.151 177.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.705 HG23 ' O ' ' A' ' 27' ' ' LYS 0.256 5.7 t -50.06 -29.87 9.71 Favored 'General case' 0 C--N 1.301 -1.539 0 CA-C-N 114.874 -1.057 . . . . 10.0 111.747 -179.4 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.632 ' HA3' ' O ' ' A' ' 27' ' ' LYS . . . -134.99 4.44 4.23 Favored Glycine 0 N--CA 1.494 2.517 0 N-CA-C 108.16 -1.976 . . . . 10.0 108.16 178.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.53 ' HB3' ' HB3' ' A' ' 18' ' ' CYS . 0.5 OUTLIER 54.08 19.99 2.32 Favored 'General case' 0 N--CA 1.485 1.304 0 O-C-N 121.416 -1.05 . . . . 10.0 110.664 179.857 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.709 ' C ' HG22 ' B' ' 30' ' ' THR . 4.2 t80 -113.15 133.08 55.21 Favored 'General case' 0 C--N 1.296 -1.726 0 O-C-N 121.762 -0.586 . . . . 10.0 109.973 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.709 HG22 ' C ' ' B' ' 29' ' ' PHE . 0.1 OUTLIER 161.97 135.02 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.146 0 CA-C-O 121.238 0.542 . . . . 10.0 110.95 179.524 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 85.06 -179.61 50.98 Favored Glycine 0 N--CA 1.494 2.519 0 N-CA-C 110.051 -1.219 . . . . 10.0 110.051 178.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.626 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 1.1 pp -143.17 36.1 0.21 Allowed Pre-proline 0 N--CA 1.494 1.748 0 O-C-N 121.26 -1.141 . . . . 10.0 112.055 -179.794 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.626 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 46.2 Cg_endo -73.2 171.64 17.19 Favored 'Trans proline' 0 C--N 1.312 -1.376 0 O-C-N 123.172 1.091 . . . . 10.0 109.437 179.41 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.416 ' C ' ' O ' ' B' ' 33' ' ' PRO . 41.8 tp10 -48.96 167.6 0.03 OUTLIER 'General case' 0 C--N 1.303 -1.426 0 O-C-N 120.699 -1.25 . . . . 10.0 108.788 179.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.606 ' O ' ' CB ' ' B' ' 36' ' ' TRP . 2.1 mp0 -82.13 20.08 1.08 Allowed 'General case' 0 C--N 1.295 -1.792 0 O-C-N 121.39 -0.819 . . . . 10.0 110.853 -179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.679 ' O ' ' HB2' ' B' ' 37' ' ' ALA . 3.5 m95 87.84 49.09 0.01 OUTLIER 'General case' 0 N--CA 1.501 2.077 0 N-CA-C 107.514 -1.291 . . . . 10.0 107.514 -177.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.679 ' HB2' ' O ' ' B' ' 36' ' ' TRP . . . 168.56 99.95 0.0 OUTLIER 'General case' 0 C--N 1.291 -1.942 0 N-CA-C 108.455 -0.942 . . . . 10.0 108.455 -178.319 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.486 ' HD2' ' HD3' ' A' ' 68' ' ' ARG . 0.7 OUTLIER -88.16 44.14 1.18 Allowed 'General case' 0 C--N 1.291 -1.971 0 N-CA-C 106.294 -1.743 . . . . 10.0 106.294 177.863 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.825 ' HG ' HD23 ' B' ' 40' ' ' LEU . 0.9 OUTLIER -55.39 -21.11 14.21 Favored 'General case' 0 C--N 1.298 -1.633 0 CA-C-N 114.532 -1.213 . . . . 10.0 111.726 -177.747 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.825 HD23 ' HG ' ' B' ' 39' ' ' LEU . 0.7 OUTLIER -121.2 10.32 10.64 Favored 'General case' 0 N--CA 1.494 1.726 0 O-C-N 120.805 -1.184 . . . . 10.0 111.177 -179.33 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -101.35 -81.75 0.48 Allowed 'General case' 0 C--N 1.291 -1.966 0 O-C-N 121.638 -0.664 . . . . 10.0 109.401 179.181 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.487 ' O ' ' N ' ' B' ' 44' ' ' ASN . 83.8 m -128.4 122.04 30.47 Favored 'General case' 0 C--N 1.304 -1.402 0 N-CA-C 108.745 -0.835 . . . . 10.0 108.745 179.087 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -67.72 50.78 0.06 Allowed 'General case' 0 C--N 1.296 -1.719 0 O-C-N 121.162 -0.961 . . . . 10.0 110.371 -179.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.487 ' N ' ' O ' ' B' ' 42' ' ' THR . 56.3 t-20 -64.81 130.25 42.78 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.195 -0.94 . . . . 10.0 109.965 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 2.0 mt -114.54 161.61 13.22 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.734 0 O-C-N 121.031 -1.043 . . . . 10.0 109.791 179.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 9.4 t . . . . . 0 C--N 1.297 -1.692 0 CA-C-O 117.896 -1.05 . . . . 10.0 110.111 178.76 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.547 ' HA ' ' O ' ' A' ' 177' ' ' LEU . 2.5 ttp . . . . . 0 N--CA 1.492 1.655 0 CA-C-O 121.478 0.656 . . . . 10.0 110.299 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.563 ' O ' HG22 ' A' ' 4' ' ' ILE . 7.6 mm-40 -149.51 -83.06 0.1 Allowed 'General case' 0 N--CA 1.492 1.65 0 N-CA-C 108.665 -0.865 . . . . 10.0 108.665 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.734 ' N ' HG21 ' A' ' 52' ' ' THR . 4.3 m -38.87 91.16 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.69 0 O-C-N 121.584 -0.697 . . . . 10.0 110.171 179.457 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.823 ' CD1' ' HB1' ' A' ' 176' ' ' ALA . 1.6 tt -135.59 138.76 47.62 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 O-C-N 121.088 -1.008 . . . . 10.0 110.656 -179.837 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.615 ' HD2' ' CB ' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -130.35 122.84 28.64 Favored 'General case' 0 C--N 1.295 -1.795 0 CA-C-O 122.132 0.968 . . . . 10.0 111.313 179.451 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.739 ' HA ' HG13 ' A' ' 77' ' ' VAL . 40.4 t -71.34 126.1 28.73 Favored 'General case' 0 C--N 1.298 -1.649 0 CA-C-O 121.746 0.784 . . . . 10.0 110.85 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.716 HG12 ' H ' ' A' ' 8' ' ' VAL . 4.3 t -140.43 -174.97 0.86 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.633 -0.667 . . . . 10.0 109.212 179.511 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.716 ' H ' HG12 ' A' ' 7' ' ' VAL . 71.5 t -93.87 143.02 12.45 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.517 0 O-C-N 121.05 -1.031 . . . . 10.0 109.82 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.698 HG13 ' N ' ' A' ' 10' ' ' GLY . 0.3 OUTLIER -132.74 -166.38 0.47 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.41 0 O-C-N 121.505 -0.747 . . . . 10.0 110.397 -179.01 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.698 ' N ' HG13 ' A' ' 9' ' ' VAL . . . 89.49 -158.92 27.95 Favored Glycine 0 N--CA 1.495 2.592 0 N-CA-C 109.567 -1.413 . . . . 10.0 109.567 179.447 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 2.9 m-20 -69.59 -10.19 57.17 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 120.986 -1.302 . . . . 10.0 109.4 179.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.525 ' HA2' ' HG3' ' B' ' 35' ' ' GLN . . . 112.07 89.68 1.87 Allowed Glycine 0 N--CA 1.488 2.158 0 N-CA-C 109.614 -1.394 . . . . 10.0 109.614 179.87 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 14' ' ' VAL . . . -166.15 50.03 0.08 Allowed 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.211 -1.17 . . . . 10.0 110.265 179.713 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.618 ' C ' HG13 ' A' ' 8' ' ' VAL . 0.5 OUTLIER 68.32 157.38 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.302 -1.489 0 O-C-N 121.058 -1.026 . . . . 10.0 109.411 -179.995 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.685 ' N ' HG22 ' A' ' 8' ' ' VAL . . . -122.87 -153.32 8.76 Favored Glycine 0 N--CA 1.49 2.237 0 N-CA-C 108.756 -1.738 . . . . 10.0 108.756 -179.867 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 1.016 ' HA ' HD23 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -77.01 0.36 21.53 Favored 'General case' 0 N--CA 1.495 1.812 0 O-C-N 121.523 -0.986 . . . . 10.0 110.873 -179.849 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 4.8 m -74.25 -50.63 18.23 Favored 'General case' 0 C--N 1.299 -1.625 0 O-C-N 121.315 -0.866 . . . . 10.0 111.493 -178.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.585 ' SG ' HD22 ' A' ' 19' ' ' LEU . 31.9 p -61.88 -17.89 58.17 Favored 'General case' 0 C--N 1.303 -1.422 0 O-C-N 120.778 -1.201 . . . . 10.0 109.443 -179.821 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 1.016 HD23 ' HA ' ' A' ' 16' ' ' LYS . 0.4 OUTLIER -79.21 -28.15 42.54 Favored 'General case' 0 C--N 1.301 -1.504 0 O-C-N 121.371 -0.831 . . . . 10.0 109.932 179.815 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 4.0 tp -49.57 -41.39 41.58 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 120.604 -1.31 . . . . 10.0 109.331 178.845 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.724 ' HB ' ' HA2' ' B' ' 27' ' ' GLY . 1.2 mm -84.59 -39.97 14.85 Favored 'Isoleucine or valine' 0 N--CA 1.5 2.053 0 CA-C-O 122.369 1.08 . . . . 10.0 109.09 178.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.607 ' CB ' ' HA ' ' A' ' 19' ' ' LEU . 16.1 t -46.73 -49.21 19.95 Favored 'General case' 0 C--N 1.296 -1.755 0 CA-C-N 115.359 -0.837 . . . . 10.0 110.546 -179.164 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.939 ' CZ ' HD12 ' A' ' 165' ' ' LEU . 29.8 m-85 -79.94 -14.28 58.72 Favored 'General case' 0 C--N 1.304 -1.394 0 O-C-N 121.002 -1.061 . . . . 10.0 110.316 179.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 82.4 m -100.04 -31.63 11.34 Favored 'General case' 0 N--CA 1.491 1.577 0 O-C-N 121.09 -1.006 . . . . 10.0 112.849 -179.177 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.419 ' OG1' HG23 ' A' ' 21' ' ' ILE . 82.8 p -110.74 -90.2 0.48 Allowed 'General case' 0 C--N 1.312 -1.03 0 O-C-N 120.051 -1.656 . . . . 10.0 112.118 -177.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.586 ' C ' ' HG3' ' A' ' 27' ' ' LYS . 47.7 t-20 -159.85 20.96 0.17 Allowed 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.51 -0.744 . . . . 10.0 111.421 -178.759 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.602 ' O ' ' CD ' ' A' ' 29' ' ' PRO . 0.1 OUTLIER 26.86 -158.25 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.326 0 N-CA-C 113.431 0.901 . . . . 10.0 113.431 179.583 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.664 ' CD2' HG22 ' B' ' 30' ' ' THR . 1.0 OUTLIER -53.24 95.24 0.07 OUTLIER Pre-proline 0 N--CA 1.502 2.141 0 O-C-N 121.951 -0.468 . . . . 10.0 110.244 -178.066 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.602 ' CD ' ' O ' ' A' ' 27' ' ' LYS . 55.4 Cg_endo -103.92 -160.34 0.03 OUTLIER 'Trans proline' 0 C--N 1.306 -1.683 0 C-N-CA 121.695 1.596 . . . . 10.0 110.179 -179.147 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 92.7 p -112.65 33.04 5.21 Favored 'General case' 0 C--N 1.301 -1.531 0 N-CA-C 108.823 -0.806 . . . . 10.0 108.823 178.217 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -142.36 -171.29 3.37 Favored 'General case' 0 C--N 1.304 -1.4 0 CA-C-O 121.935 0.874 . . . . 10.0 109.434 179.951 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 49.9 m-85 -107.25 73.7 0.94 Allowed 'General case' 0 C--N 1.29 -2.007 0 CA-C-N 115.918 -0.583 . . . . 10.0 110.336 -179.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.66 ' HB ' ' HD2' ' A' ' 34' ' ' PRO . 1.4 m -60.91 -168.44 0.02 OUTLIER Pre-proline 0 N--CA 1.498 1.974 0 N-CA-C 108.274 -1.01 . . . . 10.0 108.274 179.453 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.66 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 36.8 Cg_endo -66.06 158.19 55.66 Favored 'Trans proline' 0 C--N 1.316 -1.135 0 CA-C-O 122.044 0.768 . . . . 10.0 112.11 -178.397 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.956 HG23 ' HB2' ' A' ' 37' ' ' PHE . 5.1 t -89.39 165.3 14.44 Favored 'General case' 0 N--CA 1.492 1.673 0 CA-C-O 121.644 0.735 . . . . 10.0 112.18 -178.025 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 58' ' ' THR . 1.6 t -54.42 -14.18 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 O-C-N 121.559 -0.713 . . . . 10.0 111.058 -179.782 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 1.121 ' CD1' HG22 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -35.69 92.44 0.01 OUTLIER 'General case' 0 N--CA 1.502 2.158 0 O-C-N 121.511 -0.743 . . . . 10.0 109.989 -179.858 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.613 ' C ' ' HA ' ' B' ' 18' ' ' ILE . 68.5 m-20 -137.79 131.96 31.96 Favored 'General case' 0 N--CA 1.493 1.721 0 N-CA-C 116.913 2.19 . . . . 10.0 116.913 -177.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.805 ' HB3' HD13 ' B' ' 18' ' ' ILE 0.26 35.1 p-10 -104.9 107.37 18.3 Favored 'General case' 0 N--CA 1.494 1.732 0 CA-C-N 115.007 -0.997 . . . . 10.0 111.101 179.596 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.567 ' CG ' ' O ' ' A' ' 39' ' ' ASN . 23.8 m-85 -155.21 108.84 2.84 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 119.368 -2.082 . . . . 10.0 113.101 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.504 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -171.65 99.34 0.18 Allowed 'General case' 0 N--CA 1.493 1.708 0 N-CA-C 107.423 -1.325 . . . . 10.0 107.423 178.316 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.65 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -156.11 -168.28 0.06 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.81 0 O-C-N 120.899 -1.125 . . . . 10.0 111.436 -177.558 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.942 HG23 ' C ' ' A' ' 51' ' ' TYR . 27.0 m -151.68 115.55 4.92 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 119.648 -0.821 . . . . 10.0 111.33 -179.584 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.61 ' O ' ' HA ' ' A' ' 50' ' ' PRO . 0.3 OUTLIER -79.76 152.05 4.72 Favored 'Isoleucine or valine' 0 N--CA 1.501 2.109 0 O-C-N 121.811 -0.556 . . . . 10.0 110.047 179.623 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.6 ' O ' ' O ' ' B' ' 10' ' ' LEU . 33.6 mtm -127.43 92.89 3.59 Favored 'General case' 0 C--N 1.298 -1.651 0 C-N-CA 118.339 -1.344 . . . . 10.0 108.125 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.793 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 38.3 mt -95.6 141.13 15.71 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 CA-C-O 120.909 0.385 . . . . 10.0 110.249 -178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.792 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 40.97 26.96 0.17 Allowed Glycine 0 N--CA 1.491 2.331 0 N-CA-C 109.519 -1.432 . . . . 10.0 109.519 -179.217 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.479 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 86.24 33.33 14.64 Favored Glycine 0 N--CA 1.491 2.342 0 O-C-N 121.161 -1.199 . . . . 10.0 110.242 179.742 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.559 ' HG3' ' CG ' ' B' ' 4' ' ' GLU . 52.7 mm-40 -127.46 102.52 23.24 Favored Pre-proline 0 N--CA 1.492 1.637 0 O-C-N 121.085 -1.244 . . . . 10.0 110.723 -179.794 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.61 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 48.0 Cg_endo -74.92 124.2 8.48 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 O-C-N 123.874 1.46 . . . . 10.0 110.303 179.596 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.942 ' C ' HG23 ' A' ' 43' ' ' THR . 6.3 m-30 -99.83 110.99 23.34 Favored 'General case' 0 N--CA 1.486 1.368 0 O-C-N 120.683 -1.261 . . . . 10.0 110.225 179.374 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.734 HG21 ' N ' ' A' ' 3' ' ' THR . 1.4 m -71.69 117.04 12.77 Favored 'General case' 0 N--CA 1.489 1.513 0 O-C-N 121.636 -0.665 . . . . 10.0 110.546 -179.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.471 ' HG ' ' C ' ' A' ' 52' ' ' THR . 5.2 mt -137.71 160.72 38.44 Favored 'General case' 0 N--CA 1.494 1.745 0 O-C-N 120.884 -1.135 . . . . 10.0 110.542 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.517 ' O ' ' CA ' ' A' ' 5' ' ' LYS . . . -170.92 110.87 0.38 Allowed Glycine 0 N--CA 1.495 2.571 0 N-CA-C 109.959 -1.256 . . . . 10.0 109.959 179.157 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.508 HD11 ' CB ' ' A' ' 40' ' ' TYR . 2.2 pp -138.57 152.53 48.25 Favored 'General case' 0 N--CA 1.49 1.556 0 O-C-N 120.97 -1.312 . . . . 10.0 111.924 -179.775 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.556 ' CD1' ' N ' ' A' ' 56' ' ' PHE . 20.6 p90 -160.27 140.65 11.67 Favored 'General case' 0 N--CA 1.49 1.553 0 CA-C-N 115.307 -0.86 . . . . 10.0 108.766 179.237 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.676 ' HB2' HG13 ' A' ' 36' ' ' VAL . 1.7 m-20 -92.8 154.37 18.31 Favored 'General case' 0 N--CA 1.498 1.961 0 O-C-N 120.804 -1.185 . . . . 10.0 111.468 -179.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.69 ' O ' HG11 ' A' ' 36' ' ' VAL . 1.6 t -60.55 133.77 56.42 Favored 'General case' 0 N--CA 1.496 1.852 0 CA-C-O 121.603 0.716 . . . . 10.0 110.919 -179.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.608 ' HA ' ' CA ' ' B' ' 21' ' ' GLY . . . -87.12 79.1 8.74 Favored 'General case' 0 C--N 1.298 -1.664 0 O-C-N 121.677 -0.64 . . . . 10.0 111.439 179.619 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.572 ' N ' ' HA2' ' B' ' 21' ' ' GLY . . . -42.94 -50.07 6.14 Favored Glycine 0 N--CA 1.497 2.715 0 N-CA-C 106.559 -2.617 . . . . 10.0 106.559 177.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.515 ' O ' ' HB2' ' A' ' 62' ' ' GLU . 3.5 mm-40 -62.99 -44.18 96.73 Favored 'General case' 0 C--N 1.308 -1.226 0 N-CA-C 107.736 -1.209 . . . . 10.0 107.736 176.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.544 ' HG3' ' O ' ' A' ' 59' ' ' ALA . 4.5 mt-10 65.41 84.98 0.15 Allowed 'General case' 0 N--CA 1.491 1.603 0 CA-C-O 122.121 0.962 . . . . 10.0 111.366 178.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.709 ' OD2' HG11 ' B' ' 20' ' ' VAL . 21.5 m-20 -95.52 -8.86 34.01 Favored 'General case' 0 C--N 1.284 -2.281 0 CA-C-O 121.811 0.815 . . . . 10.0 108.858 177.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.486 ' O ' ' N ' ' A' ' 66' ' ' ARG . 43.4 p90 -139.65 10.32 2.45 Favored 'General case' 0 N--CA 1.488 1.46 0 N-CA-C 108.664 -0.865 . . . . 10.0 108.664 179.369 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.539 ' O ' ' HG2' ' A' ' 68' ' ' ARG . 3.1 p-10 -30.62 -36.67 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.8 0 CA-C-O 121.26 0.552 . . . . 10.0 112.101 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.486 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.3 OUTLIER -48.46 -26.88 2.33 Favored 'General case' 0 C--N 1.297 -1.708 0 O-C-N 120.829 -1.169 . . . . 10.0 109.451 -179.319 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.577 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 8.4 mp -97.02 6.68 48.18 Favored 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.432 -0.792 . . . . 10.0 110.273 179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 1.048 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -72.69 -24.92 0.67 Allowed Pre-proline 0 N--CA 1.493 1.713 0 O-C-N 121.103 -0.998 . . . . 10.0 112.891 -179.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.618 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 38.0 Cg_endo -70.91 71.42 2.1 Favored 'Trans proline' 0 C--N 1.318 -1.058 0 N-CA-C 109.275 -1.086 . . . . 10.0 109.275 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 1.048 HD23 ' O ' ' A' ' 68' ' ' ARG . 0.2 OUTLIER -69.93 -84.83 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.793 -0.567 . . . . 10.0 111.519 -178.984 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.815 ' HA ' HD22 ' B' ' 39' ' ' LEU . 0.5 OUTLIER 54.67 35.21 23.25 Favored 'General case' 0 N--CA 1.488 1.426 0 O-C-N 120.805 -1.185 . . . . 10.0 108.482 -178.846 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.582 ' HB2' ' HD3' ' A' ' 73' ' ' PRO . 4.9 m-85 -118.1 -53.48 0.04 OUTLIER Pre-proline 0 N--CA 1.489 1.504 0 O-C-N 121.629 -0.669 . . . . 10.0 111.222 -179.023 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.615 ' CB ' ' HD2' ' A' ' 5' ' ' LYS . 55.7 Cg_endo -85.92 76.8 2.7 Favored 'Trans proline' 0 C--N 1.321 -0.914 0 O-C-N 122.978 0.988 . . . . 10.0 111.296 -179.473 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -85.16 0.32 52.13 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 120.904 -1.122 . . . . 10.0 110.443 179.47 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.664 HG22 ' O ' ' A' ' 75' ' ' THR . 2.7 m -140.1 84.21 1.96 Allowed 'General case' 0 N--CA 1.486 1.365 0 O-C-N 121.287 -0.883 . . . . 10.0 110.048 -179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.433 ' OD2' ' HA ' ' A' ' 4' ' ' ILE . 1.9 m-20 -140.52 -97.62 0.15 Allowed 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.704 -0.622 . . . . 10.0 109.424 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.739 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.3 OUTLIER -140.78 118.53 9.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.615 0 O-C-N 121.173 -0.955 . . . . 10.0 108.743 179.573 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.65 ' HB3' HG21 ' A' ' 9' ' ' VAL . 21.4 m-85 -114.85 125.51 53.74 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.072 -1.018 . . . . 10.0 111.443 -178.833 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.603 HD22 HD23 ' A' ' 111' ' ' LEU . 0.7 OUTLIER -111.47 99.76 8.47 Favored 'General case' 0 N--CA 1.491 1.593 0 N-CA-C 108.508 -0.923 . . . . 10.0 108.508 178.647 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.563 HG12 ' HA ' ' A' ' 112' ' ' LEU . 1.7 p -82.64 133.79 28.35 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.461 0 O-C-N 121.618 -0.676 . . . . 10.0 110.457 -179.271 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.452 ' C ' ' OG1' ' A' ' 115' ' ' THR . 11.3 t -124.27 101.21 7.07 Favored 'General case' 0 C--N 1.3 -1.581 0 O-C-N 121.176 -0.953 . . . . 10.0 109.161 179.301 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.539 ' O ' ' N ' ' A' ' 115' ' ' THR . 31.8 p90 -133.53 162.24 32.42 Favored 'General case' 0 N--CA 1.494 1.744 0 C-N-CA 118.662 -1.215 . . . . 10.0 111.488 -179.554 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.496 ' HB3' HG22 ' A' ' 85' ' ' VAL . 63.6 m -75.76 158.64 31.98 Favored 'General case' 0 N--CA 1.488 1.454 0 O-C-N 121.648 -0.658 . . . . 10.0 110.328 -179.406 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . . . . . . . . . 29.7 m -107.9 -11.4 10.77 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.56 0 O-C-N 121.472 -0.767 . . . . 10.0 109.403 179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.519 ' HA ' HD21 ' A' ' 129' ' ' LEU . 33.9 m -68.62 -1.93 1.8 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.847 0 O-C-N 121.459 -0.776 . . . . 10.0 109.701 178.564 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 68.2 m -128.08 82.86 67.62 Favored Pre-proline 0 C--N 1.303 -1.414 0 O-C-N 121.201 -0.937 . . . . 10.0 109.871 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.565 ' HG3' ' O ' ' A' ' 135' ' ' LYS . 44.2 Cg_endo -63.81 -19.26 66.71 Favored 'Trans proline' 0 C--N 1.304 -1.8 0 O-C-N 124.35 1.711 . . . . 10.0 110.389 -179.763 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.507 ' HA ' ' OE2' ' A' ' 91' ' ' GLU . 67.9 m -89.04 22.36 2.79 Favored 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.153 -0.967 . . . . 10.0 109.122 178.562 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.547 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 46.9 t -124.75 -56.23 1.59 Allowed 'General case' 0 C--N 1.3 -1.584 0 O-C-N 121.779 -0.576 . . . . 10.0 109.881 -179.823 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.531 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.4 p90 -53.38 -39.95 64.63 Favored 'General case' 0 N--CA 1.488 1.43 0 O-C-N 120.631 -1.293 . . . . 10.0 109.469 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.531 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 17.8 pt-20 -67.55 -26.5 66.33 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 121.555 -0.715 . . . . 10.0 109.55 179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.811 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -77.13 -14.3 59.82 Favored 'General case' 0 N--CA 1.488 1.433 0 O-C-N 121.224 -0.922 . . . . 10.0 108.667 178.922 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.811 HG23 ' ND2' ' A' ' 92' ' ' ASN . 32.9 t -88.5 -16.36 8.81 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.392 0 CA-C-O 121.787 0.803 . . . . 10.0 109.601 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.819 ' HE3' HD21 ' A' ' 145' ' ' LEU . 1.1 mmtt -86.22 -33.48 20.73 Favored 'General case' 0 C--N 1.296 -1.72 0 N-CA-C 107.861 -1.163 . . . . 10.0 107.861 179.539 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.552 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 5.4 pt-20 -77.02 -9.04 58.44 Favored 'General case' 0 C--N 1.303 -1.438 0 C-N-CA 120.163 -0.615 . . . . 10.0 109.421 178.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.468 ' O ' ' CG ' ' A' ' 100' ' ' GLU . 0.0 OUTLIER -90.3 -52.4 4.95 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 120.844 -1.16 . . . . 10.0 111.976 -178.453 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . . . . . . . . . 24.9 m95 -93.09 -31.83 14.68 Favored 'General case' 0 N--CA 1.501 2.123 0 O-C-N 120.563 -1.336 . . . . 10.0 112.487 -178.426 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.581 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 95.0 t -54.32 -46.75 98.87 Favored Pre-proline 0 N--CA 1.49 1.527 0 O-C-N 120.572 -1.33 . . . . 10.0 110.863 -179.128 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.581 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 44.4 Cg_endo -73.9 -23.41 16.38 Favored 'Trans proline' 0 C--N 1.31 -1.478 0 O-C-N 123.323 1.17 . . . . 10.0 110.716 179.712 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.47 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 29.1 mm-40 -63.46 -16.36 60.4 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.087 -1.008 . . . . 10.0 110.772 -179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.603 HD12 ' O ' ' A' ' 104' ' ' HIS . 9.6 mm 56.62 104.14 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.877 0 O-C-N 121.141 -0.975 . . . . 10.0 110.058 -179.802 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.565 ' HB ' ' CG ' ' A' ' 106' ' ' PRO . 5.9 m -44.08 -80.12 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.388 0 N-CA-C 108.649 -0.871 . . . . 10.0 108.649 179.325 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.524 ' O ' ' HB2' ' A' ' 104' ' ' HIS . 4.8 t-160 -112.89 -15.43 12.9 Favored 'General case' 0 C--N 1.299 -1.63 0 O-C-N 121.524 -0.735 . . . . 10.0 110.23 178.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.603 ' O ' HD12 ' A' ' 101' ' ' ILE . 0.5 OUTLIER 165.91 -49.96 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 106.875 -1.528 . . . . 10.0 106.875 -179.406 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.585 ' N ' ' HD3' ' A' ' 106' ' ' PRO . 19.5 t 179.26 58.92 0.08 OUTLIER Pre-proline 0 N--CA 1.49 1.528 0 CA-C-N 115.206 -0.906 . . . . 10.0 108.924 178.253 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.632 ' O ' ' CG ' ' A' ' 107' ' ' LYS . 52.2 Cg_endo -89.62 -62.48 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.496 0 O-C-N 124.002 1.527 . . . . 10.0 110.191 -179.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.632 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 108.2 51.1 0.0 OUTLIER 'General case' 0 N--CA 1.505 2.307 0 C-N-CA 124.972 1.309 . . . . 10.0 110.905 179.494 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.487 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 31.2 m -45.88 144.29 2.88 Favored Pre-proline 0 N--CA 1.494 1.727 0 O-C-N 120.892 -1.13 . . . . 10.0 109.319 178.74 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.487 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 43.7 Cg_endo -69.6 144.49 55.04 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 O-C-N 123.763 1.402 . . . . 10.0 110.776 -178.905 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.448 ' C ' ' CG1' ' A' ' 152' ' ' VAL . 0.5 OUTLIER -133.66 113.02 11.91 Favored 'General case' 0 N--CA 1.487 1.422 0 O-C-N 121.399 -0.813 . . . . 10.0 111.641 -179.793 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.879 HD13 ' CG1' ' A' ' 152' ' ' VAL . 2.6 mm? -83.09 97.41 8.77 Favored 'General case' 0 C--N 1.302 -1.492 0 N-CA-C 107.999 -1.112 . . . . 10.0 107.999 177.934 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.567 HD22 ' CB ' ' A' ' 154' ' ' TYR . 0.6 OUTLIER -77.02 145.68 37.84 Favored 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.413 -0.804 . . . . 10.0 110.447 -179.368 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.57 HG11 ' SG ' ' A' ' 157' ' ' CYS . 2.0 t -152.97 176.59 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.502 2.168 0 O-C-N 121.147 -0.97 . . . . 10.0 111.83 -179.005 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.545 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -112.32 159.82 13.5 Favored Glycine 0 N--CA 1.494 2.508 0 N-CA-C 108.42 -1.872 . . . . 10.0 108.42 178.176 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.696 HG22 ' HG2' ' A' ' 116' ' ' GLN . 81.8 m -127.03 150.75 49.3 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 120.675 -1.485 . . . . 10.0 111.457 -178.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.696 ' HG2' HG22 ' A' ' 115' ' ' THR . 4.2 pt20 33.6 57.35 0.54 Allowed 'General case' 0 N--CA 1.501 2.079 0 CA-C-O 121.376 0.607 . . . . 10.0 110.97 -179.753 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.964 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.4 OUTLIER -80.13 -25.06 11.68 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.599 0 O-C-N 121.077 -1.014 . . . . 10.0 109.695 179.692 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.862 ' HB2' HG21 ' A' ' 161' ' ' THR . 15.7 t0 -52.48 61.33 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.133 0 CA-C-O 122.566 1.174 . . . . 10.0 110.708 -176.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.741 ' N ' ' O ' ' A' ' 117' ' ' ILE . 4.6 tp 167.42 -30.24 0.0 OUTLIER 'General case' 0 C--N 1.284 -2.262 0 CA-C-N 114.035 -1.439 . . . . 10.0 107.634 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.537 ' N ' ' O ' ' A' ' 117' ' ' ILE . 1.1 ttp180 -46.5 -38.56 9.44 Favored 'General case' 0 C--N 1.306 -1.31 0 N-CA-C 108.961 -0.755 . . . . 10.0 108.961 178.881 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -55.07 -25.53 31.63 Favored 'General case' 0 N--CA 1.489 1.499 0 O-C-N 121.451 -0.781 . . . . 10.0 109.503 178.736 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.437 ' N ' ' O ' ' A' ' 119' ' ' LEU . 6.8 m-20 -92.63 150.6 40.03 Favored Pre-proline 0 N--CA 1.497 1.882 0 O-C-N 121.585 -0.697 . . . . 10.0 111.526 -179.472 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.525 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 56.2 Cg_endo -80.79 17.15 1.46 Allowed 'Trans proline' 0 C--N 1.304 -1.792 0 O-C-N 124.578 1.831 . . . . 10.0 111.146 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 15.9 p -96.68 -50.75 4.57 Favored 'General case' 0 N--CA 1.493 1.706 0 O-C-N 120.984 -1.072 . . . . 10.0 110.188 -179.646 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.469 ' O ' ' CD ' ' A' ' 128' ' ' LYS . 15.3 t -71.74 -28.11 63.45 Favored 'General case' 0 C--N 1.295 -1.792 0 N-CA-C 104.832 -2.284 . . . . 10.0 104.832 176.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.661 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.304 0.4 OUTLIER -49.67 -27.93 3.47 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.551 0 N-CA-C 107.529 -1.286 . . . . 10.0 107.529 176.794 . . . . . . . . 4 4 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -50.12 -32.07 14.99 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.495 0.664 . . . . 10.0 109.998 179.127 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.469 ' CD ' ' O ' ' A' ' 125' ' ' THR . 0.3 OUTLIER -65.64 -32.19 73.63 Favored 'General case' 0 N--CA 1.494 1.762 0 O-C-N 121.334 -0.854 . . . . 10.0 110.391 179.677 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.661 HD12 ' HA ' ' A' ' 126' ' ' ILE . 7.9 mt -54.71 -38.69 67.38 Favored 'General case' 0 N--CA 1.492 1.67 0 O-C-N 121.109 -0.994 . . . . 10.0 109.373 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.595 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -54.15 -51.28 64.78 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 119.551 -0.86 . . . . 10.0 109.512 179.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 8.6 mttt -71.74 -13.28 61.67 Favored 'General case' 0 N--CA 1.489 1.511 0 O-C-N 121.077 -1.014 . . . . 10.0 108.398 178.391 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.541 ' O ' ' HG2' ' A' ' 87' ' ' PRO . 17.1 m120 -126.93 46.39 2.51 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.771 -0.581 . . . . 10.0 110.307 179.801 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.476 ' N ' ' O ' ' A' ' 129' ' ' LEU . 0.0 OUTLIER 68.08 135.02 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.714 0 O-C-N 121.077 -1.015 . . . . 10.0 110.322 -179.489 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.595 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -80.74 3.71 21.35 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.628 -0.67 . . . . 10.0 110.686 -179.569 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.565 ' O ' ' HG3' ' A' ' 87' ' ' PRO . 27.2 mmtp -101.53 99.49 11.59 Favored Pre-proline 0 N--CA 1.495 1.825 0 O-C-N 121.299 -0.875 . . . . 10.0 110.265 179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 44.2 Cg_endo -69.66 161.74 44.74 Favored 'Trans proline' 0 C--N 1.308 -1.576 0 O-C-N 123.862 1.454 . . . . 10.0 112.155 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.481 HG22 ' H ' ' A' ' 137' ' ' ILE . 2.2 tp -84.71 143.17 12.22 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.61 0 O-C-N 121.419 -0.801 . . . . 10.0 109.011 179.146 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.6 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 43.6 p -134.4 171.26 9.34 Favored Pre-proline 0 N--CA 1.492 1.648 0 O-C-N 121.294 -0.879 . . . . 10.0 110.312 -178.409 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.6 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 38.1 Cg_endo -65.98 -30.55 47.99 Favored 'Trans proline' 0 C--N 1.313 -1.332 0 O-C-N 123.556 1.293 . . . . 10.0 110.473 -179.791 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -67.54 -38.13 83.74 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.15 -0.969 . . . . 10.0 109.01 179.215 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 3.5 m -88.79 -38.96 14.24 Favored 'General case' 0 N--CA 1.489 1.509 0 CA-C-O 121.518 0.675 . . . . 10.0 109.484 178.974 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.417 ' CB ' ' O ' ' A' ' 138' ' ' THR . . . -69.05 -36.17 77.4 Favored 'General case' 0 N--CA 1.489 1.493 0 O-C-N 121.692 -0.63 . . . . 10.0 110.343 -179.698 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.508 ' CB ' ' O ' ' A' ' 139' ' ' PRO . 5.2 tt0 -65.31 -37.56 87.49 Favored 'General case' 0 C--N 1.299 -1.621 0 O-C-N 121.351 -0.843 . . . . 10.0 109.403 179.642 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.406 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 42.3 tttp -66.79 -36.04 81.49 Favored 'General case' 0 N--CA 1.488 1.445 0 O-C-N 121.388 -0.82 . . . . 10.0 108.806 178.725 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.819 HD21 ' HE3' ' A' ' 94' ' ' LYS . 2.9 tp -62.56 -48.97 77.15 Favored 'General case' 0 C--N 1.306 -1.291 0 N-CA-C 108.243 -1.021 . . . . 10.0 108.243 178.477 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.493 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -63.47 -49.35 73.95 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 119.564 -0.854 . . . . 10.0 109.435 178.906 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -62.24 -27.1 68.76 Favored 'General case' 0 N--CA 1.491 1.584 0 CA-C-O 121.281 0.562 . . . . 10.0 109.567 179.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.487 ' C ' HD12 ' A' ' 149' ' ' LEU . 1.9 m-20 -74.68 -47.45 31.64 Favored 'General case' 0 N--CA 1.495 1.787 0 O-C-N 121.502 -0.749 . . . . 10.0 110.574 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.72 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 3.2 mp -88.73 12.07 15.92 Favored 'General case' 0 N--CA 1.49 1.564 0 CA-C-O 121.892 0.853 . . . . 10.0 109.445 -179.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.438 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 19.2 mtmt 59.69 33.11 21.81 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.816 0.817 . . . . 10.0 110.216 179.708 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.493 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -61.58 -152.85 0.0 OUTLIER 'General case' 0 C--N 1.295 -1.775 0 C-N-CA 120.145 -0.622 . . . . 10.0 110.117 179.667 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.879 ' CG1' HD13 ' A' ' 111' ' ' LEU . 0.6 OUTLIER -117.97 -51.52 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.505 0 O-C-N 121.035 -1.041 . . . . 10.0 111.471 -179.343 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . . . . . . . . . 1.3 tmtt? -172.52 143.62 1.38 Allowed 'General case' 0 N--CA 1.493 1.679 0 C-N-CA 118.613 -1.235 . . . . 10.0 111.847 -178.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' O ' ' CD1' ' A' ' 154' ' ' TYR . 53.8 p90 -90.32 121.64 32.51 Favored 'General case' 0 N--CA 1.497 1.907 0 O-C-N 120.88 -1.137 . . . . 10.0 109.623 178.604 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.852 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -127.14 -169.61 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.753 0 O-C-N 121.297 -0.877 . . . . 10.0 110.771 -178.805 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -145.69 148.21 32.79 Favored 'General case' 0 N--CA 1.49 1.552 0 O-C-N 121.101 -1.0 . . . . 10.0 110.033 -179.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.57 ' SG ' HG11 ' A' ' 113' ' ' VAL . 27.6 p -156.52 154.11 29.81 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 121.326 -0.859 . . . . 10.0 109.171 -179.603 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.928 ' HB3' HG23 ' A' ' 161' ' ' THR . 1.3 t -149.61 88.47 1.56 Allowed 'General case' 0 C--N 1.293 -1.867 0 C-N-CA 119.066 -1.054 . . . . 10.0 109.933 -179.878 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.744 ' HB2' HD11 ' A' ' 19' ' ' LEU . . . -42.84 -79.86 0.01 OUTLIER 'General case' 0 C--N 1.298 -1.651 0 CA-C-N 116.036 -0.529 . . . . 10.0 111.519 -179.635 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.536 ' C ' ' O ' ' A' ' 159' ' ' ALA . 0.0 OUTLIER -31.3 -39.48 0.03 OUTLIER 'General case' 0 N--CA 1.505 2.309 0 CA-C-O 122.216 1.008 . . . . 10.0 109.351 -178.742 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.928 HG23 ' HB3' ' A' ' 158' ' ' SER . 0.0 OUTLIER -111.2 -97.91 0.41 Allowed 'General case' 0 N--CA 1.495 1.783 0 CA-C-N 115.842 -0.617 . . . . 10.0 110.021 179.078 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.652 ' HA ' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 158.75 103.09 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.368 -0.833 . . . . 10.0 109.754 -179.864 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.517 ' HB3' ' CA ' ' A' ' 157' ' ' CYS . 21.8 tptt -105.47 43.59 1.11 Allowed 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.851 -1.155 . . . . 10.0 110.221 179.462 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 56.44 40.84 87.17 Favored Glycine 0 N--CA 1.493 2.454 0 N-CA-C 109.741 -1.344 . . . . 10.0 109.741 179.566 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.939 HD12 ' CZ ' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -61.71 -12.27 15.77 Favored 'General case' 0 C--N 1.303 -1.427 0 O-C-N 121.237 -1.155 . . . . 10.0 110.785 -179.475 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.581 ' N ' HD13 ' A' ' 165' ' ' LEU . 2.5 mttp -53.24 -29.67 33.84 Favored 'General case' 0 N--CA 1.494 1.735 0 O-C-N 120.889 -1.132 . . . . 10.0 109.834 178.917 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 31.8 m-80 -70.86 -29.79 66.0 Favored 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.08 -1.012 . . . . 10.0 110.282 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.852 HG22 ' HB ' ' A' ' 155' ' ' VAL . 2.3 t -66.86 -19.37 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.704 0 O-C-N 121.085 -1.009 . . . . 10.0 110.035 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.765 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 25.4 t80 -96.55 -45.3 6.79 Favored 'General case' 0 N--CA 1.498 1.967 0 O-C-N 121.212 -0.93 . . . . 10.0 112.094 -179.076 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -51.22 -49.14 61.64 Favored 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.985 -1.072 . . . . 10.0 110.82 -178.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . . . . . . . . . 2.1 mt-10 -69.78 -39.73 76.46 Favored 'General case' 0 C--N 1.297 -1.675 0 O-C-N 121.087 -1.008 . . . . 10.0 110.137 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.703 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -54.85 -27.24 40.85 Favored 'General case' 0 C--N 1.299 -1.604 0 O-C-N 121.468 -0.77 . . . . 10.0 110.913 -179.892 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.765 HD11 ' CZ ' ' A' ' 169' ' ' PHE . 34.8 mm -67.14 -45.93 85.47 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.478 0 O-C-N 120.959 -1.088 . . . . 10.0 110.272 -179.644 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.831 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -80.49 -27.63 37.71 Favored 'General case' 0 N--CA 1.488 1.438 0 O-C-N 120.945 -1.097 . . . . 10.0 109.954 -179.839 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.593 ' CB ' ' CG2' ' A' ' 152' ' ' VAL . . . -85.43 -1.66 57.27 Favored 'General case' 0 C--N 1.301 -1.521 0 O-C-N 121.478 -0.763 . . . . 10.0 109.418 178.91 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.823 ' HB1' ' CD1' ' A' ' 4' ' ' ILE . . . -83.11 -42.43 17.39 Favored 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.329 -0.857 . . . . 10.0 110.497 -179.771 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.547 ' O ' ' HA ' ' A' ' 1' ' ' MET . 0.3 OUTLIER -87.73 -19.12 28.04 Favored 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.494 -0.754 . . . . 10.0 109.826 -178.555 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.453 ' CG ' ' HA ' ' A' ' 175' ' ' ALA . 0.9 OUTLIER . . . . . 0 N--CA 1.492 1.644 0 O-C-N 120.858 -1.151 . . . . 10.0 109.998 179.234 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.286 0 N-CA-C 109.661 -1.376 . . . . 10.0 109.661 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 35.3 m -119.55 157.59 28.06 Favored 'General case' 0 N--CA 1.493 1.711 0 O-C-N 121.23 -1.159 . . . . 10.0 110.748 -179.709 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -88.08 100.66 13.1 Favored 'General case' 0 N--CA 1.492 1.655 0 O-C-N 121.376 -0.828 . . . . 10.0 110.022 179.694 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.559 ' CG ' ' HG3' ' A' ' 49' ' ' GLU . 53.4 mm-40 -81.28 157.99 24.94 Favored 'General case' 0 N--CA 1.493 1.675 0 O-C-N 121.298 -0.876 . . . . 10.0 110.669 179.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.708 ' HB2' ' HD3' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -118.09 -52.32 0.04 OUTLIER Pre-proline 0 C--N 1.305 -1.342 0 O-C-N 121.481 -0.762 . . . . 10.0 110.129 -179.866 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.708 ' HD3' ' HB2' ' B' ' 5' ' ' ARG . 56.7 Cg_endo -89.59 21.37 0.93 Allowed 'Trans proline' 0 C--N 1.321 -0.913 0 O-C-N 123.26 1.137 . . . . 10.0 109.224 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.575 ' HG3' HG22 ' A' ' 46' ' ' ILE . 4.0 pt-20 -55.39 168.44 0.37 Allowed 'General case' 0 N--CA 1.488 1.43 0 O-C-N 121.171 -0.956 . . . . 10.0 110.353 -178.43 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.837 HG23 ' N ' ' B' ' 9' ' ' SER . 0.3 OUTLIER -80.27 -148.58 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.586 0 O-C-N 121.228 -0.92 . . . . 10.0 108.649 178.767 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.837 ' N ' HG23 ' B' ' 8' ' ' ILE . 66.6 m -121.55 98.6 6.04 Favored 'General case' 0 C--N 1.296 -1.739 0 O-C-N 121.262 -0.899 . . . . 10.0 108.864 178.239 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.793 ' HB3' ' HA ' ' A' ' 46' ' ' ILE . 0.1 OUTLIER -132.8 98.06 16.51 Favored Pre-proline 0 N--CA 1.486 1.371 0 O-C-N 121.334 -0.854 . . . . 10.0 111.093 -178.725 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.513 ' HA ' HG22 ' A' ' 44' ' ' VAL . 53.0 Cg_endo -90.31 111.39 0.42 Allowed 'Trans proline' 0 C--N 1.311 -1.408 0 O-C-N 123.704 1.371 . . . . 10.0 110.25 178.724 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.513 ' O ' ' O ' ' A' ' 43' ' ' THR . 14.0 m -142.27 102.81 4.17 Favored 'General case' 0 N--CA 1.491 1.576 0 O-C-N 121.047 -1.033 . . . . 10.0 111.151 179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.557 ' HB2' ' HB ' ' A' ' 42' ' ' VAL . 7.5 p-10 -170.84 132.09 0.87 Allowed 'General case' 0 C--N 1.299 -1.612 0 O-C-N 121.486 -0.759 . . . . 10.0 110.488 179.513 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -155.49 100.02 2.08 Favored 'General case' 0 N--CA 1.496 1.836 0 O-C-N 120.978 -1.076 . . . . 10.0 112.389 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.65 ' HB3' HG13 ' A' ' 42' ' ' VAL . 27.2 tt0 -173.01 123.65 0.42 Allowed 'General case' 0 C--N 1.297 -1.68 0 O-C-N 121.592 -0.693 . . . . 10.0 109.217 178.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.615 ' C ' ' HB2' ' A' ' 39' ' ' ASN . 0.3 OUTLIER -163.72 151.13 12.49 Favored 'General case' 0 N--CA 1.491 1.624 0 O-C-N 120.538 -1.352 . . . . 10.0 111.639 -179.268 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.573 ' N ' ' HB2' ' A' ' 39' ' ' ASN . 0.1 OUTLIER -136.48 104.3 5.54 Favored 'General case' 0 N--CA 1.498 1.955 0 O-C-N 121.083 -1.011 . . . . 10.0 110.584 179.163 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 1.121 HG22 ' CD1' ' A' ' 37' ' ' PHE . 31.7 mm -50.84 106.22 0.07 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 120.998 -1.064 . . . . 10.0 112.769 -178.509 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.706 ' C ' ' HA ' ' A' ' 37' ' ' PHE . 55.4 m170 -102.75 116.45 32.59 Favored 'General case' 0 N--CA 1.488 1.442 0 O-C-N 121.069 -1.019 . . . . 10.0 111.096 177.825 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.743 ' HA ' ' N ' ' A' ' 37' ' ' PHE . 3.1 p -87.55 149.09 4.19 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.26 0 O-C-N 121.219 -0.926 . . . . 10.0 113.461 -177.336 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.608 ' CA ' ' HA ' ' A' ' 59' ' ' ALA . . . -143.47 -65.65 0.02 OUTLIER Glycine 0 CA--C 1.538 1.491 0 C-N-CA 119.791 -1.195 . . . . 10.0 112.137 -179.566 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.798 ' HB3' HG21 ' B' ' 25' ' ' VAL . 5.6 t80 -177.32 126.94 0.15 Allowed 'General case' 0 C--N 1.312 -1.057 0 O-C-N 120.674 -1.486 . . . . 10.0 109.227 -178.431 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.486 ' OD2' ' O ' ' A' ' 33' ' ' VAL . 9.4 m-20 -38.47 148.27 0.04 OUTLIER 'General case' 0 C--N 1.285 -2.207 0 CA-C-O 121.853 0.835 . . . . 10.0 111.471 -179.129 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.64 ' HB1' ' OE2' ' B' ' 28' ' ' GLU . . . 52.87 31.35 10.57 Favored 'General case' 0 N--CA 1.499 2.0 0 N-CA-C 112.37 0.507 . . . . 10.0 112.37 -179.789 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.798 HG21 ' HB3' ' B' ' 22' ' ' PHE . 9.8 t -109.63 -31.56 2.34 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.625 0 N-CA-C 106.943 -1.503 . . . . 10.0 106.943 176.911 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.574 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 5.4 t -94.21 -0.61 55.04 Favored 'General case' 0 C--N 1.305 -1.338 0 CA-C-O 121.593 0.711 . . . . 10.0 109.145 177.781 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.724 ' HA2' ' HB ' ' A' ' 21' ' ' ILE . . . -114.28 2.9 23.78 Favored Glycine 0 N--CA 1.484 1.836 0 C-N-CA 119.738 -1.22 . . . . 10.0 110.159 -178.866 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.64 ' OE2' ' HB1' ' B' ' 24' ' ' ALA . 1.7 pm0 -178.12 -158.69 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.873 0 O-C-N 120.982 -1.305 . . . . 10.0 110.602 -179.089 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.59 ' HB2' HG11 ' A' ' 14' ' ' VAL . 1.2 t80 -131.39 135.29 47.08 Favored 'General case' 0 C--N 1.286 -2.192 0 CA-C-O 121.72 0.772 . . . . 10.0 109.508 179.417 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.664 HG22 ' CD2' ' A' ' 28' ' ' PHE . 15.0 p -151.01 -64.32 0.19 Allowed 'General case' 0 C--N 1.294 -1.814 0 O-C-N 121.461 -0.774 . . . . 10.0 109.997 -179.664 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.528 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -70.86 171.13 45.62 Favored Glycine 0 N--CA 1.486 2.003 0 N-CA-C 110.116 -1.193 . . . . 10.0 110.116 -179.569 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.586 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 15.8 mm -125.72 47.79 2.45 Favored Pre-proline 0 N--CA 1.494 1.751 0 O-C-N 121.662 -0.904 . . . . 10.0 110.198 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.586 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 45.7 Cg_endo -71.01 171.97 14.79 Favored 'Trans proline' 0 C--N 1.307 -1.633 0 O-C-N 123.977 1.514 . . . . 10.0 110.385 179.608 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.477 ' HG3' ' H ' ' B' ' 35' ' ' GLN . 1.8 tp10 -50.57 -173.41 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.907 0 O-C-N 121.236 -0.915 . . . . 10.0 109.73 179.684 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.636 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 3.9 mt-30 -81.62 19.11 1.08 Allowed 'General case' 0 C--N 1.304 -1.408 0 O-C-N 121.195 -0.94 . . . . 10.0 109.45 178.864 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.65 ' CD2' ' HB ' ' A' ' 58' ' ' THR . 37.1 m0 71.1 39.38 0.98 Allowed 'General case' 0 N--CA 1.493 1.712 0 N-CA-C 106.255 -1.757 . . . . 10.0 106.255 -176.414 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.602 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -172.34 74.06 0.04 OUTLIER 'General case' 0 C--N 1.293 -1.872 0 CA-C-N 113.386 -1.734 . . . . 10.0 106.887 -178.389 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.417 ' HB3' ' HB2' ' B' ' 41' ' ' GLN . 6.7 mtm180 -72.82 55.17 0.38 Allowed 'General case' 0 C--N 1.302 -1.489 0 N-CA-C 107.238 -1.393 . . . . 10.0 107.238 179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.815 HD22 ' HA ' ' A' ' 71' ' ' SER . 11.9 mt -51.42 -36.44 43.71 Favored 'General case' 0 C--N 1.288 -2.108 0 CA-C-N 114.49 -1.232 . . . . 10.0 111.749 -177.67 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.406 ' O ' HD12 ' B' ' 40' ' ' LEU . 1.5 pp -123.35 12.49 9.44 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 120.605 -1.309 . . . . 10.0 111.846 -179.313 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.494 ' OE1' ' HA ' ' B' ' 41' ' ' GLN . 1.8 mm100 -91.82 -34.19 14.66 Favored 'General case' 0 C--N 1.292 -1.907 0 O-C-N 121.235 -0.916 . . . . 10.0 110.433 178.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.784 ' O ' HG23 ' B' ' 42' ' ' THR . 3.7 t -135.49 51.64 2.06 Favored 'General case' 0 C--N 1.305 -1.356 0 CA-C-O 122.33 1.062 . . . . 10.0 108.254 178.767 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.7 m -136.89 -34.93 0.72 Allowed 'General case' 0 C--N 1.291 -1.963 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 179.405 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 35.9 m120 -125.46 153.72 43.09 Favored 'General case' 0 N--CA 1.491 1.604 0 C-N-CA 119.995 -0.682 . . . . 10.0 110.366 179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.4 OUTLIER -45.89 -50.03 4.33 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.504 0 O-C-N 121.399 -0.813 . . . . 10.0 110.482 179.639 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 8.5 m . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 118.047 -0.977 . . . . 10.0 110.159 -179.568 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.611 0 CA-C-O 121.178 0.513 . . . . 10.0 110.313 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.702 HE21 HD23 ' A' ' 177' ' ' LEU . 0.0 OUTLIER -164.72 25.36 0.06 Allowed 'General case' 0 C--N 1.305 -1.339 0 O-C-N 121.163 -0.961 . . . . 10.0 109.453 -179.945 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.571 ' HA ' ' HB ' ' A' ' 52' ' ' THR . 30.2 m -89.47 127.01 35.8 Favored 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.581 -0.699 . . . . 10.0 110.303 179.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.869 HG22 ' O ' ' A' ' 52' ' ' THR . 0.0 OUTLIER -112.39 136.2 49.38 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.603 0 C-N-CA 119.281 -0.968 . . . . 10.0 110.266 178.961 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.523 ' O ' ' CG2' ' A' ' 75' ' ' THR . 6.6 mtpt -124.53 98.95 5.96 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 121.523 -0.736 . . . . 10.0 109.595 179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.6 t -82.37 99.83 9.62 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.895 -1.128 . . . . 10.0 110.764 -179.612 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.672 ' HB ' HG21 ' A' ' 75' ' ' THR . 61.7 t -134.29 144.48 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.749 0 O-C-N 121.545 -0.722 . . . . 10.0 109.442 179.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.779 HG11 ' HB3' ' B' ' 35' ' ' GLN . 94.4 t -59.67 166.04 0.65 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.834 0 O-C-N 120.986 -1.071 . . . . 10.0 110.925 -179.425 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.937 ' C ' ' HB3' ' B' ' 37' ' ' ALA . 3.4 t -112.39 -174.57 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.305 -1.339 0 O-C-N 121.426 -0.797 . . . . 10.0 109.348 179.06 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.711 ' H ' HG12 ' A' ' 9' ' ' VAL . . . -63.39 -144.22 0.02 OUTLIER Glycine 0 N--CA 1.492 2.368 0 C-N-CA 120.014 -1.089 . . . . 10.0 110.417 -179.136 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.632 ' OD2' HG23 ' A' ' 80' ' ' VAL . 5.9 m-20 62.24 -76.88 0.03 OUTLIER 'General case' 0 N--CA 1.491 1.586 0 O-C-N 121.416 -1.049 . . . . 10.0 109.951 -179.512 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.54 ' HA2' ' N ' ' B' ' 35' ' ' GLN . . . 112.14 54.16 0.49 Allowed Glycine 0 N--CA 1.49 2.274 0 N-CA-C 110.029 -1.228 . . . . 10.0 110.029 179.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.463 ' O ' ' HB ' ' A' ' 14' ' ' VAL . . . -175.94 68.51 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.66 0 O-C-N 121.127 -1.22 . . . . 10.0 110.559 179.789 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.563 HG13 ' O ' ' A' ' 14' ' ' VAL . 10.9 p -179.1 58.06 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 121.257 -0.902 . . . . 10.0 109.715 -179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.574 ' O ' HD23 ' A' ' 19' ' ' LEU . . . -103.95 88.28 0.61 Allowed Glycine 0 N--CA 1.491 2.356 0 N-CA-C 109.832 -1.307 . . . . 10.0 109.832 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.647 ' HB2' ' CE1' ' A' ' 169' ' ' PHE . 0.0 OUTLIER -56.13 -31.56 63.42 Favored 'General case' 0 C--N 1.299 -1.62 0 O-C-N 120.795 -1.415 . . . . 10.0 110.7 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.428 ' HB ' ' OD2' ' A' ' 57' ' ' ASP . 11.3 m -62.47 -41.32 98.69 Favored 'General case' 0 N--CA 1.492 1.664 0 O-C-N 121.287 -0.883 . . . . 10.0 111.481 -179.111 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.538 ' HA ' ' O ' ' B' ' 26' ' ' THR . 17.8 m -95.07 -15.47 23.4 Favored 'General case' 0 N--CA 1.487 1.392 0 O-C-N 120.748 -1.22 . . . . 10.0 110.449 -179.002 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.903 HD11 ' CB ' ' B' ' 29' ' ' PHE . 4.6 mm? -93.02 -34.79 13.57 Favored 'General case' 0 C--N 1.305 -1.365 0 O-C-N 121.145 -0.972 . . . . 10.0 109.808 179.703 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 1.6 tt -59.58 -37.18 77.82 Favored 'General case' 0 C--N 1.301 -1.532 0 N-CA-C 105.647 -1.983 . . . . 10.0 105.647 176.808 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.628 HG21 HG23 ' B' ' 26' ' ' THR 0.266 0.4 OUTLIER -63.41 -50.19 79.67 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.417 0 N-CA-C 107.328 -1.36 . . . . 10.0 107.328 176.34 . . . . . . . . 4 4 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.713 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 23.8 m -49.05 -49.72 39.99 Favored 'General case' 0 C--N 1.293 -1.885 0 N-CA-C 108.425 -0.954 . . . . 10.0 108.425 179.694 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.869 ' CD2' HD11 ' A' ' 165' ' ' LEU . 33.9 m-85 -72.96 -29.34 63.01 Favored 'General case' 0 N--CA 1.49 1.571 0 O-C-N 120.959 -1.088 . . . . 10.0 110.442 178.874 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . . . . . . . . . 52.7 m -65.32 -50.37 65.9 Favored 'General case' 0 N--CA 1.49 1.546 0 O-C-N 121.171 -0.956 . . . . 10.0 109.396 179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.522 HG23 ' N ' ' A' ' 26' ' ' ASN . 10.2 t -169.6 -41.23 0.02 OUTLIER 'General case' 0 N--CA 1.492 1.665 0 C-N-CA 119.253 -0.979 . . . . 10.0 111.095 179.216 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.709 ' CB ' HG11 ' A' ' 33' ' ' VAL . 35.8 t-20 -61.15 -20.46 62.72 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.184 -0.947 . . . . 10.0 111.473 -179.398 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.713 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.0 OUTLIER 26.13 -134.02 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.461 0 O-C-N 121.873 -0.517 . . . . 10.0 111.994 -178.908 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.773 ' CZ ' HG22 ' B' ' 30' ' ' THR . 6.1 t80 -129.53 45.59 1.82 Allowed Pre-proline 0 N--CA 1.496 1.842 0 O-C-N 121.02 -1.05 . . . . 10.0 112.924 -178.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.684 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 59.6 Cg_endo -97.11 -119.31 0.0 OUTLIER 'Trans proline' 0 CA--C 1.548 1.179 0 N-CA-C 108.777 -1.278 . . . . 10.0 108.777 178.769 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -168.87 69.79 0.07 Allowed 'General case' 0 N--CA 1.493 1.699 0 O-C-N 120.678 -1.264 . . . . 10.0 109.504 179.15 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.966 ' O ' ' HB2' ' B' ' 24' ' ' ALA . 18.0 pt-20 -138.56 -173.73 3.63 Favored 'General case' 0 C--N 1.309 -1.184 0 O-C-N 120.937 -1.102 . . . . 10.0 110.648 -179.367 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.55 ' C ' HG22 ' A' ' 33' ' ' VAL . 12.5 t80 -71.65 135.8 47.04 Favored 'General case' 0 N--CA 1.497 1.917 0 CA-C-N 115.868 -0.605 . . . . 10.0 110.991 -179.496 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.709 HG11 ' CB ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -157.52 -171.42 0.28 Allowed Pre-proline 0 N--CA 1.494 1.753 0 O-C-N 121.241 -0.912 . . . . 10.0 109.119 179.97 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.691 ' HG2' HG21 ' B' ' 26' ' ' THR . 40.1 Cg_endo -65.33 -148.63 0.02 OUTLIER 'Trans proline' 0 N--CA 1.491 1.362 0 O-C-N 122.859 0.926 . . . . 10.0 111.699 -178.483 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.436 ' C ' ' HB ' ' B' ' 26' ' ' THR . 46.7 p -128.0 162.68 26.23 Favored 'General case' 0 N--CA 1.495 1.809 0 O-C-N 120.696 -1.253 . . . . 10.0 113.47 -177.105 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.998 HG12 ' HB2' ' A' ' 59' ' ' ALA 0.256 6.9 t -70.6 -89.32 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.499 2.02 0 CA-C-N 115.296 -0.865 . . . . 10.0 110.311 178.78 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.733 ' N ' HG12 ' A' ' 36' ' ' VAL . 0.8 OUTLIER -33.45 129.42 0.28 Allowed 'General case' 0 N--CA 1.489 1.519 0 CA-C-O 121.572 0.701 . . . . 10.0 110.957 179.761 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.406 ' OD1' ' CD1' ' A' ' 40' ' ' TYR . 10.0 t70 -138.96 83.45 1.95 Allowed 'General case' 0 C--N 1.285 -2.199 0 N-CA-C 107.05 -1.463 . . . . 10.0 107.05 177.657 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.492 ' HB3' HG13 ' B' ' 18' ' ' ILE . 7.4 t-20 -88.42 98.45 11.62 Favored 'General case' 0 N--CA 1.487 1.415 0 O-C-N 121.209 -0.932 . . . . 10.0 110.511 -178.119 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.679 ' HA ' ' H ' ' B' ' 16' ' ' HIS . 19.6 m-85 -127.69 116.03 19.63 Favored 'General case' 0 C--N 1.301 -1.515 0 O-C-N 121.222 -0.923 . . . . 10.0 109.453 179.032 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.948 ' O ' HG23 ' A' ' 42' ' ' VAL . . . -133.69 100.34 4.75 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 121.05 -1.031 . . . . 10.0 111.506 -178.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.948 HG23 ' O ' ' A' ' 41' ' ' ALA . 3.1 t -167.33 -166.31 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.5 2.042 0 N-CA-C 107.427 -1.323 . . . . 10.0 107.427 -179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.681 HG23 ' O ' ' A' ' 51' ' ' TYR . 52.0 m -137.15 161.65 35.56 Favored 'General case' 0 N--CA 1.504 2.239 0 O-C-N 119.452 -2.03 . . . . 10.0 113.636 -176.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.812 HG22 ' HB2' ' A' ' 51' ' ' TYR . 0.7 OUTLIER -105.25 -176.34 0.52 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.66 0 O-C-N 121.765 -0.585 . . . . 10.0 110.59 179.788 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.607 ' O ' ' O ' ' B' ' 10' ' ' LEU . 27.5 mtp -139.74 96.56 3.09 Favored 'General case' 0 N--CA 1.49 1.55 0 C-N-CA 118.937 -1.105 . . . . 10.0 108.836 178.131 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.6 ' HA ' ' HB3' ' B' ' 10' ' ' LEU . 11.6 mt -102.43 131.88 49.64 Favored 'Isoleucine or valine' 0 N--CA 1.504 2.237 0 O-C-N 121.783 -0.573 . . . . 10.0 111.146 -178.967 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.53 ' HA2' ' CG1' ' B' ' 8' ' ' ILE . . . 38.2 27.81 0.04 OUTLIER Glycine 0 N--CA 1.495 2.62 0 N-CA-C 110.346 -1.102 . . . . 10.0 110.346 179.67 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.515 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 98.97 -16.85 58.96 Favored Glycine 0 N--CA 1.495 2.58 0 O-C-N 120.958 -1.319 . . . . 10.0 110.652 179.453 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.581 ' N ' ' O ' ' A' ' 46' ' ' ILE . 1.0 OUTLIER -101.74 108.59 56.61 Favored Pre-proline 0 N--CA 1.49 1.544 0 O-C-N 121.02 -1.283 . . . . 10.0 110.153 -179.712 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.633 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 42.8 Cg_endo -73.63 156.58 49.17 Favored 'Trans proline' 0 C--N 1.302 -1.871 0 O-C-N 124.063 1.559 . . . . 10.0 111.668 -179.451 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.812 ' HB2' HG22 ' A' ' 44' ' ' VAL . 1.9 m-85 -105.95 113.96 27.82 Favored 'General case' 0 N--CA 1.494 1.755 0 O-C-N 121.045 -1.034 . . . . 10.0 112.033 -179.413 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.869 ' O ' HG22 ' A' ' 4' ' ' ILE 0.271 98.2 m -75.82 110.07 9.95 Favored 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.32 -0.862 . . . . 10.0 109.459 178.385 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.823 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.7 pp -149.32 173.25 13.71 Favored 'General case' 0 N--CA 1.49 1.563 0 O-C-N 120.274 -1.516 . . . . 10.0 112.857 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.432 ' N ' HD12 ' A' ' 53' ' ' LEU . . . -172.54 118.02 0.69 Allowed Glycine 0 N--CA 1.49 2.254 0 N-CA-C 107.688 -2.165 . . . . 10.0 107.688 179.766 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.757 ' O ' HD12 ' A' ' 55' ' ' LEU . 4.6 pp -129.25 149.55 51.0 Favored 'General case' 0 N--CA 1.495 1.81 0 O-C-N 120.728 -1.454 . . . . 10.0 111.332 -178.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.514 ' CD2' ' C ' ' A' ' 55' ' ' LEU . 0.5 OUTLIER -172.16 129.38 0.59 Allowed 'General case' 0 N--CA 1.495 1.794 0 O-C-N 121.618 -0.676 . . . . 10.0 110.088 179.771 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.428 ' OD2' ' HB ' ' A' ' 17' ' ' THR . 1.3 m-20 -102.62 158.3 16.33 Favored 'General case' 0 N--CA 1.498 1.962 0 O-C-N 121.059 -1.026 . . . . 10.0 111.565 -179.189 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.615 ' HB ' ' CG ' ' B' ' 36' ' ' TRP . 13.9 t -43.55 147.86 0.39 Allowed 'General case' 0 N--CA 1.492 1.672 0 O-C-N 121.083 -1.011 . . . . 10.0 109.68 179.241 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.998 ' HB2' HG12 ' A' ' 36' ' ' VAL . . . 177.57 -72.6 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.639 0 O-C-N 121.446 -0.783 . . . . 10.0 112.144 -179.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.489 ' O ' ' HB2' ' A' ' 61' ' ' GLN . . . 45.38 52.62 8.59 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 108.154 -1.979 . . . . 10.0 108.154 -178.669 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.545 ' HA ' ' HA ' ' B' ' 20' ' ' VAL . 16.4 mm-40 60.77 40.56 15.91 Favored 'General case' 0 N--CA 1.491 1.589 0 O-C-N 121.679 -0.895 . . . . 10.0 109.869 -178.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.643 ' HB3' ' CE2' ' A' ' 64' ' ' TYR . 0.3 OUTLIER 174.24 -70.37 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.183 -0.948 . . . . 10.0 111.092 179.653 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.588 ' HA ' ' HA ' ' A' ' 59' ' ' ALA . 0.2 OUTLIER 169.14 44.0 0.0 OUTLIER 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.897 -1.127 . . . . 10.0 110.314 -179.618 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.643 ' CE2' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -148.94 -49.93 0.15 Allowed 'General case' 0 N--CA 1.497 1.914 0 O-C-N 121.355 -0.84 . . . . 10.0 109.598 179.38 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.536 ' HB3' ' CB ' ' A' ' 68' ' ' ARG . 0.5 OUTLIER 69.45 80.86 0.18 Allowed 'General case' 0 N--CA 1.494 1.745 0 CA-C-O 121.681 0.753 . . . . 10.0 109.825 -179.015 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.526 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 26.6 ttp180 -52.32 -26.81 13.13 Favored 'General case' 0 N--CA 1.49 1.57 0 O-C-N 121.642 -0.661 . . . . 10.0 110.371 179.829 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.547 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 0.3 OUTLIER -86.03 -0.62 56.0 Favored 'General case' 0 N--CA 1.49 1.529 0 O-C-N 121.267 -0.895 . . . . 10.0 110.276 -179.818 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.744 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER -110.85 13.24 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.972 0 N-CA-C 114.684 1.365 . . . . 10.0 114.684 -178.455 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.616 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 37.2 Cg_endo -60.99 126.64 20.07 Favored 'Trans proline' 0 C--N 1.313 -1.314 0 N-CA-C 108.613 -1.341 . . . . 10.0 108.613 -179.462 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.855 HD11 ' HA ' ' B' ' 37' ' ' ALA . 0.2 OUTLIER -113.62 -77.38 0.58 Allowed 'General case' 0 N--CA 1.491 1.581 0 O-C-N 121.255 -0.903 . . . . 10.0 111.874 -177.58 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.606 ' HA ' ' CA ' ' B' ' 40' ' ' LEU . 19.5 m 61.31 34.39 18.54 Favored 'General case' 0 C--N 1.305 -1.33 0 O-C-N 121.148 -0.97 . . . . 10.0 108.482 -178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -153.09 131.44 6.44 Favored Pre-proline 0 N--CA 1.487 1.399 0 CA-C-N 115.887 -0.597 . . . . 10.0 109.673 -179.558 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . . . . . . . . . 46.3 Cg_endo -74.31 79.85 2.35 Favored 'Trans proline' 0 C--N 1.303 -1.826 0 O-C-N 123.719 1.378 . . . . 10.0 110.03 179.634 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.53 ' NE2' ' O ' ' A' ' 74' ' ' GLN . 0.0 OUTLIER -131.06 60.7 1.65 Allowed 'General case' 0 N--CA 1.491 1.578 0 O-C-N 121.329 -0.857 . . . . 10.0 110.242 -179.399 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.672 HG21 ' HB ' ' A' ' 7' ' ' VAL . 9.9 m -144.47 96.91 2.95 Favored 'General case' 0 C--N 1.301 -1.502 0 O-C-N 121.143 -0.973 . . . . 10.0 109.435 179.174 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.469 ' O ' ' OG1' ' A' ' 108' ' ' THR . 84.8 m-20 -38.52 -27.86 0.02 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 O-C-N 121.947 -0.47 . . . . 10.0 111.198 -179.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.797 HG11 ' HB2' ' A' ' 176' ' ' ALA . 17.7 m -130.38 116.73 37.04 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.656 0 O-C-N 120.717 -1.239 . . . . 10.0 110.922 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.621 ' CZ ' ' HB ' ' A' ' 75' ' ' THR . 38.4 m-85 -109.2 130.87 55.48 Favored 'General case' 0 N--CA 1.488 1.471 0 O-C-N 121.477 -0.764 . . . . 10.0 108.997 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.906 HD12 ' CE1' ' A' ' 169' ' ' PHE . 2.5 mm? -103.21 96.94 7.11 Favored 'General case' 0 C--N 1.302 -1.49 0 O-C-N 120.954 -1.091 . . . . 10.0 109.08 179.467 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.632 HG23 ' OD2' ' A' ' 11' ' ' ASP . 14.8 p -108.8 143.7 18.6 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.778 0 O-C-N 121.662 -0.649 . . . . 10.0 109.264 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.458 ' C ' ' OG1' ' A' ' 115' ' ' THR . 53.7 t -133.75 129.71 37.05 Favored 'General case' 0 C--N 1.296 -1.739 0 C-N-CA 119.259 -0.976 . . . . 10.0 110.569 -178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.482 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 24.2 p90 -137.15 178.0 7.43 Favored 'General case' 0 N--CA 1.499 2.005 0 O-C-N 121.387 -0.82 . . . . 10.0 110.918 179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 80.7 p -76.68 162.54 27.64 Favored 'General case' 0 N--CA 1.5 2.07 0 O-C-N 121.126 -0.984 . . . . 10.0 111.556 -178.463 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.963 HG23 HG13 ' A' ' 85' ' ' VAL . 28.4 m -112.96 -1.5 9.84 Favored 'Isoleucine or valine' 0 C--N 1.308 -1.222 0 O-C-N 121.325 -0.86 . . . . 10.0 111.69 -178.733 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.963 HG13 HG23 ' A' ' 84' ' ' VAL . 14.5 m -128.88 38.05 0.95 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.731 0 O-C-N 120.849 -1.157 . . . . 10.0 111.468 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.556 ' N ' HD23 ' A' ' 129' ' ' LEU . 59.8 m -95.97 149.23 35.71 Favored Pre-proline 0 N--CA 1.49 1.533 0 O-C-N 121.057 -1.027 . . . . 10.0 108.964 178.69 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.492 ' HB3' ' CB ' ' A' ' 132' ' ' ASN . 41.0 Cg_endo -67.49 113.04 2.78 Favored 'Trans proline' 0 C--N 1.305 -1.742 0 O-C-N 123.632 1.333 . . . . 10.0 110.382 -179.277 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 41.5 m 54.5 64.13 1.92 Allowed 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.317 -0.865 . . . . 10.0 109.987 -179.905 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.538 ' CB ' ' HB2' ' A' ' 86' ' ' SER . 22.1 p -116.55 -60.55 1.84 Allowed 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.07 -1.019 . . . . 10.0 110.949 -179.393 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.634 ' CE1' ' NZ ' ' A' ' 94' ' ' LYS . 9.4 t80 -59.96 -38.87 83.75 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.011 -1.055 . . . . 10.0 110.817 -179.351 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 3.1 mt-10 -66.48 -17.63 64.9 Favored 'General case' 0 C--N 1.299 -1.613 0 O-C-N 120.844 -1.16 . . . . 10.0 110.383 -179.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.589 ' ND2' HG13 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -77.62 -21.62 52.01 Favored 'General case' 0 N--CA 1.489 1.517 0 O-C-N 121.097 -1.002 . . . . 10.0 110.353 -179.872 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.589 HG13 ' ND2' ' A' ' 92' ' ' ASN . 2.2 m -89.72 -5.09 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.769 0 C-N-CA 118.591 -1.243 . . . . 10.0 109.414 179.074 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.634 ' NZ ' ' CE1' ' A' ' 90' ' ' PHE . 12.9 mmtt -94.49 -32.72 13.38 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.137 -0.977 . . . . 10.0 108.391 178.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.52 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 3.6 pt-20 -77.64 -10.85 59.74 Favored 'General case' 0 C--N 1.296 -1.757 0 C-N-CA 120.021 -0.672 . . . . 10.0 109.221 178.763 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . . . . . . . . . 2.7 tttt -112.35 -50.53 2.89 Favored 'General case' 0 N--CA 1.487 1.397 0 O-C-N 121.17 -0.956 . . . . 10.0 111.852 -179.286 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.492 ' HB2' ' O ' ' A' ' 93' ' ' VAL . 60.6 m95 -69.39 -47.11 65.21 Favored 'General case' 0 N--CA 1.495 1.782 0 O-C-N 121.564 -0.71 . . . . 10.0 112.256 -178.008 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.606 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 98.9 t -55.93 -49.28 93.92 Favored Pre-proline 0 N--CA 1.49 1.574 0 O-C-N 120.49 -1.381 . . . . 10.0 110.331 -179.505 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.606 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 45.4 Cg_endo -72.86 -12.92 26.55 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.257 1.135 . . . . 10.0 110.643 179.604 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.49 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 0.6 OUTLIER -68.69 -36.68 78.81 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.858 -1.152 . . . . 10.0 110.601 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.706 HG23 ' HA ' ' A' ' 104' ' ' HIS . 78.6 mt 55.11 85.65 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.487 1.391 0 C-N-CA 119.146 -1.022 . . . . 10.0 109.206 -179.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.691 HG22 ' N ' ' A' ' 103' ' ' HIS . 1.9 m -39.37 -81.28 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.578 0 CA-C-O 121.681 0.753 . . . . 10.0 110.114 -179.307 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.691 ' N ' HG22 ' A' ' 102' ' ' THR . 6.0 m170 -109.87 -2.98 16.91 Favored 'General case' 0 C--N 1.294 -1.827 0 O-C-N 121.5 -0.75 . . . . 10.0 109.859 179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.706 ' HA ' HG23 ' A' ' 101' ' ' ILE . 66.2 t60 80.37 16.03 0.71 Allowed 'General case' 0 N--CA 1.5 2.026 0 CA-C-O 121.622 0.725 . . . . 10.0 109.494 -179.363 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.603 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 0.8 OUTLIER -150.76 -65.81 0.02 OUTLIER Pre-proline 0 C--N 1.301 -1.512 0 C-N-CA 119.808 -0.757 . . . . 10.0 111.44 -179.068 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.603 ' CD ' ' CB ' ' A' ' 105' ' ' CYS . 41.6 Cg_endo -68.81 -31.3 25.5 Favored 'Trans proline' 0 C--N 1.311 -1.435 0 O-C-N 123.51 1.268 . . . . 10.0 111.892 -179.203 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.567 ' CG ' ' O ' ' A' ' 106' ' ' PRO . 0.2 OUTLIER 42.31 63.12 1.47 Allowed 'General case' 0 N--CA 1.491 1.587 0 CA-C-O 122.367 1.079 . . . . 10.0 108.485 -178.169 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.469 ' OG1' ' O ' ' A' ' 76' ' ' ASP . 8.7 t -44.91 141.46 3.03 Favored Pre-proline 0 N--CA 1.493 1.722 0 CA-C-N 115.393 -0.821 . . . . 10.0 110.674 -179.331 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.461 ' HD2' ' O ' ' A' ' 76' ' ' ASP . 43.1 Cg_endo -69.99 163.39 38.65 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 O-C-N 124.286 1.677 . . . . 10.0 112.068 -178.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.433 ' O ' HG12 ' A' ' 152' ' ' VAL . 86.5 m-85 -127.13 114.69 18.04 Favored 'General case' 0 C--N 1.306 -1.285 0 O-C-N 121.698 -0.626 . . . . 10.0 109.701 179.294 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.027 HD13 ' CG1' ' A' ' 152' ' ' VAL . 3.1 mm? -73.95 92.59 2.12 Favored 'General case' 0 C--N 1.289 -2.049 0 N-CA-C 106.553 -1.647 . . . . 10.0 106.553 178.175 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.558 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 15.8 mt -69.33 139.33 54.24 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.732 -0.605 . . . . 10.0 109.372 -179.457 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.611 HG12 ' H ' ' A' ' 114' ' ' GLY . 2.0 t -144.98 -179.25 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.798 0 O-C-N 120.965 -1.085 . . . . 10.0 111.41 -178.526 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.611 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -118.49 125.14 6.3 Favored Glycine 0 N--CA 1.492 2.431 0 N-CA-C 108.796 -1.721 . . . . 10.0 108.796 179.009 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.681 HG22 ' HG2' ' A' ' 116' ' ' GLN . 52.9 m -92.42 140.83 29.18 Favored 'General case' 0 N--CA 1.501 2.1 0 O-C-N 120.971 -1.311 . . . . 10.0 111.36 -178.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.681 ' HG2' HG22 ' A' ' 115' ' ' THR . 6.9 mm100 40.14 57.44 2.4 Favored 'General case' 0 N--CA 1.494 1.753 0 C-N-CA 120.196 -0.602 . . . . 10.0 109.754 179.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.008 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.2 OUTLIER -76.87 -29.21 17.53 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.738 0 C-N-CA 119.29 -0.964 . . . . 10.0 110.103 -179.006 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.839 ' O ' HD23 ' A' ' 119' ' ' LEU . 44.2 t0 -51.73 57.98 0.0 OUTLIER 'General case' 0 N--CA 1.504 2.243 0 CA-C-O 121.459 0.647 . . . . 10.0 111.85 -176.458 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 118' ' ' ASP . 0.7 OUTLIER 147.33 -30.46 0.01 OUTLIER 'General case' 0 N--CA 1.508 2.445 0 CA-C-N 114.858 -1.064 . . . . 10.0 108.572 179.457 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.694 ' HG3' HG22 ' A' ' 85' ' ' VAL . 15.2 tpp180 -55.51 -31.35 61.99 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.778 -0.577 . . . . 10.0 110.315 -179.951 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 11.8 p-10 -86.88 4.93 39.31 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.414 -0.804 . . . . 10.0 111.044 -179.444 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.825 ' O ' HD13 ' A' ' 126' ' ' ILE . 0.8 OUTLIER -82.29 165.74 40.86 Favored Pre-proline 0 N--CA 1.492 1.667 0 O-C-N 121.116 -0.99 . . . . 10.0 110.403 179.807 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.434 ' HD2' ' HB3' ' A' ' 122' ' ' ASP . 54.9 Cg_endo -79.2 23.38 0.64 Allowed 'Trans proline' 0 C--N 1.306 -1.693 0 O-C-N 124.074 1.565 . . . . 10.0 111.086 179.698 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . . . . . . . . . 47.4 t -108.45 -50.14 3.07 Favored 'General case' 0 N--CA 1.491 1.607 0 O-C-N 120.92 -1.112 . . . . 10.0 110.278 -179.448 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.66 HG21 ' HA ' ' A' ' 120' ' ' ARG . 14.5 t -79.06 -28.09 43.14 Favored 'General case' 0 C--N 1.293 -1.854 0 N-CA-C 105.779 -1.934 . . . . 10.0 105.779 177.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.825 HD13 ' O ' ' A' ' 122' ' ' ASP 0.289 1.4 mp -59.82 -22.59 24.25 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 N-CA-C 107.439 -1.319 . . . . 10.0 107.439 177.102 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.408 ' O ' ' HE3' ' A' ' 131' ' ' LYS . 20.1 tt0 -48.89 -33.66 11.17 Favored 'General case' 0 N--CA 1.488 1.436 0 CA-C-O 121.49 0.662 . . . . 10.0 109.864 179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -89.36 -49.05 6.94 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.661 -0.649 . . . . 10.0 110.775 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.836 HD23 ' C ' ' A' ' 85' ' ' VAL . 1.3 tm? -49.87 -50.48 45.65 Favored 'General case' 0 N--CA 1.49 1.525 0 O-C-N 121.316 -0.865 . . . . 10.0 110.963 -179.348 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.647 ' HA ' ' HA ' ' A' ' 134' ' ' GLN . . . -55.82 -49.94 71.87 Favored 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.201 -0.937 . . . . 10.0 109.282 -179.996 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.408 ' HE3' ' O ' ' A' ' 127' ' ' GLU . 17.9 mttt -60.01 -22.49 62.67 Favored 'General case' 0 C--N 1.302 -1.485 0 O-C-N 121.612 -0.68 . . . . 10.0 110.027 179.251 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.492 ' CB ' ' HB3' ' A' ' 87' ' ' PRO . 23.0 t-20 -99.68 -62.46 1.23 Allowed 'General case' 0 N--CA 1.489 1.479 0 O-C-N 120.934 -1.104 . . . . 10.0 111.337 -178.923 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.558 ' O ' ' HB2' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -109.69 -0.36 18.59 Favored 'General case' 0 C--N 1.297 -1.714 0 O-C-N 121.365 -0.835 . . . . 10.0 111.494 -178.913 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.647 ' HA ' ' HA ' ' A' ' 130' ' ' ALA . 0.6 OUTLIER 64.13 -44.52 0.28 Allowed 'General case' 0 N--CA 1.497 1.925 0 O-C-N 121.568 -0.707 . . . . 10.0 112.334 179.291 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.531 ' HD2' ' CB ' ' A' ' 134' ' ' GLN . 0.2 OUTLIER -113.99 128.71 25.49 Favored Pre-proline 0 C--N 1.299 -1.605 0 O-C-N 120.94 -1.1 . . . . 10.0 111.087 -179.344 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -72.1 161.65 44.07 Favored 'Trans proline' 0 C--N 1.309 -1.549 0 O-C-N 123.877 1.462 . . . . 10.0 110.527 179.201 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.834 HG22 ' O ' ' A' ' 84' ' ' VAL . 4.1 tp -95.36 133.19 37.22 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.686 0 O-C-N 120.921 -1.112 . . . . 10.0 109.506 179.053 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.627 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 10.6 p -123.8 179.17 1.12 Allowed Pre-proline 0 N--CA 1.49 1.558 0 O-C-N 121.245 -0.91 . . . . 10.0 109.399 -179.265 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.627 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 44.2 Cg_endo -73.52 -26.64 13.84 Favored 'Trans proline' 0 C--N 1.313 -1.311 0 O-C-N 123.228 1.12 . . . . 10.0 110.421 -178.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 44.8 mm-40 -66.87 -47.9 70.43 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.312 -0.868 . . . . 10.0 110.413 179.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 42.1 m -74.65 -39.75 61.88 Favored 'General case' 0 N--CA 1.494 1.748 0 O-C-N 121.504 -0.747 . . . . 10.0 110.556 179.977 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.593 ' CB ' ' CD2' ' A' ' 154' ' ' TYR . . . -68.51 -35.67 77.81 Favored 'General case' 0 N--CA 1.493 1.7 0 O-C-N 121.262 -0.899 . . . . 10.0 110.663 -179.579 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.433 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 0.4 OUTLIER -51.41 -39.74 57.89 Favored 'General case' 0 C--N 1.298 -1.649 0 O-C-N 121.351 -0.843 . . . . 10.0 109.955 179.941 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.63 -49.21 78.46 Favored 'General case' 0 N--CA 1.487 1.409 0 O-C-N 121.333 -0.854 . . . . 10.0 110.422 179.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.532 ' CD2' HD22 ' A' ' 149' ' ' LEU . 7.7 tt -58.61 -33.17 69.71 Favored 'General case' 0 C--N 1.306 -1.315 0 O-C-N 121.013 -1.055 . . . . 10.0 109.644 -180.0 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.836 ' HA ' ' HB3' ' A' ' 151' ' ' ALA . . . -71.32 -48.18 52.03 Favored 'General case' 0 C--N 1.302 -1.478 0 CA-C-O 121.889 0.852 . . . . 10.0 109.471 179.409 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 29.8 tpt180 -63.46 -26.92 68.95 Favored 'General case' 0 C--N 1.296 -1.737 0 C-N-CA 120.303 -0.559 . . . . 10.0 110.137 179.86 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.473 ' HB3' HD13 ' A' ' 149' ' ' LEU . 20.4 t0 -79.61 -40.25 29.74 Favored 'General case' 0 N--CA 1.49 1.568 0 O-C-N 121.133 -0.98 . . . . 10.0 110.659 -179.559 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.688 ' N ' ' CD1' ' A' ' 149' ' ' LEU . 1.3 mp -91.47 20.83 4.98 Favored 'General case' 0 N--CA 1.497 1.89 0 O-C-N 121.092 -1.005 . . . . 10.0 109.125 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.462 ' HD3' ' HD2' ' A' ' 107' ' ' LYS . 4.8 mtpt 57.03 20.6 5.57 Favored 'General case' 0 C--N 1.295 -1.801 0 CA-C-O 121.935 0.874 . . . . 10.0 109.41 -179.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.836 ' HB3' ' HA ' ' A' ' 146' ' ' ALA . . . -69.36 -174.36 0.66 Allowed 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.663 -0.865 . . . . 10.0 108.663 178.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.027 ' CG1' HD13 ' A' ' 111' ' ' LEU . 7.2 p -91.59 -72.98 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 120.826 -1.172 . . . . 10.0 111.578 -179.427 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.915 ' H ' HG13 ' A' ' 152' ' ' VAL . 5.4 tttt -173.86 173.46 3.25 Favored 'General case' 0 N--CA 1.492 1.637 0 O-C-N 120.217 -1.552 . . . . 10.0 110.909 179.878 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.934 ' OH ' HG12 ' A' ' 84' ' ' VAL . 18.6 t80 -112.26 104.44 12.62 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 121.351 -0.843 . . . . 10.0 109.448 178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.835 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.9 OUTLIER -109.17 -168.93 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.622 0 O-C-N 121.363 -0.835 . . . . 10.0 110.405 -179.09 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.516 ' H ' HG12 ' A' ' 155' ' ' VAL . 67.3 mt-10 -152.51 135.57 15.66 Favored 'General case' 0 N--CA 1.492 1.658 0 O-C-N 120.784 -1.198 . . . . 10.0 111.164 -179.084 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.505 ' SG ' HG11 ' A' ' 113' ' ' VAL . 28.1 p -152.4 172.74 16.03 Favored 'General case' 0 N--CA 1.489 1.517 0 CA-C-O 121.722 0.773 . . . . 10.0 109.563 179.36 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.584 ' HB3' ' CB ' ' A' ' 162' ' ' GLN . 34.0 t -140.9 175.17 9.83 Favored 'General case' 0 C--N 1.293 -1.851 0 N-CA-C 108.928 -0.767 . . . . 10.0 108.928 -179.464 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.871 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -73.22 -54.62 7.98 Favored 'General case' 0 C--N 1.296 -1.747 0 O-C-N 121.409 -0.807 . . . . 10.0 111.97 -178.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 1.131 HD13 ' N ' ' A' ' 161' ' ' THR . 0.0 OUTLIER -129.23 -22.54 3.1 Favored 'General case' 0 N--CA 1.495 1.79 0 O-C-N 120.736 -1.227 . . . . 10.0 113.39 -178.017 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 1.131 ' N ' HD13 ' A' ' 160' ' ' LEU . 10.0 t -90.47 -51.87 5.19 Favored 'General case' 0 N--CA 1.505 2.304 0 O-C-N 120.312 -1.492 . . . . 10.0 113.637 -177.656 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.602 ' N ' HG23 ' A' ' 161' ' ' THR . 6.7 tp60 -59.76 -63.21 1.38 Allowed 'General case' 0 N--CA 1.499 1.995 0 O-C-N 120.308 -1.495 . . . . 10.0 111.696 -177.83 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.592 ' HB2' ' CE1' ' A' ' 23' ' ' TYR . 28.4 ttpt 79.47 34.67 0.18 Allowed 'General case' 0 N--CA 1.503 2.193 0 CA-C-O 121.513 0.673 . . . . 10.0 109.383 -178.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.45 ' O ' HG23 ' A' ' 168' ' ' VAL . . . -118.19 20.64 10.45 Favored Glycine 0 N--CA 1.488 2.141 0 N-CA-C 108.886 -1.686 . . . . 10.0 108.886 179.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.869 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -78.04 4.96 10.94 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 121.345 -1.091 . . . . 10.0 110.652 179.982 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 6.3 ttpt -93.78 -44.15 8.27 Favored 'General case' 0 N--CA 1.495 1.778 0 O-C-N 121.037 -1.039 . . . . 10.0 110.085 178.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 18.3 m120 -64.44 -31.44 72.65 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 121.045 -1.034 . . . . 10.0 110.142 179.847 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.835 HG22 ' HB ' ' A' ' 155' ' ' VAL . 14.5 t -65.09 -49.23 80.44 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.27 -0.894 . . . . 10.0 110.373 -179.943 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.906 ' CE1' HD12 ' A' ' 79' ' ' LEU . 9.0 m-85 -76.82 -23.65 52.76 Favored 'General case' 0 N--CA 1.494 1.754 0 O-C-N 121.389 -0.82 . . . . 10.0 111.302 -179.541 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . . . . . . . . . 22.1 t0 -67.37 -50.3 60.34 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 120.896 -1.127 . . . . 10.0 111.766 -178.709 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.444 ' OE2' ' HB3' ' A' ' 153' ' ' LYS . 20.0 pt-20 -61.23 -24.59 66.46 Favored 'General case' 0 N--CA 1.492 1.631 0 O-C-N 120.807 -1.183 . . . . 10.0 109.825 -179.605 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.654 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -67.53 -26.54 66.37 Favored 'General case' 0 C--N 1.303 -1.449 0 C-N-CA 119.244 -0.982 . . . . 10.0 109.045 178.882 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.538 ' O ' HD11 ' A' ' 177' ' ' LEU . 34.2 mm -60.18 -45.54 95.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.418 0 O-C-N 121.326 -0.859 . . . . 10.0 110.179 179.917 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.855 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -74.36 -38.14 63.28 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.111 -0.993 . . . . 10.0 109.642 179.757 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -78.56 -6.59 55.95 Favored 'General case' 0 C--N 1.301 -1.51 0 O-C-N 121.489 -0.757 . . . . 10.0 109.712 179.408 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.797 ' HB2' HG11 ' A' ' 77' ' ' VAL . . . -77.76 -38.15 47.49 Favored 'General case' 0 N--CA 1.492 1.634 0 O-C-N 121.329 -0.857 . . . . 10.0 110.351 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.702 HD23 HE21 ' A' ' 2' ' ' GLN . 0.4 OUTLIER -76.51 -34.79 58.6 Favored 'General case' 0 N--CA 1.493 1.723 0 O-C-N 121.568 -0.707 . . . . 10.0 110.286 -178.676 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 1.8 mt-10 . . . . . 0 N--CA 1.492 1.643 0 CA-C-O 117.893 -1.051 . . . . 10.0 110.159 179.884 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.54 ' CA ' ' HB3' ' A' ' 2' ' ' GLN . . . . . . . . 0 N--CA 1.491 2.324 0 N-CA-C 108.977 -1.649 . . . . 10.0 108.977 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.506 ' O ' ' N ' ' B' ' 4' ' ' GLU . 13.8 m -111.3 44.9 1.25 Allowed 'General case' 0 N--CA 1.489 1.521 0 O-C-N 121.31 -1.112 . . . . 10.0 111.211 -179.062 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.17 89.08 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 120.992 -1.067 . . . . 10.0 109.305 179.054 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.603 ' HB3' ' HD2' ' B' ' 6' ' ' PRO . 2.2 mm-40 -92.16 144.48 25.38 Favored 'General case' 0 N--CA 1.488 1.453 0 O-C-N 120.856 -1.152 . . . . 10.0 110.116 -179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.32 -41.74 14.36 Favored Pre-proline 0 C--N 1.292 -1.909 0 O-C-N 121.724 -0.61 . . . . 10.0 110.645 178.958 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.622 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 43.3 Cg_endo -89.39 57.78 2.01 Favored 'Trans proline' 0 C--N 1.31 -1.45 0 O-C-N 123.746 1.393 . . . . 10.0 112.418 -177.145 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.451 ' HB2' ' HA3' ' A' ' 47' ' ' GLY . 0.5 OUTLIER -97.78 160.72 14.14 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 120.69 -1.256 . . . . 10.0 108.327 177.687 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.53 ' CG1' ' HA2' ' A' ' 47' ' ' GLY . 5.8 pt -80.39 -117.19 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.3 -1.581 0 O-C-N 120.879 -1.138 . . . . 10.0 109.376 179.701 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . . . . . . . . . 42.9 t -147.58 104.05 3.59 Favored 'General case' 0 C--N 1.304 -1.412 0 O-C-N 120.69 -1.256 . . . . 10.0 109.628 179.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.607 ' O ' ' O ' ' A' ' 45' ' ' MET . 14.2 tp -143.65 97.13 5.52 Favored Pre-proline 0 C--N 1.304 -1.395 0 C-N-CA 118.957 -1.097 . . . . 10.0 112.092 -179.781 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -101.37 98.37 0.04 OUTLIER 'Trans proline' 0 C--N 1.304 -1.788 0 C-N-CA 122.166 1.911 . . . . 10.0 108.685 177.363 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.678 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 2.4 m -148.5 99.59 3.03 Favored 'General case' 0 N--CA 1.491 1.621 0 O-C-N 120.248 -1.532 . . . . 10.0 112.895 -179.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.768 ' HB3' ' CA ' ' A' ' 44' ' ' VAL . 5.0 p-10 -143.17 153.44 42.87 Favored 'General case' 0 N--CA 1.49 1.547 0 CA-C-O 121.984 0.897 . . . . 10.0 112.153 178.623 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.742 ' O ' ' HB ' ' A' ' 42' ' ' VAL . 53.6 m-85 -110.37 -172.25 2.0 Allowed 'General case' 0 C--N 1.296 -1.744 0 N-CA-C 107.387 -1.338 . . . . 10.0 107.387 176.234 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.694 ' HG3' ' HB ' ' A' ' 42' ' ' VAL . 0.9 OUTLIER -174.88 -170.5 0.47 Allowed 'General case' 0 N--CA 1.493 1.706 0 O-C-N 121.178 -0.951 . . . . 10.0 110.562 178.575 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.679 ' H ' ' HA ' ' A' ' 40' ' ' TYR . 22.8 m170 -104.52 168.98 8.73 Favored 'General case' 0 C--N 1.295 -1.779 0 N-CA-C 109.254 -0.647 . . . . 10.0 109.254 178.784 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.427 ' HA ' ' CE1' ' A' ' 40' ' ' TYR . 6.7 t -151.5 146.22 25.74 Favored 'General case' 0 N--CA 1.493 1.685 0 O-C-N 120.583 -1.323 . . . . 10.0 111.805 -179.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.695 HD13 ' CG ' ' A' ' 37' ' ' PHE . 1.6 pp -149.18 179.65 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.554 0 N-CA-C 108.358 -0.979 . . . . 10.0 108.358 178.792 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . . . . . . . . . 28.8 m-70 -134.5 159.27 41.67 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 120.578 -1.326 . . . . 10.0 112.496 -178.427 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.93 HG21 ' HB ' ' A' ' 36' ' ' VAL . 54.2 t -104.74 153.34 6.55 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.809 0 CA-C-O 121.564 0.697 . . . . 10.0 112.394 -178.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . . . . . . . . . . . -106.5 63.95 0.29 Allowed Glycine 0 N--CA 1.488 2.108 0 N-CA-C 108.661 -1.776 . . . . 10.0 108.661 179.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.83 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.3 OUTLIER -170.57 100.74 0.25 Allowed 'General case' 0 C--N 1.303 -1.443 0 O-C-N 121.452 -1.028 . . . . 10.0 109.371 -179.553 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.581 ' O ' HG23 ' B' ' 25' ' ' VAL . 11.9 t70 -53.09 150.07 6.15 Favored 'General case' 0 N--CA 1.494 1.772 0 CA-C-O 121.822 0.82 . . . . 10.0 111.968 -178.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.966 ' HB2' ' O ' ' A' ' 31' ' ' GLU . . . 39.21 51.31 2.02 Favored 'General case' 0 N--CA 1.496 1.834 0 O-C-N 121.865 -0.522 . . . . 10.0 112.254 179.394 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.904 HG12 ' CG2' ' A' ' 36' ' ' VAL . 38.9 t -111.77 -25.45 3.49 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.72 0 O-C-N 120.784 -1.198 . . . . 10.0 108.487 178.445 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.691 HG21 ' HG2' ' A' ' 34' ' ' PRO . 11.3 t -70.64 -20.66 62.71 Favored 'General case' 0 C--N 1.303 -1.438 0 N-CA-C 108.743 -0.836 . . . . 10.0 108.743 178.396 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.539 ' O ' ' O ' ' A' ' 27' ' ' LYS . . . -123.29 53.45 0.74 Allowed Glycine 0 N--CA 1.491 2.342 0 N-CA-C 106.902 -2.479 . . . . 10.0 106.902 178.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -138.25 58.02 1.69 Allowed 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.681 -0.893 . . . . 10.0 110.16 -178.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.903 ' CB ' HD11 ' A' ' 19' ' ' LEU . 20.4 t80 -85.78 133.17 34.0 Favored 'General case' 0 C--N 1.287 -2.127 0 CA-C-O 122.059 0.933 . . . . 10.0 110.153 179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.773 HG22 ' CZ ' ' A' ' 28' ' ' PHE . 19.2 p -146.9 -178.83 6.4 Favored 'General case' 0 C--N 1.29 -2.01 0 N-CA-C 108.687 -0.857 . . . . 10.0 108.687 -179.79 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -63.08 81.13 0.04 OUTLIER Glycine 0 N--CA 1.494 2.556 0 N-CA-C 108.59 -1.804 . . . . 10.0 108.59 179.283 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.7 HG23 ' HD2' ' B' ' 33' ' ' PRO . 90.2 mt -111.67 145.5 32.78 Favored Pre-proline 0 N--CA 1.492 1.638 0 O-C-N 121.366 -1.079 . . . . 10.0 111.474 -178.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.7 ' HD2' HG23 ' B' ' 32' ' ' ILE . 42.0 Cg_endo -69.91 178.59 4.51 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 121.933 1.755 . . . . 10.0 110.462 179.19 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.532 ' HG3' ' HB3' ' B' ' 38' ' ' ARG . 34.3 tt0 -8.0 131.07 0.0 OUTLIER 'General case' 0 N--CA 1.508 2.455 0 N-CA-C 113.518 0.932 . . . . 10.0 113.518 -179.285 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.779 ' HB3' HG11 ' A' ' 8' ' ' VAL . 0.1 OUTLIER -83.4 -70.52 0.56 Allowed 'General case' 0 C--N 1.304 -1.391 0 CA-C-O 121.641 0.734 . . . . 10.0 109.862 178.289 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.694 ' O ' HD12 ' B' ' 39' ' ' LEU . 0.2 OUTLIER -172.99 24.64 0.01 OUTLIER 'General case' 0 C--N 1.301 -1.522 0 C-N-CA 119.912 -0.715 . . . . 10.0 111.58 179.904 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.937 ' HB3' ' C ' ' A' ' 9' ' ' VAL . . . -127.36 -28.62 2.79 Favored 'General case' 0 C--N 1.295 -1.803 0 O-C-N 121.495 -0.753 . . . . 10.0 109.552 178.62 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.532 ' HB3' ' HG3' ' B' ' 34' ' ' GLU . 0.0 OUTLIER -56.88 -14.8 3.8 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 107.566 -1.272 . . . . 10.0 107.566 177.621 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.694 HD12 ' O ' ' B' ' 36' ' ' TRP . 23.7 mt -40.03 -25.74 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.327 0 O-C-N 121.897 -0.502 . . . . 10.0 110.982 178.909 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.606 ' CA ' ' HA ' ' A' ' 71' ' ' SER . 2.2 pp -93.1 11.76 26.55 Favored 'General case' 0 N--CA 1.495 1.814 0 O-C-N 121.077 -1.014 . . . . 10.0 111.295 -178.693 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.451 ' N ' ' O ' ' B' ' 38' ' ' ARG . 3.0 mt-30 -137.71 -92.05 0.22 Allowed 'General case' 0 C--N 1.291 -1.973 0 O-C-N 121.568 -0.707 . . . . 10.0 109.146 178.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.458 ' OG1' ' NH1' ' B' ' 38' ' ' ARG . 60.9 p -135.82 169.97 16.72 Favored 'General case' 0 C--N 1.301 -1.531 0 O-C-N 121.377 -0.827 . . . . 10.0 109.682 179.061 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.49 ' HA ' ' OE1' ' B' ' 34' ' ' GLU . 88.2 p -86.57 18.88 3.09 Favored 'General case' 0 N--CA 1.488 1.47 0 O-C-N 121.136 -0.977 . . . . 10.0 110.538 179.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -157.99 166.9 31.4 Favored 'General case' 0 N--CA 1.497 1.922 0 O-C-N 121.019 -1.051 . . . . 10.0 110.595 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . 0.488 HD12 ' H ' ' B' ' 45' ' ' ILE . 2.9 mp -87.02 -52.83 11.21 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.764 0 O-C-N 121.208 -0.932 . . . . 10.0 109.631 179.593 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 33.6 p . . . . . 0 N--CA 1.49 1.56 0 CA-C-O 118.042 -0.98 . . . . 10.0 110.524 -179.874 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.509 ' O ' ' HB2' ' A' ' 2' ' ' GLN . 0.0 OUTLIER . . . . . 0 N--CA 1.49 1.569 0 CA-C-O 121.11 0.481 . . . . 10.0 109.91 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.904 ' O ' HG21 ' A' ' 52' ' ' THR . 0.0 OUTLIER 68.7 79.17 0.21 Allowed 'General case' 0 N--CA 1.485 1.277 0 CA-C-O 121.891 0.853 . . . . 10.0 109.278 179.93 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.845 HG22 ' O ' ' A' ' 3' ' ' THR . 1.2 m -175.95 78.56 0.02 OUTLIER 'General case' 0 C--N 1.298 -1.636 0 N-CA-C 108.292 -1.003 . . . . 10.0 108.292 -179.31 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.984 HD13 ' CB ' ' A' ' 176' ' ' ALA . 0.2 OUTLIER -115.24 121.51 67.29 Favored 'Isoleucine or valine' 0 C--N 1.295 -1.777 0 O-C-N 120.764 -1.21 . . . . 10.0 110.615 -178.853 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 1.082 ' O ' HG23 ' A' ' 75' ' ' THR . 62.0 mttt -128.93 112.66 14.31 Favored 'General case' 0 C--N 1.3 -1.552 0 N-CA-C 107.808 -1.182 . . . . 10.0 107.808 178.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.488 ' SG ' ' HB2' ' A' ' 55' ' ' LEU . 26.4 p -94.67 141.29 28.78 Favored 'General case' 0 N--CA 1.488 1.457 0 C-N-CA 119.058 -1.057 . . . . 10.0 110.444 -178.887 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.608 ' O ' HG23 ' A' ' 9' ' ' VAL . 57.9 t -144.72 152.26 15.16 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.595 0 O-C-N 121.565 -0.709 . . . . 10.0 109.224 179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.846 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 35.0 m -65.84 102.37 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.467 0 O-C-N 121.204 -0.935 . . . . 10.0 111.309 -179.068 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.615 HG21 ' HB3' ' A' ' 78' ' ' PHE . 21.3 t -109.53 177.76 1.21 Allowed 'Isoleucine or valine' 0 N--CA 1.487 1.414 0 O-C-N 121.213 -0.93 . . . . 10.0 109.143 179.243 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.777 ' HA2' HG23 ' A' ' 80' ' ' VAL . . . 151.74 166.99 14.51 Favored Glycine 0 N--CA 1.489 2.229 0 C-N-CA 119.502 -1.332 . . . . 10.0 110.062 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 19.1 p-10 -47.79 -27.63 2.14 Favored 'General case' 0 N--CA 1.488 1.432 0 O-C-N 121.304 -1.116 . . . . 10.0 109.856 179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.618 ' HA2' ' HA ' ' B' ' 34' ' ' GLU . . . 140.83 43.72 0.06 OUTLIER Glycine 0 N--CA 1.49 2.248 0 N-CA-C 109.699 -1.36 . . . . 10.0 109.699 179.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -96.8 -114.09 0.13 Allowed 'General case' 0 N--CA 1.488 1.461 0 O-C-N 121.343 -1.092 . . . . 10.0 109.687 179.613 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.825 HG21 ' H ' ' B' ' 30' ' ' THR . 80.0 t -113.89 -92.95 0.12 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.629 0 O-C-N 120.736 -1.227 . . . . 10.0 110.657 -179.891 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.529 ' N ' HG12 ' A' ' 14' ' ' VAL . . . 170.14 144.65 4.39 Favored Glycine 0 N--CA 1.492 2.379 0 N-CA-C 109.927 -1.269 . . . . 10.0 109.927 -179.566 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.636 ' HA ' ' HG ' ' A' ' 19' ' ' LEU . 0.2 OUTLIER -72.14 -23.17 61.26 Favored 'General case' 0 N--CA 1.494 1.773 0 O-C-N 121.539 -0.977 . . . . 10.0 111.77 -179.515 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.698 HG21 ' OD2' ' A' ' 57' ' ' ASP . 16.6 m -62.66 -50.27 71.84 Favored 'General case' 0 N--CA 1.496 1.869 0 O-C-N 120.938 -1.101 . . . . 10.0 112.03 -178.363 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.58 ' HB3' ' CB ' ' A' ' 35' ' ' THR . 31.3 p -78.59 8.77 4.77 Favored 'General case' 0 N--CA 1.49 1.538 0 O-C-N 120.46 -1.4 . . . . 10.0 110.3 -179.452 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.753 HD22 ' HB2' ' A' ' 159' ' ' ALA . 0.7 OUTLIER -88.0 -28.01 21.69 Favored 'General case' 0 C--N 1.309 -1.164 0 O-C-N 120.553 -1.342 . . . . 10.0 107.622 178.471 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.781 ' HG ' HD12 ' A' ' 165' ' ' LEU . 0.4 OUTLIER -69.65 -34.19 73.65 Favored 'General case' 0 C--N 1.305 -1.355 0 N-CA-C 107.354 -1.35 . . . . 10.0 107.354 177.12 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.82 HG13 HG23 ' B' ' 26' ' ' THR . 6.7 mm -75.25 -48.18 32.55 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.439 0 N-CA-C 108.324 -0.991 . . . . 10.0 108.324 178.162 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.484 ' O ' ' HA ' ' A' ' 27' ' ' LYS . 26.9 t -54.29 -43.08 70.76 Favored 'General case' 0 C--N 1.301 -1.52 0 N-CA-C 108.793 -0.817 . . . . 10.0 108.793 179.225 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.622 ' CG ' ' HB2' ' A' ' 162' ' ' GLN . 74.8 t80 -77.78 -0.94 29.0 Favored 'General case' 0 C--N 1.301 -1.535 0 O-C-N 120.743 -1.223 . . . . 10.0 109.442 178.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.427 ' OG1' ' O ' ' A' ' 20' ' ' LEU . 22.2 m -112.09 -49.1 2.99 Favored 'General case' 0 N--CA 1.493 1.723 0 N-CA-C 113.828 1.047 . . . . 10.0 113.828 -178.464 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.676 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.0 OUTLIER -125.85 -84.66 0.63 Allowed 'General case' 0 N--CA 1.496 1.833 0 O-C-N 120.011 -1.681 . . . . 10.0 114.032 -176.611 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.951 ' HB3' HG11 ' A' ' 33' ' ' VAL . 2.8 m-20 -67.32 -33.49 75.38 Favored 'General case' 0 N--CA 1.489 1.476 0 O-C-N 120.891 -1.13 . . . . 10.0 112.033 -176.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.516 ' HB2' ' O ' ' A' ' 26' ' ' ASN . 0.2 OUTLIER 59.96 -144.71 0.52 Allowed 'General case' 0 C--N 1.296 -1.758 0 C-N-CA 119.048 -1.061 . . . . 10.0 110.082 179.861 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.542 ' N ' ' HD3' ' A' ' 29' ' ' PRO . 2.4 t80 -142.54 57.25 6.01 Favored Pre-proline 0 N--CA 1.491 1.579 0 C-N-CA 119.963 -0.695 . . . . 10.0 110.058 179.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.542 ' HD3' ' N ' ' A' ' 28' ' ' PHE . 51.3 Cg_endo -82.8 -88.58 0.0 OUTLIER 'Trans proline' 0 C--N 1.307 -1.61 0 O-C-N 123.767 1.404 . . . . 10.0 110.306 179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 16.0 p -130.52 44.05 3.02 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 121.14 -0.975 . . . . 10.0 110.435 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.648 ' HG3' HG12 ' A' ' 33' ' ' VAL . 7.0 pt-20 -155.63 142.44 18.93 Favored 'General case' 0 C--N 1.302 -1.457 0 O-C-N 121.215 -0.928 . . . . 10.0 109.214 179.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . . . . . . . . . 20.4 m-85 -86.08 104.32 15.56 Favored 'General case' 0 C--N 1.298 -1.672 0 O-C-N 121.49 -0.757 . . . . 10.0 110.735 -179.158 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.951 HG11 ' HB3' ' A' ' 26' ' ' ASN . 0.2 OUTLIER -129.03 68.58 80.05 Favored Pre-proline 0 C--N 1.299 -1.63 0 CA-C-O 122.42 1.105 . . . . 10.0 108.194 179.808 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.504 ' O ' ' O ' ' B' ' 25' ' ' VAL . 50.5 Cg_endo -76.44 162.93 32.87 Favored 'Trans proline' 0 N--CA 1.492 1.421 0 C-N-CA 122.13 1.887 . . . . 10.0 112.145 -179.1 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.655 HG21 ' CZ3' ' B' ' 36' ' ' TRP . 3.7 t -57.01 160.48 3.56 Favored 'General case' 0 N--CA 1.496 1.826 0 O-C-N 121.288 -0.882 . . . . 10.0 110.29 179.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.555 ' O ' ' O ' ' A' ' 58' ' ' THR . 2.8 t -148.45 -114.22 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.305 -1.365 0 O-C-N 120.836 -1.165 . . . . 10.0 110.554 178.388 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.751 ' C ' HG12 ' B' ' 20' ' ' VAL . 4.4 t80 -102.26 105.87 16.59 Favored 'General case' 0 N--CA 1.495 1.823 0 O-C-N 120.831 -1.168 . . . . 10.0 111.928 -178.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.488 ' O ' ' HA ' ' A' ' 56' ' ' PHE . 0.8 OUTLIER -128.0 93.08 3.59 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.311 -0.868 . . . . 10.0 109.433 179.685 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.637 ' HB3' ' HB ' ' B' ' 17' ' ' THR . 36.0 t-20 -91.27 98.75 11.91 Favored 'General case' 0 C--N 1.305 -1.334 0 C-N-CA 118.405 -1.318 . . . . 10.0 110.399 -179.517 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.46 ' CB ' HD12 ' A' ' 55' ' ' LEU . 16.5 t80 -107.36 126.92 53.08 Favored 'General case' 0 C--N 1.3 -1.561 0 N-CA-C 108.909 -0.774 . . . . 10.0 108.909 179.091 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.468 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -153.88 112.88 3.71 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 120.807 -1.183 . . . . 10.0 110.454 -179.38 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 43' ' ' THR . 22.2 t -131.12 172.39 16.32 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.636 0 C-N-CA 119.779 -0.768 . . . . 10.0 109.724 179.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.541 ' N ' HG12 ' A' ' 42' ' ' VAL . 63.8 m -135.66 148.97 49.15 Favored 'General case' 0 C--N 1.29 -1.992 0 C-N-CA 119.31 -0.956 . . . . 10.0 110.388 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.635 HG13 HD12 ' A' ' 46' ' ' ILE . 1.1 t -118.88 174.9 4.11 Favored 'Isoleucine or valine' 0 C--N 1.296 -1.723 0 N-CA-C 108.549 -0.908 . . . . 10.0 108.549 179.36 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.554 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 3.8 mtt -149.96 120.67 7.54 Favored 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 119.546 -0.862 . . . . 10.0 109.956 179.239 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.635 HD12 HG13 ' A' ' 44' ' ' VAL . 1.4 mp -134.64 126.75 48.55 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.507 0 N-CA-C 108.305 -0.998 . . . . 10.0 108.305 179.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.581 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 48.08 31.09 8.0 Favored Glycine 0 N--CA 1.487 2.074 0 N-CA-C 109.271 -1.532 . . . . 10.0 109.271 -178.915 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . . . . . . . . . . . 82.19 31.52 31.18 Favored Glycine 0 N--CA 1.494 2.513 0 O-C-N 121.099 -1.236 . . . . 10.0 110.652 179.604 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.523 ' O ' ' HA ' ' A' ' 45' ' ' MET . 0.3 OUTLIER -119.68 115.77 33.54 Favored Pre-proline 0 N--CA 1.488 1.466 0 O-C-N 120.846 -1.384 . . . . 10.0 110.687 179.889 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.442 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 52.7 Cg_endo -76.91 141.54 21.44 Favored 'Trans proline' 0 C--N 1.305 -1.761 0 O-C-N 123.859 1.452 . . . . 10.0 111.193 -179.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.93 ' OH ' HG23 ' A' ' 173' ' ' ILE . 0.5 OUTLIER -103.45 112.56 25.51 Favored 'General case' 0 N--CA 1.491 1.614 0 O-C-N 121.347 -0.845 . . . . 10.0 110.305 179.511 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.904 HG21 ' O ' ' A' ' 2' ' ' GLN . 27.5 p -78.05 100.28 6.45 Favored 'General case' 0 N--CA 1.49 1.548 0 O-C-N 121.003 -1.061 . . . . 10.0 110.186 179.505 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.477 ' HB2' ' O ' ' A' ' 42' ' ' VAL . 22.3 mt -117.58 140.32 49.79 Favored 'General case' 0 C--N 1.301 -1.526 0 O-C-N 120.666 -1.271 . . . . 10.0 111.01 -179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -161.54 130.23 2.28 Favored Glycine 0 N--CA 1.486 2.027 0 N-CA-C 109.219 -1.552 . . . . 10.0 109.219 179.95 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.974 HD22 ' N ' ' A' ' 56' ' ' PHE . 0.0 OUTLIER -137.99 132.29 32.06 Favored 'General case' 0 N--CA 1.49 1.564 0 O-C-N 121.36 -1.082 . . . . 10.0 108.863 179.916 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.974 ' N ' HD22 ' A' ' 55' ' ' LEU . 50.8 p90 -157.26 148.98 22.29 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 120.673 -1.267 . . . . 10.0 112.4 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.698 ' OD2' HG21 ' A' ' 17' ' ' THR . 23.7 m-20 -124.05 -169.37 1.95 Allowed 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.835 -0.54 . . . . 10.0 110.455 179.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.654 HG22 ' H ' ' A' ' 59' ' ' ALA . 0.6 OUTLIER -45.85 -167.87 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.161 0 CA-C-O 122.25 1.024 . . . . 10.0 112.532 179.956 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.846 ' HB1' ' HB2' ' A' ' 62' ' ' GLU . . . -157.24 42.17 0.33 Allowed 'General case' 0 N--CA 1.493 1.704 0 O-C-N 120.723 -1.236 . . . . 10.0 109.851 -179.269 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.422 ' C ' ' O ' ' A' ' 59' ' ' ALA . . . -47.63 -27.45 4.48 Favored Glycine 0 N--CA 1.486 2.002 0 N-CA-C 107.422 -2.271 . . . . 10.0 107.422 178.816 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.61 ' CG ' ' HA3' ' B' ' 21' ' ' GLY . 2.4 tp60 -73.34 -55.85 5.85 Favored 'General case' 0 C--N 1.305 -1.326 0 O-C-N 121.855 -0.791 . . . . 10.0 109.259 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.846 ' HB2' ' HB1' ' A' ' 59' ' ' ALA . 5.3 mm-40 -59.88 -40.71 89.6 Favored 'General case' 0 N--CA 1.492 1.631 0 C-N-CA 119.086 -1.046 . . . . 10.0 110.131 -179.986 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.526 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 7.5 t70 75.61 38.85 0.36 Allowed 'General case' 0 N--CA 1.493 1.683 0 CA-C-O 122.008 0.908 . . . . 10.0 108.588 -178.918 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.616 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.1 OUTLIER -151.96 5.26 0.42 Allowed 'General case' 0 N--CA 1.49 1.547 0 CA-C-N 115.92 -0.582 . . . . 10.0 110.943 -179.968 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.691 ' CB ' ' HB3' ' A' ' 59' ' ' ALA . 19.1 t70 -115.17 25.56 10.78 Favored 'General case' 0 N--CA 1.499 2.015 0 O-C-N 120.692 -1.255 . . . . 10.0 111.131 179.787 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.944 ' O ' HD11 ' A' ' 70' ' ' LEU . 60.3 mtm180 -83.94 -25.44 30.11 Favored 'General case' 0 C--N 1.299 -1.618 0 O-C-N 121.096 -1.002 . . . . 10.0 109.364 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.986 ' C ' HD21 ' A' ' 70' ' ' LEU . 20.8 mt -111.41 10.34 21.47 Favored 'General case' 0 N--CA 1.488 1.444 0 O-C-N 121.558 -0.714 . . . . 10.0 110.35 179.828 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.583 ' N ' ' HD2' ' A' ' 69' ' ' PRO . 0.4 OUTLIER -102.17 -41.91 0.21 Allowed Pre-proline 0 N--CA 1.497 1.919 0 N-CA-C 114.038 1.125 . . . . 10.0 114.038 -178.928 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.583 ' HD2' ' N ' ' A' ' 68' ' ' ARG . 41.4 Cg_endo -69.4 -42.71 3.51 Favored 'Trans proline' 0 N--CA 1.492 1.409 0 O-C-N 122.842 0.917 . . . . 10.0 111.727 -177.278 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.986 HD21 ' C ' ' A' ' 67' ' ' LEU . 0.0 OUTLIER -48.85 -19.84 0.42 Allowed 'General case' 0 N--CA 1.503 2.2 0 O-C-N 121.21 -0.931 . . . . 10.0 109.695 179.258 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.488 ' O ' ' HD3' ' A' ' 73' ' ' PRO . 14.2 m -126.83 51.33 1.87 Allowed 'General case' 0 C--N 1.288 -2.07 0 O-C-N 121.538 -0.726 . . . . 10.0 110.059 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.701 ' CE1' HD21 ' B' ' 39' ' ' LEU . 0.0 OUTLIER -109.68 75.66 0.83 Allowed Pre-proline 0 N--CA 1.499 2.012 0 O-C-N 121.215 -0.928 . . . . 10.0 111.987 -179.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 52.2 Cg_endo -77.31 -0.88 11.04 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 O-C-N 123.957 1.503 . . . . 10.0 111.15 179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.424 ' O ' ' CG ' ' A' ' 74' ' ' GLN . 0.3 OUTLIER -81.56 49.69 1.36 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 120.954 -1.091 . . . . 10.0 110.654 -179.474 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 1.082 HG23 ' O ' ' A' ' 5' ' ' LYS . 82.3 m -142.0 84.8 1.9 Allowed 'General case' 0 C--N 1.3 -1.579 0 O-C-N 121.443 -0.785 . . . . 10.0 110.296 179.228 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.43 ' O ' ' HG2' ' A' ' 109' ' ' PRO . 5.2 m-20 -55.09 -22.63 17.01 Favored 'General case' 0 C--N 1.298 -1.653 0 C-N-CA 119.86 -0.736 . . . . 10.0 109.979 179.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.772 HG11 HD12 ' A' ' 4' ' ' ILE . 2.5 m -118.65 116.75 52.23 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.55 0 O-C-N 121.332 -0.855 . . . . 10.0 110.066 -179.395 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.615 ' HB3' HG21 ' A' ' 9' ' ' VAL . 87.4 m-85 -107.03 144.47 33.65 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 121.327 -0.858 . . . . 10.0 110.137 -179.256 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.714 HD11 HG12 ' A' ' 168' ' ' VAL . 1.9 mm? -103.46 97.81 7.8 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.11 -0.994 . . . . 10.0 108.866 178.684 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.777 HG23 ' HA2' ' A' ' 10' ' ' GLY . 4.7 p -98.78 130.79 47.13 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.53 0 O-C-N 121.581 -0.699 . . . . 10.0 109.454 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.502 ' HB2' ' OG1' ' A' ' 115' ' ' THR . 28.2 p -133.61 115.09 14.25 Favored 'General case' 0 C--N 1.304 -1.392 0 O-C-N 121.126 -0.984 . . . . 10.0 110.731 -179.533 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.451 ' CE2' HG22 ' A' ' 80' ' ' VAL . 94.6 m-85 -97.21 157.77 15.78 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 121.584 -0.697 . . . . 10.0 110.967 -179.826 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.515 ' HA ' ' O ' ' A' ' 115' ' ' THR . 57.1 m -85.13 157.06 20.78 Favored 'General case' 0 C--N 1.304 -1.393 0 O-C-N 121.427 -0.796 . . . . 10.0 110.165 179.478 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 84' ' ' VAL . 30.4 m -60.71 -10.27 2.88 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.407 0 O-C-N 121.403 -0.81 . . . . 10.0 110.769 -179.704 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.782 HG23 HD22 ' A' ' 129' ' ' LEU . 8.6 m -134.54 -53.14 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.143 -0.973 . . . . 10.0 110.116 179.606 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.601 ' H ' HG23 ' A' ' 85' ' ' VAL . 0.1 OUTLIER 44.9 -172.82 0.0 OUTLIER Pre-proline 0 N--CA 1.498 1.925 0 O-C-N 121.029 -1.044 . . . . 10.0 111.987 178.619 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.573 ' CD ' ' CB ' ' A' ' 86' ' ' SER . 53.7 Cg_endo -82.6 41.17 1.06 Allowed 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 124.194 1.628 . . . . 10.0 111.468 -179.047 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.507 ' OG ' ' HA ' ' A' ' 133' ' ' LYS . 3.5 m 39.78 84.83 0.02 OUTLIER 'General case' 0 N--CA 1.496 1.844 0 O-C-N 121.185 -0.947 . . . . 10.0 110.795 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.537 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 3.4 t -175.63 29.72 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.901 0 O-C-N 120.839 -1.163 . . . . 10.0 111.649 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.745 ' CE2' HD13 ' A' ' 145' ' ' LEU . 27.2 t80 -90.66 -23.94 20.62 Favored 'General case' 0 C--N 1.301 -1.516 0 O-C-N 120.794 -1.191 . . . . 10.0 109.466 179.113 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . . . . . . . . . 17.6 tt0 -85.36 -22.75 28.3 Favored 'General case' 0 C--N 1.301 -1.534 0 O-C-N 121.179 -0.951 . . . . 10.0 108.855 178.557 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -83.37 -13.98 53.78 Favored 'General case' 0 C--N 1.301 -1.541 0 C-N-CA 119.258 -0.977 . . . . 10.0 110.151 179.946 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.922 HG23 ' HD3' ' A' ' 94' ' ' LYS . 1.6 m -87.72 -16.97 8.83 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.944 0 C-N-CA 118.162 -1.415 . . . . 10.0 109.28 178.726 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.922 ' HD3' HG23 ' A' ' 93' ' ' VAL . 0.7 OUTLIER -81.66 -41.54 21.27 Favored 'General case' 0 N--CA 1.491 1.583 0 O-C-N 121.257 -0.902 . . . . 10.0 109.271 179.204 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.537 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.8 OUTLIER -76.85 -4.62 44.62 Favored 'General case' 0 C--N 1.297 -1.711 0 C-N-CA 119.993 -0.683 . . . . 10.0 109.172 179.087 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.491 ' O ' ' HB2' ' A' ' 100' ' ' GLU . 0.2 OUTLIER -111.72 -47.51 3.15 Favored 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.05 -1.031 . . . . 10.0 111.688 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.617 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 8.0 m0 -77.24 -49.09 15.84 Favored 'General case' 0 N--CA 1.496 1.856 0 O-C-N 121.303 -0.873 . . . . 10.0 112.318 -177.573 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.628 HG11 ' HB2' ' A' ' 149' ' ' LEU . 4.6 t -65.67 -46.59 67.46 Favored Pre-proline 0 N--CA 1.495 1.778 0 O-C-N 120.687 -1.258 . . . . 10.0 112.814 -177.436 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.56 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 39.1 Cg_endo -69.09 -12.79 35.03 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 N-CA-C 109.338 -1.062 . . . . 10.0 109.338 -179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.629 ' C ' HG22 ' A' ' 101' ' ' ILE . 1.9 mt-10 -89.36 -58.95 2.35 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.543 -0.723 . . . . 10.0 109.569 178.356 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.629 HG22 ' C ' ' A' ' 100' ' ' GLU . 0.9 OUTLIER 161.18 80.66 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.498 1.934 0 N-CA-C 108.798 -0.815 . . . . 10.0 108.798 -179.467 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.857 HG21 ' HB ' ' A' ' 108' ' ' THR . 2.5 m -48.1 -83.83 0.01 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 O-C-N 121.436 -0.79 . . . . 10.0 109.744 -179.615 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.708 ' N ' HG22 ' A' ' 102' ' ' THR . 46.0 t-80 -105.38 -22.45 13.03 Favored 'General case' 0 C--N 1.294 -1.804 0 N-CA-C 108.192 -1.04 . . . . 10.0 108.192 178.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.49 ' CE1' ' HG ' ' A' ' 105' ' ' CYS . 5.5 p80 178.31 -33.49 0.01 OUTLIER 'General case' 0 C--N 1.304 -1.386 0 N-CA-C 107.858 -1.164 . . . . 10.0 107.858 179.604 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.49 ' HG ' ' CE1' ' A' ' 104' ' ' HIS . 4.8 p -144.66 160.04 48.9 Favored Pre-proline 0 N--CA 1.486 1.373 0 N-CA-C 108.879 -0.786 . . . . 10.0 108.879 178.466 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.498 ' HB3' HG12 ' A' ' 98' ' ' VAL . 43.8 Cg_endo -72.4 84.56 1.16 Allowed 'Trans proline' 0 C--N 1.301 -1.95 0 O-C-N 123.645 1.339 . . . . 10.0 109.743 179.699 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.433 ' HB3' ' O ' ' A' ' 106' ' ' PRO . 0.0 OUTLIER 176.02 -4.4 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.059 0 O-C-N 121.405 -0.809 . . . . 10.0 111.363 -179.616 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.857 ' HB ' HG21 ' A' ' 102' ' ' THR . 99.8 m -51.66 150.98 6.35 Favored Pre-proline 0 N--CA 1.488 1.457 0 O-C-N 120.966 -1.084 . . . . 10.0 110.31 -179.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.681 ' HD2' HG23 ' A' ' 108' ' ' THR . 37.6 Cg_endo -63.59 110.21 1.2 Allowed 'Trans proline' 0 C--N 1.308 -1.583 0 O-C-N 123.865 1.455 . . . . 10.0 110.334 179.553 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -111.13 100.24 8.94 Favored 'General case' 0 C--N 1.303 -1.454 0 CA-C-O 121.27 0.557 . . . . 10.0 109.631 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.927 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 1.6 mm? -78.37 97.92 5.8 Favored 'General case' 0 C--N 1.298 -1.652 0 N-CA-C 108.102 -1.073 . . . . 10.0 108.102 179.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.678 HD12 ' HB2' ' A' ' 146' ' ' ALA . 64.5 mt -78.23 154.48 31.0 Favored 'General case' 0 C--N 1.297 -1.689 0 O-C-N 121.793 -0.567 . . . . 10.0 109.836 -178.903 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.577 HG12 ' H ' ' A' ' 114' ' ' GLY . 6.3 t -156.53 175.2 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.626 0 O-C-N 120.96 -1.087 . . . . 10.0 111.31 -178.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.577 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -124.3 96.79 0.53 Allowed Glycine 0 N--CA 1.485 1.937 0 N-CA-C 107.239 -2.344 . . . . 10.0 107.239 177.552 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.535 ' CG2' ' N ' ' A' ' 116' ' ' GLN . 1.3 m -95.16 170.97 9.02 Favored 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.354 -1.086 . . . . 10.0 110.947 -178.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.535 ' N ' ' CG2' ' A' ' 115' ' ' THR . 36.6 tp60 57.94 38.12 26.87 Favored 'General case' 0 C--N 1.302 -1.475 0 O-C-N 121.48 -0.762 . . . . 10.0 110.831 179.722 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.042 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -95.35 -36.67 6.92 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.609 0 N-CA-C 107.901 -1.148 . . . . 10.0 107.901 178.239 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.542 ' O ' ' CB ' ' A' ' 119' ' ' LEU . 8.7 p-10 -52.13 60.92 0.0 OUTLIER 'General case' 0 N--CA 1.5 2.045 0 CA-C-O 122.554 1.169 . . . . 10.0 110.352 -177.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.752 ' N ' ' O ' ' A' ' 117' ' ' ILE . 13.0 tp 159.25 -23.01 0.0 OUTLIER 'General case' 0 C--N 1.285 -2.199 0 CA-C-N 114.472 -1.24 . . . . 10.0 108.187 -179.503 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -45.72 -42.48 11.84 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 108.771 -0.826 . . . . 10.0 108.771 178.711 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.408 ' C ' ' O ' ' A' ' 120' ' ' ARG . 3.8 m-20 -45.94 -25.73 0.59 Allowed 'General case' 0 C--N 1.305 -1.347 0 C-N-CA 119.433 -0.907 . . . . 10.0 108.875 178.811 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.569 ' HB3' HD12 ' A' ' 119' ' ' LEU . 62.7 t0 -94.84 123.17 58.58 Favored Pre-proline 0 N--CA 1.49 1.549 0 O-C-N 121.668 -0.645 . . . . 10.0 110.759 179.567 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.493 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 55.9 Cg_endo -80.76 24.73 0.65 Allowed 'Trans proline' 0 C--N 1.31 -1.469 0 C-N-CA 121.607 1.538 . . . . 10.0 110.536 178.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.471 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 73.1 m -96.52 -50.46 4.72 Favored 'General case' 0 N--CA 1.494 1.729 0 O-C-N 121.167 -0.958 . . . . 10.0 110.366 -178.908 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.615 ' HB ' HD21 ' A' ' 119' ' ' LEU . 1.6 t -72.8 -33.58 66.34 Favored 'General case' 0 C--N 1.295 -1.778 0 N-CA-C 104.906 -2.257 . . . . 10.0 104.906 177.542 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.667 HD11 ' HD2' ' A' ' 120' ' ' ARG 0.301 0.9 OUTLIER -49.43 -30.54 4.81 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.658 0 N-CA-C 107.267 -1.382 . . . . 10.0 107.267 176.573 . . . . . . . . 4 4 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.471 ' CB ' ' O ' ' A' ' 124' ' ' SER . 0.6 OUTLIER -51.65 -43.88 62.82 Favored 'General case' 0 C--N 1.304 -1.385 0 CA-C-N 115.638 -0.71 . . . . 10.0 110.594 179.885 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 15.1 mmtm -75.09 -32.25 61.4 Favored 'General case' 0 C--N 1.297 -1.688 0 O-C-N 121.538 -0.726 . . . . 10.0 110.054 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.782 HD22 HG23 ' A' ' 85' ' ' VAL . 4.3 mt -77.11 -36.95 55.15 Favored 'General case' 0 C--N 1.301 -1.505 0 O-C-N 121.272 -0.893 . . . . 10.0 110.563 -179.963 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -50.25 -49.42 53.17 Favored 'General case' 0 N--CA 1.489 1.485 0 O-C-N 121.239 -0.913 . . . . 10.0 110.267 -179.694 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -50.34 -26.51 4.97 Favored 'General case' 0 C--N 1.301 -1.511 0 O-C-N 121.212 -0.93 . . . . 10.0 109.722 179.849 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -121.79 7.69 9.94 Favored 'General case' 0 N--CA 1.489 1.5 0 C-N-CA 119.378 -0.929 . . . . 10.0 111.56 -179.675 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.548 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.3 OUTLIER -129.93 82.69 2.08 Favored 'General case' 0 N--CA 1.486 1.364 0 O-C-N 120.802 -1.186 . . . . 10.0 109.838 179.769 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -72.49 -17.95 61.71 Favored 'General case' 0 N--CA 1.489 1.489 0 O-C-N 120.847 -1.158 . . . . 10.0 109.424 179.546 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.41 113.44 4.41 Favored Pre-proline 0 C--N 1.305 -1.333 0 N-CA-C 108.448 -0.945 . . . . 10.0 108.448 178.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.484 ' HB3' ' HE3' ' A' ' 133' ' ' LYS . 40.5 Cg_endo -68.89 157.12 63.12 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 O-C-N 123.907 1.477 . . . . 10.0 110.529 -179.294 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.482 HG13 ' CD2' ' A' ' 90' ' ' PHE . 0.4 OUTLIER -103.27 132.03 50.41 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.483 0 O-C-N 121.358 -0.839 . . . . 10.0 109.738 -179.832 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.529 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 25.9 p -122.89 167.72 13.8 Favored Pre-proline 0 C--N 1.301 -1.523 0 O-C-N 121.299 -0.876 . . . . 10.0 110.046 -178.883 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.529 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 39.2 Cg_endo -66.79 -24.82 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 O-C-N 123.873 1.459 . . . . 10.0 110.517 -179.831 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 12.7 tt0 -68.43 -35.46 77.65 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.347 -0.846 . . . . 10.0 109.519 179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 91.6 m -84.81 -31.28 23.95 Favored 'General case' 0 C--N 1.298 -1.639 0 CA-C-O 121.255 0.55 . . . . 10.0 110.65 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -73.44 -34.14 65.28 Favored 'General case' 0 N--CA 1.492 1.671 0 O-C-N 121.456 -0.777 . . . . 10.0 111.53 -179.022 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 6.0 tm-20 -56.16 -43.5 78.37 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 120.927 -1.108 . . . . 10.0 109.369 179.883 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.477 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.4 OUTLIER -63.9 -41.02 97.8 Favored 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.495 -0.882 . . . . 10.0 108.681 179.338 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.919 HD11 ' HG3' ' A' ' 94' ' ' LYS . 3.1 tt -59.87 -50.72 72.68 Favored 'General case' 0 N--CA 1.484 1.258 0 O-C-N 121.56 -0.712 . . . . 10.0 109.34 179.547 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.678 ' HB2' HD12 ' A' ' 112' ' ' LEU . . . -57.43 -41.38 80.3 Favored 'General case' 0 N--CA 1.488 1.443 0 O-C-N 121.156 -0.965 . . . . 10.0 108.632 178.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 5.9 mtm180 -79.49 -0.15 32.01 Favored 'General case' 0 C--N 1.298 -1.671 0 O-C-N 121.531 -0.731 . . . . 10.0 109.388 178.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.477 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 15.8 t0 -86.51 -10.53 53.92 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.582 -0.699 . . . . 10.0 110.476 179.647 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.988 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -153.28 32.11 0.47 Allowed 'General case' 0 N--CA 1.497 1.879 0 O-C-N 121.105 -0.997 . . . . 10.0 111.673 -179.69 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.466 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 2.3 mttt 62.24 41.2 10.74 Favored 'General case' 0 N--CA 1.492 1.661 0 O-C-N 121.254 -0.904 . . . . 10.0 111.649 177.497 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.745 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -80.31 -163.38 0.55 Allowed 'General case' 0 N--CA 1.498 1.936 0 O-C-N 121.739 -0.601 . . . . 10.0 109.538 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.752 HG22 ' CB ' ' A' ' 175' ' ' ALA . 40.3 t -98.04 -79.42 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.484 0 O-C-N 121.114 -0.991 . . . . 10.0 109.969 179.543 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.51 ' N ' HG12 ' A' ' 152' ' ' VAL . 6.3 tptp -172.57 165.22 5.57 Favored 'General case' 0 C--N 1.297 -1.685 0 C-N-CA 119.759 -0.776 . . . . 10.0 110.511 -179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.565 ' CD2' ' O ' ' A' ' 154' ' ' TYR . 40.5 p90 -96.33 124.44 40.33 Favored 'General case' 0 N--CA 1.491 1.596 0 O-C-N 121.456 -0.777 . . . . 10.0 109.751 178.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.884 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.2 OUTLIER -111.86 -169.61 0.39 Allowed 'Isoleucine or valine' 0 N--CA 1.495 1.812 0 O-C-N 121.174 -0.954 . . . . 10.0 110.237 -179.514 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.432 ' HB2' ' O ' ' A' ' 163' ' ' LYS . 31.4 mt-10 -130.15 135.18 47.9 Favored 'General case' 0 N--CA 1.495 1.777 0 O-C-N 121.147 -0.971 . . . . 10.0 109.789 -179.886 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.663 ' SG ' HD22 ' A' ' 165' ' ' LEU . 6.5 t -150.9 124.76 9.18 Favored 'General case' 0 N--CA 1.493 1.703 0 O-C-N 120.962 -1.086 . . . . 10.0 111.205 -179.532 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.569 ' O ' HD21 ' A' ' 165' ' ' LEU . 30.0 m -128.39 154.61 45.82 Favored 'General case' 0 C--N 1.293 -1.865 0 N-CA-C 107.536 -1.283 . . . . 10.0 107.536 177.697 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.753 ' HB2' HD22 ' A' ' 19' ' ' LEU . . . -99.65 -45.85 5.63 Favored 'General case' 0 C--N 1.283 -2.301 0 O-C-N 120.469 -1.395 . . . . 10.0 108.305 -179.912 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.779 ' C ' HD13 ' A' ' 160' ' ' LEU 0.294 2.7 tm? -61.58 -51.29 69.16 Favored 'General case' 0 C--N 1.297 -1.713 0 CA-C-O 121.751 0.786 . . . . 10.0 109.215 177.799 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.578 ' O ' ' CE1' ' A' ' 23' ' ' TYR . 28.6 m -102.94 -18.79 14.87 Favored 'General case' 0 N--CA 1.498 1.94 0 N-CA-C 113.204 0.816 . . . . 10.0 113.204 -178.366 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.622 ' HB2' ' CG ' ' A' ' 23' ' ' TYR . 1.7 tt0 61.01 75.31 0.42 Allowed 'General case' 0 N--CA 1.5 2.042 0 O-C-N 120.367 -1.458 . . . . 10.0 109.203 -178.834 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.432 ' O ' ' HB2' ' A' ' 156' ' ' GLU . 4.6 tptt -95.08 48.15 1.17 Allowed 'General case' 0 N--CA 1.495 1.796 0 C-N-CA 119.921 -0.711 . . . . 10.0 111.767 -178.87 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.696 ' O ' HG23 ' A' ' 168' ' ' VAL . . . 119.58 31.56 1.34 Allowed Glycine 0 N--CA 1.493 2.498 0 C-N-CA 119.4 -1.381 . . . . 10.0 110.796 178.741 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.781 HD12 ' HG ' ' A' ' 20' ' ' LEU . 0.1 OUTLIER -54.99 -43.2 73.36 Favored 'General case' 0 N--CA 1.496 1.831 0 O-C-N 120.965 -1.314 . . . . 10.0 110.512 179.677 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -76.22 -35.78 58.89 Favored 'General case' 0 N--CA 1.493 1.714 0 O-C-N 120.943 -1.098 . . . . 10.0 110.825 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.625 ' C ' HG11 ' A' ' 155' ' ' VAL . 5.2 m120 -60.83 -32.54 71.93 Favored 'General case' 0 N--CA 1.494 1.75 0 O-C-N 121.267 -0.896 . . . . 10.0 111.585 -178.938 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.884 HG22 ' HB ' ' A' ' 155' ' ' VAL . 34.6 t -64.41 -46.75 92.06 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.47 0 O-C-N 120.83 -1.169 . . . . 10.0 110.492 -179.302 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.401 ' CZ ' HD11 ' A' ' 173' ' ' ILE . 12.8 t80 -70.35 -28.03 64.81 Favored 'General case' 0 C--N 1.294 -1.807 0 O-C-N 121.493 -0.754 . . . . 10.0 111.753 -179.327 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.407 ' O ' ' HB ' ' A' ' 173' ' ' ILE . 19.3 t70 -57.51 -50.02 74.43 Favored 'General case' 0 N--CA 1.497 1.886 0 O-C-N 120.771 -1.206 . . . . 10.0 111.992 -178.457 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.788 ' OE1' HG22 ' A' ' 155' ' ' VAL . 12.7 pt-20 -68.58 -23.9 64.54 Favored 'General case' 0 N--CA 1.495 1.775 0 O-C-N 120.903 -1.123 . . . . 10.0 110.814 -179.0 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.927 ' HB2' ' HG ' ' A' ' 111' ' ' LEU . . . -70.77 -21.16 62.54 Favored 'General case' 0 N--CA 1.493 1.716 0 O-C-N 121.016 -1.052 . . . . 10.0 109.05 179.081 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.93 HG23 ' OH ' ' A' ' 51' ' ' TYR . 9.8 mm -67.32 -43.34 88.0 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 O-C-N 121.564 -0.71 . . . . 10.0 109.75 179.303 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.746 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.3 OUTLIER -73.13 -42.35 62.97 Favored 'General case' 0 C--N 1.303 -1.439 0 O-C-N 121.029 -1.044 . . . . 10.0 111.645 -179.231 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.752 ' CB ' HG22 ' A' ' 152' ' ' VAL . . . -82.56 -2.58 54.09 Favored 'General case' 0 C--N 1.299 -1.61 0 O-C-N 121.323 -0.861 . . . . 10.0 109.944 -179.583 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.984 ' CB ' HD13 ' A' ' 4' ' ' ILE . . . -78.47 -43.13 27.9 Favored 'General case' 0 C--N 1.302 -1.488 0 O-C-N 121.302 -0.874 . . . . 10.0 109.704 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.832 HD21 ' HE1' ' A' ' 51' ' ' TYR . 0.6 OUTLIER -107.05 -23.34 12.35 Favored 'General case' 0 N--CA 1.493 1.678 0 CA-C-O 121.746 0.784 . . . . 10.0 110.307 -178.598 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 . . . . . 0 C--N 1.297 -1.683 0 CA-C-O 117.988 -1.006 . . . . 10.0 110.354 -179.83 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . 0.533 ' O ' ' CB ' ' B' ' 2' ' ' SER . . . . . . . . 0 N--CA 1.488 2.143 0 N-CA-C 109.396 -1.481 . . . . 10.0 109.396 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.533 ' CB ' ' O ' ' B' ' 1' ' ' GLY . 1.0 OUTLIER 73.23 137.54 0.05 Allowed 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.489 -1.007 . . . . 10.0 111.173 179.574 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 15.8 mtpt -98.33 87.1 3.79 Favored 'General case' 0 N--CA 1.485 1.324 0 O-C-N 121.174 -0.954 . . . . 10.0 109.374 178.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.482 ' OE2' ' HB3' ' A' ' 49' ' ' GLU . 41.3 mt-10 -119.38 171.3 8.42 Favored 'General case' 0 C--N 1.298 -1.669 0 CA-C-O 121.747 0.784 . . . . 10.0 110.569 -179.736 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.657 ' HB2' ' HD2' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.57 -161.55 0.01 OUTLIER Pre-proline 0 C--N 1.299 -1.598 0 N-CA-C 106.932 -1.507 . . . . 10.0 106.932 178.38 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.657 ' HD2' ' HB2' ' B' ' 5' ' ' ARG . 40.5 Cg_endo -66.89 80.57 0.35 Allowed 'Trans proline' 0 C--N 1.311 -1.424 0 N-CA-C 109.305 -1.075 . . . . 10.0 109.305 -179.453 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.494 ' CB ' ' CG2' ' A' ' 46' ' ' ILE . 10.9 pm0 -45.98 175.28 0.0 OUTLIER 'General case' 0 N--CA 1.489 1.498 0 CA-C-O 121.447 0.641 . . . . 10.0 110.666 -179.009 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.89 ' H ' HD13 ' B' ' 8' ' ' ILE . 0.2 OUTLIER -135.19 -39.39 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.303 -1.443 0 O-C-N 121.336 -0.852 . . . . 10.0 110.621 -179.001 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.581 ' O ' ' N ' ' A' ' 47' ' ' GLY . 46.1 t -123.0 151.41 41.89 Favored 'General case' 0 N--CA 1.491 1.599 0 O-C-N 121.357 -0.839 . . . . 10.0 110.985 -179.32 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.927 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -167.44 97.83 0.63 Allowed Pre-proline 0 C--N 1.302 -1.458 0 O-C-N 120.716 -1.24 . . . . 10.0 112.801 179.115 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.529 ' HD2' ' HB3' ' A' ' 45' ' ' MET . 45.2 Cg_endo -73.91 145.51 36.1 Favored 'Trans proline' 0 C--N 1.303 -1.855 0 O-C-N 123.668 1.351 . . . . 10.0 109.085 177.679 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 86.2 p -97.16 154.91 17.08 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 120.936 -1.103 . . . . 10.0 110.562 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 33.4 m-20 -151.91 136.56 17.01 Favored 'General case' 0 C--N 1.302 -1.48 0 O-C-N 121.409 -0.807 . . . . 10.0 109.623 179.251 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 43.0 m-85 -123.56 143.22 50.33 Favored 'General case' 0 N--CA 1.49 1.573 0 O-C-N 121.355 -0.841 . . . . 10.0 110.515 -179.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.468 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 42.9 tp10 -146.7 147.21 30.75 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.16 -0.962 . . . . 10.0 109.896 179.271 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 19' ' ' HIS . 2.3 t60 -143.17 129.17 19.59 Favored 'General case' 0 C--N 1.302 -1.46 0 O-C-N 121.13 -0.981 . . . . 10.0 109.93 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.637 ' HB ' ' HB3' ' A' ' 39' ' ' ASN . 0.2 OUTLIER -96.06 -167.94 1.67 Allowed 'General case' 0 N--CA 1.491 1.613 0 O-C-N 121.415 -0.803 . . . . 10.0 110.468 -179.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.633 ' CD1' ' HB3' ' A' ' 39' ' ' ASN . 0.0 OUTLIER -55.59 179.84 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 121.1 -1.0 . . . . 10.0 111.736 -178.162 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.579 ' NE2' ' NE2' ' B' ' 16' ' ' HIS . 13.2 m80 -122.62 162.65 21.48 Favored 'General case' 0 N--CA 1.491 1.62 0 CA-C-O 121.622 0.725 . . . . 10.0 111.528 -177.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.751 HG12 ' C ' ' A' ' 37' ' ' PHE . 6.4 m -64.49 152.64 8.38 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.299 0 N-CA-C 108.851 -0.796 . . . . 10.0 108.851 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.61 ' HA3' ' CG ' ' A' ' 61' ' ' GLN . . . -73.96 151.7 44.52 Favored Glycine 0 N--CA 1.489 2.179 0 N-CA-C 109.689 -1.364 . . . . 10.0 109.689 -178.718 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.062 ' CG ' HG21 ' B' ' 25' ' ' VAL . 0.1 OUTLIER 67.61 97.86 0.06 Allowed 'General case' 0 C--N 1.304 -1.381 0 O-C-N 121.415 -1.05 . . . . 10.0 109.326 -179.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.477 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 70.8 m-20 -53.76 143.23 21.33 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.184 -0.948 . . . . 10.0 110.658 -179.378 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 59.32 31.03 20.84 Favored 'General case' 0 N--CA 1.498 1.932 0 O-C-N 121.433 -0.792 . . . . 10.0 111.954 179.471 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 1.062 HG21 ' CG ' ' B' ' 22' ' ' PHE . 21.4 t -113.7 -17.32 8.44 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.522 0 O-C-N 120.917 -1.114 . . . . 10.0 109.997 179.504 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.82 HG23 HG13 ' A' ' 21' ' ' ILE . 10.3 t -83.48 31.73 0.46 Allowed 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.674 -0.641 . . . . 10.0 110.958 -179.41 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.789 ' HA3' HG22 ' A' ' 21' ' ' ILE . . . -113.07 -91.64 1.95 Allowed Glycine 0 N--CA 1.488 2.111 0 O-C-N 120.85 -1.156 . . . . 10.0 110.225 -179.696 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.778 ' HB2' HG13 ' A' ' 33' ' ' VAL . 0.0 OUTLIER -1.14 124.98 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.828 0 CA-C-O 122.859 1.314 . . . . 10.0 113.986 -178.819 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.643 ' HB2' ' CD2' ' A' ' 19' ' ' LEU . 0.8 OUTLIER -120.79 142.79 49.25 Favored 'General case' 0 C--N 1.284 -2.243 0 CA-C-N 114.484 -1.235 . . . . 10.0 109.239 178.383 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.825 ' H ' HG21 ' A' ' 14' ' ' VAL . 68.7 p -152.33 -137.54 0.07 Allowed 'General case' 0 N--CA 1.491 1.623 0 O-C-N 121.386 -0.821 . . . . 10.0 110.314 -179.281 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -115.92 45.77 1.25 Allowed Glycine 0 N--CA 1.491 2.316 0 N-CA-C 109.77 -1.332 . . . . 10.0 109.77 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.534 HG23 ' HD2' ' B' ' 33' ' ' PRO . 50.4 mm -68.29 144.21 96.44 Favored Pre-proline 0 N--CA 1.49 1.564 0 O-C-N 121.256 -1.144 . . . . 10.0 109.938 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.534 ' HD2' HG23 ' B' ' 32' ' ' ILE . 41.0 Cg_endo -70.79 141.51 41.21 Favored 'Trans proline' 0 C--N 1.304 -1.797 0 O-C-N 123.954 1.502 . . . . 10.0 111.699 -179.598 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.618 ' HA ' ' HA2' ' A' ' 12' ' ' GLY . 9.6 tp10 53.58 163.32 0.01 OUTLIER 'General case' 0 N--CA 1.495 1.817 0 CA-C-O 122.012 0.911 . . . . 10.0 112.058 179.789 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.623 ' O ' ' HB2' ' B' ' 36' ' ' TRP . 4.5 mm100 -89.91 19.4 4.86 Favored 'General case' 0 N--CA 1.486 1.355 0 CA-C-N 116.019 -0.537 . . . . 10.0 111.58 -179.221 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.846 ' CZ3' HG21 ' A' ' 8' ' ' VAL . 3.8 m-90 87.33 26.86 0.04 OUTLIER 'General case' 0 N--CA 1.511 2.6 0 CA-C-O 122.549 1.166 . . . . 10.0 108.071 -177.291 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.589 ' CA ' ' HA ' ' A' ' 70' ' ' LEU . . . -160.99 85.87 0.69 Allowed 'General case' 0 C--N 1.299 -1.61 0 N-CA-C 107.138 -1.431 . . . . 10.0 107.138 -179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.494 ' HG2' ' CB ' ' B' ' 41' ' ' GLN . 3.2 ttm180 -82.91 53.25 2.36 Favored 'General case' 0 N--CA 1.489 1.525 0 CA-C-O 122.721 1.248 . . . . 10.0 108.537 -179.335 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.701 HD21 ' CE1' ' A' ' 72' ' ' TYR . 1.1 mp -44.16 -50.09 8.8 Favored 'General case' 0 C--N 1.284 -2.245 0 CA-C-N 114.483 -1.235 . . . . 10.0 111.369 -178.769 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.638 HD23 ' HB2' ' B' ' 39' ' ' LEU . 0.5 OUTLIER -122.97 14.99 9.95 Favored 'General case' 0 N--CA 1.496 1.841 0 C-N-CA 119.449 -0.901 . . . . 10.0 111.78 -178.319 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.494 ' CB ' ' HG2' ' B' ' 38' ' ' ARG . 9.3 mt-30 -115.21 34.51 4.83 Favored 'General case' 0 C--N 1.288 -2.071 0 O-C-N 121.566 -0.709 . . . . 10.0 110.257 179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . . . . . . . . . 33.0 p -77.09 -178.05 4.81 Favored 'General case' 0 N--CA 1.487 1.417 0 O-C-N 121.163 -0.961 . . . . 10.0 109.885 179.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 1.3 p -83.53 26.87 0.64 Allowed 'General case' 0 N--CA 1.491 1.58 0 O-C-N 121.241 -0.912 . . . . 10.0 110.478 179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . . . . . . . . . 13.4 t-20 -85.31 115.92 23.35 Favored 'General case' 0 N--CA 1.489 1.507 0 O-C-N 121.035 -1.041 . . . . 10.0 109.544 179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -65.56 -179.58 0.19 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.569 0 O-C-N 121.304 -0.872 . . . . 10.0 111.875 -179.153 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 51.5 m . . . . . 0 N--CA 1.485 1.276 0 CA-C-O 117.943 -1.027 . . . . 10.0 110.149 179.295 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.562 ' HA ' ' CA ' ' A' ' 177' ' ' LEU . 15.2 mtm . . . . . 0 N--CA 1.491 1.617 0 CA-C-O 121.306 0.574 . . . . 10.0 110.6 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.71 ' O ' ' N ' ' A' ' 4' ' ' ILE . 0.0 OUTLIER -144.23 -86.11 0.13 Allowed 'General case' 0 C--N 1.301 -1.514 0 O-C-N 121.202 -0.936 . . . . 10.0 109.275 179.43 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.65 HG22 ' O ' ' A' ' 3' ' ' THR . 3.5 m -41.26 81.62 0.0 OUTLIER 'General case' 0 N--CA 1.493 1.698 0 O-C-N 121.943 -0.473 . . . . 10.0 109.887 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.983 HG22 ' O ' ' A' ' 52' ' ' THR . 1.9 tt -136.01 154.02 33.04 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.59 0 C-N-CA 118.231 -1.388 . . . . 10.0 113.321 -177.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.747 ' O ' ' HB3' ' A' ' 76' ' ' ASP . 0.0 OUTLIER -135.23 109.66 8.45 Favored 'General case' 0 N--CA 1.495 1.778 0 CA-C-O 121.816 0.817 . . . . 10.0 110.716 -179.475 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.674 ' C ' HG22 ' A' ' 7' ' ' VAL . 30.1 m -67.98 142.64 55.9 Favored 'General case' 0 N--CA 1.499 1.988 0 O-C-N 120.931 -1.106 . . . . 10.0 109.882 -179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.674 HG22 ' C ' ' A' ' 6' ' ' CYS . 0.1 OUTLIER -167.49 -169.98 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.815 0 O-C-N 120.846 -1.159 . . . . 10.0 111.004 179.909 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.556 ' HB ' ' HB3' ' B' ' 36' ' ' TRP . 3.0 t -105.47 164.49 4.1 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.771 0 O-C-N 121.548 -0.72 . . . . 10.0 110.279 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 1.029 HG11 ' HB ' ' A' ' 80' ' ' VAL . 27.7 m -79.99 -168.7 0.1 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 O-C-N 120.913 -1.117 . . . . 10.0 111.718 -179.585 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.538 ' HA3' ' CD2' ' B' ' 39' ' ' LEU . . . -148.27 17.17 1.33 Allowed Glycine 0 N--CA 1.483 1.775 0 N-CA-C 109.006 -1.638 . . . . 10.0 109.006 179.507 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 25.2 t0 -67.54 -34.92 78.07 Favored 'General case' 0 C--N 1.305 -1.327 0 O-C-N 121.073 -1.251 . . . . 10.0 108.995 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.488 ' O ' ' HB3' ' A' ' 13' ' ' ALA . . . 141.25 -151.73 22.79 Favored Glycine 0 N--CA 1.493 2.455 0 N-CA-C 109.985 -1.246 . . . . 10.0 109.985 178.647 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.488 ' HB3' ' O ' ' A' ' 12' ' ' GLY . . . 57.73 160.7 0.02 OUTLIER 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.341 -1.094 . . . . 10.0 111.4 179.433 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.623 HG22 ' SG ' ' A' ' 18' ' ' CYS . 12.4 p -52.57 152.68 0.87 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.699 0 O-C-N 121.445 -0.784 . . . . 10.0 109.981 179.579 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.461 ' O ' ' SG ' ' A' ' 18' ' ' CYS . . . -65.24 161.32 41.82 Favored Glycine 0 N--CA 1.491 2.317 0 N-CA-C 109.818 -1.313 . . . . 10.0 109.818 -179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.482 ' O ' ' HE2' ' A' ' 16' ' ' LYS . 0.2 OUTLIER -88.68 -32.34 18.05 Favored 'General case' 0 N--CA 1.489 1.514 0 O-C-N 121.137 -1.214 . . . . 10.0 109.316 179.306 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 46.5 p -67.66 -26.15 66.06 Favored 'General case' 0 N--CA 1.489 1.501 0 O-C-N 121.506 -0.746 . . . . 10.0 110.826 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.623 ' SG ' HG22 ' A' ' 14' ' ' VAL . 24.8 p -75.12 -0.1 18.02 Favored 'General case' 0 C--N 1.307 -1.274 0 O-C-N 120.821 -1.175 . . . . 10.0 110.073 -179.431 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.905 HD13 ' CA ' ' A' ' 159' ' ' ALA . 6.3 mt -104.19 -21.46 13.54 Favored 'General case' 0 N--CA 1.491 1.579 0 O-C-N 121.276 -0.89 . . . . 10.0 109.866 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . . . . . . . . . 7.3 tt -63.51 -35.81 81.69 Favored 'General case' 0 C--N 1.296 -1.727 0 CA-C-O 121.745 0.784 . . . . 10.0 110.136 179.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.72 HG22 ' CA ' ' B' ' 27' ' ' GLY . 1.6 mm -97.87 -45.9 12.56 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.892 0 CA-C-O 121.858 0.837 . . . . 10.0 109.404 179.697 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.627 ' HA ' ' N ' ' A' ' 27' ' ' LYS . 15.9 t -49.33 -46.92 47.47 Favored 'General case' 0 C--N 1.291 -1.943 0 C-N-CA 119.386 -0.926 . . . . 10.0 109.757 -179.596 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.638 ' CZ ' ' HB2' ' A' ' 163' ' ' LYS . 0.5 OUTLIER -67.68 -45.68 74.47 Favored 'General case' 0 C--N 1.302 -1.489 0 O-C-N 120.354 -1.466 . . . . 10.0 110.628 179.627 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.512 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 5.5 p -58.73 -51.19 71.03 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 120.647 -1.283 . . . . 10.0 110.442 -179.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.632 HG23 ' H ' ' A' ' 26' ' ' ASN . 0.1 OUTLIER -153.65 -59.93 0.13 Allowed 'General case' 0 N--CA 1.501 2.08 0 C-N-CA 118.001 -1.48 . . . . 10.0 114.218 -179.636 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.679 ' HB3' HG21 ' A' ' 33' ' ' VAL . 20.3 m-20 -49.45 -26.07 3.06 Favored 'General case' 0 N--CA 1.495 1.803 0 O-C-N 120.846 -1.159 . . . . 10.0 111.562 -177.117 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.627 ' N ' ' HA ' ' A' ' 22' ' ' SER . 0.4 OUTLIER 29.54 -156.88 0.0 OUTLIER 'General case' 0 N--CA 1.506 2.338 0 N-CA-C 112.753 0.649 . . . . 10.0 112.753 179.365 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.682 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 0.3 OUTLIER -126.19 65.36 56.96 Favored Pre-proline 0 N--CA 1.495 1.803 0 O-C-N 120.837 -1.164 . . . . 10.0 111.216 -178.715 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.567 ' HD3' ' HG3' ' A' ' 27' ' ' LYS . 58.3 Cg_endo -95.39 -93.54 0.0 OUTLIER 'Trans proline' 0 C--N 1.312 -1.372 0 C-N-CA 121.212 1.275 . . . . 10.0 109.691 179.813 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.471 ' OG ' ' O ' ' A' ' 29' ' ' PRO . 4.4 m -167.49 59.29 0.08 Allowed 'General case' 0 N--CA 1.494 1.732 0 O-C-N 121.346 -0.846 . . . . 10.0 110.488 179.586 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.3 pt-20 -149.02 178.75 8.42 Favored 'General case' 0 C--N 1.306 -1.299 0 O-C-N 120.858 -1.152 . . . . 10.0 108.936 179.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.705 ' HA ' ' HB2' ' B' ' 24' ' ' ALA . 16.9 m-85 -121.99 131.94 54.27 Favored 'General case' 0 C--N 1.29 -2.021 0 O-C-N 121.511 -0.743 . . . . 10.0 110.979 -179.739 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.915 HG23 ' CG2' ' A' ' 35' ' ' THR . 4.1 m -132.59 168.89 15.61 Favored Pre-proline 0 C--N 1.305 -1.329 0 O-C-N 121.498 -0.751 . . . . 10.0 109.537 179.66 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.488 ' HD2' ' HB ' ' A' ' 33' ' ' VAL . 46.7 Cg_endo -71.92 95.78 0.75 Allowed 'Trans proline' 0 C--N 1.304 -1.804 0 O-C-N 123.826 1.435 . . . . 10.0 109.106 178.108 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.915 ' CG2' HG23 ' A' ' 33' ' ' VAL . 32.7 p -131.99 163.83 27.53 Favored 'General case' 0 N--CA 1.494 1.767 0 O-C-N 121.036 -1.04 . . . . 10.0 111.482 -178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.827 HG13 HG23 ' A' ' 58' ' ' THR . 27.8 t 80.01 3.19 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.356 0.598 . . . . 10.0 109.572 -179.56 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.606 ' HA ' ' HB ' ' B' ' 20' ' ' VAL . 45.4 t80 -41.27 124.6 2.35 Favored 'General case' 0 N--CA 1.487 1.409 0 N-CA-C 108.768 -0.827 . . . . 10.0 108.768 178.61 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.811 ' CB ' ' HB ' ' B' ' 18' ' ' ILE . 5.5 m-20 -64.46 -153.52 0.01 OUTLIER 'General case' 0 C--N 1.296 -1.728 0 C-N-CA 118.769 -1.172 . . . . 10.0 111.504 -178.168 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.798 ' CB ' HD11 ' A' ' 55' ' ' LEU . 2.5 t-20 -154.09 -163.11 1.55 Allowed 'General case' 0 N--CA 1.487 1.403 0 O-C-N 121.137 -0.977 . . . . 10.0 111.79 -178.572 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.56 ' HB2' ' HB3' ' B' ' 16' ' ' HIS . 41.3 p90 -131.97 -174.49 3.44 Favored 'General case' 0 C--N 1.297 -1.699 0 CA-C-O 121.775 0.798 . . . . 10.0 110.974 -177.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.8 ' O ' HG13 ' A' ' 42' ' ' VAL . . . -156.67 139.02 14.77 Favored 'General case' 0 C--N 1.298 -1.635 0 N-CA-C 108.767 -0.827 . . . . 10.0 108.767 179.816 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.8 HG13 ' O ' ' A' ' 41' ' ' ALA . 0.1 OUTLIER -164.75 -176.39 0.05 OUTLIER 'Isoleucine or valine' 0 N--CA 1.493 1.698 0 O-C-N 120.867 -1.145 . . . . 10.0 110.701 -179.041 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.817 HG23 ' O ' ' A' ' 51' ' ' TYR . 58.6 m -121.5 144.34 48.76 Favored 'General case' 0 C--N 1.302 -1.497 0 C-N-CA 119.981 -0.688 . . . . 10.0 109.983 179.35 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.462 ' CG1' ' CD1' ' A' ' 46' ' ' ILE . 0.9 OUTLIER -111.37 164.32 7.4 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.502 0 O-C-N 121.314 -0.866 . . . . 10.0 108.844 179.216 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.515 ' O ' ' HA ' ' B' ' 10' ' ' LEU . 0.4 OUTLIER -150.55 103.91 3.16 Favored 'General case' 0 C--N 1.291 -1.948 0 N-CA-C 108.364 -0.976 . . . . 10.0 108.364 179.173 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.892 HG23 ' HB3' ' B' ' 10' ' ' LEU . 4.2 mt -125.02 130.1 73.26 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.695 0 O-C-N 121.062 -1.024 . . . . 10.0 110.904 -178.332 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.528 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 40.24 27.17 0.13 Allowed Glycine 0 N--CA 1.491 2.315 0 N-CA-C 110.472 -1.051 . . . . 10.0 110.472 179.726 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.477 ' N ' ' O ' ' A' ' 46' ' ' ILE . . . 95.85 30.4 7.99 Favored Glycine 0 N--CA 1.489 2.2 0 C-N-CA 119.701 -1.238 . . . . 10.0 110.097 179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.492 ' OE1' ' CE1' ' A' ' 51' ' ' TYR . 0.4 OUTLIER -120.98 94.97 49.04 Favored Pre-proline 0 C--N 1.305 -1.368 0 O-C-N 120.898 -1.354 . . . . 10.0 110.447 179.816 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.455 ' HA ' ' O ' ' A' ' 44' ' ' VAL . 49.4 Cg_endo -75.57 144.52 28.54 Favored 'Trans proline' 0 C--N 1.303 -1.849 0 O-C-N 124.094 1.576 . . . . 10.0 111.134 179.559 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.817 ' O ' HG23 ' A' ' 43' ' ' THR . 1.7 m-85 -126.66 122.62 35.48 Favored 'General case' 0 C--N 1.303 -1.418 0 O-C-N 121.466 -0.771 . . . . 10.0 109.092 178.419 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.983 ' O ' HG22 ' A' ' 4' ' ' ILE 0.265 93.5 m -108.43 97.41 7.09 Favored 'General case' 0 N--CA 1.493 1.708 0 O-C-N 120.956 -1.09 . . . . 10.0 109.836 -179.877 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.805 HD23 ' N ' ' A' ' 53' ' ' LEU . 1.9 pt? -153.37 174.93 13.7 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 117.634 -1.626 . . . . 10.0 111.895 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.644 ' HA3' ' HB1' ' A' ' 41' ' ' ALA . . . -172.55 136.54 3.81 Favored Glycine 0 C--N 1.29 -2.005 0 N-CA-C 108.589 -1.804 . . . . 10.0 108.589 179.577 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.798 HD11 ' CB ' ' A' ' 39' ' ' ASN . 0.4 OUTLIER -131.71 135.27 46.71 Favored 'General case' 0 C--N 1.304 -1.411 0 O-C-N 120.895 -1.356 . . . . 10.0 109.659 179.935 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.409 ' N ' HD12 ' A' ' 55' ' ' LEU . 62.3 m-85 -133.76 158.95 42.03 Favored 'General case' 0 C--N 1.301 -1.502 0 N-CA-C 108.943 -0.762 . . . . 10.0 108.943 179.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.575 ' O ' ' O ' ' A' ' 58' ' ' THR . 28.7 t0 -124.17 171.17 10.03 Favored 'General case' 0 N--CA 1.49 1.56 0 O-C-N 120.887 -1.133 . . . . 10.0 109.787 -179.531 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.827 HG23 HG13 ' A' ' 36' ' ' VAL . 0.0 OUTLIER -45.87 -176.88 0.0 OUTLIER 'General case' 0 N--CA 1.503 2.205 0 C-N-CA 119.122 -1.031 . . . . 10.0 110.647 -179.445 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.734 ' HB1' ' HB3' ' A' ' 62' ' ' GLU . . . -144.56 75.12 1.44 Allowed 'General case' 0 N--CA 1.491 1.595 0 O-C-N 120.864 -1.147 . . . . 10.0 110.517 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . . . . . . . . . . . -64.56 -15.41 59.44 Favored Glycine 0 N--CA 1.489 2.181 0 N-CA-C 109.305 -1.518 . . . . 10.0 109.305 179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.475 ' N ' ' HA3' ' B' ' 21' ' ' GLY . 26.1 mt-30 -144.53 -16.51 0.55 Allowed 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.119 -1.224 . . . . 10.0 111.643 -179.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.734 ' HB3' ' HB1' ' A' ' 59' ' ' ALA . 1.8 tt0 -62.52 -48.71 78.34 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.479 -1.388 . . . . 10.0 109.285 179.732 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.488 ' O ' ' HB2' ' A' ' 64' ' ' TYR . 4.3 t0 -134.21 1.28 3.2 Favored 'General case' 0 C--N 1.299 -1.608 0 O-C-N 121.706 -0.621 . . . . 10.0 109.559 179.317 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.488 ' HB2' ' O ' ' A' ' 63' ' ' ASP . 17.4 m-85 66.64 37.65 4.31 Favored 'General case' 0 N--CA 1.49 1.538 0 N-CA-C 107.996 -1.112 . . . . 10.0 107.996 -179.414 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.542 ' O ' ' HD3' ' A' ' 69' ' ' PRO . 1.7 t0 -137.43 72.83 1.42 Allowed 'General case' 0 C--N 1.301 -1.525 0 CA-C-N 115.333 -0.849 . . . . 10.0 110.026 -178.841 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.482 ' HG3' ' N ' ' A' ' 67' ' ' LEU . 9.6 ptt180 -85.03 -30.61 24.0 Favored 'General case' 0 C--N 1.303 -1.417 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.623 179.056 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.72 ' O ' HD11 ' A' ' 70' ' ' LEU . 20.6 mt -86.86 -25.58 24.43 Favored 'General case' 0 N--CA 1.492 1.632 0 O-C-N 121.616 -0.678 . . . . 10.0 111.29 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.696 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 7.5 mtm-85 -109.85 12.68 0.07 OUTLIER Pre-proline 0 N--CA 1.498 1.945 0 O-C-N 120.729 -1.232 . . . . 10.0 114.242 -178.362 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.696 ' CD ' ' N ' ' A' ' 68' ' ' ARG . 50.3 Cg_endo -73.59 0.96 7.43 Favored 'Trans proline' 0 C--N 1.314 -1.238 0 N-CA-C 110.189 -0.735 . . . . 10.0 110.189 -179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.785 HD23 ' N ' ' A' ' 71' ' ' SER . 0.0 OUTLIER -102.46 -113.94 0.21 Allowed 'General case' 0 N--CA 1.488 1.427 0 O-C-N 121.426 -0.796 . . . . 10.0 110.819 -179.59 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.785 ' N ' HD23 ' A' ' 70' ' ' LEU . 0.4 OUTLIER 42.43 44.11 3.33 Favored 'General case' 0 N--CA 1.492 1.673 0 O-C-N 121.231 -0.918 . . . . 10.0 110.662 179.962 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.743 ' HB2' ' HD2' ' A' ' 73' ' ' PRO . 0.0 OUTLIER -160.16 174.37 4.0 Favored Pre-proline 0 N--CA 1.496 1.859 0 O-C-N 121.276 -0.89 . . . . 10.0 110.753 179.32 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.743 ' HD2' ' HB2' ' A' ' 72' ' ' TYR . 36.6 Cg_endo -62.11 -99.66 0.0 OUTLIER 'Trans proline' 0 C--N 1.317 -1.117 0 O-C-N 123.112 1.059 . . . . 10.0 110.862 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.607 ' HG3' ' CD ' ' A' ' 5' ' ' LYS . 1.3 mp0 54.21 90.99 0.03 OUTLIER 'General case' 0 N--CA 1.488 1.449 0 O-C-N 120.35 -1.469 . . . . 10.0 108.311 -179.39 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.793 HG22 ' O ' ' A' ' 75' ' ' THR . 1.3 m -139.58 86.63 2.12 Favored 'General case' 0 C--N 1.307 -1.263 0 O-C-N 121.358 -0.839 . . . . 10.0 112.404 -177.77 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.854 ' OD2' HG22 ' A' ' 77' ' ' VAL . 1.6 t70 -110.48 -72.72 0.71 Allowed 'General case' 0 C--N 1.297 -1.681 0 N-CA-C 106.854 -1.536 . . . . 10.0 106.854 176.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 1.056 ' CG1' ' HB2' ' A' ' 176' ' ' ALA . 24.8 m -141.92 112.16 2.96 Favored 'Isoleucine or valine' 0 C--N 1.292 -1.908 0 CA-C-N 114.819 -1.082 . . . . 10.0 109.792 179.213 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.986 ' HB3' HG12 ' A' ' 9' ' ' VAL . 84.0 m-85 -88.65 127.3 35.57 Favored 'General case' 0 C--N 1.296 -1.726 0 C-N-CA 119.313 -0.955 . . . . 10.0 108.711 179.715 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.56 HD11 ' HA ' ' A' ' 169' ' ' PHE . 4.0 mm? -100.76 97.93 8.51 Favored 'General case' 0 C--N 1.304 -1.407 0 O-C-N 121.215 -0.928 . . . . 10.0 109.662 -179.096 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 1.029 ' HB ' HG11 ' A' ' 9' ' ' VAL . 7.5 p -106.65 150.55 9.13 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.578 0 C-N-CA 119.961 -0.695 . . . . 10.0 109.947 -178.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.525 ' HB3' ' HB ' ' A' ' 115' ' ' THR . 17.6 m -133.13 118.86 19.2 Favored 'General case' 0 C--N 1.302 -1.477 0 O-C-N 120.924 -1.11 . . . . 10.0 110.783 -179.913 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.536 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 31.4 p90 -127.03 166.66 17.16 Favored 'General case' 0 N--CA 1.498 1.925 0 O-C-N 121.457 -0.777 . . . . 10.0 110.431 179.639 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 97.6 p -78.93 158.51 28.01 Favored 'General case' 0 N--CA 1.498 1.963 0 O-C-N 120.63 -1.293 . . . . 10.0 111.852 -178.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.506 ' HB ' ' CG2' ' A' ' 137' ' ' ILE . 28.4 m -114.39 2.9 8.05 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.309 0 O-C-N 121.607 -0.683 . . . . 10.0 110.117 179.871 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.853 ' HA ' HD21 ' A' ' 129' ' ' LEU . 19.2 m -105.58 39.02 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.494 1.765 0 O-C-N 121.282 -0.886 . . . . 10.0 109.761 179.592 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.561 ' HB3' ' HD2' ' A' ' 87' ' ' PRO . 73.0 m -114.94 172.13 3.88 Favored Pre-proline 0 N--CA 1.495 1.781 0 N-CA-C 108.812 -0.81 . . . . 10.0 108.812 179.769 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.561 ' HD2' ' HB3' ' A' ' 86' ' ' SER . 40.2 Cg_endo -68.71 81.1 0.6 Allowed 'Trans proline' 0 C--N 1.31 -1.486 0 O-C-N 123.048 1.026 . . . . 10.0 110.771 -179.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.435 ' C ' ' O ' ' A' ' 87' ' ' PRO . 0.4 OUTLIER 37.76 39.03 0.19 Allowed 'General case' 0 N--CA 1.491 1.615 0 CA-C-O 121.206 0.527 . . . . 10.0 110.844 179.487 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . . . . . . . . . 74.8 m -62.0 -38.26 87.96 Favored 'General case' 0 N--CA 1.492 1.644 0 O-C-N 121.047 -1.033 . . . . 10.0 110.81 -179.826 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.582 ' O ' ' HG2' ' A' ' 94' ' ' LYS . 16.3 p90 -48.46 -38.15 19.15 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.943 -1.098 . . . . 10.0 111.071 -179.001 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.523 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 9.6 tt0 -59.22 -37.93 78.72 Favored 'General case' 0 N--CA 1.494 1.764 0 O-C-N 121.345 -0.847 . . . . 10.0 110.779 -179.722 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.833 ' ND2' HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -68.62 -18.32 64.28 Favored 'General case' 0 C--N 1.302 -1.482 0 O-C-N 121.223 -0.923 . . . . 10.0 109.771 -179.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.833 HG23 ' ND2' ' A' ' 92' ' ' ASN . 64.6 t -89.62 -7.98 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.471 0 O-C-N 120.942 -1.099 . . . . 10.0 109.449 179.398 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.983 ' HG3' HD11 ' A' ' 145' ' ' LEU . 0.5 OUTLIER -93.29 -25.58 17.7 Favored 'General case' 0 N--CA 1.489 1.505 0 N-CA-C 107.799 -1.186 . . . . 10.0 107.799 178.378 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.541 ' O ' ' CG ' ' A' ' 99' ' ' PRO . 8.3 pt-20 -94.78 2.67 55.52 Favored 'General case' 0 C--N 1.299 -1.61 0 CA-C-N 115.752 -0.658 . . . . 10.0 109.403 178.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.528 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.1 OUTLIER -110.08 -49.03 3.12 Favored 'General case' 0 N--CA 1.49 1.557 0 O-C-N 120.989 -1.069 . . . . 10.0 111.79 -179.093 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.57 ' N ' ' CD1' ' A' ' 97' ' ' TRP . 24.5 m95 -89.9 -33.21 16.53 Favored 'General case' 0 N--CA 1.494 1.77 0 O-C-N 120.751 -1.218 . . . . 10.0 111.643 -178.591 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.593 ' HB ' ' HD3' ' A' ' 99' ' ' PRO . 96.3 t -71.7 -49.96 10.52 Favored Pre-proline 0 N--CA 1.49 1.573 0 O-C-N 120.658 -1.276 . . . . 10.0 110.778 -179.791 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.593 ' HD3' ' HB ' ' A' ' 98' ' ' VAL . 42.0 Cg_endo -70.57 -10.49 28.02 Favored 'Trans proline' 0 C--N 1.31 -1.476 0 O-C-N 123.178 1.094 . . . . 10.0 109.764 179.79 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.469 ' HB2' ' O ' ' A' ' 96' ' ' LYS . 22.4 tt0 -64.06 -48.58 75.69 Favored 'General case' 0 N--CA 1.49 1.527 0 O-C-N 121.362 -0.836 . . . . 10.0 110.916 179.75 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.503 ' O ' ' HD2' ' A' ' 106' ' ' PRO . 20.9 tt -176.43 -29.87 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.497 1.92 0 O-C-N 121.053 -1.029 . . . . 10.0 110.395 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.745 HG22 ' HG2' ' A' ' 106' ' ' PRO . 58.3 p -61.76 -11.95 14.62 Favored 'General case' 0 N--CA 1.487 1.401 0 O-C-N 121.272 -0.892 . . . . 10.0 109.977 179.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.435 ' HB2' ' O ' ' A' ' 98' ' ' VAL . 0.6 OUTLIER -55.62 -35.21 65.64 Favored 'General case' 0 C--N 1.303 -1.421 0 O-C-N 121.337 -0.852 . . . . 10.0 110.59 -179.997 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 2.0 t-80 -152.1 10.18 0.52 Allowed 'General case' 0 N--CA 1.492 1.642 0 C-N-CA 118.965 -1.094 . . . . 10.0 111.937 -179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . 0.67 ' CB ' ' CD ' ' A' ' 106' ' ' PRO . 1.7 m -113.12 -81.42 0.0 OUTLIER Pre-proline 0 N--CA 1.494 1.752 0 O-C-N 120.452 -1.405 . . . . 10.0 111.103 179.463 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.745 ' HG2' HG22 ' A' ' 102' ' ' THR . 55.2 Cg_endo -74.84 -22.99 14.61 Favored 'Trans proline' 0 N--CA 1.49 1.293 0 O-C-N 122.557 0.767 . . . . 10.0 112.029 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.411 ' C ' ' O ' ' A' ' 106' ' ' PRO . 6.0 tttt 45.8 42.93 9.38 Favored 'General case' 0 N--CA 1.486 1.348 0 O-C-N 120.729 -1.232 . . . . 10.0 109.85 -179.102 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.564 HG23 HG23 ' A' ' 75' ' ' THR . 18.5 m -67.1 139.37 95.25 Favored Pre-proline 0 N--CA 1.49 1.539 0 O-C-N 121.433 -0.792 . . . . 10.0 110.573 -179.5 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.545 ' CG ' ' O ' ' A' ' 76' ' ' ASP . 48.8 Cg_endo -71.94 125.14 10.7 Favored 'Trans proline' 0 C--N 1.306 -1.71 0 O-C-N 124.091 1.574 . . . . 10.0 110.067 179.677 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.579 ' N ' HG12 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -100.06 99.79 10.57 Favored 'General case' 0 C--N 1.302 -1.487 0 O-C-N 121.548 -0.72 . . . . 10.0 110.224 -179.762 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.769 ' HG ' ' HB2' ' A' ' 172' ' ' ALA . 2.7 mm? -75.67 96.89 3.67 Favored 'General case' 0 C--N 1.3 -1.557 0 N-CA-C 107.665 -1.235 . . . . 10.0 107.665 178.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.537 ' O ' ' HA ' ' A' ' 154' ' ' TYR . 96.0 mt -80.02 113.44 18.19 Favored 'General case' 0 C--N 1.295 -1.794 0 CA-C-N 115.643 -0.708 . . . . 10.0 110.114 -178.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.634 HG12 ' H ' ' A' ' 114' ' ' GLY . 1.6 t -120.01 -175.61 0.97 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.526 0 O-C-N 121.087 -1.008 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.634 ' H ' HG12 ' A' ' 113' ' ' VAL . . . -147.09 101.56 0.24 Allowed Glycine 0 N--CA 1.49 2.28 0 N-CA-C 109.362 -1.495 . . . . 10.0 109.362 179.561 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.525 ' HB ' ' HB3' ' A' ' 81' ' ' CYS . 4.8 t -99.73 178.09 4.94 Favored 'General case' 0 N--CA 1.496 1.861 0 O-C-N 121.083 -1.246 . . . . 10.0 110.955 -179.574 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.505 ' HB2' ' O ' ' A' ' 115' ' ' THR . 31.2 mt-30 58.88 30.09 19.69 Favored 'General case' 0 N--CA 1.492 1.668 0 O-C-N 121.543 -0.723 . . . . 10.0 109.17 -178.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 0.978 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.7 OUTLIER -80.17 -13.71 13.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.633 0 C-N-CA 119.951 -0.7 . . . . 10.0 110.581 -179.067 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.658 ' CB ' HG21 ' A' ' 161' ' ' THR . 5.5 p-10 -51.59 58.8 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.508 0 CA-C-O 122.493 1.139 . . . . 10.0 111.544 -176.851 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.756 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.1 OUTLIER 165.72 -28.54 0.0 OUTLIER 'General case' 0 C--N 1.282 -2.333 0 N-CA-C 107.338 -1.356 . . . . 10.0 107.338 -179.972 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.654 ' HA ' HD11 ' A' ' 126' ' ' ILE . 0.0 OUTLIER -50.82 -29.54 11.97 Favored 'General case' 0 C--N 1.303 -1.442 0 O-C-N 121.729 -0.607 . . . . 10.0 109.367 178.887 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 27.0 t70 -60.28 -26.76 66.74 Favored 'General case' 0 N--CA 1.491 1.6 0 O-C-N 121.393 -0.817 . . . . 10.0 109.709 179.293 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.476 ' O ' HD13 ' A' ' 126' ' ' ILE . 22.2 m-20 -93.3 123.57 60.22 Favored Pre-proline 0 C--N 1.299 -1.59 0 O-C-N 121.568 -0.708 . . . . 10.0 109.939 179.713 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.532 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 54.0 Cg_endo -78.15 24.35 0.55 Allowed 'Trans proline' 0 C--N 1.309 -1.537 0 O-C-N 123.89 1.468 . . . . 10.0 111.41 179.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.506 ' O ' ' HB2' ' A' ' 127' ' ' GLU . 15.6 m -98.09 -50.55 4.33 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 120.967 -1.083 . . . . 10.0 110.39 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . . . . . . . . . 14.3 t -72.22 -29.73 64.24 Favored 'General case' 0 C--N 1.294 -1.819 0 N-CA-C 105.133 -2.173 . . . . 10.0 105.133 176.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.654 HD11 ' HA ' ' A' ' 120' ' ' ARG 0.306 1.1 mp -51.82 -26.51 7.39 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.593 0 CA-C-N 114.109 -1.405 . . . . 10.0 107.365 176.903 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.506 ' HB2' ' O ' ' A' ' 124' ' ' SER . 28.9 tt0 -50.6 -29.35 10.64 Favored 'General case' 0 N--CA 1.488 1.429 0 CA-C-N 115.667 -0.697 . . . . 10.0 109.926 179.18 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 10.3 mmtp -61.39 -29.08 69.69 Favored 'General case' 0 N--CA 1.495 1.817 0 O-C-N 121.566 -0.709 . . . . 10.0 111.345 -179.53 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.853 HD21 ' HA ' ' A' ' 85' ' ' VAL . 9.2 mp -65.12 -42.92 93.45 Favored 'General case' 0 N--CA 1.491 1.585 0 O-C-N 120.804 -1.185 . . . . 10.0 109.835 -179.167 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . . . . . . . . . . . -57.66 -30.4 65.4 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.762 -0.586 . . . . 10.0 110.662 -179.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.41 ' HA ' ' HD3' ' A' ' 131' ' ' LYS . 8.5 mmtp -64.85 -15.06 61.36 Favored 'General case' 0 C--N 1.302 -1.461 0 C-N-CA 119.013 -1.075 . . . . 10.0 109.161 179.766 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.5 ' ND2' ' HA ' ' A' ' 87' ' ' PRO . 0.8 OUTLIER -127.64 -41.55 1.68 Allowed 'General case' 0 N--CA 1.491 1.588 0 O-C-N 121.216 -0.928 . . . . 10.0 110.739 179.267 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.473 ' HD2' ' HB2' ' A' ' 132' ' ' ASN . 0.0 OUTLIER -149.66 136.46 19.45 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.401 -0.812 . . . . 10.0 110.213 179.331 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.595 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -82.15 -10.11 59.29 Favored 'General case' 0 C--N 1.296 -1.75 0 CA-C-O 121.362 0.601 . . . . 10.0 110.315 -179.781 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.435 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 0.8 OUTLIER -110.72 98.47 37.74 Favored Pre-proline 0 N--CA 1.487 1.418 0 O-C-N 121.122 -0.986 . . . . 10.0 111.764 -179.352 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.832 ' HB3' HD23 ' A' ' 129' ' ' LEU . 45.1 Cg_endo -71.56 161.79 44.27 Favored 'Trans proline' 0 C--N 1.305 -1.73 0 O-C-N 124.372 1.722 . . . . 10.0 109.904 178.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.617 ' O ' HG23 ' A' ' 137' ' ' ILE . 1.5 tp -77.84 116.67 21.75 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.515 0 O-C-N 120.626 -1.296 . . . . 10.0 109.682 179.364 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.585 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 42.9 p -121.8 172.19 5.34 Favored Pre-proline 0 C--N 1.301 -1.542 0 N-CA-C 108.923 -0.769 . . . . 10.0 108.923 179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.585 ' HD2' ' HB ' ' A' ' 138' ' ' THR . 42.0 Cg_endo -67.66 -16.56 46.87 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 O-C-N 123.25 1.132 . . . . 10.0 111.331 -178.717 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.546 ' HG3' ' OG1' ' A' ' 138' ' ' THR . 0.0 OUTLIER -79.62 -24.78 41.69 Favored 'General case' 0 N--CA 1.492 1.653 0 O-C-N 120.827 -1.171 . . . . 10.0 109.263 178.897 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . 0.436 ' N ' ' HG3' ' A' ' 140' ' ' GLU . 85.3 m -97.21 -35.0 10.9 Favored 'General case' 0 C--N 1.301 -1.502 0 CA-C-O 121.662 0.744 . . . . 10.0 109.341 179.181 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.572 ' HB1' ' CG ' ' A' ' 154' ' ' TYR . . . -72.3 -39.9 67.93 Favored 'General case' 0 N--CA 1.489 1.481 0 O-C-N 121.778 -0.576 . . . . 10.0 110.904 -179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.425 ' O ' ' HG3' ' A' ' 147' ' ' ARG . 25.7 mt-10 -62.23 -50.22 72.64 Favored 'General case' 0 C--N 1.298 -1.634 0 C-N-CA 119.569 -0.852 . . . . 10.0 109.597 179.847 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.459 ' O ' ' HB2' ' A' ' 148' ' ' ASP . 0.0 OUTLIER -61.24 -42.18 98.17 Favored 'General case' 0 C--N 1.301 -1.529 0 N-CA-C 108.46 -0.941 . . . . 10.0 108.46 179.159 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.983 HD11 ' HG3' ' A' ' 94' ' ' LYS . 4.8 tt -58.8 -45.68 89.35 Favored 'General case' 0 C--N 1.31 -1.146 0 O-C-N 121.33 -0.856 . . . . 10.0 109.399 178.663 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.541 ' CA ' ' HB3' ' A' ' 151' ' ' ALA . . . -60.33 -48.7 80.6 Favored 'General case' 0 C--N 1.304 -1.397 0 CA-C-O 121.522 0.677 . . . . 10.0 109.629 179.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.425 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 10.3 mtm-85 -71.13 -14.36 62.26 Favored 'General case' 0 C--N 1.295 -1.79 0 O-C-N 121.231 -0.918 . . . . 10.0 109.314 178.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.459 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 9.4 t0 -69.3 -13.33 62.33 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.572 -0.705 . . . . 10.0 111.115 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.998 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -149.51 26.98 0.83 Allowed 'General case' 0 N--CA 1.494 1.758 0 O-C-N 121.025 -1.047 . . . . 10.0 110.155 179.232 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.408 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 0.9 OUTLIER 64.45 36.27 8.94 Favored 'General case' 0 N--CA 1.488 1.439 0 CA-C-O 121.684 0.754 . . . . 10.0 110.637 177.847 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.822 ' HB2' HD11 ' A' ' 149' ' ' LEU . . . -69.4 -155.59 0.02 OUTLIER 'General case' 0 C--N 1.293 -1.864 0 N-CA-C 108.052 -1.092 . . . . 10.0 108.052 178.237 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.747 HG21 HD11 ' A' ' 111' ' ' LEU . 0.2 OUTLIER -118.77 -62.29 2.17 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.585 0 O-C-N 120.781 -1.199 . . . . 10.0 111.112 179.916 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.415 ' HG3' ' N ' ' A' ' 154' ' ' TYR . 1.9 ttmt -171.99 154.73 3.56 Favored 'General case' 0 N--CA 1.499 1.994 0 O-C-N 120.521 -1.362 . . . . 10.0 112.041 179.287 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.572 ' CG ' ' HB1' ' A' ' 142' ' ' ALA . 54.3 t80 -106.8 101.4 10.84 Favored 'General case' 0 N--CA 1.489 1.51 0 O-C-N 121.494 -0.754 . . . . 10.0 108.981 178.074 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.949 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.0 OUTLIER -107.42 -170.27 0.34 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.885 0 O-C-N 121.469 -0.769 . . . . 10.0 110.139 -179.132 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . . . . . . . . . 1.2 tt0 -152.56 133.39 14.02 Favored 'General case' 0 C--N 1.302 -1.467 0 O-C-N 121.08 -1.013 . . . . 10.0 110.773 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.607 ' SG ' HG11 ' A' ' 113' ' ' VAL . 26.9 p -153.63 157.75 40.11 Favored 'General case' 0 N--CA 1.49 1.526 0 N-CA-C 108.557 -0.905 . . . . 10.0 108.557 179.054 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.578 ' HB2' ' H ' ' A' ' 162' ' ' GLN . 54.0 m -138.68 164.32 29.84 Favored 'General case' 0 C--N 1.297 -1.675 0 N-CA-C 108.185 -1.042 . . . . 10.0 108.185 179.69 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.905 ' CA ' HD13 ' A' ' 19' ' ' LEU . . . -62.06 -59.26 5.35 Favored 'General case' 0 N--CA 1.495 1.78 0 O-C-N 120.631 -1.293 . . . . 10.0 112.33 -177.57 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.58 ' C ' ' CE2' ' A' ' 23' ' ' TYR . 2.6 pp -121.16 4.7 10.34 Favored 'General case' 0 N--CA 1.497 1.905 0 O-C-N 120.454 -1.404 . . . . 10.0 112.898 -178.256 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.658 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.3 OUTLIER -104.07 -47.34 4.2 Favored 'General case' 0 N--CA 1.503 2.204 0 O-C-N 120.333 -1.479 . . . . 10.0 113.544 -178.021 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.578 ' H ' ' HB2' ' A' ' 158' ' ' SER . 10.7 mm100 -91.51 -44.38 9.13 Favored 'General case' 0 N--CA 1.5 2.025 0 O-C-N 120.444 -1.41 . . . . 10.0 112.026 -178.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.638 ' HB2' ' CZ ' ' A' ' 23' ' ' TYR . 15.4 ttpt 63.95 28.73 14.5 Favored 'General case' 0 N--CA 1.5 2.051 0 CA-C-O 122.205 1.002 . . . . 10.0 109.325 -178.943 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . -109.45 15.86 32.18 Favored Glycine 0 N--CA 1.488 2.101 0 N-CA-C 109.088 -1.605 . . . . 10.0 109.088 179.369 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.698 ' H ' HD13 ' A' ' 165' ' ' LEU . 0.0 OUTLIER -69.51 -3.17 13.53 Favored 'General case' 0 N--CA 1.488 1.425 0 O-C-N 121.541 -0.976 . . . . 10.0 110.471 179.416 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.507 ' N ' ' CD2' ' A' ' 165' ' ' LEU . 0.0 OUTLIER -89.65 -25.32 21.32 Favored 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.178 -0.951 . . . . 10.0 109.946 179.114 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -84.43 -34.92 23.39 Favored 'General case' 0 C--N 1.303 -1.456 0 O-C-N 121.092 -1.005 . . . . 10.0 109.44 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.949 HG22 ' HB ' ' A' ' 155' ' ' VAL . 16.2 t -59.62 -38.77 77.23 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.449 0 O-C-N 121.314 -0.866 . . . . 10.0 110.692 179.645 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.56 ' HA ' HD11 ' A' ' 79' ' ' LEU . 1.9 t80 -80.17 -44.05 20.5 Favored 'General case' 0 N--CA 1.494 1.759 0 O-C-N 121.242 -0.911 . . . . 10.0 111.796 -178.821 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.696 ' O ' HD22 ' A' ' 174' ' ' LEU . 29.7 t70 -52.51 -44.08 65.47 Favored 'General case' 0 N--CA 1.494 1.775 0 O-C-N 120.528 -1.358 . . . . 10.0 110.688 -178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.598 ' HA ' HD23 ' A' ' 174' ' ' LEU . 14.5 mt-10 -60.62 -41.82 95.64 Favored 'General case' 0 N--CA 1.497 1.904 0 O-C-N 121.237 -0.914 . . . . 10.0 111.466 -179.148 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.931 ' HB1' ' HB ' ' A' ' 77' ' ' VAL . . . -56.14 -33.21 64.96 Favored 'General case' 0 C--N 1.299 -1.594 0 O-C-N 121.244 -0.91 . . . . 10.0 111.092 -178.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.659 ' O ' HD12 ' A' ' 177' ' ' LEU . 20.8 mm -61.01 -44.68 98.74 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.553 0 C-N-CA 118.316 -1.354 . . . . 10.0 108.423 178.996 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.726 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -70.84 -21.04 62.48 Favored 'General case' 0 C--N 1.306 -1.289 0 O-C-N 121.375 -0.828 . . . . 10.0 109.839 179.014 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . 0.705 ' CB ' HG23 ' A' ' 152' ' ' VAL . . . -95.95 -7.5 36.39 Favored 'General case' 0 N--CA 1.487 1.41 0 O-C-N 121.397 -0.814 . . . . 10.0 111.005 -178.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.056 ' HB2' ' CG1' ' A' ' 77' ' ' VAL . . . -85.97 -33.65 21.06 Favored 'General case' 0 N--CA 1.489 1.498 0 O-C-N 121.072 -1.017 . . . . 10.0 111.343 -179.496 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.659 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.4 OUTLIER -100.31 -10.65 21.05 Favored 'General case' 0 N--CA 1.497 1.909 0 O-C-N 120.767 -1.208 . . . . 10.0 109.418 179.782 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.425 ' OE1' ' HA ' ' A' ' 178' ' ' GLU . 0.0 OUTLIER . . . . . 0 N--CA 1.491 1.603 0 O-C-N 120.795 -1.191 . . . . 10.0 109.138 179.584 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.303 0 N-CA-C 109.369 -1.492 . . . . 10.0 109.369 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . 0.45 ' O ' ' HG2' ' B' ' 4' ' ' GLU . 56.9 m -80.39 36.82 0.38 Allowed 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.09 -1.241 . . . . 10.0 111.189 -179.749 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.481 ' NZ ' ' HB3' ' A' ' 174' ' ' LEU . 9.4 mtpp -61.0 100.54 0.12 Allowed 'General case' 0 N--CA 1.488 1.457 0 O-C-N 120.992 -1.068 . . . . 10.0 108.902 178.972 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.45 ' HG2' ' O ' ' B' ' 2' ' ' SER . 9.2 mm-40 -108.43 161.97 14.54 Favored 'General case' 0 C--N 1.297 -1.69 0 CA-C-O 121.588 0.709 . . . . 10.0 111.262 -178.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.681 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -70.48 -143.17 0.0 OUTLIER Pre-proline 0 N--CA 1.49 1.536 0 N-CA-C 108.202 -1.036 . . . . 10.0 108.202 179.04 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.681 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 43.9 Cg_endo -74.27 7.31 2.62 Favored 'Trans proline' 0 N--CA 1.485 0.972 0 CA-C-N 119.448 0.839 . . . . 10.0 110.626 179.885 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.829 ' CB ' HG22 ' A' ' 46' ' ' ILE . 0.0 OUTLIER 41.81 -149.74 0.03 OUTLIER 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.25 -0.906 . . . . 10.0 110.517 179.642 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.561 HG23 ' H ' ' B' ' 9' ' ' SER . 0.0 OUTLIER -100.48 -99.05 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.299 -1.602 0 O-C-N 121.46 -0.775 . . . . 10.0 109.951 -179.858 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.561 ' H ' HG23 ' B' ' 8' ' ' ILE . 31.1 m -78.12 151.96 33.08 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 120.592 -1.317 . . . . 10.0 111.141 -179.65 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.892 ' HB3' HG23 ' A' ' 46' ' ' ILE . 0.8 OUTLIER -164.89 98.81 0.84 Allowed Pre-proline 0 N--CA 1.488 1.471 0 O-C-N 120.459 -1.401 . . . . 10.0 112.348 179.841 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.494 ' HD2' ' O ' ' A' ' 45' ' ' MET . 45.0 Cg_endo -75.72 124.18 7.99 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 O-C-N 123.771 1.406 . . . . 10.0 108.893 177.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 15.8 m -93.14 166.37 12.37 Favored 'General case' 0 N--CA 1.492 1.656 0 O-C-N 120.88 -1.138 . . . . 10.0 111.103 -179.097 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 1.4 t70 -146.44 174.99 10.89 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 108.99 -0.744 . . . . 10.0 108.99 179.834 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.465 ' HA ' HG11 ' A' ' 42' ' ' VAL . 47.1 p90 -149.23 150.04 31.94 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.724 -1.235 . . . . 10.0 111.62 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -170.85 117.85 0.49 Allowed 'General case' 0 N--CA 1.491 1.618 0 O-C-N 121.67 -0.644 . . . . 10.0 109.7 179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . 0.56 ' HB3' ' HB2' ' A' ' 40' ' ' TYR . 2.3 p-80 -162.83 156.42 20.16 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 120.624 -1.297 . . . . 10.0 111.737 -179.442 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.928 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -166.95 96.25 0.51 Allowed 'General case' 0 C--N 1.309 -1.184 0 O-C-N 121.297 -0.877 . . . . 10.0 110.226 177.602 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.928 HG23 ' O ' ' B' ' 17' ' ' THR . 0.6 OUTLIER -172.9 167.16 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.496 1.867 0 O-C-N 121.733 -0.605 . . . . 10.0 109.466 178.998 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.42 ' N ' ' OD2' ' A' ' 38' ' ' ASP . 50.0 t60 -145.75 159.6 42.95 Favored 'General case' 0 N--CA 1.498 1.937 0 O-C-N 120.211 -1.556 . . . . 10.0 114.551 -179.692 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.827 HG23 ' O ' ' A' ' 35' ' ' THR . 4.8 p -69.08 146.23 12.84 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.808 0 CA-C-N 115.552 -0.749 . . . . 10.0 110.648 179.132 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.496 ' O ' ' HB2' ' B' ' 22' ' ' PHE . . . -146.48 155.84 26.71 Favored Glycine 0 N--CA 1.488 2.148 0 N-CA-C 108.364 -1.894 . . . . 10.0 108.364 179.002 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 1.06 ' HB3' HG21 ' B' ' 25' ' ' VAL . 8.1 m-30 58.81 92.52 0.04 OUTLIER 'General case' 0 N--CA 1.493 1.725 0 O-C-N 121.213 -1.169 . . . . 10.0 110.359 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.498 ' O ' HG23 ' B' ' 25' ' ' VAL . 72.1 m-20 -60.65 157.55 14.33 Favored 'General case' 0 N--CA 1.5 2.039 0 CA-C-O 121.634 0.73 . . . . 10.0 111.764 -179.374 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.705 ' HB2' ' HA ' ' A' ' 32' ' ' TYR . . . 43.89 43.89 5.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.69 -0.631 . . . . 10.0 111.331 178.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 1.06 HG21 ' HB3' ' B' ' 22' ' ' PHE . 6.7 t -111.7 -35.1 2.41 Favored 'Isoleucine or valine' 0 C--N 1.294 -1.848 0 C-N-CA 119.356 -0.938 . . . . 10.0 108.663 178.892 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.603 ' O ' ' HA ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -101.93 7.44 41.45 Favored 'General case' 0 N--CA 1.49 1.561 0 N-CA-C 108.558 -0.904 . . . . 10.0 108.558 177.584 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.72 ' CA ' HG22 ' A' ' 21' ' ' ILE . . . -125.14 24.87 5.87 Favored Glycine 0 N--CA 1.486 2.009 0 N-CA-C 107.881 -2.088 . . . . 10.0 107.881 179.188 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.493 ' HB2' ' O ' ' A' ' 27' ' ' LYS . 11.3 tt0 -158.66 132.59 7.71 Favored 'General case' 0 C--N 1.302 -1.467 0 N-CA-C 108.734 -0.839 . . . . 10.0 108.734 -179.832 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.768 ' HB2' HD21 ' A' ' 19' ' ' LEU . 0.0 OUTLIER -110.04 118.92 37.69 Favored 'General case' 0 C--N 1.286 -2.167 0 CA-C-O 122.238 1.018 . . . . 10.0 110.7 -179.399 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . . . . . . . . . 71.7 p -143.07 162.31 35.87 Favored 'General case' 0 C--N 1.291 -1.952 0 CA-C-N 115.575 -0.739 . . . . 10.0 109.664 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . 45.43 -165.9 0.06 OUTLIER Glycine 0 N--CA 1.494 2.542 0 N-CA-C 110.205 -1.158 . . . . 10.0 110.205 179.26 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.461 ' N ' ' CD ' ' B' ' 33' ' ' PRO . 24.2 pt -143.01 52.87 2.35 Favored Pre-proline 0 N--CA 1.498 1.93 0 O-C-N 121.372 -1.075 . . . . 10.0 110.458 -179.731 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.461 ' CD ' ' N ' ' B' ' 32' ' ' ILE . 55.5 Cg_endo -74.72 163.14 36.38 Favored 'Trans proline' 0 C--N 1.306 -1.675 0 O-C-N 123.83 1.437 . . . . 10.0 111.05 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.914 ' OE1' HD21 ' B' ' 40' ' ' LEU . 3.6 tp10 -43.7 155.39 0.07 Allowed 'General case' 0 N--CA 1.493 1.696 0 O-C-N 121.16 -0.963 . . . . 10.0 109.97 179.604 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.474 ' NE2' ' O ' ' A' ' 14' ' ' VAL . 4.1 mm-40 -67.83 -66.76 0.52 Allowed 'General case' 0 C--N 1.302 -1.457 0 C-N-CA 119.238 -0.985 . . . . 10.0 111.141 -179.182 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.625 ' CD2' ' O ' ' B' ' 36' ' ' TRP . 9.4 t90 -161.96 21.05 0.11 Allowed 'General case' 0 C--N 1.29 -2.018 0 CA-C-O 122.51 1.148 . . . . 10.0 108.114 -179.626 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.753 ' O ' HD23 ' B' ' 39' ' ' LEU . . . -155.95 93.92 1.49 Allowed 'General case' 0 C--N 1.295 -1.781 0 CA-C-N 115.444 -0.798 . . . . 10.0 109.081 -179.723 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.426 ' HG3' ' O ' ' B' ' 42' ' ' THR . 0.0 OUTLIER -88.78 45.13 1.26 Allowed 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 107.466 -1.309 . . . . 10.0 107.466 178.874 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.753 HD23 ' O ' ' B' ' 37' ' ' ALA . 0.6 OUTLIER -51.13 -20.79 1.63 Allowed 'General case' 0 C--N 1.292 -1.935 0 CA-C-N 114.832 -1.076 . . . . 10.0 111.727 -178.095 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.914 HD21 ' OE1' ' B' ' 34' ' ' GLU . 0.6 OUTLIER -79.22 9.38 4.62 Favored 'General case' 0 N--CA 1.493 1.694 0 O-C-N 120.745 -1.222 . . . . 10.0 110.502 179.842 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.515 ' HB2' ' O ' ' B' ' 40' ' ' LEU . 0.0 OUTLIER 73.63 -20.92 0.28 Allowed 'General case' 0 N--CA 1.498 1.969 0 O-C-N 121.992 -0.442 . . . . 10.0 111.707 179.126 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.628 ' O ' HD11 ' B' ' 40' ' ' LEU . 26.9 p -134.33 178.01 7.31 Favored 'General case' 0 C--N 1.302 -1.473 0 O-C-N 120.76 -1.213 . . . . 10.0 109.87 179.71 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 88.3 p -93.06 15.57 14.83 Favored 'General case' 0 C--N 1.298 -1.654 0 O-C-N 121.422 -0.798 . . . . 10.0 109.018 178.855 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.665 ' O ' HD13 ' B' ' 40' ' ' LEU . 27.2 t-20 -85.09 115.9 23.16 Favored 'General case' 0 N--CA 1.494 1.737 0 O-C-N 121.577 -0.702 . . . . 10.0 110.724 -179.307 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 26.8 mt -71.94 -45.24 65.12 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.616 0 O-C-N 121.276 -0.89 . . . . 10.0 109.5 179.363 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 81.9 p . . . . . 0 C--N 1.303 -1.44 0 CA-C-O 117.942 -1.028 . . . . 10.0 110.031 -179.769 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.492 1.674 0 CA-C-O 121.085 0.469 . . . . 10.0 110.27 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.561 ' O ' ' N ' ' A' ' 4' ' ' ILE . 2.8 mm100 -78.72 -48.54 14.74 Favored 'General case' 0 N--CA 1.488 1.447 0 O-C-N 121.236 -0.915 . . . . 10.0 108.776 179.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.59 ' HA ' HG22 ' A' ' 52' ' ' THR . 1.4 m -40.29 93.25 0.01 OUTLIER 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 108.976 -0.75 . . . . 10.0 108.976 178.745 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 1.011 HD13 ' HB1' ' A' ' 176' ' ' ALA . 1.2 tt -134.55 149.06 29.44 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.592 0 C-N-CA 119.001 -1.079 . . . . 10.0 111.935 -178.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.487 ' HG3' ' CB ' ' A' ' 76' ' ' ASP . 0.3 OUTLIER -126.95 119.38 26.58 Favored 'General case' 0 C--N 1.299 -1.63 0 N-CA-C 108.724 -0.843 . . . . 10.0 108.724 177.997 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.823 ' HA ' HG13 ' A' ' 77' ' ' VAL . 7.5 m -89.32 135.31 33.65 Favored 'General case' 0 C--N 1.302 -1.458 0 CA-C-O 121.732 0.777 . . . . 10.0 109.479 -179.069 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.802 HG11 ' CE3' ' B' ' 36' ' ' TRP . 11.0 t -144.31 158.5 15.28 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.552 0 O-C-N 121.46 -0.775 . . . . 10.0 109.972 -178.684 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.592 ' CG1' ' HB3' ' A' ' 16' ' ' LYS . 30.5 m -63.83 136.11 26.78 Favored 'Isoleucine or valine' 0 C--N 1.302 -1.493 0 O-C-N 121.44 -0.787 . . . . 10.0 111.235 -179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.88 HG11 ' HB3' ' A' ' 78' ' ' PHE . 7.6 t -145.27 -173.35 0.45 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.454 0 O-C-N 121.558 -0.714 . . . . 10.0 109.242 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.712 ' H ' HG12 ' A' ' 9' ' ' VAL . . . 126.93 -129.05 6.42 Favored Glycine 0 N--CA 1.495 2.575 0 N-CA-C 109.942 -1.263 . . . . 10.0 109.942 179.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . . . . . . . . . 87.6 m-20 -105.98 22.95 14.78 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.435 -1.038 . . . . 10.0 109.224 179.445 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.459 ' C ' ' O ' ' B' ' 33' ' ' PRO . . . 100.82 90.07 2.07 Favored Glycine 0 N--CA 1.488 2.145 0 N-CA-C 108.644 -1.782 . . . . 10.0 108.644 -179.047 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.502 ' C ' ' HA ' ' B' ' 35' ' ' GLN . . . -141.18 96.16 2.95 Favored 'General case' 0 N--CA 1.493 1.695 0 O-C-N 121.262 -1.14 . . . . 10.0 110.659 -179.347 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.44 HG23 ' O ' ' B' ' 35' ' ' GLN . 0.6 OUTLIER -82.91 133.59 28.75 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.605 0 O-C-N 120.918 -1.114 . . . . 10.0 109.684 179.704 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.585 ' O ' HD23 ' A' ' 19' ' ' LEU . . . 98.75 2.42 57.35 Favored Glycine 0 N--CA 1.488 2.122 0 C-N-CA 119.914 -1.136 . . . . 10.0 110.356 179.572 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.592 ' HB3' ' CG1' ' A' ' 8' ' ' VAL . 10.2 tttt -51.0 -47.73 61.52 Favored 'General case' 0 N--CA 1.499 2.017 0 O-C-N 121.024 -1.28 . . . . 10.0 111.013 -179.642 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.487 ' O ' ' HB2' ' A' ' 20' ' ' LEU . 22.7 m -62.06 -30.94 71.33 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 120.283 -1.511 . . . . 10.0 109.645 179.63 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.644 ' HB3' ' HA ' ' B' ' 26' ' ' THR . 14.9 m -70.18 -11.8 61.15 Favored 'General case' 0 C--N 1.304 -1.388 0 O-C-N 120.742 -1.224 . . . . 10.0 108.916 179.679 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.992 HD21 ' HB2' ' B' ' 29' ' ' PHE . 4.3 mm? -70.26 -30.67 67.77 Favored 'General case' 0 C--N 1.31 -1.127 0 N-CA-C 106.829 -1.545 . . . . 10.0 106.829 177.535 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.583 HD23 ' H ' ' A' ' 20' ' ' LEU . 0.5 OUTLIER -49.29 -40.36 34.45 Favored 'General case' 0 N--CA 1.488 1.474 0 N-CA-C 106.841 -1.541 . . . . 10.0 106.841 178.127 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.569 ' HB ' ' O ' ' A' ' 18' ' ' CYS . 3.7 mm -67.54 -36.5 76.48 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.872 0 CA-C-O 122.349 1.071 . . . . 10.0 108.948 177.04 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.578 ' HA ' ' CA ' ' A' ' 27' ' ' LYS . 3.5 p -60.05 -42.29 94.16 Favored 'General case' 0 C--N 1.287 -2.113 0 C-N-CA 119.883 -0.727 . . . . 10.0 109.855 -179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 0.818 ' CD2' HD11 ' A' ' 165' ' ' LEU . 31.7 m-85 -71.52 -7.45 47.68 Favored 'General case' 0 N--CA 1.489 1.483 0 O-C-N 120.824 -1.172 . . . . 10.0 108.768 178.649 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.526 ' OG1' ' HA ' ' A' ' 21' ' ' ILE . 66.5 p -107.65 -44.31 4.29 Favored 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 119.531 -0.867 . . . . 10.0 110.143 179.251 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.78 HG23 ' H ' ' A' ' 26' ' ' ASN . 1.9 t -166.2 -65.88 0.03 OUTLIER 'General case' 0 N--CA 1.493 1.711 0 C-N-CA 116.798 -1.961 . . . . 10.0 115.361 -179.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.794 ' CG ' HG21 ' A' ' 33' ' ' VAL . 15.9 t-20 -79.0 45.33 0.61 Allowed 'General case' 0 N--CA 1.49 1.559 0 O-C-N 120.018 -1.676 . . . . 10.0 113.181 -176.589 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.739 ' C ' ' HD3' ' A' ' 29' ' ' PRO . 0.0 OUTLIER -56.04 -126.71 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.01 0 O-C-N 121.577 -0.702 . . . . 10.0 111.392 179.022 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.619 ' O ' ' CG ' ' A' ' 28' ' ' PHE . 3.8 t80 -106.91 55.11 0.19 Allowed Pre-proline 0 N--CA 1.5 2.045 0 N-CA-C 114.337 1.236 . . . . 10.0 114.337 -177.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.739 ' HD3' ' C ' ' A' ' 27' ' ' LYS . 60.9 Cg_endo -95.87 -104.5 0.0 OUTLIER 'Trans proline' 0 CA--C 1.547 1.154 0 C-N-CA 120.827 1.018 . . . . 10.0 110.042 177.568 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 54.1 p -168.87 67.34 0.06 Allowed 'General case' 0 N--CA 1.496 1.854 0 O-C-N 120.711 -1.243 . . . . 10.0 111.564 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.559 ' HG3' ' ND2' ' A' ' 26' ' ' ASN . 22.0 pt-20 -147.45 -173.81 4.36 Favored 'General case' 0 C--N 1.304 -1.398 0 O-C-N 120.808 -1.183 . . . . 10.0 108.294 178.617 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.408 ' C ' HG13 ' A' ' 33' ' ' VAL . 87.0 m-85 -123.64 138.4 54.55 Favored 'General case' 0 N--CA 1.496 1.83 0 O-C-N 120.851 -1.156 . . . . 10.0 111.705 -179.024 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.794 HG21 ' CG ' ' A' ' 26' ' ' ASN 0.263 12.3 m -149.1 133.19 8.77 Favored Pre-proline 0 C--N 1.303 -1.414 0 N-CA-C 108.603 -0.888 . . . . 10.0 108.603 -179.973 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.455 ' O ' HG23 ' A' ' 35' ' ' THR . 50.3 Cg_endo -73.67 89.18 0.99 Allowed 'Trans proline' 0 C--N 1.307 -1.655 0 O-C-N 123.05 1.027 . . . . 10.0 110.567 -179.258 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.615 ' C ' HG23 ' A' ' 36' ' ' VAL . 0.3 OUTLIER -158.34 101.66 1.72 Allowed 'General case' 0 N--CA 1.493 1.71 0 N-CA-C 108.626 -0.879 . . . . 10.0 108.626 179.167 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.615 HG23 ' C ' ' A' ' 35' ' ' THR . 91.2 t -156.88 -97.76 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.495 1.789 0 O-C-N 120.636 -1.29 . . . . 10.0 111.995 -178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.604 ' N ' HG12 ' A' ' 36' ' ' VAL . 1.7 t80 -70.86 126.94 30.95 Favored 'General case' 0 N--CA 1.491 1.587 0 O-C-N 121.342 -0.849 . . . . 10.0 110.522 -179.007 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.604 ' HB3' ' CG ' ' A' ' 56' ' ' PHE . 3.2 t70 -160.89 -177.82 6.4 Favored 'General case' 0 C--N 1.3 -1.545 0 O-C-N 121.055 -1.028 . . . . 10.0 110.103 -179.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.776 ' HB3' HG21 ' B' ' 18' ' ' ILE . 1.2 t-20 -167.63 102.65 0.49 Allowed 'General case' 0 N--CA 1.492 1.627 0 O-C-N 121.378 -0.826 . . . . 10.0 109.125 178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.675 ' CE2' ' CG2' ' A' ' 42' ' ' VAL . 7.3 t80 -92.76 141.73 28.12 Favored 'General case' 0 C--N 1.305 -1.342 0 O-C-N 120.989 -1.07 . . . . 10.0 110.577 -178.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.479 ' O ' ' HB3' ' B' ' 15' ' ' GLU . . . -159.58 98.16 1.37 Allowed 'General case' 0 N--CA 1.49 1.544 0 O-C-N 121.394 -0.816 . . . . 10.0 109.38 179.101 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG13 ' HB3' ' B' ' 15' ' ' GLU . 0.0 OUTLIER -144.79 -174.04 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.637 0 O-C-N 121.2 -0.938 . . . . 10.0 110.622 -179.726 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.622 HG23 ' O ' ' A' ' 51' ' ' TYR . 6.8 m -142.07 146.66 35.69 Favored 'General case' 0 C--N 1.3 -1.56 0 N-CA-C 109.189 -0.671 . . . . 10.0 109.189 179.287 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.553 ' HA ' ' O ' ' B' ' 12' ' ' SER . 18.1 t -120.91 136.86 56.53 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.571 0 N-CA-C 108.36 -0.978 . . . . 10.0 108.36 179.155 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.652 ' HB3' HD23 ' B' ' 10' ' ' LEU . 10.3 mtt -89.36 109.45 20.36 Favored 'General case' 0 C--N 1.29 -1.98 0 C-N-CA 117.736 -1.586 . . . . 10.0 109.181 179.714 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.5 mp -108.25 109.16 27.26 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.711 0 O-C-N 120.185 -1.572 . . . . 10.0 109.544 -178.862 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.685 ' HA2' HG22 ' B' ' 8' ' ' ILE . . . 50.02 28.09 11.75 Favored Glycine 0 N--CA 1.49 2.253 0 N-CA-C 109.564 -1.415 . . . . 10.0 109.564 -179.441 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.483 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.07 -28.0 17.09 Favored Glycine 0 N--CA 1.49 2.244 0 N-CA-C 109.719 -1.352 . . . . 10.0 109.719 179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -77.98 111.15 16.15 Favored Pre-proline 0 N--CA 1.491 1.621 0 O-C-N 121.081 -1.246 . . . . 10.0 110.475 -179.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.483 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 56.0 Cg_endo -73.04 134.64 21.73 Favored 'Trans proline' 0 C--N 1.304 -1.779 0 O-C-N 124.159 1.61 . . . . 10.0 109.561 179.579 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.661 ' CD2' HD23 ' A' ' 53' ' ' LEU . 1.4 t80 -89.34 139.97 29.97 Favored 'General case' 0 C--N 1.3 -1.549 0 O-C-N 120.752 -1.218 . . . . 10.0 109.549 179.034 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.719 ' O ' HG22 ' A' ' 4' ' ' ILE . 0.2 OUTLIER -122.06 97.88 5.68 Favored 'General case' 0 N--CA 1.493 1.693 0 O-C-N 121.229 -0.92 . . . . 10.0 110.343 -179.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.816 HD12 ' C ' ' A' ' 53' ' ' LEU . 3.8 pp -148.85 171.36 16.42 Favored 'General case' 0 N--CA 1.495 1.799 0 O-C-N 120.733 -1.229 . . . . 10.0 111.621 179.271 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.541 ' CA ' ' O ' ' A' ' 40' ' ' TYR . . . -173.28 120.85 0.83 Allowed Glycine 0 N--CA 1.49 2.297 0 N-CA-C 108.377 -1.889 . . . . 10.0 108.377 178.816 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.849 HD12 ' C ' ' A' ' 55' ' ' LEU . 1.5 pp -157.58 144.69 18.3 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 120.408 -1.643 . . . . 10.0 112.845 -178.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.604 ' CG ' ' HB3' ' A' ' 38' ' ' ASP . 0.0 OUTLIER -174.66 172.34 3.05 Favored 'General case' 0 N--CA 1.493 1.71 0 O-C-N 121.251 -0.905 . . . . 10.0 110.384 175.093 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.427 ' OD2' ' SG ' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -90.82 157.33 17.43 Favored 'General case' 0 N--CA 1.497 1.923 0 O-C-N 121.404 -0.81 . . . . 10.0 110.187 179.636 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . . . . . . . . . 20.5 m -129.29 135.74 49.15 Favored 'General case' 0 N--CA 1.496 1.843 0 O-C-N 121.055 -1.028 . . . . 10.0 111.662 -178.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.745 ' HB2' ' HB3' ' A' ' 65' ' ' ASP . . . 55.85 -152.44 0.37 Allowed 'General case' 0 N--CA 1.499 1.98 0 O-C-N 121.39 -0.819 . . . . 10.0 110.934 179.631 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.45 ' O ' HG21 ' B' ' 25' ' ' VAL . . . 96.09 -7.84 67.22 Favored Glycine 0 N--CA 1.485 1.931 0 N-CA-C 108.236 -1.946 . . . . 10.0 108.236 -178.182 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.586 ' CG ' ' HB2' ' B' ' 23' ' ' ASP . 0.0 OUTLIER -152.84 -41.76 0.1 Allowed 'General case' 0 N--CA 1.485 1.318 0 O-C-N 121.509 -0.994 . . . . 10.0 110.444 -179.955 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.668 ' HB3' ' CD1' ' A' ' 64' ' ' TYR . 8.7 mm-40 -73.1 -43.25 62.01 Favored 'General case' 0 N--CA 1.49 1.562 0 C-N-CA 118.502 -1.279 . . . . 10.0 109.386 179.362 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.532 ' CB ' ' O ' ' A' ' 62' ' ' GLU . 2.1 t70 73.46 52.88 0.12 Allowed 'General case' 0 N--CA 1.49 1.549 0 N-CA-C 107.884 -1.154 . . . . 10.0 107.884 -179.342 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.668 ' CD1' ' HB3' ' A' ' 62' ' ' GLU . 0.2 OUTLIER -165.24 0.04 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.532 0 C-N-CA 120.046 -0.662 . . . . 10.0 111.195 -178.69 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.745 ' HB3' ' HB2' ' A' ' 59' ' ' ALA . 6.1 p30 -22.53 90.47 0.01 OUTLIER 'General case' 0 N--CA 1.503 2.179 0 CA-C-O 121.493 0.663 . . . . 10.0 112.487 179.804 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.477 ' O ' ' HD2' ' A' ' 69' ' ' PRO . 0.7 OUTLIER -54.29 -34.16 60.26 Favored 'General case' 0 N--CA 1.489 1.522 0 N-CA-C 108.306 -0.998 . . . . 10.0 108.306 178.483 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.614 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 83.7 mt -76.43 6.24 6.0 Favored 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 116.111 -0.495 . . . . 10.0 111.442 179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.756 ' O ' HD23 ' A' ' 70' ' ' LEU . 0.3 OUTLIER -57.82 -31.29 9.73 Favored Pre-proline 0 N--CA 1.497 1.875 0 O-C-N 120.826 -1.171 . . . . 10.0 113.651 -179.012 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.614 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 52.0 Cg_endo -72.47 81.11 1.57 Allowed 'Trans proline' 0 N--CA 1.487 1.112 0 CA-C-N 119.36 0.807 . . . . 10.0 110.037 179.477 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.772 HD11 ' CB ' ' B' ' 37' ' ' ALA . 0.7 OUTLIER -108.72 -34.14 6.78 Favored 'General case' 0 N--CA 1.485 1.307 0 O-C-N 120.751 -1.218 . . . . 10.0 110.913 -179.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.657 ' O ' ' CB ' ' A' ' 72' ' ' TYR . 0.3 OUTLIER 77.16 -17.3 0.57 Allowed 'General case' 0 N--CA 1.499 1.992 0 O-C-N 121.563 -0.71 . . . . 10.0 110.808 -179.381 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.663 ' N ' HD12 ' A' ' 70' ' ' LEU . 79.2 t80 104.29 115.22 0.0 OUTLIER Pre-proline 0 N--CA 1.516 2.838 0 C-N-CA 123.682 0.793 . . . . 10.0 111.181 179.244 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.4 ' O ' ' HG3' ' A' ' 74' ' ' GLN . 43.9 Cg_endo -71.58 164.7 34.86 Favored 'Trans proline' 0 C--N 1.31 -1.491 0 O-C-N 123.89 1.469 . . . . 10.0 109.307 178.783 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.4 ' HG3' ' O ' ' A' ' 73' ' ' PRO . 1.1 mt-30 -139.35 7.01 2.36 Favored 'General case' 0 N--CA 1.493 1.702 0 O-C-N 120.821 -1.174 . . . . 10.0 111.11 -179.707 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . . . . . . . . . 94.3 m -141.78 84.89 1.91 Allowed 'General case' 0 N--CA 1.487 1.398 0 O-C-N 120.852 -1.155 . . . . 10.0 110.231 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.645 ' O ' HD11 ' A' ' 4' ' ' ILE . 0.7 OUTLIER -174.15 -100.62 0.0 OUTLIER 'General case' 0 C--N 1.298 -1.633 0 O-C-N 121.516 -0.74 . . . . 10.0 109.015 179.84 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.823 HG13 ' HA ' ' A' ' 6' ' ' CYS . 0.2 OUTLIER -163.91 143.19 2.12 Favored 'Isoleucine or valine' 0 C--N 1.299 -1.623 0 O-C-N 121.19 -0.944 . . . . 10.0 108.801 -179.839 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.88 ' HB3' HG11 ' A' ' 9' ' ' VAL . 14.0 m-85 -131.72 119.56 21.51 Favored 'General case' 0 N--CA 1.492 1.629 0 O-C-N 120.899 -1.126 . . . . 10.0 111.942 -178.079 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.667 HD22 HD23 ' A' ' 111' ' ' LEU . 1.1 mm? -90.58 97.85 11.43 Favored 'General case' 0 N--CA 1.491 1.61 0 O-C-N 121.183 -0.948 . . . . 10.0 109.043 178.647 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.637 HG12 ' N ' ' A' ' 10' ' ' GLY . 11.0 m -99.38 150.62 5.09 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 121.224 -0.922 . . . . 10.0 110.35 179.796 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.521 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 3.6 p -123.66 108.41 12.54 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.225 -0.922 . . . . 10.0 111.405 -179.675 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.4 ' O ' ' HA2' ' A' ' 114' ' ' GLY . 97.9 m-85 -91.96 139.54 30.55 Favored 'General case' 0 N--CA 1.495 1.804 0 O-C-N 121.207 -0.933 . . . . 10.0 111.058 179.689 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . . . . . . . . . 69.5 p -77.98 163.64 25.78 Favored 'General case' 0 C--N 1.302 -1.474 0 N-CA-C 108.596 -0.89 . . . . 10.0 108.596 178.013 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 1.016 HG12 HG23 ' A' ' 137' ' ' ILE . 1.9 m -119.43 -14.64 8.67 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.555 0 O-C-N 120.956 -1.09 . . . . 10.0 110.321 -179.469 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.76 HG11 ' HA ' ' A' ' 120' ' ' ARG . 32.7 m -115.11 44.23 0.4 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.651 0 CA-C-O 121.798 0.809 . . . . 10.0 109.868 179.736 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.638 ' CB ' ' HD2' ' A' ' 87' ' ' PRO . 0.3 OUTLIER -133.83 -159.13 0.03 OUTLIER Pre-proline 0 C--N 1.295 -1.776 0 N-CA-C 107.983 -1.117 . . . . 10.0 107.983 179.862 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.638 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 41.6 Cg_endo -73.26 142.85 34.44 Favored 'Trans proline' 0 C--N 1.314 -1.258 0 O-C-N 122.715 0.85 . . . . 10.0 110.26 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . . . . . . . . . 8.9 m -65.29 77.15 0.06 Allowed 'General case' 0 C--N 1.302 -1.49 0 C-N-CA 119.007 -1.077 . . . . 10.0 109.695 -179.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.461 ' N ' ' O ' ' A' ' 87' ' ' PRO . 80.1 p -105.05 -15.71 15.02 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 120.979 -1.076 . . . . 10.0 111.642 -178.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.554 ' CG ' ' N ' ' A' ' 91' ' ' GLU . 3.5 p90 -49.79 -39.73 39.1 Favored 'General case' 0 N--CA 1.49 1.558 0 O-C-N 120.688 -1.258 . . . . 10.0 109.648 -179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.554 ' N ' ' CG ' ' A' ' 90' ' ' PHE . 1.5 tt0 -62.21 -34.17 75.94 Favored 'General case' 0 N--CA 1.489 1.5 0 O-C-N 121.389 -0.82 . . . . 10.0 110.269 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.594 HD22 HG23 ' A' ' 93' ' ' VAL . 0.0 OUTLIER -72.11 -14.01 61.72 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 121.063 -1.023 . . . . 10.0 109.682 179.777 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.594 HG23 HD22 ' A' ' 92' ' ' ASN . 21.2 t -87.95 -18.03 8.34 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.634 0 O-C-N 121.12 -0.988 . . . . 10.0 109.444 179.181 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.857 ' HG3' HD11 ' A' ' 145' ' ' LEU . 3.7 mmtt -85.42 -35.53 21.23 Favored 'General case' 0 C--N 1.298 -1.643 0 N-CA-C 107.978 -1.119 . . . . 10.0 107.978 -179.885 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.556 ' O ' ' HG3' ' A' ' 99' ' ' PRO . 0.6 OUTLIER -82.74 -1.03 50.32 Favored 'General case' 0 C--N 1.301 -1.529 0 CA-C-O 121.162 0.506 . . . . 10.0 109.847 179.024 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.608 ' HB3' ' CD1' ' A' ' 97' ' ' TRP . 0.9 OUTLIER -111.24 -50.01 2.97 Favored 'General case' 0 N--CA 1.491 1.62 0 O-C-N 120.832 -1.167 . . . . 10.0 112.052 -178.999 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.608 ' CD1' ' HB3' ' A' ' 96' ' ' LYS . 50.1 m95 -84.77 -49.36 8.52 Favored 'General case' 0 N--CA 1.496 1.871 0 O-C-N 121.433 -0.792 . . . . 10.0 112.339 -177.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.63 ' N ' ' HD2' ' A' ' 99' ' ' PRO . 23.2 t -52.79 -46.48 96.58 Favored Pre-proline 0 N--CA 1.491 1.615 0 O-C-N 120.657 -1.277 . . . . 10.0 109.951 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.63 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 43.0 Cg_endo -71.75 -16.3 29.88 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 O-C-N 123.392 1.206 . . . . 10.0 109.779 179.113 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.566 ' O ' ' HB ' ' A' ' 101' ' ' ILE . 43.5 tt0 -63.36 -16.55 60.8 Favored 'General case' 0 N--CA 1.492 1.649 0 O-C-N 121.298 -0.876 . . . . 10.0 109.72 179.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.566 ' HB ' ' O ' ' A' ' 100' ' ' GLU . 3.0 mt 69.02 104.86 0.04 OUTLIER 'Isoleucine or valine' 0 N--CA 1.496 1.871 0 CA-C-O 121.472 0.653 . . . . 10.0 110.837 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.723 HG22 ' N ' ' A' ' 103' ' ' HIS . 2.1 m -52.39 -85.25 0.01 OUTLIER 'General case' 0 N--CA 1.492 1.63 0 O-C-N 121.312 -0.868 . . . . 10.0 108.916 179.238 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . 0.723 ' N ' HG22 ' A' ' 102' ' ' THR . 10.9 p-80 -110.54 -4.2 15.61 Favored 'General case' 0 C--N 1.298 -1.662 0 N-CA-C 108.174 -1.047 . . . . 10.0 108.174 177.567 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . 0.503 ' CB ' ' O ' ' A' ' 103' ' ' HIS . 0.5 OUTLIER 162.58 -28.48 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 N-CA-C 107.066 -1.457 . . . . 10.0 107.066 -179.719 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 35.6 t -138.15 131.49 16.58 Favored Pre-proline 0 N--CA 1.489 1.499 0 N-CA-C 108.625 -0.88 . . . . 10.0 108.625 178.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . 0.408 ' HB3' ' O ' ' A' ' 98' ' ' VAL . 42.7 Cg_endo -69.84 67.67 1.77 Allowed 'Trans proline' 0 C--N 1.301 -1.925 0 O-C-N 123.757 1.399 . . . . 10.0 111.256 -178.636 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -108.82 -11.04 15.08 Favored 'General case' 0 C--N 1.31 -1.132 0 O-C-N 121.057 -1.027 . . . . 10.0 110.659 179.559 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . . . . . . . . . 12.9 t -49.21 147.3 5.32 Favored Pre-proline 0 N--CA 1.492 1.674 0 O-C-N 120.653 -1.279 . . . . 10.0 109.715 -179.12 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . . . . . . . . . 40.0 Cg_endo -64.62 130.42 26.4 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 O-C-N 123.852 1.448 . . . . 10.0 110.836 -179.168 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -112.8 102.21 10.25 Favored 'General case' 0 C--N 1.302 -1.462 0 O-C-N 121.44 -0.787 . . . . 10.0 109.667 179.788 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.013 HD13 HG11 ' A' ' 152' ' ' VAL . 2.6 mm? -78.62 95.41 5.23 Favored 'General case' 0 C--N 1.299 -1.593 0 C-N-CA 118.817 -1.153 . . . . 10.0 108.026 179.395 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.616 HD11 HD23 ' A' ' 145' ' ' LEU . 12.5 mt -72.31 137.91 47.0 Favored 'General case' 0 C--N 1.289 -2.025 0 N-CA-C 108.707 -0.849 . . . . 10.0 108.707 179.539 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.521 ' HB ' ' HA ' ' A' ' 81' ' ' CYS . 22.8 t -148.43 158.85 7.22 Favored 'Isoleucine or valine' 0 N--CA 1.495 1.822 0 O-C-N 120.787 -1.196 . . . . 10.0 111.594 -178.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.433 ' H ' ' HA ' ' A' ' 156' ' ' GLU . . . -96.56 148.21 18.92 Favored Glycine 0 N--CA 1.488 2.15 0 N-CA-C 108.765 -1.734 . . . . 10.0 108.765 179.154 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.424 ' OG1' ' O ' ' A' ' 81' ' ' CYS . 30.5 m -111.35 126.71 55.2 Favored 'General case' 0 C--N 1.303 -1.429 0 O-C-N 121.167 -1.196 . . . . 10.0 110.638 -179.383 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 44.17 62.18 2.08 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.438 -0.789 . . . . 10.0 110.412 179.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.021 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.1 OUTLIER -83.89 -29.24 7.42 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.636 0 C-N-CA 119.206 -0.997 . . . . 10.0 109.542 -179.952 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.656 ' O ' HD23 ' A' ' 119' ' ' LEU . 0.3 OUTLIER -52.47 62.37 0.0 OUTLIER 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 122.427 1.108 . . . . 10.0 110.175 -177.58 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.766 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.2 OUTLIER 166.73 -26.66 0.0 OUTLIER 'General case' 0 C--N 1.281 -2.39 0 CA-C-N 114.219 -1.355 . . . . 10.0 107.827 -179.348 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.76 ' HA ' HG11 ' A' ' 85' ' ' VAL . 0.0 OUTLIER -51.14 -33.21 25.73 Favored 'General case' 0 N--CA 1.485 1.302 0 CA-C-O 121.307 0.575 . . . . 10.0 109.731 178.631 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . 0.458 ' OD1' ' HD2' ' A' ' 120' ' ' ARG . 75.7 m-20 -73.77 -11.46 60.4 Favored 'General case' 0 N--CA 1.496 1.863 0 O-C-N 121.056 -1.027 . . . . 10.0 110.396 179.654 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.868 ' O ' HD13 ' A' ' 126' ' ' ILE . 38.0 t0 -86.4 115.86 63.73 Favored Pre-proline 0 N--CA 1.493 1.712 0 O-C-N 121.101 -0.999 . . . . 10.0 110.162 -179.775 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.5 Cg_endo -77.47 21.65 0.62 Allowed 'Trans proline' 0 C--N 1.308 -1.585 0 O-C-N 123.734 1.386 . . . . 10.0 111.447 179.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.48 ' O ' ' CB ' ' A' ' 127' ' ' GLU . 38.7 t -105.59 -51.24 3.04 Favored 'General case' 0 N--CA 1.491 1.601 0 O-C-N 120.829 -1.169 . . . . 10.0 109.993 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.52 HG21 HD12 ' A' ' 119' ' ' LEU . 14.3 t -72.91 -33.01 65.72 Favored 'General case' 0 C--N 1.297 -1.678 0 N-CA-C 104.967 -2.235 . . . . 10.0 104.967 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.868 HD13 ' O ' ' A' ' 122' ' ' ASP 0.296 1.3 mp -54.47 -23.56 11.1 Favored 'Isoleucine or valine' 0 C--N 1.297 -1.703 0 CA-C-N 114.227 -1.351 . . . . 10.0 107.79 176.474 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.499 ' O ' ' HD3' ' A' ' 131' ' ' LYS . 0.7 OUTLIER -49.21 -41.73 37.99 Favored 'General case' 0 C--N 1.304 -1.412 0 CA-C-O 121.583 0.706 . . . . 10.0 110.172 -179.815 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . 0.446 ' HG2' ' OE1' ' A' ' 127' ' ' GLU . 1.8 mmmm -92.44 -41.32 10.37 Favored 'General case' 0 C--N 1.295 -1.774 0 O-C-N 121.603 -0.686 . . . . 10.0 109.994 179.883 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.72 HD23 ' CG2' ' A' ' 85' ' ' VAL . 6.0 mp -65.83 -32.75 74.45 Favored 'General case' 0 N--CA 1.495 1.789 0 O-C-N 121.483 -0.761 . . . . 10.0 109.403 179.091 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.47 ' CB ' ' O ' ' A' ' 126' ' ' ILE . . . -59.88 -51.51 69.42 Favored 'General case' 0 N--CA 1.493 1.688 0 O-C-N 121.247 -0.908 . . . . 10.0 109.869 179.676 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . 0.499 ' HD3' ' O ' ' A' ' 127' ' ' GLU . 0.0 OUTLIER -64.62 -25.33 67.92 Favored 'General case' 0 N--CA 1.489 1.479 0 C-N-CA 119.196 -1.002 . . . . 10.0 108.903 178.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.57 ' ND2' ' N ' ' A' ' 87' ' ' PRO . 2.2 t30 -69.38 -8.64 48.28 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 121.38 -0.825 . . . . 10.0 110.583 -179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.484 ' O ' ' CG ' ' A' ' 133' ' ' LYS . 0.0 OUTLIER -167.67 115.3 0.75 Allowed 'General case' 0 N--CA 1.491 1.62 0 O-C-N 121.231 -0.918 . . . . 10.0 108.557 178.972 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.511 ' N ' ' NE2' ' A' ' 134' ' ' GLN . 0.1 OUTLIER -64.51 -19.9 65.88 Favored 'General case' 0 N--CA 1.493 1.678 0 O-C-N 121.348 -0.845 . . . . 10.0 111.904 -178.262 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.459 ' HA ' ' HD2' ' A' ' 136' ' ' PRO . 4.8 mptt -137.67 106.34 8.33 Favored Pre-proline 0 C--N 1.298 -1.673 0 O-C-N 120.747 -1.221 . . . . 10.0 110.284 179.665 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.459 ' HD2' ' HA ' ' A' ' 135' ' ' LYS . 41.9 Cg_endo -66.74 160.45 46.45 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 O-C-N 123.926 1.487 . . . . 10.0 109.654 179.42 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 1.016 HG23 HG12 ' A' ' 84' ' ' VAL . 3.4 tp -86.86 138.35 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.617 0 O-C-N 120.782 -1.199 . . . . 10.0 109.704 -179.542 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.495 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 55.8 p -131.43 166.33 28.79 Favored Pre-proline 0 C--N 1.298 -1.652 0 O-C-N 121.463 -0.773 . . . . 10.0 109.813 -179.285 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.546 ' HB3' ' CE2' ' A' ' 154' ' ' TYR . 42.4 Cg_endo -67.8 -11.5 32.31 Favored 'Trans proline' 0 C--N 1.304 -1.776 0 O-C-N 123.737 1.388 . . . . 10.0 110.965 -178.99 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . 0.475 ' O ' ' HD3' ' A' ' 144' ' ' LYS . 75.2 mt-10 -75.16 -44.3 47.57 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 120.946 -1.096 . . . . 10.0 109.405 179.219 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 87.3 m -77.72 -36.55 50.81 Favored 'General case' 0 C--N 1.299 -1.626 0 CA-C-O 121.662 0.744 . . . . 10.0 109.388 178.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.445 ' HA ' ' HB3' ' A' ' 145' ' ' LEU . . . -64.93 -49.94 68.41 Favored 'General case' 0 N--CA 1.491 1.597 0 O-C-N 121.471 -0.768 . . . . 10.0 111.476 -179.603 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -51.3 -46.94 62.71 Favored 'General case' 0 N--CA 1.496 1.848 0 O-C-N 121.009 -1.057 . . . . 10.0 109.578 -179.515 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . 0.475 ' HD3' ' O ' ' A' ' 140' ' ' GLU . 3.2 mtpm? -70.68 -30.05 66.53 Favored 'General case' 0 C--N 1.3 -1.584 0 C-N-CA 119.542 -0.863 . . . . 10.0 109.439 179.3 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.857 HD11 ' HG3' ' A' ' 94' ' ' LYS . 0.3 OUTLIER -69.53 -38.95 77.73 Favored 'General case' 0 C--N 1.309 -1.177 0 O-C-N 121.332 -0.855 . . . . 10.0 109.693 178.87 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.641 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -65.71 -49.67 67.67 Favored 'General case' 0 N--CA 1.49 1.547 0 O-C-N 121.056 -1.027 . . . . 10.0 108.263 178.809 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.28 -24.07 67.53 Favored 'General case' 0 C--N 1.297 -1.691 0 C-N-CA 119.852 -0.739 . . . . 10.0 109.166 178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . 0.467 ' HB2' ' O ' ' A' ' 144' ' ' LYS . 21.1 t70 -59.97 -30.93 69.43 Favored 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.278 -0.889 . . . . 10.0 111.177 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 1.029 HD22 ' O ' ' A' ' 149' ' ' LEU . 0.0 OUTLIER -132.87 29.9 4.08 Favored 'General case' 0 N--CA 1.492 1.652 0 O-C-N 120.888 -1.132 . . . . 10.0 111.358 -179.948 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.476 ' HB2' ' O ' ' A' ' 149' ' ' LEU . 31.9 mttt 67.45 36.08 3.98 Favored 'General case' 0 N--CA 1.494 1.727 0 O-C-N 121.328 -0.857 . . . . 10.0 112.176 176.997 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.641 ' HB3' ' HB1' ' A' ' 146' ' ' ALA . . . -69.68 -159.81 0.03 OUTLIER 'General case' 0 C--N 1.291 -1.959 0 C-N-CA 119.221 -0.991 . . . . 10.0 108.929 178.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 1.013 HG11 HD13 ' A' ' 111' ' ' LEU . 2.4 p -114.57 -58.7 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.716 0 O-C-N 120.596 -1.315 . . . . 10.0 112.014 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.618 ' H ' HG13 ' A' ' 152' ' ' VAL . 2.8 ttmm -172.3 148.72 2.15 Favored 'General case' 0 N--CA 1.497 1.875 0 O-C-N 120.367 -1.458 . . . . 10.0 111.675 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.589 ' HA ' ' HB2' ' A' ' 112' ' ' LEU . 83.9 t80 -86.0 121.7 29.0 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.584 -0.697 . . . . 10.0 110.466 178.569 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 0.995 ' HB ' HG22 ' A' ' 168' ' ' VAL . 0.1 OUTLIER -130.03 -174.75 1.25 Allowed 'Isoleucine or valine' 0 N--CA 1.499 2.019 0 O-C-N 120.868 -1.145 . . . . 10.0 110.169 179.4 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.433 ' HA ' ' H ' ' A' ' 114' ' ' GLY . 48.8 mt-10 -148.09 149.23 31.67 Favored 'General case' 0 N--CA 1.496 1.853 0 O-C-N 120.862 -1.149 . . . . 10.0 112.195 -178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.585 ' CB ' ' HB3' ' A' ' 165' ' ' LEU . 25.0 p -148.22 156.09 42.14 Favored 'General case' 0 N--CA 1.5 2.075 0 CA-C-O 121.905 0.859 . . . . 10.0 110.894 179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.594 ' HB2' ' CG ' ' A' ' 163' ' ' LYS . 1.7 t -139.38 89.8 2.36 Favored 'General case' 0 C--N 1.303 -1.415 0 CA-C-O 121.627 0.727 . . . . 10.0 109.495 179.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.787 ' HA ' HD12 ' A' ' 19' ' ' LEU . . . -12.05 -58.96 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.668 0 N-CA-C 113.554 0.946 . . . . 10.0 113.554 -179.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.498 ' O ' ' HG2' ' A' ' 162' ' ' GLN . 0.1 OUTLIER -106.99 -43.12 4.72 Favored 'General case' 0 N--CA 1.5 2.054 0 O-C-N 121.056 -1.028 . . . . 10.0 112.84 -178.12 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.647 HG21 ' CB ' ' A' ' 118' ' ' ASP . 6.3 p -65.25 -23.58 67.09 Favored 'General case' 0 N--CA 1.493 1.713 0 O-C-N 120.264 -1.523 . . . . 10.0 109.577 -178.778 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.588 ' N ' ' OE1' ' A' ' 162' ' ' GLN . 0.3 OUTLIER 71.19 77.9 0.17 Allowed 'General case' 0 N--CA 1.49 1.526 0 O-C-N 121.457 -0.777 . . . . 10.0 110.946 177.546 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.594 ' CG ' ' HB2' ' A' ' 158' ' ' SER . 12.6 mmmt -80.86 23.43 0.55 Allowed 'General case' 0 N--CA 1.499 2.015 0 C-N-CA 119.529 -0.868 . . . . 10.0 111.865 179.483 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . . . . . . . . . . . 77.27 45.41 11.43 Favored Glycine 0 N--CA 1.497 2.702 0 N-CA-C 110.101 -1.2 . . . . 10.0 110.101 179.265 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 0.818 HD11 ' CD2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER -74.96 -3.37 31.86 Favored 'General case' 0 N--CA 1.497 1.919 0 O-C-N 121.339 -1.095 . . . . 10.0 112.774 -179.114 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . 0.566 ' N ' HD13 ' A' ' 165' ' ' LEU . 5.7 ttmt -53.62 -38.99 64.56 Favored 'General case' 0 N--CA 1.493 1.684 0 O-C-N 120.57 -1.331 . . . . 10.0 110.223 179.451 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . . . . . . . . . 21.2 m120 -75.6 -26.1 57.57 Favored 'General case' 0 N--CA 1.498 1.947 0 O-C-N 121.159 -0.963 . . . . 10.0 111.684 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 0.995 HG22 ' HB ' ' A' ' 155' ' ' VAL . 87.7 t -52.88 -51.49 36.67 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.659 0 O-C-N 120.832 -1.167 . . . . 10.0 111.353 -178.374 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.58 ' CZ ' ' OD1' ' A' ' 170' ' ' ASP . 2.3 p90 -85.16 -32.23 22.83 Favored 'General case' 0 C--N 1.293 -1.863 0 C-N-CA 119.699 -0.801 . . . . 10.0 111.084 -178.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.58 ' OD1' ' CZ ' ' A' ' 169' ' ' PHE . 1.0 OUTLIER -56.45 -41.54 76.66 Favored 'General case' 0 N--CA 1.496 1.852 0 O-C-N 120.993 -1.067 . . . . 10.0 110.972 -179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.611 ' HA ' HD21 ' A' ' 174' ' ' LEU . 9.0 pt-20 -69.8 -30.64 68.22 Favored 'General case' 0 N--CA 1.495 1.818 0 O-C-N 120.991 -1.068 . . . . 10.0 110.676 -179.456 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.832 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -71.49 -4.61 27.63 Favored 'General case' 0 N--CA 1.49 1.536 0 O-C-N 121.012 -1.055 . . . . 10.0 109.457 179.26 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.563 HG12 ' O ' ' A' ' 169' ' ' PHE . 44.9 mm -82.52 -46.0 19.37 Favored 'Isoleucine or valine' 0 C--N 1.304 -1.396 0 C-N-CA 119.549 -0.861 . . . . 10.0 108.967 179.403 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 171' ' ' GLU . 0.3 OUTLIER -83.63 -30.97 26.48 Favored 'General case' 0 N--CA 1.484 1.255 0 C-N-CA 118.738 -1.185 . . . . 10.0 108.679 178.553 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -77.03 -0.28 23.95 Favored 'General case' 0 C--N 1.305 -1.343 0 O-C-N 121.393 -0.817 . . . . 10.0 108.97 178.424 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 1.011 ' HB1' HD13 ' A' ' 4' ' ' ILE . . . -90.04 -39.25 13.04 Favored 'General case' 0 N--CA 1.487 1.387 0 O-C-N 121.378 -0.826 . . . . 10.0 109.894 179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.547 ' CD1' ' O ' ' A' ' 173' ' ' ILE . 0.3 OUTLIER -89.74 -19.94 24.16 Favored 'General case' 0 N--CA 1.494 1.753 0 O-C-N 121.508 -0.745 . . . . 10.0 109.393 -179.489 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.408 ' HB2' ' O ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER . . . . . 0 N--CA 1.489 1.494 0 CA-C-O 117.998 -1.001 . . . . 10.0 110.283 -179.795 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.443 0 N-CA-C 109.698 -1.361 . . . . 10.0 109.698 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 4.5 m 55.43 33.28 20.59 Favored 'General case' 0 N--CA 1.492 1.645 0 O-C-N 121.48 -1.012 . . . . 10.0 110.767 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -80.76 89.39 5.79 Favored 'General case' 0 N--CA 1.488 1.465 0 O-C-N 121.099 -1.001 . . . . 10.0 110.274 179.866 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.515 ' C ' ' HD2' ' B' ' 6' ' ' PRO . 3.1 mt-10 -92.81 118.83 31.52 Favored 'General case' 0 C--N 1.305 -1.329 0 O-C-N 121.209 -0.932 . . . . 10.0 110.245 179.703 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.716 ' N ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -71.72 -21.38 0.5 Allowed Pre-proline 0 C--N 1.291 -1.948 0 O-C-N 121.38 -0.825 . . . . 10.0 111.903 178.516 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.716 ' CD ' ' N ' ' B' ' 5' ' ' ARG . 44.3 Cg_endo -88.06 -9.77 5.2 Favored 'Trans proline' 0 C--O 1.214 -0.687 0 O-C-N 122.597 0.788 . . . . 10.0 111.044 -178.442 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.483 ' OE1' ' HB2' ' B' ' 4' ' ' GLU . 0.1 OUTLIER -53.57 171.27 0.09 Allowed 'General case' 0 C--N 1.304 -1.387 0 C-N-CA 118.47 -1.292 . . . . 10.0 109.713 -179.465 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.709 HG23 ' N ' ' B' ' 9' ' ' SER . 0.4 OUTLIER -78.16 -169.27 0.09 OUTLIER 'Isoleucine or valine' 0 C--N 1.292 -1.917 0 N-CA-C 107.011 -1.477 . . . . 10.0 107.011 177.909 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.709 ' N ' HG23 ' B' ' 8' ' ' ILE . 33.3 t -129.02 98.9 5.08 Favored 'General case' 0 C--N 1.276 -2.611 0 C-N-CA 118.994 -1.082 . . . . 10.0 109.387 179.884 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.652 HD23 ' HB3' ' A' ' 45' ' ' MET . 41.1 tp -92.5 99.89 3.27 Favored Pre-proline 0 C--N 1.302 -1.476 0 C-N-CA 118.558 -1.257 . . . . 10.0 108.994 179.414 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.544 ' HD3' ' O ' ' B' ' 9' ' ' SER . 37.8 Cg_endo -61.29 99.43 0.16 Allowed 'Trans proline' 0 C--N 1.302 -1.895 0 O-C-N 123.194 1.102 . . . . 10.0 110.795 -178.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . 0.553 ' O ' ' HA ' ' A' ' 44' ' ' VAL . 4.9 m -152.36 99.83 2.53 Favored 'General case' 0 N--CA 1.486 1.344 0 O-C-N 121.327 -0.858 . . . . 10.0 111.422 179.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . 0.57 ' CB ' ' O ' ' A' ' 43' ' ' THR . 0.6 OUTLIER -169.17 121.96 0.77 Allowed 'General case' 0 N--CA 1.493 1.701 0 O-C-N 121.62 -0.675 . . . . 10.0 110.353 179.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . 0.454 ' CD1' ' N ' ' B' ' 14' ' ' PHE . 0.1 OUTLIER -159.42 102.93 1.58 Allowed 'General case' 0 C--N 1.303 -1.446 0 O-C-N 121.005 -1.059 . . . . 10.0 110.558 179.646 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.69 ' HB3' HG13 ' A' ' 42' ' ' VAL . 0.0 OUTLIER -171.64 106.5 0.22 Allowed 'General case' 0 C--N 1.296 -1.733 0 C-N-CA 119.847 -0.741 . . . . 10.0 110.273 -179.947 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 13.2 t-80 -166.82 123.24 1.2 Allowed 'General case' 0 N--CA 1.494 1.729 0 O-C-N 120.998 -1.064 . . . . 10.0 110.87 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.507 ' O ' HG23 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -161.97 111.28 1.51 Allowed 'General case' 0 N--CA 1.486 1.336 0 O-C-N 121.229 -0.92 . . . . 10.0 110.183 179.814 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.776 HG21 ' HB3' ' A' ' 39' ' ' ASN . 1.6 pp -153.43 -173.34 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.497 1.895 0 O-C-N 121.044 -1.035 . . . . 10.0 110.296 -179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.551 ' O ' ' CD2' ' A' ' 37' ' ' PHE . 64.2 m80 -115.35 142.8 46.2 Favored 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.082 -1.011 . . . . 10.0 110.569 179.541 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.537 ' HA ' ' HB3' ' A' ' 37' ' ' PHE . 1.1 p -142.88 149.11 18.96 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.485 -0.76 . . . . 10.0 111.346 -178.828 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.506 ' O ' ' HB3' ' B' ' 22' ' ' PHE . . . -87.95 -124.67 2.12 Favored Glycine 0 N--CA 1.491 2.363 0 N-CA-C 108.254 -1.938 . . . . 10.0 108.254 178.787 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.589 ' CD1' ' N ' ' B' ' 22' ' ' PHE . 0.0 OUTLIER 173.54 85.03 0.0 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 O-C-N 121.241 -1.152 . . . . 10.0 111.363 179.0 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.586 ' HB2' ' CG ' ' A' ' 61' ' ' GLN . 9.4 t70 -144.05 159.41 42.66 Favored 'General case' 0 C--N 1.295 -1.795 0 O-C-N 121.683 -0.635 . . . . 10.0 109.537 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.626 ' HB1' ' HG3' ' B' ' 28' ' ' GLU . . . -61.03 -5.54 1.46 Allowed 'General case' 0 N--CA 1.494 1.765 0 O-C-N 120.905 -1.122 . . . . 10.0 109.913 178.43 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.548 ' HA ' ' HB2' ' B' ' 28' ' ' GLU 0.276 0.5 OUTLIER -49.67 -34.98 9.3 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.542 0 CA-C-O 122.883 1.325 . . . . 10.0 107.566 178.878 . . . . . . . . 4 4 . 1 . 019 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.644 ' HA ' ' HB3' ' A' ' 18' ' ' CYS . 0.6 OUTLIER -52.63 -32.59 42.59 Favored 'General case' 0 C--N 1.287 -2.115 0 CA-C-N 114.111 -1.404 . . . . 10.0 111.064 -179.133 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 27' ' ' LYS . . . -123.79 -7.92 6.48 Favored Glycine 0 N--CA 1.492 2.378 0 N-CA-C 108.655 -1.778 . . . . 10.0 108.655 179.106 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.626 ' HG3' ' HB1' ' B' ' 24' ' ' ALA . 18.3 mt-10 -83.74 39.94 0.71 Allowed 'General case' 0 N--CA 1.487 1.39 0 O-C-N 121.68 -0.894 . . . . 10.0 110.453 -179.52 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.992 ' HB2' HD21 ' A' ' 19' ' ' LEU . 46.3 t80 -76.07 94.97 3.53 Favored 'General case' 0 C--N 1.29 -1.984 0 N-CA-C 107.756 -1.202 . . . . 10.0 107.756 179.056 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.605 HG21 ' CE1' ' A' ' 28' ' ' PHE . 34.3 p -112.89 -19.22 12.04 Favored 'General case' 0 C--N 1.281 -2.37 0 CA-C-N 115.19 -0.914 . . . . 10.0 110.491 -178.272 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . . . . . . . . . . . -116.62 -167.53 14.68 Favored Glycine 0 N--CA 1.488 2.157 0 N-CA-C 109.129 -1.588 . . . . 10.0 109.129 179.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.632 HD13 ' N ' ' B' ' 32' ' ' ILE . 0.1 OUTLIER -133.59 69.47 76.5 Favored Pre-proline 0 N--CA 1.488 1.452 0 O-C-N 121.239 -1.153 . . . . 10.0 110.811 179.49 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.496 ' O ' ' C ' ' B' ' 34' ' ' GLU . 42.4 Cg_endo -74.22 156.57 46.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 O-C-N 124.088 1.572 . . . . 10.0 108.464 178.806 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.496 ' C ' ' O ' ' B' ' 33' ' ' PRO . 0.0 OUTLIER -35.21 148.63 0.02 OUTLIER 'General case' 0 N--CA 1.503 2.211 0 O-C-N 121.268 -0.895 . . . . 10.0 111.003 -178.522 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.55 ' NE2' ' O ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -73.26 -71.22 0.32 Allowed 'General case' 0 N--CA 1.496 1.862 0 CA-C-O 121.496 0.665 . . . . 10.0 112.039 -178.175 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.802 ' CE3' HG11 ' A' ' 7' ' ' VAL . 41.1 t90 -157.26 34.65 0.28 Allowed 'General case' 0 C--N 1.288 -2.105 0 N-CA-C 108.141 -1.059 . . . . 10.0 108.141 -179.574 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.772 ' CB ' HD11 ' A' ' 70' ' ' LEU . . . -157.8 83.69 0.88 Allowed 'General case' 0 C--N 1.287 -2.137 0 N-CA-C 107.339 -1.356 . . . . 10.0 107.339 -179.243 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.559 ' O ' ' N ' ' B' ' 41' ' ' GLN . 0.0 OUTLIER -81.19 51.13 1.54 Allowed 'General case' 0 C--N 1.301 -1.523 0 N-CA-C 107.8 -1.185 . . . . 10.0 107.8 179.612 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.58 HD12 ' O ' ' B' ' 37' ' ' ALA . 1.2 mp -39.13 -29.49 0.04 OUTLIER 'General case' 0 C--N 1.294 -1.842 0 CA-C-O 121.86 0.838 . . . . 10.0 109.197 -178.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.57 ' O ' ' N ' ' B' ' 42' ' ' THR . 0.8 OUTLIER -87.39 32.45 0.71 Allowed 'General case' 0 N--CA 1.494 1.741 0 O-C-N 121.791 -0.568 . . . . 10.0 109.716 178.749 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.559 ' N ' ' O ' ' B' ' 38' ' ' ARG . 15.7 tp60 -33.39 -30.7 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.969 0 CA-C-O 121.468 0.651 . . . . 10.0 110.133 -179.454 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.793 ' O ' ' N ' ' B' ' 44' ' ' ASN . 69.1 p -120.26 65.18 0.83 Allowed 'General case' 0 C--N 1.3 -1.568 0 N-CA-C 105.758 -1.942 . . . . 10.0 105.758 177.573 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . 0.513 ' N ' ' O ' ' B' ' 40' ' ' LEU . 10.4 t -41.28 66.48 0.0 OUTLIER 'General case' 0 N--CA 1.501 2.097 0 CA-C-O 121.744 0.783 . . . . 10.0 112.282 -177.053 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.793 ' N ' ' O ' ' B' ' 42' ' ' THR . 0.8 OUTLIER 52.53 168.79 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.603 0.716 . . . . 10.0 110.947 179.217 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 40.5 mt -55.3 -29.81 24.03 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.415 0 O-C-N 121.446 -0.784 . . . . 10.0 108.927 178.691 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 7.8 m . . . . . 0 C--N 1.304 -1.382 0 CA-C-O 117.949 -1.024 . . . . 10.0 110.169 -179.461 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.561 ' O ' ' HA ' ' A' ' 177' ' ' LEU . 2.2 ptm . . . . . 0 N--CA 1.495 1.79 0 CA-C-O 121.401 0.62 . . . . 10.0 110.149 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLN . . . . . 0.562 ' HA ' ' HA ' ' A' ' 177' ' ' LEU . 0.0 OUTLIER -74.92 -33.66 62.02 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 108.814 -0.81 . . . . 10.0 108.814 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.849 HG23 HD13 ' A' ' 53' ' ' LEU . 1.2 m -40.79 118.6 0.99 Allowed 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 108.926 -0.768 . . . . 10.0 108.926 178.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' ILE . . . . . 0.955 HG13 ' HB1' ' A' ' 176' ' ' ALA . 0.0 OUTLIER -104.16 127.27 58.54 Favored 'Isoleucine or valine' 0 C--N 1.298 -1.649 0 C-N-CA 117.16 -1.816 . . . . 10.0 110.77 -179.757 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LYS . . . . . 0.954 ' O ' HG22 ' A' ' 75' ' ' THR . 1.8 mttp -121.42 97.78 5.67 Favored 'General case' 0 C--N 1.283 -2.303 0 N-CA-C 107.037 -1.468 . . . . 10.0 107.037 177.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.506 ' SG ' HG11 ' A' ' 77' ' ' VAL . 19.6 m -118.19 120.43 37.67 Favored 'General case' 0 C--N 1.3 -1.545 0 C-N-CA 118.848 -1.141 . . . . 10.0 111.216 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' VAL . . . . . 0.661 ' N ' HG21 ' A' ' 75' ' ' THR . 47.1 t -127.55 144.6 36.95 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.561 0 N-CA-C 108.488 -0.93 . . . . 10.0 108.488 178.421 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.867 HG21 ' OG1' ' A' ' 17' ' ' THR . 33.6 m -62.73 116.84 3.04 Favored 'Isoleucine or valine' 0 C--N 1.291 -1.974 0 O-C-N 121.287 -0.883 . . . . 10.0 110.709 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' VAL . . . . . 0.6 HG12 ' N ' ' A' ' 10' ' ' GLY . 77.2 t -115.72 177.69 1.96 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.34 0 O-C-N 121.182 -0.949 . . . . 10.0 109.136 179.64 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' GLY . . . . . 0.6 ' N ' HG12 ' A' ' 9' ' ' VAL . . . 167.78 172.64 35.06 Favored Glycine 0 N--CA 1.488 2.146 0 N-CA-C 109.14 -1.584 . . . . 10.0 109.14 -179.62 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' ASP . . . . . 0.401 ' HA ' HD21 ' B' ' 40' ' ' LEU . 8.3 p-10 -96.23 18.49 13.59 Favored 'General case' 0 C--N 1.3 -1.568 0 O-C-N 121.118 -1.225 . . . . 10.0 109.731 179.733 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLY . . . . . 0.54 ' CA ' ' OE1' ' B' ' 34' ' ' GLU . . . 74.61 51.74 7.92 Favored Glycine 0 N--CA 1.49 2.25 0 N-CA-C 108.583 -1.807 . . . . 10.0 108.583 -179.252 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -104.67 -54.41 2.52 Favored 'General case' 0 N--CA 1.493 1.704 0 O-C-N 121.529 -0.983 . . . . 10.0 110.785 -179.304 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.445 ' HB ' ' CE1' ' B' ' 29' ' ' PHE . 6.3 m -136.26 -7.15 0.84 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.706 0 O-C-N 121.088 -1.007 . . . . 10.0 111.586 -179.279 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . 0.452 ' HA3' HD11 ' B' ' 32' ' ' ILE . . . 81.64 81.63 0.86 Allowed Glycine 0 N--CA 1.494 2.55 0 N-CA-C 109.415 -1.474 . . . . 10.0 109.415 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.531 ' O ' ' HB2' ' A' ' 19' ' ' LEU . 3.8 tptt -63.04 -27.24 69.27 Favored 'General case' 0 N--CA 1.496 1.862 0 O-C-N 121.54 -0.977 . . . . 10.0 112.008 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.867 ' OG1' HG21 ' A' ' 8' ' ' VAL . 93.9 m -55.15 -51.85 65.15 Favored 'General case' 0 N--CA 1.497 1.924 0 O-C-N 120.399 -1.438 . . . . 10.0 110.188 -179.411 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . 0.666 ' CB ' ' HA ' ' B' ' 26' ' ' THR . 31.0 p -74.81 0.23 16.14 Favored 'General case' 0 C--N 1.298 -1.632 0 C-N-CA 119.44 -0.904 . . . . 10.0 109.985 -179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' LEU . . . . . 0.992 HD13 ' CB ' ' A' ' 159' ' ' ALA . 0.1 OUTLIER -88.16 -36.07 17.05 Favored 'General case' 0 N--CA 1.488 1.473 0 O-C-N 121.003 -1.061 . . . . 10.0 109.097 179.355 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LEU . . . . . 0.48 HD23 ' O ' ' A' ' 16' ' ' LYS . 4.3 mm? -51.68 -38.55 55.48 Favored 'General case' 0 N--CA 1.49 1.553 0 N-CA-C 107.3 -1.37 . . . . 10.0 107.3 177.65 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ILE . . . . . 0.627 HG22 ' HA2' ' B' ' 27' ' ' GLY . 0.5 OUTLIER -76.67 -51.34 19.46 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.573 0 CA-C-N 115.722 -0.672 . . . . 10.0 109.641 178.609 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' SER . . . . . 0.728 ' CB ' ' HB1' ' A' ' 159' ' ' ALA . 49.3 m -46.27 -40.85 12.22 Favored 'General case' 0 C--N 1.285 -2.21 0 C-N-CA 119.077 -1.049 . . . . 10.0 108.846 -179.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' TYR . . . . . 1.021 ' CB ' HD22 ' A' ' 165' ' ' LEU . 0.7 OUTLIER -64.22 -23.28 67.25 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.187 -0.946 . . . . 10.0 109.461 177.774 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' THR . . . . . 0.575 ' N ' ' O ' ' A' ' 21' ' ' ILE . 63.2 m -105.04 -29.97 10.07 Favored 'General case' 0 N--CA 1.494 1.738 0 CA-C-O 121.686 0.755 . . . . 10.0 109.889 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' THR . . . . . 0.839 HG22 ' HB ' ' A' ' 33' ' ' VAL . 0.0 OUTLIER -137.73 64.5 1.51 Allowed 'General case' 0 C--N 1.301 -1.538 0 N-CA-C 106.73 -1.581 . . . . 10.0 106.73 -179.938 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . 0.441 ' HA ' ' O ' ' A' ' 22' ' ' SER . 0.1 OUTLIER -33.96 49.75 0.0 OUTLIER 'General case' 0 N--CA 1.509 2.517 0 C-N-CA 125.583 1.553 . . . . 10.0 114.406 -177.638 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.802 ' N ' ' O ' ' A' ' 25' ' ' THR . 0.6 OUTLIER -67.22 109.12 2.96 Favored 'General case' 0 C--N 1.279 -2.47 0 O-C-N 121.381 -0.824 . . . . 10.0 110.749 179.909 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PHE . . . . . 0.594 ' HB3' ' HD3' ' A' ' 29' ' ' PRO . 43.4 t80 -176.12 -56.52 0.0 OUTLIER Pre-proline 0 N--CA 1.495 1.807 0 O-C-N 121.237 -0.914 . . . . 10.0 110.406 177.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PRO . . . . . 0.594 ' HD3' ' HB3' ' A' ' 28' ' ' PHE . 41.2 Cg_endo -69.69 -67.17 0.03 OUTLIER 'Trans proline' 0 C--N 1.314 -1.253 0 O-C-N 123.126 1.066 . . . . 10.0 110.58 179.676 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 19.2 p -166.29 58.67 0.1 Allowed 'General case' 0 N--CA 1.488 1.452 0 O-C-N 121.271 -0.893 . . . . 10.0 109.714 179.716 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.514 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 59.0 mm-40 -127.45 114.77 17.92 Favored 'General case' 0 C--N 1.303 -1.445 0 O-C-N 121.158 -0.964 . . . . 10.0 110.271 -179.643 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' TYR . . . . . 0.466 ' C ' ' HD3' ' A' ' 34' ' ' PRO . 5.9 t80 -73.39 59.98 0.61 Allowed 'General case' 0 C--N 1.296 -1.754 0 O-C-N 121.725 -0.609 . . . . 10.0 110.358 179.919 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.839 ' HB ' HG22 ' A' ' 25' ' ' THR . 20.3 m -119.99 76.11 22.01 Favored Pre-proline 0 N--CA 1.488 1.432 0 O-C-N 121.172 -0.955 . . . . 10.0 110.912 -179.51 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PRO . . . . . 0.53 ' O ' HG23 ' A' ' 35' ' ' THR . 44.2 Cg_endo -87.7 132.84 3.0 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.809 1.673 . . . . 10.0 110.99 179.996 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' THR . . . . . 0.609 ' OG1' HD12 ' A' ' 21' ' ' ILE . 0.3 OUTLIER -157.02 102.64 1.99 Allowed 'General case' 0 N--CA 1.496 1.835 0 O-C-N 120.729 -1.232 . . . . 10.0 111.9 179.619 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' VAL . . . . . 0.71 ' HB ' HG23 ' B' ' 20' ' ' VAL . 78.6 t -95.29 10.87 4.67 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.961 0 O-C-N 120.654 -1.279 . . . . 10.0 109.017 178.164 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' PHE . . . . . 0.786 ' CD2' HG21 ' B' ' 18' ' ' ILE . 1.3 m-30 -33.91 158.89 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.883 0 CA-C-N 115.789 -0.641 . . . . 10.0 110.087 179.455 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASP . . . . . 0.927 ' HB2' ' HA ' ' B' ' 18' ' ' ILE . 1.5 m-20 -85.81 -149.02 0.13 Allowed 'General case' 0 N--CA 1.487 1.412 0 C-N-CA 117.903 -1.519 . . . . 10.0 108.594 179.055 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ASN . . . . . 0.749 ' CG ' HD11 ' A' ' 55' ' ' LEU . 1.3 t-20 -133.7 -163.62 1.38 Allowed 'General case' 0 C--N 1.296 -1.738 0 N-CA-C 108.327 -0.99 . . . . 10.0 108.327 179.78 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . . . . . . . . . 53.0 p90 -128.05 163.27 24.94 Favored 'General case' 0 C--N 1.298 -1.645 0 O-C-N 120.605 -1.31 . . . . 10.0 112.194 -178.121 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' ALA . . . . . 0.512 ' HA ' ' HA3' ' A' ' 54' ' ' GLY . . . -153.65 153.72 32.82 Favored 'General case' 0 N--CA 1.491 1.576 0 N-CA-C 108.613 -0.884 . . . . 10.0 108.613 179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' VAL . . . . . 0.69 HG22 ' H ' ' A' ' 43' ' ' THR . 0.5 OUTLIER -172.34 -168.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.309 -1.172 0 O-C-N 120.528 -1.357 . . . . 10.0 111.625 -179.019 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' THR . . . . . 0.69 ' H ' HG22 ' A' ' 42' ' ' VAL . 92.3 m -132.39 153.31 50.92 Favored 'General case' 0 C--N 1.296 -1.759 0 CA-C-N 115.503 -0.771 . . . . 10.0 109.887 179.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . 0.714 HG13 HD12 ' A' ' 46' ' ' ILE . 0.3 OUTLIER -142.07 -171.61 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.621 0 O-C-N 121.038 -1.039 . . . . 10.0 110.395 -179.736 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' MET . . . . . 0.575 ' HB2' ' HG2' ' B' ' 11' ' ' PRO . 85.6 mtp -142.65 138.45 30.68 Favored 'General case' 0 N--CA 1.49 1.528 0 O-C-N 121.664 -0.647 . . . . 10.0 109.265 179.207 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . 0.714 HD12 HG13 ' A' ' 44' ' ' VAL . 1.1 mp -146.91 115.56 1.23 Allowed 'Isoleucine or valine' 0 N--CA 1.493 1.705 0 O-C-N 121.222 -0.924 . . . . 10.0 109.714 -179.725 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLY . . . . . 0.531 ' N ' ' O ' ' B' ' 9' ' ' SER . . . 41.01 27.58 0.2 Allowed Glycine 0 N--CA 1.49 2.294 0 C-N-CA 119.656 -1.259 . . . . 10.0 109.98 179.591 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLY . . . . . 0.534 ' O ' ' HD3' ' A' ' 50' ' ' PRO . . . 104.37 -16.18 49.22 Favored Glycine 0 N--CA 1.494 2.55 0 O-C-N 121.189 -1.183 . . . . 10.0 111.412 179.366 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' GLU . . . . . 0.442 ' OE2' ' HB2' ' B' ' 4' ' ' GLU . 1.7 mp0 -98.69 105.04 28.0 Favored Pre-proline 0 N--CA 1.501 2.083 0 O-C-N 120.553 -1.557 . . . . 10.0 110.332 -179.965 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' PRO . . . . . 0.534 ' HD3' ' O ' ' A' ' 48' ' ' GLY . 52.2 Cg_endo -82.91 151.74 14.42 Favored 'Trans proline' 0 C--N 1.311 -1.441 0 O-C-N 123.894 1.471 . . . . 10.0 112.269 -178.827 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.624 ' CG ' HG12 ' A' ' 44' ' ' VAL . 2.8 m-30 -81.52 174.07 11.79 Favored 'General case' 0 N--CA 1.49 1.528 0 N-CA-C 108.559 -0.904 . . . . 10.0 108.559 178.041 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.919 ' O ' HG22 ' A' ' 4' ' ' ILE . 16.2 m -152.73 124.1 7.67 Favored 'General case' 0 C--N 1.302 -1.481 0 O-C-N 120.611 -1.306 . . . . 10.0 112.249 -179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.849 HD13 HG23 ' A' ' 3' ' ' THR . 0.3 OUTLIER 64.65 -169.21 0.2 Allowed 'General case' 0 C--N 1.309 -1.169 0 CA-C-O 121.93 0.871 . . . . 10.0 113.282 177.541 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . 0.512 ' HA3' ' HA ' ' A' ' 41' ' ' ALA . . . -169.72 -167.17 29.86 Favored Glycine 0 N--CA 1.485 1.954 0 N-CA-C 109.054 -1.618 . . . . 10.0 109.054 -178.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.749 HD11 ' CG ' ' A' ' 39' ' ' ASN . 1.6 pp -111.22 156.57 21.25 Favored 'General case' 0 N--CA 1.487 1.42 0 O-C-N 121.303 -1.116 . . . . 10.0 110.751 -179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PHE . . . . . 0.474 ' N ' HD12 ' A' ' 55' ' ' LEU . 56.9 m-85 -132.88 166.03 23.26 Favored 'General case' 0 N--CA 1.496 1.87 0 N-CA-C 109.346 -0.613 . . . . 10.0 109.346 178.538 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . 0.56 ' HB3' ' HA ' ' A' ' 38' ' ' ASP . 8.1 t70 -104.57 179.69 4.2 Favored 'General case' 0 N--CA 1.495 1.821 0 O-C-N 120.772 -1.205 . . . . 10.0 110.701 179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' THR . . . . . 0.539 ' O ' ' O ' ' A' ' 57' ' ' ASP . 12.0 t -45.26 -167.56 0.0 OUTLIER 'General case' 0 N--CA 1.492 1.628 0 CA-C-O 122.469 1.128 . . . . 10.0 112.425 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' ALA . . . . . 0.572 ' O ' ' N ' ' A' ' 62' ' ' GLU . . . -132.94 63.35 1.64 Allowed 'General case' 0 N--CA 1.488 1.472 0 O-C-N 121.478 -0.764 . . . . 10.0 109.114 179.575 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' GLY . . . . . 0.484 ' HA3' HG11 ' A' ' 36' ' ' VAL . . . -49.42 -39.94 30.04 Favored Glycine 0 N--CA 1.484 1.885 0 N-CA-C 106.646 -2.582 . . . . 10.0 106.646 178.914 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . 0.553 ' CG ' ' HB2' ' A' ' 63' ' ' ASP . 2.7 tp60 -63.92 -35.62 81.25 Favored 'General case' 0 C--N 1.306 -1.297 0 N-CA-C 107.677 -1.231 . . . . 10.0 107.677 177.215 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLU . . . . . 0.572 ' N ' ' O ' ' A' ' 59' ' ' ALA . 4.7 mt-10 55.63 32.76 19.88 Favored 'General case' 0 N--CA 1.489 1.485 0 CA-C-O 121.939 0.876 . . . . 10.0 109.819 178.876 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . 0.603 ' HB3' ' CZ ' ' A' ' 64' ' ' TYR . 5.6 t70 -90.08 -5.68 56.29 Favored 'General case' 0 C--N 1.289 -2.026 0 N-CA-C 108.527 -0.916 . . . . 10.0 108.527 179.35 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' TYR . . . . . 0.603 ' CZ ' ' HB3' ' A' ' 63' ' ' ASP . 0.2 OUTLIER -139.23 -38.33 0.49 Allowed 'General case' 0 C--N 1.305 -1.351 0 C-N-CA 119.914 -0.714 . . . . 10.0 109.13 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . 0.594 ' O ' ' CG ' ' A' ' 68' ' ' ARG . 2.2 p30 38.9 27.89 0.02 OUTLIER 'General case' 0 N--CA 1.49 1.573 0 C-N-CA 120.187 -0.605 . . . . 10.0 109.998 -179.225 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ARG . . . . . 0.5 ' N ' ' O ' ' A' ' 64' ' ' TYR . 0.7 OUTLIER -58.17 -36.87 73.68 Favored 'General case' 0 N--CA 1.492 1.65 0 O-C-N 120.745 -1.222 . . . . 10.0 109.173 179.777 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.671 ' C ' ' HD2' ' A' ' 69' ' ' PRO . 5.1 mt -91.77 13.86 17.02 Favored 'General case' 0 N--CA 1.49 1.536 0 CA-C-O 121.331 0.586 . . . . 10.0 110.49 179.805 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ARG . . . . . 0.622 ' N ' ' CD ' ' A' ' 69' ' ' PRO . 0.0 OUTLIER -81.47 -13.12 0.2 Allowed Pre-proline 0 N--CA 1.495 1.804 0 N-CA-C 114.341 1.238 . . . . 10.0 114.341 -179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.671 ' HD2' ' C ' ' A' ' 67' ' ' LEU . 42.1 Cg_endo -69.71 67.76 1.7 Allowed 'Trans proline' 0 C--N 1.32 -0.969 0 N-CA-C 109.031 -1.18 . . . . 10.0 109.031 179.573 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.667 HD22 ' HA ' ' B' ' 37' ' ' ALA . 4.9 mt -50.46 -71.03 0.07 Allowed 'General case' 0 N--CA 1.497 1.904 0 CA-C-O 121.559 0.695 . . . . 10.0 111.665 -178.91 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.605 ' HA ' ' HA ' ' B' ' 39' ' ' LEU . 21.7 p -35.31 -29.52 0.01 OUTLIER 'General case' 0 N--CA 1.5 2.029 0 CA-C-N 115.761 -0.654 . . . . 10.0 109.958 -179.831 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.553 ' N ' ' O ' ' A' ' 70' ' ' LEU . 0.2 OUTLIER -98.29 105.83 31.55 Favored Pre-proline 0 C--N 1.301 -1.504 0 O-C-N 121.415 -0.803 . . . . 10.0 108.859 178.67 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' PRO . . . . . 0.488 ' HD3' ' O ' ' A' ' 71' ' ' SER . 43.4 Cg_endo -77.83 113.93 3.55 Favored 'Trans proline' 0 C--N 1.308 -1.564 0 O-C-N 123.859 1.452 . . . . 10.0 110.721 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLN . . . . . 0.525 ' NE2' ' O ' ' A' ' 72' ' ' TYR . 0.0 OUTLIER -133.77 60.61 1.7 Allowed 'General case' 0 N--CA 1.496 1.838 0 O-C-N 121.477 -0.764 . . . . 10.0 110.288 -179.664 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' THR . . . . . 0.954 HG22 ' O ' ' A' ' 5' ' ' LYS . 3.8 m -144.25 97.33 3.03 Favored 'General case' 0 C--N 1.307 -1.243 0 O-C-N 120.934 -1.104 . . . . 10.0 109.545 179.317 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' ASP . . . . . 0.477 ' C ' ' O ' ' A' ' 75' ' ' THR . 14.5 t70 -28.83 -38.33 0.01 OUTLIER 'General case' 0 N--CA 1.498 1.932 0 CA-C-N 115.897 -0.592 . . . . 10.0 111.662 -179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' VAL . . . . . 0.73 HG13 ' O ' ' A' ' 5' ' ' LYS . 0.2 OUTLIER -121.09 136.96 56.37 Favored 'Isoleucine or valine' 0 N--CA 1.497 1.893 0 O-C-N 121.269 -0.894 . . . . 10.0 109.706 179.131 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' PHE . . . . . 0.585 ' CE1' ' HB ' ' A' ' 75' ' ' THR . 41.8 m-85 -115.7 144.67 43.61 Favored 'General case' 0 N--CA 1.491 1.622 0 O-C-N 121.311 -0.868 . . . . 10.0 110.488 179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LEU . . . . . 0.923 ' CD2' HD23 ' A' ' 111' ' ' LEU . 0.5 OUTLIER -114.01 102.34 10.09 Favored 'General case' 0 N--CA 1.49 1.553 0 O-C-N 121.39 -0.819 . . . . 10.0 109.129 179.81 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' VAL . . . . . 0.533 ' O ' ' HB ' ' A' ' 113' ' ' VAL . 4.4 p -96.8 151.82 4.05 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.688 0 O-C-N 121.128 -0.982 . . . . 10.0 108.812 179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' CYS . . . . . 0.523 ' HA ' ' HB ' ' A' ' 113' ' ' VAL . 19.8 t -134.8 100.37 4.59 Favored 'General case' 0 N--CA 1.49 1.545 0 O-C-N 120.847 -1.158 . . . . 10.0 112.496 -177.836 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' PHE . . . . . 0.549 ' CE2' ' CE1' ' A' ' 90' ' ' PHE . 47.8 m-85 -88.45 156.18 19.26 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 121.316 -0.865 . . . . 10.0 109.884 178.638 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' SER . . . . . 0.6 ' HB2' ' CB ' ' A' ' 86' ' ' SER . 18.8 m -85.01 147.12 26.85 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 120.843 -1.161 . . . . 10.0 109.282 179.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' VAL . . . . . 0.856 HG23 ' O ' ' A' ' 115' ' ' THR . 43.7 t -47.62 -60.94 0.54 Allowed 'Isoleucine or valine' 0 C--N 1.302 -1.462 0 O-C-N 121.077 -1.014 . . . . 10.0 109.466 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . 0.799 ' HB ' HD22 ' A' ' 129' ' ' LEU . 3.8 t -78.75 -62.52 1.36 Allowed 'Isoleucine or valine' 0 N--CA 1.491 1.585 0 N-CA-C 108.476 -0.935 . . . . 10.0 108.476 178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . 0.618 ' N ' HD22 ' A' ' 129' ' ' LEU . 0.7 OUTLIER 44.8 179.05 0.0 OUTLIER Pre-proline 0 N--CA 1.496 1.847 0 CA-C-O 121.58 0.705 . . . . 10.0 112.375 178.218 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.503 ' HD2' ' CB ' ' A' ' 86' ' ' SER . 52.2 Cg_endo -78.72 145.99 20.75 Favored 'Trans proline' 0 C--N 1.305 -1.737 0 O-C-N 124.462 1.77 . . . . 10.0 109.985 179.32 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' SER . . . . . 0.492 ' HB3' ' HG2' ' A' ' 135' ' ' LYS . 95.2 p -68.38 67.81 0.13 Allowed 'General case' 0 N--CA 1.492 1.631 0 O-C-N 121.063 -1.023 . . . . 10.0 110.309 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' SER . . . . . 0.536 ' O ' ' ND2' ' A' ' 92' ' ' ASN . 0.3 OUTLIER -136.69 13.37 3.17 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 120.929 -1.107 . . . . 10.0 111.666 -179.495 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . 0.549 ' CE1' ' CE2' ' A' ' 82' ' ' PHE . 16.9 t80 -71.33 -34.15 70.29 Favored 'General case' 0 C--N 1.303 -1.423 0 O-C-N 120.619 -1.301 . . . . 10.0 110.64 179.818 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLU . . . . . 0.408 ' O ' ' HG3' ' A' ' 94' ' ' LYS . 4.5 mt-10 -74.69 -29.89 61.38 Favored 'General case' 0 N--CA 1.49 1.541 0 O-C-N 121.026 -1.046 . . . . 10.0 110.982 -179.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 89' ' ' SER . 0.0 OUTLIER -86.89 -9.69 55.12 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 118.741 -1.183 . . . . 10.0 109.496 179.56 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . 0.544 HG13 ' CD2' ' A' ' 97' ' ' TRP . 14.4 t -90.35 -36.39 8.32 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 O-C-N 120.996 -1.065 . . . . 10.0 109.102 178.283 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' LYS . . . . . 0.817 ' HE2' HD11 ' A' ' 145' ' ' LEU . 0.0 OUTLIER -71.26 -25.39 62.45 Favored 'General case' 0 C--N 1.297 -1.69 0 O-C-N 121.368 -0.833 . . . . 10.0 110.095 179.621 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' GLU . . . . . 0.493 ' N ' ' HD2' ' A' ' 94' ' ' LYS . 12.9 pt-20 -78.52 -25.06 45.47 Favored 'General case' 0 N--CA 1.491 1.609 0 O-C-N 121.339 -0.851 . . . . 10.0 111.616 -179.155 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' LYS . . . . . 0.559 ' O ' ' HG2' ' A' ' 100' ' ' GLU . 25.2 mttp -110.93 -50.65 2.93 Favored 'General case' 0 C--N 1.301 -1.538 0 O-C-N 120.892 -1.13 . . . . 10.0 111.998 -178.606 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' TRP . . . . . 0.865 ' CH2' HD13 ' B' ' 40' ' ' LEU . 23.1 m0 -64.42 -17.19 63.55 Favored 'General case' 0 C--N 1.292 -1.917 0 O-C-N 121.297 -0.877 . . . . 10.0 112.405 -177.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' VAL . . . . . 0.871 HG11 ' CD2' ' A' ' 149' ' ' LEU . 53.8 t -82.91 -50.7 0.72 Allowed Pre-proline 0 N--CA 1.501 2.09 0 O-C-N 120.772 -1.205 . . . . 10.0 112.033 -179.217 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.549 ' HD2' ' N ' ' A' ' 98' ' ' VAL . 41.8 Cg_endo -68.58 -6.47 17.83 Favored 'Trans proline' 0 C--N 1.311 -1.417 0 O-C-N 123.119 1.063 . . . . 10.0 111.209 -178.845 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' GLU . . . . . 0.559 ' HG2' ' O ' ' A' ' 96' ' ' LYS . 73.6 mm-40 -90.48 -32.0 16.54 Favored 'General case' 0 N--CA 1.49 1.566 0 O-C-N 120.876 -1.14 . . . . 10.0 110.464 -179.887 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ILE . . . . . 0.744 ' O ' HD13 ' A' ' 101' ' ' ILE . 0.2 OUTLIER -91.96 -29.14 4.61 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.497 0 O-C-N 121.038 -1.039 . . . . 10.0 110.239 179.459 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . 0.797 HG23 ' O ' ' A' ' 98' ' ' VAL . 69.9 p -62.26 -12.18 19.08 Favored 'General case' 0 N--CA 1.491 1.602 0 O-C-N 121.184 -0.947 . . . . 10.0 109.915 179.627 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' HIS . . . . . . . . . . . . . 60.1 t-80 -57.56 -40.68 79.44 Favored 'General case' 0 C--N 1.303 -1.441 0 O-C-N 121.558 -0.714 . . . . 10.0 110.639 -179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' HIS . . . . . . . . . . . . . 34.6 m170 -79.96 -33.76 39.29 Favored 'General case' 0 C--N 1.296 -1.73 0 O-C-N 121.604 -0.685 . . . . 10.0 110.803 -179.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' CYS . . . . . . . . . . . . . 41.3 t -136.29 128.49 17.37 Favored Pre-proline 0 N--CA 1.488 1.465 0 O-C-N 121.191 -0.943 . . . . 10.0 110.092 179.803 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' PRO . . . . . . . . . . . . . 47.0 Cg_endo -70.29 126.5 13.02 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 O-C-N 124.117 1.588 . . . . 10.0 111.851 -179.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.408 ' HG2' ' HB2' ' A' ' 150' ' ' LYS . 0.2 OUTLIER 55.84 52.07 11.32 Favored 'General case' 0 N--CA 1.495 1.793 0 O-C-N 121.37 -0.831 . . . . 10.0 111.119 178.707 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' THR . . . . . 0.469 ' CG2' ' HD2' ' A' ' 109' ' ' PRO . 22.4 m -63.31 145.17 97.24 Favored Pre-proline 0 N--CA 1.492 1.651 0 O-C-N 121.321 -0.862 . . . . 10.0 109.61 179.063 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' PRO . . . . . 0.469 ' HD2' ' CG2' ' A' ' 108' ' ' THR . 41.1 Cg_endo -68.37 157.63 61.01 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 O-C-N 123.642 1.338 . . . . 10.0 109.365 179.537 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' PHE . . . . . 0.59 ' H ' HG12 ' A' ' 152' ' ' VAL . 0.5 OUTLIER -159.95 121.97 3.3 Favored 'General case' 0 N--CA 1.487 1.394 0 O-C-N 120.94 -1.1 . . . . 10.0 111.237 -178.921 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.923 HD23 ' CD2' ' A' ' 79' ' ' LEU . 1.0 OUTLIER -92.29 102.51 15.01 Favored 'General case' 0 C--N 1.3 -1.562 0 CA-C-O 122.149 0.975 . . . . 10.0 110.682 179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' LEU . . . . . 0.548 ' HB2' ' HA ' ' A' ' 154' ' ' TYR . 71.2 mt -75.56 135.24 40.58 Favored 'General case' 0 C--N 1.291 -1.972 0 N-CA-C 108.817 -0.809 . . . . 10.0 108.817 179.081 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' VAL . . . . . 0.684 ' CG2' HG11 ' A' ' 168' ' ' VAL . 19.4 t -133.75 169.96 20.77 Favored 'Isoleucine or valine' 0 N--CA 1.498 1.939 0 O-C-N 120.654 -1.279 . . . . 10.0 112.694 -177.867 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLY . . . . . 0.575 ' N ' ' CG1' ' A' ' 113' ' ' VAL . . . -140.35 107.11 0.52 Allowed Glycine 0 N--CA 1.486 2.032 0 N-CA-C 107.583 -2.207 . . . . 10.0 107.583 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.856 ' O ' HG23 ' A' ' 84' ' ' VAL . 2.8 t -106.75 -179.51 3.96 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.046 -1.267 . . . . 10.0 111.708 -178.543 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' GLN . . . . . 0.542 ' NE2' ' HB3' ' A' ' 83' ' ' SER . 16.9 mt-30 61.56 48.16 5.98 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.798 -0.564 . . . . 10.0 110.074 -179.442 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ILE . . . . . 1.068 ' C ' HD12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -107.37 -50.09 7.84 Favored 'Isoleucine or valine' 0 N--CA 1.494 1.758 0 O-C-N 121.167 -0.958 . . . . 10.0 110.118 179.646 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ASP . . . . . 0.982 ' CB ' HG21 ' A' ' 161' ' ' THR . 11.6 t0 -52.7 61.66 0.0 OUTLIER 'General case' 0 N--CA 1.497 1.92 0 CA-C-O 122.191 0.996 . . . . 10.0 109.947 -177.334 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' LEU . . . . . 0.792 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.9 OUTLIER 152.57 -24.62 0.0 OUTLIER 'General case' 0 N--CA 1.499 2.023 0 CA-C-N 114.339 -1.3 . . . . 10.0 108.41 -179.205 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ARG . . . . . 0.535 ' N ' ' O ' ' A' ' 117' ' ' ILE . 0.0 OUTLIER -46.73 -37.4 8.39 Favored 'General case' 0 N--CA 1.491 1.612 0 O-C-N 121.451 -0.781 . . . . 10.0 109.135 179.076 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ASP . . . . . . . . . . . . . 29.2 t70 -54.0 -21.99 9.46 Favored 'General case' 0 N--CA 1.489 1.487 0 O-C-N 121.42 -0.8 . . . . 10.0 109.542 178.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ASP . . . . . 0.532 ' OD1' ' HD2' ' A' ' 123' ' ' PRO . 22.9 t0 -84.28 131.77 49.63 Favored Pre-proline 0 N--CA 1.494 1.728 0 O-C-N 121.702 -0.624 . . . . 10.0 110.889 -179.344 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.534 ' HA ' ' HB ' ' A' ' 126' ' ' ILE . 51.7 Cg_endo -78.22 24.66 0.54 Allowed 'Trans proline' 0 C--N 1.312 -1.363 0 O-C-N 123.925 1.487 . . . . 10.0 111.265 179.452 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' SER . . . . . 0.482 ' HB2' ' OD2' ' A' ' 122' ' ' ASP . 37.1 m -102.76 -46.96 4.55 Favored 'General case' 0 N--CA 1.492 1.657 0 O-C-N 121.002 -1.061 . . . . 10.0 109.843 -179.913 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' THR . . . . . 0.597 HG21 HD12 ' A' ' 119' ' ' LEU . 6.8 t -78.41 -27.42 46.65 Favored 'General case' 0 C--N 1.296 -1.729 0 N-CA-C 105.493 -2.039 . . . . 10.0 105.493 176.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ILE . . . . . 0.789 ' HA ' HD12 ' A' ' 129' ' ' LEU 0.29 1.1 mp -57.06 -25.26 22.32 Favored 'Isoleucine or valine' 0 C--N 1.303 -1.422 0 N-CA-C 107.337 -1.357 . . . . 10.0 107.337 177.072 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' GLU . . . . . 0.429 ' O ' ' HB3' ' A' ' 130' ' ' ALA . 5.4 tm-20 -50.24 -50.18 50.65 Favored 'General case' 0 N--CA 1.489 1.507 0 CA-C-O 121.747 0.784 . . . . 10.0 110.284 179.554 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' LYS . . . . . . . . . . . . . 11.3 mmmt -65.06 -44.77 87.91 Favored 'General case' 0 C--N 1.295 -1.784 0 O-C-N 121.691 -0.63 . . . . 10.0 111.062 -179.513 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' LEU . . . . . 0.799 HD22 ' HB ' ' A' ' 85' ' ' VAL . 5.6 mt -59.92 -35.51 75.06 Favored 'General case' 0 C--N 1.298 -1.644 0 O-C-N 121.235 -0.916 . . . . 10.0 109.702 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' ALA . . . . . 0.66 ' HA ' ' NE2' ' A' ' 134' ' ' GLN . . . -49.62 -42.24 44.33 Favored 'General case' 0 N--CA 1.494 1.751 0 O-C-N 121.606 -0.684 . . . . 10.0 110.294 179.353 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.58 -19.9 42.17 Favored 'General case' 0 C--N 1.297 -1.71 0 O-C-N 121.46 -0.775 . . . . 10.0 110.498 -179.882 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ASN . . . . . 0.527 ' OD1' ' HA ' ' A' ' 129' ' ' LEU . 0.6 OUTLIER -123.07 43.89 2.82 Favored 'General case' 0 N--CA 1.497 1.877 0 O-C-N 120.953 -1.092 . . . . 10.0 112.348 -178.711 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LYS . . . . . 0.523 ' C ' ' NE2' ' A' ' 134' ' ' GLN . 1.1 mptm? 67.72 150.74 0.07 Allowed 'General case' 0 N--CA 1.496 1.829 0 O-C-N 121.004 -1.06 . . . . 10.0 110.239 179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' GLN . . . . . 0.66 ' NE2' ' HA ' ' A' ' 130' ' ' ALA . 0.0 OUTLIER -116.77 66.24 0.72 Allowed 'General case' 0 N--CA 1.49 1.566 0 O-C-N 121.219 -0.926 . . . . 10.0 111.387 -178.624 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' LYS . . . . . 0.492 ' HG2' ' HB3' ' A' ' 88' ' ' SER . 5.0 mmmt -104.83 94.68 7.8 Favored Pre-proline 0 N--CA 1.488 1.451 0 O-C-N 121.112 -0.992 . . . . 10.0 108.958 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' PRO . . . . . 0.513 ' HD3' ' O ' ' A' ' 134' ' ' GLN . 43.7 Cg_endo -71.22 161.43 45.84 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 O-C-N 124.075 1.566 . . . . 10.0 110.681 -179.165 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ILE . . . . . 0.474 ' O ' HG23 ' A' ' 137' ' ' ILE . 3.9 tp -120.13 121.41 65.76 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.399 0 O-C-N 121.215 -0.928 . . . . 10.0 110.186 179.647 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' THR . . . . . 0.424 ' HB ' ' HD2' ' A' ' 139' ' ' PRO . 19.4 p -108.46 164.29 15.06 Favored Pre-proline 0 C--N 1.299 -1.588 0 O-C-N 121.22 -0.925 . . . . 10.0 109.206 179.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' PRO . . . . . 0.674 ' HA ' ' HB3' ' A' ' 142' ' ' ALA . 38.3 Cg_endo -67.51 -29.16 37.61 Favored 'Trans proline' 0 C--N 1.303 -1.828 0 O-C-N 123.589 1.31 . . . . 10.0 109.525 179.881 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' GLU . . . . . . . . . . . . . 47.9 tt0 -59.78 -34.12 72.6 Favored 'General case' 0 C--N 1.302 -1.478 0 N-CA-C 108.653 -0.869 . . . . 10.0 108.653 178.571 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' THR . . . . . . . . . . . . . 46.5 m -93.38 -33.51 13.84 Favored 'General case' 0 C--N 1.303 -1.422 0 CA-C-O 121.746 0.784 . . . . 10.0 109.054 178.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . 0.674 ' HB3' ' HA ' ' A' ' 139' ' ' PRO . . . -75.38 -38.56 59.93 Favored 'General case' 0 N--CA 1.487 1.399 0 O-C-N 121.601 -0.687 . . . . 10.0 110.833 -179.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLU . . . . . 0.466 ' HB2' ' O ' ' A' ' 139' ' ' PRO . 3.0 mt-10 -59.54 -49.23 78.6 Favored 'General case' 0 C--N 1.298 -1.631 0 O-C-N 121.258 -0.901 . . . . 10.0 109.836 -179.931 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -60.04 -45.26 93.42 Favored 'General case' 0 N--CA 1.488 1.449 0 O-C-N 121.204 -0.935 . . . . 10.0 109.156 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' LEU . . . . . 0.817 HD11 ' HE2' ' A' ' 94' ' ' LYS . 2.8 tt -60.05 -49.37 77.93 Favored 'General case' 0 C--N 1.306 -1.294 0 N-CA-C 108.228 -1.026 . . . . 10.0 108.228 178.866 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' ALA . . . . . 0.436 ' HB1' ' HB3' ' A' ' 151' ' ' ALA . . . -55.25 -38.71 68.87 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 121.373 -0.829 . . . . 10.0 109.128 178.641 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.459 ' HG3' ' O ' ' A' ' 143' ' ' GLU . 1.6 mtp-105 -72.23 -4.85 31.89 Favored 'General case' 0 C--N 1.299 -1.605 0 O-C-N 121.603 -0.686 . . . . 10.0 109.873 179.383 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' ASP . . . . . . . . . . . . . 21.4 t0 -82.15 -52.04 7.38 Favored 'General case' 0 N--CA 1.491 1.615 0 O-C-N 121.095 -1.003 . . . . 10.0 110.278 179.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' LEU . . . . . 0.871 ' CD2' HG11 ' A' ' 98' ' ' VAL . 0.2 OUTLIER -89.94 4.86 48.76 Favored 'General case' 0 N--CA 1.494 1.746 0 O-C-N 121.425 -0.797 . . . . 10.0 109.309 -179.892 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' LYS . . . . . 0.512 ' CB ' ' O ' ' A' ' 149' ' ' LEU . 1.8 mttp 73.16 31.17 1.48 Allowed 'General case' 0 N--CA 1.486 1.373 0 N-CA-C 108.295 -1.002 . . . . 10.0 108.295 -178.355 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' ALA . . . . . 0.458 ' O ' ' O ' ' A' ' 150' ' ' LYS . . . -55.89 -159.82 0.0 OUTLIER 'General case' 0 C--N 1.3 -1.566 0 CA-C-N 115.445 -0.798 . . . . 10.0 109.952 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' VAL . . . . . 0.593 HG11 HD13 ' A' ' 111' ' ' LEU . 0.8 OUTLIER -119.08 -54.74 3.83 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.366 0 C-N-CA 118.941 -1.103 . . . . 10.0 111.516 179.895 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' LYS . . . . . 0.473 ' HB2' HG22 ' A' ' 152' ' ' VAL . 0.1 OUTLIER -171.53 147.14 2.32 Favored 'General case' 0 N--CA 1.497 1.884 0 C-N-CA 117.934 -1.506 . . . . 10.0 112.621 -179.512 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' TYR . . . . . 0.555 ' CD1' ' HB1' ' A' ' 142' ' ' ALA . 43.2 t80 -97.64 100.05 11.44 Favored 'General case' 0 N--CA 1.491 1.616 0 O-C-N 121.735 -0.603 . . . . 10.0 109.45 178.102 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' VAL . . . . . 1.007 ' HB ' HG22 ' A' ' 168' ' ' VAL . 1.9 t -101.39 -170.05 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.492 1.657 0 O-C-N 121.23 -0.919 . . . . 10.0 110.367 -179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' GLU . . . . . 0.7 ' H ' HG12 ' A' ' 155' ' ' VAL . 12.8 pt-20 -148.22 168.2 23.11 Favored 'General case' 0 N--CA 1.492 1.648 0 O-C-N 121.376 -0.828 . . . . 10.0 110.184 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' CYS . . . . . 0.594 ' HB2' HD12 ' A' ' 165' ' ' LEU . 7.3 p -176.99 164.8 2.33 Favored 'General case' 0 N--CA 1.496 1.849 0 O-C-N 121.157 -0.965 . . . . 10.0 110.596 -179.705 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' SER . . . . . 0.628 ' CB ' HG23 ' A' ' 161' ' ' THR . 60.2 m -146.27 128.23 15.49 Favored 'General case' 0 C--N 1.302 -1.479 0 O-C-N 121.605 -0.685 . . . . 10.0 109.939 179.589 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ALA . . . . . 0.992 ' CB ' HD13 ' A' ' 19' ' ' LEU . . . -63.86 -81.64 0.03 OUTLIER 'General case' 0 C--N 1.301 -1.535 0 O-C-N 121.621 -0.674 . . . . 10.0 111.597 -179.465 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.94 HD21 ' CE2' ' B' ' 29' ' ' PHE . 0.4 OUTLIER -28.06 -52.95 0.09 Allowed 'General case' 0 N--CA 1.508 2.442 0 CA-C-O 122.57 1.176 . . . . 10.0 109.481 -179.056 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' THR . . . . . 0.982 HG21 ' CB ' ' A' ' 118' ' ' ASP . 0.1 OUTLIER -95.74 -102.28 0.16 Allowed 'General case' 0 C--N 1.29 -2.009 0 CA-C-N 114.731 -1.122 . . . . 10.0 110.43 179.845 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' GLN . . . . . 0.626 ' HB2' ' CE2' ' A' ' 23' ' ' TYR . 0.0 OUTLIER 159.27 73.36 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.42 0 N-CA-C 106.876 -1.527 . . . . 10.0 106.876 -178.989 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' LYS . . . . . 0.552 ' HD2' HG12 ' A' ' 117' ' ' ILE . 0.0 OUTLIER -97.35 27.37 4.25 Favored 'General case' 0 C--N 1.297 -1.698 0 C-N-CA 118.566 -1.254 . . . . 10.0 112.545 -177.017 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' GLY . . . . . 0.458 ' C ' ' HB3' ' A' ' 157' ' ' CYS . . . 135.95 14.96 0.95 Allowed Glycine 0 N--CA 1.487 2.048 0 C-N-CA 118.708 -1.711 . . . . 10.0 111.99 177.945 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' LEU . . . . . 1.021 HD22 ' CB ' ' A' ' 23' ' ' TYR . 0.9 OUTLIER -49.36 -53.44 22.34 Favored 'General case' 0 C--N 1.306 -1.284 0 O-C-N 120.177 -1.778 . . . . 10.0 109.833 179.322 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' LYS . . . . . . . . . . . . . 4.7 mtmt -67.14 -29.49 69.23 Favored 'General case' 0 C--N 1.299 -1.618 0 CA-C-O 121.463 0.649 . . . . 10.0 109.588 179.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ASN . . . . . 0.589 ' C ' HG11 ' A' ' 155' ' ' VAL . 1.3 m120 -62.3 -32.11 72.8 Favored 'General case' 0 N--CA 1.491 1.584 0 O-C-N 121.479 -0.763 . . . . 10.0 111.4 -178.854 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' VAL . . . . . 1.007 HG22 ' HB ' ' A' ' 155' ' ' VAL . 46.5 t -70.88 -49.47 50.05 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.628 0 O-C-N 120.448 -1.408 . . . . 10.0 109.171 179.246 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' PHE . . . . . 0.432 ' O ' HG13 ' A' ' 173' ' ' ILE . 92.4 t80 -59.31 -22.92 61.97 Favored 'General case' 0 C--N 1.296 -1.737 0 O-C-N 121.762 -0.586 . . . . 10.0 110.452 179.522 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.472 ' OD2' ' HA ' ' A' ' 167' ' ' ASN . 80.8 m-20 -59.17 -50.93 72.15 Favored 'General case' 0 N--CA 1.49 1.572 0 O-C-N 121.252 -0.905 . . . . 10.0 110.416 -179.403 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' GLU . . . . . 0.503 ' HA ' ' CD2' ' A' ' 174' ' ' LEU . 51.2 mp0 -65.88 -31.52 72.51 Favored 'General case' 0 N--CA 1.494 1.728 0 O-C-N 121.036 -1.04 . . . . 10.0 108.883 179.068 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' ALA . . . . . 0.656 ' O ' ' HB2' ' A' ' 176' ' ' ALA . . . -63.63 -24.19 67.69 Favored 'General case' 0 C--N 1.298 -1.632 0 O-C-N 121.814 -0.554 . . . . 10.0 109.625 179.815 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ILE . . . . . 0.724 ' O ' HD12 ' A' ' 177' ' ' LEU . 72.1 mt -63.61 -43.71 98.29 Favored 'Isoleucine or valine' 0 C--N 1.306 -1.285 0 C-N-CA 119.091 -1.044 . . . . 10.0 108.542 178.731 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' LEU . . . . . 0.799 ' H ' HD22 ' A' ' 174' ' ' LEU . 0.2 OUTLIER -71.75 -42.33 67.37 Favored 'General case' 0 N--CA 1.486 1.367 0 O-C-N 121.188 -0.945 . . . . 10.0 110.179 179.665 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ALA . . . . . . . . . . . . . . . -79.1 -0.12 30.3 Favored 'General case' 0 C--N 1.3 -1.57 0 O-C-N 121.526 -0.733 . . . . 10.0 109.985 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' ALA . . . . . 0.955 ' HB1' HG13 ' A' ' 4' ' ' ILE . . . -83.33 -44.57 14.73 Favored 'General case' 0 N--CA 1.488 1.435 0 O-C-N 121.264 -0.898 . . . . 10.0 109.851 179.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LEU . . . . . 0.724 HD12 ' O ' ' A' ' 173' ' ' ILE . 0.6 OUTLIER -98.85 -17.56 18.36 Favored 'General case' 0 N--CA 1.492 1.663 0 O-C-N 121.386 -0.822 . . . . 10.0 109.302 -179.958 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLU . . . . . 0.454 ' HB3' ' O ' ' A' ' 174' ' ' LEU . 0.8 OUTLIER . . . . . 0 C--N 1.301 -1.527 0 CA-C-O 118.003 -0.998 . . . . 10.0 110.028 179.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.389 0 N-CA-C 109.789 -1.324 . . . . 10.0 109.789 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 2' ' ' SER . . . . . . . . . . . . . 42.6 t -126.54 150.2 48.94 Favored 'General case' 0 N--CA 1.492 1.659 0 O-C-N 121.278 -1.131 . . . . 10.0 110.196 179.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 3' ' ' LYS . . . . . 0.478 ' HD3' ' HA ' ' A' ' 174' ' ' LEU . 0.0 OUTLIER -117.96 88.41 2.91 Favored 'General case' 0 C--N 1.303 -1.437 0 O-C-N 121.365 -0.835 . . . . 10.0 109.272 179.778 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 4' ' ' GLU . . . . . 0.442 ' HB2' ' OE2' ' A' ' 49' ' ' GLU . 2.8 mm-40 -87.36 178.18 6.91 Favored 'General case' 0 N--CA 1.494 1.763 0 CA-C-O 121.84 0.828 . . . . 10.0 111.338 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 5' ' ' ARG . . . . . 0.632 ' CB ' ' CD ' ' B' ' 6' ' ' PRO . 0.0 OUTLIER -68.12 -149.27 0.0 OUTLIER Pre-proline 0 N--CA 1.491 1.585 0 N-CA-C 107.607 -1.257 . . . . 10.0 107.607 178.719 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 6' ' ' PRO . . . . . 0.632 ' CD ' ' CB ' ' B' ' 5' ' ' ARG . 39.6 Cg_endo -72.14 0.37 7.39 Favored 'Trans proline' 0 C--N 1.316 -1.161 0 CA-C-N 119.325 0.795 . . . . 10.0 110.589 -179.45 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 7' ' ' GLU . . . . . 0.486 ' HB3' ' HA3' ' A' ' 47' ' ' GLY . 1.8 mm-40 46.21 -165.8 0.02 OUTLIER 'General case' 0 N--CA 1.489 1.492 0 O-C-N 121.201 -0.937 . . . . 10.0 110.427 179.162 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 8' ' ' ILE . . . . . 0.663 HD12 ' OG ' ' B' ' 9' ' ' SER . 1.4 pp -80.35 -45.01 22.27 Favored 'Isoleucine or valine' 0 N--CA 1.493 1.719 0 O-C-N 121.273 -0.892 . . . . 10.0 111.661 -179.412 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 9' ' ' SER . . . . . 0.663 ' OG ' HD12 ' B' ' 8' ' ' ILE . 67.4 m -122.08 151.32 41.01 Favored 'General case' 0 N--CA 1.49 1.554 0 O-C-N 120.747 -1.221 . . . . 10.0 112.137 -178.754 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 10' ' ' LEU . . . . . 0.875 HD22 ' O ' ' B' ' 10' ' ' LEU . 0.0 OUTLIER -170.84 97.53 0.43 Allowed Pre-proline 0 C--N 1.305 -1.328 0 O-C-N 121.363 -0.836 . . . . 10.0 113.153 179.842 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 11' ' ' PRO . . . . . 0.575 ' HG2' ' HB2' ' A' ' 45' ' ' MET . 45.3 Cg_endo -77.35 156.08 32.76 Favored 'Trans proline' 0 C--N 1.309 -1.537 0 N-CA-C 107.877 -1.624 . . . . 10.0 107.877 177.016 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 12' ' ' SER . . . . . . . . . . . . . 50.2 m -117.68 163.49 16.39 Favored 'General case' 0 C--N 1.3 -1.574 0 O-C-N 120.587 -1.321 . . . . 10.0 111.966 -178.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 13' ' ' ASP . . . . . . . . . . . . . 3.8 t0 -150.32 176.46 10.87 Favored 'General case' 0 C--N 1.302 -1.468 0 N-CA-C 108.073 -1.084 . . . . 10.0 108.073 178.526 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 14' ' ' PHE . . . . . . . . . . . . . 4.9 p90 -170.63 144.61 2.38 Favored 'General case' 0 C--N 1.295 -1.761 0 O-C-N 120.784 -1.198 . . . . 10.0 110.792 -179.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 15' ' ' GLU . . . . . 0.439 ' HB3' ' O ' ' A' ' 41' ' ' ALA . 59.8 tt0 -141.02 137.48 32.99 Favored 'General case' 0 C--N 1.304 -1.384 0 N-CA-C 109.234 -0.654 . . . . 10.0 109.234 179.814 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 16' ' ' HIS . . . . . . . . . . . . . 65.1 m170 -121.77 129.44 52.68 Favored 'General case' 0 N--CA 1.494 1.74 0 O-C-N 121.036 -1.04 . . . . 10.0 112.103 -178.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 17' ' ' THR . . . . . 0.647 ' C ' HD12 ' B' ' 18' ' ' ILE . 0.0 OUTLIER -141.54 98.22 3.31 Favored 'General case' 0 N--CA 1.493 1.72 0 N-CA-C 108.605 -0.887 . . . . 10.0 108.605 178.223 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 18' ' ' ILE . . . . . 0.927 ' HA ' ' HB2' ' A' ' 38' ' ' ASP . 1.4 mp -106.45 140.87 23.17 Favored 'Isoleucine or valine' 0 C--N 1.301 -1.513 0 N-CA-C 113.326 0.861 . . . . 10.0 113.326 -177.236 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 19' ' ' HIS . . . . . 0.585 ' N ' ' HB2' ' A' ' 38' ' ' ASP . 33.8 m170 -132.89 123.59 26.29 Favored 'General case' 0 C--O 1.215 -0.716 0 O-C-N 121.353 -0.842 . . . . 10.0 110.94 178.713 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 20' ' ' VAL . . . . . 0.71 HG23 ' HB ' ' A' ' 36' ' ' VAL . 1.4 p -140.37 130.18 27.95 Favored 'Isoleucine or valine' 0 N--CA 1.496 1.86 0 O-C-N 121.483 -0.761 . . . . 10.0 109.69 179.546 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 21' ' ' GLY . . . . . 0.528 ' HA3' ' HA ' ' A' ' 61' ' ' GLN . . . -145.56 10.87 1.71 Allowed Glycine 0 N--CA 1.49 2.264 0 N-CA-C 109.846 -1.302 . . . . 10.0 109.846 179.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 22' ' ' PHE . . . . . 0.769 ' HB3' HG21 ' B' ' 25' ' ' VAL . 0.4 OUTLIER -143.93 85.26 1.81 Allowed 'General case' 0 C--N 1.302 -1.486 0 O-C-N 121.334 -1.098 . . . . 10.0 109.794 179.535 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 23' ' ' ASP . . . . . 0.691 ' O ' ' HB3' ' B' ' 24' ' ' ALA . 10.7 t70 -56.97 151.88 14.01 Favored 'General case' 0 C--N 1.297 -1.71 0 CA-C-O 121.565 0.698 . . . . 10.0 111.416 -179.524 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 24' ' ' ALA . . . . . 0.691 ' HB3' ' O ' ' B' ' 23' ' ' ASP . . . 69.98 19.84 6.76 Favored 'General case' 0 N--CA 1.494 1.769 0 O-C-N 121.557 -0.714 . . . . 10.0 111.099 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 25' ' ' VAL . . . . . 0.769 HG21 ' HB3' ' B' ' 22' ' ' PHE . 25.3 t -110.47 -39.52 3.79 Favored 'Isoleucine or valine' 0 C--N 1.3 -1.583 0 O-C-N 121.057 -1.027 . . . . 10.0 110.281 179.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 26' ' ' THR . . . . . 0.666 ' HA ' ' CB ' ' A' ' 18' ' ' CYS . 6.5 m -94.95 -10.04 32.23 Favored 'General case' 0 C--N 1.306 -1.305 0 O-C-N 121.314 -0.866 . . . . 10.0 112.605 -177.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 27' ' ' GLY . . . . . 0.627 ' HA2' HG22 ' A' ' 21' ' ' ILE . . . -111.59 -15.89 9.89 Favored Glycine 0 N--CA 1.489 2.175 0 N-CA-C 108.629 -1.788 . . . . 10.0 108.629 179.308 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 28' ' ' GLU . . . . . 0.432 ' HA ' ' HG3' ' A' ' 27' ' ' LYS . 0.7 OUTLIER -86.3 108.44 18.42 Favored 'General case' 0 C--N 1.302 -1.476 0 CA-C-O 122.638 1.209 . . . . 10.0 110.683 -179.545 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 29' ' ' PHE . . . . . 0.94 ' CE2' HD21 ' A' ' 160' ' ' LEU . 0.4 OUTLIER -117.8 113.65 22.11 Favored 'General case' 0 C--N 1.273 -2.721 0 CA-C-N 114.904 -1.044 . . . . 10.0 109.31 178.829 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 30' ' ' THR . . . . . 0.583 HG22 ' CE1' ' A' ' 28' ' ' PHE . 42.3 p -154.78 -61.94 0.12 Allowed 'General case' 0 C--N 1.286 -2.154 0 CA-C-N 115.483 -0.78 . . . . 10.0 109.78 -179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 31' ' ' GLY . . . . . 0.468 ' N ' ' OG1' ' B' ' 30' ' ' THR . . . -165.52 66.62 0.21 Allowed Glycine 0 N--CA 1.492 2.413 0 N-CA-C 108.611 -1.796 . . . . 10.0 108.611 179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 32' ' ' ILE . . . . . 0.572 ' HB ' ' HD2' ' B' ' 33' ' ' PRO . 11.2 pt -102.77 168.26 9.11 Favored Pre-proline 0 N--CA 1.496 1.835 0 O-C-N 121.349 -1.089 . . . . 10.0 110.947 -178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 33' ' ' PRO . . . . . 0.572 ' HD2' ' HB ' ' B' ' 32' ' ' ILE . 38.6 Cg_endo -65.42 178.12 2.27 Favored 'Trans proline' 0 C--N 1.311 -1.425 0 O-C-N 124.004 1.528 . . . . 10.0 110.256 179.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 34' ' ' GLU . . . . . 0.54 ' OE1' ' CA ' ' A' ' 12' ' ' GLY . 6.6 tp10 -36.56 160.26 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.861 0 CA-C-O 121.744 0.783 . . . . 10.0 111.89 -178.243 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 35' ' ' GLN . . . . . 0.48 ' HB2' ' HG1' ' A' ' 17' ' ' THR . 0.0 OUTLIER -72.63 -70.68 0.33 Allowed 'General case' 0 C--N 1.305 -1.341 0 O-C-N 121.583 -0.698 . . . . 10.0 112.768 -178.724 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 36' ' ' TRP . . . . . 0.653 ' O ' HD22 ' A' ' 70' ' ' LEU . 0.0 OUTLIER -141.27 22.44 2.21 Favored 'General case' 0 N--CA 1.498 1.965 0 O-C-N 120.985 -1.072 . . . . 10.0 110.101 -179.003 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 37' ' ' ALA . . . . . 0.667 ' HA ' HD22 ' A' ' 70' ' ' LEU . . . 178.96 99.7 0.02 OUTLIER 'General case' 0 C--N 1.294 -1.832 0 CA-C-O 121.817 0.818 . . . . 10.0 110.026 -178.712 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 38' ' ' ARG . . . . . 0.556 ' CG ' ' HB3' ' B' ' 41' ' ' GLN . 1.8 ttt180 -84.16 45.52 1.11 Allowed 'General case' 0 C--N 1.297 -1.708 0 N-CA-C 106.902 -1.518 . . . . 10.0 106.902 178.071 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 39' ' ' LEU . . . . . 0.605 ' HA ' ' HA ' ' A' ' 71' ' ' SER . 0.6 OUTLIER -50.63 -39.0 49.13 Favored 'General case' 0 C--N 1.294 -1.823 0 CA-C-N 114.981 -1.009 . . . . 10.0 112.081 -177.466 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 40' ' ' LEU . . . . . 0.865 HD13 ' CH2' ' A' ' 97' ' ' TRP . 1.8 pp -105.56 16.9 24.71 Favored 'General case' 0 N--CA 1.496 1.833 0 O-C-N 121.07 -1.019 . . . . 10.0 111.174 -178.775 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 41' ' ' GLN . . . . . 0.556 ' HB3' ' CG ' ' B' ' 38' ' ' ARG . 2.3 mt-30 -142.4 26.72 1.77 Allowed 'General case' 0 C--N 1.289 -2.052 0 O-C-N 121.425 -0.797 . . . . 10.0 110.545 179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 42' ' ' THR . . . . . 0.601 HG23 ' H ' ' B' ' 44' ' ' ASN . 11.4 t -121.81 -171.06 2.16 Favored 'General case' 0 N--CA 1.489 1.495 0 O-C-N 121.196 -0.94 . . . . 10.0 110.158 179.534 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 43' ' ' SER . . . . . . . . . . . . . 49.9 m -93.19 33.67 1.18 Allowed 'General case' 0 N--CA 1.492 1.667 0 O-C-N 121.082 -1.012 . . . . 10.0 110.76 -179.276 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 44' ' ' ASN . . . . . 0.601 ' H ' HG23 ' B' ' 42' ' ' THR . 64.3 t30 -51.81 -64.45 0.81 Allowed 'General case' 0 N--CA 1.492 1.635 0 O-C-N 121.294 -0.879 . . . . 10.0 110.385 179.834 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 45' ' ' ILE . . . . . . . . . . . . . 82.2 mt -109.98 -70.7 0.8 Allowed 'Isoleucine or valine' 0 N--CA 1.489 1.521 0 O-C-N 121.196 -0.94 . . . . 10.0 109.972 179.76 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.3 -1.558 0 CA-C-O 118.099 -0.953 . . . . 10.0 110.267 -179.763 . . . . . . . . 1 1 . 1 stop_ save_